PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Sato, T; Emi, K; Bando, H; Ikeda, T				Sato, Tatsuhiko; Emi, Kazuyuki; Bando, Hajime; Ikeda, Toshihide			Retrospective comparison of 25-gauge vitrectomy for repair of proliferative vitreoretinopathy with or without anterior proliferation	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Proliferative vitreoretinopathy; Anterior proliferative vitreoretinopathy; Retinal detachment; Vitrectomy; Microincision vitrectomy surgery; Hypotony; Silicone oil	INTERNAL LIMITING MEMBRANE; RETINAL-DETACHMENT; RELAXING RETINOTOMY; SILICONE OIL; RETINECTOMY; SURGERY; EYES; OUTCOMES; FAILURE; SYSTEM	The purpose of the study was to compare the outcomes of 25-gauge vitrectomy for the repair of rhegmatogenous retinal detachment (RRD) complicated by proliferative vitreoretinopathy (PVR) with and without anterior PVR (A-PVR). We reviewed the medical records of 26 eyes of 26 patients who underwent 25-gauge vitrectomy for grade C PVR with A-PVR and 16 eyes of 16 patients who underwent the same procedure for grade C PVR without A-PVR. The number of previous surgeries for RRD was significantly higher in A-PVR cases than in those without A-PVR (P = 0.021). Scleral buckling and retinotomy/retinectomy were performed significantly more frequently in A-PVR eyes than in those without A-PVR (P = 0.017 and < 0.001, respectively). The A-PVR eyes required longer surgical times than those without A-PVR (P =0.001). Final anatomical success was achieved in 24 of 26 (92.3 %) eyes with A-PVR and 16 of 16 (100 %) eyes without A-PVR (P =0.517). Best-corrected visual acuity before and six months after vitrectomy was 1.41 +/- 0.96 and 0.86 +/- 0.78 logarithm of minimal angle of resolution (logMAR) units, respectively, in eyes with A-PVR and 1.17 +/- 0.87 and 0.63 +/- 0.72 logMAR units, respectively, in eyes without A-PVR (P =0.355 and 0.276, respectively). These results indicate that 25-gauge vitrectomy can be used for both types of PVR, although eyes with A-PVR may require scleral buckling and retinotomy/retinectomy more often and may require longer surgical times.	[Sato, Tatsuhiko; Emi, Kazuyuki; Bando, Hajime; Ikeda, Toshihide] Osaka Rosai Hosp, Clin Res Ctr Occupat Sensory Organ Disabil, Kita Ku, Sakai, Osaka 5918025, Japan	Sato, T (reprint author), Osaka Rosai Hosp, Clin Res Ctr Occupat Sensory Organ Disabil, Kita Ku, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.	tatsusatou@gmail.com			Clinical Research Center for Occupational Sensory Organ Disability under the Ministry of Health, Labour and Welfare, Tokyo, Japan	This work was supported by the Clinical Research Center for Occupational Sensory Organ Disability under the auspices of the Ministry of Health, Labour and Welfare, Tokyo, Japan. The funding organization had no role in the design or conduct of this research.	de Silva DJ, 2008, BRIT J OPHTHALMOL, V92, P954, DOI 10.1136/bjo.2007.131540; Moysidis SN, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/815937; BLUMENKRANZ MS, 1993, AM J OPHTHALMOL, V116, P557; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1807, DOI 10.1016/S0161-6420(02)01179-X; Grover S, 1999, OPHTHALMOLOGY, V106, P1780, DOI 10.1016/S0161-6420(99)90342-1; Tan HS, 2010, AM J OPHTHALMOL, V149, P447, DOI 10.1016/j.ajo.2009.10.017; LEWIS H, 1991, AM J OPHTHALMOL, V111, P8; LEWIS H, 1991, AM J OPHTHALMOL, V111, P15; Grigoropoulos VG, 2007, GRAEF ARCH CLIN EXP, V245, P641, DOI 10.1007/s00417-006-0479-z; Recchia FM, 2010, OPHTHALMOLOGY, V117, P1851, DOI 10.1016/j.ophtha.2010.06.014; Diddie KR, 1996, OPHTHALMOLOGY, V103, P1092; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159; Kadonosono K, 2000, ARCH OPHTHALMOL-CHIC, V118, P1116; Diniz B, 2013, OPHTHALMOLOGICA, V229, P15, DOI 10.1159/000343073; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; BARR CC, 1993, OPHTHALMOLOGY, V100, P1629; Quiram PA, 2006, OPHTHALMOLOGY, V113, P2041, DOI 10.1016/j.ophtha.2006.05.039; Tseng JJ, 2005, AM J OPHTHALMOL, V140, P628, DOI 10.1016/j.ajo.2005.04.021; LEWIS H, 1988, AM J OPHTHALMOL, V105, P277; Aras C, 2009, GRAEF ARCH CLIN EXP, V247, P619, DOI 10.1007/s00417-008-1025-y; Bamonte G, 2011, AM J OPHTHALMOL, V151, P156, DOI 10.1016/j.ajo.2010.06.042; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Iwahashi-Shima Chiharu, 2013, Clin Ophthalmol, V7, P2043, DOI 10.2147/OPTH.S52260; Odrobina D, 2012, RETINA-J RET VIT DIS, V32, P226, DOI 10.1097/IAE.0b013e31821a12e9; Sato Tatsuhiko, 2011, Nippon Ganka Gakkai Zasshi, V115, P832; Sato T, 2008, RETINA-J RET VIT DIS, V28, P749, DOI 10.1097/IAE.0b013e3181631907; Sato Tatsuhiko, 2012, Nippon Ganka Gakkai Zasshi, V116, P100; Tseng JJ, 2009, AM J OPHTHALMOL, V147, P875, DOI 10.1016/j.ajo.2008.10.021; Tsui I, 2009, BRIT J OPHTHALMOL, V93, P1228, DOI 10.1136/bjo.2008.140988	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	DEC	2014	252	12					1895	1902		10.1007/s00417-014-2846-5		8	Ophthalmology	Ophthalmology	AU4NW	WOS:000345589300004		
J	Komori, S; Ishida, K; Yamamoto, T				Komori, Shinya; Ishida, Kyoko; Yamamoto, Tetsuya			Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Long-term; Normal tension glaucoma; Medical therapy; Visual field progression; Risk factor	VISUAL-FIELD PROGRESSION; OPTIC DISC HEMORRHAGES; INTRAOCULAR-PRESSURE FLUCTUATION; RISK-FACTORS; PROGNOSTIC-SIGNIFICANCE; OCULAR HYPERTENSION; OPEN-ANGLE; DAMAGE; REDUCTION; TIMOLOL	To conduct a a parts per thousand yen15-year follow-up assessment of the visual field (VF) in normal-tension glaucoma (NTG) patients receiving medical therapy and to identify risk factors for VF progression. A retrospective clinical study. Medical records of 78 eyes of 78 NTG patients monitored for a parts per thousand yen15 years were reviewed. VF progression was defined by a mean deviation (MD) deteriorated twice by 3.00 dB from baseline (MD criterion) and an annual decrease in the MD slope exceeding -0.5 dB/year (MD slope criterion). Logistic regression analysis was employed to identify risk factors for VF progression. The mean follow-up period was 18.3 years. The average intraocular pressure (IOP) before treatment was 15.1 +/- 1.9 mmHg and the average treated IOP was 13.5 +/- 1.5 mmHg with 2.0 medications. Forty-two eyes (53.8%) showed VF progression using the MD criterion and 15 eyes (19.2%) showed a negative MD slope less than -0.5 dB/year. Disc hemorrhage (DH) was observed in 30 eyes (38.5%). The mean VF progression rate was -0.38 +/- 0.30 dB/year in the DH group and -0.24 +/- 0.28 dB/year in the non-DH group (P = 0.012). Multiple logistic regression analysis identified DH [relative risk (RR) 4.28; P = 0.028] as a risk factor for VF progression using the MD criterion. DH (RR 8.77; P = 0.007) and IOP fluctuation during follow-up (RR 5.03; P = 0.048) were detected as risk factors using the MD slope criterion. DH and IOP fluctuation were associated with VF progression in NTG during long-term therapy.	[Komori, Shinya; Ishida, Kyoko; Yamamoto, Tetsuya] Gifu Univ, Grad Sch Med, Dept Ophthalmol, Gifu 5011194, Japan; [Komori, Shinya] Gifu Prefectural Gen Med Ctr, Dept Ophthalmol, Gifu 5008717, Japan	Ishida, K (reprint author), Gifu Univ, Grad Sch Med, Dept Ophthalmol, 1-1 Yanagido, Gifu 5011194, Japan.	kyoko.ish@gmail.com					Ahrlich KG, 2010, INVEST OPHTH VIS SCI, V51, P1458, DOI 10.1167/iovs.09-3806; Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; Siegner SW, 1996, OPHTHALMOLOGY, V103, P1014; Tomita G, 2004, EYE, V18, P984, DOI 10.1038/sj.eye.6701373; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; Soares AS, 2004, OPHTHALMOLOGY, V111, P1653, DOI 10.1016/j.ophtha.2004.03.023; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Sakata R, 2013, J GLAUCOMA, V22, P250, DOI 10.1097/IJG.0b013e31823298fb; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Kim YD, 2010, EYE, V24, P567, DOI 10.1038/eye.2009.163; Medeiros FA, 2008, OPHTHALMOLOGY, V115, P934, DOI 10.1016/j.ophtha.2007.08.012; Broman AT, 2008, INVEST OPHTH VIS SCI, V49, P66, DOI 10.1167/iovs.07-0866; Hong S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1010, DOI 10.1001/archopht.125.8.1010; DRANCE SM, 1989, SURV OPHTHALMOL, V33, P331, DOI 10.1016/0039-6257(89)90010-6; Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; De Moraes CGV, 2009, INVEST OPHTH VIS SCI, V50, P4727, DOI 10.1167/iovs.09-3446; Nakagami T, 2006, JPN J OPHTHALMOL, V50, P38, DOI 10.1007/s10384-005-0273-1; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Daugeliene L, 1999, GRAEF ARCH CLIN EXP, V237, P105, DOI 10.1007/s004170050203; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Healey PR, 1998, OPHTHALMOLOGY, V105, P216, DOI 10.1016/S0161-6420(98)92704-X; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Kim M, 2013, ACTA OPHTHALMOL, V91, pE270, DOI 10.1111/aos.12082; Lee J, 2013, J GLAUCOMA, V22, P780, DOI 10.1097/IJG.0b013e3182595075; Sung KR, 2009, INVEST OPHTH VIS SCI, V50, P5266, DOI 10.1167/iovs.09-3716; Araie M, 2010, JPN J OPHTHALMOL, V54, P278, DOI 10.1007/s10384-010-0815-z; Araie M, 2012, ACTA OPHTHALMOL, V90, pe337; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Hsieh JW, 2010, J GLAUCOMA, V19, P483, DOI 10.1097/IJG.0b013e3181b6e5ea; Ishida K, 1998, J GLAUCOMA, V7, P372; Krakau CE, 1983, GLAUCOMA UPDATE 2, P71; Law SK, 2001, AM J OPHTHALMOL, V132, P411, DOI 10.1016/S0002-9394(01)01009-1; Ma Kyoung Tak, 2011, International Ophthalmology, V31, P355, DOI 10.1007/s10792-011-9463-7	38	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	DEC	2014	252	12					1963	1970		10.1007/s00417-014-2767-3		8	Ophthalmology	Ophthalmology	AU4NW	WOS:000345589300012		
J	Inada, N; Ishimori, A; Shoji, J				Inada, Noriko; Ishimori, Akiko; Shoji, Jun			CCL20/MIP-3 alpha mRNA expression in the conjunctival epithelium of normal individuals and patients with vernal keratoconjunctivitis	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Allergy; CCL20; Conjunctival epithelium; Impression cytology; Vernal keratoconjunctivitis	INFLAMMATORY PROTEIN 3-ALPHA; HUMAN B-CELLS; LYMPHOID-TISSUE; INTESTINAL EPITHELIUM; CCR6 EXPRESSION; DENDRITIC CELL; EYE DISEASE; T-CELLS; CCL20; ACTIVATION	CCL20, the single chemokine ligand for CCR6, contributes to recruiting CCR6-expressing memory B cells, memory T cells, Th17 cells and dendritic cells, and is involved in regulating immune responses, homeostasis, and inflammation in mucosal tissues. CCL20 messenger RNA (mRNA) expression was analyzed in the conjunctival epithelium in an in vivo study of patients with vernal keratoconjunctivitis (VKC group) and healthy volunteers (control group) using impression cytology. In vitro analysis of CCL20 mRNA was performed using cultured conjunctival epithelial cells (CECs). Real-time polymerase chain reaction was used to assess IL-8 and eotaxin-2 mRNA expression for comparison with CCL20 mRNA expression. In the control group, CCL20 mRNA expression was present in all conjunctival locations. However, CCL20 mRNA expression was significantly higher in the upper palpebral conjunctiva in the severe VKC group than in the mild VKC and control groups (p < 0.05, Steel test). In vitro stimulation of CECs with lipopolysaccharide (LPS) significantly increased CCL20 expression in a concentration-dependent manner that was significantly correlated with expression of IL-8 (p < 0.001, Spearman's rank correlation coefficient), but not eotaxin-2. We conclude that CCL 20 mRNA expression in the conjunctival epithelium plays a crucial role in regulating homeostasis at the ocular surface and in exacerbation of VKC.	[Inada, Noriko; Ishimori, Akiko; Shoji, Jun] Nihon Univ, Div Ophthalmol, Dept Visual Sci, Sch Med,Itabashi Ku, Tokyo 1738610, Japan	Inada, N (reprint author), Nihon Univ, Div Ophthalmol, Dept Visual Sci, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kamichou, Tokyo 1738610, Japan.	inada.noriko@nihon-u.ac.jp					Liao F, 1999, J IMMUNOL, V162, P186; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Sakimoto T, 2002, JPN J OPHTHALMOL, V46, P364, DOI 10.1016/S0021-5155(02)00503-8; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Liao F, 2002, J IMMUNOL, V168, P4871; Dohlman TH, 2013, INVEST OPHTH VIS SCI, V54, P4081, DOI 10.1167/iovs.12-11216; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Giuliano EA, 2002, GRAEF ARCH CLIN EXP, V240, P220, DOI 10.1007/s00417-002-0429-3; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Krzysiek R, 2000, BLOOD, V96, P2338; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-00950C; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Calonge M, 2005, CURR OPIN ALLERGY CL, V5, P441, DOI 10.1097/01.all.0000182545.75842.77; Fodor M, 2006, OPHTHALMIC RES, V38, P182, DOI 10.1159/000093068; Francis JN, 2008, CLIN EXP IMMUNOL, V152, P440, DOI 10.1111/j.1365-2249.2008.03657.x; Gamache DA, 1997, OCUL IMMUNOL INFLAMM, V5, P117; Hingorani M, 1998, EXP EYE RES, V67, P491, DOI 10.1006/exer.1998.0528; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Metz DP, 1996, J ALLERGY CLIN IMMUN, V98, P686, DOI 10.1016/S0091-6749(96)70103-3; Shoji J, 1998, JPN J OPHTHALMOL, V42, P1, DOI 10.1016/S0021-5155(97)00100-7; Shoji J, 2009, JPN J OPHTHALMOL, V53, P92, DOI 10.1007/s10384-008-0628-5; Shoji Jun, 2009, Allergology International, V58, P591, DOI 10.2332/allergolint.09-OA-0100; Takamura Etsuko, 2011, Allergology International, V60, P191, DOI 10.2332/allergolint.11-RAI-0335; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Venza I, 2007, INVEST OPHTH VIS SCI, V48, P270, DOI 10.1167/iovs.06-0081; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	DEC	2014	252	12					1977	1984		10.1007/s00417-014-2785-1		8	Ophthalmology	Ophthalmology	AU4NW	WOS:000345589300014		
J	Hata, M; Kaneko, A; Tomita, N; Inoue, T				Hata, Masaharu; Kaneko, Akihiro; Tomita, Naoto; Inoue, Tomio			Severe retinopathy following radiation therapy with a moderate dose for orbital mucosa-associated lymphoid tissue lymphoma	HEMATOLOGICAL ONCOLOGY			English	Article						mucosa-associated lymphoid tissue lymphoma; orbital lymphoma; radiation therapy; retinopathy; visual acuity	EFFICACY	Mucosa-associated lymphoid tissue (MALT) lymphoma is a radiosensitive malignancy. We report on a case of severe retinopathy following radiation therapy with a moderate dose for orbital MALT lymphoma. A 69-year-old woman with orbital MALT lymphoma received definitive radiation therapy with a total dose of 36 Gy in 18 fractions. The patient showed complete response but had severe retinopathy along with marked deterioration in visual acuity at 2 years after irradiation. Although the patient underwent treatments for retinopathy, including laser photocoagulation and steroid injection, improvement of the visual acuity was modest. This case developed severe radiation-induced retinopathy after radiation therapy with the moderate dose of 36 Gy that is considered to be usually safe. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Hata, Masaharu; Inoue, Tomio] Yokohama City Univ, Grad Sch Med, Dept Radiol, Yokohama, Kanagawa 232, Japan; [Kaneko, Akihiro] Yokohama City Univ, Grad Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan; [Tomita, Naoto] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan	Hata, M (reprint author), Yokohama City Univ, Grad Sch Med, Dept Radiol, Yokohama, Kanagawa 232, Japan.	mhata@syd.odn.ne.jp					Hata M, 2011, INT J RADIAT ONCOL, V81, P1387, DOI 10.1016/j.ijrobp.2010.07.1992; Woolf DK, 2012, CLIN ONCOL-UK, V24, P339, DOI 10.1016/j.clon.2012.03.001; Kaushik M, 2012, INT J RADIAT ONCOL, V84, P1145, DOI 10.1016/j.ijrobp.2011.12.097; Shields JA, 2004, OPHTHALMOLOGY, V111, P997, DOI 10.1016/j.orphtha.2003.01.002; Monroe AT, 2005, INT J RADIAT ONCOL, V61, P856, DOI 10.1016/j.ijrobp.2004.07.664; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109; Finger PT, 2008, INT J RADIAT ONCOL, V70, P974, DOI 10.1016/j.ijrobp.2007.11.045; Fung CY, 2003, INT J RADIAT ONCOL, V57, P1382, DOI 10.1016/S0360-3016(03)00767-3; Goda JS, 2011, INT J RADIAT ONCOL, V81, pE659, DOI 10.1016/j.ijrobp.2011.03.050; Jeganathan VSE, 2011, INT J RADIAT ONCOL, V79, P650, DOI 10.1016/j.ijrobp.2010.09.056; Nams H, 2009, RADIOTHER ONCOL, V90, P236; Pfeffer MR, 2004, INT J RADIAT ONCOL, V60, P527, DOI 10.1016/j.ijrobp.2004.03.039; Suhs CO, 2006, INT J RADIAT ONCOL, V65, P228; Tanimoto K, 2007, JPN J CLIN ONCOL, V37, P337, DOI 10.1093/jjco/hym031; Tran KH, 2013, LEUKEMIA LYMPHOMA, V54, P491, DOI 10.3109/10428194.2012.717279; Unos T, 2003, CANCER, V98, P865; Zhou P, 2005, INT J RADIAT ONCOL, V63, P866, DOI 10.1016/j.ijrobp.2005.03.005	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-0232	1099-1069		HEMATOL ONCOL	Hematol. Oncol.	DEC	2014	32	4					212	214		10.1002/hon.2124		3	Oncology; Hematology	Oncology; Hematology	AU9LL	WOS:000345914200007		
J	Lee, SE; Kang, SY; Takeuchi, K; Ko, YH				Lee, Seung Eun; Kang, So Young; Takeuchi, Kengo; Ko, Young Hyeh			Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma	HEMATOLOGICAL ONCOLOGY			English	Letter							POSSIBLE THERAPEUTIC TARGET; STAT3; TRANSLOCATION; SEC31A-ALK; SQSTM1-ALK; PROVIDES; KINASE		[Lee, Seung Eun; Kang, So Young; Ko, Young Hyeh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan	Lee, SE (reprint author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	yhko310@skku.edu					Takeuchi K, 2011, HAEMATOL-HEMATOL J, V96, P464, DOI 10.3324/haematol.2010.033514; Onciu M, 2003, BLOOD, V102, P2642, DOI 10.1182/blood-2003-04-1095; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Adam P, 2003, AM J SURG PATHOL, V27, P1473, DOI 10.1097/00000478-200311000-00012; Delsol G, 1997, BLOOD, V89, P1483; Bedwell C, 2011, HAEMATOL-HEMATOL J, V96, P343, DOI 10.3324/haematol.2010.031484; d'Amore ESG, 2013, AM J SURG PATHOL, V37, P780, DOI 10.1097/PAS.0b013e318287791f; Delasols G, 2008, WHO CLASSIFICATION T, P254; Lees HW, 2008, HEMATOL ONCOL, V26, P108; Mas Z, 2003, GENE CHROMOSOME CANC, V37, P98; Momose S, 2009, HUM PATHOL, V40, P75, DOI 10.1016/j.humpath.2008.06.009; Van Roosbroeck K, 2010, HAEMATOL-HEMATOL J, V95, P509, DOI 10.3324/haematol.2009.014761	13	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-0232	1099-1069		HEMATOL ONCOL	Hematol. Oncol.	DEC	2014	32	4					221	224		10.1002/hon.2125		4	Oncology; Hematology	Oncology; Hematology	AU9LL	WOS:000345914200010		
J	Koizumi, M; Sata, N; Kaneda, Y; Endo, K; Sasanuma, H; Sakuma, Y; Ota, M; Lefor, AT; Yasuda, Y				Koizumi, M.; Sata, N.; Kaneda, Y.; Endo, K.; Sasanuma, H.; Sakuma, Y.; Ota, M.; Lefor, A. T.; Yasuda, Y.			Optimal timeline for emergency surgery in patients with strangulated groin hernias	HERNIA			English	Article						Inguinal hernia; Femoral hernia; Strangulated hernia; Emergency operation; Postoperative complications; Timeline		This retrospective study evaluates the clinical course and outcomes of patients who underwent surgery for strangulated hernias. Among 520 groin hernias from 2001 to 2012, 51 inguinal and 42 femoral hernias were strangulated and operated emergently at a tertiary referral center. Perioperative factors, patient profiles, and time interval to surgery (T (total) = time from onset to surgery, T (1) = time from onset to initial evaluation, T (2) = time from the first hospital to the tertiary center, T (3) = time from admission at the tertiary center to surgery, T (total) = T (1) + T (2) + T (3)) were analyzed in patients with strangulation, then compared between two groups, the bowel resection (BR) group and the non-bowel resection (NBR) group. T (1), T (2) and T (total) in the bowel resection group were significantly longer than those in the non-bowel resection group (P < 0.05). Patients who presented initially to the tertiary center (T (2) = 0) had a significantly lower resection rate than patients transported from other hospitals (24 vs. 44 %, P = 0.048). There was no significant difference in morbidity between the BR and NBR groups (35 vs. 24 %, P = 0.231). The elapsed time from onset to surgery, especially T (1) and T (2), is the most important prognostic factor in patients with strangulated groin hernias. Early diagnosis and transportation are essential for good outcomes.	[Koizumi, M.; Sata, N.; Kaneda, Y.; Endo, K.; Sasanuma, H.; Sakuma, Y.; Ota, M.; Lefor, A. T.; Yasuda, Y.] Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Tochigi 3290498, Japan	Koizumi, M (reprint author), Jichi Med Univ, Sch Med, Dept Surg, Yakushiji 3311-1, Shimotsuke, Tochigi 3290498, Japan.	mkoizumi@jichi.ac.jp		Lefor, Alan/0000-0001-6673-5630			Alvarez J A, 2004, Hernia, V8, P121, DOI 10.1007/s10029-003-0186-1; ANDREWS NJ, 1981, BRIT J SURG, V68, P329, DOI 10.1002/bjs.1800680513; Primatesta P, 1996, INT J EPIDEMIOL, V25, P835, DOI 10.1093/ije/25.4.835; Tanaka N, 2010, SURG TODAY, V40, P1144, DOI 10.1007/s00595-009-4193-4; Kulah B, 2001, AM J SURG, V181, P101, DOI 10.1016/S0002-9610(00)00563-8; Kulah B, 2001, AM J SURG, V182, P455, DOI 10.1016/S0002-9610(01)00765-6; Rai S, 1998, AUST NZ J SURG, V68, P650, DOI 10.1111/j.1445-2197.1998.tb04837.x; Smith M, 1999, WASHINGTON MANUAL SU, P216	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	DEC	2014	18	6					845	848		10.1007/s10029-014-1219-7		4	Surgery	Surgery	AU6GO	WOS:000345702100011		
J	Murata, S; Yamazaki, M; Kosugi, C; Hirano, A; Yoshimura, Y; Shiragami, R; Suzuki, M; Shuto, K; Koda, K				Murata, S.; Yamazaki, M.; Kosugi, C.; Hirano, A.; Yoshimura, Y.; Shiragami, R.; Suzuki, M.; Shuto, K.; Koda, K.			Hiatal hernia following total gastrectomy with Roux-en-Y reconstruction	HERNIA			English	Article						Hiatus; Hernias; Total gastrectomy; Complications; Thoracotomy	DIAPHRAGMATIC HERNIATION; ESOPHAGECTOMY	Hiatal hernias after total gastrectomy for advanced gastric cancer are very rare. We review a case of a 44-year-old male who presented with dyspnea and chest pain 2 days after total gastrectomy, lower esophagectomy, and splenectomy with retrocolic Roux-en-Y reconstruction approached by a left thoracoabdominal incision for gastric cancer at the cardia. Plain and cross-sectional imaging identified a large hiatal hernia protruding into the right thorax containing left-sided transverse colon and small intestine. Our patient underwent a laparotomy, and after hernia reduction the hiatal defect was repaired by direct suturing. He experienced anastomotic leakage and right pyothorax, but recovered. The potential cause is discussed here and the published literature on this rare complication is reviewed briefly.	[Murata, S.; Yamazaki, M.; Kosugi, C.; Hirano, A.; Yoshimura, Y.; Shiragami, R.; Suzuki, M.; Shuto, K.; Koda, K.] Teikyo Univ, Dept Surg, Chiba Med Ctr, Ichihara, Chiba 2990111, Japan	Murata, S (reprint author), Teikyo Univ, Dept Surg, Chiba Med Ctr, 3426-3 Anesaki, Ichihara, Chiba 2990111, Japan.	soichiromurata@live.jp					Aly A, 2004, DIS ESOPHAGUS, V17, P183, DOI 10.1111/j.1442-2050.2004.00399.x; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Balazs Akos, 1997, Orvosi Hetilap, V138, P2535; Bedda S, 2006, ANN CHIR, V131, P45, DOI 10.1016/j.anchir.2005.06.010; Choi YU, 2001, AM SURGEON, V67, P30; Hamaloglu E, 2002, DIS ESOPHAGUS, V15, P186, DOI 10.1046/j.1442-2050.2002.00233.x; Larkin J O, 2011, Ann R Coll Surg Engl, V93, pe71, DOI 10.1308/147870811X590333; Miyagaki H, 2012, WORLD J SURG, V36, P851, DOI 10.1007/s00268-012-1479-2; Price TN, 2011, ANN THORAC SURG, V92, P2041, DOI 10.1016/j.athoracsur.2011.08.013; Suh Youngjin, 2012, J Gastric Cancer, V12, P49, DOI 10.5230/jgc.2012.12.1.49; Takayama T, 2011, SURG TODAY, V41, P1298, DOI 10.1007/s00595-010-4501-z; van Sandick JW, 1999, BRIT J SURG, V86, P109	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	DEC	2014	18	6					889	891		10.1007/s10029-013-1142-3		3	Surgery	Surgery	AU6GO	WOS:000345702100017		
J	Kivio, M; Holappa, L; Yoshikawa, T; Tanaka, T				Kivio, Miia; Holappa, Lauri; Yoshikawa, Takeshi; Tanaka, Toshihiro			Interfacial Phenomena in Fe/Stainless Steel-TiC Systems and the Effect of Mo	HIGH TEMPERATURE MATERIALS AND PROCESSES			English	Article						titanium carbide; molybdenum; stainless steel reinforcement; interfacial phenomena; wetting	NANOMETER-SIZED CARBIDES; MECHANICAL-PROPERTIES; CEMENTED CARBIDES; TOOL STEEL; CERMETS; MICROSTRUCTURE; PRECIPITATION; PARTICLES; NB	Titanium carbide is used as reinforcement particles in composites due to its hardness, wear resistance and stability. This work is a part of the study in which titanium carbides are formed in stainless steel castings in the mold to improve the wear resistance of a certain surface of the casting. Such local reinforcement is a very potential method but it is a quite demanding task requiring profound knowledge of interfacial phenomena in the system, wettability, stability, dissolution and precipitation of new phases in production of these materials. Good wetting between different constituents in the material is a key factor to attain maximal positive effects. Mo is used with TiC or Ti(C,N) reinforcement in composites to improve wettability. In this work the effect of Mo on the phenomena in Fe/stainless steel-TiC systems was examined by wetting experiments between the substrate and the alloy. Wetting was not significantly improved by adding Mo to the systems. Core-rim type carbides as well as more homogenous carbide particles were observed. Overall the carbide particles are very complex regarding to their chemistry, size and shape which aspects have to be taken into account in the development of these materials and manufacturing processes.	[Kivio, Miia; Holappa, Lauri] Aalto Univ, Sch Chem Technol, Dept Mat Sci & Engn, Res Grp Met, Aalto 00076, Finland; [Yoshikawa, Takeshi] Univ Tokyo, Inst Ind Sci, Dept Mat & Environm Sci, Tokyo 1538505, Japan; [Tanaka, Toshihiro] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan	Kivio, M (reprint author), Aalto Univ, Sch Chem Technol, Dept Mat Sci & Engn, Res Grp Met, Aalto 00076, Finland.	miia.kivio@aalto.fi			Finnish Funding Agency for Technology and Innovation (TEKES)	The Finnish Funding Agency for Technology and Innovation (TEKES) is acknowledged for funding this study.	ANDREN HO, 1994, APPL SURF SCI, V76, P278, DOI 10.1016/0169-4332(94)90355-7; Jang JH, 2012, ACTA MATER, V60, P208, DOI 10.1016/j.actamat.2011.09.051; Funakawa Y, 2004, ISIJ INT, V44, P1945, DOI 10.2355/isijinternational.44.1945; Pardo A, 2007, ACTA MATER, V55, P2239, DOI 10.1016/j.actamat.2006.11.021; Mari D, 2003, INT J REFRACT MET H, V21, P37, DOI 10.1016/S0263-4368(03)00010-6; Chen LM, 2000, INT J REFRACT MET H, V18, P307, DOI 10.1016/S0263-4368(00)00041-X; Bourithis L, 2003, SURF COAT TECH, V165, P286, DOI 10.1016/S0257-8972(02)00744-2; Andren HO, 2001, MATER DESIGN, V22, P491, DOI 10.1016/S0261-3069(01)00006-1; Cardinal S, 2009, INT J REFRACT MET H, V27, P521, DOI 10.1016/j.ijrmhm.2008.10.006; Vallauri D, 2008, J EUR CERAM SOC, V28, P1697, DOI 10.1016/j.jeurceramsoc.2007.11.011; ZHANG SY, 1993, MAT SCI ENG A-STRUCT, V163, P141, DOI 10.1016/0921-5093(93)90588-6; Chen CY, 2009, MAT SCI ENG A-STRUCT, V499, P162, DOI 10.1016/j.msea.2007.11.110; Cedat D, 2009, J NUCL MATER, V385, P533, DOI 10.1016/j.jnucmat.2008.12.047; Cutard T, 1996, MAT SCI ENG A-STRUCT, V209, P218, DOI 10.1016/0921-5093(95)10100-4; Erauskin JI, 2009, ISIJ INT, V49, P582; Evtushenko AT, 2007, MET SCI HEAT TREAT+, V49, P200, DOI 10.1007/s11041-007-0036-3; Heikkinen H., 2009, THESIS HELSINKI U TE, P87; Hussainova I, 2003, WEAR, V255, P121, DOI 10.1016/S0043-1648(03)00198-4; Kivio M, 2012, HIGH TEMP MAT PR-ISR, V31, P645, DOI 10.1515/htmp-2012-0102; Kuzucu V, 1998, J MATER PROCESS TECH, V82, P165, DOI 10.1016/S0924-0136(98)00028-4; Liu N, 2006, J EUR CERAM SOC, V26, P3861, DOI 10.1016/j.jeurcramsoc.2005.12.010; Liu ZS, 1997, METALL MATER TRANS A, V28, P471, DOI 10.1007/s11661-997-0148-9; Park D. S., 1999, KOREAN J CERAM, V5, P230; Qian M, 1999, J MATER SCI, V34, P3677, DOI 10.1023/A:1004603422252; Samsonov G. V., 1972, POWDER METALL MET C, V11, P300; Samsonov G. V., 1968, POWDER METALL MET C, V7, P874; Tiusanen Jyri, 2009, Estonian Journal of Engineering, V15, DOI 10.3176/eng.2009.4.06; Zhuo S. Q., 2008, ACTA METALL SIN-ENGL, V31, P211	28	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-6455	2191-0324		HIGH TEMP MAT PR-ISR	High Temp. Mater. Process.	DEC	2014	33	6					571	584		10.1515/htmp-2013-0082		14	Materials Science, Multidisciplinary	Materials Science	AU9GF	WOS:000345899000011		
J	Koelkebeck, K; Miyata, J; Kubota, M; Kohl, W; Son, S; Fukuyama, H; Sawamoto, N; Takahashi, H; Murai, T				Koelkebeck, Katja; Miyata, Jun; Kubota, Manabu; Kohl, Waldemar; Son, Shuraku; Fukuyama, Hidenao; Sawamoto, Nobukatsu; Takahashi, Hidehiko; Murai, Toshiya			The Contribution of Cortical Thickness and Surface Area to Gray Matter Asymmetries in the Healthy Human Brain	HUMAN BRAIN MAPPING			English	Article						asymmetry; cortical thickness; cortical volume; lateralization; surface area	HUMAN CEREBRAL-CORTEX; ADULT HUMAN BRAIN; HEMISPHERIC ASYMMETRIES; ANTERIOR CINGULATE; PLANUM TEMPORALE; AUDITORY-CORTEX; SCHIZOPHRENIA; GYRUS; MORPHOMETRY; MORPHOLOGY	Human cortical gray matter (GM) is structurally asymmetrical and this asymmetry has been discussed to be partly responsible for functional lateralization of human cognition and behavior. Past studies on brain asymmetry have shown mixed results so far, with some studies focusing on the global shapes of the brain's surface, such as gyrification patterns, while others focused on regional brain volumes. In this study, we investigated cortical GM asymmetries in a large sample of right-handed healthy volunteers (n=101), using a surface-based method which allows to analyze brain cortical thickness and surface area separately. As a result, substantially different patterns of symmetry emerged between cortical thickness and surface area measures. In general, asymmetry is more prominent in the measure of surface compared to that of thickness. Such a detailed investigation of structural asymmetries in the normal brain contributes largely to our knowledge of normal brain development and also offers insights into the neurodevelopmental basis of psychiatric disorders, such as schizophrenia. Hum Brain Mapp 35:6011-6022, 2014. (c) 2014 Wiley Periodicals, Inc.	[Koelkebeck, Katja; Kohl, Waldemar] Univ Munster, Sch Med, Dept Psychiat & Psychotherapy, D-48149 Munster, Germany; [Miyata, Jun; Kubota, Manabu; Son, Shuraku; Takahashi, Hidehiko; Murai, Toshiya] Kyoto Univ, Grad Sch Med, Dept Neuropsychiat, Kyoto, Japan; [Fukuyama, Hidenao; Sawamoto, Nobukatsu] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Kyoto, Japan	Koelkebeck, K (reprint author), Univ Munster, Sch Med, Dept Psychiat & Psychotherapy, Albert Schweitzer Campus 1,Bldg A9, D-48149 Munster, Germany.	koelkebeck@uni-muenster.de	Koelkebeck, Katja/F-3977-2014		Japan Society for the Promotion of Science (JSPS) [PE 07550, BR100104]; German Research Foundation (DFG) [KO 4038/1-1, KO 4038/2-1]; School of Medicine of the University of Muenster [12-002]; JSPS [21890119, B 23791329]; Ministry of Education, Culture, Sports, Science and Technology, Japan [B 23390290, S 22220003]; Research on Innovative Areas [23118004]; Research Group for Schizophrenia - Astellas Pharma Inc	Contract grant sponsor: Japan Society for the Promotion of Science (JSPS); Contract grant numbers: PE 07550; BR100104 (to K.K.); Contract grant sponsor: German Research Foundation (DFG); Contract grant numbers: KO 4038/1-1; KO 4038/2-1 (to K.K.); Contract grant sponsor: School of Medicine of the University of Muenster; Contract grant number: 12-002; Contract grant sponsor: JSPS; Contract grant numbers: 21890119; B 23791329 (to J.M.); Contract grant sponsor: Ministry of Education, Culture, Sports, Science and Technology, Japan; Contract grant numbers: B 23390290; S 22220003 (to T.M.); Contract grant sponsor: Research on Innovative Areas; Contract grant number: 23118004 (to T.M.); Contract grant sponsor: Research Group for Schizophrenia sponsored by Astellas Pharma Inc	Crespo-Facorro B, 2011, PROG NEURO-PSYCHOPH, V35, P616, DOI 10.1016/j.pnpbp.2011.01.005; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Luders E, 2006, CEREB CORTEX, V16, P1232, DOI 10.1093/cercor/bhj064; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Wang L, 2007, SCHIZOPHR RES, V93, P66, DOI 10.1016/j.schres.2007.02.021; Cykowski MD, 2008, CEREB CORTEX, V18, P1999, DOI 10.1093/cercor/bhm224; Tanaka C, 2012, DEV NEUROSCI-BASEL, V34, P477, DOI 10.1159/000345152; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cykowski MD, 2008, CEREB CORTEX, V18, P571, DOI 10.1093/cercor/bhm093; Uylings HBM, 2006, CORTEX, V42, P652, DOI 10.1016/S0010-9452(08)70401-5; Crow TJ, 1998, SCHIZOPHR RES, V30, P111, DOI 10.1016/S0920-9964(97)00139-4; Seldon HL, 2005, LATERALITY, V10, P81, DOI 10.1080/13576500342000310; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Kovalev VA, 2003, NEUROIMAGE, V19, P895, DOI 10.1016/S1053-81196(03)00140-X; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Chee MWL, 2011, J COGNITIVE NEUROSCI, V23, P1065, DOI 10.1162/jocn.2010.21513; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; YEO RA, 1987, BRAIN COGNITION, V6, P15, DOI 10.1016/0278-2626(87)90043-1; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Ecker C, 2013, JAMA PSYCHIAT, V70, P59, DOI 10.1001/jamapsychiatry.2013.265; Greve DN, 2013, J COGNITIVE NEUROSCI, V25, P1477, DOI 10.1162/jocn_a_00405; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Lyttelton OC, 2009, NEUROIMAGE, V46, P895, DOI 10.1016/j.neuroimage.2009.03.063; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Paus T, 1996, J COMP NEUROL, V376, P664, DOI 10.1002/(SICI)1096-9861(19961223)376:4<664::AID-CNE12>3.0.CO;2-M; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Oertel-Knochel V, 2013, SCHIZOPHR RES, V147, P331, DOI 10.1016/j.schres.2013.04.024; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Metzler-Baddeley C, 2012, J NEUROSCI, V32, P17612, DOI 10.1523/JNEUROSCI.3299-12.2012; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; BILDER RM, 1994, AM J PSYCHIAT, V151, P1437; Blackmon K, 2010, NEUROIMAGE, V51, P1453, DOI 10.1016/j.neuroimage.2010.03.028; CAMPAIN R, 1976, BRAIN LANG, V3, P318, DOI 10.1016/0093-934X(76)90026-2; DEUTSCH D, 1985, MUSIC PERCEPT, V3, P127; Eckert MA, 2008, NEUROIMAGE, V41, P813, DOI 10.1016/j.neuroimage.2008.03.002; Eckert MA, 2006, BRAIN LANG, V98, P102, DOI 10.1016/j.bandl.2006.04.002; VanEssen DC, 1997, NATURE, V385, P313; First M. B., 2002, STRUCTURED CLIN INTE; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Fornito A, 2006, NEUROIMAGE, V33, P843, DOI 10.1016/j.neuroimage.2006.06.061; GESCHWIN.N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Goldberg E, 2011, CORTEX, V49, P200; Hammers A, 2007, HUM BRAIN MAPP, V28, P34, DOI 10.1002/hbm.20254; Hutsler JJ, 1998, CEREB CORTEX, V8, P11; Kang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045582; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Meyer M, CORTEX; Pujol J, 2002, NEUROIMAGE, V17, P670, DOI 10.1106/nimg.2002.1203; Sisodiya S, 1996, J ANAT, V188, P425; Sisodiya SM, 1997, BRAIN, V120, P271, DOI 10.1093/brain/120.2.271; Wechsler D., 1981, MANUAL WECHSLER ADUL; Sequeira SD, 2006, NEUROPSYCHOLOGIA, V44, P622, DOI 10.1016/j.neuropsychologia.2005.06.014; Zhou DM, 2013, NEUROIMAGE, V83, P66, DOI 10.1016/j.neuroimage.2013.06.073	61	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	DEC	2014	35	12					6011	6022		10.1002/hbm.22601		12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS6WA	WOS:000344398900021		
J	Nomura, R; Saito, T; Mitomi, H; Hidaka, Y; Lee, SY; Watanabe, S; Yao, T				Nomura, Ryosuke; Saito, Tsuyoshi; Mitomi, Hiroyuki; Hidaka, Yasuhiro; Lee, Se-yong; Watanabe, Sumio; Yao, Takashi			GNAS mutation as an alternative mechanism of activation of the Wnt/beta-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type	HUMAN PATHOLOGY			English	Article						Gastric adenocarcinoma of the fundic gland type; CTNNB1; AXIN; APC; GNAS; KRAS; Mutation	CHIEF CELL-DIFFERENTIATION; POLYPOSIS-COLI GENE; ADENOMATOUS POLYPOSIS; PREDOMINANT TYPE; FREQUENT GNAS; NEOPLASMS; DYSPLASIA; PANCREAS; PROPOSAL; TUMORS	Gastric adenocarcinoma of the fundic gland type (GAFG) is a rare variant of gastric tumor. We have recently reported the frequent accumulation of beta-catenin in GAFGs and showed that approximately half of the cases studied harbored at least 1 mutation in CTNNB1/AXINs/APC, leading to the constitutive activation of the Wnt/beta-catenin pathway. However, the mechanisms of Wnt signaling activation in the remaining cases are unknown. Accumulating evidence showed that the activating mutation in GNAS promotes tumorigenesis via the activation of the Wnt/beta-catenin pathway or the ERK1/2 MAPK pathway. Therefore, we analyzed the mutations in GNAS (exons 8 and 9) and in KRAS (exon 2) in 26 GAFGs. Immunohistochemistry revealed nuclear beta-catenin expression in 22 of 26 GAFGs, and 10 (38.5%) of 26 cases harbored at least 1 mutation in CTNNB1/AXINs/APC. Activating mutations in GNAS were found in 5 (19.2%) of 26 GAFGs, all of which harbored R201C mutations. Activating mutations in KRAS were found in 2 (7.7%) of 26 GAFGs, and both of these also contained GNAS activating mutations. Four of 5 cases with GNAS mutation showed nuclear beta-catenin expression, and presence of GNAS mutation was associated with beta-catenin nuclear expression (P = .01). Furthermore, 3 of these 4 cases did not harbor mutations in CTNNB1, APC, or AXINs, suggesting that mutations in the Wnt component genes and those in GNAS occur almost exclusively. These results suggest that GNAS mutation might occur in a small subset of GAFG as an alternative mechanism of activating the Wnt/beta-catenin signaling pathway. (C) 2014 Elsevier Inc.All rights reserved.	[Nomura, Ryosuke; Saito, Tsuyoshi; Hidaka, Yasuhiro; Lee, Se-yong; Yao, Takashi] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 1138421, Japan; [Nomura, Ryosuke; Hidaka, Yasuhiro; Lee, Se-yong; Watanabe, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 1138421, Japan; [Mitomi, Hiroyuki] Dokkyo Univ, Dept Surg & Mol Pathol, Sch Med, Mibu, Tochigi 3210293, Japan	Saito, T (reprint author), Juntendo Univ, Sch Med, Dept Human Pathol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tysaitou@juntendo.ac.jp			Ministry of Education, Science, Sports, and Culture, Tokyo, Japan [26670286, 24590429, 26460428]	This work was supported, in part, by a Grant-in-Aid for General Scientific Research from the Ministry of Education, Science, Sports, and Culture (No. 26670286 to Tsuyoshi Saito, No. 24590429 to Hiroyuki Mitomi, and No. 26460428 to Takashi Yao), Tokyo, Japan.	Matsubara A, 2013, J PATHOL, V229, P579, DOI 10.1002/path.4153; Sekine S, 2002, VIRCHOWS ARCH, V440, P381, DOI 10.1007/s004280100527; Abraham SC, 2000, AM J PATHOL, V157, P747, DOI 10.1016/S0002-9440(10)64588-9; Singhi AD, 2012, AM J SURG PATHOL, V36, P1030, DOI 10.1097/PAS.0b013e31825033e7; Hidaka Y, 2013, HUM PATHOL, V44, P2438, DOI 10.1016/j.humpath.2013.06.002; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Abraham SC, 2002, AM J PATHOL, V161, P1735, DOI 10.1016/S0002-9440(10)64450-1; Amato E, 2014, J PATHOL, V233, P217, DOI 10.1002/path.4344; Kushima R, 2013, PATHOL INT, V63, P318, DOI 10.1111/pin.12070; Abraham SC, 2001, AM J PATHOL, V158, P1005, DOI 10.1016/S0002-9440(10)64047-3; Carter JM, 2014, AM J SURG PATHOL, V38, P402, DOI 10.1097/PAS.0000000000000144; Ueyama H, 2010, AM J SURG PATHOL, V34, P609, DOI 10.1097/PAS.0b013e3181d94d53; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Chen Wei-Chung, 2012, J Gastrointest Cancer, V43 Suppl 1, P262, DOI 10.1007/s12029-012-9416-z; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Jalving M, 2003, SCAND J GASTROENTERO, V38, P916, DOI 10.1080/00365520310005433; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Tsukamoto T, 2007, PATHOL INT, V57, P517, DOI 10.1111/j.1440-1827.2007.02134.x; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamada M, 2012, J PATHOL, V228, P113, DOI 10.1002/path.4012	22	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	DEC	2014	45	12					2488	2496		10.1016/j.humpath.2014.08.016		9	Pathology	Pathology	AW0AZ	WOS:000345954100016		
J	Nakayama, K; Kyo, S				Nakayama, Kentaro; Kyo, Satoru			PI3KCA in ovarian clear cell carcinoma-reply	HUMAN PATHOLOGY			English	Letter									[Nakayama, Kentaro; Kyo, Satoru] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan	Nakayama, K (reprint author), Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan.	kn88@med.shimane-u.ac.jp					Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Rahman M, 2012, HUM PATHOL, V43, P2197, DOI 10.1016/j.humpath.2012.03.011; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Aris A, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-2; Zannoni GF, 2014, HUM PATHOL IN PRESS, P45	6	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	DEC	2014	45	12					2515	2515		10.1016/j.humpath.2014.07.024		1	Pathology	Pathology	AW0AZ	WOS:000345954100023		
J	Senda, K; Hattori, S; Hishinuma, T; Kohda, T				Senda, Kei; Hattori, Suguru; Hishinuma, Toru; Kohda, Takehisa			Acceleration of Reinforcement Learning by Policy Evaluation Using Nonstationary Iterative Method	IEEE TRANSACTIONS ON CYBERNETICS			English	Article						Nonstationary iterative method; policy evaluation; policy iteration; reinforcement learning	LINEAR-SYSTEMS	Typical methods for solving reinforcement learning problems iterate two steps, policy evaluation and policy improvement. This paper proposes algorithms for the policy evaluation to improve learning efficiency. The proposed algorithms are based on the Krylov Subspace Method (KSM), which is a nonstationary iterative method. The algorithms based on KSM are tens to hundreds times more efficient than existing algorithms based on the stationary iterative methods. Algorithms based on KSM are far more efficient than they have been generally expected. This paper clarifies what makes algorithms based on KSM makes more efficient with numerical examples and theoretical discussions.	[Senda, Kei; Hattori, Suguru; Hishinuma, Toru; Kohda, Takehisa] Kyoto Univ, Dept Aeronaut & Astronaut, Kyoto 6158540, Japan	Senda, K (reprint author), Kyoto Univ, Dept Aeronaut & Astronaut, Kyoto 6158540, Japan.	senda@kuaero.kyoto-u.ac.jp					HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Xu X, 2007, IEEE T NEURAL NETWOR, V18, P973, DOI 10.1109/TNN.2007.899161; Bertsekas D. P., 1996, NEURODYNAMIC PROGRAM; Boyan JA, 2002, MACH LEARN, V49, P233, DOI 10.1023/A:1017936530646; Dutech A., 2005, P WORKSH ANN C NIPS; FLETCHER R., 1976, NUMERICAL ANAL DUNDE, P73; Fujii S., 2006, Transactions of the Society of Instrument and Control Engineers, V42; Hironaka H., 2009, GENDAI SUURI KAGAKU; Kelley C.T., 1995, ITERATIVE METHODS LI; Lagoudakis M. G., 2003, J MACHINE LEARNING R, V4, P1107, DOI DOI 10.1162/JMLR.2003.4.6.1107; Mahadevan S, 2007, J MACH LEARN RES, V8, P2169; Mori M., 1994, LINEAR CALCULATION; Natori M., 1987, NUMER ALGORITHMS, V613, P135; Powell W, 2007, APPROXIMATE DYNAMIC; Saad Y., 2003, ITERATIVE METHODS SP; Sutton R., 1998, REINFORCEMENT LEARNI; Szepesvari C., 2010, ALGORITHMS REINFORCE; VANDERVORST HA, 1992, SIAM J SCI STAT COMP, V13, P631, DOI 10.1137/0913035; Yamamoto T., 2010, FUNDAMENTALS MATRIX	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2267	2168-2275		IEEE T CYBERNETICS	IEEE T. Cybern.	DEC	2014	44	12					2696	2705		10.1109/TCYB.2014.2313655		10	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	AU5EC	WOS:000345629000037		
J	Zhao, XF; Nakagawa, T; Zuo, MJ				Zhao, Xufeng; Nakagawa, Toshio; Zuo, Ming J.			Optimal Replacement Last With Continuous and Discrete Policies	IEEE TRANSACTIONS ON RELIABILITY			English	Article						Replacement; minimal repair; replacement last; maintenance; working cycle	PREVENTIVE MAINTENANCE MODELS; 1ST	This paper proposes age and periodic replacement last models with continuous, and discrete policies. That is, an operating unit is replaced preventively at time of operation as a strategic policy, or at a number of working cycles to satisfy successive job completion, whichever occurs last. Such policies are named as replacement last, and their expected cost rates and optimal policies are obtained. However, the focus of this paper is to compare replacement last with replacement first policies, which are formulated under the classical assumption of whichever occurs first. From the points of cost and performability, different comparative methods for continuous and discrete optimizations are demonstrated to determine in what cases we should adopt replacement last rather than replacement first. All theoretical discussions in this paper are made analytically, and are computed numerically.	[Zhao, Xufeng] Aichi Inst Technol, Grad Sch Management & Informat Sci, Toyoa 4700392, Japan; [Zhao, Xufeng] Nanjing Tech Univ, Sch Econ & Management, Nanjing 211816, Jiangsu, Peoples R China; [Zhao, Xufeng] Qatar Univ, Dept Mech & Ind Engn, Doha 2713, Qatar; [Nakagawa, Toshio] Aichi Inst Technol, Grad Sch Management & Informat Sci, Toyota 4700392, Japan; [Zuo, Ming J.] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 2G8, Canada	Zhao, XF (reprint author), Aichi Inst Technol, Grad Sch Management & Informat Sci, Toyoa 4700392, Japan.	kyoku@aitech.ac.jp; toshi-nakagawa@aitech.ac.jp; ming.zuo@ualberta.ca	Zhao, Xufeng/D-6918-2014; 	Zhao, Xufeng/0000-0001-9851-9078; Zuo, Mingjian/0000-0002-8607-2923	National Natural Science Foundation of China [71371097]; Qatar National Research Fund [NPRP 09-774-2-297]; Natural Sciences and Engineering Research Council of Canada [104966-2010]	This work was supported in part by National Natural Science Foundation of China 71371097; Qatar National Research Fund under Grant No. NPRP 09-774-2-297; and Natural Sciences and Engineering Research Council of Canada under Grant No. 104966-2010.	Chen MC, 2010, IEICE T FUND ELECTR, VE93A, P500, DOI 10.1587/transfun.E93.A.500; Barlow R. E., 1965, MATH THEORY RELIABIL; Chen M., 2010, INT J RELIABILITY QU, V17, P27; HAERDER T, 1983, COMPUT SURV, V15, P287; Kobbacy KAH, 2008, SPRINGER SER RELIAB, P1; Kuo W., 2003, OPTIMAL RELIABILITY; Lewis M. L., 2002, DATABASES T PROCESSI; Manzini R, 2010, SPRINGER SER RELIAB, P1, DOI 10.1007/978-1-84882-575-8; Nakagawa T, 2008, SPRINGER SER RELIAB, P1; Nakagawa T., 2005, MAINTENANCE THEORY R; Nakagawa T, 2011, SPRINGER SER RELIAB, P1, DOI 10.1007/978-0-85729-274-2; Osaki S, 2002, STOCHASTIC MODELS RE; Reuter Andreas, 1992, T PROCESSING CONCEPT; Wang H., 2007, RELIABILITY OPTIMAL; Wu SM, 2005, RELIAB ENG SYST SAFE, V90, P99, DOI 10.1016/j.ress.2005.03.012; Zhao XF, 2015, INT J SYST SCI, V46, P1648, DOI 10.1080/00207721.2013.827263; Zhao X., 2013, J QUAL MAINT ENG, V19, P25; Zhao XF, 2013, RELIAB ENG SYST SAFE, V110, P50, DOI 10.1016/j.ress.2012.09.004; Zhao XF, 2012, EUR J OPER RES, V223, P141, DOI 10.1016/j.ejor.2012.05.035	19	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9529	1558-1721		IEEE T RELIAB	IEEE Trans. Reliab.	DEC	2014	63	4					868	880		10.1109/TR.2014.2337811		13	Computer Science, Hardware & Architecture; Computer Science, Software Engineering; Engineering, Electrical & Electronic	Computer Science; Engineering	AU9IA	WOS:000345904000005		
J	Das, BP; Onodera, H				Das, Bishnu Prasad; Onodera, Hidetoshi			Frequency-Independent Warning Detection Sequential for Dynamic Voltage and Frequency Scaling in ASICs	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						Dynamic voltage scaling (DVS); error detection sequential (EDS); resilient circuits; warning prediction sequential	LOW-POWER; VARIATION TOLERANCE; ERROR-DETECTION; COMPENSATION; PREDICTION; CIRCUITS	In this paper, a metastability immune warning flip-flop (FF) is proposed, which consists of an edge detector, a warning window generator, and a warning detector along with a traditional FF. The delayed data are monitored during the warning window to flag a warning signal before the data enter the erroneous zone. In this scheme, the warning window is independent of input clock frequency and hence is suitable for frequency scaling application. A 16-bit Kogge-stone adder is implemented in 65-nm technology, which uses warning FF for dynamic voltage and frequency scaling (DVFS). The warning FF-based DVFS allows elimination of safety margins and operates till the point of first warning of the adder without any erroneous results. The experiments were conducted with different supply voltages, phase-shifted clocks, and process conditions. The circuit is helpful to determine when to stop further reduction in supply voltage by producing the warning signal with predefined timing slacks in DVFS application. The test chip results demonstrate that the proposed circuit can track the critical path delay of 2.4-7.5 ns at warning voltage of 1.15-0.72 V, respectively. The measured results from 10 different chips show the effectiveness of the proposed concept across process variation.	[Das, Bishnu Prasad; Onodera, Hidetoshi] Kyoto Univ, Grad Sch Informat, Dept Commun & Comp Engn, Kyoto 6068501, Japan; [Onodera, Hidetoshi] Japan Sci & Technol, CREST, Tokyo, Japan	Das, BP (reprint author), Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA.	bishnu.iisc@gmail.com; onodera@i.kyoto-u.ac.jp					Agarwal M., 2008, P INT TEST C, P1; Alidash HK, 2010, LECT NOTES COMPUT SC, V5953, P256, DOI 10.1007/978-3-642-11802-9_30; Bull D, 2011, IEEE J SOLID-ST CIRC, V46, P18, DOI 10.1109/JSSC.2010.2079410; Das S, 2009, IEEE J SOLID-ST CIRC, V44, P32, DOI 10.1109/JSSC.2008.2007145; Blome J, 2007, INT SYMP MICROARCH, P109, DOI 10.1109/MICRO.2007.35; Das S, 2006, IEEE J SOLID-ST CIRC, V41, P792, DOI 10.1109/JSSC.2006.870912; Gutnik V, 1997, IEEE T VLSI SYST, V5, P425, DOI 10.1109/92.645069; Salman E, 2009, IEEE T VLSI SYST, V17, P1405, DOI 10.1109/TVLSI.2008.2003518; Bowman KA, 2009, IEEE J SOLID-ST CIRC, V44, P49, DOI 10.1109/JSSC.2008.2007148; [Anonymous], 2011, ALTER PLL USER GUIDE; Agarwal M, 2007, IEEE VLSI TEST SYMP, P277, DOI 10.1109/VTS.2007.22; Bowman KA, 2011, IEEE J SOLID-ST CIRC, V46, P194, DOI 10.1109/JSSC.2010.2089657; Baloch S., 2006, P 7 ISQED MAR, P330; Blaauw D., 2008, P INT SOL STAT CIRC, P400; Bowman K. A., 2008, P INT SOL STAT CIRC, P402; Das Bishnu Prasad, 2010, Proceedings of the 2010 25th IEEE International Symposium on Defect and Fault Tolerance in VLSI Systems (DFT 2010), DOI 10.1109/DFT.2010.52; Das BP, 2011, IEEE T SEMICONDUCT M, V24, P533, DOI 10.1109/TSM.2011.2163532; Dasdan A, 2006, ACM T DES AUTOMAT EL, V11, P306, DOI 10.1145/1142155.1142158; Fuketa H, 2009, IEEE CUST INTEGR CIR, P215; Hirose K, 2008, JPN J APPL PHYS, V47, P2779, DOI 10.1143/JJAP.47.2779; Kehl T., 1993, Proceedings 1993 IEEE International Conference on Computer Design: VLSI in Computers and Processors (Cat. No.93CH3335-7), DOI 10.1109/ICCD.1993.393383; Kunitake Y., 2011, P IEEE 54 MWSCAS AUG, P1; Liu QZ, 2010, IEEE T COMPUT AID D, V29, P211, DOI 10.1109/TCAD.2009.2035552; Meijer M, 2009, 2009 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, P110; Nakura T., 2007, P IEEE INT SOL STAT, P402; Nielsen L. S., 1994, IEEE Transactions on Very Large Scale Integration (VLSI) Systems, V2, DOI 10.1109/92.335008; Ogras UY, 2008, DES AUT CON, P614; Omana M., 2010, P 7 ACM INT C COMP F, P93, DOI 10.1145/1787275.1787299; Rebaud B, 2011, Microelectronics Journal, V42, DOI 10.1016/j.mejo.2011.02.005; Sato T., 2007, P INT S QUAL EL DES, P539; Shah N, 2008, INT SYM DEFEC FAU TO, P96, DOI 10.1109/DFT.2008.49; Tschanz J., 2007, P IEEE INT SOL STAT, P292; Wei GY, 1996, 1996 INTERNATIONAL SYMPOSIUM ON LOW POWER ELECTRONICS AND DESIGN - DIGEST OF TECHNICAL PAPERS, P313, DOI 10.1109/LPE.1996.547531	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	DEC	2014	22	12					2535	2548		10.1109/TVLSI.2013.2296033		14	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	AU4GR	WOS:000345568900008		
J	Karasuyama, H				Karasuyama, H.			Non-redundant roles for basophils in allergy and protective immunity	IMMUNOLOGY			English	Meeting Abstract									[Karasuyama, H.] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	DEC	2014	143			2	SI	88	3	3				1	Immunology	Immunology	AU6GT	WOS:000345702600005		
J	Whibley, N; Mamo, A; Coleman, B; Conti, H; Traggiai, E; Kolbinger, F; Vogel, B; Kammuller, M; Siebenlist, U; Iwakura, Y; Gaffen, S				Whibley, N.; Mamo, A.; Coleman, B.; Conti, H.; Traggiai, E.; Kolbinger, F.; Vogel, B.; Kammuller, M.; Siebenlist, U.; Iwakura, Y.; Gaffen, S.			Differential requirements of IL-17 family cytokines in anti-fungal immunity against oral candidiasis	IMMUNOLOGY			English	Meeting Abstract									[Whibley, N.; Mamo, A.; Coleman, B.; Conti, H.; Gaffen, S.] Univ Pittsburgh, Pittsburgh, PA USA; [Traggiai, E.; Kolbinger, F.; Vogel, B.; Kammuller, M.] Novartis Inst Biomed Res, Basel, Switzerland; [Siebenlist, U.] NIAID, NIH, Bethesda, MD 20892 USA; [Iwakura, Y.] Tokyo Univ Sci, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	DEC	2014	143			2	SI	433	86	86				1	Immunology	Immunology	AU6GT	WOS:000345702600232		
J	Goritzka, M; Durant, L; Pereira, C; Makris, S; Kausar, F; Kumagai, Y; Akira, S; Johansson, C				Goritzka, M.; Durant, L.; Pereira, C.; Makris, S.; Kausar, F.; Kumagai, Y.; Akira, S.; Johansson, C.			Alveolar macrophage-derived type I IFNs orchestrate immune responses to RSV through recruitment of antiviral monocytes	IMMUNOLOGY			English	Meeting Abstract									[Goritzka, M.; Durant, L.; Pereira, C.; Makris, S.; Kausar, F.; Johansson, C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Resp Infect, London, England; [Kumagai, Y.; Akira, S.] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan			Akira, Shizuo/C-3134-2009					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	DEC	2014	143			2	SI	516	104	104				1	Immunology	Immunology	AU6GT	WOS:000345702600294		
J	Sansom, DM; Schubert, D; Bode, C; Kenefeck, R; Hou, T; Wing, J; Kennedy, A; Unger, S; Bulashevska, A; Gruning, B; Petersen, B; Schaffer, A; Frede, N; Dueckers, G; Seneviratne, S; Kanariou, M; Rensing-Ehl, A; Salzer, U; Warnatz, K; Cathomen, T; Emmerich, F; Fisch, P; Rakhmanov, M; Franke, A; Sakaguchi, S; Walker, LS; Grimbacher, B				Sansom, D. M.; Schubert, D.; Bode, C.; Kenefeck, R.; Hou, T.; Wing, J.; Kennedy, A.; Unger, S.; Bulashevska, A.; Gruning, B.; Petersen, B.; Schaffer, A.; Frede, N.; Dueckers, G.; Seneviratne, S.; Kanariou, M.; Rensing-Ehl, A.; Salzer, U.; Warnatz, K.; Cathomen, T.; Emmerich, F.; Fisch, P.; Rakhmanov, M.; Franke, A.; Sakaguchi, S.; Walker, L. S.; Grimbacher, B.			Heterozygous mutations in CTLA-4 are associated with defective regulatory T-cell function, causing an immune dysregulation syndrome in humans	IMMUNOLOGY			English	Meeting Abstract									[Sansom, D. M.; Schubert, D.; Bode, C.; Kenefeck, R.; Hou, T.; Kennedy, A.; Kanariou, M.; Emmerich, F.; Fisch, P.; Walker, L. S.; Grimbacher, B.] UCL, Inst Immun & Transplantat, London, England; [Unger, S.; Bulashevska, A.; Frede, N.; Rensing-Ehl, A.; Salzer, U.; Warnatz, K.; Cathomen, T.; Rakhmanov, M.] Univ Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; Univ Freiberg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Wing, J.; Sakaguchi, S.] Osaka Univ, Dept Expt Immunol, Osaka, Japan; [Gruning, B.] Univ Freiberg, Dept Comp Sci, Freiburg, Germany; [Petersen, B.; Franke, A.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schaffer, A.] NIH, Bethesda, MD 20892 USA; [Dueckers, G.] Childrens Hosp Krefeld, Krefeld, Germany; [Seneviratne, S.] Royal Free Hosp, Dept Immunol, London NW3 2QG, England; AS Childrens Hosp, Dept Immunol & Histocompatibil, Athens, Greece; Univ Med Ctr, Dept Transfus Med, Freiburg, Germany; Univ Med Ctr, Dept Pathol, Freiburg, Germany			HOU, TIEZHENG/B-4848-2015					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	DEC	2014	143			2	SI	329	155	155				1	Immunology	Immunology	AU6GT	WOS:000345702600470		
J	Yamakami, T				Yamakami, Tomoyuki			One-way reversible and quantum finite automata with advice	INFORMATION AND COMPUTATION			English	Article						Reversible finite automaton; Quantum finite automaton; Regular language; Context-free language; Randomized advice; Quantum advice; Rewritable tape	TIME TURING-MACHINES; LINEAR-TIME	We examine the characteristic features of reversible and quantum computations in the presence of supplementary external information, known as advice. In particular, we present a simple, algebraic characterization of languages recognized by one-way reversible finite automata augmented with deterministic advice. With a further elaborate argument, we prove a similar but slightly weaker result for bounded-error one-way quantum finite automata with advice. Immediate applications of those properties lead to containments and separations among various language families when they are assisted by appropriately chosen advice. We further demonstrate the power and limitation of randomized advice and quantum advice when they are given to one-way quantum finite automata. (C) 2014 Elsevier Inc. All rights reserved.	Univ Fukui, Dept Informat Sci, Fukui 9108507, Japan	Yamakami, T (reprint author), Univ Fukui, Dept Informat Sci, 3-9-1 Bunkyo, Fukui 9108507, Japan.	TomoyukiYamakami@gmail.com					Aaronson S., 2005, THEORY COMPUTING, V1, P1, DOI 10.4086/toc.2005.v001a001; Ambainis A., 2001, LECT NOTES COMPUTER, V2010, P75; ANGLUIN D, 1982, J ACM, V29, P741, DOI 10.1145/322326.322334; Nishimura H, 2009, J COMPUT SYST SCI, V75, P255, DOI 10.1016/j.jcss.2008.12.001; Tadaki K, 2004, LECT NOTES COMPUT SC, V2932, P335; MICHEL P, 1991, THEOR COMPUT SCI, V85, P205, DOI 10.1016/0304-3975(91)90054-6; Moore C, 2000, THEOR COMPUT SCI, V237, P275, DOI 10.1016/S0304-3975(98)00191-1; Yamakami T, 2009, LECT NOTES COMPUT SC, V5878, P933, DOI 10.1007/978-3-642-10631-6_94; PIN JE, 1992, LECT NOTES COMPUT SC, V583, P401, DOI 10.1007/BFb0023844; Raz R, 2009, ALGORITHMICA, V55, P462, DOI 10.1007/s00453-007-9033-6; Nishimura H, 2004, INFORM PROCESS LETT, V90, P195, DOI 10.1016/j.ipl.2004.02.005; Yakaryilmaz A, 2012, NAT COMPUT, V11, P81, DOI 10.1007/s11047-011-9270-0; Nishimura H, 2005, LECT NOTES COMPUT SC, V3317, P225; Ambainis A, 2002, J ACM, V49, P496, DOI 10.1145/581771.581773; Ambainis A, 1998, ANN IEEE SYMP FOUND, P332; Yamakami T, 2014, INFORM PROCESS LETT, V114, P611, DOI 10.1016/j.ipl.2014.05.012; Brodsky A, 2002, SIAM J COMPUT, V31, P1456, DOI 10.1137/S0097539799353443; Damm C., 1995, LECT NOTES COMPUTER, V969, P149; Freivalds R, 2010, THEOR COMPUT SCI, V411, P3436, DOI 10.1016/j.tcs.2010.05.038; Freivalds R., 2012, LECT NOTES COMPUT SC, V7287, P537; Gruska J., 2000, QUANTUM COMPUTING; KARP R. M., 1982, ENSEIGNMENT MATH, V28, P191; Kondacs A, 1997, ANN IEEE SYMP FOUND, P66, DOI 10.1109/SFCS.1997.646094; Kucuk U., 2013, LECT NOTES COMPUT SC, V7907, P301; Nishimura H., 2014, THEOR COMPUT SCI; Paschen K., 2000, TECHNICAL REPORT; Yamakami T, 2011, THEOR COMPUT SCI, V412, P6432, DOI 10.1016/j.tcs.2011.07.013; Yamakami T., 2008, SWAPPING LEMMAS REGU; Yamakami T., 2009, PSEUDORANDOM GENERAT	29	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0890-5401	1090-2651		INFORM COMPUT	Inf. Comput.	DEC	2014	239						122	148		10.1016/j.ic.2014.10.003		27	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	AU5PE	WOS:000345658400010		
J	Fazekas, SZ; Manea, F; Mercas, R; Shikishima-Tsuji, K				Fazekas, Szilard Zsolt; Manea, Florin; Mercas, Robert; Shikishima-Tsuji, Kayoko			The pseudopalindromic completion of regular languages	INFORMATION AND COMPUTATION			English	Article						Pseudopalindromes; Pseudopalindromic completion; Pseudopalindromic iterated completion; Regular languages; Algorithms; Decidability	HAIRPIN COMPLETION; REDUCTION; WORDS	Pseudopalindromes are words that are fixed points for some antimorphic involution. In this paper we discuss a newer word operation, that of pseudopalindromic completion, in which symbols are added to either side of the word such that the new obtained words are pseudopalindromes. This notion represents a particular type of hairpin completion, where the length of the hairpin is at most one. We give precise descriptions of regular languages that are closed under this operation and show that the regularity of the closure under the operation is decidable. (C) 2014 Elsevier Inc. All rights reserved.	[Fazekas, Szilard Zsolt] Akita Univ, Dept Comp Sci & Engn, Akita 0108502, Japan; [Manea, Florin; Mercas, Robert] Univ Kiel, Dept Comp Sci, D-24098 Kiel, Germany; [Shikishima-Tsuji, Kayoko] Tenri Univ, Tenri, Nara 6328510, Japan	Mercas, R (reprint author), Univ Kiel, Dept Comp Sci, Olshaussenstr 40, D-24098 Kiel, Germany.	szilard.fazekas@gmail.com; flm@informatik.uni-kiel.de; rgm@informatik.uni-kiel.de; tsuji@sta.tenri-u.ac.jp		Fazekas, Szilard Zsolt/0000-0001-5319-0395			Manea F, 2009, THEOR COMPUT SCI, V410, P417, DOI 10.1016/j.tcs.2008.09.049; deLuca A, 1997, THEOR COMPUT SCI, V183, P45, DOI 10.1016/S0304-3975(96)00310-6; Cheptea D., 2006, TRANSGRESSIVE COMPUT, V2006, P216; de Luca A, 2006, THEOR COMPUT SCI, V362, P282, DOI 10.1016/j.tcs.2006.07.009; Diekert V, 2009, LECT NOTES COMPUT SC, V5684, P170, DOI 10.1007/978-3-642-03466-4_11; Fazekas S. Z., 2012, LECT NOTES COMPUT SC, V7410, P428; Gusfield D., 1997, ALGORITHMS STRINGS T; Harrison M. A., 1978, INTRO FORMAL LANGUAG; Holzer M., 2003, International Journal of Foundations of Computer Science, V14, DOI 10.1142/S0129054103002199; Horvath S., 1987, Journal of Information Processing and Cybernetics, V23; Ito M, 2011, INFORM COMPUT, V209, P471, DOI 10.1016/j.ic.2010.11.014; Kari L, 2012, LECT NOTES COMPUT SC, V7147, P337; Kari L, 2010, NAT COMPUT, V9, P297, DOI 10.1007/s11047-009-9131-2; Karkkainen J, 2006, J ACM, V53, P918, DOI 10.1145/1217856.1217858; Kopecki S, 2011, THEOR COMPUT SCI, V412, P3629, DOI 10.1016/j.tcs.2011.03.009; Lothaire M., 1997, COMBINATORICS WORDS; Mahalingam K., 2010, BIC TA IEEE, P1459; Manea F, 2010, LECT NOTES COMPUT SC, V6158, P296, DOI 10.1007/978-3-642-13962-8_33; Manea F, 2007, LECT NOTES COMPUT SC, V4497, P532; Manea F, 2010, INT J FOUND COMPUT S, V21, P859, DOI 10.1142/S0129054110007593; Paun G., 2001, International Journal of Foundations of Computer Science, V12, DOI 10.1142/S0129054101000904; Slama-Schwok A, 1998, NUCLEIC ACIDS RES, V26, P5142, DOI 10.1093/nar/26.22.5142	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0890-5401	1090-2651		INFORM COMPUT	Inf. Comput.	DEC	2014	239						222	236		10.1016/j.ic.2014.09.001		15	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	AU5PE	WOS:000345658400015		
J	Cai, ZS; Ren, M; Bao, SS; Hoshino, N; Akutagawa, T; Zheng, LM				Cai, Zhong-Sheng; Ren, Min; Bao, Song-Song; Hoshino, Norihisa; Akutagawa, Tomoyuki; Zheng, Li-Min			Synthetic-Method-Dependent Magnetic Relaxation in a Cobalt(II) Phosphonate Chain Compound	INORGANIC CHEMISTRY			English	Article							COORDINATION POLYMER; BEHAVIOR; SPIN; ANISOTROPY; NANOWIRES; MODEL; CO; TEMPERATURE; DYNAMICS; SYSTEMS	A polar cobalt(II) phosphonate Co(bamdpH(2))(H2O) (1) [bamdpH(4) = (benzylazanediyl)bis(methylene)diphosphonic acid] is reported. It shows a linear chain structure. The neighboring chains are connected by moderately strong hydrogen bonds forming a supramolecular layer. The interlayer spaces are filled with the organic groups of the phosphonate ligands. Compound 1 displays the coexistence of single-chain magnet behavior and canted antiferromagnetism below 2.8 K. Moreover, the magnetic dynamics is strongly dependent on the synthetic methods, a phenomenon that has not been documented before.	[Cai, Zhong-Sheng; Ren, Min; Bao, Song-Song; Zheng, Li-Min] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Hoshino, Norihisa; Akutagawa, Tomoyuki] Tohoku Univ, IMRAM, Sendai, Miyagi 9808577, Japan	Zheng, LM (reprint author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China.	lmzheng@nju.edu.cn	Hoshino, Norihisa/B-2168-2015	Hoshino, Norihisa/0000-0002-9841-6375	National Basic Research Program of China [2010CB923402, 2013CB922102]; NSF of Jiangsu Province of China [BK2009009]; NSF of China [21371094]	Financial support by the National Basic Research Program of China (2010CB923402, 2013CB922102), the NSF of Jiangsu Province of China (No. BK2009009), and the NSF of China (No. 21371094) is acknowledged. We appreciate Prof. M. Kurmoo for kind proof-reading and comments and Prof. E. Coronado for valuable discussions. We also thank Prof. Li Pi for kind help in magnetic measurements.	FISHER ME, 1964, AM J PHYS, V32, P343, DOI 10.1119/1.1970340; Liu TF, 2003, J AM CHEM SOC, V125, P13976, DOI 10.1021/ja0380751; Kajiwara T, 2005, J AM CHEM SOC, V127, P10150, DOI 10.1021/ja052653r; Venkatakrishnan TS, 2010, J AM CHEM SOC, V132, P6047, DOI 10.1021/ja9089389; Bhowmick I, 2012, CHEM COMMUN, V48, P9717, DOI 10.1039/c2cc34066f; Hoshino N, 2012, NAT CHEM, V4, P921, DOI [10.1038/nchem.1455, 10.1038/NCHEM.1455]; Miyasaka H, 2010, CHEM-EUR J, V16, P3656, DOI 10.1002/chem.200902861; Kurmoo M, 2009, CHEM SOC REV, V38, P1353, DOI 10.1039/b804757j; Dong DP, 2012, ANGEW CHEM INT EDIT, V51, P5119, DOI 10.1002/anie.201105987; Tangoulis V, 2013, INORG CHEM, V52, P6559, DOI 10.1021/ic400557f; Feng XW, 2012, J AM CHEM SOC, V134, P7521, DOI 10.1021/ja301338d; Chen X, 2014, CHEM COMMUN, V50, P2120, DOI 10.1039/c3cc48117d; Wang S, 2004, J AM CHEM SOC, V126, P8900, DOI 10.1021/ja0483995; Zhang XM, 2007, ANGEW CHEM INT EDIT, V46, P3456, DOI 10.1002/anie.200604284; Toma LM, 2012, J AM CHEM SOC, V134, P15265, DOI 10.1021/ja307042z; Vaz MGF, 2014, CHEM-EUR J, V20, P5460, DOI 10.1002/chem.201304852; Miyasaka H, 2009, INORG CHEM, V48, P3420, DOI 10.1021/ic802050j; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Caneschi A, 2001, ANGEW CHEM INT EDIT, V40, P1760, DOI 10.1002/1521-3773(20010504)40:9<1760::AID-ANIE17600>3.0.CO;2-U; Wang TT, 2014, INORG CHEM, V53, P3117, DOI 10.1021/ic403042p; Palii AV, 2008, J AM CHEM SOC, V130, P14729, DOI 10.1021/ja8050052; Sun HL, 2010, COORDIN CHEM REV, V254, P1081, DOI 10.1016/j.ccr.2010.02.010; Ma XZ, 2014, CHEM COMMUN, V50, P6340, DOI 10.1039/c4cc01909a; Coulon C, 2006, STRUCT BOND, V122, P163, DOI 10.1007/430_030; Bogani L, 2005, ANGEW CHEM INT EDIT, V44, P5817, DOI 10.1002/anie.200500464; Bernot K, 2006, J AM CHEM SOC, V128, P7947, DOI 10.1021/ja061101l; Pini MG, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094444; Mougel V, 2014, ANGEW CHEM INT EDIT, V53, P819, DOI 10.1002/anie.201307366; Camarero J, 2009, J MATER CHEM, V19, P1678, DOI 10.1039/b819594n; Harris TD, 2010, J AM CHEM SOC, V132, P3980, DOI 10.1021/ja910963x; Bai YL, 2006, J AM CHEM SOC, V128, P16428, DOI 10.1021/ja066679+; Bogani L, 2008, J MATER CHEM, V18, P4750, DOI 10.1039/b807824f; Xu HB, 2007, ANGEW CHEM INT EDIT, V46, P7388, DOI 10.1002/anie.200702648; [Anonymous], 1994, SAINT PROGR DAT EXTR; Zhang WX, 2012, J AM CHEM SOC, V134, P6908, DOI 10.1021/ja300152k; Oka Y, 2013, INORG CHEM, V52, P2142, DOI 10.1021/ic302540h; Toma LM, 2012, INORG CHEM, V51, P1216, DOI 10.1021/ic202410t; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Lescouezec R, 2003, ANGEW CHEM INT EDIT, V42, P1483, DOI 10.1002/anie.200250243; CANESCHI A, 1991, J AM CHEM SOC, V113, P5873, DOI 10.1021/ja00015a057; Clerac R, 2002, J AM CHEM SOC, V124, P12837, DOI 10.1021/ja0203115; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; Boeckmann J, 2012, CHEM-EUR J, V18, P5284, DOI 10.1002/chem.201103416; Bogani L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207204; Bernot K, 2008, J AM CHEM SOC, V130, P1619, DOI 10.1021/ja0751734; Zhang WX, 2013, RSC ADV, V3, P3772, DOI 10.1039/c2ra22675h; Ardavan A, 2009, J MATER CHEM, V19, P1754, DOI 10.1039/b809525f; Bogani L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.064406; Coronado E, 2008, J AM CHEM SOC, V130, P14987, DOI 10.1021/ja806298t; Coulon C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.167204; Ferrando-Soria J, 2011, CHEM-EUR J, V17, P2176, DOI 10.1002/chem.201002110; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Kahn O., 1993, MOL MAGNETISM; Liu T, 2010, J AM CHEM SOC, V132, P8250, DOI 10.1021/ja1027953; Liu T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3826; Mydosh J. A., 1993, SPIN GLASSES EXPT IN, P67; *SIEM IND AUT AN I, 1995, SHELXTL VERS 5 0 REF; Sun Z.-M., 2005, J APPL PHYS, V97; Sun ZM, 2003, J SOLID STATE CHEM, V176, P62, DOI 10.1016/S0022-4596(03)00347-5; Vilminot S, 2010, CHEM MATER, V22, P4090, DOI 10.1021/cm1009515; Zheng YZ, 2006, ANGEW CHEM INT EDIT, V45, P6310, DOI 10.1002/anie.200601349	61	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669	1520-510X		INORG CHEM	Inorg. Chem.	DEC 1	2014	53	23					12546	12552		10.1021/ic5021737		7	Chemistry, Inorganic & Nuclear	Chemistry	AU6OZ	WOS:000345723300039		
J	Massoud, SS; Junk, T; Mikuriya, M; Naka, Y; Mautner, FA				Massoud, Salah S.; Junk, Thomas; Mikuriya, Masahiro; Naka, Yuko; Mautner, Franz A.			Synthesis, structure and magnetic characterization of dinuclear copper (II) complexes of 2,6-bis[bis(pyridine-2-ylmethyl)aminomethy1]-4-methylphenol	INORGANIC CHEMISTRY COMMUNICATIONS			English	Article						Copper; Polynuclear complexes; Bridged phenolate; Crystal structure; Magnetic properties	IRON-OXO PROTEINS; COBALT(II) COMPLEXES; CRYSTAL-STRUCTURES; DICOPPER(II) COMPLEXES; COMPARTMENTAL LIGANDS; NICKEL(II) COMPLEXES; ZINC(II) COMPLEXES; EPR-SPECTRA; MODELS; COORDINATION	The two dinuclear complexes [Cu-2((LO)-O-Me-tmpa)(OAc)(2)]PF6 center dot H2O (1) and [Cu-2((LO)-O-Me-tmpa)(N-3)(2)]ClO4 (2), where L-Me-OH-tmpa = 2,6-bis[bis(pyridine-2-ylmethypaminomethyl]-4-methylphenol, were synthesized and structurally and magnetically characterized. The five-coordinate geometry around the Cu(II) centers is achieved through the monodentate-acetato or -azido groups, the three N-donors of the ligand and a bridged-phenoxdio group. The two complexes reveal weak antiferromagnetic interaction. (C) 2014 Elsevier B.V. All rights reserved.	[Massoud, Salah S.; Junk, Thomas] Univ SW Louisiana, Dept Chem, Lafayette, LA 70504 USA; [Mikuriya, Masahiro; Naka, Yuko] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda 6691337, Japan; [Mikuriya, Masahiro; Naka, Yuko] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Coordinat Mol Based Devices, Sanda 6691337, Japan; [Mautner, Franz A.] Graz Univ Technol, Inst Phys & Theoret Chem, A-8010 Graz, Austria	Massoud, SS (reprint author), Univ SW Louisiana, Dept Chem, POB 44370, Lafayette, LA 70504 USA.	ssmassoud@louisiana.edu; mautner@ptc.tu-graz.ac.at			Department of Chemistry-University of Louisiana at Lafayette; NAWI Graz	This research was financially supported by the Department of Chemistry-University of Louisiana at Lafayette. FAM thanks NAWI Graz for partial financial support.	ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; Comba P, 2012, INORG CHEM, V51, P12195, DOI 10.1021/ic301347t; Ambrosi G, 2008, COORDIN CHEM REV, V252, P1121, DOI 10.1016/j.ccr.2007.09.027; DIRIL H, 1989, J AM CHEM SOC, V111, P5102, DOI 10.1021/ja00196a013; Das B, 2014, J INORG BIOCHEM, V132, P6, DOI 10.1016/j.jinorgbio.2013.08.001; Adams H, 2002, INORG CHIM ACTA, V332, P195, DOI 10.1016/S0020-1693(02)00706-5; Matsufuji K, 2005, B CHEM SOC JPN, V78, P851, DOI 10.1246/bcsj.78.851; BOROVIK AS, 1988, J AM CHEM SOC, V110, P2345, DOI 10.1021/ja00215a079; Huang CH, 2007, INORG CHEM, V46, P5537, DOI 10.1021/ic062059y; Neves A, 2007, J AM CHEM SOC, V129, P7486, DOI 10.1021/ja0711841; SUZUKI M, 1987, B CHEM SOC JPN, V60, P4305, DOI 10.1246/bcsj.60.4305; Banerjee A, 2013, POLYHEDRON, V60, P102, DOI 10.1016/j.poly.2013.05.014; Selmeczi K, 2007, CHEM-EUR J, V13, P9093, DOI 10.1002/chem.200700104; Dalgaard P, 2000, POLYHEDRON, V19, P1909, DOI 10.1016/S0277-5387(00)00482-4; HOLZ RC, 1994, INORG CHEM, V33, P4609, DOI 10.1021/ic00099a002; Michel F, 2005, ANGEW CHEM INT EDIT, V44, P438, DOI 10.1002/anie.200461462; BOROVIK AS, 1990, J AM CHEM SOC, V112, P6031, DOI 10.1021/ja00172a019; Smith SJ, 2008, J BIOL INORG CHEM, V13, P499, DOI 10.1007/s00775-007-0334-7; Daumann LJ, 2013, INORG CHEM, V52, P2029, DOI 10.1021/ic302418x; Torelli S, 2000, INORG CHEM, V39, P3526, DOI 10.1021/ic991450z; Blanchard S, 2003, CHEM-EUR J, V9, P4260, DOI 10.1002/chem.200304759; Saravanakumar D, 2004, POLYHEDRON, V23, P665, DOI 10.1016/j.poly.2003.11.004; Rey NA, 2007, INORG CHEM, V46, P348, DOI 10.1021/ic0613107; Massoud SS, 2012, POLYHEDRON, V31, P601, DOI 10.1016/j.poly.2011.10.011; BOROVIK AS, 1989, J AM CHEM SOC, V111, P6183, DOI 10.1021/ja00198a032; Berreau LM, 2006, DALTON T, P183, DOI 10.1039/b512515d; Borovik A.S., 1999, J CHEM SOC DA, P1001; Das B., 2014, EUR J INORG CHEM, P2204; Daumann LJ, 2013, EUR J INORG CHEM, P3082, DOI 10.1002/ejic.201300280; Foxon S, 2007, EUR J INORG CHEM, P429, DOI 10.1002/ejic.200600944; GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0; Hathaway BJ, 1987, COMPREHENSIVE COORDI, V5, P533; Maloney J.J., 1987, INORG CHEM ACTA, V127, P133; Manago T, 1999, J CHEM SOC DALTON, P1001, DOI 10.1039/a808069k; NISHIDA Y, 1985, J CHEM SOC DALTON, P1945, DOI 10.1039/dt9850001945; Paine RT, 2001, INORG CHEM, V40, P7009, DOI 10.1021/ic0107633; SUZUKI M, 1981, CHEM LETT, P1745, DOI 10.1246/cl.1981.1745; BOROVIK AS, 1988, J AM CHEM SOC, V110, P1986, DOI 10.1021/ja00214a065; Tian JL, 2008, Z ANORG ALLG CHEM, V634, P1775, DOI 10.1002/zaac.200800130; Turba S., 2012, INORG CHEM, V5, P88	40	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-7003	1879-0259		INORG CHEM COMMUN	Inorg. Chem. Commun.	DEC	2014	50						48	50		10.1016/j.inoche.2014.10.027		3	Chemistry, Inorganic & Nuclear	Chemistry	AU8BX	WOS:000345822700012		
J	Fukumoto, K; Le, NHT; Komiya, N; Naota, T				Fukumoto, Kanako; Le, Ngoc Ha-Thu; Komiya, Naruyoshi; Naota, Takeshi			Synthesis, structure and solid-state emission properties of a vaulted trans-bis(salicylaldiminato)platinum(II) complex bearing a long poly(oxyethylene) spacer	INORGANIC CHEMISTRY COMMUNICATIONS			English	Article						Platinum(II); Vaulted complex; Schiff bases; Phosphorescence	PENTAMETHYLENE SPACERS; QUANTUM EFFICIENCY; ENHANCEMENT; MOLECULES; CRYSTALS; LIGANDS; EPOXIDATION; PORPHYRINS; CATALYSTS; METAL	A trans-bis(salicylaldiminato)platinum(II) complex (1) incorporating a 20-membered macrocyclic vaulting structure formed by an ethylenepenta(oxyethylene) bridge was synthesized and subsequently characterized by H-1 and C-13 NMR, COSY, NOESY, FT-IR, high-resolution mass spectrometry and single crystal XRD. Complex 1 in the crystalline state exhibited intense yellow emission at 298 K under UV excitation at 420 nm. The mechanistic rationale for the solid-state emission is discussed based on the molecular structure and crystal packing of this complex in comparison with those of an 11 membered, short vaulted analog (2) bearing an ethylenedi(oxyethylene) bridge. (C) 2014 Elsevier B.V. All rights reserved.	[Fukumoto, Kanako; Le, Ngoc Ha-Thu; Komiya, Naruyoshi; Naota, Takeshi] Osaka Univ, Grad Sch Engn Sci, Dept Chem, Toyonaka, Osaka 5608531, Japan	Naota, T (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Chem, Toyonaka, Osaka 5608531, Japan.	naota@chem.es.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Sdence and Technology, Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Sdence and Technology, Japan.	Komiya N, 2011, J AM CHEM SOC, V133, P6493, DOI 10.1021/ja110398p; Rose E, 2005, CHEM SOC REV, V34, P573, DOI 10.1039/b405679p; Komiya N, 2013, CHEM-EUR J, V19, P4798, DOI 10.1002/chem.201203669; Skopek K, 2007, COORDIN CHEM REV, V251, P1723, DOI 10.1016/j.ccr.2006.12.015; Komiya N, 2011, J AM CHEM SOC, V133, P16054, DOI 10.1021/ja2039369; Komiya N, 2013, TRANSIT METAL CHEM, V38, P659, DOI 10.1007/s11243-013-9734-4; Naito M, 2014, CHEM-EUR J, V20, P6991, DOI 10.1002/chem.201305054; Jung MS, 2012, POLYHEDRON, V40, P168, DOI 10.1016/j.poly.2012.04.006; COLLMAN JP, 1990, J AM CHEM SOC, V112, P5356, DOI 10.1021/ja00169a056; Ikai M, 2006, ADV FUNCT MATER, V16, P515, DOI 10.1002/adfm.200500492; Komiya N, 2014, DALTON T, V43, P10074, DOI 10.1039/c4dt00560k; TAKEUCHI KJ, 1983, J AM CHEM SOC, V105, P4261, DOI 10.1021/ja00351a025; LEXA D, 1986, J AM CHEM SOC, V108, P6937, DOI 10.1021/ja00282a018; Zhang XQ, 2009, ORGANOMETALLICS, V28, P3093, DOI 10.1021/om8011695; Naota T, 2005, J AM CHEM SOC, V127, P9324, DOI 10.1021/ja050809h; Komiya N, 2013, ACTA CRYSTALLOGR C, V69, P503, DOI 10.1107/S0108270113004484; Kawamura Y, 2004, JPN J APPL PHYS 1, V43, P7729, DOI 10.1143/JJAP.43.7729; GROVES JT, 1989, J AM CHEM SOC, V111, P8537, DOI 10.1021/ja00204a047; Goto H, 2012, INORG CHEM, V51, P4134, DOI 10.1021/ic2024742; BAILEY NA, 1984, J CHEM SOC DALTON, P2741, DOI 10.1039/dt9840002741; Komiya N., 2013, CHEM COMMUN, V27, P122; SAWAMURA M, 1992, J AM CHEM SOC, V114, P8295, DOI 10.1021/ja00047a053	22	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-7003	1879-0259		INORG CHEM COMMUN	Inorg. Chem. Commun.	DEC	2014	50						88	91		10.1016/j.inoche.2014.10.013		4	Chemistry, Inorganic & Nuclear	Chemistry	AU8BX	WOS:000345822700022		
J	Alam, MMA; Setoguchi, T; Kim, HD				Alam, M. M. A.; Setoguchi, T.; Kim, H. D.			SPONTANEOUS NONEQUILIBRIUM CONDENSATION IN SUPERSONIC JETS IMPINGING ON CAVITY	INTERNATIONAL JOURNAL OF APPLIED MECHANICS			English	Article						Compressible flow; numerical simulation; oscillation; shock wave; two-phase flow	SKIN FRICTION; HEAT-TRANSFER; IMPINGEMENT; VELOCITY; PLATES; MODEL	Spontaneous condensation of moist air in supersonic jets is of considerable interest in a variety of natural and industrial processes. During impingement of supersonic moist air jets, the nonequilibrium homogeneous condensation can be experienced at the region between downstream of nozzle exit and an obstacle. The subsequent release of latent heat thus results in a deceleration of the flow and a rise in pressure, known traditionally as the condensation shock; likely have strong effect on the flow features. The present paper reported of the effect of spontaneous nonequilibrium homogeneous condensation of moist air on the aerodynamic and oscillatory flow features of supersonic jets impinging on cavity. A total variation diminishing (TVD) scheme was used to solve the time dependent Favre averaged Navier-Stokes equations, and the droplet growth equation of liquid phase production for simulating the condensing jets. Both qualitative and quantitative validations of the numerical model were accomplished, and the results showed a good agreement between the computed results and experimental data. Predicted flow and oscillatory features of jets were presented.	[Alam, M. M. A.; Setoguchi, T.] Saga Univ, Inst Ocean Energy IOES, Saga 8408502, Japan; [Kim, H. D.] Andong Natl Univ, Dept Mech Engn, Andong, South Korea	Alam, MMA (reprint author), Saga Univ, Inst Ocean Energy IOES, 1 Honjo Machi, Saga 8408502, Japan.	dralam@me.saga-u.ac.jp					Adam S., 1996, THESIS U KARLSRUHE T; Alam M. M. A., 2013, INT J COMPUTATIONAL, V13, P2401; Alam M. M. A., 2013, P 9 PAC S FLOW VIS I; LAMONT PJ, 1980, J FLUID MECH, V100, P471, DOI 10.1017/S0022112080001255; ADDY AL, 1981, AIAA J, V19, P121, DOI 10.2514/3.7751; Alam MMA, 2008, INT J TURBO JET ENG, V25, P221; Goldberg UC, 1996, J FLUID ENG-T ASME, V118, P795, DOI 10.1115/1.2835511; Yilbas BS, 2009, INT J NUMER METHOD H, V19, P182, DOI 10.1108/09615530910930964; TAM CKW, 1990, J FLUID MECH, V214, P67, DOI 10.1017/S0022112090000052; HILL PG, 1966, J FLUID MECH, V25, P593, DOI 10.1017/S0022112066000284; KROTHAPALLI A, 1985, AIAA J, V23, P1910, DOI 10.2514/3.9195; POWELL A, 1988, J ACOUST SOC AM, V83, P515, DOI 10.1121/1.396146; Alam MMA, 2010, INT J THERM SCI, V49, P2078, DOI 10.1016/j.ijthermalsci.2010.07.004; Goldberg U. C., 1994, Transactions of the ASME. Journal of Fluids Engineering, V116; Heiler M., 1999, THESIS U KARLSRUHE T; Hirsch C., 1998, NUMERICAL COMPUTATIO, V2; Kim SI, 2005, SHOCK WAVES, V14, P259, DOI 10.1007/S00193-005-0270-9; Matsuo K, 1985, B JSME, V28, P2577; Matsuo S., 2003, T JPN SOC MECH ENG, V69, P1163; Matsuo S, 2004, INT J TURBO JET ENG, V21, P193; Mundinger G., 1994, THESIS U KARLSRUHE T; Pruppacher H. R., 1997, MICROPHYSICS CLOUDS; Shuia SZ, 2007, J FLUID STRUCT, V23, P1106, DOI [10.1016/j.jfluidstructs.2007.03.005, 10.1016/j.jfluidstructs.2007-03-005]; Shuja SZ, 2009, INT J THERM SCI, V48, P985, DOI 10.1016/j.ijthermalsci.2008.07.005; Sislian J. P., 1975, 201 UTIAS; Wegener P. P., 1958, ADVANCES APPLIED MEC, V5, P307, DOI 10.1016/S0065-2156(08)70022-X; Yamamoto S., 1991, P ASME FLUIDS ENG DI, V120, P73; Yee H. C., 1989, TM89464 NASA	28	0	0	IMPERIAL COLLEGE PRESS	LONDON	57 SHELTON ST, COVENT GARDEN, LONDON WC2H 9HE, ENGLAND	1758-8251	1758-826X		INT J APPL MECH	Int. J. Appl. Mech.	DEC	2014	6	6							1450070	10.1142/S1758825114500707		24	Mechanics	Mechanics	AW0JD	WOS:000345977200007		
J	Gan, YJ; Wang, LH; Wang, LC; Pan, P; Yang, YX				Gan, Yuanju; Wang, Lihua; Wang, Licheng; Pan, Ping; Yang, Yixian			Efficient threshold public key encryption with full security based on dual pairing vector spaces	INTERNATIONAL JOURNAL OF COMMUNICATION SYSTEMS			English	Article						threshold public key encryption; dynamic corruption model; chosen-ciphertext attacks; dual pairing vector spaces	SYSTEM ENCRYPTION; PROVABLY SECURE; CRYPTOSYSTEMS; HIBE	Most robust and noninteractive threshold public key encryption (PKE) schemes have only been proven secure against chosen-ciphertext attacks under the static corruption model; yet, the dynamic corruption model is more reasonable. In this paper, on the basis of bilinear groups of prime order and dual pairing vector spaces, we propose a threshold PKE scheme that is noninteractive, robust and, secure against adaptive chosen-ciphertext attacks under the dynamic corruption model without random oracles. Moreover, our scheme is shown to be more efficient than currently existing fully secure threshold PKE schemes. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Gan, Yuanju; Wang, Licheng; Pan, Ping; Yang, Yixian] Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China; [Wang, Lihua] Natl Inst Informat & Commun Technol, Network Secur Res Inst, Koganei, Tokyo 1848795, Japan; [Gan, Yuanju] Guangdong Ocean Univ, Sch Informat, Zhanjiang 524088, Peoples R China	Wang, LC (reprint author), 10 West Tucheng Rd, Beijing 100876, Peoples R China.	wanglc@bupt.edu.cn			National Natural Science Foundation of China (NSFC) [61070251, 61103198, 61121061, 61272534]; NSFC A3 Foresight Program [61161140320]; JSPS KAKENHI program [23500031]	This work was supported by the National Natural Science Foundation of China (NSFC) (61070251, 61103198, 61121061, 61272534), the NSFC A3 Foresight Program 61161140320, and the JSPS KAKENHI program 23500031.	Abes M, 2004, LECT NOTES COMPUTER, V3152, P317; Groth J, 2008, LECT NOTES COMPUT SC, V4965, P415; Page D, 2006, APPL ALGEBR ENG COMM, V17, P379, DOI 10.1007/s00200-006-0017-6; Cramer R, 1998, LECT NOTES COMPUT SC, V1462, P13; Boneh D, 2006, LECT NOTES COMPUT SC, V3860, P226; Haenni R, 2013, COMPUT SECUR, V33, P59, DOI 10.1016/j.cose.2012.09.003; Chen C, 2011, INT J COMMUN SYST, V24, P347, DOI 10.1002/dac.1158; Freeman DM, 2010, LECT NOTES COMPUT SC, V6110, P44; Tang HB, 2012, INT J COMMUN SYST, V25, P1639, DOI 10.1002/dac.2428; Lewko A, 2010, LECT NOTES COMPUT SC, V5978, P455; Waters B, 2009, LECT NOTES COMPUT SC, V5677, P619, DOI 10.1007/978-3-642-03356-8_36; Bellare M, 2008, IET INFORM SECUR, V2, P47, DOI [10.1049/iet-ifs:20070089, 10.1049/iet-ifs:2.0070089]; Bleichenbachers D, 1996, LECT NOTES COMPUTER, V1163, P145, DOI 10.1007/BFb0034843; Canetti R, 2004, LECT NOTES COMPUT SC, V3027, P207; Hes D, 2012, INT J COMMUNICATION, V25, P1432, DOI DOI 10.1002/DAC.1330; Lais J, 2010, LECT NOTES COMPUTER, V5985, P132; Lewko A., 2012, LNCS, V7237, P318; Lewkos A, 2011, 2011490 CRYPT EPRINT; Libert B., 2012, LNCS, V7194, P75; Liberts B, 2011, LNCS, V6756, P588; Libert B, 2013, THEOR COMPUT SCI, V478, P76, DOI 10.1016/j.tcs.2013.01.001; Lins PJ, 2011, INT J COMMUNICATION, V24, P325, DOI DOI 10.1002/DAC.1157; Lous DC, 2011, INT J COMMUNICATION, V24, P504, DOI [10.1002/dac.1172, DOI 10.1002/DAC.1172]; Okamoto T., 2012, LECT NOTES COMPUTER, V7237, P591; Okamoto T, 2011, LECT NOTES COMPUT SC, V6737, P380, DOI 10.1007/978-3-642-21969-6_25; Qins B, 2012, INFORM SCI, V210, P67; Shoups V, 1998, LECT NOTES COMPUTER, V1403, P1; Wees H., 2011, LECT NOTES COMPUTER, V6632, P589	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1074-5351	1099-1131		INT J COMMUN SYST	Int. J. Commun. Syst.	DEC	2014	27	12					4059	4077		10.1002/dac.2598		19	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AU9MP	WOS:000345917800036		
J	Zhang, MW; Wang, CZ; Yang, B; Takagi, T				Zhang, Mingwu; Wang, Chunzhi; Yang, Bo; Takagi, Tsuyoshi			Fully secure constructions of spatial encryption with vector privacy	INTERNATIONAL JOURNAL OF COMMUNICATION SYSTEMS			English	Article						spatial encryption; affine space; full security; dual system encryption; affine transformation	DUAL SYSTEM ENCRYPTION; FUNCTIONAL ENCRYPTION; HIBE; CIPHERTEXTS; ANONYMITY; SCHEMES; IBE	An encryption scheme is a tuple of algorithms used to ensure secrecy while exchanging messages over a public channel. Spatial encryption is a generalized extension of id-based encryption with the ability of partial order role delegation. In this paper, we propose an efficient spatial encryption with vector privacy preservation, which is derived from the technique of static assumption from dual system encryption in composite order groups. The proposed scheme achieves the cryptosystem properties of message confidentiality, recipient anonymity, adaptively full security, and short constant ciphertext. Provable security in our setting consists of three steps: the first one is giving a rigorous definition of security, the second one is giving the construction of a scheme, and the last one is giving a rigorous mathematical proof showing that the scheme satisfies the security definition given in the first stage. Compared with related schemes, our proposed scheme has a comparable advantage in security while it holds an approximate computing efficiency and communicating payload such as public parameters, private keys, and ciphertexts. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Zhang, Mingwu; Wang, Chunzhi] Hubei Univ Technol, Sch Comp Sci, Wuhan 430068, Peoples R China; [Yang, Bo] Shaanxi Normal Univ, Sch Comp, Xian 710071, Peoples R China; [Takagi, Tsuyoshi] Kyushu Univ, Inst Math Ind, Fukuoka 8190395, Japan	Zhang, MW (reprint author), Hubei Univ Technol, Sch Comp Sci, Wuhan 430068, Peoples R China.	csmwzhang@gmail.com	Zhang, Mingwu/Q-1571-2015		NSFC [61272404, 61272436, 61170135]; Guangdong Natural Science Foundation [S2012010010383]	The authors gratefully thank the anonymous reviewers for their helpful comments. This work is supported by the NSFC (Grant No.61272404, 61272436 and No.61170135) and Guangdong Natural Science Foundation (Grant No. S2012010010383).	Abdai M, 2002, J CRYPTOL, V15, P103; Abdalla M, 2012, LNCS, V7533, P78; Shi E, 2008, LECT NOTES COMPUT SC, V5126, P560, DOI 10.1007/978-3-540-70583-3_46; Lewko A, 2010, LECT NOTES COMPUT SC, V6110, P62; Boyen X, 2006, LECT NOTES COMPUT SC, V4117, P290; Lin CY, 2011, INT J COMMUN SYST, V24, P1520, DOI 10.1002/dac.1304; Attrapadung N, 2010, LECT NOTES COMPUT SC, V6056, P384; Shen E, 2009, LECT NOTES COMPUT SC, V5444, P457; Abdalla M, 2008, J CRYPTOL, V21, P350, DOI 10.1007/s00145-007-9006-6; GOLDWASSER S, 1984, J COMPUT SYST SCI, V28, P270, DOI 10.1016/0022-0000(84)90070-9; Lewko A, 2011, LECT NOTES COMPUT SC, V6632, P547, DOI 10.1007/978-3-642-20465-4_30; Lewko A, 2010, LECT NOTES COMPUT SC, V5978, P455; Waters B, 2009, LECT NOTES COMPUT SC, V5677, P619, DOI 10.1007/978-3-642-03356-8_36; Canetti R, 2007, J CRYPTOL, V20, P265, DOI 10.1007/s00145-006-0442-5; Chuang YH, 2012, INT J COMMUN SYST, V25, P447, DOI 10.1002/dac.1268; Bellare M., 2001, LNCS, V2248, P566; Boneh D, 2008, LECT NOTES COMPUT SC, V5350, P455, DOI 10.1007/978-3-540-89255-7_28; Boneh D, 2005, P ACM CCS 2005, V2005, P320; Chen C., 2012, LNCS, V7496, P253; Chen J, 2014, DESIGN CODE CRYPTOGR, V71, P347, DOI 10.1007/s10623-012-9742-y; Ducas L, 2010, LECT NOTES COMPUT SC, V5985, P148, DOI 10.1007/978-3-642-11925-5_11; Gentry D, 2009, LNCS, V5444, P437; Goyal V, ACM CCS 2006 ACM AL, P89; Han YL, 2009, INT J COMMUN SYST, V22, P1213, DOI 10.1002/dac.1023; He D, 2011, INT J COMMUNICATION, V25, P1432; Mohassel P, 2010, LECT NOTES COMPUT SC, V6477, P501, DOI 10.1007/978-3-642-17373-8_29; Mohamed EE, 2011, INT J COMMUN SYST, V24, P761, DOI 10.1002/dac.1185; Moriyama D, 2011, IEICE T FUND ELECTR, VE94A, P28, DOI 10.1587/transfun.E94.A.28; Tseng YM, 2012, INT COMMUNICATION SY, DOI [10.1002/dac.2395, DOI 10.1002/DAC.2395]; Zhang MW, 2011, LECT NOTES COMPUT SC, V6980, P154; Zhou MX, 2009, LECT NOTES COMPUT SC, V5848, P19	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1074-5351	1099-1131		INT J COMMUN SYST	Int. J. Commun. Syst.	DEC	2014	27	12					4307	4327		10.1002/dac.2613		21	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AU9MP	WOS:000345917800051		
J	Tsuchiya, M; Yamaguchi, F; Shimamoto, S; Fujimoto, T; Tokumitsu, H; Tokuda, M; Kobayashi, R				Tsuchiya, Mitsumasa; Yamaguchi, Fuminori; Shimamoto, Seiko; Fujimoto, Tomohito; Tokumitsu, Hiroshi; Tokuda, Masaaki; Kobayashi, Ryoji			Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN-45 gastric carcinoma cells	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						oxidative stress; S100 protein; protein phosphatase 5; MKN-45	METASTASIS-ASSOCIATED PROTEIN; CALCIUM-BINDING PROTEIN; YEAST 2-HYBRID SYSTEM; IN-VITRO; SERINE/THREONINE PHOSPHATASE; SIGNAL-TRANSDUCTION; MTS1; REPEAT; FAMILY; TARGET	S100 proteins bind to numerous target proteins, as well as other S100 proteins and activate signaling cascades. S100 proteins can be modified by various post-translational modifications, such as phosphorylation, methylation and acetylation. In addition, oxidation is important for modulating their activities. Previous studies have shown that S100A1 interacts with S100A4 in vitro and in vivo. Due to this potential cross-talk among the S100 proteins, the aim of the present study was to examine whether S100A4 modulates the activity of S100A1. S100A4 was readily oxidized and formed disulfide-linked dimers and oligomers. Although non-oxidized S100A4 bound to protein phosphatase 5 (PP5), the Cu-oxidized S100A4 failed to bind PP5. Instead, the Cu-oxidized S100A4 directly interacted with S100A1 and prevented PP5 activation. Hydrogen peroxide induced S100A4 oxidation in MKN-45 gastric adenocarcinoma cells and decreased S100A1-PP5 interaction, resulted in the inhibition of PP5 activation by S100A1. These data indicate that oxidized S100A4 regulates PP5 activity in a unique manner under oxidative stress conditions.	[Tsuchiya, Mitsumasa; Shimamoto, Seiko; Fujimoto, Tomohito; Tokumitsu, Hiroshi; Kobayashi, Ryoji] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Takamatsu, Kagawa 7610793, Japan; [Yamaguchi, Fuminori; Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Takamatsu, Kagawa 7610793, Japan	Kobayashi, R (reprint author), Kagawa Univ, Fac Med, Dept Signal Transduct Sci, 1750-1 Ikenobe, Takamatsu, Kagawa 7610793, Japan.	ryoji@med.kagawa-u.ac.jp			Kagawa University (Kagawa, Japan)	The present study was supported by the Kagawa University Characteristic Prior Research Fund 2011 (Kagawa, Japan). The authors would like to thank Keiko Tsurumi (a laboratory technician; Kagawa University) for technical assistance.	Yonemura Y, 2000, CLIN CANCER RES, V6, P4234; Zhang T, 2002, J INVEST DERMATOL, V119, P1196, DOI 10.1046/j.1523-1747.2002.19520.x; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Li CL, 2002, J CLIN PATHOL-MOL PA, V55, P250; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Tarabykina S, 2000, FEBS LETT, V475, P187, DOI 10.1016/S0014-5793(00)01652-5; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; CHEN MX, 1994, EMBO J, V13, P4278; Zuhlke RD, 1999, NATURE, V399, P159; BECKER W, 1994, J BIOL CHEM, V269, P22586; Deloulme JC, 2003, MICROSC RES TECHNIQ, V60, P560, DOI 10.1002/jemt.10298; Endo H, 2002, J BIOL CHEM, V277, P26396, DOI 10.1074/jbc.M202244200; Fritz Günter, 2013, Methods Mol Biol, V963, P87, DOI 10.1007/978-1-62703-230-8_6; Gencer S, 2011, TURK J GASTROENTEROL, V22, P145, DOI 10.4318/tjg.2011.0183; GIBBS FEM, 1994, J BIOL CHEM, V269, P18992; Haase-Kohn C, 2011, BIOCHEM BIOPH RES CO, V413, P494, DOI 10.1016/j.bbrc.2011.08.132; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Matsui L., 2000, ARCH BIOCHEM BIOPHYS, V374, P137; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Okada M, 2002, BIOCHEM BIOPH RES CO, V292, P1023, DOI 10.1006/bbrc.2002.6761; Propper C, 1999, J BIOL CHEM, V274, P183, DOI 10.1074/jbc.274.1.183; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Takata M, 2010, FEBS LETT, V584, P4517, DOI 10.1016/j.febslet.2010.09.052; TAKENAGA K, 1994, J CELL BIOL, V124, P757, DOI 10.1083/jcb.124.5.757; Tarabykina S, 2001, J BIOL CHEM, V276, P24212, DOI 10.1074/jbc.M009477200; Wang GZ, 2000, J BIOL CHEM, V275, P11141, DOI 10.1074/jbc.275.15.11141; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Wang GZ, 2004, BIOCHEM J, V382, P375, DOI 10.1042/BJ20040142; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; Yamashita K, 1999, PROTEIN EXPRES PURIF, V16, P47, DOI 10.1006/prep.1998.1026; Yammani RR, 2006, ARTHRITIS RHEUM, V54, P2901, DOI 10.1002/art.22042	39	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	DEC	2014	34	6					1713	1719		10.3892/ijmm.2014.1947		7	Medicine, Research & Experimental	Research & Experimental Medicine	AU9ZC	WOS:000345949400033		
J	Ami, T; Umekawa, H; Ozawa, M				Ami, Takeyuki; Umekawa, Hisashi; Ozawa, Mamoru			Dryout of counter-current two-phase flow in a vertical tube	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Counter-current two-phase flow; Dryout; Flooding	CRITICAL HEAT-FLUX; RECTANGULAR CHANNEL; CLOSED BOTTOM; LIQUID-FILMS; WATER	Dryout of counter-current two-phase flow is one of key issues in chemical and/or industrial systems. The aim of the present study is to provide insights into the dryout phenomena of such counter-current two-phase flow of binary gas and liquid in a vertical tube. Experimental results suggest a significant influence of the subcooling of water and the binary gas flow rate on the dryout characteristics. The observed dryout was classified into three modes, i.e.,film breakdown, dryout due to flooding and dryout due to critical flooding. At the low inlet air flow rate, dryout characteristics wereaffected by subcooling of water. The test section was partially overheated owing to the liquid film breakdown due to the Marangoni effect. At the moderate inlet air flow rate, the dryout is induced by the reduction on the falling liquid film due to flooding. At the high gas flow rate, most of the water was carried over due to the critical flooding. In the latter two cases, there was no influence of subcooling of water on dryout. These dryout phenomena were successfully realized in the numerical simulation based on the one-dimensional heat and mass transfer model, i.e., energy balance of a heat input, a heat release rate from the heating surface and a mass transfer rate due to phase change. (C) 2014 Elsevier Ltd. All rights reserved.	[Ami, Takeyuki; Umekawa, Hisashi] Kansai Univ, Dept Mech Engn, Suita, Osaka 5648680, Japan; [Ozawa, Mamoru] Kansai Univ, Fac Safety Sci, Takatsuki, Osaka 5691098, Japan	Ami, T (reprint author), Kansai Univ, Dept Mech Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	t_ami@kansai-u.ac.jp			Taiyo Nippon Sanso Corporation	Experimental part of the present investigation was supported in part by Taiyo Nippon Sanso Corporation. The authors wish to express their thanks to Mr. Takuya Suzuki and Miss Ayaka Fujiwara for their assistance in the experiment.	MISHIMA K, 1987, INT J HEAT MASS TRAN, V30, P1169, DOI 10.1016/0017-9310(87)90046-9; Zapke A, 2000, INT J MULTIPHAS FLOW, V26, P1439, DOI 10.1016/S0301-9322(99)00097-X; SUDO Y, 1985, J NUCL SCI TECHNOL, V22, P604, DOI 10.3327/jnst.22.604; Bharathan D, 1978, NP786 EPRI; CLIFT R, 1966, CHEM ENG SCI, V21, P87, DOI 10.1016/0009-2509(66)80009-X; Cullum W, 2014, NUCL ENG DES, V273, P110, DOI 10.1016/j.nucengdes.2014.03.005; Diehl J.E., 1969, CHEM ENG PROGR S SER, V65, P77; Dittus P.W., 1930, U CALIFORNIA PUBLICA, V2, P443; Feind R, 1960, FALLING LIQUID FILMS, V481; Fujii T., 1978, T JAPAN SOC MECH ENG, V44, P118; FUJITA T, 1978, INT J HEAT MASS TRAN, V21, P97, DOI 10.1016/0017-9310(78)90212-0; Hewitt G.F., 1963, ASME MULT FLOW S PHI, P62; IMURA H, 1983, INT J HEAT MASS TRAN, V26, P1181; Kamei S, 1954, CHEM ENG, V18, P364; KATTO Y, 1992, INT J HEAT MASS TRAN, V35, P3021, DOI 10.1016/0017-9310(92)90321-I; KATTO Y, 1991, INT J HEAT MASS TRAN, V34, P993, DOI 10.1016/0017-9310(91)90010-C; Koizumi Y., 1998, T JSME B, V64, P2578; Mishima K., 1984, THESIS KYOTO U; Nejat N., 1981, INT J MULTIPHASE FLO, V7, P321; Norman W.S., 1960, T I CHEM ENG-LOND, V38, P301; Okano Y., 2002, T JSME B, V71, P610; Pushkina O. L., 1969, HEAT TRANSFER SOVIET, V1, P56; SUDO Y, 1989, INT J MULTIPHAS FLOW, V15, P755, DOI 10.1016/0301-9322(89)90039-6; Sudo Y., 1994, T JSME, V60, P4222; SUDO Y, 1984, J NUCL SCI TECHNOL, V21, P32; SUZUKI S, 1977, INT J MULTIPHAS FLOW, V3, P517, DOI 10.1016/0301-9322(77)90027-1; Tien C.L., 1979, NP1283 EPRI; Watanabe T., 2002, T JSME B, V68, P3152	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	DEC	2014	67			S	SI		54	64		10.1016/j.ijmultiphaseflow.2014.09.002		11	Mechanics	Mechanics	AU8CC	WOS:000345823200008		
J	Ojima, S; Hayashi, K; Hosokawa, S; Tomiyama, A				Ojima, Shimpei; Hayashi, Kosuke; Hosokawa, Shigeo; Tomiyama, Akio			Distributions of void fraction and liquid velocity in air-water bubble column	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Bubble column; Heterogeneous regime; LDV; Velocity fluctuation; Multi-fluid model	TURBULENCE MODELS; CFD SIMULATION; POPULATION BALANCE; REGIME TRANSITION; 2-PHASE FLOW; PHASE; COALESCENCE; REACTORS; BREAKUP; FORCES	Multi-fluid simulations of heterogeneous bubbly flows in an air-water bubble column were carried out to verify the speculation that a heterogeneous bubbly flow is predictable without turbulence models such as k-epsilon and LES models, provided that the velocity fluctuation caused by large-scale vortical flow structures prevails over the bubble-induced and shear-induced turbulences. Experiments on the heterogeneous air-water bubbly flows in a rectangular bubble column were also carried out to obtain experimental data of the mean velocity, fluctuation velocity and void fraction for validation of the numerical method. A small LDV probe developed in our previous study was utilized to measure the liquid velocity in the column at high spatial and high temporal resolutions. The distribution of void fraction was measured using an electrical conductivity probe. The conclusions obtained under the present experimental conditions are as follows: (1) the small LDV probe is of great use in measuring the distributions of mean and fluctuation velocities of the liquid phase at high spatial and high temporal resolutions, (2) the velocity fluctuation in the heterogeneous regime in the bubble column is mainly due to large-scale vortical structures, and (3) the multi-fluid model can give good predictions of a heterogeneous bubbly flow without using the turbulence models, provided that large-scale vortical structures in the flow prevail over the bubble-induced and shear-induced turbulences. (C) 2014 Elsevier Ltd. All rights reserved.	[Ojima, Shimpei; Hayashi, Kosuke; Hosokawa, Shigeo; Tomiyama, Akio] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Tomiyama, A (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	tomiyama@mech.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24360070]	The authors would like to express their thanks to Mr. I. Mikihara and Mr. S. Sasaki for their assistance in experiments. This work has been supported by the Japan Society for the Promotion of Science (JSPS) (grants-in-aid for scientific research (B), No. 24360070).	Tabib MV, 2008, CHEM ENG J, V139, P589, DOI 10.1016/j.cej.2007.09.015; Perez JAS, 2006, CHEM ENG J, V124, P1, DOI 10.1016/j.cej.2006.07.002; Silva MK, 2012, COMPUT CHEM ENG, V44, P34, DOI 10.1016/j.compchemeng.2012.04.007; TSUJI Y, 1984, J FLUID MECH, V139, P417, DOI 10.1017/S0022112084000422; PRINCE MJ, 1990, AICHE J, V36, P1485, DOI 10.1002/aic.690361004; Luo H, 1996, AICHE J, V42, P1225, DOI 10.1002/aic.690420505; Chen JW, 1999, CHEM ENG SCI, V54, P2199, DOI 10.1016/S0009-2509(98)00349-2; Olmos E, 2003, CHEM ENG SCI, V58, P2113, DOI 10.1016/S0009-2509(03)00013-7; CHEN RC, 1994, AICHE J, V40, P1093, DOI 10.1002/aic.690400702; Zahradnik J, 1997, CHEM ENG SCI, V52, P3811, DOI 10.1016/S0009-2509(97)00226-1; Laborde-Boutet C, 2009, CHEM ENG SCI, V64, P4399, DOI 10.1016/j.ces.2009.07.009; Ruzicka MC, 2001, CHEM ENG SCI, V56, P4609, DOI 10.1016/S0009-2509(01)00116-6; Maretto C, 1999, CATAL TODAY, V52, P279, DOI 10.1016/S0920-5861(99)00082-6; Lehr F, 2002, AICHE J, V48, P2426, DOI 10.1002/aic.690481103; Tomiyama A, 1998, JSME INT J B-FLUID T, V41, P472; Ojima S, 2014, INT J MULTIPHAS FLOW, V58, P154, DOI 10.1016/j.ijmultiphaseflow.2013.09.005; SATO Y, 1981, INT J MULTIPHAS FLOW, V7, P167, DOI 10.1016/0301-9322(81)90003-3; Chen P, 2005, AICHE J, V51, P696, DOI 10.1002/aic.10381; Chen P, 2005, CHEM ENG SCI, V60, P1085, DOI 10.1016/j.ces.2004.09.070; Wang TF, 2005, CHEM ENG SCI, V60, P6199, DOI 10.1016/j.ces.2005.04.027; Baird M. H. I., 1975, CHEM ENG J, V9, P171, DOI 10.1016/0300-9467(75)80010-4; Chen P., 2004, THESIS SEVER I WASHI; Davidson JF, 1960, T I CHEM ENGRS, V38, P335; DEBERTODANO ML, 1994, INT J MULTIPHAS FLOW, V20, P805; DEVANATHAN N, 1990, CHEM ENG SCI, V45, P2285, DOI 10.1016/0009-2509(90)80107-P; Ekambara K, 2008, IND ENG CHEM RES, V47, P8505, DOI 10.1021/ie071393c; Gamier C, 2002, EXP THERM FLUID SCI, V26, P811; GRIENBERGER J, 1992, CHEM ENG SCI, V47, P2215, DOI 10.1016/0009-2509(92)87037-Q; HILLS JH, 1974, T I CHEM ENG-LOND, V52, P1; Hosokawa S, 2013, INT J HEAT FLUID FL, V40, P97, DOI 10.1016/j.ijheatfluidflow.2013.01.004; Hosokawa S, 2013, NUCL ENG DES, V263, P342, DOI 10.1016/j.nucengdes.2013.06.009; Judd S., 2006, MBR BOOK; Lakota A, 2001, ACTA CHIM SLOV, V48, P453; Maekawa M., 2008, T JPN SOC MECH ENG-B, V74, P1368; MENZEL T, 1990, IND ENG CHEM RES, V29, P988, DOI 10.1021/ie00102a007; Shih T.-H., 1994, NASA TECHNICAL MEMOR; Shimada N, 2012, J CHEM ENG JPN, V45, P632; Su XF, 2006, CHEM ENG SCI, V61, P3098, DOI 10.1016/j.ces.2005.11.036; Tanaka M., 2009, T JPN SOC MECH ENG-B, V75, P2182; Tomiyama A., 1995, T JSME B, V61, P2810; Tomiyama A., 2002, CHEM ENG SCI, V57, P1846; Tomiyama A., 2001, CFD J, V9, P418; Tomiyama A., 2006, MULTIPHASE SCI TECHN, V18, P73, DOI 10.1615/MultScienTechn.v18.i1.40; ZUN I, 1995, REV SCI INSTRUM, V66, P5055	44	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	DEC	2014	67			S	SI		111	121		10.1016/j.ijmultiphaseflow.2014.05.008		11	Mechanics	Mechanics	AU8CC	WOS:000345823200012		
J	Percival, JR; Pavlidis, D; Xie, ZH; Gomes, JLM; Sakai, M; Shigeto, Y; Takahashi, H; Matar, OK; Pain, CC				Percival, James R.; Pavlidis, Dimitrios; Xie, Zhihua; Gomes, Jefferson L. M.; Sakai, Mikio; Shigeto, Yusuke; Takahashi, Hiroyuki; Matar, Omar K.; Pain, Christopher C.			Control volume finite element modelling of segregation of sand and granular flows in fluidized beds	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Mesh adaptivity; Finite element method; Granular flow; Two fluid model; Polydispersity; Fluidized beds	REYNOLDS-NUMBER; SIMULATION; DRAG; MIXTURES; HYDRODYNAMICS; SUSPENSIONS; REFINEMENT; SYSTEMS; DENSE; CFD	This paper presents a computational methodology for the two and three dimensional numerical simulation of dense and dilute dispersed particles in multiphase gas-solid and liquid-solid flows. The model equations are based on the two fluids approximation, with closure terms for the fluid-solid drag interaction forces and the additional dense collisional terms arising from particle-particle interactions under the kinetic theory. These equations are discretized and solved using a novel unstructured mesh control volume-finite element framework, with an anisotropic mesh adaptivity capability. The methodology is applied to study the transport of sand particles of various sizes in fluidized beds, as well as particle segregation in a polydisperse system containing three solid particle sizes. (C) 2014 Elsevier Ltd. All rights reserved.	[Percival, James R.; Pavlidis, Dimitrios; Xie, Zhihua; Pain, Christopher C.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, Appl Modelling & Computat Grp, London SW7 2AZ, England; [Xie, Zhihua; Matar, Omar K.] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England; [Gomes, Jefferson L. M.] Univ Aberdeen, Sch Engn, Environm & Ind Fluid Mech Grp, Aberdeen AB9 1FX, Scotland; [Sakai, Mikio] Univ Tokyo, Sch Engn, Resilience Engn Res Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Shigeto, Yusuke] Univ Tokyo, Sch Engn, Dept Syst Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Takahashi, Hiroyuki] Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan	Percival, JR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, Appl Modelling & Computat Grp, London SW7 2AZ, England.	j.percival@imperial.ac.uk			EPSRC [EP/K003976/1]; EPSRC Computational modelling for advanced nuclear power plants project; EU FP7 project THINS; EU FP7 project GoFastR	We would like to thank the EPSRC MEMPHIS multiphase Programme Grant (number EP/K003976/1), the EPSRC Computational modelling for advanced nuclear power plants project and the EU FP7 projects THINS and GoFastR for helping to fund this work.	Pain CC, 2002, POWDER TECHNOL, V128, P56, DOI 10.1016/S0032-5910(02)00167-5; GELDART D, 1973, POWDER TECHNOL, V7, P285, DOI 10.1016/0032-5910(73)80037-3; Pain CC, 2001, COMPUT METHOD APPL M, V190, P3771, DOI 10.1016/S0045-7825(00)00294-2; VERFURTH R, 1994, J COMPUT APPL MATH, V50, P67, DOI 10.1016/0377-0427(94)90290-9; Sakai M, 2014, CHEM ENG J, V244, P33, DOI 10.1016/j.cej.2014.01.029; Wang W, 2010, INT J MULTIPHAS FLOW, V36, P109, DOI 10.1016/j.ijmultiphaseflow.2009.01.008; GELDART D, 1990, POWDER TECHNOL, V62, P243, DOI 10.1016/0032-5910(90)80111-B; Yin XL, 2009, AICHE J, V55, P1352, DOI 10.1002/aic.11800; Tenneti S, 2011, INT J MULTIPHAS FLOW, V37, P1072, DOI 10.1016/j.ijmultiphaseflow.2011.05.010; Farrell PE, 2009, COMPUT METHOD APPL M, V198, P2632, DOI 10.1016/j.cma.2009.03.004; Sakai M, 2012, ADV POWDER TECHNOL, V23, P673, DOI 10.1016/j.apt.2011.08.006; Neri A, 2000, AICHE J, V46, P52, DOI 10.1002/aic.690460108; Feng YQ, 2010, IND ENG CHEM RES, V49, P3459, DOI 10.1021/ie901478a; Taghipour F, 2005, CHEM ENG SCI, V60, P6857, DOI 10.1016/j.ces.2005.05.044; Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006; WEN CY, 1966, AICHE J, V12, P610, DOI 10.1002/aic.690120343; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Di Renzo A, 2008, POWDER TECHNOL, V184, P214, DOI 10.1016/j.powtec.2007.11.031; Sakai M, 2010, INT J NUMER METH FL, V64, P1319, DOI 10.1002/fld.2364; Cello F, 2010, CHEM ENG SCI, V65, P3128, DOI 10.1016/j.ces.2010.02.006; Xiong QG, 2011, CHEM ENG SCI, V66, P1859, DOI 10.1016/j.ces.2011.01.033; Benyahia S, 2006, POWDER TECHNOL, V162, P166, DOI 10.1016/j.powtec.2005.12.014; Chapman S., 1970, MATH THEORY NONUNIFO; Delebarre A., 2004, CHEM ENG RES DES, V82, P567; Doron P, 1997, INT J MULTIPHAS FLOW, V23, P313, DOI 10.1016/S0301-9322(97)80946-9; Dosta M, 2012, CHEM ENG TECHNOL, V35, P1373, DOI 10.1002/ceat.201200075; DOUEK RS, 1995, AICHE J, V41, P2508, DOI 10.1002/aic.690411116; Enwald H, 1996, INT J MULTIPHAS FLOW, V22, P21, DOI 10.1016/S0301-9322(96)90004-X; Gidaspow D., 1994, MULTIPHASE FLOW FLUI; Gomes JLMA, 2007, HEAT TRANSFER ENG, V28, P576, DOI 10.1080/01457630701194011; Hewitt G., 2005, PREDICTION TURBULENT; Hiester HR, 2011, OCEAN MODEL, V38, P1, DOI 10.1016/j.ocemod.2011.01.003; Jacobs C. T., 2012, GEOPHYS J INT, V192, P647, DOI 10. 1093/ gji/ ggs059; Luding S, 2009, NONLINEARITY, V22, pR101, DOI 10.1088/0951-7715/22/12/R01; Mostaghimi P., 2013, J ENG MATH, P1; Olaofe OO, 2014, CHEM ENG SCI, V108, P258, DOI 10.1016/j.ces.2014.01.009; Pavlidis D., 2014, INT J MULTIPHASE FLO; Peraire J, 1997, FINITE ELEM ANAL DES, V25, P343, DOI 10.1016/S0168-874X(96)00055-8; Syamlal M., 1987, PARTICLE PARTICLE DR, P188; Tagliaferri C, 2013, CHEM ENG SCI, V102, P324, DOI 10.1016/j.ces.2013.08.015; van Sint Annaland M, 2009, Chemical Engineering Science, V64, DOI 10.1016/j.ces.2009.06.043; Weller H., 2008, PHILOS T R SOC A, V367, P4523; Yang W C, 2003, HDB FLUIDIZATION FLU	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	DEC	2014	67			S	SI		191	199		10.1016/j.ijmultiphaseflow.2014.10.002		9	Mechanics	Mechanics	AU8CC	WOS:000345823200019		
J	Yamashita, Y; Sano, N; Shimohira, D; Danjo, A; Goto, M				Yamashita, Y.; Sano, N.; Shimohira, D.; Danjo, A.; Goto, M.			A parallel-group comparison study of celecoxib with loxoprofen sodium in third mandibular molar extraction patients	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						celecoxib; loxoprofen sodium; post-exodontic pain; non-steroidal anti-inflammatory drugs; analgesic effect	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; CYCLOOXYGENASE-2 INHIBITOR; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; DOUBLE-BLIND; OSTEOARTHRITIS; EFFICACY; JAPAN; ASSOCIATION	Non-steroidal anti-inflammatory drugs (NSAIDs) are used widely, but they may damage the upper gastrointestinal mucosa owing to their mechanism of action. Selective cyclooxygenase 2 (COX-2) inhibitors are known to have a reduced risk for such damage. In this comparative study, the efficacy and safety of the selective COX-2 inhibitor celecoxib for pain after third mandibular molar extraction were compared with those of loxoprofen sodium. This was a parallel-group comparison study; 107 patients who had undergone third mandibular molar extraction were given celecoxib and 102 were given loxoprofen. The level of pain on a visual analogue scale (VAS) 15 min and 30 min after taking the experimental drug decreased over time, with no significant difference between the two groups. The percentage of patients taking a second dose was 64.5% for celecoxib and 80.4% for loxoprofen. The time to second dose was significantly longer for celecoxib (533.5 min) than for loxoprofen (387.4 min). There was no significant difference in the patients' impression of efficacy between the two groups, with ratings of 'excellent' and 'good' for 77.4% in the loxoprofen group and 74.5% in the celecoxib group. These results demonstrate that celecoxib is of equal clinical value to loxoprofen for acute pain after third mandibular molar extraction.	[Yamashita, Y.; Sano, N.; Shimohira, D.; Danjo, A.; Goto, M.] Saga Univ, Fac Med, Dept Oral & Maxillofacial Surg, Saga 8498501, Japan	Yamashita, Y (reprint author), Saga Univ, Fac Med, Dept Oral & Maxillofacial Surg, 5-1-1 Nabeshima, Saga 8498501, Japan.	yamashy2@cc.saga-u.ac.jp					Bensen WG, 1999, MAYO CLIN PROC, V74, P1095; Leese PT, 2000, J CLIN PHARMACOL, V40, P124, DOI 10.1177/00912700022008766; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Sakamoto C, 2006, EUR J CLIN PHARMACOL, V62, P765, DOI 10.1007/s00228-006-0171-6; Chan FKL, 2010, LANCET, V376, P173, DOI 10.1016/S0140-6736(10)60673-3; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Mizukami K, 2013, DIGEST ENDOSC, V25, P288, DOI 10.1111/j.1443-1661.2012.01379.x; MacDonald TM, 1997, BRIT MED J, V315, P1333; GABRIEL SE, 1991, ANN INTERN MED, V115, P787; Becker Daniel E, 2010, Anesth Prog, V57, P67, DOI 10.2344/0003-3006-57.2.67; Cheung R, 2007, CLIN THER, V29, P2498, DOI 10.1016/j.clinthera.2007.12.008; Goldstein JL, 2000, J RHEUMATOL, V27, P25; Jain Neha, 2011, J Maxillofac Oral Surg, V10, P118, DOI 10.1007/s12663-011-0198-9; Japanese Society of Gastroenterology, 2009, GUID MAN PEPT ULC; Khan AA, 2002, CLIN PHARMACOL THER, V72, P44, DOI 10.1067/mcp.2002.125560; Klasser Gary D, 2005, J Can Dent Assoc, V71, P575; Niculescu L, 2009, CURR MED RES OPIN, V25, P729, DOI 10.1185/03007990802714382 ; Saito K, 2012, CLIN THER, V34, P314, DOI 10.1016/j.clinthera.2012.01.004; Sakamoto C, 2011, DIGESTION, V83, P108, DOI 10.1159/000318746; Sakamoto C, 2013, ALIMENT PHARM THER, V37, P346, DOI 10.1111/apt.12174; Shirota T, 2001, ORAL THER PHARM, V20, P154; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; Yajima H, 2006, THER RES, V27, P1211	23	2	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	DEC	2014	43	12					1509	1513		10.1016/j.ijom.2014.09.002		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AU8BO	WOS:000345821900017		
J	Osada, T; Miura, H				Osada, Toshiko; Miura, Hideshi			DYNAMIC FRACTURE CHARACTERISTICS OF INJECTION MOLDED TITANIUM ALLOY COMPACTS	INTERNATIONAL JOURNAL OF POWDER METALLURGY			English	Article								Dynamic fracture characteristics are important for the application of titanium and its alloys in various industrial fields. The fatigue properties of metal injection molded (MIM) titanium and Ti-6Al-4V(lozenge) compacts were evaluated. Fatigue strength in rotating bending was found to be about one-third of the static tensile strength; this is attributed to cracking initiated at surface pores. With the addition of chromium or TiB2 to Ti-6Al-4V, the sintered compacts exhibited a fine grain size, resulting in higher fatigue strength. Hot isostatic pressing (HIP) was used to further consolidate chromium-containing Ti-6Al-4V, resulting in >99% of the pore-free density (PFD) and an attendant fatigue strength >350 MPa. Crack-propagation behavior was studied by surface replication of Ti-6Al-4V specimens containing chromium at 80% fatigue life to understand the role of residual porosity. Surface cracks were present running from pore to pore, thereby limiting fatigue strength.	[Osada, Toshiko; Miura, Hideshi] Kyushu Univ, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan	Osada, T (reprint author), Kyushu Univ, Dept Mech Engn, Nishi Ku, 744 Motoolca, Fukuoka 8190395, Japan.	miura@mech.kyushu-u.ac.jp					Akahori T, 1998, J JPN I MET, V62, P952; Ferri OM, 2009, MAT SCI ENG A-STRUCT, V504, P107, DOI 10.1016/j.msea.2008.10.039; Hasegawa M., 1973, STAINLESS STEEL HDB; Huang W.Y., 2012, APPL MECH MAT, V229-231, P1; Itoh Y., 2009, J JAPAN SOC POWDER P, V56, P253; Itoh Y., 2009, J JAPAN SOC POWDER P, V56, P259; Miura H., 2006, J JAPAN SOC POWDER P, V53, P815, DOI 10.2497/jjspm.53.815; Osada T., 2008, J JPN SOC POWDER MET, V55, P726, DOI 10.2497/jjspm.55.726	8	1	1	AMER POWDER METALLURGY INST	PRINCETON	105 COLLEGE ROAD EAST, PRINCETON, NJ 08540 USA	0888-7462			INT J POWDER METALL	Int. J. Powder Metall.	WIN	2014	50	1					25	30				6	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AW1IZ	WOS:000346044500005		
J	Yonezawa, T; Yoshimura, T; Umeda, J; Kondoh, K; Souba, R				Yonezawa, Takayuki; Yoshimura, Tomohiro; Umeda, Junko; Kondoh, Katsuyoshi; Souba, Ryouichi			MICROSTRUCTURES AND MECHANICAL PROPERTIES OF SINTERED AND EXTRUDED TiNi SHAPE-MEMORY ALLOYS USING PREALLOYED POWDER WITH ADDITIONS OF TiO2 POWDER	INTERNATIONAL JOURNAL OF POWDER METALLURGY			English	Article							MARTENSITIC-TRANSFORMATION; AGING TREATMENT; NI-ALLOY; BEHAVIOR; SURFACE; SUPERELASTICITY; BINARY	Microstructures and mechanical properties, in particular the plateautensile stress and shaperecovery performance, of sintered and extruded TiNi shape-memory alloys (SMAs) were investigated. Powder blends of TiNi and TiO2 were consolidated by spark plasma sintering (SPS) and then extruded and heat treated. Ti-rich Ti4Ni(2)O formed in the SPS-consolidated compacts via reactions between the TiNi matrix and oxygen from the TiO2 additives. This resulted in an increase in the solute content of nickel in the matrix and a decrease in the martensitic transformation temperature (M-s). Consequently, the heat-treated TiNi alloy with an addition of 1.0 v/o TiO2 particles showed a high plateau stress of 524 MPa at ambient temperature and excellent shape-recovery performance (89.3%) for 8% strain in tension.	[Yonezawa, Takayuki; Yoshimura, Tomohiro; Umeda, Junko; Kondoh, Katsuyoshi] Osaka Univ, Joining & Welding Res Inst, Kondoh Lab, Ibaraki, Osaka, Japan; [Souba, Ryouichi] TERUMO Co, Kanagawa, Japan	Yonezawa, T (reprint author), Osaka Univ, Joining & Welding Res Inst, Kondoh Lab, 11-1 Mihogaoka, Ibaraki, Osaka, Japan.	yonezawa-t@jwri.osalca-u.ac.jp			S-Innovation (Strategic Promotion of Innovative Research and Development), Japan Science and Technology Agency (JST)	This work was supported by S-Innovation (Strategic Promotion of Innovative Research and Development), Japan Science and Technology Agency (JST).	Allafi J. K., 2010, MAT SCI ENG C, V30, P1; KATO M, 1984, PHYS STATUS SOLIDI B, V123, P415, DOI 10.1002/pssb.2221230203; Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019; Tang WJ, 1997, METALL MATER TRANS A, V28, P537, DOI 10.1007/s11661-997-0041-6; Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001; Helm D, 2003, INT J SOLIDS STRUCT, V40, P827, DOI 10.1016/S0020-7683(02)00621-2; Yang WE, 2010, THIN SOLID FILMS, V518, P7545, DOI 10.1016/j.tsf.2010.05.045; Zheng YF, 2008, ACTA MATER, V56, P736, DOI 10.1016/j.actamat.2007.10.020; Bose A, 2007, STROKE, V38, P1531, DOI 10.1161/STROKEAHA.106.477711; Miyazaki S, 1999, MAT SCI ENG A-STRUCT, V273, P106, DOI 10.1016/S0921-5093(99)00292-0; Nam TH, 2002, MATER LETT, V52, P234, DOI 10.1016/S0167-577X(01)00424-4; Kim YW, 2013, MATER RES BULL, V48, P5045, DOI 10.1016/j.materresbull.2013.04.030; Dolce M, 2001, INT J MECH SCI, V43, P2657, DOI 10.1016/S0020-7403(01)00050-9; Cai W, 2005, CURR OPIN SOLID ST M, V9, P296, DOI 10.1016/j.cossms.2006.07.002; Chuprina VG, 2002, POWDER METALL MET C+, V41, P85, DOI 10.1023/A:1016020800727; Filip P, 2001, BIOMATERIALS, V22, P2131, DOI 10.1016/S0142-9612(00)00404-X; Lina H. C., 1999, J ALLOY COMPD, V284, P213; Nishida M, 2003, MATER TRANS, V44, P2631, DOI 10.2320/matertrans.44.2631; Shugo Y., 1985, B RES I MIN PRESS ME, V41, P23; Takeda K, 2012, MATER TRANS, V53, P217, DOI 10.2320/matertrans.M2011288; Vojtech D, 2011, MAT SCI ENG A-STRUCT, V528, P1864, DOI 10.1016/j.msea.2010.10.043; Wu SK, 2006, MAT SCI ENG A-STRUCT, V438, P536, DOI 10.1016/j.msea.2005.12.059; Wu SK, 2000, MATER CHEM PHYS, V64, P81, DOI 10.1016/S0254-0584(99)00258-8; Zhao H, 2012, J MATER ENG PERFORM, V21, P2566, DOI 10.1007/s11665-012-0373-2	24	0	0	AMER POWDER METALLURGY INST	PRINCETON	105 COLLEGE ROAD EAST, PRINCETON, NJ 08540 USA	0888-7462			INT J POWDER METALL	Int. J. Powder Metall.	WIN	2014	50	1					33	39				7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AW1IZ	WOS:000346044500006		
J	Yang, YF; Imai, H; Kondoh, K; Qian, M				Yang, Ya Feng; Imai, Hisashi; Kondoh, Katsuyoshi; Qian, Ma			COMPARISON OF SPARK PLASMA SINTERING OF ELEMENTAL AND MASTER ALLOY POWDER MIXES AND PREALLOYED Ti-6Al-4V POWDER	INTERNATIONAL JOURNAL OF POWDER METALLURGY			English	Article							MECHANICAL-PROPERTIES; TITANIUM; CONSOLIDATION; COMPACTION; FIELD	Spark plasma sintering (SPS) has been used to fabricate Ti-6Al-4V from elemental titanium and 60Al-40V master alloy powder mixes (EM powder mixes) and prealloyed (PA) Ti-6Al-4V powder. The use of EM powder mixes resulted in rapid near-pore-free densification (5 min at >= 900 degrees C under 30 MPa) and noticeably higher yield strength (YS) and tensile elongation than did the use of PA powder. In addition, the homogenization of vanadium in Ti-6Al-4V was accelerated significantly by SPS (completed in 15 min at 1,100 degrees C under 30 MPa). Also, unlike conventional powder metallurgy (PM), the sintered density was essentially independent of the titanium powder size and master alloy powder size in SPS. Densification occurs primarily by plastic deformation of the titanium powder particles. SPS is effective in consolidating Ti-6Al-4V from EM powder mixes and produces excellent tensile properties (UTS = 1,037 MPa, YS = 929 MPa, elongation = 22%).	[Yang, Ya Feng; Qian, Ma] Univ Queensland, Sch Mech & Min Engn, ARC Ctr Excellence Design Light Met, Brisbane, Qld 4072, Australia; [Imai, Hisashi; Kondoh, Katsuyoshi] Osaka Univ, Joining & Welding Res Inst, Osaka, Japan; [Qian, Ma] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3001, Australia	Yang, YF (reprint author), Univ Queensland, Sch Mech & Min Engn, ARC Ctr Excellence Design Light Met, Brisbane, Qld 4072, Australia.	ma.qian@rmit.edu.au			Queensland Government through a Queensland International Fellowship; University of Queensland through an Early Career Researcher Grant; ARC Centre of Excellence for Design in Light Metals	This work was funded by the Queensland Government through a Queensland International Fellowship for Y.F. Yang and by The University of Queensland through an Early Career Researcher Grant. Support from the ARC Centre of Excellence for Design in Light Metals is also acknowledged.	Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Qian M, 2010, INT J POWDER METALL, V46, P29; Groza JR, 2000, MAT SCI ENG A-STRUCT, V287, P171, DOI 10.1016/S0921-5093(00)00771-1; Mamedov V, 2002, POWDER METALL, V45, P322, DOI 10.1179/003258902225007041; EPPELSHEIMER DS, 1950, NATURE, V166, P960, DOI 10.1038/166960a0; Eriksson M, 2005, POWDER METALL, V48, P231, DOI 10.1179/174329005X71939; Ertorer O, 2011, METALL MATER TRANS A, V42A, P964, DOI 10.1007/s11661-010-0499-5; Ivasishin OM, 2010, KEY ENG MAT, V436, P113, DOI 10.4028/www.scientific.net/KEM.436.113; Izui H, 2012, MATER SCI FORUM, V706-709, P217, DOI 10.4028/www.scientific.net/MSF.706-709.217; Luo SD, 2014, J MATER PROCESS TECH, V214, P660, DOI 10.1016/j.jmatprotec.2013.10.010; Omori M, 2000, MAT SCI ENG A-STRUCT, V287, P183, DOI 10.1016/S0921-5093(00)00773-5; Tokita M., 1993, J SOC POWDER TECH JA, V30, P790; Yang YF, 2011, MAT SCI ENG A-STRUCT, V528, P6719, DOI 10.1016/j.msea.2011.05.041; Yoshimura T., 2009, T JWRI, V38, P37; Zadra M, 2008, POWDER METALL, V51, P59, DOI 10.1179/174329008X277000	15	1	1	AMER POWDER METALLURGY INST	PRINCETON	105 COLLEGE ROAD EAST, PRINCETON, NJ 08540 USA	0888-7462			INT J POWDER METALL	Int. J. Powder Metall.	WIN	2014	50	1					41	47				7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AW1IZ	WOS:000346044500007		
J	Miyashita, M; Takahashi, M; Burns, S				Miyashita, M.; Takahashi, M.; Burns, S.			Increased Participation in Weekend Physical Activity Reduces Postprandial Lipemia in Postmenopausal Women	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						physical activity; postprandial triacylglycerol; real-life setting; postmenopausal women	NONFASTING TRIGLYCERIDES; LIPOPROTEIN-LIPASE; ENERGY-EXPENDITURE; MODERATE EXERCISE; METABOLISM; MEN; HEALTH; ADULTS; TRIAL; ASSOCIATION	This study examined the acute effect of increased participation in weekend physical activity on postprandial lipemia in postmenopausal women. Ten postmenopausal women, aged 63 +/- 4 years (mean +/- SD), completed 2 trials in a random order: 1) control trial and 2) active trial. In the control trial, participants maintained their usual weekend lifestyle. In the active trial, participants increased their weekend activities above their usual lifestyle levels, freely deciding the duration and intensity of their chosen activities. On Monday of each trial, participants rested and consumed a standardised breakfast and lunch. Capillary blood samples were collected in the fasted state (0h) and at 2, 4 and 6h after eating. In the active trial, participants increased their moderate to vigorous weekend physical activity by 16min (mean +/- SD: 12.3 +/- 6.7min vs. 27.9 +/- 11.9min, P=0.009). Area under the capillary triacylglycerol concentration vs. time curve was 13% lower in the active trial than control trial (8.8 +/- 3.8 vs. 10.1 +/- 3.9mmol/L.6h, P=0.024). These findings demonstrate that small increases in moderate to vigorous physical activity under a real-life setting lowers postprandial lipemia in postmenopausal women.	[Miyashita, M.] Tokyo Gakugei Univ, Dept Hlth & Sports Sci, Koganei, Tokyo 1848501, Japan; [Takahashi, M.] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Burns, S.] Nanyang Technol Univ, Phys Educ & Sports Sci Acad Grp, Singapore 639798, Singapore	Miyashita, M (reprint author), Tokyo Gakugei Univ, Dept Hlth & Sports Sci, 4-1-1 Nukuikitamachi, Koganei, Tokyo 1848501, Japan.	masashi@u-gakugei.ac.jp			Japan Society for the Promotion of Science [24700763]	None of the authors report any conflict of interest or financial interest with respect to this work. The authors are grateful to Miss Kyoko Kashiwabara, Miss Saki Kawaguchi and Mr Jyunpei Yamagami for their help with data collection. MM received the funding support for this study from the Japan Society for the Promotion of Science, Grant-in-Aid for young scientists (No.24700763, 2012-2013).	King JA, 2011, J CLIN ENDOCR METAB, V96, P1114, DOI 10.1210/jc.2010-2735; Ayabe M, 2012, EUR J APPL PHYSIOL, V112, P3525, DOI 10.1007/s00421-012-2342-8; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Tan MS, 2013, J SPORT SCI, V31, P989, DOI 10.1080/02640414.2012.759661; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1249/mss.0b013e3180616b27; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Treuth MS, 2007, OBESITY, V15, P1782, DOI 10.1038/oby.2007.212; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Zhang JQ, 2004, CAN J APPL PHYSIOL, V29, P590; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Peddie MC, 2012, PROG LIPID RES, V51, P11, DOI 10.1016/j.plipres.2011.11.002; Miyashita M, 2011, INT J SPORTS MED, V32, P829, DOI 10.1055/s-0031-1279770; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; King JA, 2010, APPETITE, V54, P492, DOI 10.1016/j.appet.2010.02.002; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Burton FL, 2008, INT J OBESITY, V32, P481, DOI 10.1038/sj.ijo.0803754; Harrison M, 2009, J APPL PHYSIOL, V106, P943, DOI 10.1152/japplphysiol.91367.2008; Bezafibrate Infarction Prevention (BIP) Study, 2000, CIRCULATION, V102, P21; Chen CH, 2009, J PHYS ACT HEALTH, V6, P354; Ckenes S A, 2008, PREV MED, V46, P325; Gill JMR, 2001, EUR J CLIN INVEST, V31, P201, DOI 10.1046/j.1365-2362.2001.00799.x; Gill JMR, 2003, J CLIN ENDOCR METAB, V88, P4328, DOI 10.1210/jc.2003-030226; Harchaoui K E L, 2009, Curr Cardiol Rev, V5, P216, DOI 10.2174/157340309788970315; Hardman AE, 1998, J APPL PHYSIOL, V84, P1895; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; KARPE F, 1995, CURR OPIN LIPIDOL, V6, P123, DOI 10.1097/00041433-199506000-00003; Kesaniemi YA, 2001, MED SCI SPORT EXER, V33, pS351; Maraki MI, 2013, SPORTS MED, V43, P463, DOI 10.1007/s40279-013-0046-9; Ministry of Health Labour and Welfare, 2013, PHYS ACT GUID HLTH 2; Ministry of Health Labour and Welfare, 2009, 2008 DEATHS LEAD CAU; Miyashita M, 2012, J PHYS FITNESS SPORT, V1, P541; Murase N, 2002, J HLTH WELFARE STAT, V49, P1; Seip RL, 1998, EXERCISE SPORT SCI R, V26, P191; Tsetsonis NV, 1997, AM J CLIN NUTR, V65, P525	36	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	DEC	2014	35	13					1059	1064		10.1055/s-0034-1372641		6	Sport Sciences	Sport Sciences	AU7CJ	WOS:000345757800001		
J	Yoshida, S; Koga, F; Masuda, H; Fujii, Y; Kihara, K				Yoshida, Soichiro; Koga, Fumitaka; Masuda, Hitoshi; Fujii, Yasuhisa; Kihara, Kazunori			Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						biological marker; carcinoma; diffusion magnetic resonance imaging; transitional cell; ureteral neoplasms; urinary bladder neoplasms	INVASIVE BLADDER-CANCER; LOW-DOSE CHEMORADIOTHERAPY; URINARY-TRACT CANCER; INITIAL-EXPERIENCE; TRANSURETHRAL RESECTION; RECTAL-CARCINOMA; EAU GUIDELINES; EARLY RESPONSE; BRAIN-TUMORS; MRI	Diffusion-weighted magnetic resonance imaging is a type of functional imaging that is increasingly being applied in the management of upper tract urothelial carcinoma and bladder cancer. The image contrast is derived from differences in the Brownian motion of water molecules in tissues. The homogenous high signal intensity of upper tract urothelial carcinoma and bladder cancer on diffusion-weighted magnetic resonance imaging provides helpful diagnostic information for the presence of cancerous lesions in a non-invasive manner. Recently, growing evidence has emerged showing that diffusion-weighted magnetic resonance imaging can serve as an imaging biomarker for characterizing cancer pathophysiology, because the signal reflects biophysical information about the tissues. Quantitative analysis by evaluating the apparent diffusion coefficient values potentially reflects the histological grade and the biological aggressiveness of urothelial carcinoma. The apparent diffusion coefficient value could be a biomarker predicting the clinical course of upper tract urothelial carcinoma and bladder cancer. In addition, in chemoradiotherapy-based bladder-sparing approaches against muscle-invasive bladder cancer, the role of diffusion-weighted magnetic resonance imaging for predicting the chemoradiosensitivity and for monitoring therapeutic response has been shown. Diffusion-weighted magnetic resonance imaging is expected to improve the diagnostic accuracy, and this qualitative information might allow individualized treatment strategies for patients with urothelial carcinoma.	[Yoshida, Soichiro; Fujii, Yasuhisa; Kihara, Kazunori] Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Tokyo 1138519, Japan; [Koga, Fumitaka] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Tokyo, Japan; [Masuda, Hitoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan	Yoshida, S (reprint author), Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	s-yoshida.uro@tmd.ac.jp					Abou-El-Ghar ME, 2009, RADIOLOGY, V251, P415, DOI 10.1148/radiol.2503080723; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Akita H, 2011, AM J ROENTGENOL, V197, P1130, DOI 10.2214/AJR.10.6299; Matsumoto H, 2004, JPN J CLIN ONCOL, V34, P124, DOI 10.1093/jjco/hyh026; LEBIHAN D, 1986, RADIOLOGY, V161, P401; Kobayashi S, 2014, J MAGN RESON IMAGING, V39, P172, DOI 10.1002/jmri.24148; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Giannarini G, 2012, EUR UROL, V61, P326, DOI 10.1016/j.eururo.2011.09.019; Funatsu H, 2012, EUR J RADIOL, V81, P3115, DOI 10.1016/j.ejrad.2012.06.009; Sun YS, 2010, RADIOLOGY, V254, P170, DOI 10.1148/radiol.2541082230; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Liu Y, 2009, CLIN RADIOL, V64, P1067, DOI 10.1016/j.crad.2009.07.010; Mardor Y, 2004, NEOPLASIA, V6, P136, DOI 10.1593/neo.03349; DeVries AF, 2003, INT J RADIAT ONCOL, V56, P958, DOI 10.1016/S0360-3016(03)00208-6; El-Assmy A, 2009, EUR RADIOL, V19, P1575, DOI 10.1007/s00330-009-1340-7; Green DA, 2013, J UROLOGY, V189, P1214, DOI 10.1016/j.juro.2012.05.079; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Kamat AM, 2013, EUR UROL, V63, P4, DOI 10.1016/j.eururo.2012.09.057; Yoshida S, 2008, BJU INT, V101, P978, DOI 10.1111/j.1464-410X.2007.07408.x; Tanaka H, 2011, INT J UROL, V18, P727, DOI 10.1111/j.1442-2042.2011.02824.x; Yoshida S, 2013, EUR RADIOL, V23, P2206, DOI 10.1007/s00330-013-2805-2; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Watanabe H, 2009, AM J ROENTGENOL, V192, P1361, DOI 10.2214/AJR.08.1430; Takeuchi M, 2009, RADIOLOGY, V251, P112, DOI 10.1148/radiol.2511080873; Matsuki M, 2007, EUR RADIOL, V17, P201, DOI 10.1007/s00330-006-0281-7; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Kobayashi S, 2011, EUR RADIOL, V21, P2178, DOI 10.1007/s00330-011-2174-7; Raza SA, 2012, RADIOL CLIN N AM, V50, P1085, DOI 10.1016/j.rcl.2012.08.011; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Rojas CP, 2013, UROL ONCOL-SEMIN ORI, V31, P1696, DOI 10.1016/j.urolonc.2012.05.010; Einarsdottir H, 2004, EUR RADIOL, V14, P959, DOI 10.1007/s00330-004-2237-0; Yoshida S, 2012, INT J RADIAT ONCOL, V83, pE21, DOI 10.1016/j.ijrobp.2011.11.065; Nishizawa S, 2010, INT BRAZ J UROL, V36, P18, DOI 10.1590/S1677-55382010000100004; Chen CY, 2006, RADIOLOGY, V239, P448, DOI 10.1148/radiol.2392042202; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Margulis V, 2009, CANCER, V115, P1224, DOI 10.1002/cncr.24135; Avcu S, 2011, BRIT J RADIOL, V84, P875, DOI 10.1259/bjr/30591350; Dagulli M, 2011, UROL INT, V87, P346; Dobson MJ, 2001, CLIN RADIOL, V56, P94, DOI 10.1053/crad.2000.0560; El-Assmy A, 2008, THESCIENTIFICWORLDJO, V8, P364, DOI 10.1100/tsw.2008.55; El-Assmy A, 2012, BJU INT, V110, pE622, DOI 10.1111/j.1464-410X.2012.11345.x; Green DA, 2012, BJU INT, V110, P1463, DOI 10.1111/j.1464-410X.2012.11129.x; JOHNSON RJ, 1990, CLIN RADIOL, V41, P258, DOI 10.1016/S0009-9260(05)81661-7; Kageyama Y, 2000, JPN J CLIN ONCOL, V30, P553, DOI 10.1093/jjco/hyd138; Kageyama Y, 2003, AM J CLIN ONCOL-CANC, V26, P504, DOI 10.1097/01.coc.0000037665.11701.22; Kilickesmez O, 2009, DIAGN INTERV RADIOL, V15, P104; Koga F, 2012, INT J UROL, V19, P388, DOI 10.1111/j.1442-2042.2012.02974.x; Koga F, 2008, UROLOGY, V72, P384, DOI 10.1016/j.urology.2008.03.017; Padhani Anwar R, 2009, Neoplasia, V11, P102; Rodel C, 2000, INT J RADIAT ONCOL, V46, P1213, DOI 10.1016/S0360-3016(99)00544-1; Rosenkrantz AB, 2012, J MAGN RESON IMAGING, V35, P1478, DOI 10.1002/jmri.23590; Saito W, 2000, MAGN RESON IMAGING, V18, P411, DOI 10.1016/S0730-725X(00)00124-7; Sufana IA, 2013, WORLD J UROL, V31, P13; Takahara Taro, 2004, Radiat Med, V22, P275; Takeuchi M, 2012, ACAD RADIOL, V19, P827, DOI 10.1016/j.acra.2012.01.013; Takeuchi M, 2013, J MAGN RESON IMAGING, V38, P1299, DOI 10.1002/jmri.24227; Wang NF, 2012, EUR J RADIOL, V81, P1662, DOI 10.1016/j.ejrad.2011.03.047; Yoshida S, 2010, UROLOGY, V75, P387, DOI 10.1016/j.urology.2009.06.111; Yoshida S, 2008, INT J UROL, V15, P140, DOI 10.1111/j.1442-2042.2007.01950.x; Yoshida S, 2011, AM J ROENTGENOL, V196, P110, DOI 10.2214/AJR.10.4632	61	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	DEC	2014	21	12					1190	1200		10.1111/iju.12587		11	Urology & Nephrology	Urology & Nephrology	AU8MW	WOS:000345851400002		
J	Kohjimoto, Y; Kusumoto, H; Nishizawa, S; Kikkawa, K; Kodama, Y; Ko, M; Matsumura, N; Hara, I				Kohjimoto, Yasuo; Kusumoto, Hiroki; Nishizawa, Satoshi; Kikkawa, Kazuro; Kodama, Yoshiki; Ko, Motohiro; Matsumura, Nagahide; Hara, Isao			External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treated with bacillus Calmette-Guerin	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						bacillus Calmette-Guerin instillation therapy; non-muscle invasive bladder cancer; progression; recurrence; scoring system	EORTC RISK TABLES; UROTHELIAL CARCINOMA; CHINESE PATIENTS; IMMUNOTHERAPY; TRIALS	ObjectiveTo validate two prediction models (European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment) for recurrence and progression of non-muscle invasive bladder cancer in Japanese patients who underwent bacillus Calmette-Guerin instillation therapy. MethodsFrom March 1985 to April 2007, data were analyzed from 366 patients who underwent transurethral resection of bladder tumor followed by bacillus Calmette-Guerin instillation therapy. The ability of two scoring models to predict recurrence and progression was assessed by concordance index. ResultsFor recurrence probability, the concordance index of the European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment models was 0.514 and 0.576, respectively, which was lower than that (0.604) of a selected single prognostic factor (age) by our multivariate analysis. For progression probability, the concordance index of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment models was 0.693 and 0.764, respectively, which was higher than that (0.633) of a selected single factor (T stage) by our multivariate analysis. The Spanish Urological Club for Oncological Treatment scoring system resulted in better stratification of tumor recurrence and progression when compared with the European Organization for Research and Treatment of Cancer model, probably because more patients underwent bacillus Calmette-Guerin treatment in the Spanish Urological Club for Oncological Treatment cohort than in the European Organization for Research and Treatment of Cancer cohort. ConclusionsThe Spanish Urological Club for Oncological Treatment scoring system is a good predictor of tumor recurrence and progression in Japanese patients who underwent bacillus Calmette-Guerin immunotherapy. A large prospective study is warranted to confirm the efficacy of this system.	[Kohjimoto, Yasuo; Kusumoto, Hiroki; Nishizawa, Satoshi; Kikkawa, Kazuro; Kodama, Yoshiki; Ko, Motohiro; Matsumura, Nagahide; Hara, Isao] Wakayama Med Univ, Dept Urol, Wakayama 6418509, Japan	Kohjimoto, Y (reprint author), Wakayama Med Univ, Dept Urol, 811-1 Kimidera, Wakayama 6418509, Japan.	ykohji@wakayama-med.ac.jp					Altieri VM, 2012, UROL INT, V89, P61, DOI 10.1159/000336516; Rosevear HM, 2011, J UROLOGY, V185, P67, DOI 10.1016/j.juro.2010.08.083; Hernandez V, 2011, WORLD J UROL, V29, P409, DOI 10.1007/s00345-010-0635-2; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Ding WH, 2014, CANCER EPIDEMIOL, V38, P157, DOI 10.1016/j.canep.2014.02.001; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Fernandez-Gomez J, 2011, EUR UROL, V60, P423, DOI 10.1016/j.eururo.2011.05.033; Gontero P, 2010, EUR UROL, V57, P410, DOI 10.1016/j.eururo.2009.11.023; Xylinas E, 2013, BRIT J CANCER, V109, P1460, DOI 10.1038/bjc.2013.372; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1097/01.ju.0000034450.80198.1c; Herr HW, 2005, J UROLOGY, V174, P2134, DOI 10.1097/01.ju.0000181799.8119.fc; Joudi FN, 2006, J UROLOGY, V175, P9; Joudi FN, 2006, J UROLOGY, V175, P1634, DOI 10.1016/S0022-5347(05)00973-0; Kohjimoto Y, 2010, WORLD J UROL, V28, P425, DOI 10.1007/s00345-010-0514-x; LAMM DL, 1991, NEW ENGL J MED, V325, P1205, DOI 10.1056/NEJM199110243251703; Pillai R, 2011, THESCIENTIFICWORLDJO, V11, P751, DOI 10.1100/tsw.2011.77; Seo Kyung Won, 2010, Korean J Urol, V51, P165, DOI 10.4111/kju.2010.51.3.165; Sylvester RJ, 2006, EUR UROL, V49, P475, DOI DOI 10.1016/J.EURURO.2005.12.031; Xu TY, 2013, UROLOGY, V82, P387, DOI 10.1016/j.urology.2013.04.007	20	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	DEC	2014	21	12					1201	1207		10.1111/iju.12572		7	Urology & Nephrology	Urology & Nephrology	AU8MW	WOS:000345851400003		
J	Namiki, S; Kaiho, Y; Mitsuzuka, K; Saito, H; Yamada, S; Nakagawa, H; Ito, A; Arai, Y				Namiki, Shunichi; Kaiho, Yasuhiro; Mitsuzuka, Koji; Saito, Hideo; Yamada, Shigeyuki; Nakagawa, Haruo; Ito, Akihiro; Arai, Yoichi			Long-term quality of life after radical prostatectomy: 8-Year longitudinal study in Japan	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						prostate cancer; quality of life; questionnaires; radical prostatectomy	RETROPUBIC PROSTATECTOMY; SEXUAL FUNCTION; CANCER; OUTCOMES; IMPACT; BRACHYTHERAPY; CONTINENCE; SYMPTOMS; VALIDITY; THERAPY	ObjectivesTo assess long-term health-related quality of life in patients undergoing radical prostatectomy. MethodsA total of 120 patients with at least 5years of follow up after radical prostatectomy were included in the present study. Health-related quality of life outcomes were assessed using three questionnaires, the Short Form 36-Item Health Survey, the University of California, Los Angeles Prostate Cancer Index and the International Prostate Symptom Score. ResultsA total of 91 patients (73%) responded at a median follow-up time of 102months (range 85-123months). Among general health-related quality of life domains, mental and role composite summary score remained stable throughout the follow-up period. At the final survey, no significant differences were observed in any of the domains compared with the age-matched average score of the Japanese population. Although the slight decrease in urinary function scores and International Prostate Symptom Score beyond 5years postoperatively compared with 5years, the differences were not significant. The sexual function summary score showed a substantially lower score just after radical prostatectomy and remained at a deteriorated level (P<0.001). Responders at the final survey were more likely to report favorable general, urinary and sexual outcomes at 60months compared with non-responders. ConclusionsWhen taking age-related changes into account, general health-related quality of life seems to remain stable in the long term after radical prostatectomy: patients with favorable health-related quality of life outcomes during the first 5years after radical prostatectomy maintain favorable outcomes thereafter.	[Namiki, Shunichi; Kaiho, Yasuhiro; Mitsuzuka, Koji; Saito, Hideo; Yamada, Shigeyuki; Nakagawa, Haruo; Ito, Akihiro; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 9808574, Japan	Namiki, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Urol, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	namikin@uro.med.tohoku.ac.jp					Sivarajan G, 2014, EUR UROL, V65, P58, DOI 10.1016/j.eururo.2013.08.019; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Litwin MS, 2001, J UROLOGY, V166, P587, DOI 10.1016/S0022-5347(05)65989-7; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Lepor H, 2004, J UROLOGY, V171, P1216, DOI 10.1097/01.ju.0000113964.68020.a7; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Davis JW, 2001, J UROLOGY, V166, P947, DOI 10.1016/S0022-5347(05)65870-3; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Litwin MS, 2007, CANCER, V109, P2239, DOI 10.1002/cncr.22676; Huang GJ, 2010, J UROLOGY, V183, P2206, DOI 10.1016/j.juro.2010.02.013; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Montorsi F, 2012, EUR UROL, V62, P368, DOI 10.1016/j.eururo.2012.05.057; Wei JT, 2002, J CLIN ONCOL, V20, P557, DOI 10.1200/JCO.20.2.557; Miller DC, 2005, J CLIN ONCOL, V23, P2772, DOI 10.1200/JCO.2005.07.116; Walz J, 2007, J CLIN ONCOL, V25, P3576, DOI 10.1200/JCO.2006.10.3820; BARRY MJ, 1992, J UROLOGY, V148, P1549; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Davis JW, 2009, EUR UROL, V55, P1135, DOI 10.1016/j.eururo.2008.08.051; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Khemees TA, 2013, J UROLOGY, V189, P1432, DOI 10.1016/j.juro.2012.09.097; Kuwata Y, 2007, INT J UROL, V14, P510, DOI 10.1111/j.1442-2042.2006.01695.x; Mettlin CJ, 1997, CANCER, V80, P1814, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1814::AID-CNCR20>3.0.CO;2-7; Namiki S, 2006, UROLOGY, V68, P142, DOI 10.1016/j.urology.2006.01.030; Namiki S, 2007, J UROLOGY, V178, P212, DOI 10.1016/j.juro.2007.03.043; Namiki S, 2007, INT J UROL, V14, P186, DOI 10.1111/j.1442-2042.2007.01610.x; Namiki S, 2009, INT J UROL, V16, P75, DOI 10.1111/j.1442-2042.2008.02197.x; Naselli A, 2011, INT J UROL, V18, P76, DOI 10.1111/j.1442-2042.2010.02666.x; Penson DF, 2003, J UROLOGY, V169, P1458, DOI 10.1097/01.ju.0000054462.88306.43	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	DEC	2014	21	12					1220	1226		10.1111/iju.12586		7	Urology & Nephrology	Urology & Nephrology	AU8MW	WOS:000345851400007		
J	Maekawa, S; Suzuki, M; Arai, T; Suzuki, M; Kato, M; Morikawa, T; Kasuya, Y; Kume, H; Kitamura, T; Homma, Y				Maekawa, Shigekatsu; Suzuki, Motofumi; Arai, Tomio; Suzuki, Makoto; Kato, Moriaki; Morikawa, Teppei; Kasuya, Yutaka; Kume, Haruki; Kitamura, Tadaichi; Homma, Yukio			TMPRSS2 Met160Val polymorphism: Significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						latent prostate cancer; single nucleotide polymorphism; sporadic prostate cancer; TMPRSS2	GENE FUSIONS; POPULATION; RISK; ERG	ObjectivesTo investigate the association between the TMPRSS2 Met160Val polymorphism and the risk of prostate cancer in Japanese men. MethodsGenomic DNA samples from 518 Japanese sporadic prostate cancer patients, 433 controls and 154 Japanese men who were diagnosed as having latent prostate cancer based on autopsy results were genotyped for the TMPRSS2 Met160Val polymorphism using a TaqMan assay. Logistic regression analyses were carried out to estimate the odds ratios and 95% confidence intervals. The relationship between the presence of the polymorphism, and clinicopathology and survival was also examined. ResultsThe Tallele frequency of the control group was 0.372, of the sporadic prostate cancer group was 0.435 and of the latent prostate cancer group was 0.370. The CT and TT genotypes were significantly associated with risk for sporadic prostate cancer; age-adjusted odds ratios (95% confidence intervals) were 1.418 (1.027-1.960) for CT, 1.907 (1.224-2.990) for TT and 1.524 (1.123-2.072) for CT/TT genotypes. There was no significant association observed between the TMPRSS2 Met160Val polymorphism and the risk for latent prostate cancer. The TMPRSS2 Met160Val polymorphism was not significantly associated with any clinicopathological features or prognosis. ConclusionsThe TMPRSS2 Met160Val polymorphism is a genetic risk factor for sporadic prostate cancer in a Japanese population.	[Maekawa, Shigekatsu; Suzuki, Motofumi; Kume, Haruki; Kitamura, Tadaichi; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan; [Morikawa, Teppei] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan; [Suzuki, Motofumi] Tokyo Teishin Hosp, Dept Urol, Tokyo, Japan; [Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Kasuya, Yutaka] Tokyo Metropolitan Geriatr Hosp, Dept Urol, Tokyo 173, Japan; [Suzuki, Makoto] Sakuragi Cho Ocean Clin, Yokohama, Kanagawa, Japan; [Kato, Moriaki] Tokyo Yamate Med Ctr, Dept Urol, Tokyo, Japan	Suzuki, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	uromotofumi@gmail.com			Japan Society for the Promotion of Science [24592378]	We thank K Lee for his assistance with scientific English writing. This study was supported by a Grant-in-Aid for Scientific Research (No. 24592378) provided by the Japan Society for the Promotion of Science. The sponsors of this study did not participate in study design, data collection, data analysis, data interpretation, writing of the report or in the decision to publish.	Akamatsu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046454; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Kurosaki T, 2009, INT J UROL, V16, P364, DOI 10.1111/j.1442-2042.2009.02263.x; Choudhury AD, 2012, EUR UROL, V62, P577, DOI 10.1016/j.eururo.2012.05.054; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Liu M, 2011, PROSTATE, V71, P1023, DOI 10.1002/pros.21317; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Miyagi Y, 2010, MODERN PATHOL, V23, P1492, DOI 10.1038/modpathol.2010.149; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Nam RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/sj.bjc.6604054; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Rajput AB, 2007, J CLIN PATHOL, V60, P1238, DOI 10.1136/jcp.2006.043810; HART AH, 1995, ONCOGENE, V10, P1423; FitzGerald LM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-230; Giri VN, 2011, BJU INT, V107, P466, DOI 10.1111/j.1464-410X.2010.09522.x; Liu M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-37; Lubieniecka JM, 2004, PROSTATE, V59, P357, DOI 10.1002/pros.2005; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Sawabe M, 2004, MECH AGEING DEV, V125, P547, DOI 10.1016/j.mad.2004.06.005; Sreenath Taduru L, 2011, J Carcinog, V10, P37, DOI 10.4103/1477-3163.91122; Virginia AM, 2012, ANN INTERN MED, V157, P120	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	DEC	2014	21	12					1234	1238		10.1111/iju.12578		5	Urology & Nephrology	Urology & Nephrology	AU8MW	WOS:000345851400009		
J	Iwatsubo, E; Suzuki, M; Igawa, Y; Homma, Y				Iwatsubo, Eiji; Suzuki, Motofumi; Igawa, Yasuhiko; Homma, Yukio			Individually tailored ultrasound-assisted prompted voiding for institutionalized older adults with urinary incontinence	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						cognitive impairment; continence aids; dependent elderly; urinary incontinence; voiding function	NURSING-HOME RESIDENTS; PREVALENCE; PEOPLE; CARE	ObjectivesTo assess individually tailored ultrasound-assisted prompted voiding as a means of managing urinary incontinence in hospitalized elderly patients. MethodsA total of 88 incontinent elderly individuals who were inpatients in general hospitals were included. Each individual's mean bladder volume before starting to void (voided urine volume plus residual urine volume) was regarded as the optimal bladder volume. Bladder volume was regularly monitored with an ultrasound device, and when the urine volume had reached the individual's optimal bladder volume, the subject was prompted to void. The outcomes were evaluated on the basis of scores on a four-grade scale for items in six domains: urine volume, voiding function, urinary control, physical and cognitive function for toileting, and caregivers' burden in regard to continence care. The score for use of a pad/diaper, an item of urinary control domain, was used as the primary outcome measure. ResultsA total of 80 participants were included for analysis. After ultrasound-assisted prompted voiding care for a 4-week period, the score for use of a pad/diaper in 50 out of 80 participants (62.5%) had decreased, and 21 out of 80 participants (26.3%) no longer required the use of a pad/diaper at all. The scores of the other 30 out of 80 participants (37.5%) were unchanged. The improvement was not significantly affected by patients' backgrounds at baseline. The mean scores in the domains of urinary control, physical function, cognitive function and caregivers' burden improved significantly. ConclusionThe present preliminary study suggests that individually tailored ultrasound-assisted prompted voiding can improved urinary incontinence of institutionalized elderly patients. Further studies are worth carrying out.	[Iwatsubo, Eiji] Kitakyushu Koga Hosp, Dept Internal Med & Urinary Care, Fukuoka, Japan; [Suzuki, Motofumi; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan; [Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138655, Japan	Homma, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	homma-uro@umin.ac.jp			Japanese Society of Geriatric Urology	Financial support for this study was provided by the Japanese Society of Geriatric Urology in 2009. The sponsor of this study had no role in the design, methods, subject recruitment, data collections, analysis or preparation of the paper. We thank the following care staff and doctors for their cooperation in the performance of this study: Toyoko Yamato, Einosuke Nakashita, Kimitoshi Nakahara, Tetsu Kousaka, Katsuki Tsuchiyama, Ken-ichi Kameda, Yoshitaka Aoki, Hiromi Sanematsu, Emi Ozawa, Akinori Horii, Yoshiko Takasaki, Kayoko Aoki, Satomi Kubota, Kyoko Ito and Hiromi Monden.	Alaqiakrishnan K, 2009, CAN FAM PHYSICIAN, V55, P163; Sgadari A, 1997, AGE AGEING, V26, P49; ZARIT SH, 1980, GERONTOLOGIST, V20, P649; Offermans MPW, 2009, NEUROUROL URODYNAM, V28, P288, DOI 10.1002/nau.20668; Nelson R, 2001, J AGING HEALTH, V13, P539, DOI 10.1177/089826430101300406; DuBeau CE, 2010, NEUROUROL URODYNAM, V29, P165, DOI 10.1002/nau.20842; Brandeis GH, 1997, J AM GERIATR SOC, V45, P179; Carlowe J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4688; COLLING J, 1992, J AM GERIATR SOC, V40, P135; Coppola L, 2002, ARCH GERONTOL GERIAT, V35, P27, DOI 10.1016/S0167-4943(01)00213-8; DelSer T, 1996, NEUROLOGY, V46, P682; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gotoh M, 2001, J NEUROGENIC BLADDER, V12, P207; HADLEY EC, 1986, JAMA-J AM MED ASSOC, V256, P372, DOI 10.1001/jama.256.3.372; HU TW, 1989, JAMA-J AM MED ASSOC, V261, P2656, DOI 10.1001/jama.261.18.2656; MAHONEY F I, 1965, Md State Med J, V14, P61; Ouslander JG, 2001, J AM GERIATR SOC, V49, P706, DOI 10.1046/j.1532-5415.2001.49145.x; OUSLANDER JG, 1982, JAMA-J AM MED ASSOC, V248, P1194, DOI 10.1001/jama.248.10.1194; SCHNELLE JF, 1989, J AM GERIATR SOC, V37, P1051; Sexer S, 2005, SWISS MED WEEKLY, V135, P495; Tanaka Y, 2009, ARCH GERONTOL GERIAT, V49, P278, DOI 10.1016/j.archger.2008.10.006; Valk M, 2002, ARCH GERONTOL GERIAT, V34, P79, DOI 10.1016/S0167-4943(01)00197-2	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	DEC	2014	21	12					1253	1257		10.1111/iju.12569		5	Urology & Nephrology	Urology & Nephrology	AU8MW	WOS:000345851400012		
J	Wada, N; Matsumoto, S; Kita, M; Hashizume, K; Kakizaki, H				Wada, Naoki; Matsumoto, Seiji; Kita, Masafumi; Hashizume, Kazumi; Kakizaki, Hidehiro			Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						benign prostatic hyperplasia; dutasteride; lower urinary tract symptoms; nerve growth factor	CYSTITIS/BLADDER PAIN SYNDROME; OVERACTIVE BLADDER; FACTOR LEVEL; THERAPY; CANCER; BIOMARKER	ObjectivesTo examine urinary nerve growth factor before and after dutasteride treatment, and to analyze correlations between clinical parameters and change of urinary nerve growth factor in patients with benign prostatic enlargement. MethodsWe prospectively studied 30 patients with benign prostatic enlargement who had not been satisfied with -adrenergic antagonist monotherapy for more than 3 months. Before and 24 weeks after dutasteride add-on treatment, we assessed International Prostate Symptom Score, prostatic volume, filling cystometry and pressure-flow study. Urinary nerve growth factor was measured by enzyme-linked immunosorbent assay, and normalized to the urinary creatinine (nerve growth factor/creatinine) before and 24 weeks after dutasteride add-on treatment. ResultsIn baseline characteristics before dutasteride, there was no significant correlation between urinary nerve growth factor/creatinine and any clinical parameters including age, International Prostate Symptom Score, prostatic volume, presence of detrusor overactivity, detrusor pressure at maximum flow rate, bladder outlet obstruction index or bladder contractility index. Dutasteride significantly reduced prostatic volume (from 6831mL to 49 +/- 28mL) and improved International Prostate Symptom Score (from 17.2 +/- 8.7 to 13.1 +/- 6.8), storage (from 8.0 +/- 4.3 to 6.0 +/- 2.9) and voiding symptom subscore of International Prostate Symptom Score (from 9.3 +/- 5.7 to 7.1 +/- 4.5). In urodynamic study, detrusor pressure at maximum flow rate (from 77 +/- 32cmH(2)O to 59 +/- 24cmH(2)O) and bladder outlet obstruction index (from 62 +/- 32 to 42 +/- 27) were significantly decreased after dutasteride treatment. Urinary nerve growth factor/creatinine was significantly decreased after dutasteride from 2.61 +/- 2.50 to 1.64 +/- 1.68. The change of urinary nerve growth factor/creatinine significantly correlated only with the change of prostatic volume (r=0.38) and bladder outlet obstruction index (r=0.36). ConclusionsUrinary nerve growth factor decreases in association with reduction of prostatic volume and relief of bladder outlet obstruction. Urinary nerve growth factor might be useful as a biomarker to monitor the improvement of bladder outlet obstruction in patients with benign prostatic enlargement.	[Wada, Naoki; Matsumoto, Seiji; Kita, Masafumi; Hashizume, Kazumi; Kakizaki, Hidehiro] Asahikawa Med Univ, Dept Renal & Urol Surg, Asahikawa, Hokkaido 0788510, Japan	Wada, N (reprint author), Asahikawa Med Univ, Dept Renal & Urol Surg, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	nwada@asahikawa-med.ac.jp					Yokoyama T, 2008, NEUROUROL URODYNAM, V27, P417, DOI 10.1002/nau.20519; Abrams P, 1999, BJU INT, V84, P14; Liu HT, 2008, UROLOGY, V72, P104, DOI 10.1016/j.urology.2008.01.069; Liu HT, 2009, BJU INT, V103, P1668, DOI 10.1111/j.1464-410X.2009.08380.x; Iczkowski KA, 2005, UROLOGY, V65, P76, DOI 10.1016/j.urology.2004.08.042; Kim JC, 2005, INT J UROL, V12, P875, DOI 10.1111/j.1442-2042.2005.01140.x; Kim JC, 2004, BJU INT, V94, P915, DOI 10.1111/j.1464-410X.2004.05059.x; Becher E, 2009, PROSTATE CANCER P D, V12, P369, DOI 10.1038/pcan.2009.37; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; Liu HT, 2010, BJU INT, V106, P1681, DOI 10.1111/j.1464-410X.2009.08851.x; LEVIMONTALCINI R, 1979, SCI AM, V240, P68; Wada N, 2013, NEUROUROL URODYNAM, V32, P1123, DOI 10.1002/nau.22349; Kuo HC, 2010, NEUROUROL URODYNAM, V29, P482, DOI 10.1002/nau.20741; Arrighi N, 2010, GROWTH FACTORS, V28, P191, DOI 10.3109/08977190903578678; Geldof AA, 1998, PROSTATE CANCER P D, V1, P236, DOI 10.1038/sj.pcan.4500247; Lee SR, 2010, J UROLOGY, V183, P2440, DOI 10.1016/j.juro.2010.02.003; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Tsukamoto T, 2010, ACTA UROL JPN, V56, P677	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	DEC	2014	21	12					1258	1262		10.1111/iju.12570		5	Urology & Nephrology	Urology & Nephrology	AU8MW	WOS:000345851400013		
J	Homma, Y; Fujimura, T				Homma, Yukio; Fujimura, Tetsuya			Linguistic validation of the English version of the Core Lower Urinary Tract Symptom Score	INTERNATIONAL JOURNAL OF UROLOGY			English	Letter									[Homma, Yukio; Fujimura, Tetsuya] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan	Homma, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan.	homma-uro@umin.ac.jp					Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Dewolf L, 2009, EORTC QUALITY LIFE G; Homma Y, 2008, INT J UROL, V15, P816, DOI 10.1111/j.1442-2042.2008.02121.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	DEC	2014	21	12					1291	1292		10.1111/iju.12584		2	Urology & Nephrology	Urology & Nephrology	AU8MW	WOS:000345851400024		
J	Aoki, Y				Aoki, Yasuharu			How Does the Largest Shareholder Affect Dividends?	INTERNATIONAL REVIEW OF FINANCE			English	Article							OWNERSHIP STRUCTURE; AGENCY PROBLEMS; INTERNATIONAL EVIDENCE; CORPORATE GOVERNANCE; CASH HOLDINGS; UNITED-STATES; FIRM VALUE; POLICIES; COSTS; PAY	Focusing on the legal protection of minority shareholders in Japan, which suggests that manager-owned firms are better governed than corporation-owned firms, this study presents a new test of two dividend models: the substitute model and the outcome model. In support of the latter, I find that manager-owned firms pay higher dividends than corporation-owned firms. The paper also examines the association between ownership by the largest shareholder and dividend payments. I find an inverted U-shaped relationship for manager-owned firms and a U-shaped relationship for corporation-owned firms between them. These results can be explained by the benefits and drawbacks of concentrated ownership.	[Aoki, Yasuharu] Seijo Univ, Fac Econ, Tokyo 1578511, Japan	Aoki, Y (reprint author), Seijo Univ, Fac Econ, Setagaya Ku, 6-1-20 Seijo, Tokyo 1578511, Japan.	yaoki@seijo.ac.jp					Myers SC, 2000, J FINANC, V55, P1005, DOI 10.1111/0022-1082.00239; Faccio M, 2001, AM ECON REV, V91, P54, DOI 10.1257/aer.91.1.54; Zwiebel J, 1996, AM ECON REV, V86, P1197; La Porta R, 2000, J FINANC, V55, P1, DOI 10.1111/0022-1082.00199; DEMSETZ H, 1983, J LAW ECON, V26, P375, DOI 10.1086/467041; Konijn SJJ, 2011, J CORP FINANC, V17, P1330, DOI 10.1016/j.jcorpfin.2011.06.005; JENSEN GR, 1992, J FINANC QUANT ANAL, V27, P247, DOI 10.2307/2331370; Petersen MA, 2009, REV FINANC STUD, V22, P435, DOI 10.1093/rfs/hhn053; Gomes A, 2000, J FINANC, V55, P615, DOI 10.1111/0022-1082.00221; Shleifer A, 1997, J FINANC, V52, P737, DOI 10.1111/j.1540-6261.1997.tb04820.x; Pinkowitz L, 2006, J FINANC, V61, P2725, DOI 10.1111/j.1540-6261.2006.01003.x; Gugler K, 2003, EUR ECON REV, V47, P731, DOI 10.1016/S0014-2921(02)00291-X; Denis DJ, 2008, J FINANC ECON, V89, P62, DOI 10.1016/j.jfineco.2007.06.006; Claessens S, 2002, J FINANC, V57, P2741, DOI 10.1111/1540-6261.00511; SHLEIFER A, 1986, J POLIT ECON, V94, P461, DOI 10.1086/261385; Holderness CG, 2009, REV FINANC STUD, V22, P1377, DOI 10.1093/rfs/hhm069; Fama EF, 2001, J FINANC ECON, V60, P3, DOI 10.1016/S0304-405X(01)00038-1; La Porta R, 1999, J FINANC, V54, P471, DOI 10.1111/0022-1082.00115; Johnson S, 2000, AM ECON REV, V90, P22, DOI 10.1257/aer.90.2.22; Grullon G, 2002, J FINANC, V57, P1649, DOI 10.1111/1540-6261.00474; Claessens S, 2000, J FINANC ECON, V58, P81, DOI 10.1016/S0304-405X(00)00067-2; Lie E, 2000, REV FINANC STUD, V13, P219, DOI 10.1093/rfs/13.1.219; Bates TW, 2006, J FINANC ECON, V81, P681, DOI 10.1016/j.jfineco.2005.07.009; Kalcheva I, 2007, REV FINANC STUD, V20, P1087, DOI 10.1093/rfs/hhm023; Skinner DJ, 2008, J FINANC ECON, V87, P582, DOI 10.1016/j.jfineco.2007.05.003; Asjaoud F., 2010, J BUSINESS FINANCE A, V37, P648; Atanasov V, 2010, J FINANC QUANT ANAL, V45, P1, DOI 10.1017/S0022109010000025; Barclay MJ, 2009, REV FINANC STUD, V22, P2423, DOI 10.1093/rfs/hhn060; Bertrand M, 2002, Q J ECON, V117, P121, DOI 10.1162/003355302753399463; Crutchley Claire E., 1999, INT REV FINANC ANAL, V8, P177, DOI 10.1016/S1057-5219(99)00011-3; da Silva L. C., 2004, DIVIDEND POLICY CORP; Damodaran A., 2006, APPL CORPORATE FINAN; Dewenter KL, 1998, J FINANC, V53, P879, DOI 10.1111/0022-1082.00038; Dow S, 2009, J BANK FINANC, V33, P1817, DOI 10.1016/j.jbankfin.2009.05.012; EASTERBROOK FH, 1984, AM ECON REV, V74, P650; FAMA EF, 1983, J LAW ECON, V26, P301, DOI 10.1086/467037; Farinha Jorge, 2003, J BUSINESS FINANCE A, V30, P1173, DOI 10.1111/j.0306-686X.2003.05624.x; Hamilton R. W., 2000, LAW CORPORATIONS; Harada K., 2011, MANAGE FINANC, V37, P362, DOI 10.1108/03074351111115313; Holdemess C., 2003, EC POLICY REV, V9, P51; JENSEN MC, 1986, AM ECON REV, V76, P323; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Jiraporn Pornsit, 2006, J APPL FINANCE, V16, P24; JOHN K., 2006, WORKING PAPER; Khan T, 2006, ECON J, V116, pC172, DOI 10.1111/j.1468-0297.2006.01082.x; MCCONNELL JJ, 1990, J FINANC ECON, V27, P595, DOI 10.1016/0304-405X(90)90069-C; Mitton Todd, 2004, EMERG MARK REV, V5, P409, DOI 10.1016/j.ememar.2004.05.003; MORCK R, 1988, J FINANC ECON, V20, P293, DOI 10.1016/0304-405X(88)90048-7; Nguyen P, 2013, INT REV FINANC ANAL, V30, P170, DOI 10.1016/j.irfa.2013.08.003; Rozeff Michael, 1982, J FINANC RES, V5, P249; Sasaki T., 2010, JAPAN J FINANCE, V29, P2; SCHOOLEY DK, 1994, J FINANC RES, V17, P363; Tong J., 2012, 2012 AS FIN ASS ANN; Truong T., 2007, Q REV EC FINANCE, V47, P667, DOI 10.1016/j.qref.2007.09.002; White G., 2003, ANAL USE FINANCIAL S	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1369-412X	1468-2443		INT REV FINANC	Int. Rev. Financ.	DEC	2014	14	4					613	645		10.1111/irfi.12039		33	Business, Finance	Business & Economics	AU8LN	WOS:000345848100005		
J	Scott, KM; Al-Hamzawi, AO; Andrade, LH; Borges, G; Caldas-de-Almeida, JM; Fiestas, F; Gureje, O; Hu, CY; Karam, EG; Kawakami, N; Lee, S; Levinson, D; Lim, CCW; Navarro-Mateu, F; Okoliyski, M; Posada-Villa, J; Torres, Y; Williams, DR; Zakhozha, V; Kessler, RC				Scott, Kate M.; Al-Hamzawi, Ali Obaid; Andrade, Laura H.; Borges, Guilherme; Caldas-de-Almeida, Jose Miguel; Fiestas, Fabian; Gureje, Oye; Hu, Chiyi; Karam, Elie G.; Kawakami, Norito; Lee, Sing; Levinson, Daphna; Lim, Carmen C. W.; Navarro-Mateu, Fernando; Okoliyski, Michail; Posada-Villa, Jose; Torres, Yolanda; Williams, David R.; Zakhozha, Victoria; Kessler, Ronald C.			Associations Between Subjective Social Status and DSM-IV Mental Disorders Results From the World Mental Health Surveys	JAMA PSYCHIATRY			English	Article							SELF-RATED HEALTH; SOCIOECONOMIC-STATUS; PSYCHIATRIC-DISORDERS; AFRICAN-AMERICANS; WHITEHALL-II; SELECTION; INCOME; WOMEN; RELIABILITY; INEQUALITY	IMPORTANCE The inverse social gradient in mental disorders is a well-established research finding with important implications for causal models and policy. This research has used traditional objective social status (OSS) measures, such as educational level, income, and occupation. Recently, subjective social status (SSS) measurement has been advocated to capture the perception of relative social status, but to our knowledge, there have been no studies of associations between SSS and mental disorders. OBJECTIVES To estimate associations of SSS with DSM-IV mental disorders in multiple countries and to investigate whether the associations persist after comprehensive adjustment of OSS. DESIGN, SETTING, AND PARTICIPANTS Face-to-face cross-sectional household surveys of community-dwelling adults in 18 countries in Asia, South Pacific, the Americas, Europe, and the Middle East (N = 56 085). Subjective social status was assessed with a self-anchoring scale reflecting respondent evaluations of their place in the social hierarchies of their countries in terms of income, educational level, and occupation. Scores on the 1 to 10 SSS scale were categorized into 4 categories: low (scores 1-3), low-mid (scores 4-5), high-mid (scores 6-7), and high (scores 8-10). Objective social status was assessed with a wide range of fine-grained objective indicators of income, educational level, and occupation. MAIN OUTCOMES AND MEASURES The Composite International Diagnostic Interview assessed the 12-month prevalence of 16 DSM-IV mood, anxiety, and impulse control disorders. RESULTS The weighted mean survey response rate was 75.2%(range, 55.1%-97.2%). Graded inverse associations were found between SSS and all 16 mental disorders. Gross odds ratios (lowest vs highest SSS categories) in the range of 1.8 to 9.0 were attenuated but remained significant for all 16 disorders (odds ratio, 1.4-4.9) after adjusting for OSS indicators. This pattern of inverse association between SSS and mental disorders was significant in 14 of 18 individual countries, and in low-, middle-, and high-income country groups but was significantly stronger in high-vs lower-income countries. CONCLUSIONS AND RELEVANCE Significant inverse associations between SSS and numerous DSM-IV mental disorders exist across a wide range of countries even after comprehensive adjustment for OSS. Although it is unclear whether these associations are the result of social selection, social causation, or both, these results document clearly that research relying exclusively on standard OSS measures underestimates the steepness of the social gradient in mental disorders.	[Scott, Kate M.; Lim, Carmen C. W.] Univ Otago, Dept Psychol Med, Dunedin, New Zealand; [Al-Hamzawi, Ali Obaid] Al Qadisia Univ, Coll Med, Dept Med, Diwania, Iraq; [Andrade, Laura H.] Univ Sao Paulo, Sch Med, Sect Psychiat Epidemiol LIM 23, Dept Psychiat, Sao Paulo, Brazil; [Andrade, Laura H.] Univ Sao Paulo, Sch Med, Inst Psychiat, Sao Paulo, Brazil; [Borges, Guilherme] Natl Inst Psychiat, Dept Intervent Models, Div Epidemiol & Psychosocial Res, Mexico City, DF, Mexico; [Borges, Guilherme] Metropolitan Autonomous Univ, Dept Hlth Serv, Mexico City, DF, Mexico; [Caldas-de-Almeida, Jose Miguel] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr, P-1200 Lisbon, Portugal; [Caldas-de-Almeida, Jose Miguel] Univ Nova Lisboa, Fac Ciencias Med, Dept Mental Hlth, P-1200 Lisbon, Portugal; [Fiestas, Fabian] Natl Inst Hlth Peru, Evidence Generat Res Unit, Lima, Peru; [Gureje, Oye] WHO, Collaborating Ctr Res & Training Mental Hlth Neur, Ibadan, Nigeria; [Gureje, Oye] Univ Ibadan, Univ Coll Hosp, Coll Med, Dept Psychiat, Ibadan, Nigeria; [Hu, Chiyi] Shenzhen Inst Mental Hlth, Shenzhen, Guangdong, Peoples R China; [Hu, Chiyi] Shenzhen Kangning Hosp, Shenzhen, Guangdong, Peoples R China; [Karam, Elie G.] Balamand Univ, St George Hosp Univ, Med Ctr, Inst Dev Res Advocacy, Beirut, Lebanon; [Karam, Elie G.] Med Inst Neuropsychol Disorders, Beirut, Lebanon; [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Lee, Sing] Chinese Univ Hong Kong, Dept Psychiat, Shatin, Hong Kong, Peoples R China; [Levinson, Daphna] Minist Hlth, Mental Hlth Serv, Jerusalem, Israel; [Navarro-Mateu, Fernando] Serv Murciano Salud, Murcia, Spain; [Okoliyski, Michail] Minist Hlth, Natl Ctr Publ Hlth & Anal, Sofia, Bulgaria; [Posada-Villa, Jose] Colegio Mayor Cundinamarca Univ, Bogota, DC, Colombia; [Torres, Yolanda] Univ CES, Medellin, Colombia; [Williams, David R.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Zakhozha, Victoria] Kiev Int Inst Sociol, Kiev, Ukraine; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Scott, KM (reprint author), Univ Otago, Dept Psychol Med, POB 913, Dunedin, New Zealand.	kate.scott@otago.ac.nz	Lee, Sing/O-2136-2015		US National Institute of Mental Health (NIMH) [R01 MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly and Company; Ortho-McNeil Pharmaceutical; GlaxoSmithKline; Bristol-Myers Squibb; State of Sao Paulo Research Foundation [03/00204-3]; Ministry of Health; National Center for Public Health Protection; Ministry of Social Protection; Center for Excellence on Research in Mental Health (CES University); Secretary of Health of Medellin; Iraq Mental Health; Japanese and European Funds through United Nations Development Group Iraq Trust Fund; Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Lebanese Ministry of Public Health; WHO (Lebanon); National Institute of Health/Fogarty International Center [R03 TW006481-01]; Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; AstraZeneca; Hikma Pharmaceuticals; Janssen Cilag; Lundbeck; Novartis; Servier; National Institute of Psychiatry Ramon de la Fuente [4280]; National Council on Science and Technology [CONACyTG30544-H]; PanAmerican Health Organization; New Zealand Ministry of Health; Alcohol Advisory Council; Health Research Council; WHO (Geneva); WHO (Nigeria); Federal Ministry of Health, Abuja, Nigeria; Health & Social Care Research & Development Division of the Public Health Agency; Shenzhen Bureau of Health; Shenzhen Bureau of Science, Technology, and Information; National Institute of Health of the Ministry of Health of Peru; Norwegian Financial Mechanism; National Institute of Public Health-National Institute of Hygiene in Warsaw; European Economic Area Mechanism; Polish Ministry of Health; Champalimaud Foundation, Gulbenkian Foundation; Foundation for Science and Technology; US NIMH [R01-MH059575, R01-MH61905]; National Institute of Drug Abuse; South African Department of Health; University of Michigan; Regional Health Authorities of Murcia; Fundacion para la Formacion e Investigacion Sanitarias of Murcia; NIMH [U01-MH60220]; Substance Abuse and Mental Health Services Administration; Robert Wood Johnson Foundation [044708]; JohnW. Alden Trust; Health Research Council of New Zealand	The World Health Organization (WHO) World Mental Health (WMH) Survey Initiative is supported by the US National Institute of Mental Health (NIMH) (grant R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (grants R13-MH066849, R01MH069864, and R01 DA016558), the Fogarty International Center (grant FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb. The Sao Paulo Megacity Mental Health Survey (Brazil) is supported by the State of Sao Paulo Research Foundation Thematic Project grant 03/00204-3. The Bulgarian Epidemiological Study of Common Mental Disorders (2014 EPIBUL) is supported by the Ministry of Health and the National Center for Public Health Protection. The Colombian National Study of Mental Health is supported by the Ministry of Social Protection. The Mental Health Study Medellin-Colombia was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES University) and the Secretary of Health of Medellin. Implementation of the Iraq Mental Health Survey and data entry were carried out by the staff of the Iraqi Ministry of Health and Ministry of Planning with direct support from the Iraq Mental Health Survey team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The WMH Japan survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (grants H13-SHOGAI-023, H14-TOKUBETSU-026, and H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health/Fogarty International Center (grant R03 TW006481-01), Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, anonymous private donations to the Institute for Development, Research, Advocacy and Applied Care, Lebanon, and unrestricted grants from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Hikma Pharmaceuticals, Janssen Cilag, Lundbeck, Novartis, and Servier. The Mexican National Comorbidity Survey is supported by the National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (grant CONACyTG30544-H), with supplemental support from the PanAmerican Health Organization. New Zealand Te Rau Hinengaro: The New Zealand Mental Health Survey is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council. The Nigerian Survey of Mental Health and Well-being is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Northern Ireland Study of Mental Health is funded by the Health & Social Care Research & Development Division of the Public Health Agency. The Chinese WMH Survey Initiative is supported by the Pfizer Foundation. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The Peruvian WMH Study was funded by the National Institute of Health of the Ministry of Health of Peru.; The Polish project Epidemiology of Mental Health and Access to Care was carried out by the Institute of Psychiatry and Neurology in Warsaw in consortium with the Department of Psychiatry at the Medical University in Wroclaw and the National Institute of Public Health-National Institute of Hygiene in Warsaw and in partnership with Psykiatrist Institut Vinderen, Universitet, Oslo. The project was funded by the Norwegian Financial Mechanism and the European Economic Area Mechanism as well as the Polish Ministry of Health. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, Nova University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology, and the Ministry of Health. The South Africa Stress and Health Study is supported by the US NIMH (grant R01-MH059575) and National Institute of Drug Abuse with supplemental funding from the South African Department of Health and the University of Michigan. The Psychiatric Enquiry to General Population in Southeast Spain-Murcia project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejerea de Sanidad y Politica Social) and Fundacion para la Formacion e Investigacion Sanitarias of Murcia. The Ukraine Comorbid Mental Disorders During Periods of Social Disruption study is funded by the US NIMH (grant R01-MH61905). The US National Comorbidity Survey Replication is supported by the NIMH (grant U01-MH60220) with supplemental support from the National Institute of Drug Abuse, the Substance Abuse and Mental Health Services Administration, the Robert Wood Johnson Foundation (grant 044708), and the JohnW. Alden Trust. Work on this article was funded by a grant from the Health Research Council of New Zealand (Dr Scott).	MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Triandis HC, 2001, J PERS, V69, P907, DOI 10.1111/1467-6494.696169; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139; Hu PF, 2005, J AM GERIATR SOC, V53, P483, DOI 10.1111/j.1532-5415.2005.53169.x; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Adler N, 2008, SOC SCI MED, V66, P1034, DOI 10.1016/j.socscimed.2007.11.031; Pickett KE, 2010, BRIT J PSYCHIAT, V197, P426, DOI 10.1192/bjp.bp.109.072066; Wolff LS, 2010, SOC SCI MED, V70, P2019, DOI 10.1016/j.socscimed.2010.02.033; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Ostrove JM, 2000, HEALTH PSYCHOL, V19, P613, DOI 10.1037/0278-6133.19.6.613; Demakakos P, 2008, SOC SCI MED, V67, P330, DOI 10.1016/j.socscimed.2008.03.038; Franzini L, 2006, SOC SCI MED, V63, P788, DOI 10.1016/j.socscimed.2006.01.009; Johnson JG, 1999, J ABNORM PSYCHOL, V108, P490, DOI 10.1037/0021-843X.108.3.490; Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Subramanyam MA, 2012, SOC SCI MED, V74, P1146, DOI 10.1016/j.socscimed.2011.12.042; Marmot M, 2001, BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; Honjo K, 2014, INT J BEHAV MED, V21, P421, DOI 10.1007/s12529-013-9309-y; Layte R, 2012, EUR SOCIOL REV, V28, P498, DOI 10.1093/esr/jcr012; deBotton A, 2004, STATUS ANXIETY; DOHRENWEND BP, 1990, SOC PSYCH PSYCH EPID, V25, P41; Giatti L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1096; Kessler RC, 2008, WHO WORLD MENTAL HLT; Marmot M., 2005, STATUS SYNDROME SOCI; McLeod JD, 2013, SOCIAL STRATIFICATIO, P229; Shah B. V., 1998, ENCY BIOSTATISTICS, P2276	30	4	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-622X	2168-6238		JAMA PSYCHIAT	JAMA Psychiatry	DEC	2014	71	12					1400	1408		10.1001/jamapsychiatry.2014.1337		9	Psychiatry	Psychiatry	AU9MQ	WOS:000345917900012		
J	Niikura, N; Saji, S; Tokuda, Y; Iwata, H				Niikura, Naoki; Saji, Shigehira; Tokuda, Yutaka; Iwata, Hiroji			Brain Metastases in Breast Cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						breast cancer; brain metastases; prognostic factor; subtype; treatment	CENTRAL-NERVOUS-SYSTEM; GRADED PROGNOSTIC ASSESSMENT; LAPATINIB PLUS CAPECITABINE; STEREOTACTIC RADIOSURGERY; RADIATION-THERAPY; PHASE-II; CNS METASTASES; RETROSPECTIVE ANALYSIS; ADJUVANT TRASTUZUMAB; CEREBRAL METASTASES	Brain metastases are less common than bone or visceral metastases in patients with breast cancer. The overall prognosis of breast cancer patients with brain metastases remains poor, and these metastases are less responsive to systemic therapies. Brain metastasis is associated with a reduced quality of life due to progressive neurologic impairments. Recently, a trend of increased incidence of brain metastases in breast cancer has been noted. Reasons for this increased incidence include the more frequent use of sensitive detection methods such as contrast-enhanced magnetic resonance imaging and increased awareness of brain metastasis among patients and clinicians. Adjuvant and systemic therapy with drugs that have a low blood-brain barrier penetrance can lead to an increased risk of brain metastases in breast cancer patients. Molecular subtype is a predictive factor for overall survival after developing brain metastases. Patients who do not have a poor prognosis based on previously identified prognostic factors should be treated with radiation therapy to control symptoms. Whole-brain radiation therapy, stereotactic irradiation and surgery are tools for the local treatment of brain metastases. Novel molecular target therapy, including HER2-targeted therapy, has demonstrated an antitumor effect on brain metastases. In this review, we provide a practical algorithm for the treatment of breast cancer brain metastases. This review provides an overview of the incidence, risk factors, diagnosis, prognostic factors and current and potential future management strategies of breast cancer brain metastases.	[Niikura, Naoki; Saji, Shigehira] Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Kyoto 6068507, Japan; [Niikura, Naoki; Tokuda, Yutaka] Tokai Univ, Sch Med, Dept Breast Surg, Hiratsuka, Kanagawa 25912, Japan; [Niikura, Naoki; Tokuda, Yutaka] Tokai Univ, Sch Med, Dept Endocrine Surg, Hiratsuka, Kanagawa 25912, Japan; [Saji, Shigehira] Fukushima Med Univ, Dept Med Oncol, Fukushima, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan	Niikura, N (reprint author), Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	niikura@is.icc.u-tokai.ac.jp			National Cancer Center Research and Development Fund [23-A-17]; MEXT KAKENHI [26870597]; Tokai University School of Medicine Research Aid	This study was supported by the National Cancer Center Research and Development Fund (23-A-17), MEXT KAKENHI grant number 26870597 and Tokai University School of Medicine Research Aid, 2013-2014.	Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; Lin NU, 2008, CANCER, V113, P2638, DOI 10.1002/cncr.23930; Tsao M, 2012, CANCER-AM CANCER SOC, V118, P2486, DOI 10.1002/cncr.26515; Sperduto CM, 2008, J NEUROSURG, V109, P87, DOI 10.3171/JNS/2008/109/12/S14; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Leyland-Jones B, 2009, J CLIN ONCOL, V27, P5278, DOI 10.1200/JCO.2008.19.8481; Le Scodan R, 2007, INT J RADIAT ONCOL, V69, P839, DOI 10.1016/j.ijrobp.2007.04.024; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Bartsch R, 2006, RADIOTHER ONCOL, V80, P313, DOI 10.1016/j.radonc.2006.08.001; Church DN, 2008, AM J CLIN ONCOL-CANC, V31, P250, DOI 10.1097/COC.0b013e31815a43c4; Graesslin O, 2010, J CLIN ONCOL, V28, P2032, DOI 10.1200/JCO.2009.24.6314; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Swain SM, 2014, ANN ONCOL, V25, P1116, DOI 10.1093/annonc/mdu133; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Anders CK, 2011, CANCER-AM CANCER SOC, V117, P1602, DOI 10.1002/cncr.25746; Metro G, 2011, ANN ONCOL, V22, P625, DOI 10.1093/annonc/mdq434; Sperduto PW, 2013, J NEURO-ONCOL, V112, P467, DOI 10.1007/s11060-013-1083-9; Dawood S, 2008, ANN ONCOL, V19, P1242, DOI 10.1093/annonc/mdn036; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Yap YS, 2012, BRIT J CANCER, V107, P1075, DOI 10.1038/bjc.2012.346; Pestalozzi BC, 2006, ANN ONCOL, V17, P935, DOI 10.1093/annonc/mdl064; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Lederman G, 2001, BREAST CANCER RES TR, V65, P145, DOI 10.1023/A:1006490200335; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Tomasello G, 2010, CRIT REV ONCOL HEMAT, V75, P110, DOI 10.1016/j.critrevonc.2009.11.003; Engel J, 2003, INT J RADIAT ONCOL, V55, P1186, DOI 10.1016/S0360-3016(02)04476-0; ALEXANDER E, 1995, J NATL CANCER I, V87, P34, DOI 10.1093/jnci/87.1.34; Lin NU, 2008, J CLIN ONCOL, V26, P1993, DOI 10.1200/JCO.2007.12.3588; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Akyurek S, 2007, AM J CLIN ONCOL-CANC, V30, P310, DOI 10.1097/01.coc.0000258365.50975.f6; Bachelot T, 2013, LANCET ONCOL, V14, P64, DOI 10.1016/S1470-2045(12)70432-1; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Kondziolka D, 1999, INT J RADIAT ONCOL, V45, P427, DOI 10.1016/S0360-3016(99)00198-4; Curran MP, 2012, PEDIATR DRUGS, V14, P51, DOI 10.2165/11207730-000000000-00000; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Tamura K, 2013, J NUCL MED, V54, P1869, DOI 10.2967/jnumed.112.118612; Ekenel M, 2007, J NEURO-ONCOL, V85, P223, DOI 10.1007/s11060-007-9409-0; Sneed PK, 2002, INT J RADIAT ONCOL, V53, P519, DOI 10.1016/S0360-3016(02)02770-0; Olson EM, 2013, ANN ONCOL, V24, P1526, DOI 10.1093/annonc/mdt036; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Brufsky AM, 2011, CLIN CANCER RES, V17, P4834, DOI 10.1158/1078-0432.CCR-10-2962; TSUKADA Y, 1983, CANCER, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; Besse B, 2010, CLIN CANCER RES, V16, P269, DOI 10.1158/1078-0432.CCR-09-2439; Klos KJ, 2004, NEUROLOGIST, V10, P31, DOI 10.1097/01.nrl.0000106922.83090.71; Lin NU, 2009, CLIN CANCER RES, V15, P1452, DOI 10.1158/1078-0432.CCR-08-1080; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Niikura N, 2014, BREAST CANCER RES TR, V147, P103, DOI 10.1007/s10549-014-3090-8; Sperduto PW, 2012, INT J RADIAT ONCOL, V82, P2111, DOI 10.1016/j.ijrobp.2011.02.027; Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; Lobbezoo DJA, 2013, BREAST CANCER RES TR, V141, P507, DOI 10.1007/s10549-013-2711-y; Yamamoto M, 2014, LANCET ONCOL, V15, P387, DOI 10.1016/S1470-2045(14)70061-0; Pestalozzi BC, 2013, LANCET ONCOL, V14, P244, DOI 10.1016/S1470-2045(13)70017-2; Heitz F, 2009, EUR J CANCER, V45, P2792, DOI 10.1016/j.ejca.2009.06.027; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; Bartsch R, 2007, J NEURO-ONCOL, V85, P311, DOI 10.1007/s11060-007-9420-5; Mahmoud-Ahmed AS, 2002, INT J RADIAT ONCOL, V54, P810, DOI 10.1016/S0360-3016(02)02967-X; Bendell JC, 2003, CANCER, V97, P2972, DOI 10.1002/cncr.11436; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Niwinska A, 2010, ANN ONCOL, V21, P942, DOI 10.1093/annonc/mdp407; Andre F, 2014, LANCET ONCOL, V15, P580, DOI 10.1016/S1470-2045(14)70138-X; Melisko ME, 2008, J NEURO-ONCOL, V88, P359, DOI 10.1007/s11060-008-9578-5; Miller KD, 2003, ANN ONCOL, V14, P1072, DOI 10.1093/annonc/mdg300; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Eichler AF, 2008, CANCER, V112, P2359, DOI 10.1002/cncr.23468; Lentzsch S, 1999, EUR J CANCER, V35, P580, DOI 10.1016/S0959-8049(98)00421-3; Frisk G, 2012, BRIT J CANCER, V106, P1850, DOI 10.1038/bjc.2012.163; Sutherland S, 2010, BRIT J CANCER, V102, P995, DOI 10.1038/sj.bjc.6605586; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Black PM, 2004, J NEURO-ONCOL, V69, P119, DOI 10.1023/B:NEON.0000041875.09048.e7; Crivellari D, 2001, ANN ONCOL, V12, P353, DOI 10.1023/A:1011132609055; DISTEFANO A, 1979, CANCER, V44, P1913, DOI 10.1002/1097-0142(197911)44:5<1913::AID-CNCR2820440554>3.0.CO;2-D; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Hall WA, 2000, MED ONCOL, V17, P279, DOI 10.1007/BF02782192; Iwata H, 2013, INT J CLIN ONCOL, V18, P621, DOI 10.1007/s10147-012-0444-2; Krop I, 2013, SABCS; Lin Nancy U, 2013, Ecancermedicalscience, V7, P307, DOI 10.3332/ecancer.2013.307; Lin NU, 2011, J NEURO-ONCOL, V105, P613, DOI 10.1007/s11060-011-0629-y; Malin D, 2014, CLIN CANCER RES, V20, DOI 10.1158/1078-0432.CCR-13-1255; Matsumoto K, 2009, JPN J CLIN ONCOL, V39, P22, DOI 10.1093/jjco/hyn124; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Nam BH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1870; Nieder C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-105; Ogawa K, 2008, J NEURO-ONCOL, V86, P231, DOI 10.1007/s11060-007-9469-1; Ogura Masakazu, 2003, Breast Cancer, V10, P349, DOI 10.1007/BF02967656; Pestalozzi B C, 2000, J Clin Oncol, V18, P2349; Pienkowski T, 2010, ANN ONCOL, V21, P917, DOI 10.1093/annonc/mdp353; Pivot X, 2012, ESMO 2012 ANN M LBA1; Ro J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-322; Saito EY, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-20; Stemmler HJ, 2008, ONCOLOGIST, V13, P739, DOI 10.1634/theoncologist.2008-0052; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; Wang MLH, 2001, AM J CLIN ONCOL-CANC, V24, P421, DOI 10.1097/00000421-200108000-00026	97	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1133	1140		10.1093/jjco/hyu156		8	Oncology	Oncology	AU7HW	WOS:000345772400001		
J	Colvin, HS; Nishida, N; Koseki, J; Konno, M; Kawamoto, K; Tsunekuni, K; Doki, Y; Mori, M; Ishii, H				Colvin, Hugh S.; Nishida, Naohiro; Koseki, Jun; Konno, Masamitsu; Kawamoto, Koichi; Tsunekuni, Kenta; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi			Cancer Stem Cells of the Digestive System	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						neoplastic stem cells; digestive system; therapeutics; epithelial-mesenchymal transition; metabolism	TUMOR-INITIATING CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; COLON-CANCER; COLORECTAL-CANCER; PANCREATIC-CANCER; CELLULAR QUIESCENCE; SUPPRESSOR GENES; SMALL-INTESTINE; SELF-RENEWAL; DISTINCT	Stem cells of the digestive system are ideal in many ways for research, given they are abundant, highly proliferative and have a uniform structural arrangement. This in turn has enormously aided the research of cancer stem cells of the digestive system, which is now shaping our understanding of cancer stem cells. In this review, the recent advances in the understanding of cancer stem cells of the digestive system have been summarized, including aspects such as their identification, origin, cell-cycle dormancy, relationship with epithelial-mesenchymal transition, cellular metabolism and the underlying molecular mechanisms. Newly acquired knowledge concerning cancer stem cells have led to the development of novel cancer therapeutics with provisional yet encouraging results.	[Colvin, Hugh S.; Kawamoto, Koichi; Tsunekuni, Kenta; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Gastrointestinal Surg, Suita, Osaka 5650871, Japan; [Colvin, Hugh S.; Nishida, Naohiro; Konno, Masamitsu; Kawamoto, Koichi; Tsunekuni, Kenta; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka 5650871, Japan; [Koseki, Jun; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Canc Profiling Discovery, Suita, Osaka 5650871, Japan; [Tsunekuni, Kenta] Taisho Pharmaceut Co Ltd, Tokyo, Japan	Mori, M (reprint author), Osaka Univ, Grad Sch Med, Dept Gastrointestinal Surg, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	mmori@gesurg.med.osaka-u.ac.jp; hishii@gesurg.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare; Kobayashi Cancer Research Foundation; Princess Takamatsu Cancer Research Fund, Japan; National Institute of Biomedical Innovation; Osaka University Drug Discovery Funds; Chugai Co., Ltd; Yakult Honsha Co., Ltd; Merck Co., Ltd; Taiho Therapeutic Co., Ltd	This work received the following financial support: a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid from the Ministry of Health, Labour and Welfare; a grant from the Kobayashi Cancer Research Foundation; a grant from the Princess Takamatsu Cancer Research Fund, Japan; a grant from the National Institute of Biomedical Innovation and a grant from the Osaka University Drug Discovery Funds. Partial supports from Chugai Co., Ltd, Yakult Honsha Co., Ltd, Merck Co., Ltd and Taiho Therapeutic Co., Ltd were received through institutional endowments.	Abdullah Lissa Nurrul, 2013, Clin Transl Med, V2, P3, DOI 10.1186/2001-1326-2-3; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Venkatesha VA, 2012, NEOPLASIA, V14, P519, DOI 10.1593/neo.12538; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Wang YL, 2013, BIOCHEM BIOPH RES CO, V434, P352, DOI 10.1016/j.bbrc.2013.03.077; Oermann EK, 2012, SEMIN CELL DEV BIOL, V23, P370, DOI 10.1016/j.semcdb.2012.01.013; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Kim HM, 2012, ANN SURG ONCOL, V19, pS539, DOI 10.1245/s10434-011-2040-5; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; Zhou J, 2008, WORLD J GASTROENTERO, V14, P925, DOI 10.3748/wjg.14.925; Korinek V, 1998, NAT GENET, V19, P379; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Miraglia S, 1997, BLOOD, V90, P5013; Aikawa Y, 2010, NAT MED, V16, P580, DOI 10.1038/nm.2122; Weigert R, 2013, J CELL BIOL, V201, P969, DOI 10.1083/jcb.201212130; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Ishii H, 2008, CANCER SCI, V99, P1871, DOI 10.1111/j.1349-7006.2008.00914.x; POTTEN CS, 1992, GUT, V33, P71, DOI 10.1136/gut.33.1.71; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Gallmeier E, 2011, STEM CELLS, V29, P418, DOI 10.1002/stem.595; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Bardou M, 2013, POSTGRAD MED J, V89, P519, DOI 10.1136/postgradmedj-2013-304701rep; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; DESOUSA EMF, 2011, CELL STEM CELL, V0009; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Inada R, 2014, SURG TODAY, V44, P640, DOI 10.1007/s00595-013-0611-8; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-87; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296; Moore N, 2011, J ONCOL, V2011, DOI [10.1155/2011/396076, DOI 10.1155/2011/396076]; Paldino E, 2014, BIOMED RES INT, V2014; Pecqueur C., 2013, INT J CELL BIOL, V2013; Pericleous Marinos, 2013, J Gastrointest Oncol, V4, P409, DOI 10.3978/j.issn.2078-6891.2013.003; Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394; Roy Sanchita, 2012, J Mol Signal, V7, P11, DOI 10.1186/1750-2187-7-11; Shih Ie-Ming, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P2640, DOI 10.1073/pnas.051629398; Tanaka K, 2013, SURG TODAY, V43, P123, DOI 10.1007/s00595-012-0283-9; Yasuda H, 2010, INT J ONCOL, V37, P1537, DOI 10.3892/ijo_0000087; Zhang GC, 2013, BBA-REV CANCER, V1836, P49, DOI 10.1016/j.bbcan.2013.03.001; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85	78	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1141	1149		10.1093/jjco/hyu146		9	Oncology	Oncology	AU7HW	WOS:000345772400002		
J	Taguchi, T; Takahashi, M; Nishimura, G; Shiono, O; Komatsu, M; Sano, D; Sakuma, Y; Tanigaki, Y; Kubota, A; Taguri, M; Hata, M; Oridate, N				Taguchi, Takahide; Takahashi, Masahiro; Nishimura, Goshi; Shiono, Osamu; Komatsu, Masanori; Sano, Daisuke; Sakuma, Yasunori; Tanigaki, Yuji; Kubota, Akira; Taguri, Masataka; Hata, Masaharu; Oridate, Nobuhiko			Phase II Study of Concurrent Chemoradiotherapy with S-1 in Patients with Stage II (T2N0M0) Squamous Cell Carcinoma of the Pharynx or Larynx	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						chemoradiotherapy; S-1; laryngeal cancer; oropharyngeal cancer; hypopharyngeal cancer	T2 GLOTTIC CANCER; RADIATION-THERAPY; DEFINITIVE RADIOTHERAPY; TELECOBALT-THERAPY; NECK DISSECTION; ORAL S-1; 5-FLUOROURACIL; SURGERY; HEAD; PRESERVATION	The goals of treatment for head and neck cancer are cure and organ-function preservation. For organ preservation, primary treatment via radiotherapy alone is thought to be insufficient for Stage II squamous cell carcinoma of the larynx, oropharynx or hypopharynx. The objective of the present study was to investigate the efficacy and safety of concurrent chemoradiotherapy with S-1 for patients with Stage II squamous cell carcinoma of the pharynx or larynx for primary organ preservation. Previously untreated patients with Stage II squamous cell carcinoma of the larynx, oropharynx or hypopharynx received three courses of S-1 (40 or 50 mg twice a day; 2 weeks of administration followed by 1 week of rest every 3 weeks) during conventional radiotherapy (a single daily fraction of 1.8 Gy) to a total dose of 70.2 Gy. The primary endpoint was the local control rate at 3 years. From August 2009 to October 2012, 37 patients were evaluated for the study. The overall response rate was 100%. The 3-year local control rate was 89.0% (95% confidence interval, 78.9-99.2%), and the 3-year overall survival rate was 97.2% (95% confidence interval, 91.8-100%). Mucositis and dermatitis in the radiation field were the most common acute adverse events observed. The rates of Grade 3 mucositis and dermatitis were 27 and 35%, respectively. No patients experienced Grade 4 acute adverse events. The treatment completion rate was 89.2%. Concurrent chemoradiotherapy with S-1 was safe and effective in improving local control for Stage II squamous cell carcinoma of the pharynx or larynx.	[Taguchi, Takahide; Takahashi, Masahiro; Nishimura, Goshi; Shiono, Osamu; Komatsu, Masanori; Sano, Daisuke; Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 2360004, Japan; [Sakuma, Yasunori] Yokohama City Univ, Med Ctr, Dept Otorhinolaryngol, Yokohama, Kanagawa 2360004, Japan; [Tanigaki, Yuji] Fujisawa City Hosp, Dept Otorhinolaryngol, Fujisawa, Kanagawa, Japan; [Kubota, Akira] Kanagawa Canc Ctr, Dept Head & Neck Surg, Yokohama, Kanagawa 2410815, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 2360004, Japan; [Hata, Masaharu] Yokohama City Univ, Grad Sch Med, Dept Radiol, Yokohama, Kanagawa 2360004, Japan	Taguchi, T (reprint author), Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ttaguchi@yokohama-cu.ac.jp					Akimoto T, 2006, INT J RADIAT ONCOL, V64, P995, DOI 10.1016/j.ijrobp.2005.10.003; Garden AS, 2003, INT J RADIAT ONCOL, V55, P322, DOI 10.1016/S0360-3016(02)03938-X; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Cosmidis A, 2004, EUR ARCH OTO-RHINO-L, V261, P276, DOI 10.1007/s00405-003-0694-8; Martin A, 2008, LARYNGOSCOPE, V118, P398, DOI 10.1097/MLG.0b013e31815aeda3; Mendenhall WM, 2001, J CLIN ONCOL, V19, P4029; Nakamura K, 2006, INT J RADIAT ONCOL, V65, P1045, DOI 10.1016/j.ijrobp.2006.02.001; Budach W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-28; Mendenhall WM, 2004, CANCER, V100, P1786, DOI 10.1002/cncr.20181; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Yamada Y, 2003, BRIT J CANCER, V89, P816, DOI 10.1038/sj.bjc.6601224; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; BYFIELD JE, 1982, INT J RADIAT ONCOL, V8, P1923; Czaja JM, 1997, ANN OTO RHINOL LARYN, V106, P909; Fujimoto Y, 2014, ANTICANCER RES, V34, P209; Furusaka T, 2013, ACTA OTO-LARYNGOL, V133, P99, DOI 10.3109/00016489.2012.717179; Galati LT, 2000, HEAD NECK-J SCI SPEC, V22, P294, DOI 10.1002/(SICI)1097-0347(200005)22:3<294::AID-HED13>3.0.CO;2-9; Hinerman RW, 2002, HEAD NECK-J SCI SPEC, V24, P456, DOI 10.1002/hed.10069; HIRANO M, 1987, ANN OTO RHINOL LARYN, V96, P586; Hirata K, 1999, CLIN CANCER RES, V5, P2000; HOWELLBURKE D, 1990, ARCH OTOLARYNGOL, V116, P830; Ikeda Yoichi, 2008, Gan To Kagaku Ryoho, V35, P789; INOUE T, 1993, CANCER, V72, P57, DOI 10.1002/1097-0142(19930701)72:1<57::AID-CNCR2820720113>3.0.CO;2-3; INOUE T, 1992, CANCER-AM CANCER SOC, V70, P2797, DOI 10.1002/1097-0142(19921215)70:12<2797::AID-CNCR2820701212>3.0.CO;2-5; Inuyama Y, 2001, Gan To Kagaku Ryoho, V28, P1381; Itoh Yoshiyuki, 2006, Radiat Med, V24, P277, DOI 10.1007/s11604-005-1517-1; MENDENHALL WM, 1993, INT J RADIAT ONCOL, V27, P1017; Mizumachi T, 2012, INT J CLIN ONCOL, V18, P824; Nakata K, 2013, J RADIAT RES, V54, P679, DOI 10.1093/jrr/rrs133; Nakayama M, 2010, JPN J CLIN ONCOL, V40, P921, DOI 10.1093/jjco/hyq077; Niibe Y, 2007, ANTICANCER RES, V27, P3497; Nishimura G, 2009, ANTICANCER RES, V29, P661; Nonoshita T, 2010, J RADIAT RES, V51, P481, DOI 10.1269/jrr.09134; Sato Mitsunobu, 2006, Gan To Kagaku Ryoho, V33 Suppl 1, P179; Selek U, 2004, INT J RADIAT ONCOL, V59, P743, DOI 10.1016/j.ijrobp.2003.12.002; SMALLEY SR, 1991, INT J RADIAT ONCOL, V20, P207; Taguchi T, 2006, J LARYNGOL OTOL, V120, P478, DOI 10.1017/S0022215106000880; Tsuji H, 2006, ONCOLOGY-BASEL, V71, P369, DOI 10.1159/000108385; Tsukuda M, 2009, CANCER CHEMOTH PHARM, V64, P945, DOI 10.1007/s00280-009-0946-4; WONG CS, 1989, INT J RADIAT ONCOL, V16, P657	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1158	1163		10.1093/jjco/hyu154		6	Oncology	Oncology	AU7HW	WOS:000345772400004		
J	Takeda, Y; Nakamori, S; Eguchi, H; Kobayashi, S; Marubashi, S; Tanemura, M; Konishi, K; Yoshioka, Y; Umeshita, K; Mori, M; Doki, Y; Nagano, H				Takeda, Yutaka; Nakamori, Shoji; Eguchi, Hidetoshi; Kobayashi, Shogo; Marubashi, Shigeru; Tanemura, Masahiro; Konishi, Koji; Yoshioka, Yasuo; Umeshita, Koji; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki			Neoadjuvant Gemcitabine-based Accelerated Hyperfractionation Chemoradiotherapy for Patients with Borderline Resectable Pancreatic Adenocarcinoma	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						pancreatic cancer; gemcitabine; neoadjuvant	PHASE-III TRIAL; RANDOMIZED CONTROLLED-TRIAL; FULL-DOSE GEMCITABINE; I TRIAL; PREOPERATIVE CHEMORADIATION; COMPARING GEMCITABINE; ADJUVANT CHEMOTHERAPY; CANCER; RADIATION; THERAPY	We report the response to pre-operative gemcitabine-based chemoradiotherapy for pancreatic adenocarcinoma. Thirty-five consecutive patients with borderline resectable pancreatic adenocarcinoma of UICC Stage II or III with portal vein invasion or tumor abutment of artery received radiotherapy (twice daily fractions of 1.5 Gy, 5 days/week, total dose: 36 Gy; 30 Gy for Phase I Level 1) with weekly intravenous infusions of gemcitabine (400, 600 and 800 mg/m(2)) at Days 1 and 8 for Phase I and 800 mg/m(2) for Phase II. Restaging was repeated after completion of chemoradiotherapy. Twenty-six of the 35 (74.3%) patients underwent resection. The dose-limiting toxicities were Grade 4 neutropenia and thrombocytopenia. The recommended regimen was total radiation dose of 36 Gy with gemcitabine 800 mg/m(2). Surgical resection was conducted in 11 of the 15 (73.3%) patients in Phase I study and 15 of the 20 (75.0%) in Phase II. After recommended dose chemoradiotherapy and surgical resection, the median disease-free survival was 17.4 months (5-year survival rate = 14.3%). The median overall survival time and 5-year survival rate were 41.2 months and 28.6%, respectively, for the 21 patients who underwent resection and 10.0 months and 0%, respectively, for those 5 who did not (P = 0.004). Our pre-operative gemcitabine-based chemoradiotherapy was well tolerated and safe.	[Takeda, Yutaka] Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo 6608511, Japan; [Nakamori, Shoji] Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Eguchi, Hidetoshi; Kobayashi, Shogo; Marubashi, Shigeru; Tanemura, Masahiro; Umeshita, Koji; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; [Konishi, Koji; Yoshioka, Yasuo] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan	Takeda, Y (reprint author), Kansai Rosai Hosp, Dept Surg, 3-1-69 Inabaso, Amagasaki, Hyogo 6608511, Japan.	ytakeda@kanrou.net					Assifi MM, 2011, SURGERY, V150, P466, DOI 10.1016/j.surg.2011.07.006; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; MOERTEL CG, 1981, CANCER, V48, P1705, DOI 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4; Bramhall SR, 2002, BRIT J CANCER, V87, P161, DOI 10.1038/sj.bjc.6600446; Rothenberg ML, 1996, ANN ONCOL, V7, P347; Andriulli A, 2012, ANN SURG ONCOL, V19, P1644, DOI 10.1245/s10434-011-2110-8; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; White RR, 2001, ANN SURG ONCOL, V8, P758, DOI 10.1245/aso.2001.8.10.758; Pisters PWT, 1998, J CLIN ONCOL, V16, P3843; Ohigashi H, 2009, ANN SURG, V250, P88, DOI 10.1097/SLA.0b013e3181ad65cc; Pisters PWT, 2002, J CLIN ONCOL, V20, P2537, DOI 10.1200/JCO.2002.11.064; Moore MJ, 2003, J CLIN ONCOL, V21, P3296, DOI 10.1200/JCO.2003.02.098; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; McGinn CJ, 2001, J CLIN ONCOL, V19, P4202; Lawrence TS, 1996, INT J RADIAT ONCOL, V34, P867, DOI 10.1016/0360-3016(95)02134-5; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Massucco P, 2006, ANN SURG ONCOL, V13, P1201, DOI 10.1245/s10434-006-9032-x; Talamonti MS, 2006, ANN SURG ONCOL, V13, P150, DOI 10.1245/ASO.2006.03.039; Bramhal SR, 2001, J CLIN ONCOL, V19, P3477; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Eisbruch A, 2001, J CLIN ONCOL, V19, P792; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Festa Virginia, 2013, JOP, V14, P618, DOI 10.6092/1590-8577/1724; Gastrointestinal Tumor Study Group, 1988, JNCI-J NATL CANCER I, V80, P751; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; McGinn C, 1998, P AN M AM SOC CLIN, V17, p264a; Motoi F, 2014, J HEPATO-BIL-PAN SCI, V21, P148, DOI 10.1002/jhbp.15; Nishimura Y, 1997, J RADIAT RES, V38, P272; POPLIN EA, 1992, INVEST NEW DRUG, V10, P165, DOI 10.1007/BF00877241; Rocha LCM, 2004, J CLIN ONCOL, V22, P3776; Wolff RA, 2001, CLIN CANCER RES, V7, P2246	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1172	1180		10.1093/jjco/hyu143		9	Oncology	Oncology	AU7HW	WOS:000345772400006		
J	Yoshida, S; Amano, K; Ohta, H; Kusuki, S; Morita, T; Ogata, A; Hirai, K				Yoshida, Saran; Amano, Koji; Ohta, Hideaki; Kusuki, Shigenori; Morita, Tatsuya; Ogata, Akiko; Hirai, Kei			A Comprehensive Study of the Distressing Experiences and Support Needs of Parents of Children with Intractable Cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						intractable cancer; parents; support need; Japan	PALLIATIVE CARE; OF-LIFE; PERSPECTIVES; PHYSICIANS; IMPACT; END; DIE	The primary endpoints of this study were: (1) to explore the distressing experiences of parents of patients with intractable pediatric cancer in Japan from disclosure of poor prognosis to the present and (2) to explore support they regarded as necessary. A multi-center questionnaire survey was conducted that included 135 bereaved parents of patients with pediatric cancer in Japan. The top five distressing experiences shared by over half of the bereaved parents were: 'Realize that the child's disease was getting worse' (96.7%), 'Witness the child's suffering' (96.7%), 'Make many decisions on the basis that the child will die in the not-so-distant future' (83.6%), 'Feel anxious and nervous about the child's acute deterioration' (82.0%) and 'Realize that there was nothing that I could do for the child' (78.7%). The top five support regarded as necessary were: 'Visit the room and speak to the sick child every day' (90.2%), 'Provide up-to-date information' (80.3%), 'Sufficiently explain the disadvantages of each treatment option' (80.3%), 'Show a never-give-up attitude until the end' (78.7%) and 'Make arrangements to allow the sick child to spend time with his/her siblings' (73.8%). This study identified the common distressing experiences of parents and the support regarded as necessary by them. To provide efficient support with limited manpower in pediatric setting, healthcare professionals should recognize these tasks as high priorities when engage parents of intractable pediatric cancer patients.	[Yoshida, Saran] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Chuo Ku, Tokyo 1040045, Japan; [Amano, Koji] Seirei Mikatahara Gen Hosp, Dept Clin Lab, Hamamatsu, Shizuoka, Japan; [Ohta, Hideaki] HigashitoyonakaWatanabe Hosp, Dept Pediat, Toyonaka, Osaka, Japan; [Kusuki, Shigenori] Child Chemo Clin, Kobe, Hyogo, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, Hamamatsu, Shizuoka, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Seirei Hosp, Hamamatsu, Shizuoka, Japan; [Ogata, Akiko] Hiroshima Univ, Grad Sch Educ, Higashihiroshima, Hiroshima 724, Japan; [Hirai, Kei] Osaka Univ, Support Off Large Scale Educ & Res Projects, Suita, Osaka, Japan	Yoshida, S (reprint author), Natl Canc Ctr, Ctr Canc Control & Informat Serv, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	saryoshi@ncc.go.jp		Yoshida, Saran/0000-0003-4055-2267	Japanese Ministry of Labor, Health, and Welfare;  [24830126]	This study was supported in part by a grant-in-aid for Cancer Research from the Japanese Ministry of Labor, Health, and Welfare and grant-in-aid for Research Activity Startup number 24830126.	Bluebond-Langner M, 2007, J CLIN ONCOL, V25, P2414, DOI 10.1200/JCO.2006.08.7759; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Mack JW, 2006, J CLIN ONCOL, V24, P5265, DOI 10.1200/JCO.2006.06.5326; Kreicbergs UC, 2007, J CLIN ONCOL, V25, P3307, DOI 10.1200/JCO.2006.10.0743; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366; Back AL, 2009, ARCH INTERN MED, V169, P474, DOI 10.1001/archinternmed.2008.583; Caserta MS, 2013, ILLN CRISES LOSS, V21, P185; De Bolle M, 2008, J PSYCHOSOC ONCOL, V26, P35, DOI 10.1300/J077v26n02_03; Eiser Christine, 2005, Health Qual Life Outcomes, V3, P29, DOI 10.1186/1477-7525-3-29; HINDS C, 1992, J ADV NURS, V17, P918, DOI 10.1111/j.1365-2648.1992.tb02019.x; Hinds Pamela S, 2005, J Palliat Med, V8 Suppl 1, pS70, DOI 10.1089/jpm.2005.8.s-70; Ide H, 2009, PEDIATR INT, V51, P645, DOI 10.1111/j.1442-200X.2009.02839.x; Kane Javier R, 2004, J Pediatr Oncol Nurs, V21, P180, DOI 10.1177/1043454204264393; Kars MC, 2011, SUPPORT CARE CANCER, V19, P27, DOI 10.1007/s00520-009-0785-1; Kars MC, 2010, PEDIATR BLOOD CANCER, V54, P1000, DOI 10.1002/pbc.22532; McCarthy MC, 2010, J PALLIAT MED, V13, P1321, DOI 10.1089/jpm.2010.0037; Monterosso L, 2008, PALLIATIVE MED, V22, P59, DOI 10.1177/0269216307084608; Stiller CA, 2005, EPIDEMIOLOGY CANC CH, P1; Valdimarsdóttir Unnur, 2007, Lancet Oncol, V8, P706, DOI 10.1016/S1470-2045(07)70209-7; Wolfe J, 2002, PEDIATR CLIN N AM, V49, P1043, DOI 10.1016/S0031-3955(02)00034-2; Yoshida S, 2010, JPN J PEDIAT ONCOL, V47, P91; Yoshida S, 2014, JPN J CLIN ONCOL, V44, P729, DOI 10.1093/jjco/hyu077	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1181	1188		10.1093/jjco/hyu140		8	Oncology	Oncology	AU7HW	WOS:000345772400007		
J	Satoh, T; Uemura, H; Tanabe, K; Nishiyama, T; Terai, A; Yokomizo, A; Nakatani, T; Imanaka, K; Ozono, S; Akaza, H				Satoh, Takefumi; Uemura, Hiroji; Tanabe, Kazunari; Nishiyama, Tsutomu; Terai, Akito; Yokomizo, Akira; Nakatani, Tatsuya; Imanaka, Keiichiro; Ozono, Seiichiro; Akaza, Hideyuki			A Phase 2 Study of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer Who Had Received Docetaxel-based Chemotherapy	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						abiraterone acetate; chemotherapy; confirmed response; metastatic castration-resistant prostate cancer; prostate-specific antigen	I CLINICAL-TRIAL; INCREASED SURVIVAL; THERAPY; PREDNISONE; INHIBITOR; CYP17; MITOXANTRONE	In this Phase 2 multicenter study the efficacy and safety of oral abiraterone acetate (1000 mg/once daily) plus prednisolone (5 mg/twice daily) was evaluated in metastatic castration-resistant prostate cancer patients from Japan who had previously received docetaxel-based chemotherapy. Men (aged a parts per thousand yen20 years) with metastatic castration-resistant prostate cancer (prostate-specific antigen levels: a parts per thousand yen5 ng/ml), who had received 1 or 2 cytotoxic chemotherapies (with a parts per thousand yen1 regimen being docetaxel) for prostate cancer, were enrolled in this open-label, single-arm study. Primary efficacy endpoint was proportion of patients achieving a a parts per thousand yen50% prostate-specific antigen decline from baseline (prostate-specific antigen response rate) after 12-week treatment. Safety and pharmacokinetics were also assessed. Confirmed prostate-specific antigen response rate by Week 12 was 28.3% (90% confidence interval: 17.6%; 41.1%) or 13 out of 46 (full analysis set) treated patients. However, total prostate-specific antigen response rate including confirmed and unconfirmed responses was 34.8% (90% confidence interval: 23.2%; 47.9%). Secondary efficacy endpoints and outcomes were: improvement in Eastern Cooperative Oncology Group performance status score by a parts per thousand yen1 unit: 7/16 patients (43.8%); objective radiographic response: complete response, partial response and stable disease in 0, 1/22 (4.5%) and 9/22 (40.9%) patients, respectively; pain palliation response: 9/16 (56.3%) patients. The most common adverse events (> 20% patients) were upper respiratory tract infection (13/47, 27.7% patients) and hepatic function abnormal (10/47, 21.3% patients, Grade 3: 8.5%). All mineralocorticoid-related toxicities were Grade 1/2. Abiraterone acetate plus prednisolone showed favorable efficacy in metastatic castration-resistant prostate cancer Japanese patients who had received chemotherapy. Abiraterone acetate plus prednisolone had an acceptable safety profile. NCT01795703.	[Satoh, Takefumi] Kitasato Univ, Sch Med, Dept Urol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Uemura, Hiroji] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan; [Tanabe, Kazunari] TokyoWomens Med Univ, Dept Urol, Kidney Ctr, Tokyo, Japan; [Nishiyama, Tsutomu] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Div Urol, Niigata, Japan; [Terai, Akito] Kurashiki Cent Hosp, Dept Urol, Okayama, Japan; [Yokomizo, Akira] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan; [Nakatani, Tatsuya] Osaka City Univ, Grad Sch Med, Dept Urol, Osaka 558, Japan; [Imanaka, Keiichiro] Janssen Pharmaceut KK, Tokyo, Japan; [Ozono, Seiichiro] Hamamatsu Univ Sch Med, Dept Urol, Shizuoka, Japan; [Akaza, Hideyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	Satoh, T (reprint author), Kitasato Univ, Sch Med, Dept Urol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	tsatoh@kitasato-u.ac.jp			Janssen Pharmaceutical K.K.; Janssen Pharmaceutical K.K. (Japan)	This study was supported by Janssen Pharmaceutical K.K. Funding to pay the Open Access publication charges for this article was provided by Janssen Pharmaceutical K.K. (Japan).	Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Fossa SD, 2001, J CLIN ONCOL, V19, P62; [Anonymous], 2014, PROST CANC EST INC M; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; Ryan CJ, 2010, J CLIN ONCOL, V28, P1481, DOI 10.1200/JCO.2009.24.1281; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Akaza H, 2010, PHARMACOLOGY, V85, P110, DOI 10.1159/000274486; Ito H., 2004, EVERYTHING PROSTATE; Kawahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048186; Maggioni D, 2010, J NEUROSCI RES, V88, P3171, DOI 10.1002/jnr.22465; Nishimura K, 2013, INT J CLIN ONCOL, V18, P306, DOI 10.1007/s10147-012-0380-1; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Rathkopf D, 2014, EUR UROL; Vainas O, 2012, BRIT J CANCER, V107, P814, DOI 10.1038/bjc.2012.316; Yamada T, 2013, INT J CLIN ONCOL, V18, P711, DOI 10.1007/s10147-012-0430-8	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1206	1215		10.1093/jjco/hyu148		10	Oncology	Oncology	AU7HW	WOS:000345772400010		
J	Matsubara, N; Uemura, H; Satoh, T; Suzuki, H; Nishiyama, T; Uemura, H; Hashine, K; Imanaka, K; Ozono, S; Akaza, H				Matsubara, Nobuaki; Uemura, Hirotsugu; Satoh, Takefumi; Suzuki, Hiroyoshi; Nishiyama, Tsutomu; Uemura, Hiroji; Hashine, Katsuyoshi; Imanaka, Keiichiro; Ozono, Seiichiro; Akaza, Hideyuki			A Phase 2 Trial of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer and without Prior Chemotherapy (JPN-201 Study)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						abiraterone acetate; chemotherapy-na < ve; metastatic castration-resistant prostate cancer; prednisolone; prostate specific antigen	ANDROGEN-RECEPTOR; PLUS PREDNISONE; DOCETAXEL; THERAPY; SURVIVAL; MULTICENTER; COMBINATION; EXPRESSION; GENES	Abiraterone acetate has been approved in > 70 countries for chemotherapy-na < ve metastatic castration-resistant prostate cancer patients. Efficacy and safety of abiraterone acetate (1000 mg/once daily) with prednisolone (5 mg/twice daily) in chemotherapy-na < ve Japanese patients with metastatic castration-resistant prostate cancer was evaluated. Men, a parts per thousand yen20 years, with prostate-specific antigen levels of a parts per thousand yen5 ng/ml and evidence of progression were enrolled in this Phase 2, multicenter, open-label study. Primary efficacy endpoint was proportion of patients achieving a prostate-specific antigen decline of a parts per thousand yen50% from baseline (prostate-specific antigen response) after 12 week of treatment. Secondary efficacy endpoints and safety were assessed. A confirmed prostate-specific antigen response was observed in 29/48 (60.4%) patients by week 12; lower limit of two-sided 90% confidence interval was > 35% (threshold response rate), demonstrating efficacy of abiraterone acetate. Secondary efficacy endpoints: prostate-specific antigen response rate during treatment period: 62.5%; objective radiographic response, partial response: 4/18 (22.2%) patients; complete response: none; stable disease: 11/18 (61.1%) patients; median percent change in prostate-specific antigen level from baseline at Week 12: -66.62%. Median prostate-specific antigen response duration and progression-free survival were not reached, and median radiographic progression-free survival was 253 days. Of 31/48 (64.6%) patients experienced adverse events of special interest; most common was hepatic function abnormality (37.5%, Grade 3: 10.4%). One Grade 3 hypertension was the only mineralocorticoid adverse event > Grade 1/2. Efficacy of abiraterone acetate plus prednisolone was demonstrated by decline in prostate-specific antigen levels with evidence of antitumor activity by radiography in Japanese patients with chemotherapy-na < ve metastatic castration-resistant prostate cancer. Abiraterone acetate plus prednisolone had an acceptable safety profile. NCT01756638.	[Matsubara, Nobuaki] Natl Canc Ctr Hosp East, Div Hematol & Oncol, Kashiwa, Chiba 2778577, Japan; [Uemura, Hirotsugu] Kinki Univ, Fac Med, Dept Urol, Osaka, Japan; [Satoh, Takefumi] Kitasato Univ, Sch Med, Dept Urol, Kitasato, Kanagawa, Japan; [Suzuki, Hiroyoshi] Toho Univ, Sakura Med Ctr, Dept Urol, Chiba 2748510, Japan; [Nishiyama, Tsutomu] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Div Urol, Niigata, Japan; [Uemura, Hiroji] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan; [Hashine, Katsuyoshi] Natl Hosp Org Shikoku Canc Ctr, Dept Urol, Matsuyama, Ehime, Japan; [Imanaka, Keiichiro] Janssen Pharmaceut KK, Tokyo, Japan; [Ozono, Seiichiro] Hamamatsu Univ Sch Med, Dept Urol, Shizuoka, Japan; [Akaza, Hideyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	Matsubara, N (reprint author), Natl Canc Ctr Hosp East, Div Hematol & Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	nmatsuba@east.ncc.go.jp			Janssen Pharmaceuticals K.K.	This work was supported by Janssen Pharmaceuticals K.K. Funding to pay the Open Access publication charges for this article was provided by Janssen Pharmaceutical K.K.	Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Ryan CJ, 2011, CLIN CANCER RES, V17, P4854, DOI 10.1158/1078-0432.CCR-11-0815; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Naito S, 2008, JPN J CLIN ONCOL, V38, P365, DOI 10.1093/jjco/hyn029; Ide H, 2010, JPN J CLIN ONCOL, V40, P79, DOI 10.1093/jjco/hyp126; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Cookson MS, 2013, J UROLOGY, V190, P429, DOI 10.1016/j.juro.2013.05.005; Mizokami A, 2004, CANCER RES, V64, P765, DOI 10.1158/0008-5472.CAN-03-0130; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Danila DC, 2010, J CLIN ONCOL, V28, P1496, DOI 10.1200/JCO.2009.25.9259; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Miura N, 2010, JPN J CLIN ONCOL, V40, P1092, DOI 10.1093/jjco/hyq100; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Beer TM, 2014, J CLIN ONCOL S4, V32; Kawahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048186; Miyake H, 2013, UROL ONCOL-SEMIN ORI, V31, P733, DOI 10.1016/j.urolonc.2011.06.006; Peer A, 2014, PROSTATE, V74, P433, DOI 10.1002/pros.22765; Rathkopf DE, 2014, EUR UROL, V66, P815, DOI 10.1016/j.eururo.2014.02.056	23	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1216	1226		10.1093/jjco/hyu149		11	Oncology	Oncology	AU7HW	WOS:000345772400011		
J	Sugihara, T; Yu, CH; Kattan, MW; Yasunaga, H; Ihara, H; Onozawa, M; Hinotsu, S; Akaza, H				Sugihara, Toru; Yu, Changhong; Kattan, Michael W.; Yasunaga, Hideo; Ihara, Hiroyuki; Onozawa, Mizuki; Hinotsu, Shiro; Akaza, Hideyuki			Long-term Survival of Extremely Advanced Prostate Cancer Patients Diagnosed with Prostate-specific Antigen over 500 ng/ml	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						androgen antagonists; neoplasm metastasis; prostate neoplasms; prostate-specific antigen; survival analysis	ANDROGEN DEPRIVATION THERAPY; PALLIATIVE CARE; BLOCKADE; SOCIETY; TRIALS	To investigate survival of hormone-na < ve prostate cancer patients diagnosed with prostate-specific antigen a parts per thousand yen500 ng/ml, stratified according to the prostate-specific antigen level and type of therapy. Data of prostate cancer patients with prostate-specific antigen a parts per thousand yen500 ng/ml diagnosed between 2001 and 2003 and receiving primary androgen deprivation therapy were extracted from the Japan Study Group of Prostate Cancer database. Cancer-specific survival and overall survival were assessed according to the prostate-specific antigen level (500-999, 1000-4999 and a parts per thousand yen5000 ng/ml) and type of therapy using Kaplan-Meier analyses and multivariate Cox proportional hazards models including age, Gleason score, oncological stage and comorbidity. The median follow-up was 27 months (interquartile range, 13-51) and a total of 1961 patients were included. Five-year cancer-specific and overall mortalities were 39.0 and 33.0%, respectively. There was a significant inverse relationship between overall survival and prostate-specific antigen magnitude among combination therapy patients, but not monotherapy patients (log-rank test, P = 0.034 and 0.558, respectively). The median overall survival in combination therapy patients with low-, intermediate- and high prostate-specific antigen and monotherapy patients with any prostate-specific antigen were 79, 59, 45 and 43 months, respectively. Multivariate analysis showed that combination therapy in patients with low- and intermediate prostate-specific antigen was significantly associated with a favorable overall survival compared with monotherapy (hazard ratios 0.66 and 0.75, respectively, both P < 0.001). Similar results were obtained for cancer-specific survival. There are major survival differences in extremely high prostate-specific antigen cases according to the prostate-specific antigen level and hormone therapy type and those patients would benefit notably from combination androgen blockade.	[Sugihara, Toru; Yu, Changhong; Kattan, Michael W.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Yasunaga, Hideo] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Tokyo, Japan; [Ihara, Hiroyuki] Shintoshi Hosp, Dept Urol, Iwata, Japan; [Onozawa, Mizuki] Tokyo kita Med Ctr, Dept Urol, Tokyo, Japan; [Hinotsu, Shiro] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Akaza, Hideyuki] Univ Tokyo, Dept Strateg Invest Comprehens Canc Network, Adv Sci & Technol Res Ctr, Tokyo, Japan	Sugihara, T (reprint author), Cleveland Clin, Dept Quantitat Hlth Sci, Main Campus,Mail Code JJN3-01,9500 Euclid Ave, Cleveland, OH 44195 USA.	ezy04707@nifty.com		Yasunaga, Hideo/0000-0002-6017-469X	ITO Genboku and SAGARA Chian Memorial Scholarship from Saga Prefecture, Japan	This study was supported by the ITO Genboku and SAGARA Chian Memorial Scholarship from Saga Prefecture, Japan.	Akaza Hideyuki, 2013, Prostate Int, V1, P81, DOI 10.12954/PI.12016; Akaza H, 2009, CANCER, V115, P3437, DOI 10.1002/cncr.24395; Tangen CM, 2012, J UROLOGY, V188, P1164, DOI 10.1016/j.juro.2012.06.046; Dalesio O, 2000, LANCET, V355, P1491; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; Buuren S., 2011, J STAT SOFTW, V45, P1; Kimura T, 2013, INT J UROL, V20, P880, DOI 10.1111/iju.12064; Kimura T, 2014, INT J UROL, V21, P578, DOI 10.1111/iju.12389; PAPSIDERO LD, 1980, CANCER RES, V40, P2428; R Core Team, 2013, R LANG ENV STAT COMP; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sylvester RJ, 1998, EUR UROL, V33, P134, DOI 10.1159/000019545	17	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1227	1232		10.1093/jjco/hyu142		6	Oncology	Oncology	AU7HW	WOS:000345772400012		
J	Kondo, T; Hara, I; Takagi, T; Kodama, Y; Hashimoto, Y; Kobayashi, H; Iizuka, J; Omae, K; Ikezawa, E; Yoshida, K; Tanabe, K				Kondo, Tsunenori; Hara, Isao; Takagi, Toshio; Kodama, Yoshiki; Hashimoto, Yasunobu; Kobayashi, Hirohito; Iizuka, Junpei; Omae, Kenji; Ikezawa, Eri; Yoshida, Kazuhiko; Tanabe, Kazunari			Possible Role of Template-based Lymphadenectomy in Reducing the Risk of Regional Node Recurrence after Nephroureterectomy in Patients with Renal Pelvic Cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						kidney pelvis; lymph node excision; survival; urothelial carcinoma; neoplasm recurrence	UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; RADICAL NEPHROURETERECTOMY; LYMPH-NODES; SURVIVAL; IMPACT; DISSECTION; MANAGEMENT; EXTENT	It remains unclear whether lymphadenectomy alters regional node recurrence after nephroureterectomy in patients with urothelial carcinoma of the renal pelvis. The predictive factors for regional node recurrence are still unclear. In this study, we retrospectively examined how the extent of lymphadenectomy influences regional node recurrence in patients with urothelial carcinoma of the renal pelvis. From January 1988 through July 2013, we performed nephroureterectomy in 180 patients with non-metastatic (cN0M0) urothelial carcinoma of the renal pelvis at two Japanese institutes. Regional nodes were determined according to our previous mapping study: complete lymphadenectomy designates that all regional sites were dissected; incomplete lymphadenectomy that all sites were not dissected. A third group included those without lymphadenectomy. The 5-year cancer-specific and recurrence-free survival was significantly higher in the complete lymphadenectomy group than in the incomplete lymphadenectomy or without lymphadenectomy groups (P = 0.03). The incidence of regional node recurrence was significantly lower in the complete lymphadenectomy group at 2.9% (2/67) than in the incomplete lymphadenectomy at 18.1% (4/22) or without lymphadenectomy at 10.9% (10/91) groups (P = 0.03). In patients with incomplete lymphadenectomy, 75% of regional node recurrence occurred outside of the dissected sites. Complete lymphadenectomy is shown to be a likely predictive factor of reduced risk of recurrence at the regional nodes by multivariate analysis, after adjusting for patient age, pathological T stage, and pathological nodal metastases. This study shows that template-based lymphadenectomy reduced the risk of regional node recurrence in patients with urothelial carcinoma of the renal pelvis and appears to result in improved survival.	[Kondo, Tsunenori; Takagi, Toshio; Hashimoto, Yasunobu; Kobayashi, Hirohito; Iizuka, Junpei; Omae, Kenji; Ikezawa, Eri; Yoshida, Kazuhiko; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan; [Hara, Isao; Kodama, Yoshiki] Wakayama Med Univ, Dept Urol, Wakayama, Japan	Kondo, T (reprint author), Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tkondo@kc.twmu.ac.jp		Omae, Kenji/0000-0003-0109-7425			Abe T, 2010, EJSO-EUR J SURG ONC, V36, P1085, DOI 10.1016/j.ejso.2010.08.134; Kondo T, 2007, UROLOGY, V69, P265, DOI 10.1016/j.urology.2006.10.014; Shariat SF, 2010, BJU INT, V105, P1672, DOI 10.1111/j.1464-410X.2009.09072.x; BATATA MA, 1975, CANCER, V35, P1626, DOI 10.1002/1097-0142(197506)35:6<1626::AID-CNCR2820350623>3.0.CO;2-C; Kondo T, 2007, J UROLOGY, V178, P1212, DOI 10.1016/j.juro.2007.05.158; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Brown GA, 2006, BJU INT, V98, P1176, DOI 10.1111/j.1464-410X.2006.06524.x; Roscigno M, 2008, EUR UROL, V53, P794, DOI 10.1016/j.eururo.2008.01.008; Kondo T, 2014, INT J UROL, V21, P453, DOI [10.1111/iju.12417, 10.1111/iju.12338]; Kondo T, 2012, INT J UROL, V19, P710, DOI 10.1111/j.1442-2042.2012.03009.x; Roscigno M, 2009, EUR UROL, V56, P512, DOI 10.1016/j.eururo.2009.06.004; Lughezzani G, 2010, UROLOGY, V75, P118, DOI 10.1016/j.urology.2009.07.1296; Tanaka N, 2014, ANN SURG ONCOL, V21, P1038, DOI 10.1245/s10434-013-3349-z; Mason RJ, 2012, UROLOGY, V79, P840, DOI 10.1016/j.urology.2011.11.058; Hellenthal NJ, 2009, J UROLOGY, V182, P900, DOI 10.1016/j.juro.2009.05.011; Brausi MA, 2007, EUR UROL, V52, P1414, DOI 10.1016/j.eururo.2007.04.070; Burger M, 2011, WORLD J UROL, V29, P465, DOI 10.1007/s00345-011-0705-0; GRABSTAL.H, 1971, J AMER MED ASSOC, V218, P845, DOI 10.1001/jama.218.6.845; Hall MC, 1998, J UROLOGY, V160, P703, DOI 10.1016/S0022-5347(01)62763-0; Ito K, 2014, J UROLOGY, V191, P1685, DOI 10.1016/j.juro.2013.12.048; Kondo T, 2010, INT J UROL, V17, P848, DOI 10.1111/j.1442-2042.2010.02610.x; Ouzzane A, 2013, WORLD J UROL, V31, P189, DOI 10.1007/s00345-012-0983-1; Sagalowsky AI, 2012, CAMPBELL WALSH UROLO, P1516; Sobin L, 2009, TNM CLASSIFICATION M, P258; Yafi FA, 2014, UROL ONCOL, V32, pe17	25	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1233	1238		10.1093/jjco/hyu151		6	Oncology	Oncology	AU7HW	WOS:000345772400013		
J	Hasegawa, M; Sakai, F; Sato, A; Tsubomizu, S; Arimura, K; Katsura, H; Koh, E; Sekine, Y; Wu, D; Hiroshima, K				Hasegawa, Mizue; Sakai, Fumikazu; Sato, Akitoshi; Tsubomizu, Sayuri; Arimura, Ken; Katsura, Hideki; Koh, Eitetsu; Sekine, Yasuo; Wu, Di; Hiroshima, Kenzo			FISH Analysis of Intrapulmonary Malignant Mesothelioma without a Clinically Detectable Primary Pleural Lesion: An Autopsy Case	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						in situ hybridization; fluorescence; mesothelioma; neoplasm metastasis; genes; p16	DELETION	Patients with malignant mesothelioma typically present with a pleural effusion or pleural thickening and masses. A rare autopsy case of mesothelioma presenting with multiple bilateral lung nodules without clinically detectable pleural lesions is presented. A definitive diagnosis of the video-assisted thoracic surgery specimen could not be made, though a pattern of fibrosis mimicking organizing pneumonia was identified. Despite corticosteroid therapy, follow-up chest computed tomography showed enlargement of multiple nodules accompanied by the appearance of pleural thickening and effusions. The patient died of respiratory failure 11 months after initial presentation. Autopsy and retrospective analysis of the video-assisted thoracic surgery specimen using a p16 fluorescence in situ hybridization assay showed p16 homozygous deletion. The final diagnosis was sarcomatoid mesothelioma, and the lung nodules were intrapulmonary metastases from a clinically undetectable pleural sarcomatoid mesothelioma. It is important both to consider the possibility of mesothelioma with unusual clinical, radiological and pathological presentations and to remember that p16 fluorescence in situ hybridization analysis can play an important role in the diagnosis of mesothelioma.	[Hasegawa, Mizue; Sato, Akitoshi; Tsubomizu, Sayuri; Arimura, Ken; Katsura, Hideki] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Resp Med, Yachiyo, Japan; [Hasegawa, Mizue; Sakai, Fumikazu] Saitama Med Univ, Ctr Internal Med, Dept Diagnost Radiol, Hidaka, Japan; [Koh, Eitetsu; Sekine, Yasuo] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Thorac Surg, Yachiyo, Japan; [Wu, Di; Hiroshima, Kenzo] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pathol, Yachiyo, Japan	Hasegawa, M (reprint author), Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Resp Med, 477-96 Owadashinden, Yachiyo City, Chiba 2768524, Japan.	hasemizue@yahoo.co.jp					Wu D, 2013, AM J CLIN PATHOL, V139, P39, DOI 10.1309/AJCPT94JVWIHBKRD; Tochigi N, 2013, ARCH PATHOL LAB MED, V137, P632, DOI 10.5858/arpa.2012-0108-OA; Chung CTS, 2010, J CLIN PATHOL, V63, P630, DOI 10.1136/jcp.2010.076794; Fares M, 2008, RESPIROLOGY, V13, P746, DOI 10.1111/j.1440-1843.2008.01307.x; Lacle MM, 2013, J THORAC ONCOL, V8, P63; Lansen BT, 2013, AM J SURG PATHOL, V37, P1555; Livasy Chad A, 2003, Ann Diagn Pathol, V7, P249, DOI 10.1016/S1092-9134(03)00071-6	7	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1239	1242		10.1093/jjco/hyu139		4	Oncology	Oncology	AU7HW	WOS:000345772400014		
J	Yamaguchi, T; Koizumi, K; Arai, M; Tamura, K; Iijima, T; Horiguchi, SI; Miyaki, M				Yamaguchi, Tatsuro; Koizumi, Koichi; Arai, Masami; Tamura, Kazuo; Iijima, Takeru; Horiguchi, Shin-Ichiro; Miyaki, Michiko			A Large Deletion of Chromosome 5q22.1-22.2 Associated with Sparse Type of Familial Adenomatous Polyposis: Report of a Case	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						familial adenomatous polyposis; APC gene; chromosome 5q22; large genomic deletion	TUMOR-SUPPRESSOR PROTEIN; APC GENE; SUBMICROSCOPIC DELETIONS; COLORECTAL-CANCER; SOMATIC MUTATIONS; FAP PATIENTS; COLI GENE; IDENTIFICATION; LOCUS; PHENOTYPE	The proband was a 32-year-old man with sparse type of familial adenomatous polyposis with fundic gland and duodenal polyps and congenital hypertrophy of the retinal pigment epithelium without osteoma, dental abnormalities and desmoid tumors. Direct DNA sequencing did not detect germline mutations in any APC exon. However, using the multiplex ligation-dependent probe amplification method, we detected germline deletions of all APC exons. Using dual-color fluorescence in situ hybridization, we identified germline deletion of locus 5q22.1-22.2 that includes APC. Analysis of colorectal tumors identified somatic APC mutations in the cluster region in all polyps, but no loss of heterozygosity was detected in any polyp.	[Yamaguchi, Tatsuro; Iijima, Takeru; Miyaki, Michiko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hereditary Tumor Res Project, Tokyo, Japan; [Yamaguchi, Tatsuro] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan; [Koizumi, Koichi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gastroenterol, Tokyo, Japan; [Arai, Masami] Canc Inst Hosp, Japanese Fdn Canc Res, Tokyo, Japan; [Tamura, Kazuo] Kinki Univ, Grad Sch Sci & Engn Res, Higashiosaka, Osaka 577, Japan; [Horiguchi, Shin-Ichiro] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pathol, Tokyo, Japan	Yamaguchi, T (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	tatsuro@yamaguchi.e-mail.ne.jp					SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Takahashi M, 2006, INT J ONCOL, V29, P413; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Goss KH, 2000, J CLIN ONCOL, V18, P1967; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Miyaki M, 2008, INT J CANCER, V122, P2491, DOI 10.1002/ijc.23390; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Renkonen ET, 2005, J CLIN ONCOL, V23, P5651, DOI 10.1200/JCO.2005.14.712; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Aretz S, 2005, J MED GENET, V42, P185, DOI 10.1136/jmg.2004.022822; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Rubinfeld B, 1997, CANCER RES, V57, P4624; Venesio T, 2003, LAB INVEST, V83, P1859, DOI 10.1097/01.LAB.0000106722.37873.8D; Michils G, 2005, HUM MUTAT, V25, P125, DOI 10.1002/humu.20122; CASPARI R, 1995, HUM MOL GENET, V4, P337, DOI 10.1093/hmg/4.3.337; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Knudsen Anne Lyster, 2003, Fam Cancer, V2, P43, DOI 10.1023/A:1023286520725; Bunyan DJ, 2004, BRIT J CANCER, V91, P1155, DOI 10.1038/sj.bjc.6602121; Cao YM, 2002, AM J GASTROENTEROL, V97, P1822; De Rosa M, 1999, EUR J HUM GENET, V7, P695, DOI 10.1038/sj.ejhg.5200344; Flintoff KJ, 2001, J MED GENET, V38, P129, DOI 10.1136/jmg.38.2.129; Gismondi V, 1998, HUM MUTAT, pS220; Ishiguro H, 2000, JPN J CANCER RES, V91, P597; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Meuller J, 2004, GENET TEST, V8, P248, DOI 10.1089/gte.2004.8.248; Mihalatos M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-40; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Nielsen M, 2007, EUR J HUM GENET, V15, P1034, DOI 10.1038/sj.ejhg.5201871; OLSCHWANG S, 1993, CELL, V75, P959, DOI 10.1016/0092-8674(93)90539-3; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P2954, DOI 10.1073/pnas.042699199; Soccio RE, 2002, P NATL ACAD SCI USA, V99, P6943, DOI 10.1073/pnas.052143799; Su LK, 2000, HUM GENET, V106, P101, DOI 10.1007/s004390051016; Su LK, 2002, HUM GENET, V111, P88, DOI 10.1007/s00439-002-0758-7	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1243	1247		10.1093/jjco/hyu150		5	Oncology	Oncology	AU7HW	WOS:000345772400015		
J	Katanoda, K; Matsuda, T				Katanoda, Kota; Matsuda, Tomohiro			Cancer Statistics Digest	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Katanoda, Kota; Matsuda, Tomohiro] Natl Canc Ctr, Surveillance Div, Ctr Canc Control & Informat Serv, Tokyo 104, Japan	Katanoda, K (reprint author), Natl Canc Ctr, Surveillance Div, Ctr Canc Control & Informat Serv, Tokyo 104, Japan.						Matsuda T, 2011, JPN J CLIN ONCOL, V41, P40, DOI 10.1093/jjco/hyq167; Steliarova-Foucher E, 2012, EUROPEAN CANC OBSERV; Surveillance Epidemiology and End Results (SEER) Program, 2013, SEER STAT DAT INC SE	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	DEC	2014	44	12					1248	1248		10.1093/jjco/hyu197		1	Oncology	Oncology	AU7HW	WOS:000345772400016		
J	Kaufman, AH; Mock, J				Kaufman, Alexander Harrow; Mock, Jeremiah			Cultivating Greater Well-being: The Benefits Thai Organic Farmers Experience from Adopting Buddhist Eco-spirituality	JOURNAL OF AGRICULTURAL & ENVIRONMENTAL ETHICS			English	Article						Organic agriculture; Health; Debt; Thailand; Buddhism; Ecological values; Spirituality	AGRICULTURE; COMMUNITY; SYSTEMS	Organic farming is spreading throughout Asia, including in Thailand. Little is known about whether farmers' values change as they make the shift from conventional farming to organic farming. The benefits farmers perceive from making the shift have also scarcely been studied. We investigated these factors in Northeastern Thailand by conducting observations, key informant interviews, semi-structured interviews and questionnaire interviews. We found that as Thai farmers adopted organic methods, they developed an eco-consciousness. In comparing members of a Buddhist temple-based organic farmer support group with members of a non-profit organic agriculture support group, we found that the temple-based group adopted deeper Buddhist eco-spiritual values while the non-profit group remained more commercially oriented. Farmers who adopted Buddhist eco-spiritual values enjoyed greater financial and health benefits from making the organic shift. A higher proportion of the temple-based group eliminated their debts after making the shift (p > 0.001). Additionally, a higher proportion of members in the temple-based group felt that their physical health improved after becoming an organic farmer (p = 0.003). Interestingly, the less debt farmers carried, the healthier they felt (p > 0.001). Participants believed that eliminating the use of agro-chemicals, using organic fertilizers, consuming organic food, and increasing biodiversity on their farms also contributed to improving their health. We conclude that for Thai farmers who are devoutly committed to Buddhism, temple-based organic support programs provided an effective pathway to improving their finances, health and well-being. For Thai farmers generally, a fundamental adoption of eco-conscious values is integral to experiencing deeper non-commercial benefits from organic farming. Findings suggest that the expansion of organic farming systems depends on changing perspectives about well-being.	[Kaufman, Alexander Harrow] Khon Kaen Univ, Res Grp Wellbeing & Sustainable Dev, Fac Humanities & Social Sci, Muang Dist 40002, Khon Kaen Provi, Thailand; [Mock, Jeremiah] Osaka Univ, Ctr Study Commun Design, Toyonaka, Osaka 5600043, Japan	Kaufman, AH (reprint author), Khon Kaen Univ, Res Grp Wellbeing & Sustainable Dev, Fac Humanities & Social Sci, 123 Mitraparb Rd, Muang Dist 40002, Khon Kaen Provi, Thailand.	lex_int@yahoo.com; jeremiah.mock@gmail.com					Allen P., 2004, TOGETHER TABLE SUSTA; WISHIK SM, 1976, AM J PUBLIC HEALTH, V66, P38; Hardwick K, 2004, NEW FOREST, V27, P285, DOI 10.1023/B:NEFO.0000022228.08887.d2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Lotter DW, 2003, J SUSTAIN AGR, V21, P59, DOI 10.1300/J064v21n04_06; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; Drentea P, 2000, SOC SCI MED, V50, P517, DOI 10.1016/S0277-9536(99)00298-1; Schreinemachers P, 2012, AGR HUM VALUES, V29, P519, DOI 10.1007/s10460-012-9378-6; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Sullivan S, 1996, J AGR ENVIRON ETHIC, V9, P123; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Baconguis Rowena T., 2005, Philippine Scientist, V42, P15; Becchetti L., 2010, MARKET ACCESS UNPUB; BEUS CE, 1990, RURAL SOCIOL, V55, P590; Boonman C., 2006, POSSIBILITY HOMALI R; Charmaz Kathy, 2006, CONSTRUCTING GROUNDE; Cresswell J. W., 1998, QUALITATIVE INQUIRY; Curry JM, 2000, ANN ASSOC AM GEOGR, V90, P693, DOI 10.1111/0004-5608.00218; de Silva L., 1994, BUDDHISM ECOLOGY, P18; Duram L. A., 2000, Agriculture and Human Values, V17, P35, DOI 10.1023/A:1007632810301; Easterby-Smith M., 2008, MANAGEMENT RES; Elliot A. C., 2007, STAT ANAL QUICK REFE; Essen J., 2005, RIGHT DEV SANTI ASOK; Falvey L., 2002, BUDDH BHIKK AGR TEAC; Falvey L, 2000, THAI AGR GOLDEN CRAD; Funahashi K., 1996, SE ASIAN STUDIES, V33, P625; Glaser Barney F., 1978, THEORETICAL SENSITIV; Grandstaff T., 2008, SE ASIAN STUDIES, V46, P289; Hecht S., 1987, SCI BASIS ALTERNATIV, P1; Henning D., 2002, MANUAL BUDDHISM DEEP; Hutanawat N., 2006, SUSTAINABLE AGR VISI; IPM-DANIDA, 2004, 62 IPM DANIDA; Jitsanguan T., 2001, SUSTAINABLE AGR SYST; Kabilsingh C., 2010, BUDDHISM CONSERVATIO; Kaufman AH, 2012, WORLDVIEWS GLOB RELI, V2, P154; Kiatsuphimol J., 2002, THESIS ASIAN I MANAG; Lovelace G., 1998, RAPID RURAL APPRAISA, P3; McNeely JA, 2003, ECOAGRICULTURE STRAT; Mock J., 2000, THESIS U CALIFORNIA; National Statistics Office, 2011, STAT YB 2010; Od-ompanich W., 2007, ORGANIC INORGANIC RI; Onwuegbuzie A. J., 2007, QUALITATIVE REPORT, V12.2, P281; Onwuegbuzie A. J., 2004, Understanding Statistics, V3, DOI 10.1207/s15328031us0304_1; Panya O., 2003, STRENGTHENING COMMUN, P219; Panya O., 2003, SE ASIAN STUDIES, V41, P59; Pretty J., 2003, AGR RECINNECTING PEO; Rambo T., 1983, 14 E W ENV POL I; Ratanamalai A., 1999, REG WORKSH HELD 4 6; Rigg J., 1997, SE ASIA HUMAN LANDSC; Rogers E. M., 1971, COMMUNICATION INNOVA; Roitner-Schobesberger B, 2008, FOOD POLICY, V33, P112, DOI 10.1016/j.foodpol.2007.09.004; Samerpak P., 2006, THESIS ASIAN I MANAG; Semaan Salaam, 2002, AIDS Reviews, V4, P213; Setboonsarng S., 1999, ALTERNATIVE AGR THAI; Sirisai S., 1990, DEV MODERNIZATION TR, P163; Tanabe S., 1994, ECOLOGY PRACTICAL TE; Thongdee I., 1990, DEV MODERNIZATION TR, P178; Thongtawee C., 2006, THESIS MAHIDOL U; Wasi P., 1988, TURNING POINT THAI F, P1; White PT, 1994, NATL GEOGR, V185, P48; Willer H, 2013, WORLD ORGANIC AGR ST; Willer H., 2004, WORLD ORGANIC AGR ST; Wyatt D., 1982, THAILAND SHORT HIST	63	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1187-7863	1573-322X		J AGR ENVIRON ETHIC	J. Agric. Environ. Ethics	DEC	2014	27	6					871	893		10.1007/s10806-014-9500-4		23	Agriculture, Multidisciplinary; Ethics; Environmental Sciences; History & Philosophy Of Science	Agriculture; Social Sciences - Other Topics; Environmental Sciences & Ecology; History & Philosophy of Science	AU5JB	WOS:000345641600001		
J	Nishijima, T; Tsuchiya, K; Tanaka, N; Joya, A; Hamada, Y; Mizushima, D; Aoki, T; Watanabe, K; Kinai, E; Honda, H; Yazaki, H; Tanuma, J; Tsukada, K; Teruya, K; Kikuchi, Y; Oka, S; Gatanaga, H				Nishijima, Takeshi; Tsuchiya, Kiyoto; Tanaka, Noriko; Joya, Akane; Hamada, Yohei; Mizushima, Daisuke; Aoki, Takahiro; Watanabe, Koji; Kinai, Ei; Honda, Haruhito; Yazaki, Hirohisa; Tanuma, Junko; Tsukada, Kunihisa; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Single-nucleotide polymorphisms in the UDP-glucuronosyltransferase 1A-3 ' untranslated region are associated with atazanavir-induced nephrolithiasis in patients with HIV-1 infection: a pharmacogenetic study	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article						atazanavir sulphate; renal stones; SNPs	RITONAVIR-BOOSTED ATAZANAVIR; KIDNEY-STONES; ANTIRETROVIRAL THERAPY; PLASMA-CONCENTRATIONS; DRUG-INTERACTIONS; RECEPTOR PXR; RENAL STONES; RISK; LOPINAVIR; DISEASE	Ritonavir-boosted atazanavir (atazanavir/ritonavir) is a widely used antiretroviral drug, though it can potentially cause nephrolithiasis. The aim of this study was to determine the relationship between polymorphisms in genes encoding proteins involved in metabolism and transportation of atazanavir, and atazanavir/ritonavir-induced nephrolithiasis in HIV-1-infected patients treated with atazanavir/ritonavir. Nineteen SNPs in the ABCB1, NR1I2, UGT1A1, SLCO1B1 and CYP3A5 genes were examined in case patients with atazanavir/ritonavir-induced nephrolithiasis (naEuroS=aEuroS31) and controls (naEuroS=aEuroS47). Case patients were those with a clinical diagnosis of nephrolithiasis while on atazanavir/ritonavir, based on new-onset acute flank pain plus one of the following: (i) new-onset haematuria; (ii) documented presence of stones by either abdominal ultrasonography or CT; or (iii) confirmed stone passage. Control patients were consecutively enrolled among those with > 2 years of atazanavir/ritonavir exposure free of nephrolithiasis. Genotyping was performed by allelic discrimination using TaqMan 5'-nuclease assays with standard protocols. Associations between alleles and atazanavir/ritonavir-induced nephrolithiasis were tested by univariate and multivariate logistic regression analyses. Multivariate analysis showed a significant association between atazanavir/ritonavir-induced nephrolithiasis and genotype T/C versus C/C at position c.211 (adjusted ORaEuroS=aEuroS3.7; 95% CI, 1.13-11.9; PaEuroS=aEuroS0.030), genotype G/C versus C/C at 339 (adjusted ORaEuroS=aEuroS5.8; 95% CI, 1.56-21.3; PaEuroS=aEuroS0.009) and genotype G/G or G/C versus C/C at 440 (adjusted ORaEuroS=aEuroS5.8; 95% CI, 1.56-21.3; PaEuroS=aEuroS0.009) of the UGT1A-3' untranslated region (UTR). This is the first known study to identify the association between SNPs in the UGT1A-3'-UTR and atazanavir-induced nephrolithiasis. Further studies are warranted to confirm this association and to elucidate how these SNPs might influence atazanavir exposure.	[Nishijima, Takeshi; Tsuchiya, Kiyoto; Joya, Akane; Hamada, Yohei; Mizushima, Daisuke; Aoki, Takahiro; Watanabe, Koji; Kinai, Ei; Honda, Haruhito; Yazaki, Hirohisa; Tanuma, Junko; Tsukada, Kunihisa; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Nishijima, Takeshi; Mizushima, Daisuke; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Tanaka, Noriko] Natl Ctr Global Hlth & Med, Biostat Sect, Dept Clin Res & Informat, Ctr Clin Sci, Tokyo, Japan	Gatanaga, H (reprint author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp	Tsuchiya, Kiyoto/L-8650-2013		Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001]; Grant for National Center for Global Health and Medicine [25-106]	This work was supported by a Grant-in Aid for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001) and the Grant for National Center for Global Health and Medicine (25-106).	Alexander RT, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5287; Anderson PL, 2007, AIDS, V21, P1060, DOI 10.1097/QAD.0b013e3280c56ae1; [Anonymous], 2012, CRIX IND SULF; Rockwood N, 2011, AIDS, V25, P1671, DOI 10.1097/QAD.0b013e32834a1cd6; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; [Anonymous], 2012, REYAT AT SULF; Takeuchi K, 2004, J GASTROEN HEPATOL, V19, P1023, DOI 10.1111/j.1400-1746.2004.03370.x; Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001; Couzigou C, 2007, CLIN INFECT DIS, V45, pE105, DOI 10.1086/521930; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Ando R, 2013, J UROLOGY, V189, P1340, DOI 10.1016/j.juro.2012.11.045; Levey AS, 2006, ANN INTERN MED, V145, P247; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Maruo Y, 2005, CURR DRUG METAB, V6, P91, DOI 10.2174/1389200053586064; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Parmar MS, 2004, BRIT MED J, V328, P1420, DOI 10.1136/bmj.328.7453.1420; Court MH, 2013, J PHARMACOL EXP THER, V345, P297, DOI 10.1124/jpet.112.202010; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; Chang HR, 2006, NEW ENGL J MED, V355, P2158, DOI 10.1056/NEJMc061892; Chan-Tack KM, 2006, CLIN INFECT DIS, V42, P1344; Kile DA, 2012, AIDS RES HUM RETROV, V28, P1227, DOI 10.1089/aid.2011.0378; Kis O, 2013, PHARM RES-DORDR, V30, P1050, DOI 10.1007/s11095-012-0942-y; Ma Q, 2007, PHARMACOGENOMICS, V8, P227, DOI 10.2217/14622416.8.3.227; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077268; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Park WB, CLIN INFECT DIS; Rodríguez Nóvoa Sonia, 2006, Clin Infect Dis, V42, P291, DOI 10.1086/499056; Rodriguez-Novoa S, 2007, AIDS, V21, P41, DOI 10.1097/QAD.0b013e328011d7c1; Siccardi M, 2008, CLIN INFECT DIS, V47, P1222, DOI 10.1086/592304; Wempe MF, 2011, DRUG METAB DISPOS, V39, P522, DOI 10.1124/dmd.110.036178	36	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	DEC	2014	69	12					3320	3328		10.1093/jac/dku304		9	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AU7FX	WOS:000345767300020		
J	Fujii, N; Honda, Y; Komura, K; Tsuji, B; Sugihara, A; Watanabe, K; Kondo, N; Nishiyasu, T				Fujii, Naoto; Honda, Yasushi; Komura, Ken; Tsuji, Bun; Sugihara, Akira; Watanabe, Kazuhito; Kondo, Narihiko; Nishiyasu, Takeshi			Effect of voluntary hypocapnic hyperventilation on the relationship between core temperature and heat loss responses in exercising humans	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						respiratory alkalosis; temperature regulation; skin; evaporation; non-thermal factor	SKIN BLOOD-FLOW; CUTANEOUS ACTIVE VASODILATION; MODERATE-INTENSITY EXERCISE; SYMPATHETIC-NERVE ACTIVITY; BODY NEGATIVE-PRESSURE; PASSIVE HYPERTHERMIA; SWEATING RESPONSE; INDUCED INCREASES; PREOPTIC NEURONS; DYNAMIC EXERCISE	Two thermolytic thermoregulatory responses, cutaneous vasodilation and sweating, begin when core temperature reaches a critical threshold, after which response magnitudes increase linearly with increasing core temperature; thus the slope indicates response sensitivity. We evaluated the influence of hypocapnia induced by voluntary hyperventilation on the core temperature threshold and sensitivity of thermoregulatory responses. Ten healthy males performed 15 min of cycling at 117 W (29.5 degrees C, 50% RH) under three breathing conditions: 1) spontaneous ventilation, 2) voluntary normocapnic hyperventilation, and 3) voluntary hypocapnic hyperventilation. In the hypocapnic hyperventilation trial, end-tidal CO2 pressure was reduced throughout the exercise, whereas it was maintained around the normocapnic level in the other two trials. Cutaneous vascular conductances at the forearm and forehead were evaluated as laser-Doppler signal/mean arterial blood pressure, and the forearm sweat rate was measured using the ventilated capsule method. Esophageal temperature threshold was higher for the increase in cutaneous vascular conductance in the hypocapnic than normocapnic hyperventilation trial at the forearm (36.88 +/- 0.36 vs. 36.68 +/- 0.34 degrees C, P < 0.05) and forehead (36.89 +/- 0.31 vs. 36.75 +/- 0.31 degrees C, P < 0.05). The slope relating esophageal temperature to cutaneous vascular conductance was decreased in the hypocapnic than normocapnic hyperventilation trial at the forearm (302 +/- 177 vs. 420 +/- 178% baseline/degrees C, P < 0.05) and forehead (236 +/- 164 vs. 358 +/- 221% baseline/degrees C, P < 0.05). Neither the threshold nor the slope for the forearm sweat rate differed significantly between the hypocapnic or normocapnic hyperventilation trials. These findings indicate that in exercising humans, hypocapnia induced by voluntary hyperventilation does not influence sweating, but it attenuates the cutaneous vasodilatory response by increasing its threshold and reducing its sensitivity.	[Fujii, Naoto; Honda, Yasushi; Komura, Ken; Tsuji, Bun; Sugihara, Akira; Watanabe, Kazuhito; Nishiyasu, Takeshi] Univ Tsukuba, Inst Hlth & Sports Sci, Tsukuba, Ibaraki 3058574, Japan; [Kondo, Narihiko] Kobe Univ, Fac Human Dev, Kobe, Hyogo 657, Japan	Nishiyasu, T (reprint author), Univ Tsukuba, Inst Hlth & Sports Sci, Tsukuba, Ibaraki 3058574, Japan.	nisiyasu@taiiku.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science; Japan Society of the Promotion of Science	This study was supported by the grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan and the Japan Society for the Promotion of Science. N. Fujii is the recipient of a research fellowship for young scientists from the Japan Society of the Promotion of Science.	ALBERT RE, 1965, J APPL PHYSIOL, V20, P134; Amano T, 2014, AM J PHYSIOL-REG I, V306, pR728, DOI 10.1152/ajpregu.00515.2013; Curran-Everett D, 2004, ADV PHYSIOL EDUC, V28, P85, DOI 10.1152/advan.00019.2004; Binder K, 2012, AM J PHYSIOL-REG I, V302, pR417, DOI 10.1152/ajpregu.00463.2011; Ichinose M, 2008, J PHYSIOL-LONDON, V586, P2753, DOI 10.1113/jphysiol.2007.150060; NADEL ER, 1971, J APPL PHYSIOL, V31, P80; Tsuji B, 2012, J APPL PHYSIOL, V113, P1388, DOI 10.1152/japplphysiol.00335.2012; Fujii N, 2008, J APPL PHYSIOL, V104, P998, DOI 10.1152/japplphysiol.00146.2007; White MD, 1996, J APPL PHYSIOL, V81, P1249; Hayashi K, 2006, J APPL PHYSIOL, V100, P414, DOI 10.1152/japplphysiol.00541.2005; Cheuvront SN, 2009, J APPL PHYSIOL, V107, P69, DOI 10.1152/japplphysiol.00250.2009; Minson CT, 2010, J APPL PHYSIOL, V109, P1239, DOI 10.1152/japplphysiol.00414.2010; NADEL ER, 1974, J APPL PHYSIOL, V37, P515; Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008; White MD, 2006, J APPL PHYSIOL, V101, P655, DOI 10.1152/japplphysiol.00210.2006; Fan JL, 2008, J APPL PHYSIOL, V105, P433, DOI 10.1152/japplphysiol.00010.2008; Fujii N, 2012, AM J PHYSIOL-REG I, V303, pR975, DOI 10.1152/ajpregu.00169.2012; JONES NL, 1979, J APPL PHYSIOL, V47, P954; BOULANT JA, 1974, J PHYSIOL-LONDON, V240, P639; Pearson J, 2013, EXP PHYSIOL, V98, P1156, DOI 10.1113/expphysiol.2013.072082; Robertshaw D, 2006, J APPL PHYSIOL, V101, P664, DOI 10.1152/japplphysiol.01380.2005; CABANAC M, 1995, EUR J APPL PHYSIOL O, V71, P71, DOI 10.1007/BF00511235; Beaudin AE, 2009, AM J PHYSIOL-REG I, V297, pR605, DOI 10.1152/ajpregu.90672.2008; Shibasaki M, 2002, J APPL PHYSIOL, V93, P1947, DOI 10.1152/japplphysiol.00036.2002; Amano T, 2011, J APPL PHYSIOL, V111, P524, DOI 10.1152/japplphysiol.00212.2011; KELLOGG DL, 1995, CIRC RES, V77, P1222; Balasubramanyan N, 2000, PEDIATR PULM, V30, P241, DOI 10.1002/1099-0496(200009)30:3<241::AID-PPUL8>3.0.CO;2-K; Chin LMK, 2013, EXP PHYSIOL, V98, P1668, DOI 10.1113/expphysiol.2013.074021; DODT E, 1956, PFLUG ARCH GES PHYS, V263, P188, DOI 10.1007/BF00362907; El Mays TY, 2011, CAN J PHYSIOL PHARM, V89, P513, DOI 10.1139/Y11-052; Farrukh IS, 1996, J APPL PHYSIOL, V80, P496; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Hayashi K, 2011, J APPL PHYSIOL, V110, P1334, DOI 10.1152/japplphysiol.00010.2010; JOHNSON JM, 1974, J APPL PHYSIOL, V37, P880; Kellogg DL, 2012, J APPL PHYSIOL, V113, P1512, DOI 10.1152/japplphysiol.00859.2012; Kenny GP, 1996, EUR J APPL PHYSIOL O, V74, P258, DOI 10.1007/BF00377448; Lucas RAI, 2013, AM J PHYSIOL-REG I, V305, pR604, DOI 10.1152/ajpregu.00052.2013; Lynn AG, 2012, AM J PHYSIOL-REG I, V302, pR634, DOI 10.1152/ajpregu.00411.2011; MASKREY M, 1981, J APPL PHYSIOL, V50, P315; McGinn R, 2014, AM J PHYSIOL-REG I, V306, pR82, DOI 10.1152/ajpregu.00364.2013; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nybo L, 2001, J PHYSIOL-LONDON, V534, P279, DOI 10.1111/j.1469-7793.2001.t01-1-00279.x; Ogoh S, 2008, J PHYSIOL-LONDON, V586, P4327, DOI 10.1113/jphysiol.2008.157073; Ogoh S, 2007, AM J PHYSIOL-HEART C, V293, pH2202, DOI 10.1152/ajpheart.00708.2007; ROBINSON SM, 1971, J APPL PHYSIOL, V31, P656; Sancheti A, 2006, EUR J APPL PHYSIOL, V96, P495, DOI 10.1007/s00421-005-0101-9; Shibasaki M, 2003, J PHYSIOL-LONDON, V553, P999, DOI 10.1113/jphysiol.2003.051102; Shibasaki M, 2005, J PHYSIOL-LONDON, V565, P667, DOI 10.1113/jphysiol.2005.083535; Simmons GH, 2011, EXP PHYSIOL, V96, P822, DOI 10.1113/expphysiol.2010.056176; TAM HS, 1978, J APPL PHYSIOL, V45, P451; TAMAKI Y, 1987, PFLUG ARCH EUR J PHY, V409, P1, DOI 10.1007/BF00584743; TAMAKI Y, 1986, PFLUG ARCH EUR J PHY, V407, P8, DOI 10.1007/BF00580713; WENGER CB, 1975, J APPL PHYSIOL, V38, P58; Wilsmore BR, 2006, SPINAL CORD, V44, P160, DOI 10.1038/sj.sc.3101823; Wong BJ, 2006, J PHYSIOL-LONDON, V577, P1043, DOI 10.1113/jphysiol.2006.112508	55	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	DEC 1	2014	117	11					1317	1324		10.1152/japplphysiol.00334.2014		8	Physiology; Sport Sciences	Physiology; Sport Sciences	AW0ZZ	WOS:000346021300011		
J	Fukuoka, D; Okahara, F; Hashizume, K; Yanagawa, K; Osaki, N; Shimotoyodome, A				Fukuoka, Daisuke; Okahara, Fumiaki; Hashizume, Kohjiro; Yanagawa, Kiyotaka; Osaki, Noriko; Shimotoyodome, Akira			Triterpene alcohols and sterols from rice bran lower postprandial glucose-dependent insulinotropic polypeptide release and prevent diet-induced obesity in mice	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						cycloartenol; GIP; obesity; triterpene alcohol	HIGH-FAT DIET; GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; GENE-EXPRESSION; C57BL/6J MICE; BODY-WEIGHT; ACID UPTAKE; GIP; RECEPTOR; ADIPOCYTES	Obesity is now a worldwide health problem. Glucose-dependent insulinotropic polypeptide (GIP) is a gut hormone that is secreted following the ingestion of food and modulates energy metabolism. Previous studies reported that lowering diet-induced GIP secretion improved energy homeostasis in animals and humans, and attenuated diet-induced obesity in mice. Therefore, food-derived GIP regulators may be used in the development of foods that prevent obesity. Rice bran oil and its components are known to have beneficial effects on health. Therefore, the aim of the present study was to clarify the effects of the oil-soluble components of rice bran on postprandial GIP secretion and obesity in mice. Triterpene alcohols [cycloartenol (CA) and 24-methylene cycloartanol (24Me)], beta-sitosterol, and campesterol decreased the diet-induced secretion of GIP in C57BL/6J mice. Mice fed a high-fat diet supplemented with a triterpene alcohol and sterol preparation (TASP) from rice bran for 23 wk gained less weight than control mice. Indirect calorimetry revealed that fat utilization was higher in TASP-fed mice than in control mice. Fatty acid oxidation-related gene expression in the muscles of mice fed a TASP-supplemented diet was enhanced, whereas fatty acid synthesis-related gene expression in the liver was suppressed. The treatment of HepG2 cells with CA and 24Me decreased the gene expression of sterol regulatory element-binding protein (SREBP)-1c. In conclusion, we clarified for the first time that triterpene alcohols and sterols from rice bran prevented diet-induced obesity by increasing fatty acid oxidation in muscles and decreasing fatty acid synthesis in the liver through GIP-dependent and GIP-independent mechanisms.	[Fukuoka, Daisuke; Okahara, Fumiaki; Hashizume, Kohjiro; Osaki, Noriko; Shimotoyodome, Akira] Kao Corp, Biol Sci Lab, Ichikai, Tochigi, Japan; [Yanagawa, Kiyotaka] Kao Corp, Analyt Sci Res Labs, Ichikai, Tochigi, Japan	Shimotoyodome, A (reprint author), 2606 Akabane, Ichikai, Tochigi 3213497, Japan.	shimotoyodome.akira@kao.co.jp			Kao Corporation	The present study was supported financially by the Kao Corporation.	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Shimotoyodome A, 2010, AM J PHYSIOL-ENDOC M, V298, pE652, DOI 10.1152/ajpendo.00468.2009; Rong N, 1997, LIPIDS, V32, P303, DOI 10.1007/s11745-997-0037-9; Kozuka C, 2012, DIABETES, V61, P3084, DOI 10.2337/db11-1767; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Kim SJ, 2010, J LIPID RES, V51, P3145, DOI 10.1194/jlr.M006841; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; HAUNER H, 1988, ANN NUTR METAB, V32, P282, DOI 10.1159/000177467; Shimotoyodome A, 2009, ENDOCRINOLOGY, V150, P2118, DOI 10.1210/en.2008-1162; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113; Montgomery IA, 2010, DIABETES OBES METAB, V12, P744, DOI 10.1111/j.1463-1326.2010.01228.x; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Foretz M, 1999, MOL CELL BIOL, V19, P3760; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Akihisa T, 2000, J AGR FOOD CHEM, V48, P2313, DOI 10.1021/jf000135o; Jonckheere AR, 1954, BRIT J STATIST PSYCH, V7, P93; Cicero A. F. G., 2005, Current Topics in Nutraceutical Research, V3, P29; DENKE MA, 1993, ARCH INTERN MED, V153, P1093, DOI 10.1001/archinte.153.9.1093; FALKO JM, 1975, J CLIN ENDOCR METAB, V41, P260; FOLCH J, 1957, J BIOL CHEM, V226, P497; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Jin Son M, 2010, J CLIN BIOCHEM NUTR, V46, P150; Murase T, 2001, J LIPID RES, V42, P372; Naitoh R, 2008, BIOCHEM BIOPH RES CO, V376, P21, DOI 10.1016/j.bbrc.2008.08.052; OBEN J, 1991, J ENDOCRINOL, V130, P267, DOI 10.1677/joe.0.1300267; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Shimotoyodome A, 2012, AM J PHYSIOL-GASTR L, V303, pG298, DOI 10.1152/ajpgi.00457.2011; Son MJ, 2011, J FOOD SCI, V76, pH7, DOI 10.1111/j.1750-3841.2010.01907.x; Ugleholdt R, 2011, J BIOL CHEM, V286, P44632, DOI 10.1074/jbc.M111.311779; Yasukawa K, 1998, BIOL PHARM BULL, V21, P1072; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164	45	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	DEC 1	2014	117	11					1337	1348		10.1152/japplphysiol.00268.2014		12	Physiology; Sport Sciences	Physiology; Sport Sciences	AW0ZZ	WOS:000346021300013		
J	Yamazaki, E; Nakai, S; Sahoo, Y; Yokoyama, T; Mifune, H; Saito, T; Chen, J; Takagi, N; Hokanishi, N; Yasuda, A				Yamazaki, E.; Nakai, S.; Sahoo, Y.; Yokoyama, T.; Mifune, H.; Saito, T.; Chen, J.; Takagi, N.; Hokanishi, N.; Yasuda, A.			Feasibility studies of Sn isotope composition for provenancing ancient bronzes	JOURNAL OF ARCHAEOLOGICAL SCIENCE			English	Article						Sn isotope composition; Bronze; Cassiterite; Casting experiment; ICP-MS; China	MASS-SPECTROMETRY; ATOMIC WEIGHTS; ICP-MS; TIN; FRACTIONATION; CASSITERITES; EQUILIBRIUM; ARCHAEOLOGY; TELLURIUM; SYSTEM	This study examined isotope fractionation during bronze casting and assessed variation in Sn isotope composition of Chinese bronze products to ascertain whether a Sn isotope tracer is applicable to provenance studies of bronze products or not. A casting experiment revealed that the Sn isotope composition of a bronze block surface becomes slightly heavier, 0.22 parts per thousand in delta Sn-124/Sn-120 scale, (delta Sn-124/Sn-120 = [(Sn-124/Sn-120(sample))/ (Sn-124/Sn-120(standard))-1] x 10(3)), than original Sn beads because of selective evaporation of light isotopes. The Sn isotope compositions of six bronze product samples excavated in China were analyzed. The variation of delta Sn-124/Sn-120 in the six samples was as great as 0.4 parts per thousand. Six bronze samples showed small but detectable isotope variation that surpassed isotope shift during casting. Results suggested that the application of Sn isotope ratio to provenance studies of bronze products was of limited use because of the small variation. However, it was also shown that the Sn isotope ratio can be applied for provenancing a bronze sample with a distinct isotope composition. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamazaki, E.; Nakai, S.; Sahoo, Y.; Takagi, N.; Hokanishi, N.; Yasuda, A.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Yamazaki, E.; Yokoyama, T.] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528851, Japan; [Mifune, H.] Toyama Univ, Fac Art & Design, Takaoka, Toyama 9338588, Japan; [Saito, T.] Natl Museum Japanese Hist, Sakura, Chiba 2858502, Japan; [Chen, J.] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China	Nakai, S (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	snakai@eri.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23300322]; Global COE program, From the Earth to "Earths"	This research was supported by a Grant-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, #23300322, to SN. EY is supported by Global COE program, From the Earth to "Earths". We also appreciated Ms. S. Shibata for her help in casting experiments. Discussions with Dr. T. Nagae are also acknowledged. Comments from three anonymous reviewers improved the manuscript.	BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; LEE DC, 1995, INT J MASS SPECTROM, V146, P35, DOI 10.1016/0168-1176(95)04201-U; Radivojevic M, 2013, ANTIQUITY, V87, P1030; De Laeter JR, 2003, PURE APPL CHEM, V75, P683, DOI 10.1351/pac200375060683; LEHMANN M, 1991, J GLACIOL, V37, P23; LOSS RD, 1990, GEOCHIM COSMOCHIM AC, V54, P3525, DOI 10.1016/0016-7037(90)90302-2; Haustein M, 2010, ARCHAEOMETRY, V52, P816, DOI 10.1111/j.1475-4754.2010.00515.x; RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9; ROSMAN KJR, 1984, INT J MASS SPECTROM, V56, P281, DOI 10.1016/0168-1176(84)85055-7; Stos-Gale ZA, 2009, ARCHAEOL ANTHROP SCI, V1, P195, DOI 10.1007/s12520-009-0011-6; Balliana E, 2013, ANAL BIOANAL CHEM, V405, P2973, DOI 10.1007/s00216-012-6542-1; BUDD P, 1995, ISRAEL J CHEM, V35, P125; Clayton R, 2002, J ANAL ATOM SPECTROM, V17, P1248, DOI 10.1039/b205835a; DELAETER JR, 1967, GEOCHIM COSMOCHIM AC, V31, P969, DOI 10.1016/0016-7037(67)90074-9; DELAETER JR, 1965, J GEOPHYS RES, V70, P2895, DOI 10.1029/JZ070i012p02895; DEVILLERS C, 1983, INT J MASS SPECTROM, V50, P205, DOI 10.1016/0020-7381(83)80010-2; Gale NH, 1999, INT J MASS SPECTROM, V184, P1, DOI 10.1016/S1387-3806(98)14294-X; Gale NH, 1997, ARCHAEOMETRY, V39, P71, DOI 10.1111/j.1475-4754.1997.tb00791.x; Hubei Provincial Institute of Cultural Relics and Archaeology, 2001, PANL 1963 1994 ARCH; Jin Z.Y., 1987, J DIALECTICS NAT, V9, P80; Jin Z.Y., 1987, J DIALECTICS NAT, V9, P47; Jones W. R., 1925, TINFIELDS WORLD; Kazenas EK, 1996, RUSS METALL+, P23; Liulihe Archaeology Team, 1990, 1193 LIUL ARCH TEAM, P20; LONGERICH HP, 1987, SPECTROCHIM ACTA B, V42, P39, DOI 10.1016/0584-8547(87)80048-4; Malinovskiy D, 2009, ENVIRON SCI TECHNOL, V43, P4399, DOI 10.1021/es9000856; McNaughton N.J., 1990, STABLE ISOTOPES FLUI, P269; MCNAUGHTON NJ, 1991, GEOCHIM COSMOCHIM AC, V55, P499, DOI 10.1016/0016-7037(91)90007-R; Moynier F, 2009, ANAL CHIM ACTA, V632, P234, DOI 10.1016/j.aca.2008.11.015; Nickel D, 2012, ARCHAEOMETRY, V54, P167, DOI 10.1111/j.1475-4754.2011.00598.x; Niu S.Y., 2008, INN MONOG GEOL CHINA, V35, P714; Osawa T, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/64001; Penhallurick R.D., 1986, TIN ANTIQUITY ITS MI; Rapp G, 2009, NAT SCI ARCHAEOL, P1, DOI 10.1007/978-3-540-78594-1_1; ROSMAN KJR, 1987, INT J MASS SPECTROM, V75, P91, DOI 10.1016/0168-1176(87)83066-5; Sun S., 2001, PANLONGCHENG SITE RE, V1, P545; [王京彬 WANG Jingbin], 2005, [地质与勘探, Geology and Prospecting], V41, P15; Yamazaki E, 2013, GEOCHEM J, V47, P21; Yi E., 1995, GEOCHIM COSMOCHIM AC, V59, P5081; [翟德高 Zhai Degao], 2012, [岩石矿物学杂志, Acta Petrologica et Mineralogica], V31, P513; Zimmermann E, 1996, Z PHYS CHEM, V193, P195	41	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0305-4403	1095-9238		J ARCHAEOL SCI	J. Archaeol. Sci.	DEC	2014	52						458	467		10.1016/j.jas.2014.09.014		10	Anthropology; Archaeology; Geosciences, Multidisciplinary	Anthropology; Archaeology; Geology	AU6TM	WOS:000345734600038		
J	Murakami, M; Egashira, A; Tanaka, K; Mine, C; Otsubo, H; Kuramoto, T				Murakami, Masao; Egashira, Akiyoshi; Tanaka, Keiko; Mine, Chizuru; Otsubo, Hitomi; Kuramoto, Takeshi			Perinatal outcomes for transfer of blastocysts vitrified and warmed in defined solutions with recombinant human albumin: 374 babies born after 898 embryo transfers	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Blastocyst; Human; Vitrification; Defined; Recombinant human albumin	NEONATAL OUTCOMES; MOUSE EMBRYOS; BOVINE BLASTOCYSTS; ETHYLENE-GLYCOL; SEX-RATIO; IN-VITRO; VITRIFICATION; CRYOPRESERVATION; SURVIVAL; OOCYTES	Purpose To assess the efficacy of a novel, defined vitrification procedure using recombinant human albumin (rHA) for cryopreservation of human blastocysts. Design: Retrospective study. Setting: Private IVF clinic. Patients: 1,496 patients received vitrified/warmed embryo transfer (ET). Methods Surplus blastocysts, and blastocysts from patients undergoing elective embryo cryopreservation, were vitrified/warmed using Cryotop carriers in homemade solutions containing either human serum albumin (HSA) or rHA. Main Outcome Measures: Clinical and neonatal outcomes regarding the vitrified/warmed ET procedures. Results The HSA and rHA groups had a total of 1,163 and 898 vitrified/warmed cycles, respectively. Embryo survival rates (98.7 % vs. 98.9 %, respectively) and the number of embryos transferred (1.08 +/- 0.01 vs. 1.06 +/- 0.01, respectively) were similar in the HSA and rHA groups. Clinical pregnancy rates/ET were higher (P<0.05) in the rHA group (56.0 %) than in the HSA group (51.5 %). The HSA and rHA groups had similar live delivery rates/pregnancy (72.2 % vs. 72.3 %, respectively) and perinatal outcomes, including birth weight (2,988 +/- 28 vs. 3,046 +/- 26 g, respectively). Birth defects occurred in 0.9 % and 1.6 % of neonates in the HSA and rHA groups, respectively. Conclusions rHA effectively replaced HSA for human embryo vitrification procedures, and yielded high rates of pregnancy and live births after vitrified/warmed ET. This new approach will support the development of defined ART systems, which will eliminate the variation and risks associated with the use of blood-derived products.	[Murakami, Masao; Egashira, Akiyoshi; Tanaka, Keiko; Mine, Chizuru; Otsubo, Hitomi; Kuramoto, Takeshi] Kuramoto Womens Clin, Hakata Ku, Fukuoka 8120013, Japan	Murakami, M (reprint author), Kuramoto Womens Clin, Hakata Ku, 1-1-19 Hakataeki Higashi, Fukuoka 8120013, Japan.	murakami@kuramoto.or.jp					Arav A, 2002, MOL CELL ENDOCRINOL, V187, P77, DOI 10.1016/S0303-7207(01)00700-6; Roy TK, 2014, FERTIL STERIL, V101, P1294, DOI 10.1016/j.fertnstert.2014.01.046; Vajta G, 1997, ACTA VET SCAND, V38, P349; Liu SY, 2013, HUM REPROD, V28, P2093, DOI 10.1093/humrep/det104; Murakami M, 2011, FERTIL STERIL, V95, P2648, DOI 10.1016/j.fertnstert.2010.12.038; Pugh PA, 2000, ANIM REPROD SCI, V58, P9, DOI 10.1016/S0378-4320(99)00087-1; Hiraoka K, 2004, HUM REPROD, V19, P2884, DOI 10.1093/humrep/deh504; Chang HJ, 2009, FERTIL STERIL, V91, P2381, DOI 10.1016/j.fertnstert.2008.03.066; RALL WF, 1987, CRYOBIOLOGY, V24, P387, DOI 10.1016/0011-2240(87)90042-3; Shi WH, 2012, FERTIL STERIL, V97, P1338, DOI 10.1016/j.fertnstert.2012.02.051; Gardner DK, 2003, FERTIL STERIL, V79, P407, DOI 10.1016/S0015-0282(02)04576-4; Maalouf WE, 2014, FERTIL STERIL, V101, P1321, DOI 10.1016/j.fertnstert.2014.01.041; Checura CM, 2007, THERIOGENOLOGY, V67, P919, DOI 10.1016/j.theriogenology.2006.09.044; Lane M, 1999, NAT BIOTECHNOL, V17, P1234, DOI 10.1038/70795; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Sanchez-Osorio J, 2010, THERIOGENOLOGY, V73, P300, DOI 10.1016/j.theriogenology.2009.07.031; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Kasai M, 2004, REPROD BIOMED ONLINE, V9, P164; Bavister BD, 2003, HUM REPROD, V18, P113, DOI 10.1093/humrep/deg017; Blake D, 2002, J ASSIST REPROD GEN, V19, P137, DOI 10.1023/A:1014788821965; Bungum M, 2002, Reprod Biomed Online, V4, P233; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Gardner DK, 2000, FERTIL STERIL S1, V74, pS31, DOI 10.1016/S0015-0282(00)00809-8; GUTIERREZ A, 1993, THERIOGENOLOGY, V39, P1111, DOI 10.1016/0093-691X(93)90010-3; ISHIMORI H, 1992, THERIOGENOLOGY, V38, P1175, DOI 10.1016/0093-691X(92)90129-F; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300; Lane M, 2003, MOL REPROD DEV, V64, P70, DOI 10.1002/mrd.10210; Larman MG, 2011, FERTIL STERIL, V95, P1462, DOI 10.1016/j.fertnstert.2010.12.003; LEIBO SP, 1993, CRYO-LETT, V14, P133; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Murakami M, 2012, HUM REPROD, V27, pi71; Murakami M, 2011, HUM REPROD, V26, pI45; Takahashi K, 2005, FERTIL STERIL, V84, P88, DOI 10.1016/j.fertnstert.2004.12.051; TITTERINGTON JL, 1995, HUM REPROD, V10, P649	34	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	DEC	2014	31	12					1605	1610		10.1007/s10815-014-0343-8		6	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	AU7FK	WOS:000345766000005		
J	Sabharwal, L; Kamimura, D; Meng, J; Bando, H; Ogura, H; Nakayama, C; Jiang, JJ; Kumai, N; Suzuki, H; Atsumi, T; Arima, Y; Murakami, M				Sabharwal, Lavannya; Kamimura, Daisuke; Meng, Jie; Bando, Hidenori; Ogura, Hideki; Nakayama, Chiemi; Jiang, Jing-Jing; Kumai, Noriko; Suzuki, Hironao; Atsumi, Toru; Arima, Yasunobu; Murakami, Masaaki			The Gateway Reflex, which is mediated by the inflammation amplifier, directs pathogenic immune cells into the CNS	JOURNAL OF BIOCHEMISTRY			English	Review						blood-brain barrier; Gateway reflex; inflammation amplifier; NF-kappa B; STAT	T-CELLS; MULTIPLE-SCLEROSIS; IL-6 AMPLIFIER; AUTOIMMUNE ARTHRITIS; POSITIVE-FEEDBACK; ACTIVATION; GP130; RESPONSES; ROLES; LOOP	The brain-blood barrier (BBB) tightly limits immune cell migration into the central nervous system (CNS), avoiding unwanted inflammation under the normal state. However, immune cells can traverse the BBB when inflammation occurs within the CNS, suggesting a certain signal that creates a gateway that bypasses the BBB might exist. We revealed the inflammation amplifier as a mechanism of this signal, and identified dorsal vessels of the fifth lumber (L5) spinal cord as the gateway. The inflammation amplifier is driven by a simultaneous activation of NF-kappa B and STATs in non-immune cells, causing the production of a large amount of inflammatory chemokines to open the gateway at L5 vessels. It was found that the activation of the amplifier can be modulated by neural activation and artificially operated by electric pulses followed by establishment of new gateways, Gateway Reflex, at least in mice. Furthermore, genes required for the inflammation amplifier have been identified and are highly associated with various inflammatory diseases and disorders in the CNS. Thus, physical and/or pharmacological manipulation of the inflammation amplifier holds therapeutic value to control neuro-inflammation.	[Sabharwal, Lavannya; Kamimura, Daisuke; Meng, Jie; Bando, Hidenori; Ogura, Hideki; Nakayama, Chiemi; Jiang, Jing-Jing; Kumai, Noriko; Suzuki, Hironao; Atsumi, Toru; Arima, Yasunobu; Murakami, Masaaki] Hokkaido Univ, Grad Sch Med, Inst Med Genet, Kita Ku, Sapporo, Hokkaido 0600815, Japan	Murakami, M (reprint author), Hokkaido Univ, Grad Sch Med, Inst Med Genet, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	murakami@igm.hokudai.ac.jp			KAKENHI; JST-CREST program; Takeda Research Foundation; Mochida Memorial Foundation; Japan Intractable Diseases Research Foundation; Uehara Foundation; Naito Foundation; Waksman Foundation of Japan; Tokyo Biochemical Research Foundation; Osaka Cancer Research Foundation; Osaka Foundation for the Promotion of Clinical Immunology	We thank Ms. N. Kumai and Ms. R. Masuda for their excellent assistance. We thank Dr. P. Karagiannis (RIKEN QBiC, Osaka, Japan) for carefully reading the manuscript. We appreciate this work was supported by KAKENHI (Y.A., M.H., M.M., and T.H.) and the JST-CREST program (H.T. and M.M.), Takeda Research Foundation (M.M. and Y.A.), Mochida Memorial Foundation (Y.A.), Japan Intractable Diseases Research Foundation (Y.A.), Uehara Foundation (M.M.), the Naito Foundation (M.M.), the Waksman Foundation of Japan (M.M.), Tokyo Biochemical Research Foundation (M.M.), Osaka Cancer Research Foundation (M.M.), and the Osaka Foundation for the Promotion of Clinical Immunology (M.M.).	Komiyama Y, 2006, J IMMUNOL, V177, P566; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Murakami M, 2013, CELL REP, V3, P946, DOI 10.1016/j.celrep.2013.01.028; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Lee J, 2012, J IMMUNOL, V189, P1928, DOI 10.4049/jimmunol.1103613; Hendrix S, 2007, J NEUROIMMUNOL, V184, P100, DOI 10.1016/j.jneyroim.2006.11.019; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Murakami M, 2012, INT J BIOL SCI, V8, P1267, DOI 10.7150/ijbs.4828; Hoehlig K, 2012, EUR J IMMUNOL, V42, P1164, DOI 10.1002/eji.201142242; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Tracey KJ, 2012, CELL, V148, P392, DOI 10.1016/j.cell.2012.01.025; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Murakami M, 2004, GROWTH FACTORS, V22, P75, DOI 10.1080/08977190410001715181; Deutschman C. S., 2014, IMMUNITY, V40, P463; Kamimura D, 2003, Rev Physiol Biochem Pharmacol, V149, P1; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Lee J, 2013, INT IMMUNOL, V25, P319, DOI 10.1093/intimm/dxs158; Mori Y, 2014, INT IMMUNOL, V26, P93, DOI 10.1093/intimm/dxt044; Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005; Ohira Y., 2004, J GRAVIT PHYSL, V11, pP127; Shen J, 2006, AM J NEURORADIOL, V27, P2098	29	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	DEC	2014	156	6					299	304		10.1093/jb/mvu057		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU7HA	WOS:000345770200001		
J	Yokokura, Y; Isobe, Y; Matsueda, S; Iwamoto, R; Goto, T; Yoshioka, T; Urabe, D; Inoue, M; Arai, H; Arita, M				Yokokura, Yoshiyuki; Isobe, Yosuke; Matsueda, Shinnosuke; Iwamoto, Ryo; Goto, Tomomi; Yoshioka, Takeshi; Urabe, Daisuke; Inoue, Masayuki; Arai, Hiroyuki; Arita, Makoto			Identification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite	JOURNAL OF BIOCHEMISTRY			English	Article						anti-inflammation; lipidomics; 12; 15-lipoxygenase; omega-3 polyunsaturated fatty acid	DOCOSAHEXAENOIC ACID; LIPID MEDIATORS; INFLAMMATION; RESOLUTION; OMEGA-3-FATTY-ACIDS; PATHWAYS; BRAIN; CELLS; MICE	Docosahexaenoic acid (DHA) exhibits anti-inflammatory activity related to some of its oxygenated metabolites, such as D-series resolvins, protectin and maresin. Here, we analysed the lipids in inflammatory exudates using liquid chromatography-tandem mass spectrometry and identified a novel DHA metabolite, 14,20-dihydroxy-DHA (14,20-diHDHA) and showed that it is biosynthesized by eosinophils through the 12/15-lipoxygenase pathway. The chemical structure of the dominant 14,20-diHDHA isomer, which is endogenously biosynthesized by eosinophils, was identified as 14S,20R-diHDHA using chemically synthesized stereoisomers. Nanogram doses of 14,20-diHDHA displayed a potent anti-inflammatory action by limiting neutrophil infiltration in zymosan-induced peritonitis. The in vivo formation and potent anti-inflammatory action of 14,20-diHDHA may contribute to the protective effects of DHA.	[Yokokura, Yoshiyuki; Isobe, Yosuke; Matsueda, Shinnosuke; Arai, Hiroyuki; Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Isobe, Yosuke; Iwamoto, Ryo; Goto, Tomomi; Yoshioka, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Business Acad Collaborat Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Isobe, Yosuke; Arita, Makoto] RIKEN Ctr Integrat Med Sci iMS, Lab Metabol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Goto, Tomomi; Urabe, Daisuke; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Integral Analyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Arita, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Arita, M (reprint author), RIKEN Ctr Integrat Med Sci iMS, Lab Metabol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	makoto.arita@riken.jp			Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; programme for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry	This work was supported by Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) (to M.A.), Grant in aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M.A.) and the programme for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry (to H.A. and M.A.).	Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Duffield JS, 2006, J IMMUNOL, V177, P5902; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; COREY EJ, 1983, P NATL ACAD SCI-BIOL, V80, P3581, DOI 10.1073/pnas.80.12.3581; Lu Y, 2010, J LIPID RES, V51, P923, DOI 10.1194/jlr.M000059; Guillot N, 2009, FASEB J, V23, P2909, DOI 10.1096/fj.09-133421; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; De Caterina R., 1993, N 3 FATTY ACIDS VASC, P166; McLennan P, 1996, EUR J PHARMACOL, V300, P83, DOI 10.1016/0014-2999(95)00861-6; SHIKANO M, 1994, BBA-LIPID LIPID MET, V1212, P211, DOI 10.1016/0005-2760(94)90255-0; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429	28	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	DEC	2014	156	6					315	321		10.1093/jb/mvu044		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU7HA	WOS:000345770200003		
J	Asaoka, M; Segami, S; Maeshima, M				Asaoka, Mariko; Segami, Shoji; Maeshima, Masayoshi			Identification of the critical residues for the function of vacuolar H+-pyrophosphatase by mutational analysis based on the 3D structure	JOURNAL OF BIOCHEMISTRY			English	Article						energy conversion; H+-translocating pyrophosphatase; site-directed mutagenesis; structure-function relationship; vacuolar membrane	TRANSLOCATING INORGANIC PYROPHOSPHATASE; AMINO-ACID-RESIDUES; FREE-ENERGY CHANGE; PROTON TRANSPORT; PUMPING PYROPHOSPHATASE; MEMBRANES; ROLES; PURIFICATION; ARABIDOPSIS; MUTAGENESIS	H+-translocating pyrophosphatase (H+-PPase) converts energy from hydrolysis of inorganic pyrophosphate (PPi) to active H+ translocation across membranes. From the 3D structure resolved by crystallography, 17 amino acid residues in several domains of mung bean (Vigna radiata) enzyme were selected and substituted with alanine individually. The mutant enzymes were expressed in yeast cells to evaluate their biochemical role. The highly conserved residues in the substrate-binding site (T249, D269, D507 and N534) were shown to be essential for PPi hydrolysis and H+ pump. The amino acid substitution of residues in the H+ translocation pathway (I545, L555, N738, V746 and L749) resulted in mild decrease in the PPase activity and strong suppression of the H+ pump. These results suggest that the decoupling of PPi hydrolysis and active H+ translocation occurred in these five mutants including I545A. The alanine substitution of the C124 and C132, which form an intra-molecular disulfide bond, did not affect the enzyme activity. The modifications of the other residues in the vacuolar lumen loop, and M15 had relatively mild effect on the enzyme function. Functional roles of the 17 residues are discussed with consideration of the 3D structural information.	[Asaoka, Mariko; Segami, Shoji; Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan	Maeshima, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan.	maeshima@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23248017, 26252011]; JSPS	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS; grants: 23248017 and 26252011) to M.M. M.A. received financial support through the grant of Program for Leading Graduate Schools from JSPS.	Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Schultz A, 2003, BBA-BIOENERGETICS, V1607, P141, DOI 10.1016/j.bbabio.2003.09.003; Mimura H, 2005, FEBS LETT, V579, P3625, DOI 10.1016/j.febslet.2005.05.045; Mimura H, 2005, BBA-BIOENERGETICS, V1708, P393, DOI 10.1016/j.bbabio.2005.05.004; Hirono M, 2009, J BIOCHEM, V146, P617, DOI 10.1093/jb/mvp114; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P930, DOI 10.1016/j.bbabio.2007.03.014; TAKESHIGE K, 1988, PLANT PHYSIOL, V86, P1168, DOI 10.1104/pp.86.4.1168; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; [Anonymous], 1991, METHOD ENZYMOL; MAESHIMA M, 1990, BIOCHEM BIOPH RES CO, V168, P1157, DOI 10.1016/0006-291X(90)91150-Q; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; CHANSON A, 1985, PLANT PHYSIOL, V79, P159, DOI 10.1104/pp.79.1.159; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; Zancani M, 2007, BBA-BIOMEMBRANES, V1768, P311, DOI 10.1016/j.bbamem.2006.10.003; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P1401, DOI 10.1016/j.bbabio.2007.09.007; BALTSCHE.M, 1967, BIOCHEM BIOPH RES CO, V28, P270, DOI 10.1016/0006-291X(67)90440-8; DAVIES JM, 1993, BIOCHIM BIOPHYS ACTA, V1141, P29, DOI 10.1016/0005-2728(93)90185-I; Ferjani A., 2013, PROGR BOT, V75, P145; FREY PA, 1995, BIOCHEMISTRY-US, V34, P11307, DOI 10.1021/bi00036a001; Hsiao YY, 2007, BBA-BIOENERGETICS, V1767, P965, DOI 10.1016/j.bbabio.2007.04.007; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Lopez-Marques RL, 2005, BBA-BIOMEMBRANES, V1716, P69, DOI 10.1016/j.bbamem.2005.08.004; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Nakanishi Y, 1998, PLANT PHYSIOL, V116, P589, DOI 10.1104/pp.116.2.589; Nakanishi Y, 2003, J BIOCHEM, V134, P615, DOI 10.1093/jb/mvg184; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; REA PA, 1986, PLANT PHYSIOL, V81, P126, DOI 10.1104/pp.81.1.126; SATO MH, 1991, FEBS LETT, V290, P177, DOI 10.1016/0014-5793(91)81254-6; Sherman F, 1979, METHODS YEAST GENETI; Tammenkosky M., 2005, J BIOL CHEM, V280, P41818; TANAKA K, 1990, MOL CELL BIOL, V10, P4303; Van RC, 2005, BBA-BIOENERGETICS, V1709, P84, DOI 10.1016/j.bbabio.2005.05.011	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	DEC	2014	156	6					333	344		10.1093/jb/mvu046		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU7HA	WOS:000345770200005		
J	Iwura, T; Fukuda, J; Yamazaki, K; Arisaka, F				Iwura, Takafumi; Fukuda, Jun; Yamazaki, Katsuyoshi; Arisaka, Fumio			Conformational stability, reversibility and heat-induced aggregation of alpha-1-acid glycoprotein	JOURNAL OF BIOCHEMISTRY			English	Article						alpha-1-acid glycoprotein; aggregation; conformational stability; differential scanning microcalorimetry; reversibility of denaturation	DIFFERENTIAL SCANNING CALORIMETRY; PROTEIN; GROWTH	To investigate the relationship between conformational stability, reversibility of denaturation and aggregation of protein, we determined the conformation, melting temperature (T-m), and reversibility of heat-induced denaturation of alpha-1-acid glycoprotein (AGP) in aqueous solutions at various pH values using circular dichroism (CD) and differential scanning microcalorimetry. To quantitate and characterize heat-induced AGP aggregation under the same pH conditions, solutions of AGP were incubated at 50A degrees C and then analysed by size exclusion chromatography (SEC), sodium dodecyl sulfate-polyacrylamide gel electrophoresis, CD and SEC in the presence of 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid. The conformational stability of AGP was reduced at lower pH, whereas the reversibility of protein denaturation was reduced at higher pH. AGP formed some large non-covalent aggregates during incubation at lower pH, whereas incubation at higher pH tended to cause the formation of dimer species without the formation of large aggregates. These results indicated that lower conformational stability was related to the formation of non-covalent large aggregates, whereas reduced reversibility was related to dimer formation. Thus, evaluating both conformational stability and reversibility is necessary for developing optimal formulations and to predict the kinds of aggregates that will be induced during protein storage.	[Iwura, Takafumi; Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Iwura, Takafumi; Fukuda, Jun; Yamazaki, Katsuyoshi] Kyowa Hakko Kirin Co Ltd, Prod Div, Bio Proc Res & Dev Labs, Takasaki, Gunma 3700013, Japan	Arisaka, F (reprint author), 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	arisaka.fumio@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23570190]	This work was supported by Grant-in-Aid for Scientific Research (C) (No. 23570190) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to F.A.	Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Hawe A, 2008, ANAL BIOCHEM, V378, P115, DOI 10.1016/j.ab.2008.03.050; Remmele RL, 1999, BIOCHEMISTRY-US, V38, P5241; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; MANNING MC, 1989, PHARMACEUT RES, V6, P903, DOI 10.1023/A:1015929109894; Chen BL, 1996, J PHARM SCI, V85, P419, DOI 10.1021/js9504393; Arakawa T, 2001, BIOSCI BIOTECH BIOCH, V65, P1321, DOI 10.1271/bbb.65.1321; Bleeker WK, 2000, BLOOD, V95, P1856; Henriksson G., 1996, ELECTROPHORESIS, V16, P1388; Narhi LO, 1999, PHARMACEUT RES, V16, P799, DOI 10.1023/A:1018893115557; Remmele RL, 1998, PHARMACEUT RES, V15, P200; Remmele RL, 2000, BIOPHARM-APPL T BIO, V13, P36; Rosenberg Amy S, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Schmid K., 1975, ALPHA ACID GLYCOPROT, P183; SCHRIER JA, 1993, PHARMACEUT RES, V10, P933, DOI 10.1023/A:1018990001310; Wang Wei, 1999, International Journal of Pharmaceutics (Amsterdam), V185, P129, DOI 10.1016/S0378-5173(99)00152-0	17	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	DEC	2014	156	6					345	352		10.1093/jb/mvu050		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU7HA	WOS:000345770200006		
J	Ota, M; Sato, N; Sakai, K; Okazaki, M; Maikusa, N; Hattori, K; Hori, H; Teraishi, T; Shimoji, K; Yamada, K; Kunugi, H				Ota, Miho; Sato, Noriko; Sakai, Koji; Okazaki, Mitsutoshi; Maikusa, Norihide; Hattori, Kotaro; Hori, Hiroaki; Teraishi, Toshiya; Shimoji, Keigo; Yamada, Kei; Kunugi, Hiroshi			Altered coupling of regional cerebral blood flow and brain temperature in schizophrenia compared with bipolar disorder and healthy subjects	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						arterial spin labeling; bipolar disorder; brain temperature; diffusion-weighted imaging thermometry; schizophrenia	MAGNETIC-RESONANCE-SPECTROSCOPY; NEUROLEPTIC MALIGNANT SYNDROME; SPIN-LABELING MRI; CORNEAL TEMPERATURE; RATING-SCALE; METABOLISM; THERMOREGULATION; METAANALYSIS; RELIABILITY; VALIDITY	Previous studies have suggested that schizophrenia patients have dysfunctional thermoregulation. The aim of this study was to examine whether brain temperature (BT) in schizophrenia patients differs from that in patients with bipolar disorder and healthy subjects by using magnetic resonance imaging. We also evaluated the possible relationship between BT and cerebral blood flow. (CBF). We analyzed the temperature Of lateral ventricles as the mean BT using diffusion-weighted imaging (DWI) thermometry, and evaluated the relationships between the BT and the CBF using pseudo continuous arterial spin labeling (pCASL) among 3 diagnostic groups, 22 male patients with schizophrenia, 19 male patients with bipolar disorder, and 23 healthy male subjects. There were significant positive correlations between BT in the lateral ventricles and CBF in both the patients with bipolar disorder and healthy subjects. By contrast, there were significant negative correlations in patients With schizophrenia. We could not detect the Significant difference in the Surrogates of BT among three diagnostic groups. We showed that patients with schizophrenia, but hot those with bipolar disorder, have dysfunctional thermoregulation in the brain. Brain temperature is highly dependent on cerebral metabolism and CBF, and thus uncoupling of cerebral metabolism and CBF may occur in schizophrenics.	[Ota, Miho; Hattori, Kotaro; Hori, Hiroaki; Teraishi, Toshiya; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Natl Inst Neurosci, Kodaira, Tokyo 108502, Japan; [Sato, Noriko; Shimoji, Keigo] Natl Ctr Neurol & Psychiat, Dept Radiol, Kodaira, Tokyo 108502, Japan; [Sakai, Koji] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, Kyoto, Japan; [Okazaki, Mitsutoshi] Natl Ctr Neurol & Psychiat, Dept Psychiat, Kodaira, Tokyo 108502, Japan; [Maikusa, Norihide] Natl Ctr Neurol & Psychiat, Dept Imaging Neuroinformat, Integrat Brain Imaging Ctr, Kodaira, Tokyo 108502, Japan; [Yamada, Kei] Kyoto Prefectural Univ Med, Dept Radiol, Grad Sch Med Sci, Kamigyo Ku, Kyoto, Japan	Ota, M (reprint author), Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Natl Inst Neurosci, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 108502, Japan.	ota@ncnp.go.jp			Health and Labor Sciences Research Grant (for Comprehensive Research on Disability, Health, and Welfare); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [24-11]; grant for 'Understanding of molecular and environmental bases for brain health' by the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported by a Health and Labor Sciences Research Grant (for Comprehensive Research on Disability, Health, and Welfare) (MO and HK), an Intramural Research Grant (24-11) for Neurological and Psychiatric Disorders of NCNP (MO and HK), and a grant for 'Understanding of molecular and environmental bases for brain health' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (HK).	American Psychiatric Association, 1994, DSM 4 DIAGN STAT MAN; Kraguljac NV, 2012, PSYCHIAT RES-NEUROIM, V203, P111, DOI 10.1016/j.pscychresns.2012.02.003; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Lambert G, 2000, ARCH GEN PSYCHIAT, V57, P787, DOI 10.1001/archpsyc.57.8.787; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Contreras-Shannon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059012; Hermesh H, 2000, AM J PSYCHIAT, V157, P1327, DOI 10.1176/appi.ajp.157.8.1327; Chong TW, 2004, SCHIZOPHR RES, V69, P149, DOI 10.1016/S0920-9964(03)00222-6; Lahti AC, 2006, NEUROPSYCHOPHARMACOL, V31, P221, DOI 10.1038/sj.npp.1300837; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Jiang LH, 2013, J CLIN INVEST, V123, P1605, DOI 10.1172/JCI65153; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Nybo L, 2002, J PHYSIOL-LONDON, V545, P697, DOI 10.1113/jphysiol.2002.030023; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Shiloh R, 2001, EUR NEUROPSYCHOPHARM, V11, P285, DOI 10.1016/S0924-977X(01)00096-7; Zheng G, 2013, EUR J RADIOL, V82, P1981, DOI 10.1016/j.ejrad.2013.06.002; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Yamada K, 2010, NEUROREPORT, V21, P851, DOI 10.1097/WNR.0b013e32833d6b7a; Ota M, 2013, MAGN RESON IMAGING, V31, P990, DOI 10.1016/j.mri.2013.03.016; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Pinkham A, 2011, PSYCHIAT RES-NEUROIM, V194, P64, DOI 10.1016/j.pscychresns.2011.06.013; CAPE G, 1994, BRIT J PSYCHIAT, V164, P120, DOI 10.1192/bjp.164.1.120; Dunn RT, 2005, PSYCHIAT RES-NEUROIM, V140, P181, DOI 10.1016/j.pscychresns.2005.07.005; Fink GR, 1996, J NEUROL SCI, V137, P28, DOI 10.1016/0022-510X(95)00323-T; Friston KJ, 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fusar-Poli P, 2013, SCHIZOPHRENIA BULL, V39, P33, DOI 10.1093/schbul/sbr180; Gonul AS, 2009, INT REV PSYCHIATR, V21, P323, DOI 10.1080/09540260902962131; Goodwin FK Jamison KKR, 2007, MANIC DEPRESSIVE ILL, P54; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Inagaki A., 1999, EQUIVALENT DOSE PSYC; Jayasundar R, 2002, NEUROL INDIA, V50, P436; Kuwabara Yasuo, 1995, Kaku Igaku, V32, P253; Mirza M, 1998, ACTA NEUROL BELG, V98, P190; Sakai K, 2012, NMR BIOMED, V25, P340, DOI 10.1002/nbm.1755; Sakai K, 2013, PROC SPIE, V8669, DOI 10.1117/12.2003330; Shiloh R, 2003, NEUROPSYCHOBIOLOGY, V48, P1, DOI 10.1159/000071820; Shiloh R, 2000, EUR NEUROPSYCHOPHARM, V10, P443, DOI 10.1016/S0924-977X(00)00106-1; Shiloh R, 2008, EUR NEUROPSYCHOPHARM, V18, P557, DOI 10.1016/j.euroneuro.2008.04.007; Shiloh R, 2003, EUR NEUROPSYCHOPHARM, V13, P49, DOI 10.1016/S0924-977X(02)00080-9; SPIVAK B, 1990, ACTA PSYCHIAT SCAND, V81, P168, DOI 10.1111/j.1600-0447.1990.tb06473.x; Yablonskiy DA, 2000, P NATL ACAD SCI USA, V97, P7603, DOI 10.1073/pnas.97.13.7603	45	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2014	34	12					1868	1872		10.1038/jcbfm.2014.151		5	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AU7YM	WOS:000345814200002		
J	Abe, K; Takai, N; Fukumoto, K; Imamoto, N; Tonomura, M; Ito, M; Kanegawa, N; Sakai, K; Morimoto, K; Todoroki, K; Inoue, O				Abe, Kohji; Takai, Nozomi; Fukumoto, Kazumi; Imamoto, Natsumi; Tonomura, Misato; Ito, Miwa; Kanegawa, Naoki; Sakai, Katsunori; Morimoto, Kenji; Todoroki, Kenichiro; Inoue, Osamu			In vivo imaging of reactive oxygen species in mouse brain by using [H-3]Hydromethidine as a potential radical trapping radiotracer	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						in vivo molecular imaging; radical trapping radiotracer; reactive oxygen species	SODIUM-NITROPRUSSIDE; NADPH OXIDASE; HYDROXYL RADICALS; OXIDATIVE STRESS; SUPEROXIDE-PRODUCTION; ENDOTHELIAL-CELLS; FLUORESCENCE; DISEASE; INJURY; DIHYDROETHIDIUM	To assess reactive oxygen species (ROS) production by detecting the fluorescent oxidation product, hydroethidine has been used extensively. The present study was undertaken to evaluate the potential of the hydroethidine derivative as a radiotracer to measure in vivo brain ROS production. [H-3]-labeled N-methyl-2,3-diamino-6-phenyl-dihydrophenanthridine ([H-3]Hydromethidine) was synthesized, and evaluated using in vitro radical-induced oxidization and in vivo brain ROS production model. In vitro studies have indicated that [H-3]Hydromethidine is converted to oxidized products by a superoxide radical (O-2(center dot)-) and a hydroxyl radical (OH center dot-) but not hydrogen peroxide (H2O2). In vivo whole-body distribution study showed that [H-3]Hydromethidine rapidly penetrated the brain and then was washed out in normal mice. Microinjection of sodium nitroprusside (SNP) into the brain was performed to produce ROS such as OH center dot- via Fenton reaction. A significant accumulation of radioactivity immediately after [H-3]Hydromethidine injection was seen in the side of the brain treated with SNP (5 and 20 nmol) compared with that in the contralateral side. These results indicated that [H-3]Hydromethidine freely penetrated into the brain where it was rapidly converted to oxidized forms, which were trapped there in response to the production of ROS. Thus, [H-3]Hydromethidine should be useful as a radical trapping radiotracer in the brain.	[Abe, Kohji; Takai, Nozomi; Imamoto, Natsumi; Tonomura, Misato; Ito, Miwa; Kanegawa, Naoki] Shionogi & Co Ltd, Res Lab Dev, Dept Drug Metab & Pharmacokinet, Toyonaka, Osaka 5610825, Japan; [Fukumoto, Kazumi; Sakai, Katsunori; Morimoto, Kenji] Shionogi & Co Ltd, Res Lab Dev, Dept Appl Chem & Anal, Toyonaka, Osaka 5610825, Japan; [Todoroki, Kenichiro] Univ Shizuoka, Sch Pharmaceut Sci, Dept Analyt & Bioanalyt Chem, Shizuoka 4228526, Japan; [Inoue, Osamu] Osaka Univ, Sch Allied Hlth Sci, Fac Med, Osaka, Japan	Abe, K (reprint author), Shionogi & Co Ltd, Res Lab Dev, Dept Drug Metab & Pharmacokinet, 3-1-1 Futaba, Toyonaka, Osaka 5610825, Japan.	kohji.abe@shionogi.co.jp	Todoroki, Kenichiro/D-6152-2011				Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; Murakami K, 1998, J NEUROSCI, V18, P205; Barbacanne MA, 2000, FREE RADICAL BIO MED, V29, P388, DOI 10.1016/S0891-5849(00)00336-1; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Aleryani S, 1999, BBA-GEN SUBJECTS, V1472, P181, DOI 10.1016/S0304-4165(99)00119-1; Ide T, 2000, CIRC RES, V86, P152; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Michalski R, 2013, FREE RADICAL BIO MED, V54, P135, DOI 10.1016/j.freeradbiomed.2012.09.018; Droge W, 2002, PHYSIOL REV, V82, P47; Quick KL, 2001, ANN NEUROL, V49, P627, DOI 10.1002/ana.1005; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; WARBURG O, 1956, SCIENCE, V124, P269; Jung KH, 2013, J NUCL MED, V54, P2161, DOI 10.2967/jnumed.112.115436; Asano M, 2014, J BIOSCI BIOENG, V118, P98, DOI 10.1016/j.jbiosc.2013.12.015; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Hall DJ, 2012, J CEREBR BLOOD F MET, V32, P23, DOI 10.1038/jcbfm.2011.119; HALL ED, 1993, J NEUROSCI RES, V34, P107, DOI 10.1002/jnr.490340111; Inoue O, 2004, NEUROREPORT, V15, P141, DOI 10.1097/01.wnr.0000102264.71579.fe; Kim DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035476; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Nazari OA, 2012, J PHARM SCI, p[120, 105]; Paxinos G, MOUSE BRAIN STEREOTA; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Sayre LM, 2001, CURR MED CHEM, V8, P721; Tanno M, 1996, CHEM PHARM BULL, V44, P1849; Yanamoto K, 2003, SYNAPSE, V50, P137, DOI 10.1002/syn.10256	31	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2014	34	12					1907	1913		10.1038/jcbfm.2014.160		7	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AU7YM	WOS:000345814200007		
J	Abe, T; Suzuki, M; Sasabe, J; Takahashi, S; Unekawa, M; Mashima, K; Iizumi, T; Hamase, K; Konno, R; Aiso, S; Suzuki, N				Abe, Takato; Suzuki, Masataka; Sasabe, Jumpei; Takahashi, Shinichi; Unekawa, Miyuki; Mashima, Kyoko; Iizumi, Takuya; Hamase, Kenji; Konno, Ryuichi; Aiso, Sadakazu; Suzuki, Norihiro			Cellular origin and regulation of D- and L-serine in in vitro and in vivo models of cerebral ischemia	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						excitotoxicity; focal ischemia; glial cells; glutamate; neuronal-glial interaction	AMINO-ACID OXIDASE; RACEMASE; BRAIN; MICE; RECEPTOR; NEURONS; NEUROTOXICITY; PROTECTS; GLYCINE; GLUCOSE	D-Serine is known to be essential for the activation of the N-methyl-D-aspartate (NMDA) receptor in the excitation of glutamatergic neurons, which have critical roles in long-term potentiation and memory formation. D-Serine is also thought to be involved in NMDA receptor-mediated neurotoxicity. The deletion of serine racemase (SRR), which synthesizes D-serine from L-serine, was recently reported to improve ischemic damage in mouse middle cerebral artery occlusion model. However, the cell type in which this phenomenon originates and the regulatory mechanism for D-/L-serine remain elusive. The D-/L-serine content in ischemic brain increased until 20 hours after recanalization and then leveled off gradually. The results of in vitro experiments using cultured cells suggested that D-serine is derived from neurons, while L-serine seems to be released from astroglia. Immunohistochemistry studies of brain tissue after cerebral ischemia showed that SRR is expressed in neurons, and 3-phosphoglycerate dehydrogenase (3-PGDH), which synthesizes L-serine from 3-phosphoglycerate, is located in astrocytes, supporting the results of the in vitro experiments. A western blot analysis showed that neither SRR nor 3-PGDH was upregulated after cerebral ischemia. Therefore, the increase in D-/L-serine was not related to an increase in SRR or 3-PGDH, but to an increase in the substrates of SRR and 3-PGDH.	[Abe, Takato; Takahashi, Shinichi; Unekawa, Miyuki; Mashima, Kyoko; Iizumi, Takuya; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan; [Suzuki, Masataka; Sasabe, Jumpei; Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo 1608582, Japan; [Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 812, Japan; [Konno, Ryuichi] Int Univ Hlth & Welf, Dept Pharmacol Sci, Ohtawara, Tochigi, Japan	Takahashi, S (reprint author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	takashin@tka.att.ne.jp	Abe, Takato/L-8393-2013; Takahashi, Shinichi/L-3454-2013; Suzuki, Norihiro/J-5125-2013	Abe, Takato/0000-0002-4185-5254; 	JSPS KAKENHI [26461279]	The authors thank Shiseido Co., Ltd., for essential technical support in performing the 2D-HPLC experiments. This work was supported by JSPS KAKENHI Grant Number 26461279.	Abe T, 2002, NEUROSCI LETT, V326, P179, DOI 10.1016/S0304-3940(02)00347-6; Abe T, 2013, STROKE, V44, P2284, DOI 10.1161/STROKEAHA.113.001320; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Itoh Y, 2006, CLIN HEMORHEOL MICRO, V34, P163; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Miyoshi Y, 2012, AMINO ACIDS, V43, P1919, DOI 10.1007/s00726-012-1398-4; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; Danysz W, 1998, PHARMACOL REV, V50, P597; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P185, DOI 10.1159/000085991; Jackman K, 2013, J NEUROSCI, V33, P19579, DOI 10.1523/JNEUROSCI.4318-13.2013; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PAGE B, 1993, INT J ONCOL, V3, P473; GROTTA J, 1995, STROKE, V26, P602; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Ren TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067044; Suzuki M, 2012, BRAIN RES, V1466, P167, DOI 10.1016/j.brainres.2012.05.042; Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2; Takahashi S, 2012, ASN NEURO, V4, P71, DOI 10.1042/AN20120002	36	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2014	34	12					1928	1935		10.1038/jcbfm.2014.164		8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AU7YM	WOS:000345814200010		
J	Takakura, K; Koido, S; Takahara, A; Odahara, S; Mitobe, J; Matsudaira, H; Tsukinaga, S; Yukawa, T; Matsumoto, K; Nagatsuma, K; Uchiyama, K; Kajihara, M; Ohkusa, T; Tajiri, H				Takakura, Kazuki; Koido, Shigeo; Takahara, Akitaka; Odahara, Shunichi; Mitobe, Jimi; Matsudaira, Hiroshi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Matsumoto, Kei; Nagatsuma, Keisuke; Uchiyama, Kan; Kajihara, Mikio; Ohkusa, Toshifumi; Tajiri, Hisao			Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis	JOURNAL OF CHEMOTHERAPY			English	Article						Pancreatic cancer; Haemodialysis; Gemcitabine; Dose modification	STAGE RENAL-DISEASE; PHASE-I; METABOLITE; SURVIVAL	Gemcitabine application for patients with impaired renal function or undergoing haemodialysis will increase if the efficacy and safety are proved as the treatment for pancreatic cancer of these patients. However, there is no guideline about the usage of gemcitabine in patients with impaired renal function or haemodialysis. We report the case of a 70-year-old man with advanced pancreatic cancer undergoing haemodialysis. After discontinuation of 100% or 80% dosage, 60% dose of gemcitabine was administered biweekly. Serum carbohydrate antigen 19-9 and carcinoembryonic antigen levels were marked by slight variations and abdominal computed tomography (CT) showed the tumour size hardly changed. We administered gemcitabine for the patient 14 times in total, and he survived over 8 months from the definitive diagnosis. These findings confirm the efficacy and safety of treatment with a biweekly 60% dose of gemcitabine for patients with advanced pancreatic cancer undergoing haemodialysis in the face of dose modification.	[Takakura, Kazuki; Koido, Shigeo; Takahara, Akitaka; Odahara, Shunichi; Mitobe, Jimi; Matsudaira, Hiroshi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Nagatsuma, Keisuke; Uchiyama, Kan; Kajihara, Mikio; Ohkusa, Toshifumi] Jikei Univ, Kashiwa Hosp, Div Internal Med, Div Gastroenterol & Hepatol, Kashiwa, Chiba 2770004, Japan; [Matsumoto, Kei] Jikei Univ, Kashiwa Hosp, Div Nephrol & Hypertens, Dept Internal Med, Kashiwa, Chiba 2770004, Japan; [Tajiri, Hisao] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Tokyo, Japan; [Tajiri, Hisao] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan	Takakura, K (reprint author), Jikei Univ, Kashiwa Hosp, Div Gastroenterol & Hepatol, 163-1 Kashiwa Shita, Kashiwa, Chiba 2770004, Japan.	ktakakura@jikei.ac.jp					Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Venook AP, 2000, J CLIN ONCOL, V18, P2780; Carmichael J, 1997, DIGESTION, V58, P503; Cubiella J, 1999, AM J GASTROENTEROL, V94, P1271; Delaloge S, 2004, AM J CLIN ONCOL-CANC, V27, P289, DOI 10.1097/01.COC.0000071382.14174.C5; Edge SB, 2010, AJCC CANC STAGING MA; Eneman JD, 2005, ONCOLOGY-NY, V19, P1199; Guchelaar HJ, 1996, CANCER TREAT REV, V22, P15, DOI 10.1016/S0305-7372(96)90014-6; GUDJONSSON B, 1978, CANCER, V42, P2494, DOI 10.1002/1097-0142(197811)42:5<2494::AID-CNCR2820420554>3.0.CO;2-R; Kiani A, 2003, CANCER CHEMOTH PHARM, V51, P266, DOI 10.1007/s00280-003-0574-3; KUNE GA, 1981, MED J AUSTRALIA, V1, P361; Masumori N, 2008, JPN J CLIN ONCOL, V38, P182, DOI 10.1093/jjco/hym171; Matsuda M., 2007, J CLIN ONCOL, V25; Pini TM, 2003, P AM SOC CLIN ONCOL, V22; Sobin LH, 2010, TNM CLASSIFICATION M; Storniolo A M, 1997, Semin Oncol, V24, pS7	16	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1120-009X	1973-9478		J CHEMOTHERAPY	J. Chemother.	DEC	2014	26	6					369	372		10.1179/1973947813Y.0000000150		4	Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy	Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy	AU5HL	WOS:000345637500009		
J	Giurco, D; McLellan, B; Franks, DM; Nansai, K; Prior, T				Giurco, Damien; McLellan, Benjamin; Franks, Daniel M.; Nansai, Keisuke; Prior, Timothy			Responsible mineral and energy futures: views at the nexus	JOURNAL OF CLEANER PRODUCTION			English	Article						Mineral-energy nexus; Foresight; Mining; Environment; Social licence; Sustainability	SOCIAL LICENSE; SUSTAINABLE DEVELOPMENT; RESOURCE DEPLETION; STEEL CONSUMPTION; MINING-INDUSTRY; UK IRON; CYCLE; FLOW; TECHNOLOGIES; CARBON	In an era of mineral resource constraints and radical transition in the energy sector, this paper reviews the extent to which a long-term view of production and use is adopted in both sectors. A long-term view including the mineral-energy nexus is deemed to be necessary (although not sufficient) for managing future resource constraints and energy transitions. Alarmingly, it identifies that the future of minerals resources and production is generally viewed only 5-10 years ahead rather than several decades or more as for energy. Additionally, the sectors are generally studied independently, rather than with a focus on the nexus. With these findings as evidence of an unaddressed problem, the paper then focusses on the current forces for change in the minerals industry: namely community drivers regarding social licence to operate, new technologies and consumer and government drivers on responsible minerals. As discussions of sustainable development become displaced by the emerging discourse of 'responsible' minerals, what is adopted and discarded? Whilst responsible minerals considers chain-of-custody, it does not adopt a long-term view and overlooks the mineral-energy nexus. Using three illustrative cases at the nexus of (i) rare earths-renewables, (ii) coal-steel and (iii) uranium-nuclear we extend the theoretical discussion on 'responsible' with a range of contemporary examples from the perspectives of producing (Australia) and consuming countries (Japan, Switzerland) and propose a research agenda for an expanded notion of responsible minerals which recognises the complexity of the mineral-energy nexus and connects it to progressing sustainable futures. (C) 2014 Elsevier Ltd. All rights reserved.	[Giurco, Damien; Prior, Timothy] Univ Technol Sydney, Inst Sustainable Futures, Sydney, NSW 2007, Australia; [McLellan, Benjamin] Kyoto Univ, Grad Sch Energy Sci, Kyoto 6068501, Japan; [McLellan, Benjamin; Franks, Daniel M.] Univ Queensland, Sustainable Minerals Inst, Brisbane, Qld 4072, Australia; [Nansai, Keisuke] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki, Japan; [Prior, Timothy] ETH, CSS, Zurich, Switzerland	Giurco, D (reprint author), Univ Technol Sydney, Inst Sustainable Futures, POB 123, Broadway, NSW 2007, Australia.	Damien.Giurco@uts.edu.au	McLellan, Benjamin/B-7833-2009; 	McLellan, Benjamin/0000-0002-4802-3864; Giurco, Damien/0000-0002-1707-9531	Wealth from Waste Cluster; UTS; University of Queensland; Swinburne University of Technology; Monash University; Yale University; CSIRO	Part of this research was undertaken as part of the Minerals Futures Research Cluster, a collaborative program between the Australian CSIRO (Commonwealth Scientific and Industrial Research Organisation); The University of Queensland; The University of Technology, Sydney (UTS); Curtin University; CQUniversity; and The Australian National University. This research was also supported by the Wealth from Waste Cluster, a collaboration between UTS, The University of Queensland, Swinburne University of Technology, Monash University, Yale University and CSIRO. The authors gratefully acknowledge the contribution of each partner and the CSIRO Flagship Collaboration Fund.	Access Economics, 2008, GLOB COMM DEM SCEN R; African Union, 2009, AFR MIN VIS 2050; Alberta P.O, 2012, RESPONSIBLE ENERGY D; Ali S., 2014, RESOURCES, V3, P123, DOI [DOI 10.3390/RESOURCES3010123, 10.3390/resources3010123]; Aluminum Association Inc, 2003, AL IND TECHN ROADM; American Iron and Steel Institute, 2006, AUT STEEL TECHN ROAD, P93; AMIRA, 2004, COPP TECHN ROADM; Amira International, 2001, AL TECHN ROADM; Zhang Q, 2012, RENEW ENERG, V44, P99, DOI 10.1016/j.renene.2012.01.003; Jenkins H, 2006, J CLEAN PROD, V14, P271, DOI 10.1016/j.jclepro.2004.10.004; van Vuuren DP, 1999, RESOUR POLICY, V25, P239, DOI 10.1016/S0301-4207(99)00031-8; Weldegiorgis FS, 2014, J CLEAN PROD, V84, P281, DOI 10.1016/j.jclepro.2013.09.056; Jiang XM, 2007, ENERGY, V32, P772, DOI 10.1016/j.energy.2006.05.001; Hall N, 2013, ENERG POLICY, V58, P200, DOI 10.1016/j.enpol.2013.03.009; Mudd GM, 2007, RESOUR POLICY, V32, P42, DOI 10.1016/j.resourpol.2007.05.002; McLellan BC, 2012, J CLEAN PROD, V32, P32, DOI 10.1016/j.jclepro.2012.03.016; Yellishetty M, 2011, ENVIRON SCI POLICY, V14, P650, DOI 10.1016/j.envsci.2011.04.008; Graedel TE, 2011, ANNU REV MATER RES, V41, P323, DOI 10.1146/annurev-matsci-062910-095759; Mudd GM, 2001, ENVIRON GEOL, V41, P390, DOI 10.1007/s02540100406; Gomi K, 2011, TECHNOL FORECAST SOC, V78, P852, DOI 10.1016/j.techfore.2011.01.002; Norgate T, 2012, ISIJ INT, V52, P1472, DOI 10.2355/isijinternational.52.1472; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Bernardes AM, 2004, J POWER SOURCES, V130, P291, DOI 10.1016/j.jpowsour.2003.12.026; Corden WM, 2012, AUST ECON REV, V45, P290, DOI 10.1111/j.1467-8462.2012.00685.x; Mudd GM, 2010, RESOUR POLICY, V35, P98, DOI 10.1016/j.resourpol.2009.12.001; Gaustad G, 2010, J IND ECOL, V14, P286, DOI 10.1111/j.1530-9290.2010.00229.x; Furukawa K, 2008, ENERG CONVERS MANAGE, V49, P1832, DOI 10.1016/j.enconman.2007.09.027; Spatari S, 2002, ECOL ECON, V42, P27, DOI 10.1016/S0921-8009(02)00103-9; Daigo I, 2007, ISIJ INT, V47, P1065, DOI 10.2355/isijinternational.47.1065; Huang K, 2009, J HAZARD MATER, V164, P399, DOI 10.1016/j.jhazmat.2008.08.051; Moriguchi Y, 2007, J MATER CYCLES WASTE, V9, P112, DOI 10.1007/s10163-007-0182-0; Vivoda V, 2012, ENERG POLICY, V46, P135, DOI 10.1016/j.enpol.2012.03.044; Mohr S, 2011, INT J COAL GEOL, V86, P329, DOI 10.1016/j.coal.2011.03.006; Bosecker K, 1997, FEMS MICROBIOL REV, V20, P591, DOI 10.1111/j.1574-6976.1997.tb00340.x; Fonseca A, 2013, MINER ENG, V46-47, P180, DOI 10.1016/j.mineng.2013.04.008; Binnemans K, 2013, J CLEAN PROD, V51, P1, DOI 10.1016/j.jclepro.2012.12.037; Prior T, 2013, GEOFORUM, V44, P316, DOI 10.1016/j.geoforum.2012.07.009; Hilson G, 2000, RESOUR POLICY, V26, P227, DOI 10.1016/S0301-4207(00)00041-6; Schiffer HW, 2008, ENERG POLICY, V36, P2464, DOI 10.1016/j.enpol.2008.02.045; Turner GM, 2008, GLOBAL ENVIRON CHANG, V18, P397, DOI 10.1016/j.gloenvcha.2008.05.001; Giurco D, 2007, MINER ENG, V20, P842, DOI 10.1016/j.mineng.2007.04.014; Cowell SJ, 1999, RESOUR POLICY, V25, P277, DOI 10.1016/S0301-4207(00)00003-9; Crompton P, 2000, RESOUR POLICY, V26, P103, DOI 10.1016/S0301-4207(00)00020-9; Melo MT, 1999, RESOUR CONSERV RECY, V26, P91, DOI 10.1016/S0921-3449(98)00077-9; Prno J, 2012, RESOUR POLICY, V37, P346, DOI 10.1016/j.resourpol.2012.04.002; Halfar J, 2002, MAR POLICY, V26, P103, DOI 10.1016/S0308-597X(01)00041-0; Norgate T, 2010, J CLEAN PROD, V18, P266, DOI 10.1016/j.jclepro.2009.09.020; Moffat K, 2014, RESOUR POLICY, V39, P61, DOI 10.1016/j.resourpol.2013.11.003; Allwood JM, 2010, ENVIRON SCI TECHNOL, V44, P1888, DOI 10.1021/es902909k; Huang CL, 2012, RESOUR CONSERV RECY, V68, P104, DOI 10.1016/j.resconrec.2012.08.012; Yellishetty M, 2011, J CLEAN PROD, V19, P78, DOI 10.1016/j.jclepro.2010.08.020; Spatari S, 2003, RESOUR CONSERV RECY, V39, P137, DOI 10.1016/S0921-3449(02)00168-4; Nansai K, 2014, ENVIRON SCI TECHNOL, V48, P1391, DOI 10.1021/es4033452; Northey S, 2014, RESOUR CONSERV RECY, V83, P190, DOI 10.1016/j.resconrec.2013.10.005; Anderson CWN, 1999, J GEOCHEM EXPLOR, V67, P407, DOI 10.1016/S0375-6742(99)00055-2; Prior T, 2012, GLOBAL ENVIRON CHANG, V22, P577, DOI 10.1016/j.gloenvcha.2011.08.009; Rutledge D, 2011, INT J COAL GEOL, V85, P23, DOI 10.1016/j.coal.2010.10.012; Hoenderdaal S, 2013, ENERGY, V49, P344, DOI 10.1016/j.energy.2012.10.043; Yuan ZW, 2006, J IND ECOL, V10, P4, DOI 10.1162/108819806775545321; Zeltner C, 1999, REG ENVIRON CHANGE, V1, P31, DOI 10.1007/s101130050006; [Anonymous], 2014, EARTHWORKS NO DIRTY; Ashina S, 2012, ENERG POLICY, V41, P584, DOI 10.1016/j.enpol.2011.11.020; Australian Uranium Association, 2013, EC OUTL AUSTR UR IND; Benn S., 2014, RESOURCES, V3, P275; BHP Billiton, 2013, OUR SHAR VAL SUST RE; BP, 2011, BP EN OUTL; Bradshaw AM, 2012, CHEMSUSCHEM, V5, P550, DOI 10.1002/cssc.201100563; BREE, 2013, RES EN Q CANB; Chen ZH, 2011, J RARE EARTH, V29, P1, DOI 10.1016/S1002-0721(10)60401-2; Chitombo G P, 2010, Mining Technology, V119, DOI 10.1179/174328610X12820409992255; Cooper Carlia, 2011, International Journal of Technology Intelligence and Planning, V7, DOI 10.1504/IJTIP.2011.041250; Copper Development Centre Australia Limited, 2004, BUILD CONSTR TECHN R; Cragg W, 2002, J BUS ETHICS, V39, P319, DOI 10.1023/A:1016523113429; Crawford M., 2012, SHALE EXPLORATION DR; Crompton P, 1999, RESOUR POLICY, V25, P111, DOI 10.1016/S0301-4207(99)00014-8; CSIRO, 2008, DISC AUSTR MIN RES M; CSIRO, 2006, HEAT FUT EN AUSTR CA; Department of Energy (South Africa), 2011, INT RES PLAN EL 2010; D'Sa A, 2005, ENERG POLICY, V33, P1271, DOI 10.1016/j.enpol.2003.12.003; Energie B.f., 2011, ENERGY PERSPECTIVES; Federal Statistical Office (FSO), 2011, ENV DOM MAT CONS; Federal Statistical Office (FSO), 2010, FSO NEWS; Franks D.M., 2014, P NATL ACAD SCI USA, V11, P7577; Franks DM, 2012, TECHNOL FORECAST SOC, V79, P1229, DOI 10.1016/j.techfore.2012.03.001; Giljum S., 2010, SERI WORKING PAPER S; Giurco D., 2012, Australian Journal of Electrical & Electronics Engineering, V10, DOI 10.7158/C11-687.2012.10.1; Giurco D., 2014, RESOURCES, V3, P432; Giurco D, 2005, SUSTAINABLE METAL CY; Giurco D, 2011, TECHNOL FORECAST SOC, V78, P797, DOI 10.1016/j.techfore.2010.09.004; Giurco D., 2009, MINERAL FUTURES DISC; Graedel T., 2010, METAL STOCKS SOC SCI; Graedel T., 2013, P NATL ACAD SCI; Graedel T.E., 2011, RECYCLING RATES META; Graedel TE, 1996, ANNU REV ENERG ENV, V21, P69, DOI 10.1146/annurev.energy.21.1.69; Haraldsson H. V., 2009, AUSTR ID MIN RES 200, P211; Hoejmose S.U., 2013, IS DOING MORE DOING; ICMM, 2013, MAT STEW TOOLK; IEA, 2010, EN BAL OECD COUNTR I; IEA, 2009, TECHN ROADM WIND ENV; IEA (International Energy Agency), 2013, WORLD EN OUTL; International Council on Mining & Metals-ICMM, 2012, MIN CONTR SUST DEV O; International Energy Agency (IEA), 2009, TECHN ROADM CARB CAP; International Energy Agency (IEA), 2009, TECHN ROADM EL PLUG; Ishii M., 2013, ECS T, V50, P549; Japanese Government, 2013, FUND PLAN EST SOUND; JISF, 2013, ACT JAP IR STEEL FED; Kanekiyo K., 2011, JAP EN BRIEF; Krieg T., 2013, NUCL WASTE DISPOSAL; Lacey J, 2014, J CLEAN PROD, V84, P831, DOI 10.1016/j.jclepro.2013.11.047; Lambert I., 2013, EPISODES, V36; Lederwasch A., 2011, J FUTURES STUDIES, V15, P203; Mason L., 2013, ADV AUSTR RESOURCE G; Mason L., 2011, VISION 2040 MINING M; McLaren J, 2000, RESOUR CONSERV RECY, V31, P83, DOI 10.1016/S0921-3449(00)00073-2; McLellan B.C., 2013, ENERGY STRATEGY REV, V2, P190, DOI DOI 10.1016/J.ESR.2013.04.004); McNab K., 2013, EXPLORING SOCIAL DIM; Meadows D. H., 1972, LIMITS GROWTH REPORT; Meadows D. H., 2004, LIMITS GROWTH 30 YEA; Melbourne Energy Institute, 2010, ZER CARB AUSTR STAT; Memary R, 2012, J CLEAN PROD, V33, P97, DOI 10.1016/j.jclepro.2012.04.025; Memary R., 2011, 2 INT FUT MIN C 2011, P217; Michaelis P, 2000, RESOUR CONSERV RECY, V29, P131, DOI 10.1016/S0921-3449(00)00048-3; Michaelis P, 2000, RESOUR CONSERV RECY, V29, P209, DOI 10.1016/S0921-3449(00)00041-0; Mohr S., 2010, PROJECTION WORLD FOS; Mohr SH, 2012, MINERAL-BASEL, V2, P65, DOI 10.3390/min2010065; Morf L.S., 2012, WASTE MANAGE, V33, P634; National Policy Unit, 2012, INN STRAT EN ENV, P25; Newman H.R., 2013, MINERAL IND SWITZERL; NMI, 2008, NIPP MET IND WEB PAG; OECD, 2008, RES PROD G8 OECD REP, P43; OECD/IAEA, 2008, SWITZ UR 2007 RES PR; OECD/IEA, 2012, EN POL IEA COUNTR SW; Policy H.f.O., 2013, BAS PLAN OC POL; Prior T, 2013, SCI TOTAL ENVIRON, V461, P785, DOI 10.1016/j.scitotenv.2013.05.042; Reseau Trans-Al Inc, 2007, CAN AL TRANSF TECHN; Reuter M. A., 2013, REPORT WORKING GROUP; Reuter MA, 1998, MINER ENG, V11, P891, DOI 10.1016/S0892-6875(98)00078-8; Riedy C., 2009, FUTURES, V11, P40; ROBINSON JB, 1982, ENERG POLICY, V10, P337, DOI 10.1016/0301-4215(82)90048-9; Schluep M., 2009, RECYCLING E WASTE RE; Shell, 2013, NEW LENS SCEN SHIFT; Sovacool BK, 2008, ENERG POLICY, V36, P2950, DOI 10.1016/j.enpol.2008.04.017; Steel Stewardship Forum (SSF), 2014, RESP STEEL RUL; SURREY J, 1974, ENERG POLICY, V2, P204, DOI 10.1016/0301-4215(74)90047-0; Swiss Federal Office of Energy, 2014, EN STRAT 2050; The International Copper Association, 2007, COPP APPL TECHN ROAD, P46; Thomson I., 2011, SMW MINING ENG HDB; United Nations Environment Programme (UNEP), 2007, GLOB ENV OUTL 4; USGS, 2013, MIN COMM SUMM 2013; USGS, 2011, MIN YB REC MET; Verhoef E. V., 2004, Journal of Industrial Ecology, V8, P23, DOI 10.1162/1088198041269382; Wang A., 2013, GEOL SOC AM 125 ANN; WCA, 2012, COAL STAT; Whitwill M., 2013, WORLD NUCL FUEL CYCL; WNA, 2013, UR PROD FIG 2005 201; World Economic Forum, 2010, MIN MET SCEN 2030; Zabalza Bribian I., 2011, BUILD ENVIRON, V46, P1133; Zhang Q, 2012, FUSION SCI TECHNOL, V61, P423; Zhang Q, 2012, ENERGY, V38, P376, DOI 10.1016/j.energy.2011.11.046	159	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	DEC 1	2014	84						322	338		10.1016/j.jclepro.2014.05.102		17	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AU6SB	WOS:000345731000034		
J	Kobayashi, H; Watando, H; Kakimoto, M				Kobayashi, Hideki; Watando, Hiroko; Kakimoto, Mitsuru			A global extent site-level analysis of land cover and protected area overlap with mining activities as an indicator of biodiversity pressure	JOURNAL OF CLEANER PRODUCTION			English	Article						Biodiversity pressure; Mining; Vegetation; Protected area; Site-specific evaluation; Base metals	CONSERVATION; CHALLENGES; FOOTPRINT; PATTERNS; HOTSPOTS; METALS; PLANET; LCA; KEY	The need to ensure environmental sustainability is a critical challenge for humanity. The forces driving increased environmental pressure are world population growth, economic growth, and increasing urbanization. As a result, demand for base metals, such as iron and copper, used for producing industrial products and infrastructure has been rising. At the same time, biodiversity has ascended the global agenda because of its bearing on sustainability. Industry needs to take into account its impact on biodiversity in terms of product life cycles, from raw material extraction to product retirement. Despite the need to evaluate the influence of industry on biodiversity, a quantitative and practical biodiversity evaluation index has yet to be established. In this study, we focus on base metals that affect biodiversity through mining. This paper presents a new quantitative index, MiBiD (TM), which is based on the geographic relationship among land cover, protected areas, and mining operations. Using available global databases, we developed the MiBiD intensity database, which covers over 700 mines of iron, copper, bauxite (aluminum), zinc, and lead around the world. Some findings achieved using the database are shown, such as that the MiBiD intensity of copper is much larger than that of any other mineral on average. Through comparison with existing indices, advantages and disadvantages of MiBiD are discussed. MiBiD is significant because it is the first site-specific global index of the pressure of mining on biodiversity, and it can provide new information for corporate management. (C) 2014 The Authors. Published by Elsevier Ltd.	[Kobayashi, Hideki; Watando, Hiroko; Kakimoto, Mitsuru] Toshiba Co Ltd, Corp R&D Ctr, Kawasaki, Kanagawa 210, Japan; [Kobayashi, Hideki] Osaka Univ, Ctr Environm Innovat Design Sustainabil, Suita, Osaka 565, Japan	Kobayashi, H (reprint author), Toshiba Co Ltd, Corp R&D Ctr, Saiwai Ku, 1 Komukai Toshiba Cho, Kawasaki, Kanagawa 210, Japan.	hide.kobayashi@toshiba.co.jp					Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Huang GL, 2011, ECOL ECON, V70, P1492, DOI 10.1016/j.ecolecon.2011.03.010; Goodland R, 2012, SUSTAINABILITY-BASEL, V4, P2099, DOI 10.3390/su4092099; Canals LMI, 2007, INT J LIFE CYCLE ASS, V12, P5, DOI 10.1065/lca2006.05.250; Halada K, 2008, MATER TRANS, V49, P402, DOI 10.2320/matertrans.ML200704; Galli A, 2012, ECOL INDIC, V16, P100, DOI 10.1016/j.ecolind.2011.06.017; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ring I, 2010, CURR OPIN ENV SUST, V2, P15, DOI 10.1016/j.cosust.2010.03.005; Halada K, 2001, J JPN I MET, V65, P564; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Loh J, 2005, PHILOS T ROY SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; [Anonymous], 2010, GLOBAL BIODIVERSITY; Canals LMI, 2007, J CLEAN PROD, V15, P1426, DOI 10.1016/j.jclepro.2006.05.005; BAAN L, 2013, INT J LCA, V18, P1216; Dudley N., 2008, GUIDELINES APPL PROT; Emerson J.W., 2012, 2012 ENV PERFORMANCE; Ii R., 2008, P 8 INT C EC JAP, P273; International Copper Study Group (ICSG), 2012, WORLD COPP FACTB 201; International Finance Corporation (IFC), 2007, ENV HLTH SAF GUID MI; International Organization for Standardization (ISO), 2006, ISO14025; Intierra Raw Materials Group (RMG), 2012, RAW MAT DAT RMD; Itsubo N., 2010, UPDATED VERSION LIFE; Itsubo N., 2003, INT J LCA, V8-5, P305, DOI 10.1007/BF02978923; Kobayashi Yoshinori, 2007, International Journal of Environmental Technology and Management, V7, DOI 10.1504/IJETM.2007.015637; Mason L., 2011, VISION 2040 MINING M; Matsuda H., 2003, CHEMOSPHERE; Mudd G.M., 2009, P 48 ANN C MET LURG; NASA, 2013, MODIS LAND COV TYP P; Schauer M., 2008, EC ECOSYSTEM BIODIVE; United Nations, 2012, MILL DEV GOALS REP 2; United Nations, 2005, MILLENNIUM ECOSYSTEM; Vackar D, 2012, ECOL INDIC, V16, P40, DOI 10.1016/j.ecolind.2011.08.008; Wackernagel M., 1996, OUR ECOLOGICAL FOOTP; Watando H., 2012, P 10 INT C EC JAP, pD2; WBCSD (World Business Council for Sustainable Development), 2011, GUID CORP EC VAL; World Database on Protected Areas (WDPA), 2011, DISC LEARN PROT AR P; World Resources Institute (WRI) Meridian Institute World Business Council for Sustainable Development (WBCSD), 2008, CORP EC SERV REV; WRI IUCN and UNEP, 1992, GLOB BIOD STRAT	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	DEC 1	2014	84						459	468		10.1016/j.jclepro.2014.04.049		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AU6SB	WOS:000345731000047		
J	Ali, ZA; Perez, VD; Yuan, K; Orcholski, M; Pan, S; Qi, W; Chopra, G; Adams, C; Kojima, Y; Leeper, NJ; Qu, XM; Zaleta-Rivera, K; Kato, K; Yamada, Y; Oguri, M; Kuchinsky, A; Hazen, SL; Jukema, JW; Ganesh, SK; Nabe, EG; Channon, K; Leon, MB; Charest, A; Quertermous, T; Ashley, EA				Ali, Ziad A.; Perez, Vinicio de Jesus; Yuan, Ke; Orcholski, Mark; Pan, Stephen; Qi, Wei; Chopra, Gaurav; Adams, Christopher; Kojima, Yoko; Leeper, Nicholas J.; Qu, Xiumei; Zaleta-Rivera, Kathia; Kato, Kimihiko; Yamada, Yoshiji; Oguri, Mitsutoshi; Kuchinsky, Allan; Hazen, Stanley L.; Jukema, J. Wouter; Ganesh, Santhi K.; Nabe, Elizabeth G.; Channon, Keith; Leon, Martin B.; Charest, Alain; Quertermous, Thomas; Ashley, Euan A.			Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1	JOURNAL OF CLINICAL INVESTIGATION			English	Article							DRUG-ELUTING STENTS; GLUTATHIONE-PEROXIDASE DEFICIENCY; SMOOTH-MUSCLE-CELLS; ACCELERATED ATHEROSCLEROSIS; CARDIOVASCULAR EVENTS; VITAMIN-E; MICE; RESTENOSIS; ANTIOXIDANT; DISEASE	Angioplasty and stenting is the primary treatment for flow-limiting atherosclerosis; however, this strategy is limited by pathological vascular remodeling. Using a systems approach, we identified a role for the network hub gene glutathione peroxidase-1 (GPX1) in pathological remodeling following human blood vessel stenting. Constitutive deletion of Gpx1 in atherosclerotic mice recapitulated this phenotype of increased vascular smooth muscle cell (VSMC) proliferation and plaque formation. In an independent patient cohort, gene variant pair analysis identified an interaction of GPX1 with the orphan protooncogene receptor tyrosine kinase ROS1. A meta-analysis of the only genome-wide association studies of human neointima-induced in-stent stenosis confirmed the association of the ROS1 variant with pathological remodeling. Decreased GPX1 expression in atherosclerotic mice led to reductive stress via a time-dependent increase in glutathione, corresponding to phosphorylation of the ROS1 kinase activation site Y2274. Loss of GPX1 function was associated with both oxidative and reductive stress, the latter driving ROS1 activity via s-glutathiolation of critical residues of the ROS1 tyrosine phosphatase SHP-2. ROS1 inhibition with crizotinib and deglutathiolation of SHP-2 abolished GPX1-mediated increases in VSMC proliferation while leaving endothelialization intact. Our results indicate that GPX1-dependent alterations in oxido-reductive stress promote ROS1 activation and mediate vascular remodeling.	[Ali, Ziad A.; Perez, Vinicio de Jesus; Yuan, Ke; Orcholski, Mark; Pan, Stephen; Adams, Christopher; Kojima, Yoko; Leeper, Nicholas J.; Qu, Xiumei; Zaleta-Rivera, Kathia; Kuchinsky, Allan; Quertermous, Thomas; Ashley, Euan A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Ali, Ziad A.; Leon, Martin B.] Columbia Univ, Ctr Intervent Vasc Therapy, New York, NY 10019 USA; [Ali, Ziad A.; Qi, Wei; Leon, Martin B.] Cardiovasc Res Fdn, New York, NY USA; [Chopra, Gaurav] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Kato, Kimihiko; Yamada, Yoshiji] Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, Tsu, Mie, Japan; [Oguri, Mitsutoshi] Japanese Red Cross Nagoya First Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst, Utrecht, Netherlands; [Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ganesh, Santhi K.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Nabe, Elizabeth G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Channon, Keith] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Charest, Alain] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA	Ali, ZA (reprint author), Columbia Univ, Div Cardiovasc Med, 650 W 168th St, New York, NY 10019 USA.	zaa2112@columbia.edu; euan@stanford.edu		Pan, Stephen/0000-0002-1189-4199	NIH [R00HL109256, P01 HL076491, R00HL089413, DP2 OD004613, R01 HL105993]; Juvenile Diabetes Research Foundation; Netherlands Heart Foundation [2001D032]; Division of Intramural Research, NIH; Interuniversity Cardiology Institute of the Netherlands (ICIN); Durrer Center for Cardiogenetic Research; Netherlands Heart Foundation; Center for Medical Systems Biology; European Union [HEALTH-F2-2009-223004]	Z.A. Ali is supported by NIH grant R00HL109256; G. Chopra is supported by a Juvenile Diabetes Research Foundation fellowship; S.L. Hazen and GeneBank are supported by NIH grant P01 HL076491; J. Wouter Jukema is supported by the Netherlands Heart Foundation (2001D032); S. Ganesh is supported by NIH grant R00HL089413; and E. Ashley is supported by the NIH Director's New Innovator Award (DP2 OD004613) and NIH grant R01 HL105993. The CardioGene Study and deCODE analysis were supported, in part, by the Division of Intramural Research, NIH. GENDER was supported by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) and the Durrer Center for Cardiogenetic Research, both of which are Institutes of the Netherlands Royal Academy of Arts and Sciences, the Netherlands Heart Foundation, the Center for Medical Systems Biology approved by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research, and the Netherlands Consortium for Healthy Ageing. The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement HEALTH-F2-2009-223004. We are grateful to Reto Asmis (University of Texas San Antonio), Victoria Rimkunas (Cell Signaling), Diane Handy (Harvard University), Susumu Kobayashi (Beth Israel Deaconess Medical Center), and Jonathan Pollack (Stanford University) for their critical advice and supply of reagents. The authors would like to dedicate this article to the memory of Allan Kuchinsky, who was instumental to the development of high-throughput and network technology.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Hu YJ, 2003, CANCER RES, V63, P3347; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267; Oelze M, 2014, HYPERTENSION, V63, P390, DOI 10.1161/HYPERTENSIONAHA.113.01602; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Weisz G, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.050; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; Ali ZA, 2008, CIRCULATION, V118, pS71, DOI 10.1161/CIRCULATIONAHA.107.753558; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Perez VAD, 2011, J CELL BIOL, V192, P171, DOI 10.1083/jcb.201008060; Lee HJ, 2013, ANN SURG ONCOL, V20, P200, DOI 10.1245/s10434-012-2553-6; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; IP JH, 1990, J AM COLL CARDIOL, V15, P1667; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Ali ZA, 2007, ARTERIOSCL THROM VAS, V27, P833, DOI 10.1161/01.ATV.0000257135.39571.5b; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Acquaviva J, 2009, BBA-REV CANCER, V1795, P37, DOI 10.1016/j.bbcan.2008.07.006; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Lee J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/cncr.27967; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Oguri M, 2007, ATHEROSCLEROSIS, V194, pE172, DOI 10.1016/j.atherosclerosis.2006.12.019; Ashley EA, 2006, CIRCULATION, V114, P2644, DOI 10.1161/CIRCULATIONAHA.106.637025; Lu SC, 1999, FASEB J, V13, P1169; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suehara Y, 2012, CLIN CANCER RES, V18, P6599, DOI 10.1158/1078-0432.CCR-12-0838; Bernard B, 2009, PROTEINS, V76, P115, DOI 10.1002/prot.22323; Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI DOI 10.1145/1656274.1656278; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Lapenna D, 1998, CIRCULATION, V97, P1930; Mechanic LE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-146; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; ZHAO JF, 1995, CANCER GENET CYTOGEN, V83, P148, DOI 10.1016/0165-4608(95)00043-O	54	1	2	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	DEC	2014	124	12					5159	5174		10.1172/JCI77484		16	Medicine, Research & Experimental	Research & Experimental Medicine	AU5XP	WOS:000345677200011		
J	Funato, Y; Yamazaki, D; Mizukami, S; Du, LS; Kikuchi, K; Miki, H				Funato, Yosuke; Yamazaki, Daisuke; Mizukami, Shin; Du, Lisa; Kikuchi, Kazuya; Miki, Hiroaki			Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression	JOURNAL OF CLINICAL INVESTIGATION			English	Article							MOUSE MELANOMA-CELLS; GROWTH-CONTROL; PRL-3 PHOSPHATASE; COLORECTAL-CANCER; IN-VIVO; METASTASIS; HOMEOSTASIS; METABOLISM; MTOR; MAGNESIUM	Intracellular Mg2+ levels are strictly regulated; however, the biological importance of intracellular Mg2+ levels and the pathways that regulate them remain poorly understood. Here, we determined that intracellular Mg2+ is important in regulating both energy metabolism and tumor progression. We determined that CNNM4, a membrane protein that stimulates Mg2+ efflux, binds phosphatase of regenerating liver (PRL), which is frequently overexpressed in malignant human cancers. Biochemical analyses of cultured cells revealed that PRL prevents CNNM4-dependent Mg2+ efflux and that regulation of intracellular Mg2+ levels by PRL and CNNM4 is linked to energy metabolism and AMPK/mTOR signaling. Indeed, treatment with the clinically available mTOR inhibitor rapamycin suppressed the growth of cancer cells in which PRL was overexpressed. In Apc(Delta 14/+) mice, which spontaneously form benign polyps in the intestine, deletion of Cnnm4 promoted malignant progression of intestinal polyps to adenocarcinomas. IHC analyses of tissues from patients with colon cancer demonstrated an inverse relationship between CNNM4 expression and colon cancer malignancy. Together, these results indicate that CNNM4-dependent Mg2+ efflux suppresses tumor progression by regulating energy metabolism.	[Funato, Yosuke; Yamazaki, Daisuke; Du, Lisa; Miki, Hiroaki] Osaka Univ, Grad Sch Engn, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Mizukami, Shin; Kikuchi, Kazuya] Osaka Univ, Grad Sch Engn, Div Adv Sci & Biotechnol, Suita, Osaka 5650871, Japan	Miki, H (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@biken.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [LS083]; Osaka University; JSPS; MEXT [26111007, 26291042, 22770195, 23117710]	We thank M. Okada and K. Saito for mass spectrometry; M. Giovannini for the Apc<SUP>Flox14/+</SUP> mice; M. Okabe for the CAG-Cre mice; Q, Zeng for the PRL3 antibodies; T. Sawasaki, Y. Endo, H. Kidoya, N. Takakura, S. Kurisu, A. Inanobe, K. Furutani, Y. Kurachi, S. Higashiyama, M. Yamada, and K. Sekiguchi for technical advice; and T. Ogasawara, T. Terabayashi, M. Matsuda, A. Kawasaki, and H. Yamamoto for technical support. This study was supported by the Funding Program for Next-Generation World-Leading Researchers from the Japan Society for the Promotion of Science (JSPS) (LS083, to H. Miki); Exciting Leading-Edge Research Projects from Osaka University (to H. Miki); and Grants-in-Aid for Scientific Research from the JSPS and MEXT (26111007 and 26291042, to H. Miki; 22770195 and 23117710, to Y. Funato).	Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Hemminki A, 1998, NATURE, V391, P184; Gunther T, 2006, MAGNESIUM RES, V19, P225; Rubin H, 2007, ARCH BIOCHEM BIOPHYS, V458, P16, DOI 10.1016/j.abb.2006.03.026; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zeng Q, 2003, CANCER RES, V63, P2716; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Li J, 2005, CLIN CANCER RES, V11, P2195, DOI 10.1158/1078-0432.CCR-04-1984; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Cleophas T. J., 2009, STAT APPL CLIN TRIAL; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Guo K, 2004, CANCER BIOL THER, V3, P945; Hu JA, 2010, ORAL SURG ORAL MED O, V109, P117, DOI 10.1016/j.tripleo.2009.07.052; Jahnen-Dechent W, 2012, CLIN KIDNEY J S1, V5, pi3; Kim SH, 2009, ONCOL RES, V17, P601; Molinari F, 2014, FRONT ONCOL, V3, P326, DOI DOI 10.3389/FONC.2013.00326; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; Pham Phuong-Chi T, 2014, Int J Nephrol Renovasc Dis, V7, P219, DOI 10.2147/IJNRD.S42054; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; RUBIN H, 1975, P NATL ACAD SCI USA, V72, P3551, DOI 10.1073/pnas.72.9.3551; Sahni J, 2008, CELL METAB, V8, P84, DOI 10.1016/j.cmet.2008.06.002; Tashiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073171; Vinogradov AD, 2000, J EXP BIOL, V203, P41; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Zhang AM, 1996, BRAIN RES, V728, P204, DOI 10.1016/S0006-8993(96)00401-5; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	51	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	DEC	2014	124	12					5398	5410		10.1172/JCI76614		13	Medicine, Research & Experimental	Research & Experimental Medicine	AU5XP	WOS:000345677200029		
J	Ohtsuki, M; Morita, A; Abe, M; Takahashi, H; Seko, N; Karpov, A; Shima, T; Papavassilis, C; Nakagawa, H				Ohtsuki, Mamitaro; Morita, Akimichi; Abe, Masatoshi; Takahashi, Hidetoshi; Seko, Noriko; Karpov, Alexander; Shima, Tomohiro; Papavassilis, Charis; Nakagawa, Hidemi		ERASURE Study Japanese Subgrp	Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study	JOURNAL OF DERMATOLOGY			English	Article						IL-17A; Japan; psoriasis; randomized controlled trial; secukinumab	QUALITY-OF-LIFE; DOUBLE-BLIND; STIGMATIZATION; THERAPIES; DISEASES; IMPACT	Secukinumab, a fully human anti-IL-17A monoclonal antibody, neutralizes IL-17A, a key cytokine in the pathogenesis of psoriasis. Efficacy and safety of secukinumab was evaluated in Japanese patients with moderate-to-severe plaque psoriasis as part of a large Phase 3 global study (ERASURE). In this 52-week, double-blind study (ClinicalTrials.gov Identifier: NCT01365455, JapicCTI-111529), 87 patients from Japan (11.8% of 738 patients randomized in the overall study population) were equally randomized to receive secukinumab 300mg or 150mg, or placebo once weekly at baseline and at Weeks 1, 2, 3 and 4, then every 4weeks. Co-primary endpoints (Week 12) were 75% improvement in psoriasis area-and-severity index (PASI 75) from baseline and a score of 0 (clear) or 1 (almost clear) on a 5-point Investigator's Global Assessment scale (IGA mod 2011 0/1) versus placebo. PASI 75 and IGA mod 2011 0/1 responses at Week 12 were superior with secukinumab 300mg (82.8% and 55.2%, respectively) or 150mg (86.2% and 55.2%, respectively) versus placebo (6.9% and 3.4%, respectively; P<0.0001 for all). Greater than 90% improvement in PASI (PASI 90) was also superior with secukinumab 300mg (62.1%) or 150mg (55.2%) versus placebo (0.0%) at Week 12 (P<0.0001 for both). Clinical responses were sustained up to Week 52 in the majority of patients. During a 12-week induction period, adverse event incidences were 48.3% with secukinumab 300mg, 55.2% with 150mg, and 41.4% with placebo. Secukinumab showed robust and sustainable efficacy in symptom reduction for moderate-to-severe plaque psoriasis in the Japanese patients.	[Ohtsuki, Mamitaro] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Morita, Akimichi] Nagoya City Univ, Nagoya, Aichi, Japan; [Abe, Masatoshi] Sapporo Skin Clin, Sapporo, Hokkaido, Japan; [Takahashi, Hidetoshi] Takagi Dermatol Clin, Obihiro, Hokkaido, Japan; [Seko, Noriko; Shima, Tomohiro] Novartis Pharma KK, Tokyo, Japan; [Karpov, Alexander; Papavassilis, Charis] Novartis Pharma AG, Basel, Switzerland; [Nakagawa, Hidemi] Jikei Univ, Sch Med, Tokyo, Japan	Ohtsuki, M (reprint author), Jichi Med Univ, Dept Dermatol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	mamitaro@jichi.ac.jp					Perrott SB, 2000, PHYSIOL BEHAV, V70, P567, DOI 10.1016/S0031-9384(00)00290-0; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; Krueger G, 2001, ARCH DERMATOL, V137, P280; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Edson-Heredia E, 2014, J INVEST DERMATOL, V134, P18, DOI 10.1038/jid.2013.326; Naldi L, 2005, BRIT J DERMATOL, V152, P597, DOI 10.1111/j.1365-2133.2005.06563.x; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Kubota K, 2013, JAPANESE SOC PHARMAC, P39; Langley RGB, 2013, J DERMATOL TREAT, DOI [10.3109/09546634.2013.865009, DOI 10.3109/09546634.2013.865009]; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Pearce DJ, 2006, J DERMATOL TREAT, V17, P288, DOI 10.1080/09546630600920041; Richards HL, 2001, J PSYCHOSOM RES, V50, P11, DOI 10.1016/S0022-3999(00)00210-5; Takahashi H, 2011, J DERMATOL, V38, P1125, DOI 10.1111/j.1346-8138.2010.01145.x; Weisman S, 2003, J Dermatolog Treat, V14, P158, DOI 10.1080/09546630310013360	17	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1039	1046		10.1111/1346-8138.12668		8	Dermatology	Dermatology	AU7DK	WOS:000345760700001		
J	Motegi, S; Yokoyama, Y; Uchiyama, A; Ogino, S; Takeuchi, Y; Yamada, K; Hattori, T; Hashizume, H; Ishikawa, Y; Goto, M; Ishikawa, O				Motegi, Sei-ichiro; Yokoyama, Yoko; Uchiyama, Akihiko; Ogino, Sachiko; Takeuchi, Yuko; Yamada, Kazuya; Hattori, Tomoyasu; Hashizume, Hiroaki; Ishikawa, Yuichi; Goto, Makoto; Ishikawa, Osamu			First Japanese case of atypical progeroid syndrome/atypical Werner syndrome with heterozygous LMNA mutation	JOURNAL OF DERMATOLOGY			English	Article						atypical progeroid syndrome; atypical Werner syndrome; Hutchinson-Gilford syndrome; lamin A; Werner syndrome	LAMIN A/C; ORGANIZATION	Atypical progeroid syndrome (APS), including atypical Werner syndrome (AWS), is a progeroid syndrome involving heterozygous mutations in the LMNA gene encoding the nuclear protein lamin A/C. We report the first Japanese case of APS/AWS with a LMNA mutation (p.D300N). A 53-year-old Japanese man had a history of recurrent severe cardiovascular diseases as well as brain infarction and hemorrhages. Although our APS/AWS patient had overlapping features with Werner syndrome (WS), such as high-pitched voice, scleroderma, lipoatrophy and atherosclerosis, several cardinal features of WS, including short stature, premature graying/alopecia, cataract, bird-like face, flat feet, hyperkeratosis on the soles and diabetes mellitus, were absent. In immunofluorescence staining and electron microscopic analyses of the patient's cultured fibroblasts, abnormal nuclear morphology, an increase in small aggregation of heterochromatin and a decrease in interchromatin granules in nuclei of fibroblasts were observed, suggesting that abnormal nuclear morphology and chromatin disorganization may be associated with the pathogenesis of APS/AWS.	[Motegi, Sei-ichiro; Yokoyama, Yoko; Uchiyama, Akihiko; Ogino, Sachiko; Takeuchi, Yuko; Yamada, Kazuya; Hattori, Tomoyasu; Ishikawa, Osamu] Gunma Univ, Dept Dermatol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Hashizume, Hiroaki] Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc Res, Dept Pathol, Tokyo, Japan; [Goto, Makoto] Tokyo Womens Med Univ, Div Orthoped Surg & Rheumatol, East Med Ctr, Tokyo, Japan; [Goto, Makoto] Toin Univ Yokohama, Fac Med Engn, Div Antiaging & Longev Sci, Dept Clin Engn, Yokohama, Kanagawa, Japan	Motegi, S (reprint author), Gunma Univ, Dept Dermatol, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	smotegi@gunma-u.ac.jp					Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Madej-Pilarczyk A, 2009, AM J MED GENET A, V149A, P2387, DOI 10.1002/ajmg.a.33018; Garg A, 2009, J CLIN ENDOCR METAB, V94, P4971, DOI 10.1210/jc.2009-0472; Lattanzi G, 2007, J CELL BIOCHEM, V102, P1149, DOI 10.1002/jcb.21467; Oshima J, 2014, GERONTOLOGY, V60, P239, DOI 10.1159/000356030; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; Hisama FM, 2011, AM J MED GENET A, V155A, P3002, DOI 10.1002/ajmg.a.34336; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Doubaj Y, 2012, AM J MED GENET A, V158A, P2881, DOI 10.1002/ajmg.a.35557; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; Ho JCY, 2011, AGING-US, V3, P380; Kane MS, 2013, AM J MED GENET A, V161A, P1599, DOI 10.1002/ajmg.a.35971; Nakamura Y, 2003, RHEUMATOLOGY, V42, P798, DOI 10.1093/rheumatology/keg180; Perrot A, 2009, BASIC RES CARDIOL, V104, P90, DOI 10.1007/s00395-008-0748-6; Renard D, 2009, STROKE, V40, pE11, DOI 10.1161/STROKEAHA.108.531780	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1047	1052		10.1111/1346-8138.12657		6	Dermatology	Dermatology	AU7DK	WOS:000345760700002		
J	Toki, S; Motegi, S; Yamada, K; Uchiyama, A; Ishikawa, O				Toki, Sayaka; Motegi, Sei-ichiro; Yamada, Kazuya; Uchiyama, Akihiko; Ishikawa, Osamu			Demographic and clinical features of autoimmune thyroid disorder in Japanese patients with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Article						antithyroglobulin antibody; antithyroid peroxidase antibody; autoimmune thyroid disorders; Hashimoto's disease; hyperthyroidism (Graves' disease); systemic sclerosis	ANTITHYROID ANTIBODIES; SCLERODERMA; DISEASE; HYPOTHYROIDISM; AUTOANTIBODIES; ASSOCIATION; DYSFUNCTION; PREVALENCE; THICKNESS; DIAGNOSIS	Autoimmune thyroid disorders (AITD) are characterized by the impairment of the thyroid gland as a result of systemic or organ-specific autoimmune disorders, and the presence of antithyroid autoantibodies, such as antithyroglobulin antibody (AbTg) and antithyroid peroxidase antibody (AbTPO). Several studies have reported the association of AITD with systemic sclerosis (SSc). However, none of those studies analyzed the association between AITD and skin sclerosis in SSc patients. The aim of this study was to examine the demographic and clinical features of SSc patients with AITD treated in our department. Of a total of 210 SSc patients, we identified 30 with AITD (14.3%), including 29 with Hashimoto's disease (13.8%) and one patient with Graves' disease (0.5%), indicating that hypothyroidism was more common among SSc patients with AITD. All patients with AITD were female, and anticentromere antibody positivity, the complication of Sjogren's syndrome, severe facial skin sclerosis and atrophy of the thyroid gland were significantly prevalent in SSc patients with AITD. SSc patients with such clinical features may be at high risk of AITD and require regular follow up of thyroid function including ultrasonography and the examination of serum hormone levels to start an early treatment.	[Toki, Sayaka; Motegi, Sei-ichiro; Yamada, Kazuya; Uchiyama, Akihiko; Ishikawa, Osamu] Gunma Univ, Dept Dermatol, Grad Sch Med, Maebashi, Gunma 3718511, Japan	Motegi, S (reprint author), Gunma Univ, Dept Dermatol, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	smotegi@gunma-u.ac.jp					Antonelli A, 2010, METABOLISM, V59, P896, DOI 10.1016/j.metabol.2009.10.010; LEROY EC, 1988, J RHEUMATOL, V15, P202; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Appenzeller S, 2009, JCR-J CLIN RHEUMATOL, V15, P117, DOI 10.1097/RHU.0b013e31819dbe4c; Antonelli A, 2007, EUR J ENDOCRINOL, V156, P431, DOI 10.1530/EJE-06-0591; Ota H, 2006, THYROID, V16, P983, DOI 10.1089/thy.2006.16.983; GORDON MB, 1981, ANN INTERN MED, V95, P431; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Jara LJ, 2007, CLIN RHEUMATOL, V26, P1601, DOI 10.1007/s10067-007-0638-6; Antonelli A, 2013, J CLIN ENDOCR METAB, V98, P1198; DesKeyser L, 1990, J ENDOCRINOL INVEST, V13, P161; Fujibayashi T, 1999, ANNUAL REPORT MININS, P135; Hamada N, 2010, ENDOCR J, V57, P645, DOI 10.1507/endocrj.K09E-353; Innocencio RM, 2004, MEDICINA-BUENOS AIRE, V64, P227; Koszarny A, 2013, POL ARCH MED WEWN, V123, P394; KUCHARZ EJ, 1993, CLIN RHEUMATOL, V12, P159, DOI 10.1007/BF02231519; Lin WY, 2015, J MICROBIOL IMMUNOL, V48, P676, DOI 10.1016/j.jmii.2014.03.004; MEDSGER TA, 1985, J RHEUMATOL, V12, P1041; Molnar I, 2000, CLIN EXP RHEUMATOL, V18, P719; MOLNAR I, 1992, J ENDOCRINOL INVEST, V15, P311; Molteni M, 1997, CLIN EXP RHEUMATOL, V15, P529; Motegi S, 2014, J DERMATOL, V41, P604, DOI 10.1111/1346-8138.12532; MOURIERCLAVREUL MC, 1989, ANN DERMATOL VENER, V116, P701; Sarzi-Puttini P, 2010, AUTOIMMUN REV, V9, P849, DOI 10.1016/j.autrev.2010.08.002; SCHWARZ W, 1981, ARCH DERMATOL RES, V271, P451, DOI 10.1007/BF00406692; SERUP J, 1986, ACTA DERM-VENEREOL, V66, P35; SHISHIBA Y, 1988, CONNECT TISSUE RES, V17, P119, DOI 10.3109/03008208809015024; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Takeda K, 2009, ENDOCR J, V56, P1059	30	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1053	1057		10.1111/1346-8138.12698		5	Dermatology	Dermatology	AU7DK	WOS:000345760700003		
J	Yamauchi-Yamada, A; Yamamoto, T; Nakayama, Y; Ikeda, K; Miyake, T; Yamaguchi, M; Hirai, Y; Shirafuji, Y; Morizane, S; Aoyama, Y; Iwatsuki, K				Yamauchi-Yamada, Akiko; Yamamoto, Takenobu; Nakayama, Yumi; Ikeda, Kazuko; Miyake, Tomoko; Yamaguchi, Mari; Hirai, Yoji; Shirafuji, Yoshinori; Morizane, Shin; Aoyama, Yumi; Iwatsuki, Keiji			Immune escape phenomenon in molluscum contagiosum and the induction of apoptosis	JOURNAL OF DERMATOLOGY			English	Article						dendritic cell; Langerhans cell; macrophage inflammatory protein-3; molluscum contagiosum virus; nutlin-3	SPONTANEOUS REGRESSION; ATOPIC-DERMATITIS; SKIN-LESIONS; CELLS; VIRUS; ANTAGONISTS; SURVIVAL; WARTS	Molluscum contagiosum (MC) may persist for many weeks, evading host immunity. We studied the mechanism of immune escape phenomenon in MC, and the possible inducer of apoptosis. Using tissue samples of MC, we examined the numbers of epidermal Langerhans cells (LC), the expression levels of macrophage inflammatory protein-3 (MIP-3) and thymic stromal lymphopoietin (TSLP), and the apoptotic signals. After molluscum contagiosum virus (MCV) genotyping, we studied the expression of MCV-encoded MC148 mRNA and MC159 mRNA which correspond to viral antagonist for CCR8 and viral Fas-linked interleukin (IL)-1 converting enzyme (FLICE)-like inhibitor protein (vFLIP), respectively. The nutlin-3-induced apoptosis in MC was observed ex vivo. The numbers of CD1a(+) or Langerin(+) epidermal LC and the expression levels of MIP-3 were markedly decreased in MC. The expression of TSLP was enhanced in the lesional epidermis of atopic dermatitis and human papillomavirus-induced warts, whereas the expression was observed locally in MC. All 14 MC samples examined harbored MCV type 1. The MC148 mRNA was detected in all 14 samples and the MC159 mRNA was detected in 13 samples. Apoptotic cells were absent or at a background level in the living layers of MC, but their numbers were increased in the molluscum bodies by overnight incubation with 5mol/L nutlin-3 in culture medium. In conclusion, molluscum bodies are protected from host immune responses and apoptotic signals by being surrounded by LC-depleted epidermal walls and viral immunosuppressive molecules, but could be eradicated by reagents inducing p53-dependent apoptosis.	[Yamauchi-Yamada, Akiko; Yamamoto, Takenobu; Nakayama, Yumi; Ikeda, Kazuko; Miyake, Tomoko; Yamaguchi, Mari; Hirai, Yoji; Shirafuji, Yoshinori; Morizane, Shin; Aoyama, Yumi; Iwatsuki, Keiji] Okayama Univ, Dept Dermatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Yamamoto, Takenobu] Kawasaki Hosp, Kawasaki Med Coll, Okayama, Japan	Iwatsuki, K (reprint author), Okayama Univ, Dept Dermatol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	keijiiwa@cc.okayama-u.ac.jp					Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Nakayama Y, 2011, J DERMATOL SCI, V63, P173, DOI 10.1016/j.jdermsci.2011.05.006; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; TAKEMATSU H, 1994, ARCH DERMATOL RES, V287, P102, DOI 10.1007/BF00370727; Kim BE, 2007, J ALLERGY CLIN IMMUN, V119, P457, DOI 10.1016/j.jaci.2006.10.005; Guess JC, 2005, J VIROL, V79, P14852, DOI 10.1128/JVI.79.23.14852-14862.2005; Bhawan J, 1986, J AM ACAD DERMATOL, V5, P645; Carol HT, 1997, J MED VIROL, V53, P205; David MH, 2002, J BIOL CHEM S40, V277, P37647; DeBruyne LA, 2000, GENE THER, V7, P575, DOI 10.1038/sj.gt.3301128; Hans RL, 2001, J LEUKOCYTE BIOL, V70, P272; Hans RL, 2000, J EXP MED S1, V191, P171; IWATSUKI K, 1986, ARCH DERMATOL, V122, P655, DOI 10.1001/archderm.122.6.655; Joanna L, 2001, VILOROGY, V282, P14; Jurajada M, 2002, MOL CELL PROBE, V16, P25; Lyre EM, 2005, VIROLOGY, V340, P255; PINKUS H, 1949, J INVEST DERMATOL, V13, P289, DOI 10.1038/jid.1949.99; TAGAMI H, 1985, CANCER, V55, P2437, DOI 10.1002/1097-0142(19850515)55:10<2437::AID-CNCR2820551023>3.0.CO;2-Z; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Wang X, 2003, NUCLEIC ACIDS RES, V31, P1; Wu ZQ, 2004, J IMMUNOL, V172, P6313	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1058	1064		10.1111/1346-8138.12695		7	Dermatology	Dermatology	AU7DK	WOS:000345760700004		
J	Akaza, N; Akamatsu, H; Numata, S; Matsusue, M; Mashima, Y; Miyawaki, M; Yamada, S; Yagami, A; Nakata, S; Matsunaga, K				Akaza, Narifumi; Akamatsu, Hirohiko; Numata, Shigeki; Matsusue, Miyuki; Mashima, Yasuo; Miyawaki, Masaaki; Yamada, Shunji; Yagami, Akiko; Nakata, Satoru; Matsunaga, Kayoko			Fatty acid compositions of triglycerides and free fatty acids in sebum depend on amount of triglycerides, and do not differ in presence or absence of acne vulgaris	JOURNAL OF DERMATOLOGY			English	Article						acne vulgaris; free fatty acid; Propionibacterium acnes; sebum; triglyceride	SKIN SURFACE; PROPIONIBACTERIUM; KERATINOCYTES; JAPANESE; LIPIDS	To clarify the influence of the fatty acid composition of sebum in acne vulgaris, we investigated the amounts and fatty acid compositions of triglycerides (TG) and free fatty acids (FFA), and the amounts of cutaneous superficial Propionibacterium acnes in acne patients and healthy subjects. The foreheads of 18 female patients, 10 male patients, 10 healthy females and 10 healthy males were studied in a Japanese population. There were significant differences in the amounts of sebum, TG and cutaneous superficial P.acnes, as well as the fatty acid compositions of TG and FFA between acne patients and healthy subjects in females. Their fatty acid compositions were correlated with the amount of TG with or without acne. It was clarified that the fatty acid compositions of TG and FFA depended on the amount of TG, and there were no differences in the fatty acid composition in the presence and absence of acne.	[Akaza, Narifumi; Matsusue, Miyuki; Mashima, Yasuo; Miyawaki, Masaaki; Yamada, Shunji; Nakata, Satoru] Nippon Menard Cosmet, Res Labs, Nagoya, Aichi 4510071, Japan; [Akaza, Narifumi; Numata, Shigeki; Yagami, Akiko; Matsunaga, Kayoko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 47011, Japan; [Akamatsu, Hirohiko] Fujita Hlth Univ, Sch Med, Dept Appl Cell & Regenerat Med, Toyoake, Aichi 47011, Japan	Akaza, N (reprint author), Nippon Menard Cosmet, Res Labs, Nishi Ku, 2-7 Torimi Cho, Nagoya, Aichi 4510071, Japan.	akaza.narifumi@menard.co.jp					Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Hayashi N, 2008, J DERMATOL, V35, P255, DOI 10.1111/j.1346-8138.2008.00462.x; MCGINLEY KJ, 1980, J CLIN MICROBIOL, V12, P672; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Youn SW, 2005, BRIT J DERMATOL, V153, P919, DOI 10.1111/j.1365-2133.2005.06794.x; Kim J, 2002, J IMMUNOL, V169, P1535; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Smith RN, 2008, J DERMATOL SCI, V50, P41, DOI 10.1016/j.jdermsci.2007.11.005; Akaza N, 2009, MED MYCOL, V47, P618, DOI 10.1080/13693780802398026; Destaillats F, 2011, J CHROMATOGR A, V1218, P9384, DOI 10.1016/j.chroma.2011.10.095; Downing DT, 1969, J INVEST DERMATOL, V53, P332; GOLLNICK H P M, 1991, Journal of Dermatology (Tokyo), V18, P489; Katsuta Y, 2005, J INVEST DERMATOL, V124, P1008, DOI 10.1111/j.0022-202X.2005.23682.x; KEYWORTH N, 1990, J CLIN MICROBIOL, V28, P941; LEYDEN JJ, 1975, J INVEST DERMATOL, V65, P382, DOI 10.1111/1523-1747.ep12607634; MAEDA T, 1991, Journal of Dermatology (Tokyo), V18, P397; MATSUNAGA K, 1985, Nishinihon Journal of Dermatology, V47, P1080; NICOLAID.N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; Numata S, 2014, DERMATOLOGY, V228, P86, DOI 10.1159/000356777; Papas A, 2009, DERMATOENDOCRINOLOGY, V1, P157; Papas A, 2009, DERMATOENDOCRINOLOGY, V1, P72; POCHI PE, 1988, DRUG DEVELOP RES, V13, P157, DOI 10.1002/ddr.430130208; USHIJIMA T, 1984, CAN J MICROBIOL, V30, P647; Webster G, 1995, J AM ACAD DERMATOL, V32, P247; YAMAMOTO A, 1987, J INVEST DERMATOL, V89, P507, DOI 10.1111/1523-1747.ep12461009	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1069	1076		10.1111/1346-8138.12699		8	Dermatology	Dermatology	AU7DK	WOS:000345760700006		
J	Hattori, T; Fukumoto, T; Anan, T; Kimura, T				Hattori, Tomoyasu; Fukumoto, Takaya; Anan, Takashi; Kimura, Tetsunori			Four Japanese cases of dendritic cell neurofibroma with pseudorosettes	JOURNAL OF DERMATOLOGY			English	Article						CD57; dendritic cell neurofibroma with pseudorosettes; Japanese; neurofibroma; peripheral nerve sheath tumor	GERM-LINE MUTATIONS; TYPE-2 GENE; SEVERITY; DISEASE	Dendritic cell neurofibroma with pseudorosettes (DCNWPR) is a rare peripheral nerve sheath tumor (PNST). To our knowledge, the only reported case of DCNWPR in Japan was documented by our team. We experienced three additional cases of DCNWPR in our institute since 2007, and report the clinical and histological features of DCNWPR of these Japanese cases. All four patients were adult women, with ages ranging 48-77years (mean, 63.8). All patients presented with small solitary lesions that were clinically diagnosed as fibroma, melanocytic nevus or mixed tumor of the skin. Three cases were located on the back, and one on the cheek. Histopathologically, well-circumscribed nodules were present in the dermis, and composed of small lymphocyte-like cells with dark nuclei (type I cells) and larger cells with pale vesicular nuclei and abundant eosinophilic cytoplasm (type II cells). Small type I cells were grouped concentrically around the larger type II cells, thereby forming pseudorosettes. Immunohistochemical studies using antibodies against CD57 and S100 protein revealed that type II cells contained a copious cytoplasm endowed with a network of slender dendritic extensions. CD57 should be a useful marker for identifying type II cells because it allows these cells to be stained exclusively. We should recognize DCNWPR with its characteristic histological features such as pseudorosettes and presence of dendritic type II cells as a variant of PNST.	[Hattori, Tomoyasu; Fukumoto, Takaya; Anan, Takashi; Kimura, Tetsunori] Sapporo Dermatopathol Inst, Sapporo, Hokkaido 0010018, Japan; [Hattori, Tomoyasu] Hattori Dermatol Clin, Takasaki, Gunma, Japan	Hattori, T (reprint author), Sapporo Dermatopathol Inst, Kita Ku, 2-21,N18W3, Sapporo, Hokkaido 0010018, Japan.	thattori.hifuka@gmail.com					ANDO I, 1985, BRIT J DERMATOL, V113, P175, DOI 10.1111/j.1365-2133.1985.tb02061.x; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; Parry DM, 1996, AM J HUM GENET, V59, P529; ABO T, 1981, J IMMUNOL, V127, P1024; Ghilusi M, 2009, ROM J MORPHOL EMBRYO, V50, P195; Hattori T, 2014, JPN J DERMATOL, V124, P173; Kazakov DV, 2004, AM J DERMATOPATH, V26, P72, DOI 10.1097/00000372-200402000-00012; Kazakov DV, 2005, AM J DERMATOPATH, V27, P286, DOI 10.1097/01.dad.0000157462.49463.b8; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; Michal M, 2001, AM J SURG PATHOL, V25, P587, DOI 10.1097/00000478-200105000-00004; Petersson F, 2011, AM J DERMATOPATH, V33, P742, DOI 10.1097/DAD.0b013e318206f66a; Schlitter AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042025; Simpson RHW, 2001, AM J SURG PATHOL, V25, P1458, DOI 10.1097/00000478-200111000-00017; Woodruff JM, 2002, AM J SURG PATHOL, V26, P1644, DOI 10.1097/00000478-200212000-00015; Woodruff JM, 2002, AM J SURG PATHOL, V26, P1645	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1077	1081		10.1111/1346-8138.12690		5	Dermatology	Dermatology	AU7DK	WOS:000345760700007		
J	Kogame, T; Dainichi, T; Shimomura, Y; Tanioka, M; Kabashima, K; Miyachi, Y				Kogame, Toshiaki; Dainichi, Teruki; Shimomura, Yutaka; Tanioka, Miki; Kabashima, Kenji; Miyachi, Yoshiki			Palmoplantar keratosis in oculodentodigital dysplasia with a GJA1 point mutation out of the C-terminal region of connexin 43	JOURNAL OF DERMATOLOGY			English	Article						missense mutation; oculodentodigital dysplasia; palmoplantar keratosis	DENTO-DIGITAL DYSPLASIA; PHENOTYPE; PHOSPHORYLATION; CX43	Gap junction proteins are composed of 21 genes of the connexin (Cx) family. They play important roles in cell-cell contact by exchange of small molecules through hemichannels. Hence, mutations of Cx family genes affect various tissues of a body. The mutation of the GJA1 gene, which codes Cx43, causes oculodentodigital dysplasia (ODDD), commonly in an autosomal dominant manner with phenotypic variability. It has been believed that gene mutations causing truncation of the Cx43 C-terminus is necessary and sufficient for palmoplantar keratosis (PPK) development in ODDD patients. Here, we report a case of an ODDD patient developing PPK with a GJA1 gene mutation (c.412G>A/p.Gly138Ser), which was previously reported in a case of ODDD without PPK and expected not to result in C-terminal truncation of Cx43. This case suggests not only C-terminal truncation, but also that a point mutation in the cytoplasmic region of Cx43 can cause PPK in ODDD patients.	[Kogame, Toshiaki; Dainichi, Teruki; Tanioka, Miki; Kabashima, Kenji; Miyachi, Yoshiki] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto 6068507, Japan; [Shimomura, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Lab Genet Skin Dis, Niigata, Japan	Dainichi, T (reprint author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	dainichi@kuhp.kyoto-u.ac.jp					Alao MJ, 2010, EUR J MED GENET, V53, P19, DOI 10.1016/j.ejmg.2009.08.007; Bejarano E, 2014, NAT CELL BIOL, V16, P401, DOI 10.1038/ncb2934; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Carette D, 2014, BIOCHIMIE, V101, P1, DOI 10.1016/j.biochi.2013.11.015; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Dunn CA, 2014, J CELL SCI, V127, P455, DOI 10.1242/jcs.142497; Kelly SC, 2006, EUR J DERMATOL, V16, P241; van Steensel MAM, 2005, AM J MED GENET A, V132A, P171, DOI 10.1002/ajmg.a.30412; Vreeburg M, 2007, AM J MED GENET A, V143A, P360, DOI 10.1002/ajmg.a.31558	13	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1095	1097		10.1111/1346-8138.12682		3	Dermatology	Dermatology	AU7DK	WOS:000345760700010		
J	Shibayama, Y; Imafuku, S				Shibayama, Yoshitsugu; Imafuku, Shinichi			Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients	JOURNAL OF DERMATOLOGY			English	Article						actinic keratosis; carcinogenesis; cutaneous squamous cell carcinoma; predilection site; ultraviolet	SKIN; DKK1	Cutaneous squamous cell carcinoma (cSCC) and actinic keratosis (AK) occur most often on the face. Ultraviolet light is apparently their most common cause. As AK is considered to be a precursor of cSCC, their distribution on the face should be similar. However, cSCC often occurs on the temple or mandibular area, whereas AK arises on the central forehead, cheek or nose. We retrospectively evaluated differences in affected site distribution for cSCC (n=54) and AK (n=95). We found AK to occur preferentially on the central facial area (63/95, 66%), which is the most sun-exposed area, and cSCC to occur preferentially on peripheral areas such as the temple and mandibular area (24/54, 44%). Those distributions were significantly different (P=0.011, Fisher's exact test). This result suggests that cSCC occurs preferentially in the peripheral area compared with the central facial area, which further implies that either other factors are needed to make AK progress to cSCC in peripheral areas, or that peripheral cSCC can occur without preceding AK. This is the first report to focus on geographic assessment of cSCC and AK in detail. Further studies are needed to elucidate the mechanism of our finding.	[Shibayama, Yoshitsugu; Imafuku, Shinichi] Fukuoka Univ, Dept Dermatol, Fac Med, Fukuoka 8140133, Japan	Shibayama, Y (reprint author), Fukuoka Univ, Dept Dermatol, Fac Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140133, Japan.	shibayoshi1978@hotmail.com					Mortier L, 2002, CANCER LETT, V176, P205, DOI 10.1016/S0304-3835(01)00757-1; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Ra SH, 2011, MODERN PATHOL, V24, P963, DOI 10.1038/modpathol.2011.39; Berman B, 2013, J AM ACAD DERMATOL, V68, pS10, DOI 10.1016/j.jaad.2012.09.053; Criscione VD, 2009, CANCER, V115, P2523, DOI 10.1002/cncr.24284; Anzai S, 2008, JPN J DERMATOL, V118, P29; Ishihara K, 1994, SKIN CANC TOKYO, V9, P7; Lambert SR, 2014, BRIT J CANCER, V110, P520, DOI 10.1038/bjc.2013.760; Miyazawa M, 2004, FRAGR J, V4, P54; Tao YM, 2013, DIGEST LIVER DIS, V45, P251, DOI 10.1016/j.dld.2012.10.020; Yamaguchi Y, 2009, J INVEST DERM SYMP P, V14, P73, DOI 10.1038/jidsymp.2009.4	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1102	1105		10.1111/1346-8138.12679		4	Dermatology	Dermatology	AU7DK	WOS:000345760700012		
J	Goh, CL; Abad-Casintahan, F; Chow, SKW; Kubba, R; Miyachi, Y; Noppakun, N; See, J; Suh, DH; Xiang, LF; Kang, SW				Goh, Chee Leok; Abad-Casintahan, Flordeliz; Chow, Steven K. W.; Kubba, Raj; Miyachi, Yoshiki; Noppakun, Nopadon; See, JoAnn; Suh, Dae Hun; Xiang, Leihong Flora; Kang, Sewon		Asian Acne Board	Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts	JOURNAL OF DERMATOLOGY			English	Article						acne scars; active acne; Asian skin; erythema; post-inflammatory hyperpigmentation		Post-inflammatory hyperpigmentation (PIH) is a problematic and distressing acne sequela. The difficulty of clinically assessing and managing post-inflammatory hyperpigmentation is especially prevalent in Asian populations. The Asian Acne Board conducted a study to evaluate concordance in diagnosis of post-inflammatory hyperpigmentation in patients with active acne, acne scarring, and pigmentation problems. Seven dermatologists reviewed 64 anonymous clinical photographs projected onto a screen during a single session. Results showed that there were two groups of raters, those who found a high frequency of PIH and those who found a low frequency. There was significant variability in these two groups in rating the presence of PIH, with an average of 30 diagnoses (24%) difference between high- and low-frequency raters. Results of severity ratings showed that while most cases of PIH were assessed as mild, there was marked variability between raters in their assessments of severity. Overall, variability in PIH diagnosis was greatest when active acne was present; in these cases, low PIH raters were more likely to report skin coloration as erythema instead of PIH. These findings uphold the importance of utilizing specific clinical criteria to improve accurate evaluation of skin color and we advocate future research into this area.	[Goh, Chee Leok] Natl Skin Ctr, Singapore 308205, Singapore; [Abad-Casintahan, Flordeliz] Jose R Reyes Mem Ctr, Dept Dermatol, Manila, Philippines; [Chow, Steven K. W.] KL Skin Ctr, Kuala Lumpur, Malaysia; [Kubba, Raj] Delhi Dermatol Grp, Delhi, India; [Miyachi, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Noppakun, Nopadon] Chulalongkorn Univ Hosp, Bangkok, Thailand; [See, JoAnn] Cent Sydney Dermatol, Sydney, NSW, Australia; [Suh, Dae Hun] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Xiang, Leihong Flora] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Kang, Sewon] Johns Hopkins Sch Med, Dept Dermatol, Baltimore, MD USA	Goh, CL (reprint author), Natl Skin Ctr, 1 Mandalay Rd, Singapore 308205, Singapore.	clgoh@nsc.gov.sg					RuizMaldonado R, 1997, SEMIN CUTAN MED SURG, V16, P36, DOI 10.1016/S1085-5629(97)80034-X; Stratigos AJ, 2004, AM J CLIN DERMATOL, V5, P161, DOI 10.2165/00128071-200405030-00004; Cayce Kimberly A, 2004, Dermatol Nurs, V16, P401; Cayce KA, 2004, DERMATOL NURS, V16, P17; Cayce KA, 2004, DERMATOL NURS, V16, P13; Ha S, 2009, SKIN RES TECHNOL, V15, P200, DOI 10.1111/j.1600-0846.2009.00355.x; Kircik LH, 2011, J DRUGS DERMATOL, V10, P586; Woolery-Lloyd H, 2011, SEMIN CUTAN MED SURG, V30, P171, DOI 10.1016/j.sder.2011.06.004	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1106	1108		10.1111/1346-8138.12667		3	Dermatology	Dermatology	AU7DK	WOS:000345760700013		
J	Hayashi, R; Bito, T; Taniguchi-Ikeda, M; Farooq, M; Ito, M; Shimomura, Y				Hayashi, Ryota; Bito, Toshinori; Taniguchi-Ikeda, Mariko; Farooq, Muhammad; Ito, Masaaki; Shimomura, Yutaka			Japanese case of oculodentodigital dysplasia caused by a mutation in the GJA1 gene	JOURNAL OF DERMATOLOGY			English	Letter									[Hayashi, Ryota; Ito, Masaaki] Niigata Univ, Div Dermatol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Hayashi, Ryota; Farooq, Muhammad; Shimomura, Yutaka] Niigata Univ, Lab Genet Skin Dis, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Bito, Toshinori] Kobe Univ, Grad Sch Med, Fac Med, Div Dermatol,Dept Internal Related, Kobe, Hyogo 657, Japan; [Taniguchi-Ikeda, Mariko] Kobe Univ, Grad Sch Med, Fac Med, Div Pediat,Dept Internal Related, Kobe, Hyogo 657, Japan	Shimomura, Y (reprint author), Niigata Univ, Lab Genet Skin Dis, Grad Sch Med & Dent Sci, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	yshimo@med.niigata-u.ac.jp					Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; SALOMON D, 1994, J INVEST DERMATOL, V103, P240, DOI 10.1111/1523-1747.ep12393218; Furuta N, 2012, INTERNAL MED, V51, P93, DOI 10.2169/internalmedicine.51.5770; Himi M, 2009, JPN J OPHTHALMOL, V53, P541, DOI 10.1007/s10384-009-0711-6; Shibayama J, 2005, CIRC RES, V96, pE83, DOI 10.1161/01.RES.0000168369.79972.d2	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1109	1110		10.1111/1346-8138.12656		2	Dermatology	Dermatology	AU7DK	WOS:000345760700014		
J	Kurihara, Y; Hayashi, R; Watanabe, E; Miyakawa, S; Kajiwara, K; Matsuda, M; Yoshida, K; Shimomura, Y; Niizeki, H				Kurihara, Yuichi; Hayashi, Ryota; Watanabe, Emiko; Miyakawa, Shun-ichi; Kajiwara, Kumiko; Matsuda, Maiko; Yoshida, Kazue; Shimomura, Yutaka; Niizeki, Hironori			Novel EDA hemizygous frame-shift mutation c. 731delG (p.R244Qfs*36) underlies hypohidrotic ectodermal dysplasia in a Japanese family	JOURNAL OF DERMATOLOGY			English	Letter							ECTODYSPLASIN; PROTEIN; GENE		[Kurihara, Yuichi; Watanabe, Emiko; Miyakawa, Shun-ichi] Kawasaki Municipal Hosp, Div Dermatol, Kawasaki, Kanagawa, Japan; [Hayashi, Ryota; Shimomura, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Lab Genet Skin Dis, Niigata, Japan; [Kajiwara, Kumiko] Kawasaki Municipal Hosp, Div Pediat, Kawasaki, Kanagawa, Japan; [Matsuda, Maiko; Yoshida, Kazue; Niizeki, Hironori] Natl Ctr Child Hlth & Dev, Dept Dermatol, Setagaya Ku, Tokyo 1578535, Japan	Niizeki, H (reprint author), Natl Ctr Child Hlth & Dev, Dept Dermatol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	niizeki-h@ncchd.go.jp					Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Huang CZ, 2006, J HUM GENET, V51, P1133, DOI 10.1007/s10038-006-0071-8	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1110	1112		10.1111/1346-8138.12701		3	Dermatology	Dermatology	AU7DK	WOS:000345760700015		
J	Ohmori, S; Hino, R; Nakamura, M				Ohmori, Shun; Hino, Ryosuke; Nakamura, Motonobu			Inflammatory response to heparinoid and heparin in a patient with tumor necrosis factor receptor-associated periodic syndrome: The second case with a T61I mutation in the TNFRSF1A gene	JOURNAL OF DERMATOLOGY			English	Letter							TNF RECEPTOR		[Ohmori, Shun; Hino, Ryosuke; Nakamura, Motonobu] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka 8078556, Japan	Ohmori, S (reprint author), Univ Occupat & Environm Hlth, Dept Dermatol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078556, Japan.	oh-sh@med.uoeh-u.ac.jp					Simon A, 2010, P NATL ACAD SCI USA, V107, P9801, DOI 10.1073/pnas.0914118107; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Hochart H, 2008, THROMB HAEMOSTASIS, V99, P570, DOI 10.1160/TH07-06-0424; Ohmori S, 2012, J DERMATOL SCI, V66, P82, DOI 10.1016/j.jdermsci.2011.11.006; Toro JR, 2000, ARCH DERMATOL, V136, P1487, DOI 10.1001/archderm.136.12.1487	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1112	1113		10.1111/1346-8138.12689		2	Dermatology	Dermatology	AU7DK	WOS:000345760700016		
J	Ichimura, Y; Asano, Y; Takahashi, T; Toyama, T; Taniguchi, T; Tamaki, Z; Isomura, S; Miyagaki, T; Mitsui, H; Sato, S				Ichimura, Yohei; Asano, Yoshihide; Takahashi, Takehiro; Toyama, Tetsuo; Taniguchi, Takashi; Tamaki, Zenshiro; Isomura, Sayako; Miyagaki, Tomomitsu; Mitsui, Hiroshi; Sato, Shinichi			Development of systemic sclerosis in patients with Behcet's disease: Remission of Behcet's disease in parallel with the progression of skin sclerosis	JOURNAL OF DERMATOLOGY			English	Letter							INTERLEUKIN-12		[Ichimura, Yohei; Asano, Yoshihide; Takahashi, Takehiro; Toyama, Tetsuo; Taniguchi, Takashi; Tamaki, Zenshiro; Isomura, Sayako; Miyagaki, Tomomitsu; Mitsui, Hiroshi; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp					Matsushita T, 2006, J RHEUMATOL, V33, P275; Frassanito MA, 1999, ARTHRITIS RHEUM, V42, P1967, DOI 10.1002/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z; Chang HK, 2003, CLIN EXP RHEUMATOL, V21, pS31; Hartung AD, 2003, CLIN EXP RHEUMATOL, V21, P481; Miyagaki T, 2011, MOD RHEUMATOL, V21, P406, DOI 10.1007/s10165-010-0404-5	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1113	1114		10.1111/1346-8138.12688		2	Dermatology	Dermatology	AU7DK	WOS:000345760700017		
J	Nakagawa, K; Oshimo, T; Okabayashi, A; Kinoshita, R; Tatebayashi, M; Kawada, A; Imanishi, H; Ozawa, T; Tsuruta, D				Nakagawa, Koichi; Oshimo, Tomoko; Okabayashi, Aya; Kinoshita, Rie; Tatebayashi, Megumi; Kawada, Akira; Imanishi, Hisayoshi; Ozawa, Toshiyuki; Tsuruta, Daisuke			Development of terminal hairs following the treatment of pigmented nevus with vellus hairs by Q-switched alexandrite laser	JOURNAL OF DERMATOLOGY			English	Letter							PARADOXICAL HYPERTRICHOSIS; GROWTH		[Nakagawa, Koichi; Oshimo, Tomoko; Okabayashi, Aya; Kinoshita, Rie] Saiseikai Tondabayashi Hosp, Dept Dermatol, Tondabayashi City, Osaka 5840082, Japan; [Tatebayashi, Megumi; Kawada, Akira] Kinki Univ, Fac Med, Dept Dermatol, Osaka, Japan; [Imanishi, Hisayoshi; Ozawa, Toshiyuki; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan	Nakagawa, K (reprint author), Saiseikai Tondabayashi Hosp, Dept Dermatol, 1-3-36 Koyodai, Tondabayashi City, Osaka 5840082, Japan.	yama_and_sawa@tonbyo.org					Bernstein EF, 2005, DERMATOL SURG, V31, P584; Radmanesh M, 2009, J DERMATOL TREAT, V20, P52, DOI 10.1080/09546630802178224; Alajlan A, 2005, J AM ACAD DERMATOL, V53, P85, DOI 10.1016/j.jaad.2004.06.054; Bouzari N, 2006, DERMATOL SURG, V32, P460, DOI 10.1111/j.1524-4725.2006.32092.x; Vlachos SP, 2002, AESTHET PLAST SURG, V26, P303, DOI 10.1007/s00266-002-2002-1	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1115	1116		10.1111/1346-8138.12706		2	Dermatology	Dermatology	AU7DK	WOS:000345760700018		
J	Kato, M; Shimizu, A; Ishikawa, O				Kato, Madoka; Shimizu, Akira; Ishikawa, Osamu			Metastatic tuberculous abscess as a manifestation of miliary tuberculosis	JOURNAL OF DERMATOLOGY			English	Letter							CELLULITIS		[Kato, Madoka; Shimizu, Akira; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gunma 3718511, Japan	Kato, M (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	mado95@gunma-u.ac.jp					Gu JH, 2014, INT WOUND J, DOI [10.1111/iwj.12263, DOI 10.1111/IWJ.12263]; Kim JE, 2011, J AM ACAD DERMATOL, V65, P450, DOI 10.1016/j.jaad.2010.03.012; Lee NH, 2000, CLIN EXP DERMATOL, V25, P222, DOI 10.1046/j.1365-2230.2000.00621.x; Seung OP, 2012, MOD RHEUMATOL, V22, P931, DOI 10.1007/s10165-012-0605-1; Seyahi N, 2005, TRANSPL INFECT DIS, V7, P80, DOI 10.1111/j.1399-3062.2005.00095.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1117	1118		10.1111/1346-8138.12662		2	Dermatology	Dermatology	AU7DK	WOS:000345760700020		
J	Yamamoto, Y; Kounami, S; Okuhira, H; Nakamura, Y; Furukawa, F				Yamamoto, Yuki; Kounami, Shinji; Okuhira, Hisako; Nakamura, Yasushi; Furukawa, Fukumi			Successful treatment of tufted angioma with propranolol	JOURNAL OF DERMATOLOGY			English	Letter									[Yamamoto, Yuki; Okuhira, Hisako; Furukawa, Fukumi] Wakayama Med Univ, Dept Dermatol, Wakayama 6410012, Japan; [Kounami, Shinji] Wakayama Med Univ, Dept Pediat, Wakayama 6410012, Japan; [Nakamura, Yasushi] Wakayama Med Univ, Dept Clin Lab Med, Wakayama 6410012, Japan	Yamamoto, Y (reprint author), Wakayama Med Univ, Dept Dermatol, 811-1 Kimiidera, Wakayama 6410012, Japan.	yukiy@wakayama-med.ac.jp					Storch CH, 2010, BRIT J DERMATOL, V163, P269, DOI 10.1111/j.1365-2133.2010.09848.x; Chiu YE, 2012, PEDIATR BLOOD CANCER, V59, P934, DOI 10.1002/pbc.24103; Sans V, 2009, PEDIATRICS, V124, P423; Wilson-Jones E, 1989, J AM ACAD DERMATOL, V20, P214	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1120	1122		10.1111/1346-8138.12665		3	Dermatology	Dermatology	AU7DK	WOS:000345760700022		
J	Kurashige, Y; Kurashige, K; Nagatani, T; Hayashi, M				Kurashige, Yuta; Kurashige, Kumiko; Nagatani, Tetsuo; Hayashi, Mitsuhiro			Primary breast carcinoma en cuirasse derived from invasive lobular carcinoma: The first case report	JOURNAL OF DERMATOLOGY			English	Letter									[Kurashige, Yuta] Tokai Univ, Dept Dermatol, Sch Med, Isehara, Kanagawa 2591193, Japan; [Kurashige, Yuta; Kurashige, Kumiko; Nagatani, Tetsuo] Tokyo Med Univ, Hachioji Med Ctr, Dept Dermatol, Tokyo 1608402, Japan; [Hayashi, Mitsuhiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Breast Oncol, Tokyo 1608402, Japan	Kurashige, Y (reprint author), Tokai Univ, Dept Dermatol, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	kurasige@is.icc.u-tokai.ac.jp					Lakhani SR, 2012, WHO CLASSIFICATION T; Mordenti C, 2000, ACTA DERM-VENEREOL, V9, P143; Rosen PP, 2009, ROSENS BREAST PATHOL	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1122	1123		10.1111/1346-8138.12671		2	Dermatology	Dermatology	AU7DK	WOS:000345760700023		
J	Kitamura, S; Hata, H; Imafuku, K; Nishie, W; Shimizu, H				Kitamura, Shinya; Hata, Hiroo; Imafuku, Keisuke; Nishie, Wataru; Shimizu, Hiroshi			"Sprinkle brightness lesion" appearance in ultrasound B-mode findings of sinusoidal hemangioma	JOURNAL OF DERMATOLOGY			English	Letter									[Kitamura, Shinya; Hata, Hiroo; Imafuku, Keisuke; Nishie, Wataru; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Hata, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	hata07jp@yahoo.co.jp					CALONJE E, 1991, AM J SURG PATHOL, V15, P1130, DOI 10.1097/00000478-199112000-00003; Fletcher CDM, 2013, VASCULAR TUMORS WHO, P137; Nakamura M, 1999, BRIT J DERMATOL, V141, P377; Song BH, 2011, ANN DERMATOL, V23, pS250, DOI 10.5021/ad.2011.23.S2.S250; Yong MS, 2011, KOREAN J HEPATOL, V17, P331	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1123	1124		10.1111/1346-8138.12672		2	Dermatology	Dermatology	AU7DK	WOS:000345760700024		
J	Okabayashi, A; Nakagawa, K; Kishida, M; Oshimo, T; Taguchi, M; Imanishi, H; Ozawa, T; Tsuruta, D				Okabayashi, Aya; Nakagawa, Koichi; Kishida, Masaru; Oshimo, Tomoko; Taguchi, Mari; Imanishi, Hisayoshi; Ozawa, Toshiyuki; Tsuruta, Daisuke			Case of malignant melanoma with a clinically obvious bulla in a Japanese patient	JOURNAL OF DERMATOLOGY			English	Letter									[Okabayashi, Aya; Nakagawa, Koichi; Kishida, Masaru; Oshimo, Tomoko; Taguchi, Mari] Saiseikai Tondabayashi Hosp, Dept Dermatol, Tondabayashi City, Osaka 5840082, Japan; [Imanishi, Hisayoshi; Ozawa, Toshiyuki; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan	Nakagawa, K (reprint author), Saiseikai Tondabayashi Hosp, Dept Dermatol, 1-3-36 Koyodai, Tondabayashi City, Osaka 5840082, Japan.	yama_and_sawa@tonbyo.org					Aneiros-Fernandez J, 2010, AM J DERMATOPATH, V32, P364, DOI 10.1097/DAD.0b013e3181bad002; Botet M V, 1979, J Dermatol Surg Oncol, V5, P798; Kartono F, 2009, J CUTAN PATHOL, V36, P274, DOI 10.1111/j.1600-0560.2007.01054.x; Vogt T, 2003, DERMATOL SURG, V29, P102, DOI 10.1046/j.1524-4725.2003.29005.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1124	1126		10.1111/1346-8138.12677		3	Dermatology	Dermatology	AU7DK	WOS:000345760700025		
J	Nakazono, S; Takayama, N; Nojima, K; Kumagai, J; Izumi, M; Namiki, T				Nakazono, Sonoko; Takayama, Naoko; Nojima, Kohei; Kumagai, Jiro; Izumi, Miki; Namiki, Takeshi			Well-differentiated syringomatous carcinoma with solid carcinoma-like features	JOURNAL OF DERMATOLOGY			English	Letter									[Nakazono, Sonoko; Takayama, Naoko; Nojima, Kohei; Namiki, Takeshi] Yokohama City Minato Red Cross Hosp, Dept Dermatol, Yokohama, Kanagawa, Japan; [Kumagai, Jiro] Yokohama City Minato Red Cross Hosp, Dept Pathol, Yokohama, Kanagawa, Japan; [Izumi, Miki] Tokyo Med Univ, Dept Diagnost Pathol, Tokyo 1608402, Japan	Namiki, T (reprint author), Yokohama City Minato Hosp, Dept Dermatol, Naka Ku, 3-12-1 Shin Yamashita, Yokohama, Kanagawa 2310801, Japan.	tnamderm@tmd.ac.jp					Abenoza P, 1990, NEOPLASMS ECCRINE DI, P373; Ohnishi T, 2002, AM J DERMATOPATH, V24, P409, DOI 10.1097/01.DAD.0000021433.86177.6E; Petersson F, 2009, AM J DERMATOPATH, V31, P691, DOI 10.1097/DAD.0b013e3181a5d246; Requena L, 1998, NEOPLASMS APOCRINE D, P833; Washio K, 2012, J DERMATOL, V39, P1041, DOI 10.1111/j.1346-8138.2012.01589.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1126	1127		10.1111/1346-8138.12683		2	Dermatology	Dermatology	AU7DK	WOS:000345760700026		
J	Jimura, N; Matsushita, S; Baba, N; Kubo, H; Takeda, K; Fukushige, T; Fujii, K; Kanekura, T				Jimura, Nozomi; Matsushita, Shigeto; Baba, Naoko; Kubo, Hidemichi; Takeda, Koichiro; Fukushige, Tomoko; Fujii, Kazuyasu; Kanekura, Takuro			Rare case of Langerhans cell sarcoma with cutaneous manifestation arising on the inguinal region	JOURNAL OF DERMATOLOGY			English	Letter									[Jimura, Nozomi; Matsushita, Shigeto; Baba, Naoko; Kubo, Hidemichi; Takeda, Koichiro; Fukushige, Tomoko; Fujii, Kazuyasu; Kanekura, Takuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Field Sensory Organol, Kagoshima 8908520, Japan	Jimura, N (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Field Sensory Organol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	non@m2.kufm.kagoshima-u.ac.jp					Wang YN, 2013, ACTA HAEMATOL-BASEL, V129, P114, DOI 10.1159/000342103; Jaffe ES, 2001, PATHOLOGY GENETICS T, P273; WOOD C, 1984, CANCER, V54, P347, DOI 10.1002/1097-0142(19840715)54:2<347::AID-CNCR2820540228>3.0.CO;2-J	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1127	1128		10.1111/1346-8138.12692		2	Dermatology	Dermatology	AU7DK	WOS:000345760700027		
J	Mizumoto, K; Niihara, H; Kusatake, K; Morita, E				Mizumoto, Kazuo; Niihara, Hiroyuki; Kusatake, Kenji; Morita, Eishin			Stage IV malignant melanoma successfully treated with OK-432 and percutaneous ethanol injection therapy after mass reduction surgery	JOURNAL OF DERMATOLOGY			English	Letter							SURVIVAL		[Mizumoto, Kazuo] Ohda Gen Med Educ Ctr, Dept Surg, Ohda, Shimane 6940063, Japan; [Niihara, Hiroyuki; Kusatake, Kenji; Morita, Eishin] Shimane Univ, Fac Med, Dept Dermatol, Izumo, Shimane, Japan	Mizumoto, K (reprint author), Ohda Gen Med Educ Ctr, Dept Surg, 1428-3 Yoshinaga Ohda Chou, Ohda, Shimane 6940063, Japan.	k.mizumoto@ohda-hp.ohda.shimane.jp					Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Boasberg PD, 2006, J INVEST DERMATOL, V126, P2658, DOI 10.1038/sj.jid.5700545; McDermott D, 2014, CANCER TREAT REV, V40, P1056, DOI 10.1016/j.ctrv.2014.06.012; Nakayama Juichiro, 1996, Journal of Dermatology (Tokyo), V23, P156; Umeda Masahiro, 2010, Kobe J Med Sci, V56, pE140	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1129	1130		10.1111/1346-8138.12707		2	Dermatology	Dermatology	AU7DK	WOS:000345760700028		
J	Shimizu, N; Fukai, K; Yanagihara, S; Maruyama, H; Arakawa, T; Tsuruta, D				Shimizu, Nami; Fukai, Kazuyoshi; Yanagihara, Shigeto; Maruyama, Hirotsugu; Arakawa, Tetsuo; Tsuruta, Daisuke			Percutaneous cardiopulmonary support as a possible risk factor for symmetrical peripheral gangrene of the toes	JOURNAL OF DERMATOLOGY			English	Letter									[Shimizu, Nami; Fukai, Kazuyoshi; Yanagihara, Shigeto; Tsuruta, Daisuke] Osaka City Univ, Dept Dermatol, Grad Sch Med, Osaka 5458585, Japan; [Maruyama, Hirotsugu; Arakawa, Tetsuo] Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Osaka 5458585, Japan	Fukai, K (reprint author), Osaka City Univ, Dept Dermatol, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	fukai@msic.med.osaka-cu.ac.jp					Bisdas T, 2011, ANN THORAC SURG, V92, P626, DOI 10.1016/j.athoracsur.2011.02.018; Foley PJ, 2010, J VASC SURG, V52, P850, DOI 10.1016/j.jvs.2010.05.012; Ghosh SK, 2010, J EUR ACAD DERMATOL, V24, P214, DOI 10.1111/j.1468-3083.2009.03329.x; Sharma BD, 2004, TROP DOCT, V34, P2	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1130	1131		10.1111/1346-8138.12673		2	Dermatology	Dermatology	AU7DK	WOS:000345760700029		
J	Obara, K; Maejima, H; Katayama, C; Takasu, H; Amoh, Y				Obara, Koya; Maejima, Hideki; Katayama, Chieko; Takasu, Hiroshi; Amoh, Yasuyuki			A case of symmetrical drug-related intertriginous and flexural exanthema induced by acetaminophen	JOURNAL OF DERMATOLOGY			English	Letter							ALLERGIC CONTACT-DERMATITIS; BABOON SYNDROME		[Obara, Koya; Maejima, Hideki; Katayama, Chieko; Takasu, Hiroshi; Amoh, Yasuyuki] Kitasato Univ, Sch Med, Dept Dermatol, Sagamihara, Kanagawa 2520374, Japan	Obara, K (reprint author), Kitasato Univ, Sch Med, Dept Dermatol, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	obarakoya@yahoo.co.jp					ANDERSEN KE, 1984, CONTACT DERMATITIS, V10, P97, DOI 10.1111/j.1600-0536.1984.tb00343.x; Hausermann P, 2004, CONTACT DERMATITIS, V51, P297, DOI 10.1111/j.0105-1873.2004.00445.x; Halevi A, 2000, ANN PHARMACOTHER, V34, P32; Lugovi ML, 2013, ACTA DERM-VENEREOL, V21; Tan SC, 2011, CURR OPIN ALLERGY CL, V11, P313, DOI 10.1097/ACI.0b013e3283489d5f	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1132	1133		10.1111/1346-8138.12666		2	Dermatology	Dermatology	AU7DK	WOS:000345760700030		
J	Ishikawa, M; Ohashi, T; Yamamoto, T				Ishikawa, Masato; Ohashi, Takenobu; Yamamoto, Toshiyuki			Lichen striatus following influenza infection	JOURNAL OF DERMATOLOGY			English	Letter									[Ishikawa, Masato; Ohashi, Takenobu; Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima 9601295, Japan	Ishikawa, M (reprint author), Fukushima Med Univ, Dept Dermatol, 1 Hikarigaoka, Fukushima 9601295, Japan.	ishimasa@fmu.ac.jp					Patrizi A, 2004, PEDIATR DERMATOL, V21, P197, DOI 10.1111/j.0736-8046.2004.21302.x; Karakas M, 2005, J DERMATOL, V32, P506; Hafner C, 2006, J EUR ACAD DERMATOL, V20, P1345, DOI 10.1111/j.1468-3083.2006.01691.x; Kennedy D, 1996, PEDIATR DERMATOL, V13, P95; TAIEB A, 1991, J AM ACAD DERMATOL, V25, P637, DOI 10.1016/0190-9622(91)70245-W	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1133	1134		10.1111/1346-8138.12684		2	Dermatology	Dermatology	AU7DK	WOS:000345760700031		
J	Ishii, S; Hasegawa, T; Hirasawa, Y; Tsunemi, Y; Kawashima, M; Ikeda, S				Ishii, Satoko; Hasegawa, Toshio; Hirasawa, Yusuke; Tsunemi, Yuichiro; Kawashima, Makoto; Ikeda, Shigaku			Acute generalized exanthematous pustulosis induced by oral prednisolone	JOURNAL OF DERMATOLOGY			English	Letter									[Ishii, Satoko; Hasegawa, Toshio; Hirasawa, Yusuke; Ikeda, Shigaku] Juntendo Univ, Dept Dermatol & Allergol, Grad Sch Med, Tokyo 1138421, Japan; [Tsunemi, Yuichiro; Kawashima, Makoto] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan	Hasegawa, T (reprint author), Juntendo Univ, Dept Dermatol & Allergol, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	t-hase@juntendo.ac.jp					Bircher AJ, 1995, ACTA DERM-VENEREOL, V75, P490; Demitsu T, 1996, DERMATOLOGY, V193, P56; Mussot-Chia C, 2001, ANN DERMATOL VENER, V128, P241; ROUJEAU JC, 1991, ARCH DERMATOL, V127, P1333, DOI 10.1001/archderm.127.9.1333	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1135	1136		10.1111/1346-8138.12658		2	Dermatology	Dermatology	AU7DK	WOS:000345760700032		
J	Mabuchi, T; Yamaoka, H; Kawai, M; Ota, T; Ozawa, A				Mabuchi, Tomotaka; Yamaoka, Hanako; Kawai, Mayu; Ota, Tami; Ozawa, Akira			Elevation of serum KL-6 levels during treatment with tumor necrosis factor-alpha inhibitor in patients with psoriasis	JOURNAL OF DERMATOLOGY			English	Letter							AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; JAPAN COLLEGE; SAFETY		[Mabuchi, Tomotaka; Yamaoka, Hanako; Kawai, Mayu; Ota, Tami; Ozawa, Akira] Tokai Univ, Dept Dermatol, Sch Med, Isehara, Kanagawa 2591193, Japan	Mabuchi, T (reprint author), Tokai Univ, Dept Dermatol, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	mabuchi@is.icc.u-tokai.ac.jp					Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Harigai M, 2013, MOD RHEUMATOL, V23, P284, DOI 10.1007/s10165-012-0657-2; Ishikawa Nobuhisa, 2012, Respir Investig, V50, P3, DOI 10.1016/j.resinv.2012.02.001; Takamura A, 2013, MOD RHEUMATOL, V23, P297, DOI 10.1007/s10165-012-0658-1	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	DEC	2014	41	12					1136	1137		10.1111/1346-8138.12681		2	Dermatology	Dermatology	AU7DK	WOS:000345760700033		
J	Mizuno, A; Asano, T; Niwa, K				Mizuno, Atsushi; Asano, Taku; Niwa, Koichiro			SKIN COLOR CHANGE WITH CIRCULATORY ASSIST DEVICES: SUPERIOR VENA CAVA SYNDROME	JOURNAL OF EMERGENCY MEDICINE			English	Article							CARDIOPULMONARY-RESUSCITATION; TAMPONADE		[Mizuno, Atsushi; Asano, Taku; Niwa, Koichiro] St Lukes Int Hosp, Ctr Cardiovasc, Dept Cardiol, Tokyo 1040043, Japan	Mizuno, A (reprint author), St Lukes Int Hosp, Dept Cardiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1040043, Japan.						Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Shin J, 2007, RESUSCITATION, V75, P305, DOI 10.1016/j.resuscitation.2007.05.003; CHOE YH, 1987, AM J ROENTGENOL, V149, P693; Forauer AR, 2003, J VASC INTERV RADIOL, V14, P255, DOI 10.1097/01.RVI.0000058329.82956.5c; Jansen T, 2000, CLIN EXP DERMATOL, V25, P198, DOI 10.1046/j.1365-2230.2000.00613.x; Khouzam RN, 2011, J EMERG MED, V40, P547, DOI 10.1016/j.jemermed.2009.03.018; Pierli C, 2002, INT J CARDIOL, V83, P195, DOI 10.1016/S0167-5273(02)00053-0; Spodick DH, 2003, NEW ENGL J MED, V349, P684, DOI 10.1056/NEJMra022643	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2014	47	6					E153	E155		10.1016/j.jemermed.2014.09.014		3	Emergency Medicine	Emergency Medicine	AU5EB	WOS:000345628900007		
J	Shimada, Y				Shimada, Yoshihisa			Another Back Door to the Endovascular Future: An Antegrade Pedal Approach for Retrograde Revascularization	JOURNAL OF ENDOVASCULAR THERAPY			English	Editorial Material							CRITICAL LIMB ISCHEMIA; CRITICAL LEG ISCHEMIA; INFRAPOPLITEAL ANGIOPLASTY; BYPASS-SURGERY; ARTERIAL-DISEASE; FOOT; RECANALIZATION; INTERVENTION; OCCLUSIONS; MANAGEMENT		[Shimada, Yoshihisa] Shiroyama Hosp, Ctr Cardiovasc, Habikino, Osaka, Japan	Shimada, Y (reprint author), Shiroyama Hosp, Ctr Cardiovasc, 2-8-1 Habikino, Osaka 5830872, Japan.	shimada@shiroyama-hsp.or.jp					Abdelhamid MF, 2010, EUR J VASC ENDOVASC, V39, P762, DOI 10.1016/j.ejvs.2010.01.027; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Giles KA, 2008, J VASC SURG, V48, P128, DOI 10.1016/j.jvs.2008.02.027; Rashid H, 2013, J VASC SURG, V57, P1219, DOI 10.1016/j.jvs.2012.10.129; Manzi M, 2009, J CARDIOVASC SURG, V50, P331; Montero-Baker M, 2008, J ENDOVASC THER, V15, P594, DOI 10.1583/08-2440.1; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; Iida O, 2012, J VASC SURG, V55, P363, DOI 10.1016/j.jvs.2011.08.014; Spinosa DJ, 2005, J VASC INTERV RADIOL, V16, P37, DOI 10.1097/01.RVI.0000141336.53745.4A; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Schamp KBC, 2012, ANN VASC SURG, V26, P1145, DOI 10.1016/j.avsg.2012.02.006; Botti CF, 2003, J ENDOVASC THER, V10, P614, DOI 10.1583/1545-1550(2003)010<0614:PRTAIL>2.0.CO;2; Alexandrescu V, 2011, J ENDOVASC THER, V18, P376, DOI 10.1583/10-3260.1; Lumsden AB, 2009, J ENDOVASC THER, V16, P31; Soderstrom MI, 2010, ANN SURG, V252, P765, DOI 10.1097/SLA.0b013e3181fc3c73; Rana MA, 2012, SEMIN VASC SURG, V25, P29, DOI 10.1053/j.semvascsurg.2012.03.003; Palena LM, 2012, J ENDOVASC THER, V19, P805, DOI 10.1583/JEVT-12-3998R.1; Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Palena LM, 2014, J ENDOVASC THER, V21, P775, DOI 10.1583/14-4801R.1; Shimada Y, 2012, J ENDOVASC THER, V19, P620, DOI 10.1583/JEVT-12-3927.1; Singh GD, 2014, J VASC SURG, V59, P1300, DOI 10.1016/j.jvs.2013.11.061; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; Walker SR, 1998, EUR J VASC ENDOVASC, V15, P478, DOI 10.1016/S1078-5884(98)80106-8; Zhu YQ, 2010, J ENDOVASC THER, V17, P712, DOI 10.1583/10-3207.1	25	1	1	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	DEC	2014	21	6					779	782		10.1583/14-4801C.1		4	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AW1AK	WOS:000346022500003		
J	Nishiki, I; Minami, T; Itami, T; Yoshida, T				Nishiki, I.; Minami, T.; Itami, T.; Yoshida, T.			Cloning and expression of a surface immunogenic protein in Streptococcus dysgalactiae isolated from fish and its application in enzyme-linked immunosorbent assays to diagnose S-dysgalactiae infections in fish	JOURNAL OF FISH DISEASES			English	Article						diagnosis; enzyme-linked immunosorbent assay; Streptococcus dysgalactiae; surface immunogenic protein	YELLOWTAIL SERIOLA-QUINQUERADIATA; LANCEFIELD GROUP-C; LACTOCOCCUS-GARVIEAE; ANTIBODIES; BACTERIA; IDENTIFICATION; MASTITIS; IMMUNITY; STRAINS; ALBUMIN	Lancefield group C Streptococcus dysgalactiae (GCSD) causes severe necrotic lesions in the caudal peduncle in the genus Seriola farmed in Japan. To develop a sero-diagnostic method for GCSD infection in farmed fish, we attempted to identify a surface immunogenic protein that induces an antibody after infection with GCSD by immunoblot analysis using sera collected from infected fish. A protein obtained from sodium dodecyl sulfate (SDS) extracts of GCSD was identified as S.dysgalactiae surface immunogenic protein (Sd-Sip). Sd-Sip exhibited more than 94% homology with a surface antigen or a hypothetical protein from S.dysgalactiae mammalian isolates at the nucleotide sequence level. Expression of the recombinant Sd-Sip (rSd-Sip) was confirmed by immunoblot analysis, that is, its reactivity to GCSD-infected sera. Antibody detection ELISA using rSd-Sip and their usefulness for diagnosis of GCSD infection were examined. GCSD-infected sera collected from farmed amberjack, Seriola dumerili (Risso), showed strong reaction with immobilized rSd-Sip. Meanwhile, sera immunized by other pathogenic bacteria of fish were showed ELISA values similar to those of non-infected sera. These results of this study suggest that the antibody detection ELISA using rSd-Sip is an effective diagnostic method for GCSD infection in fish.	[Nishiki, I.] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki 8892192, Japan; [Minami, T.] Miyazaki Prefectural Fisheries Expt Stn, Miyazaki, Japan; [Itami, T.; Yoshida, T.] Miyazaki Univ, Fac Agr, Miyazaki 8892192, Japan	Yoshida, T (reprint author), Miyazaki Univ, Fac Agr, Miyazaki 8892192, Japan.	t-yosh@cc.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [24580272]; Japan Society for the Promotion of Science Fellows [24009057]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (24580272) and a Grant-in-Aid from the Japan Society for the Promotion of Science Fellows (24009057).	Aarestrup FM, 1996, VET MICROBIOL, V53, P315, DOI 10.1016/S0378-1135(96)01221-7; Rato MG, 2011, J CLIN MICROBIOL, V49, P2470, DOI 10.1128/JCM.00008-11; Waage S, 1999, J DAIRY SCI, V82, P712; Hagiwara H, 2010, J COMP PATHOL, V143, P262, DOI 10.1016/j.jcpa.2010.04.005; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Manning SD, 2006, VACCINE, V24, P6905, DOI 10.1016/j.vaccine.2006.06.020; Yang WM, 2009, AQUACULTURE, V294, P14, DOI 10.1016/j.aquaculture.2009.05.018; Nomoto R, 2008, LETT APPL MICROBIOL, V46, P95, DOI 10.1111/j.1472-765X.2007.02272.x; Sidorin EV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P295, DOI 10.1134/S0006297911030023; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Abdelsalam M, 2010, FEMS MICROBIOL LETT, V302, P32, DOI 10.1111/j.1574-6968.2009.01828.x; Lancefield RC, 1933, J EXP MED, V57, P571, DOI 10.1084/jem.57.4.571; Brodeur BR, 2000, INFECT IMMUN, V68, P5610, DOI 10.1128/IAI.68.10.5610-5618.2000; David C., 2004, INFECT IMMUN, V72, P2720; EFSTRATIOU A, 1994, J MED MICROBIOL, V41, P145; GERBER MA, 1990, J CLIN MICROBIOL, V28, P413; Hagiwara H., 2009, J COMP PATHOL, V140, P35; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; JONSSON H, 1995, INFECT IMMUN, V63, P2968; JONSSON H, 1995, BBA-PROTEIN STRUCT M, V1249, P65, DOI 10.1016/0167-4838(95)00065-3; Kusuda R., 1979, NIHON SUISAN GAKKAI, V42, P1345; Matsui T, 2010, FISH PATHOL, V45, P80; Minami T., 1979, Fish Pathology, V14, P33; Nishiki I, 2011, FEMS MICROBIOL LETT, V323, P68, DOI 10.1111/j.1574-6968.2011.02360.x; Nishiki I, 2010, FISHERIES SCI, V76, P661, DOI 10.1007/s12562-010-0243-5; Nomoto R, 2004, J FISH DIS, V27, P679, DOI 10.1111/j.1365-2761.2004.00591.x; Ooyama T, 1999, DIS AQUAT ORGAN, V37, P121, DOI 10.3354/dao037121; Ooyama T, 2002, DIS AQUAT ORGAN, V51, P169, DOI 10.3354/dao051169; Shimahara Y, 2005, B EUR ASSOC FISH PAT, V25, P270; Stollerman GH, 1965, CIRCULATION, V32, P664; Talay SR, 1996, BIOCHEM J, V315, P577; Vidova B, 2009, FOLIA MICROBIOL, V54, P161, DOI 10.1007/s12223-009-0025-6	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7775	1365-2761		J FISH DIS	J. Fish Dis.	DEC	2014	37	12					1031	1039		10.1111/jfd.12180		9	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	AU6HA	WOS:000345703200005		
J	Koomyart, I; Nagamizu, H; Khuwijitjaru, P; Kobayashi, T; Shiga, H; Yoshii, H; Adachi, S				Koomyart, Intira; Nagamizu, Hironori; Khuwijitjaru, Pramote; Kobayashi, Takashi; Shiga, Hirokazu; Yoshii, Hidefumi; Adachi, Shuji			SUBCRITICAL WATER TREATMENT FOR PRODUCING SEASONING FROM SEMIDRIED ISADA KRILL	JOURNAL OF FOOD PROCESS ENGINEERING			English	Article							AMINO-ACIDS; RICE BRAN; HYDROLYSIS; VISCERA	Semidried Isada krill (Euphausia pacifica) was treated with boiling water and subcritical water at 100-240C for 10min with a semidried krill to a water ratio of 8/52 w/v to produce seasoning. The protein concentration, lipid content and odor concentration of the extract increased after increasing the treatment temperature. The highest protein content of the extract (0.047-0.049kg/kg-extract) was obtained by subcritical water treatment at 180 or 200C. Compounds with lower molecular mass were detected in the extracts derived from subcritical water treatment at temperatures higher than 160C. The extract prepared by subcritical water treatment at 160 and 180C received the high score in the flavor preference test by a group of panelists. Treatment at temperatures lower and higher than 160-180C, respectively, conferred undesirable fishy and smoky or burnt odors to the extracts and residues. Practical ApplicationAlthough Isada krill is abundant in the Sanriku coast, Japan, its usage is limited to low-value-added products such as animal and aquaculture feeds. However, we found that subcritical water treatment of the krill produces an extract solution and a solid residue, both of which possess good flavor and proffer a great prospective for use as seasoning. Establishment of a method for using the krill as a raw material for seasoning with shrimp-like flavor would increase the value of the krill as a food resource for human consumption.	[Koomyart, Intira; Nagamizu, Hironori; Kobayashi, Takashi; Adachi, Shuji] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; [Khuwijitjaru, Pramote] Silpakorn Univ, Fac Engn & Ind Technol, Dept Food Technol, Nakhon Pathom 73000, Thailand; [Shiga, Hirokazu; Yoshii, Hidefumi] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Takamatsu, Kagawa 7610795, Japan	Adachi, S (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan.	adachi@kais.kyoto-u.ac.jp	Khuwijitjaru, Pramote/B-8831-2008		Program for Revitalization Promotion, Japan Science and Technology Agency (JST)	This study was performed under the project "The Creation of Innovative Technology for Marine Products Industry" of the Program for Revitalization Promotion, Japan Science and Technology Agency (JST).	Yoshida H, 1999, BIOTECHNOL PROGR, V15, P1090, DOI 10.1021/bp9900920; Khuwijitjaru P, 2002, BIOSCI BIOTECH BIOCH, V66, P1723, DOI 10.1271/bbb.66.1723; Zhu GY, 2010, J ANAL APPL PYROL, V88, P187, DOI 10.1016/j.jaap.2010.04.005; Tou JC, 2007, NUTR REV, V65, P63, DOI 10.1301/nr.2007.feb.63-77; Plaza M, 2010, FOOD RES INT, V43, P2341, DOI 10.1016/j.foodres.2010.07.036; Pourali O, 2009, FOOD CHEM, V115, P1, DOI 10.1016/j.foodchem.2008.11.099; LOWRY OH, 1951, J BIOL CHEM, V193, P265; AOAC, 2006, OFFICIAL METHODS ANA; Ba H. V., 2012, LATEST RES QUALITY C, P145; Budzinski E., 1985, FAO FISH TECH PAP, P1; Gascon V., 2005, ANTARCTIC KRILL CASE, P30; Giogios I, 2013, MEDITERR MAR SCI, V14, P343; Goodwin T. W., 1960, PHYSL CRUSTACEA, V1, P101; Ileleji KE, 2010, J AOAC INT, V93, P825; Lamoolphak W, 2006, J HAZARD MATER, V137, P1643, DOI 10.1016/j.jhazmat.2006.05.029; Mottram D. S., 2007, FLAVOURS FRAGRANCES, P269, DOI 10.1007/978-3-540-49339-6_12; Nicol S., 1997, FAO FISH TECH PAP, P17; Nunes A. J. P., 2010, GLOB AQUAC ADVOCATE, V13, P36; SHIMIZU C, 1990, AQUACULTURE, V89, P43, DOI 10.1016/0044-8486(90)90232-C; Sweeten J. M., 1999, INT WORKSH ATM NITR; Tavakoli O, 2006, GREEN CHEM, V8, P100, DOI 10.1039/b507441j; Uddin MS, 2010, J ENVIRON BIOL, V31, P675; Wiboonsirikul J, 2007, J AGR FOOD CHEM, V55, P8759, DOI 10.1021/jf072041l	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-8876	1745-4530		J FOOD PROCESS ENG	J. Food Process Eng.	DEC	2014	37	6					567	574		10.1111/jfpe.12110		8	Engineering, Chemical; Food Science & Technology	Engineering; Food Science & Technology	AU8DB	WOS:000345825600004		
J	Friedl, M; Bergauer, T; Buchsteiner, F; Casarosa, G; Forti, F; Hara, K; Higuchi, T; Irmler, C; Itoh, R; Konno, T; Lettenbichler, J; Liu, ZA; Nakamura, KR; Nakao, M; Natkaniec, Z; Ostrowicz, W; Paoloni, E; Schluter, T; Schnell, M; Suzuki, SY; Thalmeier, R; Tsuboyama, T; Yamada, S; Yin, H				Friedl, M.; Bergauer, T.; Buchsteiner, F.; Casarosa, G.; Forti, F.; Hara, K.; Higuchi, T.; Irmler, C.; Itoh, R.; Konno, T.; Lettenbichler, J.; Liu, Z-A; Nakamura, K. R.; Nakao, M.; Natkaniec, Z.; Ostrowicz, W.; Paoloni, E.; Schlueter, T.; Schnell, M.; Suzuki, S. Y.; Thalmeier, R.; Tsuboyama, T.; Yamada, S.; Yin, H.			First results of the Belle II Silicon Vertex Detector readout system	JOURNAL OF INSTRUMENTATION			English	Article						Electronic detector readout concepts (solid-state); Particle tracking detectors (Solid-state detectors); Data acquisition concepts; Analysis and statistical methods		At the heart of the Belle II experiment at KEK (Japan), there will be a Vertex Detector (VXD) composed of 2 layers of DEPFET pixels (PXD) and 4 layers of double-sided silicon strip detectors (SVD). The latter use the APV25 front-end chip - originally developed for CMS - which is reading out the inner part of the SVD sensors through the Origami chip-on-sensor concept, including a state-of-the-art two-phase CO2 cooling. The whole system (including the full DAQ chain) was successfully tested in a beam at DESY in January 2014 and first results are presented here.	[Friedl, M.; Bergauer, T.; Buchsteiner, F.; Irmler, C.; Lettenbichler, J.; Thalmeier, R.; Yin, H.] Austrian Acad Sci, HEPHY Vienna, Inst High Energy Phys, A-1050 Vienna, Austria; [Casarosa, G.; Forti, F.; Paoloni, E.] Ist Nazl Fis Nucl, I-56127 Pisa, Italy; [Casarosa, G.; Forti, F.; Paoloni, E.] Univ Pisa, I-56127 Pisa, Italy; [Hara, K.; Itoh, R.; Nakamura, K. R.; Nakao, M.; Suzuki, S. Y.; Tsuboyama, T.; Yamada, S.] KEK, Tsukuba, Ibaraki 3050801, Japan; [Higuchi, T.] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Konno, T.] Tokyo Metropolitan Univ, Dept Phys, Tokyo 1920397, Japan; [Liu, Z-A] Inst High Energy Phys, Expt Phys Ctr, Beijing 100049, Peoples R China; [Natkaniec, Z.; Ostrowicz, W.] Inst Nucl Phys, Div Particle Phys & Astrophys, PL-31342 Krakow, Poland; [Schlueter, T.] Ludwig Maximilians Univ Munchen, Fac Phys, D-80539 Munich, Germany; [Schnell, M.] Univ Bonn, Dept Phys & Astron, D-53115 Bonn, Germany	Friedl, M (reprint author), Austrian Acad Sci, HEPHY Vienna, Inst High Energy Phys, Nikolsdorfer Gasse 18, A-1050 Vienna, Austria.	markus.friedl@oeaw.ac.at	Forti, Francesco/H-3035-2011; 	Forti, Francesco/0000-0001-6535-7965; Paoloni, Eugenio/0000-0001-5969-8712			Rummel S, 2010, NUCL INSTRUM METH A, V623, P189, DOI 10.1016/j.nima.2010.02.191; Dolezal Z., 2010, BELLE 2 TECHNICAL DE; Friedl M, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/02/C02037; Friedl M., 2011, POS; Irmler C, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/01/C01082; Nakamura K., POS TIPP 20 IN PRESS; Ohnishi Y., 2013, PROG THEOR EXP PHYS, V2013; Raymond M., 2001, HIPS PINHOLE EFFECTS; Rubinskiy I, 2012, PHYSCS PROC, V37, P923, DOI 10.1016/j.phpro.2012.02.434; French MJ, 2001, NUCL INSTRUM METH A, V466, P359, DOI 10.1016/S0168-9002(01)00589-7	10	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-0221			J INSTRUM	J. Instrum.	DEC	2014	9								C12005	10.1088/1748-0221/9/12/C12005		9	Instruments & Instrumentation	Instruments & Instrumentation	AU8PR	WOS:000345859200005		
J	Wang, JC; Rashed, S; Murakawa, H				Wang, Jiangchao; Rashed, Sherif; Murakawa, Hidekazu			FE Analysis of Buckling Behavior Caused by Welding in Thin Plates of High Tensile Strength Steel	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						high tensile strength steel; lightweight welded structure; thermal elastic plastic FEM; transient buckling; welding-induced buckling		The target of this study was to investigate buckling behavior during the entire welding process which consists of the heating and the cooling processes. For thin plate structures made of high tensile strength steel, not only residual buckling during or after cooling down but also transient buckling during heating may occur. The thermal elastic plastic FE analysis to investigate welding-induced buckling during the entire welding process is presented. Because of the high yield stress of high tensile strength steel, larger longitudinal compressive thermal stress is produced near the welding line compared with that in the case of carbon steel. Therefore, the plate may buckle due to thermal expansion, before the material nears yielding. During cooling down, the longitudinal compressive thermal stress close to the welding line disappears, and longitudinal tensile residual stress is produced due to contraction. Meanwhile, longitudinal compressive residual stress occurs far from the welding line to balance the tensile stress close to the welding line. This distribution of longitudinal residual stress would change the deformed dish shape of transient buckling into a saddle buckling type when the stress exceeds the critical buckling condition.	[Wang, Jiangchao] Carleton Univ, Dept Mech & Aerosp Engn, Ottawa, ON K1S 5B6, Canada; [Rashed, Sherif; Murakawa, Hidekazu] Osaka Univ, Joining & Welding Res Inst, Osaka, Japan	Wang, JC (reprint author), Carleton Univ, Dept Mech & Aerosp Engn, Ottawa, ON K1S 5B6, Canada.	WangJiangchaocn@gmail.com					Wang JC, 2013, J MATER PROCESS TECH, V213, P1447, DOI 10.1016/j.jmatprotec.2013.02.009; Michaleris P, 2006, SCI TECHNOL WELD JOI, V11, P707, DOI 10.1179/174329306X147724; Gossard M.L., 1952, 2771 NAT ADV COMM AE; Heldenfels R.R., 1952, 2769 NAT ADV COMM AE; Masubuchi K., 1953, P 3 JAP NAT C APPL M, P107; Michaleris P., 1996, J SHIP PRODUCTION, V12, P269; Satoh K., 1957, J JPN WELD SOC, V26, P399; Tajiama Y, 2007, T JWRI, V36, P65; Tauchert T. R., 1991, APPL MECH REV, V44, P347; Terasaki T, 1998, T JPN SOC MECH ENG A, V64, P2239; Thornton E. A., 1993, APPL MECH REV, V46, P485; Toshiharu N, 1997, T JPN SOC MECH ENG A, V63, P1063; Tsai C.L., 2006, WELD J, V85, P151; Vanli OA, 2001, J SHIP PRODUCTION, V17, P226; Verhaeghe G, 1999, PREDICTIVE FORMULAE; Wang J. C, 2011, P 21 INT SOC OC POL, P125; Watanabe M, 1958, J JAPAN WELDING SOC, V27, P313	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	DEC	2014	23	12					4358	4365		10.1007/s11665-014-1230-2		8	Materials Science, Multidisciplinary	Materials Science	AU7HQ	WOS:000345771900026		
J	Suzuki, K; Shimohira, M; Hashizume, T; Ozawa, Y; Sobue, R; Mimura, M; Mori, Y; Ijima, H; Watanabe, K; Yano, M; Yoshioka, H; Shibamoto, Y				Suzuki, Kazushi; Shimohira, Masashi; Hashizume, Takuya; Ozawa, Yoshiyuki; Sobue, Ryoji; Mimura, Mikio; Mori, Yuji; Ijima, Hidenori; Watanabe, Kenichi; Yano, Motoki; Yoshioka, Hiromu; Shibamoto, Yuta			Usefulness of CT-guided hookwire marking before video-assisted thoracoscopic surgery for small pulmonary lesions	JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY			English	Article						air embolism; CT-guided marking; hookwire; video-assisted thoracic surgery	SYSTEMIC AIR-EMBOLISM; THORACIC-SURGERY; PREOPERATIVE LOCALIZATION; SUTURE SYSTEM; NEEDLE-BIOPSY; LUNG-CANCER; NODULES; RESECTION; WIRE; GUIDANCE	Purpose: The aim of this study was to evaluate the technical and clinical efficacy and safety of CT-guided hookwire marking before video-assisted thoracoscopic surgery (VATS) for small pulmonary lesions. Materials and Methods: This procedure was performed on 161 lesions in 154 patients (75 men and 79 women; median age, 62 years; age range 23-89 years). Medical records and images were reviewed, and the technical success rate, surgical success rate and complications were evaluated. Technical success was defined as successful hookwire marking at the target site without marker dropping before VATS. Surgical success was defined as negative surgical margins on pathological examination after VATS. Results: There were 97 nodules and 64 ground-glass opacities, and their mean size was 9.8 mm (range 2-34). The technical success rate was 97.5% (157/161). In three of the four failed cases, another hookwire marker was placed, and in the remaining case, VATS was performed without a marker. The surgical success rate was 98.1% (158/161). In the three failed cases, the margin was positive, so lung lobectomy was performed in one case, and the other two cases were observed carefully. Complication rates were as follows: pneumothorax, 37.9% (61/161); focal intrapulmonary haemorrhage, 34.8% (58/139); haemoptysis, 0.6% (1/161); haemothorax, 0% (0/161); air embolism, 0.6% (1/161); dissemination, 0% (0/161); and death, 0% (0/161). Conclusion: CT-guided hookwire marking appears to be useful for VATS, but the procedure may, although rarely, cause severe complications such as air embolism.	[Suzuki, Kazushi; Shimohira, Masashi; Hashizume, Takuya; Ozawa, Yoshiyuki; Shibamoto, Yuta] Nagoya City Univ Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi 4678601, Japan; [Sobue, Ryoji; Mimura, Mikio] Japanese Red Cross Nagoya Daini Hosp, Dept Radiol, Nagoya, Aichi, Japan; [Yoshioka, Hiromu] Japanese Red Cross Nagoya Daini Hosp, Dept Thorac Surg, Nagoya, Aichi, Japan; [Mori, Yuji] Nagoya City East Med Ctr, Dept Radiol, Nagoya, Aichi, Japan; [Yano, Motoki] Nagoya City Univ Med Sch, Dept Thorac Surg, Nagoya, Aichi, Japan; [Ijima, Hidenori; Watanabe, Kenichi] Okazaki City Hosp, Dept Radiol, Okazaki, Aichi, Japan	Suzuki, K (reprint author), Nagoya City Univ Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi 4678601, Japan.	eightetudes@gmail.com					Powell TI, 2004, ANN SURG, V240, P481, DOI 10.1097/01.sla.0000137132.01881.57; Yan TD, 2009, J CLIN ONCOL, V27, P2553, DOI 10.1200/JCO.2008.18.2733; Suzuki K, 1999, CHEST, V115, P563, DOI 10.1378/chest.115.2.563; Vandoni RE, 1998, EUR J CARDIO-THORAC, V14, P265, DOI 10.1016/S1010-7940(98)00160-2; LANDRENEAU RJ, 1993, ANN THORAC SURG, V56, P1285; Watanabe K, 2006, J THORAC CARDIOV SUR, V132, P320, DOI 10.1016/j.jtcvs.2006.04.012; Ciriaco P, 2004, EUR J CARDIO-THORAC, V25, P429, DOI 10.1016/j.ejcts.2003.11.036; Chella A, 2000, EUR J CARDIO-THORAC, V18, P17, DOI 10.1016/S1010-7940(00)00411-5; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Horan TA, 2002, ANN THORAC SURG, V73, P1647, DOI 10.1016/S0003-4975(01)03371-9; Miyoshi K, 2009, EUR J CARDIO-THORAC, V36, P378, DOI 10.1016/j.ejcts.2009.03.039; Dendo S, 2002, RADIOLOGY, V225, P511, DOI 10.1148/radiol.2252011025; KANAZAWA S, 1995, CARDIOVASC INTER RAD, V18, P122, DOI 10.1007/BF02807237; Kaseda S, 2000, ANN THORAC SURG, V70, P1644, DOI 10.1016/S0003-4975(00)01909-3; Sakiyama S, 2003, J THORAC CARDIOV SUR, V126, P1207, DOI 10.1016/S0022-5223(03)00821-3; Kaneko M, 1996, RADIOLOGY, V201, P798; KERRIGAN DC, 1992, ANN THORAC SURG, V53, P163; Burdine J, 2002, CHEST, V122, P1467, DOI 10.1378/chest.122.4.1467; Eichfeld U, 2005, ANN THORAC SURG, V79, P313, DOI 10.1016/j.athoracsur.2003.10.122; Freund MC, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-2; Gonflotti A, 2007, EUR J CARDIO-THORAC, V32, P843, DOI 10.1016/j.ejcts.2007.09.002; Iguchi T, 2009, JPN J RADIOL, V27, P385, DOI 10.1007/s11604-009-0353-0; Kamiyoshihara M, 2001, J CARDIOVASC SURG, V42, P699; Karasaki Takahiro, 2009, Interact Cardiovasc Thorac Surg, V8, P316, DOI 10.1510/icvts.2008.193672; LALLI AF, 1978, RADIOLOGY, V127, P35; Oikawa T, 2008, J JPN ASS CHEST SURG, V22, P914; Santambrogio R, 1999, ANN THORAC SURG, V68, P218, DOI 10.1016/S0003-4975(99)00459-2; Sato Koichi, 2005, Jpn J Thorac Cardiovasc Surg, V53, P404; SINNER WN, 1976, ACTA RADIOL DIAGN, V17, P813; TOLLY TL, 1988, AM J ROENTGENOL, V150, P555; Yoshida Y, 2011, INTERACT CARDIOV TH, V13, P25, DOI 10.1510/icvts.2011.266932	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1754-9477	1754-9485		J MED IMAG RADIAT ON	J. Med. Imag. Radiat. Oncol.	DEC	2014	58	6					657	662		10.1111/1754-9485.12214		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU8NW	WOS:000345854100002		
J	Ohtakara, K; Hoshi, H				Ohtakara, Kazuhiro; Hoshi, Hiroaki			Target volume geometric change and/or deviation from the cranium during fractionated stereotactic radiotherapy for brain metastases: Potential pitfalls in image guidance based on bony anatomy alignment	JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY			English	Article						brain metastases; fractionated stereotactic radiotherapy; image guidance; internal change; treatment uncertainty	RADIATION-THERAPY; RADIOSURGERY; TUMORS; RADIONECROSIS; IRRADIATION; RESECTION; DYNAMICS; SURFACE; SINGLE	Introduction: This study sought to evaluate the potential geometrical change and/or displacement of the target relative to the cranium during fractionated stereotactic radiotherapy (FSRT) for treating newly developed brain metastases. Methods: For 16 patients with 21 lesions treated with image-guided frameless FSRT in 5 or 10 fractions using a 6-degree-of-freedom image guidance system-integrated platform, the unenhanced computed tomography or T2-weighted magnetic resonance images acquired until the completion of FSRT were fused to the planning image datasets for comparison. Significant change was defined as >= 3-mm change in the tumour diameter or displacement of the tumour centroid. Results: FSRT was started 1 day after planning image acquisition. Tumour shrinkage, deviation and both were observed in 2, 1 and 1 of the 21 lesions, respectively, over a period of 7-13 days. Tumour shrinkage or deviation resulted in an increase or decrease in the marginal dose to the tumour, respectively, and a substantial increase in the irradiated volume for the surrounding tissue irrespective of the pattern of alteration. No obvious differences in the clinical and treatment characteristics were noted among the populations with or without significant changes in tumour volume or position. Conclusion: Target deformity and/or deviation can unexpectedly occur even during relatively short-course FSRT, inevitably leading to a gradual discrepancy between the planned and actually delivered doses to the tumour and surrounding tissue. To appropriately weigh the treatment outcome against the planned dose distribution, target deformity and/or deviation should also be considered in addition to the immobilisation accuracy, as image guidance with bony anatomy alignment does not necessarily guarantee accurate target localisation until completion of FSRT.	[Ohtakara, Kazuhiro; Hoshi, Hiroaki] Gifu Univ Grad Sch Med, Dept Radiol, Gifu 5011194, Japan; [Ohtakara, Kazuhiro] Gifu Univ Hosp, Div Radiat Oncol, Gifu, Japan	Ohtakara, K (reprint author), Gifu Univ Grad Sch Med, Dept Radiol, 1-1 Yanagido, Gifu 5011194, Japan.	ohtakara@gifu-u.ac.jp			Japanese Society for Promotion of Science (JSPS) KAKENHI	This study was supported in part by grants-in-aid from the Japanese Society for Promotion of Science (JSPS) KAKENHI. The authors are grateful to Dr Noriyuki Nakayama, Dr Naoyuki Ohe, Dr Hirohito Yano, Mr Katsuya Matsuyama, Mr Masashi Kitahara and Mr Kimihiro Kajita for their valuable support.	Inoue HK, 2014, J RADIAT RES, V55, P334, DOI 10.1093/jrr/rrt127; Higuchi Y, 2009, INT J RADIAT ONCOL, V74, P1543, DOI 10.1016/j.ijrobp.2008.10.035; Ohtakara K, 2012, J NEURO-ONCOL, V108, P201, DOI 10.1007/s11060-012-0834-3; Beltran C, 2010, RADIOTHER ONCOL, V97, P399, DOI 10.1016/j.radonc.2010.10.017; Wiggenraad R, 2011, RADIOTHER ONCOL, V98, P292, DOI 10.1016/j.radonc.2011.01.011; Shibamoto Y, 2012, CANCER-AM CANCER SOC, V118, P2078, DOI 10.1002/cncr.26470; Sharpton SR, 2014, NEUROSURGERY, V74, P9, DOI 10.1227/NEU.0000000000000190; Atalar B, 2013, NEUROSURGERY, V72, P180, DOI 10.1227/NEU.0b013e31827b99f3; Ernst-Stecken A, 2006, RADIOTHER ONCOL, V81, P18, DOI 10.1016/j.radonc.2006.08.024; Igaki H, 2009, ACTA ONCOL, V48, P314, DOI 10.1080/02841860802310983; Jarvis LA, 2012, INT J RADIAT ONCOL, V84, P943, DOI 10.1016/j.ijrobp.2012.01.067; Kosaki K, 2012, CANCER SCI, V103, P1967, DOI 10.1111/j.1349-7006.2012.02392.x; Minniti G, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-48; Ohtakara K, 2012, RADIOTHER ONCOL, V102, P198, DOI 10.1016/j.radonc.2011.10.012; Ohtakara K, 2012, BRIT J RADIOL, V85, pE640, DOI 10.1259/bjr/21015703; Ohtakara K, 2012, J CANCER RES CLIN, V138, P1511, DOI 10.1007/s00432-012-1225-z; Ohtakara K, 2012, BRIT J RADIOL, V85, P69, DOI 10.1259/bjr/20905396; Ohtakara K, 2011, J RADIAT RES, V52, P592, DOI 10.1269/jrr.11005; Oku Yohei, 2012, Pract Radiat Oncol, V2, P46, DOI 10.1016/j.prro.2011.06.001; Rodrigues G, 2012, RADIOTHER ONCOL, V102, P180, DOI 10.1016/j.radonc.2011.05.032; Yomo S, 2012, J NEURO-ONCOL, V109, P159, DOI 10.1007/s11060-012-0882-8	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1754-9477	1754-9485		J MED IMAG RADIAT ON	J. Med. Imag. Radiat. Oncol.	DEC	2014	58	6					729	736		10.1111/1754-9485.12194		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU8NW	WOS:000345854100014		
J	Zhang, SS; Wang, T; Lou, L; Tsang, WM; Sawada, R; Kwong, DL; Lee, CK				Zhang, Songsong; Wang, Tao; Lou, Liang; Tsang, Wei Mong; Sawada, Renshi; Kwong, Dim-Lee; Lee, Chengkuo			Annularly Grooved Diaphragm Pressure Sensor With Embedded Silicon Nanowires for Low Pressure Application	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						Piezoresistance; silicon nanowires (SiNWs); pressure sensor; annular groove; low pressure; biomedical	P-TYPE SILICON; 1ST-ORDER PIEZORESISTANCE COEFFICIENTS; MECHANICAL SENSORS; BOSSED DIAPHRAGMS; DIFFUSED LAYERS; DEVICE; NONLINEARITY; SENSITIVITY; DEFORMATION; FABRICATION	We present a nanoelectromechanical system piezoresistive pressure sensor with annular grooves on the circular diaphragm where silicon nanowires (SiNWs) are embedded as sensing elements around the edge. In comparison with our previous flat diaphragm pressure sensor, this new diaphragm structure enhances the device sensitivity by 2.5 times under pressure range of 0-120 mmHg. By leveraging SiNWs as piezoresistors, this improvement is even remarkable in contrast to other recently reported piezoresistive pressure sensing devices. In addition, with the miniaturized sensing diaphragm (radius of 100 mu m), the sensor can be potentially used as implantable device for low-pressure sensing applications.	[Zhang, Songsong; Wang, Tao; Lee, Chengkuo] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117576, Singapore; [Zhang, Songsong; Lou, Liang; Tsang, Wei Mong; Kwong, Dim-Lee] Agcy Sci Technol & Res, Inst Microelect, Singapore 117685, Singapore; [Sawada, Renshi] Kyushu Univ, Dept Mech Engn, Fukuoka 8190395, Japan	Zhang, SS (reprint author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117576, Singapore.	elezss79@gmail.com; elelc@nus.edu.sg; llnusback1023@gmail.com			Science and Engineering Research Council (SERC), Agency for Science, Technology, and Research [1021710159, 1220103064]	This work was supported by the Science and Engineering Research Council (SERC), Agency for Science, Technology, and Research under Grant 1021710159 and Grant 1220103064. Subject Editor A. J. Ricco.	Toriyama T, 2002, J MICROELECTROMECH S, V11, P605, DOI 10.1109/JMEMS.2002.802905; PETERSEN KE, 1982, P IEEE, V70, P420, DOI 10.1109/PROC.1982.12331; TUFTE ON, 1963, J APPL PHYS, V34, P313, DOI 10.1063/1.1702605; Milne JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.226802; Yoshikawa G, 2011, NANO LETT, V11, P1044, DOI 10.1021/nl103901a; Kim KH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/3/035022; Barlian AA, 2009, P IEEE, V97, P513, DOI 10.1109/JPROC.2009.2013612; SMITH CS, 1954, PHYS REV, V94, P42, DOI 10.1103/PhysRev.94.42; Soree B, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3669509; Richter J, 2008, J APPL PHYS, V104, DOI 10.1063/1.2960335; Zhang Y, 2011, J MICROELECTROMECH S, V20, P959, DOI 10.1109/JMEMS.2011.2153825; HERRING C, 1956, PHYS REV, V101, P944, DOI 10.1103/PhysRev.101.944; Xiang J, 2006, NATURE, V441, P489, DOI 10.1038/nature04796; LENKKERI JT, 1986, PHYS STATUS SOLIDI B, V136, P373, DOI 10.1002/pssb.2221360141; Soree B, 2010, ECS TRANSACTIONS, V28, P15, DOI 10.1149/1.3367932; CLARK SK, 1979, IEEE T ELECTRON DEV, V26, P1887, DOI 10.1109/T-ED.1979.19792; TUFTE ON, 1962, J APPL PHYS, V33, P3322, DOI 10.1063/1.1931164; Lou L, 2011, IEEE ELECTR DEVICE L, V32, P1764, DOI 10.1109/LED.2011.2169931; He RR, 2006, NAT NANOTECHNOL, V1, P42, DOI 10.1038/nnano.2006.53; KANDA Y, 1991, SENSOR ACTUAT A-PHYS, V28, P83, DOI 10.1016/0924-4247(91)85017-I; JOHNSON RH, 1992, SENSOR ACTUAT A-PHYS, V35, P93, DOI 10.1016/0924-4247(92)80146-T; Toriyama T, 2002, J MICROELECTROMECH S, V11, P598, DOI 10.1109/JMEMS.2002.802904; Kang TK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704564; Koumela A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/39/395701; Hu CF, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/11/115012; Richter J, 2005, SENSOR ACTUAT A-PHYS, V123-24, P388, DOI 10.1016/j.sna.2005.02.038; Lin LW, 1998, MECHATRONICS, V8, P505, DOI 10.1016/S0957-4158(98)00012-9; Tsuchiya T, 2012, J MICROELECTROMECH S, V21, P523, DOI 10.1109/JMEMS.2011.2182503; Tong HD, 2009, NANO LETT, V9, P1015, DOI 10.1021/nl803181x; Kozlovskiy SI, 2007, SENSOR ACTUAT A-PHYS, V133, P72, DOI 10.1016/j.sna.2006.03.009; PIKUS GE, 1960, SOV PHYS-SOL STATE, V1, P1502; MORIN FJ, 1957, PHYS REV, V105, P525, DOI 10.1103/PhysRev.105.525; Bae B., 2005, P 3 ANN INT IEEE EMB, P126; BAO MH, 1991, SENSOR ACTUAT A-PHYS, V28, P105, DOI 10.1016/0924-4247(91)85019-K; Beeby Stephen, 2004, MEMS ELECTROMECHANIC, V2nd; Carrillo-Nunez H, 2013, J APPL PHYS, V113, DOI 10.1063/1.4803715; Chiou A. J., 2008, SENSOR ACTUAT A-PHYS, V147, P332; Ginet P, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/6/065008; Hsieh HS, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/10/105006; Ikehara T, 2012, J MICROELECTROMECH S, V21, P830, DOI 10.1109/JMEMS.2012.2194771; Jiachou Wang, 2012, Journal of Microelectromechanical Systems, V21, DOI 10.1109/JMEMS.2011.2178117; KANDA Y, 1982, IEEE T ELECTRON DEV, V29, P64, DOI 10.1109/T-ED.1982.20659; Kozlovskiy SI, 2005, SENSOR ACTUAT A-PHYS, V118, P33, DOI 10.1016/j.sna.2004.07.003; Krieger W., 1970, THEORY PLATES SHELLS; Liang Lou, 2012, IEEE Transactions on Electron Devices, V59, DOI 10.1109/TED.2012.2214440; Liu JD, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/3/035020; Liwei Lin, 1999, Journal of Microelectromechanical Systems, V8, DOI 10.1109/84.809067; Lou L, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/5/055012; MALLON JR, 1990, SENSOR ACTUAT A-PHYS, V21, P89, DOI 10.1016/0924-4247(90)85018-Y; Marco S, 1996, MEAS SCI TECHNOL, V7, P1195, DOI 10.1088/0957-0233/7/9/002; MARCO S, 1993, SENSOR ACTUAT A-PHYS, V37-8, P790, DOI 10.1016/0924-4247(93)80133-2; MATSUDA K, 1990, SENSOR ACTUAT A-PHYS, V21, P45, DOI 10.1016/0924-4247(90)85008-R; Melvas P, 2003, IEEE T ELECTRON DEV, V50, P503, DOI 10.1109/TED.2003.809026; Min-Hang Bao, 1990, Sensors and Actuators A (Physical), VA21; Park WT, 2013, MICROSYST TECHNOL, V19, P1005, DOI 10.1007/s00542-012-1691-x; Qian Y., 2012, APPL PHYS LETT, V100; Roper CS, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/22/225303; SANDMAIER H, 1991, SENSOR ACTUAT A-PHYS, V27, P815, DOI 10.1016/0924-4247(91)87092-H; SHIMAZOE M, 1982, SENSOR ACTUATOR, V2, P275, DOI 10.1016/0250-6874(81)80047-9; Tymon Barwicz L. K., 2010, APPL PHYS LETT, V97; Van Thanh D., 2013, J MICROMECH MICROENG, V23; Wang QA, 2011, J MICROELECTROMECH S, V20, P42, DOI 10.1109/JMEMS.2010.2100031; Wu Z., 1779, P 17 INT C SOL STAT; YAMADA K, 1982, IEEE T ELECTRON DEV, V29, P71, DOI 10.1109/T-ED.1982.20660; YASUKAWA A, 1989, IEEE T ELECTRON DEV, V36, P1295, DOI 10.1109/16.30935; Yu X, 2013, SMALL, V9, P525, DOI 10.1002/smll.201201599; Zhang SS, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/9/095008; Zhang S., 2012, APPL PHYS LETT, V100	68	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	DEC	2014	23	6					1396	1407		10.1109/JMEMS.2014.2313635		12	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	AU8MS	WOS:000345851100017		
J	Kusaka, Y; Miyashita, K; Ushijima, H				Kusaka, Yasuyuki; Miyashita, Kaori; Ushijima, Hirobumi			Extending microcontact printing for patterning of thick polymer layers: semi-drying of inks and contact mechanisms	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						microcontact printing; resist patterning; semi-drying; AFM; contact mechanics; micromechanics; etching	SURFACES; SIMULATION; RESISTANCE; DEVICES; SYSTEMS; STAMPS	We investigate the applicability of the microcontact printing technique for the patterning of polymeric etch-resistant layers with thicknesses in the order of micrometers. In contrast to small molecular materials such as thiols and silane coupling agents typically used in microcontact printing, the patterning of thick layers requires tuning of the rheological properties of an ink film to prevent pattern deformation and attain high-quality transfer. By evaluating the swelling rate of a microcontact stamp material (i.e. poly(dimethylsiloxane) (PDMS)) and the evaporation rate of solvents, we find an optimal ink formulation to attain the desired semi-dried state for the printing of polymer layers. In polymer films with solid content below the optimal limit, split-or wrinkle-type deformations were found depending on the adhesion force and deformability of ink films, while overly-dried polymer films failed to be transferred. These phenomena are in qualitative agreement with deformation curves obtained from colloidal probe microscopy measurements that successfully revealed the deformability and adhesion of semi-dried polymer films. Further investigation of the effects of stamp stiffness on pattern formation reveals that a pattern region in which the thickness profile has a small curvature radius failed to be transferred when a stiffer PDMS stamp was used. This type of defect is thought to be caused by incomplete contact between the film and substrate due to a semi-circular cap structure of the polymer film and insufficient deformation of the stamp. Herein, a detailed contacting mechanism for high-quality patterning is discussed on the basis of the Hertz contact model. Using the developed etch-resistant ink and optimized printing process conditions, a finely defined etched structure for a silicon substrate is obtained.	[Kusaka, Yasuyuki; Ushijima, Hirobumi] Natl Inst Adv Ind Sci & Technol, Flexible Elect Res Ctr, Tsukuba, Ibaraki 3058565, Japan; [Miyashita, Kaori] Nagano Keiki Co Ltd, Thin Film Proc Engn Dept, Ueda, Nagano 3860412, Japan	Kusaka, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Flexible Elect Res Ctr, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	y-kusaka@aist.go.jp			Japan Society for the Promotion of Science [26889075]	This research was financially supported in part by Grant-in-Aid for Research Activity Start-up, Japan Society for the Promotion of Science (Project No. 26889075). The authors gratefully acknowledge the technical assistance of Mariko Fujita.	Diaz E, 2013, LANGMUIR, V29, P12608, DOI 10.1021/la402101d; Huang WX, 2008, INT J HEAT FLUID FL, V29, P1436, DOI 10.1016/j.ijheatfluidflow.2008.07.002; ZOSEL A, 1985, COLLOID POLYM SCI, V263, P541, DOI 10.1007/BF01421887; Kaufmann T, 2010, POLYM CHEM-UK, V1, P371, DOI 10.1039/b9py00281b; Matsui H, 2012, LANGMUIR, V28, P15450, DOI 10.1021/la303717n; Kim L, 2008, NANO LETT, V8, P4513, DOI 10.1021/nl8025218; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Adams GG, 2000, TRIBOL INT, V33, P431, DOI 10.1016/S0301-679X(00)00063-3; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030; Chang CJ, 2013, J APPL POLYM SCI, V130, P2049, DOI 10.1002/app.39396; Hambsch M, 2010, MATER SCI ENG B-ADV, V170, P93, DOI 10.1016/j.mseb.2010.02.035; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Santhanam V, 2004, NANO LETT, V4, P41, DOI 10.1021/nl034851r; Kusaka Y, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035020; Yan X, 2004, J AM CHEM SOC, V126, P10510, DOI 10.1021/ja0479078; Pudas M, 2005, PROG ORG COAT, V54, P310, DOI 10.1016/j.porgcoat.2005.07.008; Hidber PC, 1996, LANGMUIR, V12, P1375, DOI 10.1021/la9507500; Kim M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4755878; Menard E, 2007, CHEM REV, V107, P1117, DOI 10.1021/cr050139y; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; Bietsch A, 2000, J APPL PHYS, V88, P4310, DOI 10.1063/1.1289816; Ghadiri F, 2011, INT J HEAT FLUID FL, V32, P308, DOI 10.1016/j.ijheatfluidflow.2010.09.004; Kina O, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.01AB07; Kusaka Y, 2013, SOFT MATTER, V9, P3155, DOI 10.1039/c2sm27486h; Kusaka Y, 2010, ENVIRON SCI TECHNOL, V44, P9413, DOI 10.1021/es1026689; Masaki T, 1985, Japanese Patent, Patent No. 1303507; Miller SM, 2002, J VAC SCI TECHNOL B, V20, P2320, DOI 10.1116/1.1520554; Mujumdar A. S., 2006, HDB IND DRYING; Rentzhog M, 2006, PROG ORG COAT, V57, P183, DOI 10.1016/j.porgcoat.2006.08.003; Swei J, 2003, J APPL POLYM SCI, V90, P1153, DOI 10.1002/app.12799	31	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	DEC	2014	24	12							125019	10.1088/0960-1317/24/12/125019		10	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	AU8CO	WOS:000345824400019		
J	Pal, P; Gosalvez, MA; Sato, K; Hida, H; Xing, Y				Pal, Prem; Gosalvez, Miguel A.; Sato, Kazuo; Hida, H.; Xing, Yan			Anisotropic etching on Si{110}: experiment and simulation for the formation of microstructures with convex corners	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						anisotropic wet chemical etching; bulk micromachining; silicon; {110}; corner compensation; TMAH; continuous cellular automaton	CELLULAR-AUTOMATON; 110 SILICON; COMPENSATION STRUCTURES; FABRICATION; DEEP; WAFERS; KOH	We combine experiment, theory and simulation to design and fabricate 3D structures with protected edges and corners on Si{1 1 0} using anisotropic wet chemical etching in 25 wt% tetramethylammonium hydroxide (TMAH) at 71 degrees C. In order to protect the convex corners formed by <1 1 2 > and <1 1 0> directions, two methods are considered, namely, corner compensation and two-step etching. The mask design methodology for corner compensation is explained for various microstructures whose edges are aligned along different directions. The detailed geometry of each compensation pattern is shown to depend on the desired etch depth. The two-step wet etching process is explored in order to realize improved sharp convex corners. Using the same etchant concentration and temperature, the second etching is carried out after mask inversion from silicon nitride (Si3N4) to silicon dioxide (SiO2), obtained by local oxidation of silicon (LOCOS) followed by nitride etching. Based on the use of the continuous cellular automaton (CCA), the simulation results for both corner undercutting and two-step etching show that the CCA is suitable for the analysis and prediction of anisotropic etching on Si{1 1 0} wafers.	[Pal, Prem] Indian Inst Technol, Dept Phys, MEMS & Micronano Syst Lab, Hyderabad, Andhra Pradesh, India; [Gosalvez, Miguel A.] Univ Basque Country, UPV EHU, Dept Mat Phys, San Sebastian 20018, Spain; [Gosalvez, Miguel A.] Univ Basque Country, Ctr Mixto CSIC, Ctr Fis Mat, San Sebastian 20018, Spain; [Gosalvez, Miguel A.] DIPC, San Sebastian 20018, Spain; [Sato, Kazuo] Aichi Inst Technol, Dept Mech Engn, Aichi, Japan; [Hida, H.] Kobe Univ, Dept Engn, Machine Dynam Lab, Kobe, Hyogo, Japan; [Xing, Yan] Southeast Univ, Dept Mech Engn, Lab Micronano Med Devices, Nanjing, Jiangsu, Peoples R China	Pal, P (reprint author), Indian Inst Technol, Dept Phys, MEMS & Micronano Syst Lab, Hyderabad, Andhra Pradesh, India.	prem@iith.ac.in	DONOSTIA INTERNATIONAL PHYSICS CTR., DIPC/C-3171-2014; Hida, Hirotaka/J-2100-2014; Gosalvez, Miguel/H-1054-2012	Hida, Hirotaka/0000-0002-4749-1893; 	Department of Science and Technology, India [SR/S3/MERC/072/2011]; Ramon y Cajal Fellowship Program by the Spanish Ministry of Science and Innovation; Japan Society for the Promotion of Science (JSPS) [L14538]; NSFC, China [51375093 NSFC]	We acknowledge support by a research grant from the Department of Science and Technology (Project No. SR/S3/MERC/072/2011), India, the Ramon y Cajal Fellowship Program by the Spanish Ministry of Science and Innovation, the Japan Society for the Promotion of Science (JSPS, Fellowship ID No. L14538), and a research grant from NSFC (No. 51375093 NSFC), China. We thank Markku Tilli (Okmetic, Finland) for generously providing silicon nitride deposited wafers, and IntelliSense Software Corporation for generously providing the IntelliEtch wet etching simulator.	Ferrando N, 2011, COMPUT PHYS COMMUN, V182, P628, DOI 10.1016/j.cpc.2010.11.004; Mukhiya R, 2011, MICROELECTRON J, V42, P127, DOI 10.1016/j.mejo.2010.08.018; Zhu ZJ, 2000, J MICROELECTROMECH S, V9, P252; Ahn M, 2007, J VAC SCI TECHNOL B, V25, P2593, DOI 10.1116/1.2779048; Gosalvez MA, 2008, J MICROELECTROMECH S, V17, P410, DOI 10.1109/JMEMS.2008.916339; Lipson A, 2007, J MICROELECTROMECH S, V16, P521, DOI 10.1109/JMEMS.2007.892894; Pal P, 2009, SENSOR ACTUAT A-PHYS, V154, P192, DOI 10.1016/j.sna.2008.09.002; KENDALL DL, 1979, ANNU REV MATER SCI, V9, P373, DOI 10.1146/annurev.ms.09.080179.002105; Haneveld J, 2003, J MICROMECH MICROENG, V13, pS62, DOI 10.1088/0960-1317/13/4/310; [Anonymous], 2002, J MICROMECH MICROENG; Dwivedi VK, 2000, MICROELECTR J, V31, P405, DOI 10.1016/S0026-2692(00)00015-X; Apanius M, 2007, SENSOR ACTUAT A-PHYS, V140, P168, DOI 10.1016/j.sna.2007.06.028; Asaumi K, 1997, PROC IEEE MICR ELECT, P412, DOI 10.1109/MEMSYS.1997.581877; Chang WH, 2005, MICROSYST TECHNOL, V11, P117, DOI [10.1007/S00542-004-0456-6, 10.1007/s00542-004-0456-6]; Dong W, 2004, MICROELECTRON J, V35, P417, DOI 10.1016/j.mejo.2004.01.005; Dong W, 2002, P SOC PHOTO-OPT INS, V4928, P103, DOI 10.1117/12.483156; Ferrando N, 2012, J MICROMECH MICROENG; Fruhauf J., 1993, Journal of Micromechanics and Microengineering, V3, DOI 10.1088/0960-1317/3/3/004; Giousouf M, 1999, SENSOR ACTUAT A-PHYS, V76, P416, DOI 10.1016/S0924-4247(99)00066-7; Gosalvez MA, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/6/065017; Gosalvez MA, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/12/125007; Gosalvez MA, 2009, SENSOR ACTUAT A-PHYS, V155, P98, DOI 10.1016/j.sna.2009.08.012; Holke A, 1999, J MICROMECH MICROENG, V9, P51, DOI 10.1088/0960-1317/9/1/306; James TD, 2006, J MICROMECH MICROENG, V16, P2177, DOI 10.1088/0960-1317/16/10/034; Kalesar E S, 1989, CHEM MATER, V1, P634; Kummamuru RK, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/9/095027; Lee D, 2009, J MICROELECTROMECH S, V18, P217, DOI 10.1109/JMEMS.2008.2009840; Montoliu C, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/7/075017; Montoliu C, 2013, COMPUT PHYS COMMUN, V184, P2299, DOI 10.1016/j.cpc.2013.05.016; Pal P, 2007, J MICROMECH MICROENG, V17, pR1; Pal P, 2013, ENGINEERING, V5, P1; Pal P, 2013, MICRONANOSYST LETT, V1, P1; PUERS B, 1990, SENSOR ACTUAT A-PHYS, V23, P1036, DOI 10.1016/0924-4247(90)87085-W; Radjenovic B, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388860; Radjenovic B, 2010, SENSORS-BASEL, V10, P4950, DOI 10.3390/s100504950; Smiljanic MM, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/11/115011; Tolmachev VA, 2002, SEMICONDUCTORS+, V36, P932, DOI 10.1134/1.1500475; Wacogne B, 2006, SENSOR ACTUAT A-PHYS, V126, P264, DOI 10.1016/j.sna.2005.09.014; Xing Y, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/436; Yu J C, 2011, SYMP ON DESIGN TEST, P197; Zhou ZF, 2007, J MICROMECH MICROENG, V17, pS38, DOI 10.1088/0960-1317/17/4/S03; Zhou ZF, 2009, J ELECTROCHEM SOC, V156, pF29, DOI 10.1149/1.3031485; Zubel I, 2009, J MICROMECH MICROENG, V15, P485	43	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	DEC	2014	24	12							125001	10.1088/0960-1317/24/12/125001		12	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	AU8CO	WOS:000345824400001		
J	Kondo, H; Nakamura, T; Tanaka, S				Kondo, hirotaka; Nakamura, Takashi; Tanaka, Shigenori			A significant role of Arg41 residue in the enzymatic reaction of haloacid dehalogenase L-DEX YL studied by QM/MM method	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Enzymatic reaction; 2-Haloacid dehalogenase; L-2-Chloropropionic acid; ONIOM method; Transition state	PSEUDOMONAS SP YL; L-2-HALO ACID DEHALOGENASE; MOLECULAR-ORBITAL METHODS; CATALYTIC MECHANISM; FLUOROACETATE DEHALOGENASE; HALOALKANE DEHALOGENASE; REACTION INTERMEDIATE; SEMIEMPIRICAL METHODS; CRYSTAL-STRUCTURES; ORGANIC-MOLECULES	L-2-Haloacid dehalogenase (L-DEX) is one of a family of enzymes that decompose a variety of environmental pollutants such as L-2-chloropropionate (L-2-CPA). This enzyme specifically produces a D-2-hydroxy acid from a L-2-haloacid, and, to date, some residues have been suggested as important in this enzymatic reaction. Here, quantum-mechanical (QM)/molecular-mechanical (MM) calculations for the L-DEX from Pseudomonas sp. YL (L-DEX YL) 2-CPA complex were performed to elucidate the structure of transition state and the energy profile in this enzymatic reaction. QM/MM simulations using the ONIOM (PM3:Amber) method revealed that the activation energy of dehalogenation reaction was around 9.0 kcal/mol and that one of the most important residues in the ester intermediate formation step was Arg41, which was found to decrease the activation energy by about 40 kcal/mol compared to the case of its absence. On the other hand, this stabilization effect by Arg41 was significantly counterbalanced by the presence of Asnl 77. Simulations of enzymes mutated at Arg41 indicated that mutants possessing a positive charge near the Arg41 position would allow the dehalogenation reaction as well. Specifically, it was suggested by our simulations that homolysine (homK) mutant of Arg41, which contains one more methylene group in the side chain compared to lysine, could be active as well as the wild-type enzyme. The distance from the chloride ion to the position of the positive charge of the acceptor seems to dictate the activation energy. (C) 2014 Elsevier B.V. All rights reserved.	[Kondo, hirotaka] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 6578501, Japan; [Nakamura, Takashi] Nagahama Inst Biosci & Technol, Nagahama, Shiga 5260829, Japan; [Tanaka, Shigenori] Kobe Univ, Grad Sch Informat Syst, Nada Ku, Kobe, Hyogo 6578501, Japan	Kondo, H (reprint author), Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	kondo@eniac.scitec.kobe-u.ac.jp; t_nakamura@nagahama-i-bio.ac.jp; tanaka2@kobe-u.ac.jp					ANDERS E, 1993, J COMPUT CHEM, V14, P1301, DOI 10.1002/jcc.540141106; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Kamachi T, 2009, CHEM-EUR J, V15, P7394, DOI 10.1002/chem.200801813; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; [Anonymous], MOE VER 2006 08; Nakayama T, 2012, CHEM-EUR J, V18, P8392, DOI 10.1002/chem.201103369; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Case D. A., 2012, AMBER12; Case D.A., 2004, AMBER 8; Damborsky J, 1997, J CHEM INF COMP SCI, V37, P562, DOI 10.1021/ci960483j; Dapprich S., 1999, J MOL STRUC-THEOCHEM, V462, P1, DOI DOI 10.1016/S0166-1280(98)00475-8; Dennington R., 2009, GAUSSVIEW VERSION 5; Edelsbrunner H., 1995, P 28 HAW INT C SYST, P256; Frisch M. J., 2009, GAUSSIAN 09 REVISION; FUKUI K, 1970, J PHYS CHEM-US, V74, P4161, DOI 10.1021/j100717a029; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HASAN AKMQ, 1994, BIOSCI BIOTECH BIOCH, V58, P1599; Hisano T, 1996, J BIOL CHEM, V271, P20322; Ichiyama S, 2000, J BIOL CHEM, V275, P40804, DOI 10.1074/jbc.M008065200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KURIHARA T, 1995, J BIOCHEM-TOKYO, V117, P1317; Kurihara T, 2011, BIOSCI BIOTECH BIOCH, V75, P189, DOI 10.1271/bbb.100746; Kuty M, 1998, J CHEM INF COMP SCI, V38, P736, DOI 10.1021/ci970290b; Li YF, 2003, J MOL CATAL B-ENZYM, V23, P337, DOI 10.1016/S1381-1177(03)00097-3; Li YF, 1998, J BIOCHEM-TOKYO, V124, P20; Li YF, 1998, J BIOL CHEM, V273, P15035, DOI 10.1074/jbc.273.24.15035; LIU JQ, 1994, J BIOCHEM-TOKYO, V116, P248; LIU JQ, 1994, APPL ENVIRON MICROB, V60, P2389; LIU JQ, 1995, J BIOL CHEM, V270, P18309; Liu JQ, 1997, J BIOL CHEM, V272, P3363; Nakamura T, 2009, J COMPUT CHEM, V30, P2625, DOI 10.1002/jcc.21273; O'Hagan D, 2010, NAT PROD REP, V27, P900, DOI 10.1039/b919371p; Schmidberger JW, 2007, J MOL BIOL, V368, P706, DOI 10.1016/j.jmb.2007.02.015	46	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	DEC	2014	110						23	31		10.1016/j.molcatb.2014.09.006		9	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	AU5LM	WOS:000345648500004		
J	Nonaka, H; Hideno, A				Nonaka, Hiroshi; Hideno, Akihiro			Quantification of cellulase adsorbed on saccharification residue without the use of colorimetric protein assays	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Cellulase; Enzymatic saccharification; Adsorption; Elemental analysis; Colorimetric protein assay	TRICHODERMA-REESEI; ADSORPTION; LIGNIN; HYDROLYSIS; SOFTWOOD; ENZYMES; BINDING; BIOMASS; SOLIDS; ACID	Adsorption of cellulase onto the saccharification residues of lignocellulose, especially onto lignin, is unproductive and poses a significant problem for recycling of the enzyme. We developed a direct method to quantify residue-adsorbed cellulase by elemental analysis without use of calorimetric methods such as the Bradford, BCA, or Lowry assays. First, initial cellulase loading was estimated from the absorbance at 280 nm using the weight adsorption coefficient of cellobiohydrolase I (CBHI), predicted using the amino acid sequence. Secondly, small amounts of nitrogen derived from adsorbed cellulase were detected using an elemental analyzer by analyzing various large quantities of residue. The nitrogen content of the Trichoderma reesei cellulolytic enzymes was calculated to be 16.5-17.3% based on the amino acid sequences, and the quantity of residue-adsorbed cellulase was calculated from the nitrogen content of the residue, using the nitrogen content of CBHI (16.5%). For example, following enzymatic saccharification of ball-milled softwood for 72 h with Accellerase 1500 (25 filter paper units/g substrate), it was possible to estimate that 18-28 mg cellulase/g of residue was adsorbed onto the residues, indicating that 19-28% of the initially added cellulase would be difficult to recover because of adsorption. (C) 2014 Elsevier B.V. All rights reserved.	[Nonaka, Hiroshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Hideno, Akihiro] Ehime Univ, Fac Agr, Paper Ind Innovat Ctr, Grad Sch, Shikokuchuo, Ehime 7990113, Japan	Nonaka, H (reprint author), Mie Univ, Grad Sch Bioresources, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.	nonaka@bio.mie-u.ac.jp			JSPS KAKENHI [25850232]	This work was supported by a JSPS KAKENHI Grant-in-Aid for Young Scientists (B) (Grant no. 25850232). The authors thank Dr. Seiya Watanabe (Ehime University) for supplying the commercial enzyme (ACC1500), Dr. Shuichi Karita (Mie University), and Dr. Hideo Miyake (Mie University) for helpful comments.	SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V133, P270, DOI 10.1016/j.biortech.2013.01.075; Nakagame S, 2011, BIORESOURCE TECHNOL, V102, P4507, DOI 10.1016/j.biortech.2010.12.082; Tu MB, 2009, J AGR FOOD CHEM, V57, P7771, DOI 10.1021/jf901031m; Kumar R, 2009, BIORESOURCE TECHNOL, V100, P4193, DOI 10.1016/j.biortech.2008.11.058; CHERNOGLAZOV VM, 1988, ENZYME MICROB TECH, V10, P503, DOI 10.1016/0141-0229(88)90029-4; PACE CN, 1995, PROTEIN SCI, V4, P2411; [Anonymous], 1992, TAPPI TEST METHODS; Berlin A, 2005, APPL BIOCHEM BIOTECH, V121, P163, DOI 10.1385/ABAB:121:1-3:0163; Kumar R, 2008, ENZYME MICROB TECH, V42, P426, DOI 10.1016/j.enzmictec.2007.12.005; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Tu MB, 2009, BIORESOURCE TECHNOL, V100, P6407, DOI 10.1016/j.biortech.2009.06.108; Zhu ZG, 2009, ANALYST, V134, P2267, DOI 10.1039/b906065k; Qi BK, 2011, BIORESOURCE TECHNOL, V102, P2881, DOI 10.1016/j.biortech.2010.10.092; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Gao DH, 2011, BIOTECHNOL BIOENG, V108, P1788, DOI 10.1002/bit.23140; Kumar R, 2009, BIOTECHNOL BIOENG, V103, P252, DOI 10.1002/bit.22258; Inoue H., 2008, BIOTECHNOL BIOFUELS, V1, P2; Kobayashi Y., 2013, Seibutsu-kogaku Kaishi, V91, P556; Nonaka H., 2013, BIORESOURCE TECHNOL, V133, P53; Nonaka Hiroshi, 2011, Journal of the Japan Institute of Energy, V90, DOI 10.3775/jie.90.977; Qing Q., 2010, BIORESOURCE TECHNOL, V101, P5941; Shi J, 2011, BIORESOURCE TECHNOL, V102, P11080, DOI 10.1016/j.biortech.2011.04.003; Sutcliffe R., 1986, BIOTECHNOL BIOENG S, V17, P749; TATSUMOTO K, 1988, APPL BIOCHEM BIOTECH, V18, P159, DOI 10.1007/BF02930823	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	DEC	2014	110						54	58		10.1016/j.molcatb.2014.09.008		5	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	AU5LM	WOS:000345648500008		
J	Miyamoto, T; Maeno, S; Zhu, QQ; Fukushima, M				Miyamoto, Takafumi; Maeno, Shohei; Zhu, Qianqian; Fukushima, Masami			Inclusion complex of iron(III)-tetrakis(p-sulfonatephenyl)porphyrin with 2,3,6-tri-O-methyl-beta-cyclodextrin as a biomimetic model of oxidative enzymes: Catalytic oxidation of tetrabromobisphenol A with peroxomonosulfate	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Iron(III)-porphyrin; Cyclodextrin; Inclusion complex; Humic acid; Tetrabromobisphenol A	METHYLATED BETA-CYCLODEXTRIN; HUMIC-ACID; POTASSIUM MONOPERSULFATE; AQUEOUS-SOLUTION; IRON(III)-PHTHALOCYANINE-TETRASULFONIC ACID; MANGANESE PORPHYRINS; RIVER SEDIMENT; PENTACHLOROPHENOL; WATER; DEGRADATION	An inclusion complex composed of iron(III)-tetrakis(p-sulfonatephenyl)porphyrin (FeTPPS) with 2,3,6-tri-O-methyl-beta-CD (TM-beta-CD), regarded as biomimetic models for oxidative enzymes, catalyzed the degradation of a tetrabromobisphenol A (TBBPA) derivative that is found in soil. The inclusion complex was characterized by UV-vis absorption spectroscopy and the efficiency of degradation of TBBPA by this inclusion complex was evaluated in the presence of humic acid (HA), a major component of soil organic matter. At pH 4, the formation of the 1:1 inclusion complex of FeTPPS with TM-beta-CD (FeTPPS Tm-beta-CD) was confirmed and the resulting complexation enhanced the degradation efficiency of TBBPA by suppressing the self-degradation of the catalyst. In the presence of HA, the catalytic activity for TBBPA oxidation with the FeTPPS TM-beta-CD complex was optimal in the range of pH 4-5, which is comparable to the optimal pH values for oxidative enzymes. Thus, the FeTPPS TM-beta-CD complex can be regarded as a suitable model for the enzymatic oxidation of TBBPA. (C) 2014 Elsevier BY. All rights reserved.	[Miyamoto, Takafumi; Maeno, Shohei; Zhu, Qianqian; Fukushima, Masami] Hokkaido Univ, Fac Engn, Div Sustainable Resources Engn, Lab Chem Resources, Sapporo, Hokkaido 0608628, Japan	Fukushima, M (reprint author), Hokkaido Univ, Fac Engn, Div Sustainable Resources Engn, Lab Chem Resources, Sapporo, Hokkaido 0608628, Japan.	m-fukush@eng.hokudai.ac.jp	Fukushima, Masami/D-6150-2012		Japan Society for the Promotion of Science [25241017]	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25241017).	Ahmed SM, 1997, J INCLUS PHENOM MOL, V27, P85, DOI 10.1023/A:1007946525783; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; Kano K, 2004, J AM CHEM SOC, V126, P15202, DOI 10.1021/ja045472i; Chang BV, 2012, CHEMOSPHERE, V87, P535, DOI 10.1016/j.chemosphere.2011.12.057; SZENTE L, 1993, J INCLUS PHENOM MOL, V16, P339, DOI 10.1007/BF00708714; Miyamoto T, 2014, J MOL CATAL B-ENZYM, V99, P150, DOI 10.1016/j.molcatb.2013.11.002; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Ravit B, 2005, SOIL BIOL BIOCHEM, V37, P1049, DOI 10.1016/j.soilbio.2004.11.003; Wang GH, 2006, J PHOTOCH PHOTOBIO A, V179, P49, DOI 10.1016/j.jphotochem.2005.07.011; Aeschbacher M, 2012, ENVIRON SCI TECHNOL, V46, P4916, DOI 10.1021/es300039h; Hanna K, 2005, WATER RES, V39, P2763, DOI 10.1016/j.watres.2005.04.057; Eriksson J, 2004, CHEMOSPHERE, V54, P117, DOI 10.1016/S0045-6535(03)00704-5; Ronen Z, 2000, APPL ENVIRON MICROB, V66, P2372, DOI 10.1128/AEM.66.6.2372-2377.2000; Rismayani S, 2004, J MOL CATAL A-CHEM, V217, P13, DOI 10.1016/j.molcata.2004.03.030; Hamai S, 2010, J INCL PHENOM MACRO, V67, P471, DOI 10.1007/s10847-009-9730-7; Law RJ, 2008, CHEMOSPHERE, V73, P223, DOI 10.1016/j.chemosphere.2008.02.066; Gallo M, 2004, MICROBIAL ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; Calza P, 2008, SCI TOTAL ENVIRON, V398, P196, DOI 10.1016/j.scitotenv.2008.03.023; Hanna K, 2004, SCI TOTAL ENVIRON, V332, P51, DOI 10.1016/j.scitotenv.2004.04.022; Fukushima M, 2007, BIOMACROMOLECULES, V8, P386, DOI 10.1021/bm060829r; Arnon S, 2006, CHEMOSPHERE, V62, P17, DOI 10.1016/j.chemosphere.2005.04.050; BOLLAG JM, 1992, ENVIRON SCI TECHNOL, V26, P1876, DOI 10.1021/es00034a002; Breslow R, 2002, TETRAHEDRON, V58, P653, DOI 10.1016/S0040-4020(01)01098-5; BUSCHMANN HJ, 1992, J INCLUS PHENOM MOL, V14, P91, DOI 10.1007/BF01029656; Carofiglio T, 1996, TETRAHEDRON LETT, V37, P8019, DOI 10.1016/0040-4039(96)01814-X; Chang BV, 2012, ECOL ENG, V49, P73, DOI 10.1016/j.ecoleng.2012.08.038; Chen SP, 1998, J PHYS CHEM B, V102, P9101, DOI 10.1021/jp981350z; French RR, 1998, HELV CHIM ACTA, V81, P1521, DOI 10.1002/hlca.19980810555; Fukushima M., 2007, METHODS SOIL ANAL 3, V144, P222; Fukushima M, 2003, ENVIRON SCI TECHNOL, V37, P386, DOI 10.1021/es020747k; Fukushima M, 2006, J MOL CATAL A-CHEM, V245, P178, DOI 10.1016/j.molcata.2005.09.051; Fukushima M, 2012, MOLECULES, V17, P48, DOI 10.3390/molecules17010048; Fukushima M, 2006, BIORESOURCE TECHNOL, V97, P1605, DOI 10.1016/j.biortech.2005.07.032; Fukushima M, 2005, ENVIRON SCI TECHNOL, V39, P9337, DOI 10.1021/es051355r; Fukushima M, 2010, CHEMOSPHERE, V80, P860, DOI 10.1016/j.chemosphere.2010.05.041; Fukushima M, 2008, J MOL CATAL A-CHEM, V293, P103, DOI 10.1016/j.molcata.2008.07.014; Hama K., 2003, METHODS SOIL ANAL 3, V100, P109; Hamai S, 2001, SPECTROCHIM ACTA A, V57, P985, DOI 10.1016/S1386-1425(00)00417-0; Harriman A., 1979, J CHEM SOC FARADAY T, V275, P1532; Kano K, 2006, EUR J INORG CHEM, P4043, DOI 10.1002/ejic.200600336; Kawasaki M, 2003, J PORPHYR PHTHALOCYA, V7, P645; Khavasi HR, 2007, J PORPHYR PHTHALOCYA, V11, P874; Komatsu T, 2003, CHEM COMMUN, P50, DOI 10.1039/b208882g; Maeno S, 2014, J ENVIRON SCI HEAL A, V49, P981, DOI 10.1080/10934529.2014.894810; MANKA JS, 1989, TETRAHEDRON LETT, V30, P7341, DOI 10.1016/S0040-4039(00)70692-7; Mizutani Y, 2014, J ENVIRON SCI HEAL A, V49, P365, DOI 10.1080/10934529.2014.854148; MOSSERI S, 1991, J PHYS CHEM-US, V95, P4659, DOI 10.1021/j100165a014; NAPPA MJ, 1985, INORG CHEM, V24, P4711, DOI 10.1021/ic00220a056; Nimaeva O.D., 2014, RUSS J PLANT PHYSL, V61, P350; Praveen K, 2012, J MICROBIOL BIOTECHN, V22, P1540, DOI 10.4014/jmb.1112.12011; Ramirez-Gutierrez O, 2005, J PORPHYR PHTHALOCYA, V9, P368; ROWLAND CY, 1994, MYCOL RES, V98, P1453; SAENGER W, 1980, ANGEW CHEM INT EDIT, V19, P344, DOI 10.1002/anie.198003441; Sazawa K, 2013, TOXICOL ENVIRON CHEM, V95, P472, DOI 10.1080/02772248.2013.775290; Strack S., 2007, CHEMOSPHERE, V67, P8405; SUR SK, 1995, J PHYS CHEM-US, V99, P4900, DOI 10.1021/j100014a005; Swift R.S., 1996, METHODS SOIL ANAL 3, P1018; Szente L, 1998, J INCLUS PHENOM MOL, V32, P81, DOI 10.1023/A:1007970501916; Tan K.H., 2003, HUMIC MATTER SOIL EN; Volchatova IV, 1997, APPL BIOCHEM MICRO+, V33, P84; WAGNER SL, 1991, ARCH ENVIRON CON TOX, V21, P596; Wang G., 2006, J CHEM TECHNOL BIOT, V811, P805; World Health Organization (WHO), 1997, TETRABROMOBISPHENOL; Zhou HC, 2003, BIOPHYS CHEM, V105, P639, DOI 10.1016/S0301-4622(03)00094-2; Zhu Q., 2013, J PORPHYR PHTHALOCYA, V18, P5360	65	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	DEC	2014	110						147	153		10.1016/j.molcatb.2014.10.003		7	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	AU5LM	WOS:000345648500021		
J	Poole, AM; Horinouchi, N; Catchpole, RJ; Si, DY; Hibi, M; Tanaka, K; Ogawa, J				Poole, Anthony M.; Horinouchi, Nobuyuki; Catchpole, Ryan J.; Si, Dayong; Hibi, Makoto; Tanaka, Koichi; Ogawa, Jun			The Case for an Early Biological Origin of DNA	JOURNAL OF MOLECULAR EVOLUTION			English	Article						Ribonucleotide reductase; Deoxyriboaldolase; Last Universal Common Ancestor; RNA world; DNA origins	UNIVERSAL COMMON ANCESTOR; DEPENDENT RNA-POLYMERASE; RIBONUCLEOTIDE REDUCTASE; CRYSTAL-STRUCTURE; 2-DEOXYRIBOSE 5-PHOSPHATE; REPLICATION MACHINERIES; ESCHERICHIA-COLI; GENETIC-CODE; 3 DOMAINS; EVOLUTION	All life generates deoxyribonucleotides, the building blocks of DNA, via ribonucleotide reductases (RNRs). The complexity of this reaction suggests it did not evolve until well after the advent of templated protein synthesis, which in turn suggests DNA evolved later than both RNA and templated protein synthesis. However, deoxyribonucleotides may have first been synthesised via an alternative, chemically simpler route-the reversal of the deoxyriboaldolase (DERA) step in deoxyribonucleotide salvage. In light of recent work demonstrating that this reaction can drive synthesis of deoxyribonucleosides, we consider what pressures early adoption of this pathway would have placed on cell metabolism. This in turn provides a rationale for the replacement of DERA-dependent DNA production by RNR-dependent production.	[Poole, Anthony M.; Catchpole, Ryan J.] Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Poole, Anthony M.] Univ Canterbury, Allan Wilson Ctr, Christchurch 8140, New Zealand; [Horinouchi, Nobuyuki; Si, Dayong; Hibi, Makoto; Tanaka, Koichi; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Si, Dayong] Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA	Poole, AM (reprint author), Univ Canterbury, Allan Wilson Ctr, Christchurch 8140, New Zealand.	anthony.poole@canterbury.ac.nz			Japan Society for the Promotion of Science (JSPS) Invitation Fellowship [S137 22]; New Zealand-Japan Joint Research Project Programme; Royal Society of New Zealand; Royal Society of New Zealand via a Rutherford Discovery Fellowship	We thank two anonymous reviewers for helpful comments on the manuscript. JO and AMP gratefully acknowledge receipt of a Japan Society for the Promotion of Science (JSPS) Invitation Fellowship (S137 22), plus research funding via the New Zealand-Japan Joint Research Project Programme administered by JSPS and the Royal Society of New Zealand. AMP gratefully acknowledges the support of the Royal Society of New Zealand via a Rutherford Discovery Fellowship.	Anastasi C, 2007, CHEM BIODIVERS, V4, P721, DOI 10.1002/cbdv.200790060; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Burton AS, 2009, ASTROBIOLOGY, V9, P125, DOI 10.1089/ast.2008.0240; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Tourasse NJ, 1999, MOL PHYLOGENET EVOL, V13, P159, DOI 10.1006/mpev.1999.0675; Becerra A, 1997, J MOL EVOL, V45, P115, DOI 10.1007/PL00006209; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Hud NV, 2013, CHEM BIOL, V20, P466, DOI 10.1016/j.chembiol.2013.03.012; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/VI.79.13.7951-7958.2005; Poole AM, 2009, RES MICROBIOL, V160, P473, DOI 10.1016/j.resmic.2009.07.009; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Lutz S, 2004, CURR OPIN BIOTECH, V15, P291, DOI 10.1016/j.copbio.2004.05.004; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Goldman AD, 2013, NUCLEIC ACIDS RES, V41, pD1079, DOI 10.1093/nar/gks1217; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Brindefalk B, 2013, NUCLEIC ACIDS RES, V41, P2832, DOI 10.1093/nar/gkt045; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Forterre P, 2006, P NATL ACAD SCI USA, V103, P3669, DOI 10.1073/pnas.051033103; Lundin D, 2012, J BIOL CHEM, V287, P20565, DOI 10.1074/jbc.M112.367458; Lehman N, 2003, J MOL EVOL, V56, P770, DOI 10.1007/s00239-003-2454-1; Poole AM, 2002, J MOL EVOL, V55, P180, DOI 10.1007/s00239-002-2315-3; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Leppanen VM, 1999, STRUCT FOLD DES, V7, P733, DOI 10.1016/S0969-2126(99)80098-7; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Poole A, 2001, NAT REV MOL CELL BIO, V2, P147, DOI 10.1038/35052091; Petrov AS, 2014, P NATL ACAD SCI USA, V111, P10251, DOI 10.1073/pnas.1407205111; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Dworkin JP, 2003, J THEOR BIOL, V222, P127, DOI 10.1016/S0022-5193(03)00020-1; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; Breaker RR, 2014, CHEM BIOL, V21, P1059, DOI 10.1016/j.chembiol.2014.07.008; Cendra MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046350; Collins LJ, 2000, J MOL EVOL, V51, P194; Daly TK, 2013, GENOME BIOL EVOL, V5, P217, DOI 10.1093/gbe/evs135; DELLARCO VL, 1988, MUTAT RES, V195, P1, DOI 10.1016/0165-1110(88)90013-9; Dwivedi B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-33; Fels A, 2001, NUCLEIC ACIDS RES, V29, P4589, DOI 10.1093/nar/29.22.4589; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forterre P, 2004, MOL B INT U, P145; Forterre P, 1999, MOL MICROBIOL, V33, P457, DOI 10.1046/j.1365-2958.1999.01497.x; Forterre P, 2013, J MOL BIOL, V425, P4714, DOI 10.1016/j.jmb.2013.09.032; Hoeppner MP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002752; Horinouchi N, 2006, BIOTECHNOL LETT, V28, P877, DOI 10.1007/s10529-006-9019-5; Horinouchi N, 2003, APPL ENV MICROBIOL; Horinouchi N, 2006, BIOSCI BIOTECH BIOCH, V70, P1371, DOI 10.1271/bbb.50648; Horinouchi N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-82; Horinouchi N, 2006, APPL MICROBIOL BIOT, V71, P615, DOI 10.1007/s00253-005-0205-5; Kawahara-Kobayashi A, 2012, NUCLEIC ACIDS RES, V40, P10576, DOI 10.1093/nar/gks786; Kelch BA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-34; LAZCANO A, 1988, J MOL EVOL, V27, P283, DOI 10.1007/BF02101189; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805; Noller HF, 2010, COLD SPRING HARB PER, V4; Ogawa J, 2003, BIOSCI BIOTECH BIOCH, V67, P933; Penny D, 2015, BIOCHIMIE, V119, P278, DOI 10.1016/j.biochi.2014.10.020; Poole A, 2000, CHEM BIOL, V7, pR207, DOI 10.1016/S1074-5521(00)00042-9; Poole AM, 2011, ORIGINS LIFE PRIMAL, P209, DOI DOI 10.1007/978-3-642-21625-1_10; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; Poole AM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015990; Poole AM, 2006, BIOESSAYS, V28, P105, DOI 10.1002/bies.20367; RACKER E, 1952, J BIOL CHEM, V196, P347; RACKER E, 1951, NATURE, V167, P408, DOI 10.1038/167408b0; REANNEY DC, 1987, COLD SPRING HARB SYM, V52, P751; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; REICHARD P, 1960, BIOCHIM BIOPHYS ACTA, V37, P554, DOI 10.1016/0006-3002(60)90524-2; Takeuchi N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002024; Tauer A, 1997, P NATL ACAD SCI USA, V94, P53, DOI 10.1073/pnas.94.1.53; Torrents E, 2002, J MOL EVOL, V55, P138, DOI 10.1007/s00239-002-2311-7; Yarus M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003590; Yarus M, 2002, ANNU REV GENET, V36, P125, DOI 10.1146/annurev.genet.36.031902.105056; Yarus M, 1999, CURR OPIN CHEM BIOL, V3, P260, DOI 10.1016/S1367-5931(99)80041-6	94	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2844	1432-1432		J MOL EVOL	J. Mol. Evol.	DEC	2014	79	5-6			SI		204	212		10.1007/s00239-014-9656-6		9	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	AU6GP	WOS:000345702200005		
J	Yamamoto, M; Hashimoto, M; Takahashi, H; Shinomura, Y				Yamamoto, Motohisa; Hashimoto, Masato; Takahashi, Hiroki; Shinomura, Yasuhisa			IgG4 Disease	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Review							IGG4-RELATED TUBULOINTERSTITIAL NEPHRITIS; AUTOIMMUNE PANCREATITIS; MIKULICZS-DISEASE; DIAGNOSTIC-CRITERIA; SCLEROSING PANCREATITIS; SERUM IGG4; INTERNATIONAL CONSENSUS; NERVE INVOLVEMENT; SJOGRENS-SYNDROME; SYSTEMIC-DISEASE	Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a chronic inflammatory disorder characterized by elevated serum level of IgG4 and abundant infiltration of IgG4-bearing plasmacytes and fibrosis in various organs, typically including the lacrimal glands, salivary glands, pancreas, thyroid gland, lungs, and kidneys. Lacrimal and orbital involvements are called IgG4-related ophthalmic disease, often presenting as orbital myositis, perineuritis of the optic and trigeminal nerves, and orbital inflammation. In particular, a characteristic finding is infraorbital nerve enlargement on magnetic resonance imaging. Systemic screening is necessary to establish the diagnosis of IgG4-RD, and it must be distinguished from neoplastic disease. Corticosteroid treatment is effective in inducing remission but some patients may relapse during tapering of pharmacotherapy. This review encompasses the history, clinical profile, diagnostic criteria, treatment, and prognosis of IgG4-RD. (C) 2014 by North American Neuro-Ophthalmology Society	[Yamamoto, Motohisa; Takahashi, Hiroki; Shinomura, Yasuhisa] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido 0608543, Japan; [Hashimoto, Masato] Sapporo Med Univ, Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 0608543, Japan	Yamamoto, M (reprint author), Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	mocha@cocoa.plala.or.jp			Ministry of Health, Labour and Welfare, Japan	Supported by a Research on Measures for Intractable Diseases Project matching fund subsidy from the Ministry of Health, Labour and Welfare, Japan.	Andrew N, 2013, ACTA OPHTHALMOL, V91, P694, DOI 10.1111/j.1755-3768.2012.02526.x; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Kasashima S, 2011, CURR OPIN RHEUMATOL, V23, P18, DOI 10.1097/BOR.0b013e32833ee95f; Kubota T, 2010, ARCH OPHTHALMOL-CHIC, V128, P577, DOI 10.1001/archophthalmol.2010.45; Park DH, 2009, GUT, V58, P1680, DOI 10.1136/gut.2008.155853; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Tsubota K, 2000, INVEST OPHTH VIS SCI, V41, P1666; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P6225; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Yamamoto M, 2005, RHEUMATOLOGY, V44, P227, DOI 10.1093/rheumatology/keh447; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Takahashi H, 2010, AUTOIMMUN REV, V9, P591, DOI 10.1016/j.autrev.2010.05.003; Watanabe T, 2013, SCAND J RHEUMATOL, V42, P325, DOI 10.3109/03009742.2012.761281; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Yamamoto M, 2010, INTERNAL MED, V49, P1365, DOI 10.2169/internalmedicine.49.3532; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Chan SK, 2009, AM J SURG PATHOL, V33, P1249, DOI 10.1097/PAS.0b013e3181abdfc2; Yoshimura Y, 2006, INTERNAL MED, V45, P897, DOI 10.2169/internalmedicine.45.1752; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Sato Y, 2009, MODERN PATHOL, V22, P589, DOI 10.1038/modpathol.2009.17; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Shimizu Y, 2013, RHEUMATOLOGY, V52, P679, DOI 10.1093/rheumatology/kes358; Yamamoto M, 2012, MOD RHEUMATOL, V22, P419, DOI 10.1007/s10165-011-0532-6; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Yamamoto M, 2006, SCAND J RHEUMATOL, V35, P410; Matsui S, 2013, RESPIROLOGY, V18, P480, DOI 10.1111/resp.12016; MORGAN WS, 1953, AM J PATHOL, V29, P471; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Yamamoto M, 2012, MOD RHEUMATOL, V22, P414, DOI 10.1007/s10165-011-0520-x; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Dahlgren M, 2010, ARTHRIT CARE RES, V62, P1312, DOI 10.1002/acr.20215; Raissian Y, 2011, J AM SOC NEPHROL, V22, P1343, DOI 10.1681/ASN.2011010062; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Inoue D, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/401890; Irie H, 1998, AM J ROENTGENOL, V170, P1323; Ito T, 2011, J DIGEST DIS, V12, P210, DOI 10.1111/j.1751-2980.2011.00498.x; Katsura M, 2011, AJNR Am J Neuroradiol, V32, pE150, DOI 10.3174/ajnr.A2256; Kawakami Y, 2014, RHEUMATOLOGY, V53, P610, DOI 10.1093/rheumatology/ket340; Kitagawa S, 2005, AM J SURG PATHOL, V29, P783, DOI 10.1097/01.pas.0000164031.59940.fc; Mikulicz J, 1892, BEITR CHIR FESRSCHR, P610; Oshima K, 2012, JPN J OPHTHALMOL, V56, P380; Sato Y, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/572539; Schaffer AJ, 1927, AM J DIS CHILD, V34, P327; Okazaki K, 2012, PANCREAS, V41, P1341; Sjogren H., 1933, ACTA OPHTHALMOGIC S2, V11, P1; Takahashi Y, 2014, J NEURO-OPHTHALMOL, V34, P16, DOI 10.1097/WNO.0b013e3182a304f4; Toki F, 1992, ENDOSCOPY, V24, P640; Yamamoto M, 2008, SCAND J RHEUMATOL S, V123, P38; Yamamoto M, CURR IMMUNOL REV; Yamamoto Motohisa, 2006, Mod Rheumatol, V16, P335, DOI 10.1007/s10165-006-0518-Y; Yamamoto M, 2012, ANN RHEUM DIS, V71, P1755, DOI 10.1136/annrheumdis-2012-201694; Yamamoto M, 2004, SCAND J RHEUMATOL, V33, P432, DOI 10.1080/03009740410006439; Yamamoto M, 2005, RHEUMATOLOGY, V44, P1322, DOI 10.1093/rheumatology/kei026; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	63	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	DEC	2014	34	4					393	399		10.1097/WNO.0000000000000172		7	Clinical Neurology; Ophthalmology	Neurosciences & Neurology; Ophthalmology	AU8QL	WOS:000345861100020		
J	Kashii, S				Kashii, Satoshi			IgG4-Related Disease: A Neuro-Ophthalmological Perspective	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Review							LYMPHOPLASMACYTIC INFILTRATIVE DISORDER; G4-RELATED SYSTEMIC-DISEASE; HYPERTROPHIC PACHYMENINGITIS; SCLEROSING DISEASE; MIKULICZS-DISEASE; ORBITAL INFLAMMATION; DIAGNOSTIC-CRITERIA; OCULAR ADNEXA; PLASMA-CELLS; HYPOPHYSITIS	Immunoglobulin G4-related disease (IgG4-RD) is a multifocal inflammatory disorder that causes tumefactive lesions with a dense lymphoplasmacytic infiltrate rich in IgG4 plasma cells and storiform-pattern fibrosis. The clinical symptoms are relatively mild, and the condition is usually recognized by organ swelling and damage. When referring to the ophthalmic manifestations of IgG4-RD, the term IgG4-related ophthalmic disease (IgG4-ROD) is used. IgG4-ROD is characterized by bilateral lacrimal gland enlargement accompanied by 3 distinctive features: infraorbital nerve enlargement, extraocular myositis, and compressive optic neuropathy. IgG4 implies an underlying systemic disease process requiring evaluation to detect other systemic involvement. This includes hypophysitis and hypertrophic pachymeningitis, entities of neuro-ophthalmic interest. IgG4-ROD usually responds favorably to systemic corticosteroids but may be complicated by relapse during steroid taper. Rituximab has been shown to be effective for controlling steroid-refractory IgG4-RD. In contrast to IgG4-RD, an increasing number of cases of extranodal marginal B-cell lymphoma (MALT type) associated with IgG4-ROD have been described. IgG4 may be a risk factor for later emergence of low-grade B-cell lymphoma. (C) 2014 by North American Neuro-Ophthalmology Society	Aichi Shukutoku Univ, Fac Hlth & Med Sci, Dept Visual Sci & Ophthalmol, Aichi, Aichi 4801197, Japan	Kashii, S (reprint author), Aichi Shukutoku Univ, Fac Hlth & Med Sci, Dept Visual Sci & Ophthalmol, Nagakute Campus, Aichi, Aichi 4801197, Japan.						Alt Jeremiah A, 2012, Allergy Rhinol (Providence), V3, pe41, DOI 10.2500/ar.2012.3.0026; Andrew N, 2013, ACTA OPHTHALMOL, V91, P694, DOI 10.1111/j.1755-3768.2012.02526.x; Leporati P, 2011, J CLIN ENDOCR METAB, V96, P1971, DOI 10.1210/jc.2010-2970; Singh K, 2010, OCUL IMMUNOL INFLAMM, V18, P373, DOI 10.3109/09273948.2010.490629; Plaza JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P421, DOI 10.1001/archophthalmol.2011.16; Kubota T, 2010, ARCH OPHTHALMOL-CHIC, V128, P577, DOI 10.1001/archophthalmol.2010.45; Mudhar Hardeep S., 2011, International Ophthalmology, V31, P245, DOI 10.1007/s10792-011-9451-y; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Hattori Y, 2013, J CLIN ENDOCR METAB, V98, P1808, DOI 10.1210/jc.2013-1088; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Ishida M, 2009, PATHOL INT, V59, P670, DOI 10.1111/j.1440-1827.2009.02425.x; Sato Y, 2008, PATHOL INT, V58, P465, DOI 10.1111/j.1440-1827.2008.02257.x; Aihara Y, 2013, JPN J OPHTHALMOL, V57, P573, DOI 10.1007/s10384-013-0266-4; Oyama T, 2011, JPN J OPHTHALMOL, V55, P304, DOI 10.1007/s10384-011-0003-9; Hardy TG, 2014, OPHTHALMOLOGY, V121, P1297, DOI 10.1016/j.ophtha.2013.12.028; Cheuk W, 2007, AM J SURG PATHOL, V31, P643, DOI 10.1097/01.pas.0000213445.08902.11; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Karamchandani JR, 2012, AM J CLIN PATHOL, V137, P699, DOI 10.1309/AJCPE1G8DRHXRPIH; Sivak-Callcott JA, 2006, BRIT J OPHTHALMOL, V90, P602, DOI 10.1136/bjo.2005.085894; Wong S, 2007, HUM PATHOL, V38, P1720, DOI 10.1016/j.humpath.2007.06.011; Sah RP, 2011, CURR OPIN RHEUMATOL, V23, P108, DOI 10.1097/BOR.0b013e3283413469; Kubota T, 2010, J CLIN PATHOL, V63, P1059, DOI 10.1136/jcp.2010.082156; Himi T, 2012, AURIS NASUS LARYNX, V39, P9, DOI 10.1016/j.anl.2011.01.023; Cheuk W, 2008, AM J SURG PATHOL, V32, P1159, DOI 10.1097/PAS.0b013e31816148ad; Ohkubo Y, 2014, INTERNAL MED, V53, P753, DOI 10.2169/internalmedicine.53.0714; Yonekawa T, 2014, J NEUROL NEUROSUR PS, V85, P732, DOI 10.1136/jnnp-2013-306410; Iseda I, 2014, ENDOCR J, V61, P195; Della-Torre E, 2014, J NEUROIMMUNOL, V266, P82, DOI 10.1016/j.jneuroim.2013.10.008; Mehta M, 2009, ARCH PATHOL LAB MED, V133, P1251, DOI 10.1043/1543-2165-133.8.1251; Deschamps R, 2013, BRIT J OPHTHALMOL, V97, P999, DOI 10.1136/bjophthalmol-2013-303131; van der Vliet HJJ, 2004, ANN INTERN MED, V141, P896; Masaki Y, 2010, J RHEUMATOL, V37, P1380, DOI 10.3899/jrheum.091153; Wallace ZS, 2014, SEMIN ARTHRITIS RHEU, V43, P806, DOI 10.1016/j.semarthrit.2013.11.008; Lu LX, 2014, JAMA NEUROL, V71, P785, DOI 10.1001/jamaneurol.2014.243; Shimatsu A, 2009, ENDOCR J, V56, P1033; Song YS, 2013, BRIT J OPHTHALMOL, V97, P412, DOI 10.1136/bjophthalmol-2012-302857; Sogabe Y, 2014, GRAEF ARCH CLIN EXP, V252, P531, DOI 10.1007/s00417-013-2548-4; Go H, HISTOPATHOLOGY; Goto H, JPN J OPHTH IN PRESS, DOI [10.1007/s10384-014-0352-2, DOI 10.1007/S10384-014-0352-2]; Inaba H, 2013, INTERNAL MED, V52, P2545, DOI 10.2169/internalmedicine.52.0902; Inoue D, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/401890; Kanoke Atsushi, 2013, BMC Res Notes, V6, P560, DOI 10.1186/1756-0500-6-560; Katsura M, 2011, AJNR Am J Neuroradiol, V32, pE150, DOI 10.3174/ajnr.A2256; Katsura M, 2012, NEURORADIOLOGY, V54, P873, DOI 10.1007/s00234-012-1012-1; Matsui S, 2012, MOD RHEUMATOL, V22, P31, DOI 10.1007/s10165-011-0504-x; Ohshima K, 2012, JPN J OPHTHALMOL, V56, P380, DOI 10.1007/s10384-012-0151-6; Pace C, 2010, J ORAL MAXIL SURG, V68, P2591, DOI 10.1016/j.joms.2009.07.073; Sasaki T, 2012, AM J NEURORADIOL, V33, P19; Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x; Sato Yasuharu, 2012, J Clin Exp Hematop, V52, P51; Takahira M, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/635473; Wallace ZS, 2013, MEDICINE, V92, P206, DOI 10.1097/MD.0b013e31829cce35; Yamamoto Motohisa, 2006, Mod Rheumatol, V16, P335, DOI 10.1007/s10165-006-0518-Y; Yamamoto M, 2014, J NEURO-OPHTHALMOL, V34, P393, DOI 10.1097/WNO.0000000000000172; Yamamoto M, 2004, SCAND J RHEUMATOL, V33, P432, DOI 10.1080/03009740410006439	58	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	DEC	2014	34	4					400	407		10.1097/WNO.0000000000000193		8	Clinical Neurology; Ophthalmology	Neurosciences & Neurology; Ophthalmology	AU8QL	WOS:000345861100021		
J	Schuster, DM; Nanni, C; Fanti, S; Oka, S; Okudaira, H; Inoue, Y; Sorensen, J; Owenius, R; Choyke, P; Turkbey, B; Bogsrud, TV; Bach-Gansmo, T; Halkar, RK; Nye, JA; Odewole, OA; Savir-Baruch, B; Goodman, MM				Schuster, David M.; Nanni, Cristina; Fanti, Stefano; Oka, Shuntaro; Okudaira, Hiroyuki; Inoue, Yusuke; Sorensen, Jens; Owenius, Rikard; Choyke, Peter; Turkbey, Baris; Bogsrud, Trond V.; Bach-Gansmo, Tore; Halkar, Raghuveer K.; Nye, Jonathon A.; Odewole, Oluwaseun A.; Savir-Baruch, Bital; Goodman, Mark M.			Anti-1-Amino-3-F-18-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease	JOURNAL OF NUCLEAR MEDICINE			English	Article						F-18-FACBC; physiologic uptake; positron emission tomography	RECURRENT PROSTATE CARCINOMA; RADIOLABELED AMINO-ACIDS; TRANSPORT MECHANISMS; RADIATION-DOSIMETRY; CANCER; PET/CT; BIODISTRIBUTION; RADIOTRACER; AGENT; CELLS	Anti-1-amino-3-F-18-fluorocyclobutane-1-carboxylic acid (F-18-FACBC) is a synthetic amino acid analog PET radiotracer undergoing clinical trials for the evaluation of prostate and other cancers. We aimed to describe common physiologic uptake patterns, incidental findings, and variants in patients who had undergone F-18-FACBC PET. Methods: Sixteen clinical trials involving 611 F-18-FACBC studies from 6 centers, which included dosimetry studies on 12 healthy volunteers, were reviewed. Qualitative observations of common physiologic patterns, incidental uptake, and variants that could simulate disease were recorded and compared with similar observations in studies of the healthy volunteers. Quantitative analysis of select data and review of prior published reports and observations were also made. Results: The liver and pancreas demonstrated the most intense uptake. Moderate salivary and pituitary uptake and variable mild to moderate bowel activity were commonly visualized. Moderate bone marrow and mild muscle activity were present on early images, with marrow activity decreasing and muscle activity increasing with time. Brain and lungs demonstrated activity less than blood pool. Though F-18-FACBC exhibited little renal excretion or bladder uptake during the clinically useful early imaging time window, mild to moderate activity might accumulate in the bladder and interfere with evaluation of adjacent prostate bed and seminal vesicles in 5%-10% of patients. Uptake might also occur from benign processes such as infection, inflammation, prostatic hyperplasia, and metabolically active benign bone lesions such as osteoid osteoma. Conclusion: Common physiologic uptake patterns were similar to those noted in healthy volunteers. The activity in organs followed the presence of amino acid transport and metabolism described with other amino acid-based PET radiotracers. As with other PET radiotracers such as F-18-FDG, focal nonphysiologic uptake may represent incidental malignancy. Uptake due to benign etiologies distinct from physiologic background also occurred and could lead to misinterpretations if the reader is unaware of them.	[Schuster, David M.; Halkar, Raghuveer K.; Nye, Jonathon A.; Odewole, Oluwaseun A.; Savir-Baruch, Bital; Goodman, Mark M.] Emory Univ Hosp, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Nanni, Cristina; Fanti, Stefano] Univ Bologna, Dept Nucl Med, Policlin S Orsola, Bologna, Italy; [Oka, Shuntaro; Okudaira, Hiroyuki] Nihon Mediphys Co Ltd, Res Ctr, Chiba, Japan; [Inoue, Yusuke] Kitasato Univ, Dept Diagnost Radiol, Sch Med, Kitasato, Japan; [Sorensen, Jens] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Owenius, Rikard] GE Healthcare, Imaging R&D, Uppsala, Sweden; [Choyke, Peter; Turkbey, Baris] NCI, Mol Imaging Program, Bethesda, MD 20892 USA; [Bogsrud, Trond V.; Bach-Gansmo, Tore] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Bogsrud, Trond V.] Aarhus Univ Hosp, Dept Nucl Med, DK-8000 Aarhus, Denmark; [Bogsrud, Trond V.] Aarhus Univ Hosp, PET Ctr, DK-8000 Aarhus, Denmark	Schuster, DM (reprint author), Emory Univ Hosp, Div Nucl Med & Mol Imaging, Dept Radiol & Imaging Sci, Room E152,1364 Clifton Rd, Atlanta, GA 30322 USA.	dschust@emory.edu			National Institutes of Health [5R01CA129356, P50 CA 128301]; Society of Nuclear Medicine and Molecular Imaging Research and Education Foundation; Nihon Medi-Physics Co., Ltd.; GE Healthcare; Blue Earth Diagnostics Limited; Glenn Family Breast Center Award, Winship Cancer Institute of Emory University; Programma di Ricerca Regione (Emilia Romagna)-Universita, Bando Giovani Ricercatori; Georgia Cancer Coalition	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. Support was provided by the National Institutes of Health (5R01CA129356 and P50 CA 128301); Society of Nuclear Medicine and Molecular Imaging Research and Education Foundation; Nihon Medi-Physics Co., Ltd.; GE Healthcare; Blue Earth Diagnostics Limited; Glenn Family Breast Center Award, Winship Cancer Institute of Emory University; Georgia Cancer Coalition; and Programma di Ricerca Regione (Emilia Romagna)-Universita 2010-2012, Bando Giovani Ricercatori. Emory University and Dr. Mark Goodman are eligible to receive royalties for <SUP>18</SUP>F-FACBC. Dr. Schuster participates in sponsored research involving <SUP>18</SUP>F-FACBC and other radiotracers. No other potential conflict of interest relevant to this article was reported.	Amzat R, 2013, MOL IMAGING BIOL, V15, P633, DOI 10.1007/s11307-012-0606-7; Amzat R, 2012, J NUCL MED S, V53, p1096P; Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Schuster DM, 2014, J UROLOGY, V191, P1446, DOI 10.1016/j.juro.2013.10.065; Schuster DM, 2007, J NUCL MED, V48, P56; Drummond MJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1011, DOI 10.1152/ajpendo.00690.2009; Schuster DM, 2011, RADIOLOGY, V259, P852, DOI 10.1148/radiol.11102023; Kobayashi K, 2012, RADIOGRAPHICS, V32, P1483, DOI 10.1148/rg.325115159; Asano Y, 2011, ANN NUCL MED, V25, P414, DOI 10.1007/s12149-011-0477-z; McConathy J, 2012, MED RES REV, V32, P868, DOI 10.1002/med.20250; Shoup TM, 1999, J NUCL MED, V40, P331; Oka S, 2012, NUCL MED BIOL, V39, P109, DOI 10.1016/j.nucmedbio.2011.06.008; Verrey F, 2009, PFLUG ARCH EUR J PHY, V458, P53, DOI 10.1007/s00424-009-0638-2; Turkbey B, 2014, RADIOLOGY, V270, P849, DOI 10.1148/radiol.13130240; Huang CF, 2013, J NUCL MED, V54, P1007, DOI 10.2967/jnumed.112.113100; Okudaira H, 2013, NUCL MED BIOL, V40, P670, DOI 10.1016/j.nucmedbio.2013.03.009; Okudaira H, 2011, J NUCL MED, V52, P822, DOI 10.2967/jnumed.110.086074; Sorensen J, 2013, EUR J NUCL MED MOL I, V40, P394, DOI 10.1007/s00259-012-2291-9; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Jager PL, 2001, J NUCL MED, V42, P432; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Bombardieri E, 2003, EUR J NUCL MED MOL I, V30, pBP115, DOI 10.1007/s00259-003-1355-2; Harris SM, 2013, J NUCL MED, V54, P1902, DOI 10.2967/jnumed.112.118125; Inoue T, 1998, J NUCL MED, V39, P663; Kostakoglu L, 2004, RADIOGRAPHICS, V24, P1411, DOI 10.1148/rg.245035725; McConathy J, 2003, APPL RADIAT ISOTOPES, V58, P657, DOI 10.1016/S0969-8043(03)00029-0; McParland BJ, 2013, EUR J NUCL MED MOL I, V40, P1256, DOI 10.1007/s00259-013-2403-1; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; Nanni C, 2014, CLIN GENITOURIN CANC, V12, P106, DOI 10.1016/j.clgc.2013.08.002; Nye JA, 2007, J NUCL MED, V48, P1017, DOI 10.2967/jnumed.107.040097; Oka S, 2014, MOL IMAGING BIOL, V16, P322, DOI 10.1007/s11307-013-0693-0; Plathow C, 2008, J NUCL MED, V49, p43S, DOI 10.2967/jnumed.107.045930; Schuster David M, 2013, Am J Nucl Med Mol Imaging, V3, P85; Schuster DM, 2003, J NUCL MED S, V44, p167P; Schuster DM, 2009, MOL IMAGING BIOL, V11, P434, DOI 10.1007/s11307-009-0220-5; WASHBURN LC, 1979, J NUCL MED, V20, P1055	36	1	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	DEC	2014	55	12					1986	1992		10.2967/jnumed.114.143628		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU8EC	WOS:000345828300015		
J	Iwamoto, M; Kawada, K; Nakamoto, Y; Itatani, Y; Inamoto, S; Toda, K; Kimura, H; Sasazuki, T; Shirasawa, S; Okuyama, H; Inoue, M; Hasegawa, S; Togashi, K; Sakai, Y				Iwamoto, Masayoshi; Kawada, Kenji; Nakamoto, Yuji; Itatani, Yoshiro; Inamoto, Susumu; Toda, Kosuke; Kimura, Hiroyuki; Sasazuki, Takehiko; Shirasawa, Senji; Okuyama, Hiroaki; Inoue, Masahiro; Hasegawa, Suguru; Togashi, Kaori; Sakai, Yoshiharu			Regulation of F-18-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS	JOURNAL OF NUCLEAR MEDICINE			English	Article						colon cancer; KRAS; F-18-FDG PET scans; imaging; glucose metabolism	COLON-CANCER; GLUCOSE-METABOLISM; KI-RAS; MUTATIONS; HETEROGENEITY; TUMOR; METASTASES; THERAPY	KRAS gene mutations occur in approximately 40% of colorectal cancers (CRCs) and are associated with resistance to anti-epidermal growth factor receptor antibody therapy. We previously demonstrated that F-18-FDG accumulation in PET was significantly higher in CRCs with mutated KRAS than in those with wild-type KRAS in a clinical setting. Here, we investigated the mechanisms by which mutated KRAS increased F-18-FDG accumulation. Methods: Using paired isogenic human CRC cell lines that differ only in the mutational status of the KRAS gene, we measured F-18-FDG accumulation in these cells in vitro and in vivo. We also investigated the roles of proteins that have a function in F-18-FDG accumulation. Finally, we examined the relationship among mutated KRAS, hypoxia-inducible factor 1 alpha (HIF-1 alpha), and maximum standardized uptake value with 51 clinical CRC samples. Results: In the in vitro experiments, F-18-FDG accumulation was significantly higher in KRAS-mutant cells than in wild-type controls under normoxic conditions. The expression levels of glucose transporter 1 (GLUT1) and hexokinase type 2 (HK2) were higher in KRAS-mutant cells, and F-18-FDG accumulation was decreased by knockdown of GLUT1. Hypoxic induction of HIF-1 alpha was higher in KRAS-mutant cells than in wild-type controls; in turn, elevated HIF-1a resulted in higher GLUT1 expression and F-18-FDG accumulation. In addition, HIF-1 alpha knockdown decreased F-18-FDG accumulation under hypoxic conditions only in the KRAS-mutant cells. Small-animal PET scans showed in vivo F-18-FDG accumulation to be significantly higher in xenografts with mutated KRAS than in those with wild-type KRAS. The immunohistochemistry of these xenograft tumors showed that staining of GLUT1 was consistent with that of HIF-1 alpha and pimonidazole. In a retrospective analysis of clinical samples, KRAS mutation exhibited a significantly positive correlation with expressions of GLUT1 and HIF-1 alpha and with maximum standardized uptake value. Conclusion: Mutated KRAS caused higher F-18-FDG accumulation possibly by upregulation of GLUT1; moreover, HIF-1 alpha additively increased F-18-FDG accumulation in hypoxic lesions. F-18-FDG PET might be useful for predicting the KRAS status noninvasively.	[Iwamoto, Masayoshi; Kawada, Kenji; Itatani, Yoshiro; Inamoto, Susumu; Toda, Kosuke; Hasegawa, Suguru; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Nakamoto, Yuji; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Kimura, Hiroyuki] Kyoto Univ, Div Mol Imaging, Radioisotope Res Ctr, Kyoto, Japan; [Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan; [Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka 81401, Japan; [Okuyama, Hiroaki; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan	Kawada, K (reprint author), 54 Shogoin Kawara Cho,Sakyo Ku, Kyoto 6068507, Japan.	kkawada@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Shimadzu Science Foundation	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a Shimadzu Science Foundation research grant. No other potential conflict of interest relevant to this article was reported.	Kawada K, 2012, CLIN CANCER RES, V18, P1696, DOI 10.1158/1078-0432.CCR-11-1909; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Kikuchi H, 2009, CANCER RES, V69, P8499, DOI 10.1158/0008-5472.CAN-09-2213; Albanese I, 2004, BIOCHEM BIOPH RES CO, V325, P784, DOI 10.1016/j.bbrc.2004.10.111; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Watanabe T, 2011, DIS COLON RECTUM, V54, P1170, DOI 10.1097/DCR.0b013e31821d37a3; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Prante O, 2009, J NUCL MED, V50, P1364, DOI 10.2967/jnumed.109.062331; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Vander Heiden Matthew G, 2009, Science, V324, P1029, DOI 10.1126/science.1160809	22	3	3	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	DEC	2014	55	12					2038	2044		10.2967/jnumed.114.142927		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU8EC	WOS:000345828300022		
J	Yasuda, M				Yasuda, Masanori			Immunohistochemical characterization of endometrial carcinomas: Endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Review						endometrial carcinomas; genetic analysis; immunohistochemistry; uterine corpus	LOWER UTERINE SEGMENT; E-CADHERIN EXPRESSION; RNA-BINDING PROTEINS; MICROSATELLITE INSTABILITY; BETA-CATENIN; GLANDULAR DYSPLASIA; CLINICOPATHOLOGICAL FEATURES; ENDOCERVICAL ADENOCARCINOMAS; PTEN MUTATIONS; INTRAEPITHELIAL CARCINOMA	Developments in immunohistochemistry, which are closely linked with the advances in the analyses of genetic abnormalities and their associated molecular disorders as early and late histogenetic events, have contributed greatly to the improvement of pathological diagnostic confirmation and validation. Immunohistochemistry has also generated great benefit to the innovation of therapeutic strategies for various kinds of cancers. In this article, the three representative histological types of corpus cancer, namely, endometrioid adenocarcinoma, serous adenocarcinoma and clear cell adenocarcinoma, will be histologically approached in association with their immunohistochemical profiles as well as genetic disorders. First, the focus will be on Conventional/prototypic features,' followed by Controversy over conventional histological subclassification,' and subsequently Tumorigenesis and re-subclassification.'	Saitama Med Univ, Int Med Ctr, Dept Pathol, Hidaka, Saitama 3501298, Japan	Yasuda, M (reprint author), Saitama Med Univ, Int Med Ctr, Dept Pathol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	m_yasuda@saitama-med.ac.jp					Acs G, 2004, INT J GYNECOL PATHOL, V23, P110, DOI 10.1097/01.pgp.0000116627.23685.b2; AMBROS RA, 1995, HUM PATHOL, V26, P1260, DOI 10.1016/0046-8177(95)90203-1; Modica I, 2007, AM J SURG PATHOL, V31, P744, DOI 10.1097/01.pas.0000213428.61374.06; Obata K, 1998, CANCER RES, V58, P2095; Fukuchi T, 1998, CANCER RES, V58, P3526; Lax SF, 2004, VIRCHOWS ARCH, V444, P213, DOI 10.1007/s00428-003-0947-3; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; Bansal N, 2009, CANCER CONTROL, V16, P8; Egan JA, 2004, INT J GYNECOL PATHOL, V23, P119, DOI 10.1097/01.pgp.0000116616.98868.ee; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Wright JD, 2009, CANCER, V115, P1276, DOI 10.1002/cncr.24160; Craighead PS, 2000, GYNECOL ONCOL, V77, P248, DOI 10.1006/gyno.2000.5746; Yemelyanova A, 2009, AM J SURG PATHOL, V33, P1504, DOI 10.1097/PAS.0b013e3181ac35f5; Jia L, 2008, CLIN CANCER RES, V14, P2263, DOI 10.1158/1078-0432.CCR-07-4837; Zheng WX, 2008, AM J SURG PATHOL, V32, P304, DOI 10.1097/PAS.0b013e3181483ff8; EIFEL P, 1982, CANCER, V50, P163, DOI 10.1002/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K; Soslow RA, 2007, AM J SURG PATHOL, V31, P979, DOI 10.1097/PAS.0b013e31802ee494; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Schlosshauer PW, 2002, MODERN PATHOL, V15, P1032, DOI 10.1097/01.MP.0000028573.34289.04; Creasman WT, 2004, GYNECOL ONCOL, V95, P593, DOI 10.1016/j.ygyno.2004.08.019; SPIEGEL GW, 1995, AM J SURG PATHOL, V19, P417, DOI 10.1097/00000478-199504000-00003; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Simpkins SB, 1998, GYNECOL ONCOL, V71, P391, DOI 10.1006/gyno.1998.5208; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Soslow RA, 2013, HISTOPATHOLOGY, V62, P89, DOI 10.1111/his.12029; Lax SF, 2000, CANCER, V88, P814, DOI 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U; Zannoni GF, 2010, VIRCHOWS ARCH, V457, P27, DOI 10.1007/s00428-010-0939-z; Tashiro H, 1997, CANCER RES, V57, P3935; Voss MA, 2012, GYNECOL ONCOL, V124, P15, DOI 10.1016/j.ygyno.2011.07.030; Alkushi A, 2010, INT J GYNECOL PATHOL, V29, P343, DOI 10.1097/PGP.0b013e3181cd6552; Lax SF, 1998, HUM PATHOL, V29, P551, DOI 10.1016/S0046-8177(98)80002-6; CARCANGIU ML, 1995, INT J GYNECOL PATHOL, V14, P30, DOI 10.1097/00004347-199501000-00006; Cirisano FD, 2000, GYNECOL ONCOL, V77, P55, DOI 10.1006/gyno.2000.5737; Yokoyama Y, 2000, INT J MOL MED, V6, P47; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; Mueller-Pillasch F, 1999, MECH DEVELOP, V88, P95, DOI 10.1016/S0925-4773(99)00160-4; Halperin R, 2002, EUR J GYNAECOL ONCOL, V23, P300; Risinger JI, 1997, CANCER RES, V57, P4736; Hayes MP, 2006, CLIN CANCER RES, V12, P5932, DOI 10.1158/1078-0432.CCR-06-1375; Alektiar KM, 2002, INT J RADIAT ONCOL, V54, P79, DOI 10.1016/S0360-3016(02)02913-9; Westin SN, 2008, J CLIN ONCOL, V26, P5965, DOI 10.1200/JCO.2008.18.6296; Yamamoto S, 2007, HUM PATHOL, V38, P1074, DOI 10.1016/j.humpath.2006.12.018; Zheng WX, 2004, INT J SURG PATHOL, V12, P207, DOI 10.1177/106689690401200302; ULBRIGHT TM, 1985, HUM PATHOL, V16, P28, DOI 10.1016/S0046-8177(85)80210-0; Ioffe OB, 1998, HUM PATHOL, V29, P1150, DOI 10.1016/S0046-8177(98)90429-4; Cirisano FD, 1999, GYNECOL ONCOL, V74, P385, DOI 10.1006/gyno.1999.5505; Vasen HFA, 2004, DIS MARKERS, V20, P207; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Tafe LJ, 2010, MODERN PATHOL, V23, P781, DOI 10.1038/modpathol.2010.41; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/008-5472.CAN-05-2620; Yemelyanova A, 2009, AM J SURG PATHOL, V33, P914, DOI 10.1097/PAS.0b013e3181971fdd; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Alvarez T, 2012, AM J SURG PATHOL, V36, P753, DOI 10.1097/PAS.0b013e318247b7bb; Boruta DM, 2004, CANCER, V101, P2214, DOI 10.1002/cncr.20645; Reid-Nicholson M, 2006, MODERN PATHOL, V19, P1091, DOI 10.1038/modpathol.3800620; Aquino-Parsons C, 1998, GYNECOL ONCOL, V71, P83, DOI 10.1006/gyno.1998.5147; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bussaglia E, 2000, HUM PATHOL, V31, P312, DOI 10.1016/S0046-8177(00)80244-0; CARCANGIU ML, 1990, AM J CLIN PATHOL, V94, P247; Darvishian Farbod, 2004, American Journal of Surgical Pathology, V28, P1568, DOI 10.1097/00000478-200412000-00004; desLeeuw WJ, 2000, J PATHOL, V192, P328; Fadare O, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-6; Faquin WC, 2000, GYNECOL ONCOL, V78, P152, DOI 10.1006/gyno.2000.5858; Foundation for Promotion of Cancer Research, 2013, CANC STAT JAP 2013; Goldstein NS, 2002, AM J CLIN PATHOL, V117, P541; Guida M, 2009, EUR J GYNAECOL ONCOL, V30, P267; Gynecology JSoOa, 2013, TREATM GUID UT BOD C; Hachisuga T, 1996, PATHOLOGY, V28, P28; Hachisuga T, 2001, CANCER, V92, P2578, DOI 10.1002/1097-0142(20011115)92:10<2578::AID-CNCR1610>3.0.CO;2-V; HACHISUGA T, 1989, INT J GYNECOL PATHOL, V8, P26, DOI 10.1097/00004347-198903000-00004; Hirabayashi K, 2009, INT J GYNECOL PATHOL, V28, P262, DOI 10.1097/PGP.0b013e31818e101f; Holcomb K, 2002, OBSTET GYNECOL, V100, P1290, DOI 10.1016/S0029-7844(02)02391-8; Jacques SM, 1997, INT J GYNECOL PATHOL, V16, P38, DOI 10.1097/00004347-199701000-00007; Japan Society of Obstetrics and Gynecology The Japanese Society of Pathology Japan Radiological Society Japanese Society for Therapeutic Radiology and Oncology, 2012, GEN RUL CLIN PATH MA, V3rd; JIKO K, 1994, INT J CANCER, V59, P601, DOI 10.1002/ijc.2910590505; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Kong CS, 2010, AM J SURG PATHOL, V34, P915, DOI 10.1097/PAS.0b013e3181e3291e; Konopka B, 2007, J CANCER RES CLIN, V133, P361, DOI 10.1007/s00432-006-0179-4; Kurman RJ, 2011, BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT, SIXTH EDITION, P1, DOI 10.1007/978-1-4419-0489-8; MALPICA A, 1995, AM J SURG PATHOL, V19, P769, DOI 10.1097/00000478-199507000-00004; Martin-Ondarza C, 2005, EUR J GYNAECOL ONCOL, V26, P55; Masuda K, 2011, CURR GENOMICS, V12, P25, DOI 10.2174/138920211794520169; Maxwell GL, 2005, CLIN CANCER RES, V11, P4056, DOI 10.1158/1078-0432.CCR-04-2001; McConechy MK, 2014, MODERN PATHOL, V27, P128, DOI 10.1038/modpathol.2013.107; Mell LK, 2004, CLIN CANCER RES, V10, P5546, DOI 10.1158/1078-0432.CCR-0943-03; Mhawech-Fauceglia P, 2010, EJSO-EUR J SURG ONC, V36, P1195, DOI 10.1016/j.ejso.2010.09.010; Yasuda M, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-25; Murray SK, 2005, AM J SURG PATHOL, V29, P157, DOI 10.1097/01.pas.0000149704.89463.05; Park JY, 2013, VIRCHOWS ARCH, V462, P289, DOI 10.1007/s00428-013-1382-8; Peiro G, 2002, HUM PATHOL, V33, P347, DOI 10.1053/hupa.2002.32220; Saegusa M, 2003, CANCER SCI, V94, P103, DOI 10.1111/j.1349-7006.2003.tb01360.x; Schlosshauer PW, 2000, MODERN PATHOL, V13, P1066, DOI 10.1038/modpathol.3880196; Scholten AN, 2006, INT J GYNECOL CANCER, V16, P1379, DOI 10.1111/j.1525-1438.2006.00406.x; SHERMAN ME, 1992, AM J SURG PATHOL, V16, P600, DOI 10.1097/00000478-199206000-00008; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soslow RA, 2000, INT J GYNECOL PATHOL, V19, P329, DOI 10.1097/00004347-200010000-00006; Tavassoli F.A., 2003, WHO CLASSIFICATION T; Ueda SM, 2008, AM J OBSTET GYNECOL, V198, P218; Velasco A, 2006, HUM PATHOL, V37, P1465, DOI 10.1016/j.humpath.2006.05.007; Watanabe Y, 2001, INT J GYNECOL PATHOL, V20, P368, DOI 10.1097/00004347-200110000-00009; Williams JA, 1999, EXP MOL PATHOL, V67, P135, DOI 10.1006/exmp.1999.2289; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6; Zaino R, 2014, WHO CLASSIFICATION T, P121; Zheng WX, 2005, GYNECOL ONCOL, V96, P579, DOI 10.1016/j.ygyno.2004.12.045; Zheng WX, 2007, INT J GYNECOL PATHOL, V26, P38, DOI 10.1097/01.pgp.0000228138.56222.4e; Zheng WX, 2011, AM J SURG PATHOL, V35, pE1, DOI 10.1097/PAS.0b013e318202772e	108	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	DEC	2014	40	12					2167	2176		10.1111/jog.12564		10	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8DA	WOS:000345825500001		
J	Nishida, R; Morikawa, M; Yamada, T; Akaishi, R; Yamada, T; Minakami, H				Nishida, Ryutaro; Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Yamada, Takashi; Minakami, Hisanori			Liver dysfunction in triplet pregnancies: Relation to antenatal changes in antithrombin activity and platelet count	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						acute fatty liver of pregnancy; antithrombin activity; blood vessel permeability; HELLP syndrome; liver dysfunction; thrombocytopenia	ACUTE FATTY LIVER; DISSEMINATED INTRAVASCULAR COAGULATION; SEVERE PREECLAMPSIA; TWIN PREGNANCIES; HELLP-SYNDROME; III ACTIVITY; HEMOLYSIS; ENZYMES; DEFICIENCY; MORBIDITY	AimThe aim of this study was to determine whether antenatal decline in antithrombin (AT) activity occurs frequently and precedes the development of perinatal liver dysfunction in women with triplet pregnancies. Material and MethodsA retrospective observational study was conducted on all women who gave birth to triplets at gestational week 22 at a single centre during a study period from January 2001 to March 2013. The following eight blood parameters were monitored weekly during the last 5 weeks of pregnancy and postpartum: AT activity, platelet count, fibrinogen, D-dimer, aspartate aminotransferase (AST), lactate dehydrogenase (LDH), uric acid and creatinine. Pregnancy-induced AT deficiency (PIATD) and gestational thrombocytopenia were defined as antenatal AT activity <70% of normal level and antenatal platelet count <150x10(9)/L, respectively. Liver dysfunction was defined as AST >40 IU/L. LDH elevation was defined as LDH >450 IU/L. ResultsSixteen women were eligible for this study. All variables except LDH exhibited significant changes antenatally: AT activity, platelet count and fibrinogen decreased, while D-dimer, AST, urate and creatinine increased. LDH increased significantly postpartum. PIATD, gestational thrombocytopenia, perinatal liver dysfunction, and LDH elevation occurred in eight, seven, six, and eight women, respectively. Liver dysfunction was preceded by PIATD alone in three, by both PIATD and gestational thrombocytopenia in one and by gestational thrombocytopenia alone in none of the subjects. After delivery, laboratory abnormalities similar to HELLP syndrome were seen in three women exclusively in the presence of PIATD. ConclusionsReduced AT activity was likely to precede perinatal liver dysfunction in women with triplets.	[Nishida, Ryutaro; Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Yamada, Takashi; Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido 0608638, Japan	Nishida, R (reprint author), Hokkaido Univ, Grad Sch Med, Dept Obstet, Kita Ku N14 W6, Sapporo, Hokkaido 0608638, Japan.	nishiryu@huhp.hokudai.ac.jp					Albrecht L, 1996, AM J OBSTET GYNECOL, V174, P1551; Castro MA, 1996, AM J OBSTET GYNECOL, V174, P211, DOI 10.1016/S0002-9378(96)70396-4; Martin JN, 1999, AM J OBSTET GYNECOL, V180, P1373, DOI 10.1016/S0002-9378(99)70022-0; Morikawa M, 2010, J PERINAT MED, V38, P379, DOI 10.1515/JPM.2010.049; Knight M, 2008, GUT, V57, P951, DOI 10.1136/gut.2008.148676; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P501; AARNOUDSE JG, 1986, BRIT J OBSTET GYNAEC, V93, P145, DOI 10.1111/j.1471-0528.1986.tb07879.x; Fesenmeier MF, 2005, AM J OBSTET GYNECOL, V192, P1416, DOI 10.1016/j.ajog.2004.12.035; VANDAM PA, 1989, OBSTET GYNECOL, V73, P97; Pereira SP, 1997, HEPATOLOGY, V26, P1258; Ch'ng CL, 2002, GUT, V51, P876, DOI 10.1136/gut.51.6.876; Aso K, 2010, J MATERN-FETAL NEO M, V23, P1047, DOI 10.3109/14767050903353232; Goel A, 2011, GUT, V60, P138, DOI 10.1136/gut.2009.198465; HELLGREN M, 1983, GYNECOL OBSTET INVES, V16, P107; Izumi A, 1998, J Obstet Gynaecol Res, V24, P275; Malone FD, 1998, AM J PERINAT, V15, P73, DOI 10.1055/s-2007-993902; Matsuda Yoshio, 1994, Obstetrics and Gynecology, V84, P678; Minakami H, 1982, Nihon Sanka Fujinka Gakkai Zasshi, V34, P637; Minakami H, 1999, J HEPATOL, V30, P603, DOI 10.1016/S0168-8278(99)80190-1; Minakami H, 1998, GYNECOL OBSTET INVES, V46, P41, DOI 10.1159/000009995; Morikawa Mamoru, 2012, Hokkaido Igaku Zasshi, V87, P141; MOSVOLD J, 1982, SCAND J HAEMATOL, V29, P48; Sakr Y, 2007, ANESTH ANALG, V105, P715, DOI 10.1213/01.ane.0000275194.86608.ac; Tsunoda T, 2002, ACTA OBSTET GYN SCAN, V81, P840, DOI 10.1034/j.1600-0412.2002.810907.x; Vigil-De GP, 2001, INT J GYNECOL OBSTET, V72, P193; WEINSTEIN L, 1982, AM J OBSTET GYNECOL, V142, P159; Yamada T, 2013, HYPERTENS PREGNANCY, V32, P235, DOI 10.3109/10641955.2013.792346	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	DEC	2014	40	12					2177	2183		10.1111/jog.12470		7	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8DA	WOS:000345825500002		
J	Sadakata, H; Shinozaki, H; Higuchi, T; Minegishi, T				Sadakata, Hisanobu; Shinozaki, Hiromitsu; Higuchi, Tetsuya; Minegishi, Takashi			Case of radioactive iodine exposure during pregnancy	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						congenital abnormalities; fetal thyroid function; iodine radioisotopes; maternal exposure; radiation effect	HYPOTHYROIDISM	A 43-year-old woman (gravida 0, para 0) was diagnosed with thyroid carcinoma and had been receiving radioactive iodine for remnant ablation. Eventually, her pregnant status became apparent; during radiation, she was at 5 gestational weeks. She decided to continue the pregnancy and delivered a boy of 2362g at 37 gestational weeks. The infant did not present thyroid dysfunction or developmental abnormalities at 2 months of age. The patient was in the early pregnancy stage during radiation, so the fetus did not develop radiation-related damage of the thyroid gland because at this stage, the fetal thyroid does not concentrate iodine. Although the mother had received radioactive iodine during the critical organogenesis period, the fetus did not develop teratogenicity because the radiation was administered at the borderline threshold for teratogenicity. This case suggests the importance of iodine thyroid absorption when considering radiation-related damage to the fetal thyroid gland during early pregnancy.	[Sadakata, Hisanobu; Minegishi, Takashi] Gunma Univ, Grad Sch Med, Dept Obstet & Gynecol, Maebashi, Gunma 3718511, Japan; [Higuchi, Tetsuya] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 3718511, Japan; [Shinozaki, Hiromitsu] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma 3718511, Japan	Sadakata, H (reprint author), Gunma Univ, Grad Sch Med, Dept Obstet & Gynecol, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan.	hsadakat@gunma-u.ac.jp					ABUHAMAD AZ, 1995, ULTRASOUND OBST GYN, V6, P368, DOI 10.1046/j.1469-0705.1995.06050368.x; [Anonymous], 1984, ANN ICRP, V14, P1; De Santis M, 2005, REPROD TOXICOL, V20, P323, DOI 10.1016/j.reprotox.2005.04.004; STABIN MG, 1991, J NUCL MED, V32, P808; Brent RL, 1999, TERATOLOGY, V59, P182, DOI 10.1002/(SICI)1096-9926(199904)59:4<182::AID-TERA2>3.0.CO;2-H; Evans PMS, 1998, CLIN ENDOCRINOL, V48, P281; FISHER DA, 1981, NEW ENGL J MED, V304, P702, DOI 10.1056/NEJM198103193041205; International Commission on Radiological Protection, 2000, ANN ICRP, V30, P1; Kukulska Aleksandra, 2010, Thyroid Res, V3, P9, DOI 10.1186/1756-6614-3-9; Kurtoglu S, 2012, J CLIN RES PEDIATR E, V4, P111, DOI 10.4274/jcrpe.553; Kusama Tomoko, 2002, Congenital Anomalies, V42, P10, DOI 10.1111/j.1741-4520.2002.tb00848.x; Ogris E, 1997, ACTA MED AUST, V24, P150; RICHARDS GE, 1981, J PEDIATR-US, V99, P141, DOI 10.1016/S0022-3476(81)80980-8; Streffer C, 2003, Ann ICRP, V33, P5	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	DEC	2014	40	12					2201	2203		10.1111/jog.12482		3	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8DA	WOS:000345825500005		
J	Yagi, N; Nakahashi, H; Kashima, Y; Miyazawa, M				Yagi, Nobuo; Nakahashi, Hiroshi; Kashima, Yusei; Miyazawa, Mitsuo			Isolation and Biological Activity of a Novel Cadinane-type Sesquiterpenoid from the Essential Oil of Alangium salviifolium	JOURNAL OF OLEO SCIENCE			English	Article						7, 8-dihydroxycalamenal; novel compound; Alangium salviifolium; sesquiterpenoid; tyrosinase	BIOSYNTHESIS; LAMARCKII; ALKALOIDS	The components of the essential oil from the roots of Alangium salviifolium were analyzed by capillary gas chromatography-mass spectrometry (GC-MS). Ninety compounds, representing 74.5% of the total oil, were identified; the main components of the oil were epi-alpha-cadinol, followed by trans-2hydroxycalamenene, cadalene, and cadina-4,10(15)-dien-3-one. A further unknown component comprised 5.5% of the oil. Therefore, the essential oil was purified by flash column chromatography to isolate this component. Its structure was established using extensive spectroscopic data analyses, including NMR, HR-EI-MS, and IR. The results showed that this isolated compound was (-)-7, 8-dihydroxycalamenal, which is a novel cadinane-type sesquiterpenoid. This compound was tested for its antioxidant activity and inhibition of tyrosinase, and showed particularly strong inhibition effects.	[Yagi, Nobuo; Nakahashi, Hiroshi; Kashima, Yusei] Picaso Cosmet Lab Ltd, Nishinomia, Hyogo 6620911, Japan; [Nakahashi, Hiroshi; Kashima, Yusei; Miyazawa, Mitsuo] Kinki Univ, Kindai Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan	Miyazawa, M (reprint author), Kinki Univ, Kindai Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Ahad H. A., 2011, J SCI RES RAJSHAHI B, V3, P393; Baek S, 2008, J MICROBIOL BIOTECHN, V18, P874; Hung TM, 2009, BIOORG MED CHEM LETT, V19, P4389, DOI 10.1016/j.bmcl.2009.05.070; Silva GH, 2006, PHYTOCHEMISTRY, V67, P1964, DOI 10.1016/j.phytochem.2006.06.004; Pailee P, 2011, EUR J ORG CHEM, P3809, DOI 10.1002/ejoc.201100423; Anjum A, 2002, FITOTERAPIA, V73, P526, DOI 10.1016/S0367-326X(02)00178-8; Zulueta A, 2009, FOOD CHEM, V114, P310, DOI 10.1016/j.foodchem.2008.09.033; Itoh A, 2000, J NAT PROD, V63, P723, DOI 10.1021/np0000163; Baek HS, 2008, B KOREAN CHEM SOC, V29, P43; Bama P., 2012, INT J PHARM PHARM SC, V4, P210; Chen M. J., 1980, ZHIWU XUEBAO, V22, P257; Croft K., 1978, J CHEM SOC PERK T, V1, P1267; Fujiwara M, 2011, NAT PROD RES, V25, P1540, DOI 10.1080/14786410903313106; Hou L., 1981, ZHONGCAOYAO, V12, P352; Jain R., 2011, PHARMACOLOGYONLINE, V2, P755; Jain S, 2002, PHYTOCHEMISTRY, V60, P853, DOI 10.1016/S0031-9422(02)00057-2; Leelapornpisid P, 2008, ACTA HORTIC, V786, P61; Murugan V., 2002, Journal of Natural Remedies, V2, P66; Nagashima F, 1996, PHYTOCHEMISTRY, V42, P1361, DOI 10.1016/0031-9422(96)00105-7; Ramani VA, 2003, ASIAN J CHEM, V15, P1693; Yagi N., 2006, J OLEO SCI, V55, P173	21	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1223	1229		10.5650/jos.ess14059		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500002		
J	Yamamoto, Y; Mizuta, EI; Ito, M; Harata, M; Hiramoto, S; Hara, S				Yamamoto, Yukihiro; Mizuta, En I.; Ito, Mizue; Harata, Masataka; Hiramoto, Shigeru; Hara, Setsuko			Lipase-catalyzed Preparation of Phospholipids Containing n-3 Polyunsaturated Fatty Acids from Soy Phospholipids	JOURNAL OF OLEO SCIENCE			English	Article						phospholipids; lipase; DHA; EPA; PUPA; transacylation; synthesis	ARACHIDONIC-ACID; LIPIDS; DIETS	To utilize n-3 polyunsaturated fatty acid (PUFA) for a wide range of applications, we prepared phospholipids (PLs) containing PUFAs as constituent fatty acids (PUFA-PLs) via commercially available lipase OF-mediated transacylation with PL from soy (Soy-PL) and ethyl ester of PUFA (PUFA-Et). In a preliminary study to evaluate PUFA-incorporation (wt%) on phosphatidylcholine (PC), we observed that dehydration of Soy-PL is critical. PUFA-incorporation in PLs increased with acyl ratio and time. Finally, maximum PUFA-incorporation (47.1 +/- 2.1 wt%) was obtained using the following reaction conditions: 2.0 mmol of Soy-PL, a PUFA-Et/Soy-PL acyl ratio of 7, 13 mL of hexane, 2.2 x 10(5) U of lipase OF, 500 rpm of agitation, a temperature of 37 degrees C, and 72 h of reaction time. The analysis of fatty acid composition at the sn-2 position of obtained PL revealed that PUFAs incorporated into Soy-PL localized to the sn-2 position of the PL molecule in spite of using lipase OF whose positional specificity is random for triacylglycerol.	[Yamamoto, Yukihiro; Mizuta, En I.; Hara, Setsuko] Seikei Univ, Fac Sci & Technol, Musashino, Tokyo 1808633, Japan; [Ito, Mizue; Harata, Masataka; Hiramoto, Shigeru] Nisshin Pharma Inc, Saitama 3568511, Japan	Yamamoto, Y (reprint author), Seikei Univ, Fac Sci & Technol, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.	yyamamoto@st.seikei.ac.jp					Ackman K. G., 1974, J FISH RES BOARD CAN, V31, P1812; Amate L, 1999, LIPIDS, V34, P865, DOI 10.1007/s11745-999-0434-0; MEYDANI SN, 1993, J CLIN INVEST, V92, P105, DOI 10.1172/JCI116537; Jenski LJ, 1995, P SOC EXP BIOL MED, V210, P227; MUKHERJEE KD, 1993, APPL MICROBIOL BIOT, V40, P489; Akiba S, 2000, BIOL PHARM BULL, V23, P1293; Trebble TM, 2003, AM J CLIN NUTR, V78, P376; Korbecki J, 2013, J PHYSIOL PHARMACOL, V64, P409; Awada M, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-23; Awano S, 2006, FISHERIES SCI, V72, P909, DOI 10.1111/j.1444-2906.2006.01236.x; Connye N. K., 2013, NEUTRIENTS, V5, P2777; HOLUB BJ, 1988, CAN MED ASSOC J, V139, P377; Ishigamori H, 2005, MOL CELL BIOCHEM, V275, P127, DOI 10.1007/s11010-005-1090-z; JHAM GN, 1982, J AM OIL CHEM SOC, V59, P132, DOI 10.1007/BF02662261; Kim IH, 2007, ENZYME MICROB TECH, V40, P1130, DOI 10.1016/j.enzmictec.2006.08.018; Larsen LN, 1997, LIPIDS, V32, P707, DOI 10.1007/s11745-997-0090-4; Laura A., 2001, J NUTR, V131, P1250; Martin R., 2012, PLOS ONE, V7; Mayzaud D, 1978, LIPIDS, V13, P24; TOTANI Y, 1991, J AM OIL CHEM SOC, V68, P848, DOI 10.1007/BF02660600	20	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1275	1281		10.5650/jos.ess14125		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500008		
J	Haraguchi, H; Yamada, K; Miyashita, R; Aida, K; Ohnishi, M; Gilbert, A; Yoshida, N				Haraguchi, Hiroyuki; Yamada, Keita; Miyashita, Rumiko; Aida, Kazuhiko; Ohnishi, Masao; Gilbert, Alexis; Yoshida, Naohiro			Determination of Carbon Isotopic Measurement Conditions for Ceramide in Skin using Gas Chromatography-Combustion-Isotope Ratio Mass Spectrometry	JOURNAL OF OLEO SCIENCE			English	Article						carbon stable isotope ratio; ceramide; derivatization; GC-C-IRMS; glucosylceramide	INTESTINAL TRACT; MAIZE GLUCOSYLCERAMIDE; HAIRLESS MICE; METABOLISM; SPHINGOMYELIN; LIPIDS; LEVEL	The ceramide (Cer) content of skin and glucosylceramide (GlcCer) intake affect skin moisture conditions, but their mutual relation in skin remains unclear. For clarification of that mutual relation, carbon stable isotopes (C-12 and C-13) are useful as a tracer. However, carbon isotopic measurement has not been applied to the study of clarifying their skin moisturizing effects. Therefore, we used gas chromatography / combustion / isotope ratio mass spectrometry (GC-C-IRMS) to ascertain the appropriate conditions for carbon isotopic measurements using synthesized Cer (SCer) in substitution for very low concentrations of Cer in skin. SCer was derivatized to trimethylsilylated SCer (TMS-SCer) quantitatively using N-trimethylsilylimidazole (TMSI) depending on the amount of SCer. The derivatization rates were 75-85%. Excess TMSI was removed using three cycles of hexane water distribution. Under these conditions, carbon isotopic measurements of TMS-SCer conducted using GC-C-IRMS showed high repeatability and good inter-day variation (S.D. < 0.3%o). The carbon stable isotope ratio value (delta C-13) of SCer calculated using a mass balance equation was compared with delta C-13 of underivatized SCer, which was regarded as the actual delta C-13 of SCer obtained using sealed tube combustion method. The difference between the calculated delta C-13 of SCer and delta C-13 of the underivatized SCer depended on the TMSI reagent supplier and on the number of hydroxyl groups to be derivatized in SCer. For accurate delta C-13 of Cer in skin using GC-C-IRMS, the measured delta C-13 of a target TMS-Cer must be calculated using a correction factor representing the difference in delta C-13 of underivatized standard SCer from that of TMS-standard SCer having a structure resembling that of the target Cer in skin. In addition, we show that the same lot of TMSI reagent from a specific supplier must be used throughout the experiments.	[Haraguchi, Hiroyuki; Miyashita, Rumiko; Aida, Kazuhiko] Nippon Flour Mills Co Ltd, Cent Lab, Atsugi, Kanagawa 2430041, Japan; [Haraguchi, Hiroyuki; Yamada, Keita; Yoshida, Naohiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268502, Japan; [Ohnishi, Masao] Fuji Womens Univ Ishikari, Dept Food Sci & Human Nutr, Ishikari, Hokkaido 0643204, Japan; [Gilbert, Alexis; Yoshida, Naohiro] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan	Haraguchi, H (reprint author), Nippon Flour Mills Co Ltd, Cent Lab, Atsugi, Kanagawa 2430041, Japan.	haraguchi@fasmac.co.jp	Yoshida, Naohiro/A-8335-2010	Yoshida, Naohiro/0000-0003-0454-3849	 [23224013]	This work was supported by the Grant-in-Aid for Scientific Research (#23224013)	Sugawara T, 2010, J LIPID RES, V51, P1761, DOI 10.1194/jlr.M002204; Chikaraishi Y, 2006, CHEM GEOL, V231, P190, DOI 10.1016/j.chemgeo.2006.01.026; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V187, P113, DOI 10.1016/0005-2760(69)90138-6; Meier-Augenstein W, 2002, ANAL CHIM ACTA, V465, P63, DOI 10.1016/S0003-2670(02)00194-0; Sugawara T, 2003, J NUTR, V133, P2777; Piper T, 2008, RAPID COMMUN MASS SP, V22, P2161, DOI 10.1002/rcm.3601; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339, DOI 10.1016/0005-2760(69)90192-1; NILSSON A, 1968, BIOCHIM BIOPHYS ACTA, V164, P575, DOI 10.1016/0005-2760(68)90187-2; Rogers J, 1996, ARCH DERMATOL RES, V288, P765, DOI 10.1007/BF02505294; Asai Satomi, 2007, Rinsho Byori, V55, P209; Bleton J, 2001, J CHROMATOGR A, V917, P251, DOI 10.1016/S0021-9673(01)00680-X; BRUYNES CA, 1982, J ORG CHEM, V47, P3966, DOI 10.1021/jo00141a031; CASPARRI.G, 1969, CHEM PHYS LIPIDS, V3, P1, DOI 10.1016/0009-3084(69)90024-3; Ishikawa J, 2009, J DERMATOL SCI, V56, P216, DOI 10.1016/j.jdermsci.2009.09.002; Masukawa Y, 2005, J CHROMATOGR B, V823, P131, DOI 10.1016/j.jchromb.2005.06.014; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Shimada E, 2011, J OLEO SCI, V60, P321, DOI 10.5650/jos.60.321; Tsuji K, 2006, J DERMATOL SCI, V44, P101, DOI 10.1016/j.jdermsci.2006.08.005; Uchiyama T, 2008, J HEALTH SCI, V54, P559, DOI 10.1248/jhs.54.559; Ueda O, 2010, DRUG METAB PHARMACOK, V25, P456, DOI 10.2133/dmpk.DMPK-10-RG-038; Ueki M, 1999, RAPID COMMUN MASS SP, V13, P2237, DOI 10.1002/(SICI)1097-0231(19991130)13:22<2237::AID-RCM780>3.0.CO;2-C	21	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1283	1291		10.5650/jos.essI4131		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500009		
J	Takeuchi, H; Morita, R; Shirai, Y; Nakagawa, Y; Terashima, T; Ushikubo, S; Matsuo, T				Takeuchi, Hiroyuki; Morita, Ritsuko; Shirai, Yoko; Nakagawa, Yoshihisa; Terashima, Teruya; Ushikubo, Shun; Matsuo, Tatsuhiro			Lowering Effect of Firefly Squid Powder on Triacylglycerol Content and Glucose-6-Phosphate Dehydrogenase Activity in Rat Liver	JOURNAL OF OLEO SCIENCE			English	Article						firefly squid; liver lipid; DNA microarray; lipogenic enzyme; triacylglycerol	NUTRITIONAL REGULATION; SERUM; HEPATOCYTES; METABOLISM; CULTURES; TAURINE; LEVEL	Effects of dietary firefly squid on serum and liver lipid levels were investigated. Male Wistar rats were fed a diet containing 5% freeze-dried firefly squid or Japanese flying squid for 2 weeks. There was no significant difference in the liver triacylglycerol level between the control and Japanese flying squid groups, but the rats fed the firefly squid diet had a significantly lower liver triacylglycerol content than those fed the control diet. No significant difference was observed in serum triacylglycerol levels between the control and firefly squid groups. The rats fed the firefly squid had a significantly lower activity of liver glucose-6- phosphate dehydrogenase compared to the rats fed the control diet. There was no significant difference in liver fatty acid synthetase activity among the three groups. Hepatic gene expression and lipogenic enzyme activity were investigated; a DNA microarray showed that the significantly enriched gene ontology category of down-regulated genes in the firefly squid group was "lipid metabolic process". The firefly squid group hat lower mRNA level of glucose-6-phosphate dehydrogenase compared to the controls. These results suggest that an intake of firefly squid decreases hepatic triacylglycerol in rats, and the reduction of mRNA level and enzyme activity of glucose-6-phosphate dehydrogenase might be related to the mechanisms.	[Takeuchi, Hiroyuki; Morita, Ritsuko] Toyama Coll, Dept Food & Nutr, Gankai Ji, Toyama 9300193, Japan; [Shirai, Yoko] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Nakagawa, Yoshihisa; Terashima, Teruya] Toyama Prefectural Agr Forestry & Fisheries Res C, Food Res Inst, Toyama 9398153, Japan; [Ushikubo, Shun; Matsuo, Tatsuhiro] Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan	Takeuchi, H (reprint author), Toyama Coll, Dept Food & Nutr, 444 Mizuguchi, Gankai Ji, Toyama 9300193, Japan.	takeuchi@toyama-c.ac.jp			Toyama Higher Education Foundation; Hokuriku Industrial Advancement Center [24HIAC-123]	We thank the Toyama Firefly Squid Association for providing the firefly squid samples. We also thank Bio Matrix Research, Inc. for the technical assistance with the microarray analysis. This study was supported in part by a research grant from the Toyama Higher Education Foundation in 2011, and a grant from the Hokuriku Industrial Advancement Center in 2012 (24HIAC-123).	Kondziella D, 2008, PHYSIOL RES, V57, P487; FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7; Takeuchi H, 2013, BIOSCI BIOTECH BIOCH, V77, P1219, DOI 10.1271/bbb.120983; SUGIYAMA K, 1984, AGR BIOL CHEM TOKYO, V48, P2897; KELLEY DS, 1986, BIOCHEM J, V235, P87; VICKERY HB, 1946, YALE J BIOL MED, V18, P473; Chugh A, 2003, PROG LIPID RES, V42, P37, DOI 10.1016/S0163-7827(02)00029-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; HARPER AE, 1959, J NUTR, V68, P405; Hayashi K., 2000, REAL FACE FIREFLY SQ, P59; IKEDA I, 1994, J NUTR, V124, P1898; IWASAKI M, 1984, B JPN SOC SCI FISH, V50, P1623; Japan Food Research Laboratories Cholesterol, 2001, GUID AN MAN STAND TA, P228; Japan Food Research Laboratories Lipids, 2001, GUID AN MAN STAND TA, P37; KELLEY DS, 1984, BIOCHEM J, V217, P543; Ozawa A., 1984, NIPPON EIYO SHOKURYO, V37, P561; Salati LM, 2004, J NUTR, V134, p2437S; SUGIYAMA K, 1989, AGR BIOL CHEM TOKYO, V53, P1647; Tanaka K, 1998, BIOSCI BIOTECH BIOCH, V62, P1369, DOI 10.1271/bbb.62.1369; Tanaka K, 2001, LIPIDS, V36, P461, DOI 10.1007/s11745-001-0743-3	20	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1293	1301		10.5650/jos.ess14149		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500010		
J	Jo, K; Ishizuka, M; Shimabayashi, K; Ando, T				Jo, Kiyokazu; Ishizuka, Motoyoshi; Shimabayashi, Katsuomi; Ando, Tsuyoshi			Development of New Mineral Oil-Based Antifoams Containing Size-controlled Hydrophobic Silica Particles for Gloss Paints	JOURNAL OF OLEO SCIENCE			English	Article						mineral oil; antifoam; hydrophobic silica; solid particle; foam film		Water-based architectural paints commonly contain either mineral oil-based or silicone-based antifoams. Mineral oil-based antifoams generally reduce the gloss of paint films; thus, silicone-based antifoams are mainly used in the field of architectural paints. The relationship between the antifoaming performance and the particle size of hydrophobic silica for mineral oil-based antifoams was investigated and a novel mineral oil-based antifoam that provided a glossy surface to the paint films equivalent to the surface obtained with silicone-based antifoams and with excellent antifoaming performance compared to silicone-based antifoams was developed. The novel mineral oil-based antifoam exhibits better performance than silicon-based antifoam, and thus the former is a perfect alternative to the latter for use in architectural paints.	[Jo, Kiyokazu] Sanyo Chem Ind Ltd, Surfactants Res Dept, Higashiyama Ku, Kyoto 6050995, Japan; [Ishizuka, Motoyoshi; Shimabayashi, Katsuomi; Ando, Tsuyoshi] San Nopco Ltd, Dept Res & Dev, Tokai, Ibaraki 4760005, Japan	Ishizuka, M (reprint author), San Nopco Ltd, Dept Res & Dev, Coating Chem Grp, 31-1 Shimpo Cho, Tokai, Ibaraki 4760005, Japan.	ishizuka-m@sannopco.co.jp					Ando T, 2012, NEWS SANYO CHEM IND, V470, P1; Cao J. N., 2002, J COATING TECHNOL, V42, P70; Denkov N. D., 2006, COLLOIDAL PARTICLES, P383, DOI 10.1017/CBO9780511536670.011; Hayashi Y., 2000, APPL ANTI FOAMING AG, P125; Kiryu H., 1989, ADDITIVES PAINT INK, P175; Miura F, 2007, CASES FOAM CONTROL A, P85; Nakanishi S, 1981, ACTUAL KNOWLEDGE PAI, P110; Pugh RJ, 1996, ADV COLLOID INTERFAC, V64, P67, DOI 10.1016/0001-8686(95)00280-4; Ross S, 1944, IND ENG CHEM, V36, P570, DOI 10.1021/ie50414a019; Sasage T., 1997, J JPN COAT ASS, V32, P357; Sasaki T., 1993, J JPN OIL CHEM SOC, V42, P712; Tamura T., 2000, SURFACE, V38, P482; Technical Division of Kansai Paint, 2001, LAT BAS TECHN WAT BA, P1	13	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1303	1308		10.5650/jos.ess14110		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500011		
J	Koga, K; Kimura, T; Sakai, K; Kushida, H; Yoshikawa, N				Koga, Kenjiro; Kimura, Toshiyuki; Sakai, Kenichi; Kushida, Hiroshi; Yoshikawa, Nobuji			Physicochemical and Structural Properties of Glycerin Gel Prepared using Glycyrrhizic Acid Diethyl Ester	JOURNAL OF OLEO SCIENCE			English	Article						glycerin; glycyrrhizic acid; gelation; rheology; NMR	ABSORPTION; DIFFUSION; HYDROGELS; TEXTURE; RATS	Glycyrrhizic acid diethyl ester (GZ-DE) was developed as a prodrug of glycyrrhizic acid (GZ), a hepatitis therapeutic drug. We fortuitously found that GZ-DE gels with glycerin selectively while searching for a safe solvent with which to dissolve GZ-DE. Based on this gelation, the aim of this study was to investigate the preparation of the gel and study the rheology, physicochemical and structural properties of the glycerin gel by differential scanning calorimeter (DSC), capillary electrophoresis (CEP), nuclear magnetic resonance (NMR), and small angle X-ray scattering (SAXS). The glycerin gel was prepared by the addition of at least 2.0% w/w GZ-DE. This gel did not flow at room temperature. After mixing glycerin and GZ-DE, a gel was formed after 2 days at 25 degrees C or 3 h at 60 degrees C. Glycerin gel containing 2.4% w/w GZ-DE provided the following results: 1) The glycerin gel exhibited creep at a constant stress of less than 10 Pa, but it is a fragile gel, showing Newtonian flow at 10 Pa stress. 2) Dynamic viscoelastic measurements showed that the elastic modulus (G') exceeds the viscous modulus (G"), indicating that glycerin gel has solid-like properties. 3) DSC showed a significant difference between the glass transition temperature of glycerin and glycerin gel. 4) CEP did not reveal a new compound in the glycerin gel. 5) NMR confirmed that glycerin gel is a physical gel. 6) SAXS measurements revealed that the glycerin gel has an oval-shaped basic frame (119 nm long and 65 nm wide).	[Koga, Kenjiro; Kimura, Toshiyuki] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan; [Sakai, Kenichi] Tokyo Univ Sci 2641, Fac Sci & Technol, Noda, Chiba 2788510, Japan; [Kushida, Hiroshi; Yoshikawa, Nobuji] Cokey Syst Co Ltd, Div Res & Dev, Matsusaka 5150041, Japan	Yoshikawa, N (reprint author), Cokey Syst Co Ltd, Div Res & Dev, 3639-7 Kamikawa Machi, Matsusaka 5150041, Japan.	yoshikawa@cokey.co.jp					Wang Z, 2014, FOOD HYDROCOLLOID, V36, P196, DOI 10.1016/j.foodhyd.2013.09.016; Terech P, 2007, TETRAHEDRON, V63, P7366, DOI 10.1016/j.tet.2007.02.067; Himmelein S, 2014, CHEM SCI, V5, P1054, DOI 10.1039/c3sc52964a; Weingarth M, 2011, J BIOMOL NMR, V50, P129, DOI 10.1007/s10858-011-9501-9; Gibson GE, 1923, J AM CHEM SOC, V45, P93, DOI 10.1021/ja01654a014; Gentile G, 2013, EUR POLYM J, V49, P3929, DOI 10.1016/j.eurpolymj.2013.08.023; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Tyapkova O, 2014, FOOD RES INT, V55, P336, DOI 10.1016/j.foodres.2013.10.048; Shapiro YE, 2011, PROG POLYM SCI, V36, P1184, DOI 10.1016/j.progpolymsci.2011.04.002; Burkhardt M, 2009, J COLLOID INTERF SCI, V331, P514, DOI 10.1016/j.jcis.2008.11.078; Delbecq F, 2013, J COLLOID INTERF SCI, V390, P17, DOI 10.1016/j.jcis.2012.09.029; Casieri C, 2001, J MAGN RESON, V153, P117, DOI 10.1006/jmre.2001.2429; CLAUDY P, 1988, THERMOCHIM ACTA, V128, P251, DOI 10.1016/0040-6031(88)85369-3; Glycerine Producers' Association, 1963, PHYS PROP GLYC ITS S, P1; Higaki K, 2001, RES COMMUN MOL PATH, V109, P231; Hilliou L, 2014, FOOD HYDROCOLLOID, V35, P531, DOI 10.1016/j.foodhyd.2013.07.013; Ihara T., 2009, SYNTHESIOLOGY, V2, P12; Khonina TG, 2012, J COLLOID INTERF SCI, V365, P81, DOI 10.1016/j.jcis.2011.09.018; Koga K, 2013, DRUG DES DEV THER, V7, P1235, DOI 10.2147/DDDT.S51638; Kron T, 1997, MAGN RESON IMAGING, V15, P211, DOI 10.1016/S0730-725X(96)00352-9; Lane LB, 1925, IND ENG CHEM, V17, P924, DOI 10.1021/ie50189a017; Mobius ME, 2010, J PHYS CHEM B, V114, P7439, DOI 10.1021/jp9108915; Mukai M, 2013, J COLLOID INTERF SCI, V395, P154, DOI 10.1016/j.jcis.2012.12.060; Oestlund A., 2010, J COLLOID INTERF SCI, V344, P238; Sasaki K, 2003, INT J PHARM, V265, P95, DOI 10.1016/S0378-5173(03)00407-1; Shibata N, 2001, J PHARM PHARMACOL, V53, P441, DOI 10.1211/0022357011775730; Studebaker M. L., 1978, SCI TECHNOLOGY RUBBE, P367; Tang JK, 2010, CHEM J CHINESE U, V31, P172	28	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1309	1322		10.5650/jos.ess14086		14	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500012		
J	Usami, A; Nakaya, S; Nakahashi, H; Miyazawa, M				Usami, Atsushi; Nakaya, Satoshi; Nakahashi, Hiroshi; Miyazawa, Mitsuo			Chemical Composition and Aroma Evaluation of Volatile oils from Edible Mushrooms (Pleurotus salmoneostramineus and Pleurotus sajor-caju)	JOURNAL OF OLEO SCIENCE			English	Article						Pleurotus salmoneostramineus; Pleurotus sajor-caju; hydrodistillation (HD); solvent-assisted flavor evaporation (SAFE); aroma extract dilution analysis (AEDA)	ASSISTED FLAVOR EVAPORATION; DRIED FRUITING BODIES; LACTARIUS-HATSUDAKE; TRICHOLOMA-MATSUTAKE; CHARACTERISTIC ODOR; ACTIVE COMPOUNDS; COMPONENTS; OSTREATUS; POLYSACCHARIDES; FOOD	This study is focused on the volatile oils from the fruiting bodies of Pleurotus salmoneostramineus (PS) and P. sajor-caju (PSC), which was extracted by hydrodistillation (HD) and solvent-assisted flavor evaporation (SAFE) methods. The oils are analyzed by gas chromatography-mass spectrometry (GC-MS), GC-olfactometry (GC-O), and aroma extract dilution analysis (AEDA). A total of 31, 31, 45, and 15 components were identified in PS (HD and SAFE) and PSC (HD and SAFE), representing about 80.3%, 92.2%, 88.9%, and 83.0% of the oils, respectively. Regarding the aroma-active components, 13, 12, 13, and 5 components were identified in PS (HD and SAFE) and PSC (HD and SAFE), respectively, by the GC-O analyses. The results of the sniffing test, odor activity value (OAV) and flavor dilution (FD) factor indicate that 1-octen-3-ol and 3-octanone are the main aroma-active components of PS oils. On the other hands, methional and 1-octen-3-ol were estimated as the main aroma-active components of PSC oils.	[Usami, Atsushi; Nakaya, Satoshi; Nakahashi, Hiroshi; Miyazawa, Mitsuo] Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan	Miyazawa, M (reprint author), Kinki Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Adam R. P., 2007, IDENTIFICATION ESSEN; Alam N, 2011, AFR J AGR RES, V6, P1555; Takahashi T, 2010, PHYTOCHEM ANALYSIS, V21, P489, DOI 10.1002/pca.1224; Wang HX, 2000, BIOCHEM BIOPH RES CO, V275, P810, DOI 10.1006/bbrc.2000.3373; Miyazawa M, 2007, FLAVOUR FRAG J, V22, P188, DOI 10.1002/ffj.1779; Cho IH, 2006, J AGR FOOD CHEM, V54, P6332, DOI 10.1021/jf0608241; Caglarirmak N, 2007, FOOD CHEM, V105, P1188, DOI 10.1016/j.foodchem.2007.02.021; Usami A, 2014, J OLEO SCI, V63, P731, DOI 10.5650/jos.ess14043; Leung MYK, 2006, IMMUNOL LETT, V105, P101, DOI 10.1016/j.imlet.2006.01.009; Nosaka S, 2014, J OLEO SCI, V63, P577, DOI 10.5650/jos.ess13215; Miyazawa M, 2011, J ESSENT OIL RES, V23, P58; Usami A, 2013, J OLEO SCI, V62, P563, DOI 10.5650/jos.62.563; Yin XL, 2011, CARBOHYD POLYM, V86, P1358, DOI 10.1016/j.carbpol.2011.06.053; Miyazawa M, 2010, FLAVOUR FRAG J, V25, P197, DOI 10.1002/ffj.1977; Miyazawa M, 2008, J ESSENT OIL RES, V20, P125; Wang WS, 1997, COMP IMMUNOL MICROB, V20, P261, DOI 10.1016/S0147-9571(96)00035-5; Buettner A, 1999, J AGR FOOD CHEM, V47, P5189, DOI 10.1021/jf990071l; Miyazawa M, 2006, J NAT MED, V60, P89, DOI 10.1007/s11418-005-009-z; Usami A, 2014, J OLEO SCI, V63, P83, DOI 10.5650/jos.ess13043; Miyazawa M, 2008, J ESSENT OIL RES, V20, P420; Engel W, 1999, EUR FOOD RES TECHNOL, V209, P237, DOI 10.1007/s002170050486; Bao DP, 2004, J WOOD SCI, V50, P169, DOI 10.1007/s10086-003-0539-5; Blank I, 2002, FOOD SCI, V115, P297; Cao L., 2010, HUAXUE YU SHENGWU GO, V27, P89; Chen T., 2007, JUNWU XUEBAO, V26, P279; DIJKSTRA FY, 1976, Z LEBENSM UNTERS FOR, V160, P401, DOI 10.1007/BF01106331; Fang LZ, 2006, HELV CHIM ACTA, V89, P1463, DOI 10.1002/hlca.200690147; Gao JM, 2007, PHYTOMEDICINE, V14, P821, DOI 10.1016/j.phymed.2006.12.006; Grosch Werner, 1994, Flavour and Fragrance Journal, V9, P147, DOI 10.1002/ffj.2730090403; Guan F., 2009, HARBIN SHANGYE DAXUE, V25, P395; KARACSONYI S, 1994, CARBOHYD POLYM, V24, P107, DOI 10.1016/0144-8617(94)90019-1; Kawata Jyunichi, 2007, J Oleo Sci, V56, P59; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Miyazawa M, 2008, J OLEO SCI, V57, P139, DOI 10.5650/jos.57.139; Miyazawa M, 2003, FLAVOUR FRAG J, V18, P15, DOI 10.1002/ffj.1135; Miyazawa M, 2003, FLAVOUR FRAG J, V18, P231, DOI 10.1002/ffj.1203; Miyazawa M., 2011, PHYTOCHEM ANALYSIS, V23, P208; Miyazawa M, 2003, FLAVOUR FRAG J, V18, P398, DOI 10.1002/ffj.1232; Miyazawa M, 2002, FLAVOUR FRAG J, V17, P187, DOI 10.1002/ffj.1079; Miyazawa M, 2001, FLAVOUR FRAG J, V16, P215, DOI 10.1002/ffj.982; Miyazawa M., 2005, J OLEO SCI, V54, P609; Miyazawa Mitsuo, 2007, J Oleo Sci, V56, P457; Opletal L, 1997, BRIT J BIOMED SCI, V54, P240; PAULIK S, 1992, VET MED-CZECH, V37, P675; Shibata N, 1997, ACTA CRYSTALLOGR D, V53, P335, DOI 10.1107/S0907444996014424; Vaverková S, 2001, Ceska Slov Farm, V50, P290; Xu K., 2013, ZHONGHUA ZHONGYLYAO, V31, P1797; Yang L., 2012, ZHONGGUO LIANGYOU XU, V27, P113; Yang L., 2012, ZHONGGUO LIANGYOU XU, V27, P105; Yen KH, 2013, SAINS MALAYS, V42, P943; Zhang C., 1993, BIOSCI BIOTECH BIOCH, V57, P901; Zhang Ji, 2005, Xibei Zhiwu Xuebao, V25, P786; Zou Y., 2011, SHIPIN GONGYE, V32, P61; Zusman I, 1997, ANTICANCER RES, V17, P2105	54	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1323	1332		10.5650/jos.ess14147		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500013		
J	Nahak, P; Nag, K; Hillier, A; Devraj, R; Thompson, DW; Manna, K; Makino, K; Ohshima, H; Nakahara, H; Shibata, O; Panda, AK				Nahak, Prasant; Nag, Kaushik; Hillier, Ashley; Devraj, Ravi; Thompson, David W.; Manna, Kausik; Makino, Kimiko; Ohshima, Hiroyuki; Nakahara, Hiromichi; Shibata, Osamu; Panda, Amiya Kumar			Effect of Serum, Cholesterol and Low Density Lipoprotein on the Functionality and Structure of Lung Surfactant Films	JOURNAL OF OLEO SCIENCE			English	Article						lung surfactant dysfunction; BLES; LDL; cholesterol; serum protein; Langmuir films; Raman-spectroscopy; AFM	PULMONARY SURFACTANT; LIPID MONOLAYERS; FATTY-ACIDS; PROTEINS; INHIBITION; EXTRACT; MECHANISMS; ALBUMIN; MODEL; PHOSPHATIDYLCHOLINE	Lung surfactant is a complex mixture of lipid and protein, responsible for alveolar stability, becomes dysfunctional due to alteration of its structure and function by leaked serum materials in disease. Serum proteins, cholesterol and low density lipoprotein (LDL) were studied with bovine lipid extract surfactant (BLES) using Langmuir films, and bilayer dispersions using Raman spectroscopy. While small amount of cholesterol (10 wt%) and LDL did not significantly affect the adsorption and surface tension lowering properties of BLES. However serum lipids, whole serum as well as higher amounts of cholesterol, and LDL dramatically altered the surface properties of BLES films, as well as gel-fluid structures formed in such films observed using atomic force microscopy (AFM). Raman-spectroscopic studies revealed that serum proteins, LDL and excess cholesterol had fluidizing effects on BLES bilayers dispersion, monitored from the changes in hydrocarbon vibrational modes during gel-fluid thermal phase transitions. This study clearly suggests that patho-physiological amounts of serum lipids (and not proteins) significantly alter the molecular arrangement of surfactant in films and bilayers, and can be used to model lung disease.	[Nahak, Prasant; Manna, Kausik; Panda, Amiya Kumar] Univ N Bengal, Dept Chem, Darjeeling 734013, W Bengal, India; [Nag, Kaushik; Hillier, Ashley; Devraj, Ravi] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada; [Thompson, David W.] Mem Univ Newfoundland, Dept Chem, St John, NF, Canada; [Makino, Kimiko; Ohshima, Hiroyuki] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan; [Nakahara, Hiromichi; Shibata, Osamu] Nagasaki Int Univ Nagasaki, Fac Pharmaceut Sci, Dept Biophys Chem, Nagasaki, Japan	Panda, AK (reprint author), Univ N Bengal, Dept Chem, Darjeeling 734013, W Bengal, India.	akpanda1@yahoo.com			NSERC; CIHR, Canada; DST-JSPS Exploratory Visit Program; School of Graduate Studies of Memorial University; University Grant Commission, New Delhi [F./2012-13/RGNF-2012-13D-GEN-CHH-51106/31-Oct-2013]	K. N. and D. T. sincerely acknowledges operating research funding from NSERC and CIHR, Canada. The authors acknowledge the generous gift of BLES from Dr. Dave Bjarnson of BLES(R) Biochemicals Inc. (London, Ontario, Canada). AKP sincerely acknowledge the receipt of a visiting fellowship under the DST-JSPS Exploratory Visit Program. R. D. and A. H. great fully acknowledges graduate fellowships from the School of Graduate Studies of Memorial University. P.N. acknowledges the receipt of a research fellowship from the University Grant Commission, New Delhi under the Rajiv Gandhi National Fellowship for disabled (No. F./2012-13/RGNF-2012-13D-GEN-CHH-51106/31-Oct-2013).	Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Panda AK, 2004, AM J RESP CELL MOL, V30, P641, DOI 10.1165/rcmb.2003-0279OC; Worthman LAD, 1997, BIOPHYS J, V72, P2569; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; HASS MA, 1980, LIPIDS, V15, P401, DOI 10.1007/BF02534063; Holm BA, 1999, PEDIATR RES, V46, P85, DOI 10.1203/00006450-199907000-00015; Nag K, 2006, BIOPHYS J, V90, P3632, DOI 10.1529/biophysj.105.077370; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Panda AK, 2004, COLLOID SURFACE A, V247, P9, DOI 10.1016/j.colsurfa.2004.07.008; Nag K, 2007, LANGMUIR, V23, P4421, DOI 10.1021/la062513a; SPIKER RC, 1975, BIOCHIM BIOPHYS ACTA, V388, P361, DOI 10.1016/0005-2760(75)90095-8; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Gunasekara L, 2008, BBA-BIOMEMBRANES, V1778, P433, DOI 10.1016/j.bbamem.2007.10.027; Leonenko Z, 2007, BIOPHYS J, V93, P674, DOI 10.1529/biophysj.107.106310; Daniels CB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P732, DOI 10.1086/422058; Bailey TC, 2004, J APPL PHYSIOL, V96, P1674, DOI 10.1152/japplphysiol.01143.2003; Bernhard W, 2001, AM J PHYSIOL-REG I, V281, pR327; Bringezu F, 2002, LANGMUIR, V18, P2319, DOI 10.1021/la015702w; CLEMENTS JA, 1970, AM REV RESPIR DIS, V101, P984; COCKSHUTT AM, 1991, BIOCHIM BIOPHYS ACTA, V1086, P63, DOI 10.1016/0005-2760(91)90155-B; CRANE RT, 1983, LIPIDS, V18, P74, DOI 10.1007/BF02534694; Dastis M, 2004, BIOPHYS CHEM, V109, P375, DOI 10.1016/j.bpc.2003.12.013; Devraj R., 2014, COLLOID POLYM SCI, DOI [10.1007/s00396-014-3319-4, DOI 10.1007/S00396-014-3319-4)]; Dluhy RA, 1998, THIN SOLID FILMS, V327, P308, DOI 10.1016/S0040-6090(98)00651-8; Ekelund K, 1999, LANGMUIR, V15, P6946, DOI 10.1021/la990092+; FUCHIMUKAI T, 1987, J APPL PHYSIOL, V62, P429; Gunasekara L, 2005, BBA-MOL CELL BIOL L, V1737, P27, DOI 10.1016/j.bbalip.2005.09.002; Harbottle RR, 2003, LANGMUIR, V19, P3698, DOI 10.1021/la026350b; Keating E, 2007, BIOPHYS J, V93, P1391, DOI 10.1529/biophysj.106.099762; Laing C, 2009, PHYS CHEM CHEM PHYS, V11, P1916, DOI 10.1039/b819767a; Larsson M, 2006, CHEM PHYS LIPIDS, V144, P137, DOI 10.1016/j.chemphyslip.2006.08.006; Lu KW, 2011, BBA-BIOMEMBRANES, V1808, P2366, DOI 10.1016/j.bbamem.2011.06.013; MCEACHREN TM, 1995, AM J PHYSIOL-LUNG C, V269, pL492; Nag K., 2005, LUNG SURFACTANT FUNC; Nag K., 2008, STRUCTURE DYNAMICS M; Nag K, 2010, J COLLOID INTERF SCI, V352, P456, DOI 10.1016/j.jcis.2010.08.058; Nag K, 2007, RESP PHYSIOL NEUROBI, V157, P411, DOI 10.1016/j.resp.2007.02.001; Ockene IS, 2004, ARCH INTERN MED, V164, P863, DOI 10.1001/archinte.164.8.863; Panda AK, 2007, J COLLOID INTERF SCI, V311, P551, DOI 10.1016/j.jcis.2004.04.010; Rodriguez-Capote K, 2006, BIOPHYS J, V90, P2808, DOI 10.1529/biophysj.105.073106; Schrijver R., 1991, LIPIDS, V26, P74, DOI 10.1007/BF02544028; Seeger W, 1992, AM J PHYSIOL, V261, pL286; VINCENT JS, 1993, BIOCHEMISTRY-US, V32, P8228, DOI 10.1021/bi00083a025; VOYNOYASENETSKAYA TA, 1993, P NATL ACAD SCI USA, V90, P4256, DOI 10.1073/pnas.90.9.4256; WONG PTT, 1984, ANNU REV BIOPHYS BIO, V13, P1	48	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2014	63	12					1333	1349		10.5650/jos.ess14071		17	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AU6SQ	WOS:000345732500014		
J	Kajiura, Y; Bando, M; Inagaki, Y; Nagata, T; Kido, J				Kajiura, Yukari; Bando, Mika; Inagaki, Yuji; Nagata, Toshihiko; Kido, Jun-ichi			Glycated Albumin and Calprotectin Levels in Gingival Crevicular Fluid From Patients With Periodontitis and Type 2 Diabetes	JOURNAL OF PERIODONTOLOGY			English	Article						Calprotectin; diabetes mellitus; diagnosis; gingival crevicular fluid; glycated albumin; periodontics	GENERALIZED AGGRESSIVE PERIODONTITIS; HUMAN-SERUM-ALBUMIN; GLYCEMIC CONTROL; DISEASE-ACTIVITY; MELLITUS; MARKER; COMPLICATIONS; INFLAMMATION; METAANALYSIS; ASSOCIATION	Background: Patients with diabetes mellitus (DM) have a high prevalence of periodontitis. Periodontitis in these patients is characterized by severe inflammation and tissue breakdown, and its diagnosis is important for cures of periodontitis and DM. The purpose of this study is to investigate the levels of glycated albumin (GA), a DM marker, and calprotectin, an inflammatory marker, in gingival crevicular fluid (GCF) from patients with periodontitis and DM (DM-P). Methods: The 78 participants in this study were patients with DM, chronic periodontitis (CP), DM-P, and healthy individuals (H). GCF and blood were collected, and GA and calprotectin in GCF were analyzed using Western blotting and enzyme-linked immunosorbent assay. Levels were compared among H, DM, CP, and DM-P groups. Blood GA and glycated hemoglobin (HbA1c) were measured, and the correlation among GCF GA and blood HbA1c or GA levels was investigated. Receiver operating characteristic (ROC) analysis for GCF GA to predict DM was performed. Results: GA was identified in GCF, and its amount/concentration in GCF samples from DM and DM-P were significantly higher than those of non-DM groups (H and CP). Calprotectin amounts in GCF from CP and DM-P were significantly higher than in H and DM groups. GCF GA level was positively correlated with blood HbA1c and GA level. ROC analysis of GCF GA showed an optimal cutoff value to predict DM. Conclusions: GA showed a high level in GCF from patients with DM. Examination of GA and calprotectin in GCF may be useful for predicting DM-P.	[Kajiura, Yukari; Bando, Mika; Inagaki, Yuji; Nagata, Toshihiko; Kido, Jun-ichi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Periodontol & Endodontol, Tokushima 7708504, Japan	Kido, J (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Periodontol & Endodontol, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	kido.jun-ichi@tokushima-u.ac.jp			Japan Society for the Promotion of Science (Tokyo, Japan) [24593125, 24792333]	The authors thank Dr. Haruhiko Saito (Tokushima Teishin Hospital) and Dr. Makoto Funaki, Dr. Takahisa Ikuta, Dr. Masami Ninomiya, Dr. Hiromi Murata, Dr. Yukiko Nakajima, Mr. Hiroki Shinohara, and Ms. Mari Hashimoto (Tokushima University Hospital) for support in the collection of GCF and blood samples. This study was supported in part by Grants-in-Aid (24593125 and 24792333) for Scientific Research from the Japan Society for the Promotion of Science (Tokyo, Japan). The authors report no conflicts of interest related to this study.	American Diabetes Association, 2014, DIABETES CARE S1, V37, pS81, DOI DOI 10.2337/DC14-S081; Koga M, 2010, ENDOCR J, V57, P751; LOE H, 1993, DIABETES CARE, V16, P329; Nakamura T, 2000, J PERIODONTOL, V71, P361, DOI 10.1902/jop.2000.71.3.361; Kido J, 2012, CLIN BIOCHEM, V45, P1239, DOI 10.1016/j.clinbiochem.2012.05.009; Furusyo N, 2013, BBA-GEN SUBJECTS, V1830, P5509, DOI 10.1016/j.bbagen.2013.05.010; Paneni F, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0419-z; Schmidt AM, 1996, J PERIODONTAL RES, V31, P508, DOI 10.1111/j.1600-0765.1996.tb01417.x; Khader YS, 2006, J DIABETES COMPLICAT, V20, P59, DOI 10.1016/j.jdiacomp.2005.05.006; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Furusyo N, 2013, INT J CARDIOL, V167, P2066, DOI 10.1016/j.ijcard.2012.05.045; Takahashi S, 2007, ENDOCR J, V54, P139, DOI 10.1507/endocrj.K06-103; Ritchie CS, 2009, J DENT, V37, pS578, DOI 10.1016/j.jdent.2009.05.015; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Ozmeric N, 2004, CLIN CHIM ACTA, V343, P1, DOI 10.1016/j.cccn.2004.01.022; Yang C, 2012, CLIN MED, V12, P568; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Noguchi E, 2014, CLIN BIOCHEM, V47, P67, DOI 10.1016/j.clinbiochem.2013.09.016; Kido J, 2012, J PERIODONTAL RES, V47, P488, DOI 10.1111/j.1600-0765.2011.01458.x; Lalla E, 2000, PERIODONTOL 2000, V23, P50, DOI 10.1034/j.1600-0757.2000.2230104.x; Zizzi A, 2013, J PERIODONTAL RES, V48, P293, DOI 10.1111/jre.12007; Andersen E, 2010, J PERIODONTAL RES, V45, P458, DOI 10.1111/j.1600-0765.2009.01257.x; Anguizola J, 2013, CLIN CHIM ACTA, V425, P64, DOI 10.1016/j.cca.2013.07.013; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; Gurav A, 2011, J DIABETES, V3, P21, DOI 10.1111/j.1753-0407.2010.00098.x; Kaner D, 2006, J PERIODONTAL RES, V41, P132, DOI 10.1111/j.1600-0765.2005.00849.x; Suzuki S, 2011, DIABETOLOGIA, V54, P2247, DOI 10.1007/s00125-011-2211-8; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; Kaner D, 2011, J PERIODONTAL RES, V46, P417, DOI 10.1111/j.1600-0765.2011.01355.x; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1111/jcpe.12077, 10.1902/jop.2013.1340011]; Kido J, 1999, J CLIN PERIODONTOL, V26, P653, DOI 10.1034/j.1600-051X.1999.261004.x; Bando M, 2013, BBA-GENE REGUL MECH, V1829, P954, DOI 10.1016/j.bbagrm.2013.03.010; Becerik S, 2011, J PERIODONTOL, V82, P1490, DOI 10.1902/jop.2011.100600; Becerik S, 2011, DIS MARKERS, V31, P343, DOI 10.3233/DMA-2011-0849; BERNTZEN HB, 1989, J RHEUMATOL, V16, P1416; Bulkacz J, 2012, CARRANZAS CLIN PERIO, P66; Bulut U, 2001, J Oral Sci, V43, P171; Fagerhol MK, 1990, STIMULUS RESPONSE CO, P187; Golden BE, 1996, ARCH DIS CHILD, V74, P136; GUTHROW CE, 1979, P NATL ACAD SCI USA, V76, P4258, DOI 10.1073/pnas.76.9.4258; Hiroshima Y, 2012, J PERIODONTAL RES, V47, P554, DOI 10.1111/j.1600-0765.2011.01466.x; Kalra N, 2013, J ORAL SCI, V55, P57; Kardesler L, 2008, CLIN BIOCHEM, V41, P863, DOI 10.1016/j.clinbiochem.2008.04.013; Kido J, 1998, J PERIODONTAL RES, V33, P434; Kido Jun-ichi, 2005, J Periodontol, V76, P437; Kumeda Y, 2008, CLIN ENDOCRINOL, V69, P556, DOI 10.1111/j.1365-2265.2008.03202.x; Lee MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038801; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Ngo LH, 2010, J PROTEOME RES, V9, P1683, DOI 10.1021/pr900775s; Powers AC, 2011, HALLISONS PRINCIPLES, P2980; Ryan Maria Emanuel, 2003, J Am Dent Assoc, V134 Spec No, p34S; Taylor G W, 1998, Ann Periodontol, V3, P30, DOI 10.1902/annals.1998.3.1.30; Wang FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051098	56	2	2	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	DEC	2014	85	12					1667	1675		10.1902/jop.2014.140241		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU6XI	WOS:000345744300006		
J	Komiyama, Y; Kafkova, LR; Barasch, A; Shah, GR; Grbic, JT; Novak, Z; Komiyama, K; Novak, J; Mestecky, J; Moldoveanu, Z				Komiyama, Yuske; Kafkova, Leona Raskova; Barasch, Andrei; Shah, Ging R.; Grbic, John T.; Novak, Zdenek; Komiyama, Kazuo; Novak, Jan; Mestecky, Jiri; Moldoveanu, Zina			Origin of Galactose-Deficient Immunoglobulin G in Gingival Crevicular Fluid in Periodontitis	JOURNAL OF PERIODONTOLOGY			English	Article						Enzyme-linked immunosorbent assay; fluorescence microscopy; gingival crevicular fluid; glycosylation; immunoglobulin G; periodontitis	ANTIBODY-SECRETING CELLS; RHEUMATOID-ARTHRITIS; DISEASE; IGG; GLYCOSYLATION; ADULT; INTERLEUKIN-6; COMPLEMENT; COLLAGEN; HYPOGALACTOSYLATION	Background: Periodontitis is a chronic inflammatory disease initiated by a synergistic and dysbiotic microbial community that elicits a gingival inflammatory response leading to tissue breakdown. Periodontitis shares many characteristics with other chronic inflammatory diseases, including abnormal glycosylation of immunoglobulin (Ig) G. The current authors have previously demonstrated that IgG from gingival crevicular fluid (GCF) of patients with chronic periodontitis contains galactose (Gal)-deficient IgG. Methods: The origin of the aberrantly glycosylated IgG was determined by measuring levels of Gal-deficient IgG in GCF and serum from patients with periodontitis and non-periodontitis controls using lectin enzyme-linked immunosorbent assay. The Ig-producing cells and the proportion of cells producing Gal-deficient IgG were immunohistochemically determined in gingival tissues from patients with periodontitis by fluorescence microscopy. The results were statistically evaluated and correlated with clinical data. Results: The results indicate that GCF of patients with periodontitis had higher levels of Gal-deficient IgG compared with controls (P = 0.002). In gingival tissues, IgG was the dominant isotype among Ig-producing cells, and 60% of IgG-positive cells produced Gal-deficient IgG. Moreover, the proportion of Gal-deficient IgG-producing cells directly correlated with clinical parameters of probing depth and clinical attachment loss (AL). Conclusion: These results suggest that the presence of Gal-deficient IgG is associated with gingival inflammation and may play a role in the worsening of clinical parameters of periodontitis, such as AL.	[Komiyama, Yuske; Kafkova, Leona Raskova; Novak, Jan; Mestecky, Jiri; Moldoveanu, Zina] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Komiyama, Yuske] Tokyo Univ Hosp, Intens Care Unit, Tokyo 113, Japan; [Kafkova, Leona Raskova] Palacky Univ, Fac Med & Dent, Dept Biol, CR-77147 Olomouc, Czech Republic; [Barasch, Andrei; Shah, Ging R.] Univ Alabama Birmingham, Sch Dent, Dept Gen Dent Sci, Birmingham, AL 35294 USA; [Grbic, John T.] Columbia Univ, Coll Dent Med, Div Oral Biol, New York, NY USA; [Novak, Zdenek] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Oral Pathol, Tokyo 101, Japan	Moldoveanu, Z (reprint author), Univ Alabama Birmingham, Dept Microbiol, 845 19th Ave S,BBRB 744, Birmingham, AL 35294 USA.	leona.raskova@upol.cz; zinam@uab.edu			National Institutes of Health (Bethesda, Maryland) [DE13694]; UAB Center for Research in Oral Biology (Birmingham, Alabama); Education for Competitiveness Operational Program of the Ministry of Education, Youth and Sports, Czech Republic [CZ.1.07/2.3.00/20.0164]	YK and LRK contributed equally to this study. This work was supported by grant DE13694 from the National Institutes of Health (Bethesda, Maryland) and by the UAB Center for Research in Oral Biology (Birmingham, Alabama). LRK was also supported by the Education for Competitiveness Operational Program of the Ministry of Education, Youth and Sports, Czech Republic (project CZ.1.07/2.3.00/20.0164). According to the Ethical Considerations in the Conduct and Reporting of Research, the authors report no conflicts of interest related to this study.	Nibali L, 2012, ORAL DIS, V18, P236, DOI 10.1111/j.1601-0825.2011.01867.x; Banda NK, 2007, J IMMUNOL, V179, P4101; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; PAREKH RB, 1988, LANCET, V1, P966; Novak J, 2005, J DENT RES, V84, P897; Hajishengallis G, 2012, IMMUNOBIOLOGY, V217, P1111, DOI 10.1016/j.imbio.2012.07.007; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Lamster IB, 2007, ANN NY ACAD SCI, V1098, P216, DOI 10.1196/annals.1384.027; TOMANA M, 1988, ARTHRITIS RHEUM, V31, P333, DOI 10.1002/art.1780310304; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; Nibali L, 2013, CLIN ORAL INVEST, V17, P1235, DOI 10.1007/s00784-012-0804-3; Stefani FA, 2013, IMMUNOBIOLOGY, V218, P1012, DOI 10.1016/j.imbio.2012.12.001; Kornman KS, 1997, PERIODONTOL 2000, V14, P33, DOI 10.1111/j.1600-0757.1997.tb00191.x; Abe T, 2012, J IMMUNOL, V189, P5442, DOI 10.4049/jimmunol.1202339; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; TSUCHIYA N, 1993, J IMMUNOL, V151, P1137; Ebersole JL, 2003, PERIODONTOL 2000, V31, P135, DOI 10.1034/j.1600-0757.2003.03109.x; FUJIHASHI K, 1992, RES IMMUNOL, V143, P744, DOI 10.1016/0923-2494(92)80015-D; HIRSCH HZ, 1988, J ORAL PATHOL MED, V17, P456, DOI 10.1111/j.1600-0714.1988.tb01315.x; HIRSCH HZ, 1989, J CLIN IMMUNOL, V9, P273, DOI 10.1007/BF00918658; HITSUMOTO Y, 1992, AUTOIMMUNITY, V11, P247, DOI 10.3109/08916939209035162; JONSSON R, 1991, J CLIN PERIODONTOL, V18, P703, DOI 10.1111/j.1600-051X.1991.tb00113.x; NAKAO H, 1991, CLIN CHIM ACTA, V197, P221, DOI 10.1016/0009-8981(91)90142-Y; OGAWA T, 1989, CLIN EXP IMMUNOL, V76, P103; OGAWA T, 1989, J IMMUNOL, V142, P1150; SOCRANSKY SS, 1982, J CLIN PERIODONTOL, V9, P460, DOI 10.1111/j.1600-051X.1982.tb02107.x; Stefanovic G, 2006, J PERIODONTOL, V77, P1887, DOI 10.1902/jop.2006.060049; Tian Y, 2013, INT J BIOL MARKER, V28, P100, DOI [10.5301/jbm.5000010, 10.5301/JBM.5000010]; TOMANA M, 1996, N COMP BIOC, V30, P291; VANZEBEN D, 1994, BRIT J RHEUMATOL, V33, P36; Yamamoto M, 1997, J PERIODONTAL RES, V32, P115, DOI 10.1111/j.1600-0765.1997.tb01391.x	33	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	DEC	2014	85	12					1779	1785		10.1902/jop.2014.140212		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU6XI	WOS:000345744300019		
J	Takahashi, T; Sato, M; Toyooka, K; Matsuzaki, R; Kawafune, K; Kawamura, M; Okuda, K; Nozaki, H				Takahashi, Toshiyuki; Sato, Mayuko; Toyooka, Kiminori; Matsuzaki, Ryo; Kawafune, Kaoru; Kawamura, Mai; Okuda, Kazuo; Nozaki, Hisayoshi			FIVE CYANOPHORA (CYANOPHORALES, GLAUCOPHYTA) SPECIES DELINEATED BASED ON MORPHOLOGICAL AND MOLECULAR DATA	JOURNAL OF PHYCOLOGY			English	Article						Cyanophora; field-emission scanning electron microscopy; freeze-fracture method; Glaucophyta; molecular phylogeny; morphology; new species; secondary structure of nuclear rDNA ITS-2; taxonomy; ultrastructure	ELECTRON-MICROSCOPY; MAXIMUM-LIKELIHOOD; CULTURED MATERIAL; CYANELLE DNA; PARADOXA; PHYLOGENY; CHLOROPHYCEAE; SEQUENCES; VOLVOCALES; ALGAE	Cyanophora is an important glaucophyte genus of unicellular biflagellates that may have retained ancestral features of photosynthetic eukaryotes. The nuclear genome of Cyanophora was recently sequenced, but taxonomic studies of more than two strains are lacking for this genus. Furthermore, no study has used molecular methods to taxonomically delineate Cyanophora species. Here, we delimited the species of Cyanophora using light and electron microscopy, combined with molecular data from several globally distributed strains, including one newly established. Using a light microscope, we identified two distinct morphological groups: one with ovoid to ellipsoidal vegetative cells and another with dorsoventrally flattened or broad, bean-shaped vegetative cells containing duplicated plastids. Our light and scanning electron microscopy clearly distinguished three species with ovoid to ellipsoidal cells (C. paradoxa Korshikov, C. cuspidata Tos. Takah. & Nozaki sp. nov., and C. kugrensii Tos. Takah. & Nozaki sp. nov.) and two species with broad, bean-shaped cells (C. biloba Kugrens, B.L. Clay, C.J. Mey. & R.E. Lee and C. sudae Tos. Takah. & Nozaki sp. nov.) based on differences in cell shape and surface ornamentations of the vegetative cells under the field-emission scanning electron microscope. Molecular phylogenetic analyses of P700 chl a apoprotein A2 (psaB) genes and internal transcribed spacer (ITS) regions of nuclear ribosomal DNA (rDNA), as well as a comparison of secondary structures of nuclear rDNA ITS-2 and genetic distances of psaB genes, supported the delineation of five morphological species of Cyanophora.	[Takahashi, Toshiyuki; Matsuzaki, Ryo; Kawafune, Kaoru; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sato, Mayuko; Toyooka, Kiminori] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kawamura, Mai] Kochi Univ, Dept Nat Sci, Fac Sci, Kochi 7808520, Japan; [Okuda, Kazuo] Kochi Univ, Grad Sch Integrated Arts & Sci, Doctoral Course, Kochi 7808520, Japan	Nozaki, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nozaki@bs.s.u-tokyo.ac.jp	Toyooka, Kiminori/B-5027-2011		MEXT/JSPS KAKENHI [24247042];  [24657045]	We thank Dr. Chieko Saito (University of Tokyo) for advising about TEM techniques. We used a field-emission scanning electron microscope SU8020 at Hitachi High-Technologies Corporation with gratitude. We also thank Dr. Takashi Nakada (Keio University) for nomenclatural advises. This work was supported by Grants-in-Aid for Challenging Exploratory Research (number 24657045 to HN) and Scientific Research (A) from MEXT/JSPS KAKENHI (number 24247042 to HN).	Frassanito AM, 2010, CELL MOL LIFE SCI, V67, P965, DOI 10.1007/s00018-009-0225-x; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Hayama M, 2010, PHYCOLOGIA, V49, P221, DOI 10.2216/09-56.1; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Sato M, 2009, PLANTA, V229, P781, DOI 10.1007/s00425-008-0872-4; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Kugrens P, 1999, J PHYCOL, V35, P844, DOI 10.1046/j.1529-8817.1999.3540844.x; Watanabe M, 2012, BBA-BIOENERGETICS, V1817, P1428, DOI 10.1016/j.bbabio.2011.11.013; HALL WT, 1963, J CELL BIOL, V19, P551, DOI 10.1083/jcb.19.3.551; Chong J, 2014, MOL PHYLOGENET EVOL, V76, P181, DOI 10.1016/j.ympev.2014.03.019; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Nakada T, 2007, EUR J PHYCOL, V42, P177, DOI 10.1080/09670260601145816; Takahashi T, 2014, CYTOLOGIA, V79, P119, DOI 10.1508/cytologia.79.119; Spiegel FW, 2012, SCIENCE, V335, P809, DOI 10.1126/science.1218515; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Leblond JD, 2011, PHYCOL RES, V59, P129, DOI 10.1111/j.1440-1835.2011.00610.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; KIES L, 1986, TAXON, V35, P128, DOI 10.2307/1221049; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Facchinelli F, 2013, PLANTA, V237, P637, DOI 10.1007/s00425-012-1819-3; Caisova L, 2013, PROTIST, V164, P482, DOI 10.1016/j.protis.2013.04.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Barone R., 2006, NATURALISTA SICILIAN, V30, P97; BOHNERT HJ, 1985, MOL GEN GENET, V201, P565, DOI 10.1007/BF00331357; Day JG, 2004, NOVA HEDWIGIA, V79, P27, DOI 10.1127/0029-5035/2004/0079-0027; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.2307/2408542; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kasai F., 2009, JPN J PHYCOL S, V57, P1; Kies L., 1992, ALGAE SYMBIOSES, P353; Kies L., 1979, BER DEUT BOT GES, V92, P445; Kies L., 1990, P152; Korschikov A., 1924, Archives Russes de Protistologie Moscow, V3, P57; Korshikov A. A., 1941, Archiv fuer Protistenkunde Jena, V95, P22; Kugrens P, 2002, CELL OR EX, V4, P257; LOFFELHARDT W, 1983, CURR GENET, V7, P139, DOI 10.1007/BF00365639; LOFFELHARDT W, 1987, ANN NY ACAD SCI, V503, P550, DOI 10.1111/j.1749-6632.1987.tb40642.x; Matsuzaki R, 2014, PHYCOLOGIA, V53, P293, DOI 10.2216/14-3.1; MIGNOT JP, 1969, J PROTOZOOL, V16, P138, DOI 10.1111/j.1550-7408.1969.tb02245.x; Nakada T, 2007, J PHYCOL, V43, P397, DOI 10.1111/j.1529-8817.2007.00328.x; Nakada T, 2008, J PHYCOL, V44, P751, DOI 10.1111/j.1529-8817.2008.00525.x; Nylander JAA, 2004, MRMODELTEST V2 PROGR; OKUDA K, 1994, PROTOPLASMA, V180, P49, DOI 10.1007/BF01379223; Pringsheim E. G., 1958, STUD PLANT PHYSL PRA, P165; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schlosser U. G., 1994, BOT ACTA, V107, P111; Sekida Satoko, 2001, Phycological Research, V49, P163, DOI 10.1111/j.1440-1835.2001.tb00247.x; Skuja H., 1956, NOVA ACTA R SOC SC 4, V16, P1; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Whitton B. A., 2002, FRESHWATER ALGAL FLO, P613	56	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	DEC	2014	50	6					1058	1069		10.1111/jpy.12236		12	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	AU7DG	WOS:000345760300009		
J	Qiu, B; Chen, SM; Klein, P; Sasaki, H; Sasai, Y				Qiu, Bo; Chen, Shuiming; Klein, Patrice; Sasaki, Hideharu; Sasai, Yoshikazu			Seasonal Mesoscale and Submesoscale Eddy Variability along the North Pacific Subtropical Countercurrent	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							CALIFORNIA CURRENT SYSTEM; MIXED-LAYER; SATELLITE ALTIMETRY; UPPER OCEAN; PART I; INSTABILITY; SIMULATIONS; RESOLUTION; EDDIES; FLUX	Located at the center of the western North Pacific Subtropical Gyre, the Subtropical Countercurrent (STCC) is not only abundant in mesoscale eddies, but also exhibits prominent submesoscale eddy features. Output from a 1/30 degrees high-resolution OGCM simulation and a gridded satellite altimetry product are analyzed to contrast the seasonal STCC variability in the mesoscale versus submesoscale ranges. Resolving the eddy scales of >150 km, the altimetry product reveals that the STCC eddy kinetic energy and rms vorticity have a seasonal maximum in May and April, respectively, a weak positive vorticity skewness without seasonal dependence, and an inverse (forward) kinetic energy cascade for wavelengths larger (shorter) than 250 km. In contrast, the submesoscale-resolving OGCM simulation detects that the STCC eddy kinetic energy and rms vorticity both appear in March, a large positive vorticity skewness with strong seasonality, and an intense inverse kinetic energy cascade whose short-wave cutoff migrates seasonally between the 35- and 100-km wavelengths. Using a 2.5-layer, reduced-gravity model with an embedded surface density gradient, the authors show that these differences are due to the seasonal evolution of two concurring baroclinic instabilities. Extracting its energy from the surface density gradient, the frontal instability has a growth time scale of O(7) days, a dominant wavelength of O(50) km, and is responsible for the surface-intensified submesoscale eddy signals. The interior baroclinic instability, on the other hand, extracts energy from the vertically sheared STCC system. It has a slow growth time scale of O(40) days, a dominant wavelength of O(250) km, and, together with the kinetic energy cascaded upscale from the submesoscales, determines the mesoscale eddy modulations.	[Qiu, Bo; Chen, Shuiming] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Klein, Patrice] Ifremer, UMR LPO, CNRS UBO IRD, F-29280 Plouzane, France; [Sasaki, Hideharu] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Sasai, Yoshikazu] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokohama, Kanagawa, Japan	Qiu, B (reprint author), Univ Hawaii Manoa, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA.	bo@soest.hawaii.edu	Klein, Patrice/M-4279-2015		NASA SWOT mission [NNX13AD91G, NNX13AE51E]; NASA OSTST mission [NNX13AD91G, NNX13AE51E]; CNRS (France); Agence Nationale pour la Recherche [ANR-09-BLAN-0365-02, ANR-10-LABX-19-01]; MEXT/JST KAKENHI [25400473, 22106006]	We thank Lee Fu, Jay McCreary, and Shafer Smith for fruitful discussions. Detailed and constructive comments made by Baylor Fox-Kemper and an anonymous reviewer helped improve an early version of the manuscript. The satellite altimeter products are provided by Ssalto/Duacs and distributed by AVISO with support from CNES. B.Q. and S.C. acknowledge support from NASA SWOT and OSTST missions (NNX13AD91G and NNX13AE51E). P.K. acknowledges support of CNRS (France) and Agence Nationale pour la Recherche [ANR-09-BLAN-0365-02 (REDHOT) and ANR-10-LABX-19-01 (LabexMER)]. H.S. and Y.S. are supported by MEXT/JST KAKENHI (25400473 and 22106006).	Noh Y, 1999, J GEOPHYS RES-OCEANS, V104, P15621, DOI 10.1029/1999JC900068; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; MCCREARY JP, 1991, J GEOPHYS RES-OCEANS, V96, P2515, DOI 10.1029/90JC02195; Fox-Kemper B, 2011, OCEAN MODEL, V39, P61, DOI 10.1016/j.ocemod.2010.09.002; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; Roemmich D, 2001, J PHYS OCEANOGR, V31, P675, DOI 10.1175/1520-0485(2001)031<0675:ETOHAT>2.0.CO;2; Morrow R, 2012, ADV SPACE RES, V50, P1062, DOI 10.1016/j.asr.2011.09.033; NAKAMURA N, 1988, J ATMOS SCI, V45, P3253, DOI 10.1175/1520-0469(1988)045<3253:SSOBIO>2.0.CO;2; Sasaki H, 2012, J PHYS OCEANOGR, V42, P1233, DOI 10.1175/JPO-D-11-0180.1; Eldevik T, 2002, J PHYS OCEANOGR, V32, P851, DOI 10.1175/1520-0485(2002)032<0851:SE>2.0.CO;2; Fu LL, 2010, OCEANOGRAPHY, V23, P14; Scott RB, 2005, J PHYS OCEANOGR, V35, P1650, DOI 10.1175/JPO2771.1; Tulloch R, 2011, J PHYS OCEANOGR, V41, P1057, DOI 10.1175/2010JPO4404.1; Mensa JA, 2013, OCEAN DYNAM, V63, P923, DOI 10.1007/s10236-013-0633-1; Qiu B, 2004, J PHYS OCEANOGR, V34, P2148, DOI 10.1175/1520-0485(2004)034<2148:SAFFIT>2.0.CO;2; Klein P, 2008, J PHYS OCEANOGR, V38, P1748, DOI 10.1175/2007JPO3773.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Uematsu A, 2013, INT GEOSCI REMOTE SE, P2943, DOI 10.1109/IGARSS.2013.6723442; Rio MH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006505; Arbic BK, 2013, J PHYS OCEANOGR, V43, P283, DOI 10.1175/JPO-D-11-0240.1; Capet X, 2008, J PHYS OCEANOGR, V38, P29, DOI 10.1175/2007JPO3671.1; Capet X, 2008, J PHYS OCEANOGR, V38, P2256, DOI 10.1175/2008JPO3810.1; Qiu B, 2010, J PHYS OCEANOGR, V40, P213, DOI 10.1175/2009JPO4285.1; Boccaletti G, 2007, J PHYS OCEANOGR, V37, P2228, DOI 10.1175/JPO3101.1; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; STONE PH, 1966, J ATMOS SCI, V23, P390, DOI 10.1175/1520-0469(1966)023<0390:ONGBS>2.0.CO;2; Chelton DB, 1998, J PHYS OCEANOGR, V28, P433, DOI 10.1175/1520-0485(1998)028<0433:GVOTFB>2.0.CO;2; Chang YL, 2014, J PHYS OCEANOGR, V44, P818, DOI 10.1175/JPO-D-13-0162.1; Capet X, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034736; Fu L.-L., 2008, EOS T AM GEOPHYS UN, V89, DOI [10.1029/2008EO480003, DOI 10.1029/2008EO480003]; FUKAMACHI Y, 1995, J GEOPHYS RES-OCEANS, V100, P2559, DOI 10.1029/94JC02656; Hosoda S., 2008, JAMSTEC REP RES DEV, V8, P47, DOI DOI 10.5918/JAMSTECR.8.47; Kobashi F, 2012, J OCEANOGR, V68, P113, DOI 10.1007/s10872-011-0048-x; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Munk W, 2000, P ROY SOC A-MATH PHY, V456, P1217; Noh Y, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029130; QIU B, 2008, PHYS OCEANOGR, V38, P1515, DOI DOI 10.1175/2007JPO3856.1; Rhines P. B., 1977, MARINE MODELING, V6, P189; Rudnick DL, 2001, GEOPHYS RES LETT, V28, P2045, DOI 10.1029/2000GL012265; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860	42	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	DEC	2014	44	12					3079	3098		10.1175/JPO-D-14-0071.1		20	Oceanography	Oceanography	AU7XS	WOS:000345812300007		
J	Omatsu-Kanbe, M; Matsuura, H				Omatsu-Kanbe, Mariko; Matsuura, Hiroshi			Novel intracellular mediator of adiponectin secretion from adipocytes	JOURNAL OF PHYSIOLOGY-LONDON			English	Editorial Material							GLUCOSE-TRANSPORT; PLASMA-MEMBRANE; TRANSLOCATION		[Omatsu-Kanbe, Mariko; Matsuura, Hiroshi] Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 5202192, Japan	Omatsu-Kanbe, M (reprint author), Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 5202192, Japan.	m_omatsu@belle.shiga-med.ac.jp					Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; SUGIHARA H, 1987, J LIPID RES, V28, P1038; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Komai AM, 2014, J PHYSIOL-LONDON, V592, P5169, DOI 10.1113/jphysiol.2014.280388	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	DEC 1	2014	592	23					5141	5141		10.1113/jphysiol.2014.284778		1	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AU7IF	WOS:000345773400005		
J	Tong, XL; Aoyama, H; Tsukihara, T; Bai, DL				Tong, Xiaoling; Aoyama, Hiroshi; Tsukihara, Tomitake; Bai, Donglin			Charge at the 46th residue of connexin 50 is crucial for the gap-junctional unitary conductance and transjunctional voltage-dependent gating	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							ICHTHYOSIS-DEAFNESS SYNDROME; EXTRACELLULAR LOOP DOMAIN; PORE-LINING RESIDUES; HUMAN HELA-CELLS; HEMICHANNEL PROPERTIES; CHANNEL CONDUCTANCE; MOLECULAR-BASIS; SKIN-DISEASE; BK CHANNELS; SELECTIVITY	Key points<list id="tjp6377-list-0001" list-type="bulleted"> Gap-junction (GJ) channels provide direct intercellular communication and are twice the length of most membrane channels, yet they often have high efficiency in permeation of ions, which is reflected by large unitary channel conductance ((j)). To reveal the key factors in determining the (j) of a lens GJ channel, we studied connexin 50 mutant GJ channels, where a negatively or positively charged residue was introduced into a pore-lining domain. The results indicate that the pore surface electrostatic potential is a dictating factor for the connexin 50 GJ channel (j). A change in the local resistance of the channel pore associated with these mutant channels is an important factor for their voltage-dependent gating properties. The combination of dual patch clamp and homology structure modelling is a powerful approach in revealing molecular mechanisms of GJ gating and ion permeation. AbstractGap-junction (GJ) channels are twice the length of most membrane channels, yet they often have large unitary channel conductance ((j)). What factors make this possibly the longest channel so efficient in passing ions are not fully clear. Here we studied the lens connexin (Cx) 50 GJs, which display one of the largest (j) and the most sensitive transjunctional voltage-dependent gating (V-j gating) among all GJ channels. Introduction of charged residues into a putative pore-lining domain (the first transmembrane and the first extracellular loop border) drastically altered the apparent (j). Specifically, G46D and G46E increased the Cx50 (j) from 201 to 256 and 293 pS, respectively and the G46K channel showed an apparent (j) of only 20 pS. G46K also drastically altered V-j gating properties in homotypic G46K and heterotypic Cx50/G46K channels, causing an apparent loss of fast V-j-dependent gating transitions and leaving only loop gating transitions at the single channel current records. Both macroscopic and single channel currents of heterotypic Cx50/G46K channels showed a prominent rectification. Our homology structural models indicate that the pore surface electrostatic potentials are a dictating factor in determining the (j). Our data demonstrate, at the whole GJ channel level, a crucial role of the surface charge properties in the first transmembrane/first extracellular border domain in determining the efficiency of ion permeation and the V-j gating of Cx50 and possibly other GJ channels.	[Tong, Xiaoling; Bai, Donglin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Aoyama, Hiroshi] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Osaka, Japan; [Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Bai, DL (reprint author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	donglin.bai@schulich.uwo.ca	Bai, Donglin/A-5799-2008		Natural Sciences and Engineering Research Council of Canada; Ministry of Education, Culture, Sports, Science and Technology of Japan [16087206, 18207006, 21227003, 26440029]	This work was supported by a grant to D.B. from Natural Sciences and Engineering Research Council of Canada. This work was also supported by Grants-in-Aid for Scientific Research (16087206, 18207006 and 21227003 to T.T. and 26440029 to H.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Geng YY, 2011, J GEN PHYSIOL, V137, P533, DOI 10.1085/jgp.201110616; Janecke AR, 2005, AM J MED GENET A, V133A, P128, DOI 10.1002/ajmg.a.30515; VEENSTRA RD, 1995, CIRC RES, V77, P1156; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Trexler EB, 2000, BIOPHYS J, V79, P3036; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; WILDERS R, 1992, BIOPHYS J, V63, P942; Beyer EC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00043; Sun WM, 2011, MOL VIS, V17, P1508; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Xin L, 2010, BIOPHYS J, V99, P2077, DOI 10.1016/j.bpj.2010.07.032; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Srinivas M, 2005, BIOPHYS J, V88, P1725, DOI 10.1529/biophysj.104.054023; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Gonzalez D, 2007, PROG BIOPHYS MOL BIO, V94, P66, DOI 10.1016/j.pbiomolbio.2007.03.007; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Zhang YP, 2013, BIOCHEM BIOPH RES CO, V436, P424, DOI 10.1016/j.bbrc.2013.05.118; Gong XQ, 2013, J CELL SCI, V126, P3113, DOI 10.1242/jcs.123430; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Tang QX, 2009, J GEN PHYSIOL, V133, P555, DOI 10.1085/jgp.200910207; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Bai DL, 2006, J PHARMACOL EXP THER, V319, P1452, DOI 10.1124/jpet.106.112045; Nakagawa S, 2011, J BIOL CHEM, V286, P19672, DOI 10.1074/jbc.M110.204958; Mese G, 2011, MOL BIOL CELL, V22, P4776, DOI 10.1091/mbc.E11-09-0778; Bai DL, 2014, FEBS LETT, V588, P1238, DOI 10.1016/j.febslet.2014.02.064; BUKAUSKAS FF, 1995, BIOPHYS J, V68, P2289; DeLano WL, 2006, PYMOL MOL GRAPHICS S; Dong LX, 2006, J PHYSIOL-LONDON, V576, P787, DOI 10.1113/jphysiol.2006.113837; Ek-Vitorin JF, 2005, AM J PHYSIOL-CELL PH, V289, pC1535, DOI 10.1152/ajpcell.00182.2005; Gong XQ, 2001, CELL COMMUN ADHES, V8, P187, DOI 10.3109/15419060109080721; Griffith AJ, 2006, LARYNGOSCOPE, V116, P1404, DOI 10.1097/01.mlg.0000224549.75161.ca; Hille B, 2001, ION CHANNELS EXCITAB; Hopperstad MG, 2000, BIOPHYS J, V79, P1954; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; Traub O, 1998, EUR J CELL BIOL, V77, P313; VEENSTRA RD, 1994, BIOPHYS J, V66, P1915; Xin L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00373	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	DEC 1	2014	592	23					5187	5202		10.1113/jphysiol.2014.280636		16	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AU7IF	WOS:000345773400012		
J	Han, S; Chung, H; Noh, NJ; Lee, SJ; Jo, W; Yoon, TK; Yi, K; Park, CW; Ko, S; Son, Y				Han, Saerom; Chung, Haegeun; Noh, Nam Jin; Lee, Sun Jeoung; Jo, Wooyong; Yoon, Tae Kyung; Yi, Koong; Park, Chan-Woo; Ko, Suin; Son, Yowhan			Effect of open-field experimental warming on the leaf phenology of oriental oak (Quercus variabilis) seedlings	JOURNAL OF PLANT ECOLOGY			English	Article						climate change; cumulative degree days; experimental warming; leaf senescence; leaf unfolding	CLIMATE-CHANGE; BUD BURST; SPRING PHENOLOGY; TEMPERATE TREES; SHOOT GROWTH; SCOTS PINE; RESPONSES; FOREST; CO2; BOREAL	An open-field warming experiment enables us to test the effects of projected temperature increase on change in plant phenology with fewer confounding factors and to study phenological response to temperature ranges beyond natural variability. This study aims to (i) examine the effect of temperature increase on leaf unfolding and senescence of oriental oak (Quercus variabilis Blume) under experimental warming and (ii) measure temperature-related parameters used in estimating phenological response to temperature elevation. Using an open-field warming system with infrared heaters, we increased the air temperature by similar to 3A degrees C in the warmed plots compared with that of the control plots consistently for 2 years. Leaf unfolding and senescence dates of Q. variabilis seedlings were recorded and temperature-related phenological parameters were analysed. The timing of leaf unfolding was advanced by 3-8 days (1.1-3.0 days/A degrees C) and the date of leaf senescence was delayed by 14-19 days (5.0-7.3 days/A degrees C) under elevated air temperatures. However, the cumulative degree days (CDD) of leaf unfolding were not significantly changed by experimental warming, which suggest the applicability of a constant CDD value to estimate the change in spring leaf phenology under 3A degrees C warming. Consistent ranges of advancement and temperature sensitivity in spring phenology and delayed autumn phenology and proposed temperature parameters from this study might be applied to predict future phenological change.	[Han, Saerom; Yoon, Tae Kyung; Son, Yowhan] Korea Univ, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea; [Chung, Haegeun] Konkuk Univ, Dept Environm Engn, Seoul 143701, South Korea; [Noh, Nam Jin; Son, Yowhan] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan; [Lee, Sun Jeoung] Korea Forest Res Inst, Forest & Climate Change Ctr, Seoul 130712, South Korea; [Jo, Wooyong] Hanlim Patent & Law Off, Seoul 152050, South Korea; [Yi, Koong; Park, Chan-Woo] Korea Forest Res Inst, Forest Soil & Water Conservat Div, Seoul 130712, South Korea; [Ko, Suin] Korea Environm Inst, Environm Policy Res Grp, Seoul 122706, South Korea	Son, Y (reprint author), Korea Univ, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea.	yson@korea.ac.kr			National Research Foundation of Korea [2010-0014620]; Korea Forest Service [S111112L030100]; Korea University	National Research Foundation of Korea (2010-0014620), Korea Forest Service (S111112L030100), and Korea University (2013).	Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Heide OM, 2005, TREE PHYSIOL, V25, P109; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Fracheboud Y, 2009, PLANT PHYSIOL, V149, P1982, DOI 10.1104/pp.108.133249; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Tharayil N, 2011, NEW PHYTOL, V191, P132, DOI 10.1111/j.1469-8137.2011.03667.x; Hanninen H, 2011, TRENDS PLANT SCI, V16, P412, DOI 10.1016/j.tplants.2011.05.001; Heide OM, 2008, SCI HORTIC-AMSTERDAM, V115, P309, DOI 10.1016/j.scienta.2007.10.005; Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Nakamura M, 2010, AGR FOREST METEOROL, V150, P1026, DOI 10.1016/j.agrformet.2010.04.001; Way DA, 2011, TREE PHYSIOL, V31, P469, DOI 10.1093/treephys/tpr044; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; Morisette JT, 2009, FRONT ECOL ENVIRON, V7, P253, DOI 10.1890/070217; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Repo T, 1996, PLANT CELL ENVIRON, V19, P209, DOI 10.1111/j.1365-3040.1996.tb00242.x; Estrella N, 2006, CLIMATE RES, V32, P253, DOI 10.3354/cr032253; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1046/j.1529-8817.2003.00714.x; Gunderson CA, 2012, GLOBAL CHANGE BIOL, V18, P2008, DOI 10.1111/j.1365-2486.2011.02632.x; NIZINSKI JJ, 1988, J APPL ECOL, V25, P643, DOI 10.2307/2403851; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Zhang KR, 2010, FOREST ECOL MANAG, V259, P2036, DOI 10.1016/j.foreco.2010.02.014; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Guak S, 1998, TREE PHYSIOL, V18, P671; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Askeyev OV, 2005, INT J BIOMETEOROL, V49, P262, DOI 10.1007/s00484-004-0233-3; Bronson DR, 2009, GLOBAL CHANGE BIOL, V15, P1534, DOI 10.1111/j.1365-2486.2009.01845.x; Chung H, 2013, J PLANT RES, V126, P447, DOI 10.1007/s10265-013-0565-3; Pachauri R. K, 2007, CONTRIBUTION WORKING; Kilpelainen A, 2006, TREES-STRUCT FUNCT, V20, P16, DOI 10.1007/s00468-005-0008-4; Linkosalo T, 2006, TREE PHYSIOL, V26, P1165; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Shen HH, 2013, J PLANT ECOL, V6, P418, DOI 10.1093/jpe/rtt010; Slaney M, 2007, TREE PHYSIOL, V27, P301; Xu ZF, 2012, EUR J FOREST RES, V131, P811, DOI 10.1007/s10342-011-0554-9	45	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1752-9921	1752-993X		J PLANT ECOL	J. Plant Ecol.	DEC	2014	7	6					559	566		10.1093/jpe/rtt067		8	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	AU8CZ	WOS:000345825400007		
J	Sumida, Y; Yoshikawa, T; Tanaka, S; Taketani, H; Kanemasa, K; Nishimura, T; Yamaguchi, K; Mitsuyoshi, H; Yasui, K; Minami, M; Naito, Y; Itoh, Y				Sumida, Yoshio; Yoshikawa, Toshikazu; Tanaka, Saiyu; Taketani, Hiroyoshi; Kanemasa, Kazuyuki; Nishimura, Tekeshi; Yamaguchi, Kanji; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Naito, Yuji; Itoh, Yoshito			The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patients	JOURNAL OF PUBLIC HEALTH			English	Article						intrinsic motivation; NAFLD; prosocial behavior; World Food Programme	FATTY LIVER-DISEASE; FINANCIAL INCENTIVES; WEIGHT-LOSS; NONALCOHOLIC STEATOHEPATITIS; AMINOTRANSFERASE LEVELS; OVERWEIGHT; THERAPY; TITMUSS; OBESITY; VALUES	Physicians often experience difficulties in motivating patients with non-alcoholic fatty liver disease (NAFLD) to undergo lifestyle changes. The aim of this study is to examine whether 'Donations for Decreased alanine aminotransferase (ALT)' (D4D) prosocial behavior incentive can serve as an effective intrinsic motivational factor in comparison with conventional dietary and exercise intervention alone for NAFLD patients. Twenty-five NAFLD patients with elevated ALT were randomly assigned to a control group that received conventional dietary and exercise intervention alone, or a donation group whereby, as an incentive, we would make a monetary donation to the United Nations World Food Programme (WFP) based on the decrease in their ALT levels achieved over 12 weeks, in addition to receiving control intervention. In a donation group, we would donate US$1 to the WFP for every 1 IU/l of decrease in their ALT levels. There were no differences of pre-treatment clinical characteristics between the two groups. Significant reductions of ALT levels were achieved only in a donation group, although post-treatment ALT levels were not different between the two groups. These patients raised a total of $316 for the WFP. Promoting patients' intrinsic motivation by incorporating 'D4D' prosocial behavior incentive into conventional dietary and exercise intervention may provide a means to improve NAFLD.	[Sumida, Yoshio; Nishimura, Tekeshi; Yamaguchi, Kanji; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Naito, Yuji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Kyoto, Japan; [Tanaka, Saiyu; Taketani, Hiroyoshi; Kanemasa, Kazuyuki] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan	Sumida, Y (reprint author), Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	sumida@koto.kpu-m.ac.jp			MSD Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.	Y.S. received scholarship funds from MSD Co., Ltd. Y.I. received scholarship funds from MSD Co., Ltd., and Dainippon Sumitomo Pharma Co., Ltd.	Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Hoofnagle JH, 2013, ALIMENT PHARM THER, V38, P134, DOI 10.1111/apt.12352; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Mellstrom C, 2008, J EUR ECON ASSOC, V6, P845, DOI 10.1162/JEEA.2008.6.4.845; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Finkelstein EA, 2007, J OCCUP ENVIRON MED, V49, P981, DOI 10.1097/JOM.0b013e31813c6dcb; John LK, 2011, J GEN INTERN MED, V26, P621, DOI 10.1007/s11606-010-1628-y; Bellentani S, 2008, HEPATOLOGY, V47, P746, DOI 10.1002/hep.22009; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Batson C., 2012, HDB HIST SOCIAL PSYC, P243; Gelli A, 2011, FOOD NUTR BULL, V32, P324; Government Public Relations Office of Cabinet Secretary, POLL PEOPL SOC AW; Kane R L, 2004, Evid Rep Technol Assess (Summ), P1; Marchesini G, 2005, J HEPATOL, V43, P926, DOI 10.1016/j.jhep.2005.09.005; Marteau TM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1415; Mellstrom Carl, 2008, J EUR ECON ASSOC, V6, P06; Moscatiello S, 2011, OBESITY, V19, P763, DOI 10.1038/oby.2010.254; Neuschwander-Tetri BA, 2009, CLIN LIVER DIS, V13, P649, DOI 10.1016/j.cld.2009.07.006; Rapport FL, 2002, J ADV NURS, V40, P495, DOI 10.1046/j.1365-2648.2002.02406.x; Relton C, 2011, J PUBLIC HEALTH-UK, V33, P536, DOI 10.1093/pubmed/fdr030; Sheeran J, 2011, NATURE, V479, P469, DOI 10.1038/479469a; Sheeran J, 2008, LANCET, V371, P180, DOI 10.1016/S0140-6736(07)61870-4; The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, 2010, J JAPAN DIAB SOC, V53, P450; Matsuzawa Y, 2002, CIRC J, V66, P987; Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1741-3842	1741-3850		J PUBLIC HEALTH-UK	J. Public Health	DEC	2014	36	4					629	634		10.1093/pubmed/fdt098		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AU8IX	WOS:000345840900017		
J	Hayano, RS; Watanabe, YN; Nomura, S; Nemoto, T; Tsubokura, M; Hanai, T; Kumemoto, Y; Kowata, S; Oikawa, T; Kanazawa, Y				Hayano, Ryugo S.; Watanabe, Yuni N.; Nomura, Shuhei; Nemoto, Tsuyoshi; Tsubokura, Masaharu; Hanai, Tatsuo; Kumemoto, Yuki; Kowata, Satoshi; Oikawa, Tomoyoshi; Kanazawa, Yukio			Whole-body counter survey results 4 months after the Fukushima Dai-ichi NPP accident in Minamisoma City, Fukushima	JOURNAL OF RADIOLOGICAL PROTECTION			English	Article						Fukushima Dai-ichi NPP accident; early internal dose; whole body counting	NUCLEAR-POWER-PLANT; INTERNAL RADIATION-EXPOSURE; DISASTER	Using the first WBC unit installed in Fukushima Prefecture after the accident, the radiocesium body burdens of 566 high-risk residents of Minamisoma city were measured in July 2011 at the Minamisoma Municipal General Hospital. The analysis of the data was challenging because this chair-type, WBC unit, did not have sufficient shielding against background gamma rays and methods had to be developed to reliably compensate for the body-attenuated background radiation. Fortunately, data for repeated tests of hospital staff members using both the chair-type and well-shielded FASTSCAN WBC units, installed in September 2011, were available and could be used to check the validity of the analysis. The CEDs of all subjects, estimated under the assumption of acute inhalation in March 2011, were found to be less than 1 mSv.	[Hayano, Ryugo S.; Watanabe, Yuni N.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Nemoto, Tsuyoshi; Tsubokura, Masaharu; Hanai, Tatsuo; Kumemoto, Yuki; Kowata, Satoshi; Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Fukushima 9790033, Japan	Hayano, RS (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hayano@phys.s.u-tokyo.ac.jp	Hayano, Ryugo/F-7889-2012				Akar A, 2006, J QUANT SPECTROSC RA, V102, P203, DOI 10.1016/j.jqsrt.2006.02.007; Tanaka S, 2012, P JPN ACAD B-PHYS, V88, P471, DOI 10.2183/pjab.88.471; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Ishigure N, 2004, RADIAT PROT DOSIM, V109, P235, DOI 10.1093/rpd/nch048; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Zoetelief J, 2005, J ICRU, V5, P100	8	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0952-4746	1361-6498		J RADIOL PROT	J. Radiol. Prot.	DEC	2014	34	4					787	799		10.1088/0952-4746/34/4/787		13	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AU9EZ	WOS:000345895800008		
J	Agustin, MB; Ahmmad, B; Alonzo, SMM; Patriana, FM				Agustin, Melissa B.; Ahmmad, Bashir; Alonzo, Shanna Marie M.; Patriana, Famille M.			Bioplastic based on starch and cellulose nanocrystals from rice straw	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						Rice straw; cellulose nanocrystals; starch-based bioplastic	COMPOSITES; BEHAVIOR; WHISKERS	Bioplastic based on starch as the matrix and cellulose nanocrystals from rice straw as reinforcing filler were prepared in this study. The isolation of cellulose nanocrystal (CNC) followed a series of steps: delignification, sulfuric acid hydrolysis, and sonication. The process afforded short, rod-like CNCs with particle diameter ranging from 10 to 12nm and crystallinity index of 76.1%. Fourier transform infrared analysis of the CNCs also confirmed absorption patterns typical of cellulose and the removal of silica. Bioplastic with different starch-to-CNC ratios were prepared by solution casting and evaporation method. Scanning electron micrographs of the films showed uniform dispersion of CNC in the starch matrix. Mechanical tests revealed that both tensile strength and modulus significantly increased with increasing CNC load while percent elongation decreased. The moisture uptake of the films reinforced with CNC also decreased an indication of improvement in water resistance. However, the thermal stability of the films decreased by the addition of CNC.	[Agustin, Melissa B.; Alonzo, Shanna Marie M.; Patriana, Famille M.] Cent Luzon State Univ, Coll Arts & Sci, Dept Chem, Sci City Of Munoz, Nueva Ecija, Philippines; [Ahmmad, Bashir] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Ahmmad, B (reprint author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	arima@yz.yamagata-u.ac.jp	AHMMAD, BASHIR/B-2625-2011	AHMMAD, BASHIR/0000-0001-7748-9746	International Foundation for Science [F/4928-1]; Japanese Society for the Promotion of Science [26810117, 2014-2015]	This research was supported by the International Foundation for Science through a grant (F/4928-1) for M. B. Agustin and by the Grants-in-Aid for Young Scientists (B) (No. 26810117, 2014-2015) from the Japanese Society for the Promotion of Science.	Khalil HPSA, 2013, J REINF PLAST COMP, V32, P330, DOI 10.1177/0731684412458553; Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+; Lee J, 2006, J CONTROL RELEASE, V111, P185, DOI 10.1016/j.jconrel.2005.12.003; Lu P, 2012, CARBOHYD POLYM, V87, P564, DOI 10.1016/j.carbpol.2011.08.022; Pasquini D, 2010, IND CROP PROD, V32, P486, DOI 10.1016/j.indcrop.2010.06.022; Elanthikkal S, 2010, CARBOHYD POLYM, V80, P852, DOI 10.1016/j.carbpol.2009.12.043; Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Agustin MB, 2013, POLYM COMPOSITE, V34, P1325, DOI 10.1002/pc.22546; Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059; Nunna S, 2012, J REINF PLAST COMP, V31, P759, DOI 10.1177/0731684412444325; Siqueira G, 2009, BIOMACROMOLECULES, V10, P425, DOI 10.1021/bm801193d; La Mantia FP, 2011, COMPOS PART A-APPL S, V42, P579, DOI 10.1016/j.compositesa.2011.01.017; Teixeira ED, 2009, CARBOHYD POLYM, V78, P422, DOI 10.1016/j.carbpol.2009.04.034; Teixeira ED, 2011, IND CROP PROD, V33, P63, DOI 10.1016/j.indcrop.2010.08.009; Canigueral N, 2009, CHEM ENG SCI, V64, P2651, DOI 10.1016/j.ces.2009.02.006; Fleming K, 2001, CHEM-EUR J, V7, P1831, DOI 10.1002/1521-3765(20010504)7:9<1831::AID-CHEM1831>3.3.CO;2-J; Sathishkumar TP, 2014, J REINF PLAST COMP, V33, P454, DOI 10.1177/0731684413516393; Chen XL, 2011, CARBOHYD POLYM, V85, P245, DOI 10.1016/j.carbpol.2011.02.022; Dogossy G, 2011, J REINF PLAST COMP, V30, P1819, DOI 10.1177/0731684411429728; JULIEN S, 1993, J ANAL APPL PYROL, V27, P25, DOI 10.1016/0165-2370(93)80020-Z; Philippine Rice Research Institute, 2012, PHILRICE STUD RIC ST; Segal L., 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003]; Shen L., 2009, PRODUCT OVERVIEW MAR; Wittaya T., 2009, INT FOOD RES J, V16, P493	26	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	DEC	2014	33	24					2205	2213		10.1177/0731684414558325		9	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	AU7EH	WOS:000345763100001		
J	Kumasawa, K				Kumasawa, K.			Exploit of easy handling model mice with hypertension	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Kumasawa, K.] Osaka Univ, Dept Obstet & Gynecol, Suita, Osaka 565, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						1	2		10.1016/j.jri.2014.09.003		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700003		
J	Ohkuchi, A				Ohkuchi, A.			Angiogenesis-related factors in pregnancy-induced hypertension	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Ohkuchi, A.] Jichi Med Univ, Sch Med, Dept Obstet & Gynecol, Shimotsuke, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						1	1		10.1016/j.jri.2014.09.002		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700002		
J	Iriyama, T				Iriyama, T.			Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Iriyama, T.] Tokyo Univ Hosp, Dept Obstet & Gynecol, Tokyo, Japan; [Iriyama, T.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX USA								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						2	2		10.1016/j.jri.2014.09.004		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700004		
J	Shiozaki, A; Saito, S				Shiozaki, A.; Saito, S.			Impact of maternal body mass index and fetal sex on Th1:Th2 cell ratio in preeclampsia	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Shiozaki, A.; Saito, S.] Toyama Univ, Dept Obstet & Gynecol, Toyama, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						2	3		10.1016/j.jri.2014.09.005		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700005		
J	Kitaya, K; Matsubayashi, H; Ishikawa, T				Kitaya, K.; Matsubayashi, H.; Ishikawa, T.			Chronic endometritis in infertility Symposium 2	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Kitaya, K.; Matsubayashi, H.; Ishikawa, T.] Reprod Clin Osaka, Osaka, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						3	3		10.1016/j.jri.2014.09.006		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700006		
J	Uchida, H				Uchida, H.			Endometrial epithelial cell dynamics during human implantation	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Uchida, H.] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 108, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						3	3		10.1016/j.jri.2014.09.007		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700007		
J	Yoshino, O; Nomoto, K; Akiyama, I; Osuga, Y; Fujii, T; Saito, S				Yoshino, O.; Nomoto, K.; Akiyama, I.; Osuga, Y.; Fujii, T.; Saito, S.			The relationship between granulosa cells (GC) and surrounding cells in ovarian physiology and pathophysiology	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Yoshino, O.; Nomoto, K.; Saito, S.] Toyama Univ, Dept Obstet & Gynecol, Toyama, Japan; [Akiyama, I.; Osuga, Y.; Fujii, T.] Univ Tokyo, Dept Obstet & Gynecol, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						3	4		10.1016/j.jri.2014.09.008		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700008		
J	Hasegawa, A; Shibahara, H				Hasegawa, A.; Shibahara, H.			The history and current status of anti-sperm antibody research	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Hasegawa, A.; Shibahara, H.] Ctr Reprod Med Hyogo, Coll Med, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						4	4		10.1016/j.jri.2014.09.009		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700009		
J	Nakao, J; Fujiwara, Y; Takaishi, K; Komohara, Y; Tashiro, H; Takeya, M; Katabuchi, H				Nakao, J.; Fujiwara, Y.; Takaishi, K.; Komohara, Y.; Tashiro, H.; Takeya, M.; Katabuchi, H.			Oral free communication abstracts Onionin A inhibits epithelial ovarian cancer proliferation by the suppression of STAT3 activation in tumor cells and macrophages	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Nakao, J.; Takaishi, K.; Tashiro, H.; Katabuchi, H.] Kumamoto Univ, Dept Obstet & Gynecol, Kumamoto 860, Japan; [Nakao, J.; Fujiwara, Y.; Komohara, Y.; Takeya, M.] Kumamoto Univ, Fac Life Sci, Dept Cell Pathol, Kumamoto 860, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						4	5		10.1016/j.jri.2014.09.010		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700010		
J	Itoh, M; Ota, K; Katsumata, Y; Abe, K; Hiraishi, H				Itoh, M.; Ota, K.; Katsumata, Y.; Abe, K.; Hiraishi, H.			The eosinophilic leukocytosis of a heparin calcium treatment (the 2nd report)	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									JCHO Gunma Cent Hosp, Dept Obstet & Gynecol, Gunma, Japan; Reprod Ctr, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						5	5		10.1016/j.jri.2014.09.012		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700012		
J	Yamaguchi, M; Ohnishi, K; Komohara, Y; Saito, F; Erdenebaatar, C; Fujimoto, K; Tashiro, H; Takeya, M; Katabuchi, H				Yamaguchi, M.; Ohnishi, K.; Komohara, Y.; Saito, F.; Erdenebaatar, C.; Fujimoto, K.; Tashiro, H.; Takeya, M.; Katabuchi, H.			CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with endometxial cancer	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Yamaguchi, M.; Saito, F.; Erdenebaatar, C.; Fujimoto, K.; Tashiro, H.; Katabuchi, H.] Kumamoto Univ, Dept Obstet, Kumamoto 860, Japan; [Yamaguchi, M.; Saito, F.; Erdenebaatar, C.; Fujimoto, K.; Tashiro, H.; Katabuchi, H.] Kumamoto Univ, Dept Gynecol, Kumamoto 860, Japan; [Ohnishi, K.; Komohara, Y.; Takeya, M.] Kumamoto Univ, Fac Life Sci, Kumamoto 860, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						5	5		10.1016/j.jri.2014.09.011		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700011		
J	Fuchinoue, K; Fukui, A; Kamoi, M; Funamizu, A; Fukuhara, R; Mizunuma, H				Fuchinoue, K.; Fukui, A.; Kamoi, M.; Funamizu, A.; Fukuhara, R.; Mizunuma, H.			Expression of NCRs and ROR gamma t in peripheral blood NK cells of recurrent pregnancy losses	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Fuchinoue, K.; Fukui, A.; Kamoi, M.; Fukuhara, R.; Mizunuma, H.] Hirosaki Univ, Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan; [Funamizu, A.] Kuroshi Gen Hosp, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						6	7		10.1016/j.jri.2014.09.015		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700015		
J	Funamizu, A; Fukui, A; Fuchinoue, K; Kamoi, M; Fukuhara, R; Mizunuma, H				Funamizu, A.; Fukui, A.; Fuchinoue, K.; Kamoi, M.; Fukuhara, R.; Mizunuma, H.			The change of NCR expression and cytokine production of NK cells in peripheral blood and peritoneal fluid by hormonal treatment in patients with endometriosis	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Funamizu, A.; Fukui, A.; Fuchinoue, K.; Kamoi, M.; Fukuhara, R.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan; [Funamizu, A.] Kuroishi Gen Hosp, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						6	6		10.1016/j.jri.2014.09.014		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700014		
J	Kamoi, M; Fukui, A; Funamizu, A; Sasaki, Y; Nakamura, R; Fuchinoue, K; Fukuhara, R; Mizunuma, H				Kamoi, M.; Fukui, A.; Funamizu, A.; Sasaki, Y.; Nakamura, R.; Fuchinoue, K.; Fukuhara, R.; Mizunuma, H.			Flow cytometric analysis of NK22 cells function in peripheral blood and endometrium obtained from women with recurrent pregnancy loss	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Kamoi, M.; Fukui, A.; Funamizu, A.; Sasaki, Y.; Nakamura, R.; Fuchinoue, K.; Fukuhara, R.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Aomori, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						6	6		10.1016/j.jri.2014.09.013		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700013		
J	Maekawa, R; Sinagawa, M; Okada, M; Asada, H; Taketani, T; Yamagata, Y; Tamura, H; Sugino, N; Kubo, M				Maekawa, R.; Sinagawa, M.; Okada, M.; Asada, H.; Taketani, T.; Yamagata, Y.; Tamura, H.; Sugino, N.; Kubo, M.			A woman case of familial Mediterranean fever accompanied with periodic fever during menstruation	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Maekawa, R.; Sinagawa, M.; Okada, M.; Asada, H.; Taketani, T.; Yamagata, Y.; Tamura, H.; Sugino, N.] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Yamaguchi, Japan; [Kubo, M.] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Yamaguchi, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						7	7		10.1016/j.jri.2014.09.016		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700016		
J	Yamamoto, R; Kawaguchi, R; Onota, S; Kato, A; Haino, T; Sugimoto, K; Okamoto, A				Yamamoto, R.; Kawaguchi, R.; Onota, S.; Kato, A.; Haino, T.; Sugimoto, K.; Okamoto, A.			The examination of recurrent pregnancy loss in our hospital	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Yamamoto, R.; Kawaguchi, R.; Onota, S.; Kato, A.; Haino, T.; Sugimoto, K.; Okamoto, A.] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						7	7		10.1016/j.jri.2014.09.017		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700017		
J	Sato, Y; Sugi, T; Sakai, R				Sato, Y.; Sugi, T.; Sakai, R.			Implantation failure and protein S deficiency	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Sato, Y.; Sugi, T.; Sakai, R.] Sugi Womens Clin, Lab Recurrent Pregnancy Loss, Tokyo, Japan; [Sato, Y.] EIJU Gen Hosp, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						8	8		10.1016/j.jri.2014.09.019		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700019		
J	Shinozaki, N; Deguchi, M; Tanimura, K; Ebina, Y; Yamada, H				Shinozaki, N.; Deguchi, M.; Tanimura, K.; Ebina, Y.; Yamada, H.			Genetic analysis for women with protein S deficiency	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Shinozaki, N.; Deguchi, M.; Tanimura, K.; Ebina, Y.; Yamada, H.] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Kobe, Hyogo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						8	8		10.1016/j.jri.2014.09.018		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700018		
J	Sugi, T; Sato, Y; Sakai, R				Sugi, T.; Sato, Y.; Sakai, R.			Autoantibodies to protein s and protein S deficiency in patients with recurrent pregnancy loss	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Sugi, T.; Sato, Y.; Sakai, R.] Sugi Womens Clin, Lab Recurrent Pregnancy Loss, Tokyo, Japan; [Sato, Y.] EIJU Gen Hosp, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						8	9		10.1016/j.jri.2014.09.020		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700020		
J	Koizumi, K; Nakamura, H; Matsuzaki, T; Kuroda, S; Takiuchi, T; Kumasawa, K; Kimura, T				Koizumi, K.; Nakamura, H.; Matsuzaki, T.; Kuroda, S.; Takiuchi, T.; Kumasawa, K.; Kimura, T.			A new local drug delivery system for the uterus using bio-nanocapsule (BNC)	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Koizumi, K.; Nakamura, H.; Takiuchi, T.; Kumasawa, K.; Kimura, T.] Osaka Univ, Grad Sch Med, Dept Obstet & Gynaecol, Suita, Osaka 565, Japan; [Matsuzaki, T.] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 565, Japan; [Kuroda, S.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Div Biotechnol,Lab Ind Biosci, Nagoya, Aichi 4648601, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						9	10		10.1016/j.jri.2014.09.023		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700023		
J	Li, ZL; Otsuki, Y				Li, Z. -L; Otsuki, Y.			Subcellular localization of era and their effects on cell size	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Li, Z. -L; Otsuki, Y.] Osaka Med Coll, Dept Anat & Biol, Osaka, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						9	9		10.1016/j.jri.2014.09.022		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700022		
J	Motomura, K; Sasaki, A; Hisano, M; Yamaguchi, K; Ito, Y; Ito, R; Kasahara, M; Matsumoto, K; Sago, H				Motomura, K.; Sasaki, A.; Hisano, M.; Yamaguchi, K.; Ito, Y.; Ito, R.; Kasahara, M.; Matsumoto, K.; Sago, H.			A case report of neonatal hemochromatosis treated by high-dose intravenous immunoglobulin	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Motomura, K.; Sasaki, A.; Hisano, M.; Yamaguchi, K.; Ito, Y.; Sago, H.] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan; [Ito, R.] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Tokyo, Japan; [Kasahara, M.] Natl Ctr Child Hlth & Dev, Organ Transplantat Ctr, Tokyo, Japan; [Matsumoto, K.] Natl Ctr Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						9	9		10.1016/j.jri.2014.09.021		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700021		
J	Kubo, K; Hasegawa, T; Sakamoto, A; Matsuda, M; Kotani, S; Kamada, Y; Nakatsuka, M; Hiramatsu, Y				Kubo, K.; Hasegawa, T.; Sakamoto, A.; Matsuda, M.; Kotani, S.; Kamada, Y.; Nakatsuka, M.; Hiramatsu, Y.			Anti-thyroid autoantibodies and thyroid function in women with recurrent pregnancy loss during the early stages of pregnancy	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Kubo, K.; Hasegawa, T.; Sakamoto, A.; Matsuda, M.; Kotani, S.; Kamada, Y.; Hiramatsu, Y.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Nakatsuka, M.] Okayama Univ, Grad Sch Hlth Sci, Okayama 7008530, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						10	10		10.1016/j.jri.2014.09.024		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700024		
J	Ota, K; Kwak-Kim, J; Maruyama, T; Tanaka, M				Ota, K.; Kwak-Kim, J.; Maruyama, T.; Tanaka, M.			New metabolic marker: Advanced glycation end products (AGEs) and receptor for advanced glycation end products (RAGE) system may play a role in the pathogenesis of recurrent pregnancy losses	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Ota, K.; Maruyama, T.; Tanaka, M.] Keio Univ, Dept Obstet & Gynecol, Tokyo 108, Japan; [Kwak-Kim, J.] Rosalind Franklin Univ Med & Sci, Reprod Ctr, Chicago Med Sch, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						10	11		10.1016/j.jri.2014.09.025		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700025		
J	Kai, K; Nasu, K; Aoyagi, Y; Tsukamoto, Y; Hijiya, N; Okamoto, M; Moriyama, M; Narahara, H				Kai, K.; Nasu, K.; Aoyagi, Y.; Tsukamoto, Y.; Hijiya, N.; Okamoto, M.; Moriyama, M.; Narahara, H.			DR6 is epigenetically involved in the pathogenesis of endometriosis by creating the proliferative and anti-apoptotic characteristics	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Kai, K.; Nasu, K.; Aoyagi, Y.; Okamoto, M.; Narahara, H.] Dept Obstet & Gynecol, Yonago, Tottori, Japan; [Nasu, K.] Support Syst Community Med, Div Obstet & Gynecol, Tokyo, Japan; [Tsukamoto, Y.; Hijiya, N.; Moriyama, M.] Oita Univ, Fac Med, Dept Mol Pathol, Oita 8795593, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						11	11		10.1016/j.jri.2014.09.026		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700026		
J	Ogawa, Y; Kuramasu, M; Qu, N; Hirai, S; Hayashi, S; Hatayama, N; Itoh, M				Ogawa, Y.; Kuramasu, M.; Qu, N.; Hirai, S.; Hayashi, S.; Hatayama, N.; Itoh, M.			Cadmium exposure increases the susceptibility to testicular autoimmunity in mice	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Ogawa, Y.; Kuramasu, M.; Qu, N.; Hirai, S.; Hayashi, S.; Hatayama, N.; Itoh, M.] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						11	12		10.1016/j.jri.2014.09.028		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700028		
J	Qu, N; Hirayanagi, Y; Hayashi, S; Hirai, S; Hatayama, N; Kuramasu, M; Ogawa, Y; Itoh, M				Qu, N.; Hirayanagi, Y.; Hayashi, S.; Hirai, S.; Hatayama, N.; Kuramasu, M.; Ogawa, Y.; Itoh, M.			Goshajinkigan completely recover the severe aspermatogenesis after busulfan treatment in mice	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Qu, N.; Hirayanagi, Y.; Hayashi, S.; Hirai, S.; Hatayama, N.; Kuramasu, M.; Ogawa, Y.; Itoh, M.] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						11	11		10.1016/j.jri.2014.09.027		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700027		
J	Inoue, E; Nagamatsu, T; Kawana, K; Yamashita, T; Osuga, Y; Fujii, T				Inoue, E.; Nagamatsu, T.; Kawana, K.; Yamashita, T.; Osuga, Y.; Fujii, T.			Prevention of preterm labor by omega-3 polyunsaturated fatty acids and resolvin E3	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Inoue, E.; Nagamatsu, T.; Kawana, K.; Yamashita, T.; Osuga, Y.; Fujii, T.] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						12	12		10.1016/j.jri.2014.09.029		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700029		
J	Urata, Y; Osuga, Y; Koga, K; Hirota, Y; Hirata, T; Harada, M; Takamura, M; Izumi, G; Fujii, T				Urata, Y.; Osuga, Y.; Koga, K.; Hirota, Y.; Hirata, T.; Harada, M.; Takamura, M.; Izumi, G.; Fujii, T.			Interleukin-1 beta increases expression of tryptophan 2,3-dioxygenase and stimulates tryptophan metabolism in ectopic endomtetrial stromal cells	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Urata, Y.; Osuga, Y.; Koga, K.; Hirota, Y.; Hirata, T.; Harada, M.; Takamura, M.; Izumi, G.; Fujii, T.] Univ Tokyo, Dept Obstet & Gynecol, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						12	12		10.1016/j.jri.2014.09.030		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700030		
J	Egashira, M; Hirota, Y; Saito-Fujita, T; Haraguchi, H; Matsumoto, L; Matsuo, M; Hiraoka, T; Osuga, Y; Fujii, T				Egashira, M.; Hirota, Y.; Saito-Fujita, T.; Haraguchi, H.; Matsumoto, L.; Matsuo, M.; Hiraoka, T.; Osuga, Y.; Fujii, T.			Pathophysiological role of cellular senescence in the mouse postpartum endometrium	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Egashira, M.; Hirota, Y.; Saito-Fujita, T.; Haraguchi, H.; Matsumoto, L.; Matsuo, M.; Hiraoka, T.; Osuga, Y.; Fujii, T.] Grad Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Egashira, M.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						13	13		10.1016/j.jri.2014.09.031		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700031		
J	Ichikawa, M; Nagamatsu, T; Fujii, T; Hoya, M; Kawai-Iwasawa, Y; Oda, K; Kawana, K; Yamashita, T; Osuga, Y; Fujii, T				Ichikawa, M.; Nagamatsu, T.; Fujii, T.; Hoya, M.; Kawai-Iwasawa, Y.; Oda, K.; Kawana, K.; Yamashita, T.; Osuga, Y.; Fujii, T.			Lysophosphatidic acid induces the expression of angiogenic factors in human trophoblast cells - a way of understanding the etiology of PIH	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Ichikawa, M.; Nagamatsu, T.; Fujii, T.; Hoya, M.; Kawai-Iwasawa, Y.; Oda, K.; Kawana, K.; Yamashita, T.; Osuga, Y.; Fujii, T.] Univ Tokyo, Dept Obstet & Gynecol, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						13	13		10.1016/j.jri.2014.09.032		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700032		
J	Nagasaka, T; Nagamatsu, T; Inoue, E; Hoya, M; Iwasawa-Kawai, Y; Yamashita, T; Osuga, Y; Fujii, T				Nagasaka, T.; Nagamatsu, T.; Inoue, E.; Hoya, M.; Iwasawa-Kawai, Y.; Yamashita, T.; Osuga, Y.; Fujii, T.			Impact of psychological stresses on miscarriage rate in CBA/J x DBA/2J mouse model	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Nagasaka, T.; Nagamatsu, T.; Inoue, E.; Hoya, M.; Iwasawa-Kawai, Y.; Yamashita, T.; Osuga, Y.; Fujii, T.] Univ Tokyo, Grad Sch Med, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						13	14		10.1016/j.jri.2014.09.033		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700033		
J	Fujii, T; Nagamatsu, T; Ichikawa, M; Kawai-Iwasawa, Y; Kawana, K; Yamashita, T; Osuga, Y; Fujii, T				Fujii, T.; Nagamatsu, T.; Ichikawa, M.; Kawai-Iwasawa, Y.; Kawana, K.; Yamashita, T.; Osuga, Y.; Fujii, T.			Expression of LPA receptors is elevated in preeclamptic placenta	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Fujii, T.; Nagamatsu, T.; Ichikawa, M.; Kawai-Iwasawa, Y.; Kawana, K.; Yamashita, T.; Osuga, Y.; Fujii, T.] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						14	14		10.1016/j.jri.2014.09.034		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700034		
J	Shirasuna, K; Usui, F; Karasawa, T; Kimura, H; Kawashima, A; Mizukami, H; Ohkuchi, A; Takahashi, M				Shirasuna, K.; Usui, F.; Karasawa, T.; Kimura, H.; Kawashima, A.; Mizukami, H.; Ohkuchi, A.; Takahashi, M.			Nanosilica-induced placental inflammation and pregnancy complications: different roles of the inflammasome components NLRP3 and ASC	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Shirasuna, K.; Usui, F.; Karasawa, T.; Kimura, H.; Kawashima, A.; Takahashi, M.] Div Inflammat Res, Kyoto, Japan; [Shirasuna, K.] Tokyo Univ Agr, Dept Anim Sci, Tokyo, Japan; [Mizukami, H.] Div Genet Therapeut, Tokyo, Japan; [Ohkuchi, A.] Jichi Med Univ, Ctr Mol Med, Dept Obstet & Gynecol, Shimotsuke, Japan			Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X				0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						14	14		10.1016/j.jri.2014.09.035		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700035		
J	Ouji-Sageshima, N; Akasaki, M; Geraghty, DE; Kita, E; Ishitani, A; Hatake, K; Ito, T				Ouji-Sageshima, N.; Akasaki, M.; Geraghty, D. E.; Kita, E.; Ishitani, A.; Hatake, K.; Ito, T.			Establishment of new ELISA system for HLA-G	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Ouji-Sageshima, N.; Ito, T.] Nara Med Univ, Dept Immunol, Kashihara, Nara, Japan; [Akasaki, M.] Akasaki Clin, Kotoura, Japan; [Geraghty, D. E.] Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Kita, E.] Nara Med Univ, Dept Microbiol & Infect Dis Med, Kashihara, Nara, Japan; [Ishitani, A.; Hatake, K.] Nara Med Univ, Dept Legal Med, Kashihara, Nara, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						15	15		10.1016/j.jri.2014.09.037		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700037		
J	Tani, A; Yasui, T; Kasai, K; Keyama, K; Matsui, S; Kato, T; Irahara, M				Tani, A.; Yasui, T.; Kasai, K.; Keyama, K.; Matsui, S.; Kato, T.; Irahara, M.			Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Tani, A.] Veritas Hosp, Dept Obstet & Gynecol, Orlando, FL USA; [Tani, A.; Yasui, T.; Keyama, K.; Matsui, S.; Kato, T.; Irahara, M.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Obstet & Gynecol, Tokushima, Japan; [Kasai, K.] Takamatsu Municipal Hosp, Dept Obstet & Gynecol, Takamatsu, Kagawa, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						15	15		10.1016/j.jri.2014.09.036		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700036		
J	Koike, N; Tsunemi, T; Akasaka, J; Shigemitsu, A; Yoshimoto, C; Naruse, K; Kobayashi, H				Koike, N.; Tsunemi, T.; Akasaka, J.; Shigemitsu, A.; Yoshimoto, C.; Naruse, K.; Kobayashi, H.			Urokinase-type plasminogen activator (uPA) system and invasion of early human extravillous trophoblast is regulated by hypoxia induced factor (HIF) pathway	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Koike, N.; Tsunemi, T.; Akasaka, J.; Shigemitsu, A.; Yoshimoto, C.; Naruse, K.; Kobayashi, H.] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						16	16		10.1016/j.jri.2014.09.038		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700038		
J	Kuwabara, Y; Katayama, A; Kurihara, S; Yonezawa, M; Ouchi, N; Sawa, R; Takeshita, T				Kuwabara, Y.; Katayama, A.; Kurihara, S.; Yonezawa, M.; Ouchi, N.; Sawa, R.; Takeshita, T.			Progesterone transcriptionally inhibits LPS-induced matrix metalloproteinase up-regulation in human cervical fibroblast cells	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Kuwabara, Y.; Kurihara, S.; Yonezawa, M.; Ouchi, N.; Sawa, R.; Takeshita, T.] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 113, Japan; [Katayama, A.] Nippon Med Sch, Dept Biochem & Mol Biol, Tokyo 113, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						16	17		10.1016/j.jri.2014.09.040		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700040		
J	Negishi, Y; Ichikawa, T; Takeshita, T; Takahashi, H				Negishi, Y.; Ichikawa, T.; Takeshita, T.; Takahashi, H.			Possible induction of murine miscarriages through activation of DEC-205+dendritic cells by glycolipid antigens	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Negishi, Y.; Ichikawa, T.; Takahashi, H.] Nippon Med Sch, Dept Microbiol & Immunol, Tokyo, Japan; [Negishi, Y.; Ichikawa, T.; Takeshita, T.] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						16	16		10.1016/j.jri.2014.09.039		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700039		
J	Hirohata, N; Komine-Aizawa, S; Hayakawa, S				Hirohata, N.; Komine-Aizawa, S.; Hayakawa, S.			Porphyromonas gingivalis inhibits trophoblast invasion	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Hirohata, N.; Komine-Aizawa, S.; Hayakawa, S.] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 102, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						17	18		10.1016/j.jri.2014.09.043		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700043		
J	Trinh, QD; Pham, NT; Le Nguyen, NT; Lam, BQ; Le Phan, KT; Truong, KH; Le, TQ; Nguyen, HT; Tang, TC; Izumi, Y; Komine-Aizawa, S; Ushijima, H; Hayakawa, S				Trinh, Q. D.; Pham, N. T.; Le Nguyen, N. T.; Lam, B. Q.; Le Phan, K. T.; Truong, K. H.; Le, T. Q.; Nguyen, H. T.; Tang, T. C.; Izumi, Y.; Komine-Aizawa, S.; Ushijima, H.; Hayakawa, S.			Frequent Chlamydophila pneumoniae infection in vertically HIV-infected children in Vietnam	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Trinh, Q. D.; Pham, N. T.; Le Nguyen, N. T.; Lam, B. Q.; Le Phan, K. T.; Truong, K. H.; Le, T. Q.; Nguyen, H. T.; Tang, T. C.; Izumi, Y.; Komine-Aizawa, S.; Ushijima, H.; Hayakawa, S.] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 102, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						17	17		10.1016/j.jri.2014.09.042		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700042		
J	Zhao, D; Naing, BT; Inada, K; Shima, T; Saito, S; Takeshita, T; Takizawa, T				Zhao, D.; Naing, B. Than; Inada, K.; Shima, T.; Saito, S.; Takeshita, T.; Takizawa, T.			Analysis of miRNA-mRNA expression profiles in decidual natural killer cells during early pregnancy	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Zhao, D.; Naing, B. Than; Takizawa, T.] Nippon Med Sch, Dept Mol Med & Anat, Tokyo 113, Japan; [Inada, K.; Shima, T.; Saito, S.] Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan; [Takeshita, T.] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 113, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						17	17		10.1016/j.jri.2014.09.041		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700041		
J	Kasuga, A; Takahashi, H; Murase, T; Yamazaki, M; Yamamoto, T				Kasuga, A.; Takahashi, H.; Murase, T.; Yamazaki, M.; Yamamoto, T.			Maternal and fetal effects of pandemic H1N1 2009 influenza virus infection on pregnant mice	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Kasuga, A.; Takahashi, H.; Murase, T.; Yamazaki, M.; Yamamoto, T.] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 102, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						18	18		10.1016/j.jri.2014.09.044		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700044		
J	Nakao, T; Chishima, F; Hayashi, C; Suzuki, M; Ichikawa, G; Sugita, K; Yamamoto, T				Nakao, T.; Chishima, F.; Hayashi, C.; Suzuki, M.; Ichikawa, G.; Sugita, K.; Yamamoto, T.			The ratio of expression of angiotensin receptors type 1 (AT1), type 2 (AT2) mRNA in local endometriosis lesions and eutopic endometrium	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Nakao, T.; Chishima, F.; Hayashi, C.; Suzuki, M.; Ichikawa, G.; Sugita, K.; Yamamoto, T.] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 102, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						18	18		10.1016/j.jri.2014.09.045		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700045		
J	Aoki, Y; Otsuka, N; Yamamoto, N; Miyazaki, T; Miyatake, Y; Kasahara, M				Aoki, Y.; Otsuka, N.; Yamamoto, N.; Miyazaki, T.; Miyatake, Y.; Kasahara, M.			Contribution of the NKG2D receptor to murine placental development	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Aoki, Y.; Otsuka, N.; Yamamoto, N.; Miyazaki, T.; Miyatake, Y.; Kasahara, M.] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 060, Japan			Kasahara, Masanori/G-7651-2011					0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						19	19		10.1016/j.jri.2014.09.047		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700047		
J	Hashimoto, E; Ebara, T; Yamada-Namikawa, C; Kitaori, T; Suzumori, N; Katano, K; Ozaki, Y; Sugiura-Ogasawara, M				Hashimoto, E.; Ebara, T.; Yamada-Namikawa, C.; Kitaori, T.; Suzumori, N.; Katano, K.; Ozaki, Y.; Sugiura-Ogasawara, M.			Genotyping analysis for the 46C/T polymorphism of coagulation factor XII and the involvement of factor XII activity in patients with recurrent pregnancy loss	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Hashimoto, E.; Kitaori, T.; Suzumori, N.; Katano, K.; Ozaki, Y.; Sugiura-Ogasawara, M.] Nagoya City Univ, Dept Obstet & Gynecol, Nagoya, Aichi, Japan; [Ebara, T.] Nagoya City Univ, Nagoya, Aichi, Japan; [Yamada-Namikawa, C.] Nagoya City Univ, Dept Biochem 2, Nagoya, Aichi, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						19	20		10.1016/j.jri.2014.09.048		2	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700048		
J	Ito, M; Soeda, S; Yoneda, S; Ono, Y; Yoneda, N; Shiozaki, A; Saito, S				Ito, M.; Soeda, S.; Yoneda, S.; Ono, Y.; Yoneda, N.; Shiozaki, A.; Saito, S.			Neonatal alloimmune thrombocytopenia caused by maternal past lymphocytes immunotherapy: a case report	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Ito, M.; Soeda, S.; Yoneda, S.; Ono, Y.; Yoneda, N.; Shiozaki, A.; Saito, S.] Toyama Univ, Dept Obstet & Gynecol, Toyama, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						19	19		10.1016/j.jri.2014.09.046		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700046		
J	Miyashita, M; Koga, K; Nagai, M; Taguchi, A; Sue, F; Makabe, T; Izumi, G; Takamura, M; Harada, M; Hirata, T; Hirota, Y; Osuga, Y; Fujii, T				Miyashita, M.; Koga, K.; Nagai, M.; Taguchi, A.; Sue, F.; Makabe, T.; Izumi, G.; Takamura, M.; Harada, M.; Hirata, T.; Hirota, Y.; Osuga, Y.; Fujii, T.			The serum level of vitamin D of endometriosis patients	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Miyashita, M.; Koga, K.; Nagai, M.; Taguchi, A.; Sue, F.; Makabe, T.; Izumi, G.; Takamura, M.; Harada, M.; Hirata, T.; Hirota, Y.; Osuga, Y.; Fujii, T.] Univ Tokyo, Dept Obstet & Gynecol, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						20	20		10.1016/j.jri.2014.09.050		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700050		
J	Obayashi, Y; Ozaki, Y; Kurakane, S; Goto, S; Kumagai, K; Kitaori, T; Suzumori, N; Sugiura, M				Obayashi, Y.; Ozaki, Y.; Kurakane, S.; Goto, S.; Kumagai, K.; Kitaori, T.; Suzumori, N.; Sugiura, M.			Role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with recurrent miscarriage	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract									[Obayashi, Y.; Ozaki, Y.; Kurakane, S.; Goto, S.; Kumagai, K.; Kitaori, T.; Suzumori, N.; Sugiura, M.] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	DEC	2014	106						20	20		10.1016/j.jri.2014.09.049		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	AU9YU	WOS:000345948700049		
J	Mjaavatten, MD; Radner, H; Yoshida, K; Shadick, NA; Frits, ML; Iannaccone, CK; Kvien, TK; Weinblatt, ME; Solomon, DH				Mjaavatten, Maria D.; Radner, Helga; Yoshida, Kazuki; Shadick, Nancy A.; Frits, Michelle L.; Iannaccone, Christine K.; Kvien, Tore K.; Weinblatt, Michael E.; Solomon, Daniel H.			Inconsistent Treatment with Disease-modifying Antirheumatic Drugs: A Longitudinal Data Analysis	JOURNAL OF RHEUMATOLOGY			English	Article						RHEUMATOID ARTHRITIS; DISEASE-MODIFYING ANTIRHEUMATIC DRUGS; LONGITUDINAL STUDIES; DRUG ADHERENCE	EARLY RHEUMATOID-ARTHRITIS; QUALITY-OF-LIFE; RADIOGRAPHIC PROGRESSION; EULAR RECOMMENDATIONS; BIOLOGIC AGENTS; UNITED-STATES; SOUTH-KOREA; MANAGEMENT; TRENDS; COHORT	Objective. Current recommendations advocate treatment with disease-modifying antirheumatic drugs (DMARD) in all patients with active rheumatoid arthritis (RA). We investigated the frequency of and reasons for inconsistent DMARD use among patients in a clinical rheumatology cohort. Methods. Patients in the Brigham Rheumatoid Arthritis Sequential Study were studied for DMARD use (any or none) at each semiannual study timepoint during the first 2 study years. Inconsistent use was defined as DMARD use at <= 40% of study timepoints. Characteristics were compared between inconsistent and consistent users (> 40%), and factors associated with inconsistent DMARD use were determined through multivariate logistic regression. A medical record review was performed to determine the reasons for inconsistent use. Results. Of 848 patients with >= 4 out of 5 visits recorded, 55 (6.5%) were inconsistent DMARD users. Higher age, longer disease duration, and rheumatoid factor negativity were statistically significant correlates of inconsistent use in the multivariate analyses. The primary reasons for inconsistent use identified through chart review, allowing for up to 2 co-primary reasons, were inactive disease (n = 28, 50.9%), intolerance to DMARD (n = 18, 32.7%), patient preference (n = 7, 12.7%), comorbidity (n = 6, 10.9%), DMARD not being effective (n = 3, 5.5%), and pregnancy (n = 3, 5.5%). During subsequent followup, 14/45 (31.1%) inconsistent users with sufficient data became consistent users of DMARD. Conclusion. A small proportion of patients with RA in a clinical rheumatology cohort were inconsistent DMARD users during the first 2 years of followup. While various patient factors correlate with inconsistent use, many patients re-start DMARD and become consistent users over time.	Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA; Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, Vienna, Austria; Kameda Med Ctr, Dept Rheumatol, Kamogawa, Chiba, Japan	Mjaavatten, MD (reprint author), Diakonhjemmet Hosp, Dept Rheumatol, POB 23, N-0319 Oslo, Norway.	maria_mjaavatten@hotmail.com		Yoshida, Kazuki/0000-0002-2030-3549	US National Institutes of Health [K24 AR055989]; Bristol Myers Squibb; Medimmune; Crescendo Bioscience	Dr. Solomon is supported by a mentoring award from the US National Institutes of Health (K24 AR055989). The Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study receives support from Bristol Myers Squibb, Medimmune, and Crescendo Bioscience.	Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Ziegler S, 2010, ANN RHEUM DIS, V69, P1803, DOI 10.1136/ard.2009.122101; Boyesen P, 2011, ANN RHEUM DIS, V70, P428, DOI 10.1136/ard.2009.123950; Pincus T, 1999, ARTHRITIS RHEUM, V42, P2220, DOI 10.1002/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Tutuncu Z, 2006, ANN RHEUM DIS, V65, P1226, DOI 10.1136/ard.2005.051144; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; DeWitt EM, 2009, CLIN THER, V31, P1871, DOI 10.1016/j.clinthera.2009.08.020; Iannaccone CK, 2011, RHEUMATOLOGY, V50, P40, DOI 10.1093/rheumatology/keq263; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Sung YK, 2012, SEMIN ARTHRITIS RHEU, V41, P745, DOI 10.1016/j.semarthrit.2011.09.007; Soderlin MK, 2007, RHEUMATOLOGY, V46, P1355, DOI 10.1093/rheumatology/kem143; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Solomon DH, 2007, ARTHRIT RHEUM-ARTHR, V57, P234, DOI 10.1002/art.22549; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Fraenkel L, 2006, RHEUMATOLOGY, V45, P1555, DOI 10.1093/rheumatology/kel144; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gonzalez-Alvaro I, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2561; Lillegraven S, 2013, ARTHRIT CARE RES, V65, P526, DOI 10.1002/acr.21870; Lopez-Longo FJ, 2009, DRUG NEWS PERSPECT, V22, P543, DOI [10.1358/dnp.2009.22.9.1416992, 10.1358/dnp.2009.22.91416992]; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schmajuk G, 2013, ARTHRIT CARE RES, V65, P1927, DOI 10.1002/acr.22084; Sokka T, 2010, CLIN EXP RHEUMATOL, V28, pS13; Sokka T, 2008, RHEUMATOLOGY, V47, P1543, DOI 10.1093/rheumatology/ken316; Sung YK, 2013, ARTHRITIS RHEUM-US, V65, pS438; Yamanaka Hisashi, 2007, Mod Rheumatol, V17, P283, DOI 10.1007/s10165-007-0587-6	30	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	DEC	2014	41	12					2370	2378		10.3899/jrheum.140306		9	Rheumatology	Rheumatology	AU8HY	WOS:000345838400007		
J	Inoue, Y; Sohara, E; Kobayashi, K; Chiga, M; Rai, T; Ishibashi, K; Horie, S; Su, XF; Zhou, J; Sasaki, S; Uchida, S				Inoue, Yuichi; Sohara, Eisei; Kobayashi, Katsuki; Chiga, Motoko; Rai, Tatemitsu; Ishibashi, Kenichi; Horie, Shigeo; Su, Xuefeng; Zhou, Jing; Sasaki, Sei; Uchida, Shinichi			Aberrant Glycosylation and Localization of Polycystin-1 Cause Polycystic Kidney in an AQP11 Knockout Model	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							RECEPTOR PROTEOLYTIC SITE; CYST FORMATION; RENAL-FAILURE; DISEASE; MICE; AQUAPORIN-11; EXPRESSION; CLEAVAGE; PROTEIN; MUTATIONS	We previously reported that disruption of the aquaporin-11 (AQP11) gene in mice resulted in cystogenesis in the kidney. In this study, we aimed to clarify the mechanism of cystogenesis in AQP11(-/-) mice. To enable the analyses of AQP11 at the protein level in vivo, AQP11 BAC transgenic mice (Tg(AQP11)) that express 3xHA-tagged AQP11 protein were generated. This AQP11 localized to the endoplasmic reticulum (ER) of proximal tubule cells in Tg(AQP11) mice and rescued renal cystogenesis in AQP11((-/-) mice. Therefore, we hypothesized that the absence of AQP11 in the ER could result in impaired quality control and aberrant trafficking of polycystin-1 (PC-1) and polycystin-2 (PC-2). Compared with kidneys of wild-type mice, AQP11(-/-) kidneys exhibited increased protein expression levels of PC-1 and decreased protein expression levels of PC-2. Moreover, PC-1 isolated from AQP11((-/-) mice displayed an altered electrophoretic mobility caused by impaired N-glycosylation processing, and density gradient centrifugation of kidney homogenate and in vivo protein biotinylation revealed impaired membrane trafficking of PC-1 in these mice. Finally, we showed that the Pkd1(+/-) background increased the severity of cystogenesis in AQP11(-/-/) mouse kidneys, indicating that PC-1 is involved in the mechanism of cystogenesis in AQP11(-/-) mice. Additionally, the primary cilia of proximal tubules were elongated in AQP11(-/-) mice. Taken together, these data show that impaired glycosylation processing and aberrant membrane trafficking of PC-1 in AQP11(-/-) mice could be a key mechanism of cystogenesis in AQP11(-/-) mice.	[Inoue, Yuichi; Sohara, Eisei; Chiga, Motoko; Rai, Tatemitsu; Sasaki, Sei; Uchida, Shinichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nephrol, Tokyo 1138519, Japan; [Kobayashi, Katsuki] Chiba East Natl Hosp, Clin Res Ctr, Div Mol Genet, Chiba, Japan; [Ishibashi, Kenichi] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo, Japan; [Horie, Shigeo] Juntendo Univ, Sch Med, Dept Urol, Tokyo 113, Japan; [Su, Xuefeng; Zhou, Jing] Harvard Univ, Brigham & Womens Hosp, Sch Med, Renal Div,Dept Med, Boston, MA 02115 USA	Sohara, E (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nephrol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	esohara.kid@tmd.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare; Salt Science Research Foundation [1228]; Takeda Science Foundation; Banyu Foundation Research Grant	This study was supported, in part, by Grants-in-Aid for Scientific Research (S, A) from the Japan Society for the Promotion of Science; a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Health and Labor Sciences Research Grant from the Ministry of Health, Labor, and Welfare; Salt Science Research Foundation Grant 1228; the Takeda Science Foundation; and a Banyu Foundation Research Grant.	Ahrabi AK, 2007, J AM SOC NEPHROL, V18, P1740, DOI 10.1681/ASN.2006010052; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Yakata K, 2011, J STRUCT BIOL, V174, P315, DOI 10.1016/j.jsb.2011.01.003; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; Yakata K, 2007, BBA-BIOMEMBRANES, V1768, P688, DOI 10.1016/j.bbamem.2006.11.005; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Sohara E, 2008, J AM SOC NEPHROL, V19, P469, DOI 10.1681/ASN.2006090985; Masyuk TV, 2003, GASTROENTEROLOGY, V125, P1303, DOI 10.1053/S0016-5085(03)01369-6; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Muto S, 2002, HUM MOL GENET, V11, P1731, DOI 10.1093/hmg/11.15.1731; Wu GQ, 2000, NAT GENET, V24, P75; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; Ikeda M, 2011, J BIOL CHEM, V286, P3342, DOI 10.1074/jbc.M110.180968; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Kurbegovic A, 2010, HUM MOL GENET, V19, P1174, DOI 10.1093/hmg/ddp588; Sohara E, 2006, P NATL ACAD SCI USA, V103, P14217, DOI 10.1073/pnas.0602331103; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Rojek A, 2013, AM J PHYSIOL-GASTR L, V304, pG501, DOI 10.1152/ajpgi.00208.2012; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Chapin HC, 2010, MOL BIOL CELL, V21, P4338, DOI 10.1091/mbc.E10-05-0407; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Atochina-Vasserman EN, 2013, AM J PHYSIOL-RENAL, V304, pF1295, DOI 10.1152/ajprenal.00344.2012; Cadieux C, 2008, J BIOL CHEM, V283, P13817, DOI 10.1074/jbc.M709332200; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; IbraghimovBeskrovnaya O, 1997, P NATL ACAD SCI USA, V94, P6397, DOI 10.1073/pnas.94.12.6397; Janssen MJ, 2010, J HEPATOL, V52, P432, DOI 10.1016/j.jhep.2009.12.011; Ohta E, 2009, AM J PHYSIOL-CELL PH, V297, pC1368, DOI 10.1152/ajpcell.00117.2009; Sohara E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024277; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; Uchida S, 2005, MOL CELL BIOL, V25, P7357, DOI 10.1128/MCB.25.16.7357-7363.2005; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	42	2	2	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	DEC	2014	25	12					2789	2799		10.1681/ASN.2013060614		11	Urology & Nephrology	Urology & Nephrology	AU4UT	WOS:000345607500014		
J	Hanatani, S; Izumiya, Y; Araki, S; Rokutanda, T; Kimura, Y; Walsh, K; Ogawa, H				Hanatani, Shinsuke; Izumiya, Yasuhiro; Araki, Satoshi; Rokutanda, Taku; Kimura, Yuichi; Walsh, Kenneth; Ogawa, Hisao			Akt1-Mediated Fast/Glycolytic Skeletal Muscle Growth Attenuates Renal Damage in Experimental Kidney Disease	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							NITRIC-OXIDE; HEMODIALYSIS-PATIENTS; HEART-FAILURE; CELL FUNCTION; EXERCISE; FIBROSIS; PROTEIN; METABOLISM; ATROPHY; MICE	Muscle wasting is frequently observed in patients with kidney disease, and low muscle strength is associated with poor outcomes in these patients. However, little is known about the effects of skeletal muscle growth per se on kidney diseases. In this study, we utilized a skeletal muscle-specific, inducible Akt1 transgenic (Akt1 TG) mouse model that promotes the growth of functional skeletal muscle independent of exercise to investigate the effects of muscle growth on kidney diseases. Seven days after Akt1 activation in skeletal muscle, renal injury was induced by unilateral ureteral obstruction (UUO) in Akt1 TG and wild-type (WT) control mice. The expression of atrogin-1, an atrophy-inducing gene in skeletal muscle, was upregulated 7 days after UUO in WT mice but not in Akt1 TG mice. UUO-induced renal interstitial fibrosis, tubular injury, apoptosis, and increased expression of inflammatory, fibrosis-related, and adhesion molecule genes were significantly diminished in Akt1 TG mice compared with WT mice. An increase in the activating phosphorylation of eNOS in the kidney accompanied the attenuation of renal damage by myogenic Akt1 activation. Treatment with the NOS inhibitor L-NAME abolished the protective effect of skeletal muscle Akt activation on obstructive kidney disease. In conclusion, Akt1-mediated muscle growth reduces renal damage in a model of obstructive kidney disease. This improvement appears to be mediated by an increase in eNOS signaling in the kidney. Our data support the concept that loss of muscle mass during kidney disease can contribute to renal failure, and maintaining muscle mass may improve clinical outcome.	[Hanatani, Shinsuke; Izumiya, Yasuhiro; Araki, Satoshi; Rokutanda, Taku; Kimura, Yuichi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Mol Cardiol, Boston, MA 02118 USA	Izumiya, Y (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	izumiya@kumamoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [B-24790768, B-25293186]	This work was supported in part by a Grant-in-Aid for Young Scientists (B-24790768 to Y.I.) and a Grant-in-Aid for Scientific Research (B-25293186 to H.O.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Akasaki Y, 2014, AGING CELL, V13, P80, DOI 10.1111/acel.12153; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Ishikawa Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/702948; Verzola D, 2011, KIDNEY INT, V79, P773, DOI 10.1038/ki.2010.494; Kouidi E, 1998, NEPHROL DIAL TRANSPL, V13, P685, DOI 10.1093/ndt/13.3.685; Thomas SS, 2013, CLIN EXP NEPHROL, V17, P174, DOI 10.1007/s10157-012-0729-9; Ito D, 2013, CLIN EXP PHARMACOL P, V40, P617, DOI 10.1111/1440-1681.12130; Smart N, 2011, NEPHROLOGY, V16, P626, DOI 10.1111/j.1440-1797.2011.01471.x; Castaneda C, 2001, ANN INTERN MED, V135, P965; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Anderson JE, 2004, RENAL FAILURE, V26, P539, DOI 10.1081/JDI-200031735; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Araki S, 2012, CIRC-HEART FAIL, V5, P116, DOI 10.1161/CIRCHEARTFAILURE.111.964783; Grill MA, 2003, TRANSGENIC RES, V12, P33, DOI 10.1023/A:1022119005836; Ghosh S, 2009, AM J PHYSIOL-RENAL, V296, pF700, DOI 10.1152/ajprenal.90548.2008; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Chen Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE873, DOI 10.1152/ajpendo.00068.2011; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Howden EJ, 2012, SPORTS MED, V42, P473, DOI 10.2165/11630800-000000000-00000; Kang DH, 2002, AM J PATHOL, V161, P239, DOI 10.1016/S0002-9440(10)64175-2; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Kouidi E, 1997, NEPHRON, V77, P152; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Yang J, 2013, J AM SOC NEPHROL, V24, P1644, DOI 10.1681/ASN.2013030217; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628; Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Castaneda C, 2004, AM J KIDNEY DIS, V43, P607, DOI 10.1053/j.ajkd.2003.12.025; Chen KC, 2012, EUR J PREV CARDIOL, V21, P507; Fujita M, 2006, ANTIMICROB AGENTS CH, V50, P739, DOI 10.1128/AAC.50.2.739-743.2006; Garibotto G, 2012, CURR OPIN CLIN NUTR, V15, P78, DOI 10.1097/MCO.0b013e32834d9df6; Izumiya Y, 2008, CELL METAB, V7, P159; Kosmadakis GC, 2012, NEPHROL DIAL TRANSPL, V27, P997, DOI 10.1093/ndt/gfr364; Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, pE7, DOI 10.1159/000286344; Kuan Y, 2009, GROWTH HORM IGF RES, V19, P219, DOI 10.1016/j.ghir.2008.10.002; Kusunoki H, 2012, HYPERTENSION, V59, P308, DOI 10.1161/HYPERTENSIONAHA.111.176263; Liu AC, 2012, J IMMUNOL, V188, P1544, DOI 10.4049/jimmunol.1102527; Luiz RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055363; Mustata S, 2011, INT UROL NEPHROL, V43, P1133, DOI 10.1007/s11255-010-9823-7; Silva KAD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048826; Sun D, 2012, LIFE SCI, V90, P900, DOI 10.1016/j.lfs.2012.04.018; Teppala S, 2010, CLIN EXP NEPHROL, V14, P440, DOI 10.1007/s10157-010-0307-y; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B; Zemse SM, 2010, AM J PHYSIOL-HEART C, V299, pH1160, DOI 10.1152/ajpheart.00763.2009	51	2	3	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	DEC	2014	25	12					2800	2811		10.1681/ASN.2013091025		12	Urology & Nephrology	Urology & Nephrology	AU4UT	WOS:000345607500015		
J	Kanari, K; Kaneko, H				Kanari, Kei; Kaneko, Hirohiko			Standard deviation of luminance distribution affects lightness and pupillary response	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							IMAGE STATISTICS; ANCHORING THEORY; VISUAL-SYSTEM; BRIGHTNESS; PERCEPTION; CONTRAST; ILLUMINATION; INTENSITY; INDUCTION; ILLUSIONS	We examined whether the standard deviation (SD) of luminance distribution serves as information of illumination. We measured the lightness of a patch presented in the center of a scrambled-dot pattern while manipulating the SD of the luminance distribution. Results showed that lightness decreased as the SD of the surround stimulus increased. We also measured pupil diameter while viewing a similar stimulus. The pupil diameter decreased as the SD of luminance distribution of the stimuli increased. We confirmed that these results were not obtained because of the increase of the highest luminance in the stimulus. Furthermore, results of field measurements revealed a correlation between the SD of luminance distribution and illuminance in natural scenes. These results indicated that the visual system refers to the SD of the luminance distribution in the visual stimulus to estimate the scene illumination. (C) 2014 Optical Society of America	[Kanari, Kei; Kaneko, Hirohiko] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Informat Proc, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Kanari, K (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Informat Proc, Midori Ku, 4259-G2-3 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	kei.kanari@ip.titech.ac.jp	Kaneko, Hirohiko/E-1685-2015	Kaneko, Hirohiko/0000-0002-5343-7340			Adelson E. H., 2000, NEW COGNITIVE NEUROS, P339; Alpern M., 1973, PUPILLARY DYNAMICS B, P9; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Yang ZY, 2004, P NATL ACAD SCI USA, V101, P8745, DOI 10.1073/pnas.0402192101; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Motoyoshi I, 2012, VISION RES, V53, P30, DOI 10.1016/j.visres.2011.11.010; Gilchrist AL, 2002, PERCEPTION, V31, P141, DOI 10.1068/p04sp; Laeng B, 2012, P NATL ACAD SCI USA, V109, P2162, DOI 10.1073/pnas.1118298109; HEINEMANN EG, 1955, J EXP PSYCHOL, V50, P89, DOI 10.1037/h0040919; Li XJ, 1999, PERCEPT PSYCHOPHYS, V61, P771, DOI 10.3758/BF03206896; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037//0033-295X.106.4.795; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; BARLOW RB, 1976, VISION RES, V16, P1291, DOI 10.1016/0042-6989(76)90056-0; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; Naber M, 2013, J VISION, V13, DOI 10.1167/13.6.7; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Laeng B, 2014, PSYCHOL SCI, V25, P188, DOI 10.1177/0956797613503556; Blakeslee B, 1999, VISION RES, V39, P4361, DOI 10.1016/S0042-6989(99)00119-4; Baek YS, 2010, J ELECTRON IMAGING, V19, DOI 10.1117/1.3506735; BARLOW RB, 1978, EXP BRAIN RES, V31, P163; BARTELSO.CJ, 1967, J OPT SOC AM, V57, P953, DOI 10.1364/JOSA.57.000953; Binda P, 2013, J VISION, V13, DOI 10.1167/13.7.13; Blakeslee B, 2012, VISION RES, V60, P40, DOI 10.1016/j.visres.2012.03.006; Bressan P, 2006, PSYCHON B REV, V13, P22, DOI 10.3758/BF03193808; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; Economou E, 2007, J VISION, V7, DOI 10.1167/7.12.2; Gilchrist AL, 2009, J VISION, V9, DOI 10.1167/9.9.13; JAMESON D, 1961, SCIENCE, V133, P174, DOI 10.1126/science.133.3447.174; Blakeslee B, 2009, J VISION, V9, DOI 10.1167/9.3.22; Okajima K., 2008, J ILLUM ENG I JPN, V92, P77, DOI 10.2150/jieij.92.77; Rockefeller S., 1993, VISION RES, V33, P2239; Rudd ME, 2013, J VISION, V13, DOI 10.1167/13.14.18; Spehar B., 1995, REV PSYCHOL, V2, P3	33	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	DEC	2014	31	12					2795	2805		10.1364/JOSAA.31.002795		11	Optics	Optics	AU9HK	WOS:000345902400034		
J	Ganeev, RA; Suzuki, M; Yoneya, S; Kuroda, H				Ganeev, R. A.; Suzuki, M.; Yoneya, S.; Kuroda, H.			High-order harmonic generation from the ablation of crystals	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							FLUORINE-ION-IMPLANTATION; LASER-PRODUCED PLASMAS; RESONANCE ENHANCEMENT; CAF2; DAMAGE; NM; TEMPERATURE; FIELD; LIF	We analyze the generation of high-order harmonics during propagation of ultrafast pulses through the plasma plumes produced by laser ablation of the surfaces of fluorine- (NaF, CaF2, LiF, and MgF2) and oxygen- (KTiOPO4, BaB2O4, KH2PO4, and LiB3O5) containing crystals. The similarity of plasma and harmonic emission from the ablation of fluorine-containing crystals points out the same source (F II ions) of harmonics which was also supported by the coincidence of the harmonic cutoffs defined from experiment (55th-59th orders) and theory. The comparison of these results with ablation of Ca, Mg, and Li bulk targets showed that, in the latter case, the harmonic spectra became weaker with lower cutoffs, which also supports our assumption of the decisive role of fluorine ions in the higher-order harmonic generation. The ablation of oxygen-containing crystals resulted in formation of the plasmas allowing the lower-order and weaker harmonic generation compared with the case of F-containing plasmas. The difference in the cutoffs in that case pointed out different conditions of harmonic generation from the ablation of O-containing crystals, though the O II ions could be considered as the most probable sources of harmonics. (C) 2014 Optical Society of America	[Ganeev, R. A.; Suzuki, M.; Yoneya, S.; Kuroda, H.] Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan; [Ganeev, R. A.] Voronezh State Univ, Dept Phys, Voronezh 394006, Russia	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	rashid_ganeev@mail.ru			JSPS [24760048]	This work was supported by JSPS KAKENHI (grant no. 24760048).	Haessler S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013051; Suzuki M, 2007, OPT EXPRESS, V15, P1161, DOI 10.1364/OE.15.001161; Ganeev RA, 2005, PHYS LETT A, V339, P103, DOI 10.1016/j.physleta.2005.02.073; Ganeev RA, 2006, OPT LETT, V31, P1699, DOI 10.1364/OL.31.001699; AKIYAMA Y, 1992, PHYS REV LETT, V69, P2176, DOI 10.1103/PhysRevLett.69.2176; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Ganeev RA, 1997, OPT COMMUN, V135, P251, DOI 10.1016/S0030-4018(96)00633-5; Ganeev RA, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4875738; Ganeev RA, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033838; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; WAHLSTROM CG, 1995, PHYS REV A, V51, P585, DOI 10.1103/PhysRevA.51.585; Bian XB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.093903; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; Ghimire S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043836; Toma ES, 1999, J PHYS B-AT MOL OPT, V32, P5843, DOI 10.1088/0953-4075/32/24/318; Strelkov V, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.123901; Ganeev RA, 2014, J OPT SOC AM B, V31, P911, DOI 10.1364/JOSAB.31.000911; Ganeev RA, 2014, J OPT SOC AM B, V31, P2221, DOI 10.1364/JOSAB.31.002221; Rauthan CMS, 1998, J APPL PHYS, V83, P3668, DOI 10.1063/1.366587; Krushelnick K, 1997, J OPT SOC AM B, V14, P1687, DOI 10.1364/JOSAB.14.001687; Suzuki M, 2006, OPT LETT, V31, P3306, DOI 10.1364/OL.31.003306; Ganeev RA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033821; Taieb R, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.033403; Ghimire S, 2011, NAT PHYS, V7, P138, DOI [10.1038/nphys1847, 10.1038/NPHYS1847]; Djiokap M. N., 2013, PHYS REV A, V88; ESTLER RC, 1987, J OPT SOC AM B, V4, P281, DOI 10.1364/JOSAB.4.000281; Faria F.M.C., 2002, PHYS REV A, V65; Frolov MV, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.023424; Gaarde MB, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.013820; Ganeev RA, 2013, HIGH-ORDER HARMONIC GENERATION IN LASER PLASMA PLUMES, P1; Gogoll S, 1996, NUCL INSTRUM METH B, V116, P279, DOI 10.1016/0168-583X(96)00061-4; Gordillo-Vazquez FJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1922574; Hanamoto K, 1997, NUCL INSTRUM METH B, V129, P228, DOI 10.1016/S0168-583X(97)00227-9; Henley SJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1828241; Hou XY, 2004, APPL SURF SCI, V227, P325, DOI 10.1016/j.apsusc.2003.12.009; Kramida A., 2013, NIST ATOMIC SPECTRA; Kulagin A., 2009, OPT LETT, V34, P2616; LAU WM, 1994, APPL PHYS LETT, V64, P300, DOI 10.1063/1.111185; Miller J. C., 1994, LASER ABLATION MECH; Milosevic DB, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.023802; MITZNER R, 1993, APPL SURF SCI, V69, P180, DOI 10.1016/0169-4332(93)90501-2; Oujja M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.043841; Reichling M, 1999, APPL PHYS A-MATER, V69, pS743, DOI 10.1007/s003390051520; Sakai T, 2006, SOLID STATE IONICS, V177, P1601, DOI 10.1016/j.ssi.2006.05.014; Tudorovskaya M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013430; Ying M, 2003, APPL SURF SCI, V207, P227, DOI 10.1016/S0169-4332(02)01368-5; Zeng ZN, 2002, PHYS SCRIPTA, V66, P321, DOI 10.1238/Physica.Regular.066a00321; Zhao BS, 2004, REV SCI INSTRUM, V75, P146, DOI 10.1063/1.1630836	48	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	DEC	2014	31	12					3105	3112		10.1364/JOSAB.31.003105		8	Optics	Optics	AU9HC	WOS:000345901500023		
J	Asobe, M; Umeki, T; Enbutsu, K; Tadanaga, O; Takenouchi, H				Asobe, Masaki; Umeki, Takeshi; Enbutsu, Kouji; Tadanaga, Osamu; Takenouchi, Hirokazu			Phase squeezing and dispersion tolerance of phase sensitive amplifier using periodically poled LiNbO3 waveguide	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							NOISE-FIGURE	The phase squeezing property of phase sensitive amplifiers (PSAs) is a useful feature to recover signal quality. Chromatic dispersion of transmission fiber largely affects the performance of PSAs when they are used as in-line amplifiers in long-haul transmission systems. In this work, we demonstrated that phase variation such as chirping can be reduced by phase squeezing in a periodically poled LiNbO3 (PPLN)-based PSA. We also examined the dispersion tolerance of a PPLN-based in-line PSA. Theoretical analysis and experiment revealed that we can relay the received data with negligible power penalty utilizing the phase squeezing capability of the PSA, if the phase variation due to dispersion within the data bandwidth is below pi/2. (C) 2014 Optical Society of America	[Asobe, Masaki] Tokai Univ, Dept Elect & Elect Engn, Hiratsuka, Kanagawa 2591292, Japan; [Umeki, Takeshi; Enbutsu, Kouji; Tadanaga, Osamu; Takenouchi, Hirokazu] NTT Corp, NTT Photon Labs, Atsugi, Kanagawa 2430198, Japan	Asobe, M (reprint author), Tokai Univ, Dept Elect & Elect Engn, 4-1-1 Kitakaneme, Hiratsuka, Kanagawa 2591292, Japan.	asobe@tokai-u.jp					Agrawal G. P., 1989, NONLINEAR FIBER OPTI; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Umeki T, 2013, OPT EXPRESS, V21, P12077, DOI 10.1364/OE.21.012077; Tong Z, 2011, NAT PHOTONICS, V5, P430, DOI [10.1038/nphoton.2011.79, 10.1038/NPHOTON.2011.79]; Puttnam BJ, 2011, OPT EXPRESS, V19, P131; Asobe M, 2012, OPT EXPRESS, V20, P13164, DOI 10.1364/OE.20.013164; Imajuku W, 2003, IEEE J QUANTUM ELECT, V39, P799, DOI 10.1109/JQE.2003.811089; Jeggeris A. K., 1973, P I ELECTR ENG, V120, P529; Slavik R, 2010, NAT PHOTONICS, V4, P690, DOI 10.1038/NPHOTON.2010.203; Umeki Takeshi, 2011, Opt Express, V19, P6326, DOI 10.1364/OE.19.006326	10	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	DEC	2014	31	12					3164	3169		10.1364/JOSAB.31.003164		6	Optics	Optics	AU9HC	WOS:000345901500030		
J	Oguchi, K; Yasumatsu, N; Watanabe, S				Oguchi, Kenichi; Yasumatsu, Naoya; Watanabe, Shinichi			Polarization detection of terahertz radiation via the electro-optic effect using zinc blende crystal symmetry	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							TIME-DOMAIN SPECTROSCOPY; PHOTOCONDUCTIVE ANTENNA; OPTICAL RECTIFICATION; WAVE DETECTION; PULSES; COHERENT; STATE; DEPENDENCE; SYSTEM; PHASE	We provide a frequency-domain picture of the electro-optic (EO) detection of elliptically polarized terahertz radiation utilizing the crystal angle dependence of the EO effect using zinc blende crystal symmetry. In contrast to EO detection of a linearly polarized terahertz pulse, the measured EO signal would not be a replica of the terahertz pulse, even though the phase-matching condition is completely fulfilled. However, the rotation of the EO crystal reduces the complexity, and the ellipticity and the angle of rotation of each frequency component of the elliptically polarized terahertz pulse can be determined irrespective of what kind of zinc blende crystals are used for the EO detection. We experimentally show that the ellipticity and angle of rotation are reproducibly obtained by using three different crystals with different thicknesses and compositions. Direct detection of the elliptically polarized terahertz radiation enables us to precisely determine the optical axis and retardation of a quartz crystal using the Poincare sphere representation of the state of polarization. (C) 2014 Optical Society of America	[Oguchi, Kenichi; Yasumatsu, Naoya; Watanabe, Shinichi] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Watanabe, S (reprint author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	watanabe@phys.keio.ac.jp	Watanabe, Shinichi/E-1336-2012		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24656054]; MEXT [24340070]; Research Foundation for Opt-Science and Technology; Keio Leading-edge Laboratory of Science and Technology (KLL)	The authors would like to thank Mr. A. Kasatani for fruitful discussions on the Poincare sphere representation. This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas No. 24656054 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Grant-in-Aid for Scientific Research (B) 24340070 from MEXT, Research Foundation for Opt-Science and Technology, and a grant of Keio Leading-edge Laboratory of Science and Technology (KLL).	MCCRACKIN FL, 1963, J RES NBS A PHYS CH, VA 67, P363, DOI 10.6028/jres.067A.040; Castro-Camus E, 2012, J INFRARED MILLIM TE, V33, P418, DOI 10.1007/s10762-011-9856-8; Sato M, 2013, NAT PHOTONICS, V7, P724, DOI [10.1038/nphoton.2013.213, 10.1038/NPHOTON.2013.213]; Jenkins GS, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480554; Aschaffenburg DJ, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729148; Bakker HJ, 1998, J OPT SOC AM B, V15, P1795, DOI 10.1364/JOSAB.15.001795; WU Q, 1995, APPL PHYS LETT, V67, P3523, DOI 10.1063/1.114909; Kanda N, 2007, OPT EXPRESS, V15, P11117, DOI 10.1364/OE.15.011117; Dong H, 2009, OPT COMMUN, V282, P3671, DOI 10.1016/j.optcom.2009.06.035; Planken PCM, 2001, J OPT SOC AM B, V18, P313, DOI 10.1364/JOSAB.18.000313; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Leitenstorfer A, 1999, APPL PHYS LETT, V74, P1516, DOI 10.1063/1.123601; Nahata A, 1996, APPL PHYS LETT, V69, P2321, DOI 10.1063/1.117511; Yasumatsu N, 2012, OPT LETT, V37, P2706, DOI 10.1364/OL.37.002706; Gallot G, 1999, J OPT SOC AM B, V16, P1204, DOI 10.1364/JOSAB.16.001204; Sell A, 2008, OPT LETT, V33, P2767, DOI 10.1364/OL.33.002767; van der Valk NCJ, 2005, OPT LETT, V30, P2802, DOI 10.1364/OL.30.002802; Ashida M, 2008, JPN J APPL PHYS, V47, P8221, DOI 10.1143/JJAP.47.8221; Castro-Camus E, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1951051; TSANKOV D, 1995, APPL SPECTROSC, V49, P132, DOI 10.1366/0003702953963292; Liu K, 2004, APPL PHYS LETT, V85, P863, DOI 10.1063/1.1779959; Born M, 2001, PRINCIPLES OPTICS; Han PY, 1998, APPL PHYS LETT, V73, P3049, DOI 10.1063/1.122668; Hussain A, 2008, OPT EXPRESS, V16, P7251, DOI 10.1364/OE.16.007251; Jamison SP, 2006, OPT LETT, V31, P1753, DOI 10.1364/OL.31.001753; Kanda N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1366; Kovalev SP, 2013, J OPT SOC AM B, V30, P2650, DOI 10.1364/JOSAB.30.002650; Makabe H, 2007, OPT EXPRESS, V15, P11650, DOI 10.1364/OE.15.011650; Matsubara E, 2013, J OPT SOC AM B, V30, P1627, DOI 10.1364/JOSAB.30.001627; Nahata A, 1996, APPL PHYS LETT, V68, P150, DOI 10.1063/1.116130; Nemoto N, 2014, OPT EXPRESS, V22, P17915, DOI 10.1364/OE.22.017915; Neshat M, 2012, OPT LETT, V37, P1811, DOI 10.1364/OL.37.001811; Schubert M., 1986, NONLINEAR OPTICS QUA; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Tomasino A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03116; Watanabe S, 2013, SENSORS-BASEL, V13, P3299, DOI 10.3390/s130303299; Wu Q, 1997, APPL PHYS LETT, V70, P1784, DOI 10.1063/1.118691; Yariv A., 2003, OPTICAL WAVES CRYSTA; Yasumatsu N, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.092401; Yasumatsu N, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3683570; Yasumatsu N, 2013, J OPT SOC AM B, V30, P2940, DOI 10.1364/JOSAB.30.002940; Zhang LL, 2010, OPT COMMUN, V283, P4993, DOI 10.1016/j.optcom.2010.08.014; Zhang LL, 2011, OPT COMMUN, V284, P4356, DOI 10.1016/j.optcom.2011.05.036; Zhang RX, 2008, APPL OPTICS, V47, P6422, DOI 10.1364/AO.47.006422	44	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	DEC	2014	31	12					3170	3180		10.1364/JOSAB.31.003170		11	Optics	Optics	AU9HC	WOS:000345901500031		
J	Kameyama, K; Okumura, N; Miyaoka, E; Asamura, H; Yoshino, I; Tada, H; Fujii, Y; Nakanishi, Y; Eguchi, K; Mori, M; Kobayashi, H; Sawabata, N; Okumura, M; Yokoi, K				Kameyama, Kotaro; Okumura, Norihito; Miyaoka, Etsuo; Asamura, Hisao; Yoshino, Ichiro; Tada, Hirohito; Fujii, Yoshitaka; Nakanishi, Yoichi; Eguchi, Kenji; Mori, Masaki; Kobayashi, Hideo; Sawabata, Noriyoshi; Okumura, Meinoshin; Yokoi, Kohei		Lung Canc Registry	Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: The influence of positive pleural lavage cytology results on T classification	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							CARCINOMATOUS PLEURITIS; TUMOR-CELLS; RESECTION; THORACOTOMY; METAANALYSIS; RECURRENCE; INDICATOR; REGISTRY	Objective: Although positive pleural lavage cytology (PLC) has been demonstrated to be closely associated with a poor prognosis for patients with lung cancer, it has not been incorporated into the TNM staging system of the Union for International Cancer Control. The aim of our study was to retrospectively examine the clinical significance of PLC status and illustrate the recommendations of the International Pleural Lavage Cytology Collaborators (IPLCC) in a large national database. Methods: The Japanese Joint Committee of Lung Cancer Registry database included 11,073 patients with non-small cell lung cancer who underwent resections in 2004. We extracted the clinicopathologic data for 4171 patients (37.3%) who underwent PLC. These patients were staged according to the seventh edition of the Union for International Cancer Control TNM classification and by recommendations of the IPLCC, in which T was singly upgraded up to a maximum of T4 for those who were PLC-positive. Prognoses based on these 2 systems were compared. Results: A total of 217 patients (5.2%) were PLC-positive, which was significantly associated with a higher incidence of adenocarcinoma and advanced disease. The 5-year survival for patients with positive and negative PLC results were 44.5% and 72.8%, respectively, and this difference in survival was statistically significant (P < .001). Multivariate analysis showed that positive PLC status was an independent factor for a poor prognosis (hazard ratio, 1.57; P < .001). Significant differences in survival were also found between patients with positive and negative PLC results in the same T categories and stages, including T2a, T3, stage IB, and stage IIIA. The IPLCC recommendations adjusted the prognostic differences in all T categories and stages. The significant difference in survival disappeared between the 2 groups in all T categories and stages. Conclusions: Our results indicate that a T category upgrade is prognostically adequate for patients who are PLC-positive.	[Kameyama, Kotaro; Okumura, Norihito] Kurashiki Cent Hosp, Dept Thorac Surg, Kurashiki, Okayama 7108602, Japan; [Miyaoka, Etsuo] Tokyo Univ Sci, Dept Math, Tokyo 162, Japan; [Asamura, Hisao] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan; [Yoshino, Ichiro] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan; [Tada, Hirohito] Osaka City Gen Hosp, Div Gen Thorac Surg, Osaka, Japan; [Fujii, Yoshitaka] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi, Japan; [Fujii, Yoshitaka] Sch Med, Nagoya, Aichi, Japan; [Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 812, Japan; [Eguchi, Kenji] Teikyo Univ, Sch Med, Dept Med Oncol, Tokyo 173, Japan; [Mori, Masaki] Sapporo Kosei Gen Hosp, Dept Pulm Med, Sapporo, Hokkaido, Japan; [Kobayashi, Hideo] Natl Def Med Coll, Div Resp Dis, Saitama, Japan; [Sawabata, Noriyoshi; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; [Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4648601, Japan	Kameyama, K (reprint author), Kurashiki Cent Hosp, Dept Thorac Surg, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	kk8724@kchnet.or.jp			Pfizer; Chugai; Boehringer Ingelheim Japan	Yoichi Nakanishi reports consulting fees from Pfizer, Chugai, and Boehringer Ingelheim Japan. All other authors have nothing to disclose with regard to commercial support.	Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Sawabata N, 2010, J THORAC ONCOL, V5, P1369, DOI 10.1097/JTO.0b013e3181e452b9; Hermanek P, 1999, CANCER, V86, P2668, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2668::AID-CNCR11>3.0.CO;2-R; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; [Anonymous], 1984, J THORAC CARDIOVASC, V88, P1000; Aokage K, 2010, J THORAC CARDIOV SUR, V139, P1246, DOI 10.1016/j.jtcvs.2009.07.049; Buhr J, 1997, J THORAC CARDIOV SUR, V113, P683, DOI 10.1016/S0022-5223(97)70225-3; BUHR J, 1990, CANCER, V65, P1801, DOI 10.1002/1097-0142(19900415)65:8<1801::AID-CNCR2820650822>3.0.CO;2-9; Dresler CM, 1999, ANN THORAC SURG, V67, P1435, DOI 10.1016/S0003-4975(99)00220-9; Enatsu S, 2006, ANN THORAC SURG, V81, P298, DOI 10.1016/j.athoracsur.2005.06.073; Goldstraw P, 2009, STAGING MANUAL THORA; Higashiyama M, 1997, ANN SURG ONCOL, V4, P409, DOI 10.1007/BF02305554; Higashiyama M, 2000, Jpn J Thorac Cardiovasc Surg, V48, P611; Higashiyama M, 2009, EUR J CARDIO-THORAC, V35, P337, DOI 10.1016/j.ejcts.2008.10.013; Ichinose Y, 2002, J THORAC CARDIOV SUR, V123, P695, DOI 10.1067/mtc.2002.120712; Ichinose Y, 2001, LUNG CANCER-J IASLC, V31, P37, DOI 10.1016/S0169-5002(00)00158-6; Kaneda M, 2012, EUR J CARDIO-THORAC, V41, P1335, DOI 10.1093/ejcts/ezr224; KONDO H, 1989, JPN J CANCER RES, V80, P233; KONDO H, 1993, J THORAC CARDIOV SUR, V106, P1092; Kotoulas C, 2001, EUR J CARDIO-THORAC, V20, P330, DOI 10.1016/S1010-7940(01)00718-7; Li YN, 2008, LUNG CANCER, V60, P183, DOI 10.1016/j.lungcan.2007.09.024; Lim E, 2004, J THORAC CARDIOV SUR, V127, P1113, DOI 10.1016/j.jtcvs.2003.10.025; Lim E, 2010, J THORAC CARDIOV SUR, V139, P1441, DOI 10.1016/j.jtcvs.2009.05.048; Mordant Pierre, 2013, Semin Thorac Cardiovasc Surg, V25, P251, DOI 10.1053/j.semtcvs.2013.08.002; Nakagawa T, 2007, ANN THORAC SURG, V83, P204, DOI 10.1016/j.athoracsur.2006.07.035; Okada M, 1999, ANN SURG, V229, P579, DOI 10.1097/00000658-199904000-00019; Okada M, 2003, J THORAC CARDIOV SUR, V126, P1911, DOI 10.1016/S0022-5223(03)00715-3; OKUMURA M, 1991, ANN THORAC SURG, V51, P599; Riquet M, 2003, ANN THORAC SURG, V75, P353, DOI 10.1016/S0003-4975(02)04403-X; Saso S, 2012, THORAX, V67, P526, DOI 10.1136/thoraxjnl-2011-200424; Satoh Y, 2007, ANN THORAC SURG, V83, P197, DOI 10.1016/j.athoracsur.2006.08.025; Shintani Y, 2009, J THORAC CARDIOV SUR, V137, P835, DOI 10.1016/j.jtcvs.2008.09.027; Sobin LH, 2010, INT UNION CANC TNM C; Vicidomini G, 2005, ANN THORAC SURG, V79, P254, DOI 10.1016/j.athoracsur.2004.06.115	34	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	DEC	2014	148	6					2659	2664		10.1016/j.jtcvs.2014.07.090		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6BD	WOS:000345686100051		
J	Massmann, A; Kunihara, T; Fries, P; Schneider, G; Buecker, A; Schafers, HJ				Massmann, Alexander; Kunihara, Takashi; Fries, Peter; Schneider, Guenther; Buecker, Arno; Schaefers, Hans-Joachim			Uncovered stent implantation in complicated acute aortic dissection type B	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							PERCUTANEOUS BALLOON FENESTRATION; GRAFT PLACEMENT; ISCHEMIC COMPLICATIONS; ENDOVASCULAR MANAGEMENT; MALPERFUSION SYNDROME; INTIMAL DEHISCENCE; REPAIR; REGISTRY	Objective: To retrospectively evaluate the technical feasibility and midterm results of uncovered thoracoabdominal stent placement in complicated acute aortic dissection Stanford type B (cAADB). Patients and Methods: Fourteen consecutive patients (3 females; range, 44-71 years) with cAADB who had symptomatic gastrointestinal malperfusion and claudication underwent immediate uncovered stent implantation (diameter, 7-28 mm; length, 40-100 mm) into the true lumen of the thoracoabdominal aorta (n = 23) and visceral arteries (n = 5). Results: Stenting resulted in elimination of gastrointestinal ischemia and symptoms in 13 of 14 patients; persisting symptoms led to secondary surgical revascularization in only 1 patient. More than 1 stent (<= 4) was placed in 7 patients (2 celiac, 1 mesenteric, 2 renal, 8 aorto-iliac). Follow-up computed tomographic angiography (CTA) revealed collapse of 4 aortic stents (diameter, 9-25 mm; length, 100 mm) at 1 week in the absence of symptoms. Balloon reexpansion was possible in all 4 stents, but recollapse occurred within 1 month. Despite stent collapse, the patients remained asymptomatic; ultrasonography and CTA documented sufficient perfusion of the visceral arteries in all patients. Follow-up ranged from 6 months to 5 years (average, 2.5 years). Except for the patient who underwent iliacomesenteric bypass for unspecific abdominal pain, no other patient required additional interventional or surgical therapy. Conclusions: Acute aortic dissection with suspicion of visceral ischemia should prompt for immediate intervention. Thoracoabdominal uncovered stent implantation is a technically feasible and effective minimally invasive approach that provided successful relief of acute visceral ischemia and claudication in cAADB. Stent size should be less than the normal aortic diameter to avoid possible stent collapse.	[Massmann, Alexander; Fries, Peter; Schneider, Guenther; Buecker, Arno] Univ Saarland, Med Ctr, Clin Diagnost & Intervent Radiol, D-66421 Homburg, Germany; [Schaefers, Hans-Joachim] Univ Saarland, Med Ctr, Clin Thorac & Cardiovasc Surg, D-66421 Homburg, Germany; [Kunihara, Takashi] Cardiovasc Inst, Tokyo, Japan	Massmann, A (reprint author), Univ Saarland, Med Ctr, Clin Diagnost & Intervent Radiol, Kirrberger Str, D-66421 Homburg, Germany.	alexander.massmann@uks.eu					Williams DM, 1997, J VASC INTERV RADIOL, V8, P605, DOI 10.1016/S1051-0443(97)70619-5; LAAS J, 1991, CIRCULATION, V84, P20; Svensson LG, 2008, ANN THORAC SURG, V85, pS1, DOI 10.1016/j.athoracsur.2007.10.099; FANN JI, 1990, ANN SURG, V212, P705, DOI 10.1097/00000658-199012000-00009; Sfyroeras GS, 2011, J ENDOVASC THER, V18, P78, DOI 10.1583/10-3141.1; Beregi JP, 2003, J ENDOVASC THER, V10, P486, DOI 10.1583/1545-1550(2003)010<0486:ETOACA>2.0.CO;2; Nienaber CA, 2006, J ENDOVASC THER, V13, P738, DOI 10.1583/06-1923.1; Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; Fattori R, 2008, JACC-CARDIOVASC INTE, V1, P395, DOI 10.1016/j.jcin.2008.04.009; Fattori R, 2006, J THORAC CARDIOV SUR, V132, P332, DOI 10.1016/j.jtcvs.2006.03.055; Hartnell GG, 2005, RADIOGRAPHICS, V25, P175, DOI 10.1148/rg.251045078; Wilkinson DA, 2013, ANN THORAC SURG, V96, P23, DOI 10.1016/j.athoracsur.2013.01.041; Szeto WY, 2008, ANN THORAC SURG, V86, P87, DOI 10.1016/j.athoracsur.2008.04.003; Midulla M, 2011, J THORAC CARDIOV SUR, V142, P66, DOI 10.1016/j.jtcvs.2010.07.081; Lauterbach SR, 2001, J VASC SURG, V33, P1185, DOI 10.1067/mva.2001.115377; Chavan A, 2009, EUR RADIOL, V19, P488, DOI 10.1007/s00330-008-1141-4; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; Eggebrecht H, 2005, CURR OPIN CARDIOL, V20, P477, DOI 10.1097/01.hco.0000181481.86025.a6; Fattori R, 2008, ACTA CHIR BELG, V108, P192; HEINEMANN MK, 1994, J CARDIAC SURG, V9, P748, DOI 10.1111/j.1540-8191.1994.tb00910.x; Heinemann MK, 1994, J CARDIOVASC SURG, V9, P755; von Kodolitsch Y, 2000, ARCH INTERN MED, V160, P2977, DOI 10.1001/archinte.160.19.2977; Kolluri Raghu, 2013, Curr Treat Options Cardiovasc Med, V15, P173, DOI 10.1007/s11936-013-0227-8; Lookstein RA, 2001, J VASC INTERV RADIOL, V12, P1347, DOI 10.1016/S1051-0443(07)61562-0; Maynar M, 2005, J ENDOVASC THER, V12, P103, DOI 10.1583/04-1368.1; Pradhan Sanjeev, 2007, Ann Thorac Cardiovasc Surg, V13, P296; Slonim SM, 1996, RADIOLOGY, V201, P161; Slonim SM, 1999, J THORAC CARDIOV SUR, V117, P1118, DOI 10.1016/S0022-5223(99)70248-5; Swee W, 2008, CIRCULATION, V117, P1460, DOI 10.1161/CIRCULATIONAHA.107.690966; Szeto WY, 2008, ANN THORAC SURG, V86, P93; Zeeshan A, 2010, J THORAC CARDIOVAS S, V140, pS142; Zeeshan A, 2010, J THORAC CARDIOV SUR, V140, pS109, DOI 10.1016/j.jtcvs.2010.06.024	33	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	DEC	2014	148	6					3003	3011		10.1016/j.jtcvs.2014.07.053		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6BD	WOS:000345686100121		
J	Matsuda, H; Fukuda, T; Tanaka, H; Minatoya, K				Matsuda, Hitoshi; Fukuda, Tetsuya; Tanaka, Hiroshi; Minatoya, Kenji			New technique for passage of endograft through problematic arch anatomy	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material							STENT-GRAFT PASSAGE; AORTIC-ARCH; GUIDEWIRE STABILIZATION		[Matsuda, Hitoshi; Tanaka, Hiroshi; Minatoya, Kenji] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Osaka, Japan; [Fukuda, Tetsuya] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Osaka, Japan	Matsuda, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	hitmat@mist.ocn.ne.jp					Malkawi AH, 2010, J ENDOVASC THER, V17, P474, DOI 10.1583/10-3067.1; Kolbel T, 2010, J ENDOVASC THER, V17, P744, DOI 10.1583/10-3189.1; Dorros G, 2000, J ENDOVASC THER, V7, P506, DOI 10.1583/1545-1550(2000)007<0506:TGSFSG>2.0.CO;2; Joseph G, 2013, J ENDOVASC THER, V20, P223, DOI 10.1583/1545-1550-20.2.223	4	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	DEC	2014	148	6					3246	3247		10.1016/j.jtcvs.2014.06.078		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6BD	WOS:000345686100173		
J	Kaji, S; Kim, K; Furukawa, Y				Kaji, Shuichiro; Kim, Kitae; Furukawa, Yutaka			WHY DOES PAPILLARY SEPARATION PLAY A MAJOR ROLE IN FUNCTIONAL MITRAL REGURGITATION CAUSED BY LEFT VENTRICULAR FUNCTION? Reply	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Letter							MECHANISM; GEOMETRY		[Kaji, Shuichiro; Kim, Kitae; Furukawa, Yutaka] Kobe City Med Ctr, Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan	Kaji, S (reprint author), Kobe City Med Ctr, Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan.						Kim K, 2012, JACC-CARDIOVASC IMAG, V5, P230, DOI 10.1016/j.jcmg.2011.08.023; Kumanohoso T, 2003, J THORAC CARDIOV SUR, V125, P135, DOI 10.1067/mtc.2003.78; Otsuji Y, 1997, CIRCULATION, V96, P1999; Kim K, 2014, J THORAC CARDIOV SUR, V148, P434, DOI 10.1016/j.jtcvs.2013.09.029; Lomholt M, 2002, J HEART VALVE DIS, V11, P337; Menicanti L, 2002, J THORAC CARDIOV SUR, V123, P1041, DOI 10.1067/mtc.2002.121677	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	DEC	2014	148	6					3252	3254		10.1016/j.jtcvs.2014.09.072		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6BD	WOS:000345686100177		
J	Ito, R; Morimoto, N; Liem, PH; Nakamura, Y; Kawai, K; Taira, T; Tsuji, W; Toi, M; Suzuki, S				Ito, Ran; Morimoto, Naoki; Liem, Pham Hieu; Nakamura, Yoko; Kawai, Katsuya; Taira, Tsuguyoshi; Tsuji, Wakako; Toi, Masakazu; Suzuki, Shigehiko			Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						adipogenesis; adipose tissue-derived stem cell (ASC); controlled release; bFGF; gelatin; collagen; scaffold	FREE FAT GRAFT; GELATIN MICROSPHERES; SCAFFOLD; TRANSPLANTATION; REGENERATION; BFGF	We have developed a collagen/gelatin sponge (CGS) that can provide a sustained release of basic fibroblast growth factor (bFGF). In our previous study, it was shown that CGS impregnated with the appropriate dosage of bFGF accelerates dermis-like tissue formation two or three times earlier than an existing collagen sponge. In this study, adipogenesis was evaluated using CGSs disseminated with adipose tissue-derived stem cells (ASCs). Human ASCs were primarily isolated from human adipose tissue that was obtained during breast cancer surgery with informed consent at Kyoto University Hospital. ASCs were isolated from collagenase digests of adipose tissue. ASCs were labelled with PKH26. CGSs (8mm diameterx3mm thickness) were impregnated with bFGF (0.1, 1, 7, 14 mu g/cm(2)) or normal saline solution. Then the labelled cells were disseminated (passage 3) on CGSs at a seeding density of 1x10(5) cells/cm(2) and implanted into the back subcutis of nude mice. Six weeks after implantation, adipogenesis at the administered site was evaluated. Immunohistological staining with von Willebrand factor (vWf) was performed to evaluate newly formed capillaries. Newly formed adipose tissue was observed macroscopically and histologically in all groups. The weight and area of regenerated adipose tissue were largest in the 1 mu g/cm(2) bFGF group. Under a fluorescent microscope, newly formed adipose tissue in the bFGF-administered group was PKH-positive. These findings show that ASCs differentiated and formed adipose tissue. In this study, we showed that our CGSs impregnated with bFGF could be used as scaffolds with ASCs for adipogenesis. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Ito, Ran; Morimoto, Naoki; Liem, Pham Hieu; Nakamura, Yoko; Kawai, Katsuya; Suzuki, Shigehiko] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto 6068507, Japan; [Taira, Tsuguyoshi] Gunze Res & Dev Ctr, Ayabe, Japan; [Tsuji, Wakako; Toi, Masakazu] Kyoto Univ, Dept Breast Surg, Kyoto 6068507, Japan	Ito, R (reprint author), Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	ranran_ito@yahoo.co.jp			Japan Science and Technology Agency	This study was supported by a grant from the Japan Science and Technology Agency.	Patrick CW, 2008, TISSUE ENG PT B-REV, V14, P167, DOI 10.1089/ten.teb.2007.0402; Monstrey SM, 2011, BURNS, V37, P249, DOI 10.1016/j.burns.2010.08.013; Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1; BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6; Ayvazyan A, 2011, J SURG RES, V171, pE247, DOI 10.1016/j.jss.2011.06.059; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; GOSPODAROWICZ D, 1979, EXP EYE RES, V28, P501, DOI 10.1016/0014-4835(79)90038-1; EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513; Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219; Akita S, 2008, J TRAUMA, V64, P809, DOI 10.1097/TA.0b013e31802c8247; Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215; BENNETT NT, 1993, AM J SURG, V165, P728, DOI 10.1016/S0002-9610(05)80797-4; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001; Peattie RA, 2008, DRUG DELIV, V15, P389, DOI 10.1080/10717540802035442 ; Tanaka E, 1996, BIOL PHARM BULL, V19, P1141; ELLENBOGEN R, 1986, ANN PLAS SURG, V16, P179, DOI 10.1097/00000637-198603000-00001; Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P891, DOI 10.1163/156856200744084; Tabata Y, 2005, DRUG DISCOV TODAY, V10, P1639, DOI 10.1016/S1359-6446(05)03639-1; Kloppenberg FWH, 2001, BURNS, V27, P359, DOI 10.1016/S0305-4179(00)00138-8; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Tsuji W, 2009, TISSUE ENG PT A, V15, P83, DOI 10.1089/ten.tea.2007.0297; Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8; CARLSON GW, 1994, CANCER, V74, P436; DOWNS EC, 1992, J CELL PHYSIOL, V152, P422, DOI 10.1002/jcp.1041520225; EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L; Ersek RA., 1991, PLAST RECONSTR SURG, V87, P228, DOI 10.1097/00006534-199102000-00002; Flynn Lauren, 2008, Organogenesis, V4, P228; GOSPODAR.D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; Heimburg D V, 2001, BIOMATERIALS, V22, P429; Hiraoka Y, 2006, TISSUE ENG, V12, P1475, DOI 10.1089/ten.2006.12.1475; Hokugo A, 2007, ORAL SURG ORAL MED O, V104, P44, DOI 10.1016/j.tripleo.2006.11.032; Horan P K, 1990, Methods Cell Biol, V33, P469; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Iabichella M L, 2006, Int J Low Extrem Wounds, V5, P181, DOI 10.1177/1534734606292492; Kandas N, 2011, ANN PLAST SURG; Montesanos R, 1986, P NATL ACAD SCI USA, V83, P7292; Patrick CW, 2001, ANAT REC, V263, P361, DOI 10.1002/ar.1113; Patrick CW, 2003, ANN BIOMED ENG, V31, P505, DOI 10.1114/1.1566446; PEER LA, 1956, AM J SURG, V92, P40, DOI 10.1016/S0002-9610(56)80009-3; ROSSATTI B, 1960, Br J Plast Surg, V13, P35, DOI 10.1016/S0007-1226(60)80007-0; Servold S A, 1991, Clin Podiatr Med Surg, V8, P937; SMAHEL J, 1989, BRIT J PLAST SURG, V42, P207, DOI 10.1016/0007-1226(89)90205-1; vons Heimburgs D, 2003, INT J ARTIF ORGANS, V26, P1064; Zuks PA, 2001, TISSUE ENG, V7, P211	46	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	DEC	2014	8	12					1000	1008		10.1002/term.1611		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	AU9MA	WOS:000345915800009		
J	Ashino, T; Hakukawa, K; Itoh, Y; Numazawa, S				Ashino, Takashi; Hakukawa, Kanae; Itoh, Yuka; Numazawa, Satoshi			Inhibitory effect of synthetic cannabinoids on CYPIA activity in mouse liver microsomes	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Synthetic cannabinoid; Cytochrome P450; CYP1A; Illicit drug; Recreational drug	RECEPTOR; DRUGS; METABOLITES; ENZYMES; ABUSE; CB2	Synthetic cannabinoids developed by chemical modification are believed to bind to cannabinoid receptors and cause neurological effects similar to cannabis; however, their effects on drug metabolizing enzymes are unknown. This study aimed to elucidate the effect of synthetic cannabinoids on cytochrome P450 1A activity. Naphthoylindole, a basic structure of the major synthetic cannabinoids, strongly inhibited CYP1A activity in a competitive manner; the apparent Ki value was 0.40 mu M. The N-Alkylated derivatives of naphthoylindole, MAM-2201 and JWH-019, also inhibited CYP1A activity in a concentration-dependent manner; however, their inhibitory effects were weaker than naphthoylindole. An adamantylamidoindole derivative, STS-135, showed inhibition of CYP1A activity in a concentration-dependent manner, but the adamantoylindole derivatives, AB-001 and AM-1248, did not. A tetramethylcyclopropanoylindole derivative, UR-144, showed a weak inhibition of CYP1A activity at high concentrations. These results suggest that synthetic cannabinoids and their basic molecules are capable of inhibiting CYP1A enzymatic activity.	[Ashino, Takashi; Hakukawa, Kanae; Itoh, Yuka; Numazawa, Satoshi] Showa Univ, Sch Pharm, Dept Pharmacol Toxicol & Therapeut, Div Toxicol,Shinagawa Ku, Tokyo 1428555, Japan	Ashino, T (reprint author), Showa Univ, Sch Pharm, Dept Pharmacol Toxicol & Therapeut, Div Toxicol,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	ashino@pharm.showa-u.ac.jp			MEXT	The authors are grateful to Ms. Yuki Odanaka (Showa University, Japan) for manipulation of NMR and element analysis. We also thank Enago (www.enago.jp) for the English language review. This work was supported by MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2010 to 2014.	ElSohly MA, 2014, LIFE SCI, V97, P78, DOI 10.1016/j.lfs.2013.12.212; Imaoka S, 1996, BIOCHEM PHARMACOL, V51, P1041, DOI 10.1016/0006-2952(96)00052-4; Uchiyama N, 2013, FORENSIC SCI INT, V227, P21, DOI 10.1016/j.forsciint.2012.08.047; Jerry J, 2012, CLEV CLIN J MED, V79, P258, DOI 10.3949/ccjm.79a.11147; Wintermeyer A, 2010, ANAL BIOANAL CHEM, V398, P2141, DOI 10.1007/s00216-010-4171-0; Mechoulam R, 1999, FORSCH KOMPLEMENTMED, V6, P16, DOI 10.1159/000057151; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; SHIMADA T, 1992, MOL PHARMACOL, V41, P856; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Gaffuri AL, 2012, PHARMACOLOGY, V90, P19, DOI 10.1159/000339075; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y; Ashino T, 2011, J TOXICOL SCI, V36, P635; Nelson ME, 2014, EMERG MED CLIN N AM, V32, P1, DOI 10.1016/j.emc.2013.09.001; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; Yamaori S, 2010, BIOCHEM PHARMACOL, V79, P1691, DOI 10.1016/j.bcp.2010.01.028; Zhang Q, 2006, ANAL BIOANAL CHEM, V386, P1345, DOI 10.1007/s00216-006-0717-6; Hamm JT, 1998, BIOCHEM PHARMACOL, V56, P1657, DOI 10.1016/S0006-2952(98)00241-X; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; Badal S, 2014, J APPL TOXICOL, V34, P743, DOI 10.1002/jat.2968; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; Kikura-Hanajiri R, 2014, DRUG TEST ANAL, V6, P832, DOI 10.1002/dta.1584; Seely KA, 2011, MOL INTERV, V11, P36, DOI 10.1124/mi.11.1.6	23	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2014	39	6					815	820				6	Toxicology	Toxicology	AU9YJ	WOS:000345947600001		
J	Miki, Y; Akimoto, J; Hiranuma, M; Fujiwara, Y				Miki, Yuichi; Akimoto, Jiro; Hiranuma, Michika; Fujiwara, Yasuyuki			Effect of talaporfin sodium-mediated photodynamic therapy on cell death modalities in human glioblastoma T98G cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Apoptosis; Glioma; Necrosis; Photodynamic therapy; Talaporfin sodium	APOPTOTIC CELLS; LYSOSOMAL PHOTODAMAGE; ACTIVATION; CLEARANCE; NECROSIS	While photodynamic therapy (PDT) is an effective treatment for glioma, induction of apoptotic cell death of glioma cells is important for ensuring efficacy and safety of PDT treatment in glioma patients, as necrotic cell death can induce late appearance of obstacles in treatment. Here, we investigated the relationship between type of cell death and PDT treatment conditions involved in laser and photosensitizer dosage in human glioblastoma T98G cells. Photosensitizer talaporfin sodium-mediated PDT (NPe6-PDT) treatment induced laser and NPe6 dose-dependent cell death in T98G cells, whereas almost all cells pretreated with NPe6 at >= 30 11 mu g/mL were killed by laser irradiation, regardless of laser dose. Morphological analysis showed that combination of high doses of NPe6 and laser irradiation changes the dominant cell death process from apoptosis to necrosis. Biochemical analysis (detection of caspase-3 activity and staining of cell surface-exposed phosphatidylserine) also showed that increasing laser dose changes the type of cell death from apoptotic to necrotic cell death after high-dose treatment with NPe6. Lactate dehydrogenase leakage assay demonstrated that a laser dose of 5 J/cm(2) induced less leakage than 30 J/cm(2). Our results suggested that type of glioma cell death in NPe6-PDT changed with fluctuations in laser and NPe6 dose, and that combination of 30m mu g/mL NPe6 with 5 J/cm(2) laser is the best treatment condition for inducing an increase in apoptotic cells while keeping rate of necrotic cell death low in this in vitro study.	[Miki, Yuichi; Hiranuma, Michika; Fujiwara, Yasuyuki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Environm Hlth, Hachioji, Tokyo 1920392, Japan; [Akimoto, Jiro] Tokyo Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1600023, Japan	Fujiwara, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Environm Hlth, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yasuyuki@toyaku.ac.jp			Meiji Seika Pharma Co., Ltd. (Tokyo, Japan); Panasonic Healthcare Co., Ltd. (Ehime, Japan)	Talaporfin sodium (NPe6) was provided by Meiji Seika Pharma Co., Ltd. (Tokyo, Japan). The semiconductor laser irradiation device was provided by Panasonic Healthcare Co., Ltd. (Ehime, Japan).	Akimoto J, 2012, PHOTODIAGN PHOTODYN, V9, P91, DOI 10.1016/j.pdpdt.2012.01.001; Leist M, 1997, BIOCHEM BIOPH RES CO, V236, P1, DOI 10.1006/bbrc.1997.6890; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Coupienne I, 2011, PHOTOCH PHOTOBIO SCI, V10, P1868, DOI 10.1039/c1pp05213f; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Tsutsumi M, 2013, PHOTODIAGN PHOTODYN, V10, P103, DOI 10.1016/j.pdpdt.2012.08.002; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; WILSON CB, 1992, CLIN NEUR, V38, P32; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Dougherty TJ, 1998, J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Fietta P, 2006, RIV BIOL-BIOL FORUM, V99, P69; Miki Y, 2009, BIOL PHARM BULL, V32, P564; Miki Y, 2013, BIOL PHARM BULL, V36, P215; Ogawa A, 1979, Neurol Med Chir (Tokyo), V19, P367, DOI 10.2176/nmc.19.367	22	2	2	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2014	39	6					821	827				7	Toxicology	Toxicology	AU9YJ	WOS:000345947600002		
J	Omura, K; Uehara, T; Morikawa, Y; Hayashi, H; Mitsumori, K; Minami, K; Kanki, M; Yamada, H; Ono, A; Urushidani, T				Omura, Ko; Uehara, Takeki; Morikawa, Yuji; Hayashi, Hitomi; Mitsumori, Kunitoshi; Minami, Keiichi; Kanki, Masayuki; Yamada, Hiroshi; Ono, Atsushi; Urushidani, Tetsuro			Comprehensive analysis of DNA methylation and gene expression of rat liver in a 2-stage hepatocarcinogenesis model	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Altered hepatocellular foci; GST-P; Carcinogenesis; Liver; DNA methylation	COLORECTAL-CANCER; EPIGENETIC INACTIVATION; OXIDATIVE STRESS; HEPATOTOXICITY; MECHANISMS; PREDICTION; TISSUES; CELLS; RISK	Recent studies have shown. that epigenetic alterations correlate with carcinogenesis in various tissues. Identification of these alterations might help characterize the early stages of carcinogenesis. We comprehensively analyzed DNA methylation and gene expression in livers obtained from rats exposed to nitrosodiethylamine (DEN) followed by a promoter of hepatic carcinogenesis, phenobarbital (PB). The combination of DEN and PB induced marked increases in number and area of glutathione S-transferase-placental form (GST-P)-positive foci in the liver. In the liver of rats that received 30 mg/kg of DEN, pathway analysis revealed alterations of common genes in terms of gene expression and DNA methylation, and that these alterations were related to immune responses. Hierarchical clustering analysis of the expression of common genes from public data obtained through the Toxicogenomics Project-Genomics Assisted Toxicity Evaluation system (TG-GATEs) showed that carcinogenic compounds clustered together. MBD-seq and GeneChip analysis indicated that major histocompatibility complex class Ib gene RT1-CE5, which has an important role in antigen presentation, was hypomethylated around the promoter region and specifically induced in the livers of DEN-treated rats. Further, immunohistochemical analysis indicated that the co-localization of GST-P and protein homologous to RT1-CE5 was present at the foci of some regions. These results suggest that common genes were altered in terms of both DNA methylation and expression in livers, with preneoplastic foci indicating carcinogenic potential, and that immune responses are involved in early carcinogenesis. In conclusion, the present study identified a specific profile of DNA methylation and gene expression in livers with preneoplastic foci. Early epigenetic perturbations of immune responses might correlate with the early stages of hepatocarcinogenesis.	[Omura, Ko; Kanki, Masayuki] Astellas Pharma Inc, Drug Safety Res Labs, Yodogawa Ku, Osaka 5328514, Japan; [Omura, Ko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Omura, Ko; Uehara, Takeki; Morikawa, Yuji; Minami, Keiichi; Kanki, Masayuki; Yamada, Hiroshi; Ono, Atsushi; Urushidani, Tetsuro] Natl Inst Biomed Innovat, Toxicogenom Informat Project, Ibaraki, Osaka 5670085, Japan; [Uehara, Takeki; Morikawa, Yuji] Shionogi & Co Ltd, Drug Dev Res Labs, Toyonaka, Osaka 5610825, Japan; [Hayashi, Hitomi; Mitsumori, Kunitoshi] Tokyo Univ Agr & Technol, Lab Vet Pathol, Fuchu, Tokyo 1838538, Japan; [Hayashi, Hitomi] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Minami, Keiichi] Ono Pharmaceut Co Ltd, Tsukuba Res Inst, Exploratoty Res Labs, Tsukuba, Ibaraki 3004247, Japan; [Ono, Atsushi] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Urushidani, Tetsuro] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Pathophysiol, Kyotanabe, Kyoto 6100395, Japan	Omura, K (reprint author), Astellas Pharma Inc, Drug Safety Res Labs, Yodogawa Ku, 2-1-6 Kashima, Osaka 5328514, Japan.	kou.omura@astellas.com			Ministry of Health, Labour and Welfare of Japan [H14-Toxico-001, H19-Toxico-001]	We thank Mr. Kenji Nakano for conducting the immunohistochemistry experiments, Drs. Takayuki Noto and Masahiro Matsumoto for their helpful comments regarding the results of histopathology and immunohistochemistry, and Drs. Yasuo Ohno, Marlowe Schneidkraut, and Akira Unami for their revisions to this manuscript. Studies were supported by a grant from the Ministry of Health, Labour and Welfare of Japan (H14-Toxico-001 and H19-Toxico-001).	Akbay A, 1999, HUM EXP TOXICOL, V18, P669, DOI 10.1191/096032799678839518; Ratra GS, 1998, TOXICOLOGY, V130, P79, DOI 10.1016/S0300-483X(98)00096-1; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; Yamada F, 2013, J APPL TOXICOL, V33, P1284, DOI 10.1002/jat.2790; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Jacinto FV, 2007, MUTAGENESIS, V22, P247, DOI 10.1093/mutage/gem009; Uehara T, 2011, TOXICOL APPL PHARM, V255, P297, DOI 10.1016/j.taap.2011.07.001; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Brambilla G, 2007, MUTAT RES-REV MUTAT, V635, P17, DOI 10.1016/j.mrrev.2006.09.003; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Akino K, 2005, GASTROENTEROLOGY, V129, P156, DOI 10.1053/j.gastro.2005.03.051; Snyder RD, 2001, MUTAT RES-REV MUTAT, V488, P151, DOI 10.1016/S1383-5742(01)00055-2; Uehara T, 2008, TOXICOLOGY, V250, P15, DOI 10.1016/j.tox.2008.05.013; Blommaert FA, 1996, CANCER CHEMOTH PHARM, V38, P273, DOI 10.1007/s002800050482; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010; Giurgiovich AJ, 1997, CARCINOGENESIS, V18, P93, DOI 10.1093/carcin/18.1.93; Komatsu Y, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-5; Leinpiainen H., 2011, PLOS ONE, V6; Lempiainen H, 2013, TOXICOL SCI, V131, P375, DOI 10.1093/toxsci/kfs303; Omura K, 2014, J TOXICOL SCI, V39, P785; Pogribny IP, 2007, TOXICOL APPL PHARM, V225, P61, DOI 10.1016/j.taap.2007.07.001; SHIVAPURKAR N, 1984, CARCINOGENESIS, V5, P989, DOI 10.1093/carcin/5.8.989; STROM SC, 1983, ENVIRON HEALTH PERSP, V49, P165, DOI 10.2307/3429594; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100	33	1	1	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2014	39	6					837	848				12	Toxicology	Toxicology	AU9YJ	WOS:000345947600004		
J	Du, K; Takahashi, T; Kuge, S; Naganuma, A; Hwang, GW				Du, Ke; Takahashi, Tsutomu; Kuge, Shusuke; Naganuma, Akira; Hwang, Gi-Wook			FBX06 attenuates cadmium toxicity in HEK293 cells by inhibiting ER stress and JNK activation	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						FBX06; Cadmium; Cytotoxicity; Endoplasmic reticulum-associated protein degradation	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ITAI-ITAI DISEASE; C-JUN; MOLECULAR CHAPERONES; GENE-EXPRESSION; ROLES; METALLOTHIONEIN; DEGRADATION; APOPTOSIS	Cadmium-induced cell death is associated with endoplasmic reticulum (ER) stress. We previously found that inhibition of FBXO6 expression, which is a ubiquitin ligase involved in ER-associated protein degradation (ERAD), induces high sensitivity to cadmium in HEK293 cells. However, the precise role of FBXO6 in ER stress remains unexplored. In this study, we investigated the role of FBXO6 in cadmium-induced ER stress in HEK293 cells. Our results showed that the cadmium-induced increase in expression of the ER stress marker proteins, BiP and CHOP, was further enhanced by inhibiting FBXO6 expression. Cadmium-induced c-Jun phosphorylation was also markedly increased by inhibition of FBXO6 expression. However, this c-Jun phosphorylation was almost entirely abolished by inhibition of c-Jun N-terminal kinase 1 (JNK1) expression. The level of high cadmium sensitivity induced by inhibition of FBXO6 expression was markedly lower in the JNK1-ablated cells than in the control cells. In addition, cadmium elevated the cellular level of ERAD substrate proteins, and this elevation was further enhanced by inhibiting FBXO6 expression. These results suggest that FBXO6 might inhibit cadmium-induced ER stress by functioning as a ubiquitin ligase in the ERAD system, thereby attenuating the cell death induced by subsequent JNK1 activation.	[Du, Ke; Takahashi, Tsutomu; Kuge, Shusuke; Naganuma, Akira; Hwang, Gi-Wook] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Biochem Toxicol, Sendai, Miyagi 9808578, Japan; [Du, Ke] China Med Univ, Dept Pharmacol, Shenyang 110013, Liaoning Provid, Peoples R China; [Kuge, Shusuke] Tohoku Pharmaceut Univ, Dept Microbiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Hwang, GW (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Biochem Toxicol, Sendai, Miyagi 9808578, Japan.	gwhwang@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [24651058]	We are thankful to Dr. Lisa Swanton at the University of Manchester for providing the pcDNA5-TCR alpha-FLAG plasmid and Dr. Nobuko Hosokawa at the Kyoto University for providing the pREP9-NHK plasmid. This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology via a Grant-in-Aid for challenging Exploratory Research (24651058) to G.W.H.	HEILMAIER HE, 1987, TOXICOL LETT, V38, P205, DOI 10.1016/0378-4274(87)90001-4; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Lee JY, 2013, J TOXICOL SCI, V38, P959; Kitamura M, 2010, BIOMETALS, V23, P941, DOI 10.1007/s10534-010-9296-2; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; McNeill H, 2004, BIOCHEM J, V384, P391, DOI 10.1042/BJ20041498; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Ikeda M, 2004, INT ARCH OCC ENV HEA, V77, P227, DOI 10.1007/s00420-003-0499-5; Baba H, 2014, J TOXICOL SCI, V39, P91; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Hwang GW, 2011, J TOXICOL SCI, V36, P847; NOGAWA K, 1993, INT ARCH OCC ENV HEA, V65, pS43, DOI 10.1007/BF00381306; Kwon OY, 1999, Z NATURFORSCH C, V54, P573; Liu Gang, 2005, Curr Opin Investig Drugs, V6, P979; Miura N, 2013, J TOXICOL SCI, V38, P947; SUMMER KH, 1986, HUM TOXICOL, V5, P27; Tokumoto M, 2014, J TOXICOL SCI, V39, P735	23	2	2	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2014	39	6					861	866				6	Toxicology	Toxicology	AU9YJ	WOS:000345947600006		
J	Kobayashi, K; Kubota, H; Hojo, R; Miyagawa, M				Kobayashi, Kenichi; Kubota, Hisayo; Hojo, Rieko; Miyagawa, Muneyuki			Dose-dependent effects of perinatal hypothyroidism on postnatal testicular development in rat offspring	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Hypothyroid; 6-Propyl-2-thiouracil (PTU); Testis; Epididymis; Thyroid hormone	TRANSIENT NEONATAL-HYPOTHYROIDISM; THYROID-HORMONE RECEPTORS; ADULT TESTIS SIZE; SPERM PRODUCTION; CONGENITAL HYPOTHYROIDISM; DEVELOPING BRAIN; GROWTH; 6-N-PROPYL-2-THIOURACIL; SPERMATOGENESIS; HYPERTHYROIDISM	The role of thyroid hormones in gonad development remains incompletely understood. We examined the dose-related effects of perinatal hypothyroidism induced by a reversible goitrogen, 6-propyl-2-thiouracil (PTU), on reproductive development in male rat offspring. Timed-pregnant Sprague-Dawley rats were orally administered PTU (0, 0.5, 1.0, or 2.0 mg/kg/day) by gavage from gestational day 15 through postnatal day 20. We observed a significant dose-dependent decrease in body weight in offspring with PTU exposure up to 13 weeks of age, but body weight became comparable among groups by 26 weeks of age. Testicular weight tended to be lower up to 7 weeks but was higher after 13 weeks of age. Epididymis weight was not different among the groups at any age. Plasma concentrations of thyroxine and triiodothyronine in the PTU groups were significantly lower at 3 weeks of age but recovered to normal levels by 26 weeks of age. No dose-related trend in plasma testosterone concentrations was found. Seminiferaus tubules were larger at 13 and 26 weeks of age with PTU exposure. The number of Sertoli cells was significantly higher from 3 through 26 weeks of age. The number of Leydig cells was significantly lower up to 7 weeks of age but was comparable among groups from 13 weeks of age onwards. Thus, transient gestational and lactational thyroid hormone suppression induced small testes in early life but led to paradoxical dose-dependent testicular enlargement in adults as indicated partly by larger seminiferous tubules with numerous Sertoli cells in male rat offspring.	[Kobayashi, Kenichi; Kubota, Hisayo; Hojo, Rieko; Miyagawa, Muneyuki] NIOSH, Tama Ku, Kawasaki, Kanagawa 2148585, Japan; [Miyagawa, Muneyuki] Teikyo Univ, Fac Med Technol, Dept Sport & Med Sci, Hachioji, Tokyo 1920395, Japan	Kobayashi, K (reprint author), NIOSH, Tama Ku, 6-21-1 Nagao, Kawasaki, Kanagawa 2148585, Japan.	kobayasi@h.jniosh.go.jp			Health Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan [H16-Kagaku-001]	We thank Mr. T. Murase for his technical support in this study. This study was supported in part by a Health Sciences Research Grant H16-Kagaku-001 from the Ministry of Health, Labour and Welfare, Japan.	VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Noda S, 2005, ARCH TOXICOL, V79, P414, DOI 10.1007/s00204-004-0641-5; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337; JANNINI EA, 1995, ENDOCR REV, V16, P443, DOI 10.1210/er.16.4.443; JOYCE KL, 1993, J ANDROL, V14, P448; Wagner MS, 2009, MICROSC RES TECHNIQ, V72, P796, DOI 10.1002/jemt.20759; Dittrich R, 2011, J REPROD IMMUNOL, V90, P58, DOI 10.1016/j.jri.2011.02.009; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; Shibutani M, 2009, REPROD TOXICOL, V28, P297, DOI 10.1016/j.reprotox.2009.04.011; Sharlin DS, 2010, J NEUROENDOCRINOL, V22, P153, DOI 10.1111/j.1365-2826.2009.01947.x; ASTWOOD EB, 1984, JAMA-J AM MED ASSOC, V251, P1743, DOI 10.1001/jama.251.13.1743; BARKER SB, 1952, AM J PHYSIOL, V170, P81; Buzzard JJ, 2000, BIOL REPROD, V62, P664, DOI 10.1095/biolreprod62.3.664; COOKE PS, 1991, ENDOCRINOLOGY, V129, P244; Cooke PS, 1996, TOXICOL APPL PHARM, V136, P112, DOI 10.1006/taap.1996.0013; Cristovao F.C., 2002, THYROID, V12, P13; Hayashi T, 2002, J EXP ZOOL, V292, P304, DOI 10.1002/jez.10012; HESS RA, 1993, ENDOCRINOLOGY, V132, P2607, DOI 10.1210/en.132.6.2607; Kimura T, 1996, EXP ANIM TOKYO, V45, P369, DOI 10.1538/expanim.45.369; KIRBY JD, 1992, ENDOCRINOLOGY, V131, P559, DOI 10.1210/en.131.2.559; Kobayashi K, 2007, EXP ANIM TOKYO, V56, P393, DOI 10.1538/expanim.56.393; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; LANDAU RL, 1984, JAMA-J AM MED ASSOC, V251, P1747, DOI 10.1001/jama.251.13.1747; MEISAMI E, 1992, J ENDOCRINOL, V135, P495, DOI 10.1677/joe.0.1350495; Mendis-Handagama C, 2004, ARCH ANDROLOGY, V50, P347, DOI 10.1080/01485010490474779; Ojeda S. R., 2004, TXB ENDOCRINE PHYSL, P120; OPPENHEI.JH, 1974, ENDOCRINOLOGY, V95, P897; Rockett John C., 2005, Cancer Biomarkers, V1, P93; Sakai Y, 2004, DEV GROWTH DIFFER, V46, P327; Sher ES, 1998, TOXICOL IND HEALTH, V14, P121; Tousson E, 2011, REPROD SCI, V18, P679, DOI 10.1177/1933719110395401; Umezu M, 2004, J REPROD DEVELOP, V50, P675, DOI 10.1262/jrd.50.675; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Yamasaki K, 2002, ARCH TOXICOL, V76, P495, DOI 10.1007/s00204-002-0371-5	35	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2014	39	6					867	874				8	Toxicology	Toxicology	AU9YJ	WOS:000345947600007		
J	Horie, M; Kato, H; Endoh, S; Fujita, K; Komaba, LK; Nishio, K; Nakamura, A; Miyauchi, A; Yamamoto, K; Kinugasa, S; Hagihara, Y; Yoshida, Y; Iwahashi, H				Horie, Masanori; Kato, Haruhisa; Endoh, Shigehisa; Fujita, Katsuhide; Komaba, Lilian Kaede; Nishio, Keiko; Nakamura, Ayako; Miyauchi, Arisa; Yamamoto, Kazuhiro; Kinugasa, Shinichi; Hagihara, Yoshihisa; Yoshida, Yasukazu; Iwahashi, Hitoshi			Cellular effects of industrial metal nanoparticles and hydrophilic carbon black dispersion	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Nanoparticle; Gold; Silver; Carbon black; Oxidative stress	VITRO TOXICOLOGY ASSESSMENT; IN-VITRO; SILVER NANOPARTICLES; OXIDATIVE STRESS; MANUFACTURED NANOPARTICLES; ADSORPTION ABILITY; CULTURE-MEDIUM; ION RELEASE; LUNG-CELLS; CYTOTOXICITY	The effects of five types of metal nanoparticles, gold (Au), silver (Ag), platinum (Pt), Au-polyvinylpyrrolidone (PVP) colloid, and Pt-PVP colloid, and two types of hydrophilic carbon black on cell behavior were examined. Stable nanoparticle dispersions were prepared and applied to the culture medium of human keratinocyte (HaCaT) and human lung carcinoma (A549) cells for 6 and 24 hr. Then, the mitochondrial activity (MTT assay) and the induction of cellular oxidative stress were examined. The exposure to Au and Ag decreased mitochondrial activity. The exposure to Pt nanoparticles induced an increase in the intracellular reactive oxygen species (ROS) level. In contrast, Au-PVP, Pt-PVP, and hydrophilic carbon black did not exhibit any effects. The observed increase in the ROS level induced by the Pt nanoparticles in this study contradicted our previous findings, in which Pt did not produce chemically reactive molecules. Some nanoparticle dispersions included chemicals as the dispersant, which is used in industrial applications. In some cases, the dispersing agent may have caused some cellular effects. Adsorption of agents on the surface of the nanoparticles may be an important factor here. Hence, the cellular effects of industrial nanoparticles should be evaluated carefully.	[Horie, Masanori; Komaba, Lilian Kaede; Nishio, Keiko; Hagihara, Yoshihisa; Yoshida, Yasukazu; Iwahashi, Hitoshi] Natl Inst Adv Ind Sci & Technol, HRI, Takamatsu, Kagawa 7610395, Japan; [Kato, Haruhisa; Nakamura, Ayako; Kinugasa, Shinichi] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058565, Japan; [Endoh, Shigehisa; Miyauchi, Arisa] AIST, Technol Res Assoc Single Wall Carbon Nanotubes TA, Tsukuba, Ibaraki 3058569, Japan; [Fujita, Katsuhide] AIST, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki 3058569, Japan; [Yamamoto, Kazuhiro] AIST, Res Inst Instrumentat Frontier RIIF, Ibaraki 3058568, Japan; [Iwahashi, Hitoshi] Gift Univ, Fac Appl Biol Sci, Gift 5011193, Japan	Horie, M (reprint author), Natl Inst Adv Ind Sci & Technol, HRI, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.	masa-horie@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO) entitled "Evaluating risks associated with manufactured nanomaterials" [P06041]	This work was funded by a grant from the New Energy and Industrial Technology Development Organization (NEDO) entitled "Evaluating risks associated with manufactured nanomaterials (P06041)".	Casey A, 2008, TOXICOL LETT, V179, P78, DOI 10.1016/j.toxlet.2008.04.006; Horie M, 2009, CHEM RES TOXICOL, V22, P543, DOI 10.1021/tx800289z; Fukui H, 2012, CHEM-BIOL INTERACT, V198, P29, DOI 10.1016/j.cbi.2012.04.007; Diabate S, 2011, ANAL BIOANAL CHEM, V401, P3197, DOI 10.1007/s00216-011-5102-4; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Kato H, 2009, TOXICOL IN VITRO, V23, P927, DOI 10.1016/j.tiv.2009.04.006; Monteiro-Riviere NA, 2013, TOXICOL LETT, V220, P286, DOI 10.1016/j.toxlet.2013.04.022; [Anonymous], 276872008 ISOTS; Horie M, 2010, TOXICOL IN VITRO, V24, P1629, DOI 10.1016/j.tiv.2010.06.003; Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939; Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Horie M, 2013, ARCH TOXICOL, V87, P771, DOI 10.1007/s00204-013-1033-5; Horie M, 2012, METALLOMICS, V4, P350, DOI 10.1039/c2mt20016c; Kroll A, 2009, EUR J PHARM BIOPHARM, V72, P370, DOI 10.1016/j.ejpb.2008.08.009; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Monteiro-Riviere NA, 2009, TOXICOL APPL PHARM, V234, P222, DOI 10.1016/j.taap.2008.09.030; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Horie M, 2009, CHEM RES TOXICOL, V22, P1415, DOI 10.1021/tx900171n; Monopoli MP, 2013, METHODS MOL BIOL, V1025, P137, DOI 10.1007/978-1-62703-462-3_11; Horie M, 2011, METALLOMICS, V3, P1244, DOI 10.1039/c1mt00060h; Avalos A, 2014, J APPL TOXICOL, V34, P413, DOI 10.1002/jat.2957; Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11; Gressler S., 2013, 039 NAN DOSS; Horie M, 2011, J OCCUP HEALTH, V53, P64, DOI 10.1539/joh.L10121; Horie M, 2013, TOXICOL MECH METHOD, V23, P315, DOI 10.3109/15376516.2012.755595; Kato H, 2010, TOXICOL IN VITRO, V24, P1009, DOI 10.1016/j.tiv.2009.12.006; Ng C.T., 2014, IN VITRO AN IN PRESS, DOI [10.1002/ar.23051, DOI 10.1002/AR.23051]; Tatsuishi T, 2005, TOXICOLOGY, V207, P7, DOI 10.1016/j.tox.2004.07.020; Yoo HJ, 2014, J NANOSCI NANOTECHNO, V14, P5395, DOI 10.1166/jnn.2014.8733	30	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2014	39	6					897	907				11	Toxicology	Toxicology	AU9YJ	WOS:000345947600010		
J	Takasugi, S; Kaminou, T; Ohuchi, Y; Yata, S; Adachi, A; Kawai, T; Endo, M; Ogawa, T				Takasugi, Shohei; Kaminou, Toshio; Ohuchi, Yasufumi; Yata, Shinsaku; Adachi, Akira; Kawai, Tsuyoshi; Endo, Masayuki; Ogawa, Toshihide			Coil Embolization with Side-Holed Catheter to Preserve Peripheral Flow for Visceral Artery Pseudoaneurysm: An Experimental Study in Swine	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							RUPTURED PSEUDOANEURYSM; MANAGEMENT; ANEURYSMS; IMPLANTATION; SURGERY; RISK	Purpose: To evaluate the safety and efficacy of coil embolization with an indwelling catheter with side holes to control visceral artery bleeding while simultaneously preserving peripheral artery flow. Materials and Methods: A 6-F anticoagulant-coated catheter with two symmetrically arranged side holes was used with coil embolization to induce hemostasis in the superior mesenteric artery (SMA) of 13 pigs. The SMA was punctured with a metal needle to induce bleeding. The catheter was advanced into the SMA immediately after the puncture, and the midpoint between its tip and side holes was adjusted to conform to the puncture site. The SMA was embolized by using microcoils placed around the catheter to achieve hemostasis. Hemostasis and gross ischemic changes of the intestine were visually observed during the abdominal surgery. Peripheral blood flow was assessed by using abdominal aortography for as long as 2 hours in 13 pigs and was assessed again at 7 days in three pigs. Results: Antegrade peripheral artery flow through the indwelling catheter was preserved without stagnation for as long as 2 hours in all 13 pigs and at 7 days in two of three pigs. One catheter occlusion was seen at the 7-day time point. There were no Observable instances of recurrent bleeding, ischemic changes in the intestine; or vascular adverse events during or after the procedure. Conclusions: The hemostatic method described here is a technically feasible method of controlling acute visceral artery bleeding while preserving peripheral artery flow and may be particularly useful in cases of absence of collateral circulation. Further experiments are warranted for clinical application.	[Takasugi, Shohei; Yata, Shinsaku; Adachi, Akira; Kawai, Tsuyoshi; Endo, Masayuki; Ogawa, Toshihide] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 6838504, Japan; [Ohuchi, Yasufumi] Sanin Rosai Hosp, Dept Radiol, Yonago, Tottori, Japan; [Kaminou, Toshio] Natl Hosp Org, Osaka Minami Med Ctr, Dept Radiol, Osaka, Japan	Takasugi, S (reprint author), Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, 36-1 Nishicho, Yonago, Tottori 6838504, Japan.	takasugi.sho@gmail.com					Deschamps F, 2010, J VASC INTERV RADIOL, V21, P1681, DOI 10.1016/j.jvir.2010.08.003; Hur S, 2011, J VASC INTERV RADIOL, V22, P294, DOI 10.1016/j.jvir.2010.11.020; Reber PU, 1998, J AM COLL SURGEONS, V186, P325, DOI 10.1016/S1072-7515(98)00032-5; Okuno A, 2001, AM J GASTROENTEROL, V96, P1067; Sato A, 2011, J VASC INTERV RADIOL, V22, P287, DOI 10.1016/j.jvir.2010.11.023; Tessier DJ, 2003, J VASC SURG, V38, P969, DOI 10.1016/S0741-5214(03)00710-9; Shibata T, 2002, CARDIOVASC INTER RAD, V25, P180, DOI 10.1007/s00270-001-0106-7; Etezadi V, 2011, J VASC INTERV RADIOL, V22, P1246, DOI 10.1016/j.jvir.2011.05.012; Tulsyan N, 2007, J VASC SURG, V45, P276, DOI 10.1016/j.jvs.2006.10.049; Arai Yasuaki, 2007, Tech Vasc Interv Radiol, V10, P30, DOI 10.1053/j.tvir.2007.08.007; Boufi M, 2011, J VASC SURG, V53, P1625, DOI 10.1016/j.jvs.2011.02.003; MANDEL SR, 1987, ANN SURG, V205, P126, DOI 10.1097/00000658-198702000-00004; Miller MT, 2007, J VASC SURG, V45, P381, DOI 10.1016/j.jvs.2006.09.010; Monsignore LM, 2012, DIAGN INTERV RADIOL, V18, P403, DOI 10.4261/1305-3825.DIR.5211-11.1; Noishiki Y, 1987, ASAIO Trans, V33, P359; Song NH, 2010, J VASC INTERV RADIOL, V21, P1508; Stampfl U, 2012, J VASC INTERV RADIOL, V23, P331, DOI 10.1016/j.jvir.2011.12.010; Stoupis C, 2007, EUR RADIOL, V17, P401, DOI 10.1007/s00330-006-0359-2	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	DEC	2014	25	12					1867	1872		10.1016/j.jvir.2014.06.006		6	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AU5XK	WOS:000345676700005		
J	Watanabe, M; Shibuya, A; Minamino, T; Murano, J; Matsunaga, K; Fujii, K; Ogasawara, G; Irie, T; Woodhams, R; Koizumi, W				Watanabe, Masaaki; Shibuya, Akitaka; Minamino, Tsutomu; Murano, Junya; Matsunaga, Keiji; Fujii, Kaoru; Ogasawara, Gou; Irie, Tsugumi; Woodhams, Reiko; Koizumi, Wasaburo			Benefits and Problems of Transarterial Therapy in Patients with Hepatocellular Carcinoma and Chronic Kidney Disease	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							INDUCED NEPHROPATHY CIN; CONTRAST-MEDIA; CHEMOEMBOLIZATION; RISK	Purpose: To evaluate the feasibility of transarterial therapy (transcatheter arterial chemoembolization and transcatheter arterial infusion) for patients with hepatocellular carcinoma and chronic kidney disease (CKD). Materials and Methods: The study enrolled 35 patients who received transarterial therapy. The patients were classified into a CKD group (n = 10 nondialysis chronic kidney disease [NDCKID] and n = 9 end-stage renal disease [ESRD]) or a non-CKD group (n = 16). The survival rates between the two groups were compared using two different starting points: (a) from initial diagnosis of hepatocellular carcinoma and (b) from enrollment in the study. The tolerance of transarterial therapy in patients with CKD was evaluated by comparing the incidence of major adverse events. Results: The 2-year and 5-year survival rates from initial diagnosis were 83.9% and 53.8% hi the CKD group and 70.1% and 40.4% in the non-CKD group (P = .478). The,corresponding 3-year survival rate from enrollment in the two groups was 25.6% and 41.2%, respectively (P = .995). The 2-year and 5-year survival rates from initial diagnosis were 70.1% and 40.4% in the non-CKD group, 90.% and 39.4% in NDCKD patients, and 76.2% and 76.2% in ESRD patients (P = .380). The corresponding 2-ear survival rates from enrollment in these groups were 54.9%, 48.0% and 48.6% (P = .943). Severe contrast-induced nephropathy (n = 3) and late-onset death caused by cholesterol crystal embolism (n = 1) were observed in the NDCKD group. Conclusions: Transcatheter arterial chemoembolization is feasible in patients with CKD by instituting periprocedural hemodialysis with similar 2-year and 5-year survival compared with patients without CKD.	[Watanabe, Masaaki] Kitasato Univ, Med Ctr, Dept Gastroenterol, Saitama 3648501, Japan; [Shibuya, Akitaka] Kitasato Univ, Sch Med, Dept Risk Management & Hlth Care Adm, Saitama 3648501, Japan; [Minamino, Tsutomu] Kitasato Univ, Sch Med, Dept Gastroenterol, Saitama 3648501, Japan; [Murano, Junya] Kitasato Univ, Sch Med, Dept Nephrol Internal Med, Saitama 3648501, Japan; [Matsunaga, Keiji; Fujii, Kaoru; Ogasawara, Gou; Irie, Tsugumi; Woodhams, Reiko] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Saitama 3648501, Japan; [Koizumi, Wasaburo] Kitasato Univ, East Hosp, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan	Watanabe, M (reprint author), Kitasato Univ, Med Ctr, Dept Gastroenterol, 6-100 Arai, Saitama 3648501, Japan.	masaaki@kitasato-u.ac.jp					Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Golfieri R, 2013, J VASC INTERV RADIOL, V24, P509, DOI 10.1016/j.jvir.2012.12.013; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Moschouris H, 2014, DIAGN INTERV RADIOL, V20, P136, DOI 10.5152/dir.2013.13282; Chen CF, 2014, J GASTROENT IN PRESS; Chewning RH, 2007, J VASC INTERV RADIOL, V18, P331, DOI 10.1016/j.jvir.2007.01.025; Clinical Practice Guidelines for Hepatocellular Carcinoma-The Japan Society of Hepatology, 2010, HEPATOL RES SS1, V40, P96; Delay G, 2006, KIDNEY INT, P6925; Hayakawa K, 2014, EUR RADIOL, V24, P1105, DOI 10.1007/s00330-014-3099-8; Hsu CY, 2010, LIVER INT, V30, P77, DOI 10.1111/j.1478-3231.2009.02128.x; Hsu CY, 2010, J CLIN GASTROENTEROL, V44, P171; Lee CH, 2013, WORLD J GASTROENTERO, V19, P2466, DOI 10.3748/wjg.v19.i16.2466; Lee YH, 2013, J GASTROEN HEPATOL, V28, P348, DOI 10.1111/jgh.12062; Li WH, 2013, INT UROL NEPHROL, V45, P1065, DOI 10.1007/s11255-012-0340-8; Meyrier A, 2006, KIDNEY INT, V69, P1308, DOI 10.1038/sj.ki.5000263; Morcos SK, 2005, J VASC INTERV RADIOL, V16, P13, DOI 10.1097/01.RVI.0000145224.02920.C2; Omary Reed A, 2003, J Vasc Interv Radiol, V14, pS293; Park J, 2008, BLOOD PURIFICAT, V26, P454, DOI 10.1159/000157322	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	DEC	2014	25	12					1947	1955		10.1016/j.jvir.2014.08.024		9	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AU5XK	WOS:000345676700018		
J	Sato, H; Nakai, M; Sato, M; Ikoma, A; Nishimura, Y				Sato, Hirotatsu; Nakai, Motoki; Sato, Mono; Ikoma, Akira; Nishimura, Yoshiharu			Retrograde Popliteal Endovascular Stent-Graft Repair for a Growing Persistent Sciatic Artery Aneurysm (Type IIa): Case Report and Review of the Literature	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Letter									[Sato, Hirotatsu; Nakai, Motoki; Sato, Mono; Ikoma, Akira] Wakayama Med Univ, Dept Radiol, Wakayama 6418510, Japan; [Nishimura, Yoshiharu] Wakayama Med Univ, Dept Thorac & Cardiovasc Surg, Wakayama 6418510, Japan	Sato, H (reprint author), Wakayama Med Univ, Dept Radiol, 811-1 Kimiidera, Wakayama 6418510, Japan.						van Hooft IM, 2009, EUR J VASC ENDOVASC, V37, P585, DOI 10.1016/j.ejvs.2009.01.014; GAUFFRE S, 1994, SURG RADIOL ANAT, V16, P105, DOI 10.1007/BF01627932; BOWER EB, 1977, SURGERY, V81, P588; BRANTLEY SK, 1993, J VASC SURG, V18, P242; Debels H, 2011, ACTA CHIR BELG, V111, P256; Fearing NM, 2005, ANN VASC SURG, V19, P438, DOI 10.1007/s10016-005-0024-2; Gabelmann A, 2001, J ENDOVASC THER, V8, P622, DOI 10.1583/1545-1550(2001)008<0622:EIOPSA>2.0.CO;2; Girsowicz E, 2014, ANN VASC SURG, V28, pe7; Jain S, 2004, EUR J VASC ENDOVASC, V8, P5, DOI 10.1016/j.ejvsextra.2004.05.006; Martin K W, 1986, J Vasc Surg, V4, P365, DOI 10.1067/mva.1986.avs0040365; Mascarenhas de Oliveira F, 2011, VASC ENDOVASC SURG, V45, P165; Nuno-Escobar C, 2013, ANN VASC SURG, V27; PILLET J, 1982, ANAT CLIN, V3, P329, DOI 10.1007/BF01798943; Shibutani S, 2013, ANN VASC SURG, V27, p499e5; Verikokos C, 2010, VASCULAR, V18, P162, DOI 10.2310/6670.2010.00019; Wijeyaratne SM, 2009, EUR J VASC ENDOVASC, V38, P91, DOI 10.1016/j.ejvs.2009.03.007	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	DEC	2014	25	12					1997	2000		10.1016/j.jvir.2014.08.020		4	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AU5XK	WOS:000345676700024		
J	Wakabayashi, I				Wakabayashi, Ichiro			Gender-Related Differences in Cardiometabolic Risk Profile of Japanese Patients with Diabetes	JOURNAL OF WOMENS HEALTH			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; HEART-DISEASE; PREVALENCE; MELLITUS; WOMEN; CHOLESTEROL; LIPOPROTEIN; HYPERTENSION; POPULATION	Background: In patients with diabetes, cardiovascular disease is an important determinant of their prognosis. The aim of this study was to compare cardiometabolic risk factors in Japanese women and men with diabetes. Methods: The subjects were Japanese patients with diabetes, and age-matched female and male subject groups with the ratio of number of women to that of men being 1 to 2 were prepared (total number of subjects, 1,707; mean age, 53.8 years). Cardiometabolic risk factors were compared in women and men. Results: Waist-to-height ratio was significantly higher in the female group than in the male group, while body mass index was not significantly different in the two groups. Diastolic blood pressure and pulse pressure were significantly lower and higher, respectively, in the female group than in the male group, while systolic blood pressure was not significantly different in the two groups. Low-density lipoprotein cholesterol and log-transformed triglycerides were significantly higher and lower, respectively, in the female group than in the male group. Log-transformed lipid accumulation product was significantly higher in the female group than in the male group. Odds ratios (with their 95% confidence intervals [95% CIs]) of gender (women vs. men) were 2.00 [95% CI: 1.48 to 2.69] for abdominal obesity, 1.48 [95% CI: 1.15 to 1.91]) for high pulse pressure, 1.48 [95% CI: 1.13 to 1.92] for high low-density lipoprotein cholesterolemia, 1.77 [95% CI: 1.32 to 2.37] for low high-density lipoprotein cholesterolemia, and 1.68 [95% CI: 1.28 to 2.21] for metabolic syndrome diagnosed by the International Diabetes Federation criteria. Thus, women had significantly higher odds for these cardiovascular risk factors than did men. Conclusion: The results suggest that Japanese women with diabetes have a more adverse cardiometabolic profile than do men.	Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan	Wakabayashi, I (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp					Sekikawa A, 2000, J DIABETES COMPLICAT, V14, P78, DOI 10.1016/S1056-8727(00)00074-X; Jeppesen J, 1997, ARTERIOSCL THROM VAS, V17, P1114; Safar ME, 2000, J HYPERTENS, V18, P1527, DOI 10.1097/00004872-200018110-00001; WALDEN CE, 1984, NEW ENGL J MED, V311, P953, DOI 10.1056/NEJM198410113111505; [Anonymous], 2010, DIABETES CARE, V33, pS62; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Gregg EW, 2007, ANN INTERN MED, V147, P149; Sarwar N, 2010, LANCET, V375, P2215; Kahn HS, 2006, DIABETES CARE, V29, P151, DOI 10.2337/diacare.29.01.06.dc05-1805; Gaziano JM, 1997, CIRCULATION, V96, P2520; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Schroeder EB, 2014, WOMEN HEALTH ISS, V24, pE61, DOI 10.1016/j.whi.2013.09.008; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Ferrara A, 2008, DIABETES CARE, V31, P69, DOI 10.2337/dc07-1244; Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; Arai H, 2006, J ATHEROSCLER THROMB, V13, P202; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Gerich John E, 2007, Clin Cornerstone, V8, P53, DOI 10.1016/S1098-3597(07)80028-7; Health Labour and Welfare Statistics Association, 2013, J HLTH WELFARE STAT, V60, P88; Hsieh SD, 2006, PREV MED, V42, P135, DOI 10.1016/j.ypmed.2005.08.007; TURNER RC, 1993, J HYPERTENS, V11, P309; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; SIMMONS D, 1990, DIABETIC MED, V7, P238; Stamataki KE, 1996, CLIN ENDOCRINOL, V45, P615, DOI 10.1046/j.1365-2265.1996.00795.x; Matsuzawa Y, 2002, CIRC J, V66, P987	29	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	DEC 1	2014	23	12					1046	1053		10.1089/jwh.2014.4852		8	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	AW1SM	WOS:000346070200010		
J	Sato, T				Sato, Takashi			The T-equivariant integral cohomology ring of F-4/T	KYOTO JOURNAL OF MATHEMATICS			English	Article								We determine the T-equivariant integral cohomology of F-4/T combinatorially by the Goresky, Kottwitz, and MacPherson (GKM) theory, where T is a maximal torus of the exceptional Lie group F-4 and acts on F-4/T by the left multiplication.	Kyoto Univ, Grad Sch Sci, Dept Math, Sakyo Ku, Kyoto 6068502, Japan	Sato, T (reprint author), Kyoto Univ, Grad Sch Sci, Dept Math, Sakyo Ku, Kyoto 6068502, Japan.	t-sato@math.kyoto-u.ac.jp					Adams J F, 1996, LECT EXCEPTIONAL LIE; Goresky M, 1998, INVENT MATH, V131, P25; Fukukawa Y., ARXIV12075229V1MATHA; Fukukawa Y., ARXIV11041832V3MATHA; Guillemin V, 2001, DUKE MATH J, V107, P283; Harada M, 2005, ADV MATH, V197, P198, DOI 10.1016/j.aim.2004.10.003; Hsiang W.-y., 1975, ERGEB MATH GRENZGEB, V85; Matsumura H., 1986, CAMBRIDGE STUD ADV M, V8; Neusel M. D., 2002, MATH SURVEYS MONOGRA, V94; Toda H, 1974, J MATH KYOTO U, V14, P257	10	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	WIN	2014	54	4					703	726		10.1215/21562261-2801786		24	Mathematics	Mathematics	AU9BP	WOS:000345887100001		
J	Hora, A; Hirai, T				Hora, Akihito; Hirai, Takeshi			Harmonic functions on the branching graph associated with the infinite wreath product of a compact group	KYOTO JOURNAL OF MATHEMATICS			English	Article							FACTOR REPRESENTATIONS; SYMMETRIC-GROUPS; GROUP T; CHARACTERS; LIMITS; G(INFINITY)(T)	A detailed study of the characters of infinity (T), the wreath product of compact group T with the infinite symmetric group infinity, is indispensable for harmonic analysis on this big group. In preceding works, we investigated limiting behavior of characters of the finite wreath product n (T) as n -> infinity and its connection with characters of infinity, (T). This paper takes a dual approach to these problems. We study harmonic functions on Y((T) over cap), the branching graph of the inductive system of n (T)'s, and give a classification of the minimal nonnegative harmonic functions on it. This immediately implies a classification of the characters of infinity, (T), which is a logically independent proof of the one obtained in earlier works. We obtain explicit formulas for minimal nonnegative harmonic functions on Y((T) over cap) and Martin integral expressions for harmonic functions.	[Hora, Akihito] Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan	Hora, A (reprint author), Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan.	hora@math.sci.hokudai.ac.jp; hira.takeshi.24e@st.kyoto-u.ac.jp					Ivanov V, 2002, NATO SCI SER II MATH, V74, P93; Olshanski G, 2003, J FUNCT ANAL, V205, P464, DOI 10.1016/S0022-1236(02)00022-8; Borodin A., 2000, ELECTRON J COMB, V7; Boyer R., 2005, INT J MATH MATH SCI, V9, P1365, DOI 10.1155/IJMMS.2005.1365; Hirai T, 2009, NAGOYA MATH J, V193, P1; Hirai T, 2006, J MATH KYOTO U, V46, P75; Hirai T., 2006, NAGOYA MATH J, V73, P207, DOI [10.4064/bc73-0-15., DOI 10.4064/BC73-0-15]; Hirai T, 2001, J MATH KYOTO U, V41, P475; Hirai T, 2007, J MATH KYOTO U, V47, P269; Hirai T, 2005, J MATH KYOTO U, V45, P355; Hora A, 2008, J MATH SOC JPN, V60, P1187, DOI 10.2969/jmsj/06041187; James Gordon, 1981, ENCY MATH ITS APPL, V16; Kerov S, 1998, INT MATH RES NOTICES, P173; Kerov S., 1994, DIMACS SER DISCRETE, V24, P133; Kerov S., 2003, TRANSLATIONS MATH MO, V219; Sawyer S. A., 1995, CONT MATH, V206, P17, DOI 10.1090/conm/206/02685; Vershik A. M., 1981, FUNKT ANAL PRIL, V15, P15	17	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	WIN	2014	54	4					775	817		10.1215/21562261-2801822		43	Mathematics	Mathematics	AU9BP	WOS:000345887100004		
J	Matsumoto, K; Matui, H				Matsumoto, Kengo; Matui, Hiroki			Continuous orbit equivalence of topological Markov shifts and Cuntz-Krieger algebras	KYOTO JOURNAL OF MATHEMATICS			English	Article							C-ASTERISK-ALGEBRAS; FLOW EQUIVALENCE; REDUCIBLE SHIFTS; FULL GROUPS; FINITE-TYPE; HOMOLOGY; CHAINS	Let A,B be square irreducible matrices with entries in {0,1}. We will show that if the one-sided topological Markov shifts (X-A, sigma(A)) and (X-B, sigma(B)) are continuously orbit equivalent, then the two-sided topological Markov shifts ((X) over bar (A), (sigma) over bar (A)) and ((X) over bar (B), (sigma) over bar (B)) are flow equivalent, and hence det (id-A) = det (id-B). As a result, the one-sided topological Markov shifts (X-A, sigma(A)) and (X-B, sigma(B)) are continuously orbit equivalent if and only if the Cuntz -Krieger algebras O-A and O-B are isomorphic and det(id-A) = det(id-B).	[Matsumoto, Kengo] Joetsu Univ Educ, Dept Math, Joetsu, Niigata 9438512, Japan; [Matui, Hiroki] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Matsumoto, K (reprint author), Joetsu Univ Educ, Dept Math, Joetsu, Niigata 9438512, Japan.	kengo@juen.ac.jp; matui@math.s.chiba-u.ac.jp					Giordano T, 1995, J REINE ANGEW MATH, V469, P51; CUNTZ J, 1980, INVENT MATH, V56, P251, DOI 10.1007/BF01390048; BOWEN R, 1977, ANN MATH, V106, P73, DOI 10.2307/1971159; Boyle M, 1996, ISRAEL J MATH, V95, P169, DOI 10.1007/BF02761039; Boyle M, 1998, J MATH SOC JPN, V50, P317, DOI 10.2969/jmsj/05020317; CUNTZ J, 1981, INVENT MATH, V63, P25, DOI 10.1007/BF01389192; Franks J., 1984, ERGOD THEOR DYN SYST, V4, P53, DOI 10.1017/S0143385700002261.; HUANG DR, 1995, J REINE ANGEW MATH, V462, P185; HUANG DR, 1994, ERGOD THEOR DYN SYST, V14, P695; Lind D., 1995, INTRO SYMBOLIC DYNAM; Matsumoto K, 2010, PAC J MATH, V246, P199; Matsumoto K., 1205, PREPRINT; Matsumoto K, 2013, P AM MATH SOC, V141, P2329; Matsumoto K, 2013, DISCRETE CONT DYN-A, V33, P3753, DOI 10.3934/dcds.2013.33.3753; Matui H, 2012, P LOND MATH SOC, V104, P27, DOI 10.1112/plms/pdr029; Matui H, 2015, J REINE ANGEW MATH, V705, P35, DOI 10.1515/crelle-2013-0041; PARRY W, 1975, TOPOLOGY, V14, P297; Renault J., 2008, IRISH MATH SOC B, V61, P29; Rordam M., 1995, K-THEORY, V9, P31, DOI 10.1007/BF00965458; Tomiyama J, 1996, PAC J MATH, V173, P571	20	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	WIN	2014	54	4					863	877		10.1215/21562261-2801849		15	Mathematics	Mathematics	AU9BP	WOS:000345887100007		
J	Arnett, JJ; Zukauskiene, R; Sugimura, K				Arnett, Jeffrey J.; Zukauskiene, Rita; Sugimura, Kazumi			The new life stage of emerging adulthood at ages 18-29 years: implications for mental health	LANCET PSYCHIATRY			English	Article							UNITED-STATES; SOCIAL SUPPORT; JAPAN; UNEMPLOYMENT; DEPRESSION; LONG; HIKIKOMORI; SYMPTOMS; PEOPLE; WOMEN	Since 1960 demographic trends towards longer time in education and late age to enter into marriage and of parenthood have led to the rise of a new life stage at ages 18-29 years, now widely known as emerging adulthood in developmental psychology. In this review we present some of the demographics of emerging adulthood in high-income countries with respect to the prevalence of tertiary education and the timing of parenthood. We examine the characteristics of emerging adulthood in several regions (with a focus on mental health implications) including distinctive features of emerging adulthood in the USA, unemployment in Europe, and a shift towards greater individualism in Japan.	[Arnett, Jeffrey J.] Clark Univ, Worcester, MA 01610 USA; [Zukauskiene, Rita] Mykolas Romeris Univ, Inst Psychol, Vilnius, Lithuania; [Sugimura, Kazumi] Hiroshima Univ, Grad Sch Educ, Hiroshima, Japan	Arnett, JJ (reprint author), Clark Univ, Dept Psychol, 950 Main St, Worcester, MA 01610 USA.	arnett@jeffreyarnett.com			European Social Fund under the Global Grant measure; Japan Society for the Promotion of Science [24530823]	RZ was funded by the European Social Fund under the Global Grant measure and KS was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), 24530823.	Adachi T, 2006, JAPAN LABOR REV, V3, P28; Andrews JA, 2014, OXFORD HDB EMERGING; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Axelsson L, 2002, INT J SOC WELF, V11, P111, DOI 10.1111/1468-2397.00205; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037//0003-066X.55.5.469; Hamamura T, 2012, PERS SOC PSYCHOL REV, V16, P3, DOI 10.1177/1088868311411587; Kessler RC, 2005, BIOL PSYCHIAT, V58, P668, DOI 10.1016/j.biopsych.2005.04.034; Rosenberger N, 2007, CHILD DEV PERSPECT, V1, P92; Dooley D, 2000, J HEALTH SOC BEHAV, V41, P421, DOI 10.2307/2676295; Bjarnason T, 2003, SOC SCI MED, V56, P973, DOI 10.1016/S0277-9536(02)00109-0; Arnett JJ, 1998, HUM DEV, V41, P295, DOI 10.1159/000022591; Mossakowski KN, 2009, AM J PUBLIC HEALTH, V99, P1826, DOI 10.2105/AJPH.2008.152561; Rothbaum F, 2000, CHILD DEV, V71, P1121, DOI 10.1111/1467-8624.00214; Macek P, 2007, J ADOLESCENT RES, V22, P444, DOI 10.1177/0743558407305417; Pettit JW, 2011, J FAM PSYCHOL, V25, P127, DOI 10.1037/a0022320; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Arnett J. J., 2011, BRIDGING CULTURAL DE, P255; Arnett J. J., 2012, CLARK U POLL EMERGIN; Arnett J. J., 2014, EMERGING ADULTHOOD W; Arnett JJ, 2007, CURR HIST, V106, P130; Cabinet Office, 2012, WHIT PAP SUIC PREV J; Cabinet Office, 2012, WHIT PAP CHILDR YOUN; Central Council for Education, 1996, 21SEIKI WO TENB SHIT; Central Intelligence Agency US, WORLD FACTB MOTH MEA; Cohen Dov, 2007, HDB CULTURAL PSYCHOL; Douglass CB, CHILD DEV PERS, V1, P101; Erikson E. H., 1950, CHILDHOOD SOC; Eurostat European Commission, 2009, YOUTH EUR STAT PORTR; Furlong A, SOCIOL REV, V208, P309; Furuhashi T, 2013, EVOL PSYCHIATR, V78, P249, DOI 10.1016/j.evopsy.2013.01.016; Hamalainen J, 2005, NORD J PSYCHIAT, V59, P486, DOI 10.1080/08039480500360872; Kato TA, 2011, LANCET, V378, P1070, DOI 10.1016/S0140-6736(11)61475-X; Masten A. S., 2006, EMERGING ADULTS AM C, P173, DOI DOI 10.1037/11381-007; Mathews TJ, 2009, NCHS DATA BRIEF, V21, P1; McGill B, 2013, NATL J, P14; Ministry of Health Labour and Welfare, 2013, HEIS 23 NEN BAN HAR; Modell J., 1998, ONES OWN YOUTH ADULT; Moran P, 2012, LANCET, V379, P198; Moreno Minguez A., 2012, TRANSITION ADULTHOOD; Moreno Minguez A, 2012, YOUNG, V20, P19, DOI DOI 10.1177/110330881102000102; National Institute of Population and Social Security Research, 2009, 14 JAP NAT FERT SURV; National Institute of Population and Social Security Research, POP STAT JAP; Nelson LJ, OXFORD HDB IN PRESS; OECD, 2014, OECD STAT SHORT TERM; Patton GC, LANCET, V383, P1404; Schwartz SJ, 2014, OXFORD HDB EMERGING; Shirai T, 2013, INT J EDUC VOCAT GUI, V13, P95, DOI 10.1007/s10775-013-9241-3; Shulman S, 2013, EMERG ADULTHOOD, V1, P27; Stroud C, 2013, IMPROVING HLTH SAFET; Sugimura K, 2009, INT J BEHAV DEV, V33, P77, DOI 10.1177/0165025408098010; Syed M, 2014, OXFORD HDB EMERGING; Tanner JJ., 2014, OXFORD HDB EMERGING; Tanner Jennifer L, 2013, Adolesc Med State Art Rev, V24, P485; United Nations Development Programme, HUM DEP REP 2013 RIS	54	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2215-0374			LANCET PSYCHIAT	Lancet Psychiatry	DEC	2014	1	7					569	576				8	Psychiatry	Psychiatry	AU5GR	WOS:000345635600027		
J	Fujita, K; Nagamine, S; Ide, Y; Umezawa, Y; Hosono, T; Kayanne, H; Yamano, H				Fujita, Kazuhiko; Nagamine, Sakie; Ide, Yoichi; Umezawa, Yu; Hosono, Takashi; Kayanne, Hajime; Yamano, Hiroya			Distribution of large benthic foraminifers around a populated reef island: Fongafale Island, Funafuti Atoll, Tuvalu	MARINE MICROPALEONTOLOGY			English	Article						Atolls; Distribution; Foraminifera; South Pacific (Tuvalu); Funafuti Atoll; Water quality	GREAT-BARRIER-REEF; MARGINOPORA-VERTEBRALIS; SYMBIONT-BEARING; WATER-QUALITY; CORAL-REEF; FRENCH-POLYNESIA; ENIWETOK ATOLL; SOUTH-PACIFIC; AMPHISTEGINA; GROWTH	Low-lying, small reef islands on Pacific atolls are vulnerable to coastal erosion and flooding, mainly due to rises in sea level, as well as local stresses associated with overpopulation. Because reef island sediments on Pacific atolls are composed mostly of shells of large benthic foraminifers (LBFs), their future stability depends on understanding foraminiferal shell sources and their production rates around the islands. Here, we report on the distribution and population density of LBFs around Fongafale Island, the main populated island of Tuvalu in the South Pacific, where coastal erosion and inundation have occurred. We discuss their controlling factors, in particular, anthropogenic influences on foraminiferal distribution. The results based on multivariate analyses (canonical correlation analysis and multiple regression analysis) demonstrated that Baculogypsina sphaerulata and Amphistegina lobifera were more common on the high-energy, intertidal ocean reef flats (<= 10(6) and <= 10(4) individuals m(-2), respectively), and B. sphaerulata was less common around the populated area of the island. On the relatively low-energy subtidal lagoon reef flats, Amphistegina lessonii was the most common species, particularly in the dry (leeward) season, with an increasing density in deeper offshore zones (<= 10(4) individuals m(-2)). Sorites orbiculus was less common than the other species, but was found on both sides of the reef flats (<= 10(3) individuals m(-2)). Macroalgal delta N-15 values indicated that upwelling nutrient-rich deep water could be the source of nitrogen for oceanic waters, whereas nutrients in lagoon seawater could be partly derived from groundwater mixing with domestic wastewater, especially near the populated area. These results suggest that the distribution and population density of LBFs in the study area are influenced by spatial differences in water energy and water quality, and that B. sphaerulata is less tolerant of nutrient loading than other species. Comparison of distributions between living individuals and empty shells indicated that ocean reef flats are the primary source of foraminiferal shells for reef islands and lagoon beaches. (C) 2014 Elsevier B.V. All rights reserved.	[Fujita, Kazuhiko; Nagamine, Sakie] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 9030213, Japan; [Ide, Yoichi] Ocean Planning Corp, Fukuoka 8190165, Japan; [Umezawa, Yu] Nagasaki Univ, Fac Fisheries, Nagasaki 8528521, Japan; [Hosono, Takashi; Kayanne, Hajime] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yamano, Hiroya] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan	Fujita, K (reprint author), Univ Ryukyus, Dept Phys & Earth Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	fujitaka@sci.u-ryukyu.ac.jp	Kayanne, Hajime/F-3025-2012	Kayanne, Hajime/0000-0002-6382-095X	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [A-0805]; JST/JICA SATREPS [0808918]	This research was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan (Project no. A-0805, PI: H. Yamano) and JST/JICA SATREPS (0808918, PI: H. Kayanne). We greatly appreciate the Department of Fisheries and the Government of Tuvalu for the permission and coordination of our research. We thank S. Inoue for carrying out the field survey.	Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Resig JM, 2004, MAR MICROPALEONTOL, V50, P225, DOI 10.1016/S0377-8398(03)00073-2; Woodroffe CD, 2008, GLOBAL PLANET CHANGE, V62, P77, DOI 10.1016/j.gloplacha.2007.11.001; Hohenegger J, 2004, J FORAMIN RES, V34, P9, DOI 10.2113/0340009; Koukousioura O, 2011, J MARINE SYST, V88, P489, DOI 10.1016/j.jmarsys.2011.06.004; Fujita M, 2013, SUSTAIN SCI, V8, P381, DOI 10.1007/s11625-013-0204-x; Perry CT, 2011, GLOBAL CHANGE BIOL, V17, P3679, DOI 10.1111/j.1365-2486.2011.02523.x; HALLOCK P, 1985, PALEOBIOLOGY, V11, P195; Sinutok S, 2013, MAR ECOL PROG SER, V478, P127, DOI 10.3354/meps10187; Reymond CE, 2013, GLOBAL CHANGE BIOL, V19, P291, DOI 10.1111/gcb.12035; Fujita M, 2014, CHEMOSPHERE, V95, P628, DOI 10.1016/j.chemosphere.2013.10.023; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Hallock P, 2003, ENVIRON MONIT ASSESS, V81, P221, DOI 10.1023/A:1021337310386; Fabricius KE, 2012, MAR POLLUT BULL, V65, P320, DOI 10.1016/j.marpolbul.2011.09.004; Bicchi E, 2002, CORAL REEFS, V21, P275, DOI 10.1007/s00338-002-0245-6; Carilli J, 2012, MAR ECOL PROG SER, V456, P87, DOI 10.3354/meps09684; Chapman F, 1902, J LINNAEAN SOC ZOOLO, V28, P379; CHARPYROUBAUD CJ, 1990, MAR BIOL, V107, P67, DOI 10.1007/BF01313243; Collen J, 1996, J MICROPALAEONTOL, V15, P130; Collen J.D, 1995, P S PURE MATH, P1; Collen JD, 2004, CORAL REEFS, V23, P445, DOI 10.1007/s00338-004-0396-8; Cushman J.A., 1954, GEOL SURV PROF PAP H, V260-H, P319; Ebrahim MT, 2000, T GEOBIOL, V15, P105; Emery K.O., 1954, GEOLOGY BIKINI NEA 1; Fujita K, 2009, CORAL REEFS, V28, P29, DOI 10.1007/s00338-008-0441-0; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; HALLOCK P, 1981, Journal of Foraminiferal Research, V11, P40; HALLOCK P, 1981, MAR BIOL, V62, P249, DOI 10.1007/BF00397691; HALLOCK P, 1986, J FORAMIN RES, V16, P224; HALLOCK P, 1981, J SEDIMENT PETROL, V51, P467; HIRSHFIE.HI, 1968, J PROTOZOOL, V15, P497, DOI 10.1111/j.1550-7408.1968.tb02162.x; HOHENEGGER J, 1994, PSZNI MAR ECOL, V15, P291; Kendall C, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P519; KOTLER E, 1992, Palaios, V7, P244, DOI 10.2307/3514972; LEE JJ, 1991, MAR BIOL, V109, P417, DOI 10.1007/BF01313507; Mimura N, 2007, CLIMATE CHANGE 2007, P687; Nakada S, 2012, GROUND WATER, V50, P639, DOI 10.1111/j.1745-6584.2011.00874.x; Osawa Y, 2010, MAR POLLUT BULL, V60, P1279, DOI 10.1016/j.marpolbul.2010.03.014; Patel SS, 2006, NATURE, V440, P734, DOI 10.1038/440734a; R Development Core Team, 2011, R LANG ENV STAT COMP; Reymond CE, 2011, MAR ECOL PROG SER, V435, P97, DOI 10.3354/meps09172; ROTTGER R, 1990, MAR BIOL, V106, P419, DOI 10.1007/BF01344322; Sammarco PW, 1999, MAR ECOL PROG SER, V180, P131, DOI 10.3354/meps180131; Hallock P, 1999, MODERN FORAMINIFERA, P123; Todd R., 1961, GEOL SURV PROF PAP H, V354-H, P171; Tudhope A.W., 1985, P 5 INT COR REEF C, V6, P611; Uthicke S, 2010, LIMNOL OCEANOGR, V55, P1681, DOI 10.4319/lo.2010.55.4.1681; Uthicke S, 2008, ESTUAR COAST SHELF S, V78, P763, DOI 10.1016/j.ecss.2008.02.014; WEBB KL, 1975, LIMNOL OCEANOGR, V20, P198; WETMORE KL, 1992, J FORAMIN RES, V22, P1; Woodroffe CD, 2001, CATENA, V44, P245, DOI 10.1016/S0341-8162(01)00135-7; Yamano H, 2007, GLOBAL PLANET CHANGE, V57, P407, DOI 10.1016/j.gloplacha.2007.02.007; Yamano H, 2002, MAR GEOL, V185, P233, DOI 10.1016/S0025-3227(02)00188-3; Yamano H., 2005, GLOBAL ENV RES, V9, P9	54	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0377-8398	1872-6186		MAR MICROPALEONTOL	Mar. Micropaleontol.	DEC	2014	113						1	9		10.1016/j.marmicro.2014.08.008		9	Paleontology	Paleontology	AU8YN	WOS:000345879400001		
J	McCartney, K; Witkowski, J; Jordan, RW; Daugbjerg, N; Malinverno, E; van Wezel, R; Kano, H; Abe, K; Scott, F; Schweizer, M; Young, JR; Hallegraeff, GM; Shiozawa, A				McCartney, Kevin; Witkowski, Jakub; Jordan, Richard W.; Daugbjerg, Niels; Malinverno, Elisa; van Wezel, Rene; Kano, Hiroya; Abe, Kenta; Scott, Fiona; Schweizer, Magali; Young, Jeremy R.; Hallegraeff, Gustaaf M.; Shiozawa, Ayaka			Fine structure of silicoflagellate double skeletons	MARINE MICROPALEONTOLOGY			English	Article						Apical structure; Basal ring; Dictyocha; Distephanus; Octactis; Silicoflagellates	DICTYOCHA-SPECULUM EHRENB; PIGMENT COMPOSITION; LIFE-HISTORY; MORPHOLOGY; DISTEPHANUS; OCEAN; DICTYOCHOPHYCEAE; HETEROKONT; CORBISEMA; SEA	Silicoflagellate double skeletons are commonly considered to be pre-division stages, even though their life cycle is only partially resolved, especially with respect to reproduction. Double skeletons of the modern silicoflagellate genera Diceyocha Ehrenberg, Distephanus Stohr, and Octactis Schiller are for the first time examined in detail by scanning electron microscopy in order to improve our understanding of how skeletal morphology relates to paired skeletons. A number of genus-specific mechanisms enable sibling skeletons to be held together at their abbasal surfaces, including a zig-zag design of the basal ring achieved via apical structure, strut attachment and pike rotation (in Distephanus and Dictyocha), and the presence of organic material binding the generally planar basal rings (in Octactis). Contrary to what is generally understood, the siblings are not mirror images of one another. Instead, the triple junctions formed by the skeletal elements of each apical structure are transposed across the middle of the dividing cell to produce a copy with the same rotation. Thus, two dome-shaped skeletons represent halves of a more spherical design, which suggests that the role of the silicoflagellate basal ring is to enable double skeleton formation, but the full implications of this have yet to be explored. Although the purpose of double skeleton formation in silicoflagellates remains unclear, observations from the fossil record indicate that differences in the relative alignment of doublet members can have a high significance for phylogeny. Differences in the doublet structure of living silicoflagellates call for a combined biological and geological perspective of the utility of maintaining Dictyocha, Distephanus and Octactis as separate genera. (C) 2014 Elsevier B.V. All rights reserved.	[McCartney, Kevin] Univ Maine Presque Isle, Dept Environm Studies & Sustainabil, Presque Isle, ME 04769 USA; [Witkowski, Jakub] Univ Szczecin, Fac Geosci, Geol & Palaeogeog Unit, PL-70383 Szczecin, Poland; [Jordan, Richard W.; Shiozawa, Ayaka] Yamagata Univ, Dept Earth & Environm Sci, Yamagata 9908560, Japan; [Daugbjerg, Niels] Marine Biol Sect, Dept Biol, DK-2100 Copenhagen O, Denmark; [Malinverno, Elisa] Univ Milano Bicocca, Dept Earth & Environm Sci, I-20126 Milan, Italy; [van Wezel, Rene] Koeman Bijkerk Bv, Ecol Res & Consultancy, NL-9750 AC Haren, Netherlands; [Kano, Hiroya; Abe, Kenta] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 9908560, Japan; [Scott, Fiona] Australian Antarctic Div, Kingston, Tas 7050, Australia; [Schweizer, Magali] ETHZ, Inst Geol, CH-8092 Zurich, Switzerland; [Young, Jeremy R.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Hallegraeff, Gustaaf M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia	McCartney, K (reprint author), Univ Maine Presque Isle, Dept Environm Studies & Sustainabil, Presque Isle, ME 04769 USA.	kevin.mccartney@umpi.edu	Daugbjerg, Niels/D-3521-2014; Schweizer, Magali/F-9358-2014	Daugbjerg, Niels/0000-0002-0397-3073; Schweizer, Magali/0000-0001-5115-1616	Dutch Directorate-General; Danish Centre for Marine Research; VILLUM FONDEN; NAACOS; University of Maine at Presque Isle; Foundation for Polish Science (START Programme)	We are grateful to Bert Wetsteyn for permission to use the Lake Grevelingen samples, which were taken within the Framework for Water Quality Monitoring, funded by the Dutch Directorate-General for Public Works and Water Management. The East Greenland samples were provided by Diana Krawczyk as part of the 6261PETAX project with Kristine Arendt and Thomas Juul-Pedersen (Greenland Climate Research Centre). Samples from the North Adriatic were collected by personnel of Istituto Nazionale di Oceanografia e di Geofisica Sperimentale (OGS) Oceanography Section in a Long Term Ecological Research (LTER) coastal site, also within the MEDSEA project carried out within the European Union 7th Framework Programme. The HOT series group, Mara Cortes, Hans Thierstein, Kate Darling, Hartmut Schulz and the crew of the R/V Meteor are thanked for providing the material from Hawaii and the Arabian Sea. Many people took water samples that supplied double skeletons used in this study, including the following: M. Ikehara and K. Katsuki (KH07-4, Leg 3), S. Konno, Y. Arai, S. Saito and H. Narita (Bosei Maru cruise) and N. Harada, A. Kurasawa, and M. Sato (MR08-6, Leg 2). David Mann, David Williams, Horst Lange-Bertalot, Anton Joosten, Paulian Dumitrica and Andre Rigual-Hernandez provided comments and information that improved this paper. Manfred Ruppel, Izabela Zglobicka and Przemyslaw Dabek assisted with the SEM photography and Yuko Fukunaga and Susumu Konno provided SEM photographs that were examined but not published in this article. Ewa Gorecka and Marta M. Krzywda helped find Greenland specimens for LM observation. The Danish Centre for Marine Research, VILLUM FONDEN and NAACOS provided financial support for Niels Daugbjerg. Samples from the Southwest Pacific were collected within the Abioclear (Italian PNRA) project. Rick van den Enden, Electron Microscope Unit, Australian Antarctic Division provided facilities and assistance. Andrzej Witkowski, Genowefa Daniszewska-Kowalczyk and Agnieszka Kierzek of the Palaeoceanography Unit, Faculty of Geosciences, University of Szczecin, provided facilities and assistance. This project was supported in part by a sabbatical from the University of Maine at Presque Isle. Additional financial support for Jakub Witkowski was provided by the Foundation for Polish Science (START Programme).	Daugbjerg N, 2001, J PHYCOL, V37, P1110, DOI 10.1046/j.1529-8817.2001.01061.x; McCartney Kevin, 2014, Revue de Micropaleontologie, V57, P75, DOI 10.1016/j.revmic.2014.05.001; McCartney Kevin, 2011, Revue de Micropaleontologie, V54, P31, DOI 10.1016/j.revmic.2010.08.002; Onodera J, 2012, DEEP-SEA RES PT II, V61-64, P4, DOI 10.1016/j.dsr2.2011.03.004; BONEY AD, 1976, J MAR BIOL ASSOC UK, V56, P263; Chang FH, 2012, PHYCOLOGIA, V51, P403, DOI 10.2216/10-104.1; ALMGREN FJ, 1976, SCI AM, V235, P82; McCartney K, 2010, MAR MICROPALEONTOL, V77, P83, DOI 10.1016/j.marmicro.2010.08.001; HENRIKSEN P, 1993, PHYCOLOGIA, V32, P29, DOI 10.2216/i0031-8884-32-1-29.1; Davidson AT, 2010, DEEP-SEA RES PT II, V57, P828, DOI 10.1016/j.dsr2.2009.02.011; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; Rigual-Hernandez AS, 2010, MAR MICROPALEONTOL, V77, P46, DOI 10.1016/j.marmicro.2010.07.003; BONEY AD, 1973, J MAR BIOL ASSOC UK, V53, P263; Boney A.D., 1981, J MAR BIOL ASSOC UK, V56, P1027; Borgert A. H. C., 1891, Z WISS ZOOL, V51, P629; Bukry D., 1982, Initial Reports of the Deep Sea Drilling Project, V68, P311; Bukry D., 1973, INIT REPTS DSDP, V16, P815; Bukry D., 1976, Initial Rep Deep Sea Drilling Project, V34, P715; Cefarelli AO, 2011, DEEP-SEA RES PT II, V58, P1436, DOI 10.1016/j.dsr2.2010.11.023; Deflandre G., 1950, MICROSCOPIE, V2, P191; Deflandre G., 1950, Microscope Paris, V2, P72; Deflandre G., 1950, MICROSCOPIE, V2, p[117, 191]; Desikachary T.V., 1996, BIBL PHYCOL, V100; Dumitrica Paulian, 2014, Revue de Micropaleontologie, V57, P57, DOI 10.1016/j.revmic.2014.04.001; Dumitrica P., 1978, BIBL PHYCOL, P207; Gemeinhardt K., 1930, KRYPTOGAMEN FLORA DE, V10, P1; Haeckel E., 1887, REPORT SCI RESULTS V, V18, P1; Hag B. U., 1978, INTRO MARINE MICROPA, P267; Hallegraeff Gustaaf M., 2005, P251; HOVASSE RAYMOND, 1932, BULL BIOL FRANCE ET BELGIQUE, V66, P447; Hovasse R., 1946, Resultats de Campagnes Scientifiques Monaco Fasc, V107, P1; JOCHEM F, 1989, MAR BIOL, V103, P373, DOI 10.1007/BF00397272; Lemmermann C., 1908, NORDISCHES PLANKTON, V21, P25; LING HY, 1985, MICROPALEONTOLOGY, V31, P76, DOI 10.2307/1485583; Malinverno E, 2010, MAR MICROPALEONTOL, V77, P154, DOI 10.1016/j.marmicro.2010.09.002; Marshall S. M., 1934, Scientific Reports Great Barrier Reef Expedition, V4, P623; MCCARTNEY K, 1992, MICROPALEONTOLOGY, V38, P87, DOI 10.2307/1485845; MCCARTNEY K, 1989, PALEOBIOLOGY, V15, P283; McCartney K., 2014, J MICROPALAEONTOL; McCartney K., 1995, SCI RESULTS, V138, P129; McCartney K, 2010, J MICROPALAEONTOL, V29, P185, DOI 10.1144/0262-821X09-020; McCartney K., 1990, SCI RESULTS, V113, P427; Mobius K., 1887, BERICHT KOMMISSION W, V5, P109; Moestrup O., 1990, BIOL SKRIFTER, V37, P1; O'Kane J.A., 1970, THESIS SAN JOSE STAT; POELCHAU H S, 1976, Micropaleontology (New York), V22, P164, DOI 10.2307/1485399; PREISIG HR, 1994, PROTOPLASMA, V181, P29, DOI 10.1007/BF01666387; SCHULZ PAUL, 1928, BAT ARCHIR, V21, P225; Takahashi K, 2009, MICROPALEONTOLOGY, V55, P313; Takahashi K., 1992, Deep-Sea Research Part A Oceanographic Research Papers, V39, P327; Tampieri R., 1972, GIORN GEOL, V38, P375; Thompson DW, 1942, GROWTH FORM; Van Valkenburg S. D., 1980, PHYTOFLAGELLATES, P335; VANVALKE.SD, 1970, J PHYCOL, V6, P48	54	3	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0377-8398	1872-6186		MAR MICROPALEONTOL	Mar. Micropaleontol.	DEC	2014	113						10	19		10.1016/j.marmicro.2014.08.006		10	Paleontology	Paleontology	AU8YN	WOS:000345879400002		
J	Gonda, T; Machihara, S; Ozawa, T				Gonda, Takuya; Machihara, Shuji; Ozawa, Tohru			On the semilinear Schrodinger equation with time dependent coefficients	MATHEMATISCHE NACHRICHTEN			English	Article						Nonlinear Schrodinger equation; time dependent coefficient; Lorentz space	SPACES; SCATTERING	We consider nonlinear Schrodinger equation with time dependent coefficients. Fanelli [5] found a transformation between solutions of the original equation and of the usual Schrodinger equation with power nonlinearity involving time dependent coefficients in some Lorentz spaces. In this paper we extend the results in [5] in space-time integrability properties of solutions. Particularly, we prove that the existence and uniqueness of solutions can be described exclusively in terms of Lebesgue spaces (not Lorentz spaces as in [5]) as far as the space integrability of solutions. We also discuss the equation with coefficient of an explicit homogeneous function and describe the associated Strichartz estimate and contraction mapping argument.	[Gonda, Takuya] Kawagoe High Sch, Saitama 3500053, Japan; [Machihara, Shuji] Saitama Univ, Fac Educ, Dept Math, Saitama 3388570, Japan; [Ozawa, Tohru] Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan	Machihara, S (reprint author), Saitama Univ, Fac Educ, Dept Math, Saitama 3388570, Japan.	p-rog.1232@docomo.ne.jp; machihar@rimath.saitama-u.ac.jp; txozawa@waseda.jp					Ahn C, 2005, P AM MATH SOC, V133, P3497, DOI 10.1090/S0002-9939-05-07891-3; ONEIL R, 1963, DUKE MATH J, V30, P129, DOI 10.1215/S0012-7094-63-03015-1; Nakanishi K, 2002, NODEA-NONLINEAR DIFF, V9, P45, DOI 10.1007/s00030-002-8118-9; Nakamura M, 1997, REV MATH PHYS, V9, P397; Nakanishi K, 2001, SIAM J MATH ANAL, V32, P1265, DOI 10.1137/S0036141000369083; KATO T, 1989, LECT NOTES PHYS, V345, P218; Kato T, 1995, J ANAL MATH, V67, P281, DOI 10.1007/BF02787794; Keel M, 1998, AM J MATH, V120, P955, DOI 10.1353/ajm.1998.0039; BERGH J., 1976, INTERPOLATION SPACES; CAZENAVE T, 1990, NONLINEAR ANAL-THEOR, V14, P807, DOI 10.1016/0362-546X(90)90023-A; Cazenave T., 2003, COURANT LECT NOTES M, V10; Fanelli L, 2009, MATH NACHR, V282, P976, DOI 10.1002/mana.200610784; Hunt R., 1966, ENSEIGN MATH, V12, P249; Machihara S, 2013, HOKKAIDO MATH J, V42, P247; Ozawa T, 2006, CALC VAR PARTIAL DIF, V25, P403, DOI 10.1007/s00526-005-0349-2	15	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0025-584X	1522-2616		MATH NACHR	Math. Nachr.	DEC	2014	287	17-18					1986	2001		10.1002/mana.201200108		16	Mathematics	Mathematics	AU8CM	WOS:000345824200005		
J	Terauchi, M; Hirose, A; Akiyoshi, M; Owa, Y; Kato, K; Kubota, T				Terauchi, Masakazu; Hirose, Asuka; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro			Prevalence and Determinants of Lower Urinary Tract Symptoms in Periand Postmenopausal Women	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Meeting Abstract	25th Annual Meeting of the North-American-Menopause-Society	OCT 15-18, 2014	Washington, DC	N Amer Menopause Soc					[Terauchi, Masakazu] Tokyo Med & Dent Univ, Dept Womens Hlth, Tokyo, Japan; [Hirose, Asuka; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro] Tokyo Med & Dent Univ, Dept Obstet & Gynecol, Tokyo, Japan			Terauchi, Masakazu/D-9831-2013	Terauchi, Masakazu/0000-0001-5577-0094				0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	DEC	2014	21	12				S-2	1326	1326				1	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8KY	WOS:000345846600041		
J	Ueno, T; Tousen, Y; Uchiyama, S; Iwashita, S; Jenks, BH; Ishimi, Y				Ueno, Tomomi; Tousen, Yuko; Uchiyama, Shigeto; Iwashita, Soh; Jenks, Belinda H.; Ishimi, Yoshiko			S-equol and the Fermented Soy Food Containing S-equol (SE5-OH) effect on Bone Loss, Blood Flow, and Mammary Estradiol Levels in Ovariectomized Rats	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Meeting Abstract	25th Annual Meeting of the North-American-Menopause-Society	OCT 15-18, 2014	Washington, DC	N Amer Menopause Soc					[Ueno, Tomomi; Uchiyama, Shigeto] Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan; [Tousen, Yuko; Ishimi, Yoshiko] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Iwashita, Soh; Jenks, Belinda H.] Pharmavite LLC, Sci Affairs, Northrige, CA USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	DEC	2014	21	12				P-29	1341	1342				2	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8KY	WOS:000345846600091		
J	Hirose, A; Terauchi, M; Tamura, M; Akiyoshi, M; Owa, Y; Kato, K; Kubota, T				Hirose, Asuka; Terauchi, Masakazu; Tamura, Moe; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro			Tomato juice intake lowers serum triglycerides and blood pressure in midlife women	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Meeting Abstract	25th Annual Meeting of the North-American-Menopause-Society	OCT 15-18, 2014	Washington, DC	N Amer Menopause Soc					[Hirose, Asuka; Terauchi, Masakazu; Tamura, Moe; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	DEC	2014	21	12				P-55	1349	1349				1	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8KY	WOS:000345846600116		
J	Hirose, A; Terauchi, M; Akiyoshi, M; Owa, Y; Kato, K; Kubota, T				Hirose, Asuka; Terauchi, Masakazu; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro			Low-dose isoflavone aglycone supplement alleviates menopausal symptoms: a randomized, double-blind, placebo-controlled study	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Meeting Abstract	25th Annual Meeting of the North-American-Menopause-Society	OCT 15-18, 2014	Washington, DC	N Amer Menopause Soc					[Hirose, Asuka; Terauchi, Masakazu; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	DEC	2014	21	12				P-54	1349	1349				1	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8KY	WOS:000345846600115		
J	Hirose, A; Terauchi, M; Akiyoshi, M; Owa, Y; Kato, K; Kubota, T				Hirose, Asuka; Terauchi, Masakazu; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro			Oxidative stress is associated with depression in midlife women	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Meeting Abstract	25th Annual Meeting of the North-American-Menopause-Society	OCT 15-18, 2014	Washington, DC	N Amer Menopause Soc					[Hirose, Asuka; Terauchi, Masakazu; Akiyoshi, Mihoko; Owa, Yoko; Kato, Kiyoko; Kubota, Toshiro] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	DEC	2014	21	12				P-56	1350	1350				1	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8KY	WOS:000345846600117		
J	Uchiyama, S; Ueno, T; Iwashita, S; Brooks, J; Aso, T				Uchiyama, Shigeto; Ueno, Tomomi; Iwashita, Soh; Brooks, James; Aso, Takeshi			A Pilot Study of S-equol Supplement (SE5-OH) on Reproductive Health in Postmenopausal Japanese Women	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Meeting Abstract	25th Annual Meeting of the North-American-Menopause-Society	OCT 15-18, 2014	Washington, DC	N Amer Menopause Soc					[Uchiyama, Shigeto; Ueno, Tomomi; Iwashita, Soh] Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan; [Iwashita, Soh; Brooks, James] Pharmavite LLC, Sci Affairs, Northrige, CA USA; [Aso, Takeshi] Tokyo Med & Dent Univ, Tokyo, Japan; [Aso, Takeshi] Kyoundo Hosp, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	DEC	2014	21	12				P-107	1365	1365				1	Obstetrics & Gynecology	Obstetrics & Gynecology	AU8KY	WOS:000345846600168		
J	Lin, YT; El Goresy, A; Hu, S; Zhang, JC; Gillet, P; Xu, YC; Hao, JL; Miyahara, M; Ouyang, ZY; Ohtani, E; Xu, L; Yang, W; Feng, L; Zhao, XC; Yang, J; Ozawa, S				Lin, Yangting; El Goresy, Ahmed; Hu, Sen; Zhang, Jianchao; Gillet, Philippe; Xu, Yuchen; Hao, Jialong; Miyahara, Masaaki; Ouyang, Ziyuan; Ohtani, Eiji; Xu, Lin; Yang, Wei; Feng, Lu; Zhao, Xuchao; Yang, Jing; Ozawa, Shin			NanoSIMS analysis of organic carbon from the Tissint Martian meteorite: Evidence for the past existence of subsurface organic-bearing fluids on Mars	METEORITICS & PLANETARY SCIENCE			English	Article							INTERPLANETARY DUST PARTICLES; ISOTOPIC COMPOSITION; MELT INCLUSIONS; SNC METEORITES; ATMOSPHERE; WATER; EVOLUTION; METHANE; MATTER; HYDROCARBONS	Two petrographic settings of carbonaceous components, mainly filling open fractures and occasionally enclosed in shock-melt veins, were found in the recently fallen Tissint Martian meteorite. The presence in shock-melt veins and the deuterium enrichments (delta D up to +1183 parts per thousand) of these components clearly indicate a pristine Martian origin. The carbonaceous components are kerogen-like, based on micro-Raman spectra and multielemental ratios, and were probably deposited from fluids in shock-induced fractures in the parent rock of Tissint. After precipitation of the organic matter, the rock experienced another severe shock event, producing the melt veins that encapsulated a part of the organic matter. The C isotopic compositions of the organic matter (delta C-13 = -12.8 to -33.1 parts per thousand) are significantly lighter than Martian atmospheric CO2 and carbonate, providing a tantalizing hint for a possible biotic process. Alternatively, the organic matter could be derived from carbonaceous chondrites, as insoluble organic matter from the latter has similar chemical and isotopic compositions. The presence of organic-rich fluids that infiltrated rocks near the surface of Mars has significant implications for the study of Martian paleoenvironment and perhaps to search for possible ancient biological activities on Mars.	[Lin, Yangting; Hu, Sen; Zhang, Jianchao; Xu, Yuchen; Hao, Jialong; Yang, Wei; Feng, Lu; Zhao, Xuchao] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Earth & Planetary Phys, Beijing 100029, Peoples R China; [El Goresy, Ahmed] Univ Bayreuth, Bayer Geoinst, D-95447 Bayreuth, Germany; [Gillet, Philippe] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Miyahara, Masaaki; Ohtani, Eiji; Ozawa, Shin] Tohoku Univ, Inst Mineral Petrol & Econ Geol, Grad Sch Sci, Sendai, Miyagi 9808578, Japan; [Ouyang, Ziyuan] Chinese Acad Sci, Inst Geochem, Guiyang, Peoples R China; [Xu, Lin] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China; [Yang, Jing] Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou, Guangdong, Peoples R China	Lin, YT (reprint author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Earth & Planetary Phys, Beijing 100029, Peoples R China.	linyt@mail.igcas.ac.cn	Lin, Yangting/A-8845-2015; Ahirwal, Ashish/B-8886-2015; 	Ahirwal, Ashish/0000-0002-8247-9793; Miyahara, Masaaki/0000-0002-4404-9813	Chinese Academy of Science; National Science Foundation of China [40830421, 41221002, 41430105]	The constructive reviews by three anonymous reviewers, the AE C. Floss, and the Editor T. Jull are very helpful to improve the manuscript. We thank Gangjian Wei and Lianjun Feng for the isotopic measurements of the graphite standards and the coal working reference. This work was supported by Chinese Academy of Science and National Science Foundation of China (40830421, 41221002, 41430105).	Aleon J., 2001, Geochimica et Cosmochimica Acta, V65, DOI 10.1016/S0016-7037(01)00720-7; Alexander CMO, 2007, GEOCHIM COSMOCHIM AC, V71, P4380, DOI 10.1016/j.gca.2007.06.052; Kerr RA, 2012, SCIENCE, V338, P733, DOI 10.1126/science.338.6108.733; Flynn GJ, 1996, EARTH MOON PLANETS, V72, P469, DOI 10.1007/BF00117551; Stoker CR, 1997, J GEOPHYS RES-PLANET, V102, P10881, DOI 10.1029/97JE00667; Agee CB, 2013, SCIENCE, V339, P780, DOI 10.1126/science.1228858; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Schwab V, 2005, GEOCHIM COSMOCHIM AC, V69, P1825, DOI 10.1016/j.gca.2004.09.011; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Slodzian G, 2004, APPL SURF SCI, V231, P874, DOI 10.1016/j.apsusc.2004.03.155; Alexander CMO, 2010, GEOCHIM COSMOCHIM AC, V74, P4417, DOI 10.1016/j.gca.2010.05.005; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; Hu S, 2014, GEOCHIM COSMOCHIM AC, V140, P321, DOI 10.1016/j.gca.2014.05.008; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Aoudjehane HC, 2012, SCIENCE, V338, P785, DOI 10.1126/science.1224514; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Martins Z, 2011, ELEMENTS, V7, P35, DOI 10.2113/gselements.7.1.35; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; Usui T, 2012, EARTH PLANET SC LETT, V357, P119, DOI 10.1016/j.epsl.2012.09.008; Niles PB, 2010, SCIENCE, V329, P1334, DOI 10.1126/science.1192863; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; Aleon J, 2003, GEOCHIM COSMOCHIM AC, V67, P3773, DOI 10.1016/S0016-7037(00)00170-4; McCollom TM, 2010, GEOCHIM COSMOCHIM AC, V74, P2717, DOI 10.1016/j.gca.2010.02.008; Shkrob IA, 2010, ASTROBIOLOGY, V10, P425, DOI 10.1089/ast.2009.0433; WOPENKA B, 1993, AM MINERAL, V78, P533; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Duprat J, 2010, SCIENCE, V328, P742, DOI 10.1126/science.1184832; Osterloo MM, 2008, SCIENCE, V319, P1651, DOI 10.1126/science.1150690; Foustoukos DI, 2004, SCIENCE, V304, P1002, DOI 10.1126/science.1096033; Floss C, 2006, GEOCHIM COSMOCHIM AC, V70, P2371, DOI 10.1016/j.gca.2006.01.023; Becker L, 1999, ADV SPACE RES-SERIES, V24, P477, DOI 10.1016/S0273-1177(99)00090-3; BIEMANN K, 1976, SCIENCE, V194, P72, DOI 10.1126/science.194.4260.72; Campbell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002959; El Goresy A, 2013, GEOCHIM COSMOCHIM AC, V101, P233, DOI 10.1016/j.gca.2012.10.002; El Goresy A., 2013, 44 LUN PLAN SCI C; Gillet P, 2002, EARTH PLANET SC LETT, V203, P431, DOI 10.1016/S0012-821X(02)00835-X; Grady M. M., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Hoefs J., 2009, STABLE ISOTOPE GEOCH; Irving A. J., 2012, 43 LUN PLAN SCI C; Keppler F, 2012, NATURE, V486, P93, DOI 10.1038/nature11203; Lepland A., 2010, GREENLAND GEOBIOLOGY, V9, P2; Leshin L.A., 2013, SCIENCE, V341; Li L., 2003, ANAL METHOD ELEMENT; Lin Y., 2013, GOLDSCHM C; Lin Y., 2013, METEORITICS PLANETAR, V48; Lin Y., 2013, 44 LUN PLAN SCI C; Lin Y. T., 2012, METEORIT PLANET SCI, V48, P5131; Mathew KJ, 2003, EARTH PLANET SC LETT, V214, P27, DOI 10.1016/S0012-821X(03)00365-0; Ming D. W., 2014, SCIENCE, V343; Mohapatra R. K., 2009, GEOCHIMICA COSMOCHIM, V73, P1505; Niles PB, 2005, GEOCHIM COSMOCHIM AC, V69, P2931, DOI 10.1016/j.gca.2004.12.012; ORO J, 1979, J MOL EVOL, V14, P153, DOI 10.1007/BF01732374; Pizzarello S., 2006, METEORITES EARLY SOL, P625; Poch O, 2013, PLANET SPACE SCI, V85, P188, DOI 10.1016/j.pss.2013.06.013; Schmidt ME, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003027; Lollar BS, 2008, GEOCHIM COSMOCHIM AC, V72, P4778, DOI 10.1016/j.gca.2008.07.004; Slodzian G, 2004, APPL SURF SCI, V231, P3, DOI 10.1016/j.apsusc.2004.03.015; Zhang JC, 2014, J ANAL ATOM SPECTROM, V29, P1934, DOI 10.1039/c4ja00140k	63	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	DEC	2014	49	12					2201	2218		10.1111/maps.12389		18	Geochemistry & Geophysics	Geochemistry & Geophysics	AU7EE	WOS:000345762800006		
J	Ito, F; Tamiya, T; Ohtsu, I; Fujimura, M; Fukumori, F				Ito, Fumihiro; Tamiya, Takayuki; Ohtsu, Iwao; Fujimura, Makoto; Fukumori, Fumiyasu			Genetic and phenotypic characterization of the heat shock response in Pseudomonas putida	MICROBIOLOGYOPEN			English	Article						Molecular chaperone; protein disaggregation; Pseudomonas putida	TRANSCRIPTION FACTOR SIGMA(32); GRAM-NEGATIVE BACTERIA; DNAK CHAPERONE SYSTEM; ESCHERICHIA-COLI; PROTEIN DISAGGREGATION; MOLECULAR CHAPERONES; AGGREGATED PROTEINS; ATP HYDROLYSIS; NULL MUTANTS; HOST-RANGE	Molecular chaperones function in various important physiological processes. Null mutants of genes for the molecular chaperone ClpB (Hsp104), and those that encode J-domain proteins (DnaJ, CbpA, and DjlA), which may act as Hsp40 co-chaperones of DnaK (Hsp70), were constructed from Pseudomonas putida KT2442 (KT) to elucidate their roles. The KTclpB mutant showed the same heat shock response (HSR) as the wild-type, both in terms of heat-shock protein (Hsp) synthesis (other than ClpB) and in hsp gene expression; however, the mutant was quite sensitive to high temperatures and was unable to disaggregate into thermo-mediated protein aggregates, indicating that ClpB is important for cell survival after heat stress and essential for solubilization of protein aggregates. On the other hand, the KTdnaJ mutant was temperature-sensitive, and formed more protein aggregates (especially of high molecular weight) upon heat stress than did KT. P. putida CbpA, a probable Hsp, partially substituted the functions of DnaJ in cell growth and solubilization of thermo-mediated protein aggregates, and might be involved in the HSR which was regulated by a fine-tuning system(s) that could sense subtle changes in the ambient temperature and control the levels of sigma(32) activity and quantity, as well as the mRNA levels of hsp genes.	[Ito, Fumihiro] Toyo Univ, Grad Sch Life Sci, Oura, Gunma 3740193, Japan; [Tamiya, Takayuki; Fujimura, Makoto] Toyo Univ, Fac Life Sci, Oura, Gunma 3740193, Japan; [Ohtsu, Iwao] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Fukumori, Fumiyasu] Toyo Univ, Fac Food & Life Sci, Oura, Gunma 3740193, Japan	Fukumori, F (reprint author), Toyo Univ, Fac Food & Life Sci, 1-1-1 Itakura, Oura, Gunma 3740193, Japan.	fukumori@toyo.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported in part by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry.	Acebron SP, 2008, J BIOL CHEM, V283, P1381, DOI 10.1074/jbc.M706189200; ALLAN B, 1988, J BACTERIOL, V170, P3668; Koo BM, 2009, MOL MICROBIOL, V72, P815, DOI 10.1111/j.1365-2958.2009.06690.x; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; SQUIRES CL, 1991, J BACTERIOL, V173, P4254; Kobayashi Y, 2011, ENVIRON MICROBIOL, V13, P2007, DOI 10.1111/j.1462-2920.2010.02344.x; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; PAEK KH, 1987, J BACTERIOL, V169, P283; YAMAMORI T, 1980, J BACTERIOL, V142, P843; Dubern JF, 2005, J BACTERIOL, V187, P5967, DOI 10.1128/JB.187.17.5967-5976.2005; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Zhao B, 2007, BIOTECHNOL BIOENG, V97, P506, DOI 10.1002/bit.21253; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Timmis KN, 2002, ENVIRON MICROBIOL, V4, P779, DOI 10.1046/j.1462-2920.2002.00365.x; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Venturi V, 2003, MOL MICROBIOL, V49, P1, DOI 10.1046/j.1365-2958.2003.03547.x; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; STRAUS DB, 1987, NATURE, V329, P348, DOI 10.1038/329348a0; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; GRAGEROV A, 1992, P NATL ACAD SCI USA, V89, P10341, DOI 10.1073/pnas.89.21.10341; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Gamer J, 1996, EMBO J, V15, P607; KEY JL, 1981, P NATL ACAD SCI-BIOL, V78, P3526, DOI 10.1073/pnas.78.6.3526; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Aramaki H, 2001, FEMS MICROBIOL LETT, V205, P165, DOI 10.1111/j.1574-6968.2001.tb10942.x; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Frank S, 2011, ENVIRON MICROBIOL, V13, P1309, DOI 10.1111/j.1462-2920.2011.02430.x; Genevaux P, 2001, J BACTERIOL, V183, P5747, DOI 10.1128/JB.183.19.5747-5750.2001; GEORGOPOULOS CP, 1977, MOL GEN GENET, V151, P35, DOI 10.1007/BF00446910; Gur E, 2004, J BACTERIOL, V186, P7236, DOI 10.1128/JB.186.21.7236-7242.2004; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Jorgensen F, 1999, MICROBIOL-UK, V145, P835; Keith LMW, 1999, MOL PLANT MICROBE IN, V12, P563, DOI 10.1094/MPMI.1999.12.7.563; Lim B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001735; Morita MT, 2000, P NATL ACAD SCI USA, V97, P5860, DOI 10.1073/pnas.080495197; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; SELL SM, 1990, J BACTERIOL, V172, P4827; Siegenthaler RK, 2006, J BIOL CHEM, V281, P34448, DOI 10.1074/jbc.M606382200; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; TOMOYASU T, 1995, EMBO J, V14, P2551; UEGUCHI C, 1995, J BACTERIOL, V177, P3894; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307; YAMASHINO T, 1994, MOL MICROBIOL, V13, P475, DOI 10.1111/j.1365-2958.1994.tb00442.x; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-8827			MICROBIOLOGYOPEN	MicrobiologyOpen	DEC	2014	3	6					922	936		10.1002/mbo3.217		15	Microbiology	Microbiology	AW0MM	WOS:000345986700009		
J	Adrion, JR; Kousathanas, A; Pascual, M; Burrack, HJ; Haddad, NM; Bergland, AO; Machado, H; Sackton, TB; Schlenke, TA; Watada, M; Wegmann, D; Singh, ND				Adrion, Jeffrey R.; Kousathanas, Athanasios; Pascual, Marta; Burrack, Hannah J.; Haddad, Nick M.; Bergland, Alan O.; Machado, Heather; Sackton, Timothy B.; Schlenke, Todd A.; Watada, Masayoshi; Wegmann, Daniel; Singh, Nadia D.			Drosophila suzukii: The Genetic Footprint of a Recent, Worldwide Invasion	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						Drosophila suzukii; population genetics; invasion; pest	APPROXIMATE BAYESIAN COMPUTATION; SPOTTED-WING DROSOPHILA; MOLECULAR POPULATION-GENETICS; POLYMORPHISM DATA; UNITED-STATES; SUBOBSCURA; DNA; EVOLUTION; GENOME; DIVERSITY	Native to Asia, the soft-skinned fruit pest Drosophila suzukii has recently invaded the United States and Europe. The eastern United States represents the most recent expansion of their range, and presents an opportunity to test alternative models of colonization history. Here, we investigate the genetic population structure of this invasive fruit fly, with a focus on the eastern United States. We sequenced six X-linked gene fragments from 246 individuals collected from a total of 12 populations. We examine patterns of genetic diversity within and between populations and explore alternative colonization scenarios using approximate Bayesian computation. Our results indicate high levels of nucleotide diversity in this species and suggest that the recent invasions of Europe and the continental United States are independent demographic events. More broadly speaking, our results highlight the importance of integrating population structure into demographic models, particularly when attempting to reconstruct invasion histories. Finally, our simulation results illustrate the general challenge in reconstructing invasion histories using genetic data and suggest that genome-level data are often required to distinguish among alternative demographic scenarios.	[Adrion, Jeffrey R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Kousathanas, Athanasios; Wegmann, Daniel] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Kousathanas, Athanasios; Wegmann, Daniel] Swiss Inst Bioinformat, Lausanne, Switzerland; [Pascual, Marta] Univ Barcelona, Dept Genet, Barcelona, Spain; [Pascual, Marta] Univ Barcelona, IRBio, Barcelona, Spain; [Burrack, Hannah J.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Haddad, Nick M.; Singh, Nadia D.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Bergland, Alan O.; Machado, Heather] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sackton, Timothy B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Schlenke, Todd A.] Reed Coll, Dept Biol, Portland, OR 97202 USA; [Watada, Masayoshi] Ehime Univ, Dept Biol, Matsuyama, Ehime, Japan	Singh, ND (reprint author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	ndsingh@ncsu.edu	Pascual, Marta/M-7626-2015; 	Pascual, Marta/0000-0002-6189-0612; Sackton, Timothy/0000-0003-1673-9216	Spanish Government [CTM2010-22218]; Generalitat de Catalunya (Spain) [2014SGR-336]; Swiss National Foundation [31003A_149920]	The authors gratefully acknowledge Deborah Blue, Curtis Nagle, Steven VanTimmerman, and Dmitri Petrov for their assistance in procuring D. suzukii samples for this project. Michael Eisen graciously provided a draft genome assembly for D. suzukii, without which this project would not have been possible. We also thank Brian Lazzaro for helpful discussions on this project. We thank Josep Abril for providing computer resources. Comments from three anonymous reviewers improved this manuscript considerably. Funding to M.P. came from the project CTM2010-22218 of the Spanish Government. M.P. is part of the research group 2014SGR-336 of the Generalitat de Catalunya (Spain). A.K. was funded by the Swiss National Foundation grant 31003A_149920 to D.W.	Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Cini A, 2012, B INSECTOL, V65, P149; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; SLATKIN M, 1991, GENETICS, V129, P555; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Chiu JC, 2013, G3-GENES GENOM GENET, V3, P2257, DOI 10.1534/g3.113.008185; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Rousset F, 1997, GENETICS, V145, P1219; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Cuesta-Albertos JA, 2008, COMPUT STAT DATA AN, V52, P4979, DOI 10.1016/j.csda.2008.04.021; Beaumont MA, 2002, GENETICS, V162, P2025; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Sanchez-Gracia A, 2011, HEREDITY, V106, P191, DOI 10.1038/hdy.2010.26; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Estoup A, 2010, MOL ECOL RESOUR, V10, P886, DOI 10.1111/j.1755-0998.2010.02882.x; Wright S, 1943, GENETICS, V28, P114; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Arauz PA, 2011, GENETICA, V139, P1477, DOI 10.1007/s10709-012-9647-8; Bolda M. P., 2010, AGR RESOUR EC UPDATE, V13, P5; Burrack HJ, 2012, J INTEGRATED PEST MA, V4, pB1; Carvajal Jose Ignacio, 2010, Drosophila Information Service, V93, P67; Chu JH, 2013, MOL BIOL EVOL, V30, P2519, DOI 10.1093/molbev/mst140; Cirera S, 1998, MOL BIOL EVOL, V15, P988; Dean MD, 2004, MOL PHYLOGENET EVOL, V32, P998, DOI 10.1016/j.ympev.2004.03.013; Ersts P.J., GEOGRAPHIC DISTANCE; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kaneshiro KY, 1983, P HAWAIIAN ENTOMOL S, V24, P179; Kanzawa T., 1939, REV APPL ENTOMOL, V29, P622; Nielsen R, 2000, GENETICS, V154, P931; O'Grady P.M., 2002, Bishop Museum Occasional Papers, V69, P34; Pascual M, 2000, AM MIDL NAT, V144, P19, DOI 10.1674/0003-0031(2000)144[0019:ICITLB]2.0.CO;2; Pascual M, 1998, EVOLUTION, V52, P269, DOI 10.2307/2410944; Rius M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035815; Rozas J, 1999, GENETICS, V151, P189; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116	59	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	DEC	2014	31	12					3148	3163		10.1093/molbev/msu246		16	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	AU7JU	WOS:000345777600005		
J	Andrade, SCS; Montenegro, H; Strand, M; Schwartz, ML; Kajihara, H; Norenburg, JL; Turbeville, JM; Sundberg, P; Giribet, G				Andrade, Sonia C. S.; Montenegro, Horacio; Strand, Malin; Schwartz, Megan L.; Kajihara, Hiroshi; Norenburg, Jon L.; Turbeville, James M.; Sundberg, Per; Giribet, Gonzalo			A Transcriptomic Approach to Ribbon Worm Systematics (Nemertea): Resolving the Pilidiophora Problem	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						phylogeny; Palaeonemertea; Neonemertea; Pilidiophora; supermatrix; concatenation; Illumina	MULTIPLE SEQUENCE ALIGNMENT; PHYLUM NEMERTEA; SPECIES TREES; DATA SETS; PHYLOGENETIC INFERENCE; PROTEIN EVOLUTION; PILIDIUM LARVA; ARTHROPOD TREE; GENE TREES; PHYLOGENOMICS	Resolving the deep relationships of ancient animal lineages has proven difficult using standard Sanger-sequencing approaches with a handful of markers. We thus reassess the relatively well-studied phylogeny of the phylum Nemertea (ribbon worms)-for which the targeted gene approaches had resolved many clades but had left key phylogenetic gaps-by using a phylogenomic approach using Illumina-based de novo assembled transcriptomes and automatic orthology prediction methods. The analysis of a concatenated data set of 2,779 genes (411,138 amino acids) with about 78% gene occupancy and a reduced version with 95% gene occupancy, under evolutionary models accounting or not for site-specific amino acid replacement patterns results in a well-supported phylogeny that recovers all major accepted nemertean clades with the monophyly of Heteronemertea, Hoplonemertea, Monostilifera, being well supported. Significantly, all the ambiguous patterns inferred from Sanger-based approaches were resolved, namely the monophyly of Palaeonemertea and Pilidiophora. By testing for possible conflict in the analyzed supermatrix, we observed that concatenation was the best solution, and the results of the analyses should settle prior debates on nemertean phylogeny. The study highlights the importance, feasibility, and completeness of Illumina-based phylogenomic data matrices.	[Andrade, Sonia C. S.; Giribet, Gonzalo] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Montenegro, Horacio] ESALQ USP, Dept Entomol, Sao Paulo, Brazil; [Strand, Malin] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden; [Schwartz, Megan L.] Univ Washington, Div Sci & Math, Tacoma, WA USA; [Kajihara, Hiroshi] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 060, Japan; [Norenburg, Jon L.] Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA; [Turbeville, James M.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Sundberg, Per] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	Andrade, SCS (reprint author), ESALQ USP, Dept Zootecnia, Sao Paulo, Brazil.	soniacsandrade@gmail.com	Montenegro, Horacio/B-8350-2012; Norenburg, Jon/K-3481-2015; Giribet, Gonzalo/P-1086-2015; Andrade, Sonia/F-8267-2014	Montenegro, Horacio/0000-0002-8142-896X; Norenburg, Jon/0000-0001-7776-1527; Giribet, Gonzalo/0000-0002-5467-8429; 	NSF [DEB-0844881, DEB-0732903]; FAPESP [2012/02906-4]	Many colleagues have assisted with fieldwork, specimens, and laboratory protocols. FedEx is acknowledged for the constant delivery of live nemerteans for RNA work and Robert Mesibov for Tasmanian specimens. Alicia Rodriguez Perez Porro and Ana Riesgo were instrumental in the development of the RNA and Illumina sequencing protocols. S.C.S.A. is indebted to Casey Dunn for guidance during the first steps on bioinformatics and cDNA libraries sample preparation. The Bauer Core from the Faculty of Arts and Sciences at Harvard and the Research Computing Group, also from Harvard, are deeply acknowledged for their assistance at many stages of the data acquisition and analyses. Marcelo Brandao and the Bioinformatics Group at Esalq-Usp are acknowledged for access to the Cluster Thunder. This work was funded by the NSF projects Collaborative Research: Resolving old questions in Mollusc phylogenetics with new EST data and developing general phylogenomic tools (# DEB-0844881) and Collaborative Research: AToL: Phylogeny on the half-shell-Assembling the Bivalve Tree of Life (#DEB-0732903) to G.G. and by a FAPESP scholarship (2012/02906-4) to H.M.	Sundberg P, 2001, MOL PHYLOGENET EVOL, V20, P327, DOI 10.1006/mpev.2001.0982; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Betancur-R R, 2014, SYST BIOL, V63, P257, DOI 10.1093/sysbio/syt073; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Kvist S, 2014, INVERTEBR SYST, V28, P287, DOI 10.1071/IS13061; Salichos L, 2014, MOL BIOL EVOL, V31, P1261, DOI 10.1093/molbev/msu061; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Kajihara Hiroshi, 2008, Species Diversity, V13, P245; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Thollesson M, 2003, P ROY SOC B-BIOL SCI, V270, P407, DOI 10.1098/rspb.2002.2254; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Fernandez R, 2014, MOL BIOL EVOL, V31, P1500, DOI 10.1093/molbev/msu108; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Riesgo A, 2012, MOL ECOL RESOUR, V12, P312, DOI 10.1111/j.1755-0998.2011.03097.x; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Maslakova SA, 2010, INTEGR COMP BIOL, V50, P734, DOI 10.1093/icb/icq096; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Turbeville JM, 2002, INTEGR COMP BIOL, V42, P692, DOI 10.1093/icb/42.3.692; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Grunewald S, 2013, IEEE ACM T COMPUT BI, V10, P151, DOI 10.1109/TCBB.2013.8; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Fernandez R, 2014, CURR BIOL, V24, P1772, DOI 10.1016/j.cub.2014.06.035; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Leigh JW, 2011, MOL BIOL EVOL, V28, P2773, DOI 10.1093/molbev/msr110; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-139; Chernyshev AV, 2013, J MORPHOL, V274, P1397, DOI 10.1002/jmor.20189; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; GIBSON R, 1995, J NAT HIST, V29, P271, DOI 10.1080/00222939500770161; Hartmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029843; Le SQ, 2012, MOL BIOL EVOL, V29, P2921, DOI 10.1093/molbev/mss112; Maslakova SA, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-30; McIntosh WC, 1873, MONOGRAPH BRIT ANN 1; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Satler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025355; Schultze M. S., 1851, BEITRAGE NATURGESCHI; Sharma PP, 2014, MOL BIOL EVOL, V31, P2963, DOI 10.1093/molbev/msu235; Stiasny-Wijnhoff G, 1936, SIBOGA EXPED, V22, P1; Sundberg P, 2007, BIOL LETTERS, V3, P570, DOI 10.1098/rsbl.2007.0306; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Wenzel JW, 1999, CLADISTICS, V15, P51, DOI 10.1006/clad.1999.0084	64	13	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	DEC	2014	31	12					3206	3215		10.1093/molbev/msu253		10	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	AU7JU	WOS:000345777600009		
J	Sakamaki, K; Shimizu, K; Iwata, H; Imai, K; Satou, Y; Funayama, N; Nozaki, M; Yajima, M; Nishimura, O; Higuchi, M; Chiba, K; Yoshimoto, M; Kimura, H; Gracey, AY; Shimizu, T; Tomii, K; Gotoh, O; Akasaka, K; Sawasaki, T; Miller, DJ				Sakamaki, Kazuhiro; Shimizu, Kouhei; Iwata, Hiroaki; Imai, Kenichiro; Satou, Yutaka; Funayama, Noriko; Nozaki, Masami; Yajima, Mamiko; Nishimura, Osamu; Higuchi, Mayura; Chiba, Kumiko; Yoshimoto, Michi; Kimura, Haruna; Gracey, Andrew Y.; Shimizu, Takashi; Tomii, Kentaro; Gotoh, Osamu; Akasaka, Koji; Sawasaki, Tatsuya; Miller, David J.			The Apoptotic Initiator Caspase-8: Its Functional Ubiquity and Genetic Diversity during Animal Evolution	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						caspase; FADD; intron insertions; exon shuffling; operon	FADD DEATH DOMAIN; CELL-DEATH; FLUORESCENT PROTEIN; PHYLOGENETIC ANALYSES; MAXIMUM-LIKELIHOOD; MOLECULAR-CLONING; MOUSE CASPASE-8; REVEALS; CONSERVATION; ACTIVATION	The caspases, a family of cysteine proteases, play multiple roles in apoptosis, inflammation, and cellular differentiation. Caspase-8 (Casp8), which was first identified in humans, functions as an initiator caspase in the apoptotic signaling mediated by cell-surface death receptors. To understand the evolution of function in the Casp8 protein family, casp8 orthologs were identified from a comprehensive range of vertebrates and invertebrates, including sponges and cnidarians, and characterized at both the gene and protein levels. Some introns have been conserved from cnidarians to mammals, but both losses and gains have also occurred; a new intron arose during teleost evolution, whereas in the ascidian Ciona intestinalis, the casp8 gene is intronless and is organized in an operon with a neighboring gene. Casp8 activities are near ubiquitous throughout the animal kingdom. Exogenous expression of a representative range of nonmammalian Casp8 proteins in cultured mammalian cells induced cell death, implying that these proteins possess proapoptotic activity. The cnidarian Casp8 proteins differ considerably from their bilaterian counterparts in terms of amino acid residues in the catalytic pocket, but display the same substrate specificity as human CASP8, highlighting the complexity of spatial structural interactions involved in enzymatic activity. Finally, it was confirmed that the interaction with an adaptor molecule, Fas-associated death domain protein, is also evolutionarily ancient. Thus, despite structural diversity and cooption to a variety of new functions, the ancient origins and near ubiquitous distribution of this activity across the animal kingdom emphasize the importance and utility of Casp8 as a central component of the metazoan molecular toolkit.	[Sakamaki, Kazuhiro; Chiba, Kumiko; Yoshimoto, Michi; Kimura, Haruna] Kyoto Univ, Grad Sch Biostudies, Dept Anim Dev & Physiol, Kyoto, Japan; [Shimizu, Kouhei; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan; [Iwata, Hiroaki] Kyushu Univ, Med Inst Bioregulat, Multiscale Res Ctr Med Sci, Fukuoka 812, Japan; [Imai, Kenichiro; Tomii, Kentaro; Gotoh, Osamu] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan; [Satou, Yutaka] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan; [Funayama, Noriko; Nishimura, Osamu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Nozaki, Masami] Osaka Univ, Microbial Dis Res Inst, Dept Cell Biol, Suita, Osaka 565, Japan; [Yajima, Mamiko] Brown Univ, Cellular Biol Biochem Dept, Providence, RI 02912 USA; [Gracey, Andrew Y.] Univ So Calif, Los Angeles, CA USA; [Shimizu, Takashi] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan; [Akasaka, Koji] Univ Tokyo, Ctr Marine Biol, Miura, Kanagawa, Japan; [Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia	Sakamaki, K (reprint author), Kyoto Univ, Grad Sch Biostudies, Dept Anim Dev & Physiol, Kyoto, Japan.	sakamaki.kazuhiro.7u@kyoto-u.ac.jp	Manager, MEEL/C-4732-2015; Satou, Yutaka/K-7131-2012	Satou, Yutaka/0000-0001-5193-0708	Ministry of Education, Culture, Sports, Science and Technology, Japan [20017016]	The complete sequences of the Gas. aculeatus, Leu. erinacea, L. japonicum, B. floridae, Ci. intestinalis, Ci. savignyi, T. tubifex, M. californianus, Sc. mediterranea, Ac. palmata, and Ac. millepora casp8 cDNAs (GenBank accession numbers: HQ285317, EU719070, GQ405966, FJ937786, JQ920434, JQ920435, EU719069, FJ937785, KF364484, GU808361, KJ639816), and Du. japonica casp8 cDNA and E. fluviatilis casp8 transcript (DDBJ accession numbers: AB897787 and AB898058), the M. californianus casp8-like cDNA (GenBank accession number: FJ937784), the Gas. aculeatus casp10 cDNA (GenBank accession number: DQ010055), G. gallus, X. laevis, Gas. aculeatus, and O. latipes cflar/cflip cDNAs (GenBank accession numbers: HQ687225, AY519261, HQ285319, FJ937783), the Ac. millepora fadd cDNA (GenBank accession number: KJ639817), the T. tubifex and Ac. millepora casp8 genes (GenBank accession numbers: FJ890021, KJ639818), and the M. californianus casp8-like gene (DDBJ accession number: AB924644) have been deposited. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas, 20017016 (K. Sa.) and by Platform for Drug Discovery, Informatics, and Structural Life Science (K. T.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aboobaker A, 2003, CURR OPIN GENET DEV, V13, P593, DOI 10.1016/j.gde.2003.10.009; Akagi T, 2011, FEBS LETT, V585, P1835, DOI 10.1016/j.febslet.2011.04.031; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Watt W, 1999, STRUCT FOLD DES, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj/cdd/4400989; Kominami K, 2012, BBA-MOL CELL RES, V1823, P1825, DOI 10.1016/j.bbamcr.2012.07.003; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Sakata S, 2007, GENE, V396, P134, DOI 10.1016/j.gene.2007.03.010; Wiens M, 2003, BBA-MOL CELL RES, V1593, P179, DOI 10.1016/S0167-4889(02)00388-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Sakamaki K, 1998, EUR J BIOCHEM, V253, P399, DOI 10.1046/j.1432-1327.1998.2530399.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Thomsen ND, 2013, P NATL ACAD SCI USA, V110, P8477, DOI 10.1073/pnas.1306759110; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bock FJ, 2012, ONCOGENE, V31, P4733, DOI 10.1038/onc.2011.639; Zhou Q, 1997, J BIOL CHEM, V272, P7797; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Yajima M, 2012, DEVELOPMENT, V139, P3613, DOI 10.1242/dev.081828; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Salvesen GS, 2014, SEMIN IMMUNOL, V26, P246, DOI 10.1016/j.smim.2014.03.005; Sakamaki K, 2009, J FISH BIOL, V74, P727, DOI 10.1111/j.1095-8649.2009.02184.x; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Quistad SD, 2014, P NATL ACAD SCI USA, V111, P9567, DOI 10.1073/pnas.1405912111; Xiang ZM, 2013, FISH SHELLFISH IMMUN, V35, P1797, DOI 10.1016/j.fsi.2013.08.026; Blanchard H, 1999, STRUCT FOLD DES, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Vickers CJ, 2013, ACS CHEM BIOL, V8, P1558, DOI 10.1021/cb400209w; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lee Y, 2011, FISH SHELLFISH IMMUN, V30, P480, DOI 10.1016/j.fsi.2010.11.014; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; Chereau D, 2003, BIOCHEMISTRY-US, V42, P4151, DOI 10.1021/bi0205931; Cooper DM, 2007, INSECT BIOCHEM MOLEC, V37, P559, DOI 10.1016/j.ibmb.2007.03.005; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Eswar N, 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506S15; Falschlehner C, 2012, EMBO J, V31, P2750, DOI 10.1038/emboj.2012.148; Gunther C, 2014, SEMIN CELL DEV BIOL, V35, P40, DOI 10.1016/j.semcdb.2014.06.004; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; MCMILLAN J, 1989, GENE, V83, P185, DOI 10.1016/0378-1119(89)90418-6; Ng PWP, 1999, J BIOL CHEM, V274, P10301, DOI 10.1074/jbc.274.15.10301; Sakamaki K, 2005, DEV DYNAM, V233, P562, DOI 10.1002/dvdy.20350; Sakamaki K, 2012, GENES CELLS, V17, P875, DOI 10.1111/gtc.12004; Sakamaki K, 2004, GENES CELLS, V9, P1249, DOI 10.1111/j.1365-2443.2004.00802.x; Satou Y, 2006, NUCLEIC ACIDS RES, V34, P3378, DOI 10.1093/nar/gkl418; Shaham S, 1998, J BIOL CHEM, V273, P35109, DOI 10.1074/jbc.273.52.35109; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Weill M, 2005, BIOL CELL, V97, P857, DOI 10.1042/BC20050018; Xu LQ, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-60	68	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	DEC	2014	31	12					3282	3301		10.1093/molbev/msu260		20	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	AU7JU	WOS:000345777600015		
J	Nakaminami, K; Matsui, A; Nakagami, H; Minami, A; Nomura, Y; Tanaka, M; Morosawa, T; Ishida, J; Takahashi, S; Uemura, M; Shirasu, K; Seki, M				Nakaminami, Kentaro; Matsui, Akihiro; Nakagami, Hirofumi; Minami, Anzu; Nomura, Yuko; Tanaka, Maho; Morosawa, Taeko; Ishida, Junko; Takahashi, Satoshi; Uemura, Matsuo; Shirasu, Ken; Seki, Motoaki			Analysis of Differential Expression Patterns of mRNA and Protein During Cold-acclimation and De-acclimation in Arabidopsis	MOLECULAR & CELLULAR PROTEOMICS			English	Article							MEMBRANE LIPID-COMPOSITION; FREEZING TOLERANCE; STRESS GRANULES; PROCESSING BODIES; THALIANA; GENES; PHOSPHORYLATION; DEACCLIMATION; TRANSLATION; STABILITY	Overwintering plants are capable of exhibiting high levels of cold tolerance, which is acquired through the process of cold acclimation (CA). In contrast to CA, the acquired freezing tolerance is rapidly reduced during cold de-acclimation (DA) and plants resume growth after sensing warm temperatures. In order to better understand plant growth and development, and to aid in the breeding of cold-tolerant plants, it is important to decipher the functional mechanisms of the DA process. In this study, we performed comparative transcriptomic and proteomic analyses during CA and DA. As revealed by shotgun proteomics, we identified 3987 peptides originating from 1569 unique proteins and the corresponding mRNAs were analyzed. Among the 1569 genes, 658 genes were specifically induced at the transcriptional level during the process of cold acclimation. In order to investigate the relationship between mRNA and the corresponding protein expression pattern, a Pearson correlation was analyzed. Interestingly, 199 genes showed a positive correlation of mRNA and protein expression pattern, indicating that both their transcription and translation occurred during CA. However, 226 genes showed a negative correlation of mRNA and protein expression pattern, indicating that their mRNAs were transcribed during CA and were stored for the subsequent DA step. Under this scenario, those proteins were specifically increased during DA without additional transcription of mRNA. In order to confirm the negative correlation of mRNA and protein expression patterns, qRT-PCR and western blot analyses were performed. Mitochondrial malate dehydrogenase 1 (mMDH1) exhibited a negative correlation of mRNA and protein levels, which was characterized by CA-specific mRNA induction and protein accumulation specifically during DA. These data indicate that the expression of specific mRNAs and subsequent accumulation of corresponding proteins are not always in accordance under low temperature stress conditions in plants.	[Nakaminami, Kentaro; Matsui, Akihiro; Tanaka, Maho; Morosawa, Taeko; Ishida, Junko; Takahashi, Satoshi; Seki, Motoaki] RIKEN, Plant Genom Network Res Team, CSRS, Yokohama, Kanagawa 2300045, Japan; [Nakagami, Hirofumi; Nomura, Yuko] RIKEN, Plant Prote Res Unit, CSRS, Yokohama, Kanagawa 2300045, Japan; [Minami, Anzu; Uemura, Matsuo] Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, Morioka, Iwate 0208550, Japan; [Shirasu, Ken] RIKEN, Plant Immun Res Grp, CSRS, Yokohama, Kanagawa 2300045, Japan; [Seki, Motoaki] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan; [Seki, Motoaki] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Seki, M (reprint author), RIKEN, Plant Genom Network Res Team, CSRS, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	motoaki.seki@riken.jp	Nakagami, Hirofumi/A-4122-2011; Shirasu, Ken/A-4455-2010	Shirasu, Ken/0000-0002-0349-3870	RIKEN; Japan Society for the Promotion of Science (JSPS) KAKENHI [25850247]; Japan Science and Technology Agency (JST), Core Research for Evolutionary Science and Technology (CREST); JSPS KAKENHI [24228008, 24688007, 26650106]	This project was supported by the Special Postdoctoral Researcher's Program from RIKEN and Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25850247 to K.N., by grants from RIKEN and Japan Science and Technology Agency (JST), Core Research for Evolutionary Science and Technology (CREST) to M.S., and lastly by JSPS KAKENHI Grant Numbers 24228008 to K.S., 24688007 and 26650106 to H.N.	ABE S, 1986, Memoirs of the College of Agriculture Ehime University, V31, P187; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; UEMURA M, 1994, PLANT PHYSIOL, V104, P479; UEMURA M, 1995, PLANT PHYSIOL, V109, P15; Oono Youko, 2006, Functional & Integrative Genomics, V6, P212, DOI 10.1007/s10142-005-0014-z; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mussgnug JH, 2005, PLANT CELL, V17, P3409, DOI 10.1105/tpc.105.035774; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; CHEN HH, 1980, PLANT PHYSIOL, V65, P1146, DOI 10.1104/pp.65.6.1146; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Sano N, 2012, PLANT CELL PHYSIOL, V53, P687, DOI 10.1093/pcp/pcs024; Amme S, 2006, J EXP BOT, V57, P1537, DOI 10.1093/jxb/erj129; Xu J, 2011, CURR OPIN PLANT BIOL, V14, P88, DOI 10.1016/j.pbi.2010.10.003; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; Gutierrez RA, 2002, P NATL ACAD SCI USA, V99, P11513, DOI 10.1073/pnas.152204099; Kedersha N, 2005, J CELL BIOL, V169, P871; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Mustroph A, 2009, METHODS MOL BIOL, V553, P109, DOI 10.1007/978-1-60327-563-7_6; Kedersha N, 2002, BIOCHEM SOC T, V30, P963; Rymen B, 2007, PLANT PHYSIOL, V143, P1429, DOI 10.1104/pp.106.093948; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Sasaki H, 1996, ANN BOT-LONDON, V78, P365, DOI 10.1006/anbo.1996.0131; Lee DG, 2007, CR BIOL, V330, P215, DOI 10.1016/j.crvi.2007.01.001; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Zhu Y, 2006, PLANT CELL, V18, P2879, DOI 10.1105/tpc.106.046490; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; To TK, 2011, BIOCHEM BIOPH RES CO, V406, P414, DOI 10.1016/j.bbrc.2011.02.058; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Xu J, 2012, EMBO J, V31, P1975, DOI 10.1038/emboj.2012.56; Chiba Y, 2013, PLANT CELL PHYSIOL, V54, P180, DOI 10.1093/pcp/pcs164; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; ANTIKAINEN M, 1993, PHYSIOL PLANTARUM, V89, P111; Bailey-Serres J, 2009, TRENDS PLANT SCI, V14, P443, DOI 10.1016/j.tplants.2009.05.004; Chino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073319; Kawaguchi R, 2003, PLANT CELL ENVIRON, V26, P221, DOI 10.1046/j.1365-3040.2003.00952.x; LAROCHE A, 1987, PLANT PHYSIOL, V85, P648, DOI 10.1104/pp.85.3.648; Liu ZQ, 2009, PLANT J, V59, P27, DOI 10.1111/j.1365-313X.2009.03844.x; McCue AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002474; PALTA JP, 1993, PLANT PHYSIOL, V103, P793; RANJAN M, 1993, GENE DEV, V7, P1725, DOI 10.1101/gad.7.9.1725	47	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	DEC	2014	13	12					3602	3611		10.1074/mcp.M114.039081		10	Biochemical Research Methods	Biochemistry & Molecular Biology	AU5DC	WOS:000345626400030		
J	Konuma, J; Yamamoto, S; Sota, T				Konuma, Junji; Yamamoto, Satoshi; Sota, Teiji			Morphological integration and pleiotropy in the adaptive body shape of the snail-feeding carabid beetle Damaster blaptoides	MOLECULAR ECOLOGY			English	Article						adaptive radiation; complex trait; ecological specialization; morphological integration; pleiotropy; QTL mapping	QUANTITATIVE GENETIC-ANALYSIS; ECOLOGICAL SPECIALIZATION; DARWINS FINCHES; EVO-DEVO; SUBTRIBE CARABINA; SIZE ALLOMETRY; EVOLUTION; ADAPTATION; RADIATION; DIVERSIFICATION	The snail-feeding carabid beetle Damaster blaptoides exhibits diverse head and thorax morphologies, and these morphotypes are linked with two alternative feeding behaviours. Stout-shaped beetles feed on snails by crushing the shells, whereas slender-shaped beetles consume snails by inserting their heads into the shells. A trade-off exists between these feeding strategies. Because intermediate-shaped beetles are less proficient in these two behaviours, stout-slender morphological divergence occurs between related species feeding on land snails. To examine the genetic basis of these morphotypes, we conducted morphological analyses and quantitative trait locus (QTL) mapping using backcross offspring between the stout and slender subspecies. The morphological analyses showed that the width and length of the beetle body parts were correlated with each other; in particular, the head width (HW) and thorax length (TL) were strongly negatively correlated. QTL mapping showed that QTLs for HW and TL are located in close proximity to one another on the longest linkage group and that they have positive and negative additive genetic effects. Our results suggest that the adaptive phenotypic sets of a wide head and short thorax and a narrow head and long thorax are based on the closeness of these QTLs. Morphological integration between the head and thorax may play an important role in the adaptive divergence of these beetles.	[Konuma, Junji; Yamamoto, Satoshi; Sota, Teiji] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo, Kyoto 6068502, Japan; [Konuma, Junji] Toho Univ, Fac Sci, Dept Biol, Funabashi, Chiba 2748510, Japan; [Yamamoto, Satoshi] Kobe Univ, Fac Human Dev, Grad Sch Human Dev & Environm, Kobe, Hyogo 6578501, Japan	Konuma, J (reprint author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo, Kyoto 6068502, Japan.	junji.konuma@sci.toho-u.ac.jp			JSPS [23128507, 24770020, 25128707];  [08J02093]	We express our sincere gratitude to Y. Takami and M. Sasabe for helpful advices on the experimental design of QTL mapping and to S. Wada, K. Tsuji and Y. Yamasaki for supplying land snails for beetle rearing. This work was supported by Grant-in-Aid for JSPS Fellows (No. 08J02093) and Grants-in-Aid for scientific research from JSPS (No. 23128507, No. 24770020, No. 25128707).	ALBRECHT GH, 1993, AM J PHYS ANTHROPOL, V91, P441, DOI 10.1002/ajpa.1330910404; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; Pavlicev M, 2011, EVOL BIOL, V38, P371, DOI 10.1007/s11692-011-9136-5; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; BURNABY TP, 1966, BIOMETRICS, V22, P96, DOI 10.2307/2528217; Parsons KJ, 2009, ANNU REV GENET, V43, P369, DOI 10.1146/annurev-genet-102808-114917; [Anonymous], 2012, EVOL EDUC OUTREACH, DOI DOI 10.1007/s12052-012-0430-1; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Roberts RB, 2011, P NATL ACAD SCI USA, V108, P13194, DOI 10.1073/pnas.1018456108; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Sota T, 2001, SYST BIOL, V50, P39, DOI 10.1080/106351501750107459; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.ecolsys.19.1.207; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Cheverud JM, 1996, AM ZOOL, V36, P44; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Stearns FW, 2010, GENETICS, V186, P767, DOI 10.1534/genetics.110.122549; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Sota T, 2003, MOL PHYLOGENET EVOL, V26, P139, DOI 10.1016/S1055-7903(02)00311-1; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Sota T, 2008, PHILOS T R SOC B, V363, P3377, DOI 10.1098/rstb.2008.0111; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.2307/2408911; Gavrilets S, 2003, EVOLUTION, V57, P2197; WADDINGTON CH, 1960, GENET RES, V1, P140; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.2307/2410639; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Frankino WA, 2007, EVOLUTION, V61, P2958, DOI 10.1111/j.1558-5646.2007.00249.x; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.1093/biomet/72.2.241; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.2307/2410734; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Buckling A, 2003, SCIENCE, V302, P2107, DOI 10.1126/science.1088848; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; Cheverud JM, 2007, J EVOLUTION BIOL, V20, P15, DOI 10.1111/j.1420-9101.2006.01220.x; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P139, DOI 10.1002/ajpa.1330590204; Gilchrist MA, 2001, GENETICS, V159, P423; Irschick DJ, 2013, TRENDS ECOL EVOL, V28, P267, DOI 10.1016/j.tree.2012.12.004; ISHIKAWA R, 1979, Bulletin of the National Science Museum Series A (Zoology), V5, P95; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Klingenberg CP, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P213; Konuma J, 2013, HEREDITY, V110, P86, DOI 10.1038/hdy.2012.68; Konuma J, 2013, ECOLOGY, V94, P2638, DOI 10.1890/12-2041.1; Konuma J, 2007, AM NAT, V170, P90, DOI 10.1086/518182; Konuma J, 2011, EVOLUTION, V65, P408, DOI 10.1111/j.1558-5646.2010.01150.x; Lourenco J, 2011, EVOLUTION, V65, P1559, DOI 10.1111/j.1558-5646.2011.01237.x; LUCIANO DCE, 2012, QUANTITATIVE TRAIT L, P75; Lynch M, 1998, GENETICS ANAL QUANTI; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Muller G. B., 2008, EVOLVING PATHWAYS KE, P3; Nijhout HF, 1997, AM NAT, V149, P394, DOI 10.1086/285996; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Riedl R., 1978, ORDER LIVING ORGANIS; RISKA B, 1986, EVOLUTION, V40, P1303, DOI 10.2307/2408955; Serrano Jose, 1998, P191; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sota T, 2004, BIOL J LINN SOC, V81, P135, DOI 10.1111/j.1095-8312.2004.00277.x; Sota T, 2013, ENTOMOL SCI, V16, P122, DOI 10.1111/j.1479-8298.2012.00541.x; STURANI M, 1962, ESTRATTO MEMORIE SOC, V41, P85; Waddington CH., 1957, STRATEGY GENES; Wang S, 2012, WINDOWS QTL CARTOGRA; WEBER F, 1966, CHROMOSOMA, V18, P467, DOI 10.1007/BF00332550; Young RL, 2006, EVOLUTION, V60, P1291, DOI 10.1111/j.0014-3820.2006.tb01206.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	82	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	DEC	2014	23	23					5843	5854		10.1111/mec.12976		12	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AU5ET	WOS:000345630700014		
J	Crutsinger, GM; Rudman, SM; Rodriguez-Cabal, MA; McKown, AD; Sato, T; MacDonald, AM; Heavyside, J; Geraldes, A; Hart, EM; LeRoy, CJ; El-Sabaawi, RW				Crutsinger, Gregory M.; Rudman, Seth M.; Rodriguez-Cabal, Mariano A.; McKown, Athena D.; Sato, Takuya; MacDonald, Andrew M.; Heavyside, Julian; Geraldes, Armando; Hart, Edmund M.; LeRoy, Carri J.; El-Sabaawi, Rana W.			Testing a 'genes-to-ecosystems' approach to understanding aquatic-terrestrial linkages	MOLECULAR ECOLOGY			English	Article						aquatic-terrestrial linkages; community genetics; decomposition; genes-to-ecosystems; GWAS; mesocosms; Populus trichocarpa	COTTONWOOD POPULUS-TRICHOCARPA; COMMUNITY STRUCTURE; BLACK COTTONWOOD; LITTER DECOMPOSITION; ASSOCIATION GENETICS; EVOLUTIONARY BIOLOGY; NATURAL-POPULATIONS; TRAIT VARIATION; DIVERSITY; GENOME	A genes-to-ecosystems' approach has been proposed as a novel avenue for integrating the consequences of intraspecific genetic variation with the underlying genetic architecture of a species to shed light on the relationships among hierarchies of ecological organization (genes individuals communities ecosystems). However, attempts to identify genes with major effect on the structure of communities and/or ecosystem processes have been limited and a comprehensive test of this approach has yet to emerge. Here, we present an interdisciplinary field study that integrated a common garden containing different genotypes of a dominant, riparian tree, Populus trichocarpa, and aquatic mesocosms to determine how intraspecific variation in leaf litter alters both terrestrial and aquatic communities and ecosystem functioning. Moreover, we incorporate data from extensive trait screening and genome-wide association studies estimating the heritability and genes associated with litter characteristics. We found that tree genotypes varied considerably in the quality and production of leaf litter, which contributed to variation in phytoplankton abundances, as well as nutrient dynamics and light availability in aquatic mesocosms. These after-life' effects of litter from different genotypes were comparable to the responses of terrestrial communities associated with the living foliage. We found that multiple litter traits corresponding with aquatic community and ecosystem responses differed in their heritability. Moreover, the underlying genetic architecture of these traits was complex, and many genes contributed only a small proportion to phenotypic variation. Our results provide further evidence that genetic variation is a key component of aquatic-terrestrial linkages, but challenge the ability to predict community or ecosystem responses based on the actions of one or a few genes.	[Crutsinger, Gregory M.; Rudman, Seth M.; Rodriguez-Cabal, Mariano A.; MacDonald, Andrew M.; Heavyside, Julian; Hart, Edmund M.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [McKown, Athena D.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Sato, Takuya] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Geraldes, Armando] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [LeRoy, Carri J.] Evergreen State Coll, Environm Studies Program, Olympia, WA 98505 USA; [El-Sabaawi, Rana W.] Univ Victoria, Dept Biol, Victoria, BC V8P 5C2, Canada	Crutsinger, GM (reprint author), Univ British Columbia, Dept Zool, 4200-6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	crutsinger@zoology.ubc.ca		Hart, Edmund/0000-0001-7367-7969	NSERC; Canadian Foundation for Innovation; Hakubi Project, Kyoto University; Genome Canada Large-Scale Applied Research Project [168BIO];  [24687003]	We thank K. Kubeck and E.R. Hubbard for assistance in this research. N. Sanders and the Schluter lab provided valuable comments on the manuscript. GMC was supported by a NSERC Discovery grant and the Canadian Foundation for Innovation. TS was supported partially by Grant-in-Aid for Young Scientists (A) (Grant Number: 24687003) and The Hakubi Project, Kyoto University. The phenotyping and genetic association work was supported by the Genome Canada Large-Scale Applied Research Project (Project 168BIO) funds.	Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Crutsinger GM, 2013, OECOLOGIA, V173, P1531, DOI 10.1007/s00442-013-2727-3; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Marcarelli AM, 2011, ECOLOGY, V92, P1215, DOI 10.1890/10-2240.1; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Cronk QCB, 2005, NEW PHYTOL, V166, P39, DOI 10.1111/j.1469-8137.2005.01369.x; Xie CY, 2009, CAN J FOREST RES, V39, P519, DOI 10.1139/X08-190; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; LeRoy CJ, 2006, ECOLOGY, V87, P255, DOI 10.1890/05-0159; Leroy CJ, 2006, FRESHWATER BIOL, V51, P605, DOI 10.1111/j.1365-2427.2006.01512.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Stachowicz JJ, 2013, AM NAT, V181, P715, DOI 10.1086/669969; Kominoski JS, 2011, ECOLOGY, V92, P151, DOI 10.1890/10-0028.1; Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Meiresonne L, 2007, CAN J FOREST RES, V37, P141, DOI 10.1139/X06-205; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; Werner EE, 1996, ECOLOGY, V77, P157, DOI 10.2307/2265664; ODUM EP, 1984, BIOSCIENCE, V34, P558, DOI 10.2307/1309598; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Jackrel SL, 2014, ECOLOGY, V95, P37, DOI 10.1890/13-0804.1; Madritch MD, 2002, ECOLOGY, V83, P2084; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Geraldes A, 2013, MOL ECOL RESOUR, V13, P306, DOI 10.1111/1755-0998.12056; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; WEBER JC, 1985, CAN J FOREST RES, V15, P376; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Marks JC, 2009, FRESHWATER BIOL, V54, P2616, DOI 10.1111/j.1365-2427.2009.02270.x; Rubbo MJ, 2004, ECOLOGY, V85, P2519, DOI 10.1890/03-0653; McKown AD, 2014, NEW PHYTOL, V203, P535, DOI 10.1111/nph.12815; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Nowlin WH, 2008, ECOLOGY, V89, P647, DOI 10.1890/07-0303.1; McKown AD, 2013, OECOLOGIA, V172, P653, DOI 10.1007/s00442-012-2531-5; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; LeRoy CJ, 2007, J N AM BENTHOL SOC, V26, P426, DOI 10.1899/06-113.1; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Barbour RC, 2009, OIKOS, V118, P1917, DOI 10.1111/j.1600-0706.2009.17609.x; Clarke K. R., 2006, PRIMER V6 USER MANUA; Compson ZG, 2013, OECOLOGIA, V173, P507, DOI 10.1007/s00442-013-2643-6; Cotrufo MF, 2005, GLOBAL CHANGE BIOL, V11, P1; DeWoody J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079925; Efron B, 2004, ANN STAT, V32, P407; Ellison A.M., 2004, PRIMER ECOLOGICAL ST; Farrar JL, 1995, TREES CANADA; Hesterberg T., 2008, STAT SURVEYS, V2, P61, DOI DOI 10.1214/08-SS035; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Kominoski JS, 2010, RIVER RES APPL, V26, P67, DOI 10.1002/rra.1285; Leroy CJ, 2012, FRESHW SCI, V31, P1244, DOI 10.1899/12-029.1; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Power M. E., 2004, FOOD WEBS LANDSCAPE; R Core Team, 2013, R LANG ENV STAT COMP; SATORRA A, 1990, QUAL QUANT, V24, P367, DOI 10.1007/BF00152011; Shipley B, 2002, CAUSE CORRELATION BI; Wymore AS, 2011, NEW PHYTOL, V191, P19, DOI 10.1111/j.1469-8137.2011.03730.x	71	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	DEC	2014	23	23					5888	5903		10.1111/mec.12931		16	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AU5ET	WOS:000345630700018		
J	Chang, CH; Li, F; Shao, KT; Lin, YS; Morosawa, T; Kim, S; Koo, H; Kim, W; Lee, JS; He, SP; Smith, C; Reichard, M; Miya, M; Sado, T; Uehara, K; Lavoue, S; Chen, WJ; Mayden, RL				Chang, Chia-Hao; Li, Fan; Shao, Kwang-Tsao; Lin, Yeong-Shin; Morosawa, Takahiro; Kim, Sungmin; Koo, Hyeyoung; Kim, Won; Lee, Jae-Seong; He, Shunping; Smith, Carl; Reichard, Martin; Miya, Masaki; Sado, Tetsuya; Uehara, Kazuhiko; Lavoue, Sebastien; Chen, Wei-Jen; Mayden, Richard L.			Phylogenetic relationships of Acheilognathidae (Cypriniformes: Cyprinoidea) as revealed from evidence of both nuclear and mitochondrial gene sequence variation: Evidence for necessary taxonomic revision in the family and the identification of cryptic species	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article						Acheilognathinae; Cyprinidae; Cryptic species; Nuclear loci; Cytochrome b; European bitterling	TELEOSTEI CYPRINIDAE; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; RHODEUS-SERICEUS; BITTERLING FISH; UNIONID MUSSELS; SENIOR SYNONYM; YANGTZE-RIVER; CHINA; EVOLUTION	Bitterlings are relatively small cypriniform species and extremely interesting evolutionarily due to their unusual reproductive behaviors and their coevolutionary relationships with freshwater mussels. As a group, they have attracted a great deal of attention in biological studies. Understanding the origin and evolution of their mating system demands a well-corroborated hypothesis of their evolutionary relationships. In this study, we provide the most comprehensive phylogenetic reconstruction of species relationships of the group based on partitioned maximum likelihood and Bayesian methods using DNA sequence variation of nuclear and mitochondrial genes on 41 species, several subspecies and three undescribed species. Our findings support the monophyly of the Acheilognathidae. Two of the three currently recognized genera are not monophyletic and the family can be subdivided into six clades. These clades are further regarded as genera based on both their phylogenetic relationships and a reappraisal of morphological characters. We present a revised classification for the Acheilognathidae with five genera/lineages: Rhodeus, Acheilognathus (new constitution), Tanakia (new constitution), Paratanakia gen. nov., and Pseudorhodeus gen. nov. and an unnamed clade containing five species currently referred to as "Acheilognathus". Gene trees of several bitterling species indicate that the taxa are not monophyletic. This result highlights a potentially dramatic underestimation of species diversity in this family. Using our new phylogenetic framework, we discuss the evolution of the Acheilognathidae relative to classification, taxonomy and biogeography. (C) 2014 Elsevier Inc. All rights reserved.	[Chang, Chia-Hao; Shao, Kwang-Tsao] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Chang, Chia-Hao; Lin, Yeong-Shin] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30068, Taiwan; [Chang, Chia-Hao; Mayden, Richard L.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Li, Fan] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan; [Li, Fan] Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Lin, Yeong-Shin] Natl Chino Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 30068, Taiwan; [Morosawa, Takahiro] Japan Wildlife Res Ctr, Tokyo 1308606, Japan; [Kim, Sungmin; Kim, Won] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Koo, Hyeyoung] Sangji Univ, Dept Biol Sci, Wonju 220702, South Korea; [Lee, Jae-Seong] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Smith, Carl] Univ St Andrews, Sch Biol, St Andrews KY16 8LB, Fife, Scotland; [Smith, Carl; Reichard, Martin] Acad Sci Czech Republic, Inst Vertebrate Biol, CS-60365 Brno, Czech Republic; [Miya, Masaki; Sado, Tetsuya] Nat Hist Museum & Inst, Chiba 2608682, Japan; [Uehara, Kazuhiko] Res Inst Environm Agr & Fisheries, Aquat Life Conservat Res Ctr, Osaka 5720088, Japan; [Lavoue, Sebastien; Chen, Wei-Jen] Natl Taiwan Univ, Inst Oceanog, Taipei 10617, Taiwan	Chen, WJ (reprint author), Natl Taiwan Univ, Inst Oceanog, Room 301,1 Sec 4 Roosevelt Rd, Taipei 10617, Taiwan.	wjchen.actinops@gmail.com	Reichard, Martin/C-6563-2009; CHEN, Wei-Jen/A-2605-2008; Lee, Jae-Seong/H-6013-2015	CHEN, Wei-Jen/0000-0003-4751-7632; Lee, Jae-Seong/0000-0003-0944-5172	USA NSF Grant [DEB-1021840]; Taiwanese MOST Grants [MOST 99-2611-M-002-001-MY2, MOST 101-2611-M-002-016-MY3]; Japan Science for the Promotion of Science [17207007]	The authors thank Dr. Kouichi Kawamura, Dr. Jiang Zhou, Dr. Shen-Horn Yen, Mr. Xiu-Fa Hou, Mr. Tomoki Oonaka, Mr. Akimitsu Hanado, Mr. Masumi Ozaki, Dr. Jano Kosco, Dr. Meta Povz, and Dr. Maurice Kottelat for providing bitterling specimens. This research was supported by USA NSF Grant (DEB-1021840 to RLM) and by Taiwanese MOST Grants (MOST 99-2611-M-002-001-MY2 and MOST 101-2611-M-002-016-MY3 to WJ.C.). MM acknowledges the Japan Science for the Promotion of Science (Grant No. 17207007).	Agbali M., 2011, EVOLUTION, V64, P1683; Okazaki M, 2001, J FISH BIOL, V58, P89, DOI 10.1006/jfbi.2000.1430; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; Yang J, 2012, J ZOOL SYST EVOL RES, V50, P184, DOI 10.1111/j.1439-0469.2012.00661.x; Reichard M, 2012, BIOL LETTERS, V8, P601, DOI 10.1098/rsbl.2011.1234; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Smith BT, 2013, MOL ECOL, V22, P483, DOI 10.1111/mec.12118; Yang Q, 2010, ENVIRON BIOL FISH, V88, P333, DOI 10.1007/s10641-010-9645-6; Spence R, 2013, BEHAV ECOL, V24, P82, DOI 10.1093/beheco/ars138; Liu HZ, 2006, ZOOL STUD, V45, P428; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Casalini M, 2009, EVOLUTION, V63, P366, DOI 10.1111/j.1558-5646.2008.00555.x; Tang KL, 2011, MOL PHYLOGENET EVOL, V61, P103, DOI 10.1016/j.ympev.2011.05.022; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ueda T, 1997, ICHTHYOL RES, V44, P302, DOI 10.1007/BF02678709; Kottelat M, 2013, RAFFLES B ZOOL, P1; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Iwatsuki Y, 2010, COPEIA, P123, DOI 10.1643/CI-08-073; Spence R, 2013, ACTA ZOOL-STOCKHOLM, V94, P113, DOI 10.1111/j.1463-6395.2011.00532.x; Mayden RL, 2010, MOL PHYLOGENET EVOL, V57, P152, DOI 10.1016/j.ympev.2010.04.008; Kawamura K, 2014, ZOOL SCI, V31, P321, DOI 10.2108/zs130233; Kitamura J, 2012, J EVOLUTION BIOL, V25, P566, DOI 10.1111/j.1420-9101.2011.02453.x; Bohlen J, 2006, MOL PHYLOGENET EVOL, V40, P856, DOI 10.1016/j.ympev.2006.04.020; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Reichard M, 2006, J EVOLUTION BIOL, V19, P788, DOI 10.1111/j.1420-9101.2005.01051.x; Smith C, 2004, J ZOOL, V262, P107, DOI 10.1017/S0952836903004497; Reichard M, 2007, J FISH BIOL, V70, P709, DOI 10.1111/j.1095-8649.2007.01333.x; Yang L, 2012, MOL PHYLOGENET EVOL, V65, P362, DOI 10.1016/j.ympev.2012.06.007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Arai R., 2003, U MUSEUM U TOKYO B, V40, P1; Arai Ryoichi, 2007, Bulletin of the National Museum of Nature and Science Series A-Zoology, P1; ARAI R, 1988, Bulletin of the National Science Museum Series A (Zoology), V14, P199; Arai R., 1988, FISH SYSTEMATICS CLA; Bogutskaya N.G., 2001, P ZOOL I, V287, P81; Chang C-H, 2009, ZOOLOGICAL STUDIES, V48, P839; Chen WJ, 2009, MOL PHYLOGENET EVOL, V52, P544, DOI 10.1016/j.ympev.2009.01.006; Chen YY, 1998, FAUNA SINICA OSTEICH; Cheng PL, 2014, ZOOL SCI, V31, P300, DOI 10.2108/zs130069; Duc N.H., 2013, J BIOL, V35, P18; Eschmeyer W. N., 2014, SPECIES FAMILY SUBFA; Eschmeyer W.N., 2014, CATALOG FISHES; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fujiwara M, 2009, GENETICA, V135, P355, DOI 10.1007/s10709-008-9294-2; Gunther A., 1868, CATALOGUE FISHES COL, V7, P1; Howes G.J., 1991, SYSTEMATICS BIOGEOGR; Hwang D.-S., 2014, DNA CELL BIOL, V25, P11; Imamura H, 2011, ICHTHYOL RES, V58, P166, DOI 10.1007/s10228-010-0197-8; Kottelat M., 2007, HDB EUROPEAN FRESHWA; Levin BA, 2012, MOL PHYLOGENET EVOL, V62, P542, DOI 10.1016/j.ympev.2011.09.004; Li F, 2010, ICHTHYOL EXPLOR FRES, V21, P303; Li F, 2014, ZOOTAXA, V3790, P165, DOI 10.11646/zootaxa.3790.1.7; Lopez JA, 2004, COPEIA, P449, DOI 10.1643/CG-03-087R1; Mills SC, 2005, ANIM BEHAV, V70, P31, DOI 10.1016/j.anbehav.2004.09.016; Nakabo T., 2013, FISHES JAPAN PICTORI; Nelson JS, 2006, FISHES WORLD; Nielsen JG, 2011, ZOOTAXA, P59; OJIMA Y, 1973, Zoological Magazine (Tokyo), V82, P171; Okada Y., 1961, STUDIES FRESHWATER F; Perea S., 2010, BMC EVOL BIOL, V10, P1; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Sola L, 2003, GENETICA, V119, P99, DOI 10.1023/A:1024446910161; Tanaka S., 1909, J COLL SCI IMP U TOK, V27, P1; Tao WJ, 2013, MOL PHYLOGENET EVOL, V66, P603, DOI 10.1016/j.ympev.2012.09.024; Tsigenopoulos CS, 2010, MOL PHYLOGENET EVOL, V56, P851, DOI 10.1016/j.ympev.2010.02.006; Ueda T, 2001, GENETICA, V111, P423, DOI 10.1023/A:1013703717626; Ueda Takayoshi, 2006, Cytologia (Tokyo), V71, P251, DOI 10.1508/cytologia.71.251; Wang T, 2012, J APPL ICHTHYOL, V28, P660, DOI 10.1111/j.1439-0426.2012.01971.x; Wang XZ, 2012, SCI CHINA LIFE SCI, V55, P761, DOI 10.1007/s11427-012-4366-z; Winsor MP, 2009, TAXON, V58, P43; Yang Q, 2011, ZOOL SCI, V28, P158, DOI 10.2108/zsj.28.158; YU X, 1987, GENETICA, V72, P225, DOI 10.1007/BF00116227; Zhu Yu-Rong, 2006, Acta Hydrobiologica Sinica, V30, P134	75	4	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	DEC	2014	81						182	194		10.1016/j.ympev.2014.08.026		13	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	AW0AO	WOS:000345953100017		
J	Nishikawa, T; Tung, LY; Kaneda, Y				Nishikawa, Tomoyuki; Tung, Li Yu; Kaneda, Yasufumi			Systemic Administration of Platelets Incorporating Inactivated Sendai Virus Eradicates Melanoma in Mice	MOLECULAR THERAPY			English	Article							CHEMOKINE RECEPTOR EXPRESSION; HVJ ENVELOPE VECTOR; PROSTATE-CANCER; RANTES; CELLS; LYMPHOCYTES; ACTIVATION; PARTICLES; THERAPY; BREAST	Tumor microenvironments include a number of fibrin clots due to the microbleeding caused by cancer cell invasion into blood vessels, which suggests the potential utility of a platelet vector for systemic cancer treatment. We previously reported that inactivated Sendai virus (hemagglutinating virus of Japan; HVJ) envelope (HVJ-E) activates anti-tumor immunity and induces cancer cell-selective apoptosis. The hemagglutination activity that blocks the systemic administration of HVJ-E was dramatically attenuated by incorporation into platelets. Platelets incorporating HVJ-E (PH complex) were then injected into the tail veins of B1 6F10 melanoma-bearing mice. The PH complex primarily accumulated in tumor tissues and caused the significant accumulation of various immune cells in the tumor bed. Injections of the PH complex to the melanoma-bearing mouse significantly reduced the tumor size, and the tumor growth was ultimately arrested. Secretion of the chemokine regulated upon activation normal T-expressed and presumably secreted (RANTES) was upregulated following PH stimulation. The RANTES-depletion in melanoma-bearing mice significantly attenuated the cytotoxic T lymphocyte activity and led to a dramatic abrogation of the mouse melanoma suppression induced by the PH complex. Thus, a platelet vector incorporating viral particles, a Trojan horse for cancer treatment, will provide a new approach for cancer therapy using oncolytic viruses.	[Nishikawa, Tomoyuki; Tung, Li Yu; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Suita, Osaka, Japan	Kaneda, Y (reprint author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, 2-2 Yamada Oka, Suita, Osaka, Japan.	kaneday@gts.med.osaka-u.ac.jp			Japan Society for the Promotion of Science	This work was financially supported by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science. The authors thank Masaaki Murakami (Hokkaido University, Sapporo, Japan) for providing anti-CD4 and anti-CD8 antibodies. The work was conducted in Suita, Osaka, Japan. The authors declare no conflict of interest.	Altaner C, 2014, INT J CANCER, V134, P1458, DOI 10.1002/ijc.28455; Konig JE, 2004, PROSTATE, V58, P121, DOI 10.1002/pros.10317; Campbell JJ, 2001, J IMMUNOL, V166, P6477; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Kurooka M, 2007, CANCER RES, V67, P227, DOI 10.1158/0008-5472.CAN-06-1615; Luboshits G, 1999, CANCER RES, V59, P4681; Murooka TT, 2009, BIOCHEM BIOPH RES CO, V387, P381, DOI 10.1016/j.bbrc.2009.07.035; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Flaujac C, 2010, CELL MOL LIFE SCI, V67, P545, DOI 10.1007/s00018-009-0209-x; MALE R, 1992, P NATL ACAD SCI USA, V89, P9191, DOI 10.1073/pnas.89.19.9191; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Taniguchi S, 2010, CANCER SCI, V101, P1925, DOI 10.1111/j.1349-7006.2010.01628.x; Kaneda Y, 2012, ADV DRUG DELIVER REV, V64, P730, DOI 10.1016/j.addr.2011.03.007; ALAM R, 1993, J IMMUNOL, V150, P3442; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; Fuentes-Beltran A, 2009, CLIN EXP ALLERGY, V39, P491, DOI 10.1111/j.1365-2222.2008.03190.x; Wilcox RA, 2009, BLOOD, V114, P2936, DOI 10.1182/blood-2009-05-220111; Matsumura Y, 2012, ADV DRUG DELIVER REV, V64, P710, DOI 10.1016/j.addr.2011.12.010; BISCHOFF SC, 1993, EUR J IMMUNOL, V23, P761, DOI 10.1002/eji.1830230329; Burke F, 1996, CYTOKINE, V8, P578, DOI 10.1006/cyto.1996.0077; Ehrlich P, 1906, COLLECTED STUDIES IM; Fujihara A, 2008, CANCER IMMUNOL IMMUN, V57, P73, DOI 10.1007/s00262-007-0351-y; Kaneda Y, 2005, DEV HVJ ENVELOPE VEC; Matsushima-Miyagi T, 2012, CLIN CANCER RES, V18, P6271, DOI 10.1158/1078-0432.CCR-12-1595; Mima H, 2005, J GENE MED, V7, P888, DOI 10.1002/jgm.735; Pietrzak A, 2009, IMMUNOL LETT, V123, P46, DOI 10.1016/j.imlet.2009.02.003	29	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	DEC	2014	22	12					2046	2055		10.7038/mt.2014.128		10	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AU8BW	WOS:000345822600005		
J	Kawabata, T; Iwai, H; Seko, H; Shoji, Y; Saito, K; Ishii, S; Mizutani, K				Kawabata, Takuya; Iwai, Hironori; Seko, Hiromu; Shoji, Yoshinori; Saito, Kazuo; Ishii, Shoken; Mizutani, Kohei			Cloud-Resolving 4D-Var Assimilation of Doppler Wind Lidar Data on a Meso-Gamma-Scale Convective System	MONTHLY WEATHER REVIEW			English	Article							DIFFERENTIAL ABSORPTION; BOUNDARY-LAYER; WATER-VAPOR; MODEL; PRECIPITATION; RETRIEVAL; PROFILES; RADAR; PREDICTION; FORECASTS	The authors evaluated the effects of assimilating three-dimensional Doppler wind lidar (DWL) data on the forecast of the heavy rainfall event of 5 July 2010 in Japan, produced by an isolated mesoscale convective system (MCS) at a meso-gamma scale in a system consisting of only warm rain clouds. Several impact experiments using the nonhydrostatic four-dimensional variational data assimilation system (NHM-4DVAR) and the Japan Meteorological Agency nonhydrostatic model with a 2-km horizontal grid spacing were conducted in which 1) no observations were assimilated (NODA), 2) radar reflectivity and radial velocity determined by Doppler radar and precipitable water vapor determined by GPS satellite observations were assimilated (CTL), and 3) radial velocity determined by DWL were added to the CTL experiment (LDR) and five data denial and two observational error sensitivity experiments. Although both NODA and CTL simulated an MCS, only LDR captured the intensity, location, and horizontal scale of the observed MCS. Assimilating DWL data improved the wind direction and speed of low-level airflows, thus improving the accuracy of the simulated water vapor flux. The examination of the impacts of specific assimilations and assigned observation errors showed that assimilation of all data types is important for forecasting intense MCSs. The investigation of the MCS structure showed that large amounts of water vapor were supplied to the rainfall event by southerly flow. A midlevel inversion layer led to the production of exclusively liquid water particles in the MCS, and in combination with the humid airflow into the MCS, this inversion layer may be another important factor in its development.	[Kawabata, Takuya; Seko, Hiromu; Shoji, Yoshinori; Saito, Kazuo] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki, Japan; [Iwai, Hironori; Ishii, Shoken; Mizutani, Kohei] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Kawabata, T (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	tkawabat@mri-jma.go.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21244074]	We thank Dr. Tadashi Tsuyuki at the Meteorological Research Institute (MRI) for his useful advice. We thank Mr. Hiroshige Tsuguti at the MRI for productive discussions and Mr. Akifumi Nishi at the University of Tsukuba for drawing 3D images of the MCS. We are grateful to the anonymous reviewers and the editor for their useful suggestions. The Geospatial Information Authority of Japan kindly provided GPS observations. This study was partly supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research (21244074), "Study of advanced data assimilation and cloud-resolving ensemble technique for the prediction of local heavy rainfall."	Sun JZ, 1997, J ATMOS SCI, V54, P1642, DOI 10.1175/1520-0469(1997)054<1642:DAMRFD>2.0.CO;2; Bluestein HB, 2014, J ATMOS OCEAN TECH, V31, P302, DOI 10.1175/JTECH-D-13-00112.1; Kawabata T, 2013, J METEOROL SOC JPN, V91, P705, DOI 10.2151/jmsj.2013-510; Seko H, 2004, J METEOROL SOC JPN, V82, P473, DOI 10.2151/jmsj.2004.473; Rennie SJ, 2011, MON WEATHER REV, V139, P1148, DOI 10.1175/2010MWR3482.1; Stoffelen A, 2005, B AM METEOROL SOC, V86, P73, DOI 10.1175/BAMS-86-1-73; Kawabata T, 2011, MON WEATHER REV, V139, P1911, DOI 10.1175/2011MWR3428.1; Kawabata T, 2007, J METEOROL SOC JPN, V85, P255, DOI 10.2151/jmsj.85.255; Huang XY, 2009, MON WEATHER REV, V137, P299, DOI 10.1175/2008MWR2577.1; Ishii S, 2010, APPL OPTICS, V49, P1809, DOI 10.1364/AO.49.001809; Zhang FQ, 2006, WEATHER FORECAST, V21, P149, DOI 10.1175/WAF909.1; Done J, 2004, ATMOS SCI LETT, V5, P110, DOI 10.1002/asl.72; Baker WE, 2014, B AM METEOROL SOC, V95, P543, DOI 10.1175/BAMS-D-12-00164.1; Iwai H, 2013, J ATMOS OCEAN TECH, V30, P429, DOI 10.1175/JTECH-D-12-00111.1; Saito K, 2007, J METEOROL SOC JPN, V85B, P271, DOI 10.2151/jmsj.85B.271; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Banta RM, 1996, J APPL METEOROL, V35, P330, DOI 10.1175/1520-0450(1996)035<0330:IOSSFF>2.0.CO;2; Drechsel S, 2009, J ATMOS OCEAN TECH, V26, P635, DOI 10.1175/2008JTECHA1115.1; Drechsel S, 2010, J ATMOS OCEAN TECH, V27, P1881, DOI 10.1175/2010JTECHA1495.1; Fujibe T., 2002, TENKI, V49, P393; Hara T., 2013, RES ACT ATMOS OCEANI, V43; Ishii S, 2006, P SOC PHOTO-OPT INS, V6409, pJ4090, DOI 10.1117/12.693526; Kato T, 2005, SOLA, V1, P1, DOI 10.2151/sola.2005.001; Kusunoki K, 2002, J ATMOS OCEAN TECH, V19, P1063, DOI 10.1175/1520-0426(2002)019<1063:APSOCA>2.0.CO;2; Newsom RK, 2004, J ATMOS OCEAN TECH, V21, P1328, DOI 10.1175/1520-0426(2004)021<1328:ACDLMI>2.0.CO;2; Saito K., 2012, ATMOSPHERIC MODEL AP, P85, DOI [DOI 10.5772/35368, dx.doi.org/10.5772/35368]; Shoji Y, 2013, J METEOROL SOC JPN, V91, P43, DOI 10.2151/jmsj.2013-103; Shun CM, 2008, J ATMOS OCEAN TECH, V25, P637, DOI 10.1175/2007JTECHA1057.1; Skamarock W. C., 2005, NCARTN468STR; TAKAHASHI T, 1981, J ATMOS SCI, V38, P347, DOI 10.1175/1520-0469(1981)038<0347:WRSIHI>2.0.CO;2; Tang YM, 2013, METEOROL APPL, V20, P417, DOI 10.1002/met.1300; Wang HL, 2012, MON WEATHER REV, V140, P2287, DOI 10.1175/MWR-D-12-00005.1; Weissmann M, 2012, Q J ROY METEOR SOC, V138, P118, DOI 10.1002/qj.896; Yamada Y, 2012, P 16 INT C CLOUDS PR; Zhang L, 2011, MON WEATHER REV, V139, P3369, DOI 10.1175/2011MWR3569.1	35	3	3	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	DEC	2014	142	12					4484	4498		10.1175/MWR-D-13-00362.1		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AU8QE	WOS:000345860400008		
J	Hatsuzuka, D; Yasunari, T; Fujinami, H				Hatsuzuka, Daisuke; Yasunari, Tetsuzo; Fujinami, Hatsuki			Characteristics of Low Pressure Systems Associated with Intraseasonal Oscillation of Rainfall over Bangladesh during Boreal Summer	MONTHLY WEATHER REVIEW			English	Article							GRIDDED PRECIPITATION DATASET; INTERANNUAL VARIABILITY; MONSOON DEPRESSIONS; COMPOSITE STRUCTURE; INDIAN RAINFALL; DENSE NETWORK; ASIA; CONVECTION; GAUGES; IMPACT	Characteristics of low pressure systems (LPSs) responsible for submonthly-scale (7-25 days) intraseasonal oscillation (ISO) in rainfall over Bangladesh and their impact on the amplitude of active peaks are investigated for 29 summer monsoon seasons. Extreme and moderate active peaks are obtained based on the amplitude of 7-25-day-filtered rainfall series. By detecting the LPSs that formed over the Indian monsoon region, it was found that about 59% (62%) of extreme (moderate) active peaks of rainfall are related to LPSs. These LPSs have horizontal scale of about 600km and vertical scale of about 9 km. For the extreme active peak, the locations of the LPS centers are clustered significantly over and around Bangladesh, accompanied by the maximum convergence in the southeast sector of the LPSs. After their formation, they tend to remain almost stationary over and around Bangladesh. In contrast, for the moderate active peak, the LPS centers are located over the Ganges Plain around 85 degrees E, and the maximum convergence of the LPSs occurs around their centers. This difference in the convergence fields is closely associated with the geographical features to the north and east of Bangladesh and the horizontal scale of the LPSs. These features suggest that the amplitude of the active peaks in the submonthly-scale ISO is modulated by small differences in the locations of the LPS centers. These findings suggest that improved predictions of both genesis location and the tracks of the LPSs are crucial to forecasting seasonal rainfall over Bangladesh.	[Hatsuzuka, Daisuke] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Yasunari, Tetsuzo] Res Inst Humanity & Nat, Kyoto, Japan; [Fujinami, Hatsuki] Nagoya Univ, Hydrospher Atmospher Res Ctr, Nagoya, Aichi 4648601, Japan	Hatsuzuka, D (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hatsuzuka.daisuke@f.mbox.nagoya-u.ac.jp			Japan Society for the Promotion of Sciences (JSPS) [B-22340137, B-24740320, C-26400465]	The authors thank Drs. T. Hayashi, T. Kumagai, and H. Kanamori for their valuable comments and suggestions. We obtained the APHRODITE dataset from the project website (http://www.chikyu.ac.jp/precip/). This study was conducted with the support of Grant-in-Aid for Scientific Research (B-22340137), Grant-in-Aid for Scientific Research for Young Scientists (B-24740320), and Grant-in-Aid for Scientific Research (C-26400465) from the Japan Society for the Promotion of Sciences (JSPS). Portions of this study were conducted as part of a collaborative research program of the Hydrospheric Atmospheric Research Center, Nagoya University.	Takahashi HG, 2008, J METEOROL SOC JPN, V86, P429, DOI 10.2151/jmsj.86.429; KRISHNAMURTI TN, 1976, J ATMOS SCI, V33, P1937, DOI 10.1175/1520-0469(1976)033<1937:OOAMSP>2.0.CO;2; Annamalai H, 2001, CLIM DYNAM, V18, P85, DOI 10.1007/s003820100161; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; MOOLEY DA, 1973, MON WEATHER REV, V101, P271, DOI 10.1175/1520-0493(1973)101<0271:SAOIMD>2.3.CO;2; Goswami BN, 2001, J CLIMATE, V14, P1180, DOI 10.1175/1520-0442(2001)014<1180:IOAIVO>2.0.CO;2; Xie SP, 2006, J CLIMATE, V19, P3420, DOI 10.1175/JCLI3777.1; SAHA K, 1981, MON WEATHER REV, V109, P330, DOI 10.1175/1520-0493(1981)109<0330:WPPOMD>2.0.CO;2; HARTMANN DL, 1989, J ATMOS SCI, V46, P2838, DOI 10.1175/1520-0469(1989)046<2838:IPIIR>2.0.CO;2; Hoyos CD, 2007, J CLIMATE, V20, P4402, DOI 10.1175/JCLI4252.1; Krishnamurthy V, 2010, J CLIMATE, V23, P4285, DOI 10.1175/2010JCLI2953.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Chowdhury MR, 2003, THEOR APPL CLIMATOL, V76, P105, DOI 10.1007/s00704-003-0001-z; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; GODBOLE RV, 1977, TELLUS, V29, P25; Goswami BN, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016734; CHEN TC, 1993, MON WEATHER REV, V121, P2465, DOI 10.1175/1520-0493(1993)121<2465:TDMOTI>2.0.CO;2; Fujinami H, 2014, CLIM DYNAM, V43, P2147, DOI 10.1007/s00382-013-2040-1; Fujinami H, 2011, INT J CLIMATOL, V31, P1192, DOI 10.1002/joc.2146; Houze RA, 2007, Q J ROY METEOR SOC, V133, P1389, DOI 10.1002/qj.106; Islam MN, 2005, J METEOROL SOC JPN, V83, P21, DOI 10.2151/jmsj.83.21; Kataoka A, 2005, SOLA, V1, P205, DOI 10.2151/sola.2005.053; Kripalani RH, 1996, INT J CLIMATOL, V16, P689, DOI 10.1002/(SICI)1097-0088(199606)16:6<689::AID-JOC36>3.0.CO;2-K; Krishnamurti T. N., 1975, J METEOR SOC JAPAN, V53, P227; Matsumoto J., 1996, B DEP GEOGR U TOKYO, V28, P25; Mooley D. A., 1989, Mausam, V40; Murakami M., 1977, J METEOR SOC JAPAN, V55, P442; MURAKAMI T, 1984, J METEOROL SOC JPN, V62, P440; Murata F, 2008, NAT HAZARDS, V44, P399, DOI 10.1007/s11069-007-9125-2; Ohsawa T, 2001, J METEOROL SOC JPN, V79, P333, DOI 10.2151/jmsj.79.333; Ohsawa T, 2000, J GEOPHYS RES-ATMOS, V105, P29445, DOI 10.1029/2000JD900499; Rafiuddin M, 2010, INT J CLIMATOL, V30, P1042, DOI 10.1002/joc.1949; Raghavan S, 2003, B AM METEOROL SOC, V84, P635, DOI 10.1175/BAMS-84-5-635; Sato T, 2013, MON WEATHER REV, V141, P2451, DOI 10.1175/MWR-D-12-00321.1; SIKKA DR, 1977, PURE APPL GEOPHYS, V115, P1501, DOI 10.1007/BF00874421; SINGH SV, 1992, J CLIMATE, V5, P973, DOI 10.1175/1520-0442(1992)005<0973:IVOTMJ>2.0.CO;2; Terao T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026156; Yasunari T., 1980, J METEOR SOC JAPAN, V58, P225; Yasunari T., 1979, J METEOR SOC JAPAN, V57, P227; Yasunari T, 1981, J METEOR SOC JAPAN, V59, P336, DOI DOI 10.1038/NATURE05431; Yatagai A, 2009, SOLA, V5, P137, DOI 10.2151/sola.2009-035	41	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	DEC	2014	142	12					4758	4774		10.1175/MWR-D-13-00307.1		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AU8QE	WOS:000345860400022		
J	Yoshida, I; Ibuki, Y				Yoshida, Ikuma; Ibuki, Yuko			Formaldehyde-induced histone H3 phosphorylation via JNK and the expression of proto-oncogenes	MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS			English	Article						Formaldehyde; Histone H3; Phosphorylation; gamma-H2AX; Proto-oncogene; JNK	PROTEIN CROSS-LINKS; B-INDUCED PHOSPHORYLATION; LYMPHOHEMATOPOIETIC MALIGNANCIES; CELL-TRANSFORMATION; INHALATION EXPOSURE; HUMAN-LYMPHOBLASTS; C-FOS; SERINE-10; PHOSPHOACETYLATION; CHROMATIN	Formaldehyde (FA) is a very reactive compound that forms DNA adducts and DNA-protein crosslinks, which are known to contribute to FA-induced mutations and carcinogenesis. Post-translational modifications to histones have recently attracted attention due to their link with cancer. In the present study, we examined histone modifications following a treatment with FA. FA significantly phosphorylated histone H3 at serine 10 (H3S10), and at serine 28 (H3S28), the time-course of which was similar to the phosphorylation of H2AX at serine 139 (gamma-H2AX), a marker of DNA double strand breaks. The temporal deacetylation of H3 was observed due to the reaction of FA with the lysine residues of histones. The phosphorylation mechanism was then analyzed by focusing on H3S10. The nuclear distribution of the phosphorylation of H3S10 and gamma-H2AX did not overlap, and the phosphorylation of H3S10 could not be suppressed with an inhibitor of ATM/ATR, suggesting that the phosphorylation of H3S10 was independent of the DNA damage response. ERK and JNK in the MAPK pathways were phosphorylated by the treatment with FA, in which the JNK pathway was the main target for phosphorylation. The phosphorylation of H3S10 increased at the promoter regions of c-fos and c-jun, indicating a relationship between FA-induced tumor promotion activity and phosphorylation of H3S10. These results suggested that FA both initiates and promotes cancer, as judged by an analysis of histone modifications. (C) 2014 Elsevier B.V. All rights reserved.	[Yoshida, Ikuma; Ibuki, Yuko] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan	Ibuki, Y (reprint author), Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan.	ibuki@u-shizuoka-ken.ac.jp			Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [24510084]	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare, Japan, and by a Grant - in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24510084).	Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Lu K, 2008, CHEM RES TOXICOL, V21, P1586, DOI 10.1021/tx8000576; James TT, 2012, J PHARMACOL EXP THER, V340, P237, DOI 10.1124/jpet.111.186775; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Monticello TM, 1996, CANCER RES, V56, P1012; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; CRAFT TR, 1987, MUTAT RES, V176, P147, DOI 10.1016/0027-5107(87)90262-4; SWENBERG JA, 1980, CANCER RES, V40, P3398; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Keum YS, 2013, ONCOGENE, V32, P444, DOI 10.1038/onc.2012.71; Lee YJ, 2007, EUR J PHARMACOL, V573, P29, DOI 10.1016/j.ejphar.2007.06.049; MA TH, 1988, MUTAT RES, V196, P37, DOI 10.1016/0165-1110(88)90027-9; He ZW, 2005, J BIOL CHEM, V280, P2446, DOI 10.1074/jbc.M402053200; Jakab MG, 2010, MUTAT RES-GEN TOX EN, V698, P11, DOI 10.1016/j.mrgentox.2010.02.015; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; KERNS WD, 1983, CANCER RES, V43, P4382; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Ye XL, 2005, MUTAT RES-GEN TOX EN, V588, P22, DOI 10.1016/j.mrgentox.2005.08.005; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Beane Freeman LE, 2009, J NATL CANCER I, V101, P751, DOI 10.1093/jnci/djp096; Bost F, 1999, MOL CELL BIOL, V19, P1938; Cerutti H, 2009, EPIGENETICS, V4, P71; Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197; CROSBY RM, 1988, ENVIRON MOL MUTAGEN, V12, P155, DOI 10.1002/em.2860120202; DALBEY WE, 1982, TOXICOLOGY, V24, P9, DOI 10.1016/0300-483X(82)90058-0; Edrissi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003328; Hauptmann M, 2003, J NATL CANCER I, V95, P1615, DOI 10.1093/jnci/djg083; Ibuki Y, 2014, CARCINOGENESIS, V35, P1228, DOI 10.1093/carcin/bgt492; International Agency for Research on Cancer, 2012, REV HUM CARC F, P401; International Agency for Research on Cancer, 2006, IARC MON EV CARC RIS, V88, P1; Ishihama M, 2008, TOXICOL IN VITRO, V22, P1861, DOI 10.1016/j.tiv.2008.09.005; IVERSEN O H, 1986, Environment International, V12, P541, DOI 10.1016/0160-4120(86)90148-0; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; MONTICELLO TM, 1991, TOXICOL APPL PHARM, V111, P409, DOI 10.1016/0041-008X(91)90246-B; Noda T, 2011, BIOCHEM BIOPH RES CO, V404, P206, DOI 10.1016/j.bbrc.2010.11.094; Ohnuki G, 2010, MUTAT RES-GEN TOX EN, V702, P70, DOI 10.1016/j.mrgentox.2010.07.001; Ren X., 2013, ARCH TOXICOL, V87, P89; Shaham J, 2003, OCCUP ENVIRON MED, V60, P403, DOI 10.1136/oem.60.6.403; Shaham J, 2002, MUTAT RES-GEN TOX EN, V514, P115, DOI 10.1016/S1383-5718(01)00334-5; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Toyooka T, 2009, MUTAT RES-GEN TOX EN, V676, P34, DOI 10.1016/j.mrgentox.2009.03.002; Toyooka T, 2011, J INVEST DERMATOL, V131, P1313, DOI 10.1038/jid.2011.28; Toyooka T, 2006, ENVIRON SCI TECHNOL, V40, P3603, DOI 10.1021/es060182i; Tyihak E, 2001, CELL PROLIFERAT, V34, P135, DOI 10.1046/j.1365-2184.2001.00206.x; VELCICH A, 1990, MOL CELL BIOL, V10, P6273; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508; Ye X, 2013, ENVIRON MOL MUTAGEN, V54, P705, DOI 10.1002/em.21821	57	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0027-5107	1873-135X		MUTAT RES-FUND MOL M	Mutat. Res.-Fundam. Mol. Mech. Mutagen.	DEC	2014	770						9	18		10.1016/j.mrfmmm.2014.09.003		10	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	AU5LC	WOS:000345647400002		
J	Mizushima, N				Mizushima, Noboru			Sugar modification inhibits autophagosome-lysosome fusion	NATURE CELL BIOLOGY			English	Editorial Material							C. ELEGANS; DEGRADATION; MECHANISMS; MUTANTS; DISEASE; LINK		[Mizushima, Noboru] Univ Tokyo, Grad Sch, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Mizushima, N (reprint author), Univ Tokyo, Grad Sch, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009				TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Kumar A, 2014, J BIOL CHEM, V289, P13543, DOI 10.1074/jbc.M114.553321; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011	15	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1132	1133				3	Cell Biology	Cell Biology	AU7JR	WOS:000345777300004		
J	Ono, N; Ono, W; Nagasawa, T; Kronenberg, HM				Ono, Noriaki; Ono, Wanida; Nagasawa, Takashi; Kronenberg, Henry M.			A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones	NATURE CELL BIOLOGY			English	Article							OSTEO-CHONDROPROGENITOR CELLS; STEM-CELLS; TRANSGENIC MICE; GROWTH-PLATE; CRE ACTIVITY; MARROW; DIFFERENTIATION; PRECURSORS; EXPRESSION; CARTILAGE	The hallmark of endochondral bone development is the presence of cartilaginous templates, in which osteoblasts and stromal cells are generated to form mineralized matrix and support bone marrow haematopoiesis. However, the ultimate source of these mesenchymal cells and the relationship between bone progenitors in fetal life and those in later life are unknown. Fate-mapping studies revealed that cells expressing cre-recombinases driven by the collagen II (Col2) promoter/enhancer and their descendants contributed to, in addition to chondrocytes, early perichondrial precursors before Runx2 expression and, subsequently, to a majority of osteoblasts, Cxcl12 (chemokine (C-X-C motif) ligand 12)-abundant stromal cells and bone marrow stromal/mesenchymal progenitor cells in postnatal life. Lineage-tracing experiments using a tamoxifen-inducible creER system further revealed that early postnatal cells marked by Col2-creER, as well as Sox9-creER and aggrecan (Acan)-creER, progressively contributed to multiple mesenchymal lineages and continued to provide descendants for over a year. These cells are distinct from adult mesenchymal progenitors and thus provide opportunities for regulating the explosive growth that occurs uniquely in growing mammals.	[Ono, Noriaki; Ono, Wanida; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Ono, Noriaki; Ono, Wanida; Kronenberg, Henry M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ono, Noriaki; Ono, Wanida] Univ Michigan, Dept Orthodont & Pediat Dent, Sch Dent, Ann Arbor, MI 48109 USA; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto 6068507, Japan; [Nagasawa, Takashi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan	Kronenberg, HM (reprint author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	hkronenberg@mgh.harvard.edu			National Institutes of Health [DE022564, DK056246]	The authors thank D. Rowe (University of Connecticut, USA) for Col2.3-GFP and Oc-GFP mice and S. Mackem (National Cancer Institute, USA) for Col2a1-creER<SUP>T2</SUP> mice, H. Akiyama (Kyoto University, Japan) and B. de Crombrugghe (MD Anderson Cancer Center, USA) for Sox9-creER<SUP>T2</SUP> and Acan-creER<SUP>T2</SUP> mice, and L. Prickett, K. Folz-Donahue and M. Weglarz of Harvard Stem Cell Institute/Massachusetts General Hospital flow cytometry core and T. Diefenbach of Ragon Institute imaging core for their expert assistance. This work was supported by National Institutes of Health Grants DE022564 to N.O. and DK056246 to H.M.K.	Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Ono N, 2014, DEV CELL, V29, P330, DOI 10.1016/j.devcel.2014.03.014; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Wang WX, 2011, HUM MOL GENET, V20, P3910, DOI 10.1093/hmg/ddr310; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Chen JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085161; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071318	31	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1157	U73		10.1038/ncb3067		19	Cell Biology	Cell Biology	AU7JR	WOS:000345777300007		
J	Angeli, JPF; Schneider, M; Proneth, B; Tyurina, YY; Tyurin, VA; Hammond, VJ; Herbach, N; Aichler, M; Walch, A; Eggenhofer, E; Basavarajappa, D; Radmark, O; Kobayashi, S; Seibt, T; Beck, H; Neff, F; Esposito, I; Wanke, R; Forster, H; Yefremova, O; Heinrichmeyer, M; Bornkamm, GW; Geissler, EK; Thomas, SB; Stockwell, BR; O'Donnell, VB; Kagan, VE; Schick, JA; Conrad, M				Angeli, Jose Pedro Friedmann; Schneider, Manuela; Proneth, Bettina; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Hammond, Victoria J.; Herbach, Nadja; Aichler, Michaela; Walch, Axel; Eggenhofer, Elke; Basavarajappa, Devaraj; Radmark, Olof; Kobayashi, Sho; Seibt, Tobias; Beck, Heike; Neff, Frauke; Esposito, Irene; Wanke, Ruediger; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Bornkamm, Georg W.; Geissler, Edward K.; Thomas, Stephen B.; Stockwell, Brent R.; O'Donnell, Valerie B.; Kagan, Valerian E.; Schick, Joel A.; Conrad, Marcus			Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice	NATURE CELL BIOLOGY			English	Article							ISCHEMIA-REPERFUSION INJURY; CELL-DEATH; OXIDATIVE STRESS; DISEASE-MODELS; CYTOCHROME-C; GLUTATHIONE; IRON; 5-LIPOXYGENASE; PHOSPHOLIPIDS; INFLAMMATION	Ferroptosis is a non-apoptotic form of cell death induced by small molecules in specific tumour types, and in engineered cells overexpressing oncogenic RAS. Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic. Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathologically relevant form of ferroptosis. Using inducible Gpx4(-/-) mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidation-induced acute renal failure and associated death. We furthermore systematically evaluated a library of small molecules for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine derivative called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4(-/-) mice, and in a pre-clinical model of ischaemia/reperfusion-induced hepatic damage. In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.	[Angeli, Jose Pedro Friedmann; Proneth, Bettina; Kobayashi, Sho; Seibt, Tobias; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Schick, Joel A.; Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Schneider, Manuela] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Tyurina, Yulia Y.; Tyurin, Vladimir A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Hammond, Victoria J.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Herbach, Nadja; Wanke, Ruediger] Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, D-80539 Munich, Germany; [Aichler, Michaela; Walch, Axel; Neff, Frauke] Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Neuherberg, Germany; [Eggenhofer, Elke; Geissler, Edward K.] Univ Med Ctr Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Basavarajappa, Devaraj; Radmark, Olof] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Kobayashi, Sho] Yamagata Univ, Dept Food & Appl Life Sci, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Beck, Heike] Univ Munich, Walter Brendel Ctr Expt Med, Munich Heart Alliance, D-81377 Munich, Germany; [Esposito, Irene] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany; [Bornkamm, Georg W.] Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, D-81377 Neuherberg, Germany; [Thomas, Stephen B.; Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Thomas, Stephen B.; Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, Dept Chem, New York, NY 10027 USA	Conrad, M (reprint author), Helmholtz Zentrum Munchen, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	marcus.conrad@helmholtz-muenchen.de	Walch, Axel/B-4554-2012; Aichler, Michaela/B-5356-2014	Walch, Axel/0000-0001-5578-4023; 	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3]; Alexander von Humboldt-Stiftung; Japan Society for the Promotion of Science (JSPS); Human Frontier Science Program (HFSP) [RGP0013]; m4 Award (Bavarian Ministry of Economic Affairs); NIH [HL114453]	We are grateful to D. Green for his valuable comments and critical reading of the manuscript. We would also like to thank A. Berns, The Netherlands Cancer Institute, Amsterdam, for providing the ROSA26-CreER<SUP>T2</SUP> mouse line, J. Silke (The Walter and Eliza Hall Institute, Melbourne, Australia) for the Rip1-knockout cells and M. P. Murphy (Medical Research Council, London, UK) for provision of MitoQ and Mito-BODIPY. We are most grateful to L. Pichl for excellent technical assistance. This work was in part supported by the Deutsche Forschungsgemeinschaft (DFG) CO 291/2-3 to M.C., a fellowship from Alexander von Humboldt-Stiftung to J.P.F.A., a fellowship from the Japan Society for the Promotion of Science (JSPS) to S.K., the Human Frontier Science Program (HFSP) RGP0013 to M.C. and V.E.K., HL114453 (NIH) to V.E.K., and by the m4 Award (Bavarian Ministry of Economic Affairs) to M.C. and J.A.S.	ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Eggenhofer E, 2013, J IMMUNOL, V191, P480, DOI 10.4049/jimmunol.1202975; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Tyurina YY, 2008, FREE RADICAL BIO MED, V44, P299, DOI [10.1016/j.freeradbiomed.2007.08.021, 10.1016/j.frecradbiorned.2007.08.021]; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Tyurina YY, 2014, CHEM PHYS LIPIDS, V179, P3, DOI 10.1016/j.chemphyslip.2013.12.003; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Liang HY, 2009, J BIOL CHEM, V284, P30836, DOI 10.1074/jbc.M109.032839; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Sun DX, 1996, J BIOL CHEM, V271, P24055; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Kim MS, 2005, J LIPID RES, V46, P650, DOI 10.1194/jlr.M400389-JLR200; Kriska T, 2010, J LIPID RES, V51, P3174, DOI 10.1194/jlr.M008342; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Zarjou A, 2013, J CLIN INVEST, V123, P4423, DOI 10.1172/JCI67867; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Herbach N, 2009, AM J PHYSIOL-RENAL, V296, pF819, DOI 10.1152/ajprenal.90665.2008; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kim J, 2011, J LIPID RES, V52, P389, DOI 10.1194/jlr.D010587; Mannes AM, 2011, FASEB J, V25, P2135, DOI 10.1096/fj.10-177147; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tanaka R, 2006, FISHERIES SCI, V72, P665, DOI 10.1111/j.1444-2906.2006.01197.x; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vila A, 2004, BIOCHEMISTRY-US, V43, P12592, DOI 10.1021/bi0491200; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/nmeth.2759, 10.1038/NMETH.2759]	44	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1180	U120		10.1038/ncb3064		23	Cell Biology	Cell Biology	AU7JR	WOS:000345777300009		
J	Mori, M; Watanabe, M; Shiogama, H; Inoue, J; Kimoto, M				Mori, Masato; Watanabe, Masahiro; Shiogama, Hideo; Inoue, Jun; Kimoto, Masahide			Robust Arctic sea-ice influence on the frequent Eurasian cold winters in past decades	NATURE GEOSCIENCE			English	Article							NORTH-ATLANTIC SST; ATMOSPHERIC CIRCULATION; AMPLIFICATION; ANOMALIES; TRACK; CCM3	Over the past decade, severe winters occurred frequently in mid-latitude Eurasia(1,2), despite increasing global- and annual-mean surface air temperatures(3). Observations suggest that these cold Eurasian winters could have been instigated by Arctic sea-ice decline(2,4), through excitation of circulation anomalies similar to the Arctic Oscillation(5). In climate simulations, however, a robust atmospheric response to sea-ice decline has not been found, perhaps owing to energetic internal fluctuations in the atmospheric circulation(6). Here we use a 100-member ensemble of simulations with an atmospheric general circulation model driven by observation-based sea-ice concentration anomalies to show that as a result of sea-ice reduction in the Barents-Kara Sea, the probability of severe winters has more than doubled in central Eurasia. In our simulations, the atmospheric response to sea-ice decline is approximately independent of the Arctic Oscillation. Both reanalysis data and our simulations suggest that sea-ice decline leads to more frequent Eurasian blocking situations, which in turn favour cold-air advection to Eurasia and hence severe winters. Based on a further analysis of simulations from 22 climate models we conclude that the sea-ice-driven cold winters are unlikely to dominate in a warming future climate, although uncertainty remains, due in part to an insufficient ensemble size.	[Mori, Masato; Watanabe, Masahiro; Kimoto, Masahide] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778568, Japan; [Shiogama, Hideo] Natl Inst Environm Studies, Ctr Global Environm Res, Ibaraki 3058506, Japan; [Inoue, Jun] Natl Inst Polar Res, Tokyo 1908518, Japan	Mori, M (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778568, Japan.	masato@aori.u-tokyo.ac.jp	kimoto, masahide/P-9077-2014; Shiogama, Hideo/B-9598-2012		Ministry of Education, Culture, Sports, Science and Technlogy (MEXT), Japan [24241009]	We acknowledge the modelling groups, the PCMDI and the WGCM for their efforts in making the CMIP5 multi model data set available. We thank M. Yoshimori and M. Honda for helpful discussion. This work was supported by the Grant-in-Aid 24241009 and the Program for Risk Information on Climate Change (SOUSEI program) from the Ministry of Education, Culture, Sports, Science and Technlogy (MEXT), Japan.	KUSHNIR Y, 1989, J ATMOS SCI, V46, P3122, DOI 10.1175/1520-0469(1989)046<3122:LFVITN>2.0.CO;2; Magnusdottir G, 2004, J CLIMATE, V17, P857, DOI 10.1175/1520-0442(2004)017<0857:TEONAS>2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Sakamoto TT, 2012, J METEOROL SOC JPN, V90, P325, DOI 10.2151/jmsj.2012-301; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Palmer TN, 1999, J CLIMATE, V12, P575, DOI 10.1175/1520-0442(1999)012<0575:ANDPOC>2.0.CO;2; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/ngeo2234, 10.1038/NGEO2234]; Deser C, 2004, J CLIMATE, V17, P877, DOI 10.1175/1520-0442(2004)017<0877:TEONAS>2.0.CO;2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Overland JE, 2011, POLAR RES, V30, DOI 10.3402/polar.v30i0.15787; Screen JA, 2013, J CLIMATE, V26, P1230, DOI 10.1175/JCLI-D-12-00063.1; Corti S, 1999, NATURE, V398, P799; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; D'Andrea F, 1998, CLIM DYNAM, V14, P385, DOI 10.1007/s003820050230; Inoue J, 2012, J CLIMATE, V25, P2561, DOI 10.1175/JCLI-D-11-00449.1; Alexander MA, 2004, J CLIMATE, V17, P890, DOI 10.1175/1520-0442(2004)017<0890:TARTRA>2.0.CO;2; Tang QH, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014036; Bader J, 2011, ATMOS RES, V101, P809, DOI 10.1016/j.atmosres.2011.04.007; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Peings Y, 2014, J CLIMATE, V27, P244, DOI 10.1175/JCLI-D-13-00272.1; Christensen J. H., 2013, CLIMATE CHANGE 2013, P1217, DOI [DOI 10.1017/CB09781107415324, 10.1017/CBO9781107415324]; Cohen JL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014007; Honda M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037079; Hopsch S, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.18624; Liu J., 2012, P NATL ACAD SCI USA, V109, P4074; Petoukhov V, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013568; Screen J. A., 2013, CLIM DYNAM, V43, P333, DOI DOI 10.1007/S00382-013-1830-9; Stocker T F, 2013, CLIMATE CHANGE 2013, P1	30	28	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	DEC	2014	7	12					869	873		10.1038/NGEO2277		5	Geosciences, Multidisciplinary	Geology	AU9LW	WOS:000345915300012		
J	Nishikawa, T; Ide, S				Nishikawa, Tomoaki; Ide, Satoshi			Earthquake size distribution in subduction zones linked to slab buoyancy	NATURE GEOSCIENCE			English	Article							OCCURRENCES; SEISMICITY; MAGNITUDE; DEPTH; AGE	The occurrence of subduction zone earthquakes is primarily controlled by the state of stress on the interface between the subducting and overriding plates. This stress state is influenced by tectonic properties, such as the age of the subducting plate and the rate of plate motion(1-4). It is difficult to directly measure stress on a plate interface. However, the stress state can be inferred using the Gutenberg-Richter relationship's(5) b-value, which characterizes the relative number of small compared to large earthquakes and correlates negatively with differential stress(6-13). That is, a subduction zone characterized by relatively frequent large earthquakes has a low b-value and a high stress state. The b-value for subduction zonesworldwide varies significantly(14,15), but the source of this variance is unclear. Here we use the Advanced National Seismic System earthquake catalogue to estimate b-values for 88 sections in different subduction zones globally and compare the b-values with the age of the subducting plate and plate motions. The b-value correlates positively with subducting plate age, so that large earthquakes occur more frequently in subduction zones with younger slabs, but there is no correlation between b-value and plate motion. Given that younger slabs are warmer and more buoyant, we suggest that slab buoyancy is the primary control on the stress state and earthquake size distribution in subduction zones.	[Nishikawa, Tomoaki; Ide, Satoshi] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Nishikawa, T (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	nishikawa@eps.s.u-tokyo.ac.jp			JSPS KAKENHI [23244090]; MEXT KAKENHI [21107007]	This work was supported by JSPS KAKENHI (23244090) and MEXT KAKENHI (21107007). Figures were prepared using Generic Mapping Tool (Wessel and Smith, 1998).	Aki K., 1965, B EARTHQ RES I TOKYO, V43, P237; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Ide S, 2013, NAT GEOSCI, V6, P780, DOI [10.1038/ngeo1901, 10.1038/NGEO1901]; Goebel THW, 2013, GEOPHYS RES LETT, V40, P2049, DOI 10.1002/grl.50507; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Ghosh A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031617; RUFF L, 1980, PHYS EARTH PLANET IN, V23, P240, DOI 10.1016/0031-9201(80)90117-X; GIBOWICZ SJ, 1973, B SEISMOL SOC AM, V63, P1433; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.2307/2288914; Schorlemmer D, 2005, NATURE, V437, P539, DOI 10.1038/nature04094; UYEDA S, 1979, J GEOPHYS RES, V84, P1049, DOI 10.1029/JB084iB03p01049; Woessner J, 2005, B SEISMOL SOC AM, V95, P684, DOI 10.1785/0120040007; RUFF L, 1983, TECTONOPHYSICS, V99, P99, DOI 10.1016/0040-1951(83)90097-5; Zhuang J, 2002, J AM STAT ASSOC, V97, P369, DOI 10.1198/016214502760046925; Wiemer S, 1997, J GEOPHYS RES-SOL EA, V102, P15115, DOI 10.1029/97JB00726; MOLNAR P, 1978, EARTH PLANET SC LETT, V41, P330, DOI 10.1016/0012-821X(78)90187-5; Kagan YY, 2013, B SEISMOL SOC AM, V103, P1181, DOI 10.1785/0120120110; Spada M, 2013, GEOPHYS RES LETT, V40, P709, DOI 10.1029/2012GL054198; Goebel THW, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008763; Argus DF, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003751; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185; Heuret A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050712; Hilde T. W. C., 1983, Geodynamics of the Western Pacific-Indonesian region; Nanjo KZ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052997; Scholz C. H., 1968, Bulletin of the Seismological Society of America, V58; SCHOLZ CH, 1995, J GEOPHYS RES-SOL EA, V100, P22103, DOI 10.1029/95JB01869; Scholz CH, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009003; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; TSAPANOS TM, 1990, PURE APPL GEOPHYS, V134, P229, DOI 10.1007/BF00876999	30	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	DEC	2014	7	12					904	908		10.1038/NGEO2279		5	Geosciences, Multidisciplinary	Geology	AU9LW	WOS:000345915300021		
J	Nanishi, Y				Nanishi, Yasushi			NOBEL PRIZE IN PHYSICS The birth of the blue LED	NATURE PHOTONICS			English	News Item							LIGHT-EMITTING-DIODES; AIN BUFFER LAYER; STIMULATED-EMISSION; LASER-DIODES; GAN FILMS; GROWTH		Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kusatsu, Shiga 5258577, Japan	Nanishi, Y (reprint author), Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	nanishi@se.ritsumei.ac.jp					NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1705; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; AMANO H, 1990, JPN J APPL PHYS 2, V29, pL205, DOI 10.1143/JJAP.29.L205; NAKAMURA S, 1992, JPN J APPL PHYS 1, V31, P1258, DOI 10.1143/JJAP.31.1258; NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1998; HAASE MA, 1991, APPL PHYS LETT, V59, P1272, DOI 10.1063/1.105472; AKASAKI I, 1995, JPN J APPL PHYS 2, V34, P1517; NAKAMURA S, 1992, JPN J APPL PHYS 2, V31, pL139, DOI 10.1143/JJAP.31.L139; NAKAMURA S, 1993, JPN J APPL PHYS 2, V32, pL8, DOI 10.1143/JJAP.32.L8; AMANO H, 1989, JPN J APPL PHYS 2, V28, pL2112; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; MARUSKA HP, 1969, APPL PHYS LETT, V15, P327, DOI 10.1063/1.1652845; NAKAMURA S, 1995, JPN J APPL PHYS 2, V34, pL1332; PANKOVE JI, 1971, RCA REV, V32, P383	14	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	DEC	2014	8	12					884	886				3	Optics; Physics, Applied	Optics; Physics	AU8AG	WOS:000345818600004		
J	Marandi, A; Wang, Z; Takata, K; Byer, RL; Yamamoto, Y				Marandi, Alireza; Wang, Zhe; Takata, Kenta; Byer, Robert L.; Yamamoto, Yoshihisa			Network of time-multiplexed optical parametric oscillators as a coherent Ising machine	NATURE PHOTONICS			English	Article							QUANTUM SIMULATION; SQUEEZED STATES; SPIN-GLASS; GENERATION; ALGORITHM; LATTICE; MODELS	Finding the ground states of the Ising Hamiltonian(1) maps to various combinatorial optimization problems in biology, medicine, wireless communications, artificial intelligence and social network. So far, no efficient classical and quantum algorithm is known for these problems and intensive research is focused on creating physical systems-Ising machines-capable of finding the absolute or approximate ground states of the Ising Hamiltonian(2-6). Here, we report an Ising machine using a network of degenerate optical parametric oscillators (OPOs). Spins are represented with above-threshold binary phases of the OPOs and the Ising couplings are realized by mutual injections(7). The network is implemented in a single OPO ring cavity with multiple trains of femtosecond pulses and configurable mutual couplings, and operates at room temperature. We programmed a small non-deterministic polynomial time-hard problem on a 4-OPO sing machine and in 1,000 runs no computational error was detected.	[Marandi, Alireza; Wang, Zhe; Byer, Robert L.; Yamamoto, Yoshihisa] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Marandi, Alireza; Takata, Kenta; Yamamoto, Yoshihisa] Natl Inst Informat, Tokyo 1018403, Japan; [Takata, Kenta; Yamamoto, Yoshihisa] Univ Tokyo, Dept Informat & Commun Engn, Tokyo 1138656, Japan	Marandi, A (reprint author), Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA.	marandi@stanford.edu		Takata, Kenta/0000-0001-6282-3510	FIRST Quantum Information Processing project	The authors thank S.E. Harris, H. Mabuchi, M. Armen, S. Utsunomiya, S. Tamate, K. Yan and Y. Haribara for discussions and K. Ingold, C.W. Rudy, C. Langrock and K. Urbanek for experimental support. The work is supported by the FIRST Quantum Information Processing project.	Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; WU LA, 1986, PHYS REV LETT, V57, P2520, DOI 10.1103/PhysRevLett.57.2520; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Santoro GE, 2002, SCIENCE, V295, P2427, DOI 10.1126/science.1068774; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Marandi A, 2012, OPT EXPRESS, V20, P19322, DOI 10.1364/OE.20.019322; Goemans MX, 1995, J ACM, V42, P1115, DOI 10.1145/227683.227684; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Roslund J, 2014, NAT PHOTONICS, V8, P109, DOI [10.1038/nphoton.2013.340, 10.1038/NPHOTON.2013.340]; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; Marandi A, 2012, OPT EXPRESS, V20, P7255, DOI 10.1364/OE.20.007255; Utsunomiya S, 2011, OPT EXPRESS, V19, P18091, DOI 10.1364/OE.19.018091; WOLINSKY M, 1988, PHYS REV LETT, V60, P1836, DOI 10.1103/PhysRevLett.60.1836; BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Dickson NG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2920; Galluccio A, 2000, PHYS REV LETT, V84, P5924, DOI 10.1103/PhysRevLett.84.5924; Gottesman D, 1998, PREPRINT; Graham R., 1973, COHERENCE QUANTUM OP, P851; Hochbaum DS, 1996, APPROXIMATION ALGORI; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; NABORS CD, 1990, J OPT SOC AM B, V7, P815, DOI 10.1364/JOSAB.7.000815; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI; Wang Z, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063853; Witten IH, 2005, DATA MINING PRACTICA; Wu K, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.28	30	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	DEC	2014	8	12					937	942		10.1038/NPHOTON.2014.249		6	Optics; Physics, Applied	Optics; Physics	AU8AG	WOS:000345818600013		
J	Mayaffre, H; Kramer, S; Horvatic, M; Berthier, C; Miyagawa, K; Kanoda, K; Mitrovic, VF				Mayaffre, H.; Kraemer, S.; Horvatic, M.; Berthier, C.; Miyagawa, K.; Kanoda, K.; Mitrovic, V. F.			Evidence of Andreev bound states as a hallmark of the FFLO phase in kappa-(BEDT-TTF)(2)Cu(NCS)(2)	NATURE PHYSICS			English	Article							BEDT-TTF; ORGANIC SUPERCONDUCTORS; C-13 NMR; RELAXATION; FIELD	Superconductivity is a quantum phenomenon arising, in its simplest form, from the pairing of fermions with opposite spin into a state with zero net momentum. Whether superconductivity can occur in fermionic systems with an unequal number of two species distinguished by spin or flavour presents an important open question in condensed-matter physics or quantum chromodynamics(1). In condensed matter the imbalance between spin-up and spin-down electrons that form the Cooper pairs is induced by the magnetic field. Such an imbalanced system can lead to exotic superconductivity in which pairs acquire finite momentum(2,3). This momentum leads to a spatially inhomogeneous state consisting of periodically alternating 'normal' and 'superconducting' regions. Here, we establish that the hallmark of this state is the appearance of spatially localized and spin-polarized quasiparticles forming the so-called Andreev bound states (ABS). These are detected through our nuclear magnetic resonance (NMR) measurements.	[Mayaffre, H.; Kraemer, S.; Horvatic, M.; Berthier, C.] UPS, UJF, Lab Natl Champs Magnet Intenses, CNRS UPR 3228, F-38042 Grenoble 9, France; [Mayaffre, H.; Kraemer, S.; Horvatic, M.; Berthier, C.] INSA, F-38042 Grenoble 9, France; [Miyagawa, K.; Kanoda, K.] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Mitrovic, V. F.] Brown Univ, Dept Phys, Providence, RI 02912 USA	Mitrovic, VF (reprint author), Brown Univ, Dept Phys, Providence, RI 02912 USA.	vemi@brown.edu	Berthier, Claude/D-9686-2011	Berthier, Claude/0000-0001-6796-0506	French ANR grant [06-BLAN-0111]; EuroMagNET II network under EU [228043]; visiting faculty program of Universite Joseph Fourier; ADVANCE [HRD-0548311]	We would like to thank A. Vorontsov, Y. Yanase and M. Sigrist for illuminating discussions, and I. Sheikin for providing raw data for the phase diagram. This research is supported by funds from the French ANR grant 06-BLAN-0111, the EuroMagNET II network under EU Contract No. 228043, the visiting faculty program of Universite Joseph Fourier (V.F.M.), and ADVANCE HRD-0548311 (V.F.M.).	Abragam A, 1999, PRINCIPLES NUCL MAGN; Vorontsov AB, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.184501; Yanase Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.114715; Casalbuoni R, 2004, REV MOD PHYS, V76, P263, DOI 10.1103/RevModPhys.76.263; Koutroulakis G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.087001; MAKI K, 1966, PHYS REV, V148, P362, DOI 10.1103/PhysRev.148.362; Agosta CC, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.214514; Loh YL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.067003; Loh YL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.165302; FULDE P, 1964, PHYS REV, V135, pA550, DOI 10.1103/PhysRev.135.A550; Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.187004; Lortz R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.187002; Uji S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.157001; Bergk B, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064506; CLEM JR, 1990, PHYS REV B, V42, P6209, DOI 10.1103/PhysRevB.42.6209; Cui QH, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.014503; DESOTO SM, 1995, BR PHYS REV B, V52, P10364; DESOTO SM, 1993, PHYS REV LETT, V70, P2956, DOI 10.1103/PhysRevLett.70.2956; GRUENBER.LW, 1966, PHYS REV LETT, V16, P996, DOI 10.1103/PhysRevLett.16.996; KAWAMOTO A, 1995, PHYS REV LETT, V74, P3455, DOI 10.1103/PhysRevLett.74.3455; LARKIN AI, 1965, SOV PHYS JETP-USSR, V20, P762; MANSKY PA, 1994, PHYS REV B, V50, P15944; MANSKY PA, 1993, PHYS REV LETT, V70, P1323, DOI 10.1103/PhysRevLett.70.1323; MAYAFFRE H, 1994, BR EUROPHYS LETT, V28, P205; MAYAFFRE H, 1995, PHYS REV LETT, V75, P4122, DOI 10.1103/PhysRevLett.75.4122; Singleton J, 2000, J PHYS-CONDENS MAT, V12, pL641, DOI 10.1088/0953-8984/12/40/102; URAYAMA H, 1988, CHEM LETT, P55, DOI 10.1246/cl.1988.55; Wang Q, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.117006; Won H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.180504; Wright JA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.087002	30	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	DEC	2014	10	12					928	932		10.1038/NPHYS3121		5	Physics, Multidisciplinary	Physics	AU7BI	WOS:000345755100014		
J	Lin, SZ; Wang, XY; Kamiya, Y; Chern, GW; Fan, F; Fan, D; Casas, B; Liu, Y; Kiryukhin, V; Zurek, WH; Batista, CD; Cheong, SW				Lin, Shi-Zeng; Wang, Xueyun; Kamiya, Yoshitomo; Chern, Gia-Wei; Fan, Fei; Fan, David; Casas, Brian; Liu, Yue; Kiryukhin, Valery; Zurek, Wojciech H.; Batista, Cristian D.; Cheong, Sang-Wook			Topological defects as relics of emergent continuous symmetry and Higgs condensation of disorder in ferroelectrics	NATURE PHYSICS			English	Article							SUPERCONDUCTING PHASE-TRANSITION; SUPERFLUID HE-3; 3 DIMENSIONS; VORTICES; BREAKING; CRYSTALS; DYNAMICS; MODEL; RENORMALIZATION; UNIVERSE	Lars Onsager and Richard Feynman envisaged that the three-dimensional (3D) superfluid-to-normal lambda transition in He-4 occurs through the proliferation of vortices. This process should hold for every phase transition in the same universality class. The role of topological defects in symmetry-breaking phase transitions has become a prime topic in cosmology and high-temperature superconductivity, even though direct imaging of these defects is challenging. Here we show that the U(1) continuous symmetry that emerges at the ferroelectric critical point of multiferroic hexagonal manganites leads to a similar proliferation of vortices. Moreover, the disorder field (vortices) is coupled to an emergent U(1) gauge field, which becomes massive by means of the Higgs mechanism when vortices condense (span the whole system) on heating above the ferroelectric transition temperature. Direct imaging of the vortex network in hexagonal manganites offers unique experimental access to this dual description of the ferroelectric transition, while enabling tests of the Kibble-Zurek mechanism.	[Lin, Shi-Zeng; Kamiya, Yoshitomo; Chern, Gia-Wei; Zurek, Wojciech H.; Batista, Cristian D.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Lin, Shi-Zeng; Chern, Gia-Wei; Zurek, Wojciech H.; Batista, Cristian D.] Los Alamos Natl Lab, CNLS, Los Alamos, NM 87545 USA; [Wang, Xueyun; Fan, Fei; Fan, David; Casas, Brian; Liu, Yue; Kiryukhin, Valery; Cheong, Sang-Wook] Rutgers State Univ, Rutgers Ctr Emergent Mat, Piscataway, NJ 08854 USA; [Wang, Xueyun; Fan, Fei; Fan, David; Casas, Brian; Liu, Yue; Kiryukhin, Valery; Cheong, Sang-Wook] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Kamiya, Yoshitomo] RIKEN, iTHES Res Grp, Wako, Saitama 3510198, Japan; [Kamiya, Yoshitomo] RIKEN, Condensed Matter Theory Lab, Wako, Saitama 3510198, Japan; [Fan, Fei] Northwestern Polytech Univ, Sch Sci, Shaanxi Key Lab Condensed Matter Struct & Propert, Xian 710129, Peoples R China; [Fan, David] Montgomery High Sch, Skillman, NJ 08558 USA; [Casas, Brian] Univ S Florida, Dept Phys, Funct Mat Lab, Tampa, FL 33613 USA; [Liu, Yue] Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, Tianjin 300457, Peoples R China; [Liu, Yue] Nankai Univ, TEDA Appl Phys Sch, Tianjin 300457, Peoples R China	Cheong, SW (reprint author), Rutgers State Univ, Rutgers Ctr Emergent Mat, 136 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	sangc@physics.rutgers.edu	Kamiya, Yoshitomo/B-6307-2012; Lin, Shi-Zeng/B-2906-2008	Kamiya, Yoshitomo/0000-0002-0758-0234; Lin, Shi-Zeng/0000-0002-4368-5244	DOE under the LDRD program at the Los Alamos National Laboratory; DOE [DE-FG02-07ER46382]; RIKEN iTHES Project; China Scholarship Council	We thank S. C. Chae, A. del campo and V. Zapf for stimulating discussion. This project was in part supported by the DOE under the LDRD program at the Los Alamos National Laboratory. The work at Rutgers University was supported by the DOE under Grant No. DE-FG02-07ER46382. Y.K. acknowledges the financial support by the RIKEN iTHES Project. The work was also supported by China Scholarship Council.	Anderson P W, 1984, BASIC NOTIONS CONDEN; Chae SC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.167601; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; HOHENBERG PC, 1977, REV MOD PHYS, V49, P435, DOI 10.1103/RevModPhys.49.435; Lochocki EB, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665255; Oshikawa M, 2000, PHYS REV B, V61, P3430, DOI 10.1103/PhysRevB.61.3430; VACHASPATI T, 1984, PHYS REV D, V30, P2036, DOI 10.1103/PhysRevD.30.2036; JOSE JV, 1977, PHYS REV B, V16, P1217, DOI 10.1103/PhysRevB.16.1217; BLANKSCHTEIN D, 1984, PHYS REV B, V29, P5250, DOI 10.1103/PhysRevB.29.5250; LIU F, 1992, PHYS REV B, V46, P5963, DOI 10.1103/PhysRevB.46.5963; Choi T, 2010, NAT MATER, V9, P253, DOI [10.1038/nmat2632, 10.1038/NMAT2632]; Campostrini M, 2001, PHYS REV B, V63, DOI [10.1103/PhysRevD.63.124013, 10.1103/PhysRevB.63.214503]; Chae SC, 2010, P NATL ACAD SCI USA, V107, P21366, DOI 10.1073/pnas.1011380107; Mostovoy M, 2010, NAT MATER, V9, P188, DOI 10.1038/nmat2700; Golubchik D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.247002; CHUANG I, 1991, SCIENCE, V251, P1336, DOI 10.1126/science.251.4999.1336; Ruutu VMH, 1996, NATURE, V382, P334, DOI 10.1038/382334a0; Chae SC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.167603; Jungk T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3460286; WILSON KG, 1975, REV MOD PHYS, V47, P773, DOI 10.1103/RevModPhys.47.773; Weiler CN, 2008, NATURE, V455, P948, DOI 10.1038/nature07334; Bauerle C, 1996, NATURE, V382, P332, DOI 10.1038/382332a0; del Campo A, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X1430018X; Dodd ME, 1998, PHYS REV LETT, V81, P3703, DOI 10.1103/PhysRevLett.81.3703; DOMINGUEZ D, 1995, PHYS REV LETT, V75, P717, DOI 10.1103/PhysRevLett.75.717; Feynman R. P., 1955, PROGR LOW TEMPERATUR, V1; Griffin SM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041022; Hove J, 2000, PHYS REV LETT, V84, P3426, DOI 10.1103/PhysRevLett.84.3426; Kavoussanaki E, 2000, PHYS REV LETT, V85, P3452, DOI 10.1103/PhysRevLett.85.3452; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Kibble T, 2007, PHYS TODAY, V60, P47, DOI 10.1063/1.2784684; Kiometzis M, 1995, FORTSCHR PHYS, V43, P697, DOI 10.1002/prop.2190430803; KIOMETZIS M, 1994, PHYS REV LETT, V73, P1975, DOI 10.1103/PhysRevLett.73.1975; Kleinert H, 2010, AIP CONF PROC, V1205, P103, DOI 10.1063/1.3382313; Lamporesi G, 2013, NAT PHYS, V9, P655, DOI 10.1038/NPHYS2734; Monaco R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.180501; Monaco R, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144513; Nguyen AK, 1998, PHYS REV B, V57, P3123, DOI 10.1103/PhysRevB.57.3123; Onsager L, 1949, NUOVO CIMENTO     S2, V6, P249; Pyka K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3291; Ryu S, 1998, PHYS REV B, V57, P14476, DOI 10.1103/PhysRevB.57.14476; SHENOY SR, 1995, PHYS REV B, V51, P9129, DOI 10.1103/PhysRevB.51.9129; Ulm S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3290; Vilenkin A., 1994, COSMIC STRINGS OTHER; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0; Zurek WH, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/40/404209	46	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	DEC	2014	10	12					970	977		10.1038/NPHYS3142		8	Physics, Multidisciplinary	Physics	AU7BI	WOS:000345755100022		
J	Kamei, K; Konta, T; Hirayama, A; Suzuki, K; Ichikawa, K; Fujimoto, S; Iseki, K; Moriyama, T; Yamagata, K; Tsuruya, K; Kimura, K; Narita, I; Kondo, M; Asahi, K; Watanabe, T				Kamei, Keita; Konta, Tsuneo; Hirayama, Atsushi; Suzuki, Kazuko; Ichikawa, Kazunobu; Fujimoto, Shouichi; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Watanabe, Tsuyoshi			A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						cohort study; renal function; uric acid	CHRONIC KIDNEY-DISEASE; FOLLOW-UP; BLOOD-PRESSURE; RISK-FACTORS; COHORT; ALBUMINURIA; PROGRESSION; MORTALITY; CKD	Hyperuricemia is a risk factor for adverse renal outcomes in patients with chronic kidney disease. This study investigated the effect of uric acid on renal function in a community-based population. We used a nationwide database of 165 847 subjects (aged 29-74, male 40%) who participated in the annual 'Specific Health Check and Guidance in Japan' checkup between 2008 and 2010; we examined the relationship between serum uric acid levels at baseline and 2-year change in the estimated glomerular filtration rate (eGFR) obtained by using the Japanese equation. After adjusting for possible confounders, the eGFR change was inversely correlated with uric acid at baseline. In the multivariable analysis, the decline in eGFR was significantly more rapid in subjects with the slight increase in uric acid (males a parts per thousand yen5.7 mg/dL, females a parts per thousand yen4.4 mg/dL), and the risk for incidental renal insufficiency (eGFR < 60 mL/min/1.73 m(2)) was increased at uric acid of a parts per thousand yen6.3 mg/dL in males and a parts per thousand yen5.5 mg/dL in females, compared with the lowest quintile. The multiple linear regression analysis revealed that the effect of uric acid on eGFR changes was significant, especially in females, those with proteinuria and diabetes and those without alcohol consumption. This study showed that serum uric acid is independently associated with a more rapid decline of eGFR and incident renal insufficiency, and that a slight increase within the normal range of serum uric acid might be a risk for renal damage in the general population.	[Kamei, Keita; Konta, Tsuneo; Hirayama, Atsushi; Suzuki, Kazuko; Ichikawa, Kazunobu] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Konta, Tsuneo; Fujimoto, Shouichi; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Watanabe, Tsuyoshi] Minist Hlth Labour & Welf Japan, Steering Comm Res Design Comprehens Hlth Care Sys, Fukushima, Japan	Konta, T (reprint author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	kkonta@med.id.yamagata-u.ac.jp			Health and Labor Sciences Research Grant, Ministry of Health, Labour and Welfare of Japan	This study was supported by the Health and Labor Sciences Research Grant for 'the Study on the appropriate states of Specific Health Checkups and Specific Health Guidance for prevention of CKD progression and the design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Checkups' from the Ministry of Health, Labour and Welfare of Japan.	Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; Suzuki K, 2013, CLIN EXP NEPHROL, V17, P541, DOI 10.1007/s10157-012-0743-y; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; ANTON FM, 1986, METABOLISM, V35, P343; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Iseki K, 2013, HYPERTENS RES, V36, P650, DOI 10.1038/hr.2013.11; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1053/j.ajkd.2004.06.006; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Fukui M, 2008, METABOLISM, V57, P625, DOI 10.1016/j.metabol.2007.12.005; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Beilin LJ, 1996, J HUM HYPERTENS, V10, pS1; Hak AE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2519; Konta T, 2012, AM J HYPERTENS, V25, P342, DOI 10.1038/ajh.2011.217; World Health Organization; International Association for the Study of Obesity; International Obesity Task Force, 2000, AS PAC PERSP RED OB, P15; Yokoyama H, 2011, NEPHROL DIAL TRANSPL, V26, P2924, DOI 10.1093/ndt/gfq774; Zhang LX, 2012, NEPHROL DIAL TRANSPL, V27, P1836, DOI 10.1093/ndt/gfr597	25	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0931-0509	1460-2385		NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	DEC	2014	29	12					2286	2292		10.1093/ndt/gfu256		7	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	AU8GB	WOS:000345833500019		
J	Hanafusa, N; Nomura, T; Hasegawa, T; Nangaku, M				Hanafusa, Norio; Nomura, Takanobu; Hasegawa, Takeshi; Nangaku, Masaomi			Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						aged population; anemia management; individualized therapy; mortality	CHRONIC KIDNEY-DISEASE; REGULAR DIALYSIS TREATMENT; STAGE RENAL-DISEASE; PRACTICE PATTERNS; PHYSICAL PERFORMANCE; OUTCOMES; DOPPS; RISK; ASSOCIATION; SURVIVAL	The elderly hemodialyzed population is growing. However, little is known about the relationship between hemoglobin level and survival according to age. We investigated the effect of age on the relationship between hemoglobin and survival within the Japan Dialysis Outcomes and Practice Patterns Study (DOPPS) cohort. We enrolled the entire Japan DOPPS phases 3 and 4 population. Patients were divided by the age of 75 years into two groups. Cox's proportional hazard model was used with hemoglobin at every 4 months treated as a time-dependent variable. The interaction of age and hemoglobin was analyzed. We included 3341 patients in the analyses. The primary outcome occurred in 567 patients during the median follow-up of 2.64 years. Hemoglobin of entire population was 10.3 +/- 1.3 g/dL. The median of epoetin dose was 3000 IU/week. Interaction was found between ages stratified by the age of 75 years and hemoglobin values (P = 0.045) with use of Cox's proportional hazard model. The nonelderly population had poorer prognosis with hemoglobin < 10 g/dL, while elderly population only with hemoglobin < 9 g/dL. For both hemoglobin strata < 9, a parts per thousand yen9 and < 10 g/dL, interactions between age and hemoglobin were significant. Subgroup analysis indicated that interaction between age and Hb levels was observed only in the nondiabetic nephropathy group. Several sensitivity analyses demonstrated a similar trend with the original analyses and reinforced the robustness. The elderly population might tolerate low hemoglobin levels. Our findings open the way for further investigation of individualized anemia management.	[Hanafusa, Norio; Nangaku, Masaomi] Tokyo Univ Hosp, Dept Hemodialysis & Apheresis, Tokyo 113, Japan; [Hanafusa, Norio] Tokyo Univ Hosp, Div Total Renal Care Med, Tokyo 113, Japan; [Hanafusa, Norio; Hasegawa, Takeshi; Nangaku, Masaomi] Japanese Dialysis Outcomes & Practice Patterns St, Tokyo, Japan; [Nomura, Takanobu] Kyowa Hakko Kirin Co Ltd, Med Affairs, Tokyo, Japan; [Hasegawa, Takeshi] Showa Univ, Fujigaoka Hosp, Dept Internal Med, Div Nephrol, Yokohama, Kanagawa 227, Japan; [Hasegawa, Takeshi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Hasegawa, Takeshi] Showa Univ, Sch Med, Dept Med, Div Nephrol, Yokohama, Kanagawa, Japan; [Hasegawa, Takeshi] Fukushima Med Univ, Ctr Innovat Res Commun & Clin Excellence, Fukushima, Japan; [Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Tokyo 113, Japan	Nangaku, M (reprint author), Tokyo Univ Hosp, Dept Hemodialysis & Apheresis, Tokyo 113, Japan.	mnangaku-tky@umin.ac.jp			Kyowa Hakko Kirin, Co., Ltd.	J-DOPPS is administered by the Arbor Research Collaborative for Health (Ann Arbor, MI, USA) and supported by Kyowa Hakko Kirin, Co., Ltd. without restrictions on publications. Conflict of interest statement. N.H., T.H. and M.N. have a scientific advisor contract with Kyowa Hakko Kirin, Co., Ltd. and received honoraria from Kyowa Hakko Kirin, Co., Ltd. for the study on the J-DOPPS. N.H. and M.N. received research funding from Kyowa Hakko Kirin, Co., Ltd. T.N. is a current employee of Kyowa Hakko Kirin, Co., Ltd.	Avesani CM, 2012, NEPHROL DIAL TRANSPL, V27, P2430, DOI 10.1093/ndt/gfr692; Inaba M, 2012, NEPHRON CLIN PRACT, V120, pC91, DOI 10.1159/000335979; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; GRUNZE M, 1990, AM J NEPHROL, V10, P15, DOI 10.1159/000168211; Nakai S, 2008, THER APHER DIAL, V12, P428, DOI 10.1111/j.1744-9987.2008.00634.x; Goodkin DA, 2011, J AM SOC NEPHROL, V22, P358, DOI 10.1681/ASN.2010020173; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; Johansen KL, 2001, KIDNEY INT, V60, P1586, DOI 10.1046/j.1523-1755.2001.00972.x; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Tentori F, 2010, NEPHROL DIAL TRANSPL, V25, P3050, DOI 10.1093/ndt/gfq138; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; [Anonymous], 2012, KIDNEY INT S, V2, P288; [Anonymous], 2007, OV REG DIAL TREATM J; Young EW, 2000, KIDNEY INT, V57, pS74; Szczech LA, 2010, KIDNEY INT, V77, P239, DOI 10.1038/ki.2009.415; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Brookhart MA, 2010, JAMA-J AM MED ASSOC, V303, P857, DOI 10.1001/jama.2010.206; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; Matsuzawa R, 2012, CLIN J AM SOC NEPHRO, V7, P2010, DOI 10.2215/CJN.03660412; Collins AJ, 2012, AM J KIDNEY DIS, V59, P420; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Foote C, 2012, NEPHROL DIAL TRANSPL, V27, P3581, DOI 10.1093/ndt/gfs096; Grunze M, 1990, AM J NEPHROL S2, V10, P18; Hsieh RL, 2006, AM J KIDNEY DIS, V48, P21, DOI 10.1053/j.ajkd.2006.03.081; Johansen KL, 2012, NEPHROL DIAL TRANSPL, V27, P2418, DOI 10.1093/ndt/gfr697; Levin A, 2007, AM J KIDNEY DIS, V50, P471; KDOQI; National Kidney Foundation, 2006, AM J KIDNEY DIS S, V47, pS16, DOI DOI 10.1053/J.AJKD.2006.03.010; Maekawa K, 2008, NEPHROL DIAL TRANSPL, V23, P2329, DOI 10.1093/ndt/gfm929; McMahon LP, 1999, NEPHROL DIAL TRANSPL, V14, P1182, DOI 10.1093/ndt/14.5.1182; PASCUAL J, 1991, CLIN NEPHROL, V35, P280; Pisoni Ronald L, 2004, Am J Kidney Dis, V44, P7, DOI 10.1016/S0272-6386(04)01099-6; Pisoni RL, 2005, CONTRIB NEPHROL, V149, P58; Port FK, 2006, CLIN J AM SOC NEPHRO, V1, P246, DOI 10.2215/CJN.01050905; ROSTAND SG, 1982, KIDNEY INT, V22, P304, DOI 10.1038/ki.1982.170; Sietsema KE, 2002, AM J KIDNEY DIS, V39, P76, DOI 10.1053/ajkd.2002.29884	45	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0931-0509	1460-2385		NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	DEC	2014	29	12					2316	2326		10.1093/ndt/gfu272		11	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	AU8GB	WOS:000345833500023		
J	Kato, R; Haruyama, Y; Endo, M; Tsutsumi, A; Muto, T				Kato, R.; Haruyama, Y.; Endo, M.; Tsutsumi, A.; Muto, T.			Heavy overtime work and depressive disorder among male workers	OCCUPATIONAL MEDICINE-OXFORD			English	Article						CES-D; depressive disorder; overtime work; working hours	COMMUNITY SAMPLE; FOLLOW-UP; SYMPTOMS; HEALTH; SCALE; JAPAN; ASSOCIATIONS	Background The association between overtime and depression is unclear and very few studies have examined the association between heavy overtime work, i.e. working more than 60 h per week, and depression. Aims To examine the association between heavy overtime work and the onset of depressive disorder among male workers. Methods A 1-year follow-up cohort study of male workers in a manufacturing company in Japan, between 2008 and 2009. Working hours, depressive disorder, assessed by the Center for Epidemiologic Studies Depression (CES-D) Scale (score >16 points), and covariates were measured at baseline and at follow-up. Participants who had depressive disorder at baseline were excluded. Results At follow-up, 1194 participants aged between 18 and 71 years were analysed. Multiple logistic regression analysis revealed that the odds ratio for the new onset of depressive disorder was 4.5 (95% CI 1.8-11.1) times higher for employees working >60 h per week than for those working <= 50 h per week, when adjusted for age, lifestyle factors, work-related characteristics and socio-demographic characteristics at baseline and working hours at follow-up. However, the correlation between working 50.1 to 60 h per week and depressive disorder was not significant. The trend test of depressive disorder among groups by working hours was significant (P<0.01). Conclusions Heavy overtime work is a risk factor for the new onset of depressive disorder in this population of male workers. Working >60 h per week may be the cut-off to screen for high-risk groups who need preventive action against depressive disorder.	[Kato, R.; Haruyama, Y.; Endo, M.; Muto, T.] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi 3210293, Japan; [Tsutsumi, A.] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 2520374, Japan	Kato, R (reprint author), Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Kita Kobayashi 880, Mibu, Tochigi 3210293, Japan.	rimka@mail.goo.ne.jp			ABC 19590607	Grant-in-Aid for Scientific Research (ABC 19590607).	Amagasa T, 2005, J OCCUP HEALTH, V47, P157, DOI 10.1539/joh.47.157; Takada M, 2009, IND HEALTH, V47, P649; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Nakata A, 2011, J CLIN PSYCHIAT, V72, P605, DOI 10.4088/JCP.10m06397gry; Nakashima M, 2011, J SLEEP RES, V20, P110, DOI 10.1111/j.1365-2869.2010.00852.x; Beck A, 2011, ANN FAM MED, V9, P305, DOI 10.1370/afm.1260; Bara AC, 2009, SCAND J WORK ENV HEA, V35, P361; Tarumi K, 2003, IND HEALTH, V41, P101, DOI 10.2486/indhealth.41.101; Virtanen M, 2011, PSYCHOL MED, V41, P2485, DOI 10.1017/S0033291711000171; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; MYERS JK, 1980, AM J PSYCHIAT, V137, P1081; Engel George L, 2012, Psychodyn Psychiatry, V40, P377; Fujino Yoshihisa, 2006, Sangyo Eiseigaku Zasshi, V48, P87, DOI 10.1539/sangyoeisei.48.87; Gea A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-192; IWATA N, 1989, Japanese Journal of Industrial Health, V31, P20; Kai Yuko, 2011, Bulletin of the Physical Fitness Research Institute, P1; Kang Eunjeong, 2010, J Prev Med Public Health, V43, P193, DOI 10.3961/jpmph.2010.43.3.193; Kinderman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076564; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Park JS, 2001, IND HEALTH, V39, P250, DOI 10.2486/indhealth.39.250; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shields M, 1999, Health Rep, V11, P33; Shima S, 1985, JPN J CLIN PSYCHIAT, V27, P717; Suwazono Y, 2003, OCCUP MED-OXFORD, V53, P436, DOI 10.1093/occmed/kqg102; The Japanese Ministry of Health Labour and Welfare, 2002, COMPR PROGR PREV HLT; Virtanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030719; Wada K, 2006, IND HEALTH, V44, P486, DOI 10.2486/indhealth.44.486; Wada O, 2002, OCCUP HLTH REV, V14, P183	29	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480	1471-8405		OCCUP MED-OXFORD	Occup. Med.-Oxf.	DEC	2014	64	8					622	628		10.1093/occmed/kqu120		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AU7JI	WOS:000345776400012		
J	Kish, S; Yokohira, M; Yamakawa, K; Saoo, K; Imaida, K				Kish, Sosuke; Yokohira, Masanao; Yamakawa, Keiko; Saoo, Kousuke; Imaida, Katsumi			Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice	ONCOLOGY LETTERS			English	Article						lung carcinogenesis; progesterone receptor; estrogen receptor; epidermal growth factor receptor; non-small cell lung cancer	HORMONE REPLACEMENT THERAPY; EGFR MUTATIONS; GENE-MUTATIONS; NEVER SMOKERS; CANCER; EXPRESSION; GEFITINIB; WOMEN; SURVIVAL; TUMORS	In the present study, the expression levels of female hormone receptors, estrogen receptor (ER) and progesterone receptor (PR) and the epidermal growth factor receptor, (EGFR), as well as proliferating cell nuclear antigen (PCNA) were examined in lung tumors that were induced by 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice. Each seven-week-old mouse Was administered with 2 mg NNK via intraperitoneal injection and the mice were subsequently euthanized at week 52. Lung tumors, including adenomas, carcinomas in adenomas and adenocarcinomas, were obtained and analyzed by immunohistochemistry for the expression levels of the receptors, ER, PR and EGFR, and PCNA. The results were as follows: i) In mouse lung adenomas, a significant correlation was identified between the size of the tumor and PCNA expression, although not with the expression of the receptors (ER, PR and EGFR); ii) in the carcinoma components of the carcinomas in adenomas, the size of the tumor and PCNA expression were correlated, while EGFR expression demonstrated a significant correlation with PR expression; iii) in adenocarcinomas, the tumor size significantly correlated with PCNA, EGFR and PR expression; and iv) EGFR and PR expression was identified to be significantly correlated in adenocarcinomas, and to a certain extent in the carcinoma components of the carcinomas in adenomas, although not in the adenomas. Notably, ER expression was not associated with tumor growth or the other factors, particularly EGFR expression, and no significant differences were identified between the three types of lesion. These results indicate that PR, like EGFR, may be significant in lung carcinogenesis.	[Kish, Sosuke; Yokohira, Masanao; Yamakawa, Keiko; Saoo, Kousuke; Imaida, Katsumi] Kagawa Univ, Fac Med, Dept Pathol & Host Def, Miki, Kagawa 7610793, Japan; [Saoo, Kousuke] Tomakomai City Hosp, Dept Diagnost Pathol, Tomakomai, Hokkaido 0530034, Japan	Imaida, K (reprint author), Kagawa Univ, Fac Med, Dept Pathol & Host Def, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	imaida@med.kagawa-u.ac.jp					Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Stabile LP, 2002, CANCER RES, V62, P2141; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Ganti AK, 2006, J CLIN ONCOL, V24, P59, DOI 10.1200/JCO.2005.02.9827; [Anonymous], 1973, JAMA, V226, P652; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Raso MG, 2009, CLIN CANCER RES, V15, P5359, DOI 10.1158/1078-0432.CCR-09-0033; Pietras RJ, 2005, STEROIDS, V70, P372, DOI 10.1016/j.steroids.2005.02.017; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Jemal A, 2005, CA-CANCER J CLIN, V55, P10; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; Morani A, 2008, J INTERN MED, V264, P128, DOI 10.1111/j.1365-2796.2008.01976.x; Chlebowski RT, 2010, J NATL CANCER I, V102, P1413, DOI 10.1093/jnci/djq285; Patel JD, 2004, JAMA-J AM MED ASSOC, V291, P1763, DOI 10.1001/jama.291.14.1763; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Zerbe LK, 2008, CANCER CHEMOTH PHARM, V62, P605, DOI 10.1007/s00280-007-0644-z; Pietras RJ, 2007, CLIN CANCER RES, V13, P4672, DOI 10.1158/1078-0432.CCR-07-1373; Slatore CG, 2010, J CLIN ONCOL, V28, P1540, DOI 10.1200/JCO.2009.25.9739; TAIOLI E, 1994, J NATL CANCER I, V86, P869, DOI 10.1093/jnci/86.11.869; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Skov BG, 2008, LUNG CANCER, V59, P88, DOI 10.1016/j.lungcan.2007.07.025; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Su JM, 1996, ANTICANCER RES, V16, P3803; Check JH, 2010, ANTICANCER RES, V30, P119; Di Nunno L, 2000, ARCH PATHOL LAB MED, V124, P1467; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516; Gealy R, 1999, CANCER EPIDEM BIOMAR, V8, P297; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Imaida K, 2007, J TOXICOL PATHOL, V20, P117, DOI 10.1293/tox.20.117; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Kitahashi T, 2008, CANCER SCI, V99, P241, DOI 10.1111/j.1349-7006.2008.00680.x; Massaro D, 2007, AM J PHYSIOL-LUNG C, V293, pL222, DOI 10.1152/ajplung.00384.2006; Renne R, 2009, TOXICOL PATHOL, V37, p5S, DOI 10.1177/0192623309353423; Takeuchi H, 2009, MOL MED REP, V2, P585, DOI 10.3892/mmr_00000141; Weinberg OK, 2005, CANCER RES, V65, P11287, DOI 10.1158/0008-5472.CAN-05-2737; Yamakawa K, 2010, MOL MED REP, V3, P141, DOI 10.3892/mmr_00000231	42	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2379	2386		10.3892/ol.2014.2559		8	Oncology	Oncology	AU9YT	WOS:000345948600004		
J	Nakamura, Y; Ishigaki, Y				Nakamura, Yuka; Ishigaki, Yasuhito			Immunostaining and time-lapse analysis of vinblastine-induced paracrystal formation in human A549 cells	ONCOLOGY LETTERS			English	Article						vinblastin; tubulin; paracrystal; time-lapse microscopy; A549 cells	PROTEIN RBM8A Y14; MAMMALIAN-CELLS; TUBULIN; VECTORS; CANCER; MICROTUBULES; BACULOVIRUS; EXPRESSION; APOPTOSIS; TRIAL	Vinblastine is a vinca alkaloid that binds to tubulin and inhibits microtubule formation in cells. Vinblastine treatment results in the formation of paracrystalline aggregates in the cells, which are formed from tightly packed tubulin molecules. Mitotic spindle assemblies in treated cells are disrupted and cell cycle progression is arrested at the mitosis phase. Vinblastine is therefore widely used for cancer treatment. However, the mechanism underlying paracrystal formation has not been fully elucidated. The present study attempted to observe paracrystal formation in human A549 cells. Initally, paracrystal formation was detected using the anti-tubulin antibody. Secondly, the exogenousuly expressed RFP-conjugated tubulin also formed paracrystals. Additionally, immunostaining with the anti-RBM8A antibody overlapped with paracrystal images obtained from RFP conjugated tubulin. This suggested that the localization of the RBM8A proteins was adjacent to the tubulin molecules prior to vinblastine treatment. Furthermore, a time-lapse analysis was developed for paracrystal formation in viable human A549 cells. This was achieved using exogenous expression of fluorescent proteins conjugated with tubulin and time-lapse microscopy. It may be concluded that the indicated method was successful for the real-time analysis of paracrystal formation in human cells.	[Nakamura, Yuka; Ishigaki, Yasuhito] Kanazawa Med Univ, Med Res Inst, Kahoku, Ishikawa 9200293, Japan	Ishigaki, Y (reprint author), Kanazawa Med Univ, Med Res Inst, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan.	ishigaki@kanazawa-med.ac.jp			Kanazawa Medical University [S2013-2, SR2012-02]; KAKENHI [25460376]	This study was supported by grants from Kanazawa Medical University (S2013-2 and SR2012-02) and a Grant-in-Aid for Scientific Research in Japan (KAKENHI, 25460376).	Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Sakaue-Sawano A, 2008, CHEM BIOL, V15, P1243, DOI 10.1016/j.chembiol.2008.10.015; Chuang TW, 2013, MOL BIOL CELL, V24, P1, DOI 10.1091/mbc.E12-03-0217; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sudo H, 2010, GENOMICS, V95, P210, DOI 10.1016/j.ygeno.2010.02.002; LADISCH S, 1994, MED PEDIATR ONCOL, V23, P107, DOI 10.1002/mpo.2950230207; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; DEBRABANDER M, 1977, CELL BIOL INT REP, V1, P177, DOI 10.1016/0309-1651(77)90038-8; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; BENZEEV A, 1979, CELL, V17, P319, DOI 10.1016/0092-8674(79)90157-0; NELSON RL, 1982, MED PEDIATR ONCOL, V10, P115, DOI 10.1002/mpo.2950100202; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Araki R, 2010, STEM CELLS, V28, P213, DOI 10.1002/stem.282; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; EPSTEIN JB, 1993, CANCER, V71, P1722, DOI 10.1002/1097-0142(19930301)71:5<1722::AID-CNCR2820710503>3.0.CO;2-0; Ishigaki Y, 2013, EXP BIOL MED, V238, P889, DOI 10.1177/1535370213494646; Ishigaki Y, 2014, HISTOCHEM CELL BIOL, V141, P101, DOI 10.1007/s00418-013-1135-4; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; KOVACS K, 1975, RES EXP MED, V165, P245, DOI 10.1007/BF01971384; Moudi Maryam, 2013, Int J Prev Med, V4, P1231; NOGALES E, 1995, J MOL BIOL, V254, P416, DOI 10.1006/jmbi.1995.0628; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; Salicioni AM, 2000, GENOMICS, V69, P54, DOI 10.1006/geno.2000.6315; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; SHIINO M, 1975, AM J ANAT, V144, P399, DOI 10.1002/aja.1001440314; SHIINO M, 1980, CELL TISSUE RES, V213, P433; WEHLAND J, 1983, P NATL ACAD SCI-BIOL, V80, P4286, DOI 10.1073/pnas.80.14.4286; WOODCOCK TM, 1983, J CLIN ONCOL, V1, P247	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2387	2392		10.3892/ol.2014.2549		6	Oncology	Oncology	AU9YT	WOS:000345948600005		
J	Einama, T; Uchida, K; Taniguchi, M; Ota, Y; Watanabe, K; Imai, K; Karasaki, H; Chiba, A; Oikawa, K; Miyokawa, N; Furukawa, H				Einama, Takahiro; Uchida, Koichiro; Taniguchi, Masahiko; Ota, Yu; Watanabe, Kenji; Imai, Koji; Karasaki, Hidenori; Chiba, Atsushi; Oikawa, Kensuke; Miyokawa, Naoyuki; Furukawa, Hiroyuki			Successful curative resection of gallbladder cancer following S-1 chemotherapy: A case report and review of the literature	ONCOLOGY LETTERS			English	Article						gallbladder cancer; S-1; gene expression	COLORECTAL-CANCER; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDYLATE SYNTHASE; LIVER METASTASES; THYMIDINE PHOSPHORYLASE; PHASE-II; EXPRESSION; 5-FLUOROURACIL; FLUOROURACIL; MANAGEMENT	The symptoms of gallbladder cancer (GBC) are vague and non-specific. Therefore, GBC is often detected at an advanced or metastatic stage. The most effective treatment for GBC is surgical resection, however the majority of GBC cases are unresectable at the time of diagnosis. Therefore, numerous GBC patients undergo chemotherapy. This study reports the case of a 60-year-old female with GBC who underwent successful surgical curative resection following a single dose of the chemotherapeutic agent, S-1, twice daily for 4 weeks followed by a 14-day rest period for 36 months. S-1 is a novel orally administered drug composed of a combination of the 5-fluorouracil (5-FU) prodrug, tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and oteracil potassium in a 1:0.4:1 molar concentration ratio. The focus of the present study was the candidate factors that affect the therapeutic efficacy of S-I-based chemotherapy. In particular, the gene expression involved in the S-1 metabolic pathway was investigated by assessing the intratumoral dihydropyrimidine dehydrogenase (DPD), thymidylate synthase (TS) and orotate phosphoribosyltransferase gene expression. The surgical specimen exhibited high intratumoral DPD gene expression levels compared with those observed in previously reported non S-1 responsive cases of biliary tract cancer. Due to the results obtained in the current study, we hypothesize that CDHP enhanced the antitumor efficacy of 5-FU by inhibiting the excess DPD protein produced by the tumor.	[Einama, Takahiro; Uchida, Koichiro; Taniguchi, Masahiko; Ota, Yu; Watanabe, Kenji; Imai, Koji; Karasaki, Hidenori; Furukawa, Hiroyuki] Asahikawa Med Univ, Div Gastroenterol & Gen Surg, Asahikawa, Hokkaido 0788510, Japan; [Einama, Takahiro] Hokkaido Social Work Assoc Obihiro Hosp, Dept Surg, Obihiro, Hokkaido 0800805, Japan; [Chiba, Atsushi] Asahikawa City Hosp, Ctr Digest Dis, Asahikawa, Hokkaido 0708610, Japan; [Oikawa, Kensuke; Miyokawa, Naoyuki] Asahikawa Med Univ, Dept Surg Pathol, Asahikawa, Hokkaido 0788510, Japan	Furukawa, H (reprint author), Asahikawa Med Univ, Div Gastroenterol & Gen Surg, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	titiuehahaue@hotmail.com					DIASIO RB, 1994, J CLIN ONCOL, V12, P2239; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Zhu AX, 2010, ONCOLOGIST, V15, P168, DOI 10.1634/theoncologist.2009-0302; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Soong R, 2008, ANN ONCOL, V19, P915, DOI 10.1093/annonc/mdm599; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Glimelius B, 1996, ANN ONCOL, V7, P593; Bismuth H, 1996, ANN SURG, V224, P509, DOI 10.1097/00000658-199610000-00009; Grobmyer SR, 2004, WORLD J SURG, V28, P47, DOI 10.1007/s00268-003-7131-4; Kuramochi H, 2006, CLIN CANCER RES, V12, P29, DOI 10.1158/1078-0432.CCR-05-1275; Alberts SR, 2005, J CLIN ONCOL, V23, P9243, DOI 10.1200/JCO.2005.07.740; Adam R, 2001, ANN SURG ONCOL, V8, P347; Ishikawa Tadanori, 2003, J Hepatobiliary Pancreat Surg, V10, P233, DOI 10.1007/s00534-003-0848-5; Kitajima K, 2008, INT J CLIN ONCOL, V13, P545, DOI 10.1007/s10147-008-0777-z; Manfredi S, 2000, CANCER, V89, P757, DOI 10.1002/1097-0142(20000815)89:4<757::AID-CNCR6>3.0.CO;2-H; Miyoshi Y, 2005, PROSTATE CANCER P D, V8, P260, DOI 10.1038/sj.pcan.4500817; Morimoto H, 2008, J HEPATO-BILIARY-PAN, V15, P655, DOI 10.1007/s00534-007-1311-9; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Takita Maiko, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P1263; Ueno H, 2004, BRIT J CANCER, V91, P1769, DOI 10.1038/sj.bjc.6602208	20	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2443	2447		10.3892/ol.2014.2565		5	Oncology	Oncology	AU9YT	WOS:000345948600014		
J	Noguchi, E; Kamio, T; Kamio, H; Miura, H; Tamaki, M; Nishizawa, M; Aoyama, K; Oochi, T; Kameoka, S				Noguchi, Eiichiro; Kamio, Takako; Kamio, Hidenori; Miura, Hiroko; Tamaki, Masako; Nishizawa, Masako; Aoyama, Kei; Oochi, Tetsuya; Kameoka, Shingo			Efficacy of lapatinib monotherapy on occult breast cancer presenting with cutaneous metastases: A case report	ONCOLOGY LETTERS			English	Article						occult breast cancer; lapatinib monotherapy; cutaneous metastases; serum human epidermal growth factor receptor 2	MULTICENTER PHASE-II; 1ST-LINE TREATMENT; AXILLARY METASTASES; DOUBLE-BLIND; TRASTUZUMAB; SAFETY; DOCETAXEL; THERAPY; PLUS; CHEMOTHERAPY	The case of a 72-year-old female who identified a lymph node enlargement in the left axilla is reported in the present study. A lymph node biopsy revealed a metastatic adenocarcinoma of the axillary lymph node. Following various assessments, the patient was diagnosed with occult breast cancer and lymph node metastases, for which treatment was initiated. Trastuzumab monotherapy was administered as the patient was elderly, positive for the hepatitis B virus and exhibited the following immunostaining/immunohistochemical analysis results: Estrogen receptor (ER) negative (-), progesterone receptor (PgR) negative (-) and human epidermal growth factor receptor 2 (HER2) positive (3+). Breast ultrasonography was performed 10 months after the initial trastuzumab administration and the left axillary lymph node enlargement had reduced in size and severity. However, a skin rash (erythema) was observed encompassing the left breast and extending into the axilla. As determined by the result of a skin biopsy of this area, the patient was diagnosed with occult breast cancer with cutaneous metastases. The immunohistochemical analysis results obtained from the skin biopsy were similar to those obtained from the lymph nodes: ER (-), PgR (-) and HER2 (3+). Therefore, the patient was switched from trastuzumab to lapatinib monotherapy. The erythema completely disappeared after two months of treatment. At present (34 months following lapatinib monotherapy initiation) no new lesions or severe side-effects have been observed.	[Noguchi, Eiichiro; Kamio, Takako; Kamio, Hidenori; Miura, Hiroko; Tamaki, Masako; Nishizawa, Masako; Aoyama, Kei; Oochi, Tetsuya; Kameoka, Shingo] Tokyo Womens Med Univ, Dept Surg 2, Tokyo 1628666, Japan	Kamio, T (reprint author), Tokyo Womens Med Univ, Dept Surg 2, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ako@surg2.twmu.ac.jp					Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Rimawi MF, 2013, J CLIN ONCOL, V31, P1726, DOI 10.1200/JCO.2012.44.8027; Burstein HJ, 2003, J CLIN ONCOL, V21, P2889, DOI 10.1200/JCO.2003.02.018; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Di Leo A, 2008, J CLIN ONCOL, V26, P5544, DOI 10.1200/JCO.2008.16.2578; Blanchard DK, 2004, WORLD J SURG, V28, P535, DOI 10.1007/s00268-004-7290-y; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Baselga J, 2005, J CLIN ONCOL, V23, P2162, DOI 10.1200/JCO.2005.01.014; COPELAND EM, 1973, ANN SURG, V178, P25; Fourquet A, 2004, DIS BREAST, P1047; Kaklamani V, AXILLARY NODE METAST; Luftner D, 2004, INT J BIOL MARKER, V19, P175; Sobin LH, 2009, INT UNION CANC UICC; Tsubouchi H, 2009, KANZO, V50, P38	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2448	2452		10.3892/ol.2014.2594		5	Oncology	Oncology	AU9YT	WOS:000345948600015		
J	Yokoi, T; Torii, Y; Katashiba, Y; Sugimoto, H; Tanijiri, T; Ogata, M; Inagaki, N; Kibata, K; Hayashi, M; Niki, M; Shimizu, T; Miyara, T; Kurata, T; Nomura, S				Yokoi, Takashi; Torii, Yoshitaro; Katashiba, Yuichi; Sugimoto, Hiroyuki; Tanijiri, Tsutomu; Ogata, Makoto; Inagaki, Noriko; Kibata, Kayoko; Hayashi, Mina; Niki, Maiko; Shimizu, Toshiki; Miyara, Takayuki; Kurata, Takayasu; Nomura, Shosaku			Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer	ONCOLOGY LETTERS			English	Article						non-squamous non-small cell lung cancer; chemotherapy; pemetrexed; bevacizumab; Japanese	ENDOTHELIAL GROWTH-FACTOR; SUPPORTIVE CARE; 1ST-LINE THERAPY; SOLID TUMORS; ANGIOGENESIS; CHEMOTHERAPY; PACLITAXEL; CISPLATIN; GEMCITABINE; INHIBITION	The present study evaluated the efficacy and safety of pemetrexed, carboplatin and bevacizumab, followed by maintenance pemetrexed and bevacizumab, in chemotherapy-naive. patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC). The patients were administered pemetrexed (500 mg/m(2)), carboplatin (area under the concentration-time curve, 6.0 mg/ml x min) and bevacizumab (15 mg/kg) intravenously every three weeks for up to six cycles. Patients who did not experience tumor progression remained on maintenance pemetrexed and bevacizumab until disease progression or unacceptable toxicity occurred. The primary endpoint was the overall response rate. Of the 26 patients enrolled between March 2010 and April 2011, three were excluded due to brain metastases, therefore the intention-to-treat (ITT) population consisted of 23 patients. The median age was 64 years (range, 40-74 years) and 15 patients were male. In total, six patients had a performance status of 0, and 20 had stage IV tumors. The response rate was 69.6% [95% confidence interval (CI), 47.1-86.8], the disease control rate was 100% and the time to response was 1.2 months (95% CI, 0.72-1.93). The median progression-free survival time was 8.6 months (95% CI, 5.9-10.9) and the median overall survival time was 18.6 months (95% CI, 12.924.8). There were no grade 3 or worse hemorrhagic events and the feasibility was modest. Overall, pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab, was effective and tolerable in the patients with non-squamous NSCLC, and the time to response was relatively short.	[Yokoi, Takashi; Torii, Yoshitaro; Katashiba, Yuichi; Sugimoto, Hiroyuki; Tanijiri, Tsutomu; Ogata, Makoto; Inagaki, Noriko; Kibata, Kayoko; Hayashi, Mina; Niki, Maiko; Shimizu, Toshiki; Miyara, Takayuki; Kurata, Takayasu; Nomura, Shosaku] Kansai Med Univ, Dept Internal Med 1, Hirakata, Osaka 5731010, Japan	Yokoi, T (reprint author), Kansai Med Univ, Dept Internal Med 1, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	yokoit@hirakata.kmu.ac.jp					Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Presta LG, 1997, CANCER RES, V57, P4593; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Bremnes RM, 2006, LUNG CANCER-J IASLC, V51, P143, DOI 10.1016/j.lungcan.2005.09.005; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Patel JD, 2009, J CLIN ONCOL, V27, P3284, DOI 10.1200/JCO.2008.20.8181; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; FERRARA N, 1995, BREAST CANCER RES TR, V36, P127, DOI 10.1007/BF00666035; Spiro SG, 2004, THORAX, V59, P828, DOI 10.1136/thx.2003.020164; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Patel JD, 2013, J CLIN ONCOL, V31, P4349, DOI 10.1200/JCO.2012.47.9626; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Niho S, 2012, LUNG CANCER, V76, P362, DOI 10.1016/j.lungcan.2011.12.005; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Folkman J, 1990, JNCI-J NATL CANCER I, V3, P4, DOI DOI 10.1093/JNCI/82.1.4; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; O'Byrne KJ, 2000, BRIT J CANCER, V82, P1427; 1995, BMJ, V311, P899	26	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2453	2457		10.3892/ol.2014.2552		5	Oncology	Oncology	AU9YT	WOS:000345948600016		
J	Ukita, M; Nakai, H; Kotani, Y; Tobiume, T; Koike, E; Tsuji, I; Suzuki, A; Mandai, M				Ukita, Masayo; Nakai, Hidekatsu; Kotani, Yasushi; Tobiume, Takako; Koike, Eiji; Tsuji, Iso; Suzuki, Ayako; Mandai, Masaki			Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report	ONCOLOGY LETTERS			English	Article						malignant struma ovarii; metastasis; long-term survival; chemotherapy	OF-THE-LITERATURE; THYROID-CANCER; I-131 THERAPY; FOCUS; PAPILLARY	Malignant struma ovarii is a rare type of ovarian tumor. Metastasis from malignant struma ovarii is rare and has only been documented in 5-6% of cases. The natural history and optimal treatment strategy for malignant struma ovarii remains controversial due to its rarity. The current report presents the case of a 45-year-old female who presented with a tumor of the rib bone. Following resection, the postoperative diagnosis was a metastasizing thyroid carcinoma. No abnormality was detected in the thyroid gland, however, computed tomography revealed a tumor in the left ovary. The patient underwent a left salpingo-oophorectomy and a wedge resection of the right ovary. The postoperative diagnosis was determined as a mature cystic teratoma with malignant struma ovarii (thyroid type, follicular carcinoma) of the left ovary and mature cystic teratoma of the right ovary. Four years subsequent to the initial diagnosis, multiple lung metastases were detected. The following chemotherapies were administered sequentially and intermittently: Tegafur-uracil, paclitaxel/carboplatin and oral etoposide. During this period, the metastatic lesions extended into the bone and progressed slowly. The patient continues to survive with the disease and 24 years have passed since the initial diagnosis, 20 years following the diagnosis of multiple lung metastates. The present report describes a rare case of malignant struma ovarii in which surgical resection and pathological examination of a metastatic rib tumor resulted in the identification of the primary ovarian lesion. The clinical behavior of malignant struma ovarii does not necessarily indicate a histological malignancy, therefore, prediction of future metastasis is difficult and the optimal treatment strategy for malignant struma ovarii is controversial. The present case indicates that the long-term use of oral anticancer agents may facilitate the maintenance of tumor dormancy.	[Ukita, Masayo; Nakai, Hidekatsu; Kotani, Yasushi; Tobiume, Takako; Koike, Eiji; Tsuji, Iso; Suzuki, Ayako; Mandai, Masaki] Kinki Univ, Fac Med, Dept Obstet & Gynecol, Osaka 5898511, Japan	Mandai, M (reprint author), Kinki Univ, Fac Med, Dept Obstet & Gynecol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	mandai@med.kindai.ac.jp					DEVANEY K, 1993, INT J GYNECOL PATHOL, V12, P333, DOI 10.1097/00004347-199310000-00008; DeSimone CP, 2003, GYNECOL ONCOL, V89, P543, DOI 10.1016/S0090-8258(03)00141-0; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Robboy SJ, 2009, INT J GYNECOL PATHOL, V28, P405, DOI 10.1097/PGP.0b013e3181a27777; Hatami M, 2008, GYNECOL OBSTET INVES, V65, P104, DOI 10.1159/000108654; Brenner W, 1996, EUR J NUCL MED, V23, P91, DOI 10.1007/BF01736995; Dardik RB, 1999, GYNECOL ONCOL, V73, P447, DOI 10.1006/gyno.1999.5355; Makani S, 2004, GYNECOL ONCOL, V94, P835, DOI 10.1016/j.ygyno.2004.06.003; PARDOMINDAN FJ, 1983, CANCER, V51, P337, DOI 10.1002/1097-0142(19830115)51:2<337::AID-CNCR2820510229>3.0.CO;2-5; Passler C, 2004, ENDOCR-RELAT CANCER, V11, P131, DOI 10.1677/erc.0.0110131; Salvatori M, 2008, GYNECOL ENDOCRINOL, V24, P312, DOI 10.1080/09513590802095787; Sherman SI, 2010, BIOCHEM PHARMACOL, V80, P592, DOI 10.1016/j.bcp.2010.05.003; Steinman RA, 2013, GYNECOL OBSTET INVES, V75, P139, DOI 10.1159/000345863; Vadmal MS, 1997, GYNECOL ONCOL, V64, P541, DOI 10.1006/gyno.1996.4560; Yoo Seung-Chul, 2008, J Gynecol Oncol, V19, P135, DOI 10.3802/jgo.2008.19.2.135; ZAKHEM A, 1990, J SURG ONCOL, V43, P61, DOI 10.1002/jso.2930430116	16	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2458	2462		10.3892/ol.2014.2587		5	Oncology	Oncology	AU9YT	WOS:000345948600017		
J	Ogawa, M; Watanabe, M; Mitsuyama, Y; Anan, T; Ohkuma, M; Kobayashi, T; Eto, K; Yanaga, K				Ogawa, Masaichi; Watanabe, Michiaki; Mitsuyama, Yoshinobu; Anan, Tadashi; Ohkuma, Masahisa; Kobayashi, Tetsuya; Eto, Ken; Yanaga, Katsuhiko			Thymidine phosphorylase mRNA expression may be a predictor of response to post-operative adjuvant chemotherapy with S-1 in patients with stage III colorectal cancer	ONCOLOGY LETTERS			English	Article						thymidine phosphorylase; S-1; adjuvant chemotherapy; colorectal cancer	CELL GROWTH-FACTOR; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDYLATE SYNTHASE; GENE-EXPRESSION; GASTROINTESTINAL CANCER; PROGNOSTIC-SIGNIFICANCE; ORAL FLUOROPYRIMIDINE; ANGIOGENIC FACTOR; GASTRIC-CANCER; PHASE-II	The aim of the present study was to investigate markers in surgically resected specimens of colorectal cancer that can be used to predict the response to chemotherapy. The mRNA expression levels of enzymes involved in 5-fluorouracil (5-FU) metabolism and folate metabolism were measured in formalin-fixed, paraffin-embedded tumor sections obtained from the primary tumors of 54 patients with resected stage II or III colorectal Cancer who received S-1 for one year. The 5-FU metabolizing enzymes studied were thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase (TP). The folate metabolizing enzymes studied were folypolyglutamate synthetase, gamma-glutamyl hydrolase and dihydrofolate reductase. The associations between the mRNA expression levels of these enzymes and clinical variables were investigated. Tumors were classified as exhibiting high or low expression as compared with the median mRNA expression level of each metabolizing enzyme defined as the cutoff value. The associations between the high and low expression levels of each enzyme and disease-free survival (DFS) were analyzed with the use of Kaplan-Meier curves and the log-rank test. DFS was not significantly asociated with the relative mRNA expression level of any metabolizing enzyme in the study group as a whole, but there was a trend toward longer DFS in patients with high TP expression (P=0.066). In patients with stage III colorectal cancer, high TP expression was associated with significantly improved outcomes compared with low TP expression (P=0.039). These results indicate that the mRNA expression of TP, a metabolizing enzyme of 5-FU, is a significant predictor of response to post-operative chemotherapy with S-1 in patients with stage III colorectal cancer.	[Ogawa, Masaichi; Watanabe, Michiaki; Mitsuyama, Yoshinobu; Anan, Tadashi; Ohkuma, Masahisa; Kobayashi, Tetsuya; Eto, Ken; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo 1058461, Japan	Ogawa, M (reprint author), Jikei Univ, Sch Med, Dept Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	masatchmo1962@yahoo.co.jp					SHIRASAKA T, 1993, CANCER RES, V53, P4004; Shirao K, 2004, CANCER, V100, P2355, DOI 10.1002/cncr.20277; Nishimura G, 2002, ONCOL REP, V9, P479; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; FURUKAWA T, 1992, NATURE, V356, P668, DOI 10.1038/356668a0; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Muro K, 2010, LANCET ONCOL, V11, P853, DOI 10.1016/S1470-2045(10)70181-9; Yamada Y, 2003, BRIT J CANCER, V89, P816, DOI 10.1038/sj.bjc.6601224; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Mochizuki I, 2012, BRIT J CANCER, V106, P1268, DOI 10.1038/bjc.2012.86; Takebayashi Y, 1996, J NATL CANCER I, V88, P1110, DOI 10.1093/jnci/88.16.1110; Ohtsu A, 2000, BRIT J CANCER, V83, P141; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Collie-Duguid ESR, 2001, INT J CANCER, V94, P297, DOI 10.1002/ijc.1462; Diasio RB, 1999, ONCOLOGY-NY, V13, P17; Hasegawa S, 2005, ONCOL REP, V13, P621; Jensen SA, 2008, ACTA ONCOL, V47, P1054, DOI 10.1080/02841860801942158; Lord RVN, 2000, J GASTROINTEST SURG, V4, P135, DOI 10.1016/S1091-255X(00)80049-9; Maeda K, 1996, BRIT J CANCER, V73, P884, DOI 10.1038/bjc.1996.177; Metzger R, 1998, CLIN CANCER RES, V4, P2371; Nakayama Y, 2005, ANTICANCER RES, V25, P3755; Ogawa M, 2013, INT J CLIN ONCOL, V18, P678, DOI 10.1007/s10147-012-0424-6; Sadahiro S, 2012, CANCER CHEMOTH PHARM, V70, P285, DOI 10.1007/s00280-012-1909-8; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Satoh T, 2012, EXPERT OPIN PHARMACO, V13, P1943, DOI 10.1517/14656566.2012.709234; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Sobin LH, 2002, TNM CLASSIFICATION M; TOI M, 1995, INT J CANCER, V64, P79, DOI 10.1002/ijc.2910640202; Yoshinare K, 2003, CANCER SCI, V94, P633, DOI 10.1111/j.1349-7006.2003.tb01495.x	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2463	2468		10.3892/ol.2014.2574		6	Oncology	Oncology	AU9YT	WOS:000345948600018		
J	Ogino, A; Sano, E; Ochiai, Y; Yamamuro, S; Tashiro, S; Yachi, K; Ohta, T; Fukushima, T; Okamoto, Y; Tsumoto, K; Ueda, T; Yoshino, A; Katayama, Y				Ogino, Akiyoshi; Sano, Emiko; Ochiai, Yushi; Yamamuro, Shun; Tashiro, Shinya; Yachi, Kazunari; Ohta, Takashi; Fukushima, Takao; Okamoto, Yutaka; Tsumoto, Kouhei; Ueda, Takuya; Yoshino, Atsuo; Katayama, Yoichi			Efficacy of ribavirin against malignant glioma cell lines	ONCOLOGY LETTERS			English	Article						ribavirin; malignant glioma	GENE-EXPRESSION; IMP DEHYDROGENASE; GROWTH-FACTOR; TEMOZOLOMIDE; EIF4E; PROLIFERATION; INHIBITION	Ribavirin (1-beta-D-ribofuranosy-1,2,4-triazole-3-carboxamide) has been widely administered as an antiviral agent against RNA and DNA viruses. Ribavirin, in combination with interferon, has predominantly been applied in the treatment of the hepatitis C virus infection and its potential antitumor efficacy has recently become a point of interest. The aim of the present study was to evaluate the effect of ribavirin on the growth of malignant glioma cells, to identify novel predictive genes in malignant glioma cells (by analyzing gene expression profiles) and to assess the influence of ribavirin on the cell cycle of malignant glioma cells. The present study evaluated the antitumor efficacy of ribavirin against various malignant glioma cell lines (A-172, AM-38, T98G, U-87MG, U-138MG, U-251MG and YH-13). After culturing the cells in ribavirin-containing culture medium (final concentration, 0-1,000 mu M) for 72 h, the viable proliferated cells were harvested and counted. The half maximal inhibitory concentration of ribavirin, with regard to the growth of the malignant glioma cell lines, was determined from the concentration of ribavirin required for 50% growth inhibition in comparison to the untreated control cells. Furthermore, the current study identified the genes in which the gene expression levels correlated with the ribavirin sensitivity of the malignant glioma cells lines, using a high-density oligonucleotide array. Finally, cell cycle analysis was performed on the U-87MG cell line. It was identified that ribavirin inhibited the growth of all of the malignant glioma cell lines in a dose-dependent manner, although the ribavirin sensitivity varied between each cell line. Of the extracted genes, PDGFRA demonstrated the strongest positive correlation between gene expression level and ribavirin sensitivity. Cell cycle analysis of the U-87MG cell line demonstrated that ribavirin treatment induces G0/G1 arrest and thus may be an effective agent for inhibiting malignant glioma cell growth. Therefore, the results of the current study indicate that ribavirin may have potential as a therapeutic agent in the treatment of malignant gliomas.	[Ogino, Akiyoshi; Ochiai, Yushi; Yamamuro, Shun; Yachi, Kazunari; Ohta, Takashi; Fukushima, Takao; Yoshino, Atsuo; Katayama, Yoichi] Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo 1738610, Japan; [Sano, Emiko; Tashiro, Shinya; Tsumoto, Kouhei; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Tashiro, Shinya; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo 1088639, Japan; [Okamoto, Yutaka] New Energy & Ind Technol Dev Org, Kawasaki, Kanagawa 2128554, Japan	Fukushima, T (reprint author), Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	fukushima27takao@gmail.com					SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Borden KLB, 2010, LEUKEMIA LYMPHOMA, V51, P1805, DOI 10.3109/10428194.2010.496506; Culjkovic B, 2007, CELL CYCLE, V6, P65, DOI 10.4161/cc.6.1.3688; Kokeny S, 2009, ANTICANCER RES, V29, P1971; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Yoshino A, 2010, INT J ONCOL, V36, P1367, DOI 10.3892/ijo_00000621; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; HELDIN CH, 1990, CELL REGUL, V1, P555; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Yoshino A, 2011, INT J ONCOL, V39, P529, DOI 10.3892/ijo.2011.1068; Gu X, 2005, APPL IMMUNOHISTO M M, V13, P178, DOI 10.1097/01.pai.0000135615.07325.a2; Hermanson M, 1996, CANCER RES, V56, P164; Kleihues P, 2007, WHO CLASSIFICATION T, P33; Pettersson F, 2011, CLIN CANCER RES, V17, P2874, DOI 10.1158/1078-0432.CCR-10-2334; Schlosser SF, 2003, ANTIMICROB AGENTS CH, V47, P1912, DOI 10.1128/AAC.47.6.1912-1921.2003; Vallee S, 2000, EUR J PHARMACOL, V404, P49, DOI 10.1016/S0014-2999(00)00596-3; YAMADA Y, 1988, BIOCHEMISTRY-US, V27, P2193, DOI 10.1021/bi00406a057	19	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2469	2474		10.3892/ol.2014.2569		6	Oncology	Oncology	AU9YT	WOS:000345948600019		
J	Nishii, Y; Fukuda, T; Imai, K; Yamauchi, M; Hashiguchi, Y; Ichimura, T; Yasui, T; Sumi, T				Nishii, Yuko; Fukuda, Takeshi; Imai, Kenji; Yamauchi, Makoto; Hashiguchi, Yasunori; Ichimura, Tomoyuki; Yasui, Tomoyo; Sumi, Toshiyuki			Minimal deviation mucinous adenocarcinoma of the uterine cervix that proved difficult to differentiate from endometrial cancer: A case report	ONCOLOGY LETTERS			English	Article						endometrial cancer; minimal deviation adenocarcinoma; adenoma malignum	ADENOMA-MALIGNUM	Minimal deviation adenocarcinoma (MDA), also known as adenoma malignum of the uterine cervix, accounts for only similar to 1% of uterine cervical adenocarcinomas. Adenoma malignum of the uterine cervix was initially described by Gusserow in 1870. Using magnetic resonance imaging (MRI), MDA appears as multilocular lesions with solid components that extend from the endocervical glands to the deep cervical stroma. Cytological evaluation and biopsies have low detection rates, therefore, it is difficult to diagnose MDA accurately prior to treatment. The current study describes a rare case of MDA that was difficult to differentiate from endometrial adenocarcinoma of the corpus uteri preoperatively, as the endometrial biopsy results suggested a well-differentiated endometrioid adenocarcinoma and MRI did not show typical images for MDA. A total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed under the diagnosis of endometrial cancer, and the mass was subsequently diagnosed as MDA of the uterine cervix by pathological examination of the hysterectomy specimen. Postoperatively, although two types of adjuvant chemotherapy were performed, the remaining tumor continued to grow, causing obstruction of the bilateral ureters and leading to bilateral hydronephrosis. The patient is currently alive with the disease 10 months following the surgery.	[Nishii, Yuko; Fukuda, Takeshi; Imai, Kenji; Yamauchi, Makoto; Hashiguchi, Yasunori; Ichimura, Tomoyuki; Yasui, Tomoyo; Sumi, Toshiyuki] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka 5458585, Japan	Fukuda, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	takeshif@med.osaka-cu.ac.jp					Hirai Y, 1998, GYNECOL ONCOL, V70, P219, DOI 10.1006/gyno.1998.5092; Doi T, 1997, RADIOLOGY, V204, P39; KAMINSKI PF, 1983, INT J GYNECOL PATHOL, V2, P141, DOI 10.1097/00004347-198302000-00005; Utsugi K, 1999, GYNECOL ONCOL, V75, P345, DOI 10.1006/gyno.1999.5622; MCGOWAN L, 1980, GYNECOL ONCOL, V10, P125, DOI 10.1016/0090-8258(80)90074-8; YAMASHITA Y, 1994, AM J ROENTGENOL, V162, P649; GILKS CB, 1989, AM J SURG PATHOL, V13, P717, DOI 10.1097/00000478-198909000-00001; SILVERBERG SG, 1975, AM J OBSTET GYNECOL, V121, P971; Ishii K, 1999, CANCER CYTOPATHOL, V87, P245, DOI 10.1002/(SICI)1097-0142(19991025)87:5<245::AID-CNCR2>3.0.CO;2-0; Granter SR, 1996, AM J CLIN PATHOL, V105, P327; Gusserow ALS, 1870, ARCH GYNAK, V1, P240; Li GL, 2010, INT J GYNECOL OBSTET, V110, P89, DOI 10.1016/j.ijgo.2010.03.016; MCKELVEY JL, 1963, CANCER, V16, P549, DOI 10.1002/1097-0142(196305)16:5<549::AID-CNCR2820160502>3.0.CO;2-M; Sobin LH, 2009, TNM CLASSIFICATION M; Yoden E, 2001, J COMPUT ASSIST TOMO, V25, P94, DOI 10.1097/00004728-200101000-00017	15	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2481	2484		10.3892/ol.2014.2532		4	Oncology	Oncology	AU9YT	WOS:000345948600021		
J	Urakawa, H; Tsukushi, S; Sugiura, H; Yamada, K; Yamada, Y; Kozawa, E; Arai, E; Futamura, N; Ishiguro, N; Nishida, Y				Urakawa, Hiroshi; Tsukushi, Satoshi; Sugiura, Hideshi; Yamada, Kenji; Yamada, Yoshihisa; Kozawa, Eiji; Arai, Eisuke; Futamura, Naohisa; Ishiguro, Naoki; Nishida, Yoshihiro			Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients	ONCOLOGY LETTERS			English	Article						doxorubicin; ifosfamide; chemotherapy; bone sarcoma	MALIGNANT FIBROUS HISTIOCYTOMA; SOFT-TISSUE SARCOMAS; OSTEOGENIC-SARCOMA; NONMETASTATIC OSTEOSARCOMA; ONCOLOGY-GROUP; GROUP TRIAL; EXTREMITY; METHOTREXATE; MULTICENTER; ADRIAMYCIN	The present study investigated the safety and efficacy of neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcoma in adult and older patients. A total of 18 consecutive patients with bone sarcoma (American Joint Committee on Cancer stage II in 14 patients and stage IV in four) treated with neoadjuvant and adjuvant chemotherapy at Nagoya Musculoskeletal Oncology Group hospitals in Japan between 2004 and 2011 were reviewed. The treatment efficacy and side-effects were evaluated. The responses to neoadjuvant chemotherapy were stable disease in 11 patients and progressive disease in three. Among the 12 evaluable patients, there were five with >= 90% tumor necrosis. The estimated overall survival (OS) rate at five years for the patients without metastasis prior to treatment was 56%. Major grade 3 or 4 side-effects included leukopenia in 14 cases, anemia in seven, thrombocytopenia in three, nausea in two and febrile neutropenia in two. One patient discontinued chemotherapy due to a temporarily depressed level of consciousness with arrhythmia (grade 2). The estimated five-year OS rate in this study was acceptable in patients without metastasis prior to treatment. A better coordinated prospective study of this combination regimen for older patients with bone sarcoma will be required to clarify its efficacy and tolerability.	[Urakawa, Hiroshi; Tsukushi, Satoshi; Kozawa, Eiji; Arai, Eisuke; Futamura, Naohisa; Ishiguro, Naoki; Nishida, Yoshihiro] Nagoya Univ, Grad Sch, Dept Orthopaed Surg, Nagoya, Aichi 4668550, Japan; [Urakawa, Hiroshi; Tsukushi, Satoshi; Kozawa, Eiji; Arai, Eisuke; Futamura, Naohisa; Ishiguro, Naoki; Nishida, Yoshihiro] Nagoya Univ, Sch Med, Nagoya, Aichi 4668550, Japan; [Sugiura, Hideshi] Aichi Canc Ctr Hosp, Dept Orthoped Surg, Nagoya, Aichi 4648681, Japan; [Yamada, Kenji] Aichi Hosp, Aichi Canc Ctr, Okazaki, Aichi 4440011, Japan; [Yamada, Yoshihisa] Nagoya Mem Hosp, Nagoya, Aichi 4688520, Japan	Urakawa, H (reprint author), Nagoya Univ, Grad Sch, Dept Orthopaed Surg, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	urakawa@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791533]	Funding was granted from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research, no. 24791533). The authors would like to thank Miss. Eri Ishihara for providing secretarial assistance.	Woll PJ, 2012, LANCET ONCOL, V13, P1045, DOI 10.1016/S1470-2045(12)70346-7; Ferrari S, 2012, J CLIN ONCOL, V30, P2112, DOI 10.1200/JCO.2011.38.4420; Grimer RJ, 2003, EUR J CANCER, V39, P157, DOI 10.1016/S0959-8049(02)00478-1; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Mirabello L, 2009, CANCER, V115, P1531, DOI 10.1002/cncr.24121; Goorin AM, 2002, J CLIN ONCOL, V20, P426, DOI 10.1200/JCO.20.2.426; MISER JS, 1987, J CLIN ONCOL, V5, P1191; Bacci G, 2000, J CLIN ONCOL, V18, P4016; EILBER F, 1987, J CLIN ONCOL, V5, P21; Grimer RJ, 2007, EUR J CANCER, V43, P2060, DOI 10.1016/j.ejca.2007.06.016; JAFFE N, 1973, CANCER, V31, P1367, DOI 10.1002/1097-0142(197306)31:6<1367::AID-CNCR2820310611>3.0.CO;2-6; Frustaci S, 2001, J CLIN ONCOL, V19, P1238; Longhi A, 2003, J PEDIAT HEMATOL ONC, V25, P292, DOI 10.1097/00043426-200304000-00005; WEISS SW, 1978, CANCER, V41, P2250, DOI 10.1002/1097-0142(197806)41:6<2250::AID-CNCR2820410626>3.0.CO;2-W; Song WS, 2010, EJSO-EUR J SURG ONC, V36, P483, DOI 10.1016/j.ejso.2010.03.006; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Bacci G, 2007, ACTA ORTHOP, V78, P377, DOI 10.1080/17453670710013960; Bramwell VHC, 1999, J CLIN ONCOL, V17, P3260; Comandone A, 2000, ANTICANCER RES, V20, P2077; Cores E P, 1972, JAMA, V221, P1132, DOI 10.1001/jama.221.10.1132; Edge SB, 2010, AJCC CANC STAGING MA, P281; Manoso MW, 2005, CLIN ORTHOP RELAT R, P110; National Cancer Institute, 2014, NAT CANC I COMM TOX; Nishida Y, 2009, J SURG ONCOL, V100, P48, DOI 10.1002/jso.21287; OCHS JJ, 1978, CANCER TREAT REP, V62, P239; Urakawa H, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-48	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2485	2488		10.3892/ol.2014.2567		4	Oncology	Oncology	AU9YT	WOS:000345948600022		
J	Oda, N; Sakugawa, M; Bessho, A; Horiuchi, T; Hosokawa, S; Toyota, Y; Fukamatsu, N; Nishii, K; Watanabe, Y				Oda, Naohiro; Sakugawa, Makoto; Bessho, Akihiro; Horiuchi, Takeshi; Hosokawa, Shinobu; Toyota, Yosuke; Fukamatsu, Nobuaki; Nishii, Kazuya; Watanabe, Yoichi			Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptor-mutated lung cancer	ONCOLOGY LETTERS			English	Article						lung cancer; leptomeningeal carcinomatosis; cerebral venous sinus thrombosis; epidermal growth factor receptor-tyrosine kinase inhibitor; magnetic resonance imaging	CEREBROVASCULAR COMPLICATIONS	A 64-year-old woman presented with dizziness, after two weeks of experiencing symptoms. Chest computed tomography revealed a peripheral nodule in her left upper lobe, and brain magnetic resonance imaging (MRI) demonstrated the presence of multiple brain masses. The patient underwent whole-brain radiotherapy based on a tentative diagnosis of lung cancer with multiple brain metastases. The diagnosis was confirmed by endobronchial biopsy as T4N3M1b, stage IV lung adenocarcinoma with an epidermal growth factor receptor mutation. On the 31st day of hospitalization, the patient developed severe headache. Subsequent magnetic resonance venography revealed defects in the superior sagittal, right sigmoid, and right transverse venous sinuses and the right internal jugular vein. Anticoagulation therapy with unfractionated heparin and warfarin was immediately administered following diagnosis of cerebral venous sinus thrombosis (CVST). Brain MRI demonstrated leptomeningeal gadolinium enhancement in front of the pons and medulla. Positive cerebrospinal fluid tumor cytology confirmed the diagnosis of leptomeningeal carcinomatosis. Following four weeks of antithrombotic therapy, complete thrombolysis was confirmed by magnetic resonance venography. Effective treatment with gefitinib was administered, and the patient survived for 10 months after the diagnosis of CVST and leptomeningeal carcinomatosis. Adequate early diagnosis and treatment of CVST enabled an excellent survival rate for the patient, despite leptomeningeal carcinomatosis. Following the development of headaches in patients with lung cancer, CVST, although rare, should be considered. Furthermore, following a diagnosis of CVST, leptomeningeal carcinomatosis should be investigated as an underlying cause.	[Oda, Naohiro; Sakugawa, Makoto; Bessho, Akihiro; Horiuchi, Takeshi; Hosokawa, Shinobu; Toyota, Yosuke; Fukamatsu, Nobuaki; Nishii, Kazuya; Watanabe, Yoichi] Japanese Red Cross Okayama Hosp, Dept Pulm Dis, Okayama 7008607, Japan	Sakugawa, M (reprint author), Japanese Red Cross Okayama Hosp, Dept Pulm Dis, Kita Ku Okayama, 2-1-1 Aoe, Okayama 7008607, Japan.	msakugawa@okayama-med.jrc.or.jp					Umemura S, 2012, LUNG CANCER, V77, P134, DOI 10.1016/j.lungcan.2012.03.002; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Beauchesne P, 2010, LANCET ONCOL, V11, P871, DOI 10.1016/S1470-2045(10)70034-6; GRAUS F, 1985, MEDICINE, V64, P16; Li HK, 2012, J CLIN ONCOL, V30, pE19, DOI 10.1200/JCO.2011.38.1426; Raizer JJ, 2000, NEUROLOGY, V54, P1222; Rogers LR, 2004, SEMIN NEUROL, V24, P453, DOI 10.1055/s-2004-861539; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; SIGSBEE B, 1979, NEUROLOGY, V29, P139	11	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2489	2492		10.3892/ol.2014.2603		4	Oncology	Oncology	AU9YT	WOS:000345948600023		
J	Matsunaga, A; Ishii, Y; Tsuruta, M; Okabayashi, K; Hasegawa, H; Kitagawa, Y				Matsunaga, Atsushi; Ishii, Yoshiyuki; Tsuruta, Masashi; Okabayashi, Koji; Hasegawa, Hirotoshi; Kitagawa, Yuko			Inhibition of heat shock protein 27 phosphorylation promotes sensitivity to 5-fluorouracil in colorectal cancer cells	ONCOLOGY LETTERS			English	Article						heat shock protein 27 (HSP27); 5-fluorouracil; phosphorylation; sensitivity; colorectal cancer	FLUOROURACIL-BASED CHEMOTHERAPY; COLON-CANCER; THYMIDYLATE SYNTHASE; METABOLIC ENZYMES; PROSTATE-CANCER; EXPRESSION; HSP27; RESISTANCE; STRESS; HEAT-SHOCK-PROTEIN-27	The aim of the present study was to investigate whether the inhibition of HSP27 phosphorylation, which affects certain cellular functions, modulates sensitivity to 5-fluorouracil (5-FU) in colorectal cancer cells. Exposure to 5-FU in HCT116 and HCT15 cells expressing high levels of HSP27 with a low 5-FU sensitivity caused a minimal change in HSP27 expression, but induced the upregulation of HSP27 phosphorylation, particularly at Ser78. By contrast, exposure to 5-FU in HT29 cells expressing a low level of HSP27 with a high 5-FU sensitivity marginally increased HSP27 expression, with minimal phosphorylation. Treatment with a selective inhibitor, p38 mitogen-activated protein kinase (MAPK; SB203580), caused the dose-dependent suppression of HSP27 phosphorylation, which was upregulated by 5-FU, reducing the half maximal inhibitory concentration values of 5-FU in the HCT116 and HCT15 cells. However, treatment with SB203580 exhibited no significant effect on cell growth or survival. In conclusion, this study indicated that the inhibition of HSP27 phosphorylation by a selective inhibitor of p38 MAPK promotes 5-FU sensitivity without causing cytotoxicity in colorectal cancer cells.	[Matsunaga, Atsushi; Ishii, Yoshiyuki; Tsuruta, Masashi; Okabayashi, Koji; Hasegawa, Hirotoshi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan	Ishii, Y (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yishii@a2.keio.jp					Bruey JM, 2000, NAT CELL BIOL, V2, P645; Benjamin IJ, 1998, CIRC RES, V83, P117; Soong R, 2008, ANN ONCOL, V19, P915, DOI 10.1093/annonc/mdm599; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Yu ZJ, 2010, MOL MED REP, V3, P953, DOI 10.3892/mmr.2010.372; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Sarto C, 2004, PROTEOMICS, V4, P2252, DOI 10.1002/pmic.200300797; Andrieu C, 2010, ONCOGENE, V29, P1883, DOI 10.1038/onc.2009.479; Wang F, 2012, MED ONCOL, V29, P1780, DOI 10.1007/s12032-011-0037-3; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; LANDRY J, 1992, J BIOL CHEM, V267, P794; Tsuruta M, 2008, ONCOL REP, V20, P1165, DOI 10.3892/or_00000125; Mehlen P, 1996, J BIOL CHEM, V271, P16510; Lamoureux F, 2014, EUR UROL, V66, P145, DOI 10.1016/j.eururo.2013.12.019; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Aschele C, 1999, J CLIN ONCOL, V17, P1760; Choi DH, 2007, FEBS LETT, V581, P1649, DOI 10.1016/j.febslet.2007.02.075; CIOCCA DR, 1992, CANCER RES, V52, P3648; Garrido C, 1996, EUR J BIOCHEM, V237, P653, DOI 10.1111/j.1432-1033.1996.0653p.x; Hayashi R, 2012, ONCOL REP, V28, P1269, DOI 10.3892/or.2012.1935; Hotte SJ, 2010, J CLIN ONCOL S, V28, p15s; Kinoshita M, 2007, ANTICANCER RES, V27, P851; Lambert H, 1999, J BIOL CHEM, V274, P3978; Okumura K, 2006, ONCOL REP, V15, P875; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Song TF, 2009, J INT MED RES, V37, P1375	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2496	2500		10.3892/ol.2014.2580		5	Oncology	Oncology	AU9YT	WOS:000345948600025		
J	Ozaki, S; Kawahara, E; Maenaka, S; Hoang, NV; Oyama, T; Imai, M; Oda, M; Yano, S				Ozaki, Satoru; Kawahara, Ei; Maenaka, Shiori; Nguyen Viet Hoang; Oyama, Takeru; Imai, Miwa; Oda, Makoto; Yano, Seiji			Distinct allelic expression patterns of imprinted IGF2 in adenocarcinoma and squamous cell carcinoma of the lung	ONCOLOGY LETTERS			English	Article						genomic imprinting; insulin-like growth factor 2; lung cancer; adenocarcinoma; microdissection	GROWTH-FACTOR 2; COLORECTAL-CANCER; INSULIN; METHYLATION; SYSTEM	The insulin-like growth factor 2 gene (IGF2) is an imprinting gene, which mediates cell growth and apoptosis. The loss of imprinting (LOI) of IGF2 has been associated with the development of cancer. In the present study, loss LOI of IGF2 in lung cancer was analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in combination with DNA sequencing of samples collected by laser capture microdissection. The status of each sample was assigned as imprinting when PCR-RFLP revealed only one band or sequence with a single peak; otherwise, the case was classified as LOI. LOI was identified in eight out of 13 adenocarcinoma cases (62%), but was not detected in any of the nine squamous cell carcinoma cases (0%). These results suggest that IGF2 LOI is involved in the molecular pathogenesis of lung adenocarcinoma, but not squamous cell carcinoma, and that LOI may be detected through increased IGF2 expression levels.	[Ozaki, Satoru; Kawahara, Ei; Maenaka, Shiori; Nguyen Viet Hoang] Kanazawa Univ, Dept Clin Lab Sci, Kanazawa, Ishikawa 9200942, Japan; [Oyama, Takeru] Kanazawa Univ, Dept Pathol, Kanazawa, Ishikawa 9200942, Japan; [Imai, Miwa] Ishikawa Prefectural Nursing Univ, Dept Hlth Sci, Kahoku, Ishikawa 9291212, Japan; [Oda, Makoto] Kanazawa Univ Hosp, Dept Lung Surg, Kanazawa, Ishikawa 9208641, Japan; [Yano, Seiji] Kanazawa Univ, Canc Res Inst, Dept Internal Med, Kanazawa, Ishikawa 9201192, Japan	Kawahara, E (reprint author), Kanazawa Univ, Dept Clin Lab Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	kawahara@staff.kanazawa-u.ac.jp	Ozaki, Satoru/C-3218-2015; Kawahara, Ei/C-3233-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Trajkovic-Arsic M, 2013, J MOL ENDOCRINOL, V50, pR67, DOI 10.1530/JME-12-0259; Cheng L, 2012, MODERN PATHOL, V25, P347, DOI 10.1038/modpathol.2011.215; Kaneda A, 2007, P NATL ACAD SCI USA, V104, P20926, DOI 10.1073/pnas.0710359105; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Ferguson-Smith AC, 2000, CURR BIOL, V10, pR872, DOI 10.1016/S0960-9822(00)00817-4; Kohda M, 2001, MOL CARCINOGEN, V31, P184, DOI 10.1002/mc.1053; Maenaka S, 2006, ONCOL REP, V15, P791; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Nie ZL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-86; Suzuki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073484; Takano Y, 2000, ONCOLOGY-BASEL, V59, P210, DOI 10.1159/000012163; Uejima H, 2000, Nat Genet, V25, P375; Vincent EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066963; Xu W, 2006, J EXP CLIN CANC RES, V25, P543; Zuo QS, 2011, MOL CARCINOGEN, V50, P390, DOI 10.1002/mc.20731	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2561	2564		10.3892/ol.2014.2572		4	Oncology	Oncology	AU9YT	WOS:000345948600040		
J	Shintani, M; Sangawa, A; Yamao, N; Kamoshida, S				Shintani, Michiko; Sangawa, Akiko; Yamao, Naoki; Kamoshida, Shingo			Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression	ONCOLOGY LETTERS			English	Article						survivin; Smac/DIABLO; immunohistochemistry; apoptosis	APOPTOSIS PROTEIN FAMILY; COLORECTAL-CANCER; GASTRIC-CANCER; IMMUNOHISTOCHEMICAL ANALYSIS; CYTOPLASMIC SURVIVIN; CELL-DEATH; PROGNOSIS; ADENOCARCINOMA; INHIBITOR; THERAPY	Lack of apoptosis is a key factor in carcinogenesis and tumor progression. Survivin is a member of the inhibitor of apoptosis protein (IA P) family. Second mitochondria-derived activator of caspases/direct inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO) is an antagonist of IAPs. Recently, Smac/DIABLO was identified as a potent therapeutic target. However, the clinical significance of Smac/DIABLO in gastrointestinal carcinomas remains unclear. In the present study, Smac/DIABLO expression was analyzed by immunohistochemistry in 72 gastric adenocarcinomas and 78 colorectal adenocarcinomas. The expression of Smac/DIABLO was significantly higher in colorectal carcinoma than in gastric carcinoma. Additionally, a correlation was found between the expression of Smac/DIABLO and nuclear survivin in well- to moderately-differentiated colorectal adenocarcinomas (r=0.245; P<0.01). Based on these results, it was hypothesized that gastric and colorectal carcinomas differ in the level of Smac/DIABLO expression. Our previous studies revealed that the expression of cleaved caspase-9 was significantly lower in colorectal carcinoma than in gastric carcinoma (P<0.0001). Conversely, the expression levels of microtubule-associated protein 1 light chain 3 (LC3), an autophagy marker, and survivin were significantly higher in colon cancer than in gastric cancer (P<0.0001 and P<0.01, respectively). Taken together, these results indicate that not only LC3 and survivin expression, but also Smac/DIABLO expression, are significantly higher in colorectal carcinoma than in gastric carcinoma. We hypothesize that the analysis of Smac/DIABLO, survivin and LC3 expression in colorectal carcinoma is likely to aid cancer therapy due to the involvement of these markers in apoptosis and/or autophagy.	[Shintani, Michiko; Sangawa, Akiko; Kamoshida, Shingo] Kobe Univ, Grad Sch Hlth Sci, Div Med Biophys, Pathol Lab, Kobe, Hyogo 6540142, Japan; [Sangawa, Akiko] Osaka Red Cross Hosp, Dept Diagnost Pathol, Osaka 5438555, Japan; [Yamao, Naoki] Kuma Hosp, Dept Clin Lab, Kobe, Hyogo 6500011, Japan	Shintani, M (reprint author), Kobe Univ, Grad Sch Hlth Sci, Div Med Biophys, Pathol Lab, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	mtshin@kobe-u.ac.jp			Japan Society for the Promotion of Science [23590396]	The authors would like to thank Dr Masayuki Shintaku and Dr Toshihiko Miyake for their kind support. This study was supported by a Grant-in-Aid for Scientific Research (grant no. 23590396) from the Japan Society for the Promotion of Science.	Andersen MH, 2007, CLIN CANCER RES, V13, P5991, DOI 10.1158/1078-0432.CCR-07-0686; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003; Vallbohmer D, 2009, J SURG ONCOL, V99, P409, DOI 10.1002/jso.21271; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Qi GY, 2009, ONCOL REP, V22, P557, DOI 10.3892/or_00000471; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JC126252; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Ponnelle T, 2005, J CANCER RES CLIN, V131, P504, DOI 10.1007/s00432-005-0682-z; Kim MA, 2011, VIRCHOWS ARCH, V459, P503, DOI 10.1007/s00428-011-1150-6; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Choi J, 2012, ANTICANCER RES, V32, P559; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Wang TT, 2007, WORLD J GASTROENTERO, V13, P2784; Miura K, 2011, SURG TODAY, V41, P175, DOI 10.1007/s00595-010-4390-1; KERR JFR, 1994, CANCER, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Cheung HH, 2006, CLIN CANCER RES, V12, P3238, DOI 10.1158/1078-0432.CCR-06-0817; Da Silva LC, 2013, ANTICANCER RES, V33, P647; De Oliveira Lima Flávio, 2009, Oncol Rep, V22, P295; Endo K, 2009, ONCOL REP, V21, P351, DOI 10.3892/or_00000229; Grzybowska-Izydorczyk O, 2010, EUR J CANCER, V46, P800, DOI 10.1016/j.ejca.2009.11.023; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Lee YY, 2009, DIS MARKERS, V26, P9, DOI 10.3233/DMA-2009-0598; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Okada E, 2001, CANCER LETT, V163, P109, DOI 10.1016/S0304-3835(00)00677-7; Shibata T, 2008, ANN SURG ONCOL, V15, P3579, DOI 10.1245/s10434-008-0062-4; Shintani M, 2013, INT J CLIN EXP PATHO, V6, P2919; Shintani M, 2011, BIOMED RES-TOKYO, V32, P379; Sobin LH, 2009, TNM CLASSIFICATION M; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Wrzesien-Kus A, 2004, APOPTOSIS, V9, P705, DOI 10.1023/B:APPT.0000045788.61012.b2; Yan HJ, 2012, MED ONCOL, V29, P168, DOI 10.1007/s12032-011-9819-x; Yoo NJ, 2003, APMIS, V111, P382, DOI 10.1034/j.1600-0463.2003.t01-1-1110202.x; Zheng LD, 2005, WORLD J GASTROENTERO, V11, P79	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2581	2586		10.3892/ol.2014.2598		6	Oncology	Oncology	AU9YT	WOS:000345948600044		
J	Ogawa, H; Tanaka, Y; Koma, YI; Hokka, D; Tane, S; Tauchi, S; Uchino, K; Yoshimura, M; Maniwa, Y				Ogawa, Hiroyuki; Tanaka, Yugo; Koma, Yu-Ichiro; Hokka, Daisuke; Tane, Shinya; Tauchi, Shunsuke; Uchino, Kazuya; Yoshimura, Masahiro; Maniwa, Yoshimasa			Pulmonary large cell neuroendocrine carcinoma exhibiting extensive pagetoid spread in the bronchial epithelium: A case report	ONCOLOGY LETTERS			English	Article						large cell neuroendocrine carcinoma; pagetoid spread; lung cancer	LUNG; ADENOCARCINOMA; DISEASE	Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive malignant tumor, which was proposed as a novel type of neuroendocrine tumor in 1991. Although it is categorized as a non-small cell lung carcinoma, the precise pathological condition is unknown due to its rare occurrence. The present study outlines the case of a patient presenting with an LCNEC that exhibited pagetoid spread from the region of the primary tumor to the bronchial epithelium (distance, >30 mm). The pagetoid spread was unconfirmed preoperatively, however, was identified by intraoperative rapid diagnosis. This caused us to suffer the perioperative decision of additional resection and resulted in an incomplete resection, as suture of the bronchus was not possible. Pagetoid spread, which is often apparent in the breast, presents as a rare pattern of infiltration of cancer cells when a massive carcinoma is identified beneath the intraepithelial spread. Although preoperative diagnosis of pagetoid spread is difficult due to its rarity and undefined clinical features, it is important for surgeons and pathologists treating lung cancer patients to be aware of potential pagetoid spread in the thoracic region.	[Ogawa, Hiroyuki; Tanaka, Yugo; Hokka, Daisuke; Tane, Shinya; Tauchi, Shunsuke; Maniwa, Yoshimasa] Kobe Univ Hosp, Dept Thorac Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Koma, Yu-Ichiro] Hyogo Canc Ctr, Dept Pathol, Akashi, Hyogo 6738558, Japan; [Uchino, Kazuya; Yoshimura, Masahiro] Hyogo Canc Ctr, Dept Thorac Surg, Akashi, Hyogo 6738558, Japan	Tanaka, Y (reprint author), Kobe Univ Hosp, Dept Thorac Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yugotanaka1@gmail.com					Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; den Bakker MA, 2010, HISTOPATHOLOGY, V56, P356, DOI 10.1111/j.1365-2559.2010.03486.x; Davies SJ, 2007, THORAX, V62, P248, DOI 10.1136/thx.2006.063065; Doddoli C, 2004, ANN THORAC SURG, V77, P1168, DOI 10.1016/j.athoracsur.2003.09.049; Edge SB, 2009, AJCC CANC STAGING HD; Kara M, 2001, EUR J CARDIO-THORAC, V20, P350, DOI 10.1016/S1010-7940(01)00803-X; Mandi H, 2011, OBSTET GYNECOL, V118, P461, DOI 10.1097/AOG.0b013e3182164af8; National Comprehensive Cancer Network Inc, NCCN CLIN PRACT GUID; TRAVIS WD, 1991, AM J SURG PATHOL, V15, P529, DOI 10.1097/00000478-199106000-00003	9	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2621	2623		10.3892/ol.2014.2538		3	Oncology	Oncology	AU9YT	WOS:000345948600052		
J	Ishii, H; Azuma, K; Yamada, K; Kinoshita, T; Imamura, Y; Hoshino, T				Ishii, Hidenobu; Azuma, Koichi; Yamada, Kazuhiko; Kinoshita, Takashi; Imamura, Youhei; Hoshino, Tomoaki			Predictive factors in patients with EGFR mutation-negative non-small cell lung cancer treated with erlotinib	ONCOLOGY LETTERS			English	Article						pulmonary metastasis; non-small cell lung cancer; erlotinib; epidermal growth factor receptor mutation	GROWTH-FACTOR RECEPTOR; OPEN-LABEL; 1ST-LINE TREATMENT; TYROSINE KINASE; CHEMOTHERAPY; MULTICENTER; GEFITINIB; PHASE-3; ADENOCARCINOMA; CP-358,774	Factors predicting the efficacy of erlotinib treatment in patients with EGFR mutation-negative non-small-cell lung cancer (NSCLC) have not been well studied. This retrospective study investigates whether patient characteristics, such as site of metastasis, can predict the efficacy of erlotinib treatment in NSCLC patients. In total, 53 EGFR mutation-negative NSCLC patients treated with erlotinib were enrolled, and the associations between clinicopathological characteristics and patient survival were analyzed. The EGFR mutation status was determined using the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp method. Survival curves were obtained using the Kaplan-Meier method. Among the NSCLC patients treated with erlotinib, 27 patients with pulmonary metastasis exhibited significantly longer progression-free survival (PFS) and overall survival (OS) times than those without pulmonary metastasis (median PFS time, 2.9 versus 1.2 months; P=0.0010 and median OS time, 12.4 versus 4.1 months; P=0.0007). Multivariate analyses also revealed that pulmonary metastasis independently correlated with PFS and OS times (hazard ratio, 0.39; P=0.0055 and hazard ratio, 0.33; P=0.0022, respectively). Patients with pulmonary metastasis exhibited significantly longer PFS and OS times than those without pulmonary metastasis. The presence of pulmonary metastasis may be a predictive factor in patients with EGFR mutation-negative NSCLC treated. with erlotinib.	[Ishii, Hidenobu; Azuma, Koichi; Yamada, Kazuhiko; Kinoshita, Takashi; Imamura, Youhei; Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 8300011, Japan	Azuma, K (reprint author), Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	azuma@med.kurume-u.ac.jp					Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Wu SG, 2013, EUR RESPIR J, V41, P1409, DOI 10.1183/09031936.00069812; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Pollack VA, 1999, J PHARMACOL EXP THER, V291, P739; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Moyer JD, 1997, CANCER RES, V57, P4838; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Liu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055128; Peaz JG, 2004, SCIENCE, V304, P1497; Walleser Silke, 2012, Clinicoecon Outcomes Res, V4, P269, DOI 10.2147/CEOR.S31794; Wu SG, 2013, EUR RESPIR J, V41, P417, DOI 10.1183/09031936.00006912	21	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2699	2704		10.3892/ol.2014.2548		6	Oncology	Oncology	AU9YT	WOS:000345948600070		
J	Ninomiya, I; Yamazaki, K; Oyama, K; Hayashi, H; Tajima, H; Kitagawa, H; Fushida, S; Fujimura, T; Ohta, T				Ninomiya, Itasu; Yamazaki, Keisuke; Oyama, Katsunobu; Hayashi, Hironori; Tajima, Hidehiro; Kitagawa, Hirohisa; Fushida, Sachio; Fujimura, Takashi; Ohta, Tetsuo			Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells	ONCOLOGY LETTERS			English	Article						pioglitazone; lymph node metastasis; lung metastasis; pancreatic cancer; differentiation; rectal xenograft model	ACTIVATED RECEPTOR-GAMMA; HUMAN BREAST-CANCER; NUDE-MOUSE RECTUM; PPAR-GAMMA; COLON-CANCER; LUNG-CANCER; IN-VITRO; TERMINAL DIFFERENTIATION; DIABETES-MELLITUS; BLADDER-CANCER	Proliferator-activated receptor-gamma (PPAR-gamma) is a nuclear receptor that acts as a transcription factor in several types of tissue. PPAR-gamma ligands are known to inhibit numerous cancer cell processes, including pancreatic cancer cell proliferation through terminal differentiation. Previous studies concerning the inhibitory effect of PPAR-gamma ligands derived from thiazolidinediones (TZDs) on the metastatic potential of cancer cells have been reported. The present study aimed to investigate whether pioglitazone, a prescription TZD class drug and a ligand of PPAR-gamma, inhibits the proliferation and metastasis of pancreatic cancer cells. The inhibitory effect of pioglitazone on the proliferation of the Capan-1, Aspc-1, BxPC-3, PANC-1 and MIApaCa-2 pancreatic cancer cell lines was analyzed. Alterations in carcinoembryonic antigen (CEA), interleukin-8 (IL-8) and cyclooxygenase-2 (COX-2) mRNA expression levels subsequent to pioglitazone treatment were examined in BxPC-3 cells by quantitative reverse transcription polymerase chain reaction. In addition, whether the oral administration of pioglitazone prevents tumorigenesis and spontaneous BxPC-3 cell lymph node and lung metastases was investigated using a rectal xenograft model. Pioglitazone treatment resulted in the inhibition of proliferation in all five pancreatic cancer cell lines in vitro. Pioglitazone induced CEA mRNA expression, suppressed IL-8 and COX-2 mRNA expression in vitro, and inhibited BxPC-3 xenograft growth. Pioglitazone also reduced BxPC-3 cell lymph node and lung metastasis in the rectal xenograft model. These results suggest that pioglitazone treatment inhibited the proliferation and metastasis of pancreatic cancer cells through the induction of differentiation and the inhibition of angiogenesis-associated protein expression.	[Ninomiya, Itasu; Yamazaki, Keisuke; Oyama, Katsunobu; Hayashi, Hironori; Tajima, Hidehiro; Kitagawa, Hirohisa; Fushida, Sachio; Fujimura, Takashi; Ohta, Tetsuo] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Oncol, Kanazawa, Ishikawa 9208641, Japan	Ninomiya, I (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Oncol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	nino@staff.kanazawa-u.ac.jp					ALLUM WH, 1986, J CLIN PATHOL, V39, P610, DOI 10.1136/jcp.39.6.610; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303; Shi Q, 1999, CLIN CANCER RES, V5, P3711; Schmidt CM, 2004, ARCH SURG-CHICAGO, V139, P718, DOI 10.1001/archsurg.139.7.718; Ninomiya I, 2012, ONCOL REP, V28, P777, DOI 10.3892/or.2012.1885; Kawa S, 2002, PANCREAS, V24, P1, DOI 10.1097/00006676-200201000-00001; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Takano S, 2008, ANTICANCER RES, V28, P3593; Govindarajan R, 2007, J CLIN ONCOL, V25, P1476, DOI 10.1200/JCO.2006.07.2777; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; Singh S, 2013, AM J GASTROENTEROL, V108, P510, DOI 10.1038/ajg.2013.7; Galli A, 2004, GUT, V53, P1688, DOI 10.1136/gut.20033.031997; Itami A, 2001, INT J CANCER, V94, P370, DOI 10.1002/ijc.1488; Kuwada Y, 2003, INT J ONCOL, V22, P765; Masferrer JL, 2000, CANCER RES, V60, P1306; MASFERRER JL, 1992, P NATL ACAD SCI USA, V89, P3917, DOI 10.1073/pnas.89.9.3917; Zhu ZW, 2012, DIABETES RES CLIN PR, V98, P159, DOI 10.1016/j.diabres.2012.05.006; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Brockman JA, 1998, GASTROENTEROLOGY, V115, P1049, DOI 10.1016/S0016-5085(98)70072-1; Ferrara A, 2011, DIABETES CARE, V34, P923, DOI 10.2337/dc10-1067; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Yoshizumi T, 2004, INT J ONCOL, V25, P631; Motomura W, 2000, CANCER RES, V60, P5558; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Braissant 0, 1996, ENDOCRINOLOGY, V137, P354; Choudhary R, 2010, NEOPLASIA, V12, P224, DOI 10.1593/neo.91638; Cohen SM, 2005, TOXICOL SCI, V87, P322, DOI 10.1093/toxsci/kfi266; Elnemr A, 2000, INT J ONCOL, V17, P1157; HOHNE MW, 1992, CANCER RES, V52, P2616; Kitamura S, 1999, JPN J CANCER RES, V90, P75; Kubota T, 1998, CANCER RES, V58, P3344; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Le XD, 2000, J INTERF CYTOK RES, V20, P935, DOI 10.1089/10799900050198372; Lyon CM, 2009, CARCINOGENESIS, V30, P2095, DOI 10.1093/carcin/bgp260; Ninomiya I, 2004, INT J CANCER, V112, P135, DOI 10.1002/ijc.20360; Pignatelli M, 2001, J CELL SCI, V114, P4117; Reddy RC, 2008, NEOPLASIA, V10, P597, DOI 10.1593/neo.08134; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Tannehill-Gregg SH, 2007, TOXICOL SCI, V98, P258, DOI 10.1093/toxsci/kfm083	48	2	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2709	2714		10.3892/ol.2014.2553		6	Oncology	Oncology	AU9YT	WOS:000345948600072		
J	Akahane, T; Mori, N; Yoshida, K				Akahane, Tsutomu; Mori, Naoya; Yoshida, Kazushige			Giant cell tumor of the tendon sheath extending around the patellar tendon and invading the knee joint and tibia: A case report	ONCOLOGY LETTERS			English	Article						giant cell tumor of the tendon sheath; patellar tendon; knee joint; tibia	NODULAR TENOSYNOVITIS	The current report presents the case Of a 41-year-old male exhibiting a giant cell tumor of the tendon sheath (GCT-TS) arising from the patellar tendon sheath. Plain radiography and magnetic resonance imaging revealed a well-localized mass that wrapped around the patellar tendon, and extended from the subcutis into the infrapatellar fat pad and tibia. Following histopathological determination of the diagnosis, a piecemeal resection was performed. Nodular-type GCT-TS occurs less frequently in large joints compared with the small joints of the fingers and toes. The current report presents the unique features of a case of GCT-TS extending around the patellar tendon, and invading into the knee joint and proximal tibia bone.	[Akahane, Tsutomu; Mori, Naoya; Yoshida, Kazushige] Shinshu Ueda Med Ctr, Dept Orthopaed Surg, Ueda, Nagano 3868610, Japan	Akahane, T (reprint author), Shinshu Ueda Med Ctr, Dept Orthopaed Surg, 1-27-21 Midorigaoka, Ueda, Nagano 3868610, Japan.	takahane@nagano-hosp.go.jp					Monaghan H, 2001, J CLIN PATHOL, V54, P404, DOI 10.1136/jcp.54.5.404; Kotwal PP, 2000, J BONE JOINT SURG BR, V82B, P571, DOI 10.1302/0301-620X.82B4.10328; Di Grazia S, 2013, G Chir, V34, P149; Fletcher CD, 2002, WHO CLASSIFICATION T, P110; JELINEK JS, 1994, AM J ROENTGENOL, V162, P919; KARASICK D, 1992, SKELETAL RADIOL, V21, P219; Kitagawa Y, 2003, SKELETAL RADIOL, V32, P633, DOI 10.1007/s00256-003-0689-y; Relwani J, 2003, KNEE, V10, P145, DOI 10.1016/S0968-0160(02)00058-3; Rodrigues C, 1998, J SURG ONCOL, V68, P100, DOI 10.1002/(SICI)1096-9098(199806)68:2<100::AID-JSO5>3.0.CO;2-A; Sun CT, 2012, ONCOL LETT, V3, P718, DOI 10.3892/ol.2012.555; USHIJIMA M, 1986, CANCER, V57, P875, DOI 10.1002/1097-0142(19860215)57:4<875::AID-CNCR2820570432>3.0.CO;2-Y; Weiss SW, 2007, ENZINGER WEISSS SOFT, P769	12	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2800	2802		10.3892/ol.2014.2561		3	Oncology	Oncology	AU9YT	WOS:000345948600090		
J	Hanzawa, N; Saitoh, K; Sakamoto, T; Matsui, T; Tsujikawa, K; Koshiba, M; Yamamoto, F				Hanzawa, Nobutomo; Saitoh, Kuimasa; Sakamoto, Taiji; Matsui, Takashi; Tsujikawa, Kyozo; Koshiba, Masanori; Yamamoto, Fumihiko			Mode multi/demultiplexing with parallel waveguide for mode division multiplexed transmission	OPTICS EXPRESS			English	Article							FIBER; COUPLER; EDFA; LINE	We propose a planar lightwave circuit (PLC)-based mode multi/demultiplexer (MUX/DEMUX) with an asymmetric parallel waveguide for mode division multiplexed (MDM) transmission. The PLC-based mode MUX/DEMUX has advantage of selectively exciting higher-order mode. We realize three-mode (LP01, LP(11)a, and LP(21)a) multiplexing by using an asymmetric parallel waveguide. We then design and fabricate a PLC-based mode MUX/DEMUX on one chip by using our proposed LP11 mode rotator to allow us to utilize the LP(11)b mode. We successfully multiplex the LP01, LP(11)a, and LP(11)b modes and achieve a relatively low insertion loss over the C-band using our fabricated mode MUX/DEMUX. Our results indicate that the PLC-based mode MUX/DEMUX with a uniform height has the potential to increase the mode number by using an LP(11)b mode. (C) 2014 Optical Society of America.	[Hanzawa, Nobutomo; Sakamoto, Taiji; Matsui, Takashi; Tsujikawa, Kyozo; Yamamoto, Fumihiko] NTT Corp, NTT Access Network Serv Syst Labs, Tsukuba, Ibaraki 3050805, Japan; [Saitoh, Kuimasa; Koshiba, Masanori] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan	Hanzawa, N (reprint author), NTT Corp, NTT Access Network Serv Syst Labs, Hanabatake 1-7-1, Tsukuba, Ibaraki 3050805, Japan.	hanzawa.nobutomo@lab.ntt.co.jp					SORIN WV, 1986, OPT LETT, V11, P581, DOI 10.1364/OL.11.000581; Chen HS, 2013, IEEE PHOTONIC TECH L, V25, P2039, DOI 10.1109/LPT.2013.2280669; Li A, 2013, IEEE PHOTONIC TECH L, V25, P1985, DOI 10.1109/LPT.2013.2280792; Leon-Saval SG, 2014, OPT EXPRESS, V22, P1036, DOI 10.1364/OE.22.001036; Yerolatsitis S, 2014, OPT EXPRESS, V22, P608, DOI 10.1364/OE.22.000608; Morioka T, 2012, IEEE COMMUN MAG, V50, pS31, DOI 10.1109/MCOM.2012.6146483; Sakamoto T, 2012, J LIGHTWAVE TECHNOL, V30, P2783, DOI 10.1109/JLT.2012.2208095; Hanzawa N, 2013, OPT EXPRESS, V21, P25752, DOI 10.1364/OE.21.025752; Le Cocq G, 2012, OPT EXPRESS, V20, P27051, DOI 10.1364/OE.20.027051; Hanzawa N., 2013, EUR C EXH OPT COMM O; Igarashi K., 2013, EUR C EXH OPT COMM O; Ip E., 2011, EUR C EXH OPT COMM O; Kobayashi T., 2013, EUR C EXH OPT COMM O; Maruyama R., OPT EXPRESS, V22, P14311; Mori T., 2013, NAT FIB OPT ENG C OS; Ryf R., 2012, NAT FIB OPT ENG C OS; Ryf R., 2013, NAT FIB OPT ENG C OS; Saitoh Kunimasa, 2014, Opt Express, V22, P19117, DOI 10.1364/OE.22.019117; Sleiffer VAJM, 2012, OPT EXPRESS, V20, pB428, DOI 10.1364/OE.20.00B428; Takara H., 2012, EUR C EXH OPT COMM O; Uematsu T., 2013, NAT FIB OPT ENG C OS; Uemura H., 2014, NAT FIB OPT ENG C OS	22	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29321	29330		10.1364/OE.22.029321		10	Optics	Optics	AU7HD	WOS:000345770500004		
J	Qin, J; Lu, GW; Sakamoto, T; Akahane, K; Yamamoto, N; Wang, DS; Wang, C; Wang, HX; Zhang, M; Kawanishi, T; Ji, YF				Qin, Jun; Lu, Guo-Wei; Sakamoto, Takahide; Akahane, Kouichi; Yamamoto, Naokatsu; Wang, Danshi; Wang, Cheng; Wang, Hongxiang; Zhang, Min; Kawanishi, Tetsuya; Ji, Yuefeng			Simultaneous multichannel wavelength multicasting and XOR logic gate multicasting for three DPSK signals based on four-wave mixing in quantum-dot semiconductor optical amplifier	OPTICS EXPRESS			English	Article							FORMAT CONVERSION; PHASE; FIBER; FWM; SOA; EFFICIENCY	In this paper, we experimentally demonstrate simultaneous multichannel wavelength multicasting (MWM) and exclusive-OR logic gate multicasting (XOR-LGM) for three 10Gbps non-return-to-zero differential phase-shift-keying (NRZ-DPSK) signals in quantum-dot semiconductor optical amplifier (QD-SOA) by exploiting the four-wave mixing (FWM) process. No additional pump is needed in the scheme. Through the interaction of the input three 10Gbps DPSK signal lights in QD-SOA, each channel is successfully multicasted to three wavelengths (1-to-3 for each), totally 3-to-9 MWM, and at the same time, three-output XOR-LGM is obtained at three different wavelengths. All the new generated channels are with a power penalty less than 1.2dB at a BER of 10(-9). Degenerate and non-degenerate FWM components are fully used in the experiment for data and logic multicasting. (C) 2014 Optical Society of America	[Qin, Jun; Wang, Danshi; Wang, Cheng; Wang, Hongxiang; Zhang, Min; Ji, Yuefeng] Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, State Key Lab Informat Photon & Opt Commun, Beijing 100088, Peoples R China; [Qin, Jun; Lu, Guo-Wei; Sakamoto, Takahide; Akahane, Kouichi; Yamamoto, Naokatsu; Wang, Danshi; Kawanishi, Tetsuya] Natl Inst Informat & Commun Technol NICT, Koganei, Tokyo 1848795, Japan; [Qin, Jun; Lu, Guo-Wei; Wang, Danshi] Tokai Univ, Inst Innovat Sci & Technol, Hiratsuka, Kanagawa 25912, Japan	Lu, GW (reprint author), Natl Inst Informat & Commun Technol NICT, 4-2-1 Nukui Kitamachi, Koganei, Tokyo 1848795, Japan.	gordon.guoweilu@gmail.com; jyf@bupt.edu.cn	Sakamoto, Takahide/F-3831-2014		National High Technology Research and Development Program of China (863 Program) [2012AA011302]; 863 Program of China [2011AA010306]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25709031]	The work was conducted under the collaboration contract between NICT and Tokai University. J. Qin and D. Wang would like to thank the support of the NICT trainee program, and the financial support by the National High Technology Research and Development Program of China (863 Program) (No. 2012AA011302) and the 863 Program of China (No. 2011AA010306). G.-W. Lu would like to acknowledge the financial support from the Grant-in-Aid for Young Scientist (A) (25709031) granted by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akahane K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EG02; An Y., 2013, P OFC 13; Contestabile G, 2011, IEEE J QUANTUM ELECT, V47, P541, DOI 10.1109/JQE.2010.2096500; Zhang XL, 2004, OPT EXPRESS, V12, P361, DOI 10.1364/OPEX.12.000361; Chan K, 2004, IEEE PHOTONIC TECH L, V16, P897, DOI 10.1109/LPT.2004.823750; Hansryd J, 2002, IEEE J SEL TOP QUANT, V8, P506, DOI 10.1109/JSTQE.2002.1016354; Contestabile G, 2009, J LIGHTWAVE TECHNOL, V27, P4256, DOI 10.1109/JLT.2009.2023091; Wang J, 2008, OPT LETT, V33, P1419, DOI 10.1364/OL.33.001419; Matsuura M, 2011, OPT EXPRESS, V19, P560, DOI 10.1364/OE.19.00B560; Wang J, 2009, OPT EXPRESS, V17, P12555, DOI 10.1364/OE.17.012555; Poustie AJ, 1999, OPT COMMUN, V168, P89, DOI 10.1016/S0030-4018(99)00348-X; Lu GW, 2011, J LIGHTWAVE TECHNOL, V29, P2460, DOI 10.1109/JLT.2011.2160977; Akahane K, 2011, PHYS STATUS SOLIDI A, V208, P425, DOI 10.1002/pssa.201000432; Stubkjaer KE, 2000, IEEE J SEL TOP QUANT, V6, P1428, DOI 10.1109/2944.902198; Dawei Wang, 2010, Journal of Lightwave Technology, V28, DOI 10.1109/JLT.2010.2090130; Deng N., IEEE J SEL TOP QUANT, V12, P702; Dimitriadou E, 2013, J LIGHTWAVE TECHNOL, V31, P3813, DOI 10.1109/JLT.2013.2287905; Fok MP, 2007, IEEE PHOTONIC TECH L, V19, P1166, DOI 10.1109/LPT.2007.901450; Hisano D., 2013, P OFC 13; Lacey J. P., J LIGHTWAVE TECHNOL, V16, P2419; Lu GW, 2008, OPT EXPRESS, V16, P21964, DOI 10.1364/OE.16.021964; Pu MH, 2011, OPT EXPRESS, V19, P24448, DOI 10.1364/OE.19.024448; Rouskas GN, 2003, IEEE NETWORK, V17, P60, DOI 10.1109/MNET.2003.1174179; SHIBATA N, 1987, IEEE J QUANTUM ELECT, V23, P1205, DOI 10.1109/JQE.1987.1073489; Wang J., 2008, P OFC 08; Willner AE, 2014, J LIGHTWAVE TECHNOL, V32, DOI 10.1109/JLT.2013.2287219; Zhiyu Chen, 2012, IEEE Photonics Technology Letters, V24, DOI 10.1109/LPT.2012.2217951	27	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29413	29423		10.1364/OE.22.029413		11	Optics	Optics	AU7HD	WOS:000345770500014		
J	Harako, K; Otuya, DO; Kasai, K; Hirooka, T; Nakazawa, M				Harako, Koudai; Otuya, David Odeke; Kasai, Keisuke; Hirooka, Toshihiko; Nakazawa, Masataka			High-performance TDM demultiplexing of coherent Nyquist pulses using time-domain orthogonality	OPTICS EXPRESS			English	Article							TRANSMISSION	We propose a simple and high-performance scheme for demultiplexing coherent Nyquist TDM signals by photo-mixing on a photo-detector with Nyquist LO pulses. This scheme takes advantage of the time-domain orthogonality of Nyquist pulses, which enables high-SNR demultiplexing and homodyne detection simultaneously in spite of a strong overlap with adjacent pulses in the time domain. The feasibility of this scheme is demonstrated through a demultiplexing experiment employing 80 Gbaud, 64 QAM Nyquist pulse OTDM signals. This scheme exhibits excellent demultiplexing performance with a much simpler configuration than a conventional ultrafast all-optical sampling scheme. (C) 2014 Optical Society of America	[Harako, Koudai; Otuya, David Odeke; Kasai, Keisuke; Hirooka, Toshihiko; Nakazawa, Masataka] Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan	Harako, K (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	harako@riec.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26000009]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Specially Promoted Research, 26000009.	Harako K, 2013, OPT EXPRESS, V21, P21062, DOI 10.1364/OE.21.021062; Zhang C, 2009, J LIGHTWAVE TECHNOL, V27, P224, DOI 10.1109/JLT.2008.2010333; Nakazawa M, 2012, OPT EXPRESS, V20, P1129, DOI 10.1364/OE.20.001129; Baxter G., 2006, P OFC NFOEC2006; Hu H., 2013, P C LAS EL CLEO 2013; Ito F, 1996, ELECTRON LETT, V32, P14, DOI 10.1049/el:19960065; Nakazawa M, 2011, OPT EXPRESS, V19, P574, DOI 10.1364/OE.19.00B574; Otuya D. O., 2014, P OPT FIB C OFC; Otuya DO, 2013, OPT EXPRESS, V21, P22808, DOI 10.1364/OE.21.022808; Palushani E., 2011, P EUR C OPT COMM ECO; Richter Thomas, 2014, IEEE Photonics Technology Letters, V26, DOI 10.1109/LPT.2014.2306987; Richter T., 2011, P OPT FIB COMM C OFC; Zhang JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06156	13	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29456	29464		10.1364/OE.22.029456		9	Optics	Optics	AU7HD	WOS:000345770500018		
J	Tahara, T; Kaku, T; Arai, Y				Tahara, Tatsuki; Kaku, Toru; Arai, Yasuhiko			Digital holography based on multiwavelength spatial-bandwidth-extended capturing-technique using a reference arm (Multi-SPECTRA)	OPTICS EXPRESS			English	Article							FRINGE-PATTERN ANALYSIS; FOURIER-TRANSFORM; 3-DIMENSIONAL IMAGE; FRESNEL HOLOGRAPHY; PHASE-SHIFTER; INTERFEROMETRY; MICROSCOPY; RECONSTRUCTION; WAVELENGTHS; RESOLUTION	Single-shot digital holography based on multiwavelength spatial-bandwidth-extended capturing-technique using a reference arm (Multi-SPECTRA) is proposed. Both amplitude and quantitative phase distributions of waves containing multiple wavelengths are simultaneously recorded with a single reference arm in a single monochromatic image. Then, multiple wavelength information is separately extracted in the spatial frequency domain. The crosstalk between the object waves with different wavelengths is avoided and the number of wavelengths recorded with both a single-shot exposure and no crosstalk can be increased, by a large spatial carrier that causes the aliasing, and/or by use of a grating. The validity of Multi-SPECTRA is quantitatively, numerically, and experimentally confirmed. (C) 2014 Optical Society of America	[Tahara, Tatsuki; Kaku, Toru; Arai, Yasuhiko] Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan	Tahara, T (reprint author), Kansai Univ, Fac Engn Sci, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	tahara@kansai-u.ac.jp			Research Foundation for Opt-Science and Technology; Murata Science Foundation; Research foundation of Tokyo Institute of Technology; Japan Society for the Promotion of Science (JSPS) [25886014]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	The authors appreciate Prof. Adrian Stern and the reviewers for the helpful comments and kind editorial procedures. Also we thank Ryo Kato and Kris Cutsail for checking the English grammar of this article. This study was partially supported by Research Foundation for Opt-Science and Technology, The Murata Science Foundation, Research foundation of Tokyo Institute of Technology, Grant-in-Aid for Research Activity Start-up 25886014 of the Japan Society for the Promotion of Science (JSPS), and MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	POON TC, 1995, OPT ENG, V34, P1338, DOI 10.1117/12.201662; Kato J, 2002, OPT LETT, V27, P1403, DOI 10.1364/OL.27.001403; Mann CJ, 2008, OPT EXPRESS, V16, P9753, DOI 10.1364/OE.16.009753; Funamizu H, 2014, OPT COMMUN, V312, P245, DOI 10.1016/j.optcom.2013.09.032; Yamaguchi I, 2002, OPT LETT, V27, P1108, DOI 10.1364/OL.27.001108; Demoli N, 2003, OPT EXPRESS, V11, P767, DOI 10.1364/OE.11.000767; GREIVENKAMP JE, 1987, APPL OPTICS, V26, P5245, DOI 10.1364/AO.26.005245; ITOH K, 1990, APPL OPTICS, V29, P1625, DOI 10.1364/AO.29.001625; ICHIOKA Y, 1972, APPL OPTICS, V11, P1507, DOI 10.1364/AO.11.001507; Ferraro P, 2008, J DISP TECHNOL, V4, P97, DOI 10.1109/JDT.2007.900936; Kuhn J, 2007, OPT EXPRESS, V15, P7231, DOI 10.1364/OE.15.007231; Pham QD, 2012, OPT EXPRESS, V20, P19744, DOI 10.1364/OE.20.019744; Xia P, 2011, APPL OPTICS, V50, pH177, DOI 10.1364/AO.50.00H177; Khmaladze A, 2008, OPT EXPRESS, V16, P10900, DOI 10.1364/OE.16.010900; Barada D, 2011, APPL OPTICS, V50, pH237, DOI 10.1364/AO.50.00H237; Kim MK, 2013, OPT EXPRESS, V21, P9636, DOI 10.1364/OE.21.009636; Watanabe E, 2013, OPT LETT, V38, P1319, DOI 10.1364/OL.38.001319; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; LEITH EN, 1962, J OPT SOC AM, V52, P1123, DOI 10.1364/JOSA.52.001123; Mico V, 2006, J OPT SOC AM A, V23, P3162, DOI 10.1364/JOSAA.23.003162; Stern A, 2004, OPT ENG, V43, P239, DOI 10.1117/1.1630316; BONE DJ, 1986, APPL OPTICS, V25, P1653; Kreis TM, 2002, OPT ENG, V41, P771, DOI 10.1117/1.1458551; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Desse JM, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/6/064005; Kakue T, 2010, J DISP TECHNOL, V6, P472, DOI 10.1109/JDT.2010.2046473; Mann CJ, 2005, OPT EXPRESS, V13, P8693, DOI 10.1364/OPEX.13.008693; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; Leclercq M, 2012, OPT EXPRESS, V20, P18303, DOI 10.1364/OE.20.018303; Horisaki R, 2012, OPT LETT, V37, P2013, DOI 10.1364/OL.37.002013; Takaki Y, 1999, APPL OPTICS, V38, P4990, DOI 10.1364/AO.38.004990; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Pavillon N, 2009, APPL OPTICS, V48, pH186, DOI 10.1364/AO.48.00H186; Kiire T, 2012, OPT LETT, V37, P3153, DOI 10.1364/OL.37.003153; Ito Y, 2012, J DISP TECHNOL, V8, P570, DOI 10.1109/JDT.2012.2204956; Javidi B, 2005, OPT LETT, V30, P144, DOI 10.1364/OL.30.000144; Memmolo P, 2012, OPT LETT, V37, P1445, DOI 10.1364/OL.37.001445; Garcia-Sucerquia J, 2012, OPT LETT, V37, P1724, DOI 10.1364/OL.37.001724; Murata S, 2000, OPT LASER TECHNOL, V32, P567, DOI 10.1016/S0030-3992(00)00088-8; Kubota T, 2007, OPT EXPRESS, V15, P14348, DOI 10.1364/OE.15.014348; Demoli N, 2009, OPT EXPRESS, V17, P15842, DOI 10.1364/OE.17.015842; Araiza-Esquivel MA, 2011, APPL OPTICS, V50, pB96, DOI 10.1364/AO.50.000B96; Clemente P, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.041803; Goodman J. W., 2005, INTRO FOURIER OPTICS; Hansel T, 2009, OPT EXPRESS, V17, P2686, DOI 10.1364/OE.17.002686; Kim MK, 2011, SPRINGER SER OPT SCI, V162, P1, DOI 10.1007/978-1-4419-7793-9; Kubota T, 2001, P SOC PHOTO-OPT INS, V4296, P126, DOI 10.1117/12.429450; LOHMANN AW, 1965, APPL OPTICS, V4, P1667, DOI 10.1364/AO.4.001667; Lue N, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4745785; Matoba O, 2001, APPL OPTICS, V40, P3318, DOI 10.1364/AO.40.003318; Murakami Y, 2014, OPT EXPRESS, V22, P20311, DOI 10.1364/OE.22.020311; Naik DN, 2014, OPT LETT, V39, P1857, DOI 10.1364/OL.39.001857; NODA T, 1992, APPL OPTICS, V31, P670, DOI 10.1364/AO.31.000670; Saucedo T, 2010, OPT EXPRESS, V18, P19867, DOI 10.1364/OE.18.019867; Tahara T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.022502; Tankam P, 2010, OPT LETT, V35, P2055, DOI 10.1364/OL.35.002055; Tsumura N, 2008, APPL OPTICS, V47, P6543, DOI 10.1364/AO.47.006543; Wada A, 2008, APPL OPTICS, V47, P2053, DOI 10.1364/AO.47.002053; Zhao JL, 2008, OPT EXPRESS, V16, P2514, DOI 10.1364/OE.16.002514	59	5	5	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29594	29610		10.1364/OE.22.029594		17	Optics	Optics	AU7HD	WOS:000345770500030		
J	Shirai, H; Duchesne, C; Furutani, Y; Fuji, T				Shirai, Hideto; Duchesne, Constance; Furutani, Yuji; Fuji, Takao			Attenuated total reflectance spectroscopy with chirped-pulse upconversion	OPTICS EXPRESS			English	Article							WATER LIQUID-MIXTURES; INFRARED-SPECTROSCOPY; MU-M; GENERATION; SPECTRA; GASES	Chirped-pulse upconversion technique has been applied to attenuated total reflectance (ATR) infrared spectroscopy. An extremely broadband infrared pulse was sent to an ATR diamond prism and the reflected pulse was converted to the visible by using four-wave mixing in krypton gas. Absorption spectra of liquids in the range from 200 to 5500 cm(-1) were measured with a visible spectrometer on a single-shot basis. The system was applied to observe the dynamics of exchanging process of two solvents, water and acetone, which give clear vibrational spectral contrast. We observed that the exchange was finished within similar to 10 ms. (C) 2014 Optical Society of America	[Shirai, Hideto; Duchesne, Constance; Fuji, Takao] Natl Inst Nat Sci, Inst Mol Sci, Laser Res Ctr Mol Sci, Okazaki, Aichi 4448585, Japan; [Furutani, Yuji] Natl Inst Nat Sci, Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan	Fuji, T (reprint author), Natl Inst Nat Sci, Inst Mol Sci, Laser Res Ctr Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	fuji@ims.ac.jp	Fuji, Takao/D-8627-2011	Fuji, Takao/0000-0002-1428-0889	MEXT/JSPS KAKENHI [24360030]; SENTAN, JST (Japan Science and Technology Agency); RIKEN-IMS joint programme on 'Extreme Photonics; Consortium for Photon Science and Technology	This work was supported by MEXT/JSPS KAKENHI (24360030 to T. F. and 26708002 to Y. F.), SENTAN, JST (Japan Science and Technology Agency), the RIKEN-IMS joint programme on 'Extreme Photonics,' and Consortium for Photon Science and Technology.	Kaindl RA, 2000, J OPT SOC AM B, V17, P2086, DOI 10.1364/JOSAB.17.002086; Lee KF, 2009, OPT EXPRESS, V17, P18738, DOI 10.1364/OE.17.018738; Baiz CR, 2011, OPT LETT, V36, P187, DOI 10.1364/OL.36.000187; Cerullo G, 2003, REV SCI INSTRUM, V74, P1, DOI 10.1063/1.1523642; Kubarych KJ, 2005, OPT LETT, V30, P1228, DOI 10.1364/OL.30.001228; Fuji T, 2013, APPL SCI-BASEL, V3, P122, DOI 10.3390/app3010122; Nomura Y, 2012, OPT EXPRESS, V20, P24741, DOI 10.1364/OE.20.024741; Zhu JY, 2012, OPT EXPRESS, V20, P10562, DOI 10.1364/OE.20.010562; Lanin AA, 2014, J OPT SOC AM B, V31, P1901, DOI 10.1364/JOSAB.31.001901; Nomura Y, 2013, OPT EXPRESS, V21, P18249, DOI 10.1364/OE.21.018249; Knorr J, 2013, OPT EXPRESS, V21, P30693, DOI 10.1364/OE.21.030693; Furutani Y., 2013, BIOPHYSICS-USSR, V9, P123, DOI [10.2142/biophysics.9.123, DOI 10.2142/BIOPHYSICS.9.123]; Harrick N. J., 1967, INTERNAL REFLECTION; Max JJ, 2003, J CHEM PHYS, V119, P5632, DOI 10.1063/1.1600438; Max JJ, 2004, J CHEM PHYS, V120, P6625, DOI 10.1063/1.1649936; Nyquist RM, 2004, CHEMBIOCHEM, V5, P431, DOI 10.1002/cbic.200300687; Petrov V, 2001, J OPT A-PURE APPL OP, V3, pR1, DOI 10.1088/1464-4258/3/3/201; Rich PR, 2007, MOL BIOSYST, V3, P398, DOI 10.1039/b702328f	18	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29611	29616		10.1364/OE.22.029611		6	Optics	Optics	AU7HD	WOS:000345770500031		
J	Yamamoto, N; Saito, H				Yamamoto, Naoki; Saito, Hikaru			Size dependence of band structures in a two-dimensional plasmonic crystal with a square lattice	OPTICS EXPRESS			English	Article							HOLE ARRAYS; BROAD-BAND; MODES; PHOTODETECTORS; TRANSMISSION; POLARITONS; DISPERSION; CAVITIES; GAP	A scanning transmission electron microscope (STEM) - cathodoluminescence (CL) technique is used to investigate the size dependence of the band structures in two-dimensional plasmonic crystals with a square lattice (SQ-PlCs) composed of cylindrical pillars and holes. The experimentally determined and calculated dependences of the band edge energies of the three SPP modes at the G point on the diameter of the cylindrical structure agree well. The photon maps reveal the field strength distributions of the standing SPP waves of the three eigenmodes. Additionally, a mechanism is proposed to explain the dependence of the contrast on the detected light polarization. (C) 2014 Optical Society of America	[Yamamoto, Naoki] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Yamamoto, Naoki; Saito, Hikaru] Tokyo Inst Technol, Quantum Nanoelect Reserch Ctr, Meguro Ku, Tokyo 1528551, Japan	Yamamoto, N (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan.	nyamamot@phys.titech.ac.jp			MEXT Nanotechnology Platform [12025014]	This work was supported by MEXT Nanotechnology Platform 12025014.	Billaudeau C, 2008, OPT LETT, V33, P165, DOI 10.1364/OL.33.000165; Yamamoto N, 2011, NANO LETT, V11, P91, DOI 10.1021/nl102862x; Bozhevolnyi SI, 2001, PHYS REV LETT, V86, P3008, DOI 10.1103/PhysRevLett.86.3008; Gong YY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2431450; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001; Watanabe H, 2014, OPT EXPRESS, V22, P5155, DOI 10.1364/OE.22.005155; Kociak M, 2012, MRS BULL, V37, P39, DOI 10.1557/mrs.2011.335; Takeuchi K, 2011, OPT EXPRESS, V19, P12365, DOI 10.1364/OE.19.012365; van Beijnum F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.206802; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Chou SY, 2013, OPT EXPRESS, V21, pA60, DOI 10.1364/OE.21.000A60; Parisi G, 2012, OPT EXPRESS, V20, P16690, DOI 10.1364/OE.20.016690; Davanco M, 2007, OPT EXPRESS, V15, P9681, DOI 10.1364/OE.15.009681; Rosenberg J, 2010, OPT EXPRESS, V18, P3672, DOI 10.1364/OE.18.003672; Suzuki T, 2009, OPT EXPRESS, V17, P23664, DOI 10.1364/OE.17.023664; Lakhani AM, 2011, OPT EXPRESS, V19, P18237, DOI 10.1364/OE.19.018237; Zhou W, 2013, NAT NANOTECHNOL, V8, P506, DOI [10.1038/nnano.2013.99, 10.1038/NNANO.2013.99]; Honda M, 2013, OPT EXPRESS, V21, P11973, DOI 10.1364/OE.21.011973; Okamoto T, 2012, OPT EXPRESS, V20, P5168, DOI 10.1364/OE.20.005168; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; de Abajo FJG, 2007, REV MOD PHYS, V79, P1267, DOI 10.1103/RevModPhys.79.1267; Barnes WL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107401; Boudarham G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255501; Brongersma ML, 2007, SPRINGER SER OPT SCI, V131, P1, DOI 10.1007/978-1-4020-4333-8; de Abajo FJG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.106804; Gonzalez MU, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155416; Iwanaga M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3309714; Kitson SC, 1996, PHYS REV LETT, V77, P2670, DOI 10.1103/PhysRevLett.77.2670; Kuttge M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.113405; Maier S. A., 2007, PLASMONICS FUNDAMENT; Okamoto T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115425; Raether H., 1988, SURFACE PLASMONS SMO; Senanayake P, 2011, NANO LETT, V11, P5279, DOI 10.1021/nl202732r; Truong TT, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/43/434011; Valsecchi C, 2013, LANGMUIR, V29, P5638, DOI 10.1021/la400085r; Yamamoto N., 2011, TRANSMISSION ELECT M; Zhou W, 2010, ACS NANO, V4, P1241, DOI 10.1021/nn901590p	38	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29761	29777		10.1364/OE.22.029761		17	Optics	Optics	AU7HD	WOS:000345770500044		
J	Kim, SH; Tanizawa, K; Shoji, Y; Cong, GW; Suzuki, K; Ikeda, K; Ishikawa, H; Namiki, S; Kawashima, H				Kim, Sang-Hun; Tanizawa, Ken; Shoji, Yuya; Cong, Guangwei; Suzuki, Keijiro; Ikeda, Kazuhiro; Ishikawa, Hiroshi; Namiki, Shu; Kawashima, Hitoshi			Compact 2 x 2 polarization-diversity Si-wire switch	OPTICS EXPRESS			English	Article							INSULATOR PHOTONIC WIRES; WAVE-GUIDES; ELECTROOPTIC SWITCH; OPTICAL NETWORKS; SILICON; DISPERSION; CIRCUIT; DEVICES	A polarization-independent 2 x 2 switch based on silicon-wire waveguides has been realized with a compact size of 600 x 500 mu m(2). Polarization-independent operation was achieved with a polarization-diversity technique which implements polarization splitters, TE-TM intersections, and Mach-Zehnder switches. The extinction ratios of the 2 x 2 switch for TE, TM, and a mixed polarization at a wavelength of 1550 nm were measured to be larger than 30 dB, 25 dB, and 30 dB, respectively. The measured switching powers for the TE and TM polarizations were 25 and 55 mW, respectively. The measured polarization-dependent loss was lower than 1 dB. The differential group delay (DGD) between the TE and TM modes was also evaluated using the Mueller matrix method, which was in good agreement with the values estimated from the path lengths for each mode. A path-length-compensated switch was fabricated, whose DGDs for all paths were indeed as small as similar to 2 ps, mainly from the access waveguides. The switch could provide an important route to develop ultra-compact polarization-independent integrated circuits based on silicon-wire waveguides. (C) 2014 Optical Society of America	[Kim, Sang-Hun; Tanizawa, Ken; Shoji, Yuya; Cong, Guangwei; Suzuki, Keijiro; Ikeda, Kazuhiro; Ishikawa, Hiroshi; Namiki, Shu; Kawashima, Hitoshi] Natl Inst Adv Ind Sci & Technol, Network Photon Res Ctr, Tsukuba, Ibaraki, Japan	Kim, SH (reprint author), Natl Inst Adv Ind Sci & Technol, Network Photon Res Ctr, 1-1-1 Umezono, Tsukuba, Ibaraki, Japan.	sanghun-kim@aist.go.jp	Shoji, Yuya/B-9305-2015	Shoji, Yuya/0000-0003-1907-5136	Project for Developing Innovation Systems of MEXT, Japan	This study was supported in part by the Project for Developing Innovation Systems of MEXT, Japan.	Fukuda H, 2008, OPT EXPRESS, V16, P4872, DOI 10.1364/OE.16.004872; JINGUJI K, 1990, ELECTRON LETT, V26, P1326, DOI 10.1049/el:19900855; Shoji T, 2002, ELECTRON LETT, V38, P1669, DOI 10.1049/el:20021185; Chen L, 2011, OPT LETT, V36, P469, DOI 10.1364/OL.36.000469; Fukuda H, 2006, OPT EXPRESS, V14, P12401, DOI 10.1364/OE.14.012401; Bogaerts W, 2007, OPT EXPRESS, V15, P1567, DOI 10.1364/OE.15.001567; Dulkeith E, 2006, OPT EXPRESS, V14, P3853, DOI 10.1364/OE.14.003853; Barwicz T, 2007, NAT PHOTONICS, V1, P57, DOI 10.1038/nphoton.2006.41; Suzuki K, 2014, OPT EXPRESS, V22, P3887, DOI 10.1364/OE.22.003887; Almeida VR, 2003, OPT LETT, V28, P1302, DOI 10.1364/OL.28.001302; Namiki S, 2011, IEEE J SEL TOP QUANT, V17, P446, DOI 10.1109/JSTQE.2010.2051420; Doerr CR, 2010, J LIGHTWAVE TECHNOL, V28, P520, DOI 10.1109/JLT.2009.2028656; Cong G. W., OPT EXPRESS, V21, P6889; Dong H, 2006, OPT EXPRESS, V14, P5067, DOI 10.1364/OE.14.005067; Dumon P, 2006, JPN J APPL PHYS 1, V45, P6589, DOI 10.1143/JJAP.45.6589; Kim S. - H., 2013, EUR C EXH OPT COMM; Kim SH, 2014, OPT EXPRESS, V22, P2545, DOI 10.1364/OE.22.002545; Lee B. G., 2013, OPT FIB COMM C OSA; Nakamura S., 2012, OPT FIB COMM C OSA; Nakamura S., 2011, OPT FIB COMM C OSA; Van Campenhout J, 2009, OPT EXPRESS, V17, P23793, DOI 10.1364/OE.17.023793; Wang Q, 2007, OPT EXPRESS, V15, P16500, DOI 10.1364/OE.15.016500; Zhang J., 2007, OPT EXPRESS, V15, P16500	23	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29818	29826		10.1364/OE.22.029818		9	Optics	Optics	AU7HD	WOS:000345770500049		
J	Amekura, H; Okubo, N; Ishikawa, N				Amekura, H.; Okubo, N.; Ishikawa, N.			Optical birefringence of Zn nanoparticles embedded in silica induced by swift heavy-ion irradiation	OPTICS EXPRESS			English	Article							IMPLANTATION; NANOCRYSTALS; DEFORMATION; PARTICLES	Zn nanoparticles (NPs) embedded in a silica matrix subjected to irradiation with swift heavy ions of 200 MeV Xe14+ have been found to undergo shape elongation from spheres to prolate-spheroids while maintaining the major axes of the NPs in parallel alignment. The directionally-aligned Zn spheroids enable acquisition of optical properties, such as linear dichroism and birefringence. In this paper, the birefringence of the Zn spheroids was evaluated by the crossed-Nicols (XN) transmittance, where a sample was inserted between a pair of optical polarizers that were set in an orthogonal configuration. Linearly-polarized light aligned by the first polarizer was transformed to an elliptic polarization by the birefringence of the Zn spheroids. The existence of the birefringence was confirmed by the non-zero transmittance of the second polarizer in the orthogonal configuration. The sample irradiated with a fluence of 5.0 x 10(13) ions/cm(2) exhibited a maximum XN transmittance of 2.1% at a photon energy of similar to 4 eV. The XN transmission was observed down to a fluence of 1.0 x 10(12) ions/cm(2), but reduced below the detection limit at a fluence of 1.0 x 10(11) ions/cm(2). The possible application of the elongated Zn NPs as a polarizer with nanometric thickness working in the near-and midultraviolet region is discussed. (C) 2014 Optical Society of America.	[Amekura, H.] Natl Inst Mat Sci, Sakura Ku, Tsukuba, Ibaraki 3050003, Japan; [Okubo, N.; Ishikawa, N.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Amekura, H (reprint author), Natl Inst Mat Sci, Sakura Ku, Tsukuba, Ibaraki 3050003, Japan.	amekura.hiroshi@nims.go.jp	Amekura, Hiroshi/B-3870-2008	Amekura, Hiroshi/0000-0003-2148-8431	JSPS-KAKENHI [26390032]	This work was partly supported by JSPS-KAKENHI Grant Number 26390032. The SHI irradiations were performed under the Common-Use Facility Program of JAEA. The authors are grateful to the technical staff of the accelerator facilities at JAEA-Tokai for their kind help. The authors also thank Prof. S. Mantl, and Mr. A. Dahmen (FZ Juelich) for Zn ion implantation.	Amekura H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205401; Amekura H, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.172404; Amekura H, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/43/435301; Amekura H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193327; Amekura H, 2004, NUCL INSTRUM METH B, V222, P114, DOI 10.1016/j.nimb.2004.01.214; Amekura H., 2009, LECT NOTES NANOSCALE, V5, P1; Reyes-Esqueda JA, 2008, OPT EXPRESS, V16, P710, DOI 10.1364/OE.16.000710; Muskens OL, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402906; Awazu K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.054102; Amekura H, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/39/395707; Ridgway MC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.095505; Oliver A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245425; HAGLUND RF, 1994, NUCL INSTRUM METH B, V91, P493, DOI 10.1016/0168-583X(94)96274-X; Nakajima A, 1998, APPL PHYS LETT, V73, P1071, DOI 10.1063/1.122087; Kluth P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.175503; Kunzner N, 2001, OPT LETT, V26, P1265, DOI 10.1364/OL.26.001265; D'Orleans C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.220101; Dawi EA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3103267; Fujiwara H, 2007, SPECTROSCOPIC ELLIPS; Genereux F, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.161101; Giulian R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125413; Kerboua CH, 2007, NUCL INSTRUM METH B, V257, P42, DOI 10.1016/j.nimb.2006.12.167; Klaumunzer S, 2006, NUCL INSTRUM METH B, V244, P1, DOI 10.1016/j.nimb.2005.11.006; Kluth P, 2007, RADIAT EFF DEFECT S, V162, P501, DOI 10.1080/10420150701472221; Kreibig U., 1995, OPTICAL PROPERTIES M; Lamarre JM, 2005, THIN SOLID FILMS, V479, P232, DOI 10.1016/j.tsf.2004.11.180; Mishra YK, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2764556; Penninkhof JJ, 2006, NUCL INSTRUM METH B, V242, P523, DOI 10.1016/j.nimb.2005.08.116; Ridgway MC, 2009, NUCL INSTRUM METH B, V267, P931, DOI 10.1016/j.nimb.2009.02.025; Roorda S, 2004, ADV MATER, V16, P235, DOI 10.1002/adma.200305742; Schmidt B, 2009, NUCL INSTRUM METH B, V267, P1345, DOI 10.1016/j.nimb.2009.01.062; Solzi M., 2002, MAGNETIC NANOSTRUCTU, P123; Ziegler J. F., 1985, STOPPING RANGE IONS	33	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					29888	29898		10.1364/OE.22.029888		11	Optics	Optics	AU7HD	WOS:000345770500056		
J	Juranic, PN; Stepanov, A; Ischebeck, R; Schlott, V; Pradervand, C; Patthey, L; Radovic, M; Gorgisyan, I; Rivkin, L; Hauri, CP; Monoszlai, B; Ivanov, R; Peier, P; Liu, J; Togashi, T; Owada, S; Ogawa, K; Katayama, T; Yabashi, M; Abela, R				Juranic, P. N.; Stepanov, A.; Ischebeck, R.; Schlott, V.; Pradervand, C.; Patthey, L.; Radovic, M.; Gorgisyan, I.; Rivkin, L.; Hauri, C. P.; Monoszlai, B.; Ivanov, R.; Peier, P.; Liu, J.; Togashi, T.; Owada, S.; Ogawa, K.; Katayama, T.; Yabashi, M.; Abela, R.			High-precision x-ray FEL pulse arrival time measurements at SACLA by a THz streak camera with Xe clusters	OPTICS EXPRESS			English	Article							FREE-ELECTRON LASERS; CYCLE TERAHERTZ PULSES; ATTOSECOND METROLOGY; EXTREME-ULTRAVIOLET; OPERATION	The accurate measurement of the arrival time of a hard X-ray free electron laser (FEL) pulse with respect to a laser is of utmost importance for pump-probe experiments proposed or carried out at FEL facilities around the world. This manuscript presents the latest device to meet this challenge, a THz streak camera using Xe gas clusters, capable of pulse arrival time measurements with an estimated accuracy of several femtoseconds. An experiment performed at SACLA demonstrates the performance of the device at photon energies between 5 and 10 keV with variable photon beam parameters. (C) 2014 Optical Society of America	[Juranic, P. N.; Stepanov, A.; Ischebeck, R.; Schlott, V.; Pradervand, C.; Patthey, L.; Radovic, M.; Gorgisyan, I.; Rivkin, L.; Hauri, C. P.; Monoszlai, B.; Abela, R.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Gorgisyan, I.; Rivkin, L.; Hauri, C. P.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Monoszlai, B.] Univ Pecs, H-7624 Pecs, Hungary; [Ivanov, R.; Peier, P.] DESY, D-22607 Hamburg, Germany; [Liu, J.] European XFEL GmbH, D-22761 Hamburg, Germany; [Togashi, T.] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Owada, S.; Ogawa, K.; Katayama, T.; Yabashi, M.] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Juranic, PN (reprint author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	pavle.juranic@psi.ch	Yabashi, Makina/A-2832-2015; Hauri, Christoph/B-6192-2013	Yabashi, Makina/0000-0002-2472-1684; Hauri, Christoph/0000-0002-8751-0585	JASRI [2013B8002]	We would like to acknowledge the contribution of the technical staff at PSI and SACLA in the setup and the execution of the experiment, with special thanks to Beat Rippstein, Peter Wiegand, and Goran Marinkovic. We also thank A.L. Cavalieri for his fruitful discussions with us. We express our acknowledgment to K. Tanaka and H. Hirori for their valuable advice. The experiment was performed with the approval of JASRI (proposal no. 2013B8002).	Uiberacker M, 2005, LASER PHYS, V15, P195; Harmand M, 2013, NAT PHOTONICS, V7, P215, DOI [10.1038/nphoton.2013.11, 10.1038/NPHOTON.2013.11]; Stepanov AG, 2014, APPL PHYS B-LASERS O, V115, P293, DOI 10.1007/s00340-013-5619-7; Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; KARNBACH R, 1993, REV SCI INSTRUM, V64, P2838, DOI 10.1063/1.1144371; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Bionta MR, 2011, OPT EXPRESS, V19, P21855, DOI 10.1364/OE.19.021855; Irimia D, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3263912; Drescher M, 2001, SCIENCE, V291, P1923, DOI 10.1126/science.1058561; Tavella F, 2011, NAT PHOTONICS, V5, P162, DOI [10.1038/nphoton.2010.311, 10.1038/NPHOTON.2010.311]; Hebling J, 2002, OPT EXPRESS, V10, P1161, DOI 10.1364/OE.10.001161; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Krupin O, 2012, OPT EXPRESS, V20, P11396, DOI 10.1364/OE.20.011396; Fruhling U, 2009, NAT PHOTONICS, V3, P523, DOI 10.1038/NPHOTON.2009.160; HAGENA OF, 1972, J CHEM PHYS, V56, P1793, DOI 10.1063/1.1677455; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Stepanov AG, 2010, APPL PHYS B-LASERS O, V101, P11, DOI 10.1007/s00340-010-4186-4; Tono K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083035; Beye M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3695164; Allaria E, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/075002; Dusterer S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/093024; Grguras I, 2012, NAT PHOTONICS, V6, P851, DOI [10.1038/nphoton.2012.276, 10.1038/NPHOTON.2012.276]; Juranic PN, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/03/P03006; Oberta P, 2011, PROC SPIE, V8078, DOI 10.1117/12.887162; Riedel R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2754; Ruffin AB, 1999, PHYS REV LETT, V83, P3410, DOI 10.1103/PhysRevLett.83.3410; Sato T., APPL PHYS EX INPRESS	28	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					30004	30012		10.1364/OE.22.030004		9	Optics	Optics	AU7HD	WOS:000345770500068		
J	Ohashi, M; Miyoshi, Y; Kubota, H; Maruyama, R; Kuwaki, N				Ohashi, Masaharu; Miyoshi, Yuji; Kubota, Hirokazu; Maruyama, Ryo; Kuwaki, Nobuo			Longitudinal fiber parameter measurements of multi-core fiber using OTDR	OPTICS EXPRESS			English	Article							CHROMATIC DISPERSION DISTRIBUTION; OPTICAL-FIBERS	A novel technique is proposed for measuring the longitudinal fiber parameters of multi-core fiber (MCF). The mode field diameter (MFD)of a fiber link composed of MCF is successfully estimated with a modified optical time domain reflectometer (OTDR). The measurement accuracy of the MFD distribution is revealed by simulation as a function of the mode coupling coefficient. It is also shown that the relative-index difference and chromatic dispersion of MCF can be estimated with the present technique. (C) 2014 Optical Society of America	[Ohashi, Masaharu; Miyoshi, Yuji; Kubota, Hirokazu] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Maruyama, Ryo; Kuwaki, Nobuo] Fujikura Ltd, Sakura, Chiba 2858550, Japan	Ohashi, M (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, 1-1 Gakuen, Sakai, Osaka 5998531, Japan.	ohashi@eis.osakafu-u.ac.jp					MARCUSE D, 1977, AT&T TECH J, V56, P703; Winzer PJ, 2011, OPT EXPRESS, V19, P16680, DOI 10.1364/OE.19.016680; Koshiba M, 2009, IEICE ELECTRON EXPR, V6, P98, DOI 10.1587/elex.6.98; Essiambre RJ, 2010, J LIGHTWAVE TECHNOL, V28, P662, DOI 10.1109/JLT.2009.2039464; [Anonymous], 1999, G6501 ITUT, Patent No. 0982577-A1; PASK C, 1984, ELECTRON LETT, V20, P144, DOI 10.1049/el:19840097; [Anonymous], 1999, ITU-T Recommendation G.650.1, Patent No. 0982577; OHASHI M, 1993, ELECTRON LETT, V29, P426, DOI 10.1049/el:19930285; KASHYAP R, 1988, ELECTRON LETT, V24, P47, DOI 10.1049/el:19880032; Morioka T., 2009, P OECC2009; Nakajima K, 1997, J LIGHTWAVE TECHNOL, V15, P1095, DOI 10.1109/50.596954; Nakazawa M, 2012, OPT EXPRESS, V20, P12530, DOI 10.1364/OE.20.012530; O'Sullivan M. S., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V661; Ohashi M., 2012, P 17 OECC BUS S KOR, P357; Ohashi M, 2006, IEEE PHOTONIC TECH L, V18, P2584, DOI 10.1109/LPT.2006.887335; Rossaro A, 2001, IEEE J SEL TOP QUANT, V7, P475, DOI 10.1109/2944.962271; Shibata N., 1980, I IECE JPN E, VE63, P837; Takenaga K, 2011, IEICE T COMMUN, VE94B, P409, DOI 10.1587/transcom.E94.B.409; Toge K, 2005, IEEE PHOTONIC TECH L, V17, P1704, DOI 10.1109/LPT.2005.851014; Tsutsumi Yasuhiro, 2012, IEICE Transactions on Communications (Japanese Edition), VJ95-B; Wuilpart M, 2003, ELECTRON LETT, V39, P88, DOI 10.1049/el:20030027	21	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					30137	30147		10.1364/OE.22.030137		11	Optics	Optics	AU7HD	WOS:000345770500081		
J	Enami, Y; Jouane, Y; Luo, JD; Jen, AKY				Enami, Yasufumi; Jouane, Youssef; Luo, Jingdong; Jen, Alex K-Y.			Enhanced conductivity of sol-gel silica cladding for efficient poling in electro-optic polymer/TiO2 vertical slot waveguide modulators	OPTICS EXPRESS			English	Article							OPTICAL MODULATOR; HIGH-SPEED; ELECTROABSORPTION MODULATOR; OPTIMIZATION; RANGE; PM/V	We report the enhanced conductivity of sol-gel silica under-cladding for efficient poling of electro-optic (EO) polymer in a hybrid EO polymer/TiO2 vertical slot waveguide modulator. The electrical volume conductivity of sol-gel silica cladding increases approximately 30 times when the calcining time of the cladding layer is critically reduced to 45 minutes, which increases the in-device EO coefficient of the 600-nm-thick EO polymer film in modulators and reduces the lower halfwave voltage (V-pi) of the modulators. The lowest driving voltage (V-pi) of the TiO2 slot waveguide modulator is 2.0 V for an electrode length (L-e) of 10 mm and wavelength of 1550 nm (V pi Le = 2.0 V.cm) for the low-index guest-host EO polymer SEO125. The optical propagation loss is reduced to 7 dB/cm. (C)2014 Optical Society of America	[Enami, Yasufumi; Jouane, Youssef] Kochi Univ Technol, Grad Sch Engn, Kami, Kochi 7828502, Japan; [Luo, Jingdong; Jen, Alex K-Y.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	Enami, Y (reprint author), Kochi Univ Technol, Grad Sch Engn, Kami, Kochi 7828502, Japan.	yasufumi@kochi-tech.ac.jp			MEXT, Japan [21246060, 24246063]; Air Force Office of Scientific Research under the Small Business Technology Transfer Research (STTR) program [FA8650-12-M-5130]; Soluxra, LLC	This work was supported by a Grant-in-Aid for Scientific Research (A) (Grant No. 21246060 and No. 24246063) from MEXT, Japan, the Air Force Office of Scientific Research (FA8650-12-M-5130 under the Small Business Technology Transfer Research (STTR) program), and Soluxra, LLC.	Tu XG, 2013, OPT EXPRESS, V21, P12776, DOI 10.1364/OE.21.012776; Zhang XY, 2014, J LIGHTWAVE TECHNOL, V32, P3774, DOI 10.1109/JLT.2014.2319152; Zhang XY, 2013, OPT LETT, V38, P4931, DOI 10.1364/OL.38.004931; Wang XL, 2011, OPT LETT, V36, P882, DOI 10.1364/OL.36.000882; Zhang XY, 2012, IEEE PHOTONICS J, V4, P2214, DOI 10.1109/JPHOT.2012.2228477; Watts MR, 2010, IEEE J SEL TOP QUANT, V16, P159, DOI 10.1109/JSTQE.2009.2035059; Lin CY, 2011, OPT EXPRESS, V19, P17372, DOI 10.1364/OE.19.017372; Lin XH, 2013, OPT LETT, V38, P1597, DOI 10.1364/OL.38.001597; Feng NN, 2010, OPT EXPRESS, V18, P7994, DOI 10.1364/OE.18.007994; Melikyan A, 2014, NAT PHOTONICS, V8, P229, DOI 10.1038/NPHOTON.2014.9; Zhang XY, 2014, OPT EXPRESS, V22, P20678, DOI 10.1364/OE.22.020678; Lin CY, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3486225; Enami Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2776369; Tang YB, 2011, OPT EXPRESS, V19, P5811, DOI 10.1364/OE.19.005811; Xiao X, 2013, OPT EXPRESS, V21, P4116, DOI 10.1364/OE.21.004116; Enami Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754597; Baehr-Jones T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909656; Wang J, 2013, J LIGHTWAVE TECHNOL, V31, P4119, DOI 10.1109/JLT.2013.2287671; Tang YB, 2012, OPT EXPRESS, V20, P11529, DOI 10.1364/OE.20.011529; Palmer R, 2014, J LIGHTWAVE TECHNOL, V32, P2726, DOI 10.1109/JLT.2014.2321498; Enami Y, 2007, NAT PHOTONICS, V1, P180, DOI 10.1038/nphoton.2007.25; Chen DT, 1997, APPL PHYS LETT, V70, P3335, DOI 10.1063/1.119162; Baehr-Jones T, 2012, OPT EXPRESS, V20, P12014, DOI 10.1364/OE.20.012014; Ziebell M, 2012, OPT EXPRESS, V20, P10591, DOI 10.1364/OE.20.010591; Block BA, 2008, OPT EXPRESS, V16, P18326, DOI 10.1364/OE.16.018326; Enami Y, 2014, OPT EXPRESS, V22, P16418, DOI 10.1364/OE.22.016418; Enami Y, 2011, AIP ADV, V1, DOI 10.1063/1.3662038; Jouane Y, 2014, OPT EXPRESS, V22, P27725, DOI 10.1364/OE.22.027725; Thomson DJ, 2012, IEEE PHOTONIC TECH L, V24, DOI 10.1109/LPT.2011.2177081	29	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					30191	30199		10.1364/OE.22.030191		9	Optics	Optics	AU7HD	WOS:000345770500088		
J	Ilas, S; Loiseau, P; Aka, G; Taira, T				Ilas, Simon; Loiseau, Pascal; Aka, Gerard; Taira, Takunori			240 kW peak power at 266 nm in nonlinear YAl3(BO3)(4) single crystal	OPTICS EXPRESS			English	Article							MICROCHIP LASER; GROWTH; GENERATION; BORATE; ABSORPTION	We report the fourth harmonic generation at 266 nm using a type I YAl3(BO3)4 (YAB) single crystal from a Q-switch microchip laser Nd:YAG/Cr4+:YAG frequency doubled with a LiB3O5 (LBO) crystal. 240 kW peak power at 266 nm corresponding to a mean conversion efficiency of 12.2% from 532 to 266 nm has been obtained with a 2.94 mm thick YAB crystal. The influences of optical homogeneity and absorption on the conversion efficiency are discussed. (C) 2014 Optical Society of America	[Ilas, Simon; Loiseau, Pascal; Aka, Gerard] PSL Res Univ, Chim Paristech, CNRS, Inst Rech Chim Paris, F-75005 Paris, France; [Taira, Takunori] Laser Res Ctr, Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Loiseau, P (reprint author), PSL Res Univ, Chim Paristech, CNRS, Inst Rech Chim Paris, F-75005 Paris, France.	pascal.loiseau@chimie-paristech.fr	Taira, Takunori/H-5313-2012		Airbus Group Foundation [088-A009-1006]; French National Research Agency (ANR) (ANR UV Challenge) [12-B504-0014-01]	Authors would like to acknowledge the Airbus Group Foundation for PhD funding (project 088-A009-1006). This work is supported by a public grant overseen by the French National Research Agency (ANR) (ANR UV Challenge, 12-B504-0014-01)	Alekel T., US patent application, Patent No. [US2006/ 0054864 A1, 20060054864]; Yue YC, 2011, J OPT SOC AM B, V28, P861; Yu JQ, 2012, J CRYST GROWTH, V341, P61, DOI 10.1016/j.jcrysgro.2011.12.063; Peter A, 2000, J CRYST GROWTH, V209, P102, DOI 10.1016/S0022-0248(99)00515-1; ROBERTS DA, 1992, IEEE J QUANTUM ELECT, V28, P2057, DOI 10.1109/3.159516; Liu LJ, 2009, SOLID STATE SCI, V11, P841, DOI 10.1016/j.solidstatesciences.2009.01.003; VANSTRYLAND EW, 1985, OPT LETT, V10, P490, DOI 10.1364/OL.10.000490; Sakai H, 2008, OPT EXPRESS, V16, P19891, DOI 10.1364/OE.16.019891; Bhandari R, 2012, OPT MATER EXPRESS, V2, P907; Liu Q, 2011, OPT LETT, V36, P2653, DOI 10.1364/OL.36.002653; Becker P, 1998, ADV MATER, V10, P979, DOI 10.1002/(SICI)1521-4095(199809)10:13<979::AID-ADMA979>3.0.CO;2-N; Wang GL, 2006, OPT COMMUN, V259, P820, DOI 10.1016/j.optcom.2005.09.061; Chen C T, 2012, NONLINEAR OPTICAL BO; Dekker P, 2006, APPL PHYS B-LASERS O, V83, P267, DOI 10.1007/s00340-006-2168-3; Liu H, 2011, MATER RES INNOV, V15, P102, DOI 10.1179/143307511X12998222918750; Liu Q, 2009, LASER PHYS LETT, V6, P203, DOI 10.1002/lapl.200810122; Rytz D, 2008, PROC SPIE, V6998, DOI 10.1117/12.780027; Takachiho K, 2014, OPT MATER EXPRESS, V4, P559, DOI 10.1364/OME.4.000559; WANG GF, 1995, J CRYST GROWTH, V153, P169, DOI 10.1016/0022-0248(95)00157-3; Yu XS, 2010, J CRYST GROWTH, V312, P3029, DOI 10.1016/j.jcrysgro.2010.07.005; Zhao SR, 2001, J APPL CRYSTALLOGR, V34, P661, DOI 10.1107/S0021889801010834	21	0	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	DEC 1	2014	22	24					30325	30332		10.1364/OE.22.030325		8	Optics	Optics	AU7HD	WOS:000345770500098		
J	Abe, Y; Kanehara, M; Kanai, K				Abe, Yuichi; Kanehara, Masayuki; Kanai, Kaname			Electronic structure of phthalocyanine derivative-protected pi-junction Au nanoparticles	ORGANIC ELECTRONICS			English	Article						Gold nanoparticle; Phthalocyanine derivatives; Electronic structure; Photoelectron spectroscopy	PBSE NANOCRYSTAL SOLIDS; THIN-FILM TRANSISTORS; GOLD NANOPARTICLES; ELECTRICAL-PROPERTIES; SPECTROSCOPY	Phthalocyanine derivative-protected Au nanoparticles (H2Pc-AuNPs) can be processed without post-treatment into electroconductive electrodes that exhibit high electrical conductivity. However, the reason for the high electrical conductivity of AuNP films is still unclear. To better understand the carrier transport mechanism in H2Pc-AuNP films, we performed ultraviolet photoelectron spectroscopy, inverse photoelectron spectroscopy and Xray photoelectron spectroscopy to probe the electronic structure of 2,3,9,10,16,17,23,24-octakis [2-(dimethylamino) ethylthio] phthalocyanine and 2,3,11,12,20,21,29,30-octakis[2-(dimethylamino) ethylthio] naphthalocyanine as ligands for AuNPs. We demonstrated that the ligand molecules are chemisorbed onto AuNP's surface through formation of Au-S bonds. It can be expected that strong interaction between pi-orbitals of the molecules and Au orbitals. (C) 2014 Elsevier B.V. All rights reserved.	[Abe, Yuichi; Kanai, Kaname] Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, Noda, Chiba 2788510, Japan; [Kanehara, Masayuki] Okayama Univ, Res Core Interdisciplinary Sci, Okayama 7008530, Japan	Abe, Y (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	6213601@ed.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24350013]	This work was supported by a Grant-in-Aid for Scientific Research (Grant No. 24350013) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Kahn A, 2003, J POLYM SCI POL PHYS, V41, P2529, DOI 10.1002/polb.10642; Hagemann O, 2008, SOL ENERG MAT SOL C, V92, P1327, DOI 10.1016/j.solmat.2008.05.005; Noh YY, 2007, NAT NANOTECHNOL, V2, P784, DOI 10.1038/nnano.2007.365; Minari T, 2014, ADV FUNCT MATER, V24, P4886, DOI 10.1002/adfm.201400169; Lackinger M, 2004, J PHYS CHEM B, V108, P2279, DOI 10.1021/jp036698v; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Law M, 2008, J AM CHEM SOC, V130, P5974, DOI 10.1021/ja800040c; Kanehara M, 2008, ANGEW CHEM INT EDIT, V47, P307, DOI 10.1002/anie.200703943; Wakuda D, 2007, CHEM PHYS LETT, V441, P305, DOI 10.1016/j.cplett.2007.05.033; Chang YM, 2013, SOL ENERG MAT SOL C, V109, P91, DOI 10.1016/j.solmat.2012.09.020; Iketaki K, 2005, SYNTHETIC MET, V153, P457, DOI 10.1016/j.synthmet.2005.07.255; Kanehara M, 2012, B CHEM SOC JPN, V85, P957, DOI 10.1246/bcsj.20120103; Khosousi A. Z., 2008, CHEM REV, V108, P4072; Sham TK, 2006, SOLID STATE COMMUN, V138, P553, DOI 10.1016/j.ssc.2006.03.021; Song YJ, 2010, NANO LETT, V10, P996, DOI 10.1021/nl904119y; Yamamoto M, 2010, B CHEM SOC JPN, V83, P1386, DOI 10.1246/bcsj.20100117	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	DEC	2014	15	12					3465	3470		10.1016/j.orgel.2014.09.035		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU5LS	WOS:000345649200007		
J	Tsujimura, S; Fujihara, T; Sassa, T; Kinashi, K; Sakai, W; Ishibashi, K; Tsutsumi, N				Tsujimura, Sho; Fujihara, Takashi; Sassa, Takafumi; Kinashi, Kenji; Sakai, Wataru; Ishibashi, Koji; Tsutsumi, Naoto			Enhanced photoconductivity and trapping rate through control of bulk state in organic triphenylamine-based photorefractive materials	ORGANIC ELECTRONICS			English	Article						Charge transport; Trapping rate; Photoconductivity; Organic photorefractive materials; Triphenylamine derivatives	CHARGE-TRANSPORT PROPERTIES; SOLAR-CELLS; THIN-FILMS; MOLECULAR-WEIGHT; POLYMERS; PERFORMANCE; TRANSISTORS; COMPOSITES; SEMICONDUCTORS; RECOMBINATION	In organic optical semiconductors, it is rather challenging to achieve precise control of photoconductivity and charge trapping, which determines the device performance. This paper reports on enhanced photorefractive response rate through control of the photoconductivity and trapping rate in organic triphenylamine-based photorefractive materials by means of bulk state tuning. The bulk state in organic triphenylamine-based photorefractive composites was controlled through a rapid cooling process from various melting temperatures during sample fabrication. The photoconductivity and trapping rate were determined from photocurrent measurements. Fabrication at lower melting temperatures enhanced the trapping rate for deep traps, whereas it reduced the trapping rate for shallow traps. As a result, a faster photorefractive response was obtained. (C) 2014 Elsevier B.V. All rights reserved.	[Tsujimura, Sho; Kinashi, Kenji; Sakai, Wataru; Tsutsumi, Naoto] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Macromol Sci & Engn, Sakyo, Kyoto 6068585, Japan; [Tsujimura, Sho; Fujihara, Takashi; Sassa, Takafumi; Ishibashi, Koji] RIKEN, Adv Device Lab, Wako, Saitama 3510198, Japan; [Sassa, Takafumi; Ishibashi, Koji] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Fujihara, Takashi] Inst Syst Informat Technol & Nanotechnol ISIT, Innovat Organ Device Lab, Fukuoka 8190388, Japan	Sassa, T (reprint author), RIKEN, Adv Device Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsassa@riken.jp; tsutsumi@kit.ac.jp	Ishibashi, Koji/G-7065-2012		program for Strategic Promotion of Innovative Research and Development (S-Innovation), Japan Science and Technology Agency (JST); Junior Research Associate (JRA) Program from RIKEN	This work is supported by the program for Strategic Promotion of Innovative Research and Development (S-Innovation), Japan Science and Technology Agency (JST). The author (S. Tsujimura) acknowledges the support of the Junior Research Associate (JRA) Program from RIKEN. We would like to thank Professor Takeo Sasaki at Tokyo University of Science for the DSC measurements. The HOMO levels were estimated using the AC-3, which is common equipment of CEMS, RIKEN.	Verploegen E, 2010, ADV FUNCT MATER, V20, P3519, DOI 10.1002/adfm.201000975; Wetzelaer GJAH, 2012, ADV ENERGY MATER, V2, P1232, DOI 10.1002/aenm.201200009; MOERNER WE, 1994, CHEM REV, V94, P127, DOI 10.1021/cr00025a005; Ostroverkhova O, 2004, CHEM REV, V104, P3267, DOI 10.1021/cr960055c; Thomas J, 2004, ADV MATER, V16, P2032, DOI 10.1002/adma.200400102; Ribierre JC, 2007, J APPL PHYS, V102, DOI [10.1063/1.2767379, 10.1063/1.27613790]; Peumans P, 2003, NATURE, V425, P158, DOI 10.1038/nature01949; Ostroverkhova O, 2002, J APPL PHYS, V92, P1727, DOI 10.1063/1.1491279; Hirao A, 1997, PHYS REV B, V56, pR2904; Tada A, 2011, NAT MATER, V10, P450, DOI [10.1038/nmat3026, 10.1038/NMAT3026]; SCHILDKRAUT JS, 1992, J APPL PHYS, V72, P1888, DOI 10.1063/1.351662; Kulikovsky L, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125216; Ribierre JC, 2003, MACROMOLECULES, V36, P2516, DOI 10.1021/ma021246m; Giri G, 2011, NATURE, V480, P504, DOI 10.1038/nature10683; Tsujimura S, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.064101; Rivnay J, 2009, NAT MATER, V8, P952, DOI [10.1038/nmat2570, 10.1038/NMAT2570]; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Cao ZB, 2013, POLYMER, V54, P269, DOI 10.1016/j.polymer.2012.11.028; Zhang FL, 2006, ADV FUNCT MATER, V16, P667, DOI 10.1002/adfm.200500339; Ribierre JC, 2008, ORG ELECTRON, V9, P396, DOI 10.1016/j.orgel.2008.01.005; Xu DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3200947; Sakanoue K, 1999, J PHYS CHEM A, V103, P5551, DOI 10.1021/jp990206q; Groves C, 2010, NANO LETT, V10, P1063, DOI 10.1021/nl100080r; Lee SS, 2009, ADV MATER, V21, P3605, DOI 10.1002/adma.200900705; Ribierre JC, 2010, ADV MATER, V22, P4044, DOI 10.1002/adma.201001170; Bai YW, 2002, APPL PHYS LETT, V80, P10, DOI 10.1063/1.1427427; Bittner R., 2007, PHOTOREFRACTIVE MAT, V2, P419; BORSENBERGER PM, 1993, J PHYS CHEM-US, V97, P4815, DOI 10.1021/j100120a038; Fujihara T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3284951; FUJIHARA T, 2007, J APPL PHYS, V115, P23109; Goonesekera A, 1999, J APPL PHYS, V85, P6506, DOI 10.1063/1.370154; Jung GB, 2003, JPN J APPL PHYS 1, V42, P2699, DOI 10.1143/JJAP.42.2699; Liebig CM, 2013, OPT EXPRESS, V21, P30392, DOI 10.1364/OE.21.030392; Madison TA, 2012, J PHYS CHEM C, V116, P11852, DOI 10.1021/jp207421n; Malinkiewicz O, 2014, NAT PHOTONICS, V8, P128, DOI [10.1038/nphoton.2013.341, 10.1038/NPHOTON.2013.141]; Oh JW, 2009, J PHYS CHEM B, V113, P1592, DOI 10.1021/jp809322p; Quintana JA, 2009, ADV FUNCT MATER, V19, P428, DOI 10.1002/adfm.200800790; Ribierre JC, 2011, J PHYS CHEM C, V115, P20703, DOI 10.1021/jp206129g; Ribierre JC, 2006, J APPL PHYS, V100, DOI 10.1063/1.2234811; Sassa T, 2013, OPT MATER EXPRESS, V3, P472	40	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	DEC	2014	15	12					3471	3475		10.1016/j.orgel.2014.09.032		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU5LS	WOS:000345649200008		
J	Lim, E; Taguchi, D; Iwamoto, M				Lim, Eunju; Taguchi, Dai; Iwamoto, Mitsumasa			Study of stress biasing effect observed in C-V characteristics of ITO/PI/TIPS-pentacene/Au diodes by electric field induced optical second harmonic generation	ORGANIC ELECTRONICS			English	Article						TIPS-pentacene; TR-EFISHG; Maxwell-Wagner effect element; C-V characteristics	THIN-FILM TRANSISTORS; WAGNER MODEL ANALYSIS; VOLTAGE; DEVICE	To clarify the capacitance-voltage (C-V) characteristics of organic double-layer diodes with a structure of ITO/PI/TIPS-pentacene/Au, time-resolved electric field induced optical second harmonic generation (TR-EFISHG) measurement was employed. The TR-EFISHG measurement probed the change of electric fields in the TIPS-pentacene organic layer, which originates from accumulated charges at the PI/TIPS-pentacene double-layer interface. Consequently, the shift of threshold voltage Delta Vth of the C-V curves caused by stress negative-biasing was well explained, and a potential well model was proposed on the basis of the TR-EFISHG measurement. TR-EFISHG is a very useful way to study the carrier behaviors, in terms of the C-V characteristics. (C) 2014 Elsevier B.V. All rights reserved.	[Lim, Eunju] Dankook Univ, INBT, Dept Appl Phys, Jukjeon Dong 448701, Gyeonggi Do, South Korea; [Lim, Eunju] Dankook Univ, Dept Sci Educ, Jukjeon Dong 448701, Gyeonggi Do, South Korea; [Taguchi, Dai; Iwamoto, Mitsumasa] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan	Lim, E (reprint author), Dankook Univ, INBT, Dept Appl Phys, Jukjeon Dong 448701, Gyeonggi Do, South Korea.	elim@dankook.ac.kr			Japan Society for Promotion of Science, Japan [2226007]; Mid-Career Researcher Program [2012-046931]; NRF - Ministry of Education, Science and Technology, Korea [2013R1A1A3013282]	This work is financially supported by a Grant-in-Aid for Scientific Research S (No. 2226007) from the Japan Society for Promotion of Science, Japan, and by the Mid-Career Researcher Program (2012-046931) and E.L. thanks the Basic Research Program (2013R1A1A3013282) the NRF funded by the Ministry of Education, Science and Technology, Korea.	Lim E, 2006, JPN J APPL PHYS 1, V45, P3712, DOI 10.1143/JJAP.45.3712; Lim SC, 2005, SYNTHETIC MET, V148, P75, DOI 10.1016/j.synthmet.2004.08.034; Sirringhaus H, 2005, ADV MATER, V17, P2411, DOI 10.1002/adma.200501152; Dimtrakopoulos C.D., 2002, ADV MATTER, V14, P99; Iwamoto M., 2001, PHYS PROPERTIES ORGA; Kim TH, 2008, THIN SOLID FILMS, V516, P1232, DOI 10.1016/j.tsf.2007.06.008; Lampert M. A., 1970, CURRENT INJECTION SO; Lim E, 2014, CURR APPL PHYS, V14, P1156, DOI 10.1016/j.cap.2014.06.011; Lim E, 2013, CHEM PHYS LETT, V561, P97, DOI 10.1016/j.cplett.2013.01.034; Lim E, 2013, ORG ELECTRON, V14, P1903, DOI 10.1016/j.orgel.2013.04.021; Lim E, 2011, CHEM PHYS LETT, V515, P306, DOI 10.1016/j.cplett.2011.09.030; Lim E, 2012, CURR APPL PHYS, V12, P1023, DOI 10.1016/j.cap.2011.12.025; Lim E, 2012, ORG ELECTRON, V13, P2489, DOI 10.1016/j.orgel.2012.06.031; Manaka T, 2007, NAT PHOTONICS, V1, P581, DOI 10.1038/nphoton.2007.172; Pope M., 1999, ELECT PROCESSES ORGA; Schoonveld WA, 2000, NATURE, V404, P977, DOI 10.1038/35010073; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Shirakawa H., 1971, J POLYM, V2, P231; Singh V.K., 2013, APPL PHYS LETT, V102; Sze S. M., 1981, PHYS SEMICONDUCTOR D; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Ziemelis K, 1998, NATURE, V393, P619, DOI 10.1038/31333	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	DEC	2014	15	12					3590	3594		10.1016/j.orgel.2014.09.044		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU5LS	WOS:000345649200025		
J	Noda, K; Wada, Y; Toyabe, T				Noda, Kei; Wada, Yasuo; Toyabe, Toru			Experimental and numerical analysis of channel-length-dependent electrical properties in bottom-gate, bottom-contact organic thin-film transistors with Schottky contact	ORGANIC ELECTRONICS			English	Article						Organic thin-film transistors; Schottky barrier; Thermionic field emission; Device simulation; Bottom-gate; bottom-contact configuration	FIELD-EFFECT TRANSISTORS; ENERGY-LEVEL ALIGNMENT; PENTACENE; INJECTION; RESISTANCE; MOBILITY; BARRIERS	Channel length dependence of field-effect mobility and source/drain parasitic resistance in pentacene thin-film transistors with a bottom-gate, bottom-contact configuration was investigated. Schottky barrier effect such as nonlinear behaviors in transistor output characteristics appeared and became more prominent for shorter channel length less than 10 mu m, raising some concerns for a simple utilization of conventional parameter extraction methods. Therefore the gate-voltage-dependent hole mobility and the source/drain parasitic resistance in the pentacene transistors were evaluated with the aid of device simulation accounting for Schottky contact with a thermionic field emission model. The hole mobility in the channel region shows smaller values with shorter channel length even after removing the influence of Schottky barrier, suggesting that some disordered semiconductor layers with low carrier mobility exist near the contact electrode. This experimental data analysis with the simulation enables us to discuss and understand in detail the operation mechanism of bottom-gate, bottom-contact transistors by considering properly each process of charge carrier injection, carrier flow near the contact region, and actual channel transport. (C) 2014 Elsevier B.V. All rights reserved.	[Noda, Kei; Wada, Yasuo] Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Toyabe, Toru] Toyo Univ, Kawagoe, Saitama 3500815, Japan	Noda, K (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	nodakei@elec.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Joint Research and Development Project of International Standards - Ministry of Economy, Trade and Industry, Japan (METI); Keio Gijyuku Academic Development Funds	A part of this work was conducted at the AIST Nano-Processing Facility, supported by "Nanotechnology Platform Program'' of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). This study was partly supported by Joint Research and Development Project of International Standards funded by the Ministry of Economy, Trade and Industry, Japan (METI) and Keio Gijyuku Academic Development Funds.	Minari T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2759987; Dimitrakopoulos CD, 1996, J APPL PHYS, V80, P2501, DOI 10.1063/1.363032; Vissenberg MCJM, 1998, PHYS REV B, V57, P12964, DOI 10.1103/PhysRevB.57.12964; Chan CK, 2009, APPL PHYS A-MATER, V95, P7, DOI 10.1007/s00339-008-4997-x; Jurchescu OD, 2004, APPL PHYS LETT, V84, P3061, DOI 10.1063/1.1704874; Noda K, 2014, ORG ELECTRON, V15, P1571, DOI 10.1016/j.orgel.2014.04.018; Schroeder PG, 2002, J APPL PHYS, V91, P3010, DOI 10.1063/1.1445286; Liu C, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4860958; Amy F, 2005, ORG ELECTRON, V6, P85, DOI 10.1016/j.orgel.2005.03.003; Xu Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3479476; Hamadani BH, 2005, J APPL PHYS, V97, DOI 10.1063/1.1858874; PADOVANI FA, 1966, SOLID STATE ELECTRON, V9, P695, DOI 10.1016/0038-1101(66)90097-9; Dong HL, 2010, CHEM COMMUN, V46, P5211, DOI 10.1039/c0cc00947d; Hoppe A, 2010, ORG ELECTRON, V11, P626, DOI 10.1016/j.orgel.2010.01.002; Gruber M, 2012, ORG ELECTRON, V13, P1887, DOI 10.1016/j.orgel.2012.05.009; Ishikawa Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3309935; Horowitz G, 2000, J APPL PHYS, V87, P4456, DOI 10.1063/1.373091; Wang SD, 2010, IEEE ELECTR DEVICE L, V31, P509, DOI 10.1109/LED.2010.2044137; LUAN SW, 1992, J APPL PHYS, V72, P766, DOI 10.1063/1.351809; Nakahara R, 2012, ADV MATER, V24, P5212, DOI 10.1002/adma.201201234; Natali D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2402349; Northrup JE, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.041202; Weis M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3533020; Ohashi N, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799743; Burgi L, 2003, J APPL PHYS, V94, P6129, DOI 10.1063/1.1613369; Puigdollers J, 2004, ORG ELECTRON, V5, P67, DOI 10.1016/j.orgel.2003.10.002; Brutting W., 2005, PHYS ORGANIC SEMICON, P1, DOI 10.1002/3527606637.ch; Deen MJ, 2008, J APPL PHYS, V103, DOI 10.1063/1.2942400; Hamadani BH, 2005, P IEEE, V93, P1306, DOI 10.1109/JPROC.2005.850301; Horowitz G, 2004, ADV FUNCT MATER, V14, P1069, DOI 10.1002/adfm.200305122; Kitamura M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3176480; Koch N, 2003, APPL PHYS LETT, V82, P70, DOI 10.1063/1.1532102; Li T, 2003, J APPL PHYS, V93, P4017, DOI 10.1063/1.1558998; McDonald O, 2006, SURF SCI, V600, P3217, DOI 10.1016/j.susc.2006.06.007; Noda K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JH02; Noda K., 2014, PHYS CHEM CHEM PHYS; Scholz R, 2008, PHYS STATUS SOLIDI A, V205, P591, DOI 10.1002/pssa.200723415; Torricelli F, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868042; Weis M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.011601	39	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	DEC	2014	15	12					3681	3687		10.1016/j.orgel.2014.10.017		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU5LS	WOS:000345649200038		
J	Risteska, A; Steudel, S; Nakamura, M; Knipp, D				Risteska, Anita; Steudel, Soeren; Nakamura, Masakazu; Knipp, Dietmar			Structural ordering versus energy band alignment: Effects of self-assembled monolayers on the metal/semiconductor interfaces of small molecule organic thin-film transistors	ORGANIC ELECTRONICS			English	Article						Barrier height; Bottom-contact coplanar thin-film transistors; Contact resistance; Self-assembled monolayers	LEVEL ALIGNMENT; INJECTION BARRIER; CHARGE INJECTION; METAL; PENTACENE; MORPHOLOGY; POLYMER; GOLD; ELECTRODES	A model describing the influence of self-assembled monolayers on the contact resistance of bottom-contact organic thin-film transistors is presented. The model takes the contact geometry, the energy level alignment and the structural order of the organic films into consideration when describing the contact effects of organic transistors. The treatment of the metal source/drain electrodes of the transistors by self-assembled monolayers allows for tuning the work function of the metal contact and an improved ordering of the organic molecules on top of the source/drain contacts. The results reveal that the contact resistance is mainly determined by the molecular ordering, rather than the tuning of the work function. The model is compared to experimentally measured contact resistances for different self-assembled monolayers. (C) 2014 Elsevier B.V. All rights reserved.	[Risteska, Anita; Knipp, Dietmar] Jacobs Univ Bremen, Res Ctr Funct Mat & Nanomol Sci, Elect Devices & Nanophoton Lab, D-28759 Bremen, Germany; [Steudel, Soeren] IMEC, Large Area Elect Dept, B-3001 Louvain, Belgium; [Nakamura, Masakazu] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan	Knipp, D (reprint author), Jacobs Univ Bremen, Res Ctr Funct Mat & Nanomol Sci, Elect Devices & Nanophoton Lab, D-28759 Bremen, Germany.	d.knipp@jacobs-university.de	Nakamura, Masakazu/D-9786-2011	Nakamura, Masakazu/0000-0002-4540-5816			Risteska A, 2014, ORG ELECTRON, V15, P461, DOI 10.1016/j.orgel.2013.11.028; Campbell IH, 1997, APPL PHYS LETT, V71, P3528, DOI 10.1063/1.120381; Marmont P, 2008, ORG ELECTRON, V9, P419, DOI 10.1016/j.orgel.2008.01.004; Mityashin A, 2014, ACS APPL MATER INTER, V6, P15372, DOI 10.1021/am503873f; Kera S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085304; Boudinet D, 2010, ORG ELECTRON, V11, P227, DOI 10.1016/j.orgel.2009.10.021; Benor A, 2007, ORG ELECTRON, V8, P749, DOI 10.1016/j.orgel.2007.06.005; Nakamura M, 2009, APPL PHYS A-MATER, V95, P73, DOI 10.1007/s00339-008-4991-3; Yan L, 2002, APPL PHYS LETT, V81, P2752, DOI 10.1063/1.1512826; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Diao L, 2007, J APPL PHYS, V101, DOI 10.1063/1.2424396; Ling MM, 2004, CHEM MATER, V16, P4824, DOI 10.1021/cm0496117; Street RA, 2002, APPL PHYS LETT, V81, P2887, DOI 10.1063/1.1512950; Hoppe A, 2010, ORG ELECTRON, V11, P626, DOI 10.1016/j.orgel.2010.01.002; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Chabinyc ML, 2002, J AM CHEM SOC, V124, P11730, DOI 10.1021/ja020506c; Tang JX, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149178; Campbell IH, 1996, PHYS REV B, V54, P14321; Ante F, 2012, SMALL, V8, P73, DOI 10.1002/smll.201101677; Mason MG, 2001, J APPL PHYS, V89, P2756, DOI 10.1063/1.1324681; Marinkovic M, 2012, ADV MATER, V24, P4005, DOI 10.1002/adma.201201311; Knipp D, 2003, J APPL PHYS, V93, P347, DOI 10.1063/1.1525068; Hill IG, 1998, APPL PHYS LETT, V73, P662, DOI 10.1063/1.121940; Guo D, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193055; Benor A, 2007, THIN SOLID FILMS, V515, P7679, DOI 10.1016/j.tsf.2006.11.178; Benwadih M., 2013, Process for manufacturing a self-assembled injection monolayer, Patent No. [US 20130316541 A1, 20130316541]; Bock C, 2006, J APPL PHYS, V100, DOI 10.1063/1.2400507; Demirkan K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2832306; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.041302; Goettling S, 2008, J DISP TECHNOL, V4, P300, DOI 10.1109/JDT.2008.921903; Gundlach DJ, 2006, J APPL PHYS, V100, DOI 10.1063/1.2215132; HENISCH HK, 1956, J ELECTROCHEM SOC, V103, P637, DOI 10.1149/1.2430178; Hong K, 2008, ORG ELECTRON, V9, P21, DOI 10.1016/j.orgel.2007.07.006; Kaefer D., 2007, PHYS REV B, V75; Katsuhara M, 2014, SID S DIGEST TECH PA, V45, P716; Koch N, 2003, APPL PHYS LETT, V82, P2281, DOI 10.1063/1.1565506; Koch N, 2003, APPL PHYS LETT, V82, P70, DOI 10.1063/1.1532102; Lee CS, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3099836; Mott H.F., 1938, P CAMBRIDGE PHILOS S, V34, P568; Myny K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207846; Schottky W, 1942, Z PHYS, V118, P539, DOI 10.1007/BF01329843; Schroder D. K., 2006, SEMICONDUCTOR MAT DE; Sze S. M., 1981, PHYS SEMICONDUCTOR D; Vazquez H, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.041306	44	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	DEC	2014	15	12					3723	3728		10.1016/j.orgel.2014.10.023		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU5LS	WOS:000345649200044		
J	Winkler, C				Winkler, Chris			CONTEMPORARY JAPANESE POLITICS: Institutional Changes and Power Shifts. Contemporary Asia in the World.	PACIFIC AFFAIRS			English	Book Review									[Winkler, Chris] German Inst Japanese Studies, Tokyo, Japan	Winkler, C (reprint author), German Inst Japanese Studies, Tokyo, Japan.						Shinoda Tomohito, 2013, CONT JAPANESE POLITI	1	0	0	PACIFIC AFFAIRS UNIV BRITISH COLUMBIA	VANCOUVER	#164-1855 WEST MALL, VANCOUVER, BC V6T 1Z2, CANADA	0030-851X	1715-3379		PAC AFF	Pac. Aff.	DEC	2014	87	4					856	858				3	Area Studies	Area Studies	AU9YP	WOS:000345948200025		
J	Yamada, E; Ishii, G; Aramaki, N; Aokage, K; Hishida, T; Yoshida, J; Kojima, M; Nagai, K; Ochiai, A				Yamada, Eiji; Ishii, Genichiro; Aramaki, Nao; Aokage, Keiju; Hishida, Tomoyuki; Yoshida, Junji; Kojima, Motohiro; Nagai, Kanji; Ochiai, Atsushi			Tumor-size-based morphological features of metastatic lymph node tumors from primary lung adenocarcinoma	PATHOLOGY INTERNATIONAL			English	Article						diversity; lung adenocarcinoma; lymph node metastasis; micrometastasis	EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; BREAST-CANCER; INTERNATIONAL-ASSOCIATION; HISTOLOGIC SUBTYPES; GASTRIC-CANCER; PROGRESSION; DISEASE; GROWTH; MICROMETASTASES	Most primary lung adenocarcinomas show histological diversity, however, histological diversity in the metastatic lymph node tumors (LNT) is not well defined. The aim of this study was to explore the histological characteristics of the metastatic LNT based on their sizes. We analyzed 163 primary tumors and 509 metastatic LNTs. When the primary tumor showed papillary-predominant subtype, the most frequent histological subtype in the metastatic LNT that were = 2 mm in diameter was solid subtype (49%), followed by papillary subtype (35%); on the other hand, in the metastatic LNT measuring >2 mm in size, the frequency of tumors showing papillary-predominant subtype increased significantly to 52% (P = 0.04). When the primary tumor showed acinar-predominant subtype, the most predominant subtype in the = 2 mm metastatic LN tumors was acinar subtype (55%), followed by solid subtype (40%), with the frequency of acinar subtype increasing significantly to 76% in the metastatic LNT that were >2 mm in diameter (P = 0.04). These results indicate that solid subtype is the characteristic histological subtype in the early phase of the LN metastatic process, and that as the metastatic LNT grow larger, they develop morphological features resembling those in the primary tumor.	[Yamada, Eiji; Ishii, Genichiro; Aramaki, Nao; Kojima, Motohiro; Ochiai, Atsushi] East Hosp, Natl Canc Ctr, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba 2778577, Japan; [Yamada, Eiji; Aramaki, Nao; Aokage, Keiju; Hishida, Tomoyuki; Yoshida, Junji; Nagai, Kanji] East Hosp, Natl Canc Ctr, Div Thorac Surg, Kashiwa, Chiba 2778577, Japan	Ishii, G (reprint author), East Hosp, Natl Canc Ctr, Res Ctr Innovat Oncol, Div Pathol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	gishii@east.ncc.go.jp		Yoshida, Junji/0000-0002-1433-9297			Yeung TM, 2013, BRIT J CANCER, V108, P2106, DOI 10.1038/bjc.2013.209; Yanagita S, 2008, J SURG RES, V145, P238, DOI 10.1016/j.jss.2007.04.037; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Rusch VW, 2011, J CLIN ONCOL, V29, P4313, DOI 10.1200/JCO.2011.35.2500; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Lee HJ, 2013, RADIOLOGY, V268, P254, DOI 10.1148/radiol.13112553; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Kim H, 2013, KOREAN J PATHOL, V47, P44, DOI 10.4132/KoreanJPathol.2013.47.1.44; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Yokoyama H, 2006, CLIN CANCER RES, V12, P361, DOI 10.1158/1078-0432.CCR-05-1963; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Russell PA, 2011, J THORAC ONCOL, V6, P1496, DOI 10.1097/JTO.0b013e318221f701; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511; Aokage K, 2011, INT J CANCER, V128, P1585, DOI 10.1002/ijc.25500; Aokage K, 2010, PATHOL INT, V60, P765, DOI 10.1111/j.1440-1827.2010.02596.x; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Morel Anne-Pierre, 2008, PLoS One, V3, pe2888, DOI 10.1371/journal.pone.0002888; Sobin LH, 2009, TNM CLASSIFICATION M; Takuwa T, 2012, ANN SURG ONCOL, V19, P3943, DOI 10.1245/s10434-012-2428-x; Yasumoto K, 2003, ANN THORAC SURG, V76, P194, DOI 10.1016/S0003-4975(03)00130-9	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2014	64	12					591	600		10.1111/pin.12213		10	Pathology	Pathology	AU8JM	WOS:000345842600001		
J	Tatsuno, M; Maeshima, AM; Kim, SW; Maruyama, D; Taniguchi, H; Miyamoto, K; Fukuhara, S; Kobayashi, Y; Tobinai, K; Kushima, R				Tatsuno, Mai; Maeshima, Akiko Miyagi; Kim, Sung-Won; Maruyama, Dai; Taniguchi, Hirokazu; Miyamoto, Ken-ichi; Fukuhara, Suguru; Kobayashi, Yukio; Tobinai, Kensei; Kushima, Ryoji			Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: A report of two cases	PATHOLOGY INTERNATIONAL			English	Article						classical Hodgkin lymphoma; germinal center; immunohistochemistry; nodular lymphocyte predominant Hodgkin lymphoma	FOLLICULAR DENDRITIC CELLS; CENTER B-CELL; DISEASE	We here report on two rare cases of intrafollicular classical Hodgkin lymphoma (CHL). Case 1 was a 34-year-oldmanwho underwent left supraclavicular lymph node biopsy. Case 2 was a 28-year-old woman who underwent surgical resection of an anterior mediastinal mass. The histology and microenvironment of both specimens resembled those of nodular lymphocyte predominant Hodgkin lymphoma. Nodular architecture was observed, which comprised normal-appearing small lymphocytes and scattered lymphocyte predominant (LP)-like cells. CD23(+) follicular dendritic cell meshworks were present in the nodules, surrounded by a mantle zone containing IgD(+) B cells. The LP-like cells were ringed by CD3(+) and PD-1(+) T cells, and numerous CD20(+) B cells were present in the background. However, the immunophenotypes of the LP-like cells resembled those of Hodgkin/Reed-Sternberg cells of CHL; they were positive for CD15, CD30, and PAX5, and negative for CD20, Bcl6, Oct2, and Bob1. These histopathological findings indicate that CHL can be derived from the germinal center.	[Tatsuno, Mai; Maeshima, Akiko Miyagi; Taniguchi, Hirokazu; Kushima, Ryoji] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan; [Tatsuno, Mai; Kim, Sung-Won; Maruyama, Dai; Miyamoto, Ken-ichi; Fukuhara, Suguru; Kobayashi, Yukio; Tobinai, Kensei] Natl Canc Ctr, Dept Hematol, Tokyo 1040045, Japan	Maeshima, AM (reprint author), Natl Canc Ctr, Dept Pathol & Clin Lab, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	akmaeshi@ncc.go.jp	Kobayahi, Yukio/F-2901-2015	Kobayahi, Yukio/0000-0003-2378-7865	Foundation for Promotion of Cancer Research; National Cancer Center Research and Development Fund in Japan [23-A-17, 23-A-23, 26-A-4]	This work was supported in part by the Foundation for Promotion of Cancer Research and National Cancer Center Research and Development Fund (23-A-17, 23-A-23, and 26-A-4) in Japan.	ALAVAIKKO MJ, 1991, AM J CLIN PATHOL, V95, P194; ALAVAIKKO MJ, 1994, AM J CLIN PATHOL, V101, P761; Fan Z, 2003, AM J SURG PATHOL, V27, P1346, DOI 10.1097/00000478-200310000-00007; Brauninger A, 1999, NEW ENGL J MED, V340, P1239, DOI 10.1056/NEJM199904223401604; Nam-Cha SH, 2009, MODERN PATHOL, V22, P1006, DOI 10.1038/modpathol.2009.54; Szczepanowski M, 2013, HUM PATHOL, V44, P1434, DOI 10.1016/j.humpath.2012.11.018; Marafioti T, 1999, J CLIN ONCOL, V17, P3804; Carbone A, 2012, HUM PATHOL, V43, P619, DOI 10.1016/j.humpath.2011.09.002; GELB AB, 1993, AM J SURG PATHOL, V17, P364, DOI 10.1097/00000478-199304000-00007; MIETTINEN M, 1983, CANCER, V51, P2293, DOI 10.1002/1097-0142(19830615)51:12<2293::AID-CNCR2820511221>3.0.CO;2-X; Song JY, 2011, AM J SURG PATHOL, V35, P767, DOI 10.1097/PAS.0b013e3182147f91; Swerdlow S, 2008, WHO CLASSIFICATION T	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2014	64	12					613	617		10.1111/pin.12221		5	Pathology	Pathology	AU8JM	WOS:000345842600004		
J	Okudela, K; Umeda, S; Otara, M; Honda, E; Ohmori, T; Tajari, M; Kameda, Y; Ohashi, K				Okudela, Koji; Umeda, Shigeaki; Otara, Misa; Honda, Emi; Ohmori, Takahiro; Tajari, Michihiko; Kameda, Yoichi; Ohashi, Kenichi			A case of pulmonary hamartoma with distinctive histopathological features: A discussion of its differential diagnosis and histogenesis	PATHOLOGY INTERNATIONAL			English	Article						benign tumor; fibroleiomyomatous hamartoma; lung	FIBROLEIOMYOMATOUS HAMARTOMA; LUNG; LESION; ADENOFIBROMA	We herein describe a case of a benign pulmonary tumor with distinctive histopathological features. A 55-year-old Japanese male presented with a well-demarcated tumor in the left upper lobe of his lung, which gradually increased in size from 18 to 21 mm over 24 months. The resected tumor consisted of an epithelial component of compact irregular glands and mesenchymal component of fascicles between the glands. The differentiation of pneumocytes and smooth muscle cells was immunohistochemically detected in the epithelial component and the mesenchymal component, respectively. No mitosis, necrosis, bleeding, or invasion was observed. A histopathologic diagnosis of fibroleiomyomatous hamartoma was made. We also review previously reported tumors with similar histopathological features and discuss their differential diagnosis and histogenesis.	[Okudela, Koji; Umeda, Shigeaki; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 2360004, Japan; [Okudela, Koji; Umeda, Shigeaki; Otara, Misa; Honda, Emi; Kameda, Yoichi] Kanagawa Prefectural Cardiovasc & Resp Ctr Hosp, Div Pathol, Yokohama, Kanagawa, Japan; [Okudela, Koji; Umeda, Shigeaki; Otara, Misa; Honda, Emi; Kameda, Yoichi] Kanagawa Prefectural Cardiovasc & Resp Ctr Hosp, Div Gen Thorac Surg, Yokohama, Kanagawa, Japan	Okudela, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	kojixok@yokohama-cu.ac.jp					Itoh H, 2001, PATHOL INT, V51, P661, DOI 10.1046/j.1440-1827.2001.01245.x; Takeshima Y, 2000, PATHOL INT, V50, P984, DOI 10.1046/j.1440-1827.2000.01136.x; Gjevre JA, 1996, MAYO CLIN PROC, V71, P14; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; BUTLER C, 1969, ARCH PATHOL, V88, P584; Cavazza A, 2003, Pathologica, V95, P162; Dutta Roman, 2010, Gen Thorac Cardiovasc Surg, V58, P352, DOI 10.1007/s11748-009-0535-9; GORELKIN L, 1978, SOUTHERN MED J, V71, P88; HASSANI SN, 1979, RESPIRATION, V37, P238; McGee JO, 1992, PRINCIPLES PATHOLOGY; MINASIAN H, 1977, THORAX, V32, P360, DOI 10.1136/thx.32.3.360; SUSTER S, 1993, HISTOPATHOLOGY, V23, P547, DOI 10.1111/j.1365-2559.1993.tb01241.x; Tavassoli F.A., 2003, WHO CLASSIFICATION T; Travis WD, 2003, WHO CLASSIFICATION T; Vitkovski T, 2013, DIAGN CYTOPATHOL, V41, P991, DOI 10.1002/dc.22874; Wang Y, 2013, SURG TODAY, V43, P690, DOI 10.1007/s00595-012-0341-3	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2014	64	12					618	623		10.1111/pin.12222		6	Pathology	Pathology	AU8JM	WOS:000345842600005		
J	Sano, T; Nakamura, C; Yoshida, T; Oyama, T				Sano, Takaaki; Nakamura, Chiharu; Yoshida, Tomomi; Oyama, Tetsunari			Stratified mucin-producing intraepithelial lesions (SMILEs) of the uterine cervix are associated with HPV integration	PATHOLOGY INTERNATIONAL			English	Letter							IN-SITU HYBRIDIZATION; CARCINOMA; NEOPLASIA		[Sano, Takaaki; Nakamura, Chiharu; Oyama, Tetsunari] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gumma 371, Japan; [Yoshida, Tomomi] Gunma Univ, Fac Med, Sch Hlth Sci, Maebashi, Gumma 371, Japan	Sano, T (reprint author), Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gumma 371, Japan.						Goyal A, 2014, DIAGN CYTOPATHOL, V42, P792, DOI 10.1002/dc.23066; Nishiwaki M, 2008, J CLIN MICROBIOL, V46, P1161, DOI 10.1128/JCM.00793-07; Gupta S, 2010, EUR J OBSTET GYN R B, V148, P207, DOI 10.1016/j.ejogrb.2009.10.012; Park JJ, 2000, AM J SURG PATHOL, V24, P1414, DOI 10.1097/00000478-200010000-00012; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Cha YJ, 2012, BASIC APPL PATHOL, V5, P72; Evans MF, 2002, MODERN PATHOL, V15, P1339, DOI 10.1038/modpathol.3880698; Kurman RJ, 2010, AFIP ATLAS TUMOR PAT; Ohta Y, 2013, J OBSTET GYNAECOL RE, V39, P420, DOI 10.1111/j.1447-0756.2012.01904.x; Sano T, 1998, MODERN PATHOL, V11, P19	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2014	64	12					628	630		10.1111/pin.12217		3	Pathology	Pathology	AU8JM	WOS:000345842600007		
J	Hashimoto, T; Sekine, S; Matsubara, A; Taniguchi, H; Kushima, R				Hashimoto, Taiki; Sekine, Shigeki; Matsubara, Akiko; Taniguchi, Hirokazu; Kushima, Ryoji			Frequent presence of gastric-type epithelial cells in the duodenal bulb: An immunohistochemical study	PATHOLOGY INTERNATIONAL			English	Letter							CAMPYLOBACTER-PYLORI; MUCOSA; ULCER; GLAND; METAPLASIA; ADENOMA; DISEASE		[Hashimoto, Taiki; Sekine, Shigeki; Matsubara, Akiko; Taniguchi, Hirokazu; Kushima, Ryoji] Natl Canc Ctr, Pathol & Clin Lab Div, Tokyo, Japan; [Sekine, Shigeki] Natl Canc Ctr, Res Inst, Dept Mol Pathol, Tokyo 104, Japan	Hashimoto, T (reprint author), Natl Canc Ctr, Pathol & Clin Lab Div, 1-1 Tsukiji 5 chome, Tokyo, Japan.						Genta RM, 2010, HUM PATHOL, V41, P1593, DOI 10.1016/j.humpath.2010.04.010; Kushima R, 1999, VIRCHOWS ARCH, V435, P452, DOI 10.1007/s004280050425; Kushima R, 2013, PATHOL INT, V63, P318, DOI 10.1111/pin.12070; CARRICK J, 1989, GUT, V30, P790, DOI 10.1136/gut.30.6.790; GRAHAM DY, 1989, GASTROENTEROLOGY, V96, P615; HOEDEMAE.PJ, 1970, DIGESTION, V3, P165; JOHANSEN A, 1973, ACTA PATH MICRO IM A, VA 81, P676; Kushima R, 1999, HISTOPATHOLOGY, V35, P38; LESSELLS AM, 1982, J CLIN PATHOL, V35, P591, DOI 10.1136/jcp.35.6.591; Robert ME, 2009, SURG PATHOLOGY GI TR, P321	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2014	64	12					631	633		10.1111/pin.12220		3	Pathology	Pathology	AU8JM	WOS:000345842600008		
J	Soeki, T; Koshiba, K; Niki, T; Kusunose, K; Yamaguchi, K; Yamada, H; Wakatsuki, T; Shimabukuro, M; Minakuchi, K; Kishimoto, I; Kangawa, K; Sata, M				Soeki, Takeshi; Koshiba, Kunihiko; Niki, Toshiyuki; Kusunose, Kenya; Yamaguchi, Koji; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Shimabukuro, Michio; Minakuchi, Kazuo; Kishimoto, Ichiro; Kangawa, Kenji; Sata, Masataka			Effect of ghrelin on autonomic activity in healthy volunteers	PEPTIDES			English	Article						Ghrelin; Autonomic nerve activity; Heart rate variability; Electrocardiography; Hemodynamics	CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; VAGAL NERVE; SYMPATHETIC ACTIVITY; RATS; PEPTIDE; STIMULATION; PREVENTS; STOMACH; RABBITS	Ghrelin is a novel growth hormone (GH)-releasing peptide originally isolated from the stomach. Recently, we have shown that ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. In the present study, we evaluated the effect of ghrelin on autonomic nerve activity in healthy human subjects. An intravenous bolus of human synthetic ghrelin (10 mu g/kg) was administered to 10 healthy men (mean age, 33 years). Holter monitoring assessment was performed before and during 2 h after the ghrelin therapy. The standard deviation of normal RR intervals (SDNN), square root of the mean of the sum of the squares of differences between adjacent RR intervals (rMSSD), high-frequency power (HF), and low-frequency power (LF) were analyzed. Blood samples were also obtained before and after the therapy. A single administration of ghrelin decreased both heart rate and blood pressure. Interestingly, ghrelin significantly decreased the LF and LF/HF ratio of heart rate variability and increased the SDNN, rMSSD, and HF. Ghrelin also elicited a marked increase in circulating GH, but not insulin-like growth factor-1. These data suggest that ghrelin might suppress cardiac sympathetic nerve activity and stimulate cardiac parasympathetic nerve activity. (C) 2014 Elsevier Inc. All rights reserved.	[Soeki, Takeshi; Kusunose, Kenya; Yamaguchi, Koji; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Sata, Masataka] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Koshiba, Kunihiko] Anan Cent Hosp, Med Assoc, Dept Cardiovasc Med, Anan, Japan; [Niki, Toshiyuki] Shikoku Med Ctr Children & Adults, Dept Cardiovasc Med, Zentsuji, Japan; [Shimabukuro, Michio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiodiabet Med, Tokushima 7708503, Japan; [Minakuchi, Kazuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Clin Pharm, Tokushima 7708503, Japan; [Kishimoto, Ichiro; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Suita, Osaka, Japan	Soeki, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, 2-50-1 Kuramoto, Tokushima 7708503, Japan.	soeki@tokushima-u.ac.jp			JSPS Kakenhi [21590899, 24390204]	This study was partially supported by JSPS Kakenhi Grants (Number 21590899 and 24390204).	Shimizu S, 2011, AUTON NEUROSCI-BASIC, V162, P60, DOI 10.1016/j.autneu.2011.04.001; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Matsumura K, 2002, HYPERTENSION, V40, P694, DOI 10.1161/01.HYP.0000034395.51441.10; Nagaya N, 2004, CIRCULATION, V110, P3674, DOI 10.1161/01.CIR.0000149746.62908.BB; Schwenke DO, 2008, ENDOCRINOLOGY, V149, P5172, DOI 10.1210/en.2008-0472; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Mancia G, 1999, HYPERTENSION, V34, P724; Frishman WH, 2011, J CLIN HYPERTENS, V13, P649, DOI 10.1111/j.1751-7176.2011.00515.x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; VANOLI E, 1991, CIRC RES, V68, P1471; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Lin YZ, 2004, HYPERTENSION, V43, P977, DOI 10.1161/01.HYP.0000122803.91559.55; Okumura H, 2002, J CARDIOVASC PHARM, V39, P779, DOI 10.1097/00005344-200206000-00001; Wiley KE, 2002, BRIT J PHARMACOL, V136, P1146, DOI 10.1038/sj.bjp.0704815; Leong KS, 2000, J CLIN ENDOCR METAB, V85, P628, DOI 10.1210/jc.85.2.628; Bisi G, 1999, J ENDOCRINOL INVEST, V22, P266; Katugampola SD, 2001, BRIT J PHARMACOL, V134, P143, DOI 10.1038/sj.bjp.0704228; Kishimoto I, 2009, EXP REV ENDOCRINOL M, V4, P283, DOI 10.1586/eem.09.7; Krapalis AF, 2012, AM J PHYSIOL-REG I, V302, pR1305, DOI 10.1152/ajpregu.00663.2011; Nagaya N, 2001, J CLIN ENDOCR METAB, V86, P5854, DOI 10.1210/jc.86.12.5854; Soeki T, 2008, AM J PHYSIOL-HEART C, V294, pH426, DOI 10.1152/ajpheart.00643.2007; Soeki T, 2013, HEART VESSELS, V28, P795, DOI 10.1007/s00380-013-0333-2	22	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	DEC	2014	62						1	5		10.1016/j.peptides.013.09.015		5	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AU4YQ	WOS:000345614700001		
J	Igarashi, K; Sakurai, T; Kamiyoshi, A; Ichikawa-Shindo, Y; Kawate, H; Yamauchi, A; Toriyama, Y; Tanaka, M; Liu, T; Xian, X; Imai, A; Zhai, LY; Owa, S; Koyama, T; Uetake, R; Ihara, M; Shindo, T				Igarashi, Kyoko; Sakurai, Takayuki; Kamiyoshi, Akiko; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Yamauchi, Akihiro; Toriyama, Yuichi; Tanaka, Megumu; Liu, Tian; Xian, Xian; Imai, Akira; Zhai, Liuyu; Owa, Shinji; Koyama, Teruhide; Uetake, Ryuichi; Ihara, Masafumi; Shindo, Takayuki			Pathophysiological roles of adrenomedullin-RAMP2 system in acute and chronic cerebral ischemia	PEPTIDES			English	Article						Adrenomedullin; Receptor activity-modifying protein; Cerebral ischemia; Blood vessel	SMOOTH-MUSCLE-CELLS; ENDOGENOUS ADRENOMEDULLIN; CARDIAC-HYPERTROPHY; VASCULAR INTEGRITY; ENDOTHELIAL-CELLS; ANGIOTENSIN-II; KNOCKOUT MICE; RENAL DAMAGE; PEPTIDE; INFLAMMATION	The accessory protein RAMP2 is a component of the CLR/RAMP2 dimeric adrenomedullin (AM) receptor and is the primary determinant of the vascular functionality of AM. RAMP2 is highly expressed in the brain; however, its function there remains unclear. We therefore used heterozygous RAMP2 knockout (RAMP2+/-) mice, in which RAMP2 expression was reduced by half, to examine the actions of the endogenous AM-RA1VIP2 system in cerebral ischemia. To induce acute or chronic ischemia, mice were subjected to middle cerebral artery occlusion (MCAO) or bilateral common carotid artery stenosis (BCAS), respectively. In RAMP2+/- mice subjected to MCAO, recovery of cerebral blood flow (CBF) was slower than in WT mice. AM gene expression was upregulated after infarction in both genotypes, but the increase was greater in RAMP2+/- mice. Pathological analysis revealed severe nerve cell death and demyelination, and a higher level of oxidative stress in RAMP2+/- mice. In RAMP2+/- mice subjected to BCAS, recovery of cerebral perfusion was slower and less complete than in WT mice. In an 8-arm radial maze test, RAMP2+/- mice required more time to solve the maze and showed poorer reference memory. They also showed greater reductions in nerve cells and less compensatory capillary growth than WT mice. These results indicate the AM-RAMP2 system works to protect nerve cells from both acute and chronic cerebral ischemia by maintaining CBF, suppressing oxidative stress, and in the case of chronic ischemia, enhancing capillary growth. (C) 2014 Elsevier Inc. All rights reserved.	[Igarashi, Kyoko; Sakurai, Takayuki; Kamiyoshi, Akiko; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Yamauchi, Akihiro; Toriyama, Yuichi; Tanaka, Megumu; Liu, Tian; Xian, Xian; Imai, Akira; Zhai, Liuyu; Owa, Shinji; Koyama, Teruhide; Uetake, Ryuichi; Shindo, Takayuki] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Res, Matsumoto, Nagano 3908621, Japan; [Ihara, Masafumi] Res Inst Biomed Res & Innovat, Dept Regenerat Med, Kobe, Hyogo, Japan	Shindo, T (reprint author), Shinshu Univ, Grad Sch Med, Dept Cardiovasc Res, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	tshindo@shinshu-u.ac.jp		Ihara, Masafumi/0000-0002-7102-4048	Funding Program for Next Generation World-Leading Researchers (NEXT Program) [Funding Program for Next Generation World-Leading Researchers (NEXT Program) grant No. (LS053]; Cabinet Office, Government of Cardiovascular Diseases [26293183, 26293085, 25460330, 26460337, 26670153]; National Cardiovascular Center, and research; Novartis Foundation for Gerontological Research; Ichiro Kanehara Foundation; Cosmetology Research Foundation; SENSHIN Medical Research Foundation; Nagao Memorial Fund; Kanzawa Medical Research Foundation; Ono Medical Research Foundation; Nakatomi Foundation; Japan Heart Foundation 82 Astellas/Pfizer; Research on Atherosclerosis Update; Research Foundation for Opto-Science and Technology, Takeda Science Foundation; Japan Vascular Disease Research Foundation	This study was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) grant No. (LS053) from the Cabinet Office, Government of (26293183, 26293085, 25460330, 26460337, 26670153) Cardiovascular Diseases from the National Cardiovascular Center, and research grants from the Novartis Foundation for Gerontological Research, the Ichiro Kanehara Foundation, the Cosmetology Research Foundation, the SENSHIN Medical Research Foundation, the Nagao Memorial Fund, the Kanzawa Medical Research Foundation, the Ono Medical Research Foundation, the Nakatomi Foundation, the Japan Heart Foundation 82 Astellas/Pfizer Grant for Research on Atherosclerosis Update, the Research Foundation for Opto-Science and Technology, Takeda Science Foundation, and the Japan Vascular Disease Research Foundation.	Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Miyashita K, 2003, HYPERTENS RES, V26, pS93, DOI 10.1291/hypres.26.S93; Niu P, 2004, CIRCULATION, V109, P1789, DOI 10.1161/01.CIR.0000118466.47982.CC; Shimosawa T, 2003, HYPERTENSION, V41, P1080, DOI 10.1161/01.HYP.0000066846.46422.2C; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Uzan B, 2008, J CELL PHYSIOL, V215, P122, DOI 10.1002/jcp.21294; Miller AA, 2010, CLIN SCI, V119, P1, DOI 10.1042/CS20090649; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Kano H, 1996, J HYPERTENS, V14, P209, DOI 10.1097/00004872-199602000-00009; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Koyama T, 2013, CIRCULATION, V127, P842, DOI 10.1161/CIRCULATIONAHA.112.000756; Maki T, 2011, STROKE, V42, P1122, DOI 10.1161/STROKEAHA.110.603399; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Miyamoto N, 2009, J CEREBR BLOOD F MET, V29, P1769, DOI 10.1038/jcbfm.2009.92; Isumi Y, 1999, FEBS LETT, V463, P110, DOI 10.1016/S0014-5793(99)01615-4; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Shimosawa T, 2002, CIRCULATION, V105, P106, DOI 10.1161/hc0102.101399; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19; Iinuma N, 2010, PEPTIDES, V31, P865, DOI 10.1016/j.peptides.2010.01.011; Iwasaki H, 1998, ENDOCRINOLOGY, V139, P3432, DOI 10.1210/en.139.8.3432; Maki T, 2011, NEUROREPORT, V22, P442, DOI 10.1097/WNR.0b013e32834757e4; MURPHY TC, 1995, ENDOCRINOLOGY, V136, P2459, DOI 10.1210/en.136.6.2459; Nishimatsu H, 2003, HYPERTENS RES, V26, pS79, DOI 10.1291/hypres.26.S79; Nishimatsu H, 2002, CIRC RES, V90, P657, DOI 10.1161/01.RES.0000013697.55301.E7; Niu P, 2003, HYPERTENS RES, V26, P731, DOI 10.1291/hypres.26.731; Okumura H, 2003, HYPERTENS RES, V26, pS99, DOI 10.1291/hypres.26.S99; Petrie MC, 2000, J HYPERTENS, V18, P61, DOI 10.1097/00004872-200018010-00009; SAMSON WK, 1995, ENDOCRINOLOGY, V136, P2349, DOI 10.1210/en.136.5.2349; Samson WK, 1997, ENDOCRINOLOGY, V138, P613, DOI 10.1210/en.138.2.613; Serrano J, 2002, NEUROSCIENCE, V109, P717, DOI 10.1016/S0306-4522(01)00532-2; Shah Zahoor Ahmad, 2006, J Stroke Cerebrovasc Dis, V15, P133, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.002; Taylor GM, 1996, ENDOCRINOLOGY, V137, P3260, DOI 10.1210/en.137.8.3260; Wen Ya-Dan, 2006, Neurosci Bull, V22, P171; Zaremba J, 2000, Folia Morphol (Warsz), V59, P137; Zheng Z, 2003, CURR MOL MED, V3, P361, DOI 10.2174/1566524033479717	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	DEC	2014	62						21	31		10.1016/j.peptides.2014.08.013		11	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AU4YQ	WOS:000345614700004		
J	Hiramoto, K; Yamate, Y; Sugiyama, D; Takahashi, Y; Mafune, E				Hiramoto, Keiichi; Yamate, Yurika; Sugiyama, Daijiro; Takahashi, Yumi; Mafune, Eiichi			Tranexamic acid suppresses ultraviolet B eye irradiation-induced melanocyte activation by decreasing the levels of prohormone convertase 2 and alpha-melanocyte-stimulating hormone	PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE			English	Article						dopa-positive melanocyte; prohormone convertase 2; tranexamic acid; ultraviolet B; -melanocyte-stimulating hormone	PROOPIOMELANOCORTIN; PLASMIN; CELLS; PITUITARY; PATHWAY; SYSTEM	BackgroundTranexamic acid (trans-4-aminomethylcyclohexanecarboxylic acid) is a medicinal amino acid used in skin whitening care. This study examined the effects of tranexamic acid on the melanocyte activation of the skin induced by an ultraviolet (UV) B eye irradiation. MethodsThe eye or ear was locally exposed to UVB at a dose of 1.0kJ/m(2) using a 20SE sunlamp after covering the remaining body surface with aluminum foil. ResultsUVB eye irradiation induced melanocyte activation of the skin, similar to that observed following UVB ear irradiation, which was suppressed by the administration of tranexamic acid treatment. The plasma -melanocyte-stimulating hormone (-MSH) content was increased by UVB irradiation of the eye; however, the increase in -MSH was suppressed by tranexamic acid treatment. In addition, UVB eye irradiation induced the up-regulation of prohormone convertase (PC) 2 in the pituitary gland. Meanwhile, the increase in PC2 induced by UVB eye irradiation was suppressed by tranexamic acid treatment. ConclusionsThese results clearly indicate that tranexamic acid decreases the expression of PC2, which cleavages from proopiomelanocortin to -MSH in the pituitary gland, thereby suppressing melanocyte activation.	[Hiramoto, Keiichi] Suzuka Univ Med Sci, Dept Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Hiramoto, Keiichi; Yamate, Yurika] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan; [Sugiyama, Daijiro; Takahashi, Yumi; Mafune, Eiichi] Daiichi Sankyo Healthcare CO LTD, R&D Dept, Tokyo, Japan	Hiramoto, K (reprint author), Suzuka Univ Med Sci, Dept Pharmaceut Sci, 3500-3 Minamitamagakicho, Suzuka, Mie 5138670, Japan.	hiramoto@suzuka-u.ac.jp					ABIKO Y, 1970, BIOCHIM BIOPHYS ACTA, V214, P411, DOI 10.1016/0005-2795(70)90299-0; FALCONE DJ, 1993, J BIOL CHEM, V268, P11951; Hiramoto K, 2003, J INVEST DERMATOL, V120, P123, DOI 10.1046/j.1523-1747.2003.12004.x; NALDINI L, 1992, EMBO J, V11, P4825; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; CATANIA A, 1993, ENDOCR REV, V14, P564, DOI 10.1210/er.14.5.564; Chang WC, 1993, AM J PHYSL, V264, P271; Corner J, 1991, P NATL ACAD SCI US, V88, P6834; Hook V, 2009, ENDOCRINE, V35, P429, DOI 10.1007/s12020-009-9163-5; JIMBOW K, 1982, J INVEST DERMATOL, V78, P108, DOI 10.1111/1523-1747.ep12505758; Li D, 2010, EUR J DERMATOL, V20, P289; Liao LL, 2006, CHIN J DERMATOVENERE, V20, P675; Morris HA, 2004, CLIN BIOCHEM REV, V25, P21; NAKANO T, 1994, BIOCHEM BIOPH RES CO, V198, P10, DOI 10.1006/bbrc.1994.1002; SMITH AI, 1988, ENDOCR REV, V9, P159; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; Wang N, 2004, J THROMB HAEMOST, V2, P785, DOI 10.1111/j.1538-7836.2004.00694.x; Weide I, 1996, THROMB HAEMOSTASIS, V76, P561; Zhang XY, 2003, CHIN J DERMATOVENERO, V2, P227	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-4383	1600-0781		PHOTODERMATOL PHOTO	Photodermatol. Photoimmunol. Photomed.	DEC	2014	30	6					302	307		10.1111/phpp.12131		6	Dermatology	Dermatology	AU4EF	WOS:000345561400003		
J	Kharlamova, MV; Kramberger, C; Saito, T; Shiozawa, H; Pichler, T				Kharlamova, Marianna V.; Kramberger, Christian; Saito, Takeshi; Shiozawa, Hidetsugu; Pichler, Thomas			In situ Raman spectroscopy studies on time-dependent inner tube growth in ferrocene-filled large diameter single-walled carbon nanotubes	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						double-walled carbon nanotubes; ferrocene; filled nanotubes; in situ Raman spectroscopy; single-walled carbon nanotubes	ELECTRONIC-PROPERTIES; OPTICAL-PROPERTIES; DECOMPOSITION; ENCAPSULATION; HALOGENIDES; SILVER; SCATTERING; CATALYST; COPPER; PHASE	We fill single-walled carbon nanotubes with a mean diameter of 1.7 nm with ferrocene and perform in situ studies on time-dependent inner tube growth by Raman spectroscopy. The evolution of Raman spectra dependent on annealing time is analyzed. It is found that inner tube growth does not follow a simple exponential model. The growth rates of inner tubes are calculated within a suggested growth model. It is found that the growth rate is higher for smaller diameter inner nanotubes. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kharlamova, Marianna V.; Kramberger, Christian; Shiozawa, Hidetsugu; Pichler, Thomas] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Saito, Takeshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Kharlamova, MV (reprint author), Univ Vienna, Fac Phys, Strudlhofgasse 4, A-1090 Vienna, Austria.	mv.kharlamova@gmail.com	Pichler, Thomas/E-4351-2013	Pichler, Thomas/0000-0001-5377-9896	Austrian Science Funds [P21333-N20]; Austrian Academy of Sciences	This work was supported by the Austrian Science Funds (P21333-N20). Marianna V. Kharlamova thanks the Austrian Academy of Sciences for a DOC-fFORTE fellowship.	Maruyama S, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/149; Saito T, 2008, J NANOSCI NANOTECHNO, V8, P6153, DOI 10.1166/jnn.2008.SW23; Shiozawa H, 2010, ADV MATER, V22, P3685, DOI 10.1002/adma.201001211; Kharlamova MV, 2012, JETP LETT+, V95, P314, DOI 10.1134/S0021364012060057; Kharlamova MV, 2012, PHYS STATUS SOLIDI B, V249, P2328, DOI 10.1002/pssb.201200060; Bandow S, 2001, CHEM PHYS LETT, V337, P48, DOI 10.1016/S0009-2614(01)00192-0; Kharlamova MV, 2013, J MATER SCI, V48, P8412, DOI 10.1007/s10853-013-7653-6; Sloan J, 2003, CR PHYS, V4, P1063, DOI 10.1016/S1631-0705(03)00102-6; Kharlamova MV, 2012, J EXP THEOR PHYS+, V115, P485, DOI 10.1134/S1063776112080092; Sceats EL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2349478; Kitaura R, 2008, NANO LETT, V8, P693, DOI 10.1021/nl073070d; Kharlamova MV, 2013, PHYS STATUS SOLIDI B, V250, P2575, DOI 10.1002/pssb.201300089; Kharlamova MV, 2012, APPL PHYS A-MATER, V109, P25, DOI 10.1007/s00339-012-7091-3; Sloan J, 2002, INORG CHIM ACTA, V330, P1, DOI 10.1016/S0020-1693(01)00774-5; Briones-Leon A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195435; Barreiro A, 2006, J PHYS CHEM B, V110, P20973, DOI 10.1021/jp0636571; Shiozawa H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046804; Araujo PT, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.241403; Chernov AI, 2013, ACS NANO, V7, P6346, DOI 10.1021/nn4024152; Borowiak-Palen E, 2006, NANOTECHNOLOGY, V17, P2415, DOI 10.1088/0957-4484/17/9/058; Rummeli MH, 2007, J PHYS CHEM B, V111, P8234, DOI 10.1021/jp072556f; Eliseev AA, 2012, CARBON, V50, P4021, DOI 10.1016/j.carbon.2012.04.046; Pfeiffer R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.225501; Pichler T, 2008, PHYS STATUS SOLIDI B, V245, P2038, DOI 10.1002/pssb.200879644; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Corio P, 2004, CHEM PHYS LETT, V383, P475, DOI 10.1016/j.cplett.2003.11.061; Chamberlain TW, 2012, CHEM SCI, V3, P1919, DOI 10.1039/c2sc01026g; Li LJ, 2005, NAT MATER, V4, P481, DOI 10.1038/nmat1396; Tonkikh AA, 2012, PHYS STATUS SOLIDI B, V249, P2454, DOI 10.1002/pssb.201200153; Shiozawa H, 2008, ADV MATER, V20, P1443, DOI 10.1002/adma.200701466; Ayala P, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085407; Shiozawa H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.153402; Kharlamova MV, 2013, APPL PHYS A-MATER, V112, P297, DOI 10.1007/s00339-013-7808-y; Plank W, 2010, ACS NANO, V4, P4515, DOI 10.1021/nn100615d; Simon F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017401; Cardenas JF, 2007, CHEM PHYS LETT, V442, P409, DOI 10.1016/j.cplett.2007.06.030; Dubay O, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.235506; Garcia-Suarez VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106804; Kharlamova MV, 2013, APPL PHYS A-MATER, V111, P725, DOI 10.1007/s00339-013-7639-x; Kharlamova MV, 2013, PHYS-USP+, V56, P1047, DOI [10.3367/UFNe.0183.201311a.1145, 10.3367/UFNr.0183.201311a.1145]; Kharlamova MV, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20457-6; Kharlamova MV, 2013, JETP LETT+, V98, P272, DOI 10.1134/S0021364013180069; Monthioux M, 2006, J MATER RES, V21, P2774, DOI 10.1557/JMR.2006.0366; Pfeiffer R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161404; Saito T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.095006; Simon F, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.165439	46	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2014	251	12					2394	2400		10.1002/pssb.201451166		7	Physics, Condensed Matter	Physics	AU8FC	WOS:000345830900009		
J	Kramberger, C; Kharlamova, MV; Yanagi, K				Kramberger, Christian; Kharlamova, Marianna V.; Yanagi, Kazuhiro			Multifrequency Raman spectroscopy on bulk (11,10) chirality enriched semiconducting single-walled carbon nanotubes	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						carbon nanotubes; density gradient centrifugation; Raman spectroscopy	ELECTRONIC-PROPERTIES; ORGANIC-MOLECULES; DIAMETER; ENCAPSULATION; HALOGENIDES; SILVER; MODES; DEPENDENCE; GROWTH; COPPER	We performed a thorough multifrequency Raman spectroscopy study to access the entire spread of all traces of chirality species and confirm the absence of metallic species in metallicity and single chirality sorted single-walled carbon nanotubes. On the bulk scale the diameters of all detectable species fall within 1.43 nm +/- 2% and are dominated by an outstanding abundance of the single (11,10) chirality. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kramberger, Christian; Kharlamova, Marianna V.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Yanagi, Kazuhiro] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan	Kramberger, C (reprint author), Univ Vienna, Fac Phys, Strudlhofgasse 4, A-1090 Vienna, Austria.	Christian.Kramberger-Kaplan@univie.ac.at			Austrian Academy of Sciences [11456]	Christian Kramberger acknowledges the Austrian Academy of Sciences for the APART fellowship 11456. Marianna V. Kharlamova thanks the Austrian Academy of Sciences for a DOC-fFORTE fellowship. We also acknowledge the international exchange program "The Global Human Resource Program Bridging Across Physics and Chemistry" (Tokyo Metropolitan University).	Govindaraj A, 2000, CHEM MATER, V12, P202, DOI 10.1021/cm990546o; HIURA H, 1993, CHEM PHYS LETT, V202, P509, DOI 10.1016/0009-2614(93)90040-8; Takenobu T, 2003, NAT MATER, V2, P683, DOI 10.1038/nmat976; Kharlamova MV, 2012, JETP LETT+, V95, P314, DOI 10.1134/S0021364012060057; Kharlamova MV, 2012, PHYS STATUS SOLIDI B, V249, P2328, DOI 10.1002/pssb.201200060; Telg H, 2012, ACS NANO, V6, P904, DOI 10.1021/nn2044356; Khlobystov AN, 2005, ACCOUNTS CHEM RES, V38, P901, DOI 10.1021/ar040287v; Laudenbach J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165423; Kharlamova MV, 2013, J MATER SCI, V48, P8412, DOI 10.1007/s10853-013-7653-6; Sloan J, 2003, CR PHYS, V4, P1063, DOI 10.1016/S1631-0705(03)00102-6; Kuzmany H, 2001, EUR PHYS J B, V22, P307, DOI 10.1007/s100510170108; Kharlamova MV, 2012, J EXP THEOR PHYS+, V115, P485, DOI 10.1134/S1063776112080092; Arnold MS, 2005, NANO LETT, V5, P713, DOI 10.1021/nl050133o; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Kharlamova MV, 2013, PHYS STATUS SOLIDI B, V250, P2575, DOI 10.1002/pssb.201300089; Laudenbach J, 2012, PHYS STATUS SOLIDI B, V249, P2460, DOI 10.1002/pssb.201200175; Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521; Kharlamova MV, 2012, APPL PHYS A-MATER, V109, P25, DOI 10.1007/s00339-012-7091-3; Sloan J, 2002, INORG CHIM ACTA, V330, P1, DOI 10.1016/S0020-1693(01)00774-5; Borowiak-Palen E, 2006, NANOTECHNOLOGY, V17, P2415, DOI 10.1088/0957-4484/17/9/058; Yanagi K, 2010, ACS NANO, V4, P4027, DOI 10.1021/nn101177n; Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187; Maultzsch J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.121407; Pimenta MA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.041401; Dresselhaus MS, 2002, CARBON, V40, P2043, DOI 10.1016/S0008-6223(02)00066-0; Pfeiffer R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155409; Corio P, 2004, CHEM PHYS LETT, V383, P475, DOI 10.1016/j.cplett.2003.11.061; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Li LJ, 2005, NAT MATER, V4, P481, DOI 10.1038/nmat1396; Ghosh S, 2010, NAT NANOTECHNOL, V5, P443, DOI [10.1038/nnano.2010.68, 10.1038/NNANO.2010.68]; Shiozawa H, 2008, ADV MATER, V20, P1443, DOI 10.1002/adma.200701466; Kharlamova MV, 2013, APPL PHYS A-MATER, V112, P297, DOI 10.1007/s00339-013-7808-y; Fabian G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3570819; Kawai M, 2012, J AM CHEM SOC, V134, P9545, DOI 10.1021/ja3013853; Kharlamova MV, 2013, APPL PHYS A-MATER, V111, P725, DOI 10.1007/s00339-013-7639-x; Kharlamova MV, 2013, PHYS-USP+, V56, P1047, DOI [10.3367/UFNe.0183.201311a.1145, 10.3367/UFNr.0183.201311a.1145]; Kharlamova MV, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20457-6; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Reich S., 2012, CARBON NANOTUBES BAS; Saito R, 1998, PHYS PROPERTIES CARB; Simon F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125434	41	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2014	251	12					2432	2436		10.1002/pssb.201451182		5	Physics, Condensed Matter	Physics	AU8FC	WOS:000345830900015		
J	Engels, S; Terres, B; Klein, F; Reichardt, S; Goldsche, M; Kuhlen, S; Watanabe, K; Taniguchi, T; Stampfer, C				Engels, Stephan; Terres, Bernat; Klein, Felix; Reichardt, Sven; Goldsche, Matthias; Kuhlen, Sebastian; Watanabe, Kenji; Taniguchi, Takashi; Stampfer, Christoph			Impact of thermal annealing on graphene devices encapsulated in hexagonal boron nitride	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						bilayer; graphene; heterostructures; hexagonal boron nitride; Raman spectroscopy	BILAYER GRAPHENE; RAMAN-SPECTROSCOPY; DIRAC FERMIONS; BERRYS PHASE; SUPERLATTICES; STRAIN; POINT	We present a thermal annealing study on single-layer and bilayer (BLG) graphene encapsulated in hexagonal boron nitride. The samples are characterized by electron transport and Raman spectroscopy measurements before and after each annealing step. While extracted material properties such as charge carrier mobility, overall doping, and strain are not influenced by the annealing, an initial annealing step lowers doping and strain variations and thus results in a more homogeneous sample. Additionally, the narrow 2D-sub-peak widths of the Raman spectrum of BLG, allow us to extract information about strain and doping values from the correlation of the 2D-peak and the G-peak positions. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Engels, Stephan; Terres, Bernat; Klein, Felix; Reichardt, Sven; Goldsche, Matthias; Kuhlen, Sebastian; Stampfer, Christoph] Rhein Westfal TH Aachen, JARA FIT, D-52074 Aachen, Germany; [Engels, Stephan; Terres, Bernat; Klein, Felix; Reichardt, Sven; Goldsche, Matthias; Kuhlen, Sebastian; Stampfer, Christoph] Rhein Westfal TH Aachen, Inst Phys 2, D-52074 Aachen, Germany; [Engels, Stephan; Terres, Bernat; Goldsche, Matthias; Stampfer, Christoph] Forschungszentrum Julich, Peter Grunberg Inst PGI 9, D-52425 Julich, Germany; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Engels, S (reprint author), Rhein Westfal TH Aachen, JARA FIT, D-52074 Aachen, Germany.	stephan.engels@rwth-aachen.de	WATANABE, Kenji/H-2825-2011	WATANABE, Kenji/0000-0003-3701-8119	HNF; JARA Seed Fund; DFG [SPP-1459, FOR-912]; ERC [280140]; EU [NECT-ICT-604391]	We thank R. V. Gorbachev for helpful discussions on the fabrication process. Support by the HNF, JARA Seed Fund, the DFG (SPP-1459 and FOR-912), the ERC (GA-Nr. 280140), and the EU projects Graphene Flagship (contract no. NECT-ICT-604391) are gratefully acknowledged.	Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a; Cheng ZG, 2011, NANO LETT, V11, P767, DOI 10.1021/nl103977d; Feldman BE, 2009, NAT PHYS, V5, P889, DOI 10.1038/NPHYS1406; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Castro EV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266601; Nistor RA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.041409; Mayorov AS, 2011, SCIENCE, V333, P860, DOI 10.1126/science.1208683; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Yan J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.136804; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/nphoton.2010.186, 10.1038/NPHOTON.2010.186]; Hwang EH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186806; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Abanin DA, 2011, SCIENCE, V332, P328, DOI 10.1126/science.1199595; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Zomer PJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665405; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Ni ZH, 2010, J RAMAN SPECTROSC, V41, P479, DOI 10.1002/jrs.2485; Mayorov AS, 2012, NANO LETT, V12, P4629, DOI 10.1021/nl301922d; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zabel J, 2012, NANO LETT, V12, P617, DOI 10.1021/nl203359n; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Zhang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136806; Goossens AM, 2012, NANO LETT, V12, P4656, DOI 10.1021/nl301986q; Zhao Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066801; Geringer V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076102; Bao WZ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246601; Couto N. J. G., 2014, ARXIV14015356; Engels S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.126801; Lee JE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2022; Maher P., 2014, ARXIV14032112; Malard LM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.201401; Neumann C., 2014, ARXIV14067771; Xueshen W., 2013, J NANOMATER, V2013	41	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2014	251	12					2545	2550		10.1002/pssb.201451384		6	Physics, Condensed Matter	Physics	AU8FC	WOS:000345830900037		
J	Terres, B; Reichardt, S; Neumann, C; Watanabe, K; Taniguchi, T; Stampfer, C				Terres, Bernat; Reichardt, Sven; Neumann, Christoph; Watanabe, Kenji; Taniguchi, Takashi; Stampfer, Christoph			Raman spectroscopy on mechanically exfoliated pristine graphene ribbons	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						graphene ribbons; hexagonal boron nitride; Raman spectroscopy	NANORIBBONS; CARBON; EDGES	We present Raman spectroscopy measurements of non-etched graphene nanoribbons, with widths ranging from 15 to 160 nm, where the D-line intensity is strongly dependent on the polarization direction of the incident light. The extracted edge disorder correlation length is approximately one order of magnitude larger than on previously reported graphene ribbons fabricated by reactive ion etching techniques. This suggests a more regular crystallographic orientation of the non-etched graphene ribbons here presented. We further report on the ribbons width dependence of the line-width and frequency of the long-wavelength optical phonon mode (G-line) and the 2D-line in the studied graphene ribbons. [GRAPHICS] Scanning force microscope image of graphene ribbons on hexagonal boron nitride and SiO2 substrates. The scale bar is 1 mu m. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Terres, Bernat; Reichardt, Sven; Neumann, Christoph; Stampfer, Christoph] Rhein Westfal TH Aachen, JARA FIT, D-52074 Aachen, Germany; [Terres, Bernat; Reichardt, Sven; Neumann, Christoph; Stampfer, Christoph] Rhein Westfal TH Aachen, Inst Phys 2, D-52074 Aachen, Germany; [Terres, Bernat; Neumann, Christoph; Stampfer, Christoph] Forschungszentrum Julich, Peter Grunberg Inst PGI 9, D-52425 Julich, Germany; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan	Terres, B (reprint author), Rhein Westfal TH Aachen, JARA FIT, D-52074 Aachen, Germany.	terres@physik.rwth-aachen.de	WATANABE, Kenji/H-2825-2011; Neumann, Christoph/N-5477-2015	WATANABE, Kenji/0000-0003-3701-8119; 	HNF; JARA Seed Fund; DFG [SPP-1459, FOR-912]; ERC [280140]; EU [NECT-ICT-604391]	We thank G. Rossello, D. May, and P. Nemes-Incze for valuable discussions. Support by the HNF, JARA Seed Fund, the DFG (SPP-1459 and FOR-912), the ERC (GA-Nr. 280140) and the EU project Graphene Flagship (contract no. NECT-ICT-604391) are gratefully acknowledged.	Altun AO, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/46/465302; Tombros N, 2011, NAT PHYS, V7, P697, DOI [10.1038/nphys2009, 10.1038/NPHYS2009]; Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a; Terres B, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3544580; Lin YM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.161409; Saito R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/33/334203; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Wang QH, 2012, NAT CHEM, V4, P724, DOI [10.1038/nchem.1421, 10.1038/NCHEM.1421]; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Chen CF, 2011, NATURE, V471, P617, DOI 10.1038/nature09866; Gallagher P, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115409; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Zomer PJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665405; GEICK R, 1966, PHYS REV, V146, P543, DOI 10.1103/PhysRev.146.543; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Gruneis A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.165402; Stampfer C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.056403; Mohiuddin TMG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205433; Wang XR, 2011, NAT NANOTECHNOL, V6, P563, DOI [10.1038/nnano.2011.138, 10.1038/NNANO.2011.138]; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; Ando T, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.124701; Ryu S, 2011, ACS NANO, V5, P4123, DOI 10.1021/nn200799y; Casiraghi C, 2009, NANO LETT, V9, P1433, DOI 10.1021/nl8032697; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Bischoff D, 2011, J APPL PHYS, V109, DOI 10.1063/1.3561838; Cancado LG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.247401; Gillen R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155418; Gillen R, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205426; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Lee JE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2022; Molitor F., 2010, PHYS REV B, V79; Stampfer C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2816262; Tiberj A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02355	36	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2014	251	12					2551	2555		10.1002/pssb.201451398		5	Physics, Condensed Matter	Physics	AU8FC	WOS:000345830900038		
J	Watanabe, K; Ohtani, E; Kamada, S; Sakamaki, T; Miyahara, M; Ito, Y				Watanabe, Kosui; Ohtani, Eiji; Kamada, Seiji; Sakamaki, Tatsuya; Miyahara, Masaaki; Ito, Yoshinori			The abundance of potassium in the Earth's core	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Potassium; Magma ocean; High pressure; High temperature; Earth's core; Partition coefficient	SILICATE PARTITION-COEFFICIENTS; HIGH-PRESSURE; MANTLE BOUNDARY; LIGHT-ELEMENTS; MOLTEN IRON; OUTER CORE; DEGREES-C; FE-FEO; 20 GPA; OXYGEN	We studied partitioning of potassium (K) between aluminosilicate (adularia, KAlSi3O8) and metals with and without light elements, oxygen and silicon (Fe-O, Fe-Si, and pure Fe metals). We conducted experiments at pressures up to 50 GPa, temperatures up to 3500 K, and oxygen fugacities (logfO(2)) between 2.5 and 4.0 log units below the iron-wustite (IW) buffer using a double-sided laser-heated diamond anvil cell. Our results on pressure, temperature, and compositional effects on partition coefficient of potassium, D-K (i.e., the content of potassium in metal [wt%] divided by the content of potassium in silicate [wt%]), revealed that the temperature effect is slightly positive but weaker than that reported previously, whereas the pressure effect is negative. Oxygen in metal increases the potassium content in metal, whereas silicon in metal has the opposite effect. According to the present study on potassium partitioning, we estimated that the amount of potassium in the core is less than 40 ppm and that it generates less than 0.17 TW heat in the core. The amount of heat generated in the core is very small compared with the heat escaping from the core at the core mantle boundary (5-15 TW). (C) 2014 Elsevier B.V. All rights reserved.	[Watanabe, Kosui; Ohtani, Eiji; Kamada, Seiji; Sakamaki, Tatsuya; Miyahara, Masaaki; Ito, Yoshinori] Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Sendai, Miyagi 9808578, Japan; [Ohtani, Eiji] SB RAS, VS Sobolev Inst Geol & Mineral, Novosibirsk 630090, Russia; [Kamada, Seiji] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Miyahara, Masaaki] Hiroshima Univ, Grad Sch Sci, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan	Watanabe, K (reprint author), Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Sendai, Miyagi 9808578, Japan.			Miyahara, Masaaki/0000-0002-4404-9813	Ministry of Education, Culture, Science, Sport and Technology of the Japanese Government [1804009, 22000002]; Ministry of Education and Science of Russian Federation [14.B25.31.0032]	We thank Y. Asahara for useful discussions, and N. Nishitani, S. Takahashi, and T. Sakairi for experimental assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Science, Sport and Technology of the Japanese Government (Nos. 1804009 and 22000002) to E.O. This work was also supported partly by the Ministry of Education and Science of Russian Federation, project 14.B25.31.0032 to E.O. This study was conducted as part of a Global COE Program, "Global Education and Research Center for Earth and Planetary Dynamics," at Tohoku University.	Anderson OL, 2002, PHYS EARTH PLANET IN, V131, P19, DOI 10.1016/S0031-9201(02)00017-1; Badro J, 2007, EARTH PLANET SC LETT, V254, P233, DOI 10.1016/j.epsl.2006.11.025; Murthy VM, 2003, NATURE, V423, P163, DOI 10.1038/nature01560; BIRCH F, 1964, J GEOPHYS RES, V69, P4377, DOI 10.1029/JZ069i020p04377; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Righter K, 1997, PHYS EARTH PLANET IN, V100, P115, DOI 10.1016/S0031-9201(96)03235-9; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Nimmo F, 2004, GEOPHYS J INT, V156, P363, DOI 10.1111/j.1365-246X.2003.02157.x; Siebert J, 2013, SCIENCE, V339, P1194, DOI 10.1126/science.1227923; Gessmann CK, 2002, EARTH PLANET SC LETT, V200, P63, DOI 10.1016/S0012-821X(02)00593-9; WASSERBURG GJ, 1964, SCIENCE, V143, P465, DOI 10.1126/science.143.3605.465; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; Righter K, 2011, EARTH PLANET SC LETT, V304, P158, DOI 10.1016/j.epsl.2011.01.028; Akahama Y, 2004, J APPL PHYS, V96, P3748, DOI 10.1063/1.1778482; Bouhifd MA, 2011, EARTH PLANET SC LETT, V307, P341, DOI 10.1016/j.epsl.2011.05.006; Chabot NL, 2005, GEOCHIM COSMOCHIM AC, V69, P2141, DOI 10.1016/j.gca.2004.10.019; Komabayashi T, 2014, J GEOPHYS RES-SOL EA, V119, P4164, DOI 10.1002/2014JB010980; Seagle CT, 2008, EARTH PLANET SC LETT, V265, P655, DOI 10.1016/j.epsl.2007.11.004; Asanuma H, 2010, PHYS CHEM MINER, V37, P353, DOI 10.1007/s00269-009-0338-7; Bouhifd MA, 2007, PHYS EARTH PLANET IN, V160, P22, DOI 10.1016/j.pepi.2006.08.005; Chabot N. L., 1999, EARTH PLANET SC LETT, V172, P325; Corgne A., 2007, EARTH PLANET SC LETT, V256, P967; GAST PW, 1960, J GEOPHYS RES, V65, P1287, DOI 10.1029/JZ065i004p01287; Hirao N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025324; ITO E, 1993, GEOPHYS RES LETT, V20, P1651, DOI 10.1029/93GL01538; Laeter J. R. D., 2003, PURE APPL CHEM, V75, P683; Lee KKM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018515; McDonough W.F., 2003, TREATISE GEOCHEMISTR, V2, P547, DOI DOI 10.1016/B0-08-043751-6/02015-6; Ohtani E, 1996, GEOPHYS RES LETT, V23, P1993, DOI 10.1029/96GL01469; RINGWOOD AE, 1959, GEOCHIM COSMOCHIM AC, V15, P257, DOI 10.1016/0016-7037(59)90062-6; Sakai T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026868; Shen G., 1996, ADV MAT 96 NEW TREND, P149; Tsuno K, 2013, GEOPHYS RES LETT, V40, P66, DOI 10.1029/2012GL054116; Weast R.C., 1988, CRC HDB CHEM PHYS	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	DEC	2014	237						65	72		10.1016/j.pepi.2014.10.001		8	Geochemistry & Geophysics	Geochemistry & Geophysics	AU6OT	WOS:000345722800006		
J	Wang, YM; Kwon, SJ; Wu, JN; Choi, J; Lee, YH; Agrawal, GK; Tamogami, S; Rakwal, R; Park, SR; Kim, BG; Jung, KH; Kang, KY; Kim, SG; Kim, ST				Wang, Yiming; Kwon, Soon Jae; Wu, Jingni; Choi, Jaeyoung; Lee, Yong-Hwan; Agrawal, Ganesh Kumar; Tamogami, Shigeru; Rakwal, Randeep; Park, Sang-Ryeol; Kim, Beom-Gi; Jung, Ki-Hong; Kang, Kyu Young; Kim, Sang Gon; Kim, Sun Tae			Transcriptome Analysis of Early Responsive Genes in Rice during Magnaporthe oryzae Infection	PLANT PATHOLOGY JOURNAL			English	Article						defense response; Magnaporthe oryzae; MapMan analysis; rice; transcriptomics	RECEPTOR-LIKE KINASE; BLAST FUNGUS; PLANT DEFENSE; SECONDARY METABOLITES; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; RHIZOCTONIA-SOLANI; SECRETOME ANALYSIS; INNATE IMMUNITY; PROTEIN-KINASE	Rice blast disease caused by Magnaporthe oiyzae is one of the most serious diseases of cultivated rice (Oryza saliva L.) in most rice-growing regions of the world. In order to investigate early response genes in rice, we utilized the transcriptome analysis approach using a 300 K tilling microarray to rice leaves infected with compatible and incompatible M. oryzae strains. Prior to the microarray experiment, total RNA was validated by measuring the differential expression of rice defense-related marker genes (chitinase 2, barwin, PBZ1, and PR-10) by RT-PCR, and phytoalexins (sakuranetin and momilactone A) with HPLC. Microarray analysis revealed that 231 genes were up-regulated (>2 fold change, p < 0.05) in the incompatible interaction compared to the compatible one. Highly expressed genes were functionally characterized into metabolic processes and oxidation-reduction categories. The oxidative stress response was induced in both early and later infection stages. Biotic stress overview from MapMan analysis revealed that the phytohormone ethylene as well as signaling molecules jasmonic acid and salicylic acid is important for defense gene regulation. WRICY and Myb transcription factors were also involved in signal transduction processes. Additionally, receptor-like kinases were more likely associated with the defense response, and their expression patterns were validated by RT-PCR. Our results suggest that candidate genes, including receptor-like protein kinases, may play a key role in disease resistance against M. oryzae attack.	[Wang, Yiming; Wu, Jingni] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Kwon, Soon Jae; Kim, Sun Tae] Pusan Natl Univ, Life & Ind Convergence Res Inst, Dept Plant Biosci, Miryang 627706, South Korea; [Choi, Jaeyoung; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Dept Agr Biotechnol, Seoul 151921, South Korea; [Choi, Jaeyoung; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea; [Agrawal, Ganesh Kumar; Rakwal, Randeep] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Agrawal, Ganesh Kumar; Rakwal, Randeep] GRADE Acad Pvt Ltd, Birgunj, Nepal; [Tamogami, Shigeru] Akita Prefectural Univ, Dept Biol Prod, Lab Biol Act Cpds, Akita 0100195, Japan; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki 3058577, Japan; [Park, Sang-Ryeol; Kim, Beom-Gi] RDA, Natl Acad Agr Sci, Mol Breeding Div, Suwon 441707, South Korea; [Jung, Ki-Hong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea; [Jung, Ki-Hong] Kyung Hee Univ, Crop Biotech Inst, Yongin 446701, South Korea; [Kang, Kyu Young; Kim, Sang Gon] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Div Appl Life Sci, Program BK21, Jinju 660701, South Korea	Kim, ST (reprint author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	sen600@hanmail.net; stkim71@pusan.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2013R1A1A1A05005407]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ008021]	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2013R1A1A1A05005407), and Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center, PJ008021), Rural Development Administration, Republic of Korea.	BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Chen KG, 2004, PLANT MOL BIOL, V56, P271, DOI 10.1007/s11103-004-3381-2; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1672-9072.2007.00504.x; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Chen KG, 2003, PLANT MOL BIOL, V53, P61, DOI 10.1023/B:PLAN.0000009265.72567.58; Iqbal MM, 2012, MOL BIOTECHNOL, V50, P129, DOI 10.1007/s12033-011-9426-2; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Wang YM, 2013, PROTEOMICS, V13, P1901, DOI 10.1002/pmic.201200454; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j1.1469-8137.2006.01777.x; Kim ST, 2008, PLANT CELL REP, V27, P593, DOI 10.1007/s00299-007-0485-6; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kim ST, 2009, PROTEOMICS, V9, P1302, DOI 10.1002/pmic.200800589; Couch BC, 2005, GENETICS, V170, P613, DOI 10.1534/genetics.105.041780; Hilaire E, 2001, MOL PLANT MICROBE IN, V14, P1411, DOI 10.1094/MPMI.2001.14.12.1411; Acharya BR, 2007, PLANT J, V50, P488, DOI 10.1111/j.1365-313X.2007.03064.x; Matika DEF, 2014, ANTIOXID REDOX SIGN, V21, P1373, DOI 10.1089/ars.2013.5679; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Kim SG, 2013, J PROTEOMICS, V78, P58, DOI 10.1016/j.jprot.2012.10.029; Tamogami S, 2000, PHYTOCHEMISTRY, V54, P689, DOI 10.1016/S0031-9422(00)00190-4; KODAMA O, 1992, PHYTOCHEMISTRY, V31, P3807, DOI 10.1016/S0031-9422(00)97532-0; Cantu D, 2008, TRENDS PLANT SCI, V13, P610, DOI 10.1016/j.tplants.2008.09.002; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Zhao CJ, 2008, THEOR APPL GENET, V116, P501, DOI 10.1007/s00122-007-0686-y; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Yamane H, 2013, BIOSCI BIOTECH BIOCH, V77, P1141, DOI 10.1271/bbb.130109; Shimono M, 2012, MOL PLANT PATHOL, V13, P83, DOI 10.1111/j.1364-3703.2011.00732.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; ARLORIO M, 1992, PROTOPLASMA, V171, P34, DOI 10.1007/BF01379278; Bagnaresi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051609; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Ederli L, 2011, J PLANT PHYSIOL, V168, P1784, DOI 10.1016/j.jplph.2011.05.018; Greeff C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00209; He ZH, 1996, J BIOL CHEM, V271, P19789; Iwai T, 2006, PLANT PHYSIOL, V142, P1202, DOI 10.1104/pp.106.085258; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; McGee J. David, 2001, Molecular Plant-Microbe Interactions, V14, P877, DOI 10.1094/MPMI.2001.14.7.877; Pang CH, 2011, PHYSIOL PLANTARUM, V143, P355, DOI 10.1111/j.1399-3054.2011.01515.x; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Singh MP, 2004, PHYTOPATHOLOGY, V94, P819, DOI 10.1094/PHYTO.2004.94.8.819; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Wu J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-4; Xie XZ, 2011, MOL PLANT, V4, P688, DOI 10.1093/mp/ssr005	58	0	0	KOREAN SOC PLANT PATHOLOGY	SUWON	NATIONAL INST AGRICULTURAL SCIENCE & TECHNOLOGY, PLANT PATHOLOGY DIVISION, SUWON, 441-707, SOUTH KOREA	1598-2254	2093-9280		PLANT PATHOLOGY J	Plant Pathol. J.	DEC	2014	30	4					343	354		10.5423/PPJ.OA.06.2014.0055		12	Agriculture, Multidisciplinary; Plant Sciences	Agriculture; Plant Sciences	AU5XN	WOS:000345677000002		
J	Shimada, T; Endo, T; Fujii, H; Rodriguez, A; Pena, L; Omura, M				Shimada, Takehiko; Endo, Tomoko; Fujii, Hiroshi; Rodriguez, Ana; Pena, Leandro; Omura, Mitsuo			Characterization of three linalool synthase genes from Citrus unshiu Marc. and analysis of linalool-mediated resistance against Xanthomonas citri subsp citri and Penicilium italicum in citrus leaves and fruits	PLANT SCIENCE			English	Article						Linalool; Citrus; Xanthomonas citri; Penicillium italicum; Antibacterial; Antifungal	BLANCO ESSENTIAL OIL; TERPENE DOWN-REGULATION; FUNCTIONAL-CHARACTERIZATION; CDNA LIBRARY; VOLATILE COMPONENTS; ANTIFUNGAL ACTIVITY; MOLECULAR-CLONING; DIGITATUM; PLANT; DEFENSE	Three cDNA clones from Satsuma mandarin (Citrus unshiu Marc.) were isolated and expressed in Escherichia coli. CuSTS3-1 and CuSTS3-2 encode linalool synthases and CuSTS4 encodes a nerolidol/linalool synthase. Transcripts of CuSTS3-1, CuSTS3-2 and CuSTS4 were abundant in young fruit at 60 days after flowering (DAF), flowers and leaves, respectively. Treatments with Xanthomonas citri subsp. citri (XCC), the causal agent of citrus canker and Penicillium italicum (PI), the cause of post-harvest fruit decay, and wounding up-regulated CuSTS3-1 in fruit and mainly CuSTS4 in leaves. Linalool, citral, geraniol and citronellol showed strong antibacterial and antifungal activities against XCC and PI in vitro, while most other mono-and sesquiterpenes, including limonene and gamma-terpinene, did not. Linalool, used at levels similar to those present in resistant Ponkan mandarin (Citrus reticulata Blanco) leaves, was able to inhibit growth of XCC in vitro. Compared to other five citrus.types, linalool accumulated at extraordinarily high levels in Ponkan mandarin leaves and was released at high amounts from their leaves, while it was hardly detectable in the most susceptible species, indicating that linalool biosynthesis and accumulation might be involved in plant defense against bacterial and fungal pathogens and be associated with field resistance to citrus canker. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Shimada, Takehiko; Endo, Tomoko; Fujii, Hiroshi] Natl Agr & Biooriented Res Org NARO, NIFTS, Shizuoka 4240292, Japan; [Rodriguez, Ana; Pena, Leandro] Fundecitrus, BR-14807040 Sao Paulo, Brazil; [Rodriguez, Ana; Pena, Leandro] IBMCP CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; [Omura, Mitsuo] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan	Shimada, T (reprint author), NARO, Inst Fruit Tree Sci NIFTS, Shimizu Ku, Shizuoka 4240292, Japan.	tshimada@affrc.go.jp; hfujii@affrc.go.jp; anrodbai@ibmcp.upv.es; lpenya@fundecitrus.com.br; amomura@ipc.shizuoka.ac.jp		Rodriguez, Ana/0000-0002-0612-726X	Ehime Research Institute of Agriculture, Forestry and Fisheries [KC21 (MAFF 673037), PI03045];  [25450050]	We thank Dr. Hiroshi Shiotani (NIFTS) and Dr. Takanori Miyoshi (Ehime Research Institute of Agriculture, Forestry and Fisheries) for providing X. citri subsp. citri strain KC21 (MAFF 673037) and P. italicum (PI03045), respectively. This work was supported by a Grant-in-Aid for Scientific Research (C), Grant number 25450050.	Bedon F, 2010, J EXP BOT, V61, P3847, DOI 10.1093/jxb/erq196; LAWTON MA, 1987, MOL CELL BIOL, V7, P335; Maruyama T, 2001, BIOL PHARM BULL, V24, P1171, DOI 10.1248/bpb.24.1171; Tao NG, 2014, FOOD CHEM, V153, P265, DOI 10.1016/j.foodchem.2013.12.070; Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Li GL, 2012, P NATL ACAD SCI USA, V109, P14711, DOI 10.1073/pnas.1204300109; Cseke L, 1998, MOL BIOL EVOL, V15, P1491; Vekiari SA, 2002, J AGR FOOD CHEM, V50, P147, DOI 10.1021/jf001369a; Sawamura M., 2000, Recent Research Developments in Agricultural & Food Chemistry, V4, P131; Sharon-Asa L, 2003, PLANT J, V36, P664, DOI 10.1046/j.1365-313X.2003.01910.x; Chutia M, 2009, LWT-FOOD SCI TECHNOL, V42, P777, DOI 10.1016/j.lwt.2008.09.015; Christiano RSC, 2007, CROP PROT, V26, P59, DOI 10.1016/j.cropro.2006.03.016; Green SA, 2012, J EXP BOT, V63, P1951, DOI 10.1093/jxb/err393; Kotan R, 2007, Z NATURFORSCH C, V62, P507; Nagegowda DA, 2008, PLANT J, V55, P224, DOI 10.1111/j.1365-313X.2008.03496.x; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Yamasaki Yumiko, 2007, Journal of General Plant Pathology, V73, P168, DOI 10.1007/s10327-007-0013-0; Rodriguez A, 2011, PLANT PHYSIOL, V156, P793, DOI 10.1104/pp.111.176545; Kos M, 2013, PEST MANAG SCI, V69, P302, DOI 10.1002/ps.3391; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI [10.1046/j.1364-3703.2004.00197.x, 10.1046/J.1364-3703.2003.00197.X]; Rodriguez A, 2014, PLANT PHYSIOL, V164, P321, DOI 10.1104/pp.113.224279; Caccioni DRL, 1998, INT J FOOD MICROBIOL, V43, P73, DOI 10.1016/S0168-1605(98)00099-3; Lucker J, 2002, EUR J BIOCHEM, V269, P3160, DOI 10.1046/j.1432-1033.2002.02985.x; Trapp SC, 2001, GENETICS, V158, P811; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Cheong H.Y., 2002, PLANT PHYSIOL, V129, P661; Cseke LJ, 2006, NATURAL PRODUCTS PLA; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dornelas MC, 2007, GENET MOL BIOL, V30, P832, DOI 10.1590/S1415-47572007000500011; Droby S, 2008, POSTHARVEST BIOL TEC, V49, P386, DOI 10.1016/j.postharvbio.2008.01.016; Fujii H., 2003, B NATL I FRUIT TREE, V2, P127; Gottwald T, 2002, PLANT HLTH PROGR; Hara M., 1999, FOOD SCI TECHNOL RES, V5, P80, DOI 10.3136/fstr.5.80; Hisada S, 1999, J PLANT PHYSIOL, V155, P699; Hisada S, 1996, J JPN SOC HORTIC SCI, V65, P487; Hisada T., 1997, J AM SOC HORTIC SCI, V122, P808; Ikoma Y, 1996, J JPN SOC HORTIC SCI, V64, P809; Kita M., 2000, ACTA HORTIC, V521, P179; Kita M, 2000, PLANT CELL REP, V19, P582, DOI 10.1007/s002990050777; Moriguchi T, 1998, GENE, V211, P221, DOI 10.1016/S0378-1119(98)00138-3; Pacheco C., 2011, SCI AGR, V69, P386; Sambrook J., 1989, MOL CLONING LAB MANU; Shimada T, 2012, SCI HORTIC-AMSTERDAM, V145, P102, DOI 10.1016/j.scienta.2012.08.001; Shimada T, 2003, PLANT SCI, V165, P167, DOI 10.1016/S0168-9452(03)00155-9; Shimada T, 2005, PLANT SCI, V168, P987, DOI 10.1016/j.plantsci.2004.11.012; Shimada T, 2004, PLANT SCI, V166, P49, DOI 10.1016/j.plantsci.2003.07.006; Vargas R. G., 2013, Summa Phytopathologica, V39, P235, DOI 10.1590/S0100-54052013000400001; Vilanova L, 2013, POSTHARVEST BIOL TEC, V78, P113, DOI 10.1016/j.postharvbio.2012.12.013; Wang H, 2012, J ESSENT OIL BEAR PL, V15, P715, DOI 10.1080/0972060X.2012.10644111; Yang T, 2013, PLANT BIOTECHNOL J, V11, P875, DOI 10.1111/pbi.12080	50	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	DEC	2014	229						154	166		10.1016/j.plantsci.2014.09.008		13	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AU7UY	WOS:000345807800015		
J	Yanagisawa, S				Yanagisawa, Shuichi			Transcription factors involved in controlling the expression of nitrate reductase genes in higher plants	PLANT SCIENCE			English	Review						Nitrate reductase; Nitrate response; NLP; Transcription factor; LBD transcription factors; HY5	RESPONSIVE CIS-ELEMENT; ARABIDOPSIS; NITROGEN; METABOLISM; TRANSPORT; MUTANTS; FAMILY	Nitrate reductase is a key enzyme in nitrogen assimilation, and it catalyzes the nitrate-to-nitrite reduction process in plants. A variety of factors, including nitrate, light, metabolites, phytohormones, low temperature, and drought, modulate the expression levels of nitrate reductase genes as well as nitrate reductase activity, which is consistent with its physiological role. Recently, several transcription factors involved in controlling the expression of nitrate reductase genes have been identified in Arabidopsis. NODULE-INCEPTION-like proteins (NLPs) are transcription factors responsible for nitrate-inducible expression of nitrate reductase genes. Since NLPs also control nitrate-inducible expression of genes encoding nitrate transporter, nitrite transporter, and nitrite reductase, the expression levels of nitrate reduction pathway-associated genes are coordinately modulated by NLPs in response to nitrate. LATERAL ORGAN BOUNDARIES DOMAIN (LBD) transcription factors (LBD37-LBD39) are strong candidates for transcription factors mediating negative feedback regulation in response to increases in the contents of nitrogen-containing metabolites, whereas LONG HYPOCOTYL 5 (HY5) that promotes photomorphogenesis in light may be a transcription factor involved in light-induced expression of a nitrate reductase gene. Furthermore, unidentified transcription factors likely mediate other signals and regulate the expression of nitrate reductase genes. This review presents a summary of our current knowledge of such transcription factors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	Yanagisawa, S (reprint author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	asyanagi@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science [25252014, 26221103]	This work was supported in part by the Japan Society for the Promotion of Science (Grant no. 25252014 and 26221103). I apologize to the authors of the many publications that I was unable to cite due to space constraints.	Sakakibara H, 2003, J PLANT RES, V116, P253, DOI 10.1007/s10265-003-0097-3; Gutierrez RA, 2012, SCIENCE, V336, P1673, DOI 10.1126/science.1217620; Konishi M, 2010, PLANT J, V63, P269, DOI 10.1111/j.1365-313X.2010.04239.x; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Krapp A, 2014, J EXP BOT, V65, P789, DOI 10.1093/jxb/eru001; HOFF T, 1994, PLANT CELL ENVIRON, V17, P489, DOI 10.1111/j.1365-3040.1994.tb00145.x; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Camargo A, 2007, PLANT CELL, V19, P3491, DOI 10.1105/tpc.106.045922; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Konishi M, 2011, BIOCHEM BIOPH RES CO, V411, P708, DOI 10.1016/j.bbrc.2011.07.008; MacKintosh C, 2001, CELL MOL LIFE SCI, V58, P205, DOI 10.1007/PL00000848; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; Wang RC, 2009, PLANT PHYSIOL, V151, P472, DOI 10.1104/pp.109.140434; Jonassen Else Müller, 2009, Plant Signal Behav, V4, P1084; Jones TL, 1998, PLANT PHYSIOL, V118, P149, DOI 10.1104/pp.118.1.149; Konishi M., 2014, J EXP BOT IN PRESS; Konishi M., 2012, PLANT CELL PHYSL, V52; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Krouk G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r123; Krouk G., 2010, CURR OPIN PLANT BIOL, V13, P265; Maeda S, 2014, PLANT CELL PHYSIOL, V55, P1311, DOI 10.1093/pcp/pcu075; Marchive C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2650; Medici A., 2014, J EXP BOT IN PRESS; Suzuki W., 2013, Plant Signaling and Behavior, V8, pe25975, DOI 10.4161/psb.25975	26	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	DEC	2014	229						167	171		10.1016/j.plantsci.2014.09.006		5	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AU7UY	WOS:000345807800016		
J	Lacoste, DA; Bourdon, A; Kuribara, K; Urabe, K; Stauss, S; Terashima, K				Lacoste, Deanna A.; Bourdon, Anne; Kuribara, Koichi; Urabe, Keiichiro; Stauss, Sven; Terashima, Kazuo			Pure air-plasma bullets propagating inside microcapillaries and in ambient air	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						plasma jet; nanosecond discharges; dielectric barrier discharge; atmospheric pressure	ATMOSPHERIC-PRESSURE AIR; JET	This paper reports on the characterization of air-plasma bullets in microcapillary tubes and in ambient air, obtained without the use of inert or noble gases. The bullets were produced by nanosecond repetitively pulsed discharges, applied in a dielectric barrier discharge configuration. The anode was a tungsten wire with a diameter of 50 mu m, centered in the microcapillary, while the cathode was a silver ring, fixed on the outer surface of the fused silica tube. The effects of the applied voltage and the inner diameter of the microcapillary tube on the plasma behavior were investigated. Inside the tubes, while the topology of the bullets seems to be strongly dependent on the diameter, their velocity is only a function of the amplitude of the applied voltage. In ambient air, the propagation of air bullets with a velocity of about 1.25 x 10(5) ms (1) is observed.	[Lacoste, Deanna A.] King Abdullah Univ Sci & Technol, Clean Combust Res Ctr, Thuwal 239556900, Saudi Arabia; [Bourdon, Anne] Univ Paris 11, CNRS, Ecole Polytech, LPP,UMR7648,UPMC, Palaiseau, France; [Kuribara, Koichi; Urabe, Keiichiro; Stauss, Sven; Terashima, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa, Chiba 2778562, Japan	Lacoste, DA (reprint author), King Abdullah Univ Sci & Technol, Clean Combust Res Ctr, Thuwal 239556900, Saudi Arabia.	deanna.lacoste@kaust.edu.sa	Urabe, Keiichiro/G-4524-2011	Urabe, Keiichiro/0000-0001-9743-3184	Ministry of Education, Culture, Sports, Science and Technology of Japan [21110002]; Japan Society for the Promotion of Science [24246120]	This research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Grant No 21110002, from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Grant-in-Aid for Scientific Research (A), Grant No 24246120, from the Japan Society for the Promotion of Science.	Teschke M, 2005, IEEE T PLASMA SCI, V33, P310, DOI 10.1109/TPS.2005.845377; [Anonymous], 2013, SPEC 3; Jansky J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/33/335201; Machala Z, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/22/222001; Rusterholtz DL, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/46/464010; Lu X, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034005; Park GY, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/043001; Hoentsch M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/2/025206; Jarrige J, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/6/065005; Lu X, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349475; Benilov MS, 2003, J PHYS D APPL PHYS, V36, P1834, DOI 10.1088/0022-3727/36/15/314; Babayan SE, 1998, PLASMA SOURCES SCI T, V7, P286, DOI 10.1088/0963-0252/7/3/006; Bussiahn R, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/16/165201; O'Connell D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3521502; Robert E, 2009, PLASMA PROCESS POLYM, V6, P795, DOI 10.1002/ppap.200900078; Laux CO, 2003, PLASMA SOURCES SCI T, V12, P125, DOI 10.1088/0963-0252/12/2/301; Wu S, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4791652; Babaeva NY, 1996, J PHYS D APPL PHYS, V29, P2423, DOI 10.1088/0022-3727/29/9/029; Hofmann S, 2012, IEEE T PLASMA SCI, V40, P2888, DOI 10.1109/TPS.2012.2211621; Ito Y, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.067009; Jansky J, 2012, IEEE T PLASMA SCI, V40, P2912, DOI 10.1109/TPS.2012.2209129; Kim H, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3267142; Kirkpatrick MJ, 2012, APPL CATAL B-ENVIRON, V117, P1, DOI 10.1016/j.apcatb.2011.12.022; Lacoste D, 2014, IEEE T PLASMA SCI, V42, P2562; Li Q, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/38/382001; Luque A, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/23/234005; Naidis GV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.057401; Pancheshnyi S, 2005, PLASMA SOURCES SCI T, V14, P645, DOI 10.1088/0963-0252/14/4/002; Sarron V, 2011, IEEE T PLASMA SCI, V39, P2356, DOI 10.1109/TPS.2011.2155099; Tholin F, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/4/045014; Xian YB, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3696889; Xu L, 2006, THIN SOLID FILMS, V506, P400, DOI 10.1016/j.tsf.2005.08.100	32	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							062006	10.1088/0963-0252/23/6/062006		6	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300007		
J	Muneoka, H; Urabe, K; Choi, JH; Stauss, S; Terashima, K				Muneoka, Hitoshi; Urabe, Keiichiro; Choi, Jai Hyuk; Stauss, Sven; Terashima, Kazuo			Experimental and numerical investigation of time evolution of discharge current and optical emission in helium-nitrogen cryoplasmas	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						cryoplasma; plasma gas temperature; plasma chemistry; global model; helium	DIELECTRONIC RECOMBINATION; DEGREES K; ATMOSPHERIC-PRESSURE; ELECTRONIC RECOMBINATION; METASTABLE ATOMS; MOLECULAR-IONS; PLASMA; GAS; TRANSPORT; AFTERGLOW	Cryoplasmas represent a class of non-equilibrium plasmas whose gas temperature can be controlled below room temperature. However, so far, the influence of the plasma gas temperature on the plasma chemical reactions has not yet been examined in detail. Here we investigated the time-dependent reaction dynamics related to optical emission in helium-nitrogen cryoplasmas. We acquired voltage and discharge current waveforms, optical emission spectra, and observed a temporal change of the emission intensity in helium-nitrogen cryoplasmas at two experimental conditions (temperatures of temperature detector: 5 K and plasma gas temperature: 28 K (condition A), 40 K and 54 K (condition B)). Two time-dependent phenomena were observed: the first was a longer duration of the discharge current compared to that of helium emission at both conditions A and B, and the second was nitrogen ion emission delayed by about 8 mu s with respect to the emissions of atomic helium and helium dimers at 40 K. The experimental observations could be reproduced qualitatively by a global reaction model, which took into account the effect of the plasma gas temperature on the reaction rate constants and the diffusion coefficients. The simulations suggested that the reactions related to metastable helium atom were the key reactions, and that the long lifetimes of metastable helium atoms at cryogenic gas temperatures are crucial for the appearance of the time-dependent phenomena. These results imply that the plasma gas temperature is one of the key parameters in non-equilibrium plasma chemistry.	[Muneoka, Hitoshi; Urabe, Keiichiro; Choi, Jai Hyuk; Stauss, Sven; Terashima, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan	Muneoka, H (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	muneoka@plasma.k.u-tokyo.ac.jp	Urabe, Keiichiro/G-4524-2011	Urabe, Keiichiro/0000-0001-9743-3184	Ministry of Education, Culture, Sports, Science and Technology of Japan [21110002]; Japan Society for the Promotion of Science [21360356, 24246120, 13J06697]	This work was supported financially in part by a Grant-in-Aid for Scientific Research on Innovative Areas (Frontier Science of Interactions between Plasmas and Nano-interfaces, No 21110002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by Grants-in-Aid for Scientific Research (B) (No 21360356) and (A) (No 24246120), and by a Grant-in-Aid for JSPS Fellows (No 13J06697) from Japan Society for the Promotion of Science.	TOKARYK DW, 1993, PHYS REV A, V48, P364, DOI 10.1103/PhysRevA.48.364; PHELPS AV, 1985, PHYS REV A, V31, P2932, DOI 10.1103/PhysRevA.31.2932; Stalder KR, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193170; Murakami T, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/4/045010; KOCH W, 1987, J AM CHEM SOC, V109, P5917, DOI 10.1021/ja00254a005; SANDERSON J, 1993, J PHYS B-AT MOL OPT, V26, pL465, DOI 10.1088/0953-4075/26/15/006; PHELPS AV, 1955, PHYS REV, V99, P1307, DOI 10.1103/PhysRev.99.1307; Urabe K, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/9/095201; Noma Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3552983; KOJIMA TM, 1992, J PHYS SOC JPN, V61, P6, DOI 10.1143/JPSJ.61.6; Kossyi IA, 1992, PLASMA SOURCES SCI T, V1, P207, DOI 10.1088/0963-0252/1/3/011; Iacopi F, 2011, PHYS CHEM CHEM PHYS, V13, P3634, DOI 10.1039/c0cp02660c; DUBAU J, 1980, REP PROG PHYS, V43, P199, DOI 10.1088/0034-4885/43/2/002; Sakiyama Y, 2007, J APPL PHYS, V101, DOI 10.1063/1.2715745; KOYMEN A, 1990, CHEM PHYS LETT, V168, P405, DOI 10.1016/0009-2614(90)85136-Z; SHON JW, 1994, J APPL PHYS, V75, P1883, DOI 10.1063/1.356334; Ishihara D, 2008, PLASMA SOURCES SCI T, V17, DOI 10.1088/0963-0252/17/3/035008; Stauss S, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/2/025021; PHELPS AV, 1953, PHYS REV, V89, P1202, DOI 10.1103/PhysRev.89.1202; Hagelaar GJM, 2005, PLASMA SOURCES SCI T, V14, P722, DOI 10.1088/0963-0252/14/4/011; Golubovskii YB, 2003, J PHYS D APPL PHYS, V36, P39, DOI 10.1088/0022-3727/36/1/306; Naidis GV, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/21/215203; FUGOL IY, 1971, SOV PHYS JETP-USSR, V33, P227; DELOCHE R, 1976, PHYS REV A, V13, P1140, DOI 10.1103/PhysRevA.13.1140; Choi JH, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/7/072001; Murakami T, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/1/015003; Noma Y, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2980436; Bortner M H, 1972, DEFENSE NUCL AGENCY; BURGESS A, 1969, ASTROPHYS J, V157, P1007, DOI 10.1086/150131; CALLEAR AB, 1967, NATURE, V215, P1267, DOI 10.1038/2151267a0; Choi JH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976308; DELPECH JF, 1972, PHYS REV A, V6, P1932, DOI 10.1103/PhysRevA.6.1932; Dickinson AS, 1999, J PHYS B-AT MOL OPT, V32, P4919, DOI 10.1088/0953-4075/32/20/309; FERGUSON EE, 1975, ANNU REV PHYS CHEM, V26, P17, DOI 10.1146/annurev.pc.26.100175.000313; FITZSIMM.WA, 1968, PHYS REV, V174, P193, DOI 10.1103/PhysRev.174.193; FUGOL IY, 1966, JETP LETT-USSR, V3, P254; GARRISON BJ, 1973, J CHEM PHYS, V59, P3193, DOI 10.1063/1.1680460; GERARDO JB, 1971, PHYS REV A, V3, P255, DOI 10.1103/PhysRevA.3.255; GERBER RA, 1971, PHYS REV A, V4, P2027, DOI 10.1103/PhysRevA.4.2027; GOULD RJ, 1970, ANN PHYS-NEW YORK, V61, P351, DOI 10.1016/0003-4916(70)90289-7; GUSINOW MA, 1970, PHYS REV LETT, V25, P1248, DOI 10.1103/PhysRevLett.25.1248; JOHNSON AW, 1973, PHYS REV A, V7, P807, DOI 10.1103/PhysRevA.7.807; LAGATTUTA KJ, 1985, NUCL INSTRUM METH A, V240, P549, DOI 10.1016/0168-9002(85)90680-1; LAWLER JE, 1979, PHYS LETT A, V69, P408, DOI 10.1016/0375-9601(79)90391-8; Lemmon E, 2012, NIST STANDARD REFERE; Minami K, 2003, IEEE T PLASMA SCI, V31, P429, DOI 10.1109/TPS.2003.811641; Nishio S, 2009, JSME DATA BOOK HEAT, V5th; PATTERSO.PL, 1968, J CHEM PHYS, V48, P3625, DOI 10.1063/1.1669660; PHELPS AV, 1952, PHYS REV, V86, P102, DOI 10.1103/PhysRev.86.102; SCHMELTE.AL, 1968, J CHEM PHYS, V48, P2966, DOI 10.1063/1.1669560; SHAVER PA, 1976, ASTRON ASTROPHYS, V46, P127; SMIRNOV BM, 1967, SOV PHYS JETP-USSR, V24, P1180; SMITH D, 1992, BEE WORLD, V73, P92; Stauss S, 2011, IEEE T PLASMA SCI, V39, P2184, DOI 10.1109/TPS.2011.2158857; Stauss S, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4825202; STEVEFEL.J, 1973, PHYS REV A, V8, P2507, DOI 10.1103/PhysRevA.8.2507; Takaki K, 2006, JPN J APPL PHYS 1, V45, P8241, DOI 10.1143/JJAP.45.8241; VIDMAR RJ, 1990, IEEE T PLASMA SCI, V18, P733, DOI 10.1109/27.57528; Vidmar R.J., 2004, FINAL PERFORMANCE RE	59	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							065038	10.1088/0963-0252/23/6/065038		11	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300058		
J	Nakamura, Y; Iwai, A; Sakai, O				Nakamura, Yoshihiro; Iwai, Akinori; Sakai, Osamu			Nonlinear properties of negative-permittivity microwave plasmas embedded in metamaterial of macroscopic negative permeability	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						metamaterial; nonlinearity; microwave	HIEI TANDEM MIRROR; VERIFICATION; WAVE	Plasma metamaterials at microwave ranges have nonlinear properties which arise from synthesized effects of plasma and metamaterial. An analytical model describes bistability and bifurcations of negative permittivity of the plasma when the permeability of the metamaterial is negative. Experimental results show two significant properties of nonlinearity in the same experimental apparatus: bifurcations of the permittivity and harmonic wave generation. These results indicate that plasma metamaterials work not only as variable microwave devices but also as nonlinear media with a double negative system.	[Nakamura, Yoshihiro; Iwai, Akinori; Sakai, Osamu] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan	Nakamura, Y (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan.	iwai.akinori.83c@st.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported partly by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Jha P, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2734187; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; Sakai O, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147709; Sakai O, 2011, J APPL PHYS, V109, DOI 10.1063/1.3574921; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; YASAKA Y, 1993, PLASMA PHYS CONTR F, V35, P379, DOI 10.1088/0741-3335/35/3/007; Singh KP, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1814999; SAKAI O, 1993, PHYS REV LETT, V70, P4071, DOI 10.1103/PhysRevLett.70.4071; Bliokh YP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.165003; Sakai O, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/1/013001; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; SAKAI O, 1995, PHYS PLASMAS, V2, P3249, DOI 10.1063/1.871157; Borg G G, 2000, PHYS PLASMAS, V7, P2202; Faith J, 1997, PHYS REV E, V55, P1843, DOI 10.1103/PhysRevE.55.1843; Hojo H, 2004, J PLASMA FUSION RES, V80, P89, DOI DOI 10.1585/JSPF.80.89; KALLURI DK, 1998, ELECTROMAGNETICS COM; Lieberman M. A., 1994, PRINCIPLES PLASMA DI; Lo J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3454778; Mills D. L., 1998, NONLINEAR OPTICS BAS; Nakamura Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.03DB04; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Pozar D. M., 2005, MICROWAVE ENG; Raizer Y., 1987, GAS DISCHARGE PHYS; Sakai O, 2007, PLASMA PHYS CONTR F, V49, pB453, DOI 10.1088/0741-3335/49/12B/S43; Sakai O., 2013, PLASMA FUSION RES, V8; Sakai O, 2006, IEEE T PLASMA SCI, V34, P80, DOI 10.1109/TPS.2005.863594; Sakai O, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3314334; Smith DR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036617; Solymar L., 2009, WAVES METAMATERIALS; Takahashi K, 2013, J PHYS CONF SER, V441, DOI 10.1088/1742-6596/441/1/012011; VIDMAR RJ, 1990, IEEE T PLASMA SCI, V18, P733, DOI 10.1109/27.57528	31	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							064009	10.1088/0963-0252/23/6/064009		8	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300018		
J	Sakai, O; Rauf, S				Sakai, Osamu; Rauf, Shahid			Interaction of electromagnetic waves with low-temperature plasmas Preface	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Editorial Material							MICROPLASMAS		[Sakai, Osamu] Univ Shiga Prefecture, Dept Elect Syst Engn, Hikone, Shiga 5228533, Japan; [Rauf, Shahid] Appl Mat Inc, Sunnyvale, CA 94085 USA	Sakai, O (reprint author), Univ Shiga Prefecture, Dept Elect Syst Engn, 2500 Hassaka Cho, Hikone, Shiga 5228533, Japan.	sakai.o@e.usp.ac.jp					Leipold F, 2000, J PHYS D APPL PHYS, V33, P2268, DOI 10.1088/0022-3727/33/18/310; Iza F, 2008, PLASMA PROCESS POLYM, V5, P322, DOI 10.1002/ppap.200700162; Samukawa S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/25/253001; Mariotti D, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/32/323001; Sakai O, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/1/013001; Auciello A, 1989, PLASMA DIAGNOSTICS; Becker KH, 2006, J PHYS D APPL PHYS, V39, pR55, DOI 10.1088/0022-3727/39/3/R01; Chen F F, 2003, LECT NOTES PRINCIPLE; Eden JG, 2011, IEEE PHOTONICS J, V3, P302, DOI 10.1109/JPHOT.2011.2138691; Ginzburg V. L., 1964, PROPAGATION ELECTROM; Hutchinson I H, 1991, PRINCIPLES PLASMA DI; Lieberman M. A., 1994, PRINCIPLES PLASMA DI; Lo J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3454778; Nakamura K, 2003, J VAC SCI TECHNOL A, V21, P325, DOI 10.1116/1.1532740; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Sakai Osamu, 2011, Wave Propagation; Sihvola A, 2002, ADV ELECTROMAGNETICS; Solymar L., 2009, WAVES METAMATERIALS; Stix T.H., 1962, THEORY PLASMA WAVES; Swanson D.G., 1989, PLASMA WAVES; Tachibana K, 2010, PURE APPL CHEM, V82, P1189, DOI 10.1351/PAC-CON-09-10-09	21	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							060301	10.1088/0963-0252/23/6/060301		3	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300001		
J	Suzuki, S; Itoh, H				Suzuki, S.; Itoh, H.			Secondary ionization coefficient gamma of MgO, SrO and CaO and the correlation between gamma and charge accumulated on CaO in argon	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						Townsend's secondary ionization coefficient; dielectric electrode; dielectric barrier discharge; accumulated charge; breakdown voltage	DIELECTRIC BARRIER DISCHARGES; MONTE-CARLO-SIMULATION; PLASMA DISPLAY PANELS; TRANSPORT PROPERTIES; SURFACE DISCHARGE; CROSS-SECTION; REFLECTION; EMISSION; GASES; FILM	An experimental investigation of Townsend's secondary ionization coefficient gamma is carried out for MgO, SrO and CaO film electrodes. These oxides are utilized, or are to be utilized, in next-generation plasma display panels. All of the experiments are performed in argon. In particular, in the case of CaO film, our attention is attracted to the effect of charge accumulated on CaO film. For this purpose, the breakdown voltage V-s is observed from waveforms of the gap voltage and charge accumulated on the dielectric film electrodes with the repeated breakdown. Townsend's criterion is utilized to estimate gamma from the breakdown voltage. In the case of the CaO film, gamma increases gradually with repeated breakdowns and reaches a stationary value. The increase of gamma is considered to be due to the charge that accumulates on the dielectric electrode triggering the next breakdown. Therefore, it is concluded that the increased gamma is sustained by a combined process consisting of restarted electrons that have accumulated on the CaO film and the original gamma action, as observed in metallic electrodes in a low-pressure gas discharge.	[Suzuki, S.; Itoh, H.] Chiba Inst Technol, Dept Elect Elect & Comp Engn, Narashino, Chiba 2750016, Japan	Suzuki, S (reprint author), Chiba Inst Technol, Dept Elect Elect & Comp Engn, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	susumu.suzuki@it-chiba.ac.jp			MEXT	A part of this work was supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012.	Akashi H, 2008, IEEE T PLASMA SCI, V36, P1336, DOI 10.1109/TPS.2008.920313; Stollenwerk L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.255001; Teranishi K, 2009, PLASMA SOURCES SCI T, V18, DOI [10.1088/0963-0252/18/4/045011, 10.1088/0963-0252/18/4/045012]; Bogaczyk M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/46/465202; NAKAMURA Y, 1988, J PHYS D APPL PHYS, V21, P718, DOI 10.1088/0022-3727/21/5/008; Suzuki S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.106002; Yamamoto K, 1999, J PHYS SOC JPN, V68, P1208, DOI 10.1143/JPSJ.68.1208; Stollenwerk L, 2011, CONTRIB PLASM PHYS, V51, P61, DOI 10.1002/ctpp.201000002; Penning FM, 1934, PHYSICA, V1, P1007, DOI 10.1016/S0031-8914(34)80297-2; Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0; Suzuki S, 2007, JPN J APPL PHYS 1, V46, P1129, DOI 10.1143/JJAP.46.1129; Gibalov VI, 2000, J PHYS D APPL PHYS, V33, P2618, DOI 10.1088/0022-3727/33/20/315; Kumada A, 1998, J APPL PHYS, V84, P3059, DOI 10.1063/1.368460; Almeida PGC, 2011, IEEE T PLASMA SCI, V39, P2190, DOI 10.1109/TPS.2011.2148129; KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028; Boeuf JP, 2003, J PHYS D APPL PHYS, V36, pR53, DOI 10.1088/0022-3727/36/6/201; ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P309, DOI 10.1109/27.106829; Kogelschatz U, 2010, J PHYS CONF SER, V257, DOI 10.1088/1742-6596/257/1/012015; Auday G, 2000, J APPL PHYS, V88, P4871, DOI 10.1063/1.1290461; Bachmann PK, 2001, DIAM RELAT MATER, V10, P809, DOI 10.1016/S0925-9635(01)00377-6; Becker K H, 2005, NONEQUILIBRIUM AIR P; Kashiwagi K, 2011, IEEJ T FM, V131, P547; KAWASAKI T, 1991, JPN J APPL PHYS 1, V30, P1262, DOI 10.1143/JJAP.30.1262; Massines F, 2009, EUR PHYS J-APPL PHYS, V47, DOI 10.1051/epjap/2009064; Misu T, 2007, IEEJ T FUNDAM MAT, V127, P549, DOI 10.1541/ieejfms.127.549; Shiga T, 2004, J PHYS D APPL PHYS, V37, P1221, DOI 10.1088/0022-3727/37/8/010; SKULLERU.HR, 1968, J PHYS D APPL PHYS, V1, P1567, DOI 10.1088/0022-3727/1/11/423; Sokolova MV, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120412; Stollenwerk L, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103034; SUZUKI S, 1993, J PHYS SOC JPN, V62, P2692, DOI 10.1143/JPSJ.62.2692; SUZUKI S, 1992, J PHYS D APPL PHYS, V25, P1568, DOI 10.1088/0022-3727/25/11/002; Suzuki S, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120442; Suzuki S, 2009, IEEJ T FM, V129, P909; Uetani K, 2001, MATER TRANS, V42, P1870, DOI 10.2320/matertrans.42.1870; Yagi S, 2012, ASAKURA SHOTEN; YAMAMOTO K, 1994, J PHYS SOC JPN, V63, P2157, DOI 10.1143/JPSJ.63.2157	36	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							065030	10.1088/0963-0252/23/6/065030		10	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300050		
J	Takahashi, K; Chiba, A; Ando, A				Takahashi, Kazunori; Chiba, Aiki; Ando, Akira			Modifications of wave and plasma structures by a mechanical aperture in a helicon plasma thruster	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						helicon thruster; mechanical aperture; wave propagation	DENSITY; DISCHARGE; FREQUENCY; FIELD	Plasma and wave structures in a helicon plasma thruster, and an imparted thrust are experimentally investigated with two configurations having a mechanical aperture (MA) near the thruster exit and no MA. A standing helicon wave is excited by locating the MA, where a large amplitude and no spatial change of the phase of the axial component of the radio frequency (rf) magnetic field are detected between the rf antenna and the MA; simultaneously, a higher plasma density by a factor of 2-2.5 is obtained in the source compared with that obtained with no MA. On the other hand, the plasma density downstream of the thruster exit with the MA is lower than that obtained without the MA. The magnetic field measurement downstream of the thruster exit shows the presence of a traveling electromagnetic wave, axial and radial wavenumbers of which are in the range of the slow wave dispersion branch. The directly measured thrust with the MA is only 4.5mN for 1.5kW rf power due to the lower plasma density in the magnetic nozzle, while the thrust without the MA is 12 mN.	[Takahashi, Kazunori; Chiba, Aiki; Ando, Akira] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan	Takahashi, K (reprint author), Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan.	kazunori@ecei.tohoku.ac.jp			JSPS in Japan [B 25287150, A 26247096]; Hattori Hokokai foundation; Foundation for the Promotion of Ion Engineering; Yazaki Memorial Foundation for Science and Technology	This work is partially supported by the Grant-in-Aid for scientific research (B 25287150 and A 26247096) from the JSPS in Japan, Hattori Hokokai foundation, the Foundation for the Promotion of Ion Engineering, and Yazaki Memorial Foundation for Science and Technology.	Boswell RW, 1997, IEEE T PLASMA SCI, V25, P1229, DOI 10.1109/27.650898; Harle T, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/1/015015; Degeling AW, 2004, PHYS PLASMAS, V11, P2144, DOI 10.1063/1.1689352; Guittienne P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.125005; Takahashi K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.235001; Takahashi K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3136721; Takahashi K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195003; Charles C, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/16/163001; Charles C, 2003, APPL PHYS LETT, V82, P1356, DOI 10.1063/1.1557319; Chen FF, 2003, PHYS PLASMAS, V10, P2586, DOI 10.1063/1.1575755; Charles C, 2007, PLASMA SOURCES SCI T, V16, pR1, DOI 10.1088/0963-0252/16/4/R01; Takahashi K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3577608; Fruchtman A, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3691650; Lafleur T, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3460351; Batishchev OV, 2009, IEEE T PLASMA SCI, V37, P1563, DOI 10.1109/TPS.2009.2023990; Bering EA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3389205; Boswell R W, 1970, PHYS LETT, V33, pA 457; BOSWELL RW, 1984, PLASMA PHYS CONTR F, V26, P1147, DOI 10.1088/0741-3335/26/10/001; Chabert P, 2000, APPL PHYS LETT, V76, P2310, DOI 10.1063/1.126329; Charles C, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694281; Charles C, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3309668; CHEN FF, 1991, PLASMA PHYS CONTR F, V33, P339, DOI 10.1088/0741-3335/33/4/006; Chichibu SF, 2002, J APPL PHYS, V91, P874, DOI 10.1063/1.1426238; Sun X, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2121347; Cox W, 2008, IEEE T PLASMA SCI, V36, P1386, DOI 10.1109/TPS.2008.924429; Degeling A, 1998, PHYS PLASMAS, V5, P572, DOI 10.1063/1.872749; Franck CM, 2002, PHYS PLASMAS, V9, P3254, DOI 10.1063/1.1494069; Lee D, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2715557; LIEBERMAN M. A., 2005, PRINCIPLES PLASMA DI, V2nd; Longmier BW, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/1/015007; Molvik AW, 1997, PHYS REV LETT, V79, P233, DOI 10.1103/PhysRevLett.79.233; Motomura T, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3701558; Nisoa M, 1999, JPN J APPL PHYS 2, V38, pL777, DOI 10.1143/JJAP.38.L777; Pottinger S, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/23/235201; Sakawa Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.105001; Sakawa Y, 1997, PLASMA SOURCES SCI T, V6, P96, DOI 10.1088/0963-0252/6/1/014; Sheridan TE, 2000, PHYS PLASMAS, V7, P3084, DOI 10.1063/1.874162; SHINOHARA S, 1995, PLASMA PHYS CONTR F, V37, P1015, DOI 10.1088/0741-3335/37/9/007; Swanson D G, 2003, PLASMA WAVES; Takahashi K, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4748271; Virko VF, 2004, PHYS PLASMAS, V11, P3888, DOI 10.1063/1.1764830; Williams LT, 2013, J PROPUL POWER, V29, P520, DOI 10.2514/1.B34574; Yamada T, 2008, NAT PHYS, V4, P721, DOI 10.1038/nphys1029	43	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							064005	10.1088/0963-0252/23/6/064005		9	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300014		
J	Takao, Y; Koizumi, H; Komurasaki, K; Eriguchi, K; Ono, K				Takao, Yoshinori; Koizumi, Hiroyuki; Komurasaki, Kimiya; Eriguchi, Koji; Ono, Kouichi			Three-dimensional particle-in-cell simulation of a miniature plasma source for a microwave discharge ion thruster	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						ion thruster; ECR plasma; microwave; xenon; particle-in-cell/Monte Carlo	INDUCTIVELY-COUPLED PLASMA; MONTE-CARLO COLLISIONS; CROSS-SECTIONS; GASES; ARGON	We have developed a three-dimensional particle model for a miniature microwave discharge ion thruster to elucidate the mechanism of ECR discharges confined in a small space. The model consists of a particle-in-cell simulation with a Monte Carlo collision algorithm (PIC-MCC) for the kinetics of charged particles, a finite-difference time-domain method for the electromagnetic fields of 4.2 GHz microwaves, and a finite element analysis for the magnetostatic fields of permanent magnets. The PIC-MCC results have shown that the electrons are well confined owing to the mirror magnetic fields and can be effectively heated in the ECR layer downstream of a ring-shaped antenna. The confinement results in the ring-shaped profiles of the plasma density along the antenna. The visual appearance of the plasma discharge of the thruster in operation was also ring-shaped. Moreover, the ions are expected to be accelerated effectively through the grid electrode without a large loss of ions toward side walls, that is, the plasma source developed here would be desirable in ion thrusters.	[Takao, Yoshinori; Eriguchi, Koji; Ono, Kouichi] Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Nishikyo Ku, Kyoto 6158540, Japan; [Koizumi, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Komurasaki, Kimiya] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Kashiwa, Chiba 2778583, Japan	Takao, Y (reprint author), Yokohama Natl Univ, Div Syst Res, Fac Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	ystakao@gmail.com	Takao, Yoshinori/C-6289-2009	Takao, Yoshinori/0000-0002-3468-8857	Japan Society for the Promotion of Science [25289304]	This work was financially supported in part by a Grant-in-Aid for Scientific Research (B), 25289304, from the Japan Society for the Promotion of Science. Part of the computer simulation in the present study was performed on the KDK computer system at the Research Institute for Sustainable Humanosphere, Kyoto University.	Turner MM, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2169752; Cho S, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4810798; BIRDSALL CK, 1991, IEEE T PLASMA SCI, V19, P65, DOI 10.1109/27.106800; SURENDRA M, 1991, IEEE T PLASMA SCI, V19, P144, DOI 10.1109/27.106808; Nam SK, 2004, J APPL PHYS, V95, P2272, DOI 10.1063/1.1644043; VAHEDI V, 1995, COMPUT PHYS COMMUN, V87, P179, DOI 10.1016/0010-4655(94)00171-W; Szabo J, 2014, J PROPUL POWER, V30, P197, DOI 10.2514/1.B34774; Liu H, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/16/165202; Nanbu K, 1998, J COMPUT PHYS, V145, P639, DOI 10.1006/jcph.1998.6049; Zhao YJ, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/4/045201; Nanbu K, 2000, IEEE T PLASMA SCI, V28, P971, DOI 10.1109/27.887765; Takao Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4764333; Takao Y, 2010, J APPL PHYS, V108, DOI 10.1063/1.3506536; RAPP D, 1965, J CHEM PHYS, V43, P1464, DOI 10.1063/1.1696957; Birdsall C. K., 1991, PLASMA PHYS VIA COMP; Boyd ID, 2004, J APPL PHYS, V95, P4575, DOI 10.1063/1.1688444; Coche P, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4864625; de Heer F. J., 1979, Journal of Physics B (Atomic and Molecular Physics), V12, DOI 10.1088/0022-3700/12/6/016; HAYASHI M, 1983, J PHYS D APPL PHYS, V16, P581, DOI 10.1088/0022-3727/16/4/018; Ketsdever A. D., 2000, MICROPROPULSION SMAL; Koizumi H, 2009, ADV APPL PLASMA SCI, V7, P51; Koizumi H, 2010, T JSASS AEROSPACE TE, V8, pPb _85; Koizumi H, 2010, J PROPUL POWER, V26, P601, DOI 10.2514/1.45194; Koizumi H, 2009, T JSASS SPACE TECH J, V7, pPb _89; Koizumi H, 2012, P 48 AIAA ASME SAE A; Kuninaka H, 2007, J PROPUL POWER, V23, P544, DOI 10.2514/1.25434; Kuninaka H, 1998, J PROPUL POWER, V14, P1022, DOI 10.2514/2.5369; Mahalingam S, 2010, J PROPUL POWER, V26, P673, DOI 10.2514/1.45954; Nanbu K, 1997, JPN J APPL PHYS 1, V36, P4808, DOI 10.1143/JJAP.36.4808; Sugita Y, 2013, P 33 EL PROP C WASH; Takao Y, 2014, T JSASS AEROSPACE TE, V12, pPb _13; Verboncoeur JP, 2005, PLASMA PHYS CONTR F, V47, pA231, DOI 10.1088/0741-3335/47/5A/017; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Yonemura S, 2001, JPN J APPL PHYS 1, V40, P7052, DOI 10.1143/JJAP.40.7052; Yu DR, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3688903	35	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							064004	10.1088/0963-0252/23/6/064004		11	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300013		
J	Urabe, K; Muneoka, H; Stauss, S; Terashima, K				Urabe, Keiichiro; Muneoka, Hitoshi; Stauss, Sven; Terashima, Kazuo			Microscopic heterodyne interferometry for determination of electron density in high-pressure microplasma	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						interferometry; microplasma; electron density	DISCHARGE; PLASMA	Electron density is paramount for understanding plasma characteristics and for control in plasma applications. To determine the electron density in a plasma by the use of interferometry, the phase shift of a probing electromagnetic (EM) wave induced by interaction with the plasma is measured. In this paper, for the determination of electron density in microplasmas generated under conditions of fluid density higher than that of ambient air, we discuss appropriate wavelength ranges for the probing EM wave (laser beam) in interferometry with consideration of the plasma parameters in the tested plasma source. On the basis of the discussion, we develop an interferometry system using a near-infrared diode laser in combination with a reflection system and a microscope for microplasma diagnostics, and measure the electron density in a 200 ns short-pulse microdischarge generated in a 0.3MPa helium supercritical fluid.	[Urabe, Keiichiro; Muneoka, Hitoshi; Stauss, Sven; Terashima, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Urabe, Keiichiro] Japan Soc Promot Sci, Tokyo 1020083, Japan	Urabe, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan.	k.urabe@plasma.k.u-tokyo.ac.jp; kazuo@plasma.k.u-tokyo.ac.jp	Urabe, Keiichiro/G-4524-2011	Urabe, Keiichiro/0000-0001-9743-3184	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21110002]; Japan Society for the Promotion of Science [12J03125]	This work was financially supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (Frontier Science of Interactions between Plasmas and Nano-Interfaces, grant No 21110002) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and a Grant-in-Aid for JSPS Fellows (grant No 12J03125) from the Japan Society for the Promotion of Science. The authors thank Professor O Sakai at Kyoto University, Professor M Matsui at Shizuoka University, and Professor K Tachibana at Osaka Electro-Communication University for their kind support in the construction of the NIR laser interferometer; Professor F Leipold at the Technical University of Denmark for a helpful discussion on the relationship between the probing-beam wavelength and the plasma parameters; and Mr Y Matsubayashi and Mr R Yasui at the University of Tokyo for their support in microplasma generation.	Allen C. W., 1973, ASTROPHYSICAL QUANTI; Hassaballa S, 2004, IEEE T PLASMA SCI, V32, P127, DOI 10.1109/TPS.2004.823980; Leipold F, 2000, J PHYS D APPL PHYS, V33, P2268, DOI 10.1088/0022-3727/33/18/310; Kawahata K, 1999, REV SCI INSTRUM, V70, P707, DOI 10.1063/1.1149394; Urabe K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.126101; Samukawa S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/25/253001; Foest R, 2003, SURF COAT TECH, V163, P323, DOI 10.1016/S0257-8972(02)00487-5; Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Belostotskiy SG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2939437; Mariotti D, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/32/323001; Choi JY, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/3/035013; Ito T, 2002, APPL PHYS LETT, V80, P2854, DOI 10.1063/1.1470695; Sakai O, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/1/013001; Ganguly B N, 2005, NONEQUILIBRIUM AIR P; HEBNER GA, 1988, J APPL PHYS, V63, P2226, DOI 10.1063/1.341060; Hutchinson I.H., 2002, PRINCIPLES PLASMA DI; Ito T., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/j.stam.2003.09.016; Ito T, 2001, THIN SOLID FILMS, V386, P300, DOI 10.1016/S0040-6090(00)01670-9; Kono A, 2001, JPN J APPL PHYS 2, V40, pL238, DOI 10.1143/JJAP.40.L238; Leipold F, 2014, COMMUNICATION; Lemmon E, 2012, NIST STANDARD REFERE; Lu XP, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2840194; Raizer Y. P., 1997, GAS DISCHARGE PHYS; Sakai O, 2005, PLASMA PHYS CONTR F, V47, pB617, DOI 10.1088/0741-3335/47/12B/S45; Shimamura K, 2011, J APPL PHYS, V109, DOI 10.1063/1.3574922; TERASHIMA K, 1996, THIN SOLID FILMS, V282, P634; Tomita K, 2011, J INSTRUM, V7; Urabe K, 2012, CO2 LASER OPTIMIZATI; Urabe K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/11/115203; Wang Q, 2005, J PHYS D APPL PHYS, V38, P1690, DOI 10.1088/0022-3727/38/11/008; Yariv A., 1997, OPTICAL ELECT MODERN; Zhu XM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/142003	33	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	DEC	2014	23	6							064007	10.1088/0963-0252/23/6/064007		9	Physics, Fluids & Plasmas	Physics	AU7LE	WOS:000345781300016		
J	Miyaji, T; Okamoto, H				Miyaji, Tomoyuki; Okamoto, Hisashi			A computer-assisted proof of existence of a periodic solution	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article						Three-dimensional dynamical system; periodic orbit; numerical verification	CHOREOGRAPHIES; SYSTEM	We consider a three-dimensional dynamical system proposed in Physica D, 164, (2002), 168-186. It is a conservative system and is unusual in that most of the solutions are unbounded. The paper presented a conjecture that an unstable periodic orbit determines directions of unbounded orbits of helical form. In the present paper we prove existence and local uniqueness of the conjectured periodic orbit by a method of numerical verification.	[Miyaji, Tomoyuki] Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Nakano Ku, Tokyo 1648525, Japan; [Okamoto, Hisashi] Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Miyaji, T (reprint author), Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Nakano Ku, 4-21-1 Nakano, Tokyo 1648525, Japan.				JSPS; RIMS; JSPS KAKENHI [24244007];  [24-5312]	The authors are very grateful to Prof. Alexander Craik, whose advice and encouragement has been a driving force of writing the present paper. This work was completed while T.M. was a JSPS Research Fellow at RIMS, Kyoto University. He thanks JSPS and RIMS for the support. He is supported by the Grant-in-Aid for JSPS Fellows No. 24-5312. H.O. is partially supported by JSPS KAKENHI 24244007. Finally, we thank the anonymous reviewers for their valuable comments.	Craik ADD, 2002, PHYSICA D, V164, P168, DOI 10.1016/S0167-2789(02)00372-X; Pehlivan I, 2011, OPTOELECTRON ADV MAT, V5, P1003; Rump SM, 2010, ACTA NUMER, V19, P287, DOI 10.1017/S096249291000005X; Capinski M., COMPUTER ASSISTED PR; Caprani O., 1978, BIT (Nordisk Tidskrift for Informationsbehandling), V18, DOI 10.1007/BF01947742; Galias Z., 1998, S CIRC SYST I SCAS 9, V3, P370; Galias Z, 2006, INT J BIFURCAT CHAOS, V16, P2873, DOI 10.1142/S0218127406016513; Kapela T, 2003, NONLINEARITY, V16, P1899, DOI 10.1088/0951-7715/16/6/302; Kapela T, 2007, NONLINEARITY, V20, P1241, DOI 10.1088/0951-7715/20/5/010; MAYER G, 1995, J COMPUT APPL MATH, V60, P147, DOI 10.1016/0377-0427(94)00089-J; Miyaji T., INT J BIFUR IN PRESS; Moore R.E., 1966, INTERVAL ANAL; Moore R.E., 2009, INTRO INTERVAL ANAL; Zgliczynski P, 2002, FOUND COMPUT MATH, V2, P429, DOI 10.1007/s102080010025	14	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	DEC	2014	90	10								10.3792/pjaa.90.139		6	Mathematics	Mathematics	AU9YF	WOS:000345946800001		
J	Osada, H; Tanemura, H				Osada, Hirofumi; Tanemura, Hideki			Cores of Dirichlet forms related to random matrix theory	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article						Random matrices; Dyson's model; interacting Brownian motions in infinite-dimensions; Airy random point fields; logarithmic potentials; Dirichlet forms	RANDOM POINT FIELDS; DETERMINANTAL PROCESSES; BROWNIAN-MOTION	We prove the sets of polynomials on configuration spaces are cores of Dirichlet forms describing interacting Brownian motion in infinite dimensions. Typical examples of these stochastic dynamics are Dyson's Brownian motion and Airy interacting Brownian motion. Both particle systems have logarithmic interaction potentials, and naturally arise from random matrix theory. The results of the present paper will be used in a forth coming paper to prove the identity of the infinite-dimensional stochastic dynamics related to the random matrix theories constructed by apparently different methods: the method of space-time correlation functions and that of stochastic analysis.	[Osada, Hirofumi] Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan; [Tanemura, Hideki] Chiba Univ, Fac Sci, Dept Math & Informat, Inage Ku, Chiba 2638522, Japan	Osada, H (reprint author), Kyushu Univ, Fac Math, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.				Japan Society for the Promotion of Science [24244010, 23540122]; Japan Society for the Promotion of Science	H. O. is supported in part by a Grant-in-Aid for Scientific Research (KIBAN-A, No. 24244010) of the Japan Society for the Promotion of Science. H. T. is supported in part by a Grant-in-Aid for Scientific Research (KIBAN-C, No. 23540122) of the Japan Society for the Promotion of Science.	Anderson G W, 2010, CAMBRIDGE STUDIES AD, V118; DYSON FJ, 1962, J MATH PHYS, V3, P1191, DOI 10.1063/1.1703862; Shirai T, 2003, J FUNCT ANAL, V205, P414, DOI 10.1016/S0022-1236(03)00171-X; Osada H, 2013, ANN PROBAB, V41, P1, DOI 10.1214/11-AOP736; Johansson K, 2003, COMMUN MATH PHYS, V242, P277, DOI 10.1007/s00220-003-0945-y; Osada H, 2012, PROBAB THEORY REL, V153, P471, DOI 10.1007/s00440-011-0352-9; Prahofer M, 2002, J STAT PHYS, V108, P1071, DOI 10.1023/A:1019791415147; Katori M, 2007, J STAT PHYS, V129, P1233, DOI 10.1007/s10955-007-9421-y; Soshnikov A, 2000, RUSS MATH SURV+, V55, P923, DOI 10.1070/RM2000v055n05ABEH000321; Osada H, 2013, STOCH PROC APPL, V123, P813, DOI 10.1016/j.spa.2012.11.002; Albeverio S, 1998, J FUNCT ANAL, V157, P242, DOI 10.1006/jfan.1997.3215; Fukushima M., 2010, GRUYTER STUDIES MATH, V19; Honda R., ARXIV14050523; Ma Z.M., 1992, INTRO THEORY NONSYMM; Mehta M. L., 2004, PURE APPL MATH, V142; Nagao T, 2003, PHYS LETT A, V307, P29, DOI 10.1016/S0375-9601(02)01661-4; Osada H., 2004, ADV STUD PURE MATH, V39, P325; Osada H., ARXIV14080632; Osada H, 1996, COMMUN MATH PHYS, V176, P117, DOI 10.1007/BF02099365; Osada H., PREPRINT; Spohn H., 1987, IMA VOLUMES MATH ITS, V9, P151; Yoshida MW, 1996, PROBAB THEORY REL, V106, P265, DOI 10.1007/s004400050065	22	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	DEC	2014	90	10								10.3792/pjaa.90.145		6	Mathematics	Mathematics	AU9YF	WOS:000345946800002		
J	Ueda, Y				Ueda, Yoshimichi			Absence of Cartan subalgebras in continuous cores of free product von Neumann algebras	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article						Cartan subalgebra; free product; type III factor; continuous core	AMALGAMATED FREE PRODUCT; ARAKI-WOODS FACTORS; II1 FACTORS	We show that the continuous core of any type III free product factor has no Cartan subalgebra. This is a complement to previous works due to Houdayer-Ricard and Boutonnet-Houdayer-Raum.	Kyushu Univ, Grad Sch Math, Nishi Ku, Fukuoka 8190395, Japan	Ueda, Y (reprint author), Kyushu Univ, Grad Sch Math, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.				 [24540214]	The most crucial part of this work was carried out during the author's stay at Hokkaido University in Dec. 4-7, 2013. We thank Reiji Tomatsu for his hospitality. This work is supported by Grant-in-Aid for Scientific Research (C) 24540214.	Ozawa N, 2012, KYOTO J MATH, V52, P333, DOI 10.1215/21562261-1550985; Ozawa N, 2010, AM J MATH, V132, P841; Ueda Y, 2011, ADV MATH, V228, P2647, DOI 10.1016/j.aim.2011.07.017; Ricard E, 2006, J REINE ANGEW MATH, V599, P27, DOI 10.1515/CRELLE.2006.077; Houdayer C, 2011, ADV MATH, V228, P764, DOI 10.1016/j.aim.2011.06.010; Ozawa N, 2010, ANN MATH, V172, P713; Ueda Y, 1999, PAC J MATH, V191, P359; Boutonnet R, 2014, COMPOS MATH, V150, P143, DOI 10.1112/S0010437X13007537; Chifan I, 2010, DUKE MATH J, V153, P23, DOI 10.1215/00127094-2010-020; Dbcmier J., 1981, N HOLLAND MATH LIB, V27; FELDMAN J, 1977, T AM MATH SOC, V234, P325, DOI 10.2307/1997925; Houdayer C, 2011, INT MATH RES NOTICES, P1352, DOI 10.1093/imrn/rnq117; Houdayer C, 2010, J INST MATH JUSSIEU, V9, P741, DOI 10.1017/S1474748010000058; Kechris A. S., 1995, GRADUATE TEXTS MATH, V156; loana A., ANN SCI EC IN PRESS; Neshveyev S, 2002, J FUNCT ANAL, V195, P239, DOI 10.1006/jfan.2002.3967; Papa S., 2014, ACTA MATH, V212, P141; Shlyakhtenko D, 1997, PAC J MATH, V177, P329; Takesaki M., 2003, ENCY MATH SCI, V125; Takesaki M., 1979, ENCY MATH SCI, V124; Ueda Y., ARXIV12076838V3; van Daele A., 1978, LONDON MATH SOC LECT, V31; Voiculescu D, 1996, GEOM FUNCT ANAL, V6, P172, DOI 10.1007/BF02246772; VOWDEN BJ, 1973, P LOND MATH SOC, V27, P88; Yamagami S, 2007, J MATH SOC JPN, V59, P541, DOI 10.2969/jmsj/05920541	25	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	DEC	2014	90	10								10.3792/pjaa.90.151		5	Mathematics	Mathematics	AU9YF	WOS:000345946800003		
J	Takano, Y; Yamaguchi, H; Inouye, I; Moestrup, O; Horiguchi, T				Takano, Yoshihito; Yamaguchi, Haruyo; Inouye, Isao; Moestrup, Ojvind; Horiguchi, Takeo			Phylogeny of Five Species of Nusuttodinium gen. nov (Dinophyceae), a Genus of Unarmoured Kleptoplastidic Dinoflagellates	PROTIST			English	Article						Amphidinium; dinoflagellate; Gymnodinium; kleptoplastidy; Nusuttodinium gen. nov.; molecular phylogeny	GYMNODINIUM-ACIDOTUM DINOPHYCEAE; MARINE DINOFLAGELLATE; MOLECULAR PHYLOGENY; AMPHIDINIUM-POECILOCHROUM; GRAZING RESPONSES; AMYLAX-TRIACANTHA; SEQUENCE DATA; CHLOROPLASTS; ENDOSYMBIONT; LIGHT	Cells of five unarmoured kleptoplastidic dinoflagellates, Amphidinium latum, Amphidinium poecilochroum, Gymnodinium amphidinioides, Gymnodinium acidotum and Gymnodinium aeruginosum were observed under light and/or scanning electron microscopy and subjected to single-cell PCR. The SSU rDNA and the partial LSU rDNA of all the examined species were sequenced, and the SSU rDNA of G. myriopyrenoides was sequenced. Phylogenetic analyses revealed that the unarmoured kleptoplastidic species formed a monophyletic clade within the Gymnodinium- clade sensu Daugbjerg et al. (2000). The sister taxa for this clade were Gymnodinium palustre and Spiniferodinium galeiforme, both of which possess brown-coloured chloroplasts. The results indicated that acquisition of kleptoplastidy in these unarmoured dinoflagellates was a single event and that these unarmoured kleptoplastidic dinoflagellates may have evolved from a form with permanent chloroplasts. Molecular trees suggested that the acquisition of kleptoplastidy took place in a marine habitat and later some species colonized the freshwater habitat. Because these unarmoured kleptoplastidic dinoflagellates are monophyletic and characterized by distinct morphological and cytological features (including the presence of the same type of apical groove, absence of nuclear chambers in the nuclear envelope, absence of genuine chloroplasts, and the possession of kleptochloroplasts), we propose the establishment of a new genus, Nusuttodinium, to accommodate all these dinoflagellates. (C) 2014 Elsevier GmbH. All rights reserved.	[Takano, Yoshihito] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Yamaguchi, Haruyo] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Inouye, Isao] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Moestrup, Ojvind] Univ Copenhagen, Dept Biol, Marine Biol Sect, DK-2100 Copenhagen, Denmark; [Horiguchi, Takeo] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan	Takano, Y (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, 2-12-4 Fukuura, Kanazawa, Kanagawa 2368648, Japan.	takadino@gmail.com	Horiguchi, Takeo/D-7612-2012; 	Moestrup, Ojvind/0000-0003-0965-8645	Ministry of Education, Culture, Sports, Science and Technology [24370034]	We thank Dr. Niels Daugbjerg and Dr. Gert Hansen, University of Copenhagen, Denmark, for their valuable advice and kind support during the stay of the first author in Denmark. We also thank Noriko Yamada, Hokkaido University, Japan, for discussions on photosynthetic pigments and Ryo Onuma, Hokkaido University, Japan, for discussions on morphological changes of N. aeruginosum. This work was partly supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (No. 24370034) and a Grant-in-Aid for JSPS Fellows.	Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Hansen G, 2000, PHYCOLOGIA, V39, P365, DOI 10.2216/i0031-8884-39-5-365.1; Calado AJ, 2005, PHYCOLOGIA, V44, P112, DOI 10.2216/0031-8884(2005)44[112:OTFDPI]2.0.CO;2; LOPEZ E, 1979, MAR BIOL, V53, P201, DOI 10.1007/BF00952427; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Logares R, 2007, MOL PHYLOGENET EVOL, V45, P887, DOI 10.1016/j.ympev.2007.08.005; Horiguchi T, 2012, PHYCOL RES, V60, P137, DOI 10.1111/j.1440-1835.2012.00645.x; Takano Y, 2004, PHYCOL RES, V52, P107, DOI 10.1111/j.1440-1835.2004.tb00319.x; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; Hansen G, 2007, J LIMNOL, V66, P107; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Yamaguchi H, 2011, PROTIST, V162, P650, DOI 10.1016/j.protis.2011.01.002; Park MG, 2013, J EUKARYOT MICROBIOL, V60, P363, DOI 10.1111/jeu.12041; HORIGUCHI T, 1987, PHYCOLOGIA, V26, P478, DOI 10.2216/i0031-8884-26-4-478.1; Nagai S, 2008, J PHYCOL, V44, P909, DOI 10.1111/j.1529-8817.2008.00544.x; Horiguchi T, 2006, PHYCOL RES, V54, P193, DOI 10.1111/j.1440-1835.2006.00426.x; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Koike K, 2005, PROTIST, V156, P225, DOI 10.1016/j.protis.2005.04.002; Horiguchi T, 2011, PHYCOLOGIA, V50, P616, DOI 10.2216/11-15.1; Garcia-Cuetos L, 2010, HARMFUL ALGAE, V9, P25, DOI 10.1016/j.hal.2009.07.002; Murray S, 2002, EUR J PHYCOL, V37, P279, DOI 10.1017/S0967026202003591; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; Nakayama T, 1998, PROTIST, V149, P367, DOI 10.1016/S1434-4610(98)70043-4; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Lewitus AJ, 1999, J PHYCOL, V35, P303, DOI 10.1046/j.1529-8817.1999.3520303.x; FARMER MA, 1990, PROTOPLASMA, V153, P178, DOI 10.1007/BF01354002; FARMER MA, 1989, J PHYCOL, V25, P280, DOI 10.1111/j.1529-8817.1989.tb00124.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FIELDS SD, 1991, J PHYCOL, V27, P525, DOI 10.1111/j.0022-3646.1991.00525.x; Geitler L, 1924, BOT ARCH, V6, P110; Gomez F, 2009, EUR J PROTISTOL, V45, P260, DOI 10.1016/j.ejop.2009.05.004; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Hoppenrath M, 2012, J PHYCOL, V48, P1143, DOI 10.1111/j.1529-8817.2012.01198.x; Horiguchi Takeo, 1992, Japanese Journal of Phycology, V40, P353; Hu H.J., 1983, Chinese Journal of Oceanology and Limnology, V1, P198; Huber-Pestalozzi G, 1950, BINNENGEWASSER, V16; Jakobsen HH, 2000, MAR ECOL PROG SER, V201, P121, DOI 10.3354/meps201121; Jorgensen MF, 2004, PHYCOL RES, V52, P284; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kofoid C. A., 1921, Memoirs of the University of California, V5, P1; Koike K, 2008, PHYCOL RES, V56, P301, DOI 10.1111/j.1440-1835.2008.00512.x; LARSEN J, 1988, PHYCOLOGIA, V27, P366, DOI 10.2216/i0031-8884-27-3-366.1; Larsen J., 1985, OPERA BOT, V79, P14; Lebour M.V., 1925, DINOFLAGELLATES NO S; LEWIS JM., 2002, FRESHWATER ALGAL FLO, P186; Nygaard G, 1950, K DANSKE VID SELESK, V7, P1; Onuma R, 2013, PROTIST, V164, P622, DOI 10.1016/j.protis.2013.06.003; Popovsky J, 1990, SUSSWASSERFLORA MITT, V6; Posada MA, 1998, BIOINFORMATICS, V14, P817; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schiller J, 1932, RABENHORSTS KRYPTOGA, V10; Schnepf E, 1993, ORIGINS PLASTIDS, V2, P53; SCHNEPF E, 1989, PLANT SYST EVOL, V164, P75, DOI 10.1007/BF00940431; SCHNEPF E, 1992, EUR J PROTISTOL, V28, P3, DOI 10.1016/S0932-4739(11)80315-9; Skovgaard A, 1998, AQUAT MICROB ECOL, V15, P293, DOI 10.3354/ame015293; Sparmann SF, 2008, PROTIST, V159, P383, DOI 10.1016/j.protis.2007.12.002; Stein F, 1883, ORGANISMUS INFUSIONS; Stoecker DK, 1992, ORIGINS PLASTIDS, P9; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; TSUTSUI K, 1976, J ELECTRON MICROSC, V25, P163; WILCOX LW, 1984, J PHYCOL, V20, P236, DOI 10.1111/j.0022-3646.1984.00236.x; WILCOX LW, 1985, SCIENCE, V227, P192, DOI 10.1126/science.227.4683.192; Woloszynska J, 1925, ACTA SOC BOT POL, V3, P49; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053820; Yamaguchi H, 2008, PHYCOL RES, V56, P127, DOI 10.1111/j.1440-1835.2008.00493.x	67	4	4	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-4610			PROTIST	Protist	DEC	2014	165	6					759	778		10.1016/j.protis.2014.09.001		20	Microbiology	Microbiology	AW1RJ	WOS:000346066900001		
J	Shiratori, T; Yokoyama, A; Ishida, K				Shiratori, Takashi; Yokoyama, Akiko; Ishida, Ken-Ichiro			Phylogeny, Ultrastructure, and Flagellar Apparatus of a New Marimonad Flagellate Abollifer globosa sp nov (Imbricatea, Cercozoa)	PROTIST			English	Article						Cercozoa; Marimonadida; heterotrophic flagellate; ultrastructure; phylogenetic analysis; flagellar apparatus	MOLECULAR PHYLOGENY; SEQUENCE ALIGNMENT; FINE-STRUCTURE; MIXED MODELS; N.-GEN.; CLASSIFICATION; PROTOZOA; DNA; G.	Abollifer is a little-known genus of marine heterotrophic flagellates with no ultrastructural and molecular information, and its taxonomic position remains uncertain. In this study, we report a new species of Abollifer, Abollifer globosa sp. nov., isolated from a seawater sample collected at Tokyo Bay. To reveal the taxonomic position and morphological characteristics of A. globosa, we performed light and electron microscopic observations and a phylogenetic analysis using small subunit ribosomal DNA sequences. A. globosa cells were 29.5 mu m in length and 22.4 mu m in width, oval or ovoid in shape with an apical projection. Two unequal flagella emerged from a deep subapical flagellar pit. The rim of the flagellar pit except for the ventral side was swollen. Electron microscopic observations showed that A. globosa possessed mitochondria with tubular cristae, a Golgi apparatus, microbodies, extrusomes, and many endosymbiotic bacteria. Basal bodies were arranged in parallel. The flagellar apparatus of A. globosa showed affinity with common gliding cercozoan flagellates. Our phylogenetic tree showed that A. globosa branched as the sister position of order Marimonadida (Imbricatea, Cercozoa). On the basis of the morphological and molecular phylogenetic analysis, we conclude that A. globosa is a new member of the order Marimonadida. (C) 2014 Elsevier GmbH. All rights reserved.	[Shiratori, Takashi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yokoyama, Akiko; Ishida, Ken-Ichiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Ishida, K (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ken@biol.tsukuba.ac.jp			JSPS KAKENHI [13J00587, 21247010]	This work was supported by JSPS KAKENHI Grant Numbers 13J00587 and 21247010.	Bass D, 2004, INT J SYST EVOL MICR, V54, P2393, DOI 10.1099/ijs.0.63229-0; Yabuki A, 2010, PROTIST, V161, P523, DOI 10.1016/j.protis.2010.03.001; Kashiyama Y, 2012, P NATL ACAD SCI USA, V109, P17328, DOI 10.1073/pnas.1207347109; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Howe AT, 2011, PROTIST, V162, P332, DOI 10.1016/j.protis.2010.10.002; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Cavalier-Smith T, 2011, PROTIST, V163, P47; Chantangsi C, 2010, PROTIST, V161, P133, DOI 10.1016/j.protis.2009.09.001; Chantangsi C, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-123; Hanaichi T, 1986, P 11 INT C EL MICR K, P2181; Hess S, 2014, PROTIST, V165, P605, DOI 10.1016/j.protis.2014.07.004; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; HIBBERD DJ, 1976, J PROTOZOOL, V23, P374, DOI 10.1111/j.1550-7408.1976.tb03791.x; Karpov SA, 2010, PROTISTOLOGY, V6, P326; Karpov SA, 2006, PROTIST, V157, P125, DOI 10.1016/j.protis.2006.01.001; Kuhn S, 2004, PROTIST, V155, P143, DOI 10.1078/143446104774199556; MIKRJUKOV KA, 1995, PROTOPLASMA, V188, P186, DOI 10.1007/BF01280370; Mylnikov AP, 2004, PROTISTOLOGY, V3, P201; Rogerson A, 1998, INVERTEBR BIOL, V117, P261, DOI 10.2307/3227028; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schnepf E, 2000, HELGOLAND MAR RES, V54, P18, DOI 10.1007/s101520050032; Shiratori T, 2012, J EUKARYOT MICROBIOL, V59, P527, DOI 10.1111/j.1550-7408.2012.00635.x; Struder-Kypke MC, 1998, EUR J PROTISTOL, V34, P376; VORS N, 1992, OPHELIA, V36, P1; Yabuki A, 2011, J EUKARYOT MICROBIOL, V58, P94, DOI 10.1111/j.1550-7408.2010.00524.x	29	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-4610			PROTIST	Protist	DEC	2014	165	6					808	824		10.1016/j.protis.2014.10.003		17	Microbiology	Microbiology	AW1RJ	WOS:000346066900004		
J	Noble, PB; Pascoe, CD; Lan, B; Ito, S; Kistemaker, LEM; Tatler, AL; Pera, T; Brook, BS; Gosens, R; West, AR				Noble, Peter B.; Pascoe, Chris D.; Lan, Bo; Ito, Satoru; Kistemaker, Loes E. M.; Tatler, Amanda L.; Pera, Tonio; Brook, Bindi S.; Gosens, Reinoud; West, Adrian R.			Airway smooth muscle in asthma: Linking contraction and mechanotransduction to disease pathogenesis and remodelling	PULMONARY PHARMACOLOGY & THERAPEUTICS			English	Article						Asthma; Airway smooth muscle; Contraction; Airway mechanics; Mechanotransduction	GROWTH-FACTOR-BETA; MUSCARINIC RECEPTOR STIMULATION; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE FLUID; FORCED OSCILLATION TECHNIQUE; ACTIVATES LATENT TGF-BETA-1; NONMUSCLE MYOSIN-II; DEEP INSPIRATION; MECHANICAL STRAIN; RHO-KINASE	Asthma is an obstructive airway disease, with a heterogeneous and multifactorial pathogenesis. Although generally considered to be a disease principally driven by chronic inflammation, it is becoming increasingly recognised that the immune component of the pathology poorly correlates with the clinical symptoms of asthma, thus highlighting a potentially central role for non-immune cells. In this context airway smooth muscle (ASM) may be a key player, as it comprises a significant proportion of the airway wall and is the ultimate effector of acute airway narrowing. Historically, the contribution of ASM to asthma pathogenesis has been contentious, yet emerging evidence suggests that ASM contractile activation imparts chronic effects that extend well beyond the temporary effects of bronchoconstriction. In this review article we describe the effects that ASM contraction, in combination with cellular mechanotransduction and novel contraction-inflammation synergies, contribute to asthma pathogenesis. Specific emphasis will be placed on the effects that ASM contraction exerts on the mechanical properties of the airway wall, as well as novel mechanisms by which ASM contraction may contribute to more established features of asthma such as airway wall remodelling. (C) 2014 Elsevier Ltd. All rights reserved.	[Noble, Peter B.] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Pascoe, Chris D.; Lan, Bo] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Lan, Bo] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China; [Ito, Satoru] Nagoya Univ, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Kistemaker, Loes E. M.; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, NL-9700 AB Groningen, Netherlands; [Tatler, Amanda L.] Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England; [Pera, Tonio] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Brook, Bindi S.] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [West, Adrian R.] Univ Manitoba, Dept Physiol, Winnipeg, MB R3T 2N2, Canada; [West, Adrian R.] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	West, AR (reprint author), John Buhler Res Ctr, Room 560,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	Adrian.West@umanitoba.ca		Tatler, Amanda/0000-0002-4644-4614; West, Adrian/0000-0001-8079-6915	NHMRC Career Development Fellowship [APP1045824]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25461188]; Netherlands Lung Foundation [3.2.08.014]; NC3Rs David Sainsbury Fellowship; MRC New Investigator Research Grant [G0901174]	PBN is supported by an NHMRC Career Development Fellowship (APP1045824).; SI is supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25461188).; LEMK is supported by the Netherlands Lung Foundation (Grant 3.2.08.014).; ALT is supported by an NC3Rs David Sainsbury Fellowship.; BSB is supported by an MRC New Investigator Research Grant (G0901174).	An SS, 2009, BIOCHEM BIOPH RES CO, V382, P697, DOI 10.1016/j.bbrc.2009.03.118; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Possa SS, 2012, AM J PHYSIOL-LUNG C, V303, pL939, DOI 10.1152/ajplung.00034.2012; Bossé Ynuk, 2008, Proc Am Thorac Soc, V5, P62, DOI 10.1513/pats.200705-056VS; Saharinen J, 1996, EMBO J, V15, P245; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Yu Q, 2000, GENE DEV, V14, P163; Moulton DE, 2011, J APPL PHYSIOL, V110, P1003, DOI 10.1152/japplphysiol.00991.2010; Williamson JP, 2011, AM J RESP CRIT CARE, V183, P612, DOI 10.1164/rccm.201002-0178OC; Anzueto A, 2005, PULM PHARMACOL THER, V18, P75, DOI 10.1016/j.pupt.2004.10.003; An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; Ward C, 2001, AM J RESP CRIT CARE, V164, P1718; Schaafsma D, 2008, AM J PHYSIOL-LUNG C, V295, pL214, DOI 10.1152/ajplung.00498.2007; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Mack CP, 2001, J BIOL CHEM, V276, P341; Aso H, 2013, AM J RESP CELL MOL, V48, P322, DOI 10.1165/rcmb.2012-0158OC; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Kanefsky J, 2006, AM J RESP CELL MOL, V34, P417, DOI 10.1165/rcmb.2005-0326OC; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606; Donovan GM, 2010, BIOPHYS J, V99, P3164, DOI 10.1016/j.bpj.2010.09.031; Giacomini MM, 2012, EXP CELL RES, V318, P716, DOI 10.1016/j.yexcr.2012.01.020; Cazzola M, 2005, EXPERT OPIN INV DRUG, V14, P775, DOI 10.1517/13543784.14.7.775; Skloot G, 2003, CLIN REV ALLERG IMMU, V24, P55, DOI 10.1385/CRIAI:24:1:55; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Krymskaya VP, 2000, AM J RESP CELL MOL, V23, P546; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; O'Reilly R, 2013, J ALLERGY CLIN IMMUN, V131, P1024, DOI 10.1016/j.jaci.2012.08.044; UVELIUS B, 1976, ACTA PHYSIOL SCAND, V97, P1, DOI 10.1111/j.1748-1716.1976.tb10230.x; Pera T, 2011, EUR RESPIR J, V38, P789, DOI 10.1183/09031936.00146610; Hirshman CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1468; Brown RH, 2001, AM J RESP CRIT CARE, V163, P994; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4; Ansell TK, 2013, J APPL PHYSIOL, V115, P505, DOI 10.1152/japplphysiol.01286.2012; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Bao G, 2010, CELL MOL BIOENG, V3, P91, DOI 10.1007/s12195-010-0109-z; Brook BS, 2014, MATH MED BIOL, V31, P99, DOI 10.1093/imammb/dqs031; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Horowitz A, 1996, PHYSIOL REV, V76, P967; Watanabe N, 1999, NAT CELL BIOL, V1, P136; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Tatler AL, 2008, BIOCHEM BIOPH RES CO, V370, P239, DOI 10.1016/j.bbrc.2008.03.064; Tliba O, 2008, CHEST, V133, P236, DOI 10.1378/chest.07-0262; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Bergeron Céline, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; PRATUSEVICH VR, 1995, J GEN PHYSIOL, V105, P73, DOI 10.1085/jgp.105.1.73; Qi D, 2002, AM J PHYSIOL-CELL PH, V282, pC1298, DOI 10.1152/ajpcell.00554.2001; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Noble PB, 2010, J APPL PHYSIOL, V108, P401, DOI 10.1152/japplphysiol.00511.2009; LaPrad AS, 2010, J APPL PHYSIOL, V109, P295, DOI 10.1152/japplphysiol.00107.2010; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Stamenovic D, 2008, RESP PHYSIOL NEUROBI, V163, P25, DOI 10.1016/j.resp.2008.02.009; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Disse B, 1999, LIFE SCI, V64, P457, DOI 10.1016/S0024-3205(98)00588-8; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Brown N, 2007, AM J RESP CRIT CARE, V176, P129, DOI 10.1164/rccm.200609-1317OC; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Munger JS, 1998, MOL BIOL CELL, V9, P2627; Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Brackel HJL, 2000, AM J RESP CRIT CARE, V162, P896; Kapsali T, 2000, J APPL PHYSIOL, V89, P711; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Kistemaker LEM, 2014, AM J RESP CELL MOL, V50, P690, DOI 10.1165/rcmb.2013-0220OC; Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; GUNST SJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1267; Zhang WW, 2012, J BIOL CHEM, V287, P33996, DOI 10.1074/jbc.M112.369603; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; NADEL JA, 1961, J APPL PHYSIOL, V16, P717; Gump A, 2001, J APPL PHYSIOL, V90, P2306; Gosens R, 2003, AM J RESP CELL MOL, V28, P257, DOI 10.1165/rcmb.2002-0128OC; James AL, 2002, AM J RESP CRIT CARE, V166, P1590, DOI 10.1164/rccm.2108069; WENZEL SE, 1991, J ALLERGY CLIN IMMUN, V87, P540, DOI 10.1016/0091-6749(91)90013-E; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Maarsingh H, 2009, BRIT J PHARMACOL, V158, P652, DOI 10.1111/j.1476-5381.2009.00374.x; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Lu M, 2002, J CELL SCI, V115, P4641, DOI 10.1242/jcs.00145; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Putnam AJ, 2003, AM J PHYSIOL-CELL PH, V284, pC627, DOI 10.1152/ajpcell.00137.2002; Liu HW, 2003, AM J RESP CELL MOL, V29, P39, DOI 10.1165/rcmb.2002.0206OC; Parameswaran H, 2014, J APPL PHYSIOL, V116, P825, DOI 10.1152/japplphysiol.00962.2013; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618; Wang L, 2001, J APPL PHYSIOL, V90, P734; Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; SHAVER JR, 1995, AM J RESP CRIT CARE, V152, P1189; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Stolarska MA, 2009, PHILOS T R SOC A, V367, P3525, DOI 10.1098/rsta.2009.0095; Mijailovich SM, 2000, BIOPHYS J, V79, P2667; West AR, 2013, AM J PHYSIOL-LUNG C, V304, pL4, DOI 10.1152/ajplung.00168.2012; Holzapfel GA, 2010, J R SOC INTERFACE, V7, P787, DOI 10.1098/rsif.2009.0357; Green RH, 2007, CURR OPIN ALLERGY CL, V7, P43, DOI 10.1097/ACI.0b013e3280118a32; Khan MA, 2010, AM J PHYSIOL-LUNG C, V299, pL98, DOI 10.1152/ajplung.00011.2010; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; LAMBERT RK, 1982, J APPL PHYSIOL, V52, P44; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Scichilone N, 2007, RESP MED, V101, P951, DOI 10.1016/j.rmed.2006.09.009; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Ito S, 2006, EUR J PHARMACOL, V552, P135, DOI 10.1016/j.ejphar.2006.08.067; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Johns DP, 2000, J APPL PHYSIOL, V88, P1413; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Marinkovic A, 2012, AM J PHYSIOL-LUNG C, V303, pL169, DOI 10.1152/ajplung.00108.2012; Ansell TK, 2009, EUR RESPIR J, V33, P844, DOI 10.1183/09031936.00116908; Baldwin Lindsay, 2002, Paediatr Respir Rev, V3, P315, DOI 10.1016/S1526054202002610; Bosse Y, 2009, AM J RESP CELL MOL, V40, P13, DOI 10.1165/rcmb.2008-0150OC; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308; Brook BS, 2014, J APPL PHYSIOL, V116, P980, DOI 10.1152/japplphysiol.01209.2013; Brook BS, 2010, RESP PHYSIOL NEUROBI, V170, P44, DOI 10.1016/j.resp.2009.11.006; Burrowes KS, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0057; Chakir J, 2000, J ALLERGY CLIN IMMUN, V106, P904, DOI 10.1067/mai.2000.110100; Chaudhuri S, 2008, AM J RESP CELL MOL, V39, P270, DOI 10.1165/rcmb.2007-0263OC; Chernyavsky IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090162; Crimi E, 2002, J APPL PHYSIOL, V93, P1384, DOI 10.1152/japplphysiol.00209.2002; Deng LH, 2004, AM J PHYSIOL-CELL PH, V287, pC440, DOI 10.1152/ajpcell.00374.2003; Dolhnikoff M, 2009, J ALLERGY CLIN IMMUN, V123, P1090, DOI 10.1016/j.jaci.2009.02.032; Donovan GM, 2013, J THEOR BIOL, V333, P102, DOI 10.1016/j.jtbi.2013.05.013; Donovan GM, 2012, PLOS ONE, V7; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Fairbank NJ, 2008, AM J PHYSIOL-LUNG C, V295, pL479, DOI 10.1152/ajplung.00421.2007; Foucard L, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673551; Fredberg JJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-2; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703; Frois C, 2009, CLIN THER, V31, P2779, DOI 10.1016/j.clinthera.2009.12.021; Gosens R, 2008, CURR MOL MED, V8, P741, DOI 10.2174/156652408786733720; Gosens R, 2009, EUR RESPIR J, V34, P1436, DOI 10.1183/09031936.00045209; GUNST SJ, 1983, J APPL PHYSIOL, V55, P759; GUNST SJ, 1990, J APPL PHYSIOL, V68, P2223; Harvey BC, 2013, J APPL PHYSIOL, V115, P436, DOI 10.1152/japplphysiol.00009.2013; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; HASSELL TC, 1986, BIOCHEM BIOPH RES CO, V134, P240, DOI 10.1016/0006-291X(86)90553-X; Herrera AM, 2002, AM J PHYSIOL-CELL PH, V282, pC310; Hulme KM, 2013, RESP PHYSIOL NEUROBI, V189, P506, DOI 10.1016/j.resp.2013.08.015; Ito S, 2006, AM J PHYSIOL-LUNG C, V290, pL1227, DOI 10.1152/ajplung.00299.2005; Iwata S, 2009, EUR J PHARMACOL, V605, P15, DOI 10.1016/j.ejphar.2008.12.045; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Kelly VJ, 2012, J APPL PHYSIOL, V112, P1494, DOI 10.1152/japplphysiol.01259.2011; Klion AD, 2004, BLOOD, V103, P4050, DOI 10.1182/blood-2003-11-3850; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kumar A, 2003, J BIOL CHEM, V278, P18868, DOI 10.1074/jbc.M212777200; Kuo KH, 2001, J APPL PHYSIOL, V90, P1811; Lambert RK, 2005, J APPL PHYSIOL, V99, P1885, DOI 10.1152/japplphysiol.00450.2005; Lan B, 2013, J APPL PHYSIOL, V115, P1540, DOI 10.1152/japplphysiol.00654.2013; LaPrad AS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003083; LaPrad AS, 2008, J APPL PHYSIOL, V105, P479, DOI 10.1152/japplphysiol.01220.2007; Latourelle J, 2002, J APPL PHYSIOL, V92, P771; Lauzon AM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00191; Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC; Lee-Gosselin A, 2013, J APPL PHYSIOL, V115, P1304, DOI 10.1152/japplphysiol.01480.2012; Lutchen KR, 2014, J APPL PHYSIOL, V116, P1113, DOI 10.1152/japplphysiol.00968.2013; Maksym GN, 2005, CAN J PHYSIOL PHARM, V83, P913, DOI 10.1139/Y05-091; Marinkovic A, 2011, AM J RESP CRIT CARE, V183, pA3562; MATTOLI S, 1991, J ALLERGY CLIN IMMUN, V88, P376, DOI 10.1016/0091-6749(91)90100-3; MITCHELL RW, 1991, AM J RESP CELL MOL, V5, P56; Morioka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026384; Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI [10.1016/j.mrfmmm.2009.09.005, 10.1016/j.mrfmmm.2010.09.005]; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; Naghshin J, 2003, J APPL PHYSIOL, V95, P448, DOI 10.1152/japplphysiol.01180.2002; Niimi A, 2003, AM J RESP CRIT CARE, V168, P983, DOI 10.1164/rccm.200211.1268OC; Noble PB, 2013, J APPL PHYSIOL, V114, P1460, DOI 10.1152/japplphysiol.01489.2012; Noble PB, 2007, J APPL PHYSIOL, V103, P787, DOI 10.1152/japplphysiol.00314.2007; Noble PB, 2011, J APPL PHYSIOL, V110, P1510, DOI 10.1152/japplphysiol.01226.2010; Oenema TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065580; Oenema TA, 2013, AM J RESP CELL MOL B, V49, P18; Oenema TA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-130; Oenema TA, 2012, AM J PHYSIOL-LUNG C, V303, pL589, DOI 10.1152/ajplung.00400.2011; Pascoe C, 2012, AM J RESP CELL MOL, V47, P44, DOI 10.1165/rcmb.2011-0429OC; Pascoe CD, 2013, J APPL PHYSIOL, V114, P335, DOI 10.1152/japplphysiol.00870.2012; Perez-Zoghbi JF, 2009, PULM PHARMACOL THER, V22, P388, DOI 10.1016/j.pupt.2008.09.006; Prakash YS, 2007, AM J PHYSIOL-LUNG C, V293, pL1118, DOI 10.1152/ajplung.00136.2007; Levy Mark L, 2006, Prim Care Respir J, V15, P20, DOI 10.1016/j.pcrj.2005.10.004; Raqeeb A, 2012, J APPL PHYSIOL, V112, P337, DOI 10.1152/japplphysiol.01036.2011; Ronan W, 2014, BIOMECH MODEL MECHAN, V13, P417, DOI 10.1007/s10237-013-0506-z; Salerno FG, 2005, J APPL PHYSIOL, V98, P817, DOI 10.1152/japplphysiol.00763.2004; Schaafsma D, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-121; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; Seow CY, 2013, PULM PHARMACOL THER, V26, P37, DOI 10.1016/j.pupt.2012.06.012; Quinlan AMT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023272; Smith PG, 2000, J APPL PHYSIOL, V89, P2092; Smith PG, 1997, EXP CELL RES, V232, P127, DOI 10.1006/excr.1997.3492; Smith PG, 1997, AM J PHYSIOL-LUNG C, V272, pL20; SMITH PG, 1994, AM J RESP CELL MOL, V10, P85; Smith PG, 2003, AM J PHYSIOL-LUNG C, V285, pL456, DOI 10.1152/ajplung.00329.2002; Smith PG, 1999, AM J PHYSIOL-LUNG C, V277, pL343; Suganuma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045056; Tatler AL, 2011, J IMMUNOL, V187, P6094; Tepper RS, 2005, J APPL PHYSIOL, V98, P1949, DOI 10.1152/japplphysiol.00952.2004.; Tiddens HAWM, 1999, AM J RESP CRIT CARE, V160, P1110; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Undem Bradley J, 2002, Curr Allergy Asthma Rep, V2, P159, DOI 10.1007/s11882-002-0011-4; vanNoord JA, 1996, EUR RESPIR J, V9, P1684, DOI 10.1183/09031936.96.09081684; Wang I, 2008, BIOPHYS J, V94, P2053, DOI 10.1529/biophysj.107.113977; Wang L, 2000, J APPL PHYSIOL, V88, P2246; Wang L, 2004, AM J RESP CELL MOL, V31, P54, DOI 10.1165/rcmb.2003-0240OC; West AR, 2011, AM J RESP CRIT CARE, V183, pA4052; West AR, 2012, EUR RESPIR J, V40, P455, DOI 10.1183/09031936.00187411; Wright D, 2013, PULM PHARMACOL THER, V26, P24, DOI 10.1016/j.pupt.2012.08.006; Xu GK, 2014, J BIOMECH, V47, P1479, DOI 10.1016/j.jbiomech.2014.01.022; Xu JQ, 1997, J MUSCLE RES CELL M, V18, P381, DOI 10.1023/A:1018634412117	233	5	6	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1094-5539			PULM PHARMACOL THER	Pulm. Pharmacol. Ther.	DEC	2014	29	2					96	107		10.1016/j.pupt.2014.07.005		12	Pharmacology & Pharmacy; Respiratory System	Pharmacology & Pharmacy; Respiratory System	AU9ZH	WOS:000345949900003		
J	Tsushima, K; Yamaguchi, K; Kono, Y; Yokoyama, T; Kubo, K; Matsumura, T; Ichimura, Y; Abe, M; Terada, J; Tatsumi, K				Tsushima, Kenji; Yamaguchi, Koichi; Kono, Yuta; Yokoyama, Toshiki; Kubo, Keishi; Matsumura, Takuma; Ichimura, Yasunori; Abe, Mitsuhiro; Terada, Jiro; Tatsumi, Koichiro			Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: A proof of concept study	PULMONARY PHARMACOLOGY & THERAPEUTICS			English	Article						Acute exacerbation of idiopathic pulmonary fibrosis; Recombinant human soluble thrombomodulin; High-mobility group box-1; SpO(2)/F1O2; Thrombin-antithrombin complex	LECTIN-LIKE DOMAIN; INTERSTITIAL PNEUMONIA; PROTEIN; INFLAMMATION; COAGULATION; ACTIVATION; MEDIATOR	Introduction: The mortality of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is high. Anticoagulation therapy (recombinant human soluble thrombomodulin (rhTM)) is recognized as a potential new strategy for treating disseminated intravascular coagulation in Japan. This preliminary study was to evaluate whether the coagulation factors increase or decrease in AE-IPF-patients, and whether the additional administration of rhTM for AE-IPF-patients has any beneficial effects on inflammatory mediators and activated coagulation. Methods: We retrospectively compared the clinical data of AE-IPF-patients, idiopathic pulmonary fibrosis (IPF) with pneumonia-patients and slowly progressive IPF-patients. As a subsequent study, AE-IPF-patients were prospectively treated with a bolus of rhTM intravenously for six days under mechanical ventilation. We historically investigated the improvement of the serial clinical data in both oxygenation and intravascular coagulation disturbance between treated AE-IPF-patients and untreated AE-IPF-patients. Results: Eleven AE-IPF, 21 IPF with pneumonia and 16 slowly progressive IPF-patients were enrolled, and the coagulatory levels of the AE-IPF-patients were found to be significantly higher than in the other patients. In 20 treated AE-IPF-patients, the 28-day mortality and in-hospital mortality were 35% and 45%, respectively. The levels of oxygenation rapidly increased on day 1 and continued to improve until day 7 in the survival AE-IPF-patients. The thrombin antithrombin complex levels and inflammatory cytokine levels in the survivors on day 7 were significantly different from those observed in the nonsurvivors. Conclusion: AE-IPF-patients were found to have significantly higher levels of coagulation. The rhTM administration in the surviving AE-IPF-patients led to significant differences in the oxygenation and intravascular coagulation disturbance. (C) 2014 Elsevier Ltd. All rights reserved.	[Tsushima, Kenji] Shinonoi Gen Hosp, Dept Pulm Med, Nagano 3888004, Japan; [Yamaguchi, Koichi; Kono, Yuta] Tokyo Med Univ, Dept Pulm Med, Shinjuku Ku, Tokyo 1600023, Japan; [Yokoyama, Toshiki; Kubo, Keishi] Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano 3908621, Japan; [Tsushima, Kenji; Matsumura, Takuma; Ichimura, Yasunori; Abe, Mitsuhiro; Terada, Jiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, Chiba 2608670, Japan	Tsushima, K (reprint author), Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tsushimakenji@yahoo.co.jp					American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Homma S, 2005, INTERNAL MED, V44, P1144, DOI 10.2169/internalmedicine.44.1144; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/00936.06.00114004; Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Noth I, 2012, AM J RESP CRIT CARE, V186, P88, DOI 10.1164/rccm.201202-0314OC; Abraham E, 2000, J IMMUNOL, V165, P2950; Mohri M, 1997, BLOOD COAGUL FIBRIN, V8, P274, DOI 10.1097/00001721-199707000-00003; Johkoh T, 1999, RADIOLOGY, V211, P555; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Nagato M, 2009, CRIT CARE MED, V37, P2181, DOI 10.1097/CCM.0b013e3181a55184; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631; Agarwal R, 2008, EUR J INTERN MED, V19, P227, DOI 10.1016/j.ejim.2007.04.024; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Van de Wouwer M, 2006, J THROMB HAEMOST, V4, P1813, DOI 10.1111/j.1538-7836.2006.02033.x; Shi CS, 2008, BLOOD, V112, P3661, DOI 10.1182/blood-2008-03-142760; Ogawa Y, 2012, J TRAUMA ACUTE CARE, V72, P1150, DOI 10.1097/TA.0b013e3182516ab5; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722; Cirino G, 1996, J EXP MED, V183, P821, DOI 10.1084/jem.183.3.821; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693; Lum H, 1994, AM J PHYSIOL, V267, pL233; Nicholson AG, 2001, AM J RESP CRIT CARE, V162, P2213; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yokoyama T, 2012, RESPIROLOGY, V17, P315, DOI 10.1111/j.1440-1843.2011.02051.x	26	5	6	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1094-5539			PULM PHARMACOL THER	Pulm. Pharmacol. Ther.	DEC	2014	29	2					233	240		10.1016/j.pupt.2014.04.008		8	Pharmacology & Pharmacy; Respiratory System	Pharmacology & Pharmacy; Respiratory System	AU9ZH	WOS:000345949900015		
J	Tsuji, Y; Satake, K; Ishibe, T; Harada, T; Nishiyama, A; Kusumoto, S				Tsuji, Yoshinobu; Satake, Kenji; Ishibe, Takeo; Harada, Tomoya; Nishiyama, Akihito; Kusumoto, Satoshi			Tsunami Heights along the Pacific Coast of Northern Honshu Recorded from the 2011 Tohoku and Previous Great Earthquakes	PURE AND APPLIED GEOPHYSICS			English	Article						2011 Tohoku tsunami; 1896 Sanriku tsunami; 1933 Sanriku tsunami; 1960 Chilean tsunami; 2010 Chilean tsunami; Sanriku coast	SLIP	The 2011 Tohoku earthquake generated a huge, destructive tsunami with coastal heights of up to 40 m recorded along northern Honshu. The Sanriku coast experienced similar tsunamis and damage from the 1896 and 1933 Sanriku earthquakes, whereas the only damaging tsunamis on both the Ibaraki and Chiba coasts in the previous century were from the 1960 and 2010 Chile earthquakes. We summarized 12 field surveys in which the height of the 2011 tsunami was recorded at 296 points, along with descriptions of the survey method, reliability, and accuracy. We then compared them with the above-mentioned tsunamis at locations for which specific measurements were given in previous reports. On the Sanriku coast, the 2011 tsunami heights are positively correlated with the previous Sanriku tsunamis, indicating that local variations resulting from the irregular coastline were more dominant factors than the earthquake location, type, or magnitude for near-field tsunamis. The correlations with the Chilean tsunami heights are less significant due to the differences between the local and trans-Pacific tsunamis. On the Ibaraki and Chiba coasts, the 2011 Tohoku and the two Chilean tsunami heights are positively correlated, showing the general decrease toward the south with small local variations such as large heights near peninsulas.	[Tsuji, Yoshinobu; Satake, Kenji; Ishibe, Takeo; Harada, Tomoya; Nishiyama, Akihito; Kusumoto, Satoshi] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Harada, Tomoya] Univ Tokyo, CIDIR, Interfac Initiat Informat Studies, Bunkyo Ku, Tokyo 1130033, Japan	Tsuji, Y (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	satake@eri.u-tokyo.ac.jp	Satake, Kenji/E-2312-2011		Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Haeng Yoong Kim, Toshihiro Ueno, Satoko Murotani, Satoko Oki, Megumi Sugimoto, Jiro Tomari, Mohammad Heidarzadeh, Shingo Watada, Kentaro Imai, Byung Ho Choi, Sung Bum Yoon, Jae Seok Bae, Kyeong Ok Kim, Hyun Woo Kim, Makoto Yoshimizu, and Morio Koyama for helping to measure tsunami heights. We also thank Kentaro Imai for providing data on tsunami heights from the 2010 Chile earthquake. Valuable comments and suggestions from the guest editor, Dr. Jose C. Borrero, and two anonymous reviewers were very helpful in improving our manuscript. Most of the figures were generated using Generic Mapping Tools (WESSEL and SMITH 1998). We also used a digital topographic map with a scale of 1:25,000 from the Geospatial Information Authority of Japan. This study was partially supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABE K, 1994, B SEISMOL SOC AM, V84, P415; Aida I., 1977, B EARTHQ RES I TOKYO, V52, P71; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Okal EA, 2013, PURE APPL GEOPHYS, V170, P963, DOI 10.1007/s00024-012-0500-x; Borrero JC, 2013, PURE APPL GEOPHYS, V170, P1249, DOI 10.1007/s00024-012-0559-4; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; Grilli ST, 2013, PURE APPL GEOPHYS, V170, P1333, DOI 10.1007/s00024-012-0528-y; Choi BH, 2012, NAT HAZARD EARTH SYS, V12, P1463, DOI 10.5194/nhess-12-1463-2012; CFI (Committee for Field Investigation of the Chilean Tsunami of 1960), 1961, REP CHIL TSUN MAY 24; Earthquake Research Institute, 1934, B EARTHQ RES I TOK S, V1, P9; Haraguchi T, 2011, DETAILED MAPS IMPACT, V1; Hatori T., 1995, REV DOCUMENTS 1896 M, V12, P59; Heidarzadeh M, 2013, PURE APPL GEOPHYS, V170, P1275, DOI 10.1007/s00024-012-0558-5; HONDA K., 1908, J COLL SCI IMP U TOK, V24, P1; Iki T., 1897, REP IMP EARTHQ INV C, V11, P5; Imai K., 2010, J JAPAN SOC CIVIL B2, V66, P1351; Imamura A., 1934, JPN J ASTRON GEOPHYS, V11, P79; Imamura F., 1990, SURVEYS LARGE SANRIK, V7, P123; JMA (Japan Meteorological Agency), 2011, MONTHL REP EARTHQ VO; JMA (Japan Meteorological Agency), 1961, REP TSUN CHIL EARTHQ, V8; Kanamori H., 1972, Physics of the Earth and Planetary Interiors, V6, DOI 10.1016/0031-9201(72)90058-1; Kanamori H., 1971, PHYS EARTH PLANET IN, V4, P289, DOI [10.1016/0031-9201(71)90013-6, DOI 10.1016/0031-9201(71)90013-6]; Koike K., 2005, REGIONAL GEOMORPHOLO, V3; Kunitomi S., 1933, Q J SEISMOLOGY, V7, P111; Matsuo H., 1934, REPORT SURVEY 1993 S, V27, P93; Matsuo H., 1933, REP PUBL WORKS RES S, V24, P83; Mom N., 2011, GEOPHYS RES LETT, V38, DOI DOI 10.1029/2011GL049210; Otuka Y., 1934, B EARTHQUAKE RES I S, V1, P127; Shuto N., 1984, TSUNAMI ENG TECHNICA, V1, P88; Suppasri A., 2013, RELATION EARTHQUAKE, V30, P37; Takahashi T., 2011, COAST ENG J, V54, DOI [10.1142/S0578563412500015, DOI 10.1142/S0578563412500015]; Takeda A., 1987, TSUNAMI STONE RAGA R, V39, P163; Tanioka Y, 1996, GEOPHYS RES LETT, V23, P1549, DOI 10.1029/96GL01479; Tanioka Y, 2001, GEOPHYS RES LETT, V28, P3389, DOI 10.1029/2001GL013149; Tsuji Y., 2010, J JAPAN SOC CIVIL B2, V66, P1346; Tsuji Y., 2011, B EARTHQ RES I TOKYO, V86, P29; Unohana M., 1988, DISASTER RECORDS MEI, V5, P57; Watada S., 2013, IAHS IAPSO IASPEI JO; WESSEL P, 1998, EOS T AGU, V0079; Yamashita F, 2003, HIST EARTHQUAKES, V19, P165	41	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2014	171	12					3183	3215		10.1007/s00024-014-0779-x		33	Geochemistry & Geophysics	Geochemistry & Geophysics	AU8KF	WOS:000345844700002		
J	Shimozono, T; Cui, HY; Pietrzak, JD; Fritz, HM; Okayasu, A; Hooper, AJ				Shimozono, Takenori; Cui, Haiyang; Pietrzak, Julie D.; Fritz, Hermann M.; Okayasu, Akio; Hooper, Andrew J.			Short Wave Amplification and Extreme Runup by the 2011 Tohoku Tsunami	PURE AND APPLIED GEOPHYSICS			English	Article						Tsunami; runup; amplification; topography; Sanriku coast	EARTHQUAKE TSUNAMI; OKI EARTHQUAKE; FIELD SURVEY; COASTAL	Watermarks found during the post-event surveys of the 2011 Tohoku tsunami confirmed extreme runup heights at several locations along the central to northern part of the Sanriku coast, Japan. We measured the maximum height of nearly 40 m above mean sea level at a narrow coastal valley of the Aneyoshi district. Wave records by offshore GPS-buoys suggest that the remarkably high runup was associated with a leading, impulsive crest of the tsunami amplified by local bathymetry and topography. In order to elucidate the underlying amplification mechanism, we apply a numerical model to reproduce the measured distribution of tsunami heights along the target coastline. A series of numerical tests under different boundary conditions suggests that a spectral component with a dominant period of 4-5 min in the leading wave play a key role in generating the extreme runup. Further analyses focusing on the Aneyoshi district confirm that the short wavelength component undergoes critical amplification in a narrow inlet. Our findings highlight the importance of resolving offshore waveforms as well as local bathymetry and topography when simulating extreme runup events.	[Shimozono, Takenori] Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Cui, Haiyang; Pietrzak, Julie D.] Delft Univ Technol, Fac Civil Engn & Geosci, NL-2628 CN Delft, Netherlands; [Fritz, Hermann M.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Okayasu, Akio] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo 1088477, Japan; [Hooper, Andrew J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	Shimozono, T (reprint author), Univ Tokyo, Dept Civil Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	shi-mozono@coastal.t.u-tokyo.ac.jp; h.cui@tudelft.nl; j.d.pietrzak@tudelft.nl; fritz@gatech.edu; okayasu@kaiyodai.ac.jp; a.hooper@leeds.ac.uk	Fritz, Hermann/H-5618-2013; OKAYASU, Akio/O-1877-2014	Fritz, Hermann/0000-0002-6798-5401; 	JST J-RAPID project [11103018]; NSF RAPID award [CMMI-1135768]	The post-tsunami survey was financially supported by the JST J-RAPID project (11103018). H.M.F. was supported by NSF RAPID award (CMMI-1135768).	Abe K, 2005, ADV NAT TECHNOL HAZ, V23, P97; Maeda T, 2011, EARTH PLANETS SPACE, V63, P803, DOI 10.5047/eps.2011.06.005; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Didenkulova I, 2011, PURE APPL GEOPHYS, V168, P1239, DOI 10.1007/s00024-010-0232-8; Fritz HM, 2011, PURE APPL GEOPHYS, V168, P1989, DOI 10.1007/s00024-011-0283-5; TSUJI Y, 1995, PURE APPL GEOPHYS, V144, P481, DOI 10.1007/BF00874380; Hooper A, 2013, EARTH PLANET SC LETT, V361, P469, DOI 10.1016/j.epsl.2012.11.013; Cui H, 2010, OCEAN MODEL, V35, P16, DOI 10.1016/j.ocemod.2010.06.001; Grilli ST, 2013, PURE APPL GEOPHYS, V170, P1333, DOI 10.1007/s00024-012-0528-y; Liu HJ, 2013, PURE APPL GEOPHYS, V170, P1033, DOI 10.1007/s00024-012-0496-2; Borrero JC, 2006, EARTHQ SPECTRA, V22, pS93, DOI 10.1193/1.2206793; Cui HY, 2012, OCEAN MODEL, V54-55, P55, DOI 10.1016/j.ocemod.2012.07.001; Lay T, 2011, EARTH PLANETS SPACE, V63, P687, DOI 10.5047/eps.2011.05.033; Wei Y, 2013, PURE APPL GEOPHYS, V170, P1309, DOI [10.1109/ICSSSM.2012.6252175, 10.1007/s00024-012-0519-z]; Mori N, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500015; Titov VV, 1997, GEOPHYS RES LETT, V24, P1315, DOI 10.1029/97GL01128; Saito T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049089; SHUTO N, 1995, PURE APPL GEOPHYS, V144, P649, DOI 10.1007/BF00874388; Earthquake Research Institute, 1934, B EARTHQ RES I TOK S, V1; Fritz HM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050686; Goto C., 1983, EFFECT LARGE OBSTACL, P511; Kanoglu U, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0015; Kawai H., 2012, P 33 INT C COAST ENG, P1; Keller J.B., 1964, NONR382800 DEP NAV; Liu PC, 2000, ADV COASTAL OCEAN EN, V6, P57, DOI 10.1142/9789812797537_0002; Mom N., 2011, GEOPHYS RES LETT, V38, DOI DOI 10.1029/2011GL049210; Okayasu A, 2012, P 33 INT C COAST ENG, V4; Rabinovich AB, 2009, HDB COASTAL OCEAN EN, P193, DOI DOI 10.1142/9789812819307_0009; Shimozono T, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500040; Zahibo N., 2006, International Journal of Fluid Mechanics Research, V33	30	6	6	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2014	171	12					3217	3228		10.1007/s00024-014-0803-1		12	Geochemistry & Geophysics	Geochemistry & Geophysics	AU8KF	WOS:000345844700003		
J	Sato, S; Okayasu, A; Yeh, H; Fritz, HM; Tajima, Y; Shimozono, T				Sato, Shinji; Okayasu, Akio; Yeh, Harry; Fritz, Hermann M.; Tajima, Yoshimitsu; Shimozono, Takenori			Delayed Survey of the 2011 Tohoku Tsunami in the Former Exclusion Zone in Minami-Soma, Fukushima Prefecture	PURE AND APPLIED GEOPHYSICS			English	Article						Tohoku Tsunami; inland tsunami heights; tsunami disaster followed by a nuclear accident; seawall performance		Post-tsunami field surveys in the Minami-Soma exclusion zone in the Fukushima Prefecture were delayed for 15 months after the 2011 Tohoku tsunami. The area was subject to access restrictions until June 2012 due to high radiation levels caused by the meltdown at the Fukushima Dai-ichi Nuclear Power Plant. The distribution of the measured tsunami heights is presented in combination with observed infrastructure damage. The enhanced tsunami heights in the areas along the shoreline are attributed to wave reflection, funneling and splash-up at cliffs and seawalls, as well as the increased flow resistance as the tsunami plowed through coastal pine-tree forests. Consequently, large tsunami heights exceeding 10 m were limited to areas within 500 m from the shoreline. Onshore profiles of the maximum inundation levels were dependent on inland topography: tsunami heights increased inland in steep V-shaped valleys, while decaying with inundation distance along flat coastal plains. Tsunami flood levels in the coastal plains are affected by the extent of seawall damage: coastal flood levels are higher behind completely destroyed seawalls than behind partially damaged coastal defenses. Remnant seawalls provided valuable lessons to be implemented in future designs of tenacious structures based on the Japanese concept of 'nebari' representing resiliency to endure tsunami overflow as the original design height is exceeded.	[Sato, Shinji; Tajima, Yoshimitsu; Shimozono, Takenori] Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Tokyo 113, Japan; [Okayasu, Akio] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo, Japan; [Yeh, Harry] Oregon State Univ, Sch Civil & Construct Engn, Corvallis, OR 97331 USA; [Fritz, Hermann M.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30322 USA	Sato, S (reprint author), Univ Tokyo, Dept Civil Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	sato@coastal.t.u-tokyo.ac.jp	Fritz, Hermann/H-5618-2013; OKAYASU, Akio/O-1877-2014	Fritz, Hermann/0000-0002-6798-5401; 	Japan Science and Technology Agency through the J-RAPID program; US National Science Foundation through the NSF RAPID award [CMMI-1135768]	The authors of UT and TUMST were supported by Japan Science and Technology Agency through the J-RAPID program. H.Y. and H.M.F. were supported by the US National Science Foundation through the NSF RAPID award CMMI-1135768. The authors also acknowledge field survey assistance by several students of UT and TUMST.	Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Liu HJ, 2013, PURE APPL GEOPHYS, V170, P1033, DOI 10.1007/s00024-012-0496-2; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Mori N, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500015; Fritz HM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050686; Kato F., 2013, J DISASTER RES, V8, P612; Sanuki H, 2013, P COASTAL DYNAMICS; Sato S, 2013, P COASTAL DYNAMICS; Sato S., 2013, P 2013 IAHR C; Sato S, 2012, P 33 INT C COAST ENG; Shimozono T, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500040; Shimozono T., 2014, PURE APPL GEOP UNPUB; Tohoku Tsunami Joint Survey Group (TTSG), TSUN SURV DAT	13	2	2	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2014	171	12					3229	3240		10.1007/s00024-014-0809-8		12	Geochemistry & Geophysics	Geochemistry & Geophysics	AU8KF	WOS:000345844700004		
J	Heidarzadeh, M; Satake, K				Heidarzadeh, Mohammad; Satake, Kenji			Excitation of Basin-Wide Modes of the Pacific Ocean Following the March 2011 Tohoku Tsunami	PURE AND APPLIED GEOPHYSICS			English	Article						11 March 2011 Tohoku earthquake; Pacific Ocean; free oscillation; spectral analysis; basin-wide mode; numerical modeling	FREE OSCILLATION; EARTHQUAKE; GEOMETRY	This study is an attempt towards understanding the sources of long oscillations observed within the Pacific Ocean following the 11 March 2011 Tohoku earthquake. We present evidence that extremely long modes of the Pacific Ocean in the range of 2-48 h were excited by this giant tsunami. A numerical approach was employed to calculate the basin-wide modes of the Pacific Ocean, resulting in 49 modes in the range of 2-48 h. We studied 15 tide-gauge records around the Pacific Ocean in order to extract basin-wide modes of the Pacific Ocean excited by this transoceanic tsunami. Spectral analysis of these tide-gauge records showed that some of the calculated basin-wide modes were indeed excited by the Tohoku tsunami. The observed modes ranged from 2 to 49.8 h. We attributed the long oscillations of the Pacific Ocean during the 2011 Tohoku tsunami to the excitation of these basin-wide modes, which can be grouped into global modes (15-48 h) and regional modes (2-15 h). We classified the signals on the tide gauges into three groups: (1) basin-wide modes (> 1.5 h), (2) the tsunami source periods (20-90 min), and (3) local bathymetric effects (< 20 min). The average contributions to the total tsunami energy were 6.4 % for the basin-wide mode, 64.1 % for the tsunami source, and 29.5 % for the local bathymetry, although the ratios varied from station to station. Simulations suggest that the amount of contribution of basin effects to the total tsunami energy depends on the location of the tsunami source.	[Heidarzadeh, Mohammad] Univ Kiel, Cluster Excellence Future Ocean, D-24118 Kiel, Germany; [Heidarzadeh, Mohammad; Satake, Kenji] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan	Heidarzadeh, M (reprint author), Univ Kiel, Cluster Excellence Future Ocean, Otto Hahn Pl 1, D-24118 Kiel, Germany.	mheidarzadeh@geomar.de	Satake, Kenji/E-2312-2011; Heidarzadeh, Mohammad/A-1354-2016	Heidarzadeh, Mohammad/0000-0002-1112-1276	Alexander von Humboldt Foundation in Germany	The sea level data used in this study were provided through the USA National Oceanographic and Atmospheric Administration (NOAA), and the UNESCO Intergovernmental Oceanographic Commission (IOC). Some figures were drafted using the GMT software (WESSEL and SMITH 1991). This article benefitted from detailed, constructive review comments from two anonymous reviewers, for which we are sincerely grateful. The first author was partially supported by the Alexander von Humboldt Foundation in Germany.	Yalciner AC, 2007, OCEAN ENG, V34, P747, DOI 10.1016/j.oceaneng.2006.05.016; Borrero JC, 2013, PURE APPL GEOPHYS, V170, P1249, DOI 10.1007/s00024-012-0559-4; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Rabinovich AB, 2011, PURE APPL GEOPHYS, V168, P1919, DOI 10.1007/s00024-011-0279-1; LEE JJ, 1971, J FLUID MECH, V45, P375, DOI 10.1017/S0022112071000090; Mori N, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500015; Roeber V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044419; ZELT JA, 1990, J FLUID MECH, V213, P203, DOI 10.1017/S0022112090002294; Bell C., 2000, POL PSMSL TIDAL ANAL; Carbajal N, 2002, REV MEX FIS, V48, P192; Heidarzadeh M, 2013, PURE APPL GEOPHYS, V170, P1449, DOI 10.1007/s00024-012-0509-1; Heidarzadeh M, 2013, PURE APPL GEOPHYS, V170, P1275, DOI 10.1007/s00024-012-0558-5; Heidarzadeh M., 2012, P JAP GEOSC UN M 20; Ioc Iho and Bodc, 2003, CENTENARY EDITION GE; Mathworks, 2013, MATLAB US MAN; Mofjeld HO, 2001, GEOPHYS RES LETT, V28, P335, DOI 10.1029/2000GL011710; Noaa, 2013, JAP E COAST HONSH TS; Okal EA, 2006, EARTHQ SPECTRA, V22, pS203, DOI 10.1193/1.2202647; Rabinovich AB, 2009, HDB COASTAL OCEAN EN, P193, DOI DOI 10.1142/9789812819307_0009; Rabinovich A.B., 1997, J GEOPHYS RES, V102, P663; Raichlen F., 1991, HDB COASTAL OCEAN EN; Saito T, 2013, B SEISMOL SOC AM, V103, P1429, DOI 10.1785/0120120183; SATAKE K, 1988, GEOPHYS J INT, V93, P451, DOI 10.1111/j.1365-246X.1988.tb03872.x; SATAKE K, 1988, GEOPHYS J INT, V93, P457, DOI 10.1111/j.1365-246X.1988.tb03873.x; SATAKE K, 1987, J PHYS EARTH, V35, P409; VANDORN WG, 1984, J PHYS OCEANOGR, V14, P353, DOI 10.1175/1520-0485(1984)014<0353:STCDFT>2.0.CO;2; Vich MD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039970; Wessel P., 1991, EOS T AM GEOPHYS UN, V72, P441, DOI DOI 10.1029/90EO00319; Yalciner A, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002113; Yanuma T., 1998, J OCEANOGR, V54, P9, DOI DOI 10.1007/BF02744377; Yao LS, 1999, J FLUID MECH, V395, P237, DOI 10.1017/S0022112099005832	31	4	4	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2014	171	12					3405	3419		10.1007/s00024-013-0731-5		15	Geochemistry & Geophysics	Geochemistry & Geophysics	AU8KF	WOS:000345844700014		
J	Heidarzadeh, M; Satake, K				Heidarzadeh, Mohammad; Satake, Kenji			The El Salvador and Philippines Tsunamis of August 2012: Insights from Sea Level Data Analysis and Numerical Modeling	PURE AND APPLIED GEOPHYSICS			English	Article						Tsunami; earthquake; DART; tide gauge; spectral analysis; Fourier analysis; wavelet analysis; numerical modeling; El Salvador earthquake; Philippines earthquake		We studied two tsunamis from 2012, one generated by the El Salvador earthquake of 27 August (Mw 7.3) and the other generated by the Philippines earthquake of 31 August (Mw 7.6), using sea level data analysis and numerical modeling. For the El Salvador tsunami, the largest wave height was observed in Baltra, Galapagos Islands (71.1 cm) located about 1,400 km away from the source. The tsunami governing periods were around 9 and 19 min. Numerical modeling indicated that most of the tsunami energy was directed towards the Galapagos Islands, explaining the relatively large wave height there. For the Philippines tsunami, the maximum wave height of 30.5 cm was observed at Kushimoto in Japan located about 2,700 km away from the source. The tsunami governing periods were around 8, 12 and 29 min. Numerical modeling showed that a significant part of the far-field tsunami energy was directed towards the southern coast of Japan. Fourier and wavelet analyses as well as numerical modeling suggested that the dominant period of the first wave at stations normal to the fault strike is related to the fault width, while the period of the first wave at stations in the direction of fault strike is representative of the fault length.	[Heidarzadeh, Mohammad; Satake, Kenji] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Heidarzadeh, Mohammad] Univ Kiel, Cluster Excellence Future Ocean, Kiel, Germany	Heidarzadeh, M (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	mheidar@eri.u-tokyo.ac.jp	Satake, Kenji/E-2312-2011; Heidarzadeh, Mohammad/A-1354-2016	Heidarzadeh, Mohammad/0000-0002-1112-1276	Alexander von Humboldt Foundation in Germany; Japan Society for Promotion of Science (JSPS) in Japan	The sea level data used in this study were provided through the USA National Oceanographic and Atmospheric Administration (NOAA), and UNESCO Intergovernmental Oceanographic Commission (IOC). We express our sincere gratitude to our colleagues from the sea level data centers at both NOAA and IOC for their invaluable efforts regarding the preparation, processing and timely supply of sea level data which has greatly contributed to tsunami science in the last decade. Figure 1 was drafted using the GMT software (WESSEL and SMITH 1991). The wavelet package by TORRENCE and COMPO (1998) was used in this study. This article benefitted from detailed and constructive reviews from two anonymous reviewers, for which we are sincerely grateful. We would like to thank Dr. Hermann Fritz (Georgia Institute of Technology, USA), the guest editor of this issue, for his assistance during the revision process of this article. This study was supported by the Alexander von Humboldt Foundation in Germany and the Japan Society for Promotion of Science (JSPS) in Japan.	Rabinovich AB, 2007, PURE APPL GEOPHYS, V164, P261, DOI 10.1007/s00024-006-0164-5; Borrero JC, 2013, PURE APPL GEOPHYS, V170, P1249, DOI 10.1007/s00024-012-0559-4; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Satake K, 2013, PURE APPL GEOPHYS, V170, P1567, DOI 10.1007/s00024-012-0536-y; Bell C., 2000, POL PSMSL TIDAL ANAL; BENMENAH.A, 1972, J GEOPHYS RES, V77, P3097, DOI 10.1029/JB077i017p03097; Borrero J., 2014, PURE APP GE IN PRESS; Global CMT, 2012, GLOB CENTR MOM TENS; Heidarzadeh M, 2013, PURE APPL GEOPHYS, V170, P1449, DOI 10.1007/s00024-012-0509-1; Heidarzadeh M, 2013, PURE APPL GEOPHYS, V170, P1275, DOI 10.1007/s00024-012-0558-5; Ioc IHO BODC, 2003, PUBL CD ROM BEH INT; Ioc (Intergovernmental Oceanographic Commission), 2012, SEA LEVEL STAT MONIT; KANAMORI H, 1993, NATURE, V361, P714, DOI 10.1038/361714a0; Lander J.F., 2003, SCI TSUNAMI HAZARDS, V21, P3; Mathworks, 2012, MATLAB USER MAN; Ptwc, 2012, PAC TSUN WARN SYST N; Rabinovich A.B., 1997, J GEOPHYS RES, V102, P663; SATAKE K, 1988, PURE APPL GEOPHYS, V126, P27, DOI 10.1007/BF00876912; Usgs, 2012, US GEOL SURV GLOB EA; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wessel P., 1991, EOS T AM GEOPHYS UN, V72, P441, DOI DOI 10.1029/90EO00319; Yalciner A, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002113	23	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2014	171	12					3437	3455		10.1007/s00024-014-0790-2		19	Geochemistry & Geophysics	Geochemistry & Geophysics	AU8KF	WOS:000345844700016		
J	Sakamoto, SI; Makino, S; Tampo, H				Sakamoto, S-I.; Makino, S.; Tampo, H.			Double ring sign at the macula in a patient with Valsalva retinopathy	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Editorial Material									[Sakamoto, S-I.; Makino, S.; Tampo, H.] Jichi Med Univ, Dept Ophthalmol, Yakushiji, Tochigi 3290498, Japan	Sakamoto, SI (reprint author), Jichi Med Univ, Dept Ophthalmol, Yakushiji, Tochigi 3290498, Japan.	makichan@jichi.ac.jp					García Fernández Miriam, 2012, J Med Case Rep, V6, P346, DOI 10.1186/1752-1947-6-346; Shukla D, 2005, AM J OPHTHALMOL, V140, P134, DOI 10.1016/j.ajo.2004.12.026; Srinivasan S, 2006, EYE, V20, P1099, DOI 10.1038/sj.eye.6702134	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	DEC	2014	107	12					1045	1046		10.1093/qjmed/hcu102		2	Medicine, General & Internal	General & Internal Medicine	AU8JH	WOS:000345842000019		
J	Kumabe, A; Kenzaka, T				Kumabe, A.; Kenzaka, T.			String test of hypervirulent Klebsiella pneumonia	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Editorial Material									[Kumabe, A.; Kenzaka, T.] Jichi Med Univ Hosp, Div Gen Internal Med, Shimotsuke, Japan	Kumabe, A (reprint author), Jichi Med Univ Hosp, Div Gen Internal Med, Shimotsuke, Japan.	smile.kenzaka@jichi.ac.jp					Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	DEC	2014	107	12					1053	1053		10.1093/qjmed/hcu124		1	Medicine, General & Internal	General & Internal Medicine	AU8JH	WOS:000345842000023		
J	Saito, K				Saito, Kazuyuki			AN OUTER ADMISSIBLE ACTION OF A COMMUTATIVE LOCALLY COMPACT GROUP ON THE GENERIC DYNAMICS FACTOR	QUARTERLY JOURNAL OF MATHEMATICS			English	Article							AW-STAR-ALGEBRAS; C-ASTERISK-ALGEBRAS; COMPLETIONS; PRODUCTS; SYSTEMS	The generic dynamics factor A is a small, monotone complete, hyperfinite wild factor of Type III obtained as a quotient of the Borel *-envelope of the Fermion algebra. In our earlier work with Wright, we constructed infinitely many outer actions of any Polish group equipped with a dense normal subgroup onA. These results are algebraic and in anotherwork with Wright, we constructed an outer admissible action of the additive group R of real numbers and the torus T on A. Let G be any locally compact second countable commutative Hausdorff group. In this paper, we shall show that there exists an appropriate parameterization, for A, that makes it possible to generalize the results of the works above, and to construct an admissible outer action of G on A. When an action alpha of G on A is admissible, we can define the small monotone cross product A x(alpha) G and the dual action (alpha) over cap of (G) over cap in such a way that (A x(alpha) G) x((alpha) over cap) (G) over cap congruent to A (circle times) over bar L(l(2)(G)) congruent to A, the Takesaki's duality principle holds true and this is a new parameterization of the algebra A.		Saito, K (reprint author), 2-7-5 Yoshinari,Aoba Ku, Sendai, Miyagi 9893205, Japan.	yk.saito@beige.plala.or.jp					BERBERIAN SK, 1983, MATH Z, V182, P81, DOI 10.1007/BF01162596; Blattner Robert J., 1958, PAC J MATH, V8, P665; BRATTELI O, 1979, DUKE MATH J, V46, P1, DOI 10.1215/S0012-7094-79-04601-5; Hamana M., 1982, JAPAN J MATH, V8, P259; Nakagami Y., 1977, PUBL RES I MATH SCI, V12, P727; Pedersen GK, 1979, C ALGEBRAS THEIR AUT; PEDERSEN GK, 1984, MATH Z, V187, P23, DOI 10.1007/BF01163162; Saito K, 2000, J MATH ANAL APPL, V248, P41, DOI 10.1006/jmaa.2000.6861; SAITO K, 1984, Q J MATH, V35, P209; Saito K, 1998, Q J MATH, V49, P199; Saito K., 1979, TOHOKU MATH J, V31, P31, DOI 10.2748/tmj/1178229873; Saito K, 1999, Q J MATH, V50, P231, DOI 10.1093/qjmath/50.198.231; Saito K, 2002, Q J MATH, V53, P365, DOI 10.1093/qjmath/53.3.365; SULLIVAN D, 1986, T AM MATH SOC, V295, P795, DOI 10.2307/2000065; Takesaki M., THEORY OPERATOR ALGE; von Neumann J., 1938, COMPOS MATH, V6, P1; WRIGHT JDM, 1976, MATH PROC CAMBRIDGE, V79, P443, DOI 10.1017/S0305004100052439; WRIGHT JDM, 1976, J LOND MATH SOC, V12, P299; WRIGHT JDM, 1988, J LOND MATH SOC, V38, P492	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0033-5606	1464-3847		Q J MATH	Q. J. Math.	DEC	2014	65	4					1417	1436		10.1093/qmath/hau001		20	Mathematics	Mathematics	AU8JK	WOS:000345842300016		
J	Yamada, T; Tanaka, Y; Hasegawa, R; Sakuratani, Y; Yamazoe, Y; Ono, A; Hirose, A; Hayashi, M				Yamada, Takashi; Tanaka, Yushiro; Hasegawa, Ryuichi; Sakuratani, Yuki; Yamazoe, Yasushi; Ono, Atsushi; Hirose, Akihiko; Hayashi, Makoto			Development of a category approach to predict the testicular toxicity of chemical substances structurally related to ethylene glycol methyl ether	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Category approach; Repeated-dose toxicity; Testicular toxicity; Methoxyacetic acid; Adverse outcome pathway	REPEATED-DOSE TOXICITY; ADULT MALE-RAT; MONOMETHYL ETHER; METHOXYACETIC ACID; SPERMATOCYTE APOPTOSIS; 2-METHOXYACETIC ACID; INHALATION TOXICITY; URINARY METABOLITES; DIETHYLENE GLYCOL; ANDROGEN RECEPTOR	We propose a category approach to assessing the testicular toxicity of chemicals with a similar structure to ethylene glycol methyl ether (EGME). Based on toxicity information for EGME and related chemicals and accompanied by adverse outcome pathway information on the testicular toxicity of EGME, this category was defined as chemicals that are metabolized to methoxy- or ethoxyacetic acid, a substance responsible for testicular toxicity. A Japanese chemical inventory was screened using the Hazard Evaluation Support System, which we have developed to support a category approach for predicting the repeated-dose toxicity of chemical substances. Quantitative metabolic information on the related chemicals was then considered, and seventeen chemicals were finally obtained from the inventory as a shortlist for the category. Available data in the literature shows that chemicals for which information is available on the metabolic formation of EGME, ethylene glycol ethyl ether, methoxy- or ethoxyacetic acid do in fact possess testicular toxicity, suggesting that testicular toxicity is a concern, due to metabolic activation, for the remaining chemicals. Our results clearly demonstrate practical utility of AOP-based category approach for predicting repeated-dose toxicity of chemicals. (C) 2014 Elsevier Inc. All rights reserved.	[Yamada, Takashi; Tanaka, Yushiro; Hasegawa, Ryuichi; Sakuratani, Yuki] Natl Inst Technol & Evaluat, Chem Management Ctr, Shibuya Ku, Tokyo 1510066, Japan; [Yamazoe, Yasushi] Food Safety Commiss Japan, Minato Ku, Tokyo 1076122, Japan; [Ono, Atsushi; Hirose, Akihiko] Natl Inst Hlth Sci, Biol Safety Res Ctr, Setagaya Ku, Tokyo 1588501, Japan; [Hayashi, Makoto] Biosafety Res Ctr, Iwata, Shizuoka 4371213, Japan	Yamada, T (reprint author), Natl Inst Technol & Evaluat, Chem Management Ctr, Shibuya Ku, 2-49-10 Nishihara, Tokyo 1510066, Japan.	yamada-takashi@nite.go.jp			New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and industry (METI) for the Development of Hazard Assessment Techniques Using Structure-Activity Relationship Methods	This work was supported by grants provided by the New Energy and Industrial Technology Development Organization (NEDO) (2007-2010) and the Ministry of Economy, Trade and industry (METI) (2011) for the Development of Hazard Assessment Techniques Using Structure-Activity Relationship Methods.	Abe T., 2012, PHARM STAGE, V12, P39; Wu SD, 2010, REGUL TOXICOL PHARM, V56, P67, DOI 10.1016/j.yrtph.2009.09.006; GROESENEKEN D, 1989, INT ARCH OCC ENV HEA, V61, P243, DOI 10.1007/BF00381421; FOSTER PMD, 1987, TOXICOLOGY, V43, P17, DOI 10.1016/0300-483X(87)90071-0; SABOURIN PJ, 1992, FUND APPL TOXICOL, V19, P124, DOI 10.1016/0272-0590(92)90036-H; GHANAYEM BI, 1987, J PHARMACOL EXP THER, V242, P222; MILLER RR, 1984, ENVIRON HEALTH PERSP, V57, P233, DOI 10.2307/3429921; Takei M, 2010, TOXICOL SCI, V118, P643, DOI 10.1093/toxsci/kfq211; GRAY TJB, 1985, TOXICOL APPL PHARM, V79, P490, DOI 10.1016/0041-008X(85)90146-2; CHEEVER KL, 1984, ENVIRON HEALTH PERSP, V57, P241, DOI 10.2307/3429922; KU WW, 1995, TOXICOL APPL PHARM, V134, P100, DOI 10.1006/taap.1995.1173; MILLER RR, 1984, TOXICOL APPL PHARM, V75, P521, DOI 10.1016/0041-008X(84)90188-1; STOTT WT, 1985, FUND APPL TOXICOL, V5, P399, DOI 10.1016/0272-0590(85)90088-0; Rao AVSK, 2002, FEBS LETT, V527, P133, DOI 10.1016/S0014-5793(02)03196-4; Durner J, 2009, BIOMATERIALS, V30, P2066, DOI 10.1016/j.biomaterials.2008.12.061; Johanson G, 2000, CRIT REV TOXICOL, V30, P307, DOI 10.1080/10408440091159220; RICHARDS DE, 1993, ARCH TOXICOL, V67, P531, DOI 10.1007/BF01969265; Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x; Schaafsma G, 2009, REGUL TOXICOL PHARM, V53, P70, DOI 10.1016/j.yrtph.2008.11.003; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; WELCH LS, 1988, AM J IND MED, V14, P509, DOI 10.1002/ajim.4700140503; GESSNER PK, 1961, BIOCHEM J, V79, P482; FOSTER PMD, 1984, ENVIRON HEALTH PERSP, V57, P207, DOI 10.2307/3429918; COOK RR, 1982, ARCH ENVIRON HEALTH, V37, P346; Ball GL, 2012, CRIT REV TOXICOL, V42, P28, DOI 10.3109/10408444.2011.623149; Tirado OM, 2003, BIOL REPROD, V68, P1437, DOI 10.1095/biolreprod.102.004937; van Leeuwen K, 2009, SAR QSAR ENVIRON RES, V20, P207, DOI 10.1080/10629360902949179; Yamazoe Y, 2011, DRUG METAB REV, V43, P409, DOI 10.3109/03602532.2011.624103; Bagchi G, 2009, TOXICOL APPL PHARM, V238, P101, DOI 10.1016/j.taap.2008.03.015; Ball N, 2014, REGUL TOXICOL PHARM, V68, P212, DOI 10.1016/j.yrtph.2013.12.007; Barone Fortunata, 2004, FASEB Journal, V18, P353; Blackburn K, 2011, REGUL TOXICOL PHARM, V60, P120, DOI 10.1016/j.yrtph.2011.03.002; BOATMAN RJ, 1993, J AM COLL TOXICOL, V12, P145; CHEEVER KL, 1989, TOXICOL IND HEALTH, V5, P1099; ECETOC, 2012, 116 ECETOC QSAR; Environmental Protection Agency (EPA), 2007, 110714 EPA CAS; European Chemicals Agency (ECHA), 2013, CAND LIST SUBST VER; Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914; FOSTER PMD, 1983, TOXICOL APPL PHARM, V69, P385, DOI 10.1016/0041-008X(83)90262-4; GUT I, 1988, ARCH TOXICOL, V62, P346, DOI 10.1007/BF00293621; Hayashi M., 2011, NEW HORIZONS TOXICIT, P26; HUTSON D H, 1971, Xenobiotica, V1, P105; Jansen MS, 2004, P NATL ACAD SCI USA, V101, P7199, DOI 10.1073/pnas.0402014101; Johnson W, 2002, INT J TOXICOL, V21, P9, DOI 10.1080/10915810290096388; KATZ GV, 1984, ENVIRON HEALTH PERSP, V57, P165, DOI 10.2307/3429913; Henley DV, 2006, ENDOCRINOLOGY, V147, pS25, DOI 10.1210/en.2005-1117; Ladriere L, 1999, METABOLISM, V48, P102, DOI 10.1016/S0026-0495(99)90017-3; LENK W, 1989, XENOBIOTICA, V19, P961; Li LH, 1996, J ANDROL, V17, P538; LINHART I, 1994, CHEM RES TOXICOL, V7, P1, DOI 10.1021/tx00037a001; LINHART I, 1994, XENOBIOTICA, V24, P1043; MILLER RR, 1983, FUND APPL TOXICOL, V3, P49, DOI 10.1016/S0272-0590(83)80172-9; Ministry of Health Labor and Welfare (MHLW), 2002, 28 DAY REP DOS OR TO; Ministry of Health Labor and Welfare (MHLW), 1998, COMB REP DOS REPR DE; Ministry of Health Labor and Welfare (MHLW), 2001, COMB REP DOS REPR DE; MOSS EJ, 1985, TOXICOL APPL PHARM, V79, P480, DOI 10.1016/0041-008X(85)90145-0; NAGANO K, 1984, ENVIRON HEALTH PERSP, V57, P75, DOI 10.2307/3429901; National Institute for Occupational Safety and Health (NIOSH), 1991, CRIT REC STAND OCC E; National Institute of Technology and Evaluation (NITE), 2007, 88 NITE; National Toxicology Program (NTP), 1993, NTP TOX REP SER, V26; OECD, 2014, OECD SER TEST ASS, V194; Poon R, 2005, TOXICOLOGY, V214, P99, DOI 10.1016/j.tox.2005.06.024; RITTER EJ, 1985, TERATOLOGY, V32, P25, DOI 10.1002/tera.1420320105; Sakuratani Y, 2013, SAR QSAR ENVIRON RES, V24, P617, DOI 10.1080/1062936X.2013.773375; Schultz T.W., 2010, SILICO TOXICOLOGY PR, P351; SILVER EH, 1978, TOXICOL APPL PHARM, V45, P377, DOI 10.1016/0041-008X(78)90102-3; SUMNER SJ, 1995, TOXICOL APPL PHARM, V134, P139, DOI 10.1006/taap.1995.1177; TAKAHASHI T, 1981, TOXICOLOGY, V22, P223, DOI 10.1016/0300-483X(81)90085-8; Wade MG, 2006, TOXICOL SCI, V89, P304, DOI 10.1093/toxsci/kfj002; Yamada T, 2012, J TOXICOL SCI, V37, P503; Yamada T, 2013, REGUL TOXICOL PHARM, V65, P189, DOI 10.1016/j.yrtph.2012.12.001; Yamamoto Toshinori, 2007, Journal of Toxicological Sciences, V32, P515, DOI 10.2131/jts.32.515; Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682	73	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	DEC	2014	70	3					711	719		10.1016/j.yrtph.2014.10.011		9	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	AU7ZO	WOS:000345816900016		
J	Rosenqvist, A; Lucas, R; Shimada, M				Rosenqvist, Ake; Lucas, Richard; Shimada, Masanobu			Preface: Science results from the ALOS Kyoto & Carbon Initiative	REMOTE SENSING OF ENVIRONMENT			English	Editorial Material									[Rosenqvist, Ake] Solo Earth Observat soloEO, Tokyo, Japan; [Lucas, Richard] Univ New S Wales, Sydney, NSW 2052, Australia; [Shimada, Masanobu] Japan Aerosp Explorat Agcy JAXA, Tokyo, Japan	Rosenqvist, A (reprint author), Solo Earth Observat soloEO, Tokyo, Japan.	ake.rosenqvist@soloEO.com						0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	DEC	2014	155				SI		2	2		10.1016/j.rse.2014.05.008		1	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	AU7TQ	WOS:000345804200002		
J	Rosenqvist, A; Shimada, M; Suzuki, S; Ohgushi, F; Tadono, T; Watanabe, M; Tsuzuku, K; Watanabe, T; Kamijo, S; Aoki, E				Rosenqvist, A.; Shimada, M.; Suzuki, S.; Ohgushi, F.; Tadono, T.; Watanabe, M.; Tsuzuku, K.; Watanabe, T.; Kamijo, S.; Aoki, E.			Operational performance of the ALOS global systematic acquisition strategy and observation plans for ALOS-2 PALSAR-2	REMOTE SENSING OF ENVIRONMENT			English	Article						ALOS; ALOS-2; PALSAR; PALSAR-2; BOS; L-band SAR; Systematic acquisition strategy; EO mission planning	PROJECT; BIOMASS	With the launch of the Advanced Land Observing Satellite (ALOS) in 2006, the Japanese Space Agency (JAXA) took the initiative to implement the first global-scale systematic acquisition strategy for satellite sensors at fine and medium (2.5-20 m) spatial resolution. Comprising all three sensors on ALOS (PALSAR, PRISM, AVNIR-2), the plan was designed to serve all ALOS user categories and aimed at producing spatially and temporally consistent baseline coverages over the planet on a repetitive basis, to accommodate systematic global-scale, fine-resolution, monitoring of the environment. Unlike the common background missions defined for most fine-resolution Earth Observation satellites, the observation strategy was implemented as a top-level foreground mission with a priority second only to that of special observation requests and emergency observations and sensor calibration. While the ALOS mission regrettably ended in April 2011, the global acquisition strategy nevertheless produced a comprehensive and homogeneous global archive in which consistent time-series of data are available for any arbitrary land area on Earth (excluding Antarctica >77.5 degrees South latitude, which could not be reached by the sensors). Clouds and haze inevitably constituted limitations for the optical sensors, while for the PALSAR instrument, two cloud-free and near-gap free (similar to 95%) global coverages were achieved annually during the 4.5 years in operations. Previously, such uniform data archives existed only for coarse-resolution sensors such as AVHRR, MERIS and MODIS. The ALOS BOS supported a variety applications from local to global scales, ranging from structural deformation, monitoring of wetlands regional inundation patterns and mapping of forest extent and changes over nations and continents at spatial resolutions as fine as 10 m. The Advanced Land Observing Satellite 2 (ALOS-2) was launched on May 24, 2014. Equipped with an enhanced L-band SAR sensor (PALSAR-2), ALOS-2 resumes the global wall-to-wall acquisitions to assure continuity and consistency with JAXA's global mission objectives and unique L-band SAR archive created by ALOS PALSAR. (C) 2014 Elsevier Inc. All rights reserved.	[Rosenqvist, A.] soloEO Japan, Chuo Ku, Tokyo 1040054, Japan; [Shimada, M.; Suzuki, S.; Ohgushi, F.; Tadono, T.; Watanabe, M.] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki 3058505, Japan; [Tsuzuku, K.; Watanabe, T.; Kamijo, S.; Aoki, E.] RESTEC, Tsukuba, Ibaraki 3058505, Japan	Rosenqvist, A (reprint author), soloEO Japan, Chuo Ku, TIT Mid Tower 5006,Kachidoki 6-3-2, Tokyo 1040054, Japan.	ake.rosenqvist@soloEO.com; shimada.masanobu@jaxa.jp; suzuki.shinichi@jaxa.jp; ohgushi.fumi@jaxa.jp; tadono.takeo@jaxa.jp; watanabe.manabu@jaxa.jp; tsuzuku_kaoru@restec.or.jp; tomozo@restec.or.jp; kmj@restec.or.jp; aoki_emi@restec.or.jp					Rosenqvist A, 2000, INT J REMOTE SENS, V21, P1375, DOI 10.1080/014311600210227; Shimada M, 2010, IEEE J-STARS, V3, P637, DOI 10.1109/JSTARS.2010.2077619; Hawes JE, 2012, FOREST ECOL MANAG, V281, P163, DOI 10.1016/j.foreco.2012.06.023; Evans TL, 2010, IEEE J-STARS, V3, P560, DOI 10.1109/JSTARS.2010.2089042; Paillou P, 2010, IEEE J-STARS, V3, P632, DOI 10.1109/JSTARS.2010.2056915; CEOS SDCG, 2013, BAS GLOB ACQ STRAT G; Chapman B., 2013, 20 K C SCI TEAM M TO; Crevier Y., 2014, 5 CEOS SPAC DAT COOR; Evans TL, 2014, REMOTE SENS ENVIRON, V155, P89, DOI 10.1016/j.rse.2013.08.051; Fosnight E. A., 2011, 25 PECORA18 S HERND; Frulla L., 2013, 3 CEOS SPAC DAT COOR; Hoekman DH, 2010, IEEE J-STARS, V3, P605, DOI 10.1109/JSTARS.2010.2070059; Holecz F., 2014, ALOS K C INITIATIVE; JAXA EORC, 2014, ALOS 2 BAS OBS SCEN; Kankaku Y., 2013, IGARSS 2013, P2396; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Lucas RM, 2014, REMOTE SENS ENVIRON, V155, P42, DOI 10.1016/j.rse.2013.11.025; Lucas R. M., 2014, MARINE FRES IN PRESS; Mesquita Jr H., 2011, SCI TEAM REPORTS PHA; Mitchell A. L., 2014, WETLANDS EC IN PRESS; Mitchell A. L., 2011, 34 INT S REM SENS EN; Okada Y., 2013, IGARSS 2013, P2408; Quinones, 2011, SURINAME VEGETATION; Rebelo LM, 2012, EARTH INTERACT, V16, DOI 10.1175/2011EI382.1; Rosenqvist A, 2003, IEEE T GEOSCI REMOTE, V41, P1709, DOI 10.1109/TGRS.2003.813358; Rosenqvist A., 2001, INT GEOSCIENCE REMOT; Rosenqvist A, 2004, INT GEOSCI REMOTE SE, P1033; Rosenqvist A., 2004, INT GEOSCIENCE REMOT; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Santoro M, 2012, REMOTE SENS-BASEL, V4, P1693, DOI 10.3390/rs4061693; Schmuck S., 2013, 4 LIV PLAN S ED SCOT; Shimada M, 2014, REMOTE SENS ENVIRON, V155, P13, DOI 10.1016/j.rse.2014.04.014; Shimada M., 2013, PALSAR 2 POLARIMETRI, P2309; Suzuki S., 2013, IGARSS 2013, P2412; Tadono T., 2014, INFORM SCI IN PRESS; Thiel CJ, 2009, IEEE T GEOSCI REMOTE, V47, P3993, DOI 10.1109/TGRS.2009.2021469; Torbick N., 2011, CANADIAN J REMOTE SE, V37, P1; Torbick N., 2014, WETLANDS EC IN PRESS; Walker WS, 2010, IEEE J-STARS, V3, P594, DOI 10.1109/JSTARS.2010.2076398	39	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	DEC	2014	155				SI		3	12		10.1016/j.rse.2014.04.011		10	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	AU7TQ	WOS:000345804200003		
J	Shimada, M; Itoh, T; Motooka, T; Watanabe, M; Shiraishi, T; Thapa, R; Lucas, R				Shimada, Masanobu; Itoh, Takuya; Motooka, Takeshi; Watanabe, Manabu; Shiraishi, Tomohiro; Thapa, Rajesh; Lucas, Richard			New global forest/non-forest maps from ALOS PALSAR data (2007-2010)	REMOTE SENSING OF ENVIRONMENT			English	Article						Forest and non-forest; PALSAR; ALOS; Radar backscatter; Global SAR mosaic; ALOS-2; L-band SAR; Segmentation; Classification	JERS-1 SAR; CARBON STOCKS; AVHRR DATA; COVER; AMAZON; CLASSIFICATION; BACKSCATTER; MOSAICS; MODIS	Four global mosaics of Advanced Land Observing Satellite (ALOS) Phased Arrayed L-band Synthetic Aperture Radar (SAR) HH and HV polarization data were generated at 25 m spatial resolution using data acquired annually from 2007 to 2010. Variability in L-band HH and HV gamma-naught (gamma(0)) for forests was observed between regions, with this attributed to differences in forest structure and vegetation/surface moisture conditions. Region-specific backscatter thresholds were therefore applied to produce from each annual mosaic, a global map of forest and non-forest cover from which maps of forest losses and gain were generated. The overall agreement with forest/non-forest assessments using the Degree Confluence Project, the Forest Resource Assessment and Google Earth images was 85%, 91% and 95% respectively. Using 2007 as a baseline, decreases of 0.040 and 0.028 dB (with a 0.006 dB 99% confidence level) were observed in the HH and HV gamma(0) respectively over the same areas suggesting a decrease in forest area and/or increased smoothing of the global surface at the L-band radar observation over the four-year period. The maps provide a new global resource for documenting the changing extent of forests and offer opportunities for quantifying historical and future dynamics through comparison with historical (1992-1998) Japanese Earth Resources Satellite (JERS-1) SAR and the forthcoming (from 2014) ALOS-2 PALSAR-2 data. Four year PALSAR mosaics and the forest/non-forest data, which were generated and analyzed in this paper, are opened to the public for free downloading albeit with coarser resolutions (WWW1). Future distribution of the higher (original) resolution datasets from PALSAR as well as the ALOS-2/PALSAR-2 is planned. (C) 2014 Elsevier Inc. All rights reserved.	[Shimada, Masanobu; Motooka, Takeshi; Watanabe, Manabu; Shiraishi, Tomohiro; Thapa, Rajesh] Japan Aerosp Explorat Agcy, Earth Observat Res Ctr, Tsukuba, Ibaraki 3058505, Japan; [Itoh, Takuya] Remote Sensing Technol Ctr Japan RESTEC, Tsukuba Off, Tsukuba, Ibaraki 3058505, Japan; [Lucas, Richard] Univ New S Wales, Sydney, NSW 2052, Australia	Shimada, M (reprint author), Japan Aerosp Explorat Agcy, Earth Observat Res Ctr, Sengen 2-1-1, Tsukuba, Ibaraki 3058505, Japan.			Thapa, Rajesh Bahadur/0000-0003-4467-0148			Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Rosenqvist A, 2000, INT J REMOTE SENS, V21, P1375, DOI 10.1080/014311600210227; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Shimada M, 2010, IEEE J-STARS, V3, P637, DOI 10.1109/JSTARS.2010.2077619; Englhart S, 2011, REMOTE SENS ENVIRON, V115, P1260, DOI 10.1016/j.rse.2011.01.008; Shimada M, 2009, IEEE T GEOSCI REMOTE, V47, P3915, DOI 10.1109/TGRS.2009.2023909; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P3784, DOI 10.1016/j.rse.2008.05.012; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Shimada M, 2010, P IEEE, V98, P780, DOI 10.1109/JPROC.2009.2033724; Shimada M, 2010, IEEE J-STARS, V3, P657, DOI 10.1109/JSTARS.2010.2072984; Small D, 2011, IEEE T GEOSCI REMOTE, V49, P3081, DOI 10.1109/TGRS.2011.2120616; Longepe N, 2011, IEEE T GEOSCI REMOTE, V49, P2135, DOI 10.1109/TGRS.2010.2102041; Shimada M, 2005, CAN J REMOTE SENS, V31, P132; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; ARINO O, 2007, P INT GEOSC REM SENS, P2412; Bryant D., 1997, LAST FRONTIER FOREST, P1; Christine J. T., 2007, J MT SCI, V4, P275; Cloude SR, 2003, IEE P-RADAR SON NAV, V150, P125, DOI 10.1049/ip-rsn:20030449; dos Santos R. J., 2007, P INT GEOS REM SENS, P2342; Eva HD, 2004, GLOBAL CHANGE BIOL, V10, P1; Food and Agricultural Organization, 2012, FOR RES ASS FRA 2010; Food and Agricultural Organization, 2000, FOR RES ASS FRA 2000; Food and Agriculture Department of UN Forestry Department, 2010, GLOB FOR ASS 2010 CO; Food and Agriculture Organization (FAO) of the United Nations (UN), 2012, GLOB FOR LAND US CHA, V169; Giri C., 2010, GLOBAL ECOL BIOGEOGR, V20, P154, DOI DOI 10.1111/J.1466-8238.2010.00584.X; Hansen MC, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034001; Hansen M. C., 2003, EARTH INTERACT, V7, P1, DOI DOI 10.1175/1087-3562; Hansen MC, 2004, ECOSYSTEMS, V7, P695, DOI 10.1007/s10021-004-0243-3; Hawkins R., 2000, P CEOS SAR WORKSH 20, V450; Hoekman DH, 2000, IEEE T GEOSCI REMOTE, V38, P685, DOI 10.1109/36.841998; Iwao K, 2006, GEOPHYS RES LETT, V33, DOI [10.1029/2006GL027768, 10.1029/2006GL027768,]; Lefsky MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043622; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Luckman A, 1998, REMOTE SENS ENVIRON, V63, P126, DOI 10.1016/S0034-4257(97)00133-8; Lukowski T. I., 2003, P IGARSS, P1382; Motohka T., 2014, REMOTE SENS ENVIRON, V155, P80; Natural Resources Canada, 2012, STAT CAN FOR ANN REP; Rakwatin P., 2012, INT J REMOTE SENSING, V33; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Shi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020778; Shimabukuro Y, 2013, GLOBAL FOREST MONITO, P167; Shimada M, 2002, INT J REMOTE SENS, V23, P1507, DOI 10.1080/01431160110092678; Shimada M., 2011, SYDN P ISRSE; SHIMADA M, 1995, IEEE T GEOSCI REMOTE, V33, P100, DOI 10.1109/36.368217; Shimada M., 2010, J GEOD SOC JPN, V56, P13; Shiraishi T., 1979, IEEE J SELE IN PRESS; Solomon S., 2007, CONTRIBUTION WORKING; Spalding M., 2010, WORLD ATLAS MANGROVE; Thapa R. B., 2014, REMOTE SENS ENVIRON, V155, P33; Watanabe M, 2006, IEEE T GEOSCI REMOTE, V44, P3154, DOI 10.1109/TGRS.2006.880632; Way J., 1992, IEEE T GEOSCIENCE RE, V29; World Wildlife Fund (WWF), 2007, RUSS BOR FOR; Zink M., 2002, ANTENNA ELEVATION PA	58	16	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	DEC	2014	155				SI		13	31		10.1016/j.rse.2014.04.014		19	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	AU7TQ	WOS:000345804200004		
J	Thapa, RB; Itoh, T; Shimada, M; Watanabe, M; Takeshi, M; Shiraishi, T				Thapa, Rajesh Bahadur; Itoh, Takuya; Shimada, Masanobu; Watanabe, Manabu; Takeshi, Motohka; Shiraishi, Tomohiro			Evaluation of ALOS PALSAR sensitivity for characterizing natural forest cover in wider tropical areas	REMOTE SENSING OF ENVIRONMENT			English	Article						Image segmentation; L-band radar; SAR; LULUCF; Tropical forest; Sumatra	OBJECT-BASED METHOD; CLASSIFICATION ACCURACY; DEFORESTATION; DATASETS	The transformation of natural forest to non-forest cover is a dominant phenomenon in tropical regions; this creates unprecedented pressure to climate, biodiversity, and ecosystem services. Owing to persistent clouds and other atmospheric effects in the region, forest managers are facing difficulties in mapping and monitoring the forest cover changes consistently. This article presents an automated mapping method and examines the potentials of ALOS PALSAR data for characterizing natural forest cover in the tropics. Several scenes of high-resolution PALSAR data with HH and HV polarizations were processed to cover Sumatra Island. The mapping method applied image segmentation and threshold techniques to discriminate land covers. Non-forest land covers were separated using HH backscatter thresholds, while forest cover was based on HV thresholds. Twenty-two thematic maps derived at different HV backscatter thresholds were evaluated by comparing the land cover classes of the reference data. Sampling theory was used to determine the required sample size and geographic locations of the reference data. Among the resulting maps, a map with a threshold of 115 dB HV backscatter was found to be more sensitive for portraying the spatial patterns of land covers in the study area. The overall mapping accuracy at this threshold was 79.34%. Regardless of the data size, this automated mapping approach yielded decent spatial patterns of land covers and proved to be applicable for high-resolution wall-to-wall mapping and monitoring of natural forest cover in wider tropical areas. (C) 2014 Elsevier Inc. All rights reserved.	[Thapa, Rajesh Bahadur; Shimada, Masanobu; Watanabe, Manabu; Takeshi, Motohka; Shiraishi, Tomohiro] Japan Aerosp Explorat Agcy JAXA, Earth Observat Res Ctr, Tsukuba, Ibaraki 3058505, Japan; [Itoh, Takuya] Remote Sensing Technol Ctr Japan, Tsukuba, Ibaraki 3050032, Japan	Thapa, RB (reprint author), Japan Aerosp Explorat Agcy JAXA, Earth Observat Res Ctr, 2-1-1 Sengen, Tsukuba, Ibaraki 3058505, Japan.	rajesh.thapa@jaxa.jp		Thapa, Rajesh Bahadur/0000-0003-4467-0148			Achard F, 2010, CARBON MANAG, V1, P271, DOI 10.4155/CMT.10.30; Aguirre-Gutierrez J, 2012, APPL GEOGR, V34, P29, DOI 10.1016/j.apgeog.2011.10.010; Whittle M, 2012, REMOTE SENS ENVIRON, V124, P83, DOI 10.1016/j.rse.2012.04.027; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; Foody GM, 2009, INT J REMOTE SENS, V30, P5273, DOI 10.1080/01431160903130937; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Shimada M, 2010, IEEE J-STARS, V3, P637, DOI 10.1109/JSTARS.2010.2077619; Shimada M, 2009, IEEE T GEOSCI REMOTE, V47, P3915, DOI 10.1109/TGRS.2009.2023909; Conchedda G, 2008, ISPRS J PHOTOGRAMM, V63, P578, DOI 10.1016/j.isprsjprs.2008.04.002; Shimada M, 2010, IEEE J-STARS, V3, P657, DOI 10.1109/JSTARS.2010.2072984; Laumonier Y, 2010, BIODIVERS CONSERV, V19, P1153, DOI 10.1007/s10531-010-9784-2; Stehman SV, 2011, REMOTE SENS ENVIRON, V115, P3044, DOI 10.1016/j.rse.2011.06.007; Longepe N, 2011, IEEE T GEOSCI REMOTE, V49, P2135, DOI 10.1109/TGRS.2010.2102041; Desclee B, 2006, REMOTE SENS ENVIRON, V102, P1, DOI 10.1016/j.rse.2006.01.013; Pekkarinen A, 2009, ISPRS J PHOTOGRAMM, V64, P171, DOI 10.1016/j.isprsjprs.2008.09.004; Angelsen A, 2008, INT FOREST REV, V10, P465, DOI 10.1505/ifor.10.3.465; Avitabile Valerio, 2011, Carbon Balance Manag, V6, P7, DOI 10.1186/1750-0680-6-7; BPS, 2010, HAS SENS PNDUD 2010; Congalton R. G., 2008, ASSESSING ACCURACY R; GOFC-GOLD, 2010, COP161 GOFC GOLD; Hoekman DH, 2010, IEEE J-STARS, V3, P605, DOI 10.1109/JSTARS.2010.2070059; King RB, 2002, INT J REMOTE SENS, V23, P3525, DOI 10.1080/01431160110109606; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Metz B, 2007, CONTRIBUTION WORKING; MoFor, 2008, IFCA CONS REP RED EM; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Rum G., 2009, 15 C PART COP 15 UN; Shimada M, 2011, IEEE T GEOSCI REMOTE, V49, P1712, DOI 10.1109/TGRS.2010.2090046; Sophie B., 2010, GLOBCOVER 2009 PRODU; Thapa R. B., 2007, GEOJOURNAL, V70, P161, DOI 10.1007/s10708-008-9122-3; Thapa RB, 2011, GEOJOURNAL LIB, V100, P135, DOI 10.1007/978-94-007-0671-2_9; Trimble, 2012, REF BOOK EC DEV 8 7; Uryu Y., 2010, WWF INDONESIA TECHNI; Walker WS, 2010, IEEE J-STARS, V3, P594, DOI 10.1109/JSTARS.2010.2076398	34	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	DEC	2014	155				SI		32	41		10.1016/j.rse.2013.04.025		10	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	AU7TQ	WOS:000345804200005		
J	Motohka, T; Shimada, M; Uryu, Y; Setiabudi, B				Motohka, Takeshi; Shimada, Masanobu; Uryu, Yumiko; Setiabudi, Budi			Using time series PALSAR gamma nought mosaics for automatic detection of tropical deforestation: A test study in Riau, Indonesia	REMOTE SENSING OF ENVIRONMENT			English	Article						ALOS PALSAR; Gamma nought; Indonesia; REDD; Deforestation; Automatic change detection	FOREST COVER LOSS; ALOS-PALSAR; SAR DATA; CARBON EMISSIONS; JERS-1 SAR; BACKSCATTER; BIOMASS; VEGETATION; RONDONIA; MISSION	This study intended to demonstrate the effectiveness of phased array type L-band synthetic aperture radar (PALSAR) time series mosaics for automatic detection of tropical deforestation in Riau province, Indonesia. Using six time series PALSAR mosaics, the characteristics of HH and HV gamma nought (gamma(0)) in natural forests and deforested areas from 2007 to 2010 and the accuracy of deforestation detection by using a threshold were investigated. We obtained the following results: (1) Applying a simple thresholding method to time series differences of gamma(0)(HV) was effective for fully automatic detection of deforestation areas. When we used a fixed threshold, the accuracy ranged from 72% to 96% (average of 87%). (2) gamma(0)(HH) did not always show systematic changes after deforestation. (3) The temporal variation of gamma(0) for deforested areas was larger than that for natural forests. These variations in gamma(0) were correlated with 10-day accumulated precipitation. High accumulated precipitation decreased the gamma(0) difference between deforested areas and natural forests, causing decreased accuracy of deforestation detection. (4) Integration of the results from two different dates in a given year can reduce the detection error due to time variations and provide highly accurate results (average accuracy of 91%, minimum of 82%). The accuracy values quoted except hilly areas, shadow, and lay-over. The proposed method is effective for detection of deforestation larger than 1 ha. The deforestation mapping method proposed in the study can be utilized for assessment of yearly changes in forested areas and is useful for tracking changes in forest cover on large scales. (C) 2014 Elsevier Inc All rights reserved.	[Motohka, Takeshi; Shimada, Masanobu] Japan Aerosp Explorat Agcy, EORC, Tsukuba, Ibaraki 3058505, Japan; [Uryu, Yumiko] World Wildlife Fund, Washington, DC 20037 USA; [Setiabudi, Budi] Southeast Asian Reg Ctr Trop Biol SEAMEO BIOTROP, Bogor 16000, Indonesia	Motohka, T (reprint author), 2-1-1 Sengen, Tsukuba, Ibaraki 3058505, Japan.	motooka.takeshi@jaxa.jp; shimada.masanobu@jaxa.jp; yumuryu@yahoo.com; setiabudi@biotrop.org					Anderson LO, 2005, IEEE GEOSCI REMOTE S, V2, P315, DOI 10.1109/LGRS.2005.850364; Whittle M, 2012, REMOTE SENS ENVIRON, V124, P83, DOI 10.1016/j.rse.2012.04.027; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; LETOAN T, 1992, IEEE T GEOSCI REMOTE, V30, P403, DOI 10.1109/36.134089; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Shimada M, 2010, IEEE J-STARS, V3, P637, DOI 10.1109/JSTARS.2010.2077619; Duveiller G, 2008, REMOTE SENS ENVIRON, V112, P1969, DOI 10.1016/j.rse.2007.07.026; Englhart S, 2011, REMOTE SENS ENVIRON, V115, P1260, DOI 10.1016/j.rse.2011.01.008; Shimada M, 2009, IEEE T GEOSCI REMOTE, V47, P3915, DOI 10.1109/TGRS.2009.2023909; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Shimada M, 2010, IEEE J-STARS, V3, P657, DOI 10.1109/JSTARS.2010.2072984; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Kummerow C, 2000, J APPL METEOROL, V39, P1965, DOI 10.1175/1520-0450(2001)040<1965:TSOTTR>2.0.CO;2; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Sandberg G, 2011, REMOTE SENS ENVIRON, V115, P2874, DOI 10.1016/j.rse.2010.03.018; Carreiras JMB, 2012, REMOTE SENS ENVIRON, V121, P426, DOI 10.1016/j.rse.2012.02.012; [Anonymous], 2010, GLOB FOR RES ASS 201; Broich M, 2011, INT J APPL EARTH OBS, V13, P277, DOI 10.1016/j.jag.2010.11.004; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Forest Watch Indonesia/Global Forest Watch, 2002, STAT FOR IND; Gaveau D. L A., 2006, WILDLIFE CONSERVATIO, V4, P1; GOFC-GOLD, 2011, SOURC METH PROC MON; Hansen MC, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034001; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Mitchard E. T. A., 2009, GEOPHYS RES LETT, V36, P1; Momose K., 2002, SE ASIAN STUDIES, V40, P74; Rignot E, 1997, REMOTE SENS ENVIRON, V59, P167, DOI 10.1016/S0034-4257(96)00150-2; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Salas WA, 2002, INT J REMOTE SENS, V23, P1357, DOI 10.1080/01431160110092939; Santoro M, 2010, IEEE J-STARS, V3, P618, DOI 10.1109/JSTARS.2010.2048201; Shimada M, 1999, ADV SPACE RES, V23, P1477, DOI 10.1016/S0273-1177(99)00301-4; Takeuchi S, 2000, ADV SPACE RES, V26, P1151, DOI 10.1016/S0273-1177(99)01134-5; Uryu Y., 2008, DEFORESTATION FOREST; Uryu Y., 2010, SUMATRAS FOREST THEI; Wahyunto S., 2003, PETA LUAS SEBARAN LA; Walker WS, 2010, IEEE J-STARS, V3, P594, DOI 10.1109/JSTARS.2010.2076398; Watanabe M, 2006, IEEE T GEOSCI REMOTE, V44, P3154, DOI 10.1109/TGRS.2006.880632	42	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	DEC	2014	155				SI		79	88		10.1016/j.rse.2014.04.012		10	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	AU7TQ	WOS:000345804200009		
J	Susaki, J; Kajimoto, M; Kishimoto, M				Susaki, Junichi; Kajimoto, Muneyoshi; Kishimoto, Masaaki			Urban density mapping of global megacities from polarimetric SAR images	REMOTE SENSING OF ENVIRONMENT			English	Article						Urban density; Megacities; Polarimetric synthetic aperture radar; Polarization orientation angle	PERMANENT SCATTERERS; INSAR DATA; SUBSIDENCE; LANDSAT; AREAS; INTERFEROMETRY; DECOMPOSITION; MODEL; CITY	We propose an algorithm for estimating urban density from polarimetric synthetic aperture radar (SAR) images, and compare the urban density patterns of global megacities. SAR images are uniquely able to detect structural information of objects, but they are very sensitive to orientation angle. This issue has been an obstacle to applying SAR images to urban areas. Kajimoto and Susaki (2013b) proposed an algorithm to handle this issue. The effects of polarization orientation angle (POA) are removed by rotating the coherency matrix and then calculating the mean and standard deviation of scattering power by POA domain. The algorithm can estimate urban density from a single fully polarimetric SAR image but has the drawback that the generated urban density maps of multiple images are not comparable with each other because the algorithm generates a relative urban density valid only within the analyzed image. We therefore extend the method by calculating POA-domain statistics from all images of interest so that the generated maps can be compared. Estimated urban densities are assessed on two types of urban density generated from GIS data, building-to-land ratio and floor-area ratio. We demonstrate that the extended method can estimate urban density with reasonable accuracy. Finally, we generate two scattergrams of indices derived from urban density maps of global megacities. An analysis using the scattergrams indicates insightful information about the patterns of urban development. We conclude that the proposed algorithm and the analysis using the obtained results are beneficial to understanding the conditions in megacities. (C) 2014 Elsevier Inc. All rights reserved.	[Susaki, Junichi] Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Kyoto, Japan; [Kajimoto, Muneyoshi] NTT DOCOMO INC, Tokyo, Japan; [Kishimoto, Masaaki] Kyoto Univ, Fac Engn, Dept Global Engn, Kyoto, Japan	Susaki, J (reprint author), C1-1-206 Kyotodaigakukatsura,Nishikyo Ku, Kyoto 6158540, Japan.	susaki.junichi.3r@kyoto-u.a.jp			KAKENHI [22760393]; Japanese Aerospace Exploration Agency	This research was supported by a Grant-in-Aid for Scientific Research (KAKENHI) for Young Scientists (B) (No. 22760393), and by a program of the Fourth Advanced Land Observing Satellite-2 Research Announcement, Japanese Aerospace Exploration Agency. Zmap-Town II (ZENRIN) was provided by the Center for Spatial Information Science, The University of Tokyo.	Yamaguchi Y, 2005, IEEE T GEOSCI REMOTE, V43, P1699, DOI 10.1109/TGRS.2005.852084; Ferretti A, 2011, IEEE T GEOSCI REMOTE, V49, P3460, DOI 10.1109/TGRS.2011.2124465; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Stramondo S, 2008, REMOTE SENS ENVIRON, V112, P3160, DOI 10.1016/j.rse.2008.03.008; Chaussard E, 2014, REMOTE SENS ENVIRON, V140, P94, DOI 10.1016/j.rse.2013.08.038; Ferretti A, 2001, IEEE T GEOSCI REMOTE, V39, P8, DOI 10.1109/36.898661; Schneider A, 2012, REMOTE SENS ENVIRON, V124, P689, DOI 10.1016/j.rse.2012.06.006; Thiele A, 2007, IEEE T GEOSCI REMOTE, V45, P3583, DOI 10.1109/TGRS.2007.898440; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Zhu Z, 2012, REMOTE SENS ENVIRON, V117, P72, DOI 10.1016/j.rse.2011.07.020; Ferretti A, 2000, IEEE T GEOSCI REMOTE, V38, P2202, DOI 10.1109/36.868878; Elvidge CD, 1999, REMOTE SENS ENVIRON, V68, P77, DOI 10.1016/S0034-4257(98)00098-4; Kajimoto M, 2013, IEEE GEOSCI REMOTE S, V10, P337, DOI 10.1109/LGRS.2012.2207085; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Sutton PC, 2003, REMOTE SENS ENVIRON, V86, P353, DOI 10.1016/S0034-4257(03)00078-6; Bagan H, 2012, REMOTE SENS ENVIRON, V127, P210, DOI 10.1016/j.rse.2012.09.011; Niu X, 2012, IEEE J-STARS, V5, P1129, DOI 10.1109/JSTARS.2012.2201448; Freeman A., 1998, IEEE T GEOSCI REMOTE, V36, P936, DOI DOI 10.1109/36.673687; Iwasa S., 2011, P JOINT URB REM SENS, P269; JAXA, 2006, AB ALOS PALSAR; Kajimoto M, 2013, IEEE J-STARS, V6, P1418, DOI 10.1109/JSTARS.2013.2255584; Kimura H, 2008, IEEE GEOSCI REMOTE S, V5, P217, DOI 10.1109/LGRS.2008.915737; Lee JS, 2009, IEEE T GEOSCI REMOTE, V47, P202, DOI 10.1109/TGRS.2008.2002881; Margarit G, 2010, IEEE T GEOSCI REMOTE, V48, P2038, DOI 10.1109/TGRS.2009.2035052; Perissin D., 2012, IEEE J SEL TOP QUANT, V4, P92; Shabou A, 2012, IEEE T GEOSCI REMOTE, V50, P4748, DOI 10.1109/TGRS.2012.2191155; Shimada M, 2007, INT GEOSCI REMOTE SE, P3593, DOI 10.1109/IGARSS.2007.4423622; Statistics Bureau Japan, 2011, POP CENS; Tanaka K, 2011, LAND I JAPAN 2011 FO, P1; Yamaguchi Y, 2006, IEEE GEOSCI REMOTE S, V3, P292, DOI 10.1109/LGRS.2006.869986; Yamaguchi Y, 2011, IEEE T GEOSCI REMOTE, V49, P2251, DOI 10.1109/TGRS.2010.2099124; Zenrin Co. Ltd, 2014, ZMAP TOWN H	32	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	DEC	2014	155				SI		334	348		10.1016/j.rse.2014.09.006		15	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	AU7TQ	WOS:000345804200028		
J	Ueda, M				Ueda, Masahito			Topological aspects in spinor Bose-Einstein condensates	REPORTS ON PROGRESS IN PHYSICS			English	Review						topological excitation; Bose-Einstein condensate; homotopy theory	SUPERFLUID HE-3; POINT SINGULARITIES; LIQUID-CRYSTALS; MATTER PHYSICS; DEFECTS; VORTICES; SYMMETRY; VORTEX; GASES; CLASSIFICATION	This article overviews topological excitations in spinor Bose-Einstein condensates of dilute atomic gases. Various types of line defects, point defects and skyrmions are discussed. A brief review of homotopy theory is presented for use in the classification of possible topological excitations in individual quantum phases. Some recent experiments are also reviewed.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Ueda, M (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ueda@phys.s.u-tokyo.ac.jp	Ueda, Masahito/G-3046-2012		KAKENHI from the Japan Society for the Promotion of Science [26287088]; Photon Frontier Network Program from MEXT of Japan; KAKENHI [22103005]	This work was supported by KAKENHI Grant No. 26287088 from the Japan Society for the Promotion of Science, and a Grant-in-Aid for Scientific Research on Innovation Areas 'Topological Quantum Phenomena' (KAKENHI Grant No. 22103005), and the Photon Frontier Network Program from MEXT of Japan.	Allen Hatcher, 2001, ALGEBRAIC TOPOLOGY; Kawaguchi Y, 2012, PHYS REP, V520, P253, DOI 10.1016/j.physrep.2012.07.005; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; Al Khawaja U, 2001, NATURE, V411, P918, DOI 10.1038/35082010; Leanhardt AE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.140403; Schmaljohann H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040402; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; VONKLITZING K, 1986, REV MOD PHYS, V58, P519, DOI 10.1103/RevModPhys.58.519; Ohmi T, 1998, J PHYS SOC JPN, V67, P1822, DOI 10.1143/JPSJ.67.1822; Golubov AA, 2004, REV MOD PHYS, V76, P411, DOI 10.1103/RevModPhys.76.411; Zhou F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080401; Leanhardt AE, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.190403; Song JL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160408; Kasamatsu K, 2005, INT J MOD PHYS B, V19, P1835, DOI 10.1142/S0217979205029602; Kawaguchi Y, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053616; Pasquiou B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045307; Fetter AL, 2001, J PHYS-CONDENS MAT, V13, pR135, DOI 10.1088/0953-8984/13/12/201; Ray MW, 2014, NATURE, V505, P657, DOI 10.1038/nature12954; Turner AM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190404; WU TT, 1975, PHYS REV D, V12, P3845, DOI 10.1103/PhysRevD.12.3845; Carmi R, 2000, PHYS REV LETT, V84, P4966, DOI 10.1103/PhysRevLett.84.4966; Leslie LS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.250401; [Anonymous], 1990, SUPERFLUID PHASES HE; Stamper-Kurn DM, 2013, REV MOD PHYS, V85, P1191, DOI 10.1103/RevModPhys.85.1191; VOLOVIK GE, 1976, JETP LETT+, V24, P561; Wright KC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.030405; Andersen MF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170406; Pasquiou B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.255303; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; Ho TL, 1998, PHYS REV LETT, V81, P742, DOI 10.1103/PhysRevLett.81.742; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; Koashi M, 2000, PHYS REV LETT, V84, P1066, DOI 10.1103/PhysRevLett.84.1066; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Kuwamoto T, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.063604; Griesmaier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160401; Choi JY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035301; MICHEL L, 1980, REV MOD PHYS, V52, P617, DOI 10.1103/RevModPhys.52.617; Santos L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.190404; Kawaguchi Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.080405; CHUANG I, 1991, SCIENCE, V251, P1336, DOI 10.1126/science.251.4999.1336; Ruutu VMH, 1996, NATURE, V382, P334, DOI 10.1038/382334a0; Leslie SR, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.043631; Aikawa K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210401; HENDRY PC, 1994, NATURE, V368, P315, DOI 10.1038/368315a0; MORI H, 1988, J PHYS SOC JPN, V57, P1281, DOI 10.1143/JPSJ.57.1281; Ueda M, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063602; Weiler CN, 2008, NATURE, V455, P948, DOI 10.1038/nature07334; BAIS FA, 1995, INT J MOD PHYS A, V10, P3241, DOI 10.1142/S0217751X9500156X; BARTON G, 1974, J PHYS C SOLID STATE, V7, P4220, DOI 10.1088/0022-3719/7/23/009; BARTON G, 1975, J PHYS C SOLID STATE, V8, P970, DOI 10.1088/0022-3719/8/7/014; Bauerle C, 1996, NATURE, V382, P332, DOI 10.1038/382332a0; Blaauwgeers R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.155301; BLAHA S, 1976, PHYS REV LETT, V36, P874, DOI 10.1103/PhysRevLett.36.874; Borgh MO, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.015302; Chang MS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.140403; Ciobanu CV, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.033607; del Campo A, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X1430018X; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Ho TL, 1996, PHYS REV LETT, V77, P2595, DOI 10.1103/PhysRevLett.77.2595; Isoshima T, 2001, J PHYS SOC JPN, V70, P1604, DOI 10.1143/JPSJ.70.1604; Kawaguchi Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.180403; Kawakami T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.015301; Klausen NN, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.053602; Kleman M., 1983, POINTS LINES WALLS L; Kobayashi M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.115301; Kobayashi S, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033603; Kobayashi S, 2012, NUCL PHYS B, V856, P577, DOI 10.1016/j.nuclphysb.2011.11.003; Kobayashi S, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.023612; Kraus I, 1999, PHYS REV LETT, V82, P3815, DOI 10.1103/PhysRevLett.82.3815; Kudo K, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.053614; Kumakura M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063605; Landau L D, 1999, QUANTUM MECH; Makela H, 2003, J PHYS A-MATH GEN, V36, P8555, DOI 10.1088/0305-4470/36/32/302; Makela H, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.033610; MERMIN ND, 1981, PHYS TODAY, V34, P46, DOI 10.1063/1.2914510; MERMIN ND, 1978, J MATH PHYS, V19, P1457, DOI 10.1063/1.523811; Mineev V.P., 1998, TOPOLOGICALLY STABLE; MINEYEV VP, 1978, PHYS REV B, V18, P3197, DOI 10.1103/PhysRevB.18.3197; Nakahara M., 2003, GEOMETRY TOPOLOGY PH; Nakahara M, 2000, PHYSICA B, V284, P17, DOI 10.1016/S0921-4526(99)01952-3; NAKANISHI H, 1988, COMMUN MATH PHYS, V117, P203, DOI 10.1007/BF01223590; Park SY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.217401; Ruostekoski J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.190402; Saito H, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043613; Savage CM, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043604; Scherer DR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.110402; Semenoff GW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.100401; SHANKAR R, 1977, J PHYS-PARIS, V38, P1405, DOI 10.1051/jphys:0197700380110140500; Stoof HTC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120407; Tojo S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.042704; TREBIN HR, 1982, ADV PHYS, V31, P195, DOI 10.1080/00018738200101458; Ueda M, 2012, ANNU REV CONDEN MA P, V3, P263, DOI 10.1146/annurev-conmatphys-020911-125033; Ueda M., 2010, FUNDAMENTALS NEW FRO; Volovik G. E., 2003, UNIVERSE HELIUM DROP; Volovik G E, 1977, SOV PHYS JETP, V46, P401; Volovik G. E., 1977, SOV PHYS JETP, V45, P1186; Widera A, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/152; Xu ZF, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.013621; Yip SK, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023625	99	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0034-4885	1361-6633		REP PROG PHYS	Rep. Prog. Phys.	DEC	2014	77	12							122401	10.1088/0034-4885/77/12/122401		17	Physics, Multidisciplinary	Physics	AU9EW	WOS:000345895500001		
J	Cheung, CMG; Lai, TYY; Chen, SJ; Chong, V; Lee, WK; Htoon, H; Ng, WY; Ogura, Y; Wong, TY				Cheung, Chui Ming Gemmy; Lai, Timothy Y. Y.; Chen, Shih-Jen; Chong, Victor; Lee, Won Ki; Htoon, Hla; Ng, Wei Yan; Ogura, Yuichiro; Wong, Tien Yin			UNDERSTANDING INDOCYANINE GREEN ANGIOGRAPHY IN POLYPOIDAL CHOROIDAL VASCULOPATHY The Group Experience With Digital Fundus Photography and Confocal Scanning Laser Ophthalmoscopy	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						anti-vascular endothelial growth factor; treatment; photodynamic therapy; retreatment	PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; FOLLOW-UP; RANIBIZUMAB; VERTEPORFIN; DIAGNOSIS; FEATURES; LESION	Purpose: To evaluate the angiographic features in using fundus camera-based versus confocal scanning laser ophthalmoscope (cSLO)-based indocyanine green angiography in differentiating polypoidal choroidal vasculopathy (PCV) from typical age-related macular degeneration. Methods: Sixty-five eyes of 44 patients with exudative maculopathy due to PCV or typical age-related macular degeneration were prospectively imaged with indocyanine green angiography using fundus camera and cSLO. Images were graded independently by retinal specialists. The main outcome measure was agreement between cSLO and fundus camera for the diagnosis of PCV. The rate of detection and area under the receiver operating characteristic curve of 7 preselected individual features were also compared. Results: The diagnosis of PCV was made with the cSLO system in 36 eyes (55.4%) and typical age-related macular degeneration in 29 eyes (44.6%), whereas the fundus camera diagnosed PCV in 39 eyes (60.0%) and typical age-related macular degeneration in 26 eyes (40.0%). There was moderate agreement between the two indocyanine green angiography systems (Kappa = 0.53). Using cSLO as the gold standard, fundus camera has a sensitivity and specificity of 83.3% and 69.0%, respectively. Typical nodular appearance was the most commonly detected feature (median, 88.9% for cSLO, 80.6% for fundus camera, P = 0.63) and had the highest area under the curve for the diagnosis of PCV in both systems (median, 80.2% for cSLO, 73.2% for fundus camera, P = 0.13). Confocal scanning laser ophthalmoscope was more sensitive in detecting branching vascular network and late hyperfluorescent plaque. Conclusion: Both systems detected >80% of PCV based on typical nodular appearance of polyps. However, the cSLO is superior in detecting additional features, particularly branching vascular network.	[Cheung, Chui Ming Gemmy; Ng, Wei Yan; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore 168751, Singapore; [Cheung, Chui Ming Gemmy; Htoon, Hla; Wong, Tien Yin] Singapore Eye Res Inst, Singapore, Singapore; [Cheung, Chui Ming Gemmy; Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Cheung, Chui Ming Gemmy; Wong, Tien Yin] Duke NUS Grad Med Sch, Eye Acad Clin Program, Singapore, Singapore; [Lai, Timothy Y. Y.] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Chen, Shih-Jen] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei 112, Taiwan; [Chong, Victor] Oxford Eye Hosp, Oxford, England; [Lee, Won Ki] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol, Seoul, South Korea; [Ogura, Yuichiro] Nagoya City Univ, Dept Ophthalmol, Nagoya, Aichi, Japan	Cheung, CMG (reprint author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore.	gemmy.cheung.c.m@snec.com.sg			Singapore Eye Research Institute Health Research Endowment fund [R893/02/2012]	Supported by Singapore Eye Research Institute Health Research Endowment fund R893/02/2012.	Akaza E, 2011, JPN J OPHTHALMOL, V55, P39, DOI 10.1007/s10384-010-0886-x; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478; Yuzawa M, 2005, BRIT J OPHTHALMOL, V89, P602, DOI 10.1136/bjo.2004.049296; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Kokame GT, 2012, RETINA-J RET VIT DIS, V32, P1446, DOI 10.1097/IAE.0b013e3182695bf8; Lafaut BA, 2000, RETINA-J RET VIT DIS, V20, P650, DOI 10.1097/00006982-200011000-00010; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Stangos AN, 2010, AM J OPHTHALMOL, V150, P666, DOI 10.1016/j.ajo.2010.05.035; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Cackett P, 2009, RETINA-J RET VIT DIS, V29, P187, DOI 10.1097/IAE.0b013e318188c839; Sasahara M, 2006, AM J OPHTHALMOL, V142, P601, DOI 10.1016/j.ajo.2006.05.051; Okubo A, 2008, GRAEF ARCH CLIN EXP, V246, P491, DOI 10.1007/s00417-007-0680-8; Lim TH, 2010, EYE, V24, P483, DOI 10.1038/eye.2009.323; Akaza E, 2007, JPN J OPHTHALMOL, V51, P270, DOI 10.1007/s10384-007-0452-3; Kwok AKH, 2002, BRIT J OPHTHALMOL, V86, P892, DOI 10.1136/bjo.86.8.892; Akaza E, 2008, RETINA-J RET VIT DIS, V28, P717, DOI 10.1097/IAE.0b013e31816577cb; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Maruko I, 2010, GRAEF ARCH CLIN EXP, V248, P361, DOI 10.1007/s00417-009-1276-2; Cho M, 2009, AM J OPHTHALMOL, V148, P70, DOI 10.1016/j.ajo.2009.02.012; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Cheung CMG, 2011, NEW ENGL J MED, V365, P2237, DOI 10.1056/NEJMc1107895#SA1; Cohen SY, 2011, RETINA-J RET VIT DIS, V31, P209, DOI 10.1097/IAE.0b013e31820a69db; Gomi F, 2007, GRAEF ARCH CLIN EXP, V245, P1421, DOI 10.1007/s00417-007-0564-y; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, NIPPON GANKA GAKKAI, V109, P417; Kang SW, 2009, BRIT J OPHTHALMOL, V93, P759, DOI 10.1136/bjo.2008.145862; Leal S, 2010, RETINA-J RET VIT DIS, V30, P1197, DOI 10.1097/IAE.0b013e3181d37486; Silva RM, 2005, GRAEF ARCH CLIN EXP, V243, P973, DOI 10.1007/s00417-005-1139-4; Stanga PE, 1995, RETINA, V15, P100; Yuzawa M, 2003, JPN J OPHTHALMOL, V47, P379, DOI 10.1016/S0021-5155(03)00042-X	32	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	DEC	2014	34	12					2397	2406				10	Ophthalmology	Ophthalmology	AU9KK	WOS:000345911300015		
J	Hayashi, H; Kuriyama, S				Hayashi, Hisako; Kuriyama, Shoji			FOVEAL MICROSTRUCTURE IN MACULAR HOLES SURGICALLY CLOSED BY INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						internal limiting membrane; high myopia; macular hole; spectral domain optical coherence tomography; vitrectomy; inverted internal limiting membrane flap technique	OPTICAL COHERENCE TOMOGRAPHY; HIGH MYOPIA; VISUAL-ACUITY; SURGERY; OUTCOMES; CLOSURE; IMAGES; EYES	Purpose: To evaluate reconstructive foveal anatomical change in surgically closed macular hole (MH) by pars plana vitrectomy with inverted internal limiting membrane flap technique. Methods: Spectral domain optical coherence tomography was used to evaluate foveal microstructures in 20 eyes of 19 patients who underwent pars plana vitrectomy with inverted internal limiting membrane flap technique to achieve MH closure. Eyes had idiopathic large MH with a diameter >500 mu m (n = 7), MH in high myopia (axial length >26.5 mm) without retinal detachment (RD; n = 7), and with RD caused by the MH (n = 6). Results: The 6-month postoperative spectral domain optical coherence tomography examination revealed restoration of the inner segment and outer segment junction in 3 of 7 idiopathic large MH eyes (43%), 2 of 7 highly myopic MH eyes without RD (29%), and 1 of 6 highly myopic MH eyes with RD (17%), and detected the external limiting membrane in 4 of 7 idiopathic large MH eyes (57%), 3 of 7 highly myopic MH eyes without RD (43%), 1 of 6 highly myopic MH eyes with RD (17%). Conclusion: Inverted internal limiting membrane flap technique results in more satisfactory anatomical improvements in patients with idiopathic large MH eyes and highly myopic MH eyes without RD than with highly myopic MH eyes with RD. This might suggest that the foveal photoreceptor layer in MH with RD is destroyed and not recoverable even after retinal reattachment with surgical closure of the MH.	[Hayashi, Hisako; Kuriyama, Shoji] Otsu Red Cross Hosp, Dept Ophthalmol, Otsu, Shiga 5200046, Japan	Kuriyama, S (reprint author), Otsu Red Cross Hosp, Dept Ophthalmol, 1-1-35 Nagara, Otsu, Shiga 5200046, Japan.	kuriyama@otsu.jrc.or.jp					Almony A, 2012, RETINA-J RET VIT DIS, V32, P877, DOI 10.1097/IAE.0b013e318227ab39; Itoh Y, 2012, AM J OPHTHALMOL, V153, P111, DOI 10.1016/j.ajo.2011.05.039; Benson WE, 2001, OPHTHALMOLOGY, V108, P1328, DOI 10.1016/S0161-6420(01)00731-X; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ooto S, 2012, AM J OPHTHALMOL, V154, P174, DOI 10.1016/j.ajo.2012.01.031; Michalewska Z, 2008, GRAEF ARCH CLIN EXP, V246, P823, DOI 10.1007/s00417-007-0764-5; Wakabayashi T, 2010, OPHTHALMOLOGY, V117, P1815, DOI 10.1016/j.ophtha.2010.01.017; Villate N, 2005, AM J OPHTHALMOL, V139, P280, DOI 10.1016/j.ajo.2004.09.029; Inoue M, 2009, GRAEF ARCH CLIN EXP, V247, P325, DOI 10.1007/s00417-008-0999-9; Chang LK, 2008, RETINA-J RET VIT DIS, V28, P969, DOI 10.1097/IAE.0b013e3181744165; Michalewska Z, 2010, OPHTHALMOLOGY, V117, P2018, DOI 10.1016/j.ophtha.2010.02.011; Ko TH, 2006, ARCH OPHTHALMOL-CHIC, V124, P827, DOI 10.1001/archopht.124.6.827; Kang SW, 2003, BRIT J OPHTHALMOL, V87, P1015, DOI 10.1136/bjo.87.8.1015; Hangai M, 2007, OPHTHALMOLOGY, V114, P763, DOI 10.1016/j.ophtha.2006.07.055; Michalewska Z, 2010, GRAEF ARCH CLIN EXP, V248, P1249, DOI 10.1007/s00417-010-1370-5; Ooka E, 2011, AM J OPHTHALMOL, V152, P283, DOI 10.1016/j.ajo.2011.02.001; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654; Takahashi A, 2010, OPHTHALMOLOGY, V117, P806, DOI 10.1016/j.ophtha.2009.09.022; Kuriyama S, 2013, AM J OPHTHALMOL, V156, P125, DOI 10.1016/j.ajo.2013.02.014; Brooks HL, 2000, OPHTHALMOLOGY, V107, P1939, DOI 10.1016/S0161-6420(00)00331-6; Imai M, 1999, AM J OPHTHALMOL, V128, P621, DOI 10.1016/S0002-9394(99)00200-7; Kawano H, 2011, AM J OPHTHALMOL, V151, P318, DOI 10.1016/j.ajo.2010.08.034; Michalewska Z, 2013, RETINA; Nakanishi H, 2008, AM J OPHTHALMOL, V146, P198, DOI 10.1016/j.ajo.2008.04.022; Patel SC, 2001, OPHTHALMOLOGY, V108, P377, DOI 10.1016/S0161-6420(00)00532-7	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	DEC	2014	34	12					2444	2450				7	Ophthalmology	Ophthalmology	AU9KK	WOS:000345911300021		
J	Fujikawa, M; Kawamura, H; Kakinoki, M; Sawada, O; Sawada, T; Saishin, Y; Ohji, M				Fujikawa, Masato; Kawamura, Hajime; Kakinoki, Masashi; Sawada, Osamu; Sawada, Tomoko; Saishin, Yoshitsugu; Ohji, Masahito			SCLERAL IMBRICATION COMBINED WITH VITRECTOMY AND GAS TAMPONADE FOR REFRACTORY MACULAR HOLE RETINAL DETACHMENT ASSOCIATED WITH HIGH MYOPIA	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						gas tamponade; macular hole; retinal detachment; scleral imbrication	EYES; MANAGEMENT; SURGERY	Purpose: To evaluate scleral imbrication with vitrectomy and gas tamponade for refractory macular hole retinal detachment associated with high myopia. Methods: We retrospectively reviewed the medical records of eight eyes with macular hole retinal detachment and high myopia treated with temporal scleral imbrication, pars plana vitrectomy, and gas tamponade for refractory macular hole retinal detachment with history of pars plana vitrectomy. Retinal reattachment and macular hole closure were assessed. Postoperative changes in axial length and surgically induced astigmatism were evaluated. Results: The retinas were reattached in all eyes and the macular holes closed in 6 (75%) eyes. The mean baseline logarithm of the minimum angle of resolution best-corrected visual acuity of 1.43 +/- 0.48 significantly (P < 0.01) improved to 0.87 +/- 0.34 at the final visit (889 +/- 173 postoperative days). The mean baseline axial length of 29.5 +/- 1.3 mm decreased significantly (P < 0.01) to 27.1 +/- 1.9 mm 1 month after scleral imbrication and 28.1 +/- 1.7 mm at the final visit (P < 0.05 vs. baseline, P = 0.13 vs. 1 month). The mean 1-month surgically induced astigmatism of 3.6 +/- 1.4 diopters (D) after scleral imbrication significantly (P < 0.05) decreased to 2.4 +/- 1.5 D at the final visit. Conclusion: Scleral imbrication with vitrectomy and gas tamponade resulted in high reattachment and macular hole closure rates for treating refractory macular hole retinal detachment.	[Fujikawa, Masato; Kawamura, Hajime; Kakinoki, Masashi; Sawada, Osamu; Sawada, Tomoko; Saishin, Yoshitsugu; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga 5202192, Japan	Fujikawa, M (reprint author), Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga 5202192, Japan.	fujikawa@belle.shiga-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592668]; Ministry of Health, Labor, and Welfare	Supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24592668) and a grant from the Ministry of Health, Labor, and Welfare.	AMEMIYA T, 1980, OPHTHALMOLOGICA, V181, P88; ANDO F, 1980, JPN J OPHTHALMOL, V24, P29; Saka N, 2010, AM J OPHTHALMOL, V150, P562, DOI 10.1016/j.ajo.2010.05.009; Ortisi E, 2012, RETINA-J RET VIT DIS, V32, P1704, DOI 10.1097/IAE.0b013e31826b671c; GONVERS M, 1982, AM J OPHTHALMOL, V94, P468; Sasoh M, 2000, RETINA-J RET VIT DIS, V20, P445, DOI 10.1097/00006982-200009000-00003; BLANKENSHIP GW, 1987, OPHTHALMOLOGY, V94, P333; CHAMLIN M, 1956, AM J OPHTHALMOL, V41, P633; Holladay JT, 1997, J REFRACT SURG, V13, P388; Kono T, 2006, OPHTHALMOLOGICA, V220, P159, DOI 10.1159/000091758; Matsumura M, 1996, JPN J OPHTHALMIC SUR, V9, P425; Matsuo T, 2001, JPN J OPHTHALMOL, V45, P403, DOI 10.1016/S0021-5155(01)00341-0; Mikuni M, 1967, Nihon Ganka Kiyo, V18, P659; MIYAKE Y, 1984, AM J OPHTHALMOL, V97, P243; Nakagawa N, 2000, ARCH OPHTHALMOL-CHIC, V118, P965; Ripandelli G, 2004, OPHTHALMOLOGY, V111, P726, DOI 10.1016/j.ophtha.2003.08.026; Ryan EH, 2011, AM J OPHTHALMOL, V152, P815, DOI 10.1016/j.ajo.2011.04.026; Shimizu E, 1994, JPN REV CLIN OPHTHAL, V88, P1583; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P481, DOI 10.1097/00006982-200308000-00006; Ueda T, 1992, JPN REV CLIN OPHTHAL, V86, P2616	20	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	DEC	2014	34	12					2451	2457				7	Ophthalmology	Ophthalmology	AU9KK	WOS:000345911300022		
J	Yamaguchi, R; Yamamoto, T; Motomura, G; Ikemura, S; Iwasaki, K; Zhao, G; Doi, T; Iwamoto, Y				Yamaguchi, Ryosuke; Yamamoto, Takuaki; Motomura, Goro; Ikemura, Satoshi; Iwasaki, Kenyu; Zhao, Garida; Doi, Toshio; Iwamoto, Yukihide			Bone and cartilage metabolism markers in synovial fluid of the hip joint with secondary osteoarthritis	RHEUMATOLOGY			English	Article						hip osteoarthritis; osteonecrosis of the femoral head; rapidly destructive arthrosis; developmental dysplasia of the hip; synovial fluid analysis; bone metabolism marker; cartilage metabolism marker	FEMORAL-HEAD; ROTATIONAL OSTEOTOMY; OSTEONECROSIS; NECROSIS	Objective. The aim of this study was to compare the levels of bone and cartilage metabolism markers in the synovial fluid of the hip joint between patients with secondary OA due to osteonecrosis of the femoral head (ONFH), rapidly destructive arthrosis (RDA) and developmental dysplasia of the hip (DDH). Methods. We studied 70 synovial fluid samples obtained from 57 patients with ONFH (mean age 46 years, 34 males, 23 females), 21 samples obtained from 21 patients with RDA (mean age 70 years, 2 males, 19 females) and 20 samples obtained from 20 patients with DDH (mean age 56 years, 2 males, 18 females). The levels of bone alkaline phosphatase (BAP) and tartrate-resistant acid phosphatase 5b (TRACP-5b), as bone metabolism markers, and matrix metalloproteinase 3 (MMP-3) and keratan sulphate (KS), as cartilage metabolism markers, were analysed. Results. The levels of BAP, MMP-3 and KS were significantly higher in the ONFH group than in the RDA and DDH groups. The levels of TRACP-5b were highest in the RDA group. The levels of BAP in the ONFH group after the development of osteoarthritic changes were significantly lower than those observed in earlier stages. In comparisons between the samples obtained from each group with a terminal condition, the ONFH samples exhibited significantly higher MMP-3 and KS levels, while the TRACP-5 levels were highest in the RDA group. Conclusion. The ONFH patients showed a relatively bone formative condition before the osteoarthritic stage and maintained a higher rate of cartilage turnover throughout several stages compared with the RDA and DDH patients. RDA patients were characterized by a significantly high osteoclast activity.	[Yamaguchi, Ryosuke; Yamamoto, Takuaki; Motomura, Goro; Ikemura, Satoshi; Iwasaki, Kenyu; Zhao, Garida; Doi, Toshio; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 8128582, Japan	Yamamoto, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamataku@ortho.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24-2339]; Ministry of Health, Labour and Welfare of Japan	This research was supported in part by JSPS KAKENHI grant number 24-2339 from the Japan Society for the Promotion of Science and a Research Grant for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan.	Abe H, 2014, RHEUMATOLOGY, V53, P165, DOI 10.1093/rheumatology/ket334; Zhao G, 2013, J ORTHOP SCI, V18, P277, DOI 10.1007/s00776-012-0347-0; Zhao G, 2012, J ORTHOP SCI, V17, P390, DOI 10.1007/s00776-012-0238-4; Janckila AJ, 2007, AM J CLIN PATHOL, V127, P556, DOI 10.1309/DGEA9BE2VE5VCFYH; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI [10.1016/j.joca.2007.12.013, 10.1016/j.joca.2010.01.013]; Yamamoto T, 2000, ARTHRITIS RHEUM, V43, P2423, DOI 10.1002/1529-0131(200011)43:11<2423::AID-ANR8>3.0.CO;2-Z; COOPERMAN DR, 1983, CLIN ORTHOP RELAT R, P79; Jingushi S, 2000, J ORTHOPAED RES, V18, P728, DOI 10.1002/jor.1100180508; Kato S, 2005, J RHEUMATOL, V32, P1518; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; Millis MB, 2002, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000038465.05771.02; Miyanishi K, 2000, J BONE JOINT SURG BR, V82B, P512, DOI 10.1302/0301-620X.82B4.10065; Nishio A., 1956, J JPN ORTHOP ASSOC, V30, P482; Sugano Nobuhiko, 2002, J Orthop Sci, V7, P601, DOI 10.1007/s007760200108; SUGIOKA Y, 1978, CLIN ORTHOP RELAT R, P191; THONAR EJMA, 1985, ARTHRITIS RHEUM, V28, P1367, DOI 10.1002/art.1780281209; Ueno R, 1971, J JPN ORTHOP ASSOC, V45, P826	19	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	DEC	2014	53	12					2191	2195		10.1093/rheumatology/keu253		5	Rheumatology	Rheumatology	AU8ED	WOS:000345828400010		
J	Gono, T; Kaneko, H; Kawaguchi, Y; Hanaoka, M; Kataoka, S; Kuwana, M; Takagi, K; Ichida, H; Katsumata, Y; Ota, Y; Kawasumi, H; Yamanaka, H				Gono, Takahisa; Kaneko, Hirotaka; Kawaguchi, Yasushi; Hanaoka, Masanori; Kataoka, Sayuri; Kuwana, Masataka; Takagi, Kae; Ichida, Hisae; Katsumata, Yasuhiro; Ota, Yuko; Kawasumi, Hidenaga; Yamanaka, Hisashi			Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease	RHEUMATOLOGY			English	Article						polymyositis; dermatomyositis; interstitial lung disease; TNF-alpha; IL-6; IL-8	IDIOPATHIC INFLAMMATORY MYOPATHIES; CLINICALLY AMYOPATHIC DERMATOMYOSITIS; MACROPHAGE ACTIVATION; PULMONARY-FIBROSIS; GENE 5; ADULT; BIOMARKERS; ANTIBODY; DYSREGULATION; AUTOANTIGEN	Objective. PM and DM are often complicated by interstitial lung disease (ILD). In this study we aimed to evaluate various serum cytokines in patients with PM/DM with ILD so as to clarify the differences in pathophysiology between anti-melanoma differentiation-associated gene 5 antibody-associated ILD (anti-MDA5-ILD) and anti-aminoacyl tRNA synthetase antibody-associated ILD (anti-ARS-ILD). Methods. We evaluated the serum cytokine profiles of 38 patients with PM/DM and compared the cytokine profiles of the non-ILD and ILD subsets as well as the anti-MDA5-ILD and anti-ARS-ILD subsets. Results. The myositis intention-to-treat activity index score, which indicates whole disease activity, significantly correlated with serum IL-6, IL-8, TNF-alpha and IP-10. These cytokine levels were significantly higher in the ILD subset than the non-ILD subset and were lower in the ILD subset following treatment. By multivariate analysis, TNF-alpha was the most significant cytokine [P = 0.0006, odds ratio (OR) 1.4, CI 1.1, 2.2] associated with PM/DM with ILD. IL-8 levels were significantly higher in anti-MDA5-ILD than in anti-ARS-ILD, although IL-6, TNF-alpha and IP-10 levels were high in both subsets. IL-8 was the most significant cytokine (P = 0.0006, OR 1.5, CI 1.1, 3.0) associated with anti-MDA5-ILD by multivariate analysis. Moreover, the ratio of IL-4 to IFN-gamma was lower in anti-MDA5-ILD than in anti-ARS-ILD. Conclusion. IL-6, IL-8, TNF-alpha and IP-10 are associated with global disease activity in PM/DM. These cytokine levels were high, especially in the ILD subset. Serum IL-8 levels and the balance between IL-4 and IFN-gamma may contribute to the differences in pathophysiology between anti-ARS-ILD and anti-MDA5-ILD.	[Gono, Takahisa; Kaneko, Hirotaka; Kawaguchi, Yasushi; Hanaoka, Masanori; Kataoka, Sayuri; Takagi, Kae; Ichida, Hisae; Katsumata, Yasuhiro; Ota, Yuko; Kawasumi, Hidenaga; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1620054, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan	Kawaguchi, Y (reprint author), Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, 10-22 Kawada Cho, Tokyo 1620054, Japan.	y-kawa@ior.twmu.ac.jp			Japan's Ministry of Health, Labour and Welfare	This study was supported in part by research grants from Japan's Ministry of Health, Labour and Welfare.	Agrawal A, 2012, AM J PHYSIOL-LUNG C, V303, pL634, DOI 10.1152/ajplung.00195.2012; American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Miller FW, 2012, ANN RHEUM DIS, V71, P82, DOI 10.1136/annrheumdis-2011-200587; MIYAZAKI Y, 1995, J CLIN INVEST, V96, P250, DOI 10.1172/JCI118029; Callen JP, 2000, LANCET, V355, P53, DOI 10.1016/S0140-6736(99)05157-0; Miller FW, 2001, RHEUMATOLOGY, V40, P1262, DOI 10.1093/rheumatology/40.11.1262; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Reed AM, 2012, ARTHRITIS RHEUM-US, V64, P4078, DOI 10.1002/art.34659; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Bilgic H, 2009, ARTHRITIS RHEUM-US, V60, P3436, DOI 10.1002/art.24936; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Marie I, 2012, CURR RHEUMATOL REP, V14, P275, DOI 10.1007/s11926-012-0249-3; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Labirua A, 2010, CURR OPIN RHEUMATOL, V22, P633, DOI 10.1097/BOR.0b013e32833f1970; Ernste FC, 2013, MAYO CLIN PROC, V88, P83, DOI 10.1016/j.mayocp.2012.10.017; Bargagli E, 2011, PULM MED, V2011, DOI [10.1155/2011/717130, DOI 10.1155/2011/717130]; BENFIELD TL, 1995, AM J RESP CRIT CARE, V151, P1058; Bonaccorsi A, 2003, EUR RESPIR J, V21, P187, DOI 10.1183/09031936.03.00297002; Freeburn RW, 2005, EUR CYTOKINE NETW, V16, P5; GROENEVELD ABJ, 1995, CYTOKINE, V7, P746; IMACS website, 2014, DIS ACT COR SET MEAS; Mimori T, 2012, CURR RHEUMATOL REP, V14, P264, DOI 10.1007/s11926-012-0246-6; Richards TJ, 2009, ARTHRITIS RHEUM, V60, P2183, DOI 10.1002/art.24631; Sun WC, 2012, BRIT J DERMATOL, V167, P1236, DOI 10.1111/j.1365-2133.2012.11145.x; Tristano AG, 2008, MED SCI MONITOR, V14, pRA27	33	5	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	DEC	2014	53	12					2196	2203		10.1093/rheumatology/keu258		8	Rheumatology	Rheumatology	AU8ED	WOS:000345828400011		
J	Quartuccio, L; Isola, M; Corazza, L; Ramos-Casals, M; Retamozo, S; Ragab, GM; Zoheir, MN; El-Menyawi, MAM; Salem, MN; Sansonno, D; Ferraccioli, G; Gremese, E; Tzioufas, A; Voulgarelis, M; Vassilopoulos, D; Scarpato, S; Pipitone, N; Salvarani, C; Guillevin, L; Terrier, B; Cacoub, P; Filippini, D; Saccardo, F; Gabrielli, A; Fraticelli, P; Sebastiani, M; Tomsic, M; Tavoni, A; Mazzaro, C; Pioltelli, P; Nishimoto, N; Scaini, P; Zignego, AL; Ferri, C; Monti, G; Pietrogrande, M; Bombardieri, S; Galli, M; De Vita, S				Quartuccio, Luca; Isola, Miriam; Corazza, Laura; Ramos-Casals, Manuel; Retamozo, Soledad; Ragab, Gaafar Mohamed; Zoheir, Mostafa Naguib; El-Menyawi, Manal Abdel-Moneim; Salem, Mohamed Nabil; Sansonno, Domenico; Ferraccioli, Gianfranco; Gremese, Elisa; Tzioufas, Athanasios; Voulgarelis, Michael; Vassilopoulos, Dimitris; Scarpato, Salvatore; Pipitone, Nicolo; Salvarani, Carlo; Guillevin, Loic; Terrier, Benjamin; Cacoub, Patrice; Filippini, Davide; Saccardo, Francesco; Gabrielli, Armando; Fraticelli, Paolo; Sebastiani, Marco; Tomsic, Matija; Tavoni, Antonio; Mazzaro, Cesare; Pioltelli, Pietro; Nishimoto, Norihiro; Scaini, Patrizia; Zignego, Anna Linda; Ferri, Clodoveo; Monti, Giuseppe; Pietrogrande, Maurizio; Bombardieri, Stefano; Galli, Massimo; De Vita, Salvatore			Validation of the classification criteria for cryoglobulinaemic vasculitis	RHEUMATOLOGY			English	Article						cryoglobulinaemia; hepatitis C; classification; vasculitis	HEPATITIS-C VIRUS; II MIXED CRYOGLOBULINEMIA; RHEUMATOLOGY/EUROPEAN LEAGUE; RHEUMATIC-DISEASES; AMERICAN-COLLEGE; EXPANSION	Objective. The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV). Methods. Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria. Results. The study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers. Conclusion. Classification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease.	[Quartuccio, Luca; Corazza, Laura; De Vita, Salvatore] Univ S Maria Misericordia, Azienda Osped, Dept Med & Biol Sci, Rheumatol Clin, I-33100 Udine, Italy; [Isola, Miriam] Univ Udine, Inst Stat, Dept Med & Biol Sci, I-33100 Udine, Italy; [Ramos-Casals, Manuel; Retamozo, Soledad] Hosp Clin Barcelona, IDIBAPS, Lab Enfermedades Autoinmunes Josep Font, Barcelona, Spain; [Ragab, Gaafar Mohamed; Zoheir, Mostafa Naguib; El-Menyawi, Manal Abdel-Moneim] Cairo Univ, Fac Med, Cairo, Egypt; [Salem, Mohamed Nabil] BeniSwafe Univ, Fac Med, Beniswafe, Egypt; [Sansonno, Domenico] Univ Bari, Sch Med, Dept Biomed Sci & Human Oncol, Sect Internal Med & Clin Oncol, Bari, Italy; [Ferraccioli, Gianfranco; Gremese, Elisa] Cathol Univ Sacred Heart, Div Rheumatol, Rome, Italy; [Tzioufas, Athanasios; Voulgarelis, Michael] Med Sch Athens, Dept Pathophysiol, Athens, Greece; [Vassilopoulos, Dimitris] Hippokrateion Hosp, Dept Med 2, Athens, Greece; [Scarpato, Salvatore] M Scarlato Hosp, Rheumatol Unit, Salerno, Italy; [Pipitone, Nicolo; Salvarani, Carlo] Arcispedale S Maria Nuova, Div Rheumatol, Reggio Emilia, Italy; [Guillevin, Loic; Terrier, Benjamin] Hop La Pitie Salpetriere, Ctr References Maladies Autoimmunes, Serv Med Interne 2, Paris, France; [Cacoub, Patrice] Hop Cochin, Serv Med Interne, F-75674 Paris, France; [Filippini, Davide] Osped Niguarda Ca Granda, Rheumatol Unit, Milan, Italy; [Saccardo, Francesco; Monti, Giuseppe] Saronno Hosp, Azienda Osped Busto Arsizio, Internal Med Unit, Saronno, Italy; [Gabrielli, Armando; Fraticelli, Paolo] Univ Politecn Marche, Ancona, Italy; [Sebastiani, Marco; Ferri, Clodoveo] Univ Modena, Dept Internal Med, Rheumatol Unit, I-41100 Modena, Italy; [Tomsic, Matija] Univ Med Ctr, Dept Rheumatol, Ljubljana, Slovenia; [Tavoni, Antonio; Bombardieri, Stefano] Univ Pisa, Dept Internal Med, Rheumatol Unit, Pisa, Italy; [Mazzaro, Cesare] Pordenone Gen Hosp, Dept Internal Med, Pordenone, Italy; [Pioltelli, Pietro] Donizetti Hosp, Monza, Italy; [Nishimoto, Norihiro] Tokyo Med Univ, Osaka Rheumatol Clin, Tokyo 1608402, Japan; [Nishimoto, Norihiro] Tokyo Med Univ, Dept Mol Regulat Intractable Dis, Inst Med Sci, Tokyo 1608402, Japan; [Scaini, Patrizia] AO Spedali Civili, Dept Nephrol, Brescia, Italy; [Zignego, Anna Linda] Univ Florence, Dept Internal Med, Ctr Syst Manifestn Hepatitis Viruses MaSVE, Florence, Italy; [Pietrogrande, Maurizio] Policlin San Marco, Internal Med Unit, Bergamo, Italy; [Galli, Massimo] Osped L Sacco, Univ Milano, Ist Malattie Infett & Trop, Milan, Italy	De Vita, S (reprint author), Univ S Maria Misericordia, Azienda Osped, Dept Med & Biol Sci, Rheumatol Clin, Piazzale Santa Maria Misericordia 1, I-33100 Udine, Italy.	devita.salvatore@aoud.sanita.fvg.it		SANSONNO, Domenico Ettore/0000-0001-6520-1653			AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI 10.1136/annrheumdis-2013-204424; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Ferri C, 2002, J CLIN PATHOL, V55, P4; FERRI C, 1991, ARTHRITIS RHEUM, V34, P1606; De Vita S, 2011, CLIN EXP RHEUMATOL, V29, pS99; De Vita S, 2011, ANN RHEUM DIS, V70, P1183, DOI 10.1136/ard.2011.150755; De Vita S, 2000, ARTHRITIS RHEUM, V43, P94, DOI 10.1002/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8; Dougados M, 2007, ARTHRIT RHEUM-ARTHR, V57, P1112, DOI 10.1002/art.23015; GOREVIC PD, 1991, SEMIN HEMATOL, V28, P79; Invernizzi F, 1995, CLIN EXP RHEUMATOL, V13, pS123; Johnson SR, 2007, ARTHRIT RHEUM-ARTHR, V57, P1119, DOI 10.1002/art.23018; MELTZER M, 1966, AM J MED, V40, P828, DOI 10.1016/0002-9343(66)90199-9; Quartuccio L, 2007, RHEUMATOLOGY, V46, P1657, DOI 10.1093/rheumatology/kem209; Quartuccio L, 2012, CLIN EXP RHEUMATOL, V30, pS48	16	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	DEC	2014	53	12					2209	2213		10.1093/rheumatology/keu271		5	Rheumatology	Rheumatology	AU8ED	WOS:000345828400014		
J	Segawa, S; Goto, D; Horikoshi, M; Kondo, Y; Umeda, N; Hagiwara, S; Yokosawa, M; Hirota, T; Miki, H; Tsuboi, H; Ogishima, H; Suzuki, T; Matsumoto, I; Sumida, T				Segawa, Seiji; Goto, Daisuke; Horikoshi, Masanobu; Kondo, Yuya; Umeda, Naoto; Hagiwara, Shinnya; Yokosawa, Masahiro; Hirota, Tomoya; Miki, Haruka; Tsuboi, Hiroto; Ogishima, Hiroshi; Suzuki, Takeshi; Matsumoto, Isao; Sumida, Takayuki			Involvement of CD161(+) V delta 1(+) gamma delta T cells in systemic sclerosis: association with interstitial pneumonia	RHEUMATOLOGY			English	Article						interstitial pneumonia; systemic sclerosis; CD161; gamma-delta T cell; CCL3; interferon-gamma; natural killer receptors; KL-6	PULMONARY-FIBROSIS; LUNG-DISEASE; LYMPHOCYTES; PATHOGENESIS; SCLERODERMA; MACROPHAGE; DERMATOMYOSITIS; CLASSIFICATION; POLYMYOSITIS; REPERTOIRE	Objective. Interstitial pneumonia (IP) is a chronic progressive interstitial lung disease associated with high mortality and poor prognosis. However, the pathogenesis of IP remains to be elucidated. The aim of this study was to clarify the role of CD161(+) V delta 1(+) gamma delta T cells in SSc patients with IP. Methods. The proportion of CD161(+) V delta 1(+) gamma delta T cells in peripheral blood mononuclear cells (PBMCs) and serum sialylated carbohydrate antigen (KL-6) levels were determined. GeneChip analysis was performed with CD161(-) and CD161(+) V delta 1(+) gamma delta T cells. Cytokine and chemokine expression from CD161(+) V delta 1(+) gamma delta T cells was measured and used to evaluate the effect of culture supernatant on fibroblast proliferation. Results. The proportion of CD161(+) V delta 1(+) gamma delta T cells was significantly higher in SSc than healthy controls (HCs) and correlated negatively with serum KL-6 levels in IP-positive SSc patients. The gene and mRNA expression level of chemokine ligand 3 (CCL3) was markedly higher in CD161(+) V delta 1(+) gamma delta T cells than in CD161(-) V delta 1(+) gamma delta T cells. CD161(+) V delta 1(+) gamma delta T cells in IP-positive SSc patients showed higher production of CCL3 and lower production of IFN-gamma than in HCs. Culture supernatant derived from IP-negative and IP-positive SSc patients promoted fibroblast proliferation, whereas that from HCs did not. Conclusion. The small proportion and the altered cell functions of CD161(+) V delta 1(+) gamma delta T cells among PBMCs in SSc patients play a role in the pathogenesis of IP. These findings suggest that CD161(+) V delta 1(+) gamma delta T cells may play a regulatory role in the pathogenesis of IP in SSc patients via IFN-gamma production.	[Segawa, Seiji; Goto, Daisuke; Horikoshi, Masanobu; Kondo, Yuya; Umeda, Naoto; Hagiwara, Shinnya; Yokosawa, Masahiro; Hirota, Tomoya; Miki, Haruka; Tsuboi, Hiroto; Ogishima, Hiroshi; Suzuki, Takeshi; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan	Sumida, T (reprint author), Univ Tsukuba, Fac Med, Dept Internal Med, Div Clin Immunol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	tsumida@md.tsukuba.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the Research Program for Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ishida Y, 2007, AM J PATHOL, V170, P843, DOI 10.2353/ajpath.2007.051213; LEROY EC, 1988, J RHEUMATOL, V15, P202; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Segawa S, 2010, CLIN EXP IMMUNOL, V160, P394, DOI 10.1111/j.1365-2249.2010.04094.x; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Giacomelli R, 1998, ARTHRITIS RHEUM, V41, P327, DOI 10.1002/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; LUNA MA, 1972, AM J CLIN PATHOL, V58, P501; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; King TE, 2005, AM J RESP CRIT CARE, V172, P268, DOI 10.1164/rccm.200503-483OE; Zhang Y, 2002, J IMMUNOL, V168, P3088; Gu YS, 2008, SEMIN ARTHRITIS RHEU, V38, P132, DOI 10.1016/j.semarthrit.2007.10.010; De Rosa SC, 2004, J IMMUNOL, V172, P1637; LANIER LL, 1994, J IMMUNOL, V153, P2417; Das H, 2004, J IMMUNOL, V172, P6578; Kamath AB, 2003, P NATL ACAD SCI USA, V100, P6009, DOI 10.1073/pnas.1035603100; Simonian PL, 2006, J IMMUNOL, V177, P4436; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Hasegawa M, 1999, CLIN EXP IMMUNOL, V117, P159; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Atamas SP, 2002, LIFE SCI, V72, P631, DOI 10.1016/S0024-3205(02)02299-3; Bendersky A, 2010, IMMUNOBIOLOGY, V215, P380, DOI 10.1016/j.imbio.2009.05.012; Bolster MB, 1997, ARTHRITIS RHEUM, V40, P743, DOI 10.1002/art.1780400422; Catellani S, 2007, BLOOD, V109, P2078, DOI 10.1182/blood-2006-06-028985; Hasegawa M, 2012, SEMIN ARTHRITIS RHEU, V42, P281, DOI 10.1016/j.semarthrit.2012.03.014; HOLCOMBE RF, 1995, ANN RHEUM DIS, V54, P69, DOI 10.1136/ard.54.1.69; Holtmeier W, 1997, J IMMUNOL, V158, P5632; Jimenez SA, 2002, CURR OPIN RHEUMATOL, V14, P671, DOI 10.1097/00002281-200211000-00008; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Poccia F, 1998, IMMUNOL TODAY, V19, P253, DOI 10.1016/S0167-5699(98)01266-3; Poggi A, 2002, J IMMUNOL, V168, P6071; Ramirez Allan, 2004, Treat Respir Med, V3, P339, DOI 10.2165/00151829-200403060-00002; Sato S, 2000, DERMATOLOGY, V200, P196, DOI 10.1159/000018382; SCHARFFETTER K, 1989, EXP CELL RES, V181, P409, DOI 10.1016/0014-4827(89)90098-0; Segawa S, 2011, AM J RESP CELL MOL, V45, P659, DOI 10.1165/rcmb.2010-0298OC; STANDIFORD TJ, 1993, J IMMUNOL, V151, P2852	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	DEC	2014	53	12					2259	2269		10.1093/rheumatology/keu246		11	Rheumatology	Rheumatology	AU8ED	WOS:000345828400022		
J	Akagi, R; Takahashi, H				Akagi, R.; Takahashi, H.			Effect of a 5-week static stretching program on hardness of the gastrocnemius muscle	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						shear wave ultrasound elastography; Young's modulus; passive range of motion; musculo-tendinous unit stiffness; joint torque	RANDOMIZED CONTROLLED-TRIAL; TENDON UNIT; PASSIVE STIFFNESS; PLANTAR FLEXORS; REGULAR STRETCH; IN-VIVO; EXTENSIBILITY; CONTRACTION; EXERCISE; VOLUME	This study investigated the effects of a static stretching (SS) program on muscle hardnesses of the gastrocnemius medialis (MG) and gastrocnemius lateralis (LG). Nineteen young men participated in this study. Either the right or left leg was randomly selected to conduct three bouts of 2-min SS of the plantar flexors 6 days a week for 5 weeks in each subject (the SS group), and the other leg was assigned to a control group. Before (pretest) and after (posttest) conducting the SS program, MG and LG hardnesses were measured using shear wave ultrasound elastography. The SS program was found to decrease muscle hardnesses, but not to change the ratio of MG hardness to LG hardness. There were no significant differences between the relative changes in the MG and LG hardnesses from pretest to posttest in both the SS and control groups. Significant correlations between the muscle hardness ratios at pretest and posttest were found in both groups. The results of this study suggest that the current SS program is useful for improving muscle condition in the plantar flexors, and that its long-term effects on the MG and LG hardnesses are of the same degree.	[Akagi, R.] Shibaura Inst Technol, Coll Syst Engn & Sci, Saitama 3378570, Japan; [Akagi, R.; Takahashi, H.] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan	Akagi, R (reprint author), Shibaura Inst Technol, Coll Syst Engn & Sci, Minuma Ku, 307 Fukasaku, Saitama 3378570, Japan.	rakagi12@sic.shibaura-it.ac.jp			 [24700689]	This study was supported by a Grant-in-Aid for Young Scientists (B) (No. 24700689).	Kokkonen J, 2007, MED SCI SPORT EXER, V39, P1825, DOI 10.1249/mss.0b013e3181238a2b; Ushiyama J, 2011, MED SCI SPORT EXER, V43, P2089, DOI 10.1249/MSS.0b013e31821e512d; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Kubo K, 2002, J APPL PHYSIOL, V92, P595; Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008; WILLIAMS PE, 1990, ANN RHEUM DIS, V49, P316, DOI 10.1136/ard.49.5.316; Riener R, 1999, J BIOMECH, V32, P539, DOI 10.1016/S0021-9290(99)00009-3; ROSS BH, 1995, BRAIN, V118, P983, DOI 10.1093/brain/118.4.983; Soucie JM, 2011, HAEMOPHILIA, V17, P500, DOI 10.1111/j.1365-2516.2010.02399.x; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Akagi R, 2009, AGE AGEING, V38, P564, DOI 10.1093/ageing/afp122; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Nakamura M, 2012, EUR J APPL PHYSIOL, V112, P2749, DOI 10.1007/s00421-011-2250-3; Morisada M, 2006, EUR J APPL PHYSIOL, V97, P681, DOI 10.1007/s00421-006-0225-6; Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012; Murayama M, 2000, EUR J APPL PHYSIOL, V82, P361, DOI 10.1007/s004210000242; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Gennisson JL, 2005, J BIOMECH, V38, P1543, DOI 10.1016/j.jbiomech.2004.07.013; PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4; Marshall PWM, 2011, J SCI MED SPORT, V14, P535, DOI 10.1016/j.jsams.2011.05.003; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398; Guissard N, 2004, MUSCLE NERVE, V29, P248, DOI 10.1002/mus.10549; Fukunaga T, 1996, J APPL PHYSIOL, V80, P158; Ben M, 2010, SCAND J MED SCI SPOR, V20, P136, DOI 10.1111/j.1600-0838.2009.00926.x; Fischer AA, 1987, CLIN J PAIN, V3, P23, DOI 10.1097/00002508-198703010-00005; Folpp H, 2006, AUST J PHYSIOTHER, V52, P45; Gajdosik RL, 2007, EUR J APPL PHYSIOL, V99, P449, DOI 10.1007/s00421-006-0366-7; KANEHISA H, 1994, INT J SPORTS MED, V15, P420, DOI 10.1055/s-2007-1021081; Okita M, 2001, J Jpn Phys Ther Assoc, V4, P1, DOI 10.1298/jjpta.4.1; STAUBER WT, 1994, J APPL PHYSIOL, V77, P58; Youdas JW, 2003, J ORTHOP SPORT PHYS, V33, P408	35	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2014	24	6					950	957		10.1111/sms.12111		8	Sport Sciences	Sport Sciences	AU6HB	WOS:000345703300024		
J	Dong, HJ; Geng, Y; Fujita, T; Fujii, M; Hao, D; Yu, XM				Dong, Huijuan; Geng, Yong; Fujita, Tsuyoshi; Fujii, Minoru; Hao, Dong; Yu, Xiaoman			Uncovering regional disparity of China's water footprint and inter-provincial virtual water flows	SCIENCE OF THE TOTAL ENVIRONMENT			English	Article						Water footprint; Virtual water; Regional disparity; Trade balance; IRIO	INPUT-OUTPUT-ANALYSIS; CROP PRODUCTION; RIVER-BASIN; TRADE; CONSUMPTION; RESOURCES; MANAGEMENT; CHALLENGE; NATIONS; MODEL	With rapid economic development in China, water crisis is becoming serious and may impede future sustainable development. The uneven distribution of water resources further aggravates such a problem. Under such a circumstance, the concepts of water footprint and virtual water have been proposed in order to respond water scarcity problems. This paper focuses on studying provincial disparity of China's water footprints and interprovincial virtual water trade flows by adopting inter-regional input-output (IRIO) method. The results show that fast developing areas with larger economic scales such as Guangdong, Jiangsu, Shandong, Zhejiang, Shanghai and Xinjiang had the largest water footprints. The most developed and water scarce areas such as Shanghai, Beijing, Tianjin and Shandong intended to import virtual water, a rational choice for mitigating their water crisis. Xinjiang, Jiangsu, Heilongjiang, Inner Mongolia, Guangxi and Hunan, had the largest per GDP water intensities and were the main water import regions. Another key finding is that agriculture water footprint was the main part in water footprint composition and water export trade. On the basis of these findings, policy implications on agriculture geographical dispersion, consumption behavior changes, trade structure adjustment and water use efficiency improvement are further discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Dong, Huijuan; Fujita, Tsuyoshi; Fujii, Minoru] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Geng, Yong] Shanghai Jiao Tong Univ, Sch Environm Sci & Technol, Shanghai 200240, Peoples R China; [Dong, Huijuan; Geng, Yong; Yu, Xiaoman] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Hao, Dong] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Geng, Y (reprint author), Shanghai Jiao Tong Univ, Sch Environm Sci & Technol, Shanghai 200240, Peoples R China.	ygeng@sjtu.edu.cn; fujita77@nies.go.jp			Environment Research and Technology Development Fund of the Ministry of Environment of Japan [S-7-2, K113002]; Natural Science Foundation of China [71033004, 71325006, 71311140172]	This study was financially supported by the Environment Research and Technology Development Fund of the Ministry of Environment of Japan (S-7-2, K113002) and Natural Science Foundation of China (71033004, 71325006, 71311140172).	Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; Ma J, 2006, PHILOS T R SOC B, V361, P835, DOI 10.1098/rstb.2005.1644; Pfister S, 2011, ENVIRON SCI TECHNOL, V45, P5761, DOI 10.1021/es1041755; Zhang JL, 2007, AGR WATER MANAGE, V87, P32, DOI 10.1016/j.agwat.2006.05.020; Zhang ZY, 2012, ENVIRON SCI TECHNOL, V46, P12373, DOI 10.1021/es302576u; Wang ZY, 2013, J CLEAN PROD, V42, P172, DOI 10.1016/j.jclepro.2012.11.007; Zhang ZY, 2011, ECON SYST RES, V23, P431, DOI 10.1080/09535314.2011.636733; Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Yu CQ, 2011, NATURE, V470, P307, DOI 10.1038/470307a; Wang Y, 2009, J ARID ENVIRON, V73, P894, DOI 10.1016/j.jaridenv.2009.04.005; Zhang ZY, 2011, ECOL ECON, V70, P2494, DOI 10.1016/j.ecolecon.2011.08.011; Feng KS, 2012, APPL GEOGR, V32, P691, DOI 10.1016/j.apgeog.2011.08.004; Dong HJ, 2013, SCI TOTAL ENVIRON, V442, P215, DOI 10.1016/j.scitotenv.2012.10.049; [Anonymous], 2010, WATER RESOUR MANAG, DOI DOI 10.1007/S11269-009-9480-8; Chen ZM, 2013, ECOL INDIC, V28, P142, DOI 10.1016/j.ecolind.2012.07.024; Ge LQ, 2011, WATER RESOUR MANAG, V25, P2633, DOI 10.1007/s11269-011-9830-1; Hoekstra AY, 2005, GLOBAL ENVIRON CHANG, V15, P45, DOI 10.1016/j.gloenvcha.2004.06.004; Zhang C, 2014, ECOL ECON, V100, P159, DOI 10.1016/j.ecolecon.2014.02.006; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Munksgaard J, 2005, J IND ECOL, V9, P169, DOI 10.1162/1088198054084699; Khan S, 2009, AGR WATER MANAGE, V96, P349, DOI 10.1016/j.agwat.2008.09.022; Guan D, 2007, ECOL ECON, V61, P159, DOI 10.1016/j.ecolecon.2006.02.022; Chapagain AK, 2004, WATER FOOTPRINTS NAT, V16; Choi JH, 2010, INT J PROJ MANAG, V28, P580, DOI 10.1016/j.ijproman.2009.10.010; Ercin AE, 2014, ENVIRON INT, V64, P71, DOI 10.1016/j.envint.2013.11.019; Geng Y, 2010, J CLEAN PROD, V18, P1502, DOI 10.1016/j.jclepro.2010.06.028; Geng Y, 2007, REG ENVIRON CHANGE, V7, P123, DOI 10.1007/s10113-007-0026-4; Gerbens-Leenes W, 2012, ENVIRON INT, V40, P202, DOI 10.1016/j.envint.2011.06.006; Gong P, 2011, SCIENCE, V331, P1264, DOI 10.1126/science.331.6022.1264-b; He BY, 2003, P SOC PHOTO-OPT INS, V4890, P285, DOI 10.1117/12.466760; Hoekstra A. J., 2003, VALUE WATER RES REPO, V13; Hoekstra AY, 2003, P INT EXP M VIRT WAT, V12, P1; Hoekstra AY, 2011, WATER FOOTPRINT ASSE, P1; Hoekstra AY, 2009, WATER FOOTPRINT REPO; Liu W, 2012, THEORY PRACTICE CHIN; Ministry of Water Resources People's Republic of China, 2007, CHIN WAT RES B, V2007; Mohanty KK, 2003, AICHE J, V49, P2454, DOI 10.1002/aic.690491002; National Bureau of Statistics People's Republic of China, 2008, CHIN STAT YB 2008; Raskin P., 1997, WATER FUTURES ASSESS; Seckler DW, 1998, WORLD WAT DEM SUPPL; Smakhtin V, 2004, COMPREHENSIVE ASSESS, P1; State Statistics Bureau, 2008, CHINA EC CENS YB, V2008; Sun L, 2014, ECOL ECON, V30, P12; Tian L, 2011, INN MONG WATER RES, V136, P146; United Nations (UN), 2003, 1 UN WORLD WAT DEV R, P1; Velazquez E, 2011, WATER RESOUR MANAG, V25, P743, DOI 10.1007/s11269-010-9724-7; Wang Yan, 2005, Water Policy, V7, P345; Wong S, 2007, WORLD REV REV; Yardley J, 2007, NY TIMES, P28	50	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-9697	1879-1026		SCI TOTAL ENVIRON	Sci. Total Environ.	DEC 1	2014	500						120	130		10.1016/j.scitotenv.2014.08.094		11	Environmental Sciences	Environmental Sciences & Ecology	AU6OX	WOS:000345723100013		
J	Xu, XG; Li, W; Fujibayashi, M; Nomura, M; Sakamaki, T; Nishimura, O; Li, XN				Xu, Xiaoguang; Li, Wei; Fujibayashi, Megumu; Nomura, Munehiro; Sakamaki, Takashi; Nishimura, Osamu; Li, Xianning			Feedback of threshold via estimating sources and composition of sedimentary organic matter across trophic gradients in freshwater lakes	SCIENCE OF THE TOTAL ENVIRONMENT			English	Article						Sedimentary organic matter; Source identification; Fatty acid biomarker; Trophic gradient; Freshwater lakes	FATTY-ACID BIOMARKERS; STABLE-ISOTOPES; LIPID BIOMARKER; EUTROPHIC LAKE; FOOD-WEB; CHINA; TAIHU; SHALLOW; CARBON; RIVER	The quantity and quality of sedimentary organic matter (SOM) in relation to material and energy flows are crucial for understanding the current state and future development of lake systems, yet, characterization of organic matter sources and assessment of their relative contributions in different trophic-state lakes caused by anthropogenic impacts are scarcely known. In this study, for obtaining information concerning the source of SOM and its compositional diversity along different trophic gradients, a total of thirty-one sampling sites from four freshwater lakes located in China and Japan were performed by the molecular level analysis using source-specific fatty acid biomarkers. Results indicated that SOM in these lakes was composed of microalgae-, aquatic plant-, terrestrial plant- and bacteria-derived organic matters based on their fatty acid profiles. The scatter plot matrix exhibited correlations between these sources, however, only terrestrial plant-derived organic carbon was a well predictor for sediment TOC with strong, spatiotemporal dynamics. The source and composition of SOM were evidently influenced by lake trophic state with redundancy analysis. Moreover, increase of lake trophic state led to the relatively higher contribution of aquatic organic matter sources to SOM pool compared with terrigenous sources, as evidenced by significant correlations between the trophic state index [TSI (TP)] and the ratio of terrigenous to aquatic fatty acids (TAR(FA) ratio). Yet, this changing trend became more gradual with higher trophic state and prevented the occurrence of regime shift from allochthonous to autochthonous dominant state by a threshold (0.683) of TAR(FA) ratio. Together, a conceptual diagram was proposed, which highlighted the prevailing state of allochthonous source and implicated sedimentary organics in biogeochemistry cycle within freshwater lakes. (C) 2014 Elsevier B.V. All rights reserved.	[Xu, Xiaoguang; Li, Wei; Fujibayashi, Megumu; Nomura, Munehiro; Sakamaki, Takashi; Nishimura, Osamu] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Li, Xianning] Southeast Univ, Sch Energy & Environm, Nanjing 210096, Jiangsu, Peoples R China	Li, W (reprint author), Tohoku Univ, Grad Sch Engn, Aoba 6-6-06, Sendai, Miyagi 9808579, Japan.	liwei@eco.civil.tohoku.ac.jp; osamurajp@gmail.com	许, 晓光/A-1532-2015		Tohoku University Ecosystem Adaptability Global Centers of Excellence (GCOE) by Japan's Ministry of Education, Culture, Sports, Science and Technology [J03]; Environmental Research and Technology Development Fund of the Ministry of Environment, Japan [B-1004]	We would like to thank Hailiang Song, Xiaoli Yang and other teachers of Southeast University (China) for their assistance in the field. We are grateful to the staff of YiXing Environmental Monitoring Station (China) for their help with the freeze-dry aspect of this work. This research was supported by Tohoku University Ecosystem Adaptability Global Centers of Excellence (GCOE) awarded by Japan's Ministry of Education, Culture, Sports, Science and Technology (J03), and the Environmental Research and Technology Development Fund of the Ministry of Environment, Japan (B-1004).	Aizaki M, 1981, RES REP NATL I ENV S, V23, P13; Meyers PA, 1997, ORG GEOCHEM, V27, P213, DOI 10.1016/S0146-6380(97)00049-1; Volkman JK, 2008, ORG GEOCHEM, V39, P689, DOI 10.1016/j.orggeochem.2008.02.014; Nagao S, 2002, J RADIOANAL NUCL CH, V252, P225, DOI 10.1023/A:1015741616963; Quijon PA, 2008, J EXP MAR BIOL ECOL, V366, P134, DOI 10.1016/j.jembe.2008.07.017; Zimmerman AR, 2001, ESTUAR COAST SHELF S, V53, P319, DOI 10.1006/ecss.2001.0815; PRESTON T, 1980, NATURE, V288, P365, DOI 10.1038/288365a0; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Meziane T, 2000, MAR ECOL PROG SER, V200, P49, DOI 10.3354/meps200049; Abdulkadir S, 2008, J EXP MAR BIOL ECOL, V354, P1, DOI 10.1016/j.jembe.2007.08.024; CANUEL EA, 1993, ORG GEOCHEM, V20, P563, DOI 10.1016/0146-6380(93)90024-6; Rossi L, 2010, AQUAT SCI, V72, P227, DOI 10.1007/s00027-009-0125-z; Woszczyk M, 2011, ORG GEOCHEM, V42, P1025, DOI 10.1016/j.orggeochem.2011.07.002; Waterson EJ, 2008, ORG GEOCHEM, V39, P422, DOI 10.1016/j.orggeochem.2008.01.011; Pearson EJ, 2007, ORG GEOCHEM, V38, P1169, DOI 10.1016/j.orggeochem.2007.02.007; Alfaro AC, 2006, ESTUAR COAST SHELF S, V70, P271, DOI 10.1016/j.ecss.2006.06.017; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; Gudasz C, 2012, LIMNOL OCEANOGR, V57, P163, DOI 10.4319/lo.2012.57.1.0163; Bourbonniere RA, 1996, LIMNOL OCEANOGR, V41, P352; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Otten TG, 2012, ENVIRON SCI TECHNOL, V46, P3480, DOI 10.1021/es2041288; Hieber M, 2002, ECOLOGY, V83, P1026, DOI 10.2307/3071911; Dunn RJK, 2008, CONT SHELF RES, V28, P2535, DOI 10.1016/j.csr.2008.04.009; Gui ZF, 2013, HYDROBIOLOGIA, V710, P143, DOI 10.1007/s10750-012-1365-9; Attermeyer K, 2013, ECOLOGY, V94, P2754, DOI 10.1890/13-0420.1; Mortillaro JM, 2011, ORG GEOCHEM, V42, P1159, DOI 10.1016/j.orggeochem.2011.08.011; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361; Toming K, 2013, LIMNOL OCEANOGR, V58, P1259, DOI 10.4319/lo.2013.58.4.1259; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; EBINA J, 1983, WATER RES, V17, P1721, DOI 10.1016/0043-1354(83)90192-6; Cook PLM, 2004, MAR ECOL PROG SER, V280, P55, DOI 10.3354/meps280055; de Kluijver A, 2012, LIMNOL OCEANOGR, V57, P1245, DOI 10.4319/lo.2012.57.4.1245; Gonzalez-Vila FJ, 2003, ORG GEOCHEM, V34, P1601, DOI 10.1016/j.orggeochem.2003.08.006; Hayakawa Kazuhide, 2002, Limnology, V3, P29, DOI 10.1007/s102010200003; Hu J, 2006, ESTUAR COAST SHELF S, V66, P346; Makino W, 2001, HYDROBIOLOGIA, V442, P309, DOI 10.1023/A:1017532717135; Miyagi Prefecture. Japan, 2010, 4 NAT REST IMPL PLAN, P10; Mudge SM, 1998, ORG GEOCHEM, V29, P963, DOI 10.1016/S0146-6380(98)00049-7; Napolitano G.E., 1999, LIPIDS FRESHWATER EC, P21, DOI DOI 10.1007/978-1-4612-0547-0_; OECD, 1982, FINAL REPORT; Parrish CC, 2000, HANDB ENVIRON CHEM, V5, P193; RAJENDRAN N, 1993, MAR CHEM, V42, P39, DOI 10.1016/0304-4203(93)90248-M; Sun Shuncai, 2008, V87, P1; Wang LF, 2013, ENVIRON SCI POLLUT R, V20, P2390, DOI 10.1007/s11356-012-1122-7; WANNIGAMA GP, 1981, PHYTOCHEMISTRY, V20, P659, DOI 10.1016/0031-9422(81)85152-7; Wu XD, 2009, INT REV HYDROBIOL, V94, P258, DOI 10.1002/iroh.200811141; [邢鹏 XING Peng], 2007, [生态学报, Acta Ecologica Sinica], V27, P1696; Yasuno N, 2012, LIMNOLOGY, V13, P107, DOI 10.1007/s10201-011-0360-6; Zhu M, 1994, ENV PROTECTION LAKE, P269	50	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-9697	1879-1026		SCI TOTAL ENVIRON	Sci. Total Environ.	DEC 1	2014	500						373	382		10.1016/j.scitotenv.2014.08.113		10	Environmental Sciences	Environmental Sciences & Ecology	AU6OX	WOS:000345723100037		
J	Deng, DJ; Shu, L; Kato, N				Deng, Der-Jiunn; Shu, Lei; Kato, Nei			Digital forensics in mobile computing system and ubiquitous wireless networks	SECURITY AND COMMUNICATION NETWORKS			English	Editorial Material									[Deng, Der-Jiunn] Natl Changhua Univ Educ, Dept Comp Sci & Informat Engn, Changhua, Taiwan; [Shu, Lei] Guangdong Univ Petrochem Technol, Maoming, Guangdong, Peoples R China; [Kato, Nei] Tohoku Univ, Ctr Comp, Sendai, Miyagi 980, Japan; [Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan	Deng, DJ (reprint author), Natl Changhua Univ Educ, Dept Comp Sci & Informat Engn, Changhua, Taiwan.							0	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-0114	1939-0122		SECUR COMMUN NETW	Secur. Commun. Netw.	DEC	2014	7	12					2492	2494		10.1002/sec.1167		3	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AU5FW	WOS:000345633500021		
J	Han, GJ; Shen, W; Duong, TQ; Guizani, M; Hara, T				Han, Guangjie; Shen, Wen; Duong, Trung Q.; Guizani, Mohsen; Hara, Takahiro			A proposed security scheme against Denial of Service attacks in cluster-based wireless sensor networks	SECURITY AND COMMUNICATION NETWORKS			English	Article						trust; denial of service; cluster; sensor networks; energy prediction	ROUTING PROTOCOL	Traditional security schemes developed for sensor networks are not suitable for cluster-based wireless sensor networks (WSNs) because of their susceptibility to Denial of Service (DoS) attacks. In this paper, we provide a security scheme against DoS attacks (SSAD) in cluster-based WSNs. The scheme establishes trust management with energy character, which leads nodes to elect trusted cluster heads. Furthermore, a new type of vice cluster head node is proposed to detect betrayed cluster heads. Theoretical analyses and simulation results show that SSAD can prevent and detect malicious nodes with high probability of success. Copyright (c) 2011 John Wiley & Sons, Ltd.	[Han, Guangjie; Shen, Wen] Hohai Univ, Dept Informat & Commun Syst, Changzhou, Peoples R China; [Han, Guangjie; Shen, Wen] Changzhou Key Lab Sensor Networks & Environm Sens, Changzhou, Peoples R China; [Duong, Trung Q.] Blekinge Inst Technol, Karlskrona, Sweden; [Guizani, Mohsen] Kuwait Univ, Kuwait, Kuwait; [Hara, Takahiro] Osaka Univ, Dept Multimedia Engn, Suita, Osaka 565, Japan	Han, GJ (reprint author), Hohai Univ, Dept Informat & Commun Syst, Changzhou, Peoples R China.	hanguangjie@gmail.com	Duong, Trung Q./I-1291-2013	Duong, Trung Q./0000-0002-4703-4836	Excellent Master Research Funds for the Hohai University [XZX/09B011-02]; Fundamental Research Funds for the Central Universities [2010B22814, 2010B22914, 2010B24414]; Jiangsu Key Laboratory of Power Transmission and Distribution Equipment Technology [2010JSSPD04]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21220002]	The work is supported by "the Excellent Master Research Funds for the Hohai University, no. XZX/09B011-02" and "the Fundamental Research Funds for the Central Universities, no. 2010B22814, 2010B22914, 2010B24414," and " the research fund of Jiangsu Key Laboratory of Power Transmission and Distribution Equipment Technology, no. 2010JSSPD04." Takahiro Hara's research in this paper was supported by the Grant-in-Aid for Scientific Research (S) (21220002) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Chen XQ, 2009, IEEE COMMUN SURV TUT, V11, P52, DOI 10.1109/SURV.2009.090205; Cagalj M, 2007, IEEE T MOBILE COMPUT, V6, P100, DOI 10.1109/TMC.2007.250674; Maarouf I, 2009, IET COMMUN, V3, P846, DOI 10.1049/iet-com.2008.0324; Dang H, 2010, IEEE T WIREL COMMUN, V9, P1874, DOI 10.1109/TWC.2010.06.081216; Blaze M, 1996, P IEEE S SECUR PRIV, P164, DOI 10.1109/SECPRI.1996.502679; Boukerchs A, 2007, COMPUT COMMUN, P2413; Crosbys GV, 2007, P 4 IEEE CONS COMM N, P604; Crosbys GV, 2006, P 2 IEEE WORKSH DEP; Elhdhili ME, 2008, COMPUT COMMUN, V31, P2972, DOI 10.1016/j.comcom.2008.04.001; Guos MH, 2010, IET INFORM SECUR, V4, P352; Hans G, 2010, J COMMUNICATIONS, V5, P23; Heinzelman W., 2000, P 33 ANN HAW INT C S, P3005, DOI DOI 10.1109/HICSS.2000.926982; Kuis R, 2008, IEEE T MOBILE COMPUT, V7, P585; Muruganathan SD, 2010, IEEE COMMUN LETT, V14, P486, DOI 10.1109/LCOMM.2010.05.091473; Shaikhs RA, 2009, IEEE T PARALL DISTR, V2, P1698; Suns Y, 2008, IEEE COMMUNICATIONS, V46, P112; Vullers R., 2010, IEEE SOLID STATE CIR, V2, P29, DOI DOI 10.1109/MSSC.2010.936667; Xus M, 2006, P COMP INT SEC CIS P, P1541; Youngs KT, 2010, IEEE T COMPUT, V59, P1120	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-0114	1939-0122		SECUR COMMUN NETW	Secur. Commun. Netw.	DEC	2014	7	12					2542	2554		10.1002/sec.373		13	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AU5FW	WOS:000345633500025		
J	Tamura, A; Tsukita, S				Tamura, Atsushi; Tsukita, Sachiko			Paracellular barrier and channel functions of TJ claudins in organizing biological systems: Advances in the field of barriology revealed in knockout mice	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						Claudin; Tight junction; Microenvironment; Paracellular barrier; Cell-cell adhesion	TIGHT JUNCTION STRANDS; CLAUDIN-1-DEFICIENT MICE; SUBCELLULAR-LOCALIZATION; CLAUDIN-7-DEFICIENT MICE; ZONULAE-OCCLUDENTES; ENDOTHELIAL-CELLS; STEM-CELLS; RAT-LIVER; EXPRESSION; CATION	Claudin was first identified as a four-transmembrane protein in the tight junctions (TJs) between epithelial cells. The claudin family has 27 members, which are specifically expressed depending on the epithelial cell type. Accumulating evidence has revealed that claudins are responsible for the paracellular barrier that prevents molecules from passing through epithelial cell sheets. In addition, the extracellular domains of some claudins enable them to act as a permselective paracellular channel for specific molecules, including ions and/or non-ionic solutes. Recent studies using claudin knockout mice revealed that the loss of claudins' specific paracellular barrier and/or channel functions affects specific biological functions and leads to pathological states. In this review, considering recent findings in vivo, we describe how, sometimes in concert with canonical transporters and channels, the paracellular barrier and channel functions of claudins sophisticatedly organize biological systems. (C) 2014 Published by Elsevier Ltd.	[Tsukita, Sachiko] Osaka Univ, Grad Sch Frontier Biosci, Biol Sci Lab, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Osaka 5650871, Japan	Tsukita, S (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Biol Sci Lab, Osaka 5650871, Japan.	atsukita@biosci.med.osaka-u.ac.jp			Ministry of Education, Culture, and Sports, Science and Technology of Japan; CREST (Core Research for Evolutional Science and Technology) of Japan Science and Technology Agency	We thank all the members of our laboratory for helpful discussions. We thank Drs. H. Suziki, K. Tani, and Y. Fujiyoshi in Nagoya University for collaboration and discussion. Our program is supported by Grants-in-Aid for Scientific Research (A) and Creative Scientific Research from the Ministry of Education, Culture, and Sports, Science and Technology of Japan, and by CREST (Core Research for Evolutional Science and Technology) of Japan Science and Technology Agency to Sachiko Tsukita.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Tamura A, 2011, GASTROENTEROLOGY, V140, P913, DOI 10.1053/j.gastro.2010.08.006; Sugawara T, 2013, J DERMATOL SCI, V70, P12, DOI 10.1016/j.jdermsci.2013.01.002; TSUKITA S, 1989, J CELL BIOL, V108, P31, DOI 10.1083/jcb.108.1.31; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; POWELL DW, 1981, AM J PHYSIOL, V241, pG275; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Knipp GT, 1997, J PHARM SCI, V86, P1105, DOI 10.1021/js9700309; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Wang LL, 2012, CELL RES, V22, P1082, DOI 10.1038/cr.2012.77; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Kitajiri SI, 2004, J CELL SCI, V117, P5087, DOI 10.1242/jcs.01393; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Tatum R, 2010, AM J PHYSIOL-RENAL, V298, pF24, DOI 10.1152/ajprenal.00450.2009; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Alexandre MD, 2005, J CELL SCI, V118, P2683, DOI 10.1242/jcs.02406; Kwon MJ, 2013, INT J MOL SCI, V14, P18148, DOI 10.3390/ijms140918148; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Hayashi D, 2012, GASTROENTEROLOGY, V142, P292, DOI 10.1053/j.gastro.2011.10.040; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; McMillan M, 2014, REPROD FERT DEVELOP, V26, P633, DOI 10.1071/RD12259; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Breiderhoff T, 2012, P NATL ACAD SCI USA, V109, P14241, DOI 10.1073/pnas.1203834109; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Ding Lei, 2013, Cancer Manag Res, V5, P367, DOI 10.2147/CMAR.S38294; Ehrlich P, 1885, SAUERSTOFFBEDUERFNIS, V8, P167; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Imasato M, 2014, GASTROENTER IN PRESS; Kawai Y, 2011, P NATL ACAD SCI USA, V108, P4075, DOI 10.1073/pnas.1014178108; Li GL, 2014, AM J RESP CELL MOL, V51, P210, DOI 10.1165/rcmb.2013-0353OC; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200401154; Nagatake T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090638; Niimi T, 2001, MOL CELL BIOL, V21, P7380, DOI 10.1128/MCB.21.21.7380-7390.2001; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Wada M, 2013, GASTROENTEROLOGY, V144, P369, DOI 10.1053/j.gastro.2012.10.035; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Watson CJ, 2001, AM J PHYSIOL-CELL PH, V281, pC388; Will C, 2010, AM J PHYSIOL-RENAL, V298, pF1152, DOI 10.1152/ajprenal.00499.2009	69	7	7	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	DEC	2014	36						177	185		10.1016/j.semcdb.2014.09.019		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	AU3NC	WOS:000345519300022		
J	Izumi, Y; Furuse, M				Izumi, Yasushi; Furuse, Mikio			Molecular organization and function of invertebrate occluding junctions	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						Epithelial cell; Permeability barrier; Occluding junction; Septate junction; Tight junction; Drosophila	TUBE-SIZE CONTROL; BLOOD-BRAIN-BARRIER; DROSOPHILA TRACHEAL SYSTEM; SMOOTH SEPTATE JUNCTIONS; CENTRAL NERVOUS-SYSTEM; FREEZE-FRACTURE; CELL-JUNCTIONS; TRICELLULAR JUNCTIONS; INTERCELLULAR-JUNCTIONS; TRANSMEMBRANE PROTEIN	Septate junctions (SJs) are specialized intercellular junctions that function as permeability barriers to restrict the free diffusion of solutes through the paracellular routes in invertebrate epithelia. SJs are subdivided into several morphological types that vary among different animal phyla. In several phyla, different types of SJ have been described in different epithelia within an individual. Arthropods have two types of SJs: pleated SJs (pSJs) and smooth SJs (sSJs), found in ectodermally and endodermally derived epithelia, respectively. Several lines of Drosophila research have identified and characterized a large number of pSJ-associated proteins. Two sSJ-specific proteins have been recently reported. Molecular dissection of SJs in Drosophila and animals in other phyla will lead to a better understanding of the functional differences among SJ types and of evolutionary aspects of these permeability barriers. (C) 2014 Elsevier Ltd. All rights reserved.	[Izumi, Yasushi; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol,Div Cell Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan	Izumi, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol,Div Cell Biol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yizumi@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [26291043]	We are very grateful to Kyoko Furuse for providing the electron micrograph in Fig. 2. This work is supported by the Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (26291043).	Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Gunzel D, 2012, COMPR PHYSIOL, V2, P1819, DOI 10.1002/cphy.c110045; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Oshima K, 2011, J CELL SCI, V124, P2861, DOI 10.1242/jcs.087700; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Izumi Y, 2012, J CELL SCI, V125, P4923, DOI 10.1242/jcs.112243; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Strigini M, 2006, MOL CELL NEUROSCI, V32, P91, DOI 10.1016/j.mcn.2006.03.001; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1016/S0022-2836(84)71582-8; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yanagihashi Y, 2012, J CELL SCI, V125, P1980, DOI 10.1242/jcs.096800; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; Hartenstein V, 2000, DEV GENES EVOL, V210, P399, DOI 10.1007/s004270000085; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bonnay F, 2013, P NATL ACAD SCI USA, V110, P2957, DOI 10.1073/pnas.1221910110; Rodrigues F, 2011, CELL MOL LIFE SCI, V68, P55, DOI 10.1007/s00018-010-0512-6; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Syed MH, 2011, J NEUROSCI, V31, P7876, DOI 10.1523/JNEUROSCI.0766-11.2011; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Asano A, 2003, CURR BIOL, V13, P1042, DOI 10.1016/S0960-9822(03)00395-6; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bachmann A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-55; Baldwin KM, 1999, TISSUE CELL, V31, P195, DOI 10.1054/tice.1999.0024; BALDWIN KM, 1987, TISSUE CELL, V19, P413, DOI 10.1016/0040-8166(87)90036-X; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Batz T, 2014, DEVELOPMENT, V141, P899, DOI 10.1242/dev.102160; Baumann O, 2001, EXP CELL RES, V270, P176, DOI 10.1006/excr.2001.5343; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P113, DOI 10.1016/S0968-0004(01)02049-7; COLOMBATTI A, 1993, MATRIX, V13, P297; DAVIDSON LA, 1983, TISSUE CELL, V15, P27, DOI 10.1016/0040-8166(83)90031-9; DUVERT M, 1980, J CELL SCI, V42, P227; FAINMAUR.MA, 1972, J ULTRA MOL STRUCT R, V39, P222, DOI 10.1016/S0022-5320(72)90019-6; FEHON RG, 1994, DEVELOPMENT, V120, P545; FLOWER NE, 1971, J ULTRA MOL STRUCT R, V37, P259, DOI 10.1016/S0022-5320(71)80123-5; FLOWER NE, 1975, J CELL SCI, V17, P221; FRISTROM DK, 1982, J CELL BIOL, V94, P77, DOI 10.1083/jcb.94.1.77; GRAF F, 1982, J ULTRA MOL STRUCT R, V78, P136, DOI 10.1016/S0022-5320(82)80019-1; GREEN CR, 1981, J ULTRA MOL STRUCT R, V75, P1, DOI 10.1016/S0022-5320(81)80095-0; GREEN CR, 1980, J CELL SCI, V42, P43; GREEN CR, 1981, TISSUE CELL, V13, P173, DOI 10.1016/0040-8166(81)90047-1; GREEN CR, 1982, J CELL SCI, V53, P279; GREEN CR, 1981, J ULTRA MOL STRUCT R, V75, P11, DOI 10.1016/S0022-5320(81)80096-2; GREEN CR, 1983, J CELL SCI, V62, P351; Hall S, 2014, DEVELOPMENT, V141, P889, DOI 10.1242/dev.102152; He KE, 2012, DEVELOPMENT, V139, P2535; Hijazi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017763; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; KLAMBT C, 1986, EMBO J, V5, P2955; KUKULIES J, 1983, J CELL SCI, V59, P159; LANE NJ, 1981, EXP CELL RES, V132, P482, DOI 10.1016/0014-4827(81)90126-9; LANE NJ, 1989, J NEUROCYTOL, V18, P661, DOI 10.1007/BF01187085; LANE NJ, 1977, J CELL SCI, V26, P175; Lane Nancy J., 1994, P23; LANE NJ, 1991, ANN NY ACAD SCI, V633, P348; LANE NJ, 1979, TISSUE CELL, V11, P481, DOI 10.1016/0040-8166(79)90058-2; LANE NJ, 1986, J CELL SCI, V84, P1; LANE NJ, 1989, J CELL SCI, V93, P123; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Laval M, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-38; LEDGER PW, 1975, TISSUE CELL, V7, P13; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; LOCKE M, 1965, J CELL BIOL, V25, P166, DOI 10.1083/jcb.25.1.166; LORBER V, 1972, J CELL SCI, V10, P211; LUTZELSCHWAB R, 1987, EMBO J, V6, P1791; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; MIRANDA JC, 1986, TISSUE CELL, V18, P461, DOI 10.1016/0040-8166(86)90065-0; Montell DJ, 2006, CURR OPIN GENET DEV, V16, P374, DOI 10.1016/j.gde.2006.06.010; Moyer KE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-99; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; NOIROTTIMOTHEE C, 1982, J ULTRA MOL STRUCT R, V78, P152, DOI 10.1016/S0022-5320(82)80020-8; Noirot-Timothee C., 1980, International Review of Cytology, V63, P97, DOI 10.1016/S0074-7696(08)61758-1; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; SAINTMARIE RL, 1983, J NEUROCYTOL, V12, P213, DOI 10.1007/BF01148463; Schulte J, 2003, J CELL BIOL, V161, P991, DOI 10.1083/jcb.200303192; SKAER HL, 1987, J CELL SCI, V88, P251; SPIEGEL E, 1983, J CELL SCI, V62, P27; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; SWALES LS, 1985, J NEUROSCI, V5, P117; SZOLLOSI A, 1977, J ULTRA MOL STRUCT R, V59, P158, DOI 10.1016/S0022-5320(77)80076-2; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tate J, 1998, MEANJIN, V57, P9; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; WELSCH U, 1977, CELL TISSUE RES, V185, P527; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; WOOD RL, 1959, J BIOPHYS BIOCHEM CY, V6, P343, DOI 10.1083/jcb.6.3.343; Wu VM, 2007, DEVELOPMENT, V134, P999, DOI 10.1242/dev.02785; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134	111	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	DEC	2014	36						186	193		10.1016/j.semcdb.2014.09.009		8	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	AU3NC	WOS:000345519300023		
J	Shirahase, S; Raymo, JM				Shirahase, Sawako; Raymo, James M.			Single Mothers and Poverty in Japan: The Role of Intergenerational Coresidence	SOCIAL FORCES			English	Article							LIVING ARRANGEMENTS; FAMILY-STRUCTURE; WELFARE-REFORM; UNWED MOTHERS; INEQUALITY; CHILDREN; MARRIAGE; CARE; COHABITATION; STRATEGIES	Single mothers' relatively high levels of poverty are well documented, but the role that intergenerational coresidence may play in mitigating this disadvantage is not well understood. In this paper, we use multiple rounds of a large national survey between 1986 and 2007 (n = 67,252) to evaluate the extent to which income sharing via intergenerational coresidence limits poverty among single mothers in Japan. Results indicate that conventional poverty rates based on single-mother households overstate the prevalence of poverty among single mothers by 12-20 percent as a result of excluding those who are coresiding with parents. We find no evidence that the prevalence of intergenerational coresidence has changed in a way that would offset the poverty-increasing effect of growth in single parenthood. Finally, we show not only that shared income is the most important factor in limiting poverty among single mothers living with parents, but also that many single mothers are coresiding with parents who are themselves economically disadvantaged. We discuss the implications of our findings for understanding relationships between rapid family change and poverty in countries like Japan, where public income support for single mothers is limited and where family support via intergenerational coresidence is both common and normative.	[Shirahase, Sawako] Univ Tokyo, Tokyo 1130033, Japan; [Raymo, James M.] Univ Wisconsin Madison, Ctr Demog & Ecol, Madison, WI USA	Shirahase, S (reprint author), Univ Tokyo, Dept Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sshiraha@l.u-tokyo.ac.jp					Abe A. K., 2003, JAPANESE J SOCIAL SE, V2, P59; Abe Aya, 2005, SOCIAL SECURITY HOUS, P143; Abe Aya K, 2008, CHILDRENS POVERTY ST; Akaishi Chieko, 2011, TRANSFORMING JAPAN F, P121; Western B, 2008, AM SOCIOL REV, V73, P903; Raymo JM, 2009, DEMOGRAPHY, V46, P785; Sigle-Rushton W, 2002, DEMOGRAPHY, V39, P415, DOI 10.2307/3088324; Bengtson VL, 2001, J MARRIAGE FAM, V63, P1, DOI 10.1111/j.1741-3737.2001.00001.x; Baydar N, 1998, FAM RELAT, V47, P385, DOI 10.2307/585269; Rindfuss RR, 2004, AM SOCIOL REV, V69, P838; Brown JB, 2004, RURAL SOCIOL, V69, P282, DOI 10.1526/003601104323087615; Lichter DT, 2003, SOC PROBL, V50, P60, DOI 10.1525/sp.2003.50.1.60; Teitler JO, 2004, SOC SERV REV, V78, P125, DOI 10.1086/380770; Raymo JM, 2008, J MARRIAGE FAM, V70, P847; Abebe T, 2007, SOC SCI MED, V64, P2058, DOI 10.1016/j.socscimed.2007.02.004; Martin MA, 2006, DEMOGRAPHY, V43, P421, DOI 10.1353/dem.2006.0025; McLanahan S, 2004, DEMOGRAPHY, V41, P607, DOI 10.1353/dem.2004.0033; Jones GW, 2007, POPUL DEV REV, V33, P453, DOI 10.1111/j.1728-4457.2007.00180.x; Tachibanaki T, 2006, JPN ECON REV, V57, P1, DOI 10.1111/j.1468-5876.2006.00355.x; Bauman Kurt J, 2000, 46 US CENS BUR; Blank RM, 2011, AARON WILDAV FORUM, V8, P1, DOI 10.1525/california/9780520266926.001.0001; Blank Rebecca M, 2006, PUBLIC POLICY INCOME, P33; Brinton MC, 2001, WOMENS WORKING LIVES, P1; Casper L. M., 2002, CHANGE CONTINUITY AM; CASPER LM, 1994, AM SOCIOL REV, V59, P594, DOI 10.2307/2095933; Christopher K, 2002, SOCIOL PERSPECT, V45, P219, DOI 10.1525/sop.2002.45.3.219; Christopher Karen, 2002, J POVERTY, V6, P61, DOI 10.1300/J134v06n02_04; Dalla Zuanna G., 2004, STRONG FAMILY LOW FE; Edin K, 1997, AM SOCIOL REV, V62, P253, DOI 10.2307/2657303; Ellwood David T, 2004, SOCIAL INEQUALITY, P3; Ezawa A., 2005, J SOCIOLOGY SOCIAL W, V32, P41; Fujiwara Chisa, 2007, J RES HOUSEHELD EC, P10; Furstenberg F. F., 1987, ADOLESCENT MOTHERS L; Goodman R., 1996, WELFARE STATES TRANS, P192; Gordon RA, 1999, J COMMUNITY PSYCHOL, V27, P525, DOI 10.1002/(SICI)1520-6629(199909)27:5<525::AID-JCOP3>3.0.CO;2-S; Haider S. J., 2006, WORKING POOR EC POLI, P205; Harada Sumitaka, 1988, WELFARE STATE TRANSI, P303; Iceland J, 2003, DEMOGRAPHY, V40, P499, DOI 10.2307/1515157; Iwata Masami, 2007, POVERTY CONT SOC WOR; Japan Institute for Labour Policy and Training, 2012, JAP I LAB POL TRAIN, V95; Kaestner R, 2003, J POLICY ANAL MANAG, V22, P225, DOI 10.1002/pam.10115; KAROLY LA, 1995, DEMOGRAPHY, V32, P379, DOI 10.2307/2061687; Lichter DT, 2004, SOC SCI RES, V33, P385, DOI 10.1016/j.ssresearch.2003.09.001; Magnuson Katherine, 2005, NAT POV CTR C MIX ME; Ministry of Health Labour and Welfare, 2012, REP 2011 NAT SURV SI; Misra J, 2012, RES SOC STRAT MOBIL, V30, P113, DOI 10.1016/j.rssm.2011.12.001; Mitchell B. A., 2006, BOOMERANG AGE TRANSI; MORGAN SP, 1983, AM SOCIOL REV, V48, P269, DOI 10.2307/2095111; Mutchler JE, 2009, J FAM ISSUES, V30, P1576, DOI 10.1177/0192513X09340527; National Institute of Population and Social Security Research, 2012, LAT DEM STAT; NicholsCasebolt A, 1997, J SOC SERV RES, V23, P19, DOI 10.1300/J079v23n01_02; Nishi Fumihiko, 2012, CHARACTERISTICS SING; OECD (the Organization for Economic Co-operation and Development), 2011, SOC IND; Ogawa N, 1997, POPUL DEV REV, V23, P59, DOI 10.2307/2137461; Ohtake F., 2005, INEQUALITY JAPAN ILL; Ono H., 2010, INT J LAW POLICY FAM, V24, P151; Osawa Machiko, 2006, WORK LIFE BALANCE SO; Raymo James M., 2004, DEMOGR RES, V11, P395, DOI DOI 10.4054/DEMRES.2004.11.14; Raymo JM, 2012, POPUL RES POLICY REV, V31, P727, DOI 10.1007/s11113-012-9247-4; Raymo JM, 2013, DEMOGR RES, V28, P177, DOI 10.4054/DemRes.2013.28.6; Reed Deborah, 2009, FOCUS, V26, P21; Sato Toshiki, 2000, UNEQUAL JAPAN; Shirahase S, 2014, NISSAN I ROUTL JPN S, P1; Short Kathleen, 2005, WORKING PAPER; Stack C. B., 1974, ALL OUR KIN STRATEGI; Tachibanaki Toshiaki, 1998, EC INEQUALITY JAPAN; Tamiya Yuko, 2007, SOCIAL SECURITY RES, V43, P219; Tokoro Michihiko, 2003, JAPANESE J SOCIAL SE, V2, P45; Tsumura Atsuko, 2002, SUPPORT CHILD REARIN, P19; Yuzawa Naomi, 2009, JAPANESE J SOCIAL SE, P16; Yuzawa Naomi, 2010, J OHARA I SOCIAL RES, V620, P49; Zhou Yanfei, 2008, RES EMPLOYMENT SUPPO, P26	72	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0037-7732	1534-7605		SOC FORCES	Soc. Forces	DEC	2014	93	2					545	569		10.1093/sf/sou077		25	Sociology	Sociology	AU8LS	WOS:000345848600035		
J	Nakashima, H; Imagama, S; Ito, Z; Ando, K; Matsui, H; Hirano, K; Tauchi, R; Muramoto, A; Matsumoto, T; Wakao, N; Ishiguro, N				Nakashima, Hiroaki; Imagama, Shiro; Ito, Zenya; Ando, Kei; Matsui, Hiroki; Hirano, Kenichi; Tauchi, Ryoji; Muramoto, Akio; Matsumoto, Tomohiro; Wakao, Norimitu; Ishiguro, Naoki			Intraoperative Neurological Deterioration Secondary to Spinal Kyphotic Change After Cervicothoracic Junction Laminectomy	SPINE			English	Article						cervicothoracic kyphosis; laminectomy; neurophysiological monitoring; complication; intramedullary spinal cord tumor; neurological complications; cervicothoracic junction; transcranial motor evoked potentials	SURGERY; DEFORMITY	Study Design. Case report. Objective. We report a case in which intraoperative spinal kyphosis after laminectomy led to neurological deterioration during intramedullary spinal cord tumor surgery at the cervicothoracic junction (CTJ). Summary of Background Data. CTJ is a transitional zone between the cervical and thoracic spine; this region can be easily affected by mechanical stress. Although postoperative spinal instability or kyphosis after laminectomy at CTJ has been reported, no reports of intraoperative neurological deterioration after laminectomy exist. Methods. The patient was a 40-year-old female with an intramedullary spinal cord tumor at T2 T4, which was suspected to be an ependymoma. She had no neurological deficit before the surgery. Although tumor removal surgery using a posterior approach was planned, the waves observed on intraoperative neurophysiological monitoring in the bilateral lower extremity disappeared soon after laminectomy. Results. The waveform reappeared when we manually corrected the kyphosis at CTJ by pushing the spine. However, when we stopped the manual correction, the waveform disappeared again. The cause of neurological deterioration was strongly suspected to be a spinal kyphosis secondary to laminectomy. We removed the tumor after posterior instrumentation, and her neurological status was restored in 3 months postoperatively. Conclusion. A minimal change in spinal alignment secondary to laminectomy could be a cause of intraoperative neurological deterioration during surgery at CTJ. Spinal fixation using spinal instrumentation should be performed before laminectomy, particularly in patients with preoperative neurological damage or severe spinal cord compression at CTJ.	[Nakashima, Hiroaki; Imagama, Shiro; Ito, Zenya; Ando, Kei; Matsui, Hiroki; Hirano, Kenichi; Tauchi, Ryoji; Muramoto, Akio; Matsumoto, Tomohiro; Wakao, Norimitu; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Nagoya, Aichi 4668560, Japan	Imagama, S (reprint author), Nagoya Univ, Dept Orthoped Surg, Grad Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668560, Japan.	imagama@med.nagoya-u.ac.jp					AN HS, 1994, SPINE, V19, P2557, DOI 10.1097/00007632-199411001-00011; Ramieri A, 2011, EUR SPINE J, V20, P13, DOI 10.1007/s00586-011-1748-z; Wang VY, 2007, NEUROSURG CLIN N AM, V18, P365, DOI 10.1016/j.nec.2007.02.012; YASUOKA S, 1982, J NEUROSURG, V57, P441, DOI 10.3171/jns.1982.57.4.0441; Steinmetz MP, 2006, J NEUROSURG-SPINE, V4, P278, DOI 10.3171/spi.2006.4.4.278; Inoue A, 1996, SPINAL CORD, V34, P536; Le Hoang, 2003, Neurosurg Focus, V15, pE3; Muramoto A, 2013, SPINE, V38, pE21, DOI 10.1097/BRS.0b013e3182796b15; Siu TLT, 2005, J NEUROSURG-SPINE, V3, P64, DOI 10.3171/spi.2005.3.1.0064; Stecker Mark M, 2012, Surg Neurol Int, V3, pS174, DOI 10.4103/2152-7806.98579	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436	1528-1159		SPINE	SPINE	DEC	2014	39	25					E1549	E1551		10.1097/BRS.0000000000000631		3	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU5CU	WOS:000345625600008		
J	Hanakita, S; Koga, T; Shin, M; Igaki, H; Saito, N				Hanakita, Shunya; Koga, Tomoyuki; Shin, Masahiro; Igaki, Hiroshi; Saito, Nobuhito			Application of Single-Stage Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations > 10 cm(3)	STROKE			English	Article						arteriovenous malformations; Gamma Knife radiosurgery; radiosurgery	GAMMA-KNIFE SURGERY; MARTIN GRADE-IV; TERM-FOLLOW-UP; CLINICAL ARTICLE; DOSE-RESPONSE; MANAGEMENT; OBLITERATION; HEMORRHAGE; OUTCOMES; RISK	Background and Purpose-Stereotactic radiosurgery (SRS) is a safe and effective treatment for small arteriovenous malformations (AVMs), the use of this modality for the treatment of large AVMs is still controversial, although it has been used in difficult cases. The aim of this study was to evaluate the treatment outcomes of patients who underwent single-stage SRS for large AVMs and to discuss the role of SRS in the treatment of these challenging lesions. Methods-Between 1998 and 2010, 65 patients with AVMs > 10 cm(3) underwent single-stage SRS using the Leksell Gamma Knife. Patients who had prospective volume-staged SRS were excluded from this series. Outcomes including the rates of obliteration, hemorrhage after treatment, and adverse events were retrospectively evaluated. Results-The mean nidus volume was 14.9 cm(3) (+/- 3.8 cm(3)), and a mean margin dose of 20 Gy (+/- 1.5 Gy) was applied. The mean observation period was 60 months (range, 7-178 months). The nidus obliteration rates after SRS were 44%, 76%, and 81% at 3, 5, and 6 years, respectively. The annual hemorrhage rate after SRS was 1.94% and permanent adverse events were observed in 2 patients (3%). Conclusions-For large AVMs < 20 cm(3), single-stage radiosurgery by applying > 16 Gy marginal dose presented favorable obliteration rates with relatively low rate of morbidity. Further accumulation of cases is awaited to fully evaluate the results of single-stage radiosurgery for large AVMs.	[Hanakita, Shunya; Koga, Tomoyuki; Shin, Masahiro; Saito, Nobuhito] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 1138655, Japan; [Igaki, Hiroshi] Tokyo Univ Hosp, Dept Radiol, Tokyo 1138655, Japan	Hanakita, S (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hanakita-s@umin.ac.jp					SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Kano H, 2012, J NEUROSURG, V116, P54, DOI 10.3171/2011.9.JNS11177; Han PP, 2003, J NEUROSURG, V98, P3, DOI 10.3171/jns.2003.98.1.0003; Flickinger JC, 2002, RADIOTHER ONCOL, V63, P347, DOI 10.1016/S0167-8140(02)00103-2; Pan DHC, 2000, J NEUROSURG, V93, P113; Pollock BE, 1998, NEUROSURGERY, V42, P1239, DOI 10.1097/00006123-199806000-00020; Kano H, 2012, J NEUROSURG, V116, P11, DOI 10.3171/2011.9.JNS101740; Yang SY, 2009, ACTA NEUROCHIR, V151, P113, DOI 10.1007/s00701-008-0173-5; Shin M, 2004, J NEUROSURG, V101, P18, DOI 10.3171/jns.2004.101.1.0018; Yamamoto M, 2012, J NEUROSURG, V117, P126, DOI 10.3171/2012.6.GKS12757; Flickinger JC, 1996, INT J RADIAT ONCOL, V36, P873, DOI 10.1016/S0360-3016(96)00316-1; Maruyama K, 2005, J NEUROSURG, V102, P49; Wegner RE, 2011, INT J RADIAT ONCOL, V79, P1147, DOI 10.1016/j.ijrobp.2009.12.056; Pollock BE, 2003, NEUROSURGERY, V52, P1291, DOI 10.1227/01.NEU.0000064800.26214.FE; Ogilvy CS, 2001, STROKE, V32, P1458; Flickinger JC, 2000, INT J RADIAT ONCOL, V46, P1143, DOI 10.1016/S0360-3016(99)00513-1; Huang PP, 2012, NEUROSURGERY, V71, P632, DOI 10.1227/NEU.0b013e31825fd247; Miyawaki L, 1999, INT J RADIAT ONCOL, V44, P1089, DOI 10.1016/S0360-3016(99)00102-9; Flickinger JC, 1997, INT J RADIAT ONCOL, V38, P485, DOI 10.1016/S0360-3016(97)89481-3; Laakso A, 2011, NEUROSURGERY, V68, P372, DOI 10.1227/NEU.0b013e3181ffe931; Stefani MA, 2002, STROKE, V33, P1220, DOI 10.1161/01.STR.0000013738.53113.33; Jayaraman MV, 2007, STROKE, V38, P325, DOI 10.1161/01.STR.0000254497.24545.de; Jones Jesse, 2007, Neurosurg Focus, V23, pE7; REDEKOP GJ, 1993, J NEUROSURG, V78, P413, DOI 10.3171/jns.1993.78.3.0413; St George EJ, 2002, BRIT J NEUROSURG, V16, P385, DOI 10.1080/026886902100007632; Xiao FR, 2010, NEUROSURGERY, V67, P1253, DOI 10.1227/NEU.0b013e3181efbaef	26	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2014	45	12					3543	3548		10.1161/STROKEAHA.114.007162		6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AU3ME	WOS:000345516600242		
J	Yata, K; Nishimura, Y; Unekawa, M; Tomita, Y; Suzuki, N; Tanaka, T; Mizoguchi, A; Tomimoto, H				Yata, Kenichiro; Nishimura, Yuhei; Unekawa, Miyuki; Tomita, Yutaka; Suzuki, Norihiro; Tanaka, Toshio; Mizoguchi, Akira; Tomimoto, Hidekazu			In Vivo Imaging of the Mouse Neurovascular Unit Under Chronic Cerebral Hypoperfusion	STROKE			English	Article						astrocytes; leukocytes; microcirculation; microscopy, fluorescence, multiphoton; pericytes	LEUKOCYTE-ENDOTHELIUM INTERACTIONS; POLYMORPHONUCLEAR LEUKOCYTES; COGNITIVE IMPAIRMENT; ARTERY OCCLUSION; ISCHEMIA; REPERFUSION; STROKE; MODEL; RAT; CAPILLARIES	Background and Purpose-Proper brain function is maintained by an integrated system called the neurovascular unit (NVU) comprised cellular and acellular elements. Although the individual features of specific neurovascular components are understood, it is unknown how they respond to ischemic stress as a functional unit. Therefore, we established an in vivo imaging method and clarified the NVU response to chronic cerebral hypoperfusion. Methods-Green mice (b-act-EGFP) with SR101 plasma labeling were used in this experiment. A closed cranial window was made over the left somatosensory cortex. To mimic chronic cerebral hypoperfusion, mice were subjected to bilateral common carotid artery stenosis operations using microcoils. In vivo real-time imaging was performed using 2-photon laser-scanning microscopy during the preoperative period, and after 1 day and 1 and 2 weeks of bilateral common carotid artery stenosis or sham operations. Results-Our method allowed 3-dimensional observation of most of the components of the NVU, as well as dynamic capillary microcirculation. Under chronic cerebral hypoperfusion, we did not detect any structural changes of each cellular component in the NVU; however, impairment of microcirculation was detected over a prolonged period. In the pial small arteries and veins, rolling and adhesion of leukocyte were detected, more prominently in the latter. In the deep cortical capillaries, flow stagnation because of leukocyte plugging was frequently observed. Conclusions-We established an in vivo imaging method for real-time visualization of the NVU. It seems that under chronic cerebral hypoperfusion, leukocyte activation has a critical role in microcirculation disturbance.	[Yata, Kenichiro; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 5148507, Japan; [Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 5148507, Japan; [Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie 5148507, Japan; [Unekawa, Miyuki; Tomita, Yutaka; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo, Japan	Yata, K (reprint author), Mie Univ, Grad Sch Med, Dept Neurol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	ken-yata@mbk.nifty.com	Suzuki, Norihiro/J-5125-2013				Yilmaz G, 2010, NEUROMOL MED, V12, P193, DOI 10.1007/s12017-009-8074-1; Tsukuda K, 2008, HYPERTENSION, V51, P528, DOI 10.1161/HYPERTENSIONAHA.107.101634; Yata K, 2011, BRAIN RES, V1410, P12, DOI 10.1016/j.brainres.2011.06.064; del Zoppo GJ, 2012, ANN NY ACAD SCI, V1268, P127, DOI 10.1111/j.1749-6632.2012.06686.x; Salinas Pablo, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P256; DELZOPPO GJ, 1991, STROKE, V22, P1276; Uhl E, 2000, J CEREBR BLOOD F MET, V20, P979; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Fukuda S, 2004, CIRC RES, V95, P100, DOI 10.1161/01.RES.0000133677.77465.38; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Wakita H, 2008, J CEREBR BLOOD F MET, V28, P341, DOI 10.1038/sj.jcbfm.9600528; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Tomita Y, 2005, J CEREBR BLOOD F MET, V25, P858, DOI 10.1038/sj.jcbfm.9600077; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907; Masamoto K, 2012, NEUROSCIENCE, V212, P190, DOI 10.1016/j.neuroscience.2012.03.034; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Dirnagl U, 2012, ANN NY ACAD SCI, V1268, P21, DOI 10.1111/j.1749-6632.2012.06691.x; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; GROGAARD B, 1989, J CEREBR BLOOD F MET, V9, P500; Helmke BP, 1997, AM J PHYSIOL-HEART C, V273, pH2884; Kataoka H, 2004, J CEREBR BLOOD F MET, V24, P668; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI DOI 10.1038/NRN1106; Nimmagadda A, 2008, STROKE, V39, P198, DOI 10.1161/STROKEAHA.107.495598; Tomimoto H, 2014, FUTURE NEUROLOGY, V9, P163	26	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2014	45	12					3698	+		10.1161/STROKEAHA.114.005891		16	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AU3ME	WOS:000345516600265		
J	Honjo, K; Iso, H				Honjo, Kaori; Iso, Hiroyasu			Response to Letter Regarding Article, "Socioeconomic Status Inconsistency and Risk of Stroke Among Japanese Middle-Aged Women"	STROKE			English	Letter									[Honjo, Kaori] Osaka Univ, Global Collaborat Ctr, Osaka, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth, Osaka, Japan	Honjo, K (reprint author), Osaka Univ, Global Collaborat Ctr, Osaka, Japan.			Iso, Hiroyasu/0000-0002-9241-7289			Honjo K, 2010, INT J BEHAV MED, V17, P58, DOI 10.1007/s12529-009-9051-7; Honjo K, 2014, STROKE, V45, P2592, DOI 10.1161/STROKEAHA.114.005238; Liao N, 2014, STROKE, V45, pE233, DOI 10.1161/STROKEAHA.114.006976	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2014	45	12					E307	E307		10.1161/STROKEAHA.114.006995		1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AU3ME	WOS:000345516600230		
J	Nakase, T; Sasaki, M; Suzuki, A				Nakase, T.; Sasaki, M.; Suzuki, A.			Clinical Features of Recurrent Stroke Under Eicosapentaenoic Acid Medication	STROKE			English	Meeting Abstract	Canadian Stroke Congress	OCT 04-07, 2014	Vancouver, CANADA						[Nakase, T.; Sasaki, M.; Suzuki, A.] Res Inst Brain & Blood Vessels, Akita 0100874, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2014	45	12				P.083	E284	E284				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AU3ME	WOS:000345516600144		
J	Suda, M; Fujii, W; Takanashi, K; Hattori, Y; Makabe, H				Suda, Manato; Fujii, Wataru; Takanashi, Kohki; Hattori, Yasunao; Makabe, Hidefumi			Selective Synthesis of Epicatechin Dimers By Zinc(II) Triflate Mediated Self-Condensation	SYNTHESIS-STUTTGART			English	Article						phenols; Lewis acids; oligomerization; natural products; stereoselective synthesis	EFFICIENT STEREOSELECTIVE-SYNTHESIS; OCCURRING O-HETEROCYCLES; EQUIMOLAR CONDENSATION; OLIGOMERIC PROANTHOCYANIDINS; INHIBITORY-ACTIVITY; MAILLARD REACTION; INTERFLAVAN BOND; PROCYANIDIN B3; 4-ALKOXY GROUP; CATECHIN	Epicatechin dimers were synthesized by zinc(II) triflate mediated self-condensation reactions of epicatechin monomer derivatives. One synthesized dimer was successfully converted into procyanidin C1.	[Suda, Manato; Fujii, Wataru; Takanashi, Kohki; Makabe, Hidefumi] Shinshu Univ, Grad Sch Agr, Nagano 3994598, Japan; [Hattori, Yasunao] Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan	Makabe, H (reprint author), Shinshu Univ, Grad Sch Agr, 8304 Minami Minowa, Nagano 3994598, Japan.	makabeh@shinshu-u.ac.jp					Alharthy RD, 2010, TETRAHEDRON LETT, V51, P1193, DOI 10.1016/j.tetlet.2009.12.100; Kozikowski AP, 2003, J ORG CHEM, V68, P1641, DOI 10.1021/jo020393f; Ferreira D, 2000, NAT PROD REP, V17, P193, DOI 10.1039/a705728h; Ferreira D, 2002, NAT PROD REP, V19, P517, DOI 10.1039/b008741f; Oyama K, 2011, CURR ORG CHEM, V15, P2567; Saito A, 2002, TETRAHEDRON, V58, P7829, DOI 10.1016/S0040-4020(02)00936-5; Mohri Y, 2009, HETEROCYCLES, V79, P549, DOI 10.3987/COM-08-S(D)14; Saito A, 2004, TETRAHEDRON, V60, P12043, DOI 10.1016/j.tet.2004.10.048; Ohmori K, 2004, P NATL ACAD SCI USA, V101, P12002, DOI 10.1073/pnas.0401651101; Fujii W, 2013, TETRAHEDRON LETT, V54, P7188, DOI 10.1016/j.tetlet.2013.10.113; Ohmori K, 2011, ANGEW CHEM INT EDIT, V50, P4862, DOI 10.1002/anie.201007473; Mitsuhashi S, 2008, MOLECULES, V13, P2998, DOI 10.3390/molecules13122998; Oizumi Y, 2010, J ORG CHEM, V75, P4884, DOI 10.1021/jo1009382; Oyama K, 2008, TETRAHEDRON LETT, V49, P3176, DOI 10.1016/j.tetlet.2008.02.173; Saito A, 2009, TETRAHEDRON, V65, P7422, DOI 10.1016/j.tet.2009.07.018; Tarascou I, 2006, EUR J ORG CHEM, P5367, DOI 10.1002/ejoc.200600668; Seeram NP, 2008, J AGR FOOD CHEM, V56, P1415, DOI 10.1021/jf073035s; Saito A, 2004, SYNLETT, P1069, DOI 10.1055/s-2004-822905; Saito A, 2003, HETEROCYCLES, V61, P287; Mohri Y, 2007, TETRAHEDRON LETT, V48, P5891, DOI 10.1016/j.tetlet.2007.06.047; Terra X, 2007, J AGR FOOD CHEM, V55, P4357, DOI 10.1021/jf0633185; Cheng HY, 2005, J SCI FOOD AGR, V85, P10, DOI 10.1002/jsfa.1958; Ferreira D, 2011, PLANTA MED, V77, P1071, DOI 10.1055/s-0030-1270908; Ishihara S, 2014, HETEROCYCLES, V88, P1595, DOI 10.3987/COM-13-S(S)103; Katoh M, 2012, LETT ORG CHEM, V9, P233; Makabe H, 2013, HETEROCYCLES, V87, P2225, DOI 10.3987/REV-13-782; Nakajima N, 2012, HETEROCYCLES, V84, P349, DOI 10.3987/COM-11-S(P)58; Ohmori K, 2012, CURR ORG CHEM, V16, P566; Oizumi Y, 2011, HETEROCYCLES, V83, P739, DOI 10.3987/COM-11-12159; Oizumi Y, 2012, HETEROCYCLES, V85, P2241, DOI 10.3987/COM-12-12526; Saito A, 2004, HETEROCYCLES, V62, P479; Saito A, 2004, BIOORGAN MED CHEM, V12, P4783, DOI 10.1016/j.bmc.2004.07.024; Viton F, 2008, EUR J ORG CHEM, P6069, DOI 10.1002/ejoc.200800886; Yano T, 2012, ORG BIOMOL CHEM, V10, P7685, DOI 10.1039/c2ob26337h	34	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2014	46	24					3351	3355		10.1055/s-0034-1378998		5	Chemistry, Organic	Chemistry	AU9GH	WOS:000345899300007		
J	Rao, G; Lin, AM; Yan, B; Jia, D; Wu, XJ				Rao, Gang; Lin, Aiming; Yan, Bing; Jia, Dong; Wu, Xiaojun			Tectonic activity and structural features of active intracontinental normal faults in the Weihe Graben, central China	TECTONOPHYSICS			English	Article						Active intracontinental normal fault; Fault scarp; Tectonic activity; Weihe Graben; Ordos Block	NORTH CHINA; LARGE EARTHQUAKES; YUSHU EARTHQUAKE; TIBETAN PLATEAU; EASTERN CHINA; EXTENSION; EVOLUTION; JAPAN; SLIP; RIFT	This study examines the tectonic activity and structural features of active normal faults in the Weihe Graben, central China. The Weihe Graben is an area with a high level of historic seismicity, and it is one of the intracontinental systems that developed since Tertiary in the extensional environment around the Ordos Block. Analysis of high-resolution remote-sensing imagery data, field observations, and radiocarbon dating results reveal the following: i) active normal faults are mainly developed within a zone <500 m wide along the southern border of the eastern part of the Weihe Graben; ii) the active faults that have been identified are characterized by stepwise fault scarps dipping into the graben at angles of 40 degrees-71 degrees; iii) there are numerous discontinuous individual fault traces, ranging in length from a few tens of meters to 450 m (generally <200 m); iv) fault zone structures, topographic features, and fault striations on the main fault planes indicate almost pure normal-slip; and v) late Pleistocene-Holocene terrace risers, loess, and alluvial deposits have been vertically offset by up to similar to 80 m, with a non-uniform dip-slip rate (throw-rates) ranging from similar to 2.1 to 5.7 mm/yr, mostly 2-3 mm/yr. Our results reveal that active normal faults have been developing in the Weihe Graben under an ongoing extensional environment, probably associated with the pre-existing graben and spreading of the continental crust, and this is in contrast with the Ordos Block and neighboring orogenic regions. These results provide new insights into the nature of extensional tectonic deformation in intracontinental graben systems. (C) 2014 Elsevier B.V. All rights reserved.	[Rao, Gang; Lin, Aiming; Yan, Bing] Kyoto Univ, Grad Sch Sci, Dept Geophys, Kyoto 6068502, Japan; [Rao, Gang; Yan, Bing] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka 4228529, Japan; [Jia, Dong; Wu, Xiaojun] Nanjing Univ, Dept Earth Sci, Nanjing 210093, Jiangsu, Peoples R China	Lin, AM (reprint author), Kyoto Univ, Grad Sch Sci, Dept Geophys, Kyoto 6068502, Japan.	slin@kugi.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23253002]; National S & T Major Project of China [2011ZX05003-002, 2011ZX05009-001]; Fundamental Research Funds for the Central Universities [2014QNA3010]	We are grateful to Prof. R. Lacassin and an anonymous reviewer for critical reviews that helped to improve the manuscript and Dr. Z. Ren for his help in the field. We also thank Earth Remote Sensing Data Analysis Center (ERSDAC) for making ASTER GDEM data freely available from their web site. This work was supported by the Science Project (Project no. 23253002 awarded to A. Lin) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and partially by the National S & T Major Project of China (2011ZX05003-002 and 2011ZX05009-001), and the Fundamental Research Funds for the Central Universities (No. 2014QNA3010).	Abbott RE, 2001, J GEOPHYS RES-SOL EA, V106, P4169, DOI 10.1029/2000JB900385; Abers GA, 1997, J GEOPHYS RES-SOL EA, V102, P15301, DOI 10.1029/97JB00787; Carbonel D, 2013, GEOMORPHOLOGY, V189, P93, DOI 10.1016/j.geomorph.2013.01.020; Lin AM, 2013, B SEISMOL SOC AM, V103, P1603, DOI 10.1785/0120120111; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211; MA XY, 1987, TECTONOPHYSICS, V133, P243, DOI 10.1016/0040-1951(87)90268-X; Moro M, 2012, GEOMORPHOLOGY, V151, P164, DOI 10.1016/j.geomorph.2012.01.026; Lin AM, 2011, J GEODYN, V52, P249, DOI 10.1016/j.jog.2011.01.001; Meng QR, 2000, TECTONOPHYSICS, V323, P183, DOI 10.1016/S0040-1951(00)00106-2; MOLNAR P, 1984, J GEOPHYS RES, V89, P6203, DOI 10.1029/JB089iB07p06203; CRONE AJ, 1987, B SEISMOL SOC AM, V77, P739; Rao G, 2011, TECTONOPHYSICS, V507, P86, DOI 10.1016/j.tecto.2011.05.011; Li YQ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006824; MOLNAR P, 1989, GEOPHYS J INT, V99, P123, DOI 10.1111/j.1365-246X.1989.tb02020.x; Liu M, 2004, TECTONOPHYSICS, V393, P29, DOI 10.1016/j.tecto.2004.07.029; Jia D, 2010, TECTONOPHYSICS, V491, P174, DOI 10.1016/j.tecto.2009.08.040; Deng QD, 2003, SCI CHINA SER D, V46, P356; XIAO HB, 1992, AAPG BULL, V76, P509; TAPPONNIER P, 1977, J GEOPHYS RES, V82, P2905, DOI 10.1029/JB082i020p02905; Mercier JL, 2013, TECTONOPHYSICS, V582, P50, DOI 10.1016/j.tecto.2012.09.015; Berg SS, 2005, J STRUCT GEOL, V27, P1803, DOI 10.1016/j.jsg.2005.04.012; Ratschbacher L, 2003, TECTONOPHYSICS, V366, P1, DOI 10.1016/S0040-1951(03)00053-2; Lin AM, 2002, SCIENCE, V296, P2015, DOI 10.1126/science.1070879; DOSER DI, 1989, B SEISMOL SOC AM, V79, P1383; Toda S, 2013, B SEISMOL SOC AM, V103, P1584, DOI 10.1785/0120120281; Axen GJ, 1999, GEOPHYS RES LETT, V26, P3693, DOI 10.1029/1999GL005405; Tian XB, 2011, PHYS EARTH PLANET IN, V184, P186, DOI 10.1016/j.pepi.2010.11.007; Lin AM, 2009, TECTONOPHYSICS, V471, P203, DOI 10.1016/j.tecto.2009.02.014; Wang Q, 2001, SCIENCE, V294, P574, DOI 10.1126/science.1063647; FRIEDMANN SJ, 1995, BASIN RES, V7, P109, DOI 10.1111/j.1365-2117.1995.tb00099.x; Cowie PA, 2001, J STRUCT GEOL, V23, P1901, DOI 10.1016/S0191-8141(01)00036-0; ARMIJO R, 1986, J GEOPHYS RES-SOLID, V91, P13803, DOI 10.1029/JB091iB14p13803; Bao XW, 2011, TECTONOPHYSICS, V499, P132, DOI 10.1016/j.tecto.2011.01.002; CENC (China Earthquake Networks Center), 2007, 1556 HUAX GREAT EART; Deng Q. D., 2007, ACTIVE TECTONICS MAP; Ding Z.L., 1994, QUATERNARY SCI REV, V31, P39; GIBBS AD, 1984, J GEOL SOC LONDON, V141, P609, DOI 10.1144/gsjgs.141.4.0609; Guo JM, 2012, SEISMOL RES LETT, V83, P109, DOI 10.1785/gssrl.83.1.109; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Harvard University, 2014, GLOB CMT CAT SEARCH; He JK, 2004, TERRA NOVA, V16, P38; Hou JJ, 1998, J STRUCT GEOL, V20, P549, DOI 10.1016/S0191-8141(97)00112-0; Huang ZC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035188; Jackson J. A., 1987, GEOLOGICAL SOC LONDO, V28, P3, DOI DOI 10.1144/GSL.SP.1987.028.01.02; JACKSON JA, 1989, J STRUCT GEOL, V11, P15, DOI 10.1016/0191-8141(89)90033-3; Kim YS, 2004, J STRUCT GEOL, V26, P503, DOI 10.1016/j.jsg.2003.08.002; Kuo T, 1957, ACTA GEOPHYS SINICA, V6, P59; Lecomte E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050756; Li X., 1983, N CHINA EARTHQ SCI, V1, P10; Lin AM, 2008, B SEISMOL SOC AM, V98, P2866, DOI 10.1785/0120070193; Lin AM, 2013, J STRUCT GEOL, V48, P3, DOI 10.1016/j.jsg.2013.01.005; Lin AM, 2012, J GEOL, V120, P453, DOI 10.1086/665795; Liu JH, 2013, TECTONOPHYSICS, V584, P281, DOI 10.1016/j.tecto.2012.01.025; Ma X Y., 1989, LITHOSPHERIC DYNAMIC; McCalpin JP, 2009, INT GEOPHYS SER, V95, P1; Myers W.B., 1964, US GEOL SURV PROF PA, V435, P55; PELTZER G, 1985, NATURE, V317, P500, DOI 10.1038/317500a0; Reimer R. W., 2005, CALIB RADIOCARBON CA; SHELTON JW, 1984, AAPG BULL, V68, P801; State Seismological Bureau (SSB), 1988, ACT FAULT SYST ORD M; Steven D.K., 1996, J STRUCT GEOL, V18, P359; STEWART IS, 1991, J STRUCT GEOL, V13, P191, DOI 10.1016/0191-8141(91)90066-R; Sun JB, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007849; Wallace R.E., 1984, US GEOL SURV PROF A, P1; Wang Jing-Ming, 1980, Acta Seismologica Sinica, V2; WANG JM, 1987, TECTONOPHYSICS, V133, P257, DOI 10.1016/0040-1951(87)90269-1; Xie Y., 1992, J CATASTROPHOLOGY, V7, P10; [谢振乾 Xie Zhenqian], 2011, [灾害学, Journal of Catastrophology], V26, P18; YE H, 1987, TECTONOPHYSICS, V133, P217, DOI 10.1016/0040-1951(87)90265-4; Yeats R S, 1997, GEOLOGY EARTHQUAKES; Yin GM, 2001, CHINESE SCI BULL, V46, P1665, DOI 10.1007/BF02900632; Yuan T., 2010, 1556 HUAXIAN GREAT E; ZHANG AL, 1995, QUATERN INT, V25, P25, DOI 10.1016/1040-6182(94)P3715-K; ZHANG BC, 1985, TECTONOPHYSICS, V117, P177, DOI 10.1016/0040-1951(85)90245-8; Zhang YQ, 1998, TECTONOPHYSICS, V285, P41, DOI 10.1016/S0040-1951(97)00170-4	75	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0040-1951	1879-3266		TECTONOPHYSICS	Tectonophysics	DEC 1	2014	636						270	285		10.1016/j.tecto.2014.08.019		16	Geochemistry & Geophysics	Geochemistry & Geophysics	AU8BM	WOS:000345821700020		
J	Kawazu, Y; Inamura, N; Shiono, N; Kanagawa, N; Narita, J; Hamamichi, Y; Kayatani, F				Kawazu, Y.; Inamura, N.; Shiono, N.; Kanagawa, N.; Narita, J.; Hamamichi, Y.; Kayatani, F.			'Post-LA space index' as a potential novel marker for the prenatal diagnosis of isolated total anomalous pulmonary venous connection	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Article						congenital heart disease; fetal echocardiogram; prenatal diagnosis; total anomalous pulmonary venous connection	ECHOCARDIOGRAPHIC DIAGNOSIS; FETUS; RETURN; HEART	Objectives To review the fetal echocardiograms of patients with total anomalous pulmonary venous connection (TAPVC) in order to determine whether the distance between the left atrium and the descending aorta would be useful in the prenatal diagnosis of fetal TAPVC. Methods We reviewed the fetal echocardiograms of eight cases of TAPVC (five supracardiac type and three infracardiac type) with no other cardiac malformations. We evaluated the ratio of the left atrium-descending aorta distance to the diameter of the descending aorta ('post-LA space index') in 101 normal and eight TAPVC fetuses, and compared the values between groups. In addition, we examined the tricuspid valve/mitral valve diameter ratio (TVD/MVD) and the right ventricular end-diastolic diameter/left ventricular end-diastolic diameter ratio (RVDd/LVDd). Results The echocardiograms for fetuses with TAPVC and normal fetuses were performed at mean gestational ages of 27.5weeks and 29.6 weeks, respectively. There were no significant differences in the TVD/MVD and RVDd/LVDd ratios between the groups. However, the post-LA space index was significantly higher in the TAPVC cases (mean, 1.51) than it was in the normal fetuses (mean, 0.71 +/- 0.23) (P < 0.0001). On an analysis of the receiver-operating characteristics curve, a post-LA space index cut-off of 1.27 was found to be optimal for distinguishing between TAPVC and normal hearts, with a sensitivity of 100% and specificity of 99%. Conclusions The novel post-LA space index could potentially be used for the prenatal diagnosis of TAPVC. A diagnosis of TAPVC is very likely in cases with a post-LA space index of >1.27. Copyright (c) 2014 ISUOG. Published by John Wiley & Sons Ltd.	[Kawazu, Y.] Osaka Med Ctr, Dept Pediat Cardiol, Izumi, Osaka 5941101, Japan; Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan	Kawazu, Y (reprint author), Osaka Med Ctr, Dept Pediat Cardiol, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	kadoy@mch.pref.osaka.jp					Allan LD, 2001, HEART, V85, P433, DOI 10.1136/heart.85.4.433; Seale AN, 2012, ULTRASOUND OBST GYN, V40, P310, DOI 10.1002/uog.11093; SAHN DJ, 1980, CIRCULATION, V62, P588; REED KL, 1986, CIRCULATION, V73, P41; Barrea C, 2010, ULTRASOUND OBST GYN, V35, P117, DOI 10.1002/uog.7516; Berg C, 2007, ULTRASOUND OBST GYN, V30, P721, DOI 10.1002/uog.5152; Cormier CM, 2010, FETAL DIAGN THER, V27, P118, DOI 10.1159/000279330; DISESSA TG, 1990, J ULTRAS MED, V9, P311; Inamura N, 2006, PEDIATR CARDIOL, V27, P391, DOI 10.1007/s00246-006-6008-3; Laux D, 2013, ULTRASOUND OBST GYN, V41, P291, DOI 10.1002/uog.11186; Law KM, 2007, ULTRASOUND OBST GYN, V30, P788, DOI 10.1002/uog.4085; Patel CR, 2005, J ULTRAS MED, V24, P1191; Printz BF, 1997, ULTRASOUND OBST GYN, V9, P347; Valsangiacomo ER, 2003, ULTRASOUND OBST GYN, V22, P257, DOI 10.1002/uog.214; Volpe P, 2007, ULTRASOUND OBST GYN, V30, P830, DOI 10.1002/uog.5145; YEAGER SB, 1994, AM HEART J, V128, P397, DOI 10.1016/0002-8703(94)90494-4	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	DEC	2014	44	6					682	687		10.1002/uog.13357		6	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	AU8KD	WOS:000345844400011		
J	Agamuthu, P; Hotta, Y				Agamuthu, P.; Hotta, Yasuhiko			Indicators as a tool to evaluate waste management efficiency	WASTE MANAGEMENT & RESEARCH			English	Editorial Material									[Agamuthu, P.] Univ Malaya, Kuala Lumpur, Malaysia; [Hotta, Yasuhiko] IGES, Hayama, Japan	Agamuthu, P (reprint author), Univ Malaya, Kuala Lumpur, Malaysia.	agamuthu@um.edu.my						0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0734-242X	1096-3669		WASTE MANAGE RES	Waste Manage. Res.	DEC	2014	32	12					1147	1148		10.1177/0734242X14561725		2	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AU7DY	WOS:000345762100001		
J	Toyoda, A; Suzuki, K; Imaizumi, T; Sasoh, A				Toyoda, Atsushi; Suzuki, Kakuei; Imaizumi, Takahiro; Sasoh, Akihiro			Staged Aft Body for Alleviation of Tail Boom	AIAA JOURNAL			English	Article							MINIMIZATION; SHOCKS		Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi 4648603, Japan; [Toyoda, Atsushi; Suzuki, Kakuei; Imaizumi, Takahiro; Sasoh, Akihiro] Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi 4648603, Japan	Toyoda, A (reprint author), Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi 4648603, Japan.				Japan Society for Promotion of Science [22226014]	This research was supported by Japan Society for Promotion of Science through a Grant-in-Aid for Scientific Research (S) (number 22226014). We thank Y. Naka, Y. Makino, M. Honda, A. Murakami, and K. Yoshida of JAXA for technical discussions and providing us with BoomMetre to calculate the sound pressure level of a sonic boom. We also thank K. Yamamoto, N. Shiraki, Y. Masanaka, and A. Saito of the Technical Division, Nagoya University, for their valuable technical assistance.	Carlson H. W., 1963, TMX898 NASA; GEORGE AR, 1971, AIAA J, V9, P2091, DOI 10.2514/3.6478; Kumar R, 2011, AIAA J, V49, P2751, DOI 10.2514/1.J051148; Makino Y., 2010, RM09006 JAXA; Marconi F, 2003, J AIRCRAFT, V40, P363, DOI 10.2514/2.3101; McLean F. E., 1968, SONIC BOOM RES, P37; Sasoh A., 2010, INT J AEROSPACE INNO, V2, P147, DOI [10.1260/1757-2258.2.3.147, DOI 10.1260/1757-2258.2.3.147]; Sasoh A., 2006, REV SCI INSTRUM, V77, DOI [10.1063/1.2360766RSINAK0034-6748, DOI 10.1063/1.2360766 RSINAK 0034-6748]; SEEBASS R, 1972, J ACOUST SOC AM, V51, P686, DOI 10.1121/1.1912902; Shneider MN, 2008, J PROPUL POWER, V24, P900, DOI 10.2514/1.34136; Thomas C. L., 1972, TND6832 NASA; Zaidi SH, 2004, AIAA J, V42, P326, DOI 10.2514/1.9097	12	2	2	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	DEC	2014	52	12					2899	+		10.2514/1.J052518		3	Engineering, Aerospace	Engineering	AU8NG	WOS:000345852500022		
J	Kishimoto, M; Miyamoto, R; Oda, T; Ohara, Y; Yanagihara, H; Ohkohchi, N; Kita, E				Kishimoto, Mikio; Miyamoto, Ryoichi; Oda, Tatsuya; Ohara, Yusuke; Yanagihara, Hideto; Ohkohchi, Nobuhiro; Kita, Eiji			Measurement of Intravenously Administered gamma-Fe2O3 Particle Amount in Mice Tissues Using Vibrating Sample Magnetometer	IEEE TRANSACTIONS ON NANOBIOSCIENCE			English	Article							MAGNETIC NANOPARTICLES; SURFACE; CELLS	Dispersions of platelet gamma - Fe2O3 particles 30-50nm in size were intravenously administered to mice and the amount of particles accumulated in each tissue was obtained by magnetization measurement using a vibrating sample magnetometer. Background noisewas greatly reduced by measuring dried tissues under a magnetic field of 500 Oe so that the effect of diamagnetism was slight. Remarkable particle accumulation was observed in the liver and spleen. Considerable particle accumulation was observed in the lung when a large quantity of gamma - Fe2O3 particles was administered. There was no significant particle accumulation in the kidney and heart.	[Kishimoto, Mikio; Yanagihara, Hideto; Kita, Eiji] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Miyamoto, Ryoichi; Oda, Tatsuya; Ohara, Yusuke; Ohkohchi, Nobuhiro] Univ Tsukuba, Div Med, Dept Surg, Tsukuba, Ibaraki 3058573, Japan	Kishimoto, M (reprint author), Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan.				Ministry of Education, Culture, Sports, Science and Technology of Japan [23300185, 23300362]; Innovative Research Support Programs (Pilot Models) at the University of Tsukuba	This work was supported by a Grant-in-Aid Scientific Research (Grant No. 23300185, 23300362) from The Ministry of Education, Culture, Sports, Science and Technology of Japan and Innovative Research Support Programs (Pilot Models) at the University of Tsukuba. Asterisk indicates corresponding author.	Kishimoto M, 2012, J MAGN MAGN MATER, V324, P1285, DOI 10.1016/j.jmmm.2011.11.036; Kita E, 2008, IEEE T MAGN, V44, P4452, DOI 10.1109/TMAG.2008.2002005; JOHNSON GA, 1993, MAGN RESON QUART, V9, P1; Hashimoto S, 2009, PHYS MED BIOL, V54, P2571, DOI 10.1088/0031-9155/54/8/021; Hergt R, 2005, J MAGN MAGN MATER, V293, P80, DOI 10.1016/j.jmmm.2005.01.047; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277; Yamada K, 2010, INT J HYPERTHER, V26, P465, DOI 10.3109/02656731003681028; Ujiie K, 2011, COLLOID SURFACE B, V88, P771, DOI 10.1016/j.colsurfb.2011.08.013; Flynn ER, 2007, J MAGN MAGN MATER, V311, P429, DOI 10.1016/j.jmmm.2006.10.1148; Enpuku K., 2006, J APPL PHYS, V100; Hergt R., 2007, MAGNETISM MED, P550; Horng H. E., 2006, APPL PHYS LETT, V88; Kita E., 2010, J PHYS D, V43; Kita E., 2010, J APPL PHYS, V107	16	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1241	1558-2639		IEEE T NANOBIOSCI	IEEE Trans. Nanobiosci.	DEC	2014	13	4					425	430		10.1109/TNB.2014.2337659		6	Biochemical Research Methods; Nanoscience & Nanotechnology	Biochemistry & Molecular Biology; Science & Technology - Other Topics	AU9IT	WOS:000345906200008		
J	Fujii, S; Hirota, Y; Tode, H; Murakami, K				Fujii, Shohei; Hirota, Yusuke; Tode, Hideki; Murakami, Koso			On-Demand Spectrum and Core Allocation for Reducing Crosstalk in Multicore Fibers in Elastic Optical Networks	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Crosstalk; Dynamic control; Elastic optical network; Multi-core fiber (MCF); Routing and spectrum assignment (RSA); Space division multiplexing (SDM)	PATH NETWORK; CAPACITY; BENEFITS; DESIGN	In the past few years, many researchers have studied elastic optical networks, which exhibit a dramatically improved transmission capacity compared with conventional optical networks. However, the transmission capacity per fiber will soon reach the physical limit for traditional single-mode fibers. Multicore fiber (MCF) is among the innovative fibers based on space-division multiplexing technology. MCF has multiple cores and achieves a far larger transmission capacity than traditional single-mode fibers. However, signals transmitted in these crowded multiple cores interfere with each other and are degraded. This degradation has a serious impact on the network resource management in elastic optical networks. Previous research indicates that the crosstalk effect of MCF is dependent on an arrangement of signals regarding the spectrum and core. Therefore, we approach the problem of the crosstalk in MCF with regard to the spectrum and core allocation, from the network perspective. First, this paper summarizes the related work regarding elastic optical networks and MCFs. Next, we propose an "on-demand" spectrum and core allocation method that reduces both the crosstalk and fragmentation in elastic optical networks with MCFs. This proposed method is based on two predefined policies related to the crosstalk and fragmentation. The first, the core prioritization policy, is based on the MCF's structure, and the other is a core classification policy based on the required bandwidth of the connections. The core prioritization policy realizes the core allocation that reduces crosstalk by avoiding filling adjacent cores. The core classification policy reduces the spectrum fragmentation by allocating a uniform bandwidth connection for each core. Finally, we evaluate the proposed method using computer simulations. The results indicate that the proposed method can, under various network conditions, improve both the crosstalk and blocking probability of the total network through our two policies.	[Fujii, Shohei; Hirota, Yusuke; Murakami, Koso] Osaka Univ, Dept Informat Networking, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Tode, Hideki] Osaka Prefecture Univ, Grad Sch Engn, Dept Comp Sci & Intelligent Syst, Naka Ku, Sakai, Osaka 5598531, Japan	Fujii, S (reprint author), Osaka Univ, Dept Informat Networking, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	fujii.shohei@ist.osaka-u.ac.jp; tode@cs.osakafu-u.ac.jp			National Institute of Information and Communications Technology, Japan	This research is partly supported by the National Institute of Information and Communications Technology, Japan.	Amaya N, 2013, OPT EXPRESS, V21, P8865, DOI 10.1364/OE.21.008865; Amaya N., 2012, P EUR C OPT COMM ECO; Cvijetic M, 2012, OPT EXPRESS, V20, P9144, DOI 10.1364/OE.20.009144; Gerstel O, 2012, IEEE COMMUN MAG, V50, pS12, DOI 10.1109/MCOM.2012.6146481; Amaya N, 2014, OPT EXPRESS, V22, P3638, DOI 10.1364/OE.22.003638; Sone Y, 2011, J OPT COMMUN NETW, V3, P223, DOI 10.1364/JOCN.3.000223; Jinno M, 2009, IEEE COMMUN MAG, V47, P66, DOI 10.1109/MCOM.2009.5307468; Tu JJ, 2012, OPT EXPRESS, V20, P15157, DOI 10.1364/OE.20.015157; [Anonymous], 2012, SPECTRAL GRIDS WDM A; Mitra PP, 2001, NATURE, V411, P1027, DOI 10.1038/35082518; Koshiba M, 2009, IEICE ELECTRON EXPR, V6, P98, DOI 10.1587/elex.6.98; Hayashi T, 2012, J LIGHTWAVE TECHNOL, V30, P583, DOI 10.1109/JLT.2011.2177810; Jinno M, 2010, IEEE COMMUN MAG, V48, P138, DOI 10.1109/MCOM.2010.5534599; Wang Y, 2012, J OPT COMMUN NETW, V4, P906, DOI 10.1364/JOCN.4.000906; Desurvire EB, 2006, J LIGHTWAVE TECHNOL, V24, P4697, DOI 10.1109/JLT.2006.885772; CHEN XM, 2013, P IEEE INT C COMP CO, P390; Christodoulopoulos K., 2010, P GLOB TEL C GLOBECO; Christodoulopoulos K, 2013, IEEE J SEL AREA COMM, V31, P13, DOI 10.1109/JSAC.2013.130103; Cvijetic M., 2012, P HIGH PERF SWITCH R, P198; Fini JM, 2010, OPT EXPRESS, V18, P15122, DOI 10.1364/OE.18.015122; Fujii S., 2013, P OPT FIB COMM C NAT; Fujii S., 2013, P EUR C OPT COMM ECO; HAND DP, 1988, OPT LETT, V13, P767, DOI 10.1364/OL.13.000767; Hayashi T., 2010, P EUR C OPT COMM ECO; Igarashi K, 2013, OPT EXPRESS, V21, P18053, DOI 10.1364/OE.21.018053; Imamura K, 2011, OPT EXPRESS, V19, P10595, DOI 10.1364/OE.19.010595; Jinno M., 2010, ECOC 2010 WORKSH OPE; Koshiba Masanori, 2011, Opt Express, V19, pB102, DOI 10.1364/OE.19.00B102; Liu L., 2012, P EUR C OPT COMM ECO; Liu L., 2013, P EUR C OPT COMM ECO; Morioka T., 2009, PROC OPTOELECTRONICS; Munoz R., 2012, P EUR C OPT COMM ECO; Patel A. N., 2011, P OPT FIB COMM C NAT; Sakaguchi J., 2012, P OPT FIB COMM C NAT; Scaraficci R. A., 2014, P INT C COMM ICC JUN; Shen Z., 2013, P EUR C OPT COMM ECO; Takagi T., 2011, P EUR C OPT COMM ECO; Takara H., 2012, P OPT FIB COMM C NAT; Takara H., 2012, P EUR C OPT COMM ECO; Takenaga K., 2010, P OPT FIB COMM C NAT; Takenaga K, 2011, IEICE T COMMUN, VE94B, P409, DOI 10.1587/transcom.E94.B.409; Velasco L., 2012, P OPT FIB COMM C NAT; Wang Y., 2011, P IEEE INT C COMM IC; Wang Y, 2013, OPT EXPRESS, V21, P1353, DOI 10.1364/OE.21.001353	44	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	DEC 1	2014	6	12					1059	1071		10.1364/JOCN.6.001059		13	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AU8KP	WOS:000345845800001		
J	Yamamoto, T; Yamamoto, T; Yoshida, K; Fuchinoue, S; Hayama, Y; Hidano, A; Tsutsui, T				Yamamoto, Takehisa; Yamamoto, Tomoko; Yoshida, Kirika; Fuchinoue, Sachiko; Hayama, Yoko; Hidano, Arata; Tsutsui, Toshiyuki			Effectiveness of a short training session for improving pipetting accuracy	ACCREDITATION AND QUALITY ASSURANCE			English	Article						Micropipette; Training; Accuracy; Trueness; Precision; Proportional odds mixture model		The quality of diagnostic tests conducted by the Animal Quarantine Service (AQS) is critical to the safety of national livestock production. In procedures for tests such as polymerase chain reaction and enzyme-linked immunosorbent assay, measurement of tiny quantities of samples or reagents is quite common. Therefore, many efforts have been made to maintain the quality of micropipette operations, including routine calibration of equipment and training programs for operators. In this study, we developed a pilot training program to analyze the effects of training on pipetting accuracy, i.e., trueness and precision. The program involved a self-instruction A4-sized leaflet describing how to improve pipetting technique. Thirty-three staff members from seven AQS laboratories participated in the program. Each participant repeated sampling of 300 mu L of distilled water 10 times before and after reading the leaflet, and the effects of training on the trueness and precision of the pipetting results were analyzed. To determine pipetting trueness, we examined the variation of the delivered volume from the target volume (300 mu L) using the proportional odds mixture model. Our data demonstrated that participation in the training program and the level of experience with pipetting significantly improved trueness. Analysis of standard deviations of the ten samplings, as an indicator of precision, also showed that participation in the training program improves pipetting precision. Thus, our data supported the implementation of such simple, quick training sessions to improve pipetting trueness and precision in diagnostic laboratories.	[Yamamoto, Takehisa; Hayama, Yoko; Hidano, Arata; Tsutsui, Toshiyuki] Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Yoshida, Kirika; Fuchinoue, Sachiko] Anim Quarantine Serv, Quarantine Dept, Qual Assurance Div, Isogo Ku, Yokohama, Kanagawa 2350008, Japan	Yamamoto, T (reprint author), Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	mtbook@affrc.go.jp		Hidano, Arata/0000-0003-1707-5319	Japan Society for the Promotion of Science (JSPS) [25280009]	This study was funded by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grant No. 25280009.	Altman DG, 1991, PRACTICAL STAT MED R; Ashford S, 2010, BRIT J HEALTH PSYCH, V15, P265, DOI 10.1348/135910709X461752; Carle A Bjoern, 2013, MLO Med Lab Obs, V45, P62; Dohoo I, 2012, METHODS EPIDEMIOLOGI; DYBKAER R, 1994, CLIN CHEM, V40, P1416; Pentheny G, 1997, Am Clin Lab, V16, P10; Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI; Tsang SKM, 2012, SCI WORLD J, DOI 10.1100/2012/452327	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-1775	1432-0517		ACCREDIT QUAL ASSUR	Accredit. Qual. Assur.	DEC	2014	19	6					459	463		10.1007/s00769-014-1083-2		5	Chemistry, Analytical; Instruments & Instrumentation	Chemistry; Instruments & Instrumentation	AU1PF	WOS:000345391900007		
J	Galli, S; Naito, Y; Karlsson, J; He, WX; Miyamoto, I; Xue, Y; Andersson, M; Mustafa, K; Wennerberg, A; Jimbo, R				Galli, Silvia; Naito, Yoshihito; Karlsson, Johan; He, Wenxiao; Miyamoto, Ikuya; Xue, Ying; Andersson, Martin; Mustafa, Kamal; Wennerberg, Ann; Jimbo, Ryo			Local release of magnesium from mesoporous TiO2 coatings stimulates the pen-implant expression of osteogenic markers and improves osteoconductivity in vivo	ACTA BIOMATERIALIA			English	Article						Magnesium; Local drug delivery osseointegration; Nanotopography; Diffraction-enhanced imaging; Gene expression	SURFACE-CHEMISTRY; TITANIUM IMPLANTS; GENE-EXPRESSION; BONE; OSSEOINTEGRATION; TOPOGRAPHY; GUIDELINES; ADHESION; GROWTH; REPAIR	Local release of Mg ions from titanium implant surfaces has been shown to enhance implant retention and integration. To clarify the biological events that lead to this positive outcome, threaded implants coated with mesoporous TiO2 thin films were loaded with Mg-ions and placed in the tibia of rabbits for 3 weeks, after surface characterization. Non-loaded mesoporous coated implants were used as controls. Pen-implant gene expression of a set of osteogenic and inflammatory assays was quantified by means of real-time quantitative polymerase chain reaction. The expression of three osteogenic markers (OC, RUNX-2 and IGF-1) was significantly more pronounced in the test specimens, suggesting that the release of Mg ions directly at the implant sites may stimulate an osteogenic environment. Furthermore, bone healing around implants was evaluated on histological slides and by diffraction enhanced imaging (DEI), using synchrotron radiation. The histological analysis demonstrated new bone formation around all implants, without negative responses, with a significant increase in the number of threads filled with new bone for test surfaces. DEI analysis attested the high mineral content of the newly formed bone. Improved surface osteoconductivity and increased expression of genes involved in the bone regeneration were found for magnesium-incorporation of mesoporous TiO2 coatings. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Galli, Silvia; Wennerberg, Ann; Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, S-20506 Malmo, Sweden; [Naito, Yoshihito] Tokushima Univ Hosp, Oral Implant Ctr, Tokushima, Japan; [Karlsson, Johan; He, Wenxiao; Andersson, Martin] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Miyamoto, Ikuya] Kyushu Dent Univ, Div Oral Med, Fukuoka, Japan; [Xue, Ying; Mustafa, Kamal] Univ Bergen, Ctr Clin Dent Res, Dept Clin Dent, N-5020 Bergen, Norway; [Jimbo, Ryo] Nagasaki Univ, Dept Appl Prosthodont, Grad Sch Biomed Sci, Nagasaki 852, Japan	Galli, S (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, S-20506 Malmo, Sweden.	silvia.galli@mah.se			European Union [289163]	The research leading to these results received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement No. 289163.	Ahn EH, 2014, BIOMATERIALS, V35, P2401, DOI 10.1016/j.biomaterials.2013.11.037; Albrektsson T., 1993, Clinical Materials, V12, P1, DOI 10.1016/0267-6605(93)90021-X; Sul YT, 2005, INT J ORAL MAX IMPL, V20, P349; Appel A, 2011, TISSUE ENG PART B-RE, V17, P321, DOI [10.1089/ten.TEB.2011.0230, 10.1089/ten.teb.2011.0230]; JINGUSHI S, 1992, J BONE MINER RES, V7, P1045; Park JW, 2012, CLIN ORAL IMPLAN RES, V23, P294, DOI 10.1111/j.1600-0501.2010.02144.x; Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Connor DM, 2009, PHYS MED BIOL, V54, P6123, DOI 10.1088/0031-9155/54/20/006; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331; Sul YT, 2006, CLIN ORAL IMPLAN RES, V17, P521, DOI 10.1111/j.1600-0501.2005.01230.X; Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Sul YT, 2009, J BIOMED MATER RES A, V89A, P942, DOI 10.1002/jbm.a.32041; Karlsson J, 2012, ACTA BIOMATER, V8, P4438, DOI 10.1016/j.actbio.2012.07.035; Connor DM, 2006, PHYS MED BIOL, V51, P3283, DOI 10.1088/0031-9155/51/12/019; Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; SALIMI MH, 1985, LANGMUIR, V1, P119, DOI 10.1021/la00061a019; Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673; Svanborg LM, 2010, J BIOMED MATER RES B, V92B, P462, DOI 10.1002/jbm.b.31538; Hinoi E, 2006, GENE DEV, V20, P2937, DOI 10.1101/gad.1482906; Rude RK, 2003, CALCIFIED TISSUE INT, V72, P32, DOI 10.1007/s00223-001-1091-1; SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292; Harmankaya N, 2013, ACTA BIOMATER, V9, P7064, DOI 10.1016/j.actbio.2013.02.040; Cecchinato F, 2013, J BIOMED MAT RES A; Connor DM, 2005, NUCL INSTRUM METH A, V548, P234, DOI 10.1016/j.nima.2005.03.095; Galli S, 2014, CLIN IMPLANT DENT RE; Jimbo R, 2012, CLIN ORAL IMPLAN RES, V23, P706, DOI 10.1111/j.1600-0501.2011.02182.x; Rosa A, 2013, J CELL BIOCH; Sul Y-T, 2005, J Appl Biomater Biomech, V3, P18; Sul YT, 2013, CLIN ORAL IMPLAN RES, V24, P8, DOI 10.1111/j.1600-0501.2011.02355.x; Wagner A, 2006, PHYS MED BIOL, V51, P1313, DOI 10.1088/0031-9155/51/5/019; Wennerberg A, 2013, CLIN ORAL IMPLANT RE	36	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	DEC	2014	10	12					5193	5201		10.1016/j.actbio.2014.08.011		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AU2SQ	WOS:000345468300028		
J	Yamada, N; Kakuda, W; Kondo, T; Shimizu, M; Sageshima, M; Mitani, S; Abo, M				Yamada, Naoki; Kakuda, Wataru; Kondo, Takahiro; Shimizu, Masato; Sageshima, Masashi; Mitani, Sugao; Abo, Masahiro			Continuous theta-burst stimulation combined with occupational therapy for upper limb hemiparesis after stroke: a preliminary study	ACTA NEUROLOGICA BELGICA			English	Article						Stroke; Upper limb hemiparesis; Theta-burst stimulation; Occupational therapy	TRANSCRANIAL MAGNETIC STIMULATION; UPPER EXTREMITY FUNCTION; MOTOR-FUNCTION-TEST; POSTSTROKE PATIENTS; CONTROLLED TRIAL; EXCITABILITY; DEPRESSION; CORTEX; RELIABILITY	The purpose of this study was to assess the safety, feasibility and efficacy of continuous theta-burst stimulation (cTBS) combined with intensive occupational therapy (OT) for upper limb hemiparesis after stroke. Ten patients with history of stroke and upper limb hemiparesis (age 62.0 +/- A 11.1 years, time since stroke 95.7 +/- A 70.2 months, mean +/- A SD) were studied. Each patient received 13 sessions, each comprising 160 s of cTBS applied to the skull on the area of the non-lesional hemisphere (using a 70-mm figure-8 coil, three pulse bursts at 50 Hz, repeated every 200 ms, i.e., 5 Hz, with total stimulation of 2,400 pulses), followed by intensive OT (comprising 120-min one-to-one training and 120-min self-training) during 15-day hospitalization. The motor function of the affected upper limb was evaluated by Fugl-Meyer Assessment (FMA) and Wolf Motor Function Test (WMFT) on the days of admission and discharge. All patients completed the 15-day protocol without any adverse effects. Treatment significantly increased the FMA score (from 46.6 +/- A 8.7 to 51.6 +/- A 8.2 points, p < 0.01) and shortened the log performance time of WMFT (from 2.5 +/- A 1.1 to 2.2 +/- A 1.2 s, p < 0.01). The 15-day protocol of cTBS combined with intensive OT is a safe and potentially useful therapeutic modality for upper limb hemiparesis after stroke.	[Yamada, Naoki; Kondo, Takahiro; Shimizu, Masato; Sageshima, Masashi; Mitani, Sugao] Shimizu Hosp, Kurayoshi City, Tottori 6820881, Japan; [Yamada, Naoki; Kakuda, Wataru; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, Tokyo 1058461, Japan	Abo, M (reprint author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	abo@jikei.ac.jp			Japan Society for the Promotion of Science	The authors gratefully acknowledge the support and the participation of the patients in the study. Funding for this study was provided by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Huang YZ, 2011, CLIN NEUROPHYSIOL, V122, P1011, DOI 10.1016/j.clinph.2010.08.016; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; Nyffeler T, 2006, EUR J NEUROSCI, V24, P2961, DOI 10.1111/j.1460-9568.2006.05154.x; Fregni F, 2006, STROKE, V37, P2115, DOI 10.1161/01.STR.0000231390.58967.6b; Wu T, 2000, NEUROSCI LETT, V287, P37, DOI 10.1016/S0304-3940(00)01132-0; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Cazzoli D, 2012, BRAIN, V135, P3426, DOI 10.1093/brain/aws182; Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Chen R, 1997, NEUROLOGY, V48, P1398; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Wolf SL, 2005, NEUROREHAB NEURAL RE, V19, P194, DOI 10.1177/1545968305276663; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Ebner HR, 2003, EXP BRAIN RES, V148, P1; Kakuda W, 2010, INT J REHABIL RES, V33, P339, DOI 10.1097/MRR.0b013e32833cdf10; Kakuda W, 2010, DISABIL REHABIL, V32, P801, DOI 10.3109/09638280903295474; Lomarev MP, 2006, MOVEMENT DISORD, V21, P325, DOI 10.1002/mds.20713; Nyffeler T, 2009, STROKE, V408, P2791	26	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	DEC	2014	114	4					279	284		10.1007/s13760-014-0294-y		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU1UJ	WOS:000345405200006		
J	Kato, R; Kubota, M; Higashiyama, Y; Nagai, A				Kato, Rena; Kubota, Masaru; Higashiyama, Yukie; Nagai, Ayako			Longitudinal study of thinness from birth to early childhood: the association with parental thinness	ACTA PAEDIATRICA			English	Article						Body mass index; Early childhood; Longitudinal study; Parents; Thinness	BODY-MASS INDEX; CHILDREN; UNDERWEIGHT; ADOLESCENTS; PREVALENCE; OVERWEIGHT; GROWTH; BMI; SCHOOLCHILDREN; NUTRITION	AimEpidemiological research on thinness, particularly in early childhood, is limited. This study tracked thin children aged 5years back to birth, compared them with normal-weight children and investigated the relationship with parental thinness. MethodsWe enrolled 2678 children (50.5% boys) aged 5years and attending kindergarten or nursery in the Nara Prefecture of Japan. The children's height and weight at birth, 1.5years and 3.5years, were obtained from mother-child health records. Child thinness was defined as having a body mass index (BMI) of less than the fifth percentile of the reference values for Japanese children, and parental thinness was defined as a BMI of <18.5. ResultsThe overall prevalence of thinness at 5years of age was 4%, with no significant difference between genders. At every age, weight z-scores and BMI percentiles were significantly lower in thin children than normal-weight children. The increment in weight z-scores between birth and the age of 1.5years was significantly lower in thin children. The only parental link was paternal thinness and thinness in boys. ConclusionCareful observation of body weight from birth is important to reduce thinness at 5years of age. Paternal thinness may be a risk factor for thinness in boys.	[Kato, Rena; Kubota, Masaru; Higashiyama, Yukie; Nagai, Ayako] Nara Womens Univ, Fac Human Life & Environm, Nara 6308506, Japan	Kubota, M (reprint author), Nara Womens Univ, Dept Human Life & Environm, Kita Uoya Nishi Machi, Nara 6308506, Japan.	mkubota@cc.nara-wu.ac.jp					Mei ZG, 2008, J PEDIATR, V153, P622, DOI 10.1016/j.jpeds.2008.05.048; Shrimpton R, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.5.e75; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Wang YF, 2002, AM J CLIN NUTR, V75, P971; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Dekker LH, 2010, FOOD NUTR BULL, V31, P242; Cole TJ, 2007, BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; He Q, 2001, PEDIATR RES, V49, P244; Gunstad J, 2008, APPETITE, V50, P246, DOI 10.1016/j.appet.2007.07.008; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Baptista F, 2012, J BONE MINER METAB, V30, P100, DOI 10.1007/s00774-011-0294-4; Boddy LM, 2009, PUBLIC HEALTH NUTR, V12, P953, DOI 10.1017/S136898000800311X; desOnis M, 2004, JAMA-J AM MED ASSOC, V291, P2600; Higashiyama Y., 2012, Health, V4, P1036, DOI 10.4236/health.2012.411158; Inokuchi M, 2007, ANN HUM BIOL, V34, P354, DOI 10.1080/03014460701300109; Jansen PW, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-130; Kato N, 2009, J JAPAN ASS HUM AUXO, V15, P37; Kuczmarski RJ, 2002, VITAL HLTH STAT, V11, P1; Liu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065361; Mak KK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-88; Mak KK, 2010, INT J PEDIATR OBES, V5, P390, DOI 10.3109/17477161003728451; Mak KK, 2012, EUR J PEDIATR, V171, P779, DOI 10.1007/s00431-012-1685-9; Martorell R, 2001, J NUTR, V131, p874S; Meyers A, 2013, PEDIATRICS, V131, pE1780, DOI 10.1542/peds.2012-2382; Motlagh ME, 2011, PUBLIC HEALTH NUTR, V14, P605, DOI 10.1017/S1368980010002399; Ross ES, 2009, EARLY HUM DEV, V85, P583, DOI 10.1016/j.earlhumdev.2009.06.004; Sampei MA, 2008, PEDIATR INT, V50, P679, DOI [10.1111/j.1442-200X.2008.002633.x, 10.1111/j.1442-200X.2008.02633.x]; Whitaker KL, 2011, ARCH PEDIAT ADOLESC, V165, P9800; WHO, 1995, WHO TECHN REP SER	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	DEC	2014	103	12					1285	1289		10.1111/apa.12810		5	Pediatrics	Pediatrics	AU3HR	WOS:000345503600025		
J	Gomez, EA; Kato, H; Hashiguchi, Y				Gomez, Eduardo A.; Kato, Hirotomo; Hashiguchi, Yoshihisa			Man-biting sand fly species and natural infection with the Leishmania promastigote in leishmaniasis-endemic areas of Ecuador	ACTA TROPICA			English	Article						Ecuador; Distribution; Leishmania; Sand fly	LUTZOMYIA-AYACUCHENSIS DIPTERA; CUTANEOUS LEISHMANIASIS; VIANNIA NAIFFI; FLIES DIPTERA; PSYCHODIDAE; IDENTIFICATION; VECTOR; RECORDS; FOCUS; EPIDEMIOLOGY	A countrywide surveillance of sand flies was performed to obtain information on their geographical distribution and natural infection by Leishmania protozoa in Ecuador. A total of 18,119 sand flies were collected by human landing collections during 32 years from 1982 to 2014, and 29 species were recognized. The most prevalent 10 species were Lutzomyia gomezi, Lu. robusta, Lu. hartmanni, Lu. shannoni, Lu. trapidoi, Lu. panamensis, Lu. maranonensis, Lu. ayacuchensis, Lu. tortura and Lu. yuilli yuilli, and their topographical and vertical distributions were identified. Among all the sand flies, only 197(1.09%) flies of four Lutzomyia species, Lu. gomezi, Lu. trapidoi, Lu. tortura and Lu. ayacuchensis, were positive for Leishmania. Endotrypanum, a flagellate parasite not pathogenic to humans, were detected in five Lutzomyia species, Lu. robusta, Lu. hartmanni, Lu. trapidoi, Lu. panamensis and Lu. yuilli yuilli, suggesting wide vector-ranges of Endotrypanum species. These data on the genus Lutzomyia and their natural infections with Leishmania and Endotrypanum will be useful for transmission studies and surveillance of leishmaniasis. (C) 2014 Elsevier B.V. All rights reserved.	[Gomez, Eduardo A.] Univ Catolica Guayaquil, Fac Med, Dept Trop Med, Guayaquil, Ecuador; [Kato, Hirotomo] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Parasitol Lab, Sapporo, Hokkaido 060, Japan; [Hashiguchi, Yoshihisa] Univ Cent Ecuador, Ctr Biomed, Ciudad De Quito, Pichincha, Ecuador; [Hashiguchi, Yoshihisa] Kochi Univ, Kochi Med Sch, Dept Parasitol, Kochi, Japan	Hashiguchi, Y (reprint author), Univ Cent Ecuador, Ctr Biomed, Ciudad De Quito, Pichincha, Ecuador.	yhashiguchi42@yahoo.co.jp	Kato, Hirotomo/A-4820-2012	Kato, Hirotomo/0000-0001-5429-9536	Ministry of Education, Culture and Sports, Science and Technology (MEXT) of Japan [23256002, 25257501]; Prometeo Project of the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador	This study was financially supported by the Ministry of Education, Culture and Sports, Science and Technology (MEXT) of Japan (Grant nos. 23256002 and 25257501), and the Prometeo Project of the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Kato H, 2013, ACTA TROP, V128, P710, DOI 10.1016/j.actatropica.2013.09.001; Kato H, 2010, INT J ENV RES PUB HE, V7, P814, DOI 10.3390/ijerph7030814; Kato H, 2008, AM J TROP MED HYG, V79, P719; Gomez EA, 2014, ACTA TROP, V137, P118, DOI 10.1016/j.actatropica.2014.05.006; Fujita M, 2012, ACTA TROP, V121, P93, DOI 10.1016/j.actatropica.2011.10.004; Kato H, 2007, AM J TROP MED HYG, V77, P324; Kato H, 2008, AM J TROP MED HYG, V79, P438; Terayama Y, 2008, J VET MED SCI, V70, P907, DOI 10.1292/jvms.70.907; ALEXANDER JB, 1992, MEM I OSWALDO CRUZ, V87, P123; MIMORI T, 1989, AM J TROP MED HYG, V40, P154; Jones LA, 2010, P ENTOMOL SOC WASH, V112, P47, DOI 10.4289/0013-8797.112.1.47; ARZUBE M. E., 1960, REV ECUATORIANA HIG MED TROP, V17, P155; Caceres Abraham G., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P51, DOI 10.1590/S0036-46651997000100011; Caceres AG, 2004, AM J TROP MED HYG, V70, P607; Furuya M., 2005, KOCHI JAPAN RES REP, V5, P11; Galan E.C., 2010, 5752 HEP U SAO PAUL, P1; Gomez E.A.L., 1994, KOCHI JAPAN RES REP, V5, P34; GOMEZ EAL, 1991, ANN TROP MED PARASIT, V85, P407; Hashiguchi Y., 1991, Bulletin of the Pan American Health Organization, V25, P64; HASHIGUCHI Y, 1991, AM J TROP MED HYG, V44, P205; HASHIGUCHI Y, 1985, AM J TROP MED HYG, V34, P440; Katakura K, 2003, J VET MED SCI, V65, P649, DOI 10.1292/jvms.65.649; Kato H, 2005, AM J TROP MED HYG, V72, P87; LEPONT F, 1994, ANN SOC BELG MED TR, V74, P43; MUNSTERMANN L.E., 2004, BIOL DIS VECTORS, P141; Rodriguez J. D. M., 1974, LECCIONES PARASITOLO, P170; Rodriguez M J. D., 1956, Revista Ecuatoriana de Higiene y Medicina Tropical Guayaquil, V13, P75; Rodriguez M.J.D., 1953, ECUAT HIG MED TROP, V10, P51; Rodriguez M.J.D., 1950, REV ECUAT HIG MED TR, V7, P1; TAKAOKA H, 1990, J MED ENTOMOL, V27, P701; Young D.G., 1994, MEMOIRS AM ENTOMOLOG, V54; Young D.G., 1979, AGR EXP STAT TECH B, V801, P1; YOUNG DG, 1987, J MED ENTOMOL, V24, P651	34	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	DEC	2014	140						41	49		10.1016/j.actatropica.2014.07.003		9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AU2UW	WOS:000345473800006		
J	Ikegami, T				Ikegami, Takashi			Since ECAL 1993	ADAPTIVE BEHAVIOR			English	Editorial Material							DYNAMICS; NETWORK		Univ Tokyo, Tokyo 1538902, Japan	Ikegami, T (reprint author), Univ Tokyo, 3-8-1 Komaba Meguroku, Tokyo 1538902, Japan.	ikeg@sacral.c.u-tokyo.ac.jp					Baron-Cohen S. E., 1994, UNDERSTANDING OTHER; BOERLIJST MC, 1995, PHYSICA D, V88, P29, DOI 10.1016/0167-2789(95)00178-7; Ikegami T, 2007, INFANT BEHAV DEV, V30, P278, DOI 10.1016/j.infbeh.2007.02.002; Ikegami T, 1992, CHAOS, V2, P397, DOI 10.1063/1.165882; KANEKO K, 1992, PHYSICA D, V56, P406, DOI 10.1016/0167-2789(92)90179-Q; Uno R, 2011, IEEE T AUTON MENT DE, V3, P146, DOI 10.1109/TAMD.2011.2120608	6	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1059-7123	1741-2633		ADAPT BEHAV	Adapt. Behav.	DEC	2014	22	6			SI		390	391		10.1177/1059712314553806		2	Computer Science, Artificial Intelligence; Psychology, Experimental; Social Sciences, Interdisciplinary	Computer Science; Psychology; Social Sciences - Other Topics	AU4RX	WOS:000345600300007		
J	Murase, K				Murase, Kazuyuki			Bridge to Fukui	ADAPTIVE BEHAVIOR			English	Editorial Material									Univ Fukui, Dept Human & Artificial Intelligence Syst, Fukui 910, Japan	Murase, K (reprint author), Univ Fukui, Dept Human & Artificial Intelligence Syst, Fukui 910, Japan.	murase@u-fukui.ac.jp						0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1059-7123	1741-2633		ADAPT BEHAV	Adapt. Behav.	DEC	2014	22	6			SI		398	400		10.1177/1059712314546054		3	Computer Science, Artificial Intelligence; Psychology, Experimental; Social Sciences, Interdisciplinary	Computer Science; Psychology; Social Sciences - Other Topics	AU4RX	WOS:000345600300010		
J	Shimohara, K				Shimohara, Katsunori			Interactions with Takashi Gomi	ADAPTIVE BEHAVIOR			English	Editorial Material									Doshisha Univ, Socioinformat Lab, Kyoto 602, Japan	Shimohara, K (reprint author), Doshisha Univ, Socioinformat Lab, Kyoto 602, Japan.	kshimoha@mail.doshisha.ac.jp						0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1059-7123	1741-2633		ADAPT BEHAV	Adapt. Behav.	DEC	2014	22	6			SI		401	402		10.1177/1059712314545545		2	Computer Science, Artificial Intelligence; Psychology, Experimental; Social Sciences, Interdisciplinary	Computer Science; Psychology; Social Sciences - Other Topics	AU4RX	WOS:000345600300011		
J	Fukami, K; Yamagishi, S; Sakai, K; Kaida, Y; Minami, A; Nakayama, Y; Ando, R; Obara, N; Ueda, S; Wada, Y; Okuda, S				Fukami, Kei; Yamagishi, Sho-ichi; Sakai, Kazuko; Kaida, Yusuke; Minami, Aki; Nakayama, Yosuke; Ando, Ryotaro; Obara, Nana; Ueda, Seiji; Wada, Yoshifumi; Okuda, Seiya			Carnitine deficiency is associated with late-onset hypogonadism and depression in uremic men with hemodialysis	AGING MALE			English	Article						AMS scale; carnitine deficiency; depression; hemodialysis; late-onset hypogonadism; SDS	QUALITY-OF-LIFE; GLYCATION END-PRODUCTS; ERECTILE DYSFUNCTION; REPLACEMENT THERAPY; TESTOSTERONE; TOLERABILITY; SILDENAFIL; MORTALITY; SYMPTOMS; DIALYSIS	Late-onset hypogonadism (LOH) and depression contribute to cardiovascular disease (CVD) in male hemodialysis (HD) patients. Carnitine deficiency is frequently observed in HD patients, playing a role in CVD. We examined whether carnitine deficiency was independently associated with LOH and depression in these patients. Twenty-six male HD patients underwent determinations of serum levels of free carnitine and testosterone. Status of LOH and depression were evaluated by questionnaires using aging male symptoms' (AMS) scale and self-rating depression scale (SDS), respectively. Free carnitine and testosterone levels in male HD patients were significantly lower than those in age-matched healthy male subjects. Linear regression analysis showed that AMS scale was positively associated with SDS. Univariate regression analysis revealed that total carnitine (inversely), free carnitine (inversely) and HD duration were correlated with AMS scale. Multiple stepwise regression analysis revealed that free carnitine was an independent determinant of AMS scale. Furthermore, free carnitine was also independently correlated with SDS in male HD patients. This study demonstrated that decreased free carnitine levels were independently associated with AMS scale and SDS in male HD patients. The observations suggest that decreased free carnitine levels could be a marker and therapeutic target of LOH and depression in uremic men with HD.	[Fukami, Kei; Sakai, Kazuko; Kaida, Yusuke; Minami, Aki; Nakayama, Yosuke; Ando, Ryotaro; Obara, Nana; Ueda, Seiji; Okuda, Seiya] Kurume Univ, Dept Med, Sch Med, Div Nephrol, Kurume, Fukuoka 8300011, Japan; [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan; [Wada, Yoshifumi] Wada Cardiovasc Clin, Tosu, Saga, Japan	Fukami, K (reprint author), Kurume Univ, Dept Med, Sch Med, Div Nephrol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	fukami@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461239]; Grants of MEXT-Supported Program for the Strategic Research Foundation at Private Universities, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported, in part, by a Grant-in-Aid for Welfare and Scientific Research (C) (no. 25461239) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (K. F) and by Grants of MEXT-Supported Program for the Strategic Research Foundation at Private Universities, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S. Y.).	ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Nagano M, 2011, NEPHROLOGY, V16, P299, DOI 10.1111/j.1440-1797.2010.01419.x; Carrero JJ, 2009, J AM SOC NEPHROL, V20, P613, DOI 10.1681/ASN.2008060664; Agganis BT, 2010, AM J KIDNEY DIS, V56, P704, DOI 10.1053/j.ajkd.2010.04.018; Evans AM, 2003, CLIN PHARMACOKINET, V42, P941, DOI 10.2165/00003088-200342110-00002; Cavallini G, 2004, UROLOGY, V63, P641, DOI 10.1016/j.urology.2003.11.009; Boulware LE, 2006, CLIN J AM SOC NEPHRO, V1, P496, DOI 10.2215/CJN.00030505; Cukor D, 2009, KIDNEY INT, V75, P1223, DOI 10.1038/ki.2009.51; Iglesias P, 2012, J NEPHROL, V25, P31, DOI 10.5301/JN.2011.8481; Evans A, 2003, AM J KIDNEY DIS, V41, pS13, DOI 10.1016/S0272-6386(03)00113-6; Adachi T, 2012, NEPHROLOGY, V17, P689, DOI 10.1111/j.1440-1797.2012.01642.x; Cano NJ, 2011, J RENAL NUTR, V21, P23, DOI 10.1053/j.jrn.2010.10.016; Afsar B, 2013, INT J ARTIF ORGANS, V36, P314, DOI 10.5301/ijao.5000184; Aydogan U, 2012, ENDOCR J, V59, P1099; BOHMER T, 1978, ARCH ANDROLOGY, V1, P53; BONAVITA E, 1986, INT J CLIN PHARM TH, V24, P511; Carrero JJ, 2012, NEPHROL DIAL TRANSPL, V27, P4030, DOI 10.1093/ndt/gfs383; Cavallini G, 2005, UROLOGY, V66, P1080, DOI 10.1016/j.urology.2005.05.014; Chatterjee R, 2004, J FAM PLAN REPROD H, V30, P88, DOI 10.1783/147118904322995438; Cruciani RA, 2006, J PAIN SYMPTOM MANAG, V32, P551, DOI 10.1016/j.jpainsymman.2006.09.001; DAUGIRDAS JT, 1993, AM J KIDNEY DIS, V22, P267; Fahed AC, 2012, INT J ENDOCRINOL, V2012, P793; Fernandes GV, 2010, J SEX MED, V7, P4003, DOI 10.1111/j.1743-6109.2010.01993.x; Francomano Davide, 2010, Acta Biomed, V81 Suppl 1, P101; Heinemann Lothar A J, 2003, Health Qual Life Outcomes, V1, P15, DOI 10.1186/1477-7525-1-15; Kyriazis J, 2011, NEPHROL DIAL TRANSPL, V26, P2971, DOI 10.1093/ndt/gfq847; Martiny C, 2011, COMPR PSYCHIAT, V52, P465, DOI 10.1016/j.comppsych.2010.10.009; Park HC, 2010, CLIN NEPHROL, V73, P374; SALVIOLI G, 1994, DRUG EXP CLIN RES, V20, P169; Sayed-Ahmed MM, 2001, PHARMACOL RES, V44, P235, DOI 10.1006/phrs.2001.0852; Shankar Sudha S, 2004, Ann N Y Acad Sci, V1033, P189, DOI 10.1196/annals.1320.018; TAKAHASHI M, 1994, CLIN CHEM, V40, P817; Zhang XW, 2012, CHINESE MED J-PEKING, V125, P3806, DOI 10.3760/cma.j.issn.0366-6999.2012.21.011	33	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1368-5538	1473-0790		AGING MALE	Aging Male	DEC	2014	17	4					238	242		10.3109/13685538.2014.888053		5	Endocrinology & Metabolism; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	AU2CY	WOS:000345424700008		
J	Pachon, JE; Sarmiento, H; Hoshiko, T				Pachon, Jorge E.; Sarmiento, Hugo; Hoshiko, Tomomi			Temporal and spatial variability of particle-bound polycyclic aromatic hydrocabons in Bogota, Colombia	AIR QUALITY ATMOSPHERE AND HEALTH			English	Article						PAHs; Bogota; Black carbon; Traffic; Photoelectric aerosol sensor (PAS)	BLACK CARBON; PARTICULATE MATTER; AIR-POLLUTION; ELEMENTAL CARBON; MEXICO-CITY; HYDROCARBONS; REAL; AETHALOMETER; ENVIRONMENTS; ASSOCIATION	We have assessed diurnal profiles of particle-bound polycyclic aromatic hydrocarbons (pPAHs) in Bogota, Colombia using photoelectric aerosol sensors (PAS). PAS instruments were located close to a congested avenue to assess exposure to pedestrians, bike riders, drivers, and passengers. PAS signals during weekdays were significantly larger than during weekends, observing a similar pattern to traffic. During two different periods of analysis, it was found that meteorological conditions drive differences in PAS concentrations. An aethalometer was collocated with one PAS device to observe the relationship between PAS signals and black carbon (BC) concentration. We found a significant correlation between PAS signals and BC, suggesting that pPAHs and BC are products of the same source. Two PAS devices were located at different heights to assess vertical dispersion of pollutants. Our results suggest that pPAH loadings may diminish with height possibly due to a street canyon effect in the area. An assessment of exposure indicates that during rush hours, people are exposed to particulate matter enriched with pPAHs emitted from mobile sources. Measures should be implemented to reduce emission from vehicles on the road in order to protect public health.	[Pachon, Jorge E.; Sarmiento, Hugo] La Salle Univ, Environm Engn Program, Bogota, Colombia; [Hoshiko, Tomomi] Univ Tokyo, Dept Urban Engn, Tokyo, Japan	Pachon, JE (reprint author), La Salle Univ, Environm Engn Program, Carrera 2a 10-70 Bloque A,Piso 6o, Bogota, Colombia.	jpachon@unisalle.edu.co			Global Center of Excellence Program (GCOE) of the Center for Sustainable Urban Regeneration (cSUR) from the University of Tokyo; School of Engineering at Universidad de La Salle in Bogota	We thank Helver Reyes and Sergio Hernandez at the Colombian Ministry of Environment for their help in setting up and operating the instruments at the MADS building. This project was funded by the Global Center of Excellence Program (GCOE) of the Center for Sustainable Urban Regeneration (cSUR) from the University of Tokyo and the School of Engineering at Universidad de La Salle in Bogota. We also thank the anonymous reviewers who made important contributions to improve this manuscript.	Cheng Y, 2010, SCI TOTAL ENVIRON, V408, P1621, DOI 10.1016/j.scitotenv.2009.11.061; Burtscher H, 2005, J AEROSOL SCI, V36, P896, DOI 10.1016/j.jaerosci.2004.12.001; Peng RD, 2009, ENVIRON HEALTH PERSP, V117, P957, DOI 10.1289/ehp.0800185; Ho KF, 2009, ATMOS ENVIRON, V43, P6343, DOI 10.1016/j.atmosenv.2009.09.025; Lenters V, 2010, EPIDEMIOLOGY, V21, P512, DOI 10.1097/EDE.0b013e3181dec3a7; Galarneau E, 2008, ATMOS ENVIRON, V42, P8139, DOI 10.1016/j.atmosenv.2008.07.025; Polidori A, 2008, ATMOS CHEM PHYS, V8, P1277; Wilson NK, 2003, J EXPO ANAL ENV EPID, V13, P187, DOI 10.1038/sj.jea.7500270; BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628; Hitzenberger R, 2006, ENVIRON SCI TECHNOL, V40, P6377, DOI 10.1021/es051228v; Wallace L, 2005, AEROSOL SCI TECH, V39, P1015, DOI 10.1080/02786820500365363; Dunbar JC, 2001, SCI TOTAL ENVIRON, V279, P1, DOI 10.1016/S0048-9697(01)00686-6; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131; Marr LC, 2004, ENVIRON SCI TECHNOL, V38, P2584, DOI 10.1021/es034962s; Jeong CH, 2004, ATMOS ENVIRON, V38, P5193, DOI 10.1016/j.atmosenv.2004.02.065; Hanedar A, 2011, ATMOS RES, V99, P391, DOI 10.1016/j.atmosres.2010.11.017; POPE CA, 1995, INHAL TOXICOL, V7, P1, DOI 10.3109/08958379509014267; Dickhut RM, 2000, ENVIRON SCI TECHNOL, V34, P4635, DOI 10.1021/es000971e; Martuzevicius D, 2011, ATMOS ENVIRON, V45, P310, DOI 10.1016/j.atmosenv.2010.10.026; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Aral MM, 2010, ENVIRONMENTAL MODELING AND HEALTH RISK ANALYSIS (ACTS/RISK), P1, DOI 10.1007/978-90-481-8608-2; Arciniegas A, 2006, ACTA NOV, V3, P147; ATSDR, 2005, TOXICOLOGY PROFILE F; Baker J, 2004, ATMOS ENVIRON, V38, P6883, DOI 10.1016/j.atmosenv.2004.08.051; Chan AT, 2003, ATMOS ENVIRON, V37, P2761, DOI 10.1016/1352-2310(03)00252-8; Cheng Y, 2012, AEROSOL AIR QUAL RES, V12, P1181, DOI 10.4209/aaqr.2011.11.0223; Chetwittayachan T, 2002, ATMOS ENVIRON, V36, P2027, DOI 10.1016/S1352-2310(02)00099-7; Congreso de la Republica Colombia, 2008, LEY 1205 DE 2008 POR; Dahmann D, 2000, J AEROSOL SCI, V31, P21, DOI [10.1016/ S0021- 8502( 00) 90027- 2, DOI 10.1016/S0021-8502(00)90027-2]; DANE Departamento Nacional de Estadisticas, 2013, PROYECCIONES NACIONA; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dubowsky SD, 1999, J EXPO ANAL ENV EPID, V9, P312, DOI 10.1038/sj.jea.7500034; Durant JL, 2009, ENVIRON POLLUT, V157, P528, DOI [10.1016/ j. envpol. 2008.09.041, DOI 10.1016/J.ENVP0L.2008.09.041]; EcoChem, 2000, PHOTOELECTRIC AEROSO; Fandino M, 2009, THESIS; Guerrero O, 2012, MUTUAL INFORMATION I; Hernandez, 2009, PROC 2ND COLOMB MEET; Hoshiko T, 2013, PROC 4TH COLOMB MEET; IDEAM, 2010, SEGUNDA COMUNICACIN; Li Z, 2009, ATMOS ENVIRON, V43, P1043, DOI 10.1016/j.atmosenv.2008.11.016; Oke TR, 1988, ENERGY BUILD, V11, P103, DOI [10.1016/ 0378- 7788( 88) 90026- 6, DOI 10.1016/0378-7788(88)90026-6]; Rodroguez P, 2009, ACTUALIZACION DEL IN; Rojas N, 2010, THESIS; Sapkota A, 2003, J AIR WASTE MANAGE, V53, P740; SDA Secretaria de Ambiente de Bogota, 2010, PLAN DECENAL DE DESC; SDM Secretaria de Movilidad de Bogota, 2011, EVALUACION DE ALTERN; Solarte I, 1999, CONTAMINACION ATMOSF; Strukova, 2011, ENVIRONMENTAL HEALTH; VALERIO F, 1985, INT J ENVIRON AN CH, V23, P135, DOI 10.1080/03067318508076440; Velasco E, 2004, ATMOS ENVIRON, V38, P4957, DOI 10.1016/j.atmosenv.2004.05.020	50	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1873-9318	1873-9326		AIR QUAL ATMOS HLTH	Air Qual. Atmos. Health	DEC	2014	7	4					567	576		10.1007/s11869-014-0259-6		10	Environmental Sciences	Environmental Sciences & Ecology	AU1PU	WOS:000345393400016		
J	Miyazaki, S; Usui, E; Kusa, S; Taniguchi, H; Ichihara, N; Takagi, T; Iwasawa, J; Kuroi, A; Nakamura, H; Hachiya, H; Hirao, K; Iesaka, Y				Miyazaki, Shinsuke; Usui, Eisuke; Kusa, Shigeki; Taniguchi, Hiroshi; Ichihara, Noboru; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Nakamura, Hiroaki; Hachiya, Hitoshi; Hirao, Kenzo; Iesaka, Yoshito			Prevalence and clinical outcome of phrenic nerve injury during superior vena cava isolation and circumferential pulmonary vein antrum isolation using radiofrequency energy	AMERICAN HEART JOURNAL			English	Article							ATRIAL-FIBRILLATION; CATHETER ABLATION; ELECTRICAL ISOLATION; END-POINT; INITIATION; ADENOSINE; FORCE; FOCI	Background Phrenic nerve injury (PNI) is recognized as an important complication during atrial fibrillation ablation. This study aimed to investigate the incidence and outcome of PNI during superior vena cava isolation (SVCI) and circumferential pulmonary vein isolation (CPVI) using radiofrequency (RF) energy and the factors associated with its occurrence. Methods and results Five hundred sixty-seven consecutive patients who underwent SVCI after CPVI without substrate modification who completed a 12-month follow-up were retrospectively analyzed. Point-by-point RF applications were applied with maximum energy settings of 35 W and 30 seconds for the SVCI. In the former 210 patients, sites where pacing captured the PN were avoided whenever possible; however, the maximum power was 35 W. In the latter 357 patients, RF energy was delivered regardless of PN capture; however, the power at PN capture sites was limited to 10 W during continuous diaphragmatic movement monitoring on fluoroscopy. Circumferential pulmonary vein isolation and SVCI were successfully achieved in all. Twelve patients (2.1%) had PNI during SVCI but not during CPVI. Phrenic nerve injury completely recovered in all patients a median of 8.0 months after the procedure. The prevalence was higher in the former period (3.8% vs 1.1%; P = .03). A multivariate logistic regression analysis revealed that the study period (odds ratio 3.546; 95% CI 1.051-11.965; P = .041) was the sole independent predictor for identifying patients with PNI during SVCI. Conclusions Phrenic nerve injury occurred in 2.1% of the patients. All occurred during SVCI but not during contemporary CPVI. Energy titration and continuous diaphragmatic movement monitoring significantly decreased the incidence during SVCI.	[Miyazaki, Shinsuke; Usui, Eisuke; Kusa, Shigeki; Taniguchi, Hiroshi; Ichihara, Noboru; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Nakamura, Hiroaki; Hachiya, Hitoshi; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Tsuchiura, Ibaraki 3000053, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Div Cardiol, Cardiovasc Ctr, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Miller MA, 2012, EUROPACE, V14, P653, DOI 10.1093/europace/eus048; Tsai CF, 2000, CIRCULATION, V102, P67; Shah D, 2003, PACE, V26, P1631, DOI 10.1046/j.1460-9592.2003.t01-1-00243.x; Sanchez-Quintana D, 2005, J CARDIOVASC ELECTR, V16, P309, DOI 10.1046/j.1540-8167.2005.40759.x; Arentz T, 2007, CIRCULATION, V115, P3057, DOI 10.1161/CIRCULATIONAHA.107.690578; Haissaguerre M, 2000, CIRCULATION, V101, P1409; Miyazaki S, 2014, J CARDIOVASC ELECTR, V25, P380, DOI 10.1111/jce.12342; Andrade JG, 2011, HEART RHYTHM, V8, P1444, DOI 10.1016/j.hrthm.2011.03.050; Arruda M, 2007, J CARDIOVASC ELECTR, V18, P1261, DOI 10.1111/j.1540-8167.2007.00953.x; Yokoyama K, 2008, CIRC-ARRHYTHMIA ELEC, V1, P354, DOI 10.1161/CIRCEP.108.803650; Liu XP, 2006, J CARDIOVASC ELECTR, V17, P1263, DOI 10.1111/j.1540-8167.2006.00621.x; Franceschi F, 2011, HEART RHYTHM, V8, P885, DOI 10.1016/j.hrthm.2011.01.031; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Miyazaki S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P497, DOI 10.1161/CIRCEP.113.000281; Arentz T, 2004, J CARDIOVASC ELECTR, V15, P1041, DOI 10.1046/j.1540-8167.2004.04031.x; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Sacher F, 2006, J AM COLL CARDIOL, V47, P2498, DOI 10.1016/j.jacc.2006.02.050; Bai R, 2006, J CARDIOVASC ELECTR, V17, P944, DOI 10.1111/j.1540-8167.2006.00536.x; Bunch TJ, 2005, J CARDIOVASC ELECTR, V16, P1; Goya M, 2002, CIRCULATION, V106, P1317, DOI 10.1161/01.CIR.0000033115.92612.F4; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P1; Higuchi K, 2010, HEART RHYTHM, V7, P1186, DOI 10.1016/j.hrthm.2010.05.017; Kholova I, 2004, CIRCULATION, V110, P483, DOI 10.1161/01.CIR.0000137117.87589.88; Linhart M, 2014, J CARDIOVASC ELECTRO; Miyazaki S, 2011, HEART, V9, P668	26	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-8703	1097-5330		AM HEART J	Am. Heart J.	DEC	2014	168	6					846	853		10.1016/j.ahj.2014.09.011		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3IN	WOS:000345506100006		
J	Inohara, T; Kohsaka, S; Miyata, H; Ueda, I; Noma, S; Suzuki, M; Negishi, K; Endo, A; Nishi, Y; Hayashida, K; Maekawa, Y; Kawamura, A; Higashi, T; Fukuda, K				Inohara, Taku; Kohsaka, Shun; Miyata, Hiroaki; Ueda, Ikuko; Noma, Shigetaka; Suzuki, Masahiro; Negishi, Koji; Endo, Ayaka; Nishi, Yutaro; Hayashida, Kentaro; Maekawa, Yuichiro; Kawamura, Akio; Higashi, Takahiro; Fukuda, Keiichi			Appropriateness of coronary interventions in Japan by the US and Japanese standards	AMERICAN HEART JOURNAL			English	Article							MEDICAL THERAPY; ARTERY-DISEASE; AMERICAN-COLLEGE; REVASCULARIZATION; ANGIOPLASTY; ANGIOGRAPHY; GUIDELINES; CRITERIA; SURGERY; TRIAL	Background Appropriateness use criteria (AUC) are widely used to assess quality of care. American professional organizations and Japanese experts have both developed original AUC for percutaneous coronary intervention (PCI). However, rating discrepancies have not been investigated. Methods Patients registered in the Japanese multicenter PCI registry were analyzed. We assessed the appropriateness of PCI based on both the US and Japanese criteria and compared the ratings. A logistic regression analysis was performed to identify clinical predictors of inappropriate ratings under both standards. Results From a total of 4,950 nonacute, consecutive PCIs, 1,982 and 2,077 procedures could be successfully rated using the US and Japanese criteria, respectively. The major difference between the 2 criteria was the rating of "asymptomatic, low-or intermediate-risk patients, no lesion in the proximal left anterior descending coronary artery (PLAD)"; this scenario was deemed appropriate in the Japanese but not in the US criteria. As a consequence, the rate of inappropriate PCI using the Japanese criteria (5.2%) was substantially lower when compared with the rating using the US criteria (15%). Common clinical variables associated with "inappropriate" PCI were male, multivessel diseases, and lesions in the non-PLAD. Suboptimal antianginal medication was also a significant predictor of inappropriate PCI under the US but not under the Japanese criteria. Conclusions Significant and clinically relevant rating discrepancies were observed between the US and Japanese criteria-based assessments, owing largely to the ratings of asymptomatic, non-PLAD-related, low-or intermediate-risk cases.	[Inohara, Taku; Kohsaka, Shun; Ueda, Ikuko; Hayashida, Kentaro; Maekawa, Yuichiro; Kawamura, Akio; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Miyata, Hiroaki] Univ Tokyo, Dept Healthcare Qual Assessment, Tokyo, Japan; [Noma, Shigetaka] Saiseikai Utsunomiya Hosp, Dept Cardiol, Utsunomiya, Tochigi, Japan; [Suzuki, Masahiro] Natl Hosp Org, Saitama Natl Hosp, Dept Cardiol, Saitama, Japan; [Negishi, Koji] Yokohama Municipal Citizens Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Endo, Ayaka] Saiseikai Cent Hosp, Dept Cardiol, Tokyo, Japan; [Nishi, Yutaro] St Lukes Int Hosp, Cardiovasc Ctr, Dept Cardiol, Tokyo, Japan; [Higashi, Takahiro] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Div Hlth Serv Res, Tokyo 104, Japan	Kohsaka, S (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	kohsaka@cpnet.med.keio.ac.jp			Japan Society for the Promotion of Science [25460630, 80571398]	The present study was funded by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (Grant Nos. 25460630 and 80571398).	Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Bradley SM, 2012, CIRC-CARDIOVASC QUAL, V5, P445, DOI 10.1161/CIRCOUTCOMES.111.964320; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Ohno Y, 2013, J AM COLL CARDIOL, V62, P1260, DOI 10.1016/j.jacc.2013.03.086; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Hannan EL, 2012, J AM COLL CARDIOL, V59, P1870, DOI 10.1016/j.jacc.2012.01.050; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Chan PS, 2011, J AM COLL CARDIOL, V57, P1546, DOI 10.1016/j.jacc.2010.10.050; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Higashi T, 2007, JPN J INTERV CARDIOL, V22, P34; Inohara T, 2014, JACC-CARDIOVASC INTE, V9, P1000; Fujiwara H, 2013, CIRC J, V77, P1590, DOI 10.1253/circj.CJ-66-0065; Nishigaki K, 2008, JACC-CARDIOVASC INTE, V1, P469, DOI 10.1016/j.jcin.2008.08.002; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; The Japanese Circulation Society, 2011, JCS NAT SURV MAN CAR	21	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-8703	1097-5330		AM HEART J	Am. Heart J.	DEC	2014	168	6					854	+		10.1016/j.ahj.2014.08.011		19	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3IN	WOS:000345506100007		
J	Okamoto, N; Ikeda, T; Hasegawa, T; Yamamoto, Y; Kawato, K; Komoto, T; Imoto, I				Okamoto, Nobuhiko; Ikeda, Tae; Hasegawa, Tatsuji; Yamamoto, Yuto; Kawato, Kazumi; Komoto, Tomohiro; Imoto, Issei			Early Manifestations of BPAN in a Pediatric Patient	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						BPAN; Rett syndrome; WDR45; whole exome sequencing	PROTEIN-ASSOCIATED NEURODEGENERATION; RETT-SYNDROME; MUTATIONS; CHILDHOOD; BRAIN; NBIA; FORM	Neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of progressive brain disorders with several distinguishable subtypes. Recently, WDR45 mutations were reported in patients with -propeller protein-associated neurodegeneration (BPAN), characterized by early intellectual disability followed by delayed progressive motor and cognitive deterioration with onset in the second to third decade. BPAN has a distinct brain magnetic resonance imaging (MRI) pattern showing iron deposition in the globus pallidus and substantia nigra. To date, many of the BPAN patients have been diagnosed in adulthood. Here, we report on 6-year-old girl with BPAN diagnosed by whole exome sequencing. She showed Rett syndrome-like manifestations, a peculiar facial appearance and mildly elevated serum enzymes. Brain iron accumulation was detected by T2*-weighted MRI and T2-star weighted angiography (SWAN). This unique combination of clinical and neuroimaging features may be helpful for early diagnosis of BPAN. (c) 2014 Wiley Periodicals, Inc.	[Okamoto, Nobuhiko; Yamamoto, Yuto; Kawato, Kazumi] Osaka Med Ctr, Dept Med Genet, Izumi, Osaka 5941101, Japan; [Okamoto, Nobuhiko; Ikeda, Tae; Yamamoto, Yuto; Kawato, Kazumi] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Ikeda, Tae] Osaka Med Ctr, Dept Pediat Neurol, Izumi, Osaka 5941101, Japan; [Hasegawa, Tatsuji] Maizuru Med Ctr, Dept Pediat, Maizuru, Japan; [Komoto, Tomohiro] Univ Tokushima, Fac Med, Student Lab, Tokushima 770, Japan; [Komoto, Tomohiro; Imoto, Issei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet, Tokushima 770, Japan	Okamoto, N (reprint author), Osaka Med Ctr, Dept Med Genet, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	okamoto@osaka.email.ne.jp			Ministry of Health, Labour and Welfare, Japan	Grant sponsor: Ministry of Health, Labour and Welfare, Japan.	Hayflick SJ, 2013, BRAIN, V136, P1708, DOI 10.1093/brain/awt095; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; FITZGERALD PM, 1990, NEUROLOGY, V40, P293; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Ohba C, 2014, J HUM GENET, V59, P292, DOI 10.1038/jhg.2014.18; Segawa M, 2005, BRAIN DEV-JPN, V27, pS54, DOI 10.1016/j.braindev.2004.11.010; Verhoeven WMA, 2014, PARKINSONISM RELAT D, V20, P332, DOI 10.1016/j.parkreldis.2013.11.019	8	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	DEC	2014	164	12					3095	3099		10.1002/ajmg.a.36779		5	Genetics & Heredity	Genetics & Heredity	AU0DJ	WOS:000345293300019		
J	Miyata, R; Hayashi, M; Itoh, E				Miyata, Rie; Hayashi, Masaharu; Itoh, Eisaku			Pathological Changes in Cardiac Muscle and Cerebellar Cortex in Vici Syndrome	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Letter							CORPUS-CALLOSUM; AUTOPHAGY; AGENESIS; ATROPHY		[Miyata, Rie] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Hayashi, Masaharu] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Tokyo 113, Japan; [Itoh, Eisaku] Tokyo Med & Dent Univ, Dept Pathol, Tokyo, Japan	Hayashi, M (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Tokyo 113, Japan.	hayashi-ms@igakuken.or.jp					Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; Takahashi T, 2005, NEUROPATHOLOGY, V25, P228, DOI 10.1111/j.1440-1789.2005.00604.x; Miyata R, 2007, AM J MED GENET A, V143A, P189, DOI 10.1002/ajmg.a.31584; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; del Campo M, 1999, AM J MED GENET, V85, P479, DOI 10.1002/(SICI)1096-8628(19990827)85:5<479::AID-AJMG9>3.0.CO;2-D; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Matsumoto R, 1998, ACTA NEUROPATHOL, V95, P149; Rogers RC, 2011, CASE REP GENET, V2011; VICI CD, 1988, AM J MED GENET, V29, P1, DOI 10.1002/ajmg.1320290102	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	DEC	2014	164	12					3203	3205		10.1002/ajmg.a.36753		3	Genetics & Heredity	Genetics & Heredity	AU0DJ	WOS:000345293300036		
J	Anan, Y; Ohbo, A; Tani, Y; Ogra, Y				Anan, Yasumi; Ohbo, Ai; Tani, Yuta; Ogra, Yasumitsu			Metabolic pathway of inorganic and organic selenocompounds labeled with stable isotope in Japanese quail	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Selenium; Quail; Avian; SeMet; ICP-MS; Selenosugar	PLASMA-MASS SPECTROMETRY; ICP-MS; SELENIUM; SELENOMETHIONINE; SPECIATION; URINE; ALPHA,GAMMA-ELIMINATION; SE-77-SELENOMETHIONINE; IDENTIFICATION; METHYLSELENOL	The distribution and metabolism of an inorganic selenium (Se) compound and a selenoamino acid in quails were evaluated by speciation with inductively coupled plasma mass spectrometry (ICP-MS) and a stable isotope. Quails were orally administered stable isotope [Se-77]-labeled selenite and selenomethionine (SeMet) at the nutritional dose of 10 mu g Se/bird. Then, the quails were dissected 3, 9, and 24 h after the administration to examine the metabolic pathway and the time-dependent change of Se. The concentrations of exogenous Se in all the organs and tissues of the SeMet-administered group were significantly higher than those of the selenite-administered group 3 h after the administration. This suggested that SeMet was more rapidly and/or efficiently incorporated into the quail body than selenite. A Se-containing protein in the serum was detected only in the SeMet-administered quails, but not in the selenite-administered quails. The major urinary Se metabolite, i.e., Se-methylseleno-N-acetyl-galactosamine (selenosugar), was detected in the quail serum after the administration of both selenite and SeMet. The endogenous amount of Se-methylated selenosugar (MeSeSug) in the serum of quails seemed to be larger than that of the rodents. We conclude that the metabolic pathway of Se in quails was the same as that in rodents, but the metabolic capacity for Se seemed to be larger in quails than in rodents.	[Anan, Yasumi; Ohbo, Ai; Tani, Yuta; Ogra, Yasumitsu] Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, Machida, Tokyo 1948543, Japan	Ogra, Y (reprint author), Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, Machida, Tokyo 1948543, Japan.	ogra@ac.shoyaku.ac.jp		Ogra, Yasumitsu/0000-0002-8268-1828	JSPS KAKENHI grants [23390032, 24659022, 26293030, 25870739]; MEXT; Takeda Science Foundation, Japan	This study was supported by JSPS KAKENHI grants (Nos. 23390032, 24659022, and 26293030 to Y. O. and 25870739 to Y. A.), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2013-2017), and Takeda Science Foundation, Japan.	Abbas-Ghaleb K, 2003, ANAL BIOANAL CHEM, V377, P1026, DOI 10.1007/s00216-003-2154-0; Anan Y, 2011, ANAL BIOANAL CHEM, V399, P1765, DOI 10.1007/s00216-010-4143-4; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Anan Y, 2012, METALLOMICS, V4, P457, DOI 10.1039/c2mt20013a; Bierla K, 2008, ANAL BIOANAL CHEM, V390, P1789, DOI 10.1007/s00216-008-1883-5; Infante HG, 2005, ANAL BIOANAL CHEM, V382, P957, DOI 10.1007/s00216-005-3177-5; Suzuki KT, 2005, J HEALTH SCI, V51, P107, DOI 10.1248/jhs.51.107; Nakazawa E, 2011, METALLOMICS, V3, P719, DOI 10.1039/c0mt00106f; Kuehnelt D, 2006, ANAL BIOANAL CHEM, V386, P2207, DOI 10.1007/s00216-006-0848-9; Lipiec E, 2010, ANAL BIOANAL CHEM, V397, P731, DOI 10.1007/s00216-010-3544-8; Ogra Y, 2002, J CHROMATOGR B, V767, P301, DOI 10.1016/S1570-0232(01)00581-5; Anan Y, 2013, ANAL SCI, V29, P787; Suzuki KT, 2006, TOXICOL APPL PHARM, V215, P189, DOI 10.1016/j.taap.2006.02.011; Pedrero Z, 2009, ANAL CHIM ACTA, V634, P135, DOI 10.1016/j.aca.2008.12.026; Suzuki KT, 2006, TOXICOL APPL PHARM, V217, P185, DOI 10.1016/j.taap.2006.09.006; Francesconi KA, 2004, CLIN CHEM, V50, P2240, DOI 10.1373/clinchem.2004.039875; Ogra Y, 2009, J ANAL ATOM SPECTROM, V24, P1477, DOI 10.1039/b910235c; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Suzuki KT, 1998, ANALYST, V123, P63, DOI 10.1039/a706230c; BYARD JL, 1969, ARCH BIOCHEM BIOPHYS, V130, P556, DOI 10.1016/0003-9861(69)90070-8; Schrauzer GN, 2000, J NUTR, V130, P1653; Bettmer J, 2009, J PROTEOMICS, V72, P989, DOI 10.1016/j.jprot.2009.05.003; BEILSTEIN MA, 1984, J NUTR, V114, P1501; BURK RF, 1982, ARCH BIOCHEM BIOPHYS, V213, P73, DOI 10.1016/0003-9861(82)90441-6; Kobayashi Y, 2002, P NATL ACAD SCI USA, V99, P15932, DOI 10.1073/pnas.252610699; KRASNER N, 1976, ACTA HEPATO-GASTRO, V23, P144; LEONZIO C, 1992, B ENVIRON CONTAM TOX, V49, P686; Lunoe K, 2012, ANAL BIOANAL CHEM, V402, P2749, DOI 10.1007/s00216-012-5747-7; Magi E, 2002, ANN CHIM-ROME, V92, P229; Ogra Y, 2005, ANAL CHIM ACTA, V554, P123, DOI 10.1016/j.aca.2005.08.021; Okuno T, 2005, BIOL TRACE ELEM RES, V108, P245, DOI 10.1385/BTER:108:1-3:245; Okuno T, 2005, BIOL TRACE ELEM RES, V106, P77, DOI 10.1385/BTER:106:1:077; PLENEVAUX A, 1987, APPL RADIAT ISOTOPES, V38, P59; Suzuki KT, 1996, TOHOKU J EXP MED, V178, P27, DOI 10.1620/tjem.178.27; Suzuki KT, 2006, TOXICOL APPL PHARM, V217, P43, DOI 10.1016/j.taap.2006.07.006; Tsuji Y, 2010, METALLOMICS, V2, P412, DOI 10.1039/c004026f; Yergey AL, 1996, J NUTR, V126, pS355	37	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	DEC	2014	406	30					7959	7966		10.1007/s00216-014-8260-3		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AU1JS	WOS:000345377600017		
J	Yamamoto, H; Sakura, S; Wada, M; Shido, A				Yamamoto, Hiroto; Sakura, Shinichi; Wada, Minori; Shido, Akemi			A Prospective, Randomized Comparison Between Single- and Multiple-Injection Techniques for Ultrasound-Guided Subgluteal Sciatic Nerve Block	ANESTHESIA AND ANALGESIA			English	Article							POPLITEAL BLOCK; REGIONAL ANESTHESIA; OBESE-PATIENTS; BIFURCATION	BACKGROUND: It is believed that local anesthetic injected to obtain circumferential spread around nerves produces more rapid onset and successful blockade after some ultrasound-guided peripheral nerve blocks. However, evidence demonstrating this point is limited only to the popliteal sciatic nerve block, which is relatively easy to perform by via a high-frequency linear transducer. In the present study, we tested the hypothesis that multiple injections of local anesthetic to make circumferential spread would improve the rate of sensory and motor blocks compared with a single-injection technique for ultrasound-guided subgluteal sciatic nerve block, which is considered a relatively difficult block conducted with a low-frequency, curved-array transducer. METHODS: Ninety patients undergoing knee surgery were divided randomly into 2 groups to receive the ultrasound-guided subgluteal approach to sciatic nerve block with 20 mL of 1.5% mepivacaine with epinephrine. For group M (the multiple-injection technique), the local anesthetic was injected to create circumferential spread around the sciatic nerve without limitation on the number of needle passes. For group S (the single-injection technique), the number of needle passes was limited to 1, and the local anesthetic was injected to create spread along the dorsal surface of the sciatic nerve, during which no adjustment of the needle tip was made. Sensory and motor blockade were assessed in double-blind fashion for 30 minutes after completion of the block. The primary outcome was sensory blockade of all sciatic components tested, including tibial, superficial peroneal, and sural nerves at 30 minutes after injection. RESULTS: Data from 86 patients (43 in each group) were analyzed. Block execution took more time for group M than group S. The proportion of patients with complete sensory blockade of all sciatic components at 30 minutes after injection was significantly larger for group M than group S (41.9% vs 16.3%, P = 0.018). Complete motor blockade of foot and toes extension also was observed more frequently in group M than in group S (67.4% vs 34.9%, P = 0.005 and 51.2% vs 25.6%, P = 0.027, respectively). CONCLUSIONS: When ultrasound-guided subgluteal sciatic nerve block is conducted, multiple injections of local anesthetic to make a circumferential spread around the sciatic nerve improve the rate of sensory and motor blocks compared with a single injection.	[Yamamoto, Hiroto; Sakura, Shinichi; Wada, Minori; Shido, Akemi] Shimane Univ, Sch Med, Dept Anesthesiol, Izumo, Shimane 6938501, Japan	Sakura, S (reprint author), Shimane Univ, Sch Med, Dept Anesthesiol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	ssakura@med.shimane-u.ac.jp					Sinha A, 2004, REGION ANESTH PAIN M, V29, P130, DOI 10.1016/j.rapm.2004.01.001; Sites BD, 2009, REGION ANESTH PAIN M, V34, P40, DOI 10.1097/AAP.0b013e3181926779; Karmakar MK, 2007, BRIT J ANAESTH, V98, P390, DOI 10.1093/bja/ael364; Ota J, 2009, ANESTH ANALG, V108, P660, DOI 10.1213/ane.0b013e31818fc252; Buys MJ, 2010, ANESTH ANALG, V110, P635, DOI 10.1213/ANE.0b013e3181c88f27; Abdallah FW, 2013, REGION ANESTH PAIN M, V38, P547, DOI 10.1097/AAP.0000000000000016; Morau D, 2010, REGION ANESTH PAIN M, V35, P559, DOI 10.1097/AAP.0b013e3181fa6b60; Spence BC, 2011, ANAESTHESIA, V66, P509, DOI 10.1111/j.1365-2044.2011.06712.x; Chan VWS, 2006, ANESTHESIOLOGY, V104, P309, DOI 10.1097/00000542-200602000-00017; Brull R, 2011, REGION ANESTH PAIN M, V36, P266, DOI 10.1097/AAP.0b013e318217a6a1; Chantzi C, 2007, ACTA ANAESTH SCAND, V51, P132, DOI 10.1111/j.1399-6576.2006.01177.x; Germain G, 2012, ANESTH ANALG, V114, P233, DOI 10.1213/ANE.0b013e3182373887; Hara K, 2012, REGION ANESTH PAIN M, V37, P289, DOI 10.1097/AAP.0b013e31824bde5c; Hara K, 2014, J ANESTH, V28, P524, DOI 10.1007/s00540-013-1746-x; Hara K, 2011, ANAESTH INTENS CARE, V39, P69; Peetrons P., 2002, EUR RADIOL, V12, P33; Perlas A, 2013, REGION ANESTH PAIN M, V38, P218, DOI 10.1097/AAP.0b013e31828db12f; Prasad A, 2010, REGION ANESTH PAIN M, V35, P267, DOI 10.1097/AAP.0b013e3181df2527; Sakura S, 2010, J ANESTH, V24, P411, DOI 10.1007/s00540-010-0916-3; Sakura S, 2012, TRENDS ANAESTH CRIT, V2, P274; Saranteas T, 2007, REGION ANESTH PAIN M, V32, P546, DOI 10.1016/j.rapm.2007.04.011; Tran DQH, 2011, REGION ANESTH PAIN M, V36, P548, DOI 10.1097/AAP.0b013e318235f566	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999	1526-7598		ANESTH ANALG	Anesth. Analg.	DEC	2014	119	6					1442	1448		10.1213/ANE.0000000000000462		7	Anesthesiology	Anesthesiology	AT9SO	WOS:000345266600031		
J	Sakaguchi, M; Marutani, E; Shin, HS; Chen, W; Hanaoka, K; Xian, M; Ichinose, F				Sakaguchi, Masahiro; Marutani, Eizo; Shin, Hae-sook; Chen, Wei; Hanaoka, Kenjiro; Xian, Ming; Ichinose, Fumito			Sodium Thiosulfate Attenuates Acute Lung Injury in Mice	ANESTHESIOLOGY			English	Article							HYDROGEN-SULFIDE; PROTECTS; INFLAMMATION; ACTIVATION; CISPLATIN; FAILURE; SEPSIS	Background: Acute lung injury is characterized by neutrophilic inflammation and increased lung permeability. Thiosulfate is a stable metabolite of hydrogen sulfide, a gaseous mediator that exerts antiinflammatory effects. Although sodium thiosulfate (STS) has been used as an antidote, the effect of STS on acute lung injury is unknown. The authors assessed the effects of STS on mice lung and vascular endothelial cells subjected to acute inflammation. Methods: Lung injury was assessed in mice challenged with intratracheal lipopolysaccharide or subjected to cecal ligation and puncture with or without STS. Effects of STS on endothelial permeability and the production of inflammatory cytokines and reactive oxygen species were examined in cultured endothelial cells incubated with lipopolysaccharide or tumor necrosis factor-a. Levels of sulfide and sulfane sulfur were measured using novel fluorescence probes. Results: STS inhibited lipopolysaccharide-induced production of cytokines (interleukin-6 [pg/ml]; 313 +/- 164, lipopolysaccharide; 79 +/- 27, lipopolysaccharide + STS [n = 10]), lung permeability, histologic lung injury, and nuclear factor-kappa B activation in the lung. STS also prevented up-regulation of interleukin-6 in the mouse lung subjected to cecal ligation and puncture. In endothelial cells, STS increased intracellular levels of sulfide and sulfane sulfur and inhibited lipopolysaccharide or tumor necrosis factor-alpha-induced production of cytokines and reactive oxygen species. The beneficial effects of STS were associated with attenuation of the lipopolysaccharide-induced nuclear factor-kappa B activation through the inhibition of tumor necrosis factor receptor-associated factor 6 ubiquitination. Conclusions: STS exerts robust antiinflammatory effects in mice lung and vascular endothelium. The results suggest a therapeutic potential of STS in acute lung injury.	[Sakaguchi, Masahiro; Marutani, Eizo; Shin, Hae-sook; Ichinose, Fumito] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Sakaguchi, Masahiro; Marutani, Eizo; Shin, Hae-sook; Ichinose, Fumito] Harvard Univ, Sch Med, Boston, MA USA; [Chen, Wei; Xian, Ming] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Hanaoka, Kenjiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan	Ichinose, F (reprint author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	fichinose@mgh.harvard.edu			National Institutes of Health (Bethesda, Maryland) [R01HL101930]	This study was supported by a National Institutes of Health (Bethesda, Maryland) grant R01HL101930 (to Dr. Ichinose).	Adirekkiat S, 2010, NEPHROL DIAL TRANSPL, V25, P1923, DOI 10.1093/ndt/gfp755; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; Cicone JS, 2004, AM J KIDNEY DIS, V43, P1104, DOI 10.1053/j.ajkd.2004.03.018; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044; Menden H, 2013, AM J PHYSIOL-LUNG C, V304, pL445, DOI 10.1152/ajplung.00261.2012; Pasch A, 2008, KIDNEY INT, V74, P1444, DOI 10.1038/ki.2008.455; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Chen W, 2013, CHEM SCI, V4, P2892, DOI 10.1039/c3sc50754h; Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363; Shirozu K, 2014, ANTIOXID REDOX SIGN, V20, P204, DOI 10.1089/ars.2013.5354; Ichinose F, 2001, CIRC RES, V88, P832, DOI 10.1161/hh0801.089177; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Bernard GR, 2005, AM J RESP CRIT CARE, V172, P798, DOI 10.1164/rccm.200504-663OE; Chung JY, 2002, J CELL SCI, V115, P679; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Zou L, 2011, SHOCK, V36, P370, DOI 10.1097/SHK.0b013e3182279868; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI 10.1089/ARS.2008.2253; Sasakura K, 2011, J AM CHEM SOC, V133, P18003, DOI 10.1021/ja207851s; Faller Simone, 2012, Med Gas Res, V2, P26, DOI 10.1186/2045-9912-2-26; GOEL R, 1989, J NATL CANCER I, V81, P1552, DOI 10.1093/jnci/81.20.1552; Koh H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-60; MARKMAN M, 1985, CANCER, V56, P2364, DOI 10.1002/1097-0142(19851115)56:10<2364::AID-CNCR2820561003>3.0.CO;2-4; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Neuwelt EA, 1998, J PHARMACOL EXP THER, V286, P77; Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766; PETTERSEN JC, 1985, TOXICOL APPL PHARM, V81, P265, DOI 10.1016/0041-008X(85)90163-2; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425	37	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	DEC	2014	121	6					1248	1257				10	Anesthesiology	Anesthesiology	AU2FB	WOS:000345430700016		
J	Ueda, M; Iwasaki, H; Wang, SX; Murata, E; Poon, KYT; Mao, JR; Martyn, JAJ				Ueda, Masashi; Iwasaki, Hajime; Wang, Shuxing; Murata, Eri; Poon, K. Y. Trudy; Mao, Jianren; Martyn, J. A. Jeevendra			Cannabinoid Receptor Type 1 Antagonist, AM251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury	ANESTHESIOLOGY			English	Article							PERIPHERAL MONONEUROPATHY; INSULIN-RESISTANCE; SPINAL-CORD; YOUNG-RATS; PAIN; MORPHINE; ENDOCANNABINOIDS; BEHAVIOR; PROTEIN; SENSITIZATION	Background: Burn injury causes nociceptive behaviors, and inflammation-related pathologic pain can lead to glial cell activation. This study tested the hypothesis that burn injury activates glial cells, and cannabinoid receptor 1 (CB1R) antagonist, AM251, will decrease burn pain. Methods: Anesthetized rats received 0.75-cm(2) third-degree burn on dorsal hind paw. Vehicle or AM251 30 mu g intrathecally (older rats, n = 6 per group) or, either vehicle, 0.1 or 1.0 mg/kg intraperitoneally (younger rats, n = 6 per group), started immediate postburn, was administered for 7 days. Mechanical allodynia and thermal hyperalgesia were tested on ventral paw for 14 days. Microglial and astroglial activity was assessed by immunocytochemistry. Results: Allodynia, observed on burn side from day 1 to 14, was significantly (P < 0.05) attenuated by intrathecal and intraperitoneal AM251 (1 mg/kg) starting from 3 to 14 days. Hyperalgesia, observed from day 3 to 12, was completely (P < 0.05) reversed by intrathecal and intraperitoneal AM251 (1 mg/kg). AM251 0.1 mg/kg had no effect. Microglial activity (n = 3 per time point) increased (P < 0.05) 18.5 +/- 7.5 and 12.3 +/- 1.6 (mean +/- SD) fold at 7 and 14 days, respectively. Astroglial activity (n = 4 per time point) increased 2.9 +/- 0.3 fold at day 7 only. Glial activities were unaltered by AM251. Conclusions: AM251 inhibited nociceptive behaviors after burn even beyond 7-day period of administration. Although many studies have documented the utility of CB1R agonists, this study indicates that endogenous cannabinoids may have an unexpected pronociceptive effect during development of burn pain, explaining why CB1R antagonist, AM251, improves nociceptive behaviors. The decreased nociception with AM251 without altering glial activity indicates that AM251 acts further downstream of activated glial cells.	Massachusetts Gen Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02114 USA; Shriners Hosp Children, Boston, MA USA; [Ueda, Masashi; Iwasaki, Hajime; Wang, Shuxing; Murata, Eri; Poon, K. Y. Trudy; Mao, Jianren; Martyn, J. A. Jeevendra] Harvard Univ, Sch Med, Boston, MA USA; [Murata, Eri] Univ Fukui, Dept Anesthesiol, Fukui 910, Japan	Martyn, JAJ (reprint author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesiol, 51 Blossom St,Room 206, Boston, MA 02114 USA.	jmartyn@mgh.harvard.edu			National Institutes of Health (Bethesda, Maryland) [GM P50-2500]	Supported in part by a grant from the National Institutes of Health (Bethesda, Maryland) GM P50-2500 Project I (to Dr. Martyn).	Summer GJ, 2008, PAIN, V135, P98, DOI 10.1016/j.pain.2007.05.012; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Diezi M, 2013, CURR OPIN NEUROL, V26, P481, DOI 10.1097/WCO.0b013e328364eb07; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; McDowell TS, 2013, NEUROSCI LETT, V551, P34, DOI 10.1016/j.neulet.2013.06.066; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Agarwal V, 2010, J BURN CARE RES, V31, P706, DOI [10.1097/BCR.0b013e3181eebee9, 10.1097/BCR.0bd13e3181eebee9]; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; Palazzo E, 2001, NEUROPHARMACOLOGY, V40, P319, DOI 10.1016/S0028-3908(00)00160-X; Lilleso J, 2000, BRIT J ANAESTH, V85, P228, DOI 10.1093/bja/85.2.228; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; Zogopoulos P, 2013, FUND CLIN PHARMACOL, V27, P64, DOI 10.1111/fcp.12008; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Leinders M, 2013, NEUROSCI LETT, V554, P146, DOI 10.1016/j.neulet.2013.08.062; Kaneki M, 2013, METABOLISM, V62, P341, DOI 10.1016/j.metabol.2012.08.010; Wang SX, 2011, PAIN MED, V12, P87, DOI 10.1111/j.1526-4637.2010.01021.x; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Robson PJ, 2014, DRUG TEST ANAL, V6, P24, DOI 10.1002/dta.1529; DAHL D, 1985, J COMP NEUROL, V239, P75, DOI 10.1002/cne.902390107; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Arevalo-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049057; ATCHISON NE, 1991, PAIN, V47, P41, DOI 10.1016/0304-3959(91)90009-M; Bialuk I, 2011, PHARMACOL REP, V63, P670; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; Ducourneau VRR, 2014, PAIN, V155, P275, DOI 10.1016/j.pain.2013.10.008; Juknat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061462; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Li K, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/901420; MAO J, 1993, J NEUROPHYSIOL, V70, P470; Mathes CM, 2009, PHARMACOL BIOCHEM BE, V94, P119, DOI 10.1016/j.pbb.2009.07.016; Nadal X, 2013, EUR J PHARMACOL, V716, P142, DOI 10.1016/j.ejphar.2013.01.077; OSGOOD PF, 1989, PEDIATR CLIN N AM, V36, P1001; Perego C, 2013, J VIS EXP, V79; Ru-Rong J, 2013, PAIN, V154, pS10; Sink KS, 2009, PSYCHOPHARMACOLOGY, V206, P223, DOI 10.1007/s00213-009-1602-8; Song L, 2014, BRAIN RES, V1564, P52, DOI 10.1016/j.brainres.2014.03.047; Tanioka T, 2011, J BIOL CHEM, V286, P29388, DOI 10.1074/jbc.M110.192732; Trupkovic Tomislav, 2011, J Intensive Care Med, V26, P397, DOI 10.1177/0885066610393442; Velayudhan L, 2014, CURR PHARM DESIGN, V20, P2218; Wang SX, 2005, PAIN, V116, P87, DOI 10.1016/j.pain.2005.03.044; Yuan S, 2013, J NEUROPHYSIOL, V110, P2607, DOI 10.1152/jn.00170.2013	42	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	DEC	2014	121	6					1311	1319				9	Anesthesiology	Anesthesiology	AU2FB	WOS:000345430700022		
J	Kofuku, Y; Ueda, T; Okude, J; Shiraishi, Y; Kondo, K; Mizumura, T; Suzuki, S; Shimada, I				Kofuku, Yutaka; Ueda, Takumi; Okude, Junya; Shiraishi, Yutaro; Kondo, Keita; Mizumura, Takuya; Suzuki, Shiho; Shimada, Ichio			Functional Dynamics of Deuterated beta(2)-Adrenergic Receptor in Lipid Bilayers Revealed by NMR Spectroscopy	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						G-protein-coupled receptors; isotopic labeling; lipid bilayers; membrane proteins; NMR spectroscopy	PROTEIN-COUPLED RECEPTOR; STRUCTURAL INSIGHTS; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; ACTIVATION; CELLS; EQUILIBRIUM; NANODISCS; SIGNALS; YIELDS	G-protein-coupled receptors (GPCRs) exist in conformational equilibrium between active and inactive states, and the former population determines the efficacy of signaling. However, the conformational equilibrium of GPCRs in lipid bilayers is unknown owing to the low sensitivities of their NMR signals. To increase the signal intensities, a deuteration method was developed for GPCRs expressed in an insect cell/baculovirus expression system. The NMR sensitivities of the methionine methyl resonances from the beta 2-adrenergic receptor (beta(2)AR) in lipid bilayers of reconstituted high-density lipoprotein (rHDL) increased by approximately 5-fold upon deuteration. NMR analyses revealed that the exchange rates for the conformational equilibrium of beta(2)AR in rHDLs were remarkably different from those measured in detergents. The timescales of GPCR signaling, calculated from the exchange rates, are faster than those of receptor tyrosine kinases and thus enable rapid neurotransmission and sensory perception.	[Kofuku, Yutaka; Ueda, Takumi; Okude, Junya; Shiraishi, Yutaro; Kondo, Keita; Mizumura, Takuya; Suzuki, Shiho; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ueda, Takumi] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020075, Japan	Shimada, I (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp			Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade and Industry (METI), and by a Grant-in-Aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Raschle T, 2009, J AM CHEM SOC, V131, P17777, DOI 10.1021/ja907918r; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Horst R, 2013, ANGEW CHEM INT EDIT, V52, P10762, DOI 10.1002/anie.201305286; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Etzkorn M, 2013, STRUCTURE, V21, P394, DOI 10.1016/j.str.2013.01.005; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Yoshiura C, 2010, J AM CHEM SOC, V132, P6768, DOI 10.1021/ja100830f; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Gossert AD, 2011, J BIOMOL NMR, V51, P449, DOI 10.1007/s10858-011-9570-9; Horst R., 2013, ANGEW CHEM, V125, P10962; Imai S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401265; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Kubo S., 2013, ANGEW CHEM, V125, P1246; Kubo S, 2013, ANGEW CHEM INT EDIT, V52, P1208, DOI 10.1002/anie.201207243; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108	29	9	9	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	DEC 1	2014	53	49					13376	13379		10.1002/anie.201406603		4	Chemistry, Multidisciplinary	Chemistry	AU4OG	WOS:000345590300007		
J	Takikawa, K; Asanuma, D; Namiki, S; Sakamoto, H; Ariyoshi, T; Kimpara, N; Hirose, K				Takikawa, Kenji; Asanuma, Daisuke; Namiki, Shigeyuki; Sakamoto, Hirokazu; Ariyoshi, Tetsuro; Kimpara, Naoya; Hirose, Kenzo			High-Throughput Development of a Hybrid-Type Fluorescent Glutamate Sensor for Analysis of Synaptic Transmission	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						fluorescent probes; high-throughput screening; neurotransmitters	KNOWLEDGE-BASED DESIGN; LIGAND-BINDING DOMAIN; ORGANIC-DYES; BIOSENSOR; DYNAMICS; RECEPTOR; TRYPTOPHAN; PROTEIN; PROBES; BRAIN	Fluorescent sensors are powerful tools for visualizing cellular molecular dynamics. We present a high-throughput screening system, designated hybrid-type fluorescence indicator development (HyFInD), to identify optimal position-specific fluorophore labeling in hybrid-type sensors consisting of combinations of ligand-binding protein mutants with small molecular fluorophores. We screened sensors for glutamate among hybrid molecules obtained by the reaction of four cysteine-reactive fluorescence probes with a set of cysteine-scanning mutants of the 274 amino acid S1S2 domain of AMPA-type glutamate receptor GluA2 subunit. HyFInD identified a glutamate-responsive probe (enhanced glutamate optical sensor: eEOS) with a dynamic range >2400%, good photostability, and high selectivity. When eEOS was specifically tethered to neuronal surfaces, it reliably visualized the spatiotemporal dynamics of glutamate release at single synapses, revealing synapse-to-synapse heterogeneity of short-term plasticity.	[Takikawa, Kenji; Asanuma, Daisuke; Namiki, Shigeyuki; Sakamoto, Hirokazu; Ariyoshi, Tetsuro; Kimpara, Naoya; Hirose, Kenzo] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan	Hirose, K (reprint author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	kenzoh@m.u-tokyo.ac.jp			SENTAN, JST; MEXT; KAKENHI [11J05563, 26560441, 24115502, 24590313, 25115704, 24116004]; Research Foundation for Opto-Science and Technology	We thank S. Iinuma and M. Kanda for their participation during the preliminary stage of this study. This work was supported in part by grants from SENTAN, JST (to K.H.), the Strategic Research Program for Brain Sciences, MEXT (to K.H.), KAKENHI (Grant no. 11J05563 to K.T., 26560441 to D.A., 24115502, 24590313, and 25115704 to S.N., and 24116004 to K.H.), and Research Foundation for Opto-Science and Technology (to D.A.)	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Namiki S, 2007, EUR J NEUROSCI, V25, P2249, DOI 10.1111/j.1460-9568.2007.05511.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Neuweiler H, 2002, ANGEW CHEM INT EDIT, V41, P4769, DOI 10.1002/anie.200290044; Chen GQ, 1998, PROTEIN SCI, V7, P2623; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/nmeth.2333, 10.1038/NMETH.2333]; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Brun MA, 2012, J AM CHEM SOC, V134, P7676, DOI 10.1021/ja3002277; Abe R, 2011, J AM CHEM SOC, V133, P17386, DOI 10.1021/ja205925j; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Doose S, 2005, CHEMPHYSCHEM, V6, P2277, DOI 10.1002/cphc.200500191; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; Gulyani A, 2011, NAT CHEM BIOL, V7, P437, DOI [10.1038/nchembio.585, 10.1038/NCHEMBIO.585]; Kummer L, 2013, CHEM BIOL, V20, P847, DOI 10.1016/j.chembiol.2013.04.016; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Neuweiler H., 2002, ANGEW CHEM, V114, P4964, DOI 10.1002/ange.200290043; Okubo Y, 2010, P NATL ACAD SCI USA, V107, P6526, DOI 10.1073/pnas.0913154107; Renard M, 2002, J MOL BIOL, V318, P429, DOI 10.1016/S0022-2836(02)00023-2	30	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	DEC 1	2014	53	49					13439	13443		10.1002/anie.201407181		5	Chemistry, Multidisciplinary	Chemistry	AU4OG	WOS:000345590300020		
J	Shiraishi, Y; Kanazawa, S; Kofuji, Y; Sakamoto, H; Ichikawa, S; Tanaka, S; Hirai, T				Shiraishi, Yasuhiro; Kanazawa, Shunsuke; Kofuji, Yusuke; Sakamoto, Hirokatsu; Ichikawa, Satoshi; Tanaka, Shunsuke; Hirai, Takayuki			Sunlight-Driven Hydrogen Peroxide Production from Water and Molecular Oxygen by Metal-Free Photocatalysts	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						graphitic carbon nitride; hydrogen peroxide; oxygen; photocatalysis; water	GRAPHITIC CARBON NITRIDE; VISIBLE-LIGHT IRRADIATION; SELECTIVE PRODUCTION; RAMAN-SCATTERING; PD CATALYSTS; H2O2; SEMICONDUCTORS; DIIMIDES; TIO2; DEGRADATION	Design of green, safe, and sustainable process for the synthesis of hydrogen peroxide (H2O2) is a very important subject. Early reported processes, however, require hydrogen (H-2) and palladium-based catalysts. Herein we propose a photocatalytic process for H2O2 synthesis driven by metal-free catalysts with earth-abundant water and molecular oxygen (O-2) as resources under sunlight irradiation (lambda > 400 nm). We use graphitic carbon nitride (g-C3N4) containing electron-deficient aromatic diimide units as catalysts. Incorporating the diimide units positively shifts the valence-band potential of the catalysts, while maintaining sufficient conduction-band potential for O-2 reduction. Visible light irradiation of the catalysts in pure water with O-2 successfully produces H2O2 by oxidation of water by the photoformed valence-band holes and selective two-electron reduction of O-2 by the conduction band electrons.	[Shiraishi, Yasuhiro; Kanazawa, Shunsuke; Kofuji, Yusuke; Sakamoto, Hirokatsu; Hirai, Takayuki] Osaka Univ, Grad Sch Engn Sci, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan; [Shiraishi, Yasuhiro; Kanazawa, Shunsuke; Kofuji, Yusuke; Sakamoto, Hirokatsu; Hirai, Takayuki] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan; [Ichikawa, Satoshi] Osaka Univ, Inst NanoSci Design, Toyonaka, Osaka 5608531, Japan; [Tanaka, Shunsuke] Kansai Univ, Dept Chem Energy & Environm Engn, Suita, Osaka, Japan	Shiraishi, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan.	shiraish@cheng.es.osaka-u.ac.jp	Tanaka, Shunsuke/O-3288-2014		Ministry of Education, Culture, Sports, Science and Technology (Japan) (MEXT) [26289296]	This work was supported by the Grant-in-Aid for Scientific Research (No. 26289296) from the Ministry of Education, Culture, Sports, Science and Technology (Japan) (MEXT).	Teranishi M, 2010, J AM CHEM SOC, V132, P7850, DOI 10.1021/ja102651g; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Pritchard JC, 2010, GREEN CHEM, V12, P915, DOI 10.1039/b924472g; Wang XC, 2009, J AM CHEM SOC, V131, P1680, DOI 10.1021/ja809307s; Tsukamoto D, 2012, ACS CATAL, V2, P599, DOI 10.1021/cs2006873; Wang Z, 2007, J AM CHEM SOC, V129, P13362, DOI 10.1021/ja073306f; Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f; Ji HH, 2013, CHEM ENG J, V218, P183, DOI 10.1016/j.cej.2012.12.033; Maurino V, 2005, CHEM COMMUN, P2627, DOI 10.1039/b418789j; Zinin PV, 2009, CHEM PHYS LETT, V472, P69, DOI 10.1016/j.cplett.2009.02.068; Zheng QD, 2008, J AM CHEM SOC, V130, P14410, DOI 10.1021/ja805746h; Sanli AE, 2011, INT J HYDROGEN ENERG, V36, P869, DOI 10.1016/j.ijhydene.2010.09.038; Bao QL, 2010, ADV MATER, V22, P3661, DOI 10.1002/adma.201000731; KORMANN C, 1988, ENVIRON SCI TECHNOL, V22, P798, DOI 10.1021/es00172a009; Papadimitriou D, 2002, J APPL PHYS, V92, P870, DOI 10.1063/1.1488251; Koppenol WH, 2007, J AM CHEM SOC, V129, P9686, DOI 10.1021/ja071546p; Gudarzi D, 2013, TOP CATAL, V56, P527, DOI 10.1007/s11244-013-0014-5; Dai HZ, 2013, DIAM RELAT MATER, V38, P109, DOI 10.1016/j.diamond.2013.06.012; Xu H, 2013, APPL CATAL B-ENVIRON, V129, P182, DOI 10.1016/j.apcatb.2012.08.015; Chu S, 2013, ACS CATAL, V3, P912, DOI 10.1021/cs4000624; Cui YJ, 2012, PHYS CHEM CHEM PHYS, V14, P1455, DOI 10.1039/c1cp22820j; Goldstein S, 2007, ENVIRON SCI TECHNOL, V41, P7486, DOI 10.1021/es071379t; Cai RX, 2003, J CATAL, V219, P214, DOI 10.1016/S0021-9517(03)00197-0; Xue L, 2010, J COLLOID INTERF SCI, V350, P523, DOI 10.1016/j.jcis.2010.07.012; Shiraishi Y, 2014, ACS CATAL, V4, P774, DOI 10.1021/cs401208c; Maeda K, 2006, NATURE, V440, P295, DOI 10.1038/440295a; Edwards JK, 2005, J CATAL, V236, P69, DOI 10.1016/j.jcat.2005.09.015; Sugano Y, 2013, ANGEW CHEM INT EDIT, V52, P5295, DOI 10.1002/anie.201301669; Hirakawa T, 2008, J PHYS CHEM C, V112, P15818, DOI 10.1021/jp8055015; Goto H, 2004, J CATAL, V225, P223, DOI 10.1016/j.jcat.2004.04.001; Melada S, 2006, J CATAL, V239, P422, DOI 10.1016/j.jcat.2006.02.014; Campos-Martin JM, 2006, ANGEW CHEM INT EDIT, V45, P6962, DOI 10.1002/anie.200503779; Bijak K, 2013, SYNTHETIC MET, V175, P146, DOI 10.1016/j.synthmet.2013.05.017; Campos-Martin J. M., 2006, ANGEW CHEM, V118, P7116, DOI 10.1002/ange.200503779; Chen J, 2012, ANGEW CHEM INT EDIT, V51, P1907, DOI 10.1002/anie.201107355; Chen J., 2012, ANGEW CHEM, V124, P1943; Dingemans TJ, 2004, CHEM MATER, V16, P966, DOI 10.1021/cm021723f; Hu C, 2012, POLYM BULL, V69, P63, DOI 10.1007/s00289-012-0704-3; Puniredd SR, 2005, LANGMUIR, V21, P7812, DOI 10.1021/la0509302; Qin ZY, 2000, NUCL INSTRUM METH B, V170, P406, DOI 10.1016/S0168-583X(00)00257-3; Sandelin F, 2006, IND ENG CHEM RES, V45, P986, DOI 10.1021/ie050593s; Shiraishi Y, 2013, ACS CATAL, V3, P2222, DOI 10.1021/cs400511q; Sugano Y., 2013, ANGEW CHEM, V125, P5403; TSAI WH, 1992, LANGMUIR, V8, P1443, DOI 10.1021/la00041a033; Xiao F, 2010, APPL SURF SCI, V256, P7384, DOI 10.1016/j.apsusc.2010.05.077	45	11	11	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	DEC 1	2014	53	49					13454	13459		10.1002/anie.201407938		6	Chemistry, Multidisciplinary	Chemistry	AU4OG	WOS:000345590300023		
J	Tomohiro, T; Morimoto, S; Shima, T; Chiba, J; Hatanaka, Y				Tomohiro, Takenori; Morimoto, Shota; Shima, Toshiya; Chiba, Junya; Hatanaka, Yasumaru			An Isotope-Coded Fluorogenic Cross-Linker for High-Performance Target Identification Based on Photoaffinity Labeling	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						isotopic labeling; mass spectrometry; photoaffinity labeling; proteins; recognition	MASS-SPECTROMETRY; PYRUVATE-CARBOXYLASE; PROTEIN STRUCTURES; BINDING PROTEINS; LINKING; REAGENTS; CHEMISTRY; PROBES; PROTEOMICS; DIAZIRINE	A photoaffinity labeling (PAL)-based method for the rapid identification of target proteins is presented in which a high-performance chemical tag, an isotope-coded fluorescent tag (IsoFT), can be attached to the interacting site by irradiation. Labeled peptides can be easily distinguished among numerous proteolytic digests by sequential detection with highly sensitive fluorescence spectroscopy and mass spectrometry. Subsequent MS/MS analysis provides amino acid sequence information with a higher depth of coverage. The combination of PAL and heterogeneous target-selecting techniques significantly reduces the amount of time and protein required for identification. An additional photocleavable moiety successfully accelerated proteomic analysis using cell lysate. This method is a widely applicable approach for the rapid and accurate identification of interacting proteins.	[Tomohiro, Takenori; Morimoto, Shota; Shima, Toshiya; Chiba, Junya; Hatanaka, Yasumaru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan	Tomohiro, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	ttomo@pha.u-toyama.ac.jp			MEXT [20390032]; Tamura Science and Technology Foundation; Fugaku Trust for Medicinal Research	This work was financially supported by Grants-in-Aid for Scientific Research (20390032) from MEXT, the Tamura Science and Technology Foundation, and the Fugaku Trust for Medicinal Research. We thank Dr. Tomoko Okada, AIST, for her kind support with preparation of the HeLa cell lysate.	Pacholarz KJ, 2012, CHEM SOC REV, V41, P4335, DOI 10.1039/c2cs35035a; Zeng DX, 2009, CHEM COMMUN, P3369, DOI 10.1039/b906335h; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Hatanaka Y, 1994, Bioorg Med Chem, V2, P1367, DOI 10.1016/S0968-0896(00)82088-X; Tomohiro T, 2005, CHEM REC, V5, P385, DOI 10.1002/tcr.20058; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Muller DR, 2001, ANAL CHEM, V73, P1927, DOI 10.1021/ac001379a; Li G, 2013, ANGEW CHEM INT EDIT, V52, P9544, DOI 10.1002/anie.201302161; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Cisar JS, 2012, J AM CHEM SOC, V134, P10385, DOI 10.1021/ja304213w; Song ZQ, 2012, CHEM COMMUN, V48, P3339, DOI 10.1039/c2cc00027j; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Hashimoto M, 2005, CHEM PHARM BULL, V53, P1510, DOI 10.1248/cpb.53.1510; Kumar AB, 2011, ORG BIOMOL CHEM, V9, P6284, DOI 10.1039/c1ob05748k; Lapinsky D., 2012, J BIOORG MED CHEM, V20, P6237; Li G., 2013, ANGEW CHEM, V125, P9723; Lietzan AD, 2013, J BIOL CHEM, V288, P19915, DOI 10.1074/jbc.M113.477828; Luo Y, 2009, MOL CELL PROTEOMICS, V8, P2843, DOI 10.1074/mcp.M900110-MCP200; MacKinnon A. L., 2009, CURR PROTOC CHEM BIO, V1, P55, DOI DOI 10.1002/9780470559277.CH090167; Morimoto S, 2013, CHEM COMMUN, V49, P1811, DOI 10.1039/c3cc38594a; Sohn CH, 2012, ANAL CHEM, V84, P2662, DOI 10.1021/ac202637n; Song CX, 2011, ACCOUNTS CHEM RES, V44, P709, DOI 10.1021/ar2000502; Song ZQ, 2009, ORG LETT, V11, P4882, DOI 10.1021/ol901955y; Tomohiro T, 2013, BIOORG MED CHEM LETT, V23, P5605, DOI 10.1016/j.bmcl.2013.08.041; Tomohiro T, 2011, BIOCONJUGATE CHEM, V22, P315, DOI 10.1021/bc100598r	30	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	DEC 1	2014	53	49					13502	13505		10.1002/anie.201408580		4	Chemistry, Multidisciplinary	Chemistry	AU4OG	WOS:000345590300033		
J	Sun, QF; Sato, S; Fujita, M				Sun, Qing-Fu; Sato, Sota; Fujita, Makoto			An M-12(L-1)(12)(L-2)(12) Cantellated Tetrahedron: A Case Study on Mixed-Ligand Self-Assembly	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						ligand effects; palladium; self-assembly; self-sorting	IONIZATION MASS-SPECTROMETRY; CAGES; FRAMEWORKS; POLYHEDRA; COMPLEX; FINITE	In the self-assembly of Pd-II ions and two different, but similarly shaped, ligands (1 and 2), neither random mixing nor self-sorting of the two ligands into two unmixed structures was observed. Instead a mixed, yet sorted, Pd-12(1)(12)(2)(12) cantellated tetrahedron (and its pseudoisomer) was selectively formed, thus revealing a fine example of intramolecular self-sorting. A case study showed that a homothetic ratio of >2 is necessary to observe cantellated tetrahedra.	[Sun, Qing-Fu; Sato, Sota; Fujita, Makoto] Univ Tokyo, Dept Appl Chem, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Fujita, M (reprint author), Univ Tokyo, Dept Appl Chem, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp	Sun, Qing-Fu/C-9406-2011		ACCEL; Japan Science and Technology Agency (JST); KAKENHI; MEXT [24685010, 25102007]	This research was supported by ACCEL, the Japan Science and Technology Agency (JST), and in part by KAKENHI and MEXT (24685010 and 25102007). Synchrotron X-ray diffraction studies were performed at KEK (2009G502 and 2011G522) and SPring-8.	Li JR, 2009, ANGEW CHEM INT EDIT, V48, P8465, DOI 10.1002/anie.200904722; Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Sakamoto S, 2000, TETRAHEDRON, V56, P955, DOI 10.1016/S0040-4020(99)01092-3; Yamaguchi K, 2003, J MASS SPECTROM, V38, P473, DOI 10.1002/jms.488; Wu AX, 2003, J AM CHEM SOC, V125, P4831, DOI 10.1021/ja028913b; Argent SP, 2006, J AM CHEM SOC, V128, P72, DOI 10.1021/ja056993o; Sato S, 2009, J AM CHEM SOC, V131, P6064, DOI 10.1021/ja900676f; Fujita M, 2005, ACCOUNTS CHEM RES, V38, P369, DOI 10.1021/ar040153h; Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; Granzhan A, 2011, J AM CHEM SOC, V133, P7106, DOI 10.1021/ja200580x; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Tominaga M, 2004, ANGEW CHEM INT EDIT, V43, P5621, DOI 10.1002/anie.200461422; Sun QF, 2011, ANGEW CHEM INT EDIT, V50, P10318, DOI 10.1002/anie.201104670; Ayme JF, 2014, ANGEW CHEM INT EDIT, V53, P7823, DOI 10.1002/anie.201404270; Al-Rasbi NK, 2008, J AM CHEM SOC, V130, P11641, DOI 10.1021/ja803847w; Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m; Li JR, 2010, NAT CHEM, V2, P893, DOI [10.1038/nchem.803, 10.1038/NCHEM.803]; Fujita D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2093; Li J. R., 2009, ANGEW CHEM, V121, P8617, DOI 10.1002/ANGE.200904722; Spek A. L., 1990, ACTA CRYSTALLOGR A, V46, P194; Sun Q.-F., 2011, ANGEW CHEM, V123, P10502; Tominaga M., 2004, ANGEW CHEM, V116, P5739, DOI 10.1002/ange.200461422	23	8	8	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	DEC 1	2014	53	49					13510	13513		10.1002/anie.201408652		4	Chemistry, Multidisciplinary	Chemistry	AU4OG	WOS:000345590300035		
J	Ohashi, M; Shibata, M; Ogoshi, S				Ohashi, Masato; Shibata, Mitsutoshi; Ogoshi, Sensuke			Regioselective C-F Bond Activation of Hexafluoropropylene on Palladium(0): Formation of a Cationic eta(2)-Perfluoroallylpalladium Complex	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						C-F activation; ligand effects; palladium; regioselectivity; structure elucidation	TRANSITION-METAL HYDRIDE; CROSS-COUPLING REACTION; NICKEL-COMPLEXES; RHODIUM; HYDRODEFLUORINATION; CHEMISTRY; REAGENTS; OCTAFLUOROCYCLOOCTATETRAENE; FUNCTIONALIZATION; CP-ASTERISK-2ZRH2	A chemoselective C(sp(2))-F or C(sp(3))-F bond activation of hexafluoropropylene (HFP) was achieved by adopting the proper combination of a Lewis acid co-additive with a ligand which coordinates Pd-0. The treatment of [(eta(2)-HFP) Pd(PCy3)(2)] with B(C6F5)3 allowed a chemoselective C-(sp(3))-F bond cleavage of HFP to give a unique cationic perfluoroallypalladium complex. In this complex, the coordination mode of the perfluoroallyl ligand was considered to be of the unique eta(2)-fashion.	[Ohashi, Masato; Shibata, Mitsutoshi; Ogoshi, Sensuke] Osaka Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Ogoshi, Sensuke] Adv Catalyt Transformat Program Carbon Utilizat A, JST, Suita, Osaka 5650871, Japan	Ohashi, M (reprint author), Osaka Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.	ohashi@chem.eng.osaka-u.ac.jp; ogoshi@chem.eng.osaka-u.ac.jp			MEXT [21245028, 25708018, 23105546]	This work was supported by Grant-in-Aid for Scientific Research (A) (No. 21245028), Grant-in-Aid for Young Scientists (A) (No. 25708018), and Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis" (No. 23105546) from MEXT. We thank Dr. Kyoko Inoue and Dr. Hiroaki Tanaka for assistance with <SUP>19</SUP>F-<SUP>19</SUP>F EXSY measurements. M.O. also acknowledges The Noguchi Institute.	Vela J, 2005, J AM CHEM SOC, V127, P7857, DOI 10.1021/ja042672l; Sun AD, 2010, DALTON T, V39, P10362, DOI 10.1039/c0dt00540a; [Anonymous], 2010, ANGEW CHEM, V122, P2995; Braun T, 2009, ANGEW CHEM INT EDIT, V48, P1818, DOI 10.1002/anie.200805041; Kraft BM, 2000, J AM CHEM SOC, V122, P8559, DOI 10.1021/ja001006r; Kuehnel MF, 2012, ANGEW CHEM INT EDIT, V51, P2218, DOI 10.1002/anie.201108105; Kraft BM, 2002, J AM CHEM SOC, V124, P8681, DOI 10.1021/ja0125568; Xu WG, 2013, ORGANOMETALLICS, V32, P7122, DOI 10.1021/om400782v; Kuehnel MF, 2013, ANGEW CHEM INT EDIT, V52, P3328, DOI 10.1002/anie.201205260; Yamada S, 2007, CHEM COMMUN, P3679, DOI 10.1039/b705408d; [Anonymous], 2010, ANGEW CHEM, V122, P4039; [Anonymous], 2002, ANGEW CHEM, V114, P2870; Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; [Anonymous], 2007, ANGEW CHEM, V119, P5415; Clot E, 2011, ACCOUNTS CHEM RES, V44, P333, DOI 10.1021/ar100136x; Clot E, 2004, J AM CHEM SOC, V126, P5647, DOI 10.1021/ja0499243; Meier G, 2009, ANGEW CHEM INT EDIT, V48, P1546, DOI 10.1002/anie.200805237; Braun T, 2002, ANGEW CHEM INT EDIT, V41, P2745, DOI 10.1002/1521-3773(20020802)41:15<2745::AID-ANIE2745>3.0.CO;2-C; Ohashi M, 2011, J AM CHEM SOC, V133, P3256, DOI 10.1021/ja109911p; Ohashi M, 2013, ORGANOMETALLICS, V32, P3631, DOI 10.1021/om400255t; Petrov VA, 2008, J FLUORINE CHEM, V129, P1011, DOI 10.1016/j.jfluchem.2008.06.003; Engman M, 2007, J AM CHEM SOC, V129, P4536, DOI 10.1021/ja0686763; [Anonymous], 2009, ANGEW CHEM, V121, P1850; Teltewskoi M, 2010, ANGEW CHEM INT EDIT, V49, P3947, DOI 10.1002/anie.201001070; Peterson AA, 2006, ORGANOMETALLICS, V25, P4938, DOI 10.1021/om0607292; Braun T, 2007, ANGEW CHEM INT EDIT, V46, P5321, DOI 10.1002/anie.200700711; WATSON PL, 1990, ORGANOMETALLICS, V9, P1999, DOI 10.1021/om00157a006; Kuehnel MF, 2012, CHEM-EUR J, V18, P10701, DOI 10.1002/chem.201201125; Kuhnel MF, 2010, ANGEW CHEM INT EDIT, V49, P2933, DOI 10.1002/anie.200907162; Huang DJ, 2006, POLYHEDRON, V25, P459, DOI 10.1016/j.poly.2005.08.012; Peterson AA, 2009, ORGANOMETALLICS, V28, P5982, DOI 10.1021/om900718s; BAREFOOT AC, 1981, J AM CHEM SOC, V103, P970, DOI 10.1021/ja00394a057; Belenkii GG, 1996, J FLUORINE CHEM, V77, P107, DOI 10.1016/0022-1139(95)03385-8; Braun T, 2011, EUR J INORG CHEM, P613, DOI 10.1002/ejic.201001184; Burton D. J., 1979, J AM CHEM SOC, V101, P3689; BURTON DJ, 1990, J FLUORINE CHEM, V50, P257, DOI 10.1016/S0022-1139(00)80501-1; CARL RT, 1987, ORGANOMETALLICS, V6, P611, DOI 10.1021/om00146a029; CARL RT, 1987, J AM CHEM SOC, V109, P6875, DOI 10.1021/ja00256a065; CUNDY CS, 1970, J CHEM SOC A, P1647, DOI 10.1039/j19700001647; Ferrando-Miguel G, 2002, INORG CHEM, V41, P6440, DOI 10.1021/ic020365f; Galakhov M. V., 1985, IAN SSSR KH, P306; Huang DJ, 2000, ORGANOMETALLICS, V19, P2281, DOI 10.1021/om9910017; Kirkham MS, 2001, CHEM COMMUN, P813, DOI 10.1039/b009862k; Kopaevich ., 1972, ZH VSES KHIM DI MEND, V17, P226; Kraft BM, 2010, J FLUORINE CHEM, V131, P1122, DOI 10.1016/j.jfluchem.2010.05.003; KRESPAN CG, 1981, J AM CHEM SOC, V103, P5598, DOI 10.1021/ja00408a066; Kuehnel M. F., 2013, ANGEW CHEM, V125, P3412; Kuehnel M. F., 2012, ANGEW CHEM, V124, P2261; MAPLES PK, 1973, J CHEM SOC DALTON, P2069, DOI 10.1039/dt9730002069; MCBRIDE DW, 1964, J CHEM SOC, P1752, DOI 10.1039/jr9640001752; Meier G., 2009, ANGEW CHEM, V121, P1575; Norinder J, 2006, ORGANOMETALLICS, V25, P2129, DOI 10.1021/om0600700; Ohashi M, 2013, EUR J ORG CHEM, P443, DOI 10.1002/ejoc.201201405; PARSHALL GW, 1962, J CHEM SOC, P1132; Peterson TH, 1999, ORGANOMETALLICS, V18, P2005, DOI 10.1021/om980945d; Renkema KB, 2004, J MOL CATAL A-CHEM, V224, P125, DOI 10.1016/j.molcata.2004.07.028; Rieth RD, 2007, EUR J INORG CHEM, P2839, DOI 10.1002/ejic.200600802; Saeki T, 2005, SYNLETT, P1771, DOI 10.1055/s-2005-871571; SASAOKA SI, 1989, CHEM LETT, P1163, DOI 10.1246/cl.1989.1163; STALICK JK, 1970, J AM CHEM SOC, V92, P5333, DOI 10.1021/ja00721a008; STANLEY K, 1975, CAN J CHEM, V53, P2537, DOI 10.1139/v75-362; Tsuji J., 2004, PALLADIUM REAGENTS C; Tsuji J., 1995, PALLADIUM REAGENTS C; Wlassics I, 2011, MOLECULES, V16, P6512, DOI 10.3390/molecules16086512; Yamada S, 2006, ORG LETT, V8, P843, DOI 10.1021/ol052897g	65	7	7	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	DEC 1	2014	53	49					13578	13582		10.1002/anie.201408467		5	Chemistry, Multidisciplinary	Chemistry	AU4OG	WOS:000345590300050		
J	Nonokuma, M; Kuwabara, Y; Takano, K; Tamura, K; Ishitsuka, K; Yoshimitsu, K				Nonokuma, Masanari; Kuwabara, Yasuo; Takano, Koichi; Tamura, Kazuo; Ishitsuka, Kenji; Yoshimitsu, Kengo			Evaluation of regional cerebral glucose metabolism in patients with malignant lymphoma of the body using statistical image analysis	ANNALS OF NUCLEAR MEDICINE			English	Article						Malignant lymphoma; FDG-PET/CT; Paraneoplastic syndrome; Regional cerebral glucose metabolism; Statistical image analysis	CANCER-PATIENTS; DIAGNOSIS; DISEASE; SYSTEM	The aim of this study was to clarify the characteristics of regional cerebral glucose metabolic abnormalities in patients with malignant lymphoma of the body using statistical image analyses. Post-therapeutic changes in cerebral glucose metabolism were also evaluated. The subjects consisted of 30 patients, including 16 patients with diffuse large B-cell lymphoma and 14 patients with other types of lymphoma. Patients with primary cerebral lymphoma were excluded from this study. All patients underwent CT and whole-body FDG-PET scans, including 4-min brain scans using a dedicated PET/CT scanner during both the pre- and post-treatment periods. The whole-body scans started 60 min after the administration of 185 MBq of FDG, after which the brain data were extracted from whole-body data. The degree of regional cerebral glucose metabolism was evaluated on a voxel-by-voxel basis using statistical parametric mapping (SPM). The total tumor glycolytic volume of the body was measured using a separate workstation. The normal control subjects were 12 persons who underwent medical check with FDG-PET/CT and had no lesions suggesting malignant tumor. The level of regional cerebral glucose metabolism decreased in association with an increase in the total glycolytic volume in the bilateral frontal and parietal cortices. After chemotherapy, the statistical image analysis demonstrated an interval recovery of the cerebral glucose metabolism of the bilateral parietal and occipital cortices in the good responders, whereas there were no significant differences observed in regional cerebral glucose metabolism between the pre- and post-treatment images in the poor responders. Comparison between normal control subjects and patients with pre-treatment lymphoma also showed that the regional cerebral glucose metabolism decreased in the parieto-occipital cortices in patients with lymphoma compared to normal control subjects. We demonstrated that patients with malignant lymphoma of the body exhibited abnormal regional cerebral glucose metabolism, which improves after chemotherapy. Although the mechanism underlying the reduction of cerebral glucose metabolism remains unclear, our findings indicate the functional alternation and/or subclinical damage of the brain in patients with malignant lymphoma.	[Nonokuma, Masanari; Kuwabara, Yasuo; Takano, Koichi; Yoshimitsu, Kengo] Fukuoka Univ Hosp, Dept Radiol, Fukuoka, Japan; [Tamura, Kazuo; Ishitsuka, Kenji] Fukuoka Univ Hosp, Dept Oncol Hematol & Infect Dis, Jonan Ku, Fukuoka 8140180, Japan	Nonokuma, M (reprint author), Fukuoka Univ Hosp, Dept Radiol, Fukuoka, Japan.	nono@fukuoka-u.ac.jp		Takano, Koichi/0000-0003-0885-6367			Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Ferreri AJM, 2004, BRIT J HAEMATOL, V127, P173, DOI 10.1111/j.1365-2141.2004.05177.x; CRAIG TJ, 1974, AM J PSYCHIAT, V131, P1323; Pelosof LC, 2010, MAYO CLIN PROC, V85, P838, DOI 10.4065/mcp.2010.0099; Ferreri AJM, 2009, HEMATOL ONCOL, V27, P61, DOI 10.1002/hon.881; KUWABARA Y, 1988, J COMPUT ASSIST TOMO, V12, P47, DOI 10.1097/00004728-198801000-00008; Freudenberg LS, 2004, EUR J NUCL MED MOL I, V31, P325, DOI 10.1007/s00259-003-1375-y; LISTER TA, 1989, J CLIN ONCOL, V7, P1630; FOSTER NL, 1984, ANN NEUROL, V16, P649, DOI 10.1002/ana.410160605; Voltz R, 2002, LANCET NEUROL, V1, P294, DOI 10.1016/S1474-4422(02)00135-7; De Angelis LM, 2009, NEUROLOGIC COMPLICAT, P577; Derogatis R, 1983, JAMA-J AM MED ASSOC, V249, P751; Gatter KC, 2001, PATHOLOGY GENETICS T, P177; Greenlee JE, 1998, NEW ENGL J MED, V338, P1378, DOI 10.1056/NEJM199805073381910; Hanaoka K, 2010, ANN NUCL MED, V24, P707, DOI 10.1007/s12149-010-0415-5; MARASTE R, 1992, ACTA ONCOL, V31, P641; Minagawa H, 1996, CANCER, V78, P1137; Nakamura S, 2008, WHO CLASSIFICATION T, P252; Posner JB, 1995, NEUROLOGIC COMPLICAT, P353; SHAW PJ, 1991, NEUROLOGY, V41, P228; Tashiro M, 1999, PSYCHO-ONCOL, V8, P283, DOI 10.1002/(SICI)1099-1611(199907/08)8:4<283::AID-PON384>3.0.CO;2-A	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2014	28	10					950	960		10.1007/s12149-014-0890-1		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SR	WOS:000345401000002		
J	Yamamoto, S; Watabe, T; Ikeda, H; Kanai, Y; Watabe, H; Ogata, Y; Kato, K; Hatazawa, J				Yamamoto, Seiichi; Watabe, Tadashi; Ikeda, Hayato; Kanai, Yasukazu; Watabe, Hiroshi; Ogata, Yoshimune; Kato, Katsuhiko; Hatazawa, Jun			Ultrahigh-resolution Cerenkov-light imaging system for positron radionuclides: potential applications and limitations	ANNALS OF NUCLEAR MEDICINE			English	Article						Cerenkov-light imaging; Ultrahigh resolution; CCD camera; Positron; Molecular imaging	EMITTING RADIOTRACERS; SMALL ANIMALS; RADIATION	Cerenkov-light imaging provides inherently high resolution because the light is emitted near the positron radionuclide. However, the magnitude for the high spatial resolution of Cerenkov-light imaging is unclear. Its potential molecular imaging applications also remain unclear. We developed an ultrahigh-resolution Cerenkov-light imaging system, measured its spatial resolution, and explored its applications to molecular imaging research. Our Cerenkov-light imaging system consists of a high-sensitivity charged-coupled device camera (Hamamatsu Photonics ORCA2-ER) and a bright lens (Xenon 0.95/25). An extension ring was inserted between them to magnify the subject. A similar to 100-mu m-diameter Na-22 point source was made and imaged by the system. For applications of Cerenkov-light imaging, we conducted F-18-FDG administered in vivo, ex vivo whole brain, and sliced brain imaging of rats. We obtained spatial resolution of similar to 220 mu m for a Na-22 point source with our developed imaging system. The F-18-FDG rat head images showed high light intensity in the eyes for the Cerenkov-light images, although there was no accumulation in these parts in the PET images. The sliced rat brain showed much higher spatial resolution for the Cerenkov-light images compared with CdWO4 scintillator-based autoradiography, although some contrast decrease was observed for them. Even though the Cerenkov-light images showed ultrahigh resolution of similar to 220 mu m, their distribution and contrast were sometimes different from the actual positron accumulation in the subjects. Care must be taken when evaluating positron distribution from Cerenkov-light images. However, the ultrahigh resolution of Cerenkov-light imaging will be useful for transparent subjects including phantom studies.	[Yamamoto, Seiichi; Ogata, Yoshimune; Kato, Katsuhiko] Nagoya Univ, Dept Radiol & Med Lab Sci, Grad Sch Med, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Watabe, Tadashi; Ikeda, Hayato; Kanai, Yasukazu; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Watabe, Hiroshi] Tohoku Univ, Sendai, Miyagi 980, Japan	Yamamoto, S (reprint author), Nagoya Univ, Dept Radiol & Med Lab Sci, Grad Sch Med, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4618673, Japan.	s-yama@met.nagoya-u.ac.jp	Kato, Katsuhiko/D-7965-2013	Kato, Katsuhiko/0000-0002-2083-9319	Japan Science and Technology Association; Ministry of Education, Science, Sports and Culture, Japan	This work was partly supported by the Japan Science and Technology Association and Ministry of Education, Science, Sports and Culture, Japan.	JELLEY JV, 1955, BRIT J APPL PHYS, V6, P227, DOI 10.1088/0508-3443/6/7/301; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Xu YD, 2011, J NUCL MED, V52, P2009, DOI 10.2967/jnumed.111.092965; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Park JC, 2011, NUCL MED BIOL, V38, P321, DOI 10.1016/j.nucmedbio.2010.09.003; Hu ZH, 2010, OPT EXPRESS, V18, P24441, DOI 10.1364/OE.18.024441; Park JC, 2010, SMALL, V6, P2863, DOI 10.1002/smll.201001418; Yamamoto S, 2013, PHYS MED BIOL, V58, P7875, DOI 10.1088/0031-9155/58/21/7875; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Cho JS, 2009, PHYS MED BIOL, V54, P6757, DOI 10.1088/0031-9155/54/22/001; ELRICK RH, 1968, INT J APPL RADIAT IS, V19, P263, DOI 10.1016/0020-708X(68)90023-9; Boschi F, 2011, EUR J NUCL MED MOL I, V38, P120, DOI 10.1007/s00259-010-1630-y; Knoll Glenn F., RAD DETECTION MEASUR; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Liu HG, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3514659; Rasband WS, 1997, IMAGEJ; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2014	28	10					961	969		10.1007/s12149-014-0892-z		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SR	WOS:000345401000003		
J	Kurosawa, H; Sakurai, K; Hasegawa, H; Uchida, K; Kasahara, H; Minamizawa, T; Nakajo, M; Nakajo, M				Kurosawa, Hiroyuki; Sakurai, Kazuhisa; Hasegawa, Hideaki; Uchida, Keisuke; Kasahara, Hiroyuki; Minamizawa, Takao; Nakajo, Masatoyo; Nakajo, Masayuki			Comparison of radioactive iodide uptake in the rat thyroid between oral and intravenous bolus administration	ANNALS OF NUCLEAR MEDICINE			English	Article						Radioiodine; Rat; Thyroid uptake; Oral or intravenous administration; Sodium iodide symporter (NIS)	GENE-THERAPY; SYMPORTER; RADIOIODINE; EXPRESSION; CANCER	Radioiodide is commonly used to diagnose and treat hyperthyroidism and thyroid carcinoma. However, we could not find any experimental data that strictly compared the biodistribution and thyroid uptake of radioactive iodide between the oral and intravenous (iv) routes with time. This prompted us to compare I-123 biodistribution and thyroid uptake to clarify the differences between oral and iv bolus administration in rats. The rats were divided into two groups, A and B (n = 5, each). In the first imaging experiment, (NaI)-I-123 solution (35 MBq/200 mu L) was administered as a bolus to the rats orally in group A and intravenously in group B. Two weeks later, the second imaging experiment was performed as a crossover experiment. I-123 biodistribution was evaluated visually and quantitatively with a gamma camera at 10 min, 3, 6, 12, 24, and 48 h after I-123 administration. Thyroid uptake was compared between oral and iv groups. Correlation of I-123 thyroid uptake and whole-body excretion was evaluated. The area under the curve (AUC) of thyroid uptake was also calculated. I-123 biodistribution differed visually during 6 h between the two groups. I-123 thyroid uptake was significantly higher in the iv group at 10 min (P < 0.05) and in the oral group at 6 or more hour time points (P < 0.005-P < 0.0001) and peaked at 12 h in both groups (oral: 24.4 +/- A 2.8 %ID, iv: 15.2 +/- A 2.8 %ID). I-123 thyroid uptake showed significant inverse correlations with whole-body excretion from 6 h (r = -0.799, P < 0.0001), and thereafter [12 h (r = -0.957, P < 0.0001), 24 h (r = -0.905, P < 0.0001) and 48 h (r = -0.893, P < 0.0001)], respectively. I-123 whole-body excretion was significantly higher in the iv group at each time point (P < 0.0001). The AUC of I-123 thyroid uptake was 1.6 times higher in the oral group than the iv group. These results suggest that radioiodide accumulates in the rat thyroid more effectively by oral than iv administration probably due to slower and lower I-123 clearance from the body in the oral administration when administered in a bolus fashion.	[Kurosawa, Hiroyuki; Sakurai, Kazuhisa; Hasegawa, Hideaki; Uchida, Keisuke; Kasahara, Hiroyuki; Minamizawa, Takao] FUJIFILM RI Pharma Co Ltd, Res Dept, Chiba 2891592, Japan; [Kurosawa, Hiroyuki] FUJIFILM RI Pharma Co Ltd, Prod Management & Mkt Dept, Chuo Ku, Tokyo 1040031, Japan; [Nakajo, Masatoyo; Nakajo, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima 8908544, Japan	Kurosawa, H (reprint author), FUJIFILM RI Pharma Co Ltd, Prod Management & Mkt Dept, Chuo Ku, 14-1 Kyobashi 2 Chome, Tokyo 1040031, Japan.	khiroyuki@ffri.co.jp					Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Baril P, 2010, BRIT J PHARMACOL, V159, P761, DOI 10.1111/j.1476-5381.2009.00412.x; Chung JK, 2002, J NUCL MED, V43, P1188; BROWN J, 1956, ENDOCRINOLOGY, V58, P68; BROWNGRANT K, 1961, PHYSIOL REV, V41, P189; DURBIN PW, 1961, RADIAT RES, V14, P149, DOI 10.2307/3570886; Huang M, 2001, CANCER GENE THER, V8, P612, DOI 10.1038/sj.cgt.7700354; Josefsson M, 2002, ACTA PHYSIOL SCAND, V175, P129, DOI 10.1046/j.1365-201X.2002.00968.x; MALOOF F, 1952, ENDOCRINOLOGY, V50, P612; Nakamoto Y, 2000, J NUCL MED, V41, P1898; Nicola JP, 2009, AM J PHYSIOL-CELL PH, V296, pC654, DOI 10.1152/ajpcell.00509.2008; Parthasarathy K Laxman, 2002, J Nucl Med Technol, V30, P165; PERRY WF, 1952, J CLIN INVEST, V31, P457, DOI 10.1172/JCI102630; Schneider P, 2005, EUR J NUCL MED MOL I, V32, P788, DOI 10.1007/s00259-005-1769-0; Silberstein EB, 2012, SEMIN NUCL MED, V42, P164, DOI 10.1053/j.semnuclmed.2011.12.002; THEON AP, 1994, AM J VET RES, V55, P1734; Watts RWE, 1956, UCRL, V3376, P2	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2014	28	10					986	993		10.1007/s12149-014-0909-7		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SR	WOS:000345401000006		
J	Kubota, K; Okasaki, M; Minamimoto, R; Miyata, Y; Morooka, M; Nakajima, K; Sato, T				Kubota, Kazuo; Okasaki, Momoko; Minamimoto, Ryogo; Miyata, Yoko; Morooka, Miyako; Nakajima, Kazuhiko; Sato, Takashi			Lesion-based analysis of F-18-FDG uptake and In-111-Pentetreotide uptake by neuroendocrine tumors	ANNALS OF NUCLEAR MEDICINE			English	Article						18F-fluorodeoxyglucose; FDG; Positron Emission Tomography (PET); In-111-pentetreotide; Somatostatin receptor scintigraphy; Neuroendocrine tumor; Tumor heterogeneity	SOMATOSTATIN RECEPTOR SCINTIGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; CARCINOID-TUMORS; POSITIVE TUMORS; <IN-111-DTPA-D-PHE1>-OCTREOTIDE; SURVIVAL; THERAPY; KI-67; PET	To characterize the heterogeneity of metastatic neuroendocrine tumor (NET) lesions, we compared the [F-18]-fluorodeoxyglucose (FDG) uptake and the In-111-pentetreotide (SRS) uptake for somatostatin receptor scintigraphy using the CT-based fusion imaging techniques of PET/CT and SPECT/CT. Fifteen consecutive patients with NET lesions were examined using both FDG-PET/CT and SRS SPECT/CT prospectively. A total of 45 metastatic NET lesions were evaluated for FDG uptake according to the standardized uptake value (SUV) and for SRS uptake according to the tumor-to-muscle count ratio (T/M ratio); these values were then compared according to the grade of NET (G), also compared to the tumor volume. Both the SRS uptake and FDG uptake showed no significant correlation to the tumor volume, and suggested no significant artifacts in these data. The T/M ratio for the SRS uptake ranged from 192.7 to 1.9 and exhibited very wide range of distribution. The SUV for the FDG uptake ranged from 13.8 to 0.77 and exhibited narrow range of distribution. The uptake of the two tracers in individual lesions showed an inverse correlation. The G1 + 2 lesions had a higher SRS uptake than the G3 lesions, but the difference was not significant because of the large variation (40.65 +/- A 48.03, n = 39 vs. 8.66 +/- A 13.13, n = 6). However, the G1 + 2 lesions had a significantly lower FDG uptake than the G3 lesions (3.52 +/- A 1.84, n = 39 vs. 10.82 +/- A 4.50, n = 6). The tracer uptakes varied largely not only in an inter-subject manner, but also in an intra-subject manner. An inverse correlation between SRS uptake and FDG uptake in the metastatic NET lesions observed in this study may be consistent with the opposing ideas of differentiation and proliferation in oncology. The large variations in SRS and FDG uptake by metastatic NET lesions suggest the biological heterogeneity of advanced NET. These results support the idea that combination therapy targeting both receptor-positive cells and proliferating cells may be beneficial from a functional imaging perspective.	[Kubota, Kazuo; Okasaki, Momoko; Minamimoto, Ryogo; Miyata, Yoko; Morooka, Miyako; Nakajima, Kazuhiko; Sato, Takashi] Natl Ctr Global Hlth & Med, Dept Radiol, Div Nucl Med, Shinjuku Ku, Tokyo 1628655, Japan	Kubota, K (reprint author), Natl Ctr Global Hlth & Med, Dept Radiol, Div Nucl Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	kkubota@cpost.plala.or.jp			JSPS; National Center for Global Health and Medicine [26A116]	The authors thank Ms. Kahori Miyake for her excellent secretarial assistance in performing the Octreoscan studies. A part of this study was supported by a Grants-in-Aid for Scientific Research (C) to K.K. from JSPS, and The Grant of National Center for Global Health and Medicine 26A116 to K.K.	Adams S, 1998, NUCL MED COMMUN, V19, P641, DOI 10.1097/00006231-199807000-00005; Bousquet C, 2012, J CLIN ENDOCR METAB, V97, P727, DOI 10.1210/jc.2011-2088; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Ramage JK, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2011-300831; Imhof A, 2011, J CLIN ONCOL, V29, P2416, DOI 10.1200/JCO.2010.33.7873; Garin E, 2009, J NUCL MED, V50, P858, DOI 10.2967/jnumed.108.057505; Bombardieri E, 2010, EUR J NUCL MED MOL I, V37, P1441, DOI 10.1007/s00259-010-1473-6; Binderup T, 2010, J NUCL MED, V51, P704, DOI 10.2967/jnumed.109.069765; BAKKER WH, 1991, LIFE SCI, V49, P1583, DOI 10.1016/0024-3205(91)90052-D; BAKKER WH, 1991, LIFE SCI, V49, P1593, DOI 10.1016/0024-3205(91)90053-E; Belhocine T, 2002, NUCL MED COMMUN, V23, P727, DOI 10.1097/00006231-200208000-00005; Berg KE, 2010, GASTROENTEROLOGY, V139, P742; Binderup T, 2010, CLIN CANCER RES, V16, P978, DOI 10.1158/1078-0432.CCR-09-1759; Bosman FT, 2010, WHO CLASSIFICATION T; Chen JL, 2013, CANCER MED-US, V2, P545, DOI 10.1002/cam4.102; Kaira K, 2012, EUR J CANCER, V48, P1244, DOI 10.1016/j.ejca.2012.01.016; KRENNING EP, 1992, J NUCL MED, V33, P652; Mets DC, 2008, GASTROENTEROLOGY, V135, P1469; Schulz S, 2000, CLIN CANCER RES, V6, P1865	19	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2014	28	10					1004	1010		10.1007/s12149-014-0900-3		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SR	WOS:000345401000008		
J	Takeuchi, Y; Inubushi, M; Jin, YN; Murai, C; Tsuji, AB; Hata, H; Kitagawa, Y; Saga, T				Takeuchi, Yasuto; Inubushi, Masayuki; Jin, Yong-Nan; Murai, Chika; Tsuji, Atsushi B.; Hata, Hironobu; Kitagawa, Yoshimasa; Saga, Tsuneo			Detailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions	ANNALS OF NUCLEAR MEDICINE			English	Article						Hypoxia-responsive element (HRE); Reporter genes; Tumor hypoxia; Molecular imaging; Gene therapy	HUMAN GLIOBLASTOMA; TUMOR HYPOXIA; EXPRESSION; THERAPY; CANCER; GROWTH; CELLS; MODEL; MICROSCOPY; XENOGRAFT	HIF-1/HRE pathway is a promising target for the imaging and the treatment of intractable malignancy (HIF-1; hypoxia-inducible factor 1, HRE; hypoxia-responsive element). The purposes of our study are: (1) to assess the gene activation levels resulting from various numbers of HREs under various hypoxic conditions, (2) to evaluate the bidirectional activity of multiple HREs, and (3) to confirm whether multiple HREs can induce gene expression in vivo. Human colon carcinoma HCT116 cells were transiently transfected by the constructs containing a firefly luciferase reporter gene and various numbers (2, 4, 6, 8, 10, and 12) of HREs (nHRE+, nHRE-). The relative luciferase activities were measured under various durations of hypoxia (6, 12, 18, and 24 h), O-2 concentrations (1, 2, 4, 8, and 16 %), and various concentrations of deferoxamine mesylate (20, 40, 80, 160, and 320 A mu g/mL growth medium). The bidirectional gene activation levels by HREs were examined in the constructs (dual-luc-nHREs) containing firefly and Renilla luciferase reporter genes at each side of nHREs. Finally, to test whether the construct containing 12HRE and the NIS reporter gene (12HRE-NIS) can induce gene expression in vivo, SPECT imaging was performed in a mouse xenograft model. (1) gene activation levels by HREs tended to increase with increasing HRE copy number, but a saturation effect was observed in constructs with more than 6 or 8 copies of an HRE, (2) gene activation levels by HREs increased remarkably during 6-12 h of hypoxia, but not beyond 12 h, (3) gene activation levels by HREs decreased with increasing O-2 concentrations, but could be detected even under mild hypoxia at 16 % O-2, (4) the bidirectionally proportional activity of the HRE was confirmed regardless of the hypoxic severity, and (5) NIS expression driven by 12 tandem copies of an HRE in response to hypoxia could be visualized on in vivo SPECT imaging. The results of this study will help in the understanding and assessment of the activity of multiple HREs under hypoxia and become the basis for hypoxia-targeted imaging and therapy in the future.	[Takeuchi, Yasuto; Inubushi, Masayuki; Jin, Yong-Nan; Murai, Chika; Tsuji, Atsushi B.; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 2638555, Japan; [Takeuchi, Yasuto; Murai, Chika; Hata, Hironobu; Kitagawa, Yoshimasa] Hokkaido Univ, Grad Sch Dent Med, Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Inubushi, Masayuki] Kawasaki Med Univ, Dept Radiol, Div Nucl Med, Kurashiki, Okayama 7010192, Japan	Inubushi, M (reprint author), Kawasaki Med Univ, Dept Radiol, Div Nucl Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	inubushi@med.kawasaki-m.ac.jp		Tsuji, Atsushi/0000-0003-2726-288X	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government [18390326, 22390239, 26293282, 22390377, 25293406]; Japan Society for the Promotion of Science (JSPS) [24659140]	We thank Prof. Masanori Hatakeyama of the University of Tokyo and Prof. Hideaki Higashi of Hokkaido University for technical guidance in molecular biology. We also thank SII NanoTechnology Inc. for providing us the small-animal SPECT/CT system. This work was supported in part by KAKENHI Grants-in-Aid for Scientific Research (B) (General) (M.I: No. 18390326, 22390239, 26293282; Y.K: No. 22390377, 25293406) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government, and for Challenging Exploratory Research (M.I: No. 24659140) from Japan Society for the Promotion of Science (JSPS).	O'Donoghue JA, 2005, INT J RADIAT ONCOL, V61, P1493, DOI 10.1016/j.ijrobp.2004.12.057; LIU YX, 1995, CIRC RES, V77, P638; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Hsieh CH, 2009, J NUCL MED, V50, P2049, DOI 10.2967/jnumed.108.061234; Carlin S, 2009, NUCL MED BIOL, V36, P821, DOI 10.1016/j.nucmedbio.2009.06.006; Blancher C, 2000, CANCER RES, V60, P7106; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Dachs GU, 1997, NAT MED, V3, P515, DOI 10.1038/nm0597-515; Shibata T, 2000, GENE THER, V7, P493, DOI 10.1038/sj.gt.3301124; Riethoven JJM, 2010, METHODS MOL BIOL, V674, P33, DOI 10.1007/978-1-60761-854-6_3; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; NUNN A, 1995, EUR J NUCL MED, V22, P265, DOI 10.1007/BF01081524; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Valtorta S, 2013, J NUCL MED, V54, P1106, DOI 10.2967/jnumed.112.111120; Brader P, 2007, MOL CANCER THER, V6, P2900, DOI 10.1158/1535-7163.MCT-07-0432; Cowen RL, 2004, CANCER RES, V64, P1396, DOI 10.1158/0008-5472.CAN-03-2698; Debrauwere H, 1997, BIOCHIMIE, V79, P577, DOI 10.1016/S0300-9084(97)82006-8; Greco O, 2006, GENE THER, V13, P206, DOI 10.1038/sj.gt.3302640; Inubushi M, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-46; Inubushi M, 2007, EUR J NUCL MED MOL I, V34, pS27, DOI 10.1007/s00259-007-0438-x; Janssen HLK, 2002, INT J RADIAT ONCOL, V54, P1537, DOI 10.1016/S0360-3016(02)03935-4; Jin YN, 2012, GENE THER, V19, P836, DOI 10.1038/gt.2011.128; Liu JY, 2005, J RADIAT RES, V46, P93, DOI 10.1269/jrr.46.93; Marignol L, 2005, CANCER BIOL THER, V4, P359; National Research Council, 2011, GUIDE CARE USE LAB A; Ogura M, 2005, CANCER SCI, V96, P288, DOI 10.1111/j.1349-7006.2005.00044.x; Ozawa T, 2005, CANCER GENE THER, V12, P449, DOI 10.1038/sj.cgt.7700814; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Ruan Hangjun, 1999, Neoplasia (New York), V1, P431, DOI 10.1038/sj.neo.7900059; Vordermark D, 2003, INT J RADIAT ONCOL, V56, P1184, DOI 10.1016/S0360-3016(03)00289-X	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2014	28	10					1011	1019		10.1007/s12149-014-0901-2		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SR	WOS:000345401000009		
J	Hoshikawa, H; Yamamoto, Y; Mori, T; Kishino, T; Fukumura, T; Samukawa, Y; Mori, N; Nishiyama, Y				Hoshikawa, Hiroshi; Yamamoto, Yuka; Mori, Terushige; Kishino, Takehito; Fukumura, Takashi; Samukawa, Yasushi; Mori, Nozomu; Nishiyama, Yoshihiro			Predictive value of SUV-based parameters derived from pre-treatment F-18-FLT PET/CT for short-term outcome with head and neck cancers	ANNALS OF NUCLEAR MEDICINE			English	Article						FLT; PET/CT; Metabolic tumor volume; Total lesion proliferation; SUVpeak; Prognosis	POSITRON-EMISSION-TOMOGRAPHY; METABOLIC TUMOR VOLUME; SQUAMOUS-CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; TOTAL LESION GLYCOLYSIS; PROGNOSTIC VALUE; EARLY RESPONSE; FDG-PET; 3'-DEOXY-3'-F-18-FLUOROTHYMIDINE PET; LUNG-CANCER	The aim of this study was to investigate the predictive potential of pre-treatment 3'-deoxy-3'-[18F]-fluorothymidine (FLT) uptake parameters for short-term outcome of primary head and neck squamous cell cancer (HNSCC) patients. A total of 32 patients undergoing pre-treatment FLT positron emission tomography/computed tomography (PET/CT) from May 2010 to May 2013 were evaluated. Semi-quantitative assessment was used to determine mean, peak and maximum standardized uptake values (SUVmean, SUVpeak and SUVmax), metabolic tumor volume (MTV) and total lesion proliferation (TLP). Clinicopathologic factors and PET/CT parameters were analyzed for their association with 2-year loco-regional control (LRC) and overall survival (OS). The mean (+/- A SD) SUVmean, SUVpeak, SUVmax, MTV and TLP were 5.97 +/- A 3.16, 6.71 +/- A 3.75, 10.05 +/- A 5.37, 7.31 +/- A 8.05 and 44.95 +/- A 52.82, respectively. In univariate analyses, N category was associated with OS (P = 0.037). Increased MTV a parts per thousand yen13 ml was associated with decreased LRC and OS (P < 0.0001). TLP a parts per thousand yen69.3 g was also linked with both LRC and OS (P = 0.009 and 0.015, respectively). Regarding SUVs, only the SUVpeak was associated with LRC and OS (P = 0.035 and 0.049, respectively). Pre-treatment MTV is the most useful parameter with FLT PET/CT. TLP and SUVpeak may also provide important prognostic information for patients with HNSCCs.	[Hoshikawa, Hiroshi; Mori, Terushige; Kishino, Takehito; Fukumura, Takashi; Samukawa, Yasushi; Mori, Nozomu] Kagawa Univ, Fac Med, Dept Otolaryngol, Miki, Kagawa, Japan; [Yamamoto, Yuka; Nishiyama, Yoshihiro] Kagawa Univ, Fac Med, Dept Radiol, Miki, Kagawa, Japan	Hoshikawa, H (reprint author), Kagawa Univ, Fac Med, Dept Otolaryngol, 1750-1 Ikenobe, Miki, Kagawa, Japan.	hiro@med.kagawa-u.ac.jp					Tylski P, 2010, J NUCL MED, V51, P268, DOI 10.2967/jnumed.109.066241; Pio BS, 2006, MOL IMAGING BIOL, V8, P36, DOI 10.1007/s11307-005-0029-9; Herrmann K, 2007, CLIN CANCER RES, V13, P3552, DOI 10.1158/1078-0432.CCR-06-3025; Menda Y, 2009, J NUCL MED, V50, P1028, DOI 10.2967/jnumed.108.058495; Wong RJ, 2002, J CLIN ONCOL, V20, P4199, DOI 10.1200/JCO.2002.02.590; Thorwarth D, 2006, RADIOTHER ONCOL, V80, P151, DOI 10.1016/j.radonc.2006.07.033; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Kenny L, 2007, EUR J NUCL MED MOL I, V34, P1339, DOI 10.1007/s00259-007-0379-4; Park GC, 2013, ANN ONCOL, V24, P208, DOI 10.1093/annonc/mds247; Hatt M, 2010, J NUCL MED, V51, P1368, DOI 10.2967/jnumed.110.078501; Ryan WR, 2005, LARYNGOSCOPE, V115, P645, DOI 10.1097/01.mlg.0000161345.23128.d4; Schinagl DAX, 2011, EUR J NUCL MED MOL I, V38, P1449, DOI 10.1007/s00259-011-1789-x; Kishino T, 2012, J NUCL MED, V53, P1521, DOI 10.2967/jnumed.111.099200; Roedl JB, 2008, RADIOTHER ONCOL, V89, P278, DOI 10.1016/j.radonc.2008.06.014; Hoeben BAW, 2013, J NUCL MED, V54, P532, DOI 10.2967/jnumed.112.105999; Machtay M, 2009, HEAD NECK-J SCI SPEC, V31, P195, DOI 10.1002/hed.20942; Chu KP, 2012, INT J RADIAT ONCOL, V83, P1521, DOI 10.1016/j.ijrobp.2011.10.022; Hoshikawa H, 2011, MOL IMAGING BIOL, V13, P172, DOI 10.1007/s11307-010-0331-z; Rasey JS, 2002, J NUCL MED, V43, P1210; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Allal AS, 2002, J CLIN ONCOL, V20, P1398, DOI 10.1200/JCO.20.5.1398; Lee JA, 2010, RADIOTHER ONCOL, V96, P302, DOI 10.1016/j.radonc.2010.07.003; Minn H, 1997, J NUCL MED, V38, P1907; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; van Westreenen HL, 2005, J NUCL MED, V46, P400; Troost EGC, 2010, J NUCL MED, V51, P866, DOI 10.2967/jnumed.109.069310; La TH, 2009, INT J RADIAT ONCOL, V74, P1335, DOI 10.1016/j.ijrobp.2008.10.060; Mileshkin L, 2011, CLIN CANCER RES, V17, P3304, DOI 10.1158/1078-0432.CCR-10-2763; Gulec SA, 2011, EUR J NUCL MED MOL I, V38, P1289, DOI 10.1007/s00259-011-1758-4; Halfpenny W, 2002, BRIT J CANCER, V86, P512, DOI 10.1038/sj/bjc/6600114; Kahraman D, 2012, CLIN NUCL MED, V37, P1058, DOI 10.1097/RLU.0b013e3182639747; Larson SM, 1999, CLIN POSITRON IMAGIN, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Lim R, 2012, J NUCL MED, V53, P1506, DOI 10.2967/jnumed.111.101402; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Yue JB, 2014, RADIOTHER ONCOL, V111, P475, DOI 10.1016/j.radonc.2014.04.002	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2014	28	10					1020	1026		10.1007/s12149-014-0902-1		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SR	WOS:000345401000010		
J	Kinuya, S; Kuwabara, Y; Inoue, K; Sakamoto, S; Shimosegawa, E; Takeoka, K; Takeda, Y; Toyama, H; Niio, Y; Nishiyama, Y; Yoshinaga, K; Yoshimura, M				Kinuya, Seigo; Kuwabara, Yasuo; Inoue, Kentaro; Sakamoto, Setsu; Shimosegawa, Eku; Takeoka, Keiko; Takeda, Yoshihiro; Toyama, Hiroshi; Niio, Yasuo; Nishiyama, Yoshihiro; Yoshinaga, Keiichiro; Yoshimura, Mana			Nuclear medicine practice in Japan: a report of the seventh nationwide survey in 2012	ANNALS OF NUCLEAR MEDICINE			English	Article						Nuclear medicine practice; Survey; Japan		The Subcommittee on the Survey of Nuclear Medical Practice in Japan has performed a nationwide survey of nuclear medicine practice every 5 years since 1982 to survey contemporary nuclear medicine practice and its changes over the years. The subcommittee sent questionnaires, including the number and category of examinations as well as the kind and dose of the radiopharmaceuticals during the 30 days of June 2012, to all the nuclear medicine institutes. The total numbers for the year 2012 were then estimated. A total of 1,167 institutes responded to the survey, including the 14 in vitro assay institutes and 266 PET centers. The recovery rate was 92 %. The number of gamma cameras installed was 1,425 in total, with 9 % decrease in 5 years. Dual-head cameras and hybrid SPECT/CT scanners accounted for 84 and 10.5 %, respectively. The number of single-photon tracer studies in 2012 was 1.15 million which means decrease in 19 % in 5 years and 29 % in 10 years. All but cerebral perfusion study and sentinel lymphoscintigraphy have decreased. Bone scintigraphy was a leading examination (38.7 %), followed by cardiac studies (29.4 %) and cerebral perfusion study (18.5 %) in order. SPECT studies showed an increase from 42.3 to 47.2 %. PET centers have also increased from 212 to 295, as compared to the last survey. The 135 PET centers have installed one or two in-house cyclotrons. PET studies showed 25.5 % increase in 5 years, with oncology accounting for 96.3 %. F-18-FDG accounted for 98.2 % (505,990 examinations). PET examinations using C-11-methionine have been increasing, with 3,352 examinations in 2012. The number of new PET studies using C-11-PIB PET was 695. I-131-radioiodine targeted therapies showed an increase, including 3,644 patients (53.6 %) for thyroid cancer and 4,889 patients (17.9 %) for hyperthyroidism. Out-patient thyroid bed ablation therapy with 30 mCi of I-131 accounted for 21.0 % of cancer patients. The number of admission rooms decreased from 158 to 135 in 5 years. In vitro radioassays have been declining continuously since 1992, with the number of studies of 9.0 million in 2012. Single-photon examinations showed a continuous tendency toward a decline in the survey. In contrast, the number of hybrid SPECT/CT scanner examinations has increased. PET/CT study in the oncology field and radionuclide targeted therapy have steadily increased.	[Kinuya, Seigo] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Nucl Med, Kanazawa, Ishikawa 9208641, Japan; [Kuwabara, Yasuo] Fukuoka Univ Hosp, Fukuoka, Japan; [Inoue, Kentaro] Tohoku Univ, Sendai, Miyagi 980, Japan; [Sakamoto, Setsu] Dokkyo Med Univ, Mibu, Tochigi, Japan; [Shimosegawa, Eku; Takeoka, Keiko] Osaka Univ, Osaka, Japan; [Takeda, Yoshihiro] Okayama Univ, Okayama 7008530, Japan; [Toyama, Hiroshi] Fujita Hlth Univ, Toyoake, Aichi, Japan; [Niio, Yasuo] Teikyo Univ, Chiba Med Ctr, Ichihara, Chiba, Japan; [Nishiyama, Yoshihiro] Kagawa Univ, Takamatsu, Kagawa 760, Japan; [Yoshinaga, Keiichiro] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Yoshimura, Mana] Tokyo Med Univ, Tokyo 1608402, Japan	Kinuya, S (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Nucl Med, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	kinuya@med.kanazawa-u.ac.jp					Kinoshita F, 1989, RADIOISOTOPES, V38, P219; Kinoshita F, 1983, RADIOISOTOPES, V32, P454; Koizumi K, 2004, ANN NUCL MED, V18, P73, DOI 10.1007/BF02985618; Koizumi K, 2008, RADIOISOTOPES, V57, P491; Kubo A, 1998, RADIOISOTOPES S1, V47, P1; Kuwabara Y, 2013, RADIOISOTOPES, V62, P545; Kuwabara Y, 2009, ANN NUCL MED, V23, P209, DOI 10.1007/s12149-008-0214-4; Sasaki Y, 1993, RADIOISOTOPES S1, V42, P1; Tamaki N, 2003, RADIOISOTOPES, V52, P389	9	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2014	28	10					1032	1038		10.1007/s12149-014-0893-y		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SR	WOS:000345401000012		
J	Suzuki, H; Tabata, T; Koizumi, H; Hohchi, N; Takeuchi, S; Kitamura, T; Fujino, Y; Ohbuchi, T				Suzuki, Hideaki; Tabata, Takahisa; Koizumi, Hiroki; Hohchi, Nobusuke; Takeuchi, Shoko; Kitamura, Takuro; Fujino, Yoshihisa; Ohbuchi, Toyoaki			Prediction of Hearing Outcomes by Multiple Regression Analysis in Patients With Idiopathic Sudden Sensorineural Hearing Loss	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						idiopathic sudden sensorineural hearing loss; hearing outcome; prediction model; prognostic factor; multiple regression analysis	HYPERBARIC-OXYGEN THERAPY; SALVAGE TREATMENT; PROGNOSIS; RECOVERY; EFFICACY; STEROIDS	Objective: This study aimed to create a multiple regression model for predicting hearing outcomes of idiopathic suddensensorineural hearing loss (ISSNHL). Methods: The participants were 205 consecutive patients (205 ears) with ISSNHL (hearing level 40 dB, interval between onset and treatment 30 days). They received systemic steroid administration combined with intratympanic steroid injection. Data were examined by simple and multiple regression analyses. Three hearing indices (percentage hearing improvement, hearing gain, and posttreatment hearing level [HLpost]) and 7 prognostic factors (age, days from onset to treatment, initial hearing level, initial hearing level at low frequencies, initial hearing level at high frequencies, presence of vertigo, and contralateral hearing level) were included in the multiple regression analysis as dependent and explanatory variables, respectively. Results: In the simple regression analysis, the percentage [tearing improvement, hearing gain, and HLpost, showed significant correlation with 2, 5, and 6 of the 7 prognostic factors, respectively. The multiple correlation coefficients were 0.396, 0.503, and 0.714 for the percentage hearing improvement, hearing gain, and HLpost, respectively. Predicted values of HLpost calculated by the multiple regression equation were reliable with 70% probability with a 40-dB-width prediction interval. Conclusion: Prediction of HLpost by the multiple regression model may be useful to estimate the hearing prognosis of post ISSNHL.	[Suzuki, Hideaki; Tabata, Takahisa; Koizumi, Hiroki; Hohchi, Nobusuke; Takeuchi, Shoko; Kitamura, Takuro; Ohbuchi, Toyoaki] Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Kitakyushu, Fukuoka 8078555, Japan; [Fujino, Yoshihisa] Univ Occupat & Environm Hlth, Sch Med, Dept Prevent Med & Community Hlth, Kitakyushu, Fukuoka 8078555, Japan	Suzuki, H (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	suzuhyde@med.uoeh-u.ac.jp	Fujino, Yoshihisa/F-3054-2010	Fujino, Yoshihisa/0000-0002-9126-206X			Cvorovic L, 2008, OTOL NEUROTOL, V29, P464, DOI 10.1097/MAO.0b013e31816fdcb4; Li LPH, 2013, NEUROIMAGE, V64, P356, DOI 10.1016/j.neuroimage.2012.09.002; Nosrati-Zarenoe R, 2012, OTOL NEUROTOL, V33, P523, DOI 10.1097/MAO.0b013e31824b78da; Narozny W, 2006, ANN OTO RHINOL LARYN, V115, P553; Wang CT, 2009, EAR HEARING, V30, P110, DOI 10.1097/AUD.0b013e318192655e; Chao TK, 2006, AUDIOL NEURO-OTOL, V11, P331, DOI 10.1159/000095819; Suzuki H, 2011, EUR ARCH OTO-RHINO-L, V268, P497, DOI 10.1007/s00405-010-1400-2; Suzuki H, 2012, LARYNGOSCOPE, V122, P1154, DOI 10.1002/lary.23245; WILSON WR, 1980, ARCH OTOLARYNGOL, V106, P772; Suzuki H, 2003, ACTA OTO-LARYNGOL, V123, P46, DOI 10.1080/0036554021000028082; Masuda M, 2012, OTOL NEUROTOL, V33, P1142, DOI 10.1097/MAO.0b013e3182635417; Eisenman DJ, 2000, ARCH OTOLARYNGOL, V126, P1161; Ulu S, 2013, OTOL NEUROTOL, V34, P1400, DOI 10.1097/MAO.0b013e31829b57df; Dispenza F, 2013, AM J OTOLARYNG, V34, P296, DOI 10.1016/j.amjoto.2012.12.010; Harada Hirofumi, 2005, Int Tinnitus J, V11, P115; Kakehata S, 2011, AUDIOL NEURO-OTOL, V16, P191, DOI 10.1159/000320269; Kanzaki J, 1988, Acta Otolaryngol Suppl, V456, P31; Li LPH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035055; Mori T, 2011, AURIS NASUS LARYNX, V38, P564, DOI 10.1016/j.anl.2010.12.018; Ohashi T, 2012, ACTA OTO-LARYNGOL, V132, P133, DOI 10.3109/00016489.2011.633228; Suzuki H, 2008, AURIS NASUS LARYNX, V35, P192, DOI 10.1016/j.anl.2007.06.003; Yoshida T, 2008, LARYNGOSCOPE, V118, P1433, DOI 10.1097/MLG.0b013e318172ef85	22	2	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	DEC	2014	123	12					821	825		10.1177/0003489414538606		9	Otorhinolaryngology	Otorhinolaryngology	AU0KC	WOS:000345310700001		
J	Goi, T; Nakazawa, T; Hirono, Y; Yamaguchi, A				Goi, Takanori; Nakazawa, Toshiyuki; Hirono, Yasuo; Yamaguchi, Akio			Anti-Prokineticin1 (PROK1) Monoclonal Antibody Suppresses Angiogenesis and Tumor Growth in Colorectal Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							FACTOR EG-VEGF; EXPRESSION; TUMORIGENESIS; CHEMOTHERAPY; COMBINATION; THERAPY; PLACEBO; TRIAL	Background. The prokineticin1 (PROK1) gene has been cloned as an angiogenic growth factor from endocrine gland cells. However, we have not known about potentials of anti-PROK1 monoclonal antibody in human cancers. Here we investigated how the anti-PROK1 monoclonal antibody (mAb; established by our department) would affect the high-PROK1-expressing colorectal cancer (CRC) cells in vitro and vivo. Methods. We confirmed PROK1 protein expression in the CRC cells by performing immunohistochemical staining and measured the amount of soluble PROK1 protein. Next, we mixed the CRC cell culture fluid with the anti-PROK1mAb to examine angiogenic activity in vitro and in vivo. Additionally, we investigated whether the anti-PROK1mAb would affect the tumor-forming capability of high PROK1-expressing CRC cells implanted into mice. Results. PROK1 protein expression was confirmed in 3 CRC cell lines, and soluble PROK1 protein was also confirmed in the CRC cell culture fluid. The culture fluid increased angiogenesis in vitro and vivo, whereas the anti-PROK1mAb suppressed angiogenesis. Subcutaneous tumor formation and tumor angiogenesis in mice were suppressed by the anti-PROK1mAb treatment. The anti-PROK1mAb significantly suppressed the number of CD31 stained cells in mice. Conclusions. The in vitro and vivo experimental system indicated that the anti-PROK1mAb could suppress angiogenesis and tumor growth in the CRC strains.	[Goi, Takanori; Nakazawa, Toshiyuki; Hirono, Yasuo; Yamaguchi, Akio] Univ Fukui, Dept Surg 1, Fukui 910, Japan	Goi, T (reprint author), Univ Fukui, Dept Surg 1, Fukui 910, Japan.	tgoi@u-fukui.ac.jp			Ministry of Education, Sports, Science, and Technology of Japan [25462047]	The technical assistance of Ms. Saitoh M. with this research was appreciated. This work was supported in part by a Grant-in-Aid for Science Research from the Ministry of Education, Sports, Science, and Technology of Japan (No. 25462047).	Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Nagano H, 2007, J SURG ONCOL, V96, P605, DOI 10.1002/jso.20716; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Tabernero J, 2014, EUR J CANCER, V50, P320, DOI 10.1016/j.ejca.2013.09.013; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Goi T, 2013, ANTICANCER RES, V33, P5311; Goi T, 2004, CANCER RES, V64, P1906, DOI 10.1158/0008-5472.CAN-3696-2; Ngan ESW, 2007, CLIN CANCER RES, V13, P868, DOI 10.1158/1078-0432.CCR-06-2176; Pasquali D, 2006, ENDOCRINOLOGY, V147, P4245, DOI 10.1210/en.2006-0614; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Tabata S, 2013, ONCOL REP, V29, P459, DOI 10.3892/or.2012.2124; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Morales A, 2007, J STEROID BIOCHEM, V107, P37, DOI 10.1016/j.jsbmb.2007.02.006; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Goi T, 1998, BRIT J CANCER, V77, P466, DOI 10.1038/bjc.1998.74; Kalluri R, 2006, MOL ONCOL, V4, P392; MILLER AR, 1994, ANN SURG ONCOL, V1, P436, DOI 10.1007/BF02303818; Moumen M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-132; Olino K, 2012, ANN SURG ONCOL, V19, pS597, DOI 10.1245/s10434-011-2037-0; Robert GJ, 2010, NAT REV CANCER, V6, P373	27	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S665	S671		10.1245/s10434-014-3765-8		7	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300034		
J	Kawano, H; Saeki, H; Kitao, H; Tsuda, Y; Otsu, H; Ando, K; Ito, S; Egashira, A; Oki, E; Morita, M; Oda, Y; Maehara, Y				Kawano, Hiroyuki; Saeki, Hiroshi; Kitao, Hiroyuki; Tsuda, Yasuo; Otsu, Hajime; Ando, Koji; Ito, Shuhei; Egashira, Akinori; Oki, Eiji; Morita, Masaru; Oda, Yoshinao; Maehara, Yoshihiko			Chromosomal Instability Associated with Global DNA Hypomethylation is Associated with the Initiation and Progression of Esophageal Squamous Cell Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							LINE-1 HYPOMETHYLATION; GENETIC INSTABILITY; POOR-PROGNOSIS; CANCER; P53; HETEROZYGOSITY; MUTATIONS; ONCOGENE; SURVIVAL; LUNG	Background. Global DNA hypomethylation is associated with increased chromosomal instability and plays an important role in tumorigenesis. The methylation status of the long interspersed nuclear element-1 (LINE-1) element is a useful surrogate marker for global DNA methylation. Although LINE-1 hypomethylation is recognized as a poor prognostic marker, the correlation of LINE-1 methylation level with tumor suppressor gene mutation, chromosomal instability, and clinical significance in esophageal squamous cell carcinoma (ESCC) remains unclear. Methods. Using resected tumor tissues and the corresponding normal esophageal mucosa from 105 patients with ESCC, bisulfite pyrosequencing analysis was performed to quantify the LINE-1 methylation levels. p53 mutations in exons two to ten were detected by polymerase chain reaction direct sequencing. Chromosomal instability was assessed by single nucleotide polymorphism array comparative genomic hybridization analysis. Results. The LINE-1 methylation level of ESCC was significantly lower than matched normal mucosa. LINE-1 methylation levels of normal mucosa from the esophagus had a significant inverse correlation with both cigarette smoking and alcohol consumption of the study subjects. LINE-1 hypomethylation of ESCC was significantly associated with lymph node metastasis, lymphovascular invasion, the frequency of p53 mutation and poor survivability. The LINE-1 methylation levels in ESCC had a significant inverse association with the percentage of copy number alterations in the whole genome, mirroring chromosomal instability. Conclusions. Our results suggested that whole genome hypomethylation caused by chronic inflammation could initiate carcinogenesis of esophageal squamous cells through chromosomal instability. In addition, chromosomal instability associated with the global hypomethylation might correlate highly with the progression of ESCC.	[Kawano, Hiroyuki; Saeki, Hiroshi; Tsuda, Yasuo; Otsu, Hajime; Ando, Koji; Ito, Shuhei; Egashira, Akinori; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Kitao, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Fukuoka 812, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan	Saeki, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	h-saeki@surg2.med.kyushu-u.ac.jp					Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Miyawaki Y, 2012, CANCER SCI, V103, P1558, DOI 10.1111/j.1349-7006.2012.02329.x; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Egashira A, 2007, CANCER SCI, V98, P1152, DOI 10.1111/j.1349-7006.2007.00524.x; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Ikeda K, 2013, ANN THORAC SURG, V96, P1790, DOI 10.1016/j.athoracsur.2013.06.035; Ramsey MR, 2013, J CLIN INVEST, V123, P3525, DOI 10.1172/JCI68899; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Hu N, 2004, GENE CHROMOSOME CANC, V39, P205, DOI 10.1002/gcc.10315; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Shigaki H, 2012, ANN SURG ONCOL, V19, P4238, DOI 10.1245/s10434-012-2488-y; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Cai CL, 2012, CELL CYCLE, V11, P1773, DOI 10.4161/cc.20121; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Egashira A, 2011, J SURG ONCOL, V104, P169, DOI 10.1002/jso.21920; Florea AM, 2013, BIOMED RES INT, V2013; Han X, 2012, PLOS ONE, V7; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Liu ZZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010909; Nishida N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072312; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Saeki H, 2002, SURGERY, V131, pS22, DOI 10.1067/msy.2002.119290; Takahashi Y, 2011, J THORAC ONCOL, V6, P1460, DOI 10.1097/JTO.0b013e318229189d; Toh Y, 2010, INT J CLIN ONCOL, V15, P135, DOI 10.1007/s10147-010-0057-6; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; Wang MT, 2012, DIS ESOPHAGUS, V25, P664, DOI 10.1111/j.1442-2050.2011.01291.x	43	4	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S696	S702		10.1245/s10434-014-3818-z		7	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300038		
J	Kiriyama, S; Yokoyama, S; Ueno, M; Hayami, S; Ieda, J; Yamamoto, N; Yamaguchi, S; Mitani, Y; Nakamura, Y; Tani, M; Mishra, L; Shively, JE; Yamaue, H				Kiriyama, Shigehisa; Yokoyama, Shozo; Ueno, Masaki; Hayami, Shinya; Ieda, Junji; Yamamoto, Naoyuki; Yamaguchi, Shunsuke; Mitani, Yasuyuki; Nakamura, Yasushi; Tani, Masaji; Mishra, Lopa; Shively, John E.; Yamaue, Hiroki			CEACAM1 Long Cytoplasmic Domain Isoform is Associated with Invasion and Recurrence of Hepatocellular Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							BILIARY GLYCOPROTEIN CD66A; CELL-ADHESION MOLECULE; ACTIN-BINDING DOMAIN; EPITHELIAL-CELLS; BETA-SPECTRIN; COLORECTAL CARCINOMAS; LUNG-CANCER; CEA FAMILY; EXPRESSION; PROTEIN	Background. The two isoforms of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), 1 with a long cytoplasmic domain (CEACAM1-L) and 1 with a short (CEACAM1-S), are involved in different signaling pathways. beta 2-spectrin (beta 2SP) is an adaptor protein that plays critical roles in the proper control of Smad access to activate receptors involved in regulation of TGF-beta signaling. In this study, we examined the association between CEACAM1 isoform balance and hepatocellular carcinoma (HCC) malignant potential and investigated the possibility of a molecular interaction between CEACAM1 and beta 2SP. Methods. Immunohistochemical analysis was carried out with CEACAM1-L or CEACAM1-S antibodies on 154 HCC tissues to correlate with the factors of malignancy. Invasion assay was performed for the effect of CEACAM1 expression on HCC cell lines. Moreover, immunohistochemical analysis and immunoprecipitation analysis were performed to investigate the association between CEACAM1 isoform balance and beta 2SP. Results. In immunohistochemical analysis, CEACAM1-L expression dominance was a risk factor for HCC recurrence (p = 0.04) and was significantly associated with a shorter survival compared with CEACAM1-S expression dominance. Invasion assay indicated that CEACAM1-4L-transfected HLF and PLC/PRF/5 cells showed significantly increased invasion (p<0.0001) and CEACAM1-4S-transfected HLF cells showed significantly decreased invasion. Immunohistochemical analysis of beta 2SP suggested that the HCCs with CEACAM1-L-dominant expression were more strongly stained with beta 2SP than the HCCs with CEACAM1-S-dominant expression (p = 0.013), and coprecipitation assays indicated that CEACAM1-L could bind to beta 2SP. Conclusions. CEACAM1-L may enhance the HCC invasiveness through an interaction with beta 2SP and subsequent effects on TGF-beta signaling.	[Kiriyama, Shigehisa; Yokoyama, Shozo; Ueno, Masaki; Hayami, Shinya; Ieda, Junji; Yamamoto, Naoyuki; Yamaguchi, Shunsuke; Mitani, Yasuyuki; Tani, Masaji; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan; [Nakamura, Yasushi] Wakayama Med Univ, Sch Med, Dept Clin Lab Med, Wakayama, Japan; [Mishra, Lopa] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	Yokoyama, S (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan.	yokoyama@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [20591554, 23591904]; Takeda Science Foundation, Japan	Grant-in-Aid No. 20591554 and 23591904 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Takeda Science Foundation, Japan.	Lee SY, 2007, ONCOL REP, V17, P1051; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Bamberger AM, 1998, AM J PATHOL, V152, P1401; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ieda J, 2011, INT J CANCER, V129, P1351, DOI 10.1002/ijc.26072; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; DISCHER DE, 1995, J CELL BIOL, V130, P897, DOI 10.1083/jcb.130.4.897; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Borscheri N, 2001, AM J SURG PATHOL, V25, P1297, DOI 10.1097/00000478-200110000-00011; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Mishra L, 1999, ONCOGENE, V18, P353, DOI 10.1038/sj.onc.1202313; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Sienel W, 2003, CLIN CANCER RES, V9, P2260; Yao ZX, 2010, J BIOL CHEM, V285, P36112, DOI 10.1074/jbc.M110.162347; Baek HJ, 2011, HEPATOLOGY, V53, P1676, DOI 10.1002/hep.24128; Baek HJ, 2008, HEPATOLOGY, V48, P1128, DOI 10.1002/hep.22460; Brummer J, 2001, AM J PATHOL, V159, P537, DOI 10.1016/S0002-9440(10)61725-7; BRUMMER J, 1995, ONCOGENE, V11, P1649; Cruz PV, 2005, CANCER, V104, P354, DOI 10.1002/cncr.21159; DISCHER D, 1993, J BIOL CHEM, V268, P7186; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; HIXSON DC, 1983, CANCER RES, V43, P3874; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Katuri V, 2006, ONCOGENE, V25, P1871, DOI 10.1038/sj.onc.1209211; Kinugasa T, 1998, INT J CANCER, V76, P148, DOI 10.1002/(SICI)1097-0215(19980330)76:1<148::AID-IJC23>3.0.CO;2-7; Kleinerman DI, 1996, CANCER RES, V56, P3431; Llovet JM, 2003, J HEPATOL, V38, pS136, DOI 10.1016/S0168-8278(02)00432-4; OHWADA A, 1994, AM J RESP CELL MOL, V11, P214; Sadekova S, 2000, MOL BIOL CELL, V11, P65; Sobin LH, 2002, TNM CLASSIFICATION M; SVENBERG T, 1976, INT J CANCER, V17, P588, DOI 10.1002/ijc.2910170506; Tamura K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000179; Tanaka K, 1997, INT J CANCER, V74, P15, DOI 10.1002/(SICI)1097-0215(19970220)74:1<15::AID-IJC3>3.0.CO;2-3; Tang Y, 2005, CANCER RES, V65, P4228, DOI 10.1158/0008-5472.CAN-04-4585	43	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S505	S514		10.1245/s10434-013-3460-1		10	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300015		
J	Koga, C; Kobayashi, S; Nagano, H; Tomimaru, Y; Hama, N; Wada, H; Kawamoto, K; Eguchi, H; Konno, M; Ishii, H; Umeshita, K; Doki, Y; Mori, M				Koga, Chikato; Kobayashi, Shogo; Nagano, Hiroaki; Tomimaru, Yoshito; Hama, Naoki; Wada, Hiroshi; Kawamoto, Koichi; Eguchi, Hidetoshi; Konno, Masamitsu; Ishii, Hideshi; Umeshita, Koji; Doki, Yuichiro; Mori, Masaki			Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells	ANNALS OF SURGICAL ONCOLOGY			English	Article							PLURIPOTENT STEM-CELLS; CANCER-CELLS; C-MYC; GASTROINTESTINAL CANCER; DEFINED FACTORS; GENE-TRANSFER; EXPRESSION; GROWTH; LIVER; DEMETHYLATION	Background. Although studies have shown that Oct4, Sox2, Klf4, and c-Myc (OKSM)-mediated induced pluripotent stem cell (iPSC) technology sensitizes cancer cells to drugs, the potential risk of inserting c-Myc and random insertions of exogenous sequences into the genome persists. Several authors, including us, have presented microRNA (miRNA)-mediated reprogramming as an alternative approach. Herein, we evaluated the efficacy of miRNA-mediated reprogramming on hepatocellular carcinoma (HCC) cells. Methods. Among three miRNAs (miR-200c, miR-302s, and miR-369s) that were previously presented for miRNA-mediated reprogramming, miR-302 was expressed at low levels in HCC cells. After transfecting three times with miR-302, the cells were incubated in ES medium for 3 weeks and then characterized. Results. iPSC-like spheres were obtained after the 3-week incubation. Spheres presented high NANOG and OCT4 expression, low proliferation, high apoptosis, low epithelial-mesenchymal transition marker expression (Ncadherin, TGFBR2), and sensitization to drugs. Several miRNAs were changed (e. g., low oncomiR miR-21, high miR-29b). cMyc was decreased, and methylation was elevated on histone 3 at lysine 4 (H3K4). Differentiated cells expressed markers of each germ layer (GFAP, FABP4, and ALB). AOF2 (also known as LSD1 or KDM1), one of the targets for miR-302, was repressed in iPSC-like-spheres. Silencing of AOF2 resulted in similar features of iPSC-like-spheres, including cMyc down-regulation and H3K4 methylation. In drug-resistant cells, sensitization was achieved through miR-302-mediated reprogramming. Conclusions. miR-302-mediated iPSC technology reprogrammed HCC cells and improved drug sensitivity through AOF2 down-regulation, which caused H3K4 methylation and c-Myc repression.	[Koga, Chikato; Kobayashi, Shogo; Nagano, Hiroaki; Tomimaru, Yoshito; Hama, Naoki; Wada, Hiroshi; Kawamoto, Koichi; Eguchi, Hidetoshi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; [Konno, Masamitsu; Ishii, Hideshi] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Osaka, Japan; [Umeshita, Koji] Osaka Univ, Grad Sch Med, Dept Hlth Sci, Osaka, Japan	Nagano, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan.	hnagano@gesurg.med.osaka-u.ac.jp					Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Jin LH, 2013, BIOCHEM J, V449, P459, DOI 10.1042/BJ20121360; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Hoshino H, 2012, INT J ONCOL, V40, P1423, DOI 10.3892/ijo.2012.1346; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Nagai K, 2010, BIOCHEM BIOPH RES CO, V395, P258, DOI 10.1016/j.bbrc.2010.03.176; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Kuo CH, 2012, BIOCHEM BIOPH RES CO, V417, P11, DOI 10.1016/j.bbrc.2011.11.058; Schade A, 2013, INT J MOL SCI, V14, P10710, DOI 10.3390/ijms140610710; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Tomokuni A, 2011, BIOCHEM BIOPH RES CO, V414, P675, DOI 10.1016/j.bbrc.2011.09.124; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Zhao ZK, 2013, TUMOR BIOL, V34, P173, DOI 10.1007/s13277-012-0525-x; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Bruix JSM, 2004, GASTROENTEROLOGY, V127, P179; Chin ACP, 2010, STEM CELLS DEV, V19, P753, DOI 10.1089/scd.2009.0210; Hossain S, 2013, PLOS ONE, V8, P60428; Izumi N, 2012, HEPATOL RES, V42, P226, DOI 10.1111/j.1872-034X.2011.00922.x; Kobayashi S, 2003, J GENE MED, V5, P201, DOI 10.1002/jgm.329; Kobayashi S, 2003, J GENE MED, V5, P510, DOI 10.1002/jgm.370; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Suzuki F, 2008, J GASTROEN HEPATOL, V23, P1320, DOI 10.1111/j.1440-1746.2008.05455.x; Tomimaru Y, 2010, BRIT J CANCER, V102, P1483, DOI 10.1038/sj.bjc.6605669; Zhao Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-23	40	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S591	S600		10.1245/s10434-014-3705-7		10	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300025		
J	Kurokawa, Y; Matsuura, N; Kawabata, R; Nishikawa, K; Ebisui, C; Yokoyama, Y; Shaker, MN; Hamakawa, T; Takahashi, T; Takiguchi, S; Mori, M; Doki, Y				Kurokawa, Yukinori; Matsuura, Nariaki; Kawabata, Ryohei; Nishikawa, Kazuhiro; Ebisui, Chikara; Yokoyama, Yuhki; Shaker, Mohammed Nouri; Hamakawa, Takuya; Takahashi, Tsuyoshi; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro			Prognostic Impact of Major Receptor Tyrosine Kinase Expression in Gastric Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; C-KIT EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; HUMAN STOMACH; EGF RECEPTOR; OVEREXPRESSION; MET	Background. Various kinds of molecular targeted drugs to inhibit receptor tyrosine kinases (RTKs) have been recently developed. The relationship between the expression status of major RTKs and prognosis in gastric cancer remains unclear. We conducted a multicenter study to evaluate the prognostic impact of the expression of epidermal growth factor receptor (EGFR), c-Met, platelet-derived growth factor receptor (PDGFR), and c-Kit in gastric cancer. Methods. This study included 153 gastric cancer patients who underwent gastrectomy at 9 institutions between 2000 and 2006. Expression status of EGFR, c-Met, PDGFR, and c-Kit were evaluated with immunohistochemistry (IHC) centrally. Overall survival based on RTK expression status was statistically compared. Cox multivariate analysis was conducted to adjust for potentially confounding factors. Results. The positive rates for EGFR, c-Met, PDGFR, and c-Kit were 14.4, 24.8, 41.2, and 11.1 %, respectively. Significant interactions with expression status were observed for pathological N stage with EGFR; HER2-status with c-Met; tumor location, histology, and pathological N stage with PDGFR; and no examined variables with c-Kit. Concomitant HER2 positivity was observed for 0.7 % of tumors positive for EGFR, 3.9 % for c-Met, 4.6 % for PDGFR, and 1.3 % for c-Kit. There were some differences in overall survival between patients with or without RTK expression, but only c-Kit expression showed a significant survival difference in Cox multivariate analysis (P = 0.046). Conclusions. Our multicenter study indicated that IHC expression of 4 RTKs had some prognostic impact and that c-Kit-positive status may be a significant indicator of good prognosis in gastric cancer patients.	[Kurokawa, Yukinori; Hamakawa, Takuya; Takahashi, Tsuyoshi; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Matsuura, Nariaki; Yokoyama, Yuhki; Shaker, Mohammed Nouri] Osaka Univ, Grad Sch Med, Dept Mol Pathol, Osaka, Japan; [Kawabata, Ryohei] Sakai Municipal Hosp, Dept Surg, Osaka, Japan; [Nishikawa, Kazuhiro] Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; [Ebisui, Chikara] Suita Municipal Hosp, Dept Surg, Osaka, Japan	Kurokawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan.	ykurokawa@gesurg.med.osaka-u.ac.jp			Chugai Pharmaceutical	This study was supported by Chugai Pharmaceutical.	HENRIKSEN R, 1993, CANCER RES, V53, P4550; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Nakajima M, 1999, CANCER, V85, P1894; Tsutsui S, 2006, BRIT J CANCER, V94, P1874, DOI 10.1038/sj.bjc.6603183; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Spigel DR, 2012, CLIN LUNG CANCER, V13, P500, DOI 10.1016/j.cllc.2012.05.009; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936; LEMOINE NR, 1991, BRIT J CANCER, V64, P79, DOI 10.1038/bjc.1991.243; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Drebber U, 2008, ONCOL REP, V19, P1477; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Huang TJ, 2001, ACTA ONCOL, V40, P638; Kim KC, 2011, ANN SURG ONCOL, V18, P2833, DOI 10.1245/s10434-011-1695-2; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Atmaca A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-524; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Camps C, 2006, LUNG CANCER-J IASLC, V52, P343, DOI 10.1016/j.lungcan.2006.02.003; Chu JS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-16; Chung CY, 2005, CANCER LETT, V217, P231, DOI 10.1016/j.canlet.2004.06.045; Chung H, 2009, EJC SUPPL, V7, P364; Maia BD, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-150; Garcia I, 2003, ANN SURG ONCOL, V10, P234, DOI 10.1245/ASO.2003.05.010; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; Kodama M, 2010, CANCER SCI, V101, P1984, DOI 10.1111/j.1349-7006.2010.01639.x; Massard C, 2007, BRIT J CANCER, V97, P857, DOI 10.1038/sj.bjc.6603942; Nishikawa K, 2012, J CLIN ONCOL S34, V30; Sobin LH, 2009, TNM CLASSIFICATION M; Sumida T, 2011, INT J CANCER, V128, P2050, DOI 10.1002/ijc.25812; Sung R, 2011, ONCOL REP, V26, P33, DOI 10.3892/or.2011.1293; Varela M, 2004, J SURG ONCOL, V86, P34, DOI 10.1002/jso.20036; Yuzawa S, 2012, MED ONCOL, V29, P2824, DOI 10.1007/s12032-012-0193-0	36	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S584	S590		10.1245/s10434-014-3690-x		7	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300024		
J	Maeda, N; Yoshimura, K; Yamamoto, S; Kuramasu, A; Inoue, M; Suzuki, N; Watanabe, Y; Maeda, Y; Kamei, R; Tsunedomi, R; Shindo, Y; Inui, M; Tamada, K; Yoshino, S; Hazama, S; Oka, M				Maeda, N.; Yoshimura, K.; Yamamoto, S.; Kuramasu, A.; Inoue, M.; Suzuki, N.; Watanabe, Y.; Maeda, Y.; Kamei, R.; Tsunedomi, R.; Shindo, Y.; Inui, M.; Tamada, K.; Yoshino, S.; Hazama, S.; Oka, M.			Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients	ANNALS OF SURGICAL ONCOLOGY			English	Article							COSTIMULATORY MOLECULE B7-H3; HUMAN PANCREATIC-CANCER; PROSTATE-CANCER; LUNG-CANCER; LIGAND EXPRESSION; PERIPHERAL-BLOOD; GASTRIC-CANCER; LYMPH-NODES; B7 FAMILY; PROGNOSIS	Background. In the tumor microenvironment, factors inhibiting the targeting of cancer cells by activated T cells have recently been noted. B7-H3 belongs to the B7 superfamily of immune regulatory ligands and plays an important role in the adaptive immune response of co-inhibitory/stimulatory factors in regulating T cells. However, the degree to which B7-H3 directly affects tumor immune evasion mechanisms remains unclear, particularly in patients with breast cancer. Regulatory T cells (Tregs) are known as a key player in the inhibition of immune mechanisms. The present study demonstrated that expression of B7-H3 on tumor cells and the number of Tregs in the tumor microenvironment independently affected prognosis in breast cancer patients. Methods. We immunohistochemically investigated the presence of B7-H3 and forkhead box P3 (Foxp3)-positive Tregs in pathological specimens from 90 patients with breast cancer. Results. Positive B7-H3 expression was associated with shorter recurrence-free survival (RFS) (p = 0.014). A higher percentage of Foxp3-positive cells also correlated with shorter RFS (p = 0.039). Multivariate analysis showed B7-H3 as an independent factor on RFS. Foxp3 expression in tumor-infiltrating lymphocytes (TILs) correlated significantly with larger tumor size (>2 cm), expression of human epidermal growth factor receptor 2 (HER2), and higher nuclear grade (p = 0.003, p<0.001, p = 0.001, respectively). No correlation was identified between expression of B7-H3 and the percentage of Foxp3-positive TILs. Conclusions. B7-H3 and Foxp3 can be regarded as markers of poor prognosis in breast cancer. These expressions were not correlated, suggesting that B7-H3 expression plays an independent role in tumor immune evasion, regardless of Tregs.	[Maeda, N.; Yoshimura, K.; Yamamoto, S.; Inoue, M.; Suzuki, N.; Watanabe, Y.; Maeda, Y.; Kamei, R.; Tsunedomi, R.; Shindo, Y.; Yoshino, S.; Hazama, S.; Oka, M.] Yamaguchi Univ, Sch Med, Dept Digest Surg & Surg Oncol, Ube, Yamaguchi 755, Japan; [Kuramasu, A.; Inui, M.] Yamaguchi Univ, Sch Med, Dept Pharmacol, Ube, Yamaguchi 755, Japan; [Tamada, K.] Yamaguchi Univ, Sch Med, Dept Immunol & Cell Signaling Anal, Ube, Yamaguchi 755, Japan	Oka, M (reprint author), Yamaguchi Univ, Sch Med, Dept Digest Surg & Surg Oncol, Ube, Yamaguchi 755, Japan.	2geka-1@yamaguchi-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [24591907]	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (project No. 24591907; S. Yamamoto).	Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Kawaida H, 2005, J SURG RES, V124, P151, DOI 10.1016/j.jss.2004.10.004; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Woo EY, 2001, CANCER RES, V61, P4766; Sun J, 2010, CANCER IMMUNOL IMMUN, V59, P1163, DOI 10.1007/s00262-010-0841-1; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Caras I, 2004, CANCER IMMUNOL IMMUN, V53, P1146, DOI 10.1007/s00262-004-0556-2; Arigami T, 2010, ANN SURG, V252, P1044, DOI 10.1097/SLA.0b013e3181f1939d; Arigami T, 2011, CANCER SCI, V102, P1019, DOI 10.1111/j.1349-7006.2011.01877.x; Miller AM, 2006, J IMMUNOL, V177, P7398; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Petersen RP, 2006, CANCER, V107, P2866, DOI 10.1002/cncr.22282; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Generali D, 2009, CLIN CANCER RES, V15, P1046, DOI 10.1158/1078-0432.CCR-08-1507; Brunner A, 2012, GYNECOL ONCOL, V124, P105, DOI 10.1016/j.ygyno.2011.09.012; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Wu CP, 2006, WORLD J GASTROENTERO, V12, P457; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.040525101; Liyanage UK, 2002, J IMMUNOL, V169, P2756; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Yoshimura K, 2007, CANCER RES, V67, P10058, DOI 10.1158/0008-5472.CAN-07-0573; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Viguier M, 2004, J IMMUNOL, V173, P1444; Sasada T, 2003, CANCER, V98, P1089, DOI 10.1002/cncr.11618; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Liyanage UK, 2006, J IMMUNOTHER, V29, P416, DOI 10.1097/01.cji.0000205644.43735.4e; Loos M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-463; Lupu CM, 2007, ONCOL REP, V18, P745; Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072; Yuan HX, 2011, J UROLOGY, V186, P1093, DOI 10.1016/j.juro.2011.04.103	43	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S546	S554		10.1245/s10434-014-3564-2		9	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300020		
J	Matsumura, T; Sugimachi, K; Takahashi, Y; Uchi, R; Sawada, G; Ueda, M; Hirata, H; Sakimura, S; Ueo, H; Takano, Y; Kurashige, J; Shinden, Y; Eguchi, H; Sudo, T; Yamamoto, H; Doki, Y; Mori, M; Mimori, K				Matsumura, Tae; Sugimachi, Keishi; Takahashi, Yusuke; Uchi, Ryutaro; Sawada, Genta; Ueda, Masami; Hirata, Hidenari; Sakimura, Shotaro; Ueo, Hiroki; Takano, Yuki; Kurashige, Junji; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki; Mimori, Koshi			Clinical Significance of GAB2, a Scaffolding/Docking Protein Acting Downstream of EGFR in Human Colorectal Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER; TARGETED THERAPIES; PATHWAY; AMPLIFICATION; ACTIVATION; MELANOMA; PHOSPHORYLATION; OVEREXPRESSION; PROGRESSION	Purpose. Recent studies indicated that the scaffolding adaptor protein GAB2 (GRB2-associated binding protein 2) plays a critical role in the proliferation and migration of various cancers. This study aimed to determine the role of aberrant GAB2 expression in human colorectal cancer (CRC). Methods. Quantitative real-time reverse transcription polymerase chain reaction was used to evaluate GAB2 mRNA expression in 152 CRC tissues samples to determine the clinicopathological significance of GAB2 expression. We also performed in vitro proliferation assays using siGAB2-transfected CRC cells. Results. GAB2 expression in tumor colorectal tissues was significantly higher than in normal colorectal tissues (p = 0.0212). High GAB2 expression levels were associated with malignant clinicopathologic potential factors, including lymphatic invasion (p = 0.0003), venous invasion (p = 0.0170), and liver metastasis (p = 0.0144). The survival rate of patients with high GAB2 expression levels was significantly lower than that of patients with low GAB2 expression (p = 0.0074). Multivariate analysis indicated that GAB2 expression was a factor affecting lymph node metastasis. Cell proliferation was significantly suppressed by siGAB2 expression in CRC cells in vitro. Conclusions. GAB2 expression was associated with lymph node metastasis and may play a role in the growth and metastasis of CRC. These results suggest that GAB2 is a potential therapeutic target in CRC.	[Matsumura, Tae; Sugimachi, Keishi; Uchi, Ryutaro; Ueda, Masami; Hirata, Hidenari; Sakimura, Shotaro; Ueo, Hiroki; Takano, Yuki; Kurashige, Junji; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan; [Matsumura, Tae; Takahashi, Yusuke; Sawada, Genta; Ueda, Masami; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan	Matsumura, T (reprint author), Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan.	kmimori@beppu.kyushu-u.ac.jp			CREST, Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [25430111, 25461953, 25861199, 25861200]; Japan Science and Technology Agency (JSTA) A-step [AS242Z03987P]; Founding Program for Next Generation World-leading Researchers [LS094]	We thank T. Shimooka, K. Oda, M. Kasagi, and S. Kono for their technical assistance. This work was supported in part by the following grants and foundations: CREST, Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Science Research, Grant Numbers 25430111, 25461953, 25861199, 25861200; Japan Science and Technology Agency (JSTA) A-step, Grant AS242Z03987P; and the Founding Program for Next Generation World-leading Researchers (LS094).	Abreu MTH, 2011, MOL BIOL CELL, V22, P105, DOI 10.1091/mbc.E10-03-0185; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Bertelsen BI, 2006, INT J CANCER, V118, P1877, DOI 10.1002/ijc.21461; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Adams SJ, 2012, MOL CANCER RES, V10, P1265, DOI 10.1158/1541-7786.MCR-12-0352; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Azusa A, 2013, HUM PATHOL, V44, P199; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Cance WG, 2013, SCI SIGNAL, V6, ppe10; Chernoff KA, 2009, CLIN CANCER RES, V15, P4288, DOI 10.1158/1078-0432.CCR-09-0280; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Fleuren EDG, 2010, INT J CANCER, V127, P1486, DOI 10.1002/ijc.25172; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Mermel CH, 2011, GENOME BIOL, V12, P41; Mira A, 2009, ONCOGENE, V28, P4444, DOI 10.1038/onc.2009.296; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Xu XL, 2011, INT J BIOL SCI, V7, P496; Yang Y, 2013, ONCOGENE, V32, P3627, DOI 10.1038/onc.2012.367; Zatkova A, 2006, GENE CHROMOSOME CANC, V45, P798, DOI 10.1002/gcc.20344; Zhang XC, 2013, MOL CELL BIOL, V33, P1657, DOI 10.1128/MCB.01353-12	29	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S743	S749		10.1245/s10434-014-3889-x		7	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300044		
J	Nakanoko, T; Saeki, H; Morita, M; Nakashima, Y; Ando, K; Oki, E; Ohga, T; Kakeji, Y; Toh, Y; Maehara, Y				Nakanoko, Tomonori; Saeki, Hiroshi; Morita, Masaru; Nakashima, Yuichiro; Ando, Koji; Oki, Eiji; Ohga, Takefumi; Kakeji, Yoshihiro; Toh, Yasushi; Maehara, Yoshihiko			Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus (vol 21, pg 597, 2014)	ANNALS OF SURGICAL ONCOLOGY			English	Correction									[Nakanoko, Tomonori; Saeki, Hiroshi; Morita, Masaru; Nakashima, Yuichiro; Ando, Koji; Oki, Eiji; Ohga, Takefumi; Kakeji, Yoshihiro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Gastrointestinal Surg, Fukuoka, Japan	Nakanoko, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	h-saeki@surg2.med.kyushu-u.ac.jp					Nakanoko T, 2014, ANN SURG ONCOL, V21, P597, DOI 10.1245/s10434-013-3220-2	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S776	S776		10.1245/s10434-013-3332-8		1	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300048		
J	Nakata, K; Ohuchida, K; Mizumoto, K; Aishima, S; Oda, Y; Nagai, E; Tanaka, M				Nakata, Kohei; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Aishima, Shinichi; Oda, Yoshinao; Nagai, Eishi; Tanaka, Masao			Micro RNA-373 is Down-regulated in Pancreatic Cancer and Inhibits Cancer Cell Invasion	ANNALS OF SURGICAL ONCOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; CAENORHABDITIS-ELEGANS; TUMOR INVASION; METASTASIS; EXPRESSION; PROMOTES; ZEB1; RNAS; GENES	Background. Micro RNAs (miRNAs) are small noncoding RNAs that have gained attention as key molecules in the malignant characteristics of cancers, and several recent investigations also have identified some miRNAs as potential key regulators to inhibit the malignant characteristics of tumors. MiRNA-373 (miR-373) has recently been reported to induce E-cadherin, which is a key regulator of epithelial-mesenchymal transition (EMT). However, the role of miR-373 in the characteristics of cancer cells is not still well known. Methods. We investigated the expression levels of miR-373 in pancreatic cancer cell lines and its effect on the invasiveness of pancreatic cancer by using in vitro and in vivo models. We also analyzed the expression of miR-373 using formalin-fixed paraffin-embedded (n = 152) and microdissected frozen (n = 57) samples from pancreatic tissues. Results. The levels of miR-373 expression were low in pancreatic cancer cell lines. In formalin-fixed paraffin-embedded and microdissected frozen samples, miR-373 expression was significantly down-regulated in pancreatic cancer compared with that in healthy pancreas (P<0.001 and P = 0.005, respectively). We also found that reexpression of miR-373 repressed transforming growth factor-beta-induced EMT, leading to inhibition of invasiveness of cancer cells. Furthermore, reexpression of miR-373 significantly inhibited peritoneal dissemination in vivo (P<0.001). Conclusions. MiR-373 is down-regulated in pancreatic cancer, and its reexpression represses the invasiveness of pancreatic cancer cells.	[Nakata, Kohei; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Nagai, Eishi; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg, Fukuoka 812, Japan; [Nakata, Kohei; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Nagai, Eishi; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Oncol, Fukuoka 812, Japan; [Aishima, Shinichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan	Ohuchida, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg, Fukuoka 812, Japan.	kenoki@surg1.med.kyushu-u.ac.jp			JEPS KAKENHI Grants [22390258, 24659615, 25713050]; Takeda Science Foundation; Clinical Research Promotion Foundation	This work was supported by JEPS KAKENHI Grants 22390258, 24659615, and 25713050; the Takeda Science Foundation (2012); Grant of the Japanese Society of Gastroenterology (2013); and Grant of the Clinical Research Promotion Foundation (2012). We are grateful to Emiko Manabe, Miyuki Omori, and Seiko Sadatomi (Department of Surgery and Oncology, Kyushu University) for skillful technical assistance.	Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Nakata K, 2011, SURGERY, V150, P916, DOI 10.1016/j.surg.2011.06.017; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ohuchida K, 2012, ANN SURG ONCOL, V19, P2394, DOI 10.1245/s10434-012-2252-3; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; NIEDERHUBER JE, 1995, CANCER, V76, P1671, DOI 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R; Ryu B, 2002, CANCER RES, V62, P819; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Ellenrieder V, 2001, CANCER RES, V61, P4222; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Zhang L, 1999, CANCER LETT, V142, P129, DOI 10.1016/S0304-3835(99)00107-X; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Sato N, 2000, CANCER LETT, V155, P153, DOI 10.1016/S0304-3835(00)00421-3; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Hishinuma S, 2006, J GASTROINTEST SURG, V10, P511, DOI 10.1016/j.gassur.2005.09.016; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Nakata K, 2009, NEOPLASIA, V11, P712, DOI 10.1593/neo.09418; Nakata K, 2009, MODERN PATHOL, V22, P460, DOI 10.1038/modpathol.2008.205; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Su DM, 2005, PANCREATOLOGY, V5, P316, DOI 10.1159/000086532; Tachikawa Tetsuhiko, 2004, Medical Electron Microscopy, V37, P82; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706	41	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S564	S574		10.1245/s10434-014-3676-8		11	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300022		
J	Sakashita, H; Inoue, H; Akamine, S; Ishida, T; Inase, N; Shirao, K; Mori, M; Mimori, K				Sakashita, Hiroyuki; Inoue, Hiroshi; Akamine, Shinji; Ishida, Teruyoshi; Inase, Naohiko; Shirao, Kuniaki; Mori, Masaki; Mimori, Koshi			Identification of the NEDD4L Gene as a Prognostic Marker by Integrated Microarray Analysis of Copy Number and Gene Expression Profiling in Non-small Cell Lung Cancer (vol 20, pg S590, 2013)	ANNALS OF SURGICAL ONCOLOGY			English	Correction									[Sakashita, Hiroyuki; Inoue, Hiroshi; Mori, Masaki; Mimori, Koshi] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Surg Oncol, Beppu, Oita, Japan; [Sakashita, Hiroyuki] Tokyo Med & Dent Univ, Dept Clin Oncol, Tokyo, Japan; [Akamine, Shinji] Oita Prefectural Hosp, Dept Chest Surg, Oita, Japan; [Ishida, Teruyoshi] Hiroshima Red Cross Hosp, Dept Surg, Hiroshima, Japan; [Ishida, Teruyoshi] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Sakashita, Hiroyuki; Inase, Naohiko] Tokyo Med & Dent Univ, Grad Sch Med, Dept Integrated Pulmonol, Tokyo, Japan; [Sakashita, Hiroyuki; Shirao, Kuniaki] Oita Univ, Dept Med Oncol, Oita 87011, Japan; [Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan	Sakashita, H (reprint author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Surg Oncol, Beppu, Oita, Japan.	hsakashita.pulm@tmd.ac.jp					Sakashita H, 2013, ANN SURG ONCOL, V20, pS590, DOI 10.1245/s10434-013-3059-6	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S783	S783		10.1245/s10434-013-3476-6		1	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300053		
J	Sawada, G; Takahashi, Y; Niida, A; Shimamura, T; Kurashige, J; Matsumura, T; Ueo, H; Uchi, R; Takano, Y; Ueda, M; Hirata, H; Sakimura, S; Shinden, Y; Eguchi, H; Sudo, T; Sugimachi, K; Miyano, S; Doki, Y; Mori, M; Mimori, K				Sawada, Genta; Takahashi, Yusuke; Niida, Atsushi; Shimamura, Teppei; Kurashige, Junji; Matsumura, Tae; Ueo, Hiroki; Uchi, Ryutaro; Takano, Yuki; Ueda, Masami; Hirata, Hidenari; Sakimura, Shotaro; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Sugimachi, Keishi; Miyano, Satoru; Doki, Yuichiro; Mori, Masaki; Mimori, Koshi			Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							DOMAIN-CONTAINING PROTEIN-1; LYMPH-NODE METASTASIS; CANCER; GENE; LUNG; IDENTIFICATION; TRASK; SRC	Background. Human CDCP1 gene, located on chromosome 3p21.3, is a transmembrane glycoprotein widely expressed in epithelial tissues, and its role in cancer remains to be understood. Methods. Using microarray profiles of gene expression and copy number data from 69 esophageal squamous cell carcinoma (ESCC) samples, we performed informatics analyses to reveal the significance of CDCP1 expression. We also performed migration and invasion assays of siRNA-targeted CDCP1-transfected cells and CDCP1-overexpressing cell in vitro. Moreover, we evaluated the clinical magnitude of CDCP1 expression in esophageal squamous cell cancer cases. Results. Allelic loss of chromosome 3p was confirmed by copy number analysis. The expression level of CDCP1 in tumor tissue was significantly lower than that in corresponding normal tissue. siRNA targeting of CDCP1 promoted the migratory and invasive abilities of esophageal cancer cell lines, whereas both abilities were reduced in CDCP1-overexpressing cells. Gene set enrichment analysis showed that expression levels of CDCP1 were associated with tumor differentiation and metastasis, consistent with the result of clinicopathologic analyses. Finally, multivariate analysis revealed that the expression level of CDCP1 was an independent prognostic factor for survival. Conclusions. Loss of CDCP1 expression may be a novel indicator for biological aggressiveness in ESCC.	[Sawada, Genta; Takahashi, Yusuke; Kurashige, Junji; Matsumura, Tae; Ueo, Hiroki; Uchi, Ryutaro; Takano, Yuki; Ueda, Masami; Hirata, Hidenari; Sakimura, Shotaro; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Sugimachi, Keishi; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan; [Niida, Atsushi; Shimamura, Teppei; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Sawada, Genta; Takahashi, Yusuke; Matsumura, Tae; Ueda, Masami; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan	Mimori, K (reprint author), Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan.	kmimori@beppu.kyushu-u.ac.jp			Funding Program for Next Generation World-Leading Researchers [LS094];  [21229015]	This work was supported by the following Grants and foundations: Grants-in-Aid for Scientific Research (21229015); Funding Program for Next Generation World-Leading Researchers (LS094). We thank T. Shimo-oka, M. Kasagi, T. Kohno, K. Oda, M. Aoyagi, and T. Kawano for their assistance with molecular biological procedures.	MAEHARA Y, 1992, BRIT J SURG, V79, P245, DOI 10.1002/bjs.1800790320; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Schafer M, 2009, BIOINFORMATICS, V25, P3228, DOI 10.1093/bioinformatics/btp592; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Lerman MI, 2000, CANCER RES, V60, P6116; Goel Hira Lal, 2004, Cancer Treat Res, V119, P15; Huebner K, 2001, P NATL ACAD SCI USA, V98, P14763, DOI 10.1073/pnas.261586598; Kawamura YJ, 2005, SCAND J GASTROENTERO, V40, P858, DOI 10.1080/00365520510015746; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Spassov DS, 2012, ONCOGENE, V31, P419, DOI 10.1038/onc.2011.246; Spassov DS, 2013, CANCER RES, V73, P1168, DOI 10.1158/0008-5472.CAN-12-2496; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10	19	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S640	S647		10.1245/s10434-014-3740-4		8	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300031		
J	Sugimachi, K; Niida, A; Yamamoto, K; Shimamura, T; Imoto, S; Iinuma, H; Shinden, Y; Eguchi, H; Sudo, T; Watanabe, M; Tanaka, J; Kudo, S; Hase, K; Kusunoki, M; Yamada, K; Shimada, Y; Sugihara, K; Maehara, Y; Miyano, S; Mori, M; Mimori, K				Sugimachi, Keishi; Niida, Atsushi; Yamamoto, Ken; Shimamura, Teppei; Imoto, Seiya; Iinuma, Hisae; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Watanabe, Masahiko; Tanaka, Junichi; Kudo, Shinei; Hase, Kazuo; Kusunoki, Masato; Yamada, Kazutaka; Shimada, Yasuhiro; Sugihara, Kenichi; Maehara, Yoshihiko; Miyano, Satoru; Mori, Masaki; Mimori, Koshi			Allelic Imbalance at an 8q24 Oncogenic SNP is Involved in Activating MYC in Human Colorectal Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; CHROMOSOME 8Q24; COPY NUMBER; RISK ALLELE; C-MYC; RS6983267; ASSOCIATION; PROGRESSION; SELECTION; VARIANTS	Background. The rs6983267 at 8q24.21 has been established as a significant cancer-related single nucleotide polymorphism (SNP). The risk allele showed similarity to the binding site of transcription factor TCF4/LEF1 that activates transcription of MYC. However, little is known about the role of this SNP in increasing MYC activity in colorectal cancers (CRCs). Methods. The genotypes of rs6983267 in peripheral blood and primary cancers, MYC activity and copy number (CN) alteration were examined in 107 CRCs. Next, we plotted the number of cancers cell lines exhibiting specific G/T genotypes in 746 cancer cell lines of the Sanger Institute database. Then we validated the relationship between the 8q24 SNP status and clinicopathologic parameters in 68 CRCs with loss of heterozygosity (LOH). Results. The MYC module activity was activated by either transcription in the risk allele (G) or by amplification in the non-risk allele (T). Then, we confirmed that the CN amplification dominantly occurred in the non-risk allele, whereas CN neutral LOH, which indicated uniparental disomy(UPD) was more frequently observed for the risk allele. Finally, we confirmed that risk allele dominant cases, either by amplification or by UPD, indicated a more malignant clinical phenotype than non-risk allele dominant cases. Conclusions. The development of CRC requires MYC activation through retention of the risk allele, or amplification of the non-risk allele at the oncogenic SNP in the site of primary tumor.	[Sugimachi, Keishi; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan; [Niida, Atsushi; Shimamura, Teppei; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Yamamoto, Ken] Kyushu Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Med Inst Bioregulat, Fukuoka 812, Japan; [Iinuma, Hisae] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan; [Watanabe, Masahiko] Kitazato Univ, Dept Surg, Sagamihara, Kanagawa, Japan; [Tanaka, Junichi; Kudo, Shinei] Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa, Japan; [Hase, Kazuo] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 359, Japan; [Kusunoki, Masato] Mie Univ, Dept Surg, Tsu, Mie 514, Japan; [Yamada, Kazutaka] Takano Hosp, Dept Surg, Kumamoto, Japan; [Shimada, Yasuhiro] Natl Canc Ctr, Dept Surg & Digest Tract Med, Tokyo 104, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg, Tokyo, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan	Mimori, K (reprint author), Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan.	kmimori@beppu.kyushu-u.ac.jp			CREST, Japan Science and Technology Agency; Japan Society for the Promotion of Science; Funding Program for Next Generation World-Leading Researchers [LS-094]	We thank T. Shimooka, M. Kasagi, T. Kawano, and S. Kouno for their technical assistance. This work was supported in part by the following grants and foundations: CREST, Japan Science and Technology Agency; Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research; and the Funding Program for Next Generation World-Leading Researchers (LS-094).	Abuli A, 2010, GASTROENTEROLOGY, V139, P788, DOI 10.1053/j.gastro.2010.05.072; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Ernst T, 2012, LEUKEMIA, V26, P1701, DOI 10.1038/leu.2012.16; Rochlitz CF, 1996, ONCOLOGY, V53, P448; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Washington MK, 2008, ARCH PATHOL LAB MED, V132, P1600, DOI 10.1043/1543-2165(2008)132[1600:CCSIIP]2.0.CO;2; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Lapunzina P, 2011, BIOL CELL, V103, P303, DOI 10.1042/BC20110013; Mimori K, 2012, SURG TODAY, V42, P215, DOI 10.1007/s00595-011-0038-z; Takatsuno Y, 2013, ANN SURG ONCOL, V20, P1395, DOI 10.1245/s10434-012-2657-z; Beuten J, 2009, CARCINOGENESIS, V30, P1372, DOI 10.1093/carcin/bgp148; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Haerian MS, 2011, J GASTROEN HEPATOL, V26, P1475, DOI 10.1111/j.1440-1746.2011.06831.x; Ishimaru S, 2012, ANN SURG ONCOL, V19, P2853, DOI 10.1245/s10434-012-2278-6; Kupfer SS, 2009, CARCINOGENESIS, V30, P1353, DOI 10.1093/carcin/bgp123; Mimori K, 1999, P NATL ACAD SCI USA, V96, P7456, DOI 10.1073/pnas.96.13.7456; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Takahashi Y, 2012, J GASTROEN HEPATOL, V27, P95, DOI 10.1111/j.1440-1746.2012.07081.x; Tuupanen S, 2012, CANCER GENET-NY, V205, P25, DOI 10.1016/j.cancergen.2012.01.005	22	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S515	S521		10.1245/s10434-013-3468-6		7	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300016		
J	Uemura, S; Kuramochi, H; Higuchi, R; Nakajima, G; Yamamoto, M				Uemura, Shuichiro; Kuramochi, Hidekazu; Higuchi, Ryota; Nakajima, Go; Yamamoto, Masakazu			ERCC1 mRNA Expression as a Postoperative Prognostic Marker in Extrahepatic Bile Duct Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							CELL LUNG-CANCER; NUCLEOTIDE EXCISION-REPAIR; THYMIDYLATE SYNTHASE; BILIARY-TRACT; FLUOROURACIL CHEMOTHERAPY; COLORECTAL-CANCER; CISPLATIN; SURVIVAL; GALLBLADDER; THERAPY	Background. No reliable biomarker for biliary tract cancer has yet been identified because of the varying composition of the cancer type, differences in tumor location, a mixture of curative and non-curative operations, and differences in operative methods. Methods. Fifty extrahepatic bile duct cancer patients, pathologically diagnosed with papillary or tubular adenocarcinoma who underwent a pancreatoduodenectomy with R0 resection, were included in the study. Messenger RNA (mRNA) expression levels were measured from formalin-fixed, paraffin-embedded samples by real-time reverse-transcription polymerase chain reaction. Results. The preliminary analysis selected ten patients who have survived more than 5 years (LS group) and ten who had a relapse within 2 years (SS group). mRNA expression of seven target genes was examined, but only excision repair cross-complementing 1 (ERCC1) mRNA levels showed a significant difference between the LS and SS groups (median ERCC1: LS 26.5 vs. SS 9.7; p = 0.0073). The median survival time of patients with high ERCC1 levels was significantly longer than in patients with low ERCC1 levels (p = 0.0105). Thirty more patients with identical backgrounds were added to the study, and ERCC1 mRNA levels were measured in all 50 patients. Those with high ERCC1 mRNA levels had a significantly greater overall survival (OS) time compared with those with low ERCC1 levels (MST: 174 vs. 86 M; p = 0.048). Multivariate analysis found that an absence of lymph node metastases and high ERCC1 expression were significantly associated with improved OS. Conclusion. ERCC1 mRNA expression appears to be a useful prognostic biomarker for extrahepatic bile duct cancer with R0 resection.	[Uemura, Shuichiro; Higuchi, Ryota; Yamamoto, Masakazu] Tokyo Womens Med Univ, Dept Surg, Inst Gastroenterol, Tokyo, Japan; [Kuramochi, Hidekazu; Nakajima, Go] Tokyo Womens Med Univ, Dept Chemotherapy & Palliat Care, Tokyo, Japan	Kuramochi, H (reprint author), Tokyo Womens Med Univ, Dept Chemotherapy & Palliat Care, Tokyo, Japan.	kuramochi@chemo.jp			Tokyo Women's Medical University	The authors wish to thank Yasuto Sato, PhD, for his advice on statistics. This study was supported by departmental funds from Tokyo Women's Medical University.	Akamatsu Nobuhisa, 2011, World J Clin Oncol, V2, P94, DOI 10.5306/wjco.v2.i2.94; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Maithel SK, 2011, ANN SURG ONCOL, V18, P2699, DOI 10.1245/s10434-011-1610-x; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Squires MH, 2013, CANCER-AM CANCER SOC, V119, P3242, DOI 10.1002/cncr.28175; Shirota Y, 2001, J CLIN ONCOL, V19, P4298; Metzger R, 1998, J CLIN ONCOL, V16, P309; Thomas MB, 2007, CRIT REV ONCOL HEMAT, V61, P44, DOI 10.1016/j.critrevonc.2006.07.006; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Ferry KV, 2000, BIOCHEM PHARMACOL, V60, P1305, DOI 10.1016/S0006-2952(00)00441-X; Seyhan EC, 2011, ANN THORAC CARDIOVAS, V17, P110; Simon GR, 2007, INT J BIOCHEM CELL B, V39, P1318, DOI 10.1016/j.biocel.2007.05.006; Fisher SB, 2012, CANCER, V119, P454; Hwang IG, 2011, CANCER CHEMOTH PHARM, V68, P935, DOI 10.1007/s00280-011-1558-3; Kuramochi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-88; Pacetti P, 2009, ANTICANCER RES, V29, P1835; Reed E, 2005, CLIN CANCER RES, V11, P6100, DOI 10.1158/1078-0432.CCR-05-1083; Roa I, 2011, HISTOL HISTOPATHOL, V26, P37; Won HS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-564	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S627	S633		10.1245/s10434-014-3726-2		7	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300029		
J	Wubetu, GY; Utsunomiya, T; Ishikawa, D; Yamada, S; Ikemoto, T; Morine, Y; Iwahashi, S; Saito, Y; Arakawa, Y; Imura, S; Kanamoto, M; Zhu, CZ; Bando, Y; Shimada, M				Wubetu, Gizachew Yismaw; Utsunomiya, Tohru; Ishikawa, Daichi; Yamada, Shinichiro; Ikemoto, Tetsuya; Morine, Yuji; Iwahashi, Shuichi; Saito, Yu; Arakawa, Yusuke; Imura, Satoru; Kanamoto, Mami; Zhu, Chengzhan; Bando, Yoshimi; Shimada, Mitsuo			High STAT4 Expression is a Better Prognostic Indicator in Patients with Hepatocellular Carcinoma After Hepatectomy	ANNALS OF SURGICAL ONCOLOGY			English	Article							INTERFERON-GAMMA; IFN-GAMMA; TUMOR-DEVELOPMENT; T-CELLS; LYMPHOCYTE INFILTRATION; IMMUNOREGULATORY ROLES; ANTITUMOR IMMUNITY; CANCER; METASTASIS; RESPONSES	Background. Signal transducer and activator of transcription 4 (STAT4) mediates the intracellular effects of interleukin-12, leading to the production of interferon gamma (IFN-gamma) and natural killer cells cytotoxicity. However, the clinical significance of STAT4 expression in patients with hepatocellular carcinoma (HCC) remains virtually unknown. Methods. A total of 66 HCC patients who underwent hepatectomy were enrolled in this study. Quantitative real-time polymerase chain reaction was performed to determine STAT4 and IFNG mRNA expression levels. Tissue microarray-based immunohistochemistry was performed to examine CD8(+) T cells, STAT4, and INF-gamma proteins. Results. STAT4 was differentially expressed in tumor and nontumor tissues (P = 0.001) and positively correlated with IFNG expression (R-2 = 0.506, P < 0.05) and CD8(+) T cell infiltration (R-2 = 0.53, P < 0.001). Significant correlations were observed between STAT4 expression and tumor TNM stage (P = 0.043), hepatic venous invasion (P = 0.003), desgamma-carboxy prothrombin (P = 0.011), tumor size (P = 0.036), and tumor differentiation (P = 0.034). Patients with high STAT4 expression had significantly better recurrence-free survival (P = 0.009). Low STAT4 expression (P = 0.030) and presence of portal venous invasion or hepatic venous invasion (P = 0.006) were independent risk factors for HCC recurrence. Conclusions. Downregulation of STAT4 in HCC indicated aggressive tumor behavior and predicted a worse clinical outcome. STAT4 might be a useful biomarker to identify patients at high risk of recurrence after hepatectomy.	[Wubetu, Gizachew Yismaw; Utsunomiya, Tohru; Ishikawa, Daichi; Yamada, Shinichiro; Ikemoto, Tetsuya; Morine, Yuji; Iwahashi, Shuichi; Saito, Yu; Arakawa, Yusuke; Imura, Satoru; Kanamoto, Mami; Zhu, Chengzhan; Shimada, Mitsuo] Univ Tokushima, Dept Surg, Tokushima 770, Japan; [Bando, Yoshimi] Univ Tokushima, Dept Pathol, Tokushima 770, Japan	Wubetu, GY (reprint author), Univ Tokushima, Dept Surg, Tokushima 770, Japan.	mitsuo.shimada@tokushima-u.ac.jp					Jacob CO, 2003, J IMMUNOL, V171, P1564; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Chang HC, 2009, BLOOD, V113, P5887, DOI 10.1182/blood-2008-09-179820; Bruns HA, 2006, CRIT REV ONCOL HEMAT, V57, P245, DOI 10.1016/j.critrevonc.2005.08.005; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Nakano O, 2001, CANCER RES, V61, P5132; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Lim KC, 2011, ANN SURG, V254, P108, DOI 10.1097/SLA.0b013e31821ad884; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Frucht DM, 2000, J IMMUNOL, V164, P4659; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Dunn GP, 2005, IMMUNOL RES, V32, P231, DOI 10.1385/IR:32:1-3:231; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Pedroza-Gonzalez A, 2013, HEPATOLOGY, V57, P183, DOI 10.1002/hep.26013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Beatty GL, 2001, J IMMUNOL, V166, P2276; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; YUKI K, 1990, CANCER, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Cai GF, 2000, J IMMUNOL, V165, P2619; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, P72; Ferlay J, 2010, INT J CANCER, V12, P2893, DOI DOI 10.1002/IJC.25516; Huang YH, 2004, LIVER INT, V24, P419, DOI 10.1111/j.1478-3231.2004.0941.x; Lee IC, 2013, INT J CANCER, V133, P2895, DOI 10.1002/ijc.28311; Dupre SA, 2008, EXP MOL PATHOL, V85, P174, DOI 10.1016/j.yexmp.2008.05.002; Tsuta K, 2005, AM J CLIN PATHOL, V123, P547, DOI 10.1309/APO4O9D52GNLR8W	38	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S721	S728		10.1245/s10434-014-3861-9		8	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300041		
J	Yoneda, K; Tanaka, F; Kondo, N; Hashimoto, M; Takuwa, T; Matsumoto, S; Okumura, Y; Tsubota, N; Sato, A; Tsujimura, T; Kuribayashi, K; Fukuoka, K; Tabata, C; Nakano, T; Hasegawa, S				Yoneda, Kazue; Tanaka, Fumihiro; Kondo, Nobuyuki; Hashimoto, Masaki; Takuwa, Teruhisa; Matsumoto, Seiji; Okumura, Yoshitomo; Tsubota, Noriaki; Sato, Ayuko; Tsujimura, Tohru; Kuribayashi, Kozo; Fukuoka, Kazuya; Tabata, Chiharu; Nakano, Takashi; Hasegawa, Seiki			Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM)	ANNALS OF SURGICAL ONCOLOGY			English	Article							METASTATIC BREAST-CANCER; COLORECTAL-CANCER; PERIPHERAL-BLOOD; UPDATE; VALIDATION; SURVIVAL; SYSTEM	Purpose. To investigate the diagnostic and prognostic value of circulating tumor cells (CTCs), a potential surrogate of micrometastasis, in malignant pleural mesothelioma (MPM). Methods. We prospectively evaluated CTCs in 7.5 mL of peripheral blood sampled from patients with a suspicion of MPM. A semiautomated system was used to capture CTCs with an antibody against the epithelial cell adhesion molecule. Results. Of 136 eligible patients, 32 were finally diagnosed with nonmalignant diseases (NM), and 104 had MPM. CTCs were detected in 32.7 % (34 of 104) of MPM patients but in only 9.4 % (3 of 32) of NM patients (P = 0.011). The CTC count was significantly higher in MPM patients than in NM patients (P = 0.007), and a receiver operating characteristic (ROC) curve analysis showed an insufficient capability of the CTC test in discrimination between MPM and NM, with an area under ROC curve of 0.623 (95 % confidence interval, 0.523-0.723; P = 0.036). Among MPM patients, CTCs were more frequently detected in patients with epithelioid subtype (39.7 %, 31 of 78) than in those with nonepithelioid subtypes (11.5 %, 3 of 26; P = 0.016). Positive CTCs (CTC count >= 1) were a significant factor to predict a poor prognosis among epithelioid patients (median overall survival, 22.3 months for positive CTCs vs. 12.6 months for negative CTCs; P = 0.004) and not in nonepithelioid patients (P = 0.649). A multivariate analysis showed that positive CTCs were a significant and independent factor to predict a poor prognosis (hazard ratio, 2.904; 95 % confidence interval, 1.530-5.511; P = 0.001) for epithelioid MPM patients. Conclusions. CTC was a promising marker in diagnosis and prediction of prognosis in MPM, especially in epithelioid MPM.	[Yoneda, Kazue; Tanaka, Fumihiro; Kondo, Nobuyuki; Hashimoto, Masaki; Takuwa, Teruhisa; Matsumoto, Seiji; Okumura, Yoshitomo; Hasegawa, Seiki] Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo 6638501, Japan; [Yoneda, Kazue; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Dept Surg Chest Surg 2, Kitakyushu, Japan; [Okumura, Yoshitomo] Itami City Hosp, Dept Thorac Surg, Itami, Hyogo, Japan; [Tsubota, Noriaki] Hyogo Coll Med, Dept Thorac Oncol, Nishinomiya, Hyogo 6638501, Japan; [Sato, Ayuko; Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Fukuoka, Kazuya; Tabata, Chiharu; Nakano, Takashi] Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo 6638501, Japan; [Kuribayashi, Kozo] Asahi Univ, Murakami Mem Hosp, Dept Resp Med, Gifu, Japan	Tanaka, F (reprint author), Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo 6638501, Japan.	ftanaka@med.uoeh-u.ac.jp			Special Coordination Funds for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science (JSPS) [24390335]; University of Occupational and Educational Health, Japan [H24-1]	We thank Ms. Mayo Yamamoto for assistance in preparation of the manuscript. This study was supported by "The Special Coordination Funds for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science, and Technology,'' "Grants-in-Aid for Scientific Research (KAKENHI B 24390335) from the Japan Society for the Promotion of Science (JSPS),'' and "UOEH Grant for Advanced Research (H24-1) from University of Occupational and Educational Health, Japan.''	Cohen SJ, 2009, ANN ONCOL, V20, P1223, DOI 10.1093/annonc/mdn786; Lee AY, 2007, CANCER, V109, P1454, DOI 10.1002/cncr.22552; Cao CQ, 2010, J THORAC ONCOL, V5, P1692, DOI 10.1097/JTO.0b013e3181ed0489; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Ray M, 2009, CHEST, V136, P888, DOI 10.1378/chest.08-2665; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Sastre J, 2008, ANN ONCOL, V19, P935, DOI 10.1093/annonc/mdm583; HANLEY JA, 1982, RADIOLOGY, V143, P29; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Naoe M, 2007, CANCER, V109, P1439, DOI 10.1002/cncr.22543; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Hiraiwa K, 2008, ANN SURG ONCOL, V15, P3092, DOI 10.1245/s10434-008-0122-9; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Curran D, 1998, J CLIN ONCOL, V16, P145; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Fennell DA, 2005, J CLIN ONCOL, V23, P184, DOI 10.1200/JCO.2005.07.050; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; Rusch VW, 1996, LUNG CANCER, V14, P1; Scherpereel A, 2009, EUR RESPIR J, V35, P479, DOI [DOI 10.1183/09031936.00063109, 10.1183/09031936.00063109]; Sculier JP, 2010, AM J RESP CRIT CARE, V181, P773, DOI 10.1164/rccm.201001-0045UP; Stahel RA, 2000, ANN ONCOL, V21(, pv126; Tsiouris A, 2007, NAT CLIN PRACT ONCOL, V4, P344, DOI 10.1038/ncponc0839; van der Bij S, 2011, BRIT J CANCER, V104, P1325, DOI 10.1038/bjc.2011.104; Yoneda K, 2009, AM SOC CLIN ONC 45 A	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S472	S480		10.1245/s10434-013-3399-2		9	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300011		
J	Zhu, CZ; Utsunomiya, T; Ikemoto, T; Yamada, S; Morine, Y; Imura, S; Arakawa, Y; Takasu, C; Ishikawa, D; Imoto, I; Shimada, M				Zhu, Chengzhan; Utsunomiya, Tohru; Ikemoto, Tetsuya; Yamada, Shinichiro; Morine, Yuji; Imura, Satoru; Arakawa, Yusuke; Takasu, Chie; Ishikawa, Daichi; Imoto, Issei; Shimada, Mitsuo			Hypomethylation of Long Interspersed Nuclear Element-1 (LINE-1) is Associated with Poor Prognosis via Activation of c-MET in Hepatocellular Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							DNA DEMETHYLATION; CANCER; EXPRESSION; EPIGENETICS; IMPACT	Background. Long interspersed nuclear element-1 (LINE-1) methylation status, representing global DNA methylation levels, is associated with patient prognosis in several types of cancer. This study was designed to examine the prognostic significance of LINE-1 methylation in patients with hepatocellular carcinoma (HCC) and the possible mechanisms related to oncogene activation. Methods. Seventy-five HCC patients who underwent hepatectomy between 2006 and 2012 were enrolled in this study. Quantitative pyrosequencing was performed to quantify the methylation level of three CpG sites in the LINE-1 promoter. Clinicopathological variables and prognosis were compared between LINE-1 hypo-and hypermethylation groups. LINE-1-inserted c-MET (L1-MET) gene expression and its correlation with LINE-1 methylation levels also were analyzed. Results. LINE-1 was significantly hypomethylated in tumor tissues compared with nontumor tissues (48.3 +/- 12.2 % vs. 68.2 +/- 2.0 %, respectively, p < 0.0001). LINE-1 hypomethylation was not associated with any clinicopathological factors in HCC patients, except sex (p < 0.05). However, patients with LINE-1 hypomethylation exhibited significantly poorer outcome, and multivariate analysis revealed that LINE-1 hypomethylation was an independent risk factor for overall survival (hazard ratio (HR) = 6.1, p = 0.031) and disease-free survival (HR = 2.34, p = 0.045). L1-MET expression was significantly higher in tumor tissues (p < 0.01). L1-MET expression levels were inversely correlated with LINE-1 methylation levels, and positively correlated with c-MET expression (p < 0.05). Furthermore, higher c-MET protein expression was observed in the LINE-1 hypomethylated tumor tissues compared with hypermethylated tumor tissues (p = 0.032). Conclusions. LINE-1 hypomethylation is significantly associated with poor prognosis in patients with HCC, possibly due to activation of c-MET expression.	[Zhu, Chengzhan; Utsunomiya, Tohru; Ikemoto, Tetsuya; Yamada, Shinichiro; Morine, Yuji; Imura, Satoru; Arakawa, Yusuke; Takasu, Chie; Ishikawa, Daichi; Shimada, Mitsuo] Univ Tokushima, Dept Surg, Tokushima 770, Japan; [Imoto, Issei] Univ Tokushima, Dept Human Genet, Tokushima 770, Japan	Zhu, CZ (reprint author), Univ Tokushima, Dept Surg, Tokushima 770, Japan.	mitsuo.shimada@tokushima-u.ac.jp					Weisenberger DJ, 2014, J CLIN INVEST, V124, P17, DOI 10.1172/JCI69740; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Weber B, 2010, ONCOGENE, V29, P5775, DOI 10.1038/onc.2010.227; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Kondo S, 2013, INT J CLIN ONCOL, V18, P207, DOI 10.1007/s10147-011-0361-9; Iwahashi S, 2013, SURG TODAY, V43, P654, DOI 10.1007/s00595-012-0437-9; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Shigaki H, 2013, GASTRIC CANCER, V16, P480, DOI 10.1007/s10120-012-0209-7; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Benard A, 2013, BRIT J CANCER, V109, P3073, DOI 10.1038/bjc.2013.654; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Gao XD, 2014, LIVER INT, V34, P136, DOI 10.1111/liv.12264; Feng F, 2013, WORLD J GASTROENTERO, V19, P1068, DOI 10.3748/wjg.v19.i7.1068; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Carreira PE, 2013, FEBS J, V281, P63; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; Sigalotti L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-78; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917	25	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21			4			S729	S735		10.1245/s10434-014-3874-4		7	Oncology; Surgery	Oncology; Surgery	AU0NP	WOS:000345320300042		
J	Ishii, S; Kitamura, G; Segawa, T; Kobayashi, A; Miura, T; Sano, D; Okabe, S				Ishii, Satoshi; Kitamura, Gaku; Segawa, Takahiro; Kobayashi, Ayano; Miura, Takayuki; Sano, Daisuke; Okabe, Satoshi			Microfluidic Quantitative PCR for Simultaneous Quantification of Multiple Viruses in Environmental Water Samples	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; HEPATITIS-A VIRUS; ENTERIC VIRUSES; RT-PCR; HUMAN ADENOVIRUSES; DRINKING-WATER; PATHOGENS; NOROVIRUS; ASSAY	To secure food and water safety, quantitative information on multiple pathogens is important. In this study, we developed a microfluidic quantitative PCR (MFQPCR) system to simultaneously quantify 11 major human viral pathogens, including adenovirus, Aichi virus, astrovirus, enterovirus, human norovirus, rotavirus, sapovirus, and hepatitis A and E viruses. Murine norovirus and mengovirus were also quantified in our MFQPCR system as a sample processing control and an internal amplification control, respectively. River water contaminated with effluents from a wastewater treatment plant in Sapporo, Japan, was collected and used to validate our MFQPCR system for multiple viruses. High-throughput quantitative information was obtained with a quantification limit of 2 copies/mu l of cDNA/DNA. Using this MFQPCR system, we could simultaneously quantify multiple viral pathogens in environmental water samples. The viral quantities obtained using MFQPCR were similar to those determined by conventional quantitative PCR. Thus, the MFQPCR system developed in this study can provide direct and quantitative information for viral pathogens, which is essential for risk assessments.	[Ishii, Satoshi; Kitamura, Gaku; Kobayashi, Ayano; Miura, Takayuki; Sano, Daisuke; Okabe, Satoshi] Hokkaido Univ, Fac Engn, Div Environm Engn, Sapporo, Hokkaido 060, Japan; [Segawa, Takahiro] Natl Inst Polar Res, Tokyo, Japan; [Segawa, Takahiro] Transdisciplinary Res Integrat Ctr, Tokyo, Japan	Ishii, S (reprint author), Hokkaido Univ, Fac Engn, Div Environm Engn, North 13,West 8, Sapporo, Hokkaido 060, Japan.	s.ishii@eng.hokudai.ac.jp	Sano, Daisuke/E-5819-2011; Okabe, Satoshi/C-7014-2012; Ishii, Satoshi/C-7000-2012; Miura, Takayuki/H-2013-2013	Sano, Daisuke/0000-0001-8075-6972; Ishii, Satoshi/0000-0003-3600-9165; 	CREST program from the Japan Science and Technology Agency; River Foundation, Japan	This work was supported in part by the CREST program from the Japan Science and Technology Agency and by River Foundation, Japan.	Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Aw TG, 2012, CURR OPIN BIOTECH, V23, P422, DOI 10.1016/j.copbio.2011.11.016; Ishii S, 2014, ENVIRON SCI TECHNOL, V48, P4744, DOI 10.1021/es500578s; Stedtfeld RD, 2008, APPL ENVIRON MICROB, V74, P3831, DOI 10.1128/AEM.02743-07; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Bofill-Mas S, 2006, APPL ENVIRON MICROB, V72, P7894, DOI 10.1128/AEM.00965-06; Pinto RM, 2009, APPL ENVIRON MICROB, V75, P7350, DOI 10.1128/AEM.01177-09; Maunula L, 2005, EMERG INFECT DIS, V11, P1716; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Ishii S, 2013, APPL ENVIRON MICROB, V79, P2891, DOI 10.1128/AEM.00205-13; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Hewitt J, 2007, APPL ENVIRON MICROB, V73, P7853, DOI 10.1128/AEM.00718-07; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; Hamza IA, 2011, INT J HYG ENVIR HEAL, V214, P424, DOI 10.1016/j.ijheh.2011.07.014; Kitajima M, 2013, APPL ENVIRON MICROB, V79, P3952, DOI 10.1128/AEM.00820-13; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Bosch A, 2011, FOOD ANAL METHOD, V4, P4, DOI 10.1007/s12161-010-9161-5; Miura T, 2013, APPL ENVIRON MICROB, V79, P6585, DOI 10.1128/AEM.02112-13; Kukkula M, 1999, J INFECT DIS, V180, P1771, DOI 10.1086/315145; Perez-Sautu U, 2012, ENVIRON MICROBIOL, V14, P494, DOI 10.1111/j.1462-2920.2011.02642.x; Katayama H, 2008, WATER RES, V42, P1441, DOI 10.1016/j.watres.2007.10.029; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Pang XLL, 2004, J MED VIROL, V72, P496, DOI 10.1002/jmv.20009; Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05; Liu J, 2011, J CLIN VIROL, V50, P308, DOI 10.1016/j.jcv.2010.12.009; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Gray J, 2014, EPIDEMIOL INFECT, V142, P1, DOI 10.1017/S0950268813002367; Kitajima M, 2010, J VIROL METHODS, V169, P269, DOI 10.1016/j.jviromet.2010.07.018; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Parshionikar S, 2010, APPL ENVIRON MICROB, V76, P4318, DOI 10.1128/AEM.02800-09; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; De Spiegelaere W, 2013, ANAL BIOCHEM, V439, P201, DOI 10.1016/j.ab.2013.04.024; Devonshire AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-118; Eastburn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062961; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Hass CN, 1999, QUANTITATIVE MICROBI; Hata A, 2011, APPL ENVIRON MICROB, V77, P4336, DOI 10.1128/AEM.00077-11; HEJKAL TW, 1984, APPL ENVIRON MICROB, V47, P588; Kang LH, 2013, J MICROBIOL, V51, P671, DOI 10.1007/s12275-013-3199-1; Kitajima M, 2009, T ROY SOC TROP MED H, V103, P955, DOI 10.1016/j.trstmh.2009.04.004; Kobayashi A, 2013, APPL MICROBIOL BIOT, V97, P9165, DOI 10.1007/s00253-013-5188-z; Molenkamp R, 2007, J VIROL METHODS, V141, P205, DOI 10.1016/j.jviromet.2006.12.007; Myint KSA, 2008, T ROY SOC TROP MED H, V102, P211, DOI 10.1016/j.trstmh.2007.03.014; Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tojo K, 2013, WATER SCI TECHNOL, V67, P2236, DOI 10.2166/wst.2013.114; U.S. EPA, 2010, EPA600R10181; van Doorn R, 2009, APPL ENVIRON MICROB, V75, P7253, DOI 10.1128/AEM.00796-09	52	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	DEC	2014	80	24					7505	7511		10.1128/AEM.02578-14		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AT9BS	WOS:000345223500006		
J	Tanaka, T; Kawasaki, K; Daimon, S; Kitagawa, W; Yamamoto, K; Tamaki, H; Tanaka, M; Nakatsu, CH; Kamagata, Y				Tanaka, Tomohiro; Kawasaki, Kosei; Daimon, Serina; Kitagawa, Wataru; Yamamoto, Kyosuke; Tamaki, Hideyuki; Tanaka, Michiko; Nakatsu, Cindy H.; Kamagata, Yoichi			A Hidden Pitfall in the Preparation of Agar Media Undermines Microorganism Cultivability	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							RIBOSOMAL-RNA SEQUENCES; SODIUM PYRUVATE; SOIL BACTERIA; PURE CULTURE; SOLID MEDIUM; CATALASE; COMMUNITY; RECOVERY; GROWTH; RESUSCITATION	Microbiologists have been using agar growth medium for over 120 years. It revolutionized microbiology in the 1890s when microbiologists were seeking effective methods to isolate microorganisms, which led to the successful cultivation of microorganisms as single clones. But there has been a disparity between total cell counts and cultivable cell counts on plates, often referred to as the "great plate count anomaly," that has long been a phenomenon that still remains unsolved. Here, we report that a common practice microbiologists have employed to prepare agar medium has a hidden pitfall: when phosphate was autoclaved together with agar to prepare solid growth media (PT medium), total colony counts were remarkably lower than those grown on agar plates in which phosphate and agar were separately autoclaved and mixed right before solidification (PS medium). We used a pure culture of Gemmatimonas aurantiaca T-27(T) and three representative sources of environmental samples, soil, sediment, and water, as inocula and compared colony counts between PT and PS agar plates. There were higher numbers of CFU on PS medium than on PT medium using G. aurantiaca or any of the environmental samples. Chemical analysis of PT agar plates suggested that hydrogen peroxide was contributing to growth inhibition. Comparison of 454 pyrosequences of the environmental samples to the isolates revealed that taxa grown on PS medium were more reflective of the original community structure than those grown on PT medium. Moreover, more hitherto-uncultivated microbes grew on PS than on PT medium.	[Tanaka, Tomohiro; Daimon, Serina; Kitagawa, Wataru; Tanaka, Michiko; Nakatsu, Cindy H.; Kamagata, Yoichi] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Kawasaki, Kosei; Kitagawa, Wataru; Kamagata, Yoichi] Natl Inst Adv & Ind Sci Technol AIST, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Yamamoto, Kyosuke; Tamaki, Hideyuki; Kamagata, Yoichi] Natl Inst Adv & Ind Sci & Technol AIST, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Nakatsu, Cindy H.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Kamagata, Y (reprint author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	y.kamagata@aist.go.jp			Institute of Fermentation, Osaka, Japan	This research was supported by the Institute of Fermentation, Osaka, Japan.	Alvarez B, 2007, LETT APPL MICROBIOL, V44, P569, DOI 10.1111/j.1472-765X.2007.02126.x; ANDREWS GP, 1979, APPL ENVIRON MICROB, V38, P390; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Tamaki H, 2009, ENVIRON MICROBIOL, V11, P1827, DOI 10.1111/j.1462-2920.2009.01907.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; EINARSSON H, 1983, J AGR FOOD CHEM, V31, P1043, DOI 10.1021/jf00119a031; DAHLQUIST RL, 1978, APPL SPECTROSC, V32, P1, DOI 10.1366/000370278774331828; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Heuer H, 1999, APPL ENVIRON MICROB, V65, P1045; Puspita ID, 2012, MICROBES ENVIRON, V27, P356, DOI 10.1264/jsme2.ME12092; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Nichols D, 2008, APPL ENVIRON MICROB, V74, P4889, DOI 10.1128/AEM.00393-08; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Nakashima T, 2010, J BIOSCI BIOENG, V110, P304, DOI 10.1016/j.jbiosc.2010.03.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; MARTHI B, 1991, APPL ENVIRON MICROB, V57, P2775; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; ARUOMA OI, 1987, BIOCHEM J, V248, P973; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; CALABRESE JP, 1990, APPL ENVIRON MICROB, V56, P3558; Ferrari BC, 2008, NAT PROTOC, V3, P1261, DOI 10.1038/nprot.2008.102; FINKELSTEIN RA, 1957, APPL MICROBIOL, V5, P74; FUHRMAN JA, 1988, APPL ENVIRON MICROB, V54, P1426; Hara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041142; Imazaki I, 2010, CAN J MICROBIOL, V56, P333, DOI [10.1139/w10-019, 10.1139/W10-019]; Kamagata Y, 1997, APPL ENVIRON MICROB, V63, P2266; MARTIN SE, 1976, APPL ENVIRON MICROB, V32, P731; PALMER FE, 1976, APPL ENVIRON MICROB, V31, P1003; RAMSEY HH, 1956, J BACTERIOL, V72, P511	47	5	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	DEC	2014	80	24					7659	7666		10.1128/AEM.02741-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AT9BS	WOS:000345223500023		
J	Hata, E; Suzuki, K; Hanyu, H; Itoh, M; Higuchi, H; Kobayashi, H				Hata, Eiji; Suzuki, Kan-ichiro; Hanyu, Hideki; Itoh, Megumi; Higuchi, Hidetoshi; Kobayashi, Hideki			Molecular Epidemiology of Cases of Mycoplasma californicum Infection in Japan	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; MYCOIDES SUBSPECIES MYCOIDES; TANDEM-REPEAT ANALYSIS; MASTITIS; STRAINS; BOVIS; IDENTIFICATION; LOCUS; INHIBITION	Bovine mastitis due to Mycoplasma californicum is often accompanied by huge economic losses, and the disease spreads very quickly. An appropriate molecular epidemiological analysis is needed to prevent and control infectious disease, but molecular epidemiological analysis methods for M. californicum have not yet been reported. Here we developed a combination of multiplelocus variable-number tandem repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE) methods, which are common genotyping methods for various bacteria, for M. californicum. The MLVA is based on four interspersed repeat units that were found in the M. californicum genome data. The MLVA using these repeat units showed sufficient discriminatory power for a molecular epidemiological analysis; i.e., a Hunter-Gaston diversity index (HGDI) of 0.949, against M. californicum strains in Japan and M. californicum strain ATCC 33461. The PFGE for M. californicum also showed sufficient discriminatory power, with an HGDI of 0.985. Strain ATCC 33461 showed MLVA profiles and pulsotypes that differed greatly from those of strains from Japan. These results indicate that MLVA and PFGE are good tools for identifying M. californicum transmission events more accurately. Our combined MLVA and PFGE analysis suggests the persistence of M. californicum infection among herds in a specific area for a long period of time, as well as the movement of cows and heifers accompanying the expansion of M. californicum infection. Failure to identify asymptomatic infected cows is suspected as one of the central causes of the present M. californicum infection scenario in Japan.	[Hata, Eiji; Suzuki, Kan-ichiro; Hanyu, Hideki] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Dairy Hyg Res Div, Sapporo, Hokkaido, Japan; [Suzuki, Kan-ichiro] Livestock Hyg Serv Ctr, Yoshinogawa, Tokushima, Japan; [Hanyu, Hideki] Abashiri Livestock Hyg Serv Ctr, Kitami, Hokkaido, Japan; [Itoh, Megumi] Hokkaido Res Org, Agr Res Dept, Anim Res Ctr, Shintoku, Hokkaido, Japan; [Higuchi, Hidetoshi] Rakuno Gakuen Univ, Sch Vet Med, Ebetsu, Hokkaido 069, Japan; [Kobayashi, Hideki] NARO, NIAH, Ctr Anim Dis Control & Prevent, Tsukuba, Ibaraki, Japan	Hata, E (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Dairy Hyg Res Div, Sapporo, Hokkaido, Japan.	ehata@affrc.go.jp			National Agriculture and Food Research Organization (NARO) of Japan	This work was supported in part by grants from the National Agriculture and Food Research Organization (NARO) of Japan.	JASPER DE, 1982, J AM VET MED ASSOC, V181, P158; Manso-Silvan L, 2012, VET MICROBIOL, V161, P104, DOI 10.1016/j.vetmic.2012.07.015; Pinho L, 2012, J MICROBIOL METH, V88, P377, DOI 10.1016/j.mimet.2012.01.003; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; McAuliffe L, 2007, FEMS MICROBIOL LETT, V276, P181, DOI 10.1111/j.1574-6968.2007.00936.x; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nadon CA, 2013, EUROSURVEILLANCE, V18, P10, DOI 10.2807/1560-7917.ES2013.18.35.20565; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; MACKIE DP, 1986, VET REC, V119, P350; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; JASPER DE, 1977, J AM VET MED ASSOC, V170, P1167; BALL HJ, 1989, VET REC, V125, P377; Bashiruddin JB, 1998, METH MOL B, V104, P167; CLYDE WA, 1964, J IMMUNOL, V92, P958; Eguchi M, 1994, J VET CLIN, V373, P3; Fischer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036150; Freundt EA, 1983, METHODS MYCOPLASMOLO, V1, P127; Hardy KJ, 2006, J CLIN MICROBIOL, V44, P271, DOI 10.1128/JCM.44.1.271-273.2006; Hata E, 2014, GENOME ANNOUNC, V2; Hewicker-Trautwein M, 2002, VET REC, V151, P699; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465; Kusiluka LJM, 2001, VET MICROBIOL, V82, P27, DOI 10.1016/S0378-1135(01)00352-2; McAuliffe L, 2004, J CLIN MICROBIOL, V42, P4556, DOI 10.1128/JCM.42.10.4556-4565.2004; MCNULTY M S, 1975, Journal of General Virology, V27, P399, DOI 10.1099/0022-1317-27-3-399; Mork T, 2005, J CLIN MICROBIOL, V43, P3979, DOI 10.1128/JCM.43.8.3979-3984.2005; Pettersson B, 1996, INT J SYST BACTERIOL, V46, P1093; Punyapornwithaya V, 2010, PREV VET MED, V93, P66, DOI 10.1016/j.prevetmed.2009.08.008; SENTERFI.LB, 1966, P SOC EXP BIOL MED, V122, P786; Senterfit LB, 1983, METHODS MYCOPLASMOLO, V1, P401; Shen XJ, 2000, J BACTERIOL, V182, P2900, DOI 10.1128/JB.182.10.2900-2908.2000; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118	34	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	DEC	2014	80	24					7717	7724		10.1128/AEM.02488-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AT9BS	WOS:000345223500030		
J	Kugimiya, A; Matsuzaki, E				Kugimiya, Akimitsu; Matsuzaki, Emi			Microfluidic Analysis of Serine Levels Using Seryl-tRNA Synthetase Coupled with Spectrophotometric Detection	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						Amino acid; Aminoacyl-tRNA synthetase; Biosensing; Enzyme reaction; Microfluidic analysis; Serine	AMINO-ACIDS; HISTIDINE	The measurement of amino acid content is useful for the diagnosis of several types of diseases, including cancer and diabetes. In this study, a microfluidic method for the analysis of serine using enzymatic reactions coupled with spectrophotometric detection was developed. The assay system has some advantages in the analytical field, such as the ability to detect small amounts of analyte and reaction solution and a rapid and efficient reaction. For the specific detection of serine, seryl-tRNA synthetase was coupled with the generation of hydrogen peroxide, which was then detected by the Trinder reagent spectrophotometric method. Seryl-and other aminoacyl-tRNA synthetases are involved in the biosynthesis of peptides and proteins in the human body and should allow precise recognition of the corresponding amino acids. This approach provided selective quantitation of up to 250 mu M serine in 100 mM Tris-HCl buffer (pH 8.0) in a semiautomatic system.	[Kugimiya, Akimitsu; Matsuzaki, Emi] Hiroshima City Univ, Ctr Ind & Publ Relat, Naka Ku, Hiroshima 7300052, Japan	Kugimiya, A (reprint author), Hiroshima City Univ, Ctr Ind & Publ Relat, Naka Ku, 3-8-24 Senda Machi, Hiroshima 7300052, Japan.	kugimiya@hiroshima-cu.ac.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN).	Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Shimbo K, 2009, ANAL CHEM, V81, P5172, DOI 10.1021/ac900470w; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Sekine SI, 2006, STRUCTURE, V14, P1791, DOI 10.1016/j.str.2006.10.005; Yang JH, 2010, J BIOL CHEM, V285, P41380, DOI 10.1074/jbc.M110.187443; Huang CC, 2009, ANALYST, V134, P1699, DOI 10.1039/b900028c; Chandler DP, 2003, ANAL BIOCHEM, V312, P182, DOI 10.1016/S0003-2697(02)00445-1; Itoh Y, 2008, RNA BIOL, V5, P169; Kugimiya A, 2013, MAT SCI ENG C-MATER, V33, P4867, DOI 10.1016/j.msec.2013.08.004; Kugimiya A., 2012, J CHEM CHEM ENG, V6, P397; Kugimiya A, 2008, ANAL BIOCHEM, V378, P90, DOI 10.1016/j.ab.2008.03.037; Kugimiya A, 2013, ANAL BIOCHEM, V443, P22, DOI 10.1016/j.ab.2013.08.012; Miyagi Y., 2011, PLOS ONE, V6, P1; Nikolaev AV, 2013, J ANAL CHEM+, V68, P1093, DOI 10.1134/S1061934813120083; Niwa O, 1996, ANAL CHEM, V68, P1865, DOI 10.1021/ac951154d; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Ohtsuki T, 2001, J BIOL CHEM, V276, P21571, DOI 10.1074/jbc.M011118200; Surtees R., 2003, BIOCHEM J, V371, P653; Yu LF, 2012, APPL BIOCHEM BIOTECH, V166, P786, DOI 10.1007/s12010-011-9467-9; Zimina TM, 2011, J ANAL CHEM+, V66, P1136, DOI 10.1134/S1061934811100236	20	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	DEC	2014	174	7					2527	2536		10.1007/s12010-014-1202-x		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AU0RG	WOS:000345331100016		
J	Liao, X; Chigira, M; Matsushi, Y; Wu, XY				Liao, Xin; Chigira, Masahiro; Matsushi, Yuki; Wu, Xiyong			Investigation of water-rock interactions in Cambrian black shale via a flow-through experiment	APPLIED GEOCHEMISTRY			English	Article							CARBONATE-BUFFERED SOLUTION; AQUEOUS PYRITE OXIDATION; DISSOLUTION KINETICS; DISSOLVED-OXYGEN; IRON; PH; TEMPERATURE; DIAGENESIS; MINERALS; SULFATE	This paper summarizes the results of a flow-through experiment of our own design intended to investigate the water-rock interactions between pyrite embedded in black shale and dissolved oxygen in pore water. Deionized water in equilibrium with 3 atm of P-N2 or P-O2 was flowed through a cylindrical rock specimen at 25 degrees C. The electrical conductivity (EC) and pH values of the experimental outflow solutions were continuously monitored. First, original pore water was expelled by N-2-saturated water followed by O-2-saturated water. Concentrations of major ion species were determined for solutions periodically withdrawn from the experimental system. The changes in these components over time indicated that 1. The chemical composition of the original pore water in the black shale was rich in hydrogen ions, sulfate ions and iron species and that 2. Two major reactions, namely, ion exchange and pyrite oxidation, occurred during the water flow. The oxidation of pyrite in black shale was controlled by the concentration of dissolved oxygen as FeS2 + 7/2O2(aq) + H2O -> Fe2+ + 2SO(4)(2) + 2H(+) where the rate law for the reaction at pH = 4.2-5.6 and T = 25 degrees C was determined to be R-sp = 10 (8.42 +/- 0.06) [O-2](0.5) (mol m (2) s (1)). This result is consistent with the reaction rate of pyrite grains with dissolved oxygen reported by previous researchers. Hydraulic conductivity decreased by approximately 12.5% during the nitrogen-inflow stage and by 69% during the oxygen-inflow stage. This change can be attributed to the oxidizing reaction within the rock and to the probable clogging of fine weathering products in the pore space. The geochemical modeling of the experimental outflowing water and seepage samples from the field using the PHREEQC program suggested that pore water develops into an acidic solution rich in iron and sulfate due to long-term pyrite oxidation and evaporation. (C) 2014 Elsevier Ltd. All rights reserved.	[Liao, Xin; Wu, Xiyong] Southwest Jiaotong Univ, Dept Geol Engn, Chengdu 611756, Peoples R China; [Liao, Xin; Chigira, Masahiro; Matsushi, Yuki] Kyoto Univ, Disaster Prevent Res Inst, Uji 6110011, Japan; [Wu, Xiyong] Southwest Jiaotong Univ, MOE Key Lab High Speed Railway Engn, Chengdu 611756, Peoples R China	Wu, XY (reprint author), Southwest Jiaotong Univ, Dept Geol Engn, Chengdu 611756, Peoples R China.	wuxiyong@126.com			National Natural Science Foundation of China [41172261, 51348003]; Key Technology Research and Development Program of Sichuan Province [2012SZ0051]; Fundamental Research Funds for the Central Universities [2682014BR013]; People's Republic of China; Disaster Prevention Research Institute, Kyoto University, Japan	We would like to thank Eiji Nakata (Central Research Institute of Electric Power Industry), Tomomi Terajima (Disaster Prevention Research Institute, Kyoto University), Toru Inui (School of Global Environmental Study, Kyoto University), and Takao Hirajima (Geology Department, Kyoto University) for their assistance in the chemical or petrological analysis. We would also like to express our gratitude for the cooperation of Kohei Higuchi, Maho Nakano, and Angelica Naka (Kyoto University) and for the assistance provided by Siyuan Zhao (Southwest Jiaotong University) in the numerical simulation analysis. This research was supported by the National Natural Science Foundation of China (Project Nos. 41172261 and 51348003), the Key Technology Research and Development Program of Sichuan Province (Project No. 2012SZ0051), the Fundamental Research Funds for the Central Universities (Project No. 2682014BR013), the People's Republic of China, and the Disaster Prevention Research Institute, Kyoto University, Japan. The paper has benefited considerably from constructive criticism of the editor and referees.	Aharonov E, 1998, J GEOPHYS RES-SOL EA, V103, P23969, DOI 10.1029/98JB02230; Alpers CN, 1999, REV EC GEOLOGY A, V6A, P289; MOSES CO, 1991, GEOCHIM COSMOCHIM AC, V55, P471, DOI 10.1016/0016-7037(91)90005-P; STEEFEL CI, 1990, GEOCHIM COSMOCHIM AC, V54, P2657, DOI 10.1016/0016-7037(90)90003-4; CHIGIRA M, 1990, ENG GEOL, V29, P119, DOI 10.1016/0013-7952(90)90002-I; MCKIBBEN MA, 1986, GEOCHIM COSMOCHIM AC, V50, P1509, DOI 10.1016/0016-7037(86)90325-X; Black JR, 2014, GEOCHIM COSMOCHIM AC, V125, P225, DOI 10.1016/j.gca.2013.10.021; Nordstrom DK, 1999, P NATL ACAD SCI USA, V96, P3455, DOI 10.1073/pnas.96.7.3455; HELGESON HC, 1969, GEOCHIM COSMOCHIM AC, V33, P455, DOI 10.1016/0016-7037(69)90127-6; Rimstidt JD, 2003, GEOCHIM COSMOCHIM AC, V67, P873, DOI 10.1016/S0016-7037(02)01165-1; Jambor JI, 2000, REV MINERAL GEOCHEM, V40, P303, DOI 10.2138/rmg.2000.40.6; BOWKER KA, 1991, AAPG BULL, V75, P1489; Parker VB, 1995, J PHYS CHEM REF DATA, V24, P1699; Tromans D, 1998, HYDROMETALLURGY, V48, P327, DOI 10.1016/S0304-386X(98)00007-3; Holmes PR, 2000, GEOCHIM COSMOCHIM AC, V64, P263, DOI 10.1016/S0016-7037(99)00296-3; SCHOLZ CH, 1995, GEOPHYS RES LETT, V22, P719, DOI 10.1029/94GL00163; Cama J, 2000, GEOCHIM COSMOCHIM AC, V64, P2701, DOI 10.1016/S0016-7037(00)00378-1; Hammarstrom JM, 2005, CHEM GEOL, V215, P407, DOI 10.1016/j.chemgeo.2004.06.053; Chou IM, 2013, J ASIAN EARTH SCI, V62, P734, DOI 10.1016/j.jseaes.2012.11.027; Chandra AP, 2010, SURF SCI REP, V65, P293, DOI 10.1016/j.surfrep.2010.08.003; Majzlan J, 2004, GEOCHIM COSMOCHIM AC, V68, P1049, DOI 10.1016/S0016-7037(03)00371-5; NICHOLSON RV, 1988, GEOCHIM COSMOCHIM AC, V52, P1077, DOI 10.1016/0016-7037(88)90262-1; Tenthorey E, 1998, J GEOPHYS RES-SOL EA, V103, P23951, DOI 10.1029/98JB02229; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; Bernabe Y, 2003, PURE APPL GEOPHYS, V160, P937, DOI 10.1007/PL00012574; Ball J. W., 1991, USGS OPEN FILE REPOR, V90, P129; Brantley S., 2008, KINETICS WATER ROCK, P151, DOI DOI 10.1007/978-0-387-73563-4; Bureau of Geology and Mineral Resources of Guangxi Zhuang Autonomous Region, 1985, REG GEOL GUANGX ZHUA; CHIGIRA M, 1994, J GEOPHYS RES-SOL EA, V99, P15539, DOI 10.1029/94JB01175; Chigira M, 1999, ENG GEOL, V55, P3; Chou IM, 2002, AM MINERAL, V87, P108; Drever D.I., 1997, GEOCHEMISTRY NATURAL; Farkas IM, 2009, CAN MINERAL, V47, P509, DOI 10.3749/canmin.47.3.509; Fischer C, 2005, GEOCHIM COSMOCHIM AC, V69, P1213, DOI 10.1016/j.gca.2004.09.021; Gurel A, 2006, ENVIRON GEOL, V51, P333, DOI 10.1007/s00254-006-0329-7; Hemingway B.S., 2002, 02161 US GEOL SURV O, P1; Jambor J.L., 1963, CAN MINERAL, V7, P751; Kamei G, 2000, GEOCHIM COSMOCHIM AC, V64, P2585, DOI 10.1016/S0016-7037(00)00384-7; Kohler SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P3583, DOI 10.1016/S0016-7037(03)00163-7; Lasaga C.A., 1984, J GEOPHYS RES, V89, P4009; Manaka M., 1998, THESIS TOHOKU U; Manaka M, 2003, NUCL TECHNOL, V143, P335; Mason B.H., 1982, PRINCIPLES GEOCHEMIS; MATHEWS RC, 1982, J ENVIRON QUAL, V11, P102; Nakata E., 2009, JPN MAG MINERAL PETR, V38, P161; Parkhurst D.L., 1995, USGS WATER RESOURCES, V95, P4227; PYE K, 1990, Q J ENG GEOL, V23, P365, DOI 10.1144/GSL.QJEG.1990.023.04.11; Reuss J.O., 1986, ECOLOGICAL STUDIES; Sayegh S.G., 1990, SPE FORMATION EVAL, V5, P399, DOI DOI 10.2118/19392-PA; Smith E.E., 1970, SULFIDE SULFATE REAC; VEAR A, 1981, EARTH SURF PROC LAND, V6, P191, DOI 10.1002/esp.3290060214; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0; Xu M, 2013, ENVIRON SCI TECHNOL, V47, P110, DOI 10.1021/es301284h; Zheng GD, 2001, APPL GEOCHEM, V16, P1201	55	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0883-2927			APPL GEOCHEM	Appl. Geochem.	DEC	2014	51						65	78		10.1016/j.apgeochem.2014.09.012		14	Geochemistry & Geophysics	Geochemistry & Geophysics	AU1UL	WOS:000345405400007		
J	Kuwahara, Y; Makio, M				Kuwahara, Yoshihiro; Makio, Masato			In situ AFM study on barite (001) surface dissolution in NaCl solutions at 30 degrees C	APPLIED GEOCHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; KINETICS; GROWTH; WATER; PRECIPITATION; SOLUBILITIES; SULFATES; IONS; DTPA	This paper reports in situ observations on barite (001) surface dissolution behavior in 0.1-0.001 M NaCl solutions at 30 degrees C using atomic force microscopy (AFM). The step retreating on barite (001) surfaces changed with increasing NaCl solution concentrations. In solutions with a higher NaCl concentration (>= 0.01 M), many steps showed curved or irregular fronts during the later experimental stage, while almost all steps in solutions with a lower NaCl concentration exhibited straight or angular fronts, even during the late stage. The splitting phenomenon of the initial < hk0 > one-layer steps (7.2 angstrom) into two half-layer steps (3.6 angstrom) occurred in all NaCl solutions, while that of the initial [010] one-layer steps observed only in the 0.1 M NaCl solution. The step retreat rates increased with an increasing NaCl solution concentration. We observed triangular etch pit and deep etch pit formation in all NaCl solutions, which tended to form late in solutions with lower NaCl concentrations. The deep etch pit morphology changed with increasing NaCl solution concentrations. A hexagonal form elongated in the [010] direction was bounded by the {100}, {310}, and (001) faces in a 0.001 M NaCl solution, and a rhombic form was bounded by the {510} and (001) faces in 0.01 M and 0.1 M NaCl solutions. An intermediate form was observed in a 0.005 M NaCl solution, which was defined by {100}, a curved face tangent to the [010] direction, {310}, and (001) faces: the intermediate form appeared between the hexagonal and rhombic forms in solutions with lower and higher NaCl concentrations, respectively. The triangular etch pit and deep etch pit growth rates also increased with the NaCl solution concentration. Combining the step and face retreat rates in NaCl solutions estimated in this AFM study as well as the data on the effect of water temperature on the retreat rates reported in our earlier study, we produced two new findings. One finding is that the retreat rates increase by approximately two-fold when the NaCl solution concentration increases by one order of magnitude, and the other finding is that the retreat rate increase due to a one order of magnitude increase in the NaCl concentration corresponds to an increase of approximately 8 degrees C in water temperature. This correlation may help to understand and evaluate increasing dissolution kinetics induced by the different mechanisms where barite dissolution is promoted by the catalytic effect of Na+ and Cl ions (through an increase in the NaCl solution concentration) or by an increase in the hydration of Ba2+ and SO42 (through an increase in water temperature). (C) 2014 Elsevier Ltd. All rights reserved.	[Kuwahara, Yoshihiro] Kyushu Univ, Fac Social & Cultural Studies, Dept Environm Changes, Motooka, Fukuoka 8190395, Japan; [Makio, Masato] Kyushu Univ, Grad Sch Social & Cultural Studies, Dept Evolut Earth Environm, Motooka, Fukuoka 8190395, Japan	Kuwahara, Y (reprint author), Kyushu Univ, Fac Social & Cultural Studies, Dept Environm Changes, Motooka, Fukuoka 8190395, Japan.	ykuwa@scs.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23340163, 26400518]	The authors thank Drs. K. Ishida, S. Uehara, Y. Nakamuta, and I. Kita of Kyushu University for their helpful suggestions. We also thank the two anonymous reviewers and the executive editor M. Kersten for their thorough reviews that improved the quality of the study. This study was supported in part by the Grant-in-Aid for Scientific Research (Y. Kuwahara, Nos. 23340163 and 26400518) from the Japan Society for the Promotion of Science.	Bosbach D, 2000, AM MINERAL, V85, P1209; Kinoshita M, 2005, B CHEM SOC JPN, V78, P1431, DOI 10.1246/bcsj.78.1431; Hanor JS, 2000, REV MINERAL GEOCHEM, V40, P193, DOI 10.2138/rmg.2000.40.4; Kuwahara Y, 2006, AM MINERAL, V91, P1142, DOI 10.2138/am.2006.2078; Barret S., 1997, SCI DATA MANAGEMENT, V1, P18; Becker U, 2002, MOL SIMULAT, V28, P607, DOI 10.1080/08927020290030161; Becker U, 2005, AM J SCI, V305, P791, DOI 10.2475/ajs.305.6-8.791; BLOUNT CW, 1977, AM MINERAL, V62, P942; Bosbach D, 1998, CHEM GEOL, V151, P143, DOI 10.1016/S0009-2541(98)00076-X; CHRISTY AG, 1993, GEOCHIM COSMOCHIM AC, V57, P2161, DOI 10.1016/0016-7037(93)90557-D; Culti E., 2010, GEOCHIM COSMOCHIM AC, V74, P3553; DOVE PM, 1995, GEOCHIM COSMOCHIM AC, V59, P1907, DOI 10.1016/0016-7037(95)00116-6; Gaines R.V., 1997, DANAS NEW MINERALOGY; Higgins SR, 1998, LANGMUIR, V14, P4967, DOI 10.1021/la9806606; Klein C, 2002, 22 EDITION MANUAL MI; Kowacz M, 2008, GEOCHIM COSMOCHIM AC, V72, P4476, DOI 10.1016/j.gca.2008.07.005; Kuwahara Y, 2011, GEOCHIM COSMOCHIM AC, V75, P41, DOI 10.1016/j.gca.2010.10.003; Kuwahara Y, 2008, AM MINERAL, V93, P1209; Kuwahara Y, 2012, AM MINERAL, V97, P1564, DOI 10.2138/am.2012.4130; Paige CR, 1998, GEOCHIM COSMOCHIM AC, V62, P15, DOI 10.1016/S0016-7037(97)00320-7; Piana S, 2006, J AM CHEM SOC, V128, P13568, DOI 10.1021/ja064706q; PUTNIS A, 1995, GEOCHIM COSMOCHIM AC, V59, P4623, DOI 10.1016/0016-7037(95)00324-X; Putnis CV, 2008, APPL GEOCHEM, V23, P2778, DOI 10.1016/j.apgeochem.2008.07.006; RAJU K, 1988, J CHEM ENG DATA, V33, P490, DOI 10.1021/je00054a029; Risthaus P, 2001, COLLOID SURFACE A, V191, P201, DOI 10.1016/S0927-7757(00)00843-8; Stack AG, 2012, J AM CHEM SOC, V134, P11, DOI 10.1021/ja204714k; Wang KS, 1999, COLLOID SURFACE A, V160, P217, DOI 10.1016/S0927-7757(99)00183-1; Wang KS, 1999, J COLLOID INTERF SCI, V219, P212, DOI 10.1006/jcis.1999.6473	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0883-2927			APPL GEOCHEM	Appl. Geochem.	DEC	2014	51						246	254		10.1016/j.apgeochem.2014.10.008		9	Geochemistry & Geophysics	Geochemistry & Geophysics	AU1UL	WOS:000345405400023		
J	Kawai, F; Oda, M; Tamashiro, T; Waku, T; Tanaka, N; Yamamoto, M; Mizushima, H; Miyakawa, T; Tanokura, M				Kawai, Fusako; Oda, Masayuki; Tamashiro, Tomonari; Waku, Tomonori; Tanaka, Naoki; Yamamoto, Masaki; Mizushima, Hiroki; Miyakawa, Takuya; Tanokura, Masaru			A novel Ca2+-activated, thermostabilized polyesterase capable of hydrolyzing polyethylene terephthalate from Saccharomonospora viridis AHK190	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						PET hydrolase; Polyester degradation; Cutinase-type polyesterase; Ca2+-activated cutinase; Thermostabile cutinase; Saccharomonospora viridis AHK190	ATOMIC-FORCE MICROSCOPY; EXTRACELLULAR HYDROLASE; MICROBIAL-DEGRADATION; ENZYMATIC DEGRADATION; CUTINASE; FUSCA; POLY(ETHYLENE-TEREPHTHALATE); IDENTIFICATION; ENZYMES; BIODEGRADABILITY	Only two polyethylene glycol terephthalate (PET)-degrading enzymes have been reported, and their mechanism for the biochemical degradation of PET remains unclear. To identify a novel PET-degrading enzyme, a putative cutinase gene (cut190) was cloned from the thermophile Saccharomonospora viridis AHK190 and expressed in Escherichia coli Rosetta-gami B (DE3). Mutational analysis indicated that substitution of Ser226 with Pro and Arg228 with Ser yielded the highest activity and thermostability. The Ca2+ ion enhanced the enzyme activity and thermostability of the wild-type and mutant Cut190. Circular dichroism suggested that the Ca2+ changes the tertiary structure of the Cut190 (S226P/R228S), which has optimal activity at 65-75 A degrees C and pH 6.5-8.0 in the presence of 20 % glycerol. The enzyme was stable over a pH range of 5-9 and at temperatures up to 65 A degrees C for 24 h with 40 % activity remaining after incubation for 1 h at 70 A degrees C. The Cut190 (S226P/R228S) efficiently hydrolyzed various aliphatic and aliphatic-co-aromatic polyester films. Furthermore, the enzyme degraded the PET film above 60 A degrees C. Therefore, Cut190 is the novel-reported PET-degrading enzyme with the potential for industrial applications in polyester degradation, monomer recycling, and PET surface modification. Thus, the Cut190 will be a useful tool to elucidate the molecular mechanisms of the PET degradation, Ca2+ activation, and stabilization.	[Kawai, Fusako] Kyoto Inst Technol, Ctr Nanomat & Devices, Sakyo Ku, Kyoto 6068585, Japan; [Oda, Masayuki; Tamashiro, Tomonari] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Biophys Chem Lab, Sakyo Ku, Kyoto 6068522, Japan; [Waku, Tomonori; Tanaka, Naoki] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Yamamoto, Masaki] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan; [Mizushima, Hiroki; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Kawai, F (reprint author), Kyoto Inst Technol, Ctr Nanomat & Devices, Sakyo Ku, Kyoto 6068585, Japan.	fkawai@kit.ac.jp			Institute for Fermentation, Osaka (Japan)	This work was financially supported by funding for F. K. from the Institute for Fermentation, Osaka (Japan). We thank Mr. M. Ono (Showa Denko K. K.) for kindly providing agricultural PBSA and PBS films. We acknowledge Mr. Y. Iijima, Mr. T. Matsunami, Mr. T. Takeda, and Ms. M. Nakajima for their technical assistance during this work. Dr. T. Kawabata (Inst. Protein Res., Osaka Univ.) was helpful in the structural analysis of Cut190 via 3D modeling. We are grateful to Dr. A. Sugiyama (Research Institute for Sustainable Humanosphere, Kyoto Univ.) for the LC-IT-TOF-MS analysis. We are also grateful to Dr. H. Nakajima, Center for Fiber and Textile Science, Kyoto Institute of Technology, for his valuable discussion and advice with regard to the whole polymer properties. American Journal Experts (www.aje.com) edited the manuscript.	Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; CHIBA T, 1985, CHEM LETT, P651, DOI 10.1246/cl.1985.651; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Hu XP, 2008, J POLYM ENVIRON, V16, P103, DOI 10.1007/s10924-008-0088-5; Kawai F, 2011, POLYM DEGRAD STABIL, V96, P1342, DOI 10.1016/j.polymdegradstab.2011.03.022; Kleeberg I, 2005, BIOMACROMOLECULES, V6, P262, DOI 10.1021/bm049582t; Arima J, 2006, J BIOL CHEM, V281, P5885, DOI 10.1074/jbc.M509025200; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Kikkawa Y, 2004, BIOMACROMOLECULES, V5, P1187, DOI 10.1021/bm0345007; Shinozaki Y, 2013, APPL MICROBIOL BIOT, V97, P8591, DOI 10.1007/s00253-012-4673-0; Sulaiman S, 2012, APPL ENVIRON MICROB, V78, P1556, DOI 10.1128/AEM.06725-11; Ronkvist AM, 2009, MACROMOLECULES, V42, P5128, DOI 10.1021/ma9005318; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Heumann S, 2006, J BIOCHEM BIOPH METH, V69, P89, DOI 10.1016/j.jbbm.2006.02.005; Thumarat U, 2012, APPL MICROBIOL BIOT, V95, P419, DOI 10.1007/s00253-011-3781-6; Kitadokoro K, 2012, POLYM DEGRAD STABIL, V97, P771, DOI 10.1016/j.polymdegradstab.2012.02.003; JAEGER KE, 1995, APPL ENVIRON MICROB, V61, P3113; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Muller RJ, 2005, MACROMOL RAPID COMM, V26, P1400, DOI 10.1002/marc.200500410; Nakajima-Kambe T, 2009, J BIOSCI BIOENG, V108, P513, DOI 10.1016/j.jbiosc.2009.05.018; Baker PJ, 2012, APPL MICROBIOL BIOT, V93, P229, DOI 10.1007/s00253-011-3402-4; Pio TF, 2009, ADV APPL MICROBIOL, V66, P77, DOI 10.1016/S0065-2164(08)00804-6; Sinsereekul N, 2010, APPL MICROBIOL BIOT, V86, P1775, DOI 10.1007/s00253-010-2465-y; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Calabia BP, 2004, BIOTECHNOL LETT, V26, P15, DOI 10.1023/B:BILE.0000009453.81444.51; Gouda MK, 2002, BIOTECHNOL PROGR, V18, P927, DOI 10.1021/bp020048b; Hoang KC, 2007, BIODEGRADATION, V18, P333, DOI 10.1007/s10532-006-9067-5; Hu X, 2010, APPL MICROBIOL BIOT, V87, P71; Inaba S, 2013, ARCH BIOCHEM BIOPHYS, V537, P225, DOI 10.1016/j.abb.2013.07.014; Kitamoto HK, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-44; Kobayashi R, 2010, J MOL CATAL B-ENZYM, V67, P155, DOI 10.1016/j.molcatb.2010.08.003; Nakajima-Kambe T, 2009, POLYM DEGRAD STABIL, V94, P1901, DOI 10.1016/j.polymdegradstab.2009.08.006; Phithakrotchanakoon C, 2009, BIOLOGIA, V64, P246, DOI 10.2478/s11756-009-0050-6; Sambrook J, 2001, MOL CLONING LAB MANU; Silva C, 2011, BIOTECHNOL J, V6, P1; Tokiwa Y, 2007, J POLYM ENVIRON, V15, P259, DOI 10.1007/s10924-007-0066-3; Verommen MA, 2005, J BIOTECHNOL, V120, P376; Zimmermann W, 2011, ADV BIOCHEM ENG BIOT, V125, P97, DOI 10.1007/10_2010_87	38	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2014	98	24					10053	10064		10.1007/s00253-014-5860-y		12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AU0RM	WOS:000345331700012		
J	Watsuji, T; Takano, H; Yamabe, T; Tamazawa, S; Ikemura, H; Ohishi, T; Matsuda, T; Shiratori-Takano, H; Beppu, T; Ueda, K				Watsuji, Tomo-o; Takano, Hideaki; Yamabe, Tomoya; Tamazawa, Satoshi; Ikemura, Hiroka; Ohishi, Takanori; Matsuda, Tohyo; Shiratori-Takano, Hatsumi; Beppu, Teruhiko; Ueda, Kenji			Analysis of the tryptophanase expression in Symbiobacterium thermophilum in a coculture with Geobacillus stearothermophilus	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Symbiobacterium thermophilum; Tryptophanase; Bicarbonate; Sigma 54; Microbial commensalism	SYNTROPHIC BACTERIUM; REGULON; GROWTH	The tryptophanase-positive Symbiobacterium thermophilum is a free-living syntrophic bacterium that grows effectively in a coculture with Geobacillus stearothermophilus. Our studies have shown that S. thermophilum growth depends on the high CO2 and low O-2 condition established by the precedent growth of G. stearothermophilus. The use of an anoxic atmosphere containing high CO2 allows S. thermophilum to grow independently of G. stearothermophilus, but the cellular yield is ten times lower than that achieved in the coculture. In this study, we characterized the coculture-dependent expression and activity of tryptophanase in S. thermophilum. S. thermophilum cells accumulated a marked amount of indole in a coculture with G. stearothermophilus, but not in the bacterium's pure culture irrespective of the addition of tryptophan. S. thermophilum cells accumulated indole in its pure culture consisting of conditioned medium (medium supplied with culture supernatant of G. stearothermophilus). Proteomic analysis identified the protein specifically produced in the S. thermophilum cells grown in conditioned medium, which was a tryptophanase encoded by tna2 (STH439). An attempt to isolate the tryptophanase-inducing component from the culture supernatant of G. stearothermophilus was unsuccessful, but we did discover that the indole accumulation occurs when 10 mM bicarbonate is added to the medium. RT-PCR analysis showed that the addition of bicarbonate stimulated transcription of tna2. The transcriptional start site, identified within the tna2 promoter, was preceded by the -24 and -12 consensus sequences specified by an alternative sigma factor, sigma(54). The evidence suggests that the transcription of some genes involved in amino acid metabolism is sigma(54)-dependent, and that a bacterial enhancer-binding protein containing a PAS domain controls the transcription under the presence of high levels of bicarbonate.	[Takano, Hideaki; Yamabe, Tomoya; Tamazawa, Satoshi; Ikemura, Hiroka; Ohishi, Takanori; Matsuda, Tohyo; Shiratori-Takano, Hatsumi; Beppu, Teruhiko; Ueda, Kenji] Nihon Univ, Coll Bioresource Sci, Life Sci Res Ctr, Fujisawa, Kanagawa 2520880, Japan	Ueda, K (reprint author), Nihon Univ, Coll Bioresource Sci, Life Sci Res Ctr, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	ueda.kenji@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by the grant-in-aid for research in private universities provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x; Bahn YS, 2006, CURR OPIN MICROBIOL, V9, P572, DOI 10.1016/j.mib.2006.09.003; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Nishida H, 2009, J MOL EVOL, V68, P90, DOI 10.1007/s00239-008-9191-4; Herrera MC, 2010, ENVIRON MICROBIOL, V12, P1427, DOI 10.1111/j.1462-2920.2009.02124.x; Manzoor S, 2013, GENOME ANNOUNC; Palmer GC, 2010, J BACTERIOL, V192, P2722, DOI 10.1128/JB.00112-10; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; SUZUKI S, 1988, J GEN MICROBIOL, V134, P2353; Ueda K, 2007, BIOSCI BIOTECH BIOCH, V71, P1115, DOI 10.1271/bbb.60727; Ueda K., 2012, INT J EVOL BIOL, V2012; Watsuji TO, 2006, BIOSCI BIOTECH BIOCH, V70, P753, DOI 10.1271/bbb.70.753; Watsuji Tomo-o, 2007, Appl Environ Microbiol, V73, P6159, DOI 10.1128/AEM.02835-06; Yang J, 2010, MICROB BIOTECHNOL, V3, P259, DOI 10.1111/j.1751-7915.2009.00114.x	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2014	98	24					10177	10186		10.1007/s00253-014-6053-4		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AU0RM	WOS:000345331700022		
J	Sun, W; Li, XJ; Hokamoto, K				Sun, Wei; Li, Xiaojie; Hokamoto, Kazuyuki			Fabrication of graded density impactor via underwater shock wave and quasi-isentropic compression testing at two-stage gas gun facility	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							PLATE	We show direct evidence that underwater shock wave enables us to bond multithin plates with flat, parallel, and high-strength interfaces, which are key requirements for functionally graded material (also called graded density impactor). This phenomenon is ascribed to the super short duration of the high-speed underwater shock wave, reducing the surface tension, diffusion, evaporation, deposition, and viscous flow of matter. Thin magnesium, aluminum, titanium, copper, and molybdenum foils were welded together and designed with the increase in density. Experimental evidence and numerical simulation show that well bonding between the multilayer structures. Microstructure examinations reveal that the dominant interfacial form shifts from waviness to linearity. Graded density impactor with multilayer structure is proved that can produce quasi-isentropic compression in two-stage gas gun experiment with a designed pressure loading profile, which suggests a feasible method to simulate the conditions we want to study that were previously inaccessible in a precisely controlled laboratory environment.	[Sun, Wei; Li, Xiaojie] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Sch Ocean Sci & Technol, Panjin 124000, Liaoning, Peoples R China; [Sun, Wei; Hokamoto, Kazuyuki] Kumamoto Univ, Shock Wave & Condensed Matter Res Ctr, Kumamoto 8608555, Japan	Sun, W (reprint author), Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Sch Ocean Sci & Technol, Panjin 124000, Liaoning, Peoples R China.	dust911@163.com			Natural Science Foundation of China [10972051, 11272081]; China Scholarship Council (CSC)	This research was financially supported by Natural Science Foundation of China (10972051, 11272081) and China Scholarship Council (CSC).	Edwards J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.075002; Swift DC, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066401; Kahraman N, 2005, J MATER PROCESS TECH, V169, P67, DOI 10.1016/j.jmatprotec.2005.02.264; Hokamoto K, 2009, J ALLOY COMPD, V472, P507, DOI 10.1016/j.jallcom.2008.05.002; Rajani HRZ, 2012, MAT SCI ENG A-STRUCT, V556, P454, DOI 10.1016/j.msea.2012.07.012; Davis JP, 2006, J APPL PHYS, V99, DOI 10.1063/1.2196110; Weng JD, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335948; Chhabildas L.C., 1986, SAND861888 SAND; HAWKE RS, 1972, J APPL PHYS, V43, P2734, DOI 10.1063/1.1661586; Hayes DB, 2004, J APPL PHYS, V96, P5520, DOI 10.1063/1.1803108; Jarmakani H., 2005, UCRLTR216902; Krone RT, 2008, MAT SCI ENG A-STRUCT, V479, P300, DOI 10.1016/j.msea.2007.06.056; Smith RF, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.065701; Smith RF, 2007, ASTROPHYS SPACE SCI, V307, P269, DOI 10.1007/s10509-006-9231-8; Sun W, 2012, J ADHES SCI TECHNOL, V26, P1733, DOI 10.1163/156856111X618542	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2014	117	4					1941	1946		10.1007/s00339-014-8663-1		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU0DI	WOS:000345293200037		
J	Melvin, GJH; Ni, QQ; Natsuki, T				Melvin, Gan Jet Hong; Ni, Qing-Qing; Natsuki, Toshiaki			Behavior of polymer-based electroactive actuator incorporated with mild hydrothermally treated CNTs	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							DIELECTRIC ELASTOMERS; CARBON NANOTUBES; BENDING ELECTROSTRICTION; POLYURETHANE FILMS; NANOCOMPOSITES; POLYPYRROLE	We fabricated an actuator that was made from polyurethane (PU) with carbon nanotubes (CNTs) as the filler. To improve the dispersion of the CNTs, a mild hydrothermal treatment was carried out. Carboxyl and hydroxyl groups were introduced to the surface of the CNTs, and they were found to be highly dispersed in polar solvents such as dimethylformamide. To evaluate these films, we mainly focused on electrical properties, such as dielectric spectroscopy, space charge measurements, and actuator behavior. We found that the PU/CNTs film bents toward the cathode when an electric field was applied, and it reverted to its original position when the electric field was removed. Upon the inclusion of the CNTs as the filler for the polymer, the electrical properties of the films improved significantly. The highly polarized films had a high relative permittivity, and this produced a higher Maxwell pressure, which assisted the actuation. A high accumulated charge density was observed from space charge measurements in some of the films, and this explains the bending direction and the actuation mechanism.	[Melvin, Gan Jet Hong] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868576, Japan; [Ni, Qing-Qing; Natsuki, Toshiaki] Shinshu Univ, Dept Funct Machinery & Mech, Ueda, Nagano 3868576, Japan; [Ni, Qing-Qing] Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Minist Educ, Hangzhou, Zhejiang, Peoples R China	Ni, QQ (reprint author), Shinshu Univ, Dept Funct Machinery & Mech, Ueda, Nagano 3868576, Japan.	niqq@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by Grants for Excellent Graduate Schools by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ali M, 2011, J MATER SCI, V46, P7681, DOI 10.1007/s10853-011-5746-7; Yadav SK, 2009, FIBER POLYM, V10, P756, DOI 10.1007/s12221-009-0756-7; Petit L, 2008, SENSOR ACTUAT A-PHYS, V148, P105, DOI 10.1016/j.sna.2008.08.009; Zhang L, 2011, APPL SURF SCI, V257, P1845, DOI 10.1016/j.apsusc.2010.08.106; Chen LZ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2955513; Shankar R, 2007, SOFT MATTER, V3, P1116, DOI 10.1039/b705737g; Kofod G, 2003, J INTEL MAT SYST STR, V14, P787, DOI 10.1177/104538903039260; Ali M, 2012, J MATER SCI, V47, P3777, DOI 10.1007/s10853-011-6229-6; Sahoo NG, 2007, COMPOS SCI TECHNOL, V67, P1920, DOI 10.1016/j.compscitech.2006.10.013; Pelrine RE, 1998, SENSOR ACTUAT A-PHYS, V64, P77, DOI 10.1016/S0924-4247(97)01657-9; Chen LZ, 2011, ACS NANO, V5, P1588, DOI 10.1021/nn102251a; Bai YK, 2013, J MATER SCI, V48, P2207, DOI 10.1007/s10853-012-6996-8; Cai Z, 2010, J APPL POLYM SCI, V115, P2044, DOI 10.1002/app.31261; Cho KY, 2008, J PHYS CHEM C, V112, P7001, DOI 10.1021/jp067012c; Jo NJ, 2010, J MATER SCI TECHNOL, V26, P763; Karabanova LV, 2012, COMPOS SCI TECHNOL, V72, P865, DOI 10.1016/j.compscitech.2012.02.008; Kunanuruksapong R, 2008, APPL PHYS A-MATER, V92, P313, DOI 10.1007/s00339-008-4513-3; Zhang XQ, 2005, ADV ENG MATER, V7, P361; Melvin GJH, 2014, MICROELECTRON ENG, V126, P9, DOI 10.1016/j.mee.2014.04.001; Nakama Y, 2003, SYNTHETIC MET, V135, P749, DOI 10.1016/S0379-6779(02)00831-7; O'Brien BM, 2010, APPL PHYS A-MATER, V100, P385, DOI 10.1007/s00339-010-5857-z; Watanabe M, 2003, J APPL PHYS, V94, P2494, DOI 10.1063/1.1582380; Watanabe M, 2007, POLYM INT, V56, P1265, DOI 10.1002/pi.2270; Yoshino K., 1980, Oyo Buturi, V49; Yun S, 2009, SENSOR ACTUAT A-PHYS, V154, P73, DOI 10.1016/j.sna.2009.06.011	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2014	117	4					2043	2050		10.1007/s00339-014-8616-8		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU0DI	WOS:000345293200050		
J	Wang, YJ; Li, SF; Wu, T; Hu, F; Cao, ZP				Wang, Yongjin; Li, Shoufeng; Wu, Tong; Hu, Frangren; Cao, Ziping			Fabrication of freestanding nanoscale gratings on silicon-on-insulator wafer	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							GUIDED-MODE RESONANCE; FILTER; MEMBRANE; BAND	We report a bottom-up process for the fabrication of freestanding nanoscale gratings on silicon-on-insulator (SOI) wafer. Freestanding membrane devices suffer deflection due to the residual stress of the buried oxide layer of SOI wafer. The deflection will affect the device shape and result in the fracture problem for devices fabricated on thin silicon membrane. The bottom-up process is developed to overcome the fabrication issue for thin silicon membrane gratings. The silicon handle layer is removed through back wafer etching of silicon, where the buried oxide layer acts as an etch stop layer. The grating structures are then defined on thin silicon device layer by electron beam lithography and generated by fast atom beam etching. The grating structures are finally released in vapor HF to form the freestanding nanoscale gratings. The freestanding linear/circular gratings, 1,500-nm period grating with the grating width of 200- and 850-nm period grating with the grating width of 100 nm, are successfully achieved on 260-nm silicon device layer.	[Wang, Yongjin; Li, Shoufeng; Hu, Frangren; Cao, Ziping] Nanjing Univ Posts & Telecommun, Grunberg Res Ctr, Nanjing 210003, Jiangsu, Peoples R China; [Wu, Tong] Tohoku Univ, Dept Nanomech, Sendai, Miyagi 9808579, Japan	Wang, YJ (reprint author), Nanjing Univ Posts & Telecommun, Grunberg Res Ctr, Nanjing 210003, Jiangsu, Peoples R China.	wangyj@njupt.edu.cn			Natural Science Foundation of China [11104147, 61322112];  [NY211001];  [BJ211026]	This work is financially supported by Natural Science Foundation of China (11104147, 61322112) and Research Projects (NY211001, BJ211026).	Lezec HJ, 2002, SCIENCE, V297, P820, DOI 10.1126/science.1071895; Mehta AA, 2007, IEEE PHOTONIC TECH L, V19, P2030, DOI 10.1109/LPT.2007.908776; Suh W, 2003, APPL PHYS LETT, V82, P1999, DOI 10.1063/1.1563739; Sasaki T, 2011, SENSOR ACTUAT A-PHYS, V172, P516, DOI 10.1016/j.sna.2011.09.042; Ahn M, 2007, J VAC SCI TECHNOL B, V25, P2593, DOI 10.1116/1.2779048; Fehrembach AL, 2007, OPT LETT, V32, P2269, DOI 10.1364/OL.32.002269; Mukherjee P, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/32/325301; Rosenblatt D, 1997, IEEE J QUANTUM ELECT, V33, P2038, DOI 10.1109/3.641320; Hokari R, 2009, IEEE J SEL TOP QUANT, V15, P1310, DOI 10.1109/JSTQE.2009.2017034; Bruccoleri A, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4755815; Dobbs DW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356695; Hane K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193989; Hsu CL, 2006, J LIGHTWAVE TECHNOL, V24, P1922, DOI 10.1109/JLT.2006.871117; Hsu CL, 2006, IEEE PHOTONIC TECH L, V18, P2572, DOI 10.1109/LPT.2006.887193; Kanamori Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2431452; Kanamori Y, 2008, IEEE PHOTONIC TECH L, V20, P1136, DOI 10.1109/LPT.2008.924655; Mukherjee P, 2010, J VAC SCI TECHNOL B, V28, pC6P70, DOI 10.1116/1.3507427; Savas TA, 1996, J VAC SCI TECHNOL B, V14, P4167, DOI 10.1116/1.588613; Sharon A, 1996, APPL PHYS LETT, V69, P4154, DOI 10.1063/1.116969; Zhang X. M., 2007, P 14 INT C SOL STAT, P2417	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2014	117	4					2101	2105		10.1007/s00339-014-8625-7		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU0DI	WOS:000345293200058		
J	Nagatsu, K; Minegishi, K; Fukada, M; Suzuki, H; Hasegawa, S; Zhang, MR				Nagatsu, Kotaro; Minegishi, Katsuyuki; Fukada, Masami; Suzuki, Hisashi; Hasegawa, Sumitaka; Zhang, Ming-Rong			Production of At-211 by a vertical beam irradiation method	APPLIED RADIATION AND ISOTOPES			English	Article						At-211 production; Vertical irradiation; Encapsulated target; Dry distillation	BISMUTH TARGETS; ELEMENT 85; CYCLOTRON; ASTATINE-211; BI-209	We produced At-211 by irradiating the semi-sealed encapsulated Bi target with an external vertical beam. At 28.5 MeV, the yield of At-211 was 22 MBq/mu A h (600 mu Ci/mu A h). At-211 was recovered by dry distillation, and 80% of the produced At-211 was successfully obtained in dry (NaAt)-At-211 form within 2 h from the end of bombardment (EOB). The radionuclidic purity of At-211 was >99% at 5 h from EOB. (C) 2014 Elsevier Ltd. All rights reserved.	[Nagatsu, Kotaro; Minegishi, Katsuyuki; Fukada, Masami; Suzuki, Hisashi; Hasegawa, Sumitaka; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan	Nagatsu, K (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Postal Address 4-9-1 Anagawa, Chiba 2638555, Japan.	nagatsu@nirs.go.jp			JSPS [24390296]; President's Grant for National Institute of Radiological Sciences	We are grateful to our cyclotron staff for their excellent operation of NIRS cyclotron and measurement of particle energies. This study was supported by both JSPS Grant-in-Aid for Scientific Research (B) (#24390296, S. H.) and President's Grant for National Institute of Radiological Sciences (S. H.).	[Anonymous], NUDAT 2 6; Lindegren S, 2001, APPL RADIAT ISOTOPES, V55, P157, DOI 10.1016/S0969-8043(01)00044-6; CORSON DR, 1947, NATURE, V159, P24, DOI 10.1038/159024b0; Corson DR, 1940, PHYS REV, V58, P672, DOI 10.1103/PhysRev.58.672; Elgqvist J, 2005, J NUCL MED, V46, P1907; Gagnon K., 2012, P 14 INT WORKSH TARG, P45; Hamilton JG, 1940, P NATL ACAD SCI USA, V26, P483, DOI 10.1073/pnas.26.8.483; Henriksen G, 2001, APPL RADIAT ISOTOPES, V54, P839, DOI 10.1016/S0969-8043(00)00346-8; Hermanne A, 2005, APPL RADIAT ISOTOPES, V63, P1, DOI 10.1016/j.apradiso.2005.01.015; International Commission on Radiation Protection, 1991, ICRP PUBL, V61; International Commission on Radiological Protection, 1991, ICRP PUBL, V60; LAMBRECHT RM, 1985, INT J APPL RADIAT IS, V36, P443, DOI 10.1016/0020-708X(85)90207-8; Larsen RH, 1996, APPL RADIAT ISOTOPES, V47, P135, DOI 10.1016/0969-8043(95)00285-5; Lebeda O, 2005, APPL RADIAT ISOTOPES, V63, P49, DOI 10.1016/j.apradiso.2005.02.006; Schwarz UP, 1998, NUCL MED BIOL, V25, P89, DOI 10.1016/S0969-8051(97)00165-0; Stocklin G, 1995, RADIOCHIM ACTA, V70-1, P249; Zalutsky MR, 2001, J NUCL MED, V42, P1508; Ziegler J. F., 2013, STOPPING RANGE IONS	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	DEC	2014	94						363	371		10.1016/j.apradiso.2014.09.012		9	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AU2XK	WOS:000345477700056		
J	Nakajima, D; Kikuchi, T; Natsui, S; Suzuki, RO				Nakajima, Daiki; Kikuchi, Tatsuya; Natsui, Shungo; Suzuki, Ryosuke O.			Growth behavior of anodic oxide formed by aluminum anodizing in glutaric and its derivative acid electrolytes	APPLIED SURFACE SCIENCE			English	Article						Aluminum; Anodizing; Glutaric acid; Ketoglutaric acid; Acetonedicarboxylic acid	RELATIVELY HIGH-TEMPERATURES; ORDERED POROUS ALUMINA; SULFURIC-ACID; NANOPOROUS ALUMINA; TARTARIC ACID; OXALIC-ACID; ANODIZATION; FABRICATION; FILMS; ARRAYS	The growth behavior of anodic oxide films formed via anodizing in glutaric and its derivative acid solutions was investigated based on the acid dissociation constants of electrolytes. High-purity aluminum foils were anodized in glutaric, ketoglutaric, and acetonedicarboxylic acid solutions under various electrochemical conditions. A thin barrier anodic oxide film grew uniformly on the aluminum substrate by glutaric acid anodizing, and further anodizing caused the film to breakdown due to a high electric field. In contrast, an anodic porous alumina film with a submicrometer-scale cell diameter was successfully formed by ketoglutaric acid anodizing at 293 K. However, the increase and decrease in the temperature of the ketoglutaric acid resulted in non-uniform oxide growth and localized pitting corrosion of the aluminum substrate. An anodic porous alumina film could also be fabricated by acetonedicarboxylic acid anodizing due to the relatively low dissociation constants associated with the acid. Acid dissociation constants are an important factor for the fabrication of anodic porous alumina films. (C) 2014 Elsevier B.V. All rights reserved.	[Nakajima, Daiki; Kikuchi, Tatsuya; Natsui, Shungo; Suzuki, Ryosuke O.] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Kikuchi, T (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, N13-W8, Sapporo, Hokkaido 0608628, Japan.	kiku@eng.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS)"KEKENHI"; Toyota Physical & Chemical Research Institute	This research was conducted at Hokkaido University and was supported by the "Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The work was financially supported by the Japan Society for the Promotion of Science (JSPS) "KEKENHI" and Toyota Physical & Chemical Research Institute Scholars.	Yanagishita T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.067004; Stepniowski WJ, 2012, APPL SURF SCI, V259, P324, DOI 10.1016/j.apsusc.2012.07.043; Ono S, 2005, ELECTROCHIM ACTA, V51, P827, DOI 10.1016/j.electacta.2005.05.058; Hebert KR, 2012, NAT MATER, V11, P162, DOI [10.1038/nmat3185, 10.1038/NMAT3185]; Lee W, 2014, CHEM REV, V114, P7487, DOI 10.1021/cr500002z; Sulka GD, 2007, ELECTROCHIM ACTA, V52, P1880, DOI 10.1016/j.electacta.2006.07.053; Kikuchi T, 2014, APPL SURF SCI, V313, P276, DOI 10.1016/j.apsusc.2014.05.204; Sulka GD, 2009, ELECTROCHIM ACTA, V54, P3683, DOI 10.1016/j.electacta.2009.01.046; THOMPSON GE, 1981, NATURE, V290, P230, DOI 10.1038/290230a0; Zaraska L, 2014, APPL SURF SCI, V305, P650, DOI 10.1016/j.apsusc.2014.03.154; Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0; Li Y, 1997, J ELECTROCHEM SOC, V144, P866, DOI 10.1149/1.1837501; Li AP, 2000, ELECTROCHEM SOLID ST, V3, P131; Pashchanka M, 2013, PHYS CHEM CHEM PHYS, V15, P7070, DOI 10.1039/c3cp50805f; Masuda H, 1998, JPN J APPL PHYS 2, V37, pL1340, DOI 10.1143/JJAP.37.L1340; Houser JE, 2009, NAT MATER, V8, P415, DOI [10.1038/nmat2423, 10.1038/NMAT2423]; Sulka GD, 2006, THIN SOLID FILMS, V515, P338, DOI 10.1016/j.tsf.2005.12.094; Lee W, 2006, NAT MATER, V5, P741, DOI 10.1038/nmat1717; Kondo T, 2011, J PHOTOCH PHOTOBIO A, V221, P199, DOI 10.1016/j.jphotochem.2011.03.019; Ash H., 2001, J VAC SCI TECHNOL B, V19, P569; Chu SZ, 2006, J ELECTROCHEM SOC, V153, pB384, DOI 10.1149/1.2218822; Fukushima T., 1974, Journal of the Metal Finishing Society of Japan, V25; Fukushima T., 1970, Journal of the Metal Finishing Society of Japan, V21; Garcia-Vergara SJ, 2007, SURF INTERFACE ANAL, V39, P860, DOI 10.1002/sia.2601; Hay R.W., 1971, J CHEM SOC A; Iwasawa Y., 2004, HDB CHEM PURE CHEM; Katsuta Y, 2008, J NON-CRYST SOLIDS, V354, P451, DOI 10.1016/j.jnoncrysol.2007.06.085; Kerber R.C., 2010, J CHEM EDUC, V84, P1079; Kikuchi T., 2014, ELECTROCHIM ACTA, V123; Kikuchi T, 2014, ECS ELECTROCHEM LETT, V3, pC25, DOI 10.1149/2.0071407eel; Kikuchi T., 2014, ELECTROCHIM ACTA, V137; Kikuchi T., 2013, APPL SURF SCI, V284; Klein I. E., 1971, Metallography, V4, DOI 10.1016/0026-0800(71)90048-6; Kondo T, 2006, ELECTROCHEM SOLID ST, V9, pC189, DOI 10.1149/1.2351959; Lee W, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/47/475713; Masuda H., 1997, J ELECTROCHEM SOC, V144; Masuda H., 1995, SCIENCE, V268; Nishinaga O, 2013, SCI REP-UK, V3, DOI 10.1038/srep02748; OSULLIVA.JP, 1970, PROC R SOC LON SER-A, V317, P511, DOI 10.1098/rspa.1970.0129; Stepniowski W.J., 2014, MAT LETT, V117; Sulka GD, 2002, J ELECTROCHEM SOC, V149, pD97, DOI 10.1149/1.1481527; SURGANOV VF, 1993, MATER LETT, V17, P121, DOI 10.1016/0167-577X(93)90069-A; Tallman D.E., 1969, J AM CHEM SOC, V91; Vrublevsky I, 2009, J SOLID STATE ELECTR, V13, P1873, DOI 10.1007/s10008-008-0765-2; Vrublevsky IA, 2014, THIN SOLID FILMS, V556, P230, DOI 10.1016/j.tsf.2014.01.074; Yasui K, 2005, JPN J APPL PHYS 2, V44, pL469, DOI [10.1143/JJAP.44.L469, 10.1143/JJAP.44.L496]	46	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2014	321						364	370		10.1016/j.apsusc.2014.10.014		7	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AU3JE	WOS:000345507900050		
J	Saito, H; Tanaka, H				Saito, Hiroki; Tanaka, Hitoshi			The Kakeya maximal operator on the variable Lebesgue spaces	ARCHIV DER MATHEMATIK			English	Article						Nikodym maximal operator; Kakeya maximal operator; Variable Lebesgue spaces	L-P SPACES	We shall verify that the Kakeya (Nikodym) maximal operator K (N) , , is bounded on the variable Lebesgue space when the exponent function is N-modified locally log-Holder continuous and log-Holder continuous at infinity.	[Saito, Hiroki] Saitama Univ, Dept Math, Sakura Ku, Saitama 3388570, Japan; [Tanaka, Hitoshi] Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan	Saito, H (reprint author), Saitama Univ, Dept Math, Sakura Ku, 255 Shimo Ookubo, Saitama 3388570, Japan.	j1107703@gmail.com; htanaka@ms.u-tokyo.ac.jp			FMSP program at Graduate School of Mathematical Sciences, University of Tokyo; Japan Society for the Promotion of Science [23540187]	The second author is supported by the FMSP program at Graduate School of Mathematical Sciences, the University of Tokyo, and Grant-in-Aid for Scientific Research (C) (No. 23540187), the Japan Society for the Promotion of Science.	Diening L, 2005, B SCI MATH, V129, P657, DOI 10.1016/j.bulsci.2003.10.003; Cruz-Uribe D, 2004, ANN ACAD SCI FENN-M, V29, P247; Cruz-Uribe D, 2006, ANN ACAD SCI FENN-M, V31, P239; Lerner AK, 2010, T AM MATH SOC, V362, P4229; Capone C, 2007, REV MAT IBEROAM, V23, P743; Nekvinda A, 2004, MATH INEQUAL APPL, V7, P255; KOVACIK O, 1991, CZECH MATH J, V41, P592; CORDOBA A, 1977, AM J MATH, V99, P1, DOI 10.2307/2374006; Alfonseca A, 2003, CONTEMP MATH, V320, P1; Diening L, 2004, MATH INEQUAL APPL, V7, P245; STROMBERG JO, 1978, ANN MATH, V107, P399, DOI 10.2307/1971122; Cruz-Uribe D., 2009, B UNIONE MAT ITAL, V2, P151; Diening L., 2004, FSDONA04 P MIL CZECH, P38; Diening L, 2011, LECT NOTES MATH, V2017, P1, DOI 10.1007/978-3-642-18363-8; Grafakos L, 2008, GRAD TEXTS MATH, V249, P1, DOI 10.1007/978-0-387-09432-8_1; KOKILASHVILI V., 2012, SPECTRAL THEORY FUNC, V219, P105; Kopaliani T. S., 2007, P A RAZMADZE MATH I, V145, P43	17	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0003-889X	1420-8938		ARCH MATH	Arch. Math.	DEC	2014	103	6					481	491		10.1007/s00013-014-0709-2		11	Mathematics	Mathematics	AU5BS	WOS:000345622800004		
J	Terao, C; Ohmura, K; Ikari, K; Kawaguchi, T; Takahashi, M; Setoh, K; Nakayama, T; Kosugi, S; Sekine, A; Tabara, Y; Taniguchi, A; Momohara, S; Yamanaka, H; Yamada, R; Matsuda, F; Mimori, T				Terao, Chikashi; Ohmura, Koichiro; Ikari, Katsunori; Kawaguchi, Takahisa; Takahashi, Meiko; Setoh, Kazuya; Nakayama, Takeo; Kosugi, Shinji; Sekine, Akihiro; Tabara, Yasuharu; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi; Yamada, Ryo; Matsuda, Fumihiko; Mimori, Tsuneyo		Nagahama Study Grp	Effects of Smoking and Shared Epitope on the Production of Anti-Citrullinated Peptide Antibody in a Japanese Adult Population	ARTHRITIS CARE & RESEARCH			English	Article							NEGATIVE RHEUMATOID-ARTHRITIS; CHRONIC HEPATITIS-C; RADIOLOGICAL PROGRESSION; ANTINUCLEAR ANTIBODIES; HLA-DRB1 ALLELES; AUTOANTIBODIES; PREVALENCE; RISK; MANIFESTATIONS; SUSCEPTIBILITY	Objective. Anti citrullinated peptide antibody (ACPA) and rheumatoid factor (RE) are markers to rheumatoid arthritis (RA). Smoking and shared epitope (SE) in HLA-DRB1 are associated with the production of these autoantibodies in RA. Detailed distribution and characterization of ACPA and RE in the general population have remained unclear. We aimed to evaluate positivity of ACPA and RE in a general Japanese population and to detect correlates, including genetic components. Methods. ACPA and RE were quantified in 9,804 Japanese volunteers ages 30-75 years. Logistic regression analyses were performed to evaluate the effects of candidates of correlates on the autoantibody positivity. A genome-wide association study (GWAS) was performed using 394,239 single nucleotide polymorphisms for 3,170 participants, and HLA-DRB1 alleles were imputed based on the GWAS data. Results. A total of 1.7% and 6.4% of subjects were positive for ACPA and RE, respectively, and the 2 markers showed a significant correlation (P = 2.0 x 10(-23)). Old age was associated with ACPA positivity (P = 0.00062). Sex, smoking, SE, and other candidates of correlates did not have significant effects. Interaction between smoking and SE positivity was not apparent, but smoking showed a significant association with high levels of ACPA (P = 0.0019). Conclusion. ACPA and RE could be detected in 1.7% and 6.4% of the Japanese adult population without RA, respectively. ACPA and RE were suggested to share mechanisms even in healthy populations. Old age was associated with increasing ACPA positivity. While positivity of ACPA and RE was not associated with SE and smoking, an association between high ACPA and smoking was observed.	[Terao, Chikashi; Ohmura, Koichiro; Kawaguchi, Takahisa; Takahashi, Meiko; Setoh, Kazuya; Nakayama, Takeo; Kosugi, Shinji; Sekine, Akihiro; Tabara, Yasuharu; Yamada, Ryo; Matsuda, Fumihiko; Mimori, Tsuneyo] Kyoto Univ, Kyoto 6068507, Japan; [Ikari, Katsunori; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Tokyo, Japan	Terao, C (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan.	a0001101@kuhp.kyoto-u.ac.jp					Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Jonsson T, 1998, APMIS, V106, P970; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; PAWLOTSKY JM, 1995, ANN INTERN MED, V122, P169; Yoshimura K, 2013, INT J UROL, V20, P911, DOI 10.1111/iju.12074; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Klareskog L, 2006, ARTHRITIS RHEUM, V54, P38, DOI 10.1002/art.21575; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P924, DOI 10.1002/art.24410; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Nishimura K, 2007, ANN INTERN MED, V146, P797; Vittecoq O, 2003, RHEUMATOLOGY, V42, P939, DOI 10.1093/rheumatology/keg257; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Terao C, 2012, ANN RHEUM DIS, V71, P1095, DOI 10.1136/annrheumdis-2011-200907; Nielen MMJ, 2004, ARTHRITIS RHEUM, V50, P380, DOI 10.1002/art.20018; Berglin E, 2004, ARTHRITIS RES THER, V6, pR303, DOI 10.1186/ar1187; Tan EM, 1997, ARTHRITIS RHEUM, V40, P1601, DOI 10.1002/art.1780400909; Morgan AW, 2009, ARTHRITIS RHEUM-US, V60, P2565, DOI 10.1002/art.24752; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; CAMMARAT.RJ, 1967, J AMER MED ASSOC, V199, P455, DOI 10.1001/jama.199.7.455; CLIFFORD BD, 1995, HEPATOLOGY, V21, P613, DOI 10.1016/0270-9139(95)90507-3; DEQUEKER J, 1969, ANN RHEUM DIS, V28, P431, DOI 10.1136/ard.28.4.431; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; DUGOWSON CE, 1991, ARTHRITIS RHEUM, V34, P1502; Haj Hensvold A, 2013, ANN RHEUM DIS; Mattey DL, 2002, ARTHRIT RHEUM-ARTHR, V47, P403, DOI 10.1002/art.10514; Nielsen SF, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5244; Palosuo T, 2003, ANN RHEUM DIS, V62, P261, DOI 10.1136/ard.62.3.261; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Renaudineau Y, 2005, AUTOIMMUNITY, V38, P11, DOI 10.1080/08916930400022574; SHMERLING RH, 1991, AM J MED, V91, P528, DOI 10.1016/0002-9343(91)90190-9; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Tasliyurt T, 2013, RHEUMATOL INT, V33, P939, DOI 10.1007/s00296-012-2458-5; Terao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040067; Vallbracht I, 2004, ANN RHEUM DIS, V63, P1079, DOI 10.1136/ard.2003.019877; VANSCHAARDENBURG D, 1993, BRIT J RHEUMATOL, V32, P546; WALLER M, 1964, ARTHRITIS RHEUM, V7, P513, DOI 10.1002/art.1780070507; WOLFE F, 1993, J RHEUMATOL, V20, P2005; Yoshida H, 1994, Rinsho Byori, V42, P455	45	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2151-464X	2151-4658		ARTHRIT CARE RES	Arthritis Care Res.	DEC	2014	66	12					1818	1827		10.1002/acr.22385		10	Rheumatology	Rheumatology	AU3MY	WOS:000345518800008		
J	De Boer, R; Body, JJ; Bone, HG; Van Poznak, C; Stopeck, A; Damiao, R; Fizazi, K; Ibrahim, T; Lipton, A; Saad, F; Shore, N; Takano, T; Wang, H; Bracco, OL; Balakumaran, A; Kostenuik, PJ				De Boer, Richard; Body, Jean-Jacques; Bone, Henry G.; Van Poznak, Catherine; Stopeck, Alison; Damiao, Ronaldo; Fizazi, Karim; Ibrahim, Toni; Lipton, Allan; Saad, Fred; Shore, Neal; Takano, Toshimi; Wang, Huei; Bracco, Oswaldo L.; Balakumaran, Arun; Kostenuik, Paul J.			RISK FACTORS FOR HYPOCALCAEMIA IN PATIENTS WITH CANCER RECEIVING DENOSUMAB	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract									[De Boer, Richard] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Body, Jean-Jacques] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium; [Bone, Henry G.] Michigan Bone & Mineral Clin, Detroit, MI USA; [Van Poznak, Catherine] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Stopeck, Alison] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Damiao, Ronaldo] Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil; [Fizazi, Karim] Univ Paris Sud, Inst Gustave Roussy, Villejuif, France; [Ibrahim, Toni] IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy; [Lipton, Allan] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Saad, Fred] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada; [Shore, Neal] Carolina Urol Res Ctr, Myrtle Beach, SC USA; [Takano, Toshimi] Toranomon Gen Hosp, Tokyo, Japan; [Wang, Huei; Bracco, Oswaldo L.; Balakumaran, Arun; Kostenuik, Paul J.] Amgen Inc, Thousand Oaks, CA 91320 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	DEC	2014	10			8	SI	94	105	105				1	Oncology	Oncology	AU0ZN	WOS:000345350900093		
J	Baird, AM; Godwin, P; Heavey, S; Umezawa, K; Barr, M; Richard, D; Gately, K; O'Byrne, K				Baird, Anne-Marie; Godwin, Peter; Heavey, Susan; Umezawa, Kazuo; Barr, Martin; Richard, Derek; Gately, Kathy; O'Byrne, Kenneth			DHMEQ MAY PROVIDE A THERPEUTIC OPTION IN TARGETING INFLAMMATORY MEDIATED ACQUIRED AND INTRINSIC CISPLATIN RESISTANCE IN NON-SMALL CELL LUNG CANCER	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract									[Baird, Anne-Marie; Godwin, Peter; Heavey, Susan; Barr, Martin; Gately, Kathy; O'Byrne, Kenneth] Univ Dublin Trinity Coll, St Jamess Hosp, Thorac Oncol Res Grp, Dublin 2, Ireland; [Baird, Anne-Marie; Richard, Derek; O'Byrne, Kenneth] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld 4001, Australia; [Umezawa, Kazuo] Aichi Med Univ, Nagakute, Aichi, Japan; [O'Byrne, Kenneth] Princess Alexandra Hosp, Div Canc Serv, Brisbane, Qld 4102, Australia								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	DEC	2014	10			8	SI	295	155	156				2	Oncology	Oncology	AU0ZN	WOS:000345350900243		
J	Nakase, K; Kita, K; Kyo, T; Tanaka, I; Katayama, N; Tajima, K				Nakase, Kazunori; Kita, Kenkichi; Kyo, Taiichi; Tanaka, Isao; Katayama, Naoyuki; Tajima, Kazuo			CYTOKINE RECEPTOR EXPRESSION IN ACUTE MYELOID LEUKEMIA: HIGH EXPRESSION OF INTERLEUKIN-2 RECEPTOR A-CHAIN PREDICTS A POOR PROGNOSIS	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract									[Nakase, Kazunori] Mie Univ Hosp, Ctr Canc, Tsu, Mie, Japan; [Kita, Kenkichi] Japan Baptist Hosp, Dept Internal Med, Kyoto, Japan; [Kyo, Taiichi] Hiroshima Red Cross & Atom Bomb Survivors Hosp, Dept Internal Med, Hiroshima, Japan; [Tanaka, Isao] Suzuka Kaisei Hosp, Dept Internal Med, Suzuka, Japan; [Katayama, Naoyuki] Mie Univ Hosp, Dept Hematol & Oncol, Tsu, Mie, Japan; [Tajima, Kazuo] Mie Univ, Sch Med, Dept Publ Hlth, Tsu, Mie 514, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	DEC	2014	10			8	SI	398	184	184				1	Oncology	Oncology	AU0ZN	WOS:000345350900325		
J	Uchida, M; Sugie, C; Yoshimura, M; Suzuki, E; Shibamoto, Y; Hiraoka, M; Akechi, T				Uchida, Megumi; Sugie, Chikao; Yoshimura, Michio; Suzuki, Eiji; Shibamoto, Yuuta; Hiraoka, Masahiro; Akechi, Tatsuo			FACTORS ASSOCIATED WITH PREFERENCE OF COMMUNICATION ABOUT LIFE EXPECTANCY WITH PHYSICIANS AMONG CANCER PATIENTS UNDER RADIATION THERAPY	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract									[Uchida, Megumi; Akechi, Tatsuo] Nagoya City Univ, Dept Psychiat & Cognit Behav Med, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Sugie, Chikao; Shibamoto, Yuuta] Nagoya City Univ, Dept Radiol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Yoshimura, Michio; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Suzuki, Eiji] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto, Japan; [Akechi, Tatsuo] Nagoya City Univ Hosp, Div Palliat Care & Psychooncol, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	DEC	2014	10			8	SI	471	208	208				1	Oncology	Oncology	AU0ZN	WOS:000345350900393		
J	Uchida, M; Okuyama, T; Sugie, C; Yoshimura, M; Suzuki, E; Shibamoto, Y; Hiraoka, M; Akechi, T				Uchida, Megumi; Okuyama, Toru; Sugie, Chikao; Yoshimura, Michio; Suzuki, Eiji; Shibamoto, Yuuta; Hiraoka, Masahiro; Akechi, Tatsuo			PREVALENCE OF FATIGUE AMONG CANCER PATIENTS UNDER RADIATION THERAPY AND ITS ASSOCIATED FACTORS	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract									[Uchida, Megumi; Okuyama, Toru; Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan; [Okuyama, Toru; Akechi, Tatsuo] Nagoya City Univ Hosp, Div Palliat Care & Psychooncol, Nagoya, Aichi, Japan; [Sugie, Chikao; Shibamoto, Yuuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Yoshimura, Michio; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Suzuki, Eiji] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	DEC	2014	10			8	SI	472	208	208				1	Oncology	Oncology	AU0ZN	WOS:000345350900394		
J	Lee, SI; Song, DH; Shin, DW; Kim, JH; Lee, YS; Hwang, JW; Park, TW; Yook, KH; Lee, JI; Bahn, GH; Hirata, Y; Goto, T; Takita, Y; Takahashi, M; Lee, S; Treuer, T				Lee, Soyoung Irene; Song, Dong-Ho; Shin, Dong Won; Kim, Ji Hoon; Lee, Young Sik; Hwang, Jun-Won; Park, Tae Won; Yook, Ki-Hwan; Lee, Jong Il; Bahn, Geon Ho; Hirata, Yuko; Goto, Taro; Takita, Yasushi; Takahashi, Michihiro; Lee, Sanghoon; Treuer, Tamas			Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder	ASIA-PACIFIC PSYCHIATRY			English	Article						ADHD; atomoxetine; executive function; Korea; quality of life	LIFE SCALE AAQOL; DEFICIT/HYPERACTIVITY DISORDER; CONTROLLED TRIALS; RANDOMIZED-TRIALS; QUALITY; METAANALYSIS; ADHD; TOLERABILITY; PREVALENCE; GENDER	IntroductionThis article aims to assess the efficacy and safety of atomoxetine in Korean adults with attention-deficit hyperactivity disorder (ADHD). MethodsThis post hoc double-blind, placebo-controlled study of atomoxetine (40-120mg/day) over 10 weeks in adults with ADHD at 45 Japanese, Korean, and Taiwanese study sites focused on patient data from Korea (atomoxetine, n=37; placebo, n=37). Primary efficacy outcome was change in baseline-to-endpoint Conners' Adult ADHD Rating Scale-Investigator-rated: Screening Version (CAARS-Inv:SV) Total ADHD Symptoms score. Secondary efficacy outcomes included changes in Adult ADHD Quality of Life (AAQoL) total, Behavior Rating Inventory of Executive Function-Adult Version Self-Report (BRIEF-A:Self-Report), and Clinical Global Impression-ADHD-Severity (CGI-ADHD-S) scale scores. ResultsAtomoxetine-treated patients demonstrated a mean 18.9-point reduction in CAARS-Inv:SV total ADHD Symptoms score, compared with the 7.45-point reduction in placebo-treated patients (P0.01). Significantly greater improvement was found for atomoxetine versus placebo in CGI-ADHD-S (P0.01), BRIEF-A:Self-Report global executive composite (P0.05), and metacognition index (P0.01) executive function scores. Nausea, decreased appetite, and dry mouth were reported with significantly greater frequency by atomoxetine-treated patients, and only one placebo-treated patient discontinued because of adverse event. A 2.1-kg reduction in weight and a 7.5-beat/minute increase in pulse rate were observed in atomoxetine-treated patients. DiscussionThese data support a significant benefit of 80- to 120-mg once daily atomoxetine versus placebo for treatment of ADHD in adult Korean patients. A high placebo response rate was observed in this adult Korean sample; a higher discontinuation rate was also observed in atomoxetine-treated patients. These observations warrant further investigation.	[Lee, Soyoung Irene] Soonchunhyang Univ, Bucheon Hosp, Coll Med, Dept Psychiat, Puchon, South Korea; [Song, Dong-Ho] Yonsei Univ, Coll Med, Severance Hosp, Dept Pediat Psychiat, Seoul, South Korea; [Shin, Dong Won] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Psychiat, Seoul, South Korea; [Kim, Ji Hoon] Pusan Natl Univ, Sch Med, Dept Psychiat, Yangsan Si, South Korea; [Lee, Young Sik] Chung Ang Univ, Coll Med, Med Ctr, Dept Neuropsychiat, Seoul 156756, South Korea; [Hwang, Jun-Won] Kangwon Natl Univ, Sch Med, Kangwon Natl Univ Hosp, Dept Neuropsychiat, Chunchon, South Korea; [Park, Tae Won] Chonbuk Natl Univ, Sch Med, Dept Psychiat, Jeonju, South Korea; [Yook, Ki-Hwan] CHA Univ, Sch Med, Bundang CHA Med Ctr, Dept Psychiat, Songnam, South Korea; [Lee, Jong Il] Seoul Natl Hosp, Dept Psychiat, Seoul, South Korea; [Bahn, Geon Ho] Kyung Hee Univ, Sch Med, Dept Neuropsychiat, Seoul, South Korea; [Hirata, Yuko; Goto, Taro; Takita, Yasushi; Takahashi, Michihiro] Eli Lilly Japan KK, Kobe, Hyogo, Japan; [Takahashi, Michihiro] Takahashi Psychiat Clin, Ashiya, Japan; [Lee, Sanghoon] Eli Lilly Korea Ltd, Seoul, South Korea; [Treuer, Tamas] Eli Lilly & Co, Neurosci Res, Budapest, Hungary	Lee, SI (reprint author), Eli Lilly Korea Ltd, STX Namsan Tower,631,Namdaemunro 5Ga, Seoul 100958, South Korea.	lee_sang_hoon@lilly.com			Eli Lilly and Company; Eli Lilly Korea	The authors would like to thank the principal investigators and their clinical staff, as well as the patients who generously agreed to participate in the main clinical trial. The authors would also like to thank Dr Shannon Gardell, PhD (inVentiv Health Clinical, LLC) for assistance with the preparation of the manuscript and Ms. Angela Lorio, ELS (inVentiv Health Clinical, LLC) for editorial assistance. This trial was funded by Eli Lilly and Company and/or any of its subsidiaries, Indianapolis, IN, USA. Drs Hirata, Goto, Takahashi, (Sanghoon) Lee and Treuer, as well as Mr Takita are employees of, and stake-holders in, Eli Lilly and Company. Dr Hwang has acted as a speaker in activities sponsored by Eli Lilly Korea and has participated in atomoxetine trials as a subinvestigator and an investigator. Dr Bahn was the recipient of a research grant from Eli Lilly and Company in 2010 to develop the adult ADHD scale. Drs (Soyoung Irene) Lee, Song, Shin, Kim, (Young Sik) Lee, Park, Yook, and (Jong Il) Lee have no conflicts of interest to declare.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Matza LS, 2007, QUAL LIFE RES, V16, P1511, DOI 10.1007/s11136-007-9254-9; Wender PH, 2001, ANN NY ACAD SCI, V931, P1; Buitelaar JK, 2012, J CLIN PSYCHIAT, V73, P1097, DOI 10.4088/JCP.11m07528; Hewitt CE, 2010, J CLIN EPIDEMIOL, V63, P1264, DOI 10.1016/j.jclinepi.2010.01.010; Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; GITTELMAN R, 1985, ARCH GEN PSYCHIAT, V42, P937; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Gaub M, 1997, J AM ACAD CHILD PSY, V36, P1036, DOI 10.1097/00004583-199708000-00011; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Park S, 2011, PSYCHIAT RES, V186, P378, DOI 10.1016/j.psychres.2010.07.047; Takahashi M, 2011, PSYCHIAT CLIN NEUROS, V65, P55, DOI 10.1111/j.1440-1819.2010.02159.x; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Waschbusch DA, 2009, J DEV BEHAV PEDIATR, V30, P158, DOI 10.1097/DBP.0b013e31819f1c15; Brod M, 2006, QUAL LIFE RES, V15, P117, DOI 10.1007/s11136-005-8325-z; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; Biederman J, 2004, BIOL PSYCHIAT, V55, P692, DOI 10.1016/j.biopsych.2003.12.003; DARMANSJAH I, 1992, CLIN PHARMACOL THER, V52, P449; Fillingim RB, 2005, MAYO CLIN PROC, V80, P1119; Goto T, 2013, J ATTEN DISORD, DOI [10.1177/1087054713510352., DOI 10.1177/1087054713510352]; Guy W., 1976, ECDEU ASSESSMENT MAN; Hong M, 2014, J CHILD ADOL PSYCHOP, V24, P341, DOI 10.1089/cap.2013.0090; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Kjaergard LL, 2001, ANN INTERN MED, V135, P982; Lee SI, 2007, PROG NEURO-PSYCHOPH, V31, P210, DOI 10.1016/j.pnpbp.2006.09.002; Lin KM, 2001, J CLIN PSYCHIAT, V62, P13; Matsui A, 2012, J CLIN PHARMACOL, V52, P388, DOI 10.1177/0091270011398657; National Institute of Mental Health, 1985, PSYCHOPHARMACOL BULL, V21, P839; Novik TS, 2006, EUR CHILD ADOLES PSY, V15, P15, DOI 10.1007/s00787-006-1003-z; Roth RM, 2005, BEHAV RATING INVENTO; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shimizu Takako, 2003, Drug Metab Pharmacokinet, V18, P48, DOI 10.2133/dmpk.18.48; van den Ban Els, 2010, Atten Defic Hyperact Disord, V2, P213, DOI 10.1007/s12402-010-0044-9	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-5864	1758-5872		ASIA-PAC PSYCHIAT	Asia-Pac. Psychiatry	DEC	2014	6	4					386	396		10.1111/appy.12160		11	Psychiatry	Psychiatry	AU4QH	WOS:000345596300005		
J	Kishi, T; Matsuda, Y; Iwata, N				Kishi, Taro; Matsuda, Yuki; Iwata, Nakao			The position of blonanserin as a treatment for schizophrenia	ASIA-PACIFIC PSYCHIATRY			English	Letter							EFFICACY		[Kishi, Taro; Matsuda, Yuki; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan	Kishi, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan.	tarok@fujita-hu.ac.jp					Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Garcia E, 2009, CNS DRUGS, V23, P615, DOI 10.2165/00023210-200923070-00006	2	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-5864	1758-5872		ASIA-PAC PSYCHIAT	Asia-Pac. Psychiatry	DEC	2014	6	4					462	462		10.1111/appy.12144		1	Psychiatry	Psychiatry	AU4QH	WOS:000345596300016		
J	Currie, T; Muto, T; Kudo, T; Honda, M; Brandt, TD; Grady, C; Fukagawa, M; Burrows, A; Janson, M; Kuzuhara, M; McElwain, MW; Follette, K; Hashimoto, J; Henning, T; Kandori, R; Kusakabe, N; Kwon, J; Mede, K; Morino, J; Nishikawa, J; Pyo, TS; Serabyn, G; Suenaga, T; Takahashi, Y; Wisniewski, J; Tamura, M				Currie, Thayne; Muto, Takayuki; Kudo, Tomoyuki; Honda, Mitsuhiko; Brandt, Timothy D.; Grady, Carol; Fukagawa, Misato; Burrows, Adam; Janson, Markus; Kuzuhara, Masayuki; McElwain, Michael W.; Follette, Katherine; Hashimoto, Jun; Henning, Thomas; Kandori, Ryo; Kusakabe, Nobuhiko; Kwon, Jungmi; Mede, Kyle; Morino, Jun-ichi; Nishikawa, Jun; Pyo, Tae-Soo; Serabyn, Gene; Suenaga, Takuya; Takahashi, Yasuhiro; Wisniewski, John; Tamura, Motohide			RECOVERY OF THE CANDIDATE PROTOPLANET HD 100546 b WITH GEMINI/NICI AND DETECTION OF ADDITIONAL (PLANET-INDUCED ?) DISK STRUCTURE AT SMALL SEPARATIONS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						planetary systems; stars: early-type; stars: individual (HD 100546)	ORBITING HR 8799; HERBIG AE STARS; SUN-LIKE STAR; SPACE-TELESCOPE; CIRCUMSTELLAR DISK; TRANSITIONAL DISK; BETA-PICTORIS; COMPANION; DISCOVERY; CONFIRMATION	We report the first independent, second epoch (re-) detection of a directly imaged protoplanet candidate. Using L' high-contrast imaging of HD 100546 taken with the Near-Infrared Coronagraph and Imager on Gemini South, we recover "HD 100546 b" with a position and brightness consistent with the original Very Large Telescope/NAos-COnica detection from Quanz et al., although data obtained after 2013 will be required to decisively demonstrate common proper motion. HD 100546 b may be spatially resolved, up to approximate to 12-13 AU in diameter, and is embedded in a finger of thermal IR-bright, polarized emission extending inward to at least 0 ''.3. Standard hot-start models imply a mass of approximate to 15 M-J. However, if HD 100546 b is newly formed or made visible by a circumplanetary disk, both of which are plausible, its mass is significantly lower (e.g., 1-7 M-J). Additionally, we discover a thermal IR-bright disk feature, possibly a spiral density wave, at roughly the same angular separation as HD 100546 b but 90 degrees. away. Our interpretation of this feature as a spiral arm is not decisive, but modeling analyses using spiral density wave theory implies a wave launching point exterior to approximate to 0 ''.45 embedded within the visible disk structure: plausibly evidence for a second, hitherto unseen, wide-separation planet. With one confirmed protoplanet candidate and evidence for one to two others, HD 100546 is an important evolutionary precursor to intermediate-mass stars with multiple super-Jovian planets at moderate/wide separations like HR 8799.	[Currie, Thayne; Kudo, Tomoyuki; Pyo, Tae-Soo] Subaru Telescope, NAOJ, Hilo, HI 96720 USA; [Muto, Takayuki] Kogashin Univ, Div Liberal Arts, Shinjuku Ku, Tokyo 1638677, Japan; [Honda, Mitsuhiko] Kanagawa Univ, Dept Math & Phys, Hiratsuka, Kanagawa 2591293, Japan; [Brandt, Timothy D.] Inst Adv Study, Dept Astrophys, Princeton, NJ 08540 USA; [Grady, Carol] Eureka Sci, Oakland, CA 96002 USA; [Fukagawa, Misato] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Burrows, Adam] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Janson, Markus] Stockholm Univ, SE-10691 Stockholm, Sweden; [Kuzuhara, Masayuki] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [McElwain, Michael W.] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; [Follette, Katherine] Univ Arizona, Steward Observ, Dept Astron, Tucson, AZ 85721 USA; [Hashimoto, Jun; Wisniewski, John] Univ Oklahoma, HL Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Henning, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Kandori, Ryo; Kusakabe, Nobuhiko; Morino, Jun-ichi; Nishikawa, Jun; Suenaga, Takuya; Takahashi, Yasuhiro; Tamura, Motohide] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Kwon, Jungmi; Mede, Kyle; Takahashi, Yasuhiro; Tamura, Motohide] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Serabyn, Gene] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Currie, T (reprint author), Subaru Telescope, NAOJ, 650 N Aohoku Pl, Hilo, HI 96720 USA.	currie@naoj.org					Thalmann C, 2009, ASTROPHYS J LETT, V707, pL123, DOI 10.1088/0004-637X/707/2/L123; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Geers VC, 2007, ASTRON ASTROPHYS, V476, P279, DOI 10.1051/0004-6361:20078466; Marois C, 2008, SCIENCE, V322, P1348, DOI 10.1126/science.1166585; Ardila DR, 2007, ASTROPHYS J, V665, P512, DOI 10.1086/519296; Marois C, 2010, NATURE, V468, P1080, DOI 10.1038/nature09684; Hernandez J, 2007, ASTROPHYS J, V662, P1067, DOI 10.1086/513735; Pogodin MA, 2012, ASTRON NACHR, V333, P594, DOI 10.1002/asna.201211706; Lagrange AM, 2010, SCIENCE, V329, P57, DOI 10.1126/science.1187187; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; Beuzit J., 2008, P SOC PHOTO-OPT INS, V7014, P41; Biller BA, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L22; Boccaletti A, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322365; Bonnefoy M., 2014, ASTRON ASTROPHYS, V562, P127; Brandt TD, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/183; Brittain SD, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/136; Carson J, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/2/L32; Chun M., 2008, P SOC PHOTO-OPT INS, V7015, P70151; Cieza LA, 2013, ASTROPHYS J LETT, V762, DOI 10.1088/2041-8205/762/1/L12; Cloutier R., 2014, APJ IN PRESS; Currie T, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L32; Currie T, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L30; Currie T, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/128; Currie T, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/133; Currie T, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/15; Fujii YI, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/101; Garufi A, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322429; Grady CA, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/48; Grady CA, 2005, ASTROPHYS J, V630, P958, DOI 10.1086/430731; Huelamo N, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016395; Kenyon SJ, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/70; Kraus AL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/5; Kuzuhara M, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/11; Lyra W., 2014, A A IN PRESS; Macintosh B.A., 2008, P SOC PHOTO-OPT INS, V7015, P31; Marois C., 2010, P SOC PHOTO-OPT INS, V7736, P52; Mawet D, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/97; Milli J., 2012, ASTRON ASTROPHYS, V545, P111; Muto T, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/2/L22; Olofsson J, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220675; Pineda JE, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L34; Quanz SP, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/1/L1; Quanz SP, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/1/L2; Quillen AC, 2006, ASTROPHYS J, V640, P1078, DOI 10.1086/500165; Rameau J, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L26; Reggiani M, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L23; Soummer R, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L28; Spiegel DS, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/174; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Walsh C, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/1/L6; Zhu Z., 2014, APJ IN PRESS	51	17	17	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	DEC 1	2014	796	2							L30	10.1088/2041-8205/796/2/L30		6	Astronomy & Astrophysics	Astronomy & Astrophysics	AU3HP	WOS:000345503400009		
J	Inagaki, T; Nakanishi, R; Odintsov, SD				Inagaki, T.; Nakanishi, R.; Odintsov, S. D.			Inflationary parameters in renormalization group improved I center dot (4) theory	ASTROPHYSICS AND SPACE SCIENCE			English	Article						Inflation; Renormalization group; Effective Lagrangian; Spectrum index; Tensor-to-scalar ratio	CURVED SPACE-TIME; RUNNING INFLATION; MODEL	Inflation models can be examined by the cosmological observations, WMAP, Planck, BICEP2 and so on. These observations directly constrain the spectral index, n (s) , and the tensor-to-scalar ratio, r. Besides, from a theoretical point of view, it has been shown that any inflation models asymptote a universal attractor in (n (s) ,r) plane for a larger scalar-gravity coupling. In this work we consider a simple chaotic inflation model with a scalar quartic and a scalar-curvature interactions. The quantum corrections are introduced for these interactions through the renormalization group. The inflationary parameters, n (s) and r, are numerically calculated with shifting the bare scalar-gravity coupling xi (0), the quartic scalar bare coupling lambda (0), the renormalization scale mu and the e-folding number N. The Planck data is consistent with the I center dot (4) theory with a finite scalar-curvature coupling. It is found that the renormalization group running induces a non-universal contribution for n (s) and r. It can increase the tensor-to-scalar ratio, r, which is consistent with Planck data so that it may approach the BICEP2 data for a small renormalization scale.	[Inagaki, T.] Hiroshima Univ, Informat Media Ctr, Higashihiroshima 7398521, Japan; [Nakanishi, R.] Hiroshima Univ, Dept Phys, Higashihiroshima 7398526, Japan; [Odintsov, S. D.] ICREA, Barcelona, Spain; [Odintsov, S. D.] ICE CSIC IEEC, CSIC, Bellaterra 08193, Spain; [Odintsov, S. D.] Tomsk State Pedag Univ, Tomsk 634061, Russia; [Odintsov, S. D.] Natl Res Tomsk State Univ, Tomsk 634050, Russia	Inagaki, T (reprint author), Hiroshima Univ, Informat Media Ctr, Higashihiroshima 7398521, Japan.	inagaki@hiroshima-u.ac.jp			JSPS KAKENHI [26400250]; MINECO (Spain) [FIS2010-15640]; MES (Russia) [TSPU-139]	The authors are grateful to K. Yamamoto for fruitful discussions. TI is supported by JSPS KAKENHI Grant Number 26400250. SDO is supported in part by MINECO (Spain), FIS2010-15640 and by MES project TSPU-139 (Russia).	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321569; ELIZALDE E, 1994, Z PHYS C PART FIELDS, V64, P699, DOI 10.1007/BF01957780; Barenboim G, 2014, PHYS LETT B, V730, P81, DOI 10.1016/j.physletb.2014.01.039; De Simone A, 2009, PHYS LETT B, V678, P1, DOI 10.1016/j.physletb.2009.05.054; Kobakhidze A, 2013, PHYS LETT B, V722, P130, DOI 10.1016/j.physletb.2013.04.013; Lee HM, 2013, PHYS LETT B, V722, P198, DOI 10.1016/j.physletb.2013.04.024; LINDE AD, 1983, PHYS LETT B, V129, P177, DOI 10.1016/0370-2693(83)90837-7; MUTA T, 1991, MOD PHYS LETT A, V6, P3641, DOI 10.1142/S0217732391004206; ELIZALDE E, 1993, PHYS LETT B, V303, P240, DOI 10.1016/0370-2693(93)91427-O; Ade PAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.241101; Kallosh R, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.011303; Elizalde E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.084001; Bamba K., 2014, ARXIV14062417HEPTH; Buchbinder I., 1992, EFFECTIVE ACTION QUA; Buchel A., 2005, JCAP, V0503; Hamada Y., 2014, J HIGH ENERGY PHYS, V1407, P026; Herranen M., 2014, ARXIV14073141HEPPH; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Inagaki T, 1997, PROG THEOR PHYS SUPP, P93; Kallosh R., 2013, J COSMOL ASTROPART P, V1310; Oda I., 2014, ARXIV14041538HEPPH; ODINTSOV SD, 1993, PHYS LETT B, V306, P233, DOI 10.1016/0370-2693(93)90073-Q; Okada N., 2013, ARXIV13110921HEPPH	24	5	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0004-640X	1572-946X		ASTROPHYS SPACE SCI	Astrophys. Space Sci.	DEC	2014	354	2					627	632		10.1007/s10509-014-2108-3		6	Astronomy & Astrophysics	Astronomy & Astrophysics	AU1QO	WOS:000345395400040		
J	Shi, YS; Yamaguchi, Y				Shi, Yusheng; Yamaguchi, Yasushi			A high-resolution and multi-year emissions inventory for biomass burning in Southeast Asia during 2001-2010	ATMOSPHERIC ENVIRONMENT			English	Article						Biomass burning emissions; Burned area; High resolution; Southeast Asia	FOREST; CARBON; CHINA; PARTICULATE; VARIABILITY; INDONESIA; STRAW; FIRES; PEAT	Biomass burning (BB) emissions from forest fires, agricultural waste burning, and peatland combustion contain large amounts of greenhouse gases (e.g., CO2, CH4, and N2O), which significantly impact ecosystem productivity, global atmospheric chemistry, and climate change. With the help of recently released satellite products, biomass density based on satellite and observation data, and spatiotemporal variable combustion factors, this study developed a new high-resolution and multi-year emissions inventory for BB in Southeast Asia (SEA) during 2001-2010. The 1-km grid was effective for quantifying emissions from small-sized fires that were frequently misinterpreted by coarse grid data due to their large smoothed pixels. The average annual BB emissions in SEA during 2001-2010 were 277 Gg SO2, 1125 Gg NOx, 55,388 Gg CO, 3831 Gg NMVOC, 553 Gg NH3, 324 Gg BC, 2406 Gg OC, 3832 Gg CH4, 817,809 Gg CO2, and 99 Gg N2O. Emissions were high in western Myanmar, Northern Thailand, eastern Cambodia, northern Laos, and South Sumatra and South Kalimantan of Indonesia. Emissions from forest burning were the dominant contributor to the total emissions among all land types. The spatial pattern of BB emissions was consistent with that of the burned areas. In addition, BB emissions exhibited similar temporal trends from 2001 to 2010, with strong interannual and intraannual variability. Interannual and intraannual emission peaks were seen during 2004, 2007, 2010, and January March and August October, respectively. (C) 2014 Elsevier Ltd. All rights reserved.	[Shi, Yusheng] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Shi, Yusheng; Yamaguchi, Yasushi] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Environm Sci, Nagoya, Aichi 4648601, Japan	Shi, YS (reprint author), Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan.	shiyusheng@gmail.com		Shi, Yusheng/0000-0001-7256-3628			Chang D, 2010, ATMOS CHEM PHYS, V10, P2335; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Shi YS, 2014, ECOL MODEL, V272, P98, DOI 10.1016/j.ecolmode1.2013.09.021; Kanabkaew T, 2011, ENVIRON MODEL ASSESS, V16, P453, DOI 10.1007/s10666-010-9244-0; Marlier ME, 2013, NAT CLIM CHANGE, V3, P131, DOI [10.1038/nclimate1658, 10.1038/NCLIMATE1658]; Field RD, 2009, NAT GEOSCI, V2, P185, DOI 10.1038/NGEO443; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Giglio L, 2010, BIOGEOSCIENCES, V7, P1171; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423; Randerson JT, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002128; Giglio L, 2009, REMOTE SENS ENVIRON, V113, P408, DOI 10.1016/j.rse.2008.10.006; Li XG, 2007, ENVIRON SCI TECHNOL, V41, P6052, DOI 10.1021/es0705137; HARMON ME, 1991, BIOSCIENCE, V41, P604, DOI 10.2307/1311697; Huang X, 2011, ENVIRON SCI TECHNOL, V45, P9442, DOI 10.1021/es202224e; Taylor D, 2010, BIODIVERS CONSERV, V19, P1025, DOI 10.1007/s10531-009-9756-6; Cao GL, 2008, CHINESE SCI BULL, V53, P784, DOI 10.1007/s11434-008-0145-4; Permadi DA, 2013, ATMOS ENVIRON, V78, P250, DOI 10.1016/j.atmosenv.2012.10.016; Christian TJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003704; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Field RD, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000694; Hoelzemann JJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003666; IPCC, 2000, GOOD PRACT GUID UNC; IPCC, 2006, AGR FOR OTH LAND US, V4; Jones D.S., 2006, ASIA EUROPE J, V4, P431, DOI 10.1007/s10308-006-0067-1; Liu Chun-jiang, 2003, Journal of Forestry Research (Harbin), V14, P27; SEILER W, 1980, CLIMATIC CHANGE, V2, P207, DOI 10.1007/BF00137988; Song Y, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003344; Song Y, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014014; Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093; Zhang XY, 2008, ATMOS ENVIRON, V42, P6959, DOI 10.1016/j.atmosenv.2008.04.060	32	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	DEC	2014	98						8	16		10.1016/j.atmosenv.2014.08.050		9	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AU2WI	WOS:000345475000002		
J	Loyola-Rodriguez, JP; Garcia-Cortes, JO; Martinez-Martinez, RE; Patino-Marin, N; Martinez-Castanon, GA; Zavala-Alonso, NV; Amano, A				Loyola-Rodriguez, J. P.; Garcia-Cortes, J. O.; Martinez-Martinez, R. E.; Patino-Marin, N.; Martinez-Castanon, G. A.; Zavala-Alonso, N. V.; Amano, A.			Molecular identification and antibiotic resistant bacteria isolated from primary dentition infections	AUSTRALIAN DENTAL JOURNAL			English	Article						Antibiotic; bacterial resistance; children; dental infection; primary dentition	POLYMERASE-CHAIN-REACTION; PCR-BASED IDENTIFICATION; DNA-DNA HYBRIDIZATION; RIBOSOMAL-RNA GENE; ENDODONTIC INFECTIONS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ANTIMICROBIAL SUSCEPTIBILITY; PORPHYROMONAS-GINGIVALIS; STAPHYLOCOCCUS-AUREUS; CLINICAL IMPACT	BackgroundBacterial resistance to antibiotics is a health problem in many parts of the world. The aim of this study was to identify bacteria from dental infections and determine bacterial resistance to antibiotics used in dental care in the primary dentition. MethodsThis cross-sectional study comprised 60 children who presented for dental treatment for active dental infections in the primary dentition. Samples from dental infections were collected and bacteria were identified by polymerase chain reaction (PCR) assay. Bacterial resistance to antibiotics was determined by colony forming units on agar plates containing amoxicillin, clindamycin and amoxillicin-clavulanic acid (A-CA) tested at 8 g/ml or 16 g/ml. ResultsClindamycin in both concentrations tested (8 g/ml and 16 g/ml) showed the highest bacterial resistance (85.9%), followed by amoxicillin (43.7%) and A-CA (12.0%). All comparisons among the three antibiotics used in the study exhibited statistical significance (p = <0.05) in both concentrations tested (8 g/ml and 16 g/ml), and under aerobic and anaerobic conditions. The most prevalent resistant species identified by PCR in primary dentition infections were: Streptococcus oralis and Prevotella intermedia (75.0%); Treponema denticola and Porphyromonas gingivalis (48.3%); Streptococcus mutans (45.0%); Campylobacter rectus; and Streptococcus salivarius (40%). ConclusionsThis study demonstrated that A-CA exhibited the lowest bacterial resistance for clinical isolates in primary dentition infections.	[Loyola-Rodriguez, J. P.; Garcia-Cortes, J. O.; Martinez-Martinez, R. E.; Patino-Marin, N.; Martinez-Castanon, G. A.; Zavala-Alonso, N. V.] San Luis Potosi Univ, Dent Sci Program Specializat Adv Educ Gen Dent, San Luis Potosi 78250, SLP, Mexico; [Amano, A.] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka, Japan	Loyola-Rodriguez, JP (reprint author), San Luis Potosi Univ, Mariano Avila 295-2, San Luis Potosi 78250, SLP, Mexico.	jloyola@uaslp.mx	Martinez-Castanon, Gabriel-Alejandro/A-5797-2010	Martinez-Castanon, Gabriel-Alejandro/0000-0003-4982-5225	PIFI; CB-CONACYT	This research was supported by grants PIFI 2012 and CB-CONACYT.	Landersdorfer CB, 2009, ANTIMICROB AGENTS CH, V53, P2569, DOI 10.1128/AAC.01119-08; Poeschl PW, 2010, ORAL SURG ORAL MED O, V110, P151, DOI 10.1016/j.tripleo.2009.12.039; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Sobottka I, 2012, ANTIMICROB AGENTS CH, V56, P2565, DOI 10.1128/AAC.06428-11; Fouad AF, 2002, J CLIN MICROBIOL, V40, P3223, DOI 10.1128/JCM.40.9.3223-3231.2002; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; Siqueira JF, 2009, ORAL SURG ORAL MED O, V107, P721, DOI 10.1016/j.tripleo.2009.01.042; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Khemaleelakul S, 2002, ORAL SURG ORAL MED O, V94, P746, DOI 10.1067/moe.2002.129535; Tavares WLF, 2011, INT ENDOD J, V44, P225, DOI 10.1111/j.1365-2591.2010.01805.x; Stubbs S, 1999, J MED MICROBIOL, V48, P1017; Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Tran SD, 1996, J CLIN MICROBIOL, V34, P2674; Dajani AS, 1997, CIRCULATION, V96, P358; Rocas IN, 2011, J ENDODONT, V37, P1206, DOI 10.1016/j.joen.2011.05.026; Sassone LM, 2012, J ENDODONT, V38, P889, DOI 10.1016/j.joen.2012.03.021; Ricucci D, 2010, J ENDODONT, V36, P1277, DOI 10.1016/j.joen.2010.04.007; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Kadlec K, 2012, CLIN MICROBIOL INFEC, V18, P745, DOI 10.1111/j.1469-0691.2012.03842.x; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P1267; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Poeschl PW, 2011, J ENDODONT, V37, P1201, DOI 10.1016/j.joen.2011.05.029; Ardila CM, 2010, MED ORAL PATOL ORAL, V15, P947; Burton MJ, 2008, AM J MED, V121, P484, DOI 10.1016/j.amjmed.2007.11.024; Cogulu D, 2008, ORAL SURG ORAL MED O, V106, P443, DOI 10.1016/j.tripleo.2008.03.004; Conrads G, 1996, J PERIODONTOL, V67, P994; Gomes BPFA, 2011, J ENDODONT, V37, P1058, DOI 10.1016/j.joen.2011.05.015; GONCHAROFF P, 1993, ORAL MICROBIOL IMMUN, V8, P105, DOI 10.1111/j.1399-302X.1993.tb00554.x; Maestre JR, 2007, REV ESP QUIM, V20, P61; Martinez-Martinez RE, 2009, J CLIN PERIODONTOL, V36, P1004, DOI 10.1111/j.1600-051X.2009.01496.x; Pazelli Luciana Cunha, 2003, Pesqui Odontol Bras, V17, P367; Rams TE, 2012, J PERIODONTAL RES, V48, P493; Rocas IN, 2004, J ENDODONT, V30, P15; Silva-Soares GM, 2012, J APPL ORAL SCI, V20, P295; Watanabe K, 1996, J CLIN PERIODONTOL, V23, P212, DOI 10.1111/j.1600-051X.1996.tb02078.x	40	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0421	1834-7819		AUST DENT J	Aust. Dent. J.	DEC	2014	59	4					497	503		10.1111/adj.12213		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU4JF	WOS:000345576100014		
J	Miyake, K; Adachi, K; Watanabe, M; Sasatomi, Y; Ogahara, S; Abe, Y; Ito, K; Dan Justin, YK; Saito, T; Nakashima, H; Hamano, S				Miyake, Katsuhisa; Adachi, Keishi; Watanabe, Maho; Sasatomi, Yoshie; Ogahara, Satoru; Abe, Yasuhiro; Ito, Kenji; Dan Justin, Yombo K.; Saito, Takao; Nakashima, Hitoshi; Hamano, Shinjiro			Parasites alter the pathological phenotype of lupus nephritis	AUTOIMMUNITY			English	Article						Diffuse proliferative lupus nephritis; membranous lupus nephritis; MRL/lpr mice; Schistosoma manson; Th2 type immune responses	T-HELPER-CELLS; IDIOPATHIC MEMBRANOUS NEPHROPATHY; MURINE SCHISTOSOMIASIS-MANSONI; HELMINTH INFECTION PROTECTS; I CYTOKINE RECEPTOR; SYSTEMIC AUTOIMMUNITY; AIRWAY INFLAMMATION; IMMUNE-RESPONSE; IGG SUBCLASSES; TH2 RESPONSES	Lupus nephritis is one of the most serious complications of systemic lupus erythematosus and manifests with considerable phenotypic and histological heterogeneity. In particular, diffuse proliferative lupus nephritis (DPLN) and membranous lupus nephritis (MLN) represent morphologic forms that are polar opposites. DPLN is associated with autoimmune responses dominated by Th1 immune response associated with high levels of interferon (IFN)-gamma. In contrast, a Th2 cytokine response is associated with the pathogenesis of MLN. MRL/lpr mice develop human LN-like immune complex-associated nephritis and provide a suitable histological model for human DPLN. Infection with Schistosoma mansoni skewed a Th2-type immune response induction and IL-10 in MRL/lpr mice, drastically changing the pathophysiology of glomerulonephritis from DPLN to MLN accompanied by increased IgG1 and IgE in the sera. T cells in 32-week-old MRL/lpr mice infected with S. mansoni expressed significantly more IL-4 and IL-10 than T cells of uninfected mice; T cells with IFN-gamma were comparable between infected and uninfected MR/lpr mice. Thus, the helminthic infection modified the cytokine microenvironment and altered the pathological phenotype of autoimmune nephritis.	[Miyake, Katsuhisa; Watanabe, Maho; Sasatomi, Yoshie; Ogahara, Satoru; Abe, Yasuhiro; Ito, Kenji; Saito, Takao; Nakashima, Hitoshi] Fukuoka Univ, Fac Med, Dept Internal Med, Div Nephrol & Rheumatol, Fukuoka 8140180, Japan; [Adachi, Keishi; Dan Justin, Yombo K.; Hamano, Shinjiro] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Parasitol, Nagasaki 852, Japan; [Adachi, Keishi; Dan Justin, Yombo K.; Hamano, Shinjiro] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan; [Hamano, Shinjiro] Nagasaki Univ, Nairobi Res Stn, NUITM KEMRI Project, Nairobi, Kenya	Nakashima, H (reprint author), Fukuoka Univ, Fac Med, Dept Internal Med, Div Nephrol & Rheumatol,Johnan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	hnakashi@fukuoka-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Technology, Sports and Culture of Japan [21591049, 21591048, 24591221]	This study is supported, in part, by a grant for the Progressive Renal Research Projects from the Ministry of Health, Labor and Welfare of Japan (to T. S.) and grants from the Ministry of Education, Science, Technology, Sports and Culture of Japan to T. S. (#21591049) and H. N. (#21591048, #24591221).	Adachi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082698; Andrade ZA, 2004, MEM I OSWALDO CRUZ, V99, P51, DOI 10.1590/S0074-02762004000900009; Yoshimura T, 2006, J IMMUNOL, V177, P5377; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Chen Q, 2000, NATURE, V407, P916; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Platts-Mills TAE, 2004, SPRINGER SEMIN IMMUN, V25, P271, DOI 10.1007/s00281-003-0149-8; DOI T, 1984, CLIN EXP IMMUNOL, V58, P57; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Akahoshi M, 1999, ARTHRITIS RHEUM, V42, P1644, DOI 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L; Theofilopoulos AN, 1999, P ASSOC AM PHYSICIAN, V111, P228, DOI 10.1046/j.1525-1381.1999.99244.x; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Shimizu S, 2005, J IMMUNOL, V175, P7185; Hoffmann KF, 2000, J IMMUNOL, V164, P6406; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Fallon PG, 2000, IMMUNOL TODAY, V21, P29, DOI 10.1016/S0167-5699(99)01551-0; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Igawa T, 2009, MOD RHEUMATOL, V19, P33, DOI 10.1007/s10165-008-0117-1; Masutani K, 2004, NEPHROL DIAL TRANSPL, V19, P580, DOI 10.1093/ndt/gfg572; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; APPEL GB, 1987, AM J MED, V83, P877, DOI 10.1016/0002-9343(87)90645-0; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Haas C, 1997, J IMMUNOL, V158, P5484; Negrao-Correa D, 2003, INFECT IMMUN, V71, P2607, DOI 10.1128/IAI.71.5.2607-2614.2003; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Mangan NE, 2004, J IMMUNOL, V173, P6346; JENNETTE JC, 1983, KIDNEY INT, V24, P377, DOI 10.1038/ki.1983.170; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; Bashir MEH, 2002, J IMMUNOL, V169, P3284; Kikawada E, 2003, J IMMUNOL, V170, P3915; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Appel G. D. A., 2007, DUBOIS LUPUS ERYTHEM, P1049; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Correa-Oliveira R, 1998, BRAZ J MED BIOL RES, V31, P171, DOI 10.1590/S0100-879X1998000100024; DONADIO JV, 1977, MEDICINE, V56, P527, DOI 10.1097/00005792-197711000-00007; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; KLINMAN DM, 1995, IMMUNOL REV, V144, P157; Liu XD, 2002, AM J PHYSIOL-LUNG C, V282, pL1049, DOI 10.1152/ajplung.00321.2001; MOSMANN TR, 1991, ANN NY ACAD SCI, V628, P337, DOI 10.1111/j.1749-6632.1991.tb17266.x; Sloan RP, 1996, J AM SOC NEPHROL, V7, P299; Wynn TA, 1998, J IMMUNOL, V160, P4473; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	51	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0891-6934	1607-842X		AUTOIMMUNITY	Autoimmunity	DEC	2014	47	8					538	547		10.3109/08916934.2014.929669		10	Immunology	Immunology	AU3FK	WOS:000345497700007		
J	Sugiura, M; Ozaki, Y; Nakamura, M; Cox, N; Rappaport, F; Boussac, A				Sugiura, Miwa; Ozaki, Yui; Nakamura, Masato; Cox, Nicholas; Rappaport, Fabrice; Boussac, Alain			The D1-173 amino acid is a structural determinant of the critical interaction between D1-Tyr161 (Tyr(z)) and D1-His190 in Photosystem II	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						Photosystem II; PsbA; D1; Thermosynechococcus elongatus; Tyr(z); Proline	PHOTOSYNTHETIC WATER OXIDATION; TYROSINE Y-Z; THERMOSYNECHOCOCCUS-ELONGATUS BP-1; HIGH-FIELD EPR; GENE-EXPRESSION; D1 PROTEIN; P680(+CENTER-DOT) REDUCTION; PRIMARY PHOTOCHEMISTRY; OXYGEN EVOLUTION; CORE COMPLEXES	The main cofactors of Photosystem II (PSII) are borne by the D1 and D2 subunits. In the thermophilic cyanobacterium The rmosynechococcus elongatus, three psbA genes encoding D1 are found in the genome. Among the 344 residues constituting the mature form of D1, there are 21 substitutions between PsbAl and PsbA3, 31 between PsbAl and PsbA2, and 27 between PsbA2 and PsbA3. In a previous study (Sugiura et al., J. Biol. Chem. 287 (2012), 13336-13347) we found that the oxidation kinetics and spectroscopic properties of Tyr(z) were altered in PsbA2-PSII when compared to PsbA(1/3)-PSII. The comparison of the different amino add sequences identified the residues Cys144 and Pro173 found in PsbAl and PsbA3, as being substituted in PsbA2 by Pro144 and Met173, and thus possible candidates accounting for the changes in the geometry and/or the environment of the Tyr(z)/His190 phenol/imidizol motif. Indeed, these amino acids are located upstream of the alpha-helix bearing Tyr(z) and between the two alpha-helices bearing Tyr(z) and its hydrogen-bonded partner, Dl/His190. Here, site-directed mutants of PSII, PsbA3/Pro173Met and PsbA2/Met173Pro, were analyzed using X-and W-band EPR and UV-visible time-resolved absorption spectroscopy. The Pro173Met substitution in PsbA2-PSII versus PsbA3-PSII is shown to be the main structural determinant of the previously described functional differences between PsbA2-PSII and PsbA3-PSII. In PsbA2-PSII and PsbA3/Pro173Met-PSII, we found that the oxidation of Tyr(z) by P-680(+center dot) was specifically slowed during the transition between S-states associated with proton release. We thus propose that the increase of the electrostatic charge of the Mn4CaO5 cluster in the S-2 and S-3 states could weaken the strength of the H-bond interaction between Tyr(z)(center dot) and Dl/His190 in PsbA2 versus PsbA3 and/or induce structural modification(s) of the water molecules network around Tyr(z). (C) 2014 Elsevier B.V. All rights reserved.	[Sugiura, Miwa; Ozaki, Yui] Ehime Univ, Proteosci Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa; Nakamura, Masato] Ehime Univ, Dept Chem, Grad Sch Sci & Technol, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa] Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Cox, Nicholas] Max Planck Inst Chem Energiekonvers, D-45470 Mulheim, Germany; [Rappaport, Fabrice] CNRS, UMR 7141, Inst Biol Physicochim, F-75005 Paris, France; [Rappaport, Fabrice] Univ Paris 06, F-75005 Paris, France; [Boussac, Alain] CEA Saclay, IBiTec S, CNRS UMR 8221, F-91191 Gif Sur Yvette, France	Sugiura, M (reprint author), Ehime Univ, Proteosci Res Ctr, Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	miwa.sugiura@ehime-u.ac.jp; alain.boussac@cea.fr	Cox, Nicholas/J-8047-2014		JST-PRESTO program [4018]; Ministry of Education, Science, Sports, Culture and Technology [21612007]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; CEA/DSV "Bioenergie" program; CNRS; French state [ANR11-LABX-0011-01]	This study was supported by JST-PRESTO program (4018 for M.S.) and Grant-in-Aid for scientific research from the Ministry of Education, Science, Sports, Culture and Technology (21612007 for M.S.). AB was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01 and the CEA/DSV "Bioenergie" program. FR acknowledges financial support from the CNRS and the "Initiative d'Excellence" program from the French state (Grant "DYNAMO", ANR11-LABX-0011-01).	Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; RAPPAPORT F, 1991, BIOCHEMISTRY-US, V30, P10004, DOI 10.1021/bi00105a027; Boussac A, 2012, BBA-BIOENERGETICS, V1817, P802, DOI 10.1016/j.bbabio.2012.02.031; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; Murray JW, 2012, PHOTOSYNTH RES, V110, P177, DOI 10.1007/s11120-011-9714-5; Bao H, 2013, PHOTOSYNTH RES, V116, P215, DOI 10.1007/s11120-013-9907-1; Sugiura M, 2012, J BIOL CHEM, V287, P13336, DOI 10.1074/jbc.M112.340323; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P9973, DOI 10.1073/pnas.90.21.9973; Rappaport F, 2009, J AM CHEM SOC, V131, P4425, DOI 10.1021/ja808604h; Schilstra MJ, 1998, BIOCHEMISTRY-US, V37, P3974, DOI 10.1021/bi9713815; Boussac A, 2013, BBA-BIOENERGETICS, V1827, P1174, DOI 10.1016/j.bbabio.2013.06.002; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Mulo P, 2012, BBA-BIOENERGETICS, V1817, P247, DOI 10.1016/j.bbabio.2011.04.011; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; Christen G, 1999, BIOCHEMISTRY-US, V38, P2068, DOI 10.1021/bi982188t; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; TOMMOS C, 1995, J AM CHEM SOC, V117, P10325, DOI 10.1021/ja00146a017; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Petrouleas V, 2005, BIOCHEMISTRY-US, V44, P6723, DOI 10.1021/bi0503201; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Zhang XH, 2012, PHOTOSYNTH RES, V114, P133, DOI 10.1007/s11120-012-9783-0; Boussac A, 2008, PHILOS T R SOC B, V363, P1203, DOI 10.1098/rstb.2007.2216; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Kiss E, 2012, BBA-BIOENERGETICS, V1817, P1083, DOI 10.1016/j.bbabio.2012.04.010; Retegan M, 2014, PHYS CHEM CHEM PHYS, V16, P11901, DOI 10.1039/c4cp00696h; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Nakamura S, 2014, BIOCHEMISTRY-US, V53, P3131, DOI 10.1021/bi500237y; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1427, DOI 10.1016/j.bbabio.2013.12.011; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Debus R.J., 2014, BIOCHIM BIO IN PRESS; Dorlet P, 1999, J PHYS CHEM B, V103, P10945, DOI 10.1021/jp992420k; GOLDEN SS, 1995, J BACTERIOL, V177, P1651; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; Klauss A, 2012, BBA-BIOENERGETICS, V1817, P1196, DOI 10.1016/j.bbabio.2012.04.017; Komenda J, 2000, PLANT MOL BIOL, V42, P635, DOI 10.1023/A:1006305308196; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Koua F.H.M., 2013, P NATL ACAD SCI USA, V110, P3389; Kuhn P, 2004, PHYS CHEM CHEM PHYS, V6, P4838, DOI 10.1039/b407656g; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; MINO H, 1994, BBA-BIOENERGETICS, V1185, P213, DOI 10.1016/0005-2728(94)90212-7; Noguchi T., 2014, BIOCHIM BIO IN PRESS; Sanakis Y, 2001, J AM CHEM SOC, V123, P10766, DOI 10.1021/ja016418u; Sander J, 2010, J BIOL CHEM, V285, P29851, DOI 10.1074/jbc.M110.127142; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219; Sugiura M., 2013, BIOCHIM BIOPHYS ACTA, V1837, P139; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m; Teutloff C., 2009, PHYS CHEM CHEM PHYS, V11, P6716; UN S, 1994, P NATL ACAD SCI USA, V91, P5262, DOI 10.1073/pnas.91.12.5262; Un S, 1996, BIOCHEMISTRY-US, V35, P679, DOI 10.1021/bi9523769; Un S, 2007, BIOCHEMISTRY-US, V46, P3138, DOI 10.1021/bi062084f	62	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	DEC	2014	1837	12					1922	1931		10.1016/j.bbabio.2014.08.008		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AU6RO	WOS:000345729800002		
J	Hayashi, T; Ikehata, S; Matsuzaki, H; Yasuda, K; Makihara, T; Futamura, A; Arakawa, Y; Kuki, R; Fukuura, K; Takahashi, H; Mori, N; Higashiguchi, T; Yamada, S				Hayashi, Takahiro; Ikehata, Saori; Matsuzaki, Haruna; Yasuda, Kimio; Makihara, Toshiyasu; Futamura, Akihiko; Arakawa, Yuki; Kuki, Rika; Fukuura, Kumiko; Takahashi, Hiroshi; Mori, Naoharu; Higashiguchi, Takashi; Yamada, Shigeki			Influence of Serum Albumin Levels during Opioid Rotation from Morphine or Oxycodone to Fentanyl for Cancer Pain	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						serum albumin level; opioid rotation; fentanyl; cancer pain; numerical rating scale	TRANSDERMAL FENTANYL; ORAL MORPHINE; BINDING; CONVERSION; PROFILES; SUPPORT; HEAT; RAT	Morphine, oxycodone, and fentanyl are commonly used to control cancer pain. Because these drugs have differences in receptor affinity or pharmacokinetic parameters, changing the opioid formulation may result in an unexpected outcome, depending on the patient's condition. This study investigated whether low serum protein levels influence the effectiveness of opioid rotation by determining the impact of serum albumin levels on the analgesic effect before and after opioid rotation from morphine or oxycodone to fentanyl in cancer patients. The patients were classified into 3 groups according to their serum albumin levels before opioid rotation: group 1, <2.5g/dL; group 2, from 2.5g/dL to <3.0g/dL; and group 3, >= 3.0g/dL. There was no significant change in the percentage of patients with good pain control after rotation in group 1 or group 2; however, the percentage of patients with good pain control increased significantly in group 3. When the percentage of patients whose numerical rating scale scores increased, were unchanged, or decreased after rotation were compared, a significant difference in the percentage of those showing improvement was noted among the 3 groups and between groups 1 and 3. These findings suggest that monitoring serum albumin levels during fentanyl therapy is useful for pain management, and that the effectiveness of opioid rotation to fentanyl in patients with serum albumin levels of <2.5 g/dL should be carefully evaluated after rotation.	[Hayashi, Takahiro; Makihara, Toshiyasu; Arakawa, Yuki; Kuki, Rika; Fukuura, Kumiko; Yamada, Shigeki] Fujita Hlth Univ Hosp, Dept Pharm, Toyoake, Aichi 4701192, Japan; [Futamura, Akihiko; Mori, Naoharu; Higashiguchi, Takashi] Fujita Hlth Univ, Sch Med, Dept Surg & Palliat Med, Toyoake, Aichi 4701192, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Div Med Stat, Toyoake, Aichi 4701192, Japan; [Ikehata, Saori; Matsuzaki, Haruna; Yasuda, Kimio] Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Hayashi, Takahiro] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan	Hayashi, T (reprint author), Fujita Hlth Univ Hosp, Dept Pharm, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	taka-h@fujita-hu.ac.jp					Mercadante S, 1999, CANCER, V86, P1856, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G; Ashburn MA, 2003, J PAIN, V4, P291, DOI 10.1016/S1526-5900(03)00618-7; Ahmedzai S, 1997, J PAIN SYMPTOM MANAG, V13, P254, DOI 10.1016/S0885-3924(97)00082-1; Rivadeneira DE, 1998, CA-CANCER J CLIN, V48, P69, DOI 10.3322/canjclin.48.2.69; Moore KT, 2012, J CLIN PHARMACOL, V52, P1174, DOI 10.1177/0091270011411710; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Gallego AO, 2007, CLIN TRANSL ONCOL, V9, P298, DOI 10.1007/s12094-007-0057-9; Donner B, 1996, PAIN, V64, P527, DOI 10.1016/0304-3959(95)00180-8; CHEN JC, 1993, LIFE SCI, V52, P389, DOI 10.1016/0024-3205(93)90152-S; Heiskanen T, 1997, PAIN, V73, P37, DOI 10.1016/S0304-3959(97)00072-9; Higashiguchi Takashi, 2011, Gan To Kagaku Ryoho, V38, P1235; Hohenberger P, 1999, CHIRURG, V70, P1422, DOI 10.1007/PL00002578; Ishizaki T., 1985, CLIN PHARM LECT, P89; Kokubun H, 2004, JPN HOSPICE PALLIATI, V14, P464; MEULDERMANS WEG, 1982, ARCH INT PHARMACOD T, V257, P4; Monory K, 1999, LIFE SCI, V64, P2011, DOI 10.1016/S0024-3205(99)00148-4; Mortimer J, 2011, PALLIATIVE CARE FORM, P345; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Nielsen CK, 2007, PAIN, V132, P289, DOI 10.1016/j.pain.2007.03.022; Nomura M, 2013, CLIN J PAIN, V29, P487, DOI 10.1097/AJP.0b013e318266f6a5; Okazawa M, 2008, JPN J PHARM PALLIAT, V1, P53; Tomibayashi A, 2011, JPN J CANC CLIN, V57, P135; Twycross R, 2001, SYMPTOM MANAGEMENT A, P17; WHO, 1996, CANC PAIN REL; Yang YR, 1998, EUR J PHARMACOL, V351, P23	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1860	1865				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600002		
J	Wakuda, H; Uchida, S; Ikeda, M; Tabuchi, M; Akahoshi, Y; Shinozuka, K; Yamada, S				Wakuda, Hirokazu; Uchida, Shinya; Ikeda, Masahiko; Tabuchi, Masaki; Akahoshi, Yasumitsu; Shinozuka, Kazumasa; Yamada, Shizuo			Is Hyperuricemia a Risk Factor for Arteriosclerosis? Uric Acid and Arteriosclerosis in Apolipoprotein E-Deficient Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						hyperuricemia; atherosclerosis; apolipoprotein E-deficient mouse; allopurinol; benzbromarone	CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; ALLOPURINOL; ADIPONECTIN; GOUT; HYPERCHOLESTEROLEMIA; BENZBROMARONE; ASSOCIATION	Although hyperlipidemia, high blood pressure, and diabetes increase the risk of arteriosclerosis, it is not clear whether hyperuricemia increases the risk of arteriosclerosis or not. We examined the effects of uric acid and curative drugs for hyperuricemia on atherosclerosis-susceptible C57BL/6J apolipoprotein E-deficient (apoE(-/-)) mice. Male apoE(-/-) mice (age: 6 weeks) were fed a normal diet (normal diet group) or a uric acid-enriched diet. Mice fed the uric acid-enriched diet were divided into three groups and administered a drinking vehicle (high uric acid diet group), allopurinol (20 mg.kg(-1).d(-1)), or benzbromarone (20 mg.kg(-1).d(-1)) for 10 weeks. Serum uric acid concentrations were higher in the high uric acid diet group than in the normal diet group, and concentrations in the allopurinol and benzbromarone groups were lower than in the high uric acid diet group. Serum total cholesterol and triglyceride levels were lower in the allopurinol group than in the high uric acid diet group. Oxidative stress was lower in the benzbromarone group than in the high uric acid diet group. Atherosclerotic lesion areas were smaller in the allopurinol and benzbromarone groups than in the high uric acid diet group. Thus, hyperuricemia may not be an independent risk factor for arteriosclerosis; however, the administration of allopurinol and benzbromarone prevented the development of atherosclerosis in apoE(-/-) mice fed a uric acid-enriched diet. The anti-atherosclerotic effect was in part due to lower total cholesterol and oxidative stress in the serum. Other possible mechanisms underlying this effect should be investigated.	[Wakuda, Hirokazu; Shinozuka, Kazumasa] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Nishinomiya, Hyogo 6638179, Japan; [Wakuda, Hirokazu] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacokinet & Pharmacodynam, Suruga Ku, Shizuoka 4228526, Japan; [Uchida, Shinya] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharm Practice & Sci, Suruga Ku, Shizuoka 4228526, Japan; [Yamada, Shizuo] Univ Shizuoka, Grad Sch Pharmaceut Sci, CPFR, Suruga Ku, Shizuoka 4228526, Japan; [Ikeda, Masahiko] Fuji Tokoha Univ, Coll Environm & Disaster Res, Fuji, Shizuoka 4170801, Japan; [Tabuchi, Masaki] Kinki Univ, Sch Med, Dept Pharmacol, Higashiosaka, Osaka 5778502, Japan; [Akahoshi, Yasumitsu] Kinki Univ, Sch Med, Life Sci Res Inst, Higashiosaka, Osaka 5778502, Japan	Yamada, S (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, CPFR, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	yamada@u-shizuoka-ken.ac.jp					ELION GB, 1966, ANN RHEUM DIS, V25, P608; Ukkola O, 2002, J MOL MED-JMM, V80, P696, DOI 10.1007/s00109-002-0378-7; Wannamethee SG, 1997, HEART, V78, P147; Culleton BF, 1999, ANN INTERN MED, V131, P7; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Terkeltaub R, 2010, NAT REV RHEUMATOL, V6, P30, DOI 10.1038/nrrheum.2009.236; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Engberding N, 2004, CIRCULATION, V110, P2175, DOI 10.1161/01.CIR.0000144303.24894.1C; Alderman MH, 1999, HYPERTENSION, V34, P144; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Higgins P, 2014, HEART, V100, P1085, DOI 10.1136/heartjnl-2014-305683; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; RAO GN, 1992, CIRC RES, V70, P593; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Grimaldi-Bensouda L, 2014, ANN RHEUM DIS, V2014; Inokuchi T, 2009, HORM METAB RES, V41, P327, DOI 10.1055/s-0028-1102947; Kok VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099102; Okuda C, 2011, INT J CLIN PHARM TH, V49, P191, DOI 10.5414/CP201425; RUNDLES RW, 1966, ANN INTERN MED, V64, P229; Sezer Siren, 2014, Saudi J Kidney Dis Transpl, V25, P316; Uysal OK, 2014, ANGIOLOGY, V65, P227, DOI 10.1177/0003319713500706; Yamamoto Tetsuya, 2008, Nihon Rinsho, V66, P636	28	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1866	1871				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600003		
J	Taki, M; Tsuboi, I; Harada, T; Naito, M; Hara, H; Inoue, T; Aizawa, S				Taki, Masafumi; Tsuboi, Isao; Harada, Tomonori; Naito, Michiko; Hara, Hiroyuki; Inoue, Tohru; Aizawa, Shin			Lipopolysaccharide Reciprocally Alters the Stromal Cell-Regulated Positive and Negative Balance between Myelopoiesis and B Lymphopoiesis in C57BL/6 Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						lipopolysaccharide; stromal cell; myelopoiesis; B lymphopoiesis; cell cycle	GROWTH-FACTOR-BETA; SENESCENCE-ACCELERATED MICE; COLONY-STIMULATING FACTOR; BONE-MARROW; EMERGENCY GRANULOPOIESIS; MESSENGER-RNA; C-KIT; EXPRESSION; RESPONSES; IL-7	Hematopoiesis in the bone marrow (BM) and spleen is controlled by stromal cells. Inflammation promotes myelopoiesis and simultaneously suppresses B lymphopoiesis. However, the role of the reciprocal regulation of myelopoiesis and B lymphopoiesis by stromal cells during inflammation is not fully understood. We investigated inflammation-induced alteration of hematopoietic regulation in lipopolysaccharide (LPS)-treated mice. C57BL/6 female mice were intravenously injected with a single, 5-mu g dose of LPS, which induced a rapid decrease in the number of granulocyte-macrophage progenitors (colony-forming unit granulocyte-macrophage; CFU-GM) and B cell progenitors (CFU-preB) in BM. The CFU-GM count rapidly recovered, whereas the recovery of CFU-preB was delayed. LPS induced a marked increase in the number of CFU-GM but not in the number of CFU-preB in spleen. After LPS treatment, gene expression levels of positive regulators of myelopoiesis such as granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in BM and spleen were markedly upregulated whereas levels of positive regulators for B lymphopoiesis such as stromal cell-derived factor (SDF)-1, stem cell factor (SCF), and IL-7 remained unchanged. Meanwhile, the negative regulator of B lymphopoiesis tumor necrosis factor (TNF)-alpha was markedly up-regulated. The number of CFU-GM in S-phase in BM increased after LPS treatment, whereas the number of CFU-preB in S-phase decreased. These results suggest that LPS-activated stromal cells induce positive-dominant regulation of myelopoiesis and negative-dominant regulation of B lymphopoiesis, which facilitates emergency myelopoiesis during inflammation by suppressing B lymphopoiesis, thereby contributing to the host defense against infection.	[Taki, Masafumi; Tsuboi, Isao; Harada, Tomonori; Naito, Michiko; Hara, Hiroyuki; Inoue, Tohru; Aizawa, Shin] Nihon Univ, Sch Med, Dept Funct Morphol, Div Anat Sci, Tokyo 1738610, Japan	Tsuboi, I (reprint author), Nihon Univ, Sch Med, Dept Funct Morphol, Div Anat Sci, Tokyo 1738610, Japan.	tsuboi.isao@nihon-u.ac.jp			Japan Society for the Promotion of Science	We thank Sonoko Araki and Miyuki Yuda for their technical assistance. This work was supported in part by a Grant-in-Aid for Science Research C from the Japan Society for the Promotion of Science.	AIZAWA S, 1994, EXP HEMATOL, V22, P482; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253; Song XP, 2005, J IMMUNOL, V175, P8200; Basu S, 2000, BLOOD, V95, P3725; Cain D, 2009, J INVEST DERMATOL, V129, P266, DOI 10.1038/jid.2008.286; LEE G, 1989, J IMMUNOL, V142, P3875; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Tang JH, 1997, J IMMUNOL, V159, P117; Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Tsuboi I, 2012, EXP BIOL MED, V237, P1289, DOI 10.1258/ebm.2012.012158; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; DUBINETT SM, 1993, J IMMUNOL, V151, P6670; Fernandez S, 2003, CELL IMMUNOL, V226, P67, DOI 10.1016/j.cellimm.2003.11.010; GOUGH NM, 1985, EMBO J, V4, P645; HEINRICH MC, 1995, BLOOD, V85, P1769; Hokari T, 2011, BIOL PHARM BULL, V34, P1533; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; Kumagai T, 2000, MECH AGEING DEV, V112, P153, DOI 10.1016/S0047-6374(99)00085-8; Minami A, 2007, EXP BIOL MED, V232, P134; MORI KJ, 1979, EXP HEMATOL, V7, P171; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; Tsuboi I, 2010, IMMUNOBIOLOGY, V215, P348, DOI 10.1016/j.imbio.2009.05.004; Tsuboi I, 2004, EXP BIOL MED, V229, P494; Zhang P, 2005, SHOCK, V23, P344, DOI 10.1097/01.shk.0000158960.93832.de; Zhang Q, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2391	32	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1872	1881				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600004		
J	Jin, JS; Touyama, M; Yamada, S; Yamazaki, T; Benno, Y				Jin, Jong-Sik; Touyama, Mutsumi; Yamada, Shin; Yamazaki, Takashi; Benno, Yoshimi			Alteration of a Human Intestinal Microbiota under Extreme Life Environment in the Antarctica	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Antarctic expedition; human intestinal microbiota; Bifidobacterium; terminal restriction fragment length polymorphism (T-RFLP)	16S RIBOSOMAL-RNA; FRAGMENT-LENGTH-POLYMORPHISMS; COLD STRESS; BACTEROIDES-THETAIOTAOMICRON; ULCERATIVE-COLITIS; QUANTITATIVE PCR; FECAL MICROBIOTA; GUT MICROBIOTA; HUMAN FECES; FLORA	The human intestinal microbiota (HIM) settles from birth and continues to change phenotype by some factors (e.g. host's diet) throughout life. However, the effect of extreme life environment on human HIM composition is not well known. To understand HIM fluctuation under extreme life environment in humans, fecal samples were collected from six Japanese men on a long Antarctic expedition. They explored Antarctica for 3 months and collected their fecal samples at once-monthly intervals. Using terminal restriction fragment length polymorphism (T-RFLP) and real time polymerase chain reaction (PCR) analysis, the composition of HIM in six subjects was investigated. Three subjects presented restoration of HIM after the expedition compared versus before and during the expedition. Two thirds samples collected during the expedition belonged to the same cluster in dendrogram. However, all through the expedition, T-RFLP patterns showed interindividual variability. Especially, Bifidobacterium spp. showed a tendency to decrease during and restore after the expedition. A reduction of Bifidobacterium spp. was observed in five subjects the first 1 month of the expedition. Bacteroides thetaiotaomicron, which is thought to proliferate during emotional stress, significantly decreased in one subject, indicating that other factors in addition to emotional stress may affect the composition of HIM in this study. These findings could be helpful to understand the effect of extreme life environment on HIM.	[Jin, Jong-Sik] Chonbuk Natl Univ, Coll Environm & Bioresource Sci, Dept Oriental Med Resources, Iksan 570752, Jeonbuk, South Korea; [Jin, Jong-Sik; Touyama, Mutsumi; Benno, Yoshimi] RIKEN, Innovat Ctr, Benno Lab, Wako, Saitama 3510198, Japan; [Yamada, Shin] Japan Aerosp Explorat Agcy, Space Biomed Res Off, Tsukuba, Ibaraki 3058505, Japan; [Yamazaki, Takashi] Japan Aerosp Explorat Agcy, Space Environm Utilizat Ctr, Tsukuba, Ibaraki 3058505, Japan	Benno, Y (reprint author), RIKEN, Innovat Ctr, Benno Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	benno828@riken.jp					Logan AC, 2003, MED HYPOTHESES, V60, P915, DOI 10.1016/S0306-9877(03)00096-3; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257; ANDERLIK P, 1990, ACTA MICROBIOL HUNG, V37, P289; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Teng LJ, 2004, J CLIN MICROBIOL, V42, P1727, DOI 10.1128/JCM.42.4.1727-1730.2004; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Wang XY, 2007, J PROTEOME RES, V6, P3449, DOI 10.1021/pr070051w; Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231; Moro MH, 1998, LETT APPL MICROBIOL, V27, P251, DOI 10.1046/j.1472-765X.1998.00443.x; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Nomura T, 2005, ALIMENT PHARM THER, V21, P1017, DOI 10.1111/j.1365-2036.2005.02428.x; Wang SX, 2005, WORLD J GASTROENTERO, V11, P2016; HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Guarner F, 2006, DIGESTION, V73, P5, DOI 10.1159/000089775; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; WON SJ, 1995, J APPL PHYSIOL, V79, P732; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Sakamoto M, 2003, J MED MICROBIOL, V52, P79, DOI 10.1099/jmm.0.04991-0; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; THOMPSON DG, 1983, GUT, V24, P277, DOI 10.1136/gut.24.4.277; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516; Carson CA, 2005, APPL ENVIRON MICROB, V71, P4945, DOI 10.1128/AEM.71.8.4945-4949.2005; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17; LIZKO NN, 1987, ANTIBIOT MED BIOTEK, V32, P184; LIZKO NN, 1984, NAHRUNG, V28, P599; MAIER BR, 1974, AM J CLIN NUTR, V27, P1470; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P37; Matsumoto M, 2005, J MICROBIOL METH, V61, P305, DOI 10.1016/j.mimet.2004.12.009; Nagashima K., 2006, Bioscience and Microflora, V25, P99; Sakamoto M, 2003, MICROBIOL IMMUNOL, V47, P133; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wood J, 1999, ENVIRON BEHAV, V31, P299, DOI 10.1177/0013916599313001	38	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1899	1906				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600007		
J	Matsui, H; Noguchi, T; Takakusaki, K; Kashiwayanagi, M				Matsui, Hitoshi; Noguchi, Tomohiro; Takakusaki, Kaoru; Kashiwayanagi, Makoto			Co-localization of TRPV2 and Insulin-Like Growth Factor-I Receptor in Olfactory Neurons in Adult and Fetal Mouse	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						olfactory neuron; olfactory epithelium; olfactory bulb; insulin-like growth factor-I receptor; transient receptor potential V2	SENSORY NEURONS; STEM-CELLS; EPITHELIUM; EXPRESSION; NEUROGENESIS; SYSTEM; CONES; DIFFERENTIATION; REGENERATION; CHANNELS	TRPV2, a member of the transient receptor potential family, has been isolated as a capsaicin-receptor homolog and is thought to respond to noxious heat. Here we show that TRPV2 mRNA is predominantly expressed in the subpopulation of olfactory sensory neurons (OSNs). We carried out histochemical analyses of TRPV2 and insulin-like growth factor-I receptor (IGF-IR) using in situ hybridization and immunofluorescence in the adult olfactory system. In olfactory mucosa, intensive TRPV2 immunostaining was observed at the olfactory axon bundles but not at the soma. TRPV2-positive labeling was preferentially found in the olfactory nerve layer in the olfactory bulb (OB). Furthermore, we demonstrated that a positive signal for IGF-IR mRNA was detected in OSNs expressing TRPV2 mRNA. In embryonic stages, TRPV2 immunoreactivity was observed on axon bundles of developing OSNs in the nasal region starting from 12.5d of gestation and through fetal development. Observations in this study suggest that TRPV2 coupled with IGF-IR localizes to growing olfactory axons in the OSNs.	[Matsui, Hitoshi; Noguchi, Tomohiro; Takakusaki, Kaoru; Kashiwayanagi, Makoto] Asahikawa Med Univ, Dept Sensory Physiol, Asahikawa, Hokkaido 0788510, Japan	Kashiwayanagi, M (reprint author), Asahikawa Med Univ, Dept Sensory Physiol, Midorigaoka E2-1, Asahikawa, Hokkaido 0788510, Japan.	yanagi@asahikawa-med.ac.jp					Ahmed MK, 2009, RHINOLOGY, V47, P242, DOI 10.4193/Rhin.08.155; CUSCHIERI A, 1975, J ANAT, V119, P471; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Cau E, 2002, DEVELOPMENT, V129, P1871; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; MAHANTHAPPA NK, 1993, NEURON, V10, P293, DOI 10.1016/0896-6273(93)90319-M; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Vicario-Abejon C, 2003, J NEUROSCI, V23, P895; Kanzaki M, 1999, NAT CELL BIOL, V1, P165; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Bauer S, 2003, J NEUROSCI, V23, P1792; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Wada A, 2005, J PHARMACOL SCI, V99, P128, DOI 10.1254/jphs.CRJ05006X; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Caterina MJ, 1999, NATURE, V398, P436; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Brunjes P C, 1986, Brain Res, V396, P1, DOI 10.1016/S0006-8993(86)80188-3; CUSCHIERI A, 1975, J ANAT, V119, P277; Federico G, 1999, BRAIN RES, V835, P306, DOI 10.1016/S0006-8993(99)01614-5; FERNYHOUGH P, 1993, BRAIN RES, V607, P117, DOI 10.1016/0006-8993(93)91496-F; Ferrari CC, 2003, NEUROCHEM RES, V28, P29, DOI 10.1023/A:1021639926941; GutierrezOspina G, 1996, ENDOCRINOLOGY, V137, P5484, DOI 10.1210/en.137.12.5484; Hansel DE, 2001, J NEUROSCI RES, V66, P1, DOI 10.1002/jnr.1191; HOLCOMB JD, 1995, DEV BIOL, V172, P307, DOI 10.1006/dbio.1995.0025; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; Mathonnet M, 2001, NEUROSCI LETT, V308, P67, DOI 10.1016/S0304-3940(01)01715-3; Nakashimo Y, 2010, ACTA OTO-LARYNGOL, V130, P1278, DOI 10.3109/00016489.2010.489573; Pixley SK, 1998, ANN NY ACAD SCI, V855, P244, DOI 10.1111/j.1749-6632.1998.tb10575.x; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Roskams AJI, 1996, J NEUROSCI, V16, P1294; Suzuki Y, 2002, ANAT EMBRYOL, V205, P401, DOI 10.1007/s00429-002-0266-5; Tamura S, 2005, NEUROSCIENCE, V130, P223, DOI 10.1016/j.neuroscience.2004.09.021; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; YAMAGUCHI F, 1990, BRAIN RES, V533, P344, DOI 10.1016/0006-8993(90)91361-J; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Zhang CB, 2000, J COMP NEUROL, V426, P1, DOI 10.1002/1096-9861(20001009)426:1<1::AID-CNE1>3.0.CO;2-Y; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expncurol.2003.10.022	43	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1907	1912				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600008		
J	Kotaka, T; Kimura, S; Kashiwayanagi, M; Iwamoto, J				Kotaka, Tomohiko; Kimura, Shoji; Kashiwayanagi, Makoto; Iwamoto, Jun			Camphor Induces Cold and Warm Sensations with Increases in Skin and Muscle Blood Flow in Human	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						camphor; cold sensation; warm sensation	MENTHOL; THERMOSENSATION; CHANNEL	Application of camphor to the skin has been empirically thought to improve blood circulation. However, camphor's effects on blood circulation to the skin and on thermal sensation have not been well elucidated. In this study, we examined its effects on the quality of sensation as well as on skin and muscle blood flow in human. Nine adults (average age 37 +/- 9.4 years) participated in the study. Petroleum jelly containing 5%, 10%, 20% camphor, or 2% menthol was separately applied to the skin on the medial side of one forearm of each subject. Just after the application, camphor at each concentration induced a cold sensation in a dose-dependent manner. Within 10 mm, each subject reported that the cold sensation had faded, after which it was replaced by a warm sensation. As reported previously, a cold sensation was induced by application of 2% menthol, but the subjects did not adapt to that sensation. In addition, menthol did not induce a warm sensation at all. Application of menthol has been shown to increase blood flow in the skin. Finally, we measured blood flow in skin and muscle after the application of camphor or menthol. Application of camphor or menthol separately induced increases in local blood flow in the skin and muscle. The present results indicate that camphor induces both cold and warm sensations and improves blood circulation.	[Kotaka, Tomohiko; Kimura, Shoji] Asahikawa Med Univ, Sch Nursing, Asahikawa, Hokkaido 0788510, Japan; [Kotaka, Tomohiko; Kashiwayanagi, Makoto] Asahikawa Med Univ, Dept Sensory Physiol, Asahikawa, Hokkaido 0788510, Japan	Kashiwayanagi, M (reprint author), Asahikawa Med Univ, Dept Sensory Physiol, Midorigaoka E2-1, Asahikawa, Hokkaido 0788510, Japan.	yanagi@asahikawa-med.ac.jp					Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; BURROW A, 1983, ACTA OTO-LARYNGOL, V96, P157, DOI 10.3109/00016488309132886; Minson CT, 2001, J APPL PHYSIOL, V91, P1619; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Johnson JM, 2005, AM J PHYSIOL-HEART C, V288, pH1573, DOI 10.1152/ajpheart.00849.2004; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minson CT, 2010, J APPL PHYSIOL, V109, P1239, DOI 10.1152/japplphysiol.00414.2010; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Selescu T, 2013, CHEM SENSES, V38, P563, DOI 10.1093/chemse/bjt027; Roustit M, 2013, TRENDS PHARMACOL SCI, V34, P373, DOI 10.1016/j.tips.2013.05.007; GREEN BG, 1990, J INVEST DERMATOL, V94, P662, DOI 10.1111/1523-1747.ep12876242; Hamidpour R, 2013, IJCRI, V4, P86; THEIS JGW, 1995, CAN MED ASSOC J, V152, P1821; Zuccarini P., 2009, Journal of Applied Sciences and Environmental Management, V13, P69	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1913	1918				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600009		
J	Kibria, G; Hatakeyama, H; Akiyama, K; Hida, K; Harashima, H				Kibria, Golam; Hatakeyama, Hiroto; Akiyama, Kosuke; Hida, Kyoko; Harashima, Hideyoshi			Comparative Study of the Sensitivities of Cancer Cells to Doxorubicin, and Relationships between the Effect of the Drug-Efflux Pump P-gp	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						multi-drug resistance; doxorubicin; cytotoxicity; drug availability-cell sensitivity correlation; P-glycoprotein (P-gp) dependence	MULTIDRUG-RESISTANCE MECHANISMS; TUMOR-ENDOTHELIAL-CELLS; BREAST-CANCER; OVARIAN-CANCER; GLYCOPROTEIN EXPRESSION; PANCREATIC-CARCINOMA; DOWN-REGULATION; CHEMOTHERAPY; REVERSAL; LINES	Multi-drug resistance (MDR) of cancers to chemotherapy including doxorubicin (DOX) is mediated by several factors. To design an effective therapy for the treatment of chemotherapy-resistant cancers, it is essential to explore the elements responsible for mediating MDR. However, exploring these factors in detail in a wide range of tumor types is challenging as several critical analytical steps are involved. Here, we demonstrated the way of exploring the factors mediating MDR in the tumor types without performing the analysis at the molecular level of cells. The sensitivities of 15 different types of cancer cells to DOX were evaluated, and the role of P-glycoprotein (P-gp), one of the major efflux-pumps, was explored. A correlation curve was developed between the intracellular amounts of DOX and the sensitivities of cells, and, based on this correlation, the cells were classified in response to the involvement of P-gp that mediates MDR. P-gp plays an active role in mediating MDR of cancer cells where a correlation between the sensitivities of cells and the accumulated DOX exists. In contrast, in cells that show a resistance to DOX but whose sensitivities are independent of the amount of accumulated drug, it was reasonably presumed that mechanisms other than P-gp are likely to be involved in mediating MDR. Based on the correlation between the availability of a drug and cell sensitivity, it would be reasonable to explore the factors governing cancer MDR, which is essential in designing an effective therapeutic approach for treating chemotherapy-resistant cancers using chemotherapeutic drugs.	[Kibria, Golam; Hatakeyama, Hiroto; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Innovat Nanomed, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Akiyama, Kosuke; Hida, Kyoko] Hokkaido Univ, Grad Sch Dent Med, Div Vasc Biol, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Harashima, H (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Innovat Nanomed, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	harasima@pharm.hokudai.ac.jp	Hida, Kyoko/A-8444-2012		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Nagai Foundation, Tokyo; Ministry of Health, Labour and Welfare (MHLW) of Japan	This study was supported in parts by Grants from the Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Nagai Foundation, Tokyo; as well as by a Grant-in-Aid for Research on Medical Device Development from the Ministry of Health, Labour and Welfare (MHLW) of Japan.	Solomon R, 2008, CLIN LYMPHOMA MYELOM, V8, P21, DOI 10.3816/CLM.2008.n.001; Worm J, 2001, J BIOL CHEM, V276, P39990, DOI 10.1074/jbc.M103181200; Kibria G, 2013, BIOMATERIALS, V34, P5617, DOI 10.1016/j.biomaterials.2013.03.094; Katayama K, 2007, MOL CANCER THER, V6, P2092, DOI 10.1158/1535-7163.MCT-07-0148; Jin ZH, 2004, J BIOL CHEM, V279, P23837, DOI 10.1074/jbc.M402566200; O'Driscoll L, 2006, CURR CANCER DRUG TAR, V6, P365, DOI 10.2174/156800906777723958; BELL DR, 1985, J CLIN ONCOL, V3, P311; Nguyen H, 2003, J PHARM SCI, V92, P250, DOI 10.1002/jps10283; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; RAMU A, 1984, CANCER RES, V44, P144; Goldie JH, 2001, CANCER METAST REV, V20, P63, DOI 10.1023/A:1013164609041; BRADLEY G, 1989, CANCER RES, V49, P2790; Kaye SB, 2008, J CLIN ONCOL, V26, P2616, DOI 10.1200/JCO.2008.16.2123; Huffman KE, 2005, BIOCHEMISTRY-US, V44, P2253, DOI 10.1021/bi047948g; YUSA K, 1989, CANCER RES, V49, P5002; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 ; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Malhotra V, 2003, CANCER BIOL THER, V2, pS2; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; SAFA AR, 1987, J BIOL CHEM, V262, P7884; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; An Y, 2009, EXPERT OPIN DRUG MET, V5, P1529, DOI 10.1517/17425250903228834; Mutoh K, 2006, CANCER SCI, V97, P1198, DOI 10.1111/j.1349-7006.2006.00300.x; Mimeault M, 2007, J CELL MOL MED, V11, P981, DOI 10.1111/j.1582-4934.2007.00088.x; Laurencot CM, 1997, INT J CANCER, V72, P1021; Elez R, 2003, ONCOGENE, V22, P69, DOI 10.1038/sj.onc.1206038; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; O'Driscoll L, 2007, ANTICANCER RES, V27, P2115; Stein U, 2012, BRIT J CANCER, V106, P1395, DOI 10.1038/bjc.2012.81; Vogelzang NJ, 1998, LANCET, V352, P1691, DOI 10.1016/S0140-6736(98)01041-1; Bao LL, 2012, AM J PATHOL, V180, P2490, DOI 10.1016/j.ajpath.2012.02.024; Choi CH, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-30; De Rosa MF, 2004, J BIOL CHEM, V279, P7867, DOI 10.1074/jbc.M305645200; Efferth Thomas, 2004, Cancer Genomics & Proteomics, V1, P17; FORD JM, 1990, PHARMACOL REV, V42, P155; Gautschi O, 2001, J NATL CANCER I, V93, P463, DOI 10.1093/jnci/93.6.463; Kausch I, 2005, EUR UROL, V47, P703, DOI 10.1016/j.eurero.2004.11.013; Kibria G, 2014, ARCH PHARM RES, V37, P4, DOI 10.1007/s12272-013-0276-2; Li GP, 2007, J HUAZHONG UNIV SCI, V27, P173, DOI 10.1007/s11596-007-0217-8; Milane L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-3; Mladkova J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-449; MULLER C, 1994, INT J CANCER, V56, P749, DOI 10.1002/ijc.2910560523; Oudard S, 2002, ANTICANCER RES, V22, P121; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Sampath D, 2003, MOL CANCER THER, V2, P873; SIMPSON WG, 1985, CELL CALCIUM, V6, P449, DOI 10.1016/0143-4160(85)90021-1; Soto-Vega E, 2009, UROL ONCOL-SEMIN ORI, V27, P363, DOI 10.1016/j.urolonc.2008.01.011; Staehler M, 2005, BJU INT, V95, P1153, DOI 10.1111/j.1464-410X.2005.05537.x; Stein U, 1997, J NATL CANCER I, V89, P807; Thomas Hilary, 2003, Cancer Control, V10, P159; Urn JH, 2004, J PHARMACOL EXP THER, V311, P1062; Yen WC, 2005, MOL CANCER THER, V4, P824, DOI 10.1158/1535-7163.MCT-05-0018; YOUNG RC, 1984, SEMIN ONCOL, V11, P327; Yu LJ, 2001, DRUG METAB DISPOS, V29, P304; Zellweger T, 2001, NEOPLASIA, V3, P360, DOI 10.1038/sj.neo.7900174; Zhu HX, 2012, CANCER BIOL THER, V13, P401, DOI [10.4161/cbt.19291, 10.4161/cbt.13.6.19291]; Zhu ZN, 2012, ONCOL REP, V27, P1567, DOI 10.3892/or.2012.1697	57	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1926	1935				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600011		
J	Kazami, S; Takaine, M; Itoh, H; Kubota, T; Kobayashi, J; Usui, T				Kazami, Sayaka; Takaine, Masak; Itoh, Hiroyasu; Kubota, Takaaki; Kobayashi, Jun'ichi; Usui, Takeo			Iejimalide C Is a Potent V-ATPase Inhibitor, and Induces Actin Disorganization	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						antitumor; cytotoxicity; iejimalide C; V-ATPase; actin cytoskeleton	VACUOLAR H+-ATPASE; MACROLIDES; RIGIDA	Iejimalides (IEJLs) A-D are 24-membered macrolides isolated from a tunicate Eudistoma cf. rigida, and exhibit potent cytotoxicity in vitro and antitumor activity in vivo. We previously reported that the molecular target of IEJL-A and -B was the vacuolar-type H+-ATPases (V-ATPases). However IEJL-C and -D, which are sulfonylated IEJL-A and -B, respectively, show more potent antitumor activity, and their molecular targets remain to be discovered. Here, we report that IEJL-C is also a potent V-ATPase inhibitor by binding in a site similar to the bafilomycin-binding site. Two-hour treatment with IEJL-C resulted in the complete disappearance of acidic organelles in HeLa cells. Interestingly, after 24-h treatment, small actin aggregates were observed instead of actin fibers. The same actin reorganization was also observed in cells treated with another V-ATPase inhibitor, bafilomycin A(1). Because IEJLs did not inhibit actin polymerization in vitro, these results suggest that the primary target of IEJL-C, as well as IEJL-A and -B, is V-ATPase, and actin reorganizations are probably caused by the disruption of pH homeostasis via V-ATPase inhibition.	[Kazami, Sayaka; Itoh, Hiroyasu] Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; [Takaine, Masak; Usui, Takeo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kubota, Takaaki; Kobayashi, Jun'ichi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Usui, T (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	usui.takeo.kb@u.tsukuba.ac.jp	Kobayashi, Junjiro/J-8547-2015				Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; PALMGREN MG, 1990, PLANT PHYSIOL, V94, P882, DOI 10.1104/pp.94.3.882; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; KOBAYASHI J, 1988, J ORG CHEM, V53, P6147, DOI 10.1021/jo00261a040; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; Bowman EJ, 2003, J BIOL CHEM, V278, P44147, DOI 10.1074/jbc.M306595200; Furstner A, 2007, J AM CHEM SOC, V129, P9150, DOI 10.1021/ja072334v; Furstner A, 2006, ANGEW CHEM INT EDIT, V45, P5837, DOI 10.1002/anie.200601860; Kazami S, 2006, BIOSCI BIOTECH BIOCH, V70, P1364, DOI 10.1271/bbb.50644; KIKUCHI Y, 1991, TETRAHEDRON LETT, V32, P797, DOI 10.1016/S0040-4039(00)74889-1; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lu Xiaodong, 2005, Cancer Res, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Nozawa K, 2006, BIOORGAN MED CHEM, V14, P1063, DOI 10.1016/j.bmc.2005.09.033; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Torigoe T, 2002, J BIOL CHEM, V277, P36534, DOI 10.1074/jbc.M202605200; Usui T, 2004, CHEM BIOL, V11, P1269, DOI 10.1016/j.chembiol.2004.07.014; Zhang JW, 1998, J BIOL CHEM, V273, P18470, DOI 10.1074/jbc.273.29.18470	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1944	1947				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600013		
J	Kamatsuka, Y; Fukagawa, M; Furuta, T; Ohishi, A; Nishida, K; Nagasawa, K				Kamatsuka, Yosuke; Fukagawa, Manami; Furuta, Takahiro; Ohishi, Akihiro; Nishida, Kentaro; Nagasawa, Kazuki			Astrocytes, but Not Neurons, Exhibit Constitutive Activation of P2X7 Receptors in Mouse Acute Cortical Slices under Non-stimulated Resting Conditions	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						P2X7 receptor; astrocyte; mouse cortical slice; neuron	EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; ATP RELEASE; P2X(7) RECEPTORS; CULTURED ASTROCYTES; RAT ASTROCYTES; EXPRESSION; CELLS; ZINC; MORPHOLOGY; CHANNEL	We previously demonstrated that the P2X7 receptor (P2X7R), a purinergic receptor, expressed by mouse cultured cortical astrocytes is constitutively activated without any exogenous stimulus, differing from the case of neurons. It is well known that astrocytic morphology differs between in vitro and in vivo situations, implying different functionalities. Brain acute slices are widely accepted as an in vitro experimental system that reflects in vivo cell conditions better than in vitro cell culture ones. We examined whether astrocytic P2X7Rs exhibited constitutive activation in mouse cortical slices. In acute cortical slices, P2X7R-immunoreactivity was detected in both glial fibrillary acidic protein-immunopositive astrocytes and microtubule-associated protein 2-immunopositive neurons. Astrocytic, but not neuronal, spontaneous uptake of propidium iodide, an indicator of P2X7R channel/pore activity, was inhibited by representative antagonists of P2X7R, but they had no effect on the uptake by astrocytes in membrane-permeabilized fixed slices. These findings indicate that astrocytes, but not neurons, in acute cortical slices exhibit constitutive activation of P2X7Rs under non-stimulated resting conditions as in the case of cell culture systems.	[Kamatsuka, Yosuke; Fukagawa, Manami; Furuta, Takahiro; Ohishi, Akihiro; Nishida, Kentaro; Nagasawa, Kazuki] Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, Kyoto 6078414, Japan	Nagasawa, K (reprint author), Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, 5 Nakauchi Cho, Kyoto 6078414, Japan.	nagasawa@mb.kyoto-phu.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590128]	A part of this study was financially supported by a Grant-in-Aid for Scientific Research (C) (24590128) from the Japan Society for the Promotion of Science (JSPS).	BICKNELL RJ, 1989, BRAIN RES BULL, V22, P379, DOI 10.1016/0361-9230(89)90065-8; Vardjan N, 2014, GLIA, V62, P566, DOI 10.1002/glia.22626; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Yamamoto M, 2013, BIOCHEM BIOPH RES CO, V439, P90, DOI 10.1016/j.bbrc.2013.08.022; Baraldi PG, 2000, BIOORG MED CHEM LETT, V10, P681, DOI 10.1016/S0960-894X(00)00083-4; Cervetto C, 2013, J NEUROCHEM, V124, P821, DOI 10.1111/jnc.12143; Jiang LH, 2000, MOL PHARMACOL, V58, P82; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Nishida K, 2012, J NEUROCHEM, V122, P1118, DOI 10.1111/j.1471-4159.2012.07868.x; Kruczek C, 2009, GLIA, V57, P79, DOI 10.1002/glia.20737; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Swanson RA, 1997, GLIA, V21, P142, DOI 10.1002/(SICI)1098-1136(199709)21:1<142::AID-GLIA16>3.0.CO;2-S; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; SHAIN W, 1987, J CELL BIOL, V105, P2307, DOI 10.1083/jcb.105.5.2307; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Swanson RA, 1997, J NEUROSCI, V17, P932; Liu HT, 2008, CELL RES, V18, P558, DOI 10.1038/cr.2008.49; Higashi Y, 2011, GLIA, V59, P1933, DOI 10.1002/glia.21235; Jabs R, 2007, GLIA, V55, P1648, DOI 10.1002/glia.20580; Kido Y, 2014, GLIA, V62, P440, DOI 10.1002/glia.22615; Nagasawa K, 2009, GLIA, V57, P622, DOI 10.1002/glia.20791; Nishida K, 2013, NEUROSCI LETT, V533, P104, DOI 10.1016/j.neulet.2012.10.063; Segawa S, 2014, LIFE SCI, V94, P137, DOI 10.1016/j.lfs.2013.11.007; Sluyter R, 2010, J PSYCHIATR RES, V44, P1116, DOI 10.1016/j.jpsychires.2010.04.013; Tanaka A, 2011, NEUROSCI LETT, V498, P52, DOI 10.1016/j.neulet.2011.04.060	32	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1958	1962				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600015		
J	Karino, F; Nishimura, N; Ishihara, N; Moriyama, H; Miura, K; Hamaguchi, S; Sutani, A; Kuraki, T; Ikawa, K; Morikawa, N; Naora, K; Isobe, T				Karino, Fumi; Nishimura, Nobuhiro; Ishihara, Noriyuki; Moriyama, Hidehiko; Miura, Kiyotaka; Hamaguchi, Shunichi; Sutani, Akihisa; Kuraki, Takashige; Ikawa, Kazuro; Morikawa, Norifumi; Naora, Kohji; Isobe, Takeshi			Nephrotoxicity Induced by Piperacillin-Tazobactam in Late Elderly Japanese Patients with Nursing and Healthcare Associated Pneumonia	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						piperacillin-tazobactam; Japanese late elderly patient; nephrotoxicity; nursing and healthcare associated pneumonia	COMMUNITY-ACQUIRED PNEUMONIA; TAZOBACTAM/PIPERACILLIN	This study aimed to clarify the efficacy, safety, and pharmacokinetics of piperacillin tazobactam (PIPC-TAZ) in late elderly Japanese patients. This is the first antimicrobial pilot study in late elderly patients with nursing and healthcare associated pneumonia. After PIPC-TAZ administration, PIPC concentrations in plasma were measured chromatographically and the pharmacokinetic parameters were estimated. Efficacy, safety, and bacteriological evaluations were also carried out. The mean age was 85.0 years old and most of the patients were late elderly. Chest X-rays, body temperature, white blood cell count, and C reactive protein all improved significantly, and a high efficacy ratio of 90.9% was observed. Serious nephrotoxicity was observed in 4 cases (18.2%) after administration of PIPC-TAZ. Creatinine clearance (mean +/- S.D.) measured before PIPC-TAZ therapy was significantly lower in the nephrotoxicity group (32.5 +/- 4.4mL/min) than in the non-nephrotoxicity group (46.1 +/- 16.7mL/min), although the ages were not different between the 2 groups. In the pharmacokinetic parameters for PIPC, total clearance was slightly lower in the nephrotoxicity group than in the non-nephrotoxicity group. However, no significant difference was observed in plasma PIPC levels between the 2 groups. In patients with renal impairment, especially with a creatinine clearance of <40 mL/min, renal impairment was found to be an influencing factor for severe nephrotoxicity following PIPC-TAZ administration. In conclusion, the results suggest that physicians should pay close attention in order to avoid possible toxicity, and that deliberate administration planning and careful follow-up are required in late elderly patients with comprised organ dysfunction.	[Karino, Fumi; Miura, Kiyotaka; Hamaguchi, Shunichi; Sutani, Akihisa; Kuraki, Takashige; Isobe, Takeshi] Shimane Univ, Fac Med, Dept Internal Med, Div Med Oncol & Resp Med, Izumo, Shimane 6938501, Japan; [Nishimura, Nobuhiro; Ishihara, Noriyuki; Naora, Kohji] Shimane Univ Hosp, Dept Pharm, Izumo, Shimane 6938501, Japan; [Moriyama, Hidehiko] Shimane Univ Hosp, Cent Clin Lab, Izumo, Shimane 6938501, Japan; [Ikawa, Kazuro; Morikawa, Norifumi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Pharmacotherapy, Minami Ku, Hiroshima 7348551, Japan	Nishimura, N (reprint author), Shimane Univ Hosp, Dept Pharm, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	nnishi@med.shimane-u.ac.jp					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160; Miyashita N, 2006, INTERNAL MED, V45, P419, DOI 10.2169/internalmedicine.45.1691; Casu GS, 2013, INT J ANTIMICROB AG, V42, P422, DOI 10.1016/j.ijantimicag.2013.06.021; Di Giovamberardino G, 2009, J CHROMATOGR B, V877, P86, DOI 10.1016/j.jchromb.2008.11.010; Gilbert DN, 2011, STANFORD GUIDE ANTIM, P192; Hamada Yukihiro, 2013, Jpn J Antibiot, V66, P189; Ito I, 2010, PULM PHARMACOL THER, V23, P403, DOI 10.1016/j.pupt.2010.05.007; Jensen JUS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000635; JOHNSON CA, 1992, CLIN PHARMACOL THER, V51, P32; Karino F, 2013, J INFECT CHEMOTHER, V19, P909, DOI 10.1007/s10156-013-0605-x; Kohno Shigeru, 2013, Respir Investig, V51, P103, DOI 10.1016/j.resinv.2012.11.001; Mandell Gerald L, 2009, MANDELL DOUGLAS BENN, P314; Ministry of Health Labour and Welfare of Japan, 2007, SPEC REP VIT STAT FI; Ministry of Health Labour and Welfare of Japan, 2003, CLASS CRIT SEV ADV D, P100; Saito A, 1999, J INFECT CHEMOTHER, V5, P110, DOI 10.1007/s101560050020; SHIBA K, 2011, JPN J CHEMOTHER, V59, P359; Tsukada H, 2012, J INFECT CHEMOTHER, V18, P715, DOI 10.1007/s10156-012-0407-6; WATANABE A, 2010, JPN J CHEMOTHER S1, V58, P29; WATANABE A, 2010, JPN J CHEMOTHER S1, V58, P11	20	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1971	1976				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600017		
J	Makino, K; Omachi, R; Suzuki, H; Tomobe, K; Kawashima, T; Nakajima, T; Kawashima-Ohya, Y				Makino, Kota; Omachi, Runa; Suzuki, Hiroka; Tomobe, Koji; Kawashima, Tsuyoshi; Nakajima, Toshiharu; Kawashima-Ohya, Yoshie			Apoptosis Occurs during Early Development of the Bursa of Fabricius in Chicken Embryos	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						early development; chicken; Fabricius; apoptosis; caspase	PROGRAMMED CELL-DEATH; ANIMAL DEVELOPMENT; THYMUS; ORIGIN; CLOACA	The bursa of Fabricius (BF) is a unique primary lymphoid organ, and among vertebrates is unique to birds. Despite its importance to the immune systems of various avian species, little is known of the molecular mechanisms underlying early BF development. In the present study, we demonstrated that apoptosis occurs during early development of the bursa of Fabricius in chicken embryos. Initial histological analyses of BF morphogenesis in chicken embryos led to the hypothesis that formation of the bursal lumen correlates with fusion of vacuoles, which appear in the cloacal epithelial bud. Using terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL) analysis and immunostaining with an anti-cleaved (activated) caspase-3 antibody, we detected multiple apoptotic cells around these vacuoles. In further experiments, treatments with a caspase inhibitor caused abnormal bursal lumen in vivo. The present data indicate that apoptosis may play important roles in BF morphogenesis in chickens.	[Makino, Kota; Omachi, Runa; Suzuki, Hiroka; Nakajima, Toshiharu; Kawashima-Ohya, Yoshie] Yokohama Coll Pharm, Immunol Lab, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan; [Tomobe, Koji] Yokohama Coll Pharm, Lab Pathophysiol, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan; [Kawashima, Tsuyoshi] Yokohama Coll Pharm, Lab Mol Biol, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan	Kawashima-Ohya, Y (reprint author), Yokohama Coll Pharm, Immunol Lab, Totsuka Ku, 601 Matano Cho, Yokohama, Kanagawa 2450066, Japan.	y.kawashima@hamayaku.ac.jp					HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Fellah JS, 2008, AVIAN IMMUNOLOGY, P51, DOI 10.1016/B978-012370634-8.50006-8; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; GLICK B, 1991, VET IMMUNOL IMMUNOP, V30, P3, DOI 10.1016/0165-2427(91)90003-U; HOUSSAINT E, 1976, DEV BIOL, V53, P250, DOI 10.1016/0012-1606(76)90227-X; Boyden EA, 1922, AM J ANAT, V30, P163, DOI 10.1002/aja.1000300202; CLARKE PGH, 1995, NATURE, V378, P230, DOI 10.1038/378230c0; GLICK B, 1985, ADV VET SCI COMP MED, V30, P67; Jolly T, 1915, ARCH ANAT MIER, V16, P363; Miller SA, 1996, DEV DYNAM, V206, P212, DOI 10.1002/(SICI)1097-0177(199606)206:2<212::AID-AJA10>3.0.CO;2-4; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Minot CS, 1900, J BOSTON SOC MED SCI, V4, P153; Nagy N, 2010, DEVELOPMENT, V137, P3019, DOI 10.1242/dev.055194; OLAH I, 1986, POULTRY SCI, V65, P574; Qi BQ, 2000, J PEDIATR SURG, V35, P1556, DOI 10.1053/jpsu.2000.18309; Rodriguez I, 1997, DEV BIOL, V184, P115, DOI 10.1006/dbio.1997.8522; Sasaki C, 2004, ANAT REC PART A, V279A, P761, DOI 10.1002/ar.a.20062; Xu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029372	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1982	1985				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600019		
J	Morita, A; Nakahara, T; Ushikubo, H; Mori, A; Sakamoto, K; Ishii, K				Morita, Akane; Nakahara, Tsutomu; Ushikubo, Hiroko; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio			Treatment of Newborn Mice with Inhibitors of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Induces Abnormal Retinal Vascular Patterning	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						axitinib; vascular development; vascular patterning; vascular endothelial growth factor; retina	OXYGEN-INDUCED RETINOPATHY; SELECTIVE INHIBITOR; ANGIOGENESIS; MOUSE; KRN633; MODEL; LUNG	We have previously reported that treatment of newborn mice with KRN633, a vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor, delayed retinal vascularization leading to abnormal retinal vascular growth and patterns. To determine whether similar abnormalities are observed in newborn mice treated with other VEGF receptor tyrosine kinase inhibitors, we administered axitinib to mice on the day of birth and on the following day. When compared with control pups, a significant delay in retinal vascularization was observed in pups treated with axitinib (5 mg/kg). Axitinib-treated pups had a very dense capillary network on postnatal day (P) 6 and fewer central arteries and veins on P8 and P12. Central veins, but not arteries, were significantly enlarged on P8. These abnormalities were similar to those observed in KRN633-treated pups and probably represent a common phenotype induced by short-term treatment with VEGF receptor inhibitors in newborn mice. Therefore, mice treated postnatally with VEGFR inhibitors could serve as an animal model for studying the mechanisms of retinal vascular formation and patterning.	[Morita, Akane; Nakahara, Tsutomu; Ushikubo, Hiroko; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, Tokyo 1088641, Japan	Nakahara, T (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nakaharat@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25122712, 26460103]	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 25122712, T.N.), and a Grant-in-Aid for Scientific Research (C) (No. 26460103, T.N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600; STONE J, 1995, J NEUROSCI, V15, P4738; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Morita A, 2014, EXP EYE RES, V120, P127, DOI 10.1016/j.exer.2014.01.009; Hu-Lowe DD, 2008, CLIN CANCER RES, V14, P7272, DOI 10.1158/1078-0432.CCR-08-0652; Stalmans I, 2002, J CLIN INVEST, V109, P327; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Kelly RJ, 2009, TARGET ONCOL, V4, P297, DOI 10.1007/s11523-009-0126-9; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Nakamura K, 2004, MOL CANCER THER, V3, P1639; Thurston G, 2005, DEVELOPMENT, V132, P3317, DOI 10.1242/dev.01888	15	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1986	1989				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600020		
J	Yamamoto, H; Habu, Y; Yano, I; Ozaki, J; Kimura, Y; Sato, E; Shida, A; Fukatsu, S; Matsubara, K				Yamamoto, Hiroki; Habu, Yasushi; Yano, Ikuko; Ozaki, Junko; Kimura, Yoshihiko; Sato, Eriko; Shida, Ayumi; Fukatsu, Sachio; Matsubara, Kazuo			Comparison of the Effects of Azole Antifungal Agents on the Anticoagulant Activity of Warfarin	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						warfarin; azole antifungal; interaction; prothrombin time; warfarin sensitivity index	DRUG-INTERACTION; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE; METABOLISM	The package insert of the antithrombotic agent warfarin warns users of its interaction with azole anti-fungals. However, information on the frequency or degree of these interactions is limited. In particular, the time to onset of azole-mediated prothrombin time prolongation, expressed as the international normalized ratio (INR), is poorly characterized. Therefore, we retrospectively examined the INR in 29 patients administered warfarin with fluconazole (FLCZ), voriconazole (VRCZ), or itraconazole (ITCZ). INRs in 18 patients taking FLCZ and in 5 patients taking VRCZ significantly increased from 1.40 to 2.94 and from 1.95 to 2.89, respectively. The warfarin sensitivity index (WSI), calculated as INR/daily warfarin dose, also significantly increased from 1.06 to 1.89 with FLCZ and showed an upward trend from 1.13 to 2.23 with VRCZ. ITCZ had no influence on the INR or WSI in 6 patients. The INRs observed when warfarin was coadministered with azoles (Y) correlated significantly with those observed in the absence of azoles (X): FLCZ, Y=4.94X-3.96, r(2)=0.80; VRCZ, Y=2.13X-1.27, r(2)=0.93. Moreover, in all 8 patients with closely monitored INRs, the WSI increased within 1 week of FLCZ or VRCZ coadministration. In conclusion, FLCZ and VRCZ augmented the anticoagulant activity of warfarin. The INR should be closely monitored within 1 week of initiating FLCZ or VRCZ coadministration with warfarin, especially in patients with high INRs.	[Yamamoto, Hiroki; Habu, Yasushi; Yano, Ikuko; Ozaki, Junko; Kimura, Yoshihiko; Sato, Eriko; Shida, Ayumi; Fukatsu, Sachio; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan; [Habu, Yasushi] Kobe Pharmaceut Univ, Inst Informat Technol Support, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Matsubara, K (reprint author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan.	kmatsuba@kuhp.kyoto-u.ac.jp					Schelleman H, 2008, CLIN PHARMACOL THER, V84, P581, DOI 10.1038/clpt.2008.150; van der Elst KCM, 2013, ANTIMICROB AGENTS CH, V57, P4999, DOI 10.1128/AAC.00707-13; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Miura M, 2011, CLIN CHIM ACTA, V412, P2002, DOI 10.1016/j.cca.2011.06.035; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P24, DOI 10.1128/AAC.00705-08; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; FDA, 2012, DRUG INT STUD STUD D; Halkin H, 2003, CLIN PHARMACOL THER, V74, P215, DOI 10.1016/S0009-9236(03)00166-8; Hosokawa M, 2012, JPN J PHARM HLTH CAR, V38, P258; Hu ZY, 2012, DRUG METAB DISPOS, V40, P1487, DOI 10.1124/dmd.112.045799; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Kunze KL, 1996, DRUG METAB DISPOS, V24, P414; Mootha VV, 2002, ARCH OPHTHALMOL-CHIC, V120, P94; Niwa T, 2005, BIOL PHARM BULL, V28, P1805, DOI 10.1248/bpb.28.1805; Purkins L, 2003, BRIT J CLIN PHARMACO, V56, P24, DOI 10.1046/j.1365-2125.2003.01995.x; YEH J, 1990, BRIT MED J, V301, P669	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2014	37	12					1990	1993				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EO	WOS:000345495600021		
J	Kato, K; Choi, I; Wake, A; Uike, N; Taniguchi, S; Moriuchi, Y; Miyazaki, Y; Nakamae, H; Oku, E; Murata, M; Eto, T; Akashi, K; Sakamaki, H; Kato, K; Suzuki, R; Yamanaka, T; Utsunomiya, A				Kato, Koji; Choi, Ilseung; Wake, Atsushi; Uike, Naokuni; Taniguchi, Shuichi; Moriuchi, Yukiyoshi; Miyazaki, Yasushi; Nakamae, Hirohisa; Oku, Eijirou; Murata, Makoto; Eto, Tetsuya; Akashi, Koichi; Sakamaki, Hisashi; Kato, Koji; Suzuki, Ritsuro; Yamanaka, Takeharu; Utsunomiya, Atae			Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Adult T cell leukemia/lymphoma (ATTL); Cord blood transplantation; Graft-versus-adult T cell leukemia/lymphoma	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LEUKEMIA-LYMPHOMA; UNRELATED DONORS; COMPETING RISKS; ANTIBODY; LEUKAEMIA/LYMPHOMA; EXPERIENCE; CLINICIAN; FEATURES	Allogeneic bone marrow and peripheral blood stem cell transplantations are curative treatment modalities for adult T cell leukemia/lymphoma (ATLL) because of the intrinsic graft-versus-ATLL effect. However, limited information is available regarding whether cord blood transplantation (CBT) induces a curative graft-versus-ATLL effect against aggressive ATLL. To evaluate the effect of CBT against ATLL, we retrospectively analyzed data from 175 patients with ATLL who initially underwent single-unit CBT. The 2-year overall survival (OS) rate was 20.6% (95% confidence interval [CI), 13.8% to 27.4%). A multivariate analysis revealed that the development of graft-versus-host disease (GVHD) was a favorable prognostic factor for OS (hazard ratio, .10; 95% CI, .01 to .94; P = .044). Furthermore, the 2-year OS (42.7%; 95% Cl, 28.1% to 56.6%) of patients with grade 1 to 2 acute GVHD was higher than that of patients without acute GVHD (24.2%; 95% CI, 11.2% to 39.8%; P = .048). However, the cumulative incidence of treatment-related mortality (TRM) was high (46.1%; 95% Cl, 38.2% to 53.7%), and early death was particularly problematic. In conclusion, CBT cures patients with ATLL partly through a graft-versus-ATLL effect. However, novel interventions will be required, particularly in the early phase, to reduce TRM and optimize GVHD. (C) 2014 American Society for Blood and Marrow Transplantation.	[Kato, Koji; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Choi, Ilseung; Uike, Naokuni] Kyushu Natl Canc Ctr, Dept Hematol, Fukuoka, Japan; [Wake, Atsushi; Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Moriuchi, Yukiyoshi] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan; [Miyazaki, Yasushi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Hematol, Nagasaki 852, Japan; [Miyazaki, Yasushi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Mol Med Unit, Nagasaki 852, Japan; [Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Dept Hematol, Osaka 558, Japan; [Oku, Eijirou] Kurume Univ, Grad Sch Med, Dept Hematol, Kurume, Fukuoka 830, Japan; [Murata, Makoto] Nagoya Univ, Dept Hematol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Hematol, Tokyo, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Suzuki, Ritsuro] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management Biostat, Nagoya, Aichi 4648601, Japan; [Yamanaka, Takeharu] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Utsunomiya, Atae] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan	Kato, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kojikato@intmed1.med.kyushu-u.ac.jp			MEXT KAKENHI [25461453, H22-Ganrinsho-Ippan-028]	The authors thank the physicians and data managers at the institutes who contributed valuable data regarding ATLL-related transplantation to the Japan Society for Hematopoietic Cell Transplantation. We also thank all members of the data management committees of the JSHCT. This work was supported in part by MEXT KAKENHI Grant Number 25461453 (K.K.) and H22-Ganrinsho-Ippan-028 (N.U.).	Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Itonaga H, 2013, BIOL BLOOD MARROW TR, V19, P607, DOI 10.1016/j.bbmt.2013.01.011; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Sanz MA, 2004, NEW ENGL J MED, V351, P2328, DOI 10.1056/NEJMe048275; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Rocha V, 2010, BEST PRACT RES CL HA, V23, P223, DOI 10.1016/j.beha.2010.07.005; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; UCHIYAMA T, 1977, BLOOD, V50, P481; Atsuta Y, 2012, BIOL BLOOD MARROW TR, V18, P780, DOI 10.1016/j.bbmt.2011.10.008; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Ishida T, 2012, BLOOD, V120, P1734, DOI 10.1182/blood-2012-03-414490; Kato K, 2013, INT J HEMATOL, V97, P430, DOI 10.1007/s12185-013-1278-z; Utsunomiya A, 2001, BONE MARROW TRANSPL, V27, P15, DOI 10.1038/sj.bmt.1702731; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Yonekura K, 2008, BONE MARROW TRANSPL, V41, P1029, DOI 10.1038/bmt.2008.39; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Choi I, 2011, BONE MARROW TRANSPL, V46, P116, DOI 10.1038/bmt.2010.92; Cortese G, 2010, BIOMETRICAL J, V52, P138, DOI 10.1002/bimj.200900076; Fukushima T, 2005, LEUKEMIA, V19, P829, DOI 10.1038/sj.leu.2403682; Fukushima T, 2013, INT J HEMATOL, V97, P485, DOI 10.1007/s12185-013-1307-y; Harashima N, 2004, CANCER RES, V64, P391, DOI 10.1158/0008-5472.CAN-03-1452; Ito Y, 2013, BONE MARROW TRANSPL, V48, P998, DOI 10.1038/bmt.2012.268; Itonaga H, 2013, BLOOD, V121, P219, DOI 10.1182/blood-2012-07-444372; Kami M, 2003, BRIT J HAEMATOL, V120, P304, DOI 10.1046/j.1365-2141.2003.04054.x; Kanda J, 2012, BLOOD, V119, P2141, DOI 10.1182/blood-2011-07-368233; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato K, 2007, BIOL BLOOD MARROW TR, V13, P90, DOI 10.1016/j.bbmt.2006.09.002; Nakamura T, 2012, INT J HEMATOL, V96, P657, DOI 10.1007/s12185-012-1177-8; Nakase K, 2006, BONE MARROW TRANSPL, V37, P41, DOI 10.1038/sj.bmt.1705197; Shiratori S, 2008, BIOL BLOOD MARROW TR, V14, P817, DOI 10.1016/j.bbmt.2008.04.014; Takizawa J, 2007, AM J HEMATOL, V82, P1113, DOI 10.1002/ajh.21042; Tsukasaki K, 1999, BONE MARROW TRANSPL, V23, P87, DOI 10.1038/sj.bmt.1701533; Uchida N, 2011, TRANSPLANTATION, V92, P366, DOI 10.1097/TP.0b013e318223d7ac	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	DEC	2014	20	12					1968	1974		10.1016/j.bbmt2014.08.012		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	AU4UJ	WOS:000345606500015		
J	Shingai, N; Morito, T; Najima, Y; Igarashi, A; Kobayashi, T; Doki, N; Kakihana, K; Ohashi, K; Ando, M				Shingai, Naoki; Morito, Taku; Najima, Yuho; Igarashi, Aiko; Kobayashi, Takeshi; Doki, Noriko; Kakihana, Kazuhiko; Ohashi, Kazuteru; Ando, Minoru			Urinary Liver-Type Fatty Acid-Binding Protein Linked with Increased Risk of Acute Kidney Injury after Allogeneic Stem Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Urinary biomarker; Acute tubular injury; Comorbidity index; Mortality	ACUTE-RENAL-FAILURE; BONE-MARROW-TRANSPLANTATION; CARDIAC-SURGERY; DISEASE; OUTCOMES; NEPHROPATHY; PATHOLOGY; BIOMARKER; NETWORK	Stem cell transplantation (SCT) involves a great risk of acute kidney injury (AKI). Urinary liver-type fatty acid-binding protein (uL-FABP) is a sensitive biomarker to detect kidney damage before an increase in serum creatinine (Cr); however, the utility of uL-FABP is not fully understood in the platform of SCT. A prospective study was conducted in 84 allogeneic SCT recipients to ascertain a link between the uL-FABP level before preparative procedures and AKI incidence after SCT. The association between them was analyzed using Gray's method and a multivariate Fine-Gray proportional hazards regression model. The recipients were stratified into high and low uL-FABP groups, according to the reference value for healthy subjects (8.4 mu g/g Cr). AKI developed more frequently in the high (n = 20) than low (n = 64) group (55.0% versus 26.6% at day 30, P = .005), and high uL-FABP was an independent risk for the emergence of AKI (hazard ratio, 2.78; 95% confidence interval, 1.24 to 6.22, P = .01). In conclusion, increased baseline uL-FABP, which may indicate previous incipient kidney injury, is linked with a high risk of AKI after allogeneic SCT. (C) 2014 American Society for Blood and Marrow Transplantation.	[Shingai, Naoki; Najima, Yuho; Igarashi, Aiko; Kobayashi, Takeshi; Doki, Noriko; Kakihana, Kazuhiko; Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc Ctr, Dept Med, Div Hematol, Tokyo 1138677, Japan; [Morito, Taku; Ando, Minoru] Komagome Hosp, Tokyo Metropolitan Canc Ctr, Dept Med, Div Nephrol, Tokyo 1138677, Japan	Ando, M (reprint author), Komagome Hosp, Tokyo Metropolitan Canc Ctr, Dept Med, Div Nephrol,Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	hdcn@cick.jp					Ando M, 2010, NEPHROL DIAL TRANSPL, V25, P278, DOI 10.1093/ndt/gfp485; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Matsui K, 2012, CIRC J, V76, P213, DOI 10.1253/circj.CJ-11-0342; VEERKAMP JH, 1991, BIOCHIM BIOPHYS ACTA, V1081, P1, DOI 10.1016/0005-2760(91)90244-C; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; ZAGER RA, 1989, AM J KIDNEY DIS, V13, P210; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Shimoi T, 2013, BONE MARROW TRANSPL, V48, P80, DOI 10.1038/bmt.2012.85; Nakamura T, 2006, AM J KIDNEY DIS, V47, P439, DOI 10.1053/j.ajkd.2005.11.006; Mori J, 2012, INTERNAL MED, V51, P2105, DOI 10.2169/internalmedicine.51.7418; Ferguson MA, 2010, KIDNEY INT, V77, P708, DOI 10.1038/ki.2009.422; Noiri E, 2009, AM J PHYSIOL-RENAL, V296, pF669, DOI 10.1152/ajprenal.90513.2008; Rogosheske JR, 2014, BONE MARROW TRANSPL, V49, P122, DOI 10.1038/bmt.2013.139; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; Parikh CR, 2006, KIDNEY INT, V69, P430, DOI 10.1038/sj.ki.5000055; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Chang A, 2007, CLIN J AM SOC NEPHRO, V2, P1014, DOI 10.2215/CJN.01700407; Ellis MJ, 2008, AM J TRANSPLANT, V8, P2378, DOI 10.1111/j.1600-6143.2008.02408.x; Hingorani SR, 2005, KIDNEY INT, V67, P272, DOI 10.1111/j.1523-1755.2005.00078.x; Honda K, 2014, CASE REP, V3, P34; Imai H, 2000, AM J KIDNEY DIS, V36, P474, DOI 10.1053/ajkd.2000.9787; Kagoya Y, 2011, BIOL BLOOD MARROW TR, V17, P394, DOI 10.1016/j.bbmt.2010.07.010; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo-Ikemori A, 2011, DIABETES CARE, V34, P691, DOI 10.2337/dc10-1392; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Parikh CR, 2005, KIDNEY INT, V67, P1999, DOI 10.1111/j.1523-1755.2005.00301.x; Schrier RW, 2005, NEPHROL DIAL TRANSPL, V20, P678, DOI 10.1093/ndt/gfh720; Troxell ML, 2008, MODERN PATHOL, V21, P396, DOI 10.1038/modpathol.3801011; ZAGER RA, 1994, KIDNEY INT, V46, P1443, DOI 10.1038/ki.1994.417	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	DEC	2014	20	12					2010	2014		10.1016/j.bbmt.2014.08.022		5	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	AU4UJ	WOS:000345606500021		
J	Aoki, J; Ishiyama, K; Taniguchi, S; Fukuda, T; Ohashi, K; Ogawa, H; Kanamori, H; Eto, T; Iwato, K; Sakamaki, H; Morishima, Y; Nagamura, T; Atsuta, Y; Takami, A				Aoki, Jun; Ishiyama, Ken; Taniguchi, Shuichi; Fukuda, Takahiro; Ohashi, Kazuteru; Ogawa, Hiroyasu; Kanamori, Heiwa; Eto, Tetsuya; Iwato, Koji; Sakamaki, Hisashi; Morishima, Yasuo; Nagamura, Tokiko; Atsuta, Yoshiko; Takami, Akiyoshi			Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients with Central Nervous System Involvement	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Acute myeloid leukemia; Central nervous system involvement	INTRATHECAL CHEMOPROPHYLAXIS; ADULTS; THERAPY; RELAPSE; IRRADIATION; MANAGEMENT; CHILDREN; BLOOD	Central nervous system (CNS) involvement in adult acute myeloid leukemia (AML) is rare and associated with poor outcomes. Therefore, CNS involvement in AML is an indicator for allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the impact of CNS involvement in AML on the outcome of allo-HSCT remains unclear. We performed a large-scale nationwide retrospective analysis to elucidate the outcomes of allo-HSCT on AML with CNS involvement (CNS+AML). Clinical data were collected from a registry database of the Japan Society for Hematopoietic Cell Transplantation. CNS involvement was defined as the infiltration of leukemia cells into the CNS or myeloid sarcoma in the CNS identified at any time from diagnosis to transplantation. One hundred fifty-seven patients with CNS+AML underwent allo-HSCT between 2006 and 2011. The estimated overall survival, cumulative incidence of relapse and nonrelapse mortality at 2 years for CNS+AML (51.2%, 30.2%, and 14.5%, respectively) were comparable with those for AML without CNS involvement (48.6%, 27.4%, and 22.0%, respectively). Univariate and multivariate analyses indicated that the development of chronic graft-versus-host disease, disease status, and cytogenetic risk category were independent prognostic factors for overall survival for CNS+AML. These results suggest that allo-HSCT may improve outcomes in patients with CNS+AML. (C) 2014 American Society for Blood and Marrow Transplantation.	[Aoki, Jun; Ishiyama, Ken; Ohashi, Kazuteru; Sakamaki, Hisashi] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Dept Hematol, Tokyo, Japan; [Aoki, Jun; Ishiyama, Ken] Tokyo Metropolitan Otsuka Hosp, Dept Hematol, Tokyo, Japan; [Aoki, Jun; Kanamori, Heiwa] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2418515, Japan; [Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Kobe, Hyogo, Japan; [Eto, Tetsuya] Hamanoumachi Hosp, Dept Hematol, Fukuoka, Japan; [Iwato, Koji] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan; [Iwato, Koji] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Morishima, Yasuo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Nagamura, Tokiko] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Tokyo, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Takami, Akiyoshi] Aichi Med Univ, Dept Internal Med, Div Hematol, Nagoya, Aichi, Japan	Aoki, J (reprint author), Kanagawa Canc Ctr, Dept Hematol, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	jaoki-thk@umin.acjp					Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Oshima K, 2008, BIOL BLOOD MARROW TR, V14, P1100, DOI 10.1016/j.bbmt.2008.07.002; Slovak ML, 2000, BLOOD, V96, P4075; Bommer M, 2010, HAEMATOL-HEMATOL J, V95, P1969, DOI 10.3324/haematol.2010.025999; Castagnola C, 1997, HAEMATOLOGICA, V82, P577; DEKKER AW, 1985, CANCER, V56, P2078, DOI 10.1002/1097-0142(19851015)56:8<2078::AID-CNCR2820560832>3.0.CO;2-0; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Mayadev JS, 2011, INT J RADIAT ONCOL, V80, P193, DOI 10.1016/j.ijrobp.2010.01.062; REES JKH, 1986, LANCET, V2, P1236; Rubin J, 2008, PEDIATR TRANSPLANT, V12, P889, DOI 10.1111/j.1399-3046.2008.00964.x; Rubin J, 2011, BONE MARROW TRANSPL, V46, P372, DOI 10.1038/bmt.2010.121; Ruutu T, 2005, BONE MARROW TRANSPL, V35, P121, DOI 10.1038/sj.bmt.1704727; Sanders KE, 2004, CANCER, V100, P2176, DOI 10.1002/cncr.20280; Shihadeh F, 2012, CANCER-AM CANCER SOC, V118, P112, DOI 10.1002/cncr.26253; STEWART DJ, 1981, CANCER, V47, P184, DOI 10.1002/1097-0142(19810101)47:1<184::AID-CNCR2820470130>3.0.CO;2-M; STEWART DJ, 1985, CANCER, V56, P632, DOI 10.1002/1097-0142(19850801)56:3<632::AID-CNCR2820560333>3.0.CO;2-R; THOMPSON CB, 1986, BLOOD, V67, P195	18	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	DEC	2014	20	12					2029	2033		10.1016/j.bbmt.2014.09.001		5	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	AU4UJ	WOS:000345606500024		
J	Hiruma, T; Asada, T; Yamamoto, M; Inokuchi, R; Matsubara, T; Ishii, T; Sumida, M; Isshiki, R; Mayumi, K; Noiri, E; Nangaku, M; Yahagi, N; Doi, K				Hiruma, Takahiro; Asada, Toshifumi; Yamamoto, Miyuki; Inokuchi, Ryota; Matsubara, Takehiro; Ishii, Takeshi; Sumida, Maki; Isshiki, Rei; Mayumi, Kengo; Noiri, Eisei; Nangaku, Masaomi; Yahagi, Naoki; Doi, Kent			Mortality prediction by acute kidney injury biomarkers in comparison with serum creatinine	BIOMARKERS			English	Article						Intensive care units; L-type fatty acid-binding protein; N-acetyl-beta-D-glucosaminidase	ACID-BINDING PROTEIN; INTENSIVE-CARE-UNIT; OPERATING CHARACTERISTIC CURVES; GELATINASE-ASSOCIATED LIPOCALIN; CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; URINARY BIOMARKERS; CARDIAC-SURGERY; SUBCLINICAL AKI; CLASSIFICATION	Objectives: To investigate the performance of acute kidney injury (AKI) biomarkers for mortality prediction. Materials and methods: Cutoff values of urinary L-type fatty acid-binding protein (L-FABP) and N-acetyl-beta-D-glucosaminidase (NAG) for AKI diagnosis in ICU were determined in the derivation cohort. The performance of these AKI biomarkers for mortality prediction was evaluated in the validation cohort with stratification of serum-creatinine based AKI diagnosis. Results: Mortality in the AKI patients diagnosed by serum creatinine was increased remarkably when urinary L-FABP and NAG were positive. Conclusions: These AKI biomarkers can specifically detect high-risk patients among creatinine-base diagnosed AKI.	[Hiruma, Takahiro; Asada, Toshifumi; Yamamoto, Miyuki; Inokuchi, Ryota; Matsubara, Takehiro; Ishii, Takeshi; Yahagi, Naoki; Doi, Kent] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Tokyo 1130033, Japan; [Sumida, Maki; Isshiki, Rei; Mayumi, Kengo; Noiri, Eisei; Nangaku, Masaomi] Tokyo Univ Hosp, Dept Nephrol & Endocrinol, Tokyo 1130033, Japan	Doi, K (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	inokuchir-icu@h.u-tokyo.ac.jp; kdoi-tky@umin.ac.jp			Tokyo Society of Medical Sciences	This study was supported by The Tokyo Society of Medical Sciences (KD). The authors declare that they have no conflict of interest.	KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Matsui K, 2012, CIRC J, V76, P213, DOI 10.1253/circj.CJ-11-0342; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1569, DOI 10.1093/ndt/gfn009; Liangos O, 2007, J AM SOC NEPHROL, V18, P904, DOI 10.1681/ASN.2006030221; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; [Anonymous], 2012, KIDNEY INT S, V2, P1, DOI DOI 10.1038/KISUP.2012.3; Doi K, 2012, KIDNEY INT, V82, P1114, DOI 10.1038/ki.2012.266; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI [10.1681/ASN.2010080796, 10.1681/ASN.201.0080796]; Katagiri D, 2012, ANN THORAC SURG, V93, P577, DOI 10.1016/j.athoracsur.2011.10.048; Siew ED, 2013, CLIN J AM SOC NEPHRO, V8, P10, DOI 10.2215/CJN.00200112; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Nakamura T, 2006, AM J KIDNEY DIS, V47, P439, DOI 10.1053/j.ajkd.2005.11.006; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Haase M, 2012, NAT REV NEPHROL, V8, P735, DOI 10.1038/nrneph.2012.197; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Noiri E, 2009, AM J PHYSIOL-RENAL, V296, pF669, DOI 10.1152/ajprenal.90513.2008; WELLWOOD JM, 1975, BRIT MED J, V3, P408; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Liu KD, 2011, CRIT CARE MED, V39, P2665, DOI 10.1097/CCM.0b013e318228234b; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Susantitaphong P, 2013, AM J KIDNEY DIS, V61, P430, DOI 10.1053/j.ajkd.2012.10.016; Liu YW, 2013, AM J KIDNEY DIS, V62, P1058, DOI 10.1053/j.ajkd.2013.05.014; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Cruz DN, 2007, CRIT CARE, V11, DOI 10.1186/cc5965; Doi K, 2010, CURR OPIN CRIT CARE, V16, P545, DOI 10.1097/MCC.0b013e32833e2fa4; Fujita D, 2014, HEART VESSE IN PRESS; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase M, 2010, CURR OPIN CRIT CARE, V16, P526, DOI 10.1097/MCC.0b013e328340063b; HANLEY JA, 1983, RADIOLOGY, V148, P839; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Ronco C, 2012, CRIT CARE, V16, DOI 10.1186/cc11240	39	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-750X	1366-5804		BIOMARKERS	Biomarkers	DEC	2014	19	8					646	651		10.3109/1354750X.2014.968209		6	Biotechnology & Applied Microbiology; Toxicology	Biotechnology & Applied Microbiology; Toxicology	AU3FO	WOS:000345498100004		
J	Seo, DJ; Sakoda, A				Seo, Dong-June; Sakoda, Akiyoshi			Assessment of the structural factors controlling the enzymatic saccharification of rice straw cellulose	BIOMASS & BIOENERGY			English	Article						Rice straw; Pretreatment; Cellulase; Saccharification; Structural factors	BIOETHANOL PRODUCTION; CELL-WALLS; HYDROLYSIS; PRETREATMENT; BIOMASS; LIGNIN; SILICA	In this study, the structural factors controlling the enzymatic saccharification of rice straw cellulose were examined by preparing structure-modified rice straw samples such as dewaxed, alkali-treated, oxidized, and swollen rice straw. It was found that the initial enzymatic saccharification rate of the various structure-modified samples was largely controlled by the initial cellulose surface area of the cellulose unit. Although the presence of lignin limited the cellulose surface area, there was no strong relationship between the lignin content and the initial reaction. On the other hand, the long-term enzymatic saccharification of rice straw cellulose highly depended on the lignin removal rate (lignin content). It was also found that silica is not a crucial factor in controlling the enzymatic saccharification. (C) 2014 Elsevier Ltd. All rights reserved.	[Seo, Dong-June; Sakoda, Akiyoshi] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Seo, DJ (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	bassdj80@iis.u-tokyo.ac.jp; sakoda@iis.u-tokyo.ac.jp			JST/JICA, SATREPS, "Sustainable Integration of Local Agriculture and Biomass Industries"	This work was in part supported by JST/JICA, SATREPS, "Sustainable Integration of Local Agriculture and Biomass Industries."	Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; INANAGA S, 1995, SOIL SCI PLANT NUTR, V41, P103; Yang LF, 2012, BIORESOURCE TECHNOL, V124, P283, DOI 10.1016/j.biortech.2012.08.041; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; Alvira P, 2010, BIORESOURCE TECHNOL, V101, P4851, DOI 10.1016/j.biortech.2009.11.093; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Zhang YHP, 2008, J IND MICROBIOL BIOT, V35, P367, DOI 10.1007/s10295-007-0293-6; Currie HA, 2007, ANN BOT-LONDON, V100, P1383, DOI 10.1093/aob/mcm247; Ghaffar SH, 2013, BIOMASS BIOENERG, V57, P264, DOI 10.1016/j.biombioe.2013.07.015; Binod P, 2010, BIORESOURCE TECHNOL, V101, P4767, DOI 10.1016/j.biortech.2009.10.079; Han LR, 2012, BRAZ J MICROBIOL, V43, P53, DOI 10.1590/S1517-83822012000100006; Matsumura Y, 2005, BIOMASS BIOENERG, V29, P347, DOI 10.1016/j.biombioe.2004.06.015; Zheng Y, 2009, BIOTECHNOL BIOENG, V102, P1558, DOI 10.1002/bit.22197; Van Soest PJ, 2006, ANIM FEED SCI TECH, V130, P137, DOI 10.1016/j.anifeedsci.2006.01.023; Drnovsek T, 2005, DYES PIGMENTS, V67, P197, DOI 10.1016/j.dyepig.2004.10.013; Hsu TC, 2010, BIORESOURCE TECHNOL, V101, P4907, DOI 10.1016/j.biortech.2009.10.009; Arantes V., 2010, BIOTECHNOL BIOFUELS, V3, P1; Chen Y., 2013, BIOTECHNOL BIOFUELS, V6, P1; Drapcho C. M., 2008, BIOFUELS ENG PROCESS; Hames B, 2008, TP51042620; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Jin SY, 2006, PROCESS BIOCHEM, V41, P1261, DOI 10.1016/j.procbio.2005.12.022; Kumar R., 2013, AQUEOUS PRETREATMENT, P281; PERRY CC, 1987, J PLANT PHYSIOL, V126, P437; Peterlin S, 2009, CELLULOSE, V16, P833, DOI 10.1007/s10570-009-9291-3; Peterlin S, 2009, ACTA CHIM SLOV, V56, P418; Rehbein M, 2011, INT BIODETER BIODEGR, V65, P913, DOI 10.1016/j.ibiod.2011.04.009; Seo DJ, 2012, BIORESOURCE TECHNOL, V118, P323, DOI 10.1016/j.biortech.2012.05.039; Siqueira G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-7; Sluiter A, 2005, TP51042622; Sluiter A, 2010, TP51042618; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0961-9534	1873-2909		BIOMASS BIOENERG	Biomass Bioenerg.	DEC	2014	71						47	57		10.1016/j.biombioe.2014.10.027		11	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AU0ZA	WOS:000345349500005		
J	Wu, WJ; Wang, ZG; Jin, YC; Matsumoto, Y; Zhai, HM				Wu, Wenjuan; Wang, Zhiguo; Jin, Yongcan; Matsumoto, Yuji; Zhai, Huamin			Effects of LiCl/DMSO dissolution and enzymatic hydrolysis on the chemical composition and lignin structure of rice straw	BIOMASS & BIOENERGY			English	Article						Rice straw; DMSO/LiCl solvent; Dissolution; Regeneration; Lignin; Enzymatic hydrolysis	MILLED WOOD LIGNIN; CELL-WALLS; HYDROXYCINNAMIC ACIDS; IONIC LIQUIDS; SOLVENT; FRACTIONATION; PRETREATMENT; CELLULOSE; LINKAGES; RESIDUES	The exploration of solvent system to completely dissolve lignocellulosic biomass is of great important for the development of biomass based materials and chemicals. Dimethyl sulfoxide containing certain amount of lithium chloride (LiCl/DMSO) was proved an effective solvent system for the dissolution of ball-milled wood. In this paper, four samples of rice straw, internode (stem without node), stem, leaf (leaf and sheath) and whole straw, with and without 1 h of ball milling treatment, were used to investigate the effects of their dissolution in LiCl/DMSO solvent on the chemical composition of regenerated and enzymatically hydrolyzed materials. Because of the structural difference from wood, samples expose d to 1 h of milling were almost completely dissolved. The chemical nature of the regenerated material and of residual after enzymatic hydrolysis of rice straw was analyzed and the susceptibility of this rice straw to the enzymatic hydrolysis was evaluated. (C) 2014 Elsevier Ltd. All rights reserved.	[Wu, Wenjuan; Wang, Zhiguo; Jin, Yongcan; Zhai, Huamin] Nanjing Forestry Univ, Jiangsu Prov Key Lab Pulp & Paper Sci & Technol, Nanjing 210037, Jiangsu, Peoples R China; [Wu, Wenjuan; Jin, Yongcan; Matsumoto, Yuji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Wu, WJ (reprint author), Nanjing Forestry Univ, Jiangsu Prov Key Lab Pulp & Paper Sci & Technol, Nanjing 210037, Jiangsu, Peoples R China.	wenjuanwu@njfu.edu.cn			National Natural Science Foundation of China [31070524, 31370571, 31200444]; National Basic Research Program of China (973 Program) [2010CB732205]; Priority Academic Program Development of Jiangsu Higher Education Institutions	The authors are grateful for the financial support of the National Natural Science Foundation of China (Grant Nos. 31070524, 31370571 and 31200444), the National Basic Research Program of China (973 Program, Grant No. 2010CB732205), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Wang ZG, 2013, J WOOD CHEM TECHNOL, V33, P188, DOI 10.1080/02773813.2013.773042; Fujimoto A, 2005, J WOOD SCI, V51, P89, DOI 10.1007/s10086-004-0682-7; HATFIELD RD, 1994, J SCI FOOD AGR, V65, P51, DOI 10.1002/jsfa.2740650109; HIGUCHI T, 1967, PHYTOCHEMISTRY, V6, P1551, DOI 10.1016/S0031-9422(00)82949-0; Grabber JH, 2003, J AGR FOOD CHEM, V51, P4984, DOI 10.1021/jf030027c; Sun RC, 2002, IND CROP PROD, V15, P179, DOI 10.1016/S0926-6690(01)00112-1; Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238; Lu FC, 2003, PLANT J, V35, P535, DOI 10.1046/j.1365-313X.2003.01817.x; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; PETRUS L, 1995, CARBOHYD RES, V268, P319, DOI 10.1016/0008-6215(94)00330-I; Nakagame S, 2011, BIOTECHNOL BIOENG, V108, P538, DOI 10.1002/bit.22981; Emmel A, 2003, BIORESOURCE TECHNOL, V86, P105, DOI 10.1016/S0960-8524(02)00165-7; Wang ZG, 2009, J AGR FOOD CHEM, V57, P6167, DOI 10.1021/jf900441q; Ghaffar SH, 2013, BIOMASS BIOENERG, V57, P264, DOI 10.1016/j.biombioe.2013.07.015; Binod P, 2010, BIORESOURCE TECHNOL, V101, P4767, DOI 10.1016/j.biortech.2009.10.079; Ikeda T, 2002, J AGR FOOD CHEM, V50, P129, DOI 10.1021/jf010870f; Jin ZF, 2006, BIOPOLYMERS, V83, P103, DOI 10.1002/bip.20533; Li B, 2010, IND ENG CHEM RES, V49, P2477, DOI 10.1021/ie901560p; Chen LJ, 2009, RENEW SUST ENERG REV, V13, P2689, DOI 10.1016/j.rser.2009.06.025; BORCHARD.LG, 1970, TAPPI, V53, P257; Buranov AU, 2008, IND CROP PROD, V28, P237, DOI 10.1016/j.indcrop.2008.03.008; Chen C.L., 1992, METHODS LIGNIN CHEM, P301; Dence C. W., 1992, METHODS LIGNIN CHEM, P33; Fasching M, 2008, HOLZFORSCHUNG, V62, P15, DOI 10.1515/HF.2008.003; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Lam TBT, 2001, PHYTOCHEMISTRY, V57, P987, DOI 10.1016/S0031-9422(01)00052-8; Min DY, 2014, RSC ADV, V4, P10845, DOI 10.1039/c3ra47032f; Papa G, 2012, BIORESOURCE TECHNOL, V117, P352, DOI 10.1016/j.biortech.2012.04.065; Sun SN, 2013, IND CROP PROD, V43, P570, DOI 10.1016/j.indcrop.2012.07.074; [Anonymous], 1989, ACS SYM SER; Zhang AP, 2010, J AGR FOOD CHEM, V58, P3446, DOI 10.1021/jf903998d; Zhang XM, 2010, SEP SCI TECHNOL, V45, P2497, DOI 10.1080/01496391003793892	32	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0961-9534	1873-2909		BIOMASS BIOENERG	Biomass Bioenerg.	DEC	2014	71						357	362		10.1016/j.biombioe.2014.09.021		6	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AU0ZA	WOS:000345349500036		
J	Ikeda, K; Ikawa, K; Yokoshige, S; Yoshikawa, S; Morikawa, N				Ikeda, Kayo; Ikawa, Kazuro; Yokoshige, Satoko; Yoshikawa, Satoshi; Morikawa, Norifumi			Gas chromatography-electron ionization-mass spectrometry quantitation of valproic acid and gabapentin, using dried plasma spots, for therapeutic drug monitoring in in-home medical care	BIOMEDICAL CHROMATOGRAPHY			English	Article						dried plasma spot testing; valproic acid; gabapentin; gas chromatography-mass spectrometry; electron ionization		A simple and sensitive gas chromatography-electron ionization-mass spectrometry (GC-EI-MS) method using dried plasma spot testing cards was developed for determination of valproic acid and gabapentin concentrations in human plasma from patients receiving in-home medical care. We have proposed that a simple, easy and dry sampling method is suitable for in-home medical patients for therapeutic drug monitoring. Therefore, in the present study, we used recently developed commercially available easy handling cards: Whatman FTA DMPK-A and Bond Elut DMS. In-home medical care patients can collect plasma using these simple kits. The spots of plasma on the cards were extracted into methanol and then evaporated to dryness. The residues were trimethylsilylated using N-methyl-N-trimethylsilyltrifluoroacetamide. For GC-EI-MS analysis, the calibration curves on both cards were linear from 10 to 200 mu g/mL for valproic acid, and from 0.5 to 10 mu g/mL for gabapentin. Intra- and interday precisions in plasma were both 13.0% (coefficient of variation), and the accuracy was between 87.9 and 112% for both cards within the calibration curves. The limits of quantification were 10 mu g/mL for valproic acid and 0.5 mu g/mL for gabapentin on both cards. We believe that the present method will be useful for in-home medical care. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ikeda, Kayo; Ikawa, Kazuro; Yokoshige, Satoko; Yoshikawa, Satoshi; Morikawa, Norifumi] Hiroshima Univ, Dept Clin Pharmacotherapy, Minami Ku, Hiroshima 7348551, Japan	Ikeda, K (reprint author), Hiroshima Univ, Dept Clin Pharmacotherapy, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	ikeda@hiroshima-u.ac.jp			JSPS KAKENHI [23590183]	This work was supported by JSPS KAKENHI Grant Number 23590183.	Shibata M, 2012, BIOMED CHROMATOGR, V26, P1519, DOI 10.1002/bmc.2726; Edelbroek PM, 2009, THER DRUG MONIT, V31, P327, DOI 10.1097/FTD.0b013e31819e91ce; Kolocouri F, 2010, ANAL BIOANAL CHEM, V398, P1339, DOI 10.1007/s00216-010-4048-2; Spooner N, 2009, ANAL CHEM, V81, P1557, DOI 10.1021/ac8022839; Pujadas M, 2007, J PHARMACEUT BIOMED, V44, P594, DOI 10.1016/j.jpba.2007.02.022; Beaudette P, 2004, J CHROMATOGR B, V809, P153, DOI 10.1016/j.jchromb.2004.06.018; Leis HJ, 2003, J CHROMATOGR B, V784, P69; Kamaura Mitsumasa, 2007, Sangyo Eiseigaku Zasshi, V49, P89, DOI 10.1539/sangyoeisei.49.89; Kims KB, 2011, J PHARMACEUT BIOMED, V56, P771; Lees MS, 2009, ARCH PHARM RES, V32, P1029; Lehner AF, 2007, J ANAL TOXICOL, V31, P555; Nakajima M, 2000, THER DRUG MONIT, V22, P716, DOI 10.1097/00007691-200012000-00011; Shimizus N, 2009, CLIN EVALUATION, V36, P725; US DHHS FDA and CDER, 2001, GUID IND BION METH V; Yus JT, 2012, ANAL BIOANAL CHEM, V403, P583	15	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	DEC	2014	28	12					1756	1762		10.1002/bmc.3217		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	AT8XO	WOS:000345212600023		
J	Guo, XJ; Meng, Q; Liu, Q; Wang, CY; Huo, XK; Zhang, Z; Kaku, TC; Liu, KX				Guo, Xinjin; Meng, Qiang; Liu, Qi; Wang, Changyuan; Huo, Xiaokui; Zhang, Zhe; Kaku, Taiichi; Liu, Kexin			Simultaneous determination of three dipeptides (JBP485, Gly-Sar and JBP923) in the cell lysates by liquid chromatography-tandem mass spectrometry: application to identify the function of the PEPT1 transfected cell	BIOMEDICAL CHROMATOGRAPHY			English	Article						JBP485; Gly-Sar; JBP923; LC-MS; MS; cell lysates	RAT; PHARMACOKINETICS; TRANSPORTERS	A simple and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of JBP485, Gly-Sar and JBP923 in the cell lysates using methanol as a deproteinization solvent was developed and validated. Detection was performed by turbo ionspray ionization in multiple reaction monitoring mode using the transitions of m/z 147.1m/z 90.1 for Gly-Sar, m/z 201.1m/z 86.1 for JBP485, m/z 219.1m/z 86.1 for JBP923 and m/z 152.0m/z 110.0 for paracetamol (internal standard). The analytes were separated on a Hypersil ODS C-18 HPLC column using isocratic elution mode with a mobile phase containing 0.1% formic acid in water-methanol (97:3, v/v) at a flow rate of 0.2mL/min. The calibration curves were demonstrated to be linear over the concentration range of 5.00-5000nm with coefficient of 0.9968 for Gly-Sar, 0.9975 for JBP485 and 0.9952 for JBP923. The intra- and inter-day precisions were <10.2% for each quality contro; level, and the accuracy was within +/- 5.6% for each analyte. The matrix effect, the extraction recovery and stabilities of LC-MS/MS analysis were also investigated. This validated method was successfully applied to the simultaneous determination of JBP485, Gly-Sar and JBP923 in the cell lysates for identification of stably transfected HeLa cells with human PEPT1. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Guo, Xinjin; Meng, Qiang; Liu, Qi; Wang, Changyuan; Huo, Xiaokui; Liu, Kexin] Dalian Med Univ, Coll Pharm, Dept Clin Pharmacol, Dalian 116044, Peoples R China; [Kaku, Taiichi] Japan Bioprod Ind Co Ltd, Shibuya Ku, Tokyo, Japan; [Meng, Qiang; Liu, Qi; Wang, Changyuan; Huo, Xiaokui; Liu, Kexin] Dalian Med Univ, Prov Key Lab Pharmacokinet & Transport, Dalian 116044, Liaoning, Peoples R China; [Zhang, Zhe] Dalian Med Univ, Affiliated Hosp 1, Dalian 116044, Liaoning, Peoples R China	Liu, KX (reprint author), Dalian Med Univ, Coll Pharm, Dept Clin Pharmacol, 9 West Sect,Lvshun South Rd, Dalian 116044, Peoples R China.	kexinliu@dlmedu.edu.cn			National Natural Science Foundation of China [81072694, 81273580]; Dalian Government [2010E12SF060]	We especially thank Yukio Kato (Kanazawa university, Kanazawa, Japan) for providing pcDNA3-PEPT1. This work was supported in part by a grant from the National Natural Science Foundation of China (nos 81072694 and 81273580) and Dalian Government (no. 2010E12SF060).	Zhang J, 2010, DRUG METAB DISPOS, V38, P930, DOI 10.1124/dmd.110.032060; Terada T, 1997, AM J PHYSIOL-RENAL, V273, pF706; Kusuhara H, 2002, J CONTROL RELEASE, V78, P43, DOI 10.1016/S0168-3659(01)00480-1; Cang JA, 2010, DRUG METAB PHARMACOK, V25, P500, DOI 10.2133/dmpk.DMPK-10-RG-045; Wang W, 2011, PEPTIDES, V32, P946, DOI 10.1016/j.peptides.2011.01.031; Bais JP, 1992, PHARM RES, V9, P969; Cang JA, 2011, J LIQ CHROMATOGR R T, V34, P350, DOI 10.1080/10826076.2011.551606; Guos X, 2012, PEPTIDES, V34, P395; Guos X, 2012, DRUG METABOLISM PHAR, V27, P232; Guos X, 2013, TOXICOLOGY APPL PHAR, V271, P285; Lius KX, 1998, BIOL PHARM BULL, V21, P44; Lius KX, 2000, J PHARM EXPT THERAPE, V294, P510; Lius Z, 2011, PEPTIDES, V32, P747; Suns YB, 2009, J CHROMATOGR B, V877, P649; U.S. Food and Drug Administration (FDA), 2001, GUID IND BIOAN METH; Wang CY, 2011, CHROMATOGRAPHIA, V73, P481, DOI 10.1007/s10337-011-1920-y; Wus J, 2008, EUROPEAN J PHARM, V589, P299; Yangs T, 2009, J PHARM PHARMACOL, V6, P767	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	DEC	2014	28	12					1839	1845		10.1002/bmc.3228		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	AT8XO	WOS:000345212600033		
J	Riccardo, F; Shigematsu, M; Chow, C; McKnight, CJ; Linge, J; Doherty, B; Dente, MG; Declich, S; Barker, M; Barboza, P; Vaillant, L; Donachie, A; Mawudeku, A; Blench, M; Arthur, R				Riccardo, Flavia; Shigematsu, Mika; Chow, Catherine; McKnight, C. Jason; Linge, Jens; Doherty, Brian; Dente, Maria Grazia; Declich, Silvia; Barker, Mike; Barboza, Philippe; Vaillant, Laetitia; Donachie, Alastair; Mawudeku, Abla; Blench, Michael; Arthur, Ray			Interfacing a Biosurveillance Portal and an International Network of Institutional Analysts to Detect Biological Threats	BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE			English	Article							EARLY-WARNING SYSTEM; EMERGING DISEASES; HEALTH SECURITY; PROMED-MAIL; SURVEILLANCE; INTERNET; RUMORS	The Early Alerting and Reporting (EAR) project, launched in 2008, is aimed at improving global early alerting and risk assessment and evaluating the feasibility and opportunity of integrating the analysis of biological, chemical, radionuclear (CBRN), and pandemic influenza threats. At a time when no international collaborations existed in the field of event-based surveillance, EAR's innovative approach involved both epidemic intelligence experts and internet-based biosurveillance system providers in the framework of an international collaboration called the Global Health Security Initiative, which involved the ministries of health of the G7 countries and Mexico, the World Health Organization, and the European Commission. The EAR project pooled data from 7 major internet-based biosurveillance systems onto a common portal that was progressively optimized for biological threat detection under the guidance of epidemic intelligence experts from public health institutions in Canada, the European Centre for Disease Prevention and Control, France, Germany, Italy, Japan, the United Kingdom, and the United States. The group became the first end users of the EAR portal, constituting a network of analysts working with a common standard operating procedure and risk assessment tools on a rotation basis to constantly screen and assess public information on the web for events that could suggest an intentional release of biological agents. Following the first 2-year pilot phase, the EAR project was tested in its capacity to monitor biological threats, proving that its working model was feasible and demonstrating the high commitment of the countries and international institutions involved. During the testing period, analysts using the EAR platform did not miss intentional events of a biological nature and did not issue false alarms. Through the findings of this initial assessment, this article provides insights into how the field of epidemic intelligence can advance through an international network and, more specifically, how it was further developed in the EAR project.	[Riccardo, Flavia; Dente, Maria Grazia; Declich, Silvia] Inst Super Sanita ISS Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Shigematsu, Mika] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Chow, Catherine; McKnight, C. Jason; Arthur, Ray] US Ctr Dis Control & Prevent, Global Dis Detect Operat Ctr, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Linge, Jens; Doherty, Brian] Commiss European Communities, Joint Res Ctr, Inst Protect & Secur Citizen, Global Secur & Crisis Management Unit, I-21020 Ispra, VA, Italy; [Barker, Mike] Publ Hlth England, Emergency Response Dept, Porton Down Salisbury, Wilts, England; [Barboza, Philippe; Vaillant, Laetitia] French Publ Hlth Inst, Insitut Veille Sanit, Int Dept, St Maurice, France; [Donachie, Alastair] European Ctr Dis Prevent & Control ECDC, Surveillance & Response Unit, Stockholm, Sweden; [Mawudeku, Abla; Blench, Michael] Publ Hlth Agcy Canada, Ctr Emergency Preparedness & Response, Ottawa, ON, Canada	Riccardo, F (reprint author), Inst Super Sanita ISS Natl Inst Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	flavia.riccardo@iss.it					Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; Hartley DM, 2013, CLIN MICROBIOL INFEC, V19, P1006, DOI 10.1111/1469-0691.12273; Barboza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057252; Aldis W, 2008, HEALTH POLICY PLANN, V23, P369, DOI 10.1093/heapol/czn030; Grein TW, 2000, EMERG INFECT DIS, V6, P97; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Madoff LC, 2005, ARCH MED RES, V36, P724, DOI 10.1016/j.arcmed.2005.06.005; Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003; Brownstein JS, 2007, EUROSURVEILLANCE, V12; Chan HE, 2010, P NATL ACAD SCI USA, V107, P21701; Chiu YW, 2009, ASIA PAC J CLIN NUTR, V18, P679; Generous N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086601; Guglielmetti P, 2006, Euro Surveill, V11, P215; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Linge JP, 2009, EUROSURVEILLANCE, V14; Linge J.P., 2010, ADV ICTS DISASTER MA, P131; Linge JP, 2012, LECT NOTES I COMPUTE, V91, P178; Lober WB, 2002, J AM MED INFORM ASSN, V9, P105, DOI 10.1197/jamia.M1052; Nelson Noele P, 2012, Emerg Themes Epidemiol, V9, P4, DOI 10.1186/1742-7622-9-4; Paquet C, 2006, Euro Surveill, V11, P212; Riccardo F, 2010, EUR SCI C APPL INF D, P11; Rortais A, 2010, FOOD RES INT, V43, P1553, DOI 10.1016/j.foodres.2010.04.009; United Nations Development Program, 1994, HUM DEV REP 1994; World Health Organization, 2014, WHOHSEGCRLYO20144	25	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1538-7135	1557-850X		BIOSECUR BIOTERROR	Biosecur. Bioterror.	DEC 1	2014	12	6					325	336		10.1089/bsp.2014.0031		12	Public, Environmental & Occupational Health; International Relations	Public, Environmental & Occupational Health; International Relations	AU4YK	WOS:000345614100006		
J	Miyashita, M; Sasano, H; Tamaki, K; Chan, M; Hirakawa, H; Suzuki, A; Tada, H; Watanabe, G; Nemoto, N; Nakagawa, S; Ishida, T; Ohuchi, N				Miyashita, Minoru; Sasano, Hironobu; Tamaki, Kentaro; Chan, Monica; Hirakawa, Hisashi; Suzuki, Akihiko; Tada, Hiroshi; Watanabe, Go; Nemoto, Noriko; Nakagawa, Saki; Ishida, Takanori; Ohuchi, Noriaki			Tumor-infiltrating CD8+and FOXP3+lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Triple-negative breast cancer; Chemo-sensitivity; pCR; CD8; FOXP3; Ki-67	REGULATORY T-CELLS; PROGNOSTIC INDICATOR; MOLECULAR SUBTYPES; CARCINOMA; ANGIOGENESIS; EXPRESSION; VASOHIBIN-1; SURVIVAL; THERAPY; IDENTIFICATION	The anti-tumor immune response was recently reported to play a critical role in the chemotherapeutic sensitivity of breast cancer. Therefore, we investigated the correlation between CD8+ and FOXP3+ tumor-infiltrating lymphocytes and the pathological complete response (pCR) following neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC), in conjunction with neoangiogenesis, basal and proliferation markers. CD8+ and FOXP3+ lymphocytes were assessed in biopsy specimens by double-staining immunohistochemistry, in combination with immunostaining of vasohibin-1, CD31, EGFR, CK5/6, and Ki-67. Earlier age, pre-menopausal status, smaller tumor size, and high Ki-67 were significantly associated with pCR, as in high CD8+, high CD8+/FOXP3+ ratio, and low vasohibin-1 positive ratio. Multivariate analysis did reveal that a high CD8+/FOXP3+ ratio was a strong predictor of pCR with an odds ratio of 5.32 (P = 0.005). High Ki-67 was also significantly associated with pCR (P = 0.002). TNBCs with a high CD8+/FOXP3+ ratio and high Ki-67 had the highest pCR rate (70 %) following NAC. However, the pCR rate of the patients with low CD8+/FOXP3+ ratio and low Ki-67 was only 5 %. The pCR rates of a high CD8+/FOXP3+ ratio and low Ki-67 patients and those with a low CD8+/FOXP3+ ratio and high Ki-67 were 24 and 21 %, respectively. TNBCs with a high CD8+/FOXP3+ ratio were more sensitive to anthracycline and taxane-based chemotherapeutic regimens, and the CD8+/FOXP3+ ratio in conjunction with Ki-67 could predict pCR following NAC in TNBC. This predictor may represent a new surrogate for testing the efficacy of investigational agents in the neoadjuvant setting.	[Miyashita, Minoru; Suzuki, Akihiko; Tada, Hiroshi; Watanabe, Go; Nemoto, Noriko; Nakagawa, Saki; Ishida, Takanori; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Miyashita, Minoru; Sasano, Hironobu; Tamaki, Kentaro; Chan, Monica; Nemoto, Noriko; Nakagawa, Saki] Tohoku Univ Hosp, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Tamaki, Kentaro] Nahanishi Clin, Dept Breast Surg, Naha 9010154, Japan; [Hirakawa, Hisashi] Tohoku Kosai Hosp, Dept Breast Surg, Aoba Ku, Sendai, Miyagi 9800803, Japan	Miyashita, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	atihsayim8m8@med.tohoku.ac.jp			Japan Society for the Promotion of Science [26830094]	We wish to thank Yayoi Takahashi, MT, for her excellent technical assistance. This work was partly supported by a Grant-in-Aid for researches on the construction of treatment algorithm in triple-negative breast cancer (No. 26830094) from the Japan Society for the Promotion of Science.	Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Denkert C, 2013, ANN ONCOL, V24, P2786, DOI 10.1093/annonc/mdt350; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Oda N, 2012, BREAST CANCER RES TR, V136, P107, DOI 10.1007/s10549-012-2245-8; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.012; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; Bertucci F, 2005, CANCER RES, V65, P2170, DOI 10.1158/0008-5472.CAN-04-4115; Liyanage UK, 2002, J IMMUNOL, V169, P2756; WEIDNER N, 1992, J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Viguier M, 2004, J IMMUNOL, V173, P1444; Tamaki K, 2010, CANCER SCI, V101, P1051, DOI 10.1111/j.1349-7006.2009.01483.x; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; BEVILACQUA P, 1995, BREAST CANCER RES TR, V36, P205, DOI 10.1007/BF00666041; Chan MSM, 2012, EXPERT OPIN THER TAR, V16, pS69, DOI 10.1517/14728222.2011.628938; Darb-Esfahani S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2363; Lerma E, 2007, MODERN PATHOL, V20, P1200, DOI 10.1038/modpathol.3800961; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148	37	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	DEC	2014	148	3					525	534		10.1007/s10549-014-3197-y		10	Oncology	Oncology	AU1HC	WOS:000345370600006		
J	Muroi, C; Fujioka, M; Okuchi, K; Fandino, J; Keller, E; Sakamoto, Y; Mishima, K; Iwasaki, K; Fujiwara, M				Muroi, Carl; Fujioka, Masayuki; Okuchi, Kazuo; Fandino, Javier; Keller, Emanuela; Sakamoto, Yuya; Mishima, Kenichi; Iwasaki, Katsunori; Fujiwara, Michihiro			Filament perforation model for mouse subarachnoid hemorrhage: Surgical-technical considerations	BRITISH JOURNAL OF NEUROSURGERY			English	Article						mouse model; microthrombosis; subarachnoid hemorrhage; vasospasm	CEREBRAL-ARTERY OCCLUSION; CUZN-SUPEROXIDE DISMUTASE; NITRIC-OXIDE SYNTHASE; EARLY BRAIN-INJURY; MURINE MODEL; VASOSPASM; MICE; INFLAMMATION; INHIBITION; INDUCTION	Objective. Mouse subarachnoid hemorrhage (SAH) models are becoming increasingly important. We aimed to report and discuss the detailed technical-surgical approach and difficulties associated with the circle of Willis perforation (cWp) model, with reference to the existing literature. Methods. First, the cWp model was reproduced using ddY mice following scarification at 0 h, Days 1, 2, and 3 after SAH. Second, C57BL/6 mice were subjected to SAH with histological examination on Days 1, 2, and 3. Sham-operated mice were sacrificed on Day 2. Neurological performance, amount of subarachnoid blood, cerebral vasospasm (CVS), and neuronal injury were assessed. Relevant articles found in the MEDLINE database were reviewed. Results. Induction of SAH was successfully reproduced. The volume of subarachnoid blood decreased with time due to resorption. Neurological performance was worse in SAH compared with sham. Signs of CVS could be confirmed on Days 2 and 3, but not Day 1. The cumulative number of microthrombi was significantly higher on Days 2 and 3, but not Day 1. Apoptotic and degenerative neurons were found in the cortex and hippocampal area. Our review of the literature revealed the cWp model to be the most frequently used. The present findings largely confirmed previously published results. However, detailed technical-surgical description and its discussion were sparse, which we provide here. Conclusions. The current study provides additional useful information characterizing the cWp model. This model may be of first choice at present, as important pathologies can be reproduced and most findings in the literature are based on it.	[Muroi, Carl; Fujioka, Masayuki; Sakamoto, Yuya; Mishima, Kenichi; Iwasaki, Katsunori; Fujiwara, Michihiro] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Fukuoka 8140180, Japan; [Muroi, Carl; Mishima, Kenichi; Iwasaki, Katsunori] Fukuoka Univ, Fac Pharmaceut Sci, Inst Aging & Brain Sci, Fukuoka 8140180, Japan; [Muroi, Carl; Fandino, Javier] Kantonsspital, Dept Neurosurg, Aarau, Switzerland; [Fujioka, Masayuki; Okuchi, Kazuo] Nara Med Univ, Dept Emergency & Crit Care Med, Nara, Japan; [Keller, Emanuela] Univ Zurich Hosp, Dept Neurosurg, Neurocrit Care Unit, CH-8091 Zurich, Switzerland	Muroi, C (reprint author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Jonan Ku, 19-1 Nanakuma, Fukuoka 8140180, Japan.	carl.muroi@ksa.ch	Keller, Emanuela/M-2917-2015	Keller, Emanuela/0000-0001-7892-8261	Swiss Foundation for Grants in Biology and Medicine; F. Hoffmann-La Roche Ltd., Basel, Switzerland; Okinaka Memorial Institute for Medical Research, Tokyo, Japan	CM has been supported by a personal research grant from the Swiss Foundation for Grants in Biology and Medicine and F. Hoffmann-La Roche Ltd., Basel, Switzerland. The project was partially supported by a research grant from the Okinaka Memorial Institute for Medical Research, Tokyo, Japan. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Altay T, 2009, J NEUROSCI METH, V183, P136, DOI 10.1016/j.jneumeth.2009.06.027; McGirt MJ, 2002, STROKE, V33, P2950, DOI 10.1161/01.STR.0000038986.68044.39; Suzuki H, 2009, STROKE, V40, P3872, DOI 10.1161/STROKEAHA.109.566109; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Chen Y, 2008, J NEUROSCI METH, V174, P18, DOI 10.1016/j.jneumeth.2008.06.021; Altay O, 2012, STROKE, V43, P2513, DOI 10.1161/STROKEAHA.112.661728; Muroi C, 2012, CURR OPIN CRIT CARE, V18, P119, DOI 10.1097/MCC.0b013e32835075ae; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Vellimana AK, 2011, STROKE, V42, P776, DOI 10.1161/STROKEAHA.110.607200; Altay O, 2012, CRIT CARE MED, V40, P1908, DOI 10.1097/CCM.0b013e3182474bc1; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; GARCIA JH, 1995, STROKE, V26, P627; Momin EN, 2009, NEUROSURGERY, V65, P937, DOI 10.1227/01.NEU.0000356974.14230.B8; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Sabri M, 2011, J CEREBR BLOOD F MET, V31, P190, DOI 10.1038/jcbfm.2010.76; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Feiler S, 2011, CEREBROVASC DIS, V32, P289, DOI 10.1159/000328248; Ishikawa M, 2009, NEUROSURGERY, V64, P546, DOI 10.1227/01.NEU.0000337579.05110.F4; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Sabri M, 2011, STROKE, V42, P1454, DOI 10.1161/STROKEAHA.110.604728; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Ayer R, 2011, ACTA NEUROCHIR SUPPL, V111, P145, DOI 10.1007/978-3-7091-0693-8_24; Friedrich B, 2011, J CEREB BLOOD FLOW M, V32, P447; Froehler MT, 2010, J CLIN NEUROSCI, V17, P1169, DOI 10.1016/j.jocn.2010.04.014; Han BH, 2012, NEUROSURGERY, V70, P178, DOI 10.1227/NEU.0b013e31822ec2b0; Ishikawa M, 2009, NEUROSURGERY, V64, P553; Kamii H, 1999, STROKE, V30, P867; Lin CL, 2005, SURG NEUROL, V64, P201, DOI 10.1016/j.surneu.2005.04.038; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Lin CL, 2005, SURG NEUROL, V64, P205; Liu SM, 2007, CAN J NEUROL SCI, V34, P356; McGirt MJ, 2002, STROKE, V33, P2317, DOI 10.1161/01.STR.0000027207.67639.1E; Mesis Rachel G, 2006, Neurosurg Focus, V21, pE4; Mino M, 2003, NEUROL RES, V25, P839, DOI 10.1179/016164103771953934; Muroi C, 2011, ACTA NEUROCHIR SUPPL, V110, P191, DOI 10.1007/978-3-7091-0353-1_33; Parra A, 2002, NEUROL RES, V24, P510, DOI 10.1179/016164102101200276; Pisapia JM, 2011, EXP NEUROL, V233, P357; Provencio JJ, 2011, J NEUROIMMUNOL, V232, P94, DOI 10.1016/j.jneuroim.2010.10.016; Sabri M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017062; Sabri M, 2012, NEUROSCIENCE, V224, P26, DOI 10.1016/j.neuroscience.2012.08.002; Saito A, 2001, STROKE, V32, P1652; Scholler K, 2011, NEUROSURGERY, V68, P1118, DOI 10.1227/NEU.0b013e31820a0024; Sehba FA, 2010, J NEUROSURG, V113, P826, DOI 10.3171/2009.9.JNS09802; Sheng HX, 2011, STROKE, V42, P471, DOI 10.1161/STROKEAHA.110.600569; Smithason S, 2011, NEUROCRIT CARE, V16, P327; Wakade C, 2009, ANTIOXID REDOX SIGN, V11, P35, DOI 10.1089/ars.2008.2056	52	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2014	28	6					722	732		10.3109/02688697.2014.918579		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU0XG	WOS:000345344900007		
J	Kuroda, H; Kashimura, H; Murakami, T; Endo, H; Mase, T; Ogasawara, K				Kuroda, Hiroki; Kashimura, Hiroshi; Murakami, Toshiyuki; Endo, Hidehiko; Mase, Tomohiko; Ogasawara, Kuniaki			Early onset of PRES in a patient with a subarachnoid haemorrhage due to a ruptured intracranial aneurysm	BRITISH JOURNAL OF NEUROSURGERY			English	Article						hyperperfusion; hyperdynamic therapy; posterior reversible encephalopathy syndrome; subarachnoid haemorrhage		Posterior reversible encephalopathy syndrome (PRES) is rarely associated with subarachnoid haemorrhage (SAH). We present a case involving a patient who developed PRES, prior to induction of hypertensive therapy, 2 days after the onset of a SAH due to a ruptured intracranial aneurysm.	[Kuroda, Hiroki] Iwate Prefectural Miyako Hosp, Dept Neurosurg, Miyako 0270096, Japan; [Kashimura, Hiroshi; Murakami, Toshiyuki; Endo, Hidehiko; Mase, Tomohiko; Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 020, Japan	Kuroda, H (reprint author), Iwate Prefectural Miyako Hosp, Dept Neurosurg, 1-11-26 Sakikuwagasaki, Miyako 0270096, Japan.	hkuroda@iwate-med.ac.jp					Amin-Hanjani S, 1999, NEUROSURGERY, V44, P1113, DOI 10.1097/00006123-199905000-00097; Sato K, 2010, J CEREBR BLOOD F MET, V30, P1110, DOI 10.1038/jcbfm.2009.264; Jang HW, 2010, J CLIN NEUROSCI, V17, P1059, DOI 10.1016/j.jocn.2009.10.006	3	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2014	28	6					785	786		10.3109/02688697.2014.913778		2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU0XG	WOS:000345344900017		
J	Hayashi, K; Nakada, M; Miyashita, K; Hayashi, Y; Hamada, J				Hayashi, Koji; Nakada, Mitsutoshi; Miyashita, Katsuyoshi; Hayashi, Yutaka; Hamada, Jun-ichiro			Reversible acute bilateral blindness resulting from a frontal brain tumor: A case report	BRITISH JOURNAL OF NEUROSURGERY			English	Article						blindness; brain tumour; papilledema	OPTIC-NERVE	We experienced an unusual case of a 15-year-old girl who suffered acute bilateral blindness caused by a frontal lobe tumour. She underwent emergent operation, after which her vision recovered. This case emphasizes that a brain mass can cause sudden onset blindness and an emergency intervention might save the patient's sight.	[Hayashi, Koji; Nakada, Mitsutoshi; Miyashita, Katsuyoshi; Hayashi, Yutaka; Hamada, Jun-ichiro] Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa 9208641, Japan	Nakada, M (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	mnakada@med.kanazawa-u.ac.jp					Killer HE, 2007, BRAIN, V130, P514, DOI 10.1093/brain/awl324; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Seth A, 2009, BMJ CASE REP, V1, P1513	3	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2014	28	6					793	795		10.3109/02688697.2014.913774		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU0XG	WOS:000345344900020		
J	Ichikawa, J; Inoue, R				Ichikawa, Jun; Inoue, Ryuji			TRPC6 regulates cell cycle progression by modulating membrane potential in bone marrow stromal cells	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							MESENCHYMAL STEM-CELLS; OPERATED CA2+ ENTRY; SMOOTH-MUSCLE-CELLS; CALCIUM-ENTRY; CONCISE GUIDE; SUSTAINED DEPOLARIZATION; NFAT ACTIVATION; CATION CHANNELS; DNA-SYNTHESIS; ION CHANNELS	Background and PurposeCa(2+) influx is important for cell cycle progression, but the mechanisms involved seem to vary. We investigated the potential roles of transient receptor potential (TRP) channels and store-operated Ca2+ entry (SOCE)-related molecules STIM (stromal interaction molecule)/Orai in the cell cycle progression of rat bone marrow stromal cells (BMSCs), a reliable therapeutic resource for regenerative medicine. Experimental ApproachPCR and immunoblot analyses were used to examine mRNA and protein levels, fluorescence imaging and patch clamping for Ca2+ influx and membrane potential measurements, and flow cytometry for cell cycle analysis. Key ResultsCell cycle synchronization of BMSCs revealed S phase-specific enhancement of TRPC1, STIM and Orai mRNA and protein expression. In contrast, TRPC6 expression decreased in the S phase and increased in the G(1) phase. Resting membrane potential (RMP) of BMSCs was most negative and positive in the S and G(1) phases, respectively, and was accompanied by an enhancement and attenuation of SOCE respectively. Chemically depolarizing/hyperpolarizing the membrane erased these differences in SOCE magnitude during the cell cycle. siRNA knockdown of TRPC6 produced a negative shift in RMP, increased SOCE and caused redistribution of BMSCs with increased populations in the S and G(2)/M phases and accumulation of cyclins A2 and B1. A low concentration of Gd3+ (1M) suppressed BMSC proliferation at its concentration to inhibit SOC channels relatively specifically. Conclusions and ImplicationsTRPC6, by changing the membrane potential, plays a pivotal role in controlling the SOCE magnitude, which is critical for cell cycle progression of BMSCs. This finding provides a new therapeutic strategy for regulating BMSC proliferation.	[Ichikawa, Jun; Inoue, Ryuji] Fukuoka Univ, Sch Med, Dept Physiol, Fukuoka 8140180, Japan	Ichikawa, J (reprint author), Fukuoka Univ, Sch Med, Dept Physiol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	ichikawaj@fukuoka-u.ac.jp			Clinical Research Promotion Foundation	We thank Professor Yasuo Mori (Kyoto University) for providing us with Pyr2 compound. This work was supported by a Grant-in-Aid to J. I. from The Clinical Research Promotion Foundation.	Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Li MQ, 2012, CELL CALCIUM, V51, P486, DOI 10.1016/j.ceca.2012.04.014; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2005.05.007; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; KONG SK, 1991, IMMUNOPHARM IMMUNOT, V13, P329, DOI 10.3109/08923979109019708; Armisen R, 2011, J CELL PHYSIOL, V226, P103, DOI 10.1002/jcp.22310; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Ryu JM, 2010, J CELL PHYSIOL, V224, P59, DOI [10.1002/jcp.22091, 10.1002/jcp.2209]; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; Cheng H, 2010, STEM CELLS DEV, V19, P1393, DOI 10.1089/scd.2009.0262; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Hofmann T, 1999, NATURE, V397, P259; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; El Boustany C, 2010, CELL CALCIUM, V47, P350, DOI 10.1016/j.ceca.2010.01.006; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Ding X, 2010, J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; CONE CD, 1976, SCIENCE, V192, P155, DOI 10.1126/science.56781; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Wang ET, 2003, FASEB J, V17, P458, DOI 10.1096/fj.02-0510fje; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Estacion M, 2006, J PHYSIOL-LONDON, V572, P359, DOI 10.1113/jphysiol.2005.103143; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165; Cai R, 2009, INT J CANCER, V125, P2281, DOI 10.1002/ijc.24551; Sel S, 2008, CLIN EXP ALLERGY, V38, P1548, DOI 10.1111/j.1365-2222.2008.03043.x; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Beech DJ, 2007, BIOCHEM SOC T, V35, P890, DOI 10.1042/BST0350890; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Ichikawa J, 2009, J CELL PHYSIOL, V219, P372, DOI 10.1002/jcp.21680; Leuner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014716; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Oguri A, 2010, AM J PHYSIOL-CELL PH, V298, pC1414, DOI 10.1152/ajpcell.00488.2009; Parekh AB, 2007, CELL CALCIUM, V42, P111, DOI 10.1016/j.ceca.2007.02.012; STILLWEL.EF, 1973, NATURE-NEW BIOL, V246, P110; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441	59	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	DEC	2014	171	23					5280	5294		10.1111/bph.12840		15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4DU	WOS:000345560300009		
J	Nozaki, C; Nagase, H; Nemoto, T; Matifas, A; Kieffer, BL; Gaveriaux-Ruff, C				Nozaki, C.; Nagase, H.; Nemoto, T.; Matifas, A.; Kieffer, B. L.; Gaveriaux-Ruff, C.			In vivo properties of KNT-127, a novel delta opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; ANALGESIC TOLERANCE; NEUROTROPHIC FACTOR; PHARMACOLOGY; PAIN; CONVULSIONS; MECHANISMS; DISCOVERY; LIGANDS; ADL5859	Background and PurposeActivation of opioid (DOP) receptors regulates pain and emotional responses, and also displays ligand-biased agonism. KNT-127 (1,2,3,4,4a,5,12,12a-octahydro-2-methyl-4a,1-([1,2]benzenomethano)-2,6-diazanaphthacene-12a,17-diol) is a novel DOP receptor agonist inducing analgesia and antidepressant effects in mice. Here, we have assessed KNT-127 for (i) analgesia against chronic inflammatory pain; (ii) effects on depression, locomotion and DOP receptor internalization; and (iii) for cross-tolerance to analgesic and antidepressant effects of acute treatment by other DOP receptor agonists. Experimental ApproachInflammatory pain was induced by complete Freund's adjuvant injection into tail or hindpaw, and thermal and mechanical sensitivities were determined in mice. Locomotor and antidepressant-like effects were measured using actimetry and forced swim test respectively. In vivoKNT-127 selectivity and internalization were assessed using DOP receptor knockout mice and knock-in mice expressing fluorescent-tagged DOP receptors. KNT-127 was injected acutely at 0.1-10.0mg<bold>kg(</bold>-1) or administered chronically at 5mg<bold>kg(</bold>-1) daily over 5 days. Key ResultsAcute treatment with KNT-127 reversed inflammatory hyperalgesia, produced an antidepressant-like effect but induced neither hyperlocomotion nor receptor sequestration. Chronic treatment with KNT-127 induced tolerance and cross-tolerance to SNC80-induced analgesia, but no tolerance to SNC80-evoked hyperlocomotor or antidepressant-like effects. Conclusions and ImplicationsThe DOP receptor agonist KNT-127 induced agonist-specific acute and chronic responses, at both behavioural and cellular levels. It displays activities similar to the other recently reported DOP agonists, AR-M1000390, ADL5747 and ADL5859, and differs from SNC80. SNC80 differs from the other DOP receptor agonists including KNT-127, by exhibiting ligand-biased tolerance at this receptor.	[Nozaki, C.] Univ Bonn, Inst Mol Psychiat, D-53127 Bonn, Germany; [Nozaki, C.; Matifas, A.; Kieffer, B. L.; Gaveriaux-Ruff, C.] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, Inst Natl Sante & Rech Med, CNRS, Strasbourg, France; [Nagase, H.] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Nemoto, T.] Kitasato Univ, Sch Pharm, Lab Med Chem, Tokyo, Japan; [Kieffer, B. L.] McGill Univ, Douglas Mental Hlth Univ Inst Res Ctr, Montreal, PQ, Canada; [Gaveriaux-Ruff, C.] Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France	Nozaki, C (reprint author), Univ Bonn, Inst Mol Psychiat, Sigmund Freud Str 25, D-53127 Bonn, Germany.	chihiron@uni-bonn.de			CNRS; INSERM; Universite de Strasbourg; US NIH NIDA grant [DA05010]; Fondation pour la Recherche Medicale (FRM)	We thank Amynah A. Pradhan, Akiyoshi Saitoh and Alain M. Gardier for helpful discussion. This research was supported by the CNRS, INSERM, the Universite de Strasbourg (C.G.-R.), the US NIH NIDA grant #DA05010 (B.L.K.). C.N. was supported by the Fondation pour la Recherche Medicale (FRM).	Aguila B, 2012, CELL SIGNAL, V24, P699, DOI 10.1016/j.cellsig.2011.10.018; Wang HB, 2010, P NATL ACAD SCI USA, V107, P13117, DOI 10.1073/pnas.1008382107; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Nozaki C, 2012, J PHARMACOL EXP THER, V342, P799, DOI 10.1124/jpet.111.188987; Gaveriaux-Ruff C, 2008, EUR J NEUROSCI, V27, P2558, DOI 10.1111/j.1460-9568.2008.06223.x; Nagase H, 2010, BIOORG MED CHEM LETT, V20, P6302, DOI 10.1016/j.bmcl.2010.08.083; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Audet N, 2012, J NEUROSCI, V32, P4827, DOI 10.1523/JNEUROSCI.3734-11.2012; Zhang HN, 2006, EUR J NEUROSCI, V23, P984, DOI 10.1111/j.1460-9568.2006.04621.x; Gardier AM, 2009, BEHAV PHARMACOL, V20, P18, DOI 10.1097/FBP.0b013e3283243fcd; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Gaveriaux-Ruff C, 2011, BEHAV PHARMACOL, V22, P405, DOI 10.1097/FBP.0b013e32834a1f2c; BILSKY EJ, 1995, J PHARMACOL EXP THER, V273, P359; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Filliol D, 2000, NAT GENET, V25, P195; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Pradhan AAA, 2010, J NEUROSCI, V30, P16459, DOI 10.1523/JNEUROSCI.3748-10.2010; Pradhan AA, 2012, BRIT J PHARMACOL, V167, P960, DOI 10.1111/j.1476-5381.2012.02075.x; Lutz PE, 2013, CURR OPIN NEUROBIOL, V23, P473, DOI 10.1016/j.conb.2013.02.005; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Le Bourdonnec B, 2009, J MED CHEM, V52, P5685, DOI 10.1021/jm900773n; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Saitoh A, 2011, BEHAV BRAIN RES, V223, P271, DOI 10.1016/j.bbr.2011.04.041; Hudzik TJ, 2011, J PHARMACOL EXP THER, V338, P195, DOI 10.1124/jpet.111.179432; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Jutkiewicz EM, 2006, MOL INTERV, V6, P162, DOI 10.1124/mi.6.3.7; Bardoni R, 2014, NEURON, V81, P1312, DOI 10.1016/j.neuron.2014.01.044; Charfi I, 2014, CELL MOL LIFE SCI, V71, P1529, DOI 10.1007/s00018-013-1461-7; Chung PCS, 2013, PHARMACOL THERAPEUT, V140, P112, DOI 10.1016/j.pharmthera.2013.06.003; Jutkiewicz EM, 2005, PSYCHOPHARMACOLOGY, V182, P588, DOI 10.1007/s00213-005-0138-9; Kilkenny Carol, 2010, J Pharmacol Pharmacother, V1, P94, DOI 10.4103/0976-500X.72351; Le Bourdonnec B, 2008, J MED CHEM, V51, P5893, DOI 10.1021/jm8008986; Nagi K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-25; Nguyen HT, 2013, BRIT J PHARMACOL, V168, P103, DOI 10.1111/j.1476-5381.2012.01850.x; Pradhan AAA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005425; Saitoh A, 2013, CURR NEUROPHARMACOL, V10, P231; Saitoh A, 2004, J PHARMACOL SCI, V95, P374, DOI 10.1254/jphs.FPJ04014X; Tanahashi S, 2012, NEUROPHARMACOLOGY, V62, P2057, DOI 10.1016/j.neuropharm.2012.01.005; Tian XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069252; Tudashki HB, 2014, MOL PHARMACOL, V85, P148, DOI 10.1124/mol.113.089003; vansRijn RM, 2013, PSYCHOPHARMACOLOGY B, V228, P1	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	DEC	2014	171	23					5376	5386		10.1111/bph.12852		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4DU	WOS:000345560300015		
J	Awai, K; Higaki, T; Tatsugami, F				Awai, K.; Higaki, T.; Tatsugami, F.			Clinically essential requirement for brain CT with iterative reconstruction	BRITISH JOURNAL OF RADIOLOGY			English	Letter							INFARCTION		[Awai, K.; Higaki, T.; Tatsugami, F.] Hiroshima Univ, Inst & Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan	Awai, K (reprint author), Hiroshima Univ, Inst & Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan.	awai@hiroshima-u.ac.jp					Love A, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130388; TOMURA N, 1988, RADIOLOGY, V168, P463; TRUWIT CL, 1990, RADIOLOGY, V176, P801	3	1	1	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.	DEC	2014	87	1044							20140474	10.1259/bjr.20140474		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2CM	WOS:000345423600013		
J	Kishi, T; Shimizu, K; Hashimoto, S; Onoda, H; Washida, Y; Sakaida, I; Matsunaga, N				Kishi, T.; Shimizu, K.; Hashimoto, S.; Onoda, H.; Washida, Y.; Sakaida, I.; Matsunaga, N.			CT enteroclysis/enterography findings in drug-induced small-bowel damage	BRITISH JOURNAL OF RADIOLOGY			English	Article							VIDEO CAPSULE ENDOSCOPY; GASTRIC-CARCINOMA; PLUS OMEPRAZOLE; MUCOSAL INJURY; CROHN-DISEASE; SPIRAL CT; ENTEROGRAPHY; ENTEROCLYSIS; CELECOXIB; DIAGNOSIS	Objective: To evaluate the CT enteroclysis (CTE)/enterography findings of patients with small-bowel mucosal damage induced by aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) and to compare these findings with the duration of drug use and endoscopic findings. Methods: CTE findings of 11 patients (22 lesions) with drug-induced small-bowel damage were reviewed, including 8 NSAID users and 3 aspirin users. Three patients were short-term users (6 months or shorter) and eight were long-term users (3 years or longer). Nine patients also underwent videocapsule endoscopy (VCE) or double-balloon enteroscopy (DBE). Results: Small-bowel abnormalities were visible in 8 of 11 patients (73%) on CTE. Multiple lesions were seen in five patients, including all short-term users. Lesions were classified into three types. Type 1 (mucosal patchy enhancement) was found in four of eight patients (50%, 12 lesions) all were short-term users. Small erosions with mild oedema/redness were shown by DBE. Type 2 (homogeneous hyperenhancement) was found in two of eight patients (25%, four lesions) who were long-term users. Large ulcers with marked oedema/redness were shown by DBE. Type 3 (stratification enhancement) was found in four of eight patients (50%, six lesions), both short-term and long-term users. Annular or large ulcers with strictures were shown by VCE or DBE. Conclusion: On CTE, Type 1 lesions in patients with mostly short-term aspirin or NSAID use, Type 2 lesions in patients with long-term use and Type 3 lesions in both types of patients were detected. CTE may have usefulness for the detection of mild damage. Advances in knowledge: Small-bowel abnormalities owing to aspirin or NSAID present with three different patterns on CTE.	[Kishi, T.; Shimizu, K.; Onoda, H.; Matsunaga, N.] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 755, Japan; [Hashimoto, S.; Sakaida, I.] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan; [Washida, Y.] Fukuoka Seiyukai Hosp, Dept Radiol, Fukuoka, Japan	Kishi, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 755, Japan.	takayuki_k_11_21@yahoo.co.jp					BALTHAZAR EJ, 1991, AM J ROENTGENOL, V156, P23; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1053/S1542-3565(04)00619-6; Khalife S, 2011, EUR RADIOL, V21, P79, DOI 10.1007/s00330-010-1896-2; Sohn KM, 2000, AM J ROENTGENOL, V174, P1551; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1053/S1542-3565(04)00603-2; Boudiaf M, 2004, RADIOLOGY, V233, P338, DOI 10.1148/radiol.2332030308; Goldstein JL, 2007, ALIMENT PHARM THER, V25, P1211, DOI 10.1111/j.1365-2036.2007.03312.x; Wittenberg J, 2002, RADIOGRAPHICS, V22, P1093; Bodily KD, 2006, RADIOLOGY, V238, P505, DOI 10.1148/radiol.2382041159; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Matsumoto T, 2008, SCAND J GASTROENTERO, V43, P490, DOI 10.1080/00365520701794121; Dux M, 1999, J COMPUT ASSIST TOMO, V23, P913, DOI 10.1097/00004728-199911000-00015; Haghighi D, 2005, GASTROINTEST ENDOSC, V61, pAB104, DOI 10.1016/S0016-5107(05)00671-1; Kadowaki K, 2000, Radiat Med, V18, P47; Lee DH, 2000, ABDOM IMAGING, V25, P1, DOI 10.1007/s002619910001; Liu YB, 2006, ABDOM IMAGING, V31, P668, DOI 10.1007/s00261-006-9092-1; Maglinte DDT, 2007, AM J ROENTGENOL, V189, P306, DOI 10.2214/AJR.07.2253; Mazzeo S, 2005, RADIOL MED, V109, P516; Soyer P, 2012, EUR RADIOL, V22, P1167, DOI 10.1007/s00330-012-2398-1; Takao M, 1998, J COMPUT ASSIST TOMO, V22, P288, DOI 10.1097/00004728-199803000-00024	20	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.	DEC	2014	87	1044							20140367	10.1259/bjr.20140367		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2CM	WOS:000345423600007		
J	Hagino, H; Yoshida, S; Hashimoto, J; Matsunaga, M; Tobinai, M; Nakamura, T				Hagino, Hiroshi; Yoshida, Seitaro; Hashimoto, Junko; Matsunaga, Masayuki; Tobinai, Masato; Nakamura, Toshitaka			Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study	CALCIFIED TISSUE INTERNATIONAL			English	Article						Ibandronate; Vertebral fracture; Hip BMD change; Osteoporosis; MOVER study	POSTMENOPAUSAL OSTEOPOROSIS; NONVERTEBRAL FRACTURES; VERTEBRAL FRACTURES; CLINICAL FRACTURES; ORAL IBANDRONATE; POOLED ANALYSIS; RISEDRONATE; EFFICACY; WOMEN; TOLERABILITY	The relationship between gains in bone mineral density (BMD) in the hip and the incidence of vertebral fractures in the MOVER study was examined. Japanese patients from the ibandronate and risedronate treatment groups whose hip BMD had increased during the 3-year treatment period were classified into those with or without vertebral fractures. In both the ibandronate group and the risedronate group, hip BMD gains in the patients who had developed no vertebral fractures during the treatment period were greater than in the patients who developed vertebral fractures. We categorized the gains in hip BMD at 6 months into 3 groups (a parts per thousand currency sign0, > 0 to a parts per thousand currency sign3, and > 3 %), and used logistic regression analysis to estimate odds ratios and the probabilities of incidence of vertebral fractures at 12, 24, and 36 months. The current study demonstrated that greater gains in hip BMD during the first 6 months of treatment were associated with a reduction in the risk of subsequent vertebral fractures during the duration of treatment, and suggested that measurement of hip BMD gain at that time could lead to a prediction of the risk of the future vertebral fracture incidence.	[Hagino, Hiroshi] Tottori Univ, Fac Med, Sch Hlth Sci, Tottori 680, Japan; [Hagino, Hiroshi] Tottori Univ, Fac Med, Rehabil Div, Tottori 680, Japan; [Yoshida, Seitaro; Tobinai, Masato] Chugai Pharmaceut Co Ltd, Clin Dev Div, Tokyo, Japan; [Hashimoto, Junko] Chugai Pharmaceut Co Ltd, Project & Lifecycle Management Unit, Tokyo, Japan; [Matsunaga, Masayuki] Chugai Pharmaceut Co Ltd, Med Affairs Div, Tokyo, Japan; [Nakamura, Toshitaka] Natl Ctr Global Hlth & Med, Tokyo, Japan	Hagino, H (reprint author), Tottori Univ, Fac Med, Sch Hlth Sci, Tottori 680, Japan.	hagino@med.tottori-u.ac.jp			Asahi Kasei Pharma Corp.; Astellas Pharma Inc.; Banyu Pharmaceutical Co. Ltd.; Chugai Pharmaceutical Co. Ltd.; Eisai Co. Ltd.; Eli Lilly Japan K.K.; Mitsubishi Tanabe Pharma Corp.; Ono Pharmaceutical Co. Ltd.; Pfizer Inc.; Takeda Pharmaceutical Co. Ltd.; Teijin Pharma Ltd.; Daiichi Sankyo Inc.	Hiroshi Hagino has received consulting fees from Asahi Kasei Pharma Corp., Astellas Pharma Inc., Banyu Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corp., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teijin Pharma Ltd. Seitaro Yoshida, Junko Hashimoto, Masayuki Matsunaga, and Masato Tobinai are employees of Chugai Pharmaceutical Co. Ltd. Toshitaka Nakamura has received research Grants and/or consulting fees from Asahi Kasei Pharma Corp., Astellas Pharma Inc., Banyu Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Inc., Eisai Co. Ltd., Eli Lilly Japan K.K., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Teijin Pharma Ltd., and belongs to the Japan Ministry of Health, Welfare and Labor as a councilor for hospital administration and social medical insurance.	Zebaze RM, 2014, BONE, V59, P173, DOI 10.1016/j.bone.2013.11.016; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Cranney A, 2009, OSTEOPOROSIS INT, V20, P291, DOI 10.1007/s00198-008-0653-8; Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Sebba AI, 2009, BONE, V44, P423, DOI 10.1016/j.bone.2008.10.052; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Reginster JY, 2006, ANN RHEUM DIS, V65, P654, DOI 10.1136/ard.2005.044958; Leslie WD, 2007, J CLIN ENDOCR METAB, V92, P77, DOI 10.1210/jc.2006-1415; Miller PD, 2010, CALCIFIED TISSUE INT, V87, P305, DOI 10.1007/s00223-010-9403-y; Miller PD, 2014, OSTEOPOROSIS INT, V25, P349, DOI 10.1007/s00198-013-2518-z; Watts NB, 2004, J CLIN DENSITOM, V7, P255, DOI 10.1385/JCD:7:3:255; Eisman JA, 2008, J RHEUMATOL, V35, P488; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Berger C, 2009, J BONE MINER RES, V24, P361, DOI [10.1359/jbmr.081004, 10.1359/JBMR.081004]; Nakamura T, 2013, CALCIFIED TISSUE INT, V93, P137, DOI 10.1007/s00223-013-9734-6; Harris ST, 2008, CURR MED RES OPIN, V24, P237, DOI 10.1185/030079908X253717; Roux C, 2004, CURR MED RES OPIN, V20, P433, DOI 10.1185/030079903125003125	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	DEC	2014	95	6					557	563		10.1007/s00223-014-9927-7		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AU1RD	WOS:000345397000008		
J	Okada, H; Amano, K; Okutomi, T; Unno, N; Hoshi, K				Okada, Hisako; Amano, Kan; Okutomi, Toshiyuki; Unno, Nobuya; Hoshi, Keika			Association between intrapartum fetal head malrotation and motor block by neuraxial analgesia: a randomized trial	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Letter							DELIVERY; LABOR		[Okada, Hisako] Keiyu Hosp, Dept Anesthesiol, Yokohama, Kanagawa, Japan; [Amano, Kan; Okutomi, Toshiyuki; Unno, Nobuya] Kitasato Univ Hosp, Ctr Perinatal Med, Sagamihara, Kanagawa, Japan; [Hoshi, Keika] Kitasato Univ, Sch Med, Dept Prevent Med, Sagamihara, Kanagawa 228, Japan	Okada, H (reprint author), Keiyu Hosp, Dept Anesthesiol, Yokohama, Kanagawa, Japan.	okadahisako@gmail.com					MERCER BM, 1995, AM J OBSTET GYNECOL, V173, P1321, DOI 10.1016/0002-9378(95)91379-3; Cheng YW, 2006, J MATERN-FETAL NEO M, V19, P563, DOI 10.1080/14767050600682487; Bromage PR, 1965, ACTA ANAESTH SCAND, V9, P55; STODDART AP, 1994, ANAESTHESIA, V49, P1087, DOI 10.1111/j.1365-2044.1994.tb04362.x; Yancey MK, 2001, OBSTET GYNECOL, V97, P608, DOI 10.1016/S0029-7844(00)01230-8	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	DEC	2014	61	12					1132	1133		10.1007/s12630-014-0236-4		2	Anesthesiology	Anesthesiology	AU1NO	WOS:000345387700011		
J	Kurotobi, T; Shimada, Y; Kino, N; Ito, K; Tonomura, D; Yano, K; Tanaka, C; Yoshida, M; Tsuchida, T; Fukumoto, H				Kurotobi, Toshiya; Shimada, Yoshihisa; Kino, Naoto; Ito, Kazato; Tonomura, Daisuke; Yano, Kentaro; Tanaka, Chiharu; Yoshida, Masataka; Tsuchida, Takao; Fukumoto, Histohi			Residual Arrhythmogenic Foci Predict Recurrence in Long-Standing Persistent Atrial Fibrillation Patients After Sinus Rhythm Restoration Ablation	CANADIAN JOURNAL OF CARDIOLOGY			English	Article							CATHETER ABLATION; END-POINT; PULMONARY VEIN; NONINDUCIBILITY; MECHANISM	Background: The mechanism of persistent atrial fibrillation (AF) is multifactorial, and arrhythmogenic foci (AMF) might be involved in the occurrence of persistent AF. In this study, we examined the electrophysiological features of AMF during and immediately after ablation, and evaluated the relationship between the presence and number of residual AMF on the risk of AF recurrence after a vigorous sinus rhythm restoration ablation in patients with long-standing persistent AF. Methods: The study consisted of 117 consecutive patients with persistent AF who underwent catheter ablation (CA). We performed direct cardioversion to restore sinus rhythm before the pulmonary vein (PV) isolation and at the end of the CA. Then we evaluated the features of the AMF inducible with isoproterenol and the pacing-based AF inducibility. Results: After the completion of ablation, AF could still be induced in 37 of 117 patients (31.6%). Spontaneous PV AMF during CA were observed in 104 of 117 patients (91%), and non-PV AMF in 63 of 117 (54%). Residual non-PV AMF were significantly associated with the pacing-based AF inducibility and an enlarged left atrial volume. In the multivariate analysis, the AF duration (1.01 [range, 1.00-1.02] months; P = 0.012), left atrial volume (1.01 [range, 1.01-1.02] mm; P = 0.006), and residual AMF (3.95 [range, 1.32-11.8] yes, no; P = 0.004) were independent risk factors for recurrent AF. Conclusions: Residual AMF are associated with an increased long-term AF recurrence after sinus rhythm restoration ablation for long-standing persistent AF.	[Kurotobi, Toshiya; Shimada, Yoshihisa; Kino, Naoto; Ito, Kazato; Tonomura, Daisuke; Yano, Kentaro; Tanaka, Chiharu; Yoshida, Masataka; Tsuchida, Takao; Fukumoto, Histohi] Shiroyama Hosp, Div Cardiovasc, Habikino, Osaka 5830872, Japan	Kurotobi, T (reprint author), Shiroyama Hosp, Div Cardiovasc, 2-8-1 Habikino, Habikino, Osaka 5830872, Japan.	drk21cent@gmail.com					Patterson E, 2005, HEART RHYTHM, V2, P624, DOI 10.1016/j.hrthm.2005.02.012; Po SS, 2005, J AM COLL CARDIOL, V45, P1871, DOI 10.1016/j.jacc.2005.02.070; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Inoue K, 2012, CIRC-ARRHYTHMIA ELEC, V5, P295, DOI 10.1161/CIRCEP.111.964080; Haissaguerre M, 2000, CIRCULATION, V101, P1409; Crawford T, 2010, J CARDIOVASC ELECTR, V21, P13, DOI 10.1111/j.1540-8167.2009.01571.x; Lin YJ, 2010, HEART RHYTHM, V7, P1255, DOI 10.1016/j.hrthm.2010.06.019; O'Neill MD, 2009, EUR HEART J, V30, P1105, DOI 10.1093/eurheartj/ehp063; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Oral H, 2004, CIRCULATION, V110, P2797, DOI 10.1161/01.CIR.0000146786.87037.26; Chen S A, 2000, Curr Cardiol Rep, V2, P322, DOI 10.1007/s11886-000-0088-0; Chen YJ, 2002, CIRCULATION, V105, P2679, DOI 10.1161/01.CIR.0000016822.96362.26; Jais P, 2006, HEART RHYTHM, V3, P140, DOI 10.1016/j.hrthm.2005.11.012; Kurotobi T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P39, DOI 10.1161/CIRCEP.109.885095; Kurotobi T, 2006, J CARDIOVASC ELECTR, V17, P1062, DOI 10.1111/j.1540-8167.2006.00542.x; Nademanee K, 2007, CIRCULATION, V115, P2592, DOI 10.1161/CIRCULATIONAHA.107.700187; Pak HN, 2006, J CARDIOVASC ELECTR, V17, P818, DOI 10.1111/j.1540-8167.2006.00503.x	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	DEC	2014	30	12					1535	1540		10.1016/j.cjca.2014.10.013		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU4ME	WOS:000345584400017		
J	Toh, Y; Nicolson, GL				Toh, Yasushi; Nicolson, Garth L.			Identification and characterization of metastasis-associated gene/protein 1 (MTA1)	CANCER AND METASTASIS REVIEWS			English	Review						Metastasis-associated gene/protein family; MTA proteins; Chromatin remodeling; Histone deacetylation; Human cancers; Nucleosome remodeling and histone deacetylation complex (NuRD)	BREAST-CANCER; MAMMARY ADENOCARCINOMA; CELL-LINES; TUMOR-METASTASIS; DNA METHYLATION; COMPLEX; GENE; SEQUENCE; NURD; OVEREXPRESSION	Metastasis is a complex series of sequential events involving several gene products and the regulated expression of several tumor cell genes. Using rat mammary adenocarcinoma cell lines of differing metastatic potentials and a differential complementary DNA (cDNA) hybridization method, our laboratory embarked in 1992 on a project to identify candidate metastasis-associated genes. Among the genes that were found to be abundantly overexpressed in highly metastatic rat cell lines compared to poorly metastatic cell lines, we identified a completely novel gene without any homologous or related genes in the database in 1994. The full-length cDNA of this gene was cloned, sequenced, and named mta1 (metastasis-associated gene 1), and eventually, its human cDNA counterpart, MTA1, was also cloned and sequenced by our group. MTA1 has now been identified as one of the members of a gene family (MTA gene family). The products of the MTA genes, the MTA proteins, are transcriptional co-regulators that function in histone deacetylation and nucleosome remodeling. In this review, we will briefly discuss the researches for the identification and characterization of the mta1 gene, its human counterpart MTA1, and their protein products.	[Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Minami Ku, Fukuoka 8111395, Japan; [Nicolson, Garth L.] Inst Mol Med, Dept Mol Pathol, Huntington Beach, CA 92647 USA	Toh, Y (reprint author), Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	ytoh@nk-cc.go.jp					Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Tong JK, 1998, NATURE, V395, P917; ZHANG RD, 1991, INVAS METAST, V11, P204; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; NERI A, 1982, J NATL CANCER I, V68, P507; TOH Y, 1994, J BIOL CHEM, V269, P22958; Wade PA, 1999, NAT GENET, V23, P62; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.0.CO;2-4; Mazumdar A, 2001, NAT CELL BIOL, V3, P30; LIOTTA LA, 1986, CANCER RES, V46, P1; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; NICOLSON GL, 1988, BIOCHIM BIOPHYS ACTA, V948, P175, DOI 10.1016/0304-419X(88)90010-8; TANIGUCHI S, 1991, NUCLEIC ACIDS RES, V19, P6949, DOI 10.1093/nar/19.24.6949; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; BRUNNER N, 1993, CANCER RES, V53, P3229; CHAMBERS AF, 1993, CRIT REV ONCOGENESIS, V4, P95; Manavathi B., 2007, NUCL RECEPTOR SIGNAL, V5, P1; Nawa A, 2000, J CELL BIOCHEM, V79, P202, DOI 10.1002/1097-4644(20001101)79:2<202::AID-JCB40>3.0.CO;2-L; NICOLSON GL, 1992, ONCOGENE, V7, P1127; PENCIL SD, 1993, BREAST CANCER RES TR, V25, P165, DOI 10.1007/BF00662141; Singh RR, 2007, J MAMMARY GLAND BIOL, V12, P115, DOI 10.1007/s10911-007-9043-7; THOMPSON EW, 1993, CLIN EXP METASTAS, V11, P15, DOI 10.1007/BF00880062; Toh Y., 2013, TRENDS STEM CELL PRO, P251; TOH Y, 2011, ATLAS GENET CYTOGENE, V15, P303; TOH Y, 1995, GENE, V159, P97, DOI 10.1016/0378-1119(94)00410-T; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-7659	1573-7233		CANCER METAST REV	Cancer Metastasis Rev.	DEC	2014	33	4			SI		837	842		10.1007/s10555-014-9510-8		6	Oncology	Oncology	AU1KU	WOS:000345380500002		
J	Toh, Y; Nicolson, GL				Toh, Yasushi; Nicolson, Garth L.			Properties and clinical relevance of MTA1 protein in human cancer	CANCER AND METASTASIS REVIEWS			English	Review						Metastasis-associated gene/protein family; NuRD complex; Human cancers; Overexpression; Clinical relevance	METASTASIS-ASSOCIATED PROTEIN-1; TUMOR-ANTIGEN 1; SQUAMOUS-CELL CARCINOMAS; HISTONE DEACETYLASE 1; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; MI-2/NURD COMPLEX; MESSENGER-RNA; LUNG-CANCER; NASOPHARYNGEAL CARCINOMA	Among the genes that were found to be abundantly overexpressed in highly metastatic rat cell lines compared to poorly metastatic cell lines, we identified a completely novel complementary DNA (cDNA) without any homologous or related genes in the database in 1994. The full-length cDNA of this rat gene was cloned, sequenced, and named metastasis-associated gene 1 (mta1), and eventually, its human cDNA counterpart, MTA1, was also cloned and sequenced by our group. MTA1 has now been identified as one of the members of a gene family (MTA gene family) and the products of the MTA genes, the MTA proteins, are transcriptional co-regulators that function in histone deacetylation and nucleosome remodeling and have been found in nuclear histone remodeling complexes. Furthermore, MTA1 along with its protein product MTA1 has been repeatedly and independently reported to be overexpressed in a vast range of human cancers and cancer cell lines compared to non-cancerous tissues and cell lines. The expression levels of MTA1 correlate well with the malignant properties of human cancers, strongly suggesting that MTA1 and possibly other MTA proteins (and their genes) could be a new class of molecular targets for cancer diagnosis and therapy.	[Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Minami Ku, Fukuoka 8111395, Japan; [Nicolson, Garth L.] Inst Mol Med, Dept Mol Pathol, Huntington Beach, CA 92647 USA	Toh, Y (reprint author), Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	ytoh@nk-cc.go.jp					Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Tong JK, 1998, NATURE, V395, P917; Jang KS, 2006, CANCER SCI, V97, P374, DOI 10.1111/j.1349-7006.2006.00186.x; Hamatsu T, 2003, ONCOL REP, V10, P599; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Higashijima J, 2011, ONCOL REP, V26, P343, DOI 10.3892/or.2011.1312; Luo JY, 2000, NATURE, V408, P377; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Jin YJ, 2012, DIGEST DIS SCI, V57, P2917, DOI 10.1007/s10620-012-2296-z; Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; Du B, 2011, WORLD J GASTROENTERO, V17, P1219, DOI 10.3748/wjg.v17.i9.1219; TOH Y, 1994, J BIOL CHEM, V269, P22958; Moon WS, 2004, HUM PATHOL, V35, P424, DOI 10.1016/j.humpath.2003.11.007; Wade PA, 1999, NAT GENET, V23, P62; Zhu XX, 2010, J THORAC ONCOL, V5, P1159, DOI 10.1097/JTO.0b013e3181e04d98; Sharma G, 2011, TUMOR BIOL, V32, P23, DOI 10.1007/s13277-010-0087-8; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Modlin IM, 2006, ANN SURG, V244, P52, DOI 10.1097/01.sla.0000217617.06782.d5; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.0.CO;2-4; Mazumdar A, 2001, NAT CELL BIOL, V3, P30; Pakala SB, 2010, J BIOL CHEM, V285, P32787, DOI 10.1074/jbc.M110.151340; Hofer MD, 2004, CANCER RES, V64, P825, DOI 10.1158/0008-5472.CAN-03-2755; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P; Yu Y, 2011, INTERACT CARDIOV TH, V12, P166, DOI 10.1510/icvts.2010.243741; Toh Y, 2004, INT J CANCER, V110, P362, DOI 10.1002/ijc.20154; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Li SH, 2011, ANN SURG ONCOL, V18, P2048, DOI 10.1245/s10434-010-1510-5; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Roepman P, 2006, CANCER RES, V66, P11110, DOI 10.1158/0008-5472.CAN-06-3161; Li DQ, 2012, CANCER RES, V72, P387, DOI 10.1158/0008-5472.CAN-11-2345; Ramirez J, 2009, EPIGENETICS, V4, P532; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Giannini R, 2005, ANTICANCER RES, V25, P4287; Ryu SH, 2008, HEPATOLOGY, V47, P929, DOI 10.1002/hep.22124; Aramaki Y., FEBS LETT, V579, P3731; Basta J, 2015, TRANSL RES, V165, P36, DOI 10.1016/j.trsl.2014.05.003; Cheng CW, 2012, ANN SURG ONCOL, V19, P4129, DOI 10.1245/s10434-012-2541-x; Dannenmann Christine, 2008, Cancer Biol Ther, V7, P1460, DOI 10.4161/cbt.7.9.6427; Deng XM, 2013, WORLD J SURG, V37, P792, DOI 10.1007/s00268-012-1898-0; Deng YF, 2012, ANN OTO RHINOL LARYN, V121, P457; Dias SJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02331; Futamura M, 1999, J HUM GENET, V44, P52, DOI 10.1007/s100380050107; Herman MA, 1999, DEVELOPMENT, V126, P1055; Hofer MD, 2006, ARCH PATHOL LAB MED, V130, P989; Hofer MD, 2009, MODERN PATHOL, V22, P933, DOI 10.1038/modpathol.2009.50; Kawasaki G, 2008, INT J ORAL MAX SURG, V37, P1039, DOI 10.1016/j.ijom.2008.05.020; Kidd M, 2006, CANCER, V106, P1480, DOI 10.1002/cncr.21758; Kidd M, 2006, ANN SURG ONCOL, V13, P253, DOI 10.1245/ASO.2006.12.011; Kleene R, 1999, J CELL SCI, V112, P2539; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/S0093-7754(03)00438-X; Lee SH, 2012, LIVER INT, V32, P457, DOI 10.1111/j.1478-3231.2011.02648.x; Li DQ, 2010, CELL CYCLE, V9, P2071; Li SH, 2012, WORLD J SURG, V36, P623, DOI 10.1007/s00268-011-1421-z; Li SH, 2009, WORLD J SURG, V33, P1876, DOI 10.1007/s00268-009-0119-y; Li WF, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-78; Liu J, 2014, ONCOTARGET, V5, P5153; Liu TB, 2013, HUM PATHOL, V44, P2275, DOI 10.1016/j.humpath.2013.05.009; Luo HQ, 2014, TUMOR BIOL, V35, P5823, DOI 10.1007/s13277-014-1772-9; Manavathi B., 2007, NUCL RECEPTOR SIGNAL, V5, P1; Mao XY, 2012, TUMOR BIOL, V33, P1565, DOI 10.1007/s13277-012-0410-7; Martin MD, 2001, CANCER RES, V61, P3578; Martin MD, 2006, BREAST CANCER RES TR, V95, P7, DOI 10.1007/s10549-005-9016-8; Miyatani T, 2011, HEPATO-GASTROENTEROL, V58, P472; Moon HE, 2007, ONCOL REP, V18, P1311; Moon HE, 2006, ONCOL REP, V16, P929; Nawa A, 2000, J CELL BIOCHEM, V79, P202, DOI 10.1002/1097-4644(20001101)79:2<202::AID-JCB40>3.0.CO;2-L; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Park JO, 2011, EUR ARCH OTO-RHINO-L, V268, P1329, DOI 10.1007/s00405-010-1478-6; Paterno GD, 1997, J BIOL CHEM, V272, P25591, DOI 10.1074/jbc.272.41.25591; Paterno GD, 1998, GENE, V222, P77, DOI 10.1016/S0378-1119(98)00473-9; Prisco MG, 2012, HUM PATHOL, V43, P282, DOI 10.1016/j.humpath.2011.05.002; Qian Haili, 2007, Biol Cell, V99, P573; Qian HL, 2005, CLIN EXP METASTAS, V22, P653, DOI 10.1007/s10585-006-9005-2; Sasaki H, 2002, LUNG CANCER-J IASLC, V35, P149, DOI 10.1016/S0169-5002(01)00329-4; Sasaki H, 2001, CANCER LETT, V174, P159, DOI 10.1016/S0304-3835(01)00704-2; Singh RR, 2007, J MAMMARY GLAND BIOL, V12, P115, DOI 10.1007/s10911-007-9043-7; Solari F, 1999, DEVELOPMENT, V126, P2483; Song L, 2013, THORAC CARDIOV SURG, V61, P479, DOI 10.1055/s-0032-1304545; Toh Y., 2013, TRENDS STEM CELL PRO, P251; Toh Y, 2000, J EXP CLIN CANC RES, V19, P105; TOH Y, 2011, ATLAS GENET CYTOGENE, V15, P303; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274; Yi Song, 2003, Chin Med Sci J, V18, P87	85	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-7659	1573-7233		CANCER METAST REV	Cancer Metastasis Rev.	DEC	2014	33	4			SI		891	900		10.1007/s10555-014-9516-2		10	Oncology	Oncology	AU1KU	WOS:000345380500007		
J	Kanazawa, K; Yokouchi, H; Wang, XT; Ishida, T; Fujita, Y; Fujiuchi, S; Harada, T; Harada, M; Takamura, K; Oizumi, S; Kinoshita, I; Katsuura, Y; Honjo, O; Kojima, T; Dosaka-Akita, H; Isobe, H; Munakata, M; Nishimura, M				Kanazawa, Kenya; Yokouchi, Hiroshi; Wang, Xintao; Ishida, Takashi; Fujita, Yuka; Fujiuchi, Satoru; Harada, Toshiyuki; Harada, Masao; Takamura, Kei; Oizumi, Satoshi; Kinoshita, Ichiro; Katsuura, Yutaka; Honjo, Osamu; Kojima, Tetsuya; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Munakata, Mitsuru; Nishimura, Masaharu		Hokkaido Lung Canc Clinical Study	Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Non-squamous non-small cell lung cancer; Carboplatin; Pemetrexed; Genetic polymorphisms; Methylenetetrahydrofolate reductase (MTHFR); Thymidylate synthase (TS)	RANDOMIZED CONTROLLED-TRIALS; THYMIDYLATE SYNTHASE GENE; INDIVIDUAL PATIENT DATA; PLUS CARBOPLATIN; COMPARING CISPLATIN; MAINTENANCE THERAPY; ELDERLY-PATIENTS; SUPPORTIVE CARE; REDUCTASE GENE; METAANALYSIS	This phase II study evaluated the response rate (RR) and safety of combination therapy with carboplatin (CBDCA) and pemetrexed (PEM) in Japanese patients with non-squamous non-small cell lung cancer (non-sq NSCLC). Further, the relationship between therapy efficacy/toxicity and genetic polymorphisms associated with PEM metabolism was analyzed. Forty-one patients received CBDCA at a dose targeting an area under the concentration-time curve of 5 mg/mL x min and PEM of 500 mg/m(2) on day 1 every 3 weeks. Single-nucleotide polymorphisms of the thymidylate synthase (TYMS) coding gene, the variable number of tandem repeat (VNTR) in the TYMS, and the methylenetetrahydrofolate reductase (MTHFR) coding gene were analyzed. The overall RR was 36.6 %. Median progression-free survival and median survival time were 4.7 months [95 % confidence interval (CI) 3.9-5.6 months] and 16.2 months (95 % CI 6.1-26.2 months), respectively. Epidermal growth factor receptor gene mutations were detected in 6 patients (14.6 %). The VNTR in the TYMS significantly correlated with anemia (p = 0.047) and thrombocytopenia (p = 0.038). This combination therapy was effective and tolerable in patients with advanced non-sq NSCLC. The VNTR in the TYMS appears to be a predictive factor for anemia and thrombocytopenia in patients treated with this regimen.	[Kanazawa, Kenya; Yokouchi, Hiroshi; Wang, Xintao; Ishida, Takashi; Munakata, Mitsuru] Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima 9601295, Japan; [Ishida, Takashi] Fukushima Med Univ Hosp, Clin Oncol Ctr, Fukushima 9601295, Japan; [Fujita, Yuka; Fujiuchi, Satoru] Natl Hosp Org Asahikawa Med Ctr, Dept Resp Med, Asahikawa, Hokkaido 0708644, Japan; [Harada, Toshiyuki] Japan Community Hlth Care Org Hokkaido Hosp, Ctr Resp Dis, Toyohira Ku, Sapporo, Hokkaido 0628618, Japan; [Harada, Masao] Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Shiroishi Ku, Sapporo, Hokkaido 0030804, Japan; [Takamura, Kei] Hokkaido PWFAC Obihiro Kosei Gen Hosp, Dept Med 1, Obihiro, Hokkaido 0800016, Japan; [Oizumi, Satoshi; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Kita Ku, Sapporo, Hokkaido 0600808, Japan; [Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi] Hokkaido Univ, Dept Med Oncol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0600808, Japan; [Katsuura, Yutaka] Saiseikai Fukushima Gen Hosp, Dept Pulm Med, Fukushima 9608133, Japan; [Honjo, Osamu] Hokkaido PWFAC Sapporo Kosei Gen Hosp, Dept Resp Med, Chuo Ku, Sapporo, Hokkaido 0030804, Japan; [Kojima, Tetsuya; Isobe, Hiroshi] KKR Sapporo Med Ctr, Dept Med Oncol & Resp Med, Toyohira Ku, Sapporo, Hokkaido 0620931, Japan; [Kojima, Tetsuya; Isobe, Hiroshi] Hokkaido Lung Canc Clin Study Grp, Sapporo, Hokkaido, Japan	Kanazawa, K (reprint author), Fukushima Med Univ, Sch Med, Dept Pulm Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	k-kenya@fmu.ac.jp	Nishimura, Masaharu/A-4062-2012		Eli Lilly	Satoshi Oizumi received an honorarium from AstraZeneca and a grant from Eli Lilly. Others had no conflict of interest to declare.	Al-Saleh K, 2012, CURR ONCOL, V19, pE9, DOI 10.3747/co.19.891; Kaira K, 2012, MED ONCOL, V29, P1663, DOI 10.1007/s12032-011-0069-8; Chen CY, 2011, LUNG CANCER, V74, P132, DOI 10.1016/j.lungcan.2011.01.024; Zukin M, 2013, J CLIN ONCOL, V31, P2849, DOI 10.1200/JCO.2012.48.1911; Ozasa H, 2010, CANCER SCI, V101, P161, DOI 10.1111/j.1349-7006.2009.01358.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Smit EF, 2009, J CLIN ONCOL, V27, P2038, DOI 10.1200/JCO.2008.19.1650; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Takeda M, 2011, LUNG CANCER, V73, P103, DOI 10.1016/j.lungcan.2010.10.022; Hanauske AR, 2001, ONCOLOGIST, V6, P363, DOI 10.1634/theoncologist.6-4-363; Hashimoto H, 2006, CANCER, V106, P1595, DOI 10.1002/cncr.21777; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Kawakami K, 2003, CANCER RES, V63, P6004; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Jiang JW, 2007, LUNG CANCER, V57, P348, DOI 10.1016/j.lungcan.2007.03.014; Maring JG, 2005, PHARMACOGENOMICS J, V5, P226, DOI 10.1038/sj.tpj.6500320; Tanaka F, 2011, ANN ONCOL, V22, P1791, DOI 10.1093/annonc/mdq730; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Hotta K, 2004, J CLIN ONCOL, V22, P3852, DOI 10.1200/JCO.2004.02.109; Quoix E, 2011, LANCET, V378, P1079, DOI 10.1016/S0140-6736(11)60780-0; Treat J, 2012, LUNG CANCER, V76, P222, DOI 10.1016/j.lungcan.2011.10.021; Go RS, 1999, J CLIN ONCOL, V17, P409; Askari BS, 2010, CURR GENOMICS, V11, P578, DOI 10.2174/138920210793360925; Gervais R, 2013, LUNG CANCER, V80, P185, DOI 10.1016/j.lungcan.2013.01.008; Hotta K, 2007, CANCER, V109, P939, DOI 10.1002/cncr.22478; Ishihama H, 2009, JPN J CLIN ONCOL, V39, P33, DOI 10.1093/jjco/hyn121; Kim YH, 2012, CANCER CHEMOTH PHARM, V70, P271, DOI 10.1007/s00280-012-1910-2; Lee MS, 2012, INT J CANCER, V131, P1203, DOI 10.1002/ijc.27338; Liu HL, 2008, LUNG CANCER, V61, P21, DOI 10.1016/j.lungcan.2007.12.001; Manegold C, 2000, ANN ONCOL, V11, P435, DOI 10.1023/A:1008336931378; Martin DN, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-257; Muhsin M, 2004, NAT REV DRUG DISCOV, V3, P825, DOI 10.1038/nrd1528; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Okamoto I, 2013, INVEST NEW DRUG, V31, P1275, DOI 10.1007/s10637-013-9941-z; Rose Michal G, 2002, Clin Colorectal Cancer, V1, P220, DOI 10.3816/CCC.2002.n.003; Shepherd FA, 2001, CANCER, V92, P595, DOI 10.1002/1097-0142(20010801)92:3<595::AID-CNCR1359>3.0.CO;2-D; Takehara A, 2005, ANTICANCER RES, V25, P4455; Takimoto CH, 1996, ONCOLOGIST, V1, P68; Zinner RG, 2005, CANCER, V104, P2449, DOI 10.1002/cncr.21480	42	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2014	74	6					1149	1157		10.1007/s00280-014-2589-3		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AU0RB	WOS:000345330400005		
J	Shimizu, R; Fujimoto, D; Kato, R; Otoshi, T; Kawamura, T; Tamai, K; Matsumoto, T; Nagata, K; Otsuka, K; Nakagawa, A; Otsuka, K; Katakami, N; Tomii, K				Shimizu, Ryoko; Fujimoto, Daichi; Kato, Ryoji; Otoshi, Takehiro; Kawamura, Takahisa; Tamai, Koji; Matsumoto, Takeshi; Nagata, Kazuma; Otsuka, Kyoko; Nakagawa, Atsushi; Otsuka, Kojiro; Katakami, Nobuyuki; Tomii, Keisuke			The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Chemotherapy-related exacerbation; Interstitial lung disease; Idiopathic pulmonary fibrosis; Non-small cell lung cancer; Usual interstitial pneumonia; Vascular endothelial growth factor	IDIOPATHIC PULMONARY-FIBROSIS; RANDOMIZED PHASE-II; PLUS WEEKLY PACLITAXEL; DIAGNOSIS; EXACERBATION; PNEUMONIAS; TRIAL; ANGIOGENESIS; CHEMOTHERAPY; COMBINATION	Optimal chemotherapy for patients with advanced non-small cell lung cancer (NSCLC) with interstitial lung disease (ILD) is established for paclitaxel and carboplatin, but is otherwise controversial. Therefore, we assessed the efficacy and safety of paclitaxel and carboplatin with or without bevacizumab for treating these patients. We analyzed the outcomes of 21 patients with advanced nonsquamous NSCLC with ILD who received paclitaxel and carboplatin without (paclitaxel-carboplatin group; n = 11) or with bevacizumab (paclitaxel-carboplatin-bevacizumab group; n = 10) between April 2008 and October 2013. The median progression-free survival time of the paclitaxel-carboplatin-bevacizumab group was 5.3 months (95 % CI 0.4-11.6 months) compared with 4.4 months (95 % CI 0.9-6.3 months) for the paclitaxel-carboplatin group (p = 0.060). Their respective median overall survival times were 16.1 months (range 0.4-34.8 months) and 9.7 months (range 2.6-37.0 months) (p = 0.772) with corresponding overall response rates of 40 and 27 % (p = 0.659), respectively. One patient in the paclitaxel-carboplatin-bevacizumab group experienced chemotherapy-related exacerbation of ILD (0/11 vs. 1/10; p = 0.476). The addition of bevacizumab to paclitaxel and carboplatin may provide an effective and safe treatment option for patients with advanced nonsquamous NSCLC with ILD.	[Shimizu, Ryoko; Fujimoto, Daichi; Kato, Ryoji; Otoshi, Takehiro; Kawamura, Takahisa; Tamai, Koji; Matsumoto, Takeshi; Nagata, Kazuma; Otsuka, Kyoko; Nakagawa, Atsushi; Otsuka, Kojiro; Katakami, Nobuyuki; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Chuo Ku, Kobe, Hyogo 6500047, Japan	Shimizu, R (reprint author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Chuo Ku, 2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	ryoko1031@gmail.com; daichianzen@yahoo.co.jp			Ethics Committee of Kobe City Medical Center General Hospital	We thank Keiko Sakuragawa for administrative assistance. This study was supported by internal funding and the Ethics Committee of Kobe City Medical Center General Hospital.	American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/00936.06.00114004; Belani CP, 2008, J CLIN ONCOL, V26, P468, DOI 10.1200/JCO.2007.13.1912; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Pavlakis N, 1997, CANCER, V80, P286, DOI 10.1002/(SICI)1097-0142(19970715)80:2<286::AID-CNCR17>3.0.CO;2-Q; Read WL, 2002, CANCER, V94, P847, DOI 10.1002/cncr.10263; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; Kenmotsu H, 2011, J THORAC ONCOL, V6, P1242, DOI 10.1097/JTO.0b013e318216ee6b; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Sakakibara T, 2010, ANN ONCOL, V21, P795, DOI 10.1093/annonc/mdp401; Ebina M, 2004, AM J RESP CRIT CARE, V169, P1203, DOI 10.1164/rccm.200308-1111OC; Johkoh T, 1999, RADIOLOGY, V211, P555; Ozawa Y, 2009, RESPIROLOGY, V14, P723, DOI 10.1111/j.1440-1843.2009.01547.x; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Nathan N, 2011, PAEDIATR RESPIR REV, V12, P216, DOI 10.1016/j.prrv.2011.04.003; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Minegishi Y, 2011, LUNG CANCER, V71, P70, DOI 10.1016/j.lungcan.2010.04.014; Cosgrove GP, 2004, AM J RESP CRIT CARE, V170, P242, DOI 10.1164/rccm.200308-11510c; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Hanumegowda C, 2012, CHEST, V142, P200, DOI 10.1378/chest.11-1962; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Niho S, 2012, LUNG CANCER, V76, P362, DOI 10.1016/j.lungcan.2011.12.005; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Socinski MA, 2009, J CLIN ONCOL, V27, P5255, DOI 10.1200/JCO.2009.22.0616; Sverzellati N, 2011, EUR RESPIR J, V38, P392, DOI 10.1183/09031936.00201809; Sato T, 2014, J THORAC CARDIOV SUR, V147, P1604, DOI 10.1016/j.jtcvs.2013.09.050; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Yamamoto H, 2009, LUNG CANCER, V63, P315, DOI 10.1016/j.lungcan.2008.06.021; Flaherty KR, 2004, AM J RESP CRIT CARE, V170, P904, DOI 10.1164/rccm.200402-147OC; Jin GY, 2013, RADIOLOGY, V268, P563, DOI 10.1148/radiol.13120816; Bouros D, 2002, CHEST, V121, P1278, DOI 10.1378/chest.121.4.1278; Cushley MJ, 1999, THORAX, V54, pS1; Fisseler-Eckhoff A, 2009, Pathologe, V30 Suppl 2, P193, DOI 10.1007/s00292-009-1195-3; Fujimoto D, 2013, LUNG CANCER, V80, P159, DOI 10.1016/j.lungcan.2013.01.017; Hata A, 2014, ANTICANCER RES, V34, P275; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shukuya T, 2010, ANTICANCER RES, V30, P4357; Watanabe N, 2014, ACTA ONCOL, V53, P158, DOI 10.3109/0284186X.2013.802838	44	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2014	74	6					1159	1166		10.1007/s00280-014-2590-x		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AU0RB	WOS:000345330400006		
J	Sonobe, M; Okubo, K; Teramukai, S; Yanagihara, K; Sato, M; Sato, T; Chen, FS; Sato, K; Fujinaga, T; Shoji, T; Omasa, M; Sakai, H; Miyahara, R; Bando, T; Date, H				Sonobe, Makoto; Okubo, Ken-ichi; Teramukai, Satoshi; Yanagihara, Kazuhiro; Sato, Masaaki; Sato, Toshihiko; Chen, Fengshi; Sato, Kiyoshi; Fujinaga, Takuji; Shoji, Tsuyoshi; Omasa, Mitsugu; Sakai, Hiroaki; Miyahara, Ryo; Bando, Toru; Date, Hiroshi			Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Non-small cell lung cancer; Adjuvant chemotherapy; Cisplatin; Vinorelbine	FACTOR-RECEPTOR GENE; PLUS CISPLATIN; CHEMOTHERAPY; MUTATIONS; PROGNOSIS; SURVIVAL; TRIAL; EGFR; IB	Adjuvant vinorelbine and cisplatin chemotherapy is recognized as a standard regimen for patients with completely resected stage II and III non-small cell lung cancer (NSCLC). However, efficacy of adjuvant chemotherapy in Japanese phase III trials with cisplatin-containing regimen has been controversial, and data are limited on the long-term outcome of adjuvant vinorelbine and cisplatin chemotherapy for NSCLC patients. This was a single-arm phase II study in patients with completely resected pathological stage II or III NSCLC, who had not received prior chemotherapy or radiotherapy. Patients received 4 cycles of vinorelbine [25 mg/m(2) of body surface area (BSA)] and cisplatin (40 mg/m(2) of BSA) on days 1 and 8, every 4 weeks. Primary end point was the 3-year relapse-free survival; secondary end points were overall survival and safety. Between December 2006 and January 2011, 60 patients (40 men and 20 women, median age 64 years) were enrolled; all patients were evaluable for survival and safety. Three-year relapse-free survival rate was 55.0 % (95 % confidence interval 42.4-67.6 %). Three- and five-year overall survival rates were 83.3 and 77.8 %, respectively. There were no chemotherapy-related deaths, and adverse effects were acceptable. Adjuvant vinorelbine and cisplatin chemotherapy was safe and showed a valid relapse-free survival rate. This regimen could be used as a standard regimen and deserves to be a control arm of trials on adjuvant chemotherapy in the Japanese NSCLC patient population.	[Sonobe, Makoto; Okubo, Ken-ichi; Sato, Masaaki; Sato, Toshihiko; Chen, Fengshi; Sato, Kiyoshi; Fujinaga, Takuji; Shoji, Tsuyoshi; Omasa, Mitsugu; Sakai, Hiroaki; Miyahara, Ryo; Bando, Toru; Date, Hiroshi] Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan; [Teramukai, Satoshi] Kyoto Univ Hosp, Dept Clin Trial Design & Management, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; [Yanagihara, Kazuhiro] Kyoto Univ Hosp, Outpatient Oncol Unit, Sakyo Ku, Kyoto 6068507, Japan	Sonobe, M (reprint author), Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, Shogoin Kawara Cho 54, Kyoto 6068507, Japan.	mysonobe@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25462174]	This work was supported by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Makoto Sonobe (#25462174). None of the authors have any conflicts of interest to disclose with regard to this study.	Sonobe M, 2013, J THORAC CARDIOV SUR, V146, P788, DOI 10.1016/j.jtcvs.2013.04.043; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; Sonobe M, 2007, J SURG ONCOL, V95, P63, DOI 10.1002/jso.20547; Douillard JY, 2010, J THORAC ONCOL, V5, P220, DOI 10.1097/JTO.0b013e3181c814e7; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Tada H, 2004, LUNG CANCER-J IASLC, V43, P167, DOI 10.1016/j.lungcan.2003.08.028; Sonobe M, 2005, BRIT J CANCER, V93, P355, DOI 10.1038/sj.bjc.6602707; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Wada H, 1996, J CLIN ONCOL, V14, P1048; Spiro SG, 2004, THORAX, V59, P828, DOI 10.1136/thx.2003.020164; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; ANTAKLI T, 1995, ANN THORAC SURG, V59, P863, DOI 10.1016/0003-4975(95)00067-U; Scagliotti GV, 2003, J NATL CANCER I, V95, P1453, DOI 10.1093/jnci/djg059; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Sonobe M, 2012, ANN SURG ONCOL, V19, pS347, DOI 10.1245/s10434-011-1799-8; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Hirai F, 2014, ANTICANCER RES, V34, P927; Kenmotsu Hirotsugu, 2012, Respir Investig, V50, P157, DOI 10.1016/j.resinv.2012.09.002; Non-small Cell Lung Cancer Collaborative Group, 1995, BMJ-BRIT MED J, V311, P899, DOI DOI 10.1136/BMJ.311.7010.899; Shukuya T, 2009, JPN J CLIN ONCOL, V39, P158, DOI 10.1093/jjco/hyn147	23	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2014	74	6					1199	1206		10.1007/s00280-014-2595-5		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AU0RB	WOS:000345330400010		
J	Shirakawa, T; Kato, K; Nagashima, K; Nishikawa, A; Sawada, R; Takahashi, N; Shoji, H; Sasaki, Y; Honma, Y; Iwasa, S; Takashima, A; Okita, N; Hamaguchi, T; Yamada, Y; Shimada, Y				Shirakawa, Tsuyoshi; Kato, Ken; Nagashima, Kengo; Nishikawa, Akiko; Sawada, Ryoichi; Takahashi, Naoki; Shoji, Hirokazu; Sasaki, Yusuke; Honma, Yoshitaka; Iwasa, Satoru; Takashima, Atsuo; Okita, Natsuko; Hamaguchi, Tetsuya; Yamada, Yasuhide; Shimada, Yasuhiro			A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Docetaxel; Esophageal squamous cell carcinoma; Paclitaxel; Prognostic factor; Second-line chemotherapy	RANDOMIZED PHASE-II; PERIPHERAL NEUROPATHY; CANCER STATISTICS; TRIAL; CISPLATIN; 5-FLUOROURACIL; DULOXETINE; INFUSION; THERAPY; LIFE	Fluoropyrimidine plus platinum (FP)-based chemotherapy has been widely used as a first-line regimen for advanced or recurrent esophageal cancer, and taxanes have shown efficacy after FP-based chemotherapy, but there is no standard regimen for second-line chemotherapy (SLC). We retrospectively investigated the clinical features of taxane therapy in SLC for esophageal squamous cell carcinoma (ESCC). The selection criteria were pathologically proven ESCC; advanced or recurrent disease previously treated with FP at our hospital; performance status (PS) 0-2; and adequate organ function. Docetaxel (DTX) was administered 3-weekly at 70 mg/m(2). Paclitaxel (PTX) was administered at 100 mg/m(2) weekly for 6 weeks, with 1 week's rest. The analysis covered 163 patients from August 2006 to June 2012. Median age was 64 years (range 37-83: DTX group 132 patients and PTX group 31). Progression-free survival and median overall survival (OS) were 2.3 and 6.1 months, respectively, with PTX and 2.3 and 5.3 months with DTX. Response rates were 20.7 % for PTX and 5.9 % for DTX. The rate of grades 3-4 neutropenia was higher with DTX (32.6 %) than with PTX (16.1 %). Grade 3 febrile neutropenia was seen in 6.1 % of DTX recipients but in no PTX group. According to multivariate analyses of OS, PS 2, number of metastatic sites a parts per thousand 2, and CRP a parts per thousand 1 mg/dL were independent predictors of poor prognosis. PTX and DTX were both effective in SLC for ESCC, but their toxicity profiles differed. In terms of febrile neutropenia, PTX seems more appropriate.	[Shirakawa, Tsuyoshi; Kato, Ken; Nishikawa, Akiko; Sawada, Ryoichi; Takahashi, Naoki; Shoji, Hirokazu; Sasaki, Yusuke; Honma, Yoshitaka; Iwasa, Satoru; Takashima, Atsuo; Okita, Natsuko; Hamaguchi, Tetsuya; Yamada, Yasuhide; Shimada, Yasuhiro] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Chuo Ku, Tokyo 1040045, Japan; [Shirakawa, Tsuyoshi] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Minami Ku, Fukuoka 8111395, Japan; [Nagashima, Kengo] Chiba Univ Hosp, Clin Res Ctr, Chuo Ku, Chiba 2608677, Japan	Kato, K (reprint author), Natl Canc Ctr, Gastrointestinal Med Oncol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	twriver1979@gmail.com; kenkato@ncc.go.jp	Nagashima, Kengo/I-1726-2013	Nagashima, Kengo/0000-0003-4529-9045			Anderson SE, 2003, CANCER INVEST, V21, P512, DOI 10.1081/CNV-120022360; Lorenzen S, 2009, ANN ONCOL, V20, P1667, DOI 10.1093/annonc/mdp069; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Takenaka M, 2013, AM J HOSP PALLIAT ME, V30, P734, DOI 10.1177/1049909112463416; Thallinger CMR, 2011, J CLIN ONCOL, V29, P4709, DOI 10.1200/JCO.2011.36.7599; Muro K, 2004, ANN ONCOL, V15, P955, DOI 10.1093/annonc/mdh231; COX DR, 1972, J R STAT SOC B, V34, P187; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Vanhoefer U, 2000, J CLIN ONCOL, V18, P2648; Bleiberg H, 1997, EUR J CANCER, V33, P1216, DOI 10.1016/S0959-8049(97)00088-9; Hayashi K, 2001, JPN J CLIN ONCOL, V31, P419, DOI 10.1093/jjco/hye090; Heath EI, 2002, INVEST NEW DRUG, V20, P95, DOI 10.1023/A:1014476602804; Hirao M, 2011, BRIT J SURG, V98, P1735, DOI 10.1002/bjs.7683; Ilson DH, 2003, CANCER TREAT REV, V29, P525, DOI 10.1016/S0305-7372(03)00104-X; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kato K, 2011, CANCER CHEMOTH PHARM, V67, P1265, DOI 10.1007/s00280-010-1422-x; Ministry of Health Labour and Welfare, 2006, DEM STAT; Mizota A, 2011, ONCOLOGY-BASEL, V81, P237, DOI 10.1159/000334057; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X	23	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2014	74	6					1207	1215		10.1007/s00280-014-2597-3		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AU0RB	WOS:000345330400011		
J	Aoyama, T; Katayama, Y; Murakawa, M; Asari, M; Kanazawa, A; Higuchi, A; Shiozawa, M; Kobayashi, S; Ueno, M; Morimoto, M; Ohkawa, S; Akaike, M; Yamamoto, N; Yoshikawa, T; Rino, Y; Masuda, M; Morinaga, S				Aoyama, Toru; Katayama, Yusuke; Murakawa, Masaaki; Asari, Masahiro; Kanazawa, Amane; Higuchi, Akio; Shiozawa, Manabu; Kobayashi, Satoshi; Ueno, Makoto; Morimoto, Manabu; Ohkawa, Shinnichi; Akaike, Makoto; Yamamoto, Naoto; Yoshikawa, Takaki; Rino, Yasushi; Masuda, Munetaka; Morinaga, Soichiro			Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for resected pancreatic cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Pancreatic cancer; Adjuvant chemotherapy; S-1; Continuation; Renal function	5-FLUOROURACIL	The factors which affect the 6-month continuation of adjuvant chemotherapy with S-1 have not been fully evaluated in pancreatic cancer. The objective of this retrospective study was to clarify the risk factors for the discontinuation of S-1 adjuvant chemotherapy after 6 months of treatment. The study included patients who underwent curative surgery for pancreatic cancer, were diagnosed with stage II or III disease, had a serum creatinine level a parts per thousand currency sign1.2 mg/dl and received adjuvant S-1 between June 2007 and March 2014. Forty patients were eligible for the present study. A comparison of the 6-month continuation stratified by each clinical factor using the log-rank test revealed a significant difference in the creatinine clearance (CCr) between the patients who continued and discontinued the treatment. A CCr of 60 ml/min was regarded as a critical point. The uni- and multivariate Cox's proportional hazard analyses demonstrated that the CCr was the only significant independent predictive factor. The 6-month continuation rate was 70.8 % in the patients with a CCr a parts per thousand yen60 ml/min and was 25.0 % in patients with a CCr < 60 ml/min (P = 0.008). The patients with a CCr < 60 ml/min developed adverse events more frequently and earlier than those with a CCr a parts per thousand yen60 ml/min. A CCr < 60 ml/min was a significant risk factor for the 6-month discontinuation of S-1 adjuvant chemotherapy in pancreatic cancer patients, even though the renal function was judged to be normal based on the serum creatinine level. Careful attention is therefore required to improve the S-1 continuation in patients with a CCr < 60 ml/min.	[Aoyama, Toru; Katayama, Yusuke; Murakawa, Masaaki; Asari, Masahiro; Kanazawa, Amane; Higuchi, Akio; Shiozawa, Manabu; Akaike, Makoto; Morinaga, Soichiro] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, Yokohama, Kanagawa 2410815, Japan; [Kobayashi, Satoshi; Ueno, Makoto; Morimoto, Manabu; Ohkawa, Shinnichi] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan; [Yamamoto, Naoto; Yoshikawa, Takaki; Rino, Yasushi; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan	Aoyama, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	aoyamat@kcch.jp					Aoyama T, 2013, GASTRIC CANCER, V16, P133, DOI 10.1007/s10120-012-0158-1; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Maeda A, 2008, JPN J CLIN ONCOL, V38, P227, DOI 10.1093/jjco/hym178; Bonadonna G, 1981, NEW ENGL J MED, V304, P101; Hirata K, 1999, CLIN CANCER RES, V5, P2000; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Sobin LH, 2002, TNM CLASSIFICATION M; TATSUMI K, 1987, JPN J CANCER RES, V78, P748; Uesaka K, 2013, ASCO M S, V31, P145; Yamanaka T, 2008, CANCER CHEMOTH PHARM, V61, P335, DOI 10.1007/s00280-007-0595-4	11	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2014	74	6					1235	1240		10.1007/s00280-014-2601-y		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AU0RB	WOS:000345330400014		
J	Li, HY; Takayama, K; Wang, S; Shiraishi, Y; Gotanda, K; Harada, T; Furuyama, K; Iwama, E; Ieiri, I; Okamoto, I; Nakanishi, Y				Li, Heyan; Takayama, Koichi; Wang, Shuo; Shiraishi, Yoshimasa; Gotanda, Keisuke; Harada, Taishi; Furuyama, Kazuto; Iwama, Eiji; Ieiri, Ichiro; Okamoto, Isamu; Nakanishi, Yoichi			Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Bevacizumab; Drug concentration; Erlotinib; Non-small cell lung cancer; VEGF protein	GROWTH-FACTOR RECEPTOR; FACTOR MONOCLONAL-ANTIBODY; TYROSINE KINASE; TARGETED THERAPIES; 1ST-LINE TREATMENT; EGFR INHIBITOR; DOUBLE-BLIND; CHEMOTHERAPY; COMBINATION; MECHANISMS	Erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), and bevacizumab, an anti-vascular endothelial growth factor (VEGF) agent, are promising therapies for advanced non-small cell lung cancer (NSCLC). Our study was aimed to determine whether there were conditions under which the addition of bevacizumab would enhance the antitumor activity of erlotinib against NSCLC tumors in vitro and in vivo. MTS was for NSCLC cell (PC9, 11-18, H1975, H157, H460 and A549) growth assay in vitro. ELISA was for VEGF protein assay in cells and tumor tissues. Mouse xenograft models were established with H157, H460 and A549 with primary resistance to erlotinib and treated with erlotinib plus bevacizumab or each agent alone. Erlotinib concentrations in tumors were determined by high-performance liquid chromatography. Bevacizumab alone did not inhibit NSCLC cell growth in vitro. In primarily erlotinib-resistant NSCLC cells, the levels of VEGF protein were highest in H157 cell followed in order by H460 and A549 cells. In vivo, bevacizumab alone significantly inhibited tumor growth only in xenograft models with high (H157) and/or moderate (H460) levels of VEGF protein. A combination of erlotinib and bevacizumab partially reversed resistance to erlotinib in H157 xenografts (high VEGF level) with increasing intratumoral erlotinib concentrations, but not in H460 (moderate) or A549 (low) xenografts. These results support that combined with anti-VEGF therapy could enhance antitumor activity of anti-EGFR therapy and/or partially reverse resistance to EGFR TKI, by increasing EGFR TKI concentration in specific tumors that express high levels of VEGF protein.	[Li, Heyan; Takayama, Koichi; Wang, Shuo; Shiraishi, Yoshimasa; Harada, Taishi; Furuyama, Kazuto; Iwama, Eiji; Okamoto, Isamu; Nakanishi, Yoichi] Kyushu Univ, Chest Dis Res Inst, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Gotanda, Keisuke; Ieiri, Ichiro] Kyushu Univ, Dept Clin Pharmacokinet, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan	Takayama, K (reprint author), Kyushu Univ, Chest Dis Res Inst, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	koichi-t@kokyu.med.kyushu-u.ac.jp					Cohen MH, 2005, ONCOLOGIST, V10, P461, DOI 10.1634/theoncologist.10-7-461; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Presta LG, 1997, CANCER RES, V57, P4593; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; Herbst RS, 2005, J CLIN ONCOL, V23, P2544, DOI 10.1200/JCO.2005.02.477; Johnson BE, 2013, J CLIN ONCOL, V31, P3926, DOI 10.1200/JCO.2012.47.3983; Pollack VA, 1999, J PHARMACOL EXP THER, V291, P739; Cortes-Funes H, 2005, ANN ONCOL, V16, P1081, DOI 10.1093/annonc/mdi221; Custodio A, 2012, CANCER TREAT REV, V38, P36, DOI 10.1016/j.ctrv.2011.04.001; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311; Schicher N, 2009, CLIN CANCER RES, V15, P3495, DOI 10.1158/1078-0432.CCR-08-2407; Moyer JD, 1997, CANCER RES, V57, P4838; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Heskamp S, 2013, INT J CANCER, V133, P307, DOI 10.1002/ijc.28046; Zhu JQ, 2008, CANCER LETT, V265, P307, DOI 10.1016/j.canlet.2008.02.064; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Boch C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002560; Bozec A, 2008, BRIT J CANCER, V99, P93, DOI 10.1038/sj.bjc.6604429; Choi YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056011; Gandara D, 2009, J CLIN ONCOL, V27, P2; Kim K J, 1992, Growth Factors, V7, P53, DOI 10.3109/08977199209023937; Ortholan C, 2010, EUR J CANCER, V46, P3022, DOI 10.1016/j.ejca.2010.07.021; Ouchi KF, 2006, CANCER CHEMOTH PHARM, V57, P693, DOI 10.1007/s00280-005-0079-3; Shaheen RM, 2001, BRIT J CANCER, V85, P584, DOI 10.1054/bjoc.2001.1936; Stenger M, 2013, ERLOTINIB 1 LINE TRE, V4, P68; Takayama K, 2007, CANCER GENE THER, V14, P105, DOI 10.1038/sj.cgt.7700991; Usui K, 2011, PULM MED, V2011; Viloria-Petit AM, 2004, INT J RADIAT ONCOL, V58, P914, DOI 10.1016/j.ijrobp.2003.09.091; WORKMAN P, 1988, British Journal of Cancer, V58, P109; Yamashita-Kashima Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-37	42	5	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2014	74	6					1297	1305		10.1007/s00280-014-2610-x		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AU0RB	WOS:000345330400021		
J	Sueda, T; Kudo, T; Sakai, D; Uemura, M; Nishimura, J; Hata, T; Takemasa, I; Mizushima, T; Yamamoto, H; Ezoe, S; Matsumoto, K; Doki, Y; Mori, M; Satoh, T				Sueda, Toshinori; Kudo, Toshihiro; Sakai, Daisuke; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Yamamoto, Hirofumi; Ezoe, Sachiko; Matsumoto, Kana; Doki, Yuichiro; Mori, Masaki; Satoh, Taroh			Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						S-1; Dasatinib; Pharmacokinetics; Recurrent colon cancer; Chronic myeloid leukemia	METASTATIC COLORECTAL-CANCER; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; TRIAL	The safety of S-1 in recurrent colorectal cancer patients with chronic myeloid leukemia (CML) treated with dasatinib has not been established. We evaluated the safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with CML treated with dasatinib. A 70-year-old man had undergone surgery three times for sigmoid colon cancer and recurrence. Systemic chemotherapy with S-1 plus oxaliplatin plus bevacizumab as a clinical trial had already been administered because of metastatic colon cancer. The patient's medical history was CML, and he had been receiving dasatinib treatment (100 mg once daily). Based on the diagnosis of unresectable and multiple metastases, S-1 monotherapy was started. S-1 (120 mg/day) was taken for 28 consecutive days, followed by a 14-day rest. Blood samples were obtained before and after the first administration of S-1. The plasma pharmacokinetics of S-1 were comparable to a pharmacokinetics study of S-1. The area under the plasma concentration-time curve (AUC(0-8)) of tegafur (FT), 5-chloro-2, 4-dihydroxypyridine (CDHP), oxonate (Oxo), and 5-fluorouracil (5-FU) was 4,309.2, 716.3, 86.8, and 492.75 ng h/mL, respectively, after S-1 administration. The pharmacokinetics of FT, CDHP, Oxo, and 5-FU after treatment with S-1 were not significantly different from a phase I pharmacokinetics study of S-1. During treatment with S-1 and dasatinib, CML relapse and serious myelosuppression were not observed. Our report suggests that S-1 is an important treatment option for recurrent colorectal cancer in patients with CML treated with dasatinib.	[Sueda, Toshinori; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, Osaka, Japan; [Kudo, Toshihiro; Sakai, Daisuke; Satoh, Taroh] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka 5650871, Japan; [Ezoe, Sachiko] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan; [Matsumoto, Kana] Doshisha Womans Coll Liberal Arts, Dept Clin Pharmaceut, Fac Pharmaceut Sci, Kyoto, Japan	Kudo, T (reprint author), Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tkudo@cfs.med.osaka-u.ac.jp	Nishimura, Junichi/K-8390-2015	Nishimura, Junichi/0000-0001-8220-3423			Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Yamada Y, 2013, LANCET ONCOL, V14, P1278, DOI 10.1016/S1470-2045(13)70490-X; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Yamada Y, 2008, BRIT J CANCER, V98, P1034, DOI 10.1038/sj.bjc.6604271; Muro K, 2010, LANCET ONCOL, V11, P853, DOI 10.1016/S1470-2045(10)70181-9; Shirasaka T, 2009, JPN J CLIN ONCOL, V39, P2, DOI 10.1093/jjco/hyn127; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Benson AB, 2014, J NATL COMPR CANC NE, V12, P1028; Ohtsu A, 2000, BRIT J CANCER, V83, P141; Hirata K, 1999, CLIN CANCER RES, V5, P2000; Rousselot P, 2010, BLOOD, V116, P3432; Takahashi S, 2011, CANCER SCI, V102, P205	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2014	74	6					1321	1324		10.1007/s00280-014-2620-8		4	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AU0RB	WOS:000345330400023		
J	Hirono, K; Ibuki, K; Tomita, H				Hirono, Keiichi; Ibuki, Keijiro; Tomita, Hideshi			Percutaneous Catheter Aspiration Thrombectomy for the Occluded Stents of Pulmonary Artery in Children With Single Ventricle Physiology After Fontan Surgery	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						Fontan surgery; thrombectomy; pulmonary artery; stent	CONGENITAL HEART-DISEASE; RHEOLYTIC THROMBECTOMY; THROMBOSIS; EMBOLISM; SYSTEM	Successful surgical palliation with the Fontan procedure allows survival into adulthood for many patients born with single ventricle (SV) physiology, but the limited studies reported incidence of perioperative and long-term complications including thromboembolic events. Chronic pulmonary embolism is a common complication in patients with Fontan circulation, and may have serious consequences. Percutaneous intervention may be less invasive option for such a high-risk population than surgery is. We described two patients who developed complete thrombosis of the left pulmonary artery following catheter placement of a stent in this vessel shortly after Fontan surgery. Percutaneous catheter aspiration thrombectomy was successfully performed. Percutaneous catheter aspiration thrombectomy may be considered as a viable option in acute thrombus in children with SV physiology after Fontan surgery. (c) 2014 Wiley Periodicals, Inc.	[Hirono, Keiichi; Ibuki, Keijiro] Toyama Univ, Dept Pediat, Grad Sch Med, Toyama 9300194, Japan; [Tomita, Hideshi] Showa Univ, Ctr Cardiovasc, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan	Hirono, K (reprint author), Toyama Univ, Dept Pediat, Grad Sch Med, 2630 Sugitani, Toyama 9300194, Japan.	khirono1973@gmail.com					Kaulitz R, 2005, J THORAC CARDIOV SUR, V129, P569, DOI 10.1016/j.jtcvs.2004.08.045; Dwarka D, 2006, J VASC INTERV RADIOL, V17, P1693, DOI 10.1097/01.RVI.0000236629.26319.65; Lin PH, 2006, AM J SURG, V192, P782, DOI 10.1016/j.amjsurg.2006.08.045; Anderson PAW, 2008, J AM COLL CARDIOL, V52, P85, DOI 10.1016/j.jacc.2008.01.074; Lovell AT, 2004, BRIT J ANAESTH, V93, P129, DOI 10.1093/bja/aeh172; Baim Donald S, 2006, J Invasive Cardiol, V18 Suppl C, p28C; Chauhan MS, 2007, CATHETER CARDIO INTE, V70, P121, DOI 10.1002/ccd.20997; Donnelly JP, 2003, CATHETER CARDIO INTE, V58, P268, DOI 10.1002/ccd.10410; Feldman JR, 2005, CATHETER CARDIO INTE, V66, P442, DOI 10.1002/ccd.20518; Greenberg JM, 2002, CATHETER CARDIO INTE, V56, P66, DOI 10.1002/ccd.10150; Hosking M P, 1992, J Cardiothorac Vasc Anesth, V6, P465, DOI 10.1016/1053-0770(92)90017-2; Sakamoto Kisaburo, 2007, Interact Cardiovasc Thorac Surg, V6, P150; Scott LRP, 1999, CATHETER CARDIO INTE, V47, P97, DOI 10.1002/(SICI)1522-726X(199905)47:1<97::AID-CCD21>3.0.CO;2-5; Uflacker R, 2001, J VASC INTERV RADIOL, V12, P147, DOI 10.1016/S1051-0443(07)61821-1; Vincent RN, 2004, CATHETER CARDIO INTE, V61, P253, DOI 10.1002/ccd.10768	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	DEC 1	2014	84	7			1029		1153	1156		10.1002/ccd.25470		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3LJ	WOS:000345514400024		
J	Kitajima, Y				Kitajima, Yasuo			150th Anniversary Series: Desmosomes and Autoimmune Disease, Perspective of Dynamic Desmosome Remodeling and Its Impairments in Pemphigus	CELL COMMUNICATION AND ADHESION			English	Review						PKC; EGFR; Src; desmoglein 3; wound healing	PROTEIN-KINASE-C; GROWTH-FACTOR RECEPTOR; CARCINOMA-CELL-LINE; DESMOGLEIN 3; VULGARIS-IGG; CULTURED KERATINOCYTES; TYROSINE-PHOSPHORYLATION; MOUSE MODEL; MONOCLONAL-ANTIBODIES; CALCIUM REGULATION	Desmosomes are the most important intercellular adhering junctions that adhere two adjacent keratinocytes directly with desmosomal cadherins, that is, desmogleins (Dsgs) and desmocollins, forming an epidermal sheet. Recently, two cell-cell adhesion states of desmosomes, that is, "stable hyper-adhesion" and "dynamic weak-adhesion" conditions have been recognized. They are mutually reversible through cell signaling events involving protein kinase C (PKC), Src and epidermal growth factor receptor (EGFR) during Ca2+-switching and wound healing. This remodeling is impaired in pemphigus vulgaris (PV, an autoimmune blistering disease), caused by anti-Dsg3 antibodies. The antibody binding to Dsg3 activates PKC, Src and EGFR, linked to generation of dynamic weak-adhesion desmosomes, followed by p38MAPK-mediated endocytosis of Dsg3, resulting in the specific depletion of Dsg3 from desmosomes and acantholysis. A variety of pemphigus outside-in signaling may explain different clinical (non-inflammatory, inflammatory, and necrolytic) types of pemphigus. Pemphigus could be referred to a "desmosome-remodeling disease involving pemphigus IgG-activated outside-in signaling events".	Gifu Univ, Kizawa Mem Hosp, Sch Med, Dept Dermatol, Minokamo City, Gifu 5058503, Japan	Kitajima, Y (reprint author), Gifu Univ, Kizawa Mem Hosp, Sch Med, Dept Dermatol, 590 Shimokobi, Minokamo City, Gifu 5058503, Japan.	yaskitaj@gifu-u.ac.jp					AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; Amagai M, 2011, J INVEST DERMATOL, V132, P776; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Shirakata Y, 1998, J INVEST DERMATOL, V110, P76, DOI 10.1046/j.1523-1747.1998.00085.x; Nie ZX, 2011, J BIOL CHEM, V286, P2143, DOI 10.1074/jbc.M110.192245; Amagai M, 1999, J DERMATOL SCI, V20, P92, DOI 10.1016/S0923-1811(99)00016-X; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Wallis S, 2000, MOL BIOL CELL, V11, P1077; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200; Hobbs RP, 2011, FASEB J, V25, P990, DOI 10.1096/fj.10-163261; ANHALT GJ, 1990, NEW ENGL J MED, V323, P1729, DOI 10.1056/NEJM199012203232503; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Nekrasova O, 2013, TRENDS CELL BIOL, V23, P537, DOI 10.1016/j.tcb.2013.06.004; Kitajima Y, 2013, KAOHSIUNG J MED SCI, V29, P1, DOI 10.1016/j.kjms.2012.08.001; Yamagami J, 2010, J CLIN INVEST, V120, P4111, DOI 10.1172/JCI44425; Thomason HA, 2012, J PATHOL, V227, P346, DOI 10.1002/path.4016; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; DEMLEHNER MP, 1995, J CELL BIOL, V131, P745, DOI 10.1083/jcb.131.3.745; Tu CL, 2001, J BIOL CHEM, V276, P41079, DOI 10.1074/jbc.M107122200; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Mao XM, 2014, J INVEST DERMATOL, V134, P68, DOI 10.1038/jid.2013.224; Sato M, 2000, LAB INVEST, V80, P1583; Ishii K, 1999, ARCH DERMATOL, V135, P943, DOI 10.1001/archderm.135.8.943; Garrod D, 2008, BIOCHEM SOC T, V36, P195, DOI 10.1042/BST0360195; Harmon RM, 2013, CELL COMMUN ADHES, V20, P171, DOI 10.3109/15419061.2013.855204; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Oktarina DAM, 2011, BRIT J DERMATOL, V165, P552, DOI 10.1111/j.1365-2133.2011.10463.x; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Heupel WM, 2008, J IMMUNOL, V181, P1825; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; North AJ, 1999, J CELL SCI, V112, P4325; Bektas M, 2013, J BIOL CHEM, V288, P9447, DOI 10.1074/jbc.M112.438010; Michels C, 2009, J INVEST DERMATOL, V129, P2072, DOI 10.1038/jid.2009.17; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; SHARPE GR, 1989, FEBS LETT, V254, P25, DOI 10.1016/0014-5793(89)81002-6; Spindler V, 2013, J CLIN INVEST, V123, P800, DOI 10.1172/JCI60139; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Kitajima Y, 2007, CLIN REV ALLERG IMMU, V33, P57, DOI 10.1007/s12016-007-0036-5; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Spindler V, 2011, AM J PATHOL, V179, P1905, DOI 10.1016/j.ajpath.2011.06.043; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Gil MP, 2012, EXP DERMATOL, V21, P254, DOI 10.1111/j.1600-0625.2012.01441.x; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Amagai M, 2000, NAT MED, V6, P1275; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Tsunoda K, 2003, J IMMUNOL, V170, P2170; Spindler V, 2014, CELL COMMUN ADHES, V21, P77, DOI 10.3109/15419061.2013.877000; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Aoyama Y, 2009, EXP DERMATOL, V18, P404, DOI 10.1111/j.1600-0625.2008.00814.x; Aoyama Y, 2010, BRIT J DERMATOL, V162, P1049, DOI 10.1111/j.1365-2133.2010.09672.x; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Brennan D, 2010, DERMATOL RES PRACT, V10; Cirillo N, 2014, CELL COMMUN ADHES, V21, P85, DOI 10.3109/15419061.2013.863281; Cirillo N, 2010, EXP CELL RES, V316, P580, DOI 10.1016/j.yexcr.2009.10.005; Cirillo N, 2013, CELL COMMUN ADHES, V20, P1, DOI 10.3109/15419061.2013.763799; Cirillo N, 2014, AUTOIMMUNITY, V47, P134, DOI 10.3109/08916934.2013.866100; ESAKI C, 1995, J INVEST DERMATOL, V105, P329, DOI 10.1111/1523-1747.ep12319948; Futei Y, 2000, J INVEST DERMATOL, V115, P829, DOI 10.1046/j.1523-1747.2000.00137.x; Galichet A, 2014, J INVEST DERMATOL, V134, P8, DOI 10.1038/jid.2013.439; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200; Grando AS, 2012, AUTOIMMUNITY, V45, P7; Hacker-Foegen MK, 2003, J INVEST DERMATOL, V121, P1373, DOI 10.1111/j.1523-1747.2003.12608.x; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Hisamatsu Y, 2004, BRIT J DERMATOL, V151, P73, DOI 10.1111/j.1365-2133.2004.05995.x; Hu PQ, 2001, J INVEST DERMATOL, V117, P1059, DOI 10.1046/j.0022-202x.2001.01523.x; Kasperkiewicz M, 2014, J AM ACAD DERMATOL, V70, P780, DOI 10.1016/j.jaad.2013.11.043; Lanza A, 2008, J BIOL CHEM, V283, P8736, DOI 10.1074/jbc.M702186200; Muller R, 2006, EXP DERMATOL, V15, P606, DOI 10.1111/j.0906-6705.2006.00451.x; NAGAO S, 1989, J INVEST DERMATOL, V92, P175, DOI 10.1111/1523-1747.ep12276697; Nguyen B, 2009, J INVEST DERMATOL, V129, P1710, DOI 10.1038/jid.2008.419; Osada K, 1997, J INVEST DERMATOL, V108, P482, DOI 10.1111/1523-1747.ep12289726; O'toole EA, 2000, CLIN EXP IMMUNOL, V119, P217, DOI 10.1046/j.1365-2249.2000.01104.x; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Schulze K, 2012, J INVEST DERMATOL, V132, P346, DOI 10.1038/jid.2011.299; Seishima M, 1997, J INVEST DERMATOL, V109, P650, DOI 10.1111/1523-1747.ep12337662; SHEU HM, 1989, EXP CELL RES, V185, P176, DOI 10.1016/0014-4827(89)90047-5; Shu E, 2007, ARCH DERMATOL RES, V299, P165, DOI 10.1007/s00403-007-0754-9; STANLEY JR, 1993, ADV IMMUNOL, V53, P291, DOI 10.1016/S0065-2776(08)60503-9; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yamada T, 2000, CELL STRUCT FUNCT, V25, P351, DOI 10.1247/csf.25.351; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200	95	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1541-9061	1543-5180		CELL COMMUN ADHES	Cell Commun. Adhes.	DEC	2014	21	6					269	280		10.3109/15419061.2014.943397		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AU3IU	WOS:000345506800001		
J	Ashida, H; Kim, M; Sasakawa, C				Ashida, Hiroshi; Kim, Minsoo; Sasakawa, Chihiro			Manipulation of the host cell death pathway by Shigella	CELLULAR MICROBIOLOGY			English	Review							NONCANONICAL INFLAMMASOME ACTIVATION; III SECRETION APPARATUS; PROGRAMMED NECROSIS; NLRC4 INFLAMMASOME; BACTERIAL LIGANDS; BH3-ONLY PROTEINS; INTRACELLULAR LPS; AIM2 INFLAMMASOME; EPITHELIAL-CELLS; NEEDLE PROTEIN	Host cells deploy multiple defences against microbial infection. One prominent host defence mechanism, the death of infected cells, plays a pivotal role in clearing damaged cells, eliminating pathogens, removing replicative niches, exposing intracellular bacterial pathogens to extracellular immune surveillance and presenting bacteria-derived antigens to the adaptive immune system. Although cell death can occur under either physiological or pathophysiological conditions, it acts as an innate defence mechanism against bacterial pathogens by limiting their persistent colonization. However, many bacterial pathogens, including Shigella, have evolved mechanisms that manipulate host cell death for their own benefit.	[Ashida, Hiroshi; Kim, Minsoo; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Div Bacterial Infect Biol, Tokyo 1088639, Japan; [Sasakawa, Chihiro] Nippon Inst Biol Sci, Tokyo 1980024, Japan; [Sasakawa, Chihiro] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan	Ashida, H (reprint author), Univ Tokyo, Inst Med Sci, Div Bacterial Infect Biol, Tokyo 1088639, Japan.	hashida@ims.u-tokyo.ac.jp; sasakawa@ims.u-tokyo.ac.jp			 [23000012];  [25460527]	This work was supported by a Grant-in-Aid for Specially Promoted Research (23000012, to C. S.) and a Grant-in-Aid for Scientific Research (C) (25460527 to H. A.).	Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb.7100025; Bergounioux J, 2012, CELL HOST MICROBE, V11, P240, DOI 10.1016/j.chom.2012.01.013; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Zhang Z, 2001, INFECT IMMUN, V69, P3240, DOI 10.1128/IAI.69.5.3240-3247.2001; Clark CS, 2007, INFECT IMMUN, V75, P2531, DOI 10.1128/IAI.01866-06; Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Rudel T, 2010, NAT REV MICROBIOL, V8, P693, DOI 10.1038/nrmicro2421; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Faherty CS, 2009, INFECT IMMUN, V77, P5281, DOI 10.1128/IAI.00800-09; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Sukumaran SK, 2010, MOL CELL, V37, P768, DOI 10.1016/j.molcel.2010.02.015; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Rayamajhi M, 2013, J IMMUNOL, V191, P3986, DOI 10.4049/jimmunol.1301549; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Francois M, 2000, INFECT IMMUN, V68, P1289, DOI 10.1128/IAI.68.3.1289-1296.2000; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Higa N, 2013, TRENDS MICROBIOL, V21, P342, DOI 10.1016/j.tim.2013.04.005; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Sridharan H, 2014, TRENDS MICROBIOL, V22, P199, DOI 10.1016/j.tim.2014.01.005; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Carayol N., 2013, CURR OPIN MICROBIOL, V16, P1; Cunha LD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00076; Faherty CS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-272; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Lembo-Fazio L, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.4; Mace PD, 2010, CURR OPIN CELL BIOL, V22, P828, DOI 10.1016/j.ceb.2010.08.004; MandicMulec I, 1997, INFECT IMMUN, V65, P110; Mantis N, 1996, INFECT IMMUN, V64, P2474; Nothelfer K, 2014, J EXP MED, V211, P1215, DOI 10.1084/jem.20130914; Raqib R, 2002, INFECT IMMUN, V70, P3199, DOI 10.1128/IAI.70.6.3199-3207.2002; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471; Senerovic L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.124; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Suzuki S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003926; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; vonsMoltke J., 2013, ANNU REV IMMUNOL, V31, P73	82	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-5814	1462-5822		CELL MICROBIOL	Cell Microbiol.	DEC	2014	16	12					1757	1766		10.1111/cmi.12367		10	Cell Biology; Microbiology	Cell Biology; Microbiology	AU0XO	WOS:000345345700004		
J	Haobam, B; Nozawa, T; Minowa-Nozawa, A; Tanaka, M; Oda, S; Watanabe, T; Aikawa, C; Maruyama, F; Nakagawa, I				Haobam, Bijaya; Nozawa, Takashi; Minowa-Nozawa, Atsuko; Tanaka, Misako; Oda, Seiichiro; Watanabe, Takayasu; Aikawa, Chihiro; Maruyama, Fumito; Nakagawa, Ichiro			Rab17-mediated recycling endosomes contribute to autophagosome formation in response to Group A Streptococcus invasion	CELLULAR MICROBIOLOGY			English	Article							EPITHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; ENDOPLASMIC-RETICULUM; SMALL GTPASES; MEMBRANE; RAB17; TRAFFICKING; DEGRADATION; DISSECTION; MATURATION	Autophagy plays a crucial role in host defence by facilitating the degradation of invading bacteria such as Group A Streptococcus (GAS). GAS-containing autophagosome-like vacuoles (GcAVs) form when GAS-targeting autophagic membranes entrap invading bacteria. However, the membrane origin and the precise molecular mechanism that underlies GcAV formation remain unclear. In this study, we found that Rab17 mediates the supply of membrane from recycling endosomes (REs) to GcAVs. We showed that GcAVs contain the RE marker transferrin receptor (TfR). Colocalization analyses demonstrated that Rab17 colocalized effectively with GcAV. Rab17 and TfR were visible as punctate structures attached to GcAVs and the Rab17-positive dots were recruited to the GAS-capturing membrane. Overexpression of Rab17 increased the TfR-positive GcAV content, whereas expression of the dominant-negative Rab17 form (Rab17 N132I) caused a decrease, thereby suggesting the involvement of Rab17 in RE-GcAV fusion. The efficiency of GcAV formation was lower in Rab17 N132I-overexpressing cells. Furthermore, knockdown of Rabex-5, the upstream activator of Rab17, reduced the GcAV formation efficiency. These results suggest that Rab17 and Rab17-mediated REs are involved in GcAV formation. This newly identified function of Rab17 in supplying membrane from REs to GcAVs demonstrates that RE functions as a primary membrane source during antibacterial autophagy.	[Haobam, Bijaya; Nozawa, Takashi; Minowa-Nozawa, Atsuko; Tanaka, Misako; Oda, Seiichiro; Watanabe, Takayasu; Aikawa, Chihiro; Maruyama, Fumito; Nakagawa, Ichiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Bunkyo Ku, Tokyo 1138510, Japan; [Nozawa, Takashi; Minowa-Nozawa, Atsuko; Aikawa, Chihiro; Maruyama, Fumito; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Kyoto 6068501, Japan	Nozawa, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	nozawa.bac@tmd.ac.jp			Japan Science, and Daiichi Sankyo Foundation of Life Science; Japanese Ministry of Education Global Center of Excellence (GCOE) Program;  [25115708];  [25293370];  [25305013];  [70294113];  [24790413]	This research was supported in part by Grant-in-Aid for Scientific Research (25115708, 25293370, 25305013, 70294113, 24790413), the funding program for Next Generation World-Leading Researchers (LS041) (I. N.), a Sasakawa Scientific Research Grant (T. N.) from The Japan Science, and Daiichi Sankyo Foundation of Life Science (I. N.) and the Japanese Ministry of Education Global Center of Excellence (GCOE) Program ' International Research Center for Molecular Science in Tooth and Bone Diseases'.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Sakurai A, 2010, J BIOL CHEM, V285, P22666, DOI 10.1074/jbc.M109.100131; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mori Y, 2013, J BIOL CHEM, V288, P9835, DOI 10.1074/jbc.M112.427591; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Wang CW, 2003, MOL MED, V9, P65; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Ham H, 2011, NAT REV MICROBIOL, V9, P635, DOI 10.1038/nrmicro2602; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Taguchi T, 2013, J BIOCHEM, V153, P505, DOI 10.1093/jb/mvt034; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Nozawa T, 2012, CELL MICROBIOL, V14, P1149, DOI 10.1111/j.1462-5822.2012.01792.x; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-5814	1462-5822		CELL MICROBIOL	Cell Microbiol.	DEC	2014	16	12					1806	1821		10.1111/cmi.12329		16	Cell Biology; Microbiology	Cell Biology; Microbiology	AU0XO	WOS:000345345700007		
J	Ito, Y; Sakai, Y; Nagata, K				Ito, Yasumasa; Sakai, Yasuhiko; Nagata, Kouji			Promotion of Chemical Reactions by a Grid in a Shear Mixing Layer	CHEMICAL ENGINEERING & TECHNOLOGY			English	Article						Mixing layer; Turbulence-generating grid; Turbulent mixing	INFLOW CONDITIONS; TURBULENCE	The effects of a turbulence-generating grid on fluid mixing and a passive chemical reaction are experimentally investigated in a liquid shear mixing layer under a nonpremixed condition. The grid is installed at three streamwise locations to find the optimal location to promote the chemical reaction. The results show that the grid generates disturbances at small scales that enhance fluid mixing and the chemical reaction. However, the turbulence intensity and mass diffusion in the mixing layers with the grid decrease rapidly and become even smaller than those in the mixing layer without the grid in a downstream region. Therefore, in the present study, the chemical production is maximized when the grid is installed at where the flow is turning to a developed mixing layer.	[Ito, Yasumasa; Sakai, Yasuhiko; Nagata, Kouji] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648603, Japan	Ito, Y (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	yito@nagoya-u.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25289030]	Part of this study was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through Grants-in-Aid No. 25289030.	Andre C, 2012, CHEM ENG TECHNOL, V35, P247, DOI 10.1002/ceat.201100441; Westerweel J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.174501; BELL JH, 1990, AIAA J, V28, P2034, DOI 10.2514/3.10519; BERNAL LP, 1986, J FLUID MECH, V170, P499, DOI 10.1017/S002211208600099X; Karasso PS, 1996, J FLUID MECH, V323, P23, DOI 10.1017/S0022112096000833; BRADSHAW P, 1966, J FLUID MECH, V26, P225, DOI 10.1017/S0022112066001204; Chorny A, 2009, CHEM ENG TECHNOL, V32, P1866, DOI 10.1002/ceat.200900016; Davidson P., 2004, TURBULENCE, P112; HUSSAIN AKMF, 1986, J FLUID MECH, V173, P303, DOI 10.1017/S0022112086001192; Ito Y, 2014, EXP THERM FLUID SCI, V55, P166, DOI 10.1016/j.expthermflusci.2014.03.001; Ito Y, 2002, PHYS FLUIDS, V14, P4362, DOI 10.1063/1.1518508; Ito Y, 2013, EXP THERM FLUID SCI, V51, P28, DOI 10.1016/j.expthermflusci.2013.06.013; Nagata K, 2000, J FLUID MECH, V408, P39, DOI 10.1017/S0022112099007594; Rose W. G., 1970, J FLUID MECH, V44, P767, DOI 10.1017/S0022112070002136; Slessor MD, 1998, J FLUID MECH, V376, P115, DOI 10.1017/S0022112098002857	15	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0930-7516	1521-4125		CHEM ENG TECHNOL	Chem. Eng. Technol.	DEC	2014	37	12					2103	2108		10.1002/ceat.201300835		6	Engineering, Chemical	Engineering	AU4PS	WOS:000345594600011		
J	Watanabe, K				Watanabe, Kenji			Effective Use of Heterologous Hosts for Characterization of Biosynthetic Enzymes Allows Production of Natural Products and Promotes New Natural Product Discovery	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Review						natural product; biosynthesis; polyketide synthase; nonribosomal peptide synthetase; de novo production; reaction mechanism	PSEUDEUROTIUM-OVALIS STOLK; CONCISE TOTAL-SYNTHESIS; MAMMALIAN-CELL CYCLE; DIELS-ALDER REACTION; ASPERGILLUS-FUMIGATUS; CHAETOMIUM-GLOBOSUM; GENE-CLUSTER; MACROPHOMATE SYNTHASE; ESCHERICHIA-COLI; CHAETOGLOBOSIN-A	In the past few years, there has been impressive progress in elucidating the mechanism of biosynthesis of various natural products accomplished through the use of genetic, molecular biological and biochemical techniques. Here, we present a comprehensive overview of the current results from our studies on fungal natural product biosynthetic enzymes, including nonribosomal peptide synthetase and polyketide synthase nonribosomal peptide synthetase hybrid synthetase, as well as auxiliary enzymes, such as methyltransferases and oxygenases. Specifically, biosynthesis of the following compounds is described in detail: (i) Sch210972, potentially involving a Diels-Alder reaction that may be catalyzed by CghA, a functionally unknown protein identified by targeted gene disruption in the wild type fungus; (ii) chaetoglobosin A, formed via multi-step oxidations catalyzed by three redox enzymes, one flavin-containing monooxygenase and two cytochrome P450 oxygenases as characterized by in vivo biotransformation of relevant intermediates in our engineered Saccharomyces cerevisiae; (iii) (-)-ditryptophenaline, formed by a cytochrome P450, revealing the dimerization mechanism for the biosynthesis of diketopiperazine alkaloids; (iv) pseurotins, whose variations in the C- and O-methylations and the degree of oxidation are introduced combinatorially by multiple redox enzymes; and (v) spirotryprostatins, whose spiro-carbon moiety is formed by a flavin-containing monooxygenase or a cytochrome P450 as determined by heterologous de novo production of the biosynthetic intermediates and final products in Aspergillus niger. We close our discussion by summarizing some of the key techniques that have facilitated the discovery of new natural products, production of their analogs and identification of biosynthetic mechanisms in our study.	Univ Shizuoka, Dept Pharmaceut Sci, Shizuoka 4228526, Japan	Watanabe, K (reprint author), Univ Shizuoka, Dept Pharmaceut Sci, Shizuoka 4228526, Japan.	kenji55@u-shizuoka-ken.ac.jp	Watanabe, Kenji/N-2012-2015				Abe Y, 2002, MOL GENET GENOMICS, V268, P130, DOI 10.1007/s00438-002-0736-8; ANDO O, 1991, J ANTIBIOT, V44, P382; SEKITA S, 1973, TETRAHEDRON LETT, P2109; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Berube G, 2006, CURR MED CHEM, V13, P131, DOI 10.2174/092986706775197908; Lin HC, 2013, J AM CHEM SOC, V135, P4616, DOI 10.1021/ja312503y; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; Ishiuchi K, 2012, CHEMBIOCHEM, V13, P846, DOI 10.1002/cbic.201100798; Cui CB, 1996, TETRAHEDRON, V52, P12651, DOI 10.1016/0040-4020(96)00737-5; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; BARROW CJ, 1993, J ORG CHEM, V58, P6016, DOI 10.1021/jo00074a031; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Ishiuchi K, 2013, J AM CHEM SOC, V135, P7371, DOI 10.1021/ja402828w; Nakazawa T, 2013, J AM CHEM SOC, V135, P13446, DOI 10.1021/ja405128k; Yamada T, 2007, TETRAHEDRON LETT, V48, P6294, DOI 10.1016/j.tetlet.2007.07.024; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Edmondson S, 1999, J AM CHEM SOC, V121, P2147, DOI 10.1021/ja983788i; Boyer N, 2013, CHEM SCI, V4, P1646, DOI 10.1039/c3sc50174d; Ding G, 2008, J NAT PROD, V71, P1861, DOI 10.1021/np800357g; Eberhardt S, 2001, EUR J BIOCHEM, V268, P4315, DOI 10.1046/j.1432-1327.2001.02351.x; Allen JD, 2002, MOL CANCER THER, V1, P417; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; Oikawa H, 2005, B CHEM SOC JPN, V78, P537, DOI 10.1246/bcsj.78.537; Grubbs AW, 2007, ANGEW CHEM INT EDIT, V46, P2257, DOI 10.1002/anie.200604377; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Schumann J, 2007, J AM CHEM SOC, V129, P9564, DOI 10.1021/ja072884t; Flaherty JE, 1997, APPL ENVIRON MICROB, V63, P3995; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Yang SW, 2006, J NAT PROD, V69, P1025, DOI 10.1021/np060121y; BLOCH P, 1976, HELV CHIM ACTA, V59, P133, DOI 10.1002/hlca.19760590114; Cui CB, 1996, J ANTIBIOT, V49, P832; Sims JW, 2008, J AM CHEM SOC, V130, P11149, DOI 10.1021/ja803078z; OIKAWA H, 1993, BIOSCI BIOTECH BIOCH, V57, P628; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Perez-Balado C, 2009, CHEM-EUR J, V15, P9928, DOI 10.1002/chem.200901056; Edmondson SD, 1998, ANGEW CHEM INT EDIT, V37, P1138, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1138::AID-ANIE1138>3.3.CO;2-E; Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Wang P, 2012, CURR OPIN CHEM BIOL, V16, P362, DOI 10.1016/j.cbpa.2012.04.008; Cai SX, 2012, TETRAHEDRON LETT, V53, P2615, DOI 10.1016/j.tetlet.2012.03.043; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/nchembio.1366, 10.1038/NCHEMBIO.1366]; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Scherlach K, 2010, NAT PROD REP, V27, P869, DOI 10.1039/b903913a; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Guimaraes CRW, 2005, J AM CHEM SOC, V127, P3577, DOI 10.1021/ja043905b; An ZQ, 1997, EMBO J, V16, P1742, DOI 10.1093/emboj/16.7.1742; Movassaghi M, 2008, ANGEW CHEM INT EDIT, V47, P1485, DOI 10.1002/anie.200704960; Tadano S, 2013, ANGEW CHEM INT EDIT, V52, P7990, DOI 10.1002/anie.201303143; Asami Y, 2002, ORG LETT, V4, P2845, DOI 10.1021/ol020104+; BLOCH P, 1981, HELV CHIM ACTA, V64, P304, DOI 10.1002/hlca.19810640131; BREITENSTEIN W, 1981, HELV CHIM ACTA, V64, P379, DOI 10.1002/hlca.19810640203; Bugni TS, 2004, NAT PROD REP, V21, P143, DOI 10.1039/b301926h; Chang PK, 2010, J MICROBIOL METH, V81, P240, DOI 10.1016/j.mimet.2010.03.010; Cui CM, 2010, J NAT PROD, V73, P729, DOI 10.1021/np900569t; Ezaki M, 2008, J ANTIBIOT, V61, P207, DOI 10.1038/ja.2008.30; Gomes NM, 2012, PHYTOCHEM LETT, V5, P717, DOI 10.1016/j.phytol.2012.07.010; Igarashi Y, 2004, J ANTIBIOT, V57, P748; Igarashi Y, 2004, J ANTIBIOT, V57, P537; KATAGIRI K, 1970, J ANTIBIOT, V23, P420; Kato H, 2011, TETRAHEDRON LETT, V52, P6923, DOI 10.1016/j.tetlet.2011.10.065; Kim R. R., J AM CHEM SOC, V132, P2983; Kruger EA, 2000, EXPERT OPIN INV DRUG, V9, P1383, DOI 10.1517/13543784.9.6.1383; Li GY, 2006, J NAT PROD, V69, P1374, DOI 10.1021/np0602970; Li SY, 2012, J AM CHEM SOC, V134, P788, DOI 10.1021/ja2093212; Lian GY, 2010, CHEM BIODIVERS, V7, P2660, DOI 10.1002/cbdv.201000038; LOW I, 1979, ANAL BIOCHEM, V95, P14, DOI 10.1016/0003-2697(79)90178-7; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Nakazawa T, 2012, CHEMBIOCHEM, V13, P855, DOI 10.1002/cbic.201200107; OIKAWA H, 1991, TETRAHEDRON LETT, V32, P4533, DOI 10.1016/0040-4039(91)80032-2; Oikawa H., 2010, COMPREHENSIVE NATURA, VVIII, P277; OIKAWA H, 1992, J CHEM SOC PERK T 1, P2949, DOI 10.1039/p19920002949; Pfeifer BA, 2003, APPL ENVIRON MICROB, V69, P6698, DOI 10.1128/AEM.69.11.6698-6702.2003; POPP JL, 1994, J ANTIBIOT, V47, P411; Primm T. P., 2007, CURR BIOACT COMPD, V3, P201, DOI 10.2174/157340707781695550; Rank Christian, 2012, Metabolites, V2, P39, DOI 10.3390/metabo2010039; Sato M, UNPUB; SEKITA S, 1982, CHEM PHARM BULL, V30, P1629; SILVERTON JV, 1976, TETRAHEDRON LETT, P1349; SPRINGER JP, 1977, TETRAHEDRON LETT, P2403; Tsunematsu Y, 2014, ANGEW CHEM INT EDIT, V53, P8475, DOI 10.1002/anie.201404804; Wang HS, 2000, J ORG CHEM, V65, P4685, DOI 10.1021/jo000306o; Watanabe K, 2003, P NATL ACAD SCI USA, V100, P9774, DOI 10.1073/pnas.1632167100	91	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2014	62	12					1153	1165				13	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU3EN	WOS:000345495500001		
J	Ogawa, S; Asakura, K; Osanai, S				Ogawa, Shigesaburo; Asakura, Kouichi; Osanai, Shuichi			Lyotropic Behavior of a Mono-tailed Glycolipid Assembly during Solidification and Melting of Electrolyte/Ice Eutectic Systems	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						glycolipid; freezing; micelle; lyotropic liquid crystalline; eutectic	BETA-D-GLUCOSIDE; MEMBRANE-PROTEINS; PHASE-BEHAVIOR; SOLUBILIZATION; SURFACTANTS; MIXTURES; ETHER; NACL	The properties of low molecular weight glycolipids at subzero temperatures have been paid much attention due to their great potential for applications in cryopreservation. In this study, the ability of glycolipids to maintain their lyotropic properties was investigated by analyzing the aggregation behavior of octyl-beta-D-glucoside (beta-OGlu) during solidification and melting of electrolyte/ice eutectic mixtures using a simultaneous X-ray diffraction differential scanning calorimetry measurement and cryomicroscopic observation. During the freezing process, eutectic formation increased the concentration of the beta-OGlu micelle solution in the unfrozen phase, leading to ordering of the molecular assembly. The molecular assembly exhibited a reversible phase transformation between liquid crystalline phases (e.g., lamellar (L alpha) and hexagonal (H) phases) and an isotropic micelle solution (I), depending on the degree of eutectic formation, which was regulated by temperature. Because the coexistence of electrolyte/ice eutectic often induces the dehydration of lipids, the persistence of lyotropic properties under such arid conditions demonstrates an attractive performance of glycolipids for use in low temperature applications, such as the cryopreservation of poorly water-soluble drugs or proteins.	[Ogawa, Shigesaburo; Asakura, Kouichi; Osanai, Shuichi] Keio Univ, Grad Sch Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Ogawa, S (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, Sanda, Hyogo 6691337, Japan.	dqy95419@kwansei.ac.jp	Asakura, Kouichi/E-8045-2014				Fong C, 2012, CHEM SOC REV, V41, P1297, DOI 10.1039/c1cs15148g; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; [Anonymous], 1984, ULLMANNS ENCY IND CH, V33, P208; Koutsopoulos S, 2012, CHEM SOC REV, V41, P1721, DOI 10.1039/c1cs15180k; Rangel-Yagui CO, 2005, J PHARM PHARM SCI, V8, P147; Dong RH, 2010, CHEM REV, V110, P4978, DOI 10.1021/cr9003743; Ragoonanan V, 2010, J PHYS CHEM B, V114, P16752, DOI 10.1021/jp103960r; Arii T, 1999, THERMOCHIM ACTA, V325, P151, DOI 10.1016/S0040-6031(98)00573-5; BARON C, 1975, BIOCHIM BIOPHYS ACTA, V382, P276, DOI 10.1016/0005-2736(75)90270-9; HAHN L, 1989, PHARMACEUT RES, V6, P958, DOI 10.1023/A:1015945513529; Kajiwara K, 2001, CRYOLETTERS, V22, P311; Karukstis KK, 2012, J PHYS CHEM B, V116, P3816, DOI 10.1021/jp208097c; LORBER B, 1991, J CRYST GROWTH, V110, P103, DOI 10.1016/0022-0248(91)90872-3; Ogawa S, 2007, CRYOBIOLOGY, V54, P173, DOI 10.1016/j.cryobiol.2007.01.005; Ogawa S, 2010, CARBOHYD RES, V345, P2534, DOI 10.1016/j.carres.2010.08.004; Ogawa S., 2012, SUPERCOOLING, P29; Ogawa S, 2013, RSC ADV, V3, P21439, DOI 10.1039/c3ra43187h; Ogawa S, 2012, PHYS CHEM CHEM PHYS, V14, P16312, DOI 10.1039/c2cp41439b; SAKYA P, 1994, J PHYS II, V4, P1311, DOI 10.1051/jp2:1994202; Zheng LQ, 2003, LANGMUIR, V19, P10487, DOI 10.1021/la0301821	20	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2014	62	12					1180	1184				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU3EN	WOS:000345495500004		
J	Matsuo, Y; Sakagami, H; Mimaki, Y				Matsuo, Yukiko; Sakagami, Hiroshi; Mimaki, Yoshihiro			A Rare Type of Sesquiterpene and beta-Santalol Derivatives from Santalum album and Their Cytotoxic Activities	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Santalum album; Santalaceae; beta-santalol; sandalwood; apoptosis; HL-60 cell	INDIAN SANDALWOOD OIL; ALPHA-SANTALOL; HEARTWOOD; APOPTOSIS; INSULARE; ORIGIN; CELLS; MICE; L.	A rare type of sesquiterpene with a Spiro bicyclic system (1) and seven new (2-8) and four known (9-12) beta-santalol derivatives were isolated from the heartwood of Santalum album (Santalaceae). The structures of these new compounds were determined by analysis of extensive spectroscopic data. The isolated compounds and derivatives were evaluated for their cytotoxic activity. against HL-60 human promyelocytic leukemia cells, A549 human lung adenocarcinoma cells, HSC-2 and HSC-4 human oral squamous cell carcinoma cell lines, and TIG-3 normal human diploid fibroblasts. cis-beta-Santalol (9) and beta-santaldiol (10) induced apoptotic cell death in HL-60 cells.	[Matsuo, Yukiko; Mimaki, Yoshihiro] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo 1920392, Japan; [Sakagami, Hiroshi] Meikai Univ Sch Dent, Div Dent Pharmacol, Sakado, Saitama 3500283, Japan	Matsuo, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Tokyo 1920392, Japan.	matsuoy@toyaku.ac.jp					Alpha T, 1996, PHYTOCHEMISTRY, V41, P829, DOI 10.1016/0031-9422(95)00695-8; Matsuo Y, 2010, CHEM PHARM BULL, V58, P587, DOI 10.1248/cpb.58.587; Suzuki R, 2014, ANTICANCER RES, V34, P4117; Nakaoka T, 2014, CELL ONCOL, V37, P119, DOI 10.1007/s13402-014-0167-7; Bommareddy A, 2012, PHYTOMEDICINE, V19, P804, DOI 10.1016/j.phymed.2012.04.003; Dwivedi C, 2006, CARCINOGENESIS, V27, P1917, DOI 10.1093/carcin/bgl058; Latypov SK, 1996, J ORG CHEM, V61, P8569, DOI 10.1021/jo960719i; Kim TH, 2005, CHEM PHARM BULL, V53, P641, DOI 10.1248/cpb.53.641; Ochi T, 2005, J NAT PROD, V68, P819, DOI 10.1021/np040188q; Kim TH, 2006, TETRAHEDRON, V62, P6981, DOI 10.1016/j.tet.2006.04.072; Satou T, 2014, FLAVOUR FRAG J, V29, P35, DOI 10.1002/ffj.3176; Baldovini N, 2011, FLAVOUR FRAG J, V26, P7, DOI 10.1002/ffj.2025; Brunke EJ, 1995, FLAVOUR FRAG J, V10, P211, DOI 10.1002/ffj.2730100315; Burdock GA, 2008, FOOD CHEM TOXICOL, V46, P421, DOI 10.1016/j.fct.2007.09.092; Butaud JF, 2007, NAT PROD COMMUN, V2, P239; CHRISTENSON PA, 1981, PHYTOCHEMISTRY, V20, P1139, DOI 10.1016/0031-9422(81)83047-6; Kim TH, 2005, J NAT PROD, V68, P1805, DOI 10.1021/np050386x; Matsuo Y, 2012, PHYTOCHEMISTRY, V77, P304, DOI 10.1016/j.phytochem.2012.02.007; Ohmori Asae, 2007, Japanese Journal of Neuropsychopharmacology, V27, P167; Paulpandi M, 2012, PHYTOMEDICINE, V19, P231, DOI 10.1016/j.phymed.2011.11.006; Santha S, 2013, PHOTOCHEM PHOTOBIOL, V89, P919, DOI 10.1111/php.12070; Santha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056982; Saraswati S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-147; SINDHU RK, 2010, INT J PHARMTECH RES, V2, P914; Zhang Xiaoying, 2011, Front Biosci (Schol Ed), V3, P777, DOI 10.2741/s186	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2014	62	12					1192	1199				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU3EN	WOS:000345495500006		
J	Hamaguchi, W; Masuda, N; Samizu, K; Mihara, T; Takama, K; Watanabe, T				Hamaguchi, Wataru; Masuda, Naoyuki; Samizu, Kiyohiro; Mihara, Takuma; Takama, Kaori; Watanabe, Toshihiro			Synthesis and in Vivo Evaluation of Novel Quinoline Derivatives as Phosphodiesterase 10A Inhibitors	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						phosphodiesterase 10A (PDE10A) inhibitor; schizophrenia; metabolic stability; quinoline	PDE10A INHIBITORS; BENZIMIDAZOLE DERIVATIVES; THERAPEUTIC APPROACH; IMPROVES COGNITION; SCHIZOPHRENIA; DISCOVERY; POTENT; STRIATUM; DESIGN; ANTIPSYCHOTICS	A novel class of phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability in mouse liver microsomes were designed and synthesized starting from 2-({4-[1-methyl-4-(pyridin-4-y1)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline (MP-10). Replacement of the phenoxymethyl part of MP-10 with an oxymethyl phenyl unit led to the identification of 2-[4-({[1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl]oxy} methyl)phenyl]quinoline (14), which showed moderate PDE10A inhibitory activity with improved metabolic stability in mouse and human liver microsomes over MP-10. Compound 14 showed high concentrations in plasma and brain after intraperitoneal administration and dose-dependently attenuated the hyperlocomotion induced by phencyclidine in mice, and oral administration of 14 (0.1, 0.3 mg/kg) also improved visual-recognition memory impairment in mice.	[Hamaguchi, Wataru; Masuda, Naoyuki; Samizu, Kiyohiro; Mihara, Takuma; Takama, Kaori; Watanabe, Toshihiro] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Hamaguchi, W (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	wataru.hamaguchi@astellas.com					Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Rzasa RM, 2012, BIOORG MED CHEM LETT, V22, P7371, DOI 10.1016/j.bmcl.2012.10.078; Siuciak JA, 2007, EXPERT OPIN DRUG DIS, V2, P1001, DOI 10.1517/17460441.2.7.1001; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Grauer SM, 2009, J PHARMACOL EXP THER, V331, P574, DOI 10.1124/jpet.109.155994; [Anonymous], 2013, MOE; Ho GD, 2012, BIOORG MED CHEM LETT, V22, P2585, DOI 10.1016/j.bmcl.2012.01.113; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Verhoest PR, 2009, J MED CHEM, V52, P5188, DOI [10.1021/jm900521k, 10.1021/jm9015334]; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Taylor DM, 2003, ACTA PSYCHIAT SCAND, V107, P85, DOI 10.1034/j.1600-0447.2003.02078.x; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Hamaguchi W, 2013, BIOORGAN MED CHEM, V21, P7612, DOI 10.1016/j.bmc.2013.10.035; Bauer U, 2012, BIOORG MED CHEM LETT, V22, P1944, DOI 10.1016/j.bmcl.2012.01.046; Smith SM, 2013, NEUROPHARMACOLOGY, V64, P215, DOI 10.1016/j.neuropharm.2012.06.013; Hu E, 2014, J MED CHEM, V57, P6632, DOI 10.1021/jm500713j; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Kolasa T, 2000, J MED CHEM, V43, P690, DOI 10.1021/jm9904102; Dayalu P, 2008, EXPERT OPIN PHARMACO, V9, P1451, DOI [10.1517/14656566.9.9.1451 , 10.1517/14656560802170573]; Hu E, 2013, J MED CHEM, V56, P8781, DOI 10.1021/jm401234w; Newcomer JW, 2005, CNS DRUGS, V19, P1; Hu E, 2012, BIOORG MED CHEM LETT, V22, P2262, DOI 10.1016/j.bmcl.2012.01.086; Harada K, 2012, EUR J PHARMACOL, V685, P59, DOI 10.1016/j.ejphar.2012.04.013; Chino A, 2014, BIOORGAN MED CHEM, V22, P3515, DOI 10.1016/j.bmc.2014.04.023; McElroy WT, 2012, BIOORG MED CHEM LETT, V22, P1335, DOI 10.1016/j.bmcl.2011.12.080; Bartolome-Nebreda JM, 2014, J MED CHEM, V57, P4196, DOI 10.1021/jm500073h; Belliard AM, 2003, XENOBIOTICA, V33, P341, DOI 10.1080/0049825031000065188; Casey Daniel E, 2005, Am J Med, V118 Suppl 2, p15S; Graf R., 2009, J PHARMACOL EXP THER, V331, P574; Johnson PS, 2011, BIOORG MED CHEM LETT, V21, P5684, DOI 10.1016/j.bmcl.2011.08.038; Kilburn JP, 2013, BIOORGAN MED CHEM, V21, P6053, DOI 10.1016/j.bmc.2013.07.030; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; OHKI S, 1968, CHEM PHARM BULL, V16, P1889; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; SKAGERBERG B, 1989, QUANT STRUCT-ACT REL, V8, P32, DOI 10.1002/qsar.19890080105; Verhoest P. R., [No title captured], Patent No. [WO 2006072828, 2006072828]	38	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2014	62	12					1200	1213				14	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU3EN	WOS:000345495500007		
J	Mochizuki, K; Takayama, K				Mochizuki, Koji; Takayama, Kozo			Prediction of Color Changes Using the Time-Temperature Superposition Principle in Liquid Formulations	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						color change; prediction; time temperature superposition principle; Maillard reaction	AGING DATA; STABILITY; TABLETS; DEGRADATION; KINETICS; DRUGS; LIGHT; PAPER	This study reports the results of applying the time temperature superposition principle (TTSP) to the prediction of color changes in liquid formulations. A sample solution consisting of L-tryptophan and glucose was used as the model liquid formulation for the Maillard reaction. After accelerated aging treatment at elevated temperatures, the Commission Internationale de l'Eclairage (CIE) LAB color parameters (a*, b*, L*, and E*ab) of the sample solution were measured using a spectrophotometer. The TTSP was then applied to a kinetic analysis of the color changes. The calculated values of the apparent activation energy of a*, b*, L*, and Delta E*ab were 105.2, 109.8, 91.6, and 103.7 kJ/mol, respectively. The predicted values of the color parameters at 40 degrees C were calculated using Arrhenius plots for each of the color parameters. A comparison of the relationships between the experimental and predicted values of each color parameter revealed the coefficients of determination for a*, b*, L*, and Delta E*ab to be 0.961, 0.979, 0.960, and 0.979, respectively. All the R-2 values were sufficiently high, and these results suggested that the prediction was highly reliable. Kinetic analysis using the TTSP was successfully applied to calculating the apparent activation energy and to predicting the color changes at any temperature or duration.	[Mochizuki, Koji; Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan; [Mochizuki, Koji] Taisho Pharmaceut Co Ltd, Self Medicat Business, Oral Formulat Lab, R&D Labs,Kita Ku, Saitama 3319530, Japan	Mochizuki, K (reprint author), Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	k-mochizuki@so.taisho.co.jp					Matsuo M, 2010, APPL PHYS A-MATER, V99, P47, DOI 10.1007/s00339-010-5542-2; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Waterman KC, 2005, INT J PHARM, V293, P101, DOI 10.1016/j.ijpharm.2004.12.013; Ibarz A, 2000, J SCI FOOD AGR, V80, P1162, DOI 10.1002/1097-0010(200006)80:8<1162::AID-JSFA613>3.3.CO;2-Q; Weemaes CA, 1999, J AGR FOOD CHEM, V47, P2404, DOI 10.1021/jf980663o; Ding HZ, 2008, CELLULOSE, V15, P205, DOI 10.1007/s10570-007-9166-4; Berberich J, 2002, INT J PHARM, V234, P55, DOI 10.1016/S0378-5173(01)00947-4; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Ding HZ, 2007, CELLULOSE, V14, P171, DOI 10.1007/s10570-007-9114-3; Gillen K. T., POLYM DEGRAD STAB, V24, P137; Haraguchi M., 2009, Japan Patent, Patent No. [4358535B2, 4358535]; Hunter R. S, 1981, PHARM TECHNOL, V5, P63; Japanese Standards Association, 2009, Z8730 JIS JAP STAND; Japanese Standards Association, 2004, Z8729 JIS JAP STAND; Kitamura S., 1986, YAKUZAIGAKU, V46, P9; KITAMURA S, 1988, Yakuzaigaku, V48, P270; Lau M. H, J FOOD ENG, V45, P231; Matsuda Y, J PHARM SCI, V67, P196; MATSUDA Y, 1980, YAKUGAKU ZASSHI, V100, P953; Matsuo M., J WOOD SCI, V58, P113; SEKI H, 1981, CHEM PHARM BULL, V29, P3680; Stark G, 1996, INT J PHARM, V143, P93, DOI 10.1016/S0378-5173(96)04691-1; WIRTH M, 1991, J PHARM SCI, V80, P1177, DOI 10.1002/jps.2600801216; WISE J, 1995, POLYM DEGRAD STABIL, V49, P403, DOI 10.1016/0141-3910(95)00137-B; Yamazaki N, 2010, INT J PHARMACEUT, V396, P105, DOI 10.1016/j.ijpharm.2010.06.031	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2014	62	12					1225	1230				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU3EN	WOS:000345495500009		
J	Yoshida, M; Haraguchi, T; Uchida, T				Yoshida, Miyako; Haraguchi, Tamami; Uchida, Takahiro			Bitterness Evaluation of Acidic Pharmaceutical Substances (NSAIDs) Using a Taste Sensor	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						taste sensor; gustatory sensation test; bitterness intensity; non-steroidal anti-inflammatory drug; active pharmaceutical substance; acidic bitter substance	ORALLY DISINTEGRATING TABLETS; ENTERAL NUTRIENTS; FAMOTIDINE; INHIBITION; GUIDELINES; MEDICINES; APPARATUS; MEMBRANES; USERS	The objective of this study was to evaluate an improved bitterness sensor which has been developed to allow the precise and sensitive prediction of the bitterness of acidic bitter pharmaceutical active ingredients, using as examples nine non-steroidal anti-inflammatory drugs (NSAIDs). The bitterness of the nine NSAIDs was measured using a multichannel taste-sensing system incorporating a bitterness sensor, COO, which has a membrane surface with high hydrophobicity, and was developed to allow an enhanced hydrophobic interaction with acidic bitter substances. The sourness intensities of the nine NSAIDs were also determined in gustatory sensation testing and by a taste sensor using a sourness-sensitive membrane, CA0. The 'Change in membrane Potential caused by Adsorption' (CPA) of sodium diclofenac and etodolac were also determined in the presence of increasing concentrations of tartaric acid using membrane C00. Multiple regression analysis performed on the data on bitterness intensity obtained using the taste sensor and in gustatory sensation testing showed that CPA values from C00 could be used to predict the bitterness of the NSAIDs. The derived equation was y=-0.0413xCPA+0.3164, where y represents the predicted bitterness intensity. There were concentration-dependent changes in the bitterness intensities of diclofenac sodium and etodolac without any change in their sourness intensities. For diclofenac sodium and etodolac, there was a good correlation between predicted and actual bitterness intensities in the presence of increasing concentrations of tartaric acid. The taste sensor may be useful for predicting the bitterness intensity of acidic bitter pharmaceutical active ingredients such as NSAIDs.	[Yoshida, Miyako; Haraguchi, Tamami; Uchida, Takahiro] Mukogawa Womens Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Nishinomiya, Hyogo 6638179, Japan	Uchida, T (reprint author), Mukogawa Womens Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, 11-68 Koshien 9 Bancho, Nishinomiya, Hyogo 6638179, Japan.	takahiro@mukogawa-u.ac.jp			Japan Society for Promotion of Science [24590226, 25460234]	This work was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for Promotion of Science 24590226 and 25460234 (to Takahiro Uchida and Miyako Yoshida, respectively).	Tokuyama E, 2009, CHEM PHARM BULL, V57, P382; Risser A, 2009, AM FAM PHYSICIAN, V80, P1371; Lee JL, 2003, TOXICOL APPL PHARM, V192, P294, DOI 10.1016/S0041-008X(03)00301-6; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Katsuragi Y, 1997, PHARMACEUT RES, V14, P720, DOI 10.1023/A:1012138103223; Kobayashi Y, 2010, SENSORS-BASEL, V10, P3411, DOI 10.3390/s100403411; Uchida T, 2003, J PHARM PHARMACOL, V55, P1479, DOI 10.1211/0022357022106; Harada T, 2010, CHEM PHARM BULL, V58, P1009; Harada T, 2006, CHEM PHARM BULL, V54, P1072, DOI 10.1248/cpb.54.1072; KUMAZAWA T, 1986, BIOCHIM BIOPHYS ACTA, V888, P62, DOI 10.1016/0167-4889(86)90071-6; Dinchuk JE, 2003, IMMUNOL LETT, V86, P121, DOI 10.1016/S0165-2478(02)00268-7; Haraguchi T, 2011, CHEM PHARM BULL, V59, P536; Hashimoto Y, 2007, CHEM PHARM BULL, V55, P739, DOI 10.1248/cpb.55.739; Hersh EV, 2005, CURR MED RES OPIN, V21, P1217, DOI 10.1185/030079905X56367; Ito M, 2011, SENSOR MATER, V23, P483; Kaplan B, 1993, Arch Fam Med, V2, P1167, DOI 10.1001/archfami.2.11.1167; Kashima A, 2006, JPN J HLTH CARE SCI, V32, P511; Kataoka M, 2004, INT J PHARM, V279, P107, DOI 10.1016/j.ijpharm.2004.04.006; KURIHARA K, 1994, PHYSIOL BEHAV, V56, P1125, DOI 10.1016/0031-9384(94)90356-5; Laine L, 2009, ALIMENT PHARM THER, V30, P767, DOI 10.1111/j.1365-2036.2009.04090.x; Miyanaga Y, 2004, CHEM PHARM BULL, V52, P490, DOI 10.1248/cpb.52.490; Mukai J, 2004, CHEM PHARM BULL, V52, P1416, DOI 10.1248/cpb.52.1416; Sakurai T, 2009, J AGR FOOD CHEM, V57, P2508, DOI 10.1021/jf8040148; Targownik LE, 2006, CAN FAM PHYSICIAN, V52, P1100; TOKO K, 1994, BIOSENS BIOELECTRON, V9, P359, DOI 10.1016/0956-5663(94)80036-7; Uchida T, 2013, J PHARM PHARMACOL, V65, P1312, DOI 10.1111/jphp.12101; Uchida T, 2000, CHEM PHARM BULL, V48, P1843	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2014	62	12					1252	1258				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU3EN	WOS:000345495500012		
J	Miura, T; Tanaka, T; Matsumoto, K; Murakami, M				Miura, Tomoya; Tanaka, Takamasa; Matsumoto, Kohei; Murakami, Masahiro			One-Pot Synthesis of 2,5-Dihydropyrroles from Terminal Alkynes, Azides, and Propargylic Alcohols by Relay Actions of Copper, Rhodium, and Gold	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						copper; gold; rhodium; terminal alkynes; triazoles	STEREOSELECTIVE-SYNTHESIS; AZAVINYL CARBENES; ENANTIOSELECTIVE SYNTHESIS; CATALYZED TRANSANNULATION; CONTROLLING SELECTIVITY; CLAISEN REARRANGEMENT; ASYMMETRIC-SYNTHESIS; FORMAL SYNTHESIS; SULFONYL AZIDES; CYCLIZATION	Relay actions of copper, rhodium, and gold formulate a one-pot multistep pathway, which directly gives 2,5-dihydropyrroles starting from terminal alkynes, sulfonyl azides, and propargylic alcohols. Initially, copper-catalyzed 1,3-dipolar cycloaddition of terminal alkynes with sulfonyl azides affords 1-sulfonyl-1,2,3-triazoles, which then react with propargylic alcohols under the catalysis of rhodium. The resulting alkenyl propargyl ethers subsequently undergo the thermal Claisen rearrangement to give -allenyl--amino ketones. Finally, a gold catalyst prompts 5-endo cyclization to produce 2,5-dihydropyrroles.	[Miura, Tomoya; Tanaka, Takamasa; Matsumoto, Kohei; Murakami, Masahiro] Kyoto Univ, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan	Miura, T (reprint author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	tmiura@sbchem.kyoto-u.ac.jp; murakami@sbchem.kyoto-u.ac.jp			MEXT [22105005, 24106718, 23685019, 23350041]; JST (ACT-C)	This work was supported by MEXT (Grant-in-Aid for Scientific Research on Innovative Areas nos. 22105005 and 24106718, Young Scientists (A) no. 23685019, Scientific Research (B) no. 23350041) and JST (ACT-C).	Aksin-Artok O, 2011, ADV SYNTH CATAL, V353, P385, DOI 10.1002/adsc.201000903; Binder JT, 2006, ORG LETT, V8, P2151, DOI 10.1021/ol060664z; PINDER AR, 1992, NAT PROD REP, V9, P491, DOI 10.1039/np9920900491; Yang JM, 2014, ANGEW CHEM INT EDIT, V53, P5142, DOI 10.1002/anie.201400881; Yadagiri D, 2014, ORG LETT, V16, P2510, DOI 10.1021/ol500874p; Schultz EE, 2013, J AM CHEM SOC, V135, P4696, DOI 10.1021/ja401380d; Zhu ZB, 2013, CHEM COMMUN, V49, P2272, DOI 10.1039/c3cc37258h; Raushel J, 2010, ORG LETT, V12, P4952, DOI 10.1021/ol102087r; Brown TJ, 2012, J AM CHEM SOC, V134, P9134, DOI 10.1021/ja303844h; Miura T, 2013, ANGEW CHEM INT EDIT, V52, P3883, DOI 10.1002/anie.201209603; Sampath M, 2011, CHEM SCI, V2, P1988, DOI 10.1039/c1sc00311a; Liu YT, 2011, TETRAHEDRON, V67, P6294, DOI 10.1016/j.tet.2011.06.017; Pennell MN, 2011, J ORG CHEM, V76, P1479, DOI 10.1021/jo102263t; Parr BT, 2013, J AM CHEM SOC, V135, P4716, DOI 10.1021/ja401386z; Miura T, 2009, CHEM COMMUN, P1470, DOI 10.1039/b819162j; Wang HB, 2011, ORG LETT, V13, P4316, DOI 10.1021/ol2016548; Miura T, 2013, J AM CHEM SOC, V135, P13652, DOI 10.1021/ja407166r; Luo YF, 2012, ANGEW CHEM INT EDIT, V51, P6762, DOI 10.1002/anie.201202136; Ohno H, 2006, ORG LETT, V8, P947, DOI 10.1021/ol053094w; Miura T, 2014, J AM CHEM SOC, V136, P2272, DOI 10.1021/ja412663a; Lee DJ, 2014, J AM CHEM SOC, V136, P11606, DOI 10.1021/ja5061609; Kim H, 2012, ANGEW CHEM INT EDIT, V51, P12055, DOI 10.1002/anie.201206967; Hansmann MM, 2013, ORG LETT, V15, P3226, DOI 10.1021/ol4011739; Lee PH, 2005, ANGEW CHEM INT EDIT, V44, P1840, DOI 10.1002/anie.200462512; Miura T, 2014, ORG LETT, V16, P2760, DOI 10.1021/ol5010774; Chen K, 2014, ANGEW CHEM INT EDIT, V53, P6645, DOI 10.1002/anie.201402803; Selander N, 2012, ANGEW CHEM INT EDIT, V51, P13054, DOI 10.1002/anie.201207820; Chuprakov S, 2014, J AM CHEM SOC, V136, P195, DOI 10.1021/ja408185c; Nieto-Oberhuber C, 2005, ANGEW CHEM INT EDIT, V44, P6146, DOI 10.1002/anie.200501937; Miura T, 2014, CHEM COMMUN, V50, P10474, DOI 10.1039/c4cc04786a; Xing YP, 2014, ORG LETT, V16, P1244, DOI 10.1021/ol5002347; Jung DJ, 2014, ORG LETT, V16, P2208, DOI 10.1021/ol500723s; Brichacek M, 2009, ORG BIOMOL CHEM, V7, P1761, DOI 10.1039/b900236g; Tejedor D, 2013, CHEM SOC REV, V42, P458, DOI 10.1039/c2cs35311c; Shang H, 2014, ANGEW CHEM INT EDIT, V53, P5662, DOI 10.1002/anie.201400426; Breman AC, 2009, J ORG CHEM, V74, P6327, DOI 10.1021/jo901393y; Spangler JE, 2013, J AM CHEM SOC, V135, P6802, DOI 10.1021/ja4025337; Davies HML, 2014, CHEM SOC REV, V43, P5151, DOI 10.1039/c4cs00072b; Miura T, 2012, J AM CHEM SOC, V134, P17440, DOI 10.1021/ja308285r; Chuprakov S, 2007, ANGEW CHEM INT EDIT, V46, P4757, DOI 10.1002/anie.200700804; Li ZJ, 2012, J AM CHEM SOC, V134, P15497, DOI 10.1021/ja3061529; Davis FA, 2006, TETRAHEDRON LETT, V47, P2743, DOI 10.1016/j.tetlet.2006.02.092; Brichacek M, 2011, ORG LETT, V13, P1110, DOI 10.1021/ol200263g; Krause N, 2011, CHEM REV, V111, P1994, DOI 10.1021/cr1004088; Lee DJ, 2014, CHEM COMMUN, V50, P6620, DOI 10.1039/c4cc02155j; Alford JS, 2014, J AM CHEM SOC, V136, P10266, DOI 10.1021/ja5058967; Wood JL, 1999, ORG LETT, V1, P371, DOI 10.1021/ol990697x; Boyer A, 2014, ORG LETT, V16, P1660, DOI 10.1021/ol500309x; Hashmi ASK, 2012, CHEM-EUR J, V18, P8113, DOI 10.1002/chem.201200091; Horneff T, 2008, J AM CHEM SOC, V130, P14972, DOI 10.1021/ja805079v; Dhand V, 2013, ORG LETT, V15, P1914, DOI 10.1021/ol400566j; Yoo EJ, 2007, ANGEW CHEM INT EDIT, V46, P1730, DOI 10.1002/anie.200604241; Kim CE, 2014, ORG LETT, V16, P1900, DOI 10.1021/ol500718s; O'Hagan D, 2000, NAT PROD REP, V17, P435, DOI 10.1039/a707613d; Gulevich AV, 2013, ANGEW CHEM INT EDIT, V52, P1371, DOI 10.1002/anie.201209338; Cekavicus B, 2011, TETRAHEDRON LETT, V52, P6246, DOI 10.1016/j.tetlet.2011.09.072; Chen K., 2014, ANGEW CHEM, V126, P6763; Chowdhury MA, 2006, SYNLETT, P2383, DOI 10.1055/s-2006-949622; Chuprakov S., 2007, ANGEW CHEM, V119, P4841, DOI 10.1002/ange.200700804; Deutsch C, 2007, SYNLETT, P1790, DOI 10.1055/s-2007-98256; Garcia ALL, 2005, J ORG CHEM, V70, P1050, DOI 10.1021/jo0484880; Greenwood ES, 2002, SYNLETT, P167; Gulevich A. V., 2013, ANGEW CHEM, V125, P1411; Jung ME, 1999, ORG LETT, V1, P367, DOI 10.1021/ol9900257; Kim H., 2012, ANGEW CHEM, V124, P12221; Lee P. H., 2005, ANGEW CHEM, V117, P1874, DOI 10.1002/ange.200462512; Luo Y., 2012, ANGEW CHEM, V124, P6866; Martin R, 2002, J ORG CHEM, V67, P6896, DOI 10.1021/jo025832p; Mauger AB, 1996, J NAT PROD, V59, P1205, DOI 10.1021/np9603479; Medina F, 2014, ORG LETT, V16, P3232, DOI 10.1021/ol5012532; Milton MD, 2004, CHEM COMMUN, P2712, DOI 10.1039/b411180j; Miura T., 2013, ANGEW CHEM, V125, P3975; Miura T, 2009, J ORG CHEM, V74, P6050, DOI 10.1021/jo900987w; Morita N, 2004, ORG LETT, V6, P4121, DOI 10.1021/ol0481838; Nieto-Oberhuber C., 2005, ANGEW CHEM, V117, p[6302, 6146], DOI 10.1002/ange.200501937; Schultz E. E., 2014, ANGEW CHEM, V126, P10062; Schultz EE, 2014, ANGEW CHEM INT EDIT, V53, P9904, DOI 10.1002/anie.201405356; Selander N., 2012, ANGEW CHEM, V124, P13231; Shang H., 2014, ANGEW CHEM, V126, P5768; Tsuzuki Y, 2001, TETRAHEDRON-ASYMMETR, V12, P2989, DOI 10.1016/S0957-4166(01)00530-4; Viso A, 2012, J ORG CHEM, V77, P525, DOI 10.1021/jo202144k; Yang J.-M., 2014, ANGEW CHEM, V126, P5242; Yoo EJ., 2007, ANGEW CHEM, V119, P1760, DOI DOI 10.1002/ANGE.200604241	83	5	5	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16078	16082		10.1002/chem.201405357		5	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700007		
J	Yagai, S; Suzuki, M; Lin, X; Gushiken, M; Noguchi, T; Karatsu, T; Kitamura, A; Saeki, A; Seki, S; Kikkawa, Y; Tani, Y; Nakayama, K				Yagai, Shiki; Suzuki, Mika; Lin, Xu; Gushiken, Marina; Noguchi, Takuya; Karatsu, Takashi; Kitamura, Akihide; Saeki, Akinori; Seki, Shu; Kikkawa, Yoshihiro; Tani, Yuki; Nakayama, Ken-ichi			Supramolecular Engineering of Oligothiophene Nanorods without Insulators: Hierarchical Association of Rosettes and Photovoltaic Properties	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						nanostructures; oligothiophene; photovoltaics; self-assembly; supramolecular chemistry	HETEROJUNCTION SOLAR-CELLS; DISCOTIC LIQUID-CRYSTALS; ORGANIC PHOTOVOLTAICS; MICROWAVE CONDUCTIVITY; NONCOVALENT SYNTHESIS; CONJUGATED POLYMERS; SELF-ORGANIZATION; PERFORMANCE; EFFICIENT; MOLECULE	Supramolecular rosettes of oligothiophenes that do not bear long aliphatic tails have been designed as semiconducting nanomaterials for solution-processable bulk heterojunction solar cells. The rosettes consist of six barbiturated thienyl[oligo(hexylthiophene)] units (Bar-T-hT(n); n=3,4,5) aggregated by multiple hydrogen bonds, which have been directly visualized by scanning tunneling microscopy (STM) at a solid-liquid interface. (HNMR)-H-1 spectroscopy in [D-8]toluene showed that Bar-T-hT(n) exists as a mixture of monomers and small hydrogen-bonded aggregates. Hierarchical organization of the hydrogen-bonded aggregates took place through - stacking interactions upon casting their toluene solutions, resulting in the growth of highly ordered nanorods whose widths are consistent with the diameters of the rosettes. The nanorods could be generated in the presence of soluble fullerene derivatives via solution casting or the annealing of the resulting thin films. The solar cells fabricated based on these bulk heterojunction films showed power conversion efficiencies of 1-3%, which are far higher than those of the non-hydrogen-bonded reference oligothiophene and the derivative that possesses long aliphatic tails.	[Yagai, Shiki; Suzuki, Mika; Lin, Xu; Gushiken, Marina; Noguchi, Takuya; Karatsu, Takashi; Kitamura, Akihide] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Tani, Yuki; Nakayama, Ken-ichi] Yamagata Univ, Grad Sch Sci & Engn, Tsukuba, Ibaraki 3058562, Japan; [Saeki, Akinori; Seki, Shu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Kikkawa, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Yagai, Shiki; Nakayama, Ken-ichi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Yagai, S (reprint author), Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	yagai@faculty.chiba-u.jp	Seki, Shu/E-5346-2010; Saeki, Akinori/B-7756-2011	Seki, Shu/0000-0001-7851-4405; 			Liu XF, 2012, J AM CHEM SOC, V134, P20609, DOI 10.1021/ja310483w; Sergeyev S, 2007, CHEM SOC REV, V36, P1902, DOI 10.1039/b417320c; Tsai WW, 2010, J PHYS CHEM B, V114, P14778, DOI 10.1021/jp105227p; WHITESIDES GM, 1995, ACCOUNTS CHEM RES, V28, P37, DOI 10.1021/ar00049a006; KIMIZUKA N, 1995, J AM CHEM SOC, V117, P6360, DOI 10.1021/ja00128a027; Yagai S, 2012, J AM CHEM SOC, V134, P7983, DOI 10.1021/ja302574b; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Lin YZ, 2012, CHEM SOC REV, V41, P4245, DOI 10.1039/c2cs15313k; Stone DA, 2011, CHEM COMMUN, V47, P5702, DOI 10.1039/c1cc10809c; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Matsuo Y, 2009, J AM CHEM SOC, V131, P16048, DOI 10.1021/ja9048702; Bura T, 2012, J AM CHEM SOC, V134, P17404, DOI 10.1021/ja3072513; Brabec CJ, 2011, CHEM SOC REV, V40, P1185, DOI 10.1039/c0cs00045k; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Sun YM, 2012, NAT MATER, V11, P44, DOI [10.1038/nmat3160, 10.1038/NMAT3160]; Siram RBK, 2011, J PHYS CHEM C, V115, P14369, DOI 10.1021/jp204271c; Yagai S, 2005, J AM CHEM SOC, V127, P11134, DOI 10.1021/ja052645a; Lee OP, 2011, ADV MATER, V23, P5359, DOI 10.1002/adma.201103177; MACDONALD JC, 1994, CHEM REV, V94, P2383, DOI 10.1021/cr00032a007; Li G, 2012, NAT PHOTONICS, V6, P153, DOI 10.1038/NPHOTON.2012.11; Sugiyasu K, 2010, J AM CHEM SOC, V132, P14754, DOI 10.1021/ja107444m; Miura A, 2005, SMALL, V1, P131, DOI 10.1002/smll.200400008; Piermattei A, 2006, ANGEW CHEM INT EDIT, V45, P7543, DOI 10.1002/anie.200602870; Sugiyasu K, 2008, CHEM MATER, V20, P2863, DOI 10.1021/cm800043b; Grozema FC, 2011, J PHYS CHEM LETT, V2, P2951, DOI 10.1021/jz201229a; Li C, 2012, ADV MATER, V24, P613, DOI 10.1002/adma.201104447; Loser S, 2011, J AM CHEM SOC, V133, P8142, DOI 10.1021/ja202791n; Laschat S, 2007, ANGEW CHEM INT EDIT, V46, P4832, DOI 10.1002/anie.200604203; Hoeben FJM, 2005, CHEM REV, V105, P1491, DOI 10.1021/cr030070z; Schenning APHJ, 2002, J AM CHEM SOC, V124, P1269, DOI 10.1021/ja0113403; Wurthner F, 2010, CHEM-EUR J, V16, P9366, DOI 10.1002/chem.201001153; Walker B, 2009, ADV FUNCT MATER, V19, P3063, DOI 10.1002/adfm.200900832; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Gorodetsky AA, 2010, ANGEW CHEM INT EDIT, V49, P7909, DOI 10.1002/anie.201004055; Delgado JL, 2010, CHEM COMMUN, V46, P4853, DOI 10.1039/c003088k; Yagai S, 2009, J AM CHEM SOC, V131, P5408, DOI 10.1021/ja9005892; Huang CH, 2005, ORG LETT, V7, P3409, DOI 10.1021/ol050966l; Kanibolotsky AL, 2010, CHEM SOC REV, V39, P2695, DOI 10.1039/b918154g; Grimsdale AC, 2005, ANGEW CHEM INT EDIT, V44, P5592, DOI 10.1002/anie.200500805; Mishra A, 2012, ANGEW CHEM INT EDIT, V51, P2020, DOI 10.1002/anie.201102326; Schmidt-Mende L, 2001, SCIENCE, V293, P1119, DOI 10.1126/science.293.5532.1119; Wienk MM, 2003, ANGEW CHEM INT EDIT, V42, P3371, DOI 10.1002/anie.200351647; Roncali J, 2014, ADV MATER, V26, P3821, DOI 10.1002/adma.201305999; MATHIAS JP, 1994, J AM CHEM SOC, V116, P4316, DOI 10.1021/ja00089a021; Mayerhoffer U, 2009, ANGEW CHEM INT EDIT, V48, P8776, DOI 10.1002/anie.200903125; Yasuda T, 2009, ADV FUNCT MATER, V19, P411, DOI 10.1002/adfm.200801268; Huang Y, 2014, CHEM REV, V114, P7006, DOI 10.1021/cr400353v; Hains AW, 2010, CHEM REV, V110, P6689, DOI 10.1021/cr9002984; Ma YG, 2002, J AM CHEM SOC, V124, P13757, DOI 10.1021/ja0202006; Wicklein A, 2009, ACS NANO, V3, P1107, DOI 10.1021/nn9001165; Chu CC, 2010, J AM CHEM SOC, V132, P12717, DOI [10.1021/ja104750f, 10.1021/ja104750t]; Saeki A, 2012, J AM CHEM SOC, V134, P19035, DOI 10.1021/ja309524f; Yagai S, 2012, ANGEW CHEM INT EDIT, V51, P6643, DOI 10.1002/anie.201201436; Elemans JAAW, 2009, ANGEW CHEM INT EDIT, V48, P7298, DOI 10.1002/anie.200806339; Zhou JY, 2012, J AM CHEM SOC, V134, P16345, DOI 10.1021/ja306865z; Tevis ID, 2011, J AM CHEM SOC, V133, P16486, DOI 10.1021/ja204811b; Zhao J, 2009, J PHYS CHEM B, V113, P1587, DOI 10.1021/jp804151a; Babu SS, 2012, ANGEW CHEM INT EDIT, V51, P1766, DOI 10.1002/anie.201106767; Kang SJ, 2012, ANGEW CHEM INT EDIT, V51, P8594, DOI 10.1002/anie.201203330; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Liu YS, 2013, ADV MATER, V25, P4657, DOI 10.1002/adma.201301716; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Fenniri H, 2001, J AM CHEM SOC, V123, P3854, DOI 10.1021/ja0058861; Graham KR, 2012, ADV FUNCT MATER, V22, P4801, DOI 10.1002/adfm.201102456; Saeki A, 2011, ADV ENERGY MATER, V1, P661, DOI 10.1002/aenm.201100143; Babu S. S., 2012, ANGEW CHEM, V124, P1800; Bielejewska AG, 2001, J AM CHEM SOC, V123, P7518, DOI 10.1021/ja010664o; Burckstummer H, 2011, ANGEW CHEM INT EDIT, V50, P11628, DOI 10.1002/anie.201105133; Burckstummer H., 2011, ANGEW CHEM, V123, P11832; Elemans J. A. A. W., 2009, ANGEW CHEM, V121, P7434; El-ghayoury A., 2001, ANGEW CHEM, V113, P3772, DOI 10.1002/1521-3757(20011001)113:19<3772::AID-ANGE3772>3.3.CO;2-8; El-Ghayoury A, 2001, ANGEW CHEM INT EDIT, V40, P3660, DOI 10.1002/1521-3773(20011001)40:19<3660::AID-ANIE3660>3.0.CO;2-B; Fang HP, 2012, J POLYM SCI POL CHEM, V50, P5011, DOI 10.1002/pola.26336; Gondo S, 2007, MOL CRYST LIQ CRYST, V470, P353, DOI 10.1080/15421400701503600; Gorodetsky A. A., 2010, ANGEW CHEM, V122, P8081; Grimsdale A. C., 2005, ANGEW CHEM, V117, P5732, DOI 10.1002/ange.200500805; Jin S, 2004, CHEM MATER, V16, P2975, DOI 10.1021/cm0498988; Jonkheijm P, 2006, MACROMOLECULES, V39, P784, DOI 10.1021/ma0520085; Jonkheijm P, 2004, ANGEW CHEM INT EDIT, V43, P74, DOI 10.1002/anie.200352790; Jonkheijm P., 2004, ANGEW CHEM, V116, P76, DOI 10.1002/ange.200352790; Kang S. J., 2012, ANGEW CHEM, V124, P8722; Katsonis N, 2008, ANGEW CHEM INT EDIT, V47, P4997, DOI 10.1002/anie.200800255; Katsonis N., 2008, ANGEW CHEM, V120, P5075, DOI 10.1002/ange.200800255; Katsonis N, 2008, J MATER CHEM, V18, P2065, DOI 10.1039/b718170a; Krebs FC, 2005, SOL ENERG MAT SOL C, V88, P363, DOI 10.1016/j.solmat.2004.12.003; Kumar RJ, 2013, BEILSTEIN J ORG CHEM, V9, P1102, DOI 10.3762/bjoc.9.122; Laschat S, 2007, ANGEW CHEM, V119, P4916, DOI 10.1002/ange.200604203; Li WJ, 1996, MACROMOLECULES, V29, P7329, DOI 10.1021/ma960810o; Mascal M, 1996, ANGEW CHEM INT EDIT, V35, P2204, DOI 10.1002/anie.199622041; Mascal M., 1996, ANGEW CHEM, V108, P2348, DOI 10.1002/ange.19961081908; Mayerhoffer U., 2009, ANGEW CHEM, V121, P8934; Mishra A., 2012, ANGEW CHEM, V124, P2060, DOI DOI 10.1002/ANGE.201102326; Patra D, 2012, POLYMER, V53, P1219, DOI 10.1016/j.polymer.2012.01.026; Piermattei A., 2006, ANGEW CHEM, V118, P7705, DOI 10.1002/ange.200602870; Prins L. J., 2001, ANGEW CHEM, V113, P2446, DOI 10.1002/1521-3757(20010702)113:13<2446::AID-ANGE2446>3.3.CO;2-U; Rance WL, 2011, ACS NANO, V5, P5635, DOI 10.1021/nn201251v; Sagawa T, 2010, J PHYS CHEM LETT, V1, P1020, DOI 10.1021/jz100065u; Schoonbee FS, 1999, ANGEW CHEM, V111, P1486, DOI 10.1002/(SICI)1521-3757(19990517)111:10<1486::AID-ANGE1486>3.0.CO;2-A; Schoonbeek FS, 1999, ANGEW CHEM INT EDIT, V38, P1393, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1393::AID-ANIE1393>3.0.CO;2-H; Tahara K, 2010, CHEM COMMUN, V46, P8507, DOI 10.1039/c0cc02780d; Thompson B. C., 2008, ANGEW CHEM, V120, P62, DOI 10.1002/ange.200702506; Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506; Wienk M. M., 2003, ANGEW CHEM, V115, P3493, DOI 10.1002/ange.200351647; Yagai S., 2012, ANGEW CHEM, V124, P6747; Yagai S., 2008, ANGEW CHEM, V120, P4769, DOI 10.1002/ange.200800417; Yagai S, 2010, ANGEW CHEM INT EDIT, V49, P9990, DOI 10.1002/anie.201006117; Yagai S, 2008, ANGEW CHEM INT EDIT, V47, P4691, DOI 10.1002/anie.200800417; Yagai S, 2011, CHEM-EUR J, V17, P13657, DOI 10.1002/chem.201102982; Yagai S, 2009, CHEM-EUR J, V15, P9320, DOI 10.1002/chem.200901336; Yagai S., 2010, ANGEW CHEM, V122, P10186, DOI 10.1002/ange.201006117; Yang WS, 1999, CHEM-EUR J, V5, P1144, DOI 10.1002/(SICI)1521-3765(19990401)5:4<1144::AID-CHEM1144>3.0.CO;2-K	111	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16128	16137		10.1002/chem.201404428		10	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700015		
J	Hirao, T; Tosaka, M; Yamago, S; Haino, T				Hirao, Takehiro; Tosaka, Masatoshi; Yamago, Shigeru; Haino, Takeharu			Supramolecular Fullerene Polymers and Networks Directed by Molecular Recognition between Calix[5]arene and C-60	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						calixarenes; fullerenes; supramolecular chemistry; supramolecular polymers	HOST-GUEST INTERACTIONS; PHOTOINDUCED ELECTRON-TRANSFER; HYDROGEN-BONDING INTERFACES; RING-CHAIN EQUILIBRIUM; SELF-ORGANIZATION; MAGNETIC-PROPERTIES; ENANTIOSELECTIVE RECOGNITION; ORGANIC PHOTOVOLTAICS; MECHANICAL-PROPERTIES; SEQUENCE INFORMATION	A biscalix[5]arene-C-60 supramolecular structure was utilized for the development of supramolecular fullerene polymers. Di- and tritopic hosts were developed to generate the linear and network supramolecular polymers through the complexation of a dumbbell-shaped fullerene. The molecular association between the hosts and the fullerene were carefully studied by using (HNMR)-H-1, UV/Vis absorption, and fluorescence spectroscopy. The formation of the supramolecular fullerene polymers and networks was confirmed by diffusion-ordered (HNMR)-H-1 spectroscopy (DOSY) and solution viscometry. Upon concentrating the mixtures of di- or tritopic hosts and dumbbell-shaped fullerene in the range of 1.0-10mmolL(-1), the diffusion coefficients of the complexes decreased, and the solution viscosities increased, suggesting that large polymeric assemblies were formed in solution. Scanning electron microscopy (SEM) was used to image the supramolecular fullerene polymers and networks. Atomic force microscopy (AFM) provided insight into the morphology of the supramolecular polymers. A mixture of the homoditopic host and the fullerene resulted in fibers with a height of (1.4 +/- 0.1)nm and a width of (5.0 +/- 0.8)nm. Interdigitation of the alkyl side chains provided secondary interchain interactions that facilitated supramolecular organization. The homotritopic host generated the supramolecular networks with the dumbbell-shaped fullerene. Honeycomb sheet-like structures with many voids were found. The growth of the supramolecular polymers is evidently governed by the shape, dimension, and directionality of the monomers.	[Hirao, Takehiro; Haino, Takeharu] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima, Japan; [Tosaka, Masatoshi; Yamago, Shigeru] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Haino, T (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Chem, 1-3-1 Kagamiyama, Higashihiroshima, Japan.	haino@hiroshima-u.ac.jp	Haino, Takeharu/F-2015-2010		JSPS [24350060, 23655105]; MEXT [25109529, 25102532]	We are grateful to Prof. Dr. Shin-ichi Kihara of the Department of Chemical Engineering, Graduate School of Engineering, Hiroshima University, for helpful discussions about solution rheology. This work was supported by JSPS Grants-in-Aid for Scientific Research (B) (No. 24350060) and Challenging Exploratory Research (No. 23655105), as well as MEXT Grants-in-Aid for Scientific Research on Innovative Areas, "Stimuli-responsive Chemical Species for Creation of Functional Molecules" and "New Polymeric Materials Based on Element-Blocks" (Nos. 25109529, 25102532), and Platform for Dynamic Approaches to Living System.	Moore JS, 1999, CURR OPIN COLLOID IN, V4, P108, DOI 10.1016/S1359-0294(99)00018-7; Ji XF, 2013, J AM CHEM SOC, V135, P74, DOI 10.1021/ja3108559; ALLEMAND PM, 1991, J AM CHEM SOC, V113, P1050, DOI 10.1021/ja00003a053; Miyauchi M, 2005, J AM CHEM SOC, V127, P2034, DOI 10.1021/ja042840; del Barrio J, 2013, J AM CHEM SOC, V135, P11760, DOI 10.1021/ja406556h; Haino T, 2013, ORG BIOMOL CHEM, V11, P4164, DOI 10.1039/c3ob00041a; Wu DY, 2008, PROG POLYM SCI, V33, P479, DOI 10.1016/j.progpolymsci.2008.02.001; Appel EA, 2010, J AM CHEM SOC, V132, P14251, DOI 10.1021/ja106362w; Lehn JM, 2002, POLYM INT, V51, P825, DOI 10.1002/pi.852; Fernandez G, 2008, ANGEW CHEM INT EDIT, V47, P1094, DOI 10.1002/anie.200703049; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P560, DOI 10.1039/f29787400560; Haino T, 2008, SUPRAMOL CHEM, V20, P51, DOI 10.1080/10610270701742553; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q; Wang F, 2008, J AM CHEM SOC, V130, P11254, DOI 10.1021/ja8035465; Castellano RK, 1997, P NATL ACAD SCI USA, V94, P7132, DOI 10.1073/pnas.94.14.7132; Wang Q, 2013, POLYM CHEM-UK, V4, P4192, DOI 10.1039/c3py00339f; Hu YJ, 2005, J MOL STRUCT, V738, P143, DOI 10.1016/j.molstruc.2004.11.062; Beck JB, 2003, J AM CHEM SOC, V125, P13922, DOI 10.1021/ja038521k; GULIKKRZYWICKI T, 1993, P NATL ACAD SCI USA, V90, P163, DOI 10.1073/pnas.90.1.163; Sun RY, 2013, J AM CHEM SOC, V135, P5990, DOI 10.1021/ja4016952; Liu YL, 2012, CHEM-EUR J, V18, P15650, DOI 10.1002/chem.201202985; Chen YL, 2012, NAT CHEM, V4, P467, DOI [10.1038/nchem.1314, 10.1038/NCHEM.1314]; Kuad P, 2007, J AM CHEM SOC, V129, P12630, DOI 10.1021/ja075139p; Guo DS, 2012, CHEM SOC REV, V41, P5907, DOI 10.1039/c2cs35075k; TANIGAKI K, 1991, NATURE, V352, P222, DOI 10.1038/352222a0; Miyauchi M, 2005, J AM CHEM SOC, V127, P2984, DOI 10.1021/ja043289j; Yan XZ, 2013, J AM CHEM SOC, V135, P16813, DOI 10.1021/ja4092193; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; Haino T, 2005, B CHEM SOC JPN, V78, P768, DOI 10.1246/bcsj.78.768; Shinohara H, 2000, REP PROG PHYS, V63, P843, DOI 10.1088/0034-4885/63/6/201; Yamada H, 2012, ORG LETT, V14, P4510, DOI 10.1021/ol301996q; Dong RJ, 2011, POLYM CHEM-UK, V2, P2771, DOI 10.1039/c1py00426c; Cohen Y, 2005, ANGEW CHEM INT EDIT, V44, P520, DOI 10.1002/anie.200300637; Zayed JM, 2010, CHEM SOC REV, V39, P2806, DOI 10.1039/b922348g; Zhan JY, 2014, CHEM COMMUN, V50, P722, DOI 10.1039/c3cc47468b; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Capici C, 2011, ANGEW CHEM INT EDIT, V50, P11956, DOI 10.1002/anie.201104357; Yan XZ, 2013, P NATL ACAD SCI USA, V110, P15585, DOI 10.1073/pnas.1307472110; Zhang ZB, 2011, ANGEW CHEM INT EDIT, V50, P1397, DOI 10.1002/anie.201006693; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; Herbst F, 2013, MACROMOL RAPID COMM, V34, P203, DOI 10.1002/marc.201200675; Gibson HW, 2003, J AM CHEM SOC, V125, P3522, DOI 10.1021/ja020900a; Haino T, 2006, TETRAHEDRON, V62, P2025, DOI 10.1016/j.tet.2005.07.121; Grimm B, 2010, J AM CHEM SOC, V132, P17387, DOI 10.1021/ja108744a; Imato K, 2012, ANGEW CHEM INT EDIT, V51, P1138, DOI 10.1002/anie.201104069; Wei PF, 2014, CHEM COMMUN, V50, P3973, DOI 10.1039/c4cc01091d; Haino T, 2013, POLYM J, V45, P363, DOI 10.1038/pj.2012.144; Xu YQ, 2011, CHEM COMMUN, V47, P8883, DOI 10.1039/c1cc12599k; Ko YH, 2004, J AM CHEM SOC, V126, P1932, DOI 10.1021/ja031567t; Felder T, 2014, CHEM COMMUN, V50, P2455, DOI 10.1039/c3cc46611f; Liu Y, 2004, ANGEW CHEM INT EDIT, V43, P2690, DOI 10.1002/anie.200352973; Xia BY, 2013, POLYM CHEM-UK, V4, P2019, DOI 10.1039/c3py21110j; Chen SB, 2014, POLYM CHEM-UK, V5, P2891, DOI 10.1039/c3py01482g; Haino T, 2012, ANGEW CHEM INT EDIT, V51, P1473, DOI 10.1002/anie.201107655; Yang SK, 2010, J AM CHEM SOC, V132, P1637, DOI 10.1021/ja908429e; Tada T, 2006, J ORG CHEM, V71, P1633, DOI 10.1021/jo0523991; Yebeutchou RM, 2008, ANGEW CHEM INT EDIT, V47, P4504, DOI 10.1002/anie.200801002; Zhu ZX, 2010, NAT CHEM, V2, P653, DOI [10.1038/nchem.699, 10.1038/NCHEM.699]; He YJ, 2010, J AM CHEM SOC, V132, P5532, DOI 10.1021/ja101780s; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Kaupp G, 2002, CHEM-EUR J, V8, P1395, DOI 10.1002/1521-3765(20020315)8:6<1395::AID-CHEM1395>3.0.CO;2-L; Maeda H, 2006, J AM CHEM SOC, V128, P10024, DOI 10.1021/ja0637301; Rauwald U, 2008, ANGEW CHEM INT EDIT, V47, P3950, DOI 10.1002/anie.200705591; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Schmidt R, 2011, MACROMOLECULES, V44, P3766, DOI 10.1021/ma2004184; Corbin PS, 1998, J AM CHEM SOC, V120, P9710, DOI 10.1021/ja981884d; Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738; Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b; Haino T, 2005, J AM CHEM SOC, V127, P8936, DOI 10.1021/ja0524088; Miyauchi M, 2004, J AM CHEM SOC, V126, P11418, DOI 10.1021/ja046562q; Haino T, 2007, J NANOSCI NANOTECHNO, V7, P1386, DOI [10.1166/jnn.2007.317, 10.1166/jmm.2007.317]; Delgado JL, 2010, CHEM COMMUN, V46, P4853, DOI 10.1039/c003088k; Guo DS, 2009, CHEM-ASIAN J, V4, P436, DOI 10.1002/asia.200800410; Haino T, 2006, TETRAHEDRON LETT, V47, P7915, DOI 10.1016/j.tetlet.2006.09.002; Garnier F, 1998, CHEM PHYS, V227, P253, DOI 10.1016/S0301-0104(97)00308-X; Yount WC, 2003, J AM CHEM SOC, V125, P15302, DOI 10.1021/ja036709y; Strutt NL, 2012, CHEM COMMUN, V48, P1647, DOI 10.1039/c2cc16030g; Colquhoun HM, 2004, ANGEW CHEM INT EDIT, V43, P5040, DOI 10.1002/anie.200460382; Perez EM, 2006, J AM CHEM SOC, V128, P7172, DOI 10.1016/ja0621389; Hart LR, 2014, POLYM CHEM-UK, V5, P3680, DOI 10.1039/c4py00292j; Han FS, 2007, ADV MATER, V19, P3928, DOI 10.1002/adma.200700931; Ogoshi T, 2012, CHEM SCI, V3, P3221, DOI 10.1039/c2sc20982a; Yanase M, 1999, TETRAHEDRON LETT, V40, P2781, DOI 10.1016/S0040-4039(99)00257-9; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; Haino T, 2005, TETRAHEDRON LETT, V46, P1411, DOI 10.1016/j.tetlet.2005.01.035; Zhang MM, 2012, ANGEW CHEM INT EDIT, V51, P7011, DOI 10.1002/anie.201203063; HADDON RC, 1991, NATURE, V350, P320, DOI 10.1038/350320a0; Chen ZK, 1999, MACROMOLECULES, V32, P4351, DOI 10.1021/ma981884y; Folmer BJB, 2000, ADV MATER, V12, P874, DOI 10.1002/1521-4095(200006)12:12<874::AID-ADMA874>3.3.CO;2-3; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Haino T, 2006, ORG LETT, V8, P3545, DOI 10.1021/ol061269b; Haino T, 2007, CHEM LETT, V36, P1054, DOI 10.1246/cl.2007.1054; Wei HB, 2014, CHEM COMMUN, V50, P1447, DOI 10.1039/c3cc48732f; Haino T, 1997, ANGEW CHEM INT EDIT, V36, P259, DOI 10.1002/anie.199702591; Yount WC, 2005, J AM CHEM SOC, V127, P14488, DOI 10.1021/ja054298a; Sanchez L, 2002, ANGEW CHEM INT EDIT, V41, P838, DOI 10.1002/1521-3773(20020301)41:5<838::AID-ANIE838>3.0.CO;2-F; Roncali J, 2005, CHEM SOC REV, V34, P483, DOI 10.1039/b415941c; Schmuck C, 2001, ANGEW CHEM INT EDIT, V40, P4363, DOI 10.1002/1521-3773(20011203)40:23<4363::AID-ANIE4363>3.0.CO;2-8; Yerushalmi R, 2005, J MATER CHEM, V15, P4480, DOI 10.1039/b505212b; Xiao TX, 2012, MACROMOLECULES, V45, P9585, DOI 10.1021/ma302459n; HAINO T, 1995, TETRAHEDRON LETT, V36, P5793, DOI 10.1016/00404-0399(50)1130A-; Haino T, 1998, TETRAHEDRON, V54, P12185, DOI 10.1016/S0040-4020(98)00750-9; Niu ZB, 2011, J AM CHEM SOC, V133, P2836, DOI 10.1021/ja110384v; Tian YK, 2014, ANGEW CHEM INT EDIT, V53, P6090, DOI 10.1002/anie.201402192; Huang ZH, 2014, ANGEW CHEM INT EDIT, V53, P5351, DOI 10.1002/anie.201402817; Fernandez G, 2008, J AM CHEM SOC, V130, P2410, DOI 10.1021/ja710505h; Park T, 2005, J AM CHEM SOC, V127, P6520, DOI 10.1021/ja050996j; Haino T, 1997, TETRAHEDRON LETT, V38, P3739, DOI 10.1016/S0040-4039(97)00741-7; Zheng B, 2012, CHEM SOC REV, V41, P1621, DOI 10.1039/c1cs15220c; Haino T, 1998, ANGEW CHEM INT EDIT, V37, P997, DOI 10.1002/(SICI)1521-3773(19980420)37:7<997::AID-ANIE997>3.3.CO;2-X; Haino T, 2009, P NATL ACAD SCI USA, V106, P10477, DOI 10.1073/pnas.0809602106; Adisoejoso J, 2012, J AM CHEM SOC, V134, P18526, DOI 10.1021/ja308480x; Bosman AW, 2004, MATER TODAY, V7, P34, DOI 10.1016/S1369-7021(04)00187-7; Burattini S, 2009, CHEM COMMUN, P6717, DOI 10.1039/b910648k; Capici C., 2011, ANGEW CHEM, V123, P12162; COFFEY D, 1992, PHYS REV LETT, V69, P176, DOI 10.1103/PhysRevLett.69.176; Cohen Y., 2005, ANGEW CHEM, V117, P524, DOI 10.1002/ange.200300637; Pappalardo S, 2007, CHEM-EUR J, V13, P8164, DOI 10.1002/chem.200601785; Colquhoun H. M., 2004, ANGEW CHEM, V116, P5150, DOI 10.1002/ange.200460382; Daoud WA, 2005, B CHEM SOC JPN, V78, P367, DOI 10.1246/bcsj.78.367; Dobrawa R, 2005, MACROMOLECULES, V38, P1315, DOI 10.1021/ma047737j; Dobrawa R, 2005, J POLYM SCI POL CHEM, V43, P4981, DOI 10.1002/pola.20997; Fernandez G., 2008, ANGEW CHEM, V120, P1110, DOI 10.1002/ange.200703049; Gerhardt WW, 2007, CHEM-EUR J, V13, P4467, DOI 10.1002/chem.200601601; Gingter S, 2012, MACROMOLECULES, V45, P1753, DOI 10.1021/ma3002164; Haino T., 1998, ANGEW CHEM, V110, P1044; Haino T, 2002, CHEM COMMUN, P2148, DOI 10.1039/b205048j; Haino T, 1997, SYNLETT, P673; Haino T, 2002, CHEM COMMUN, P402, DOI 10.1039/b108121g; Haino T., 1997, ANGEW CHEM, V109, P288, DOI 10.1002/ange.19971090329; Haino T., 2012, ANGEW CHEM, V124, P1502; Haino T, 2001, TETRAHEDRON LETT, V42, P3203, DOI 10.1016/S0040-4039(01)00420-8; Huang Z., 2014, ANGEW CHEM, V126, P5455, DOI DOI 10.1002/ANGE.201402817; Imahori H, 2004, ADV FUNCT MATER, V14, P525, DOI 10.1002/adfm.200305172; Imato K., 2012, ANGEW CHEM, V124, P1164; Ishihara S, 2006, TETRAHEDRON LETT, V47, P181, DOI 10.1016/j.tetlet.2005.10.152; Isla H, 2014, ANGEW CHEM INT EDIT, V53, P5629, DOI 10.1002/anie.201402828; Isla H., 2014, ANGEW CHEM, V126, P5735; Kimizuka N, 2000, ANGEW CHEM INT EDIT, V39, P389, DOI 10.1002/(SICI)1521-3773(20000117)39:2<389::AID-ANIE389>3.3.CO;2-U; Kimizuka N., 2000, ANGEW CHEM, V112, P402, DOI 10.1002/(SICI)1521-3757(20000117)112:2<402::AID-ANGE402>3.0.CO;2-A; Konishi T, 2005, TETRAHEDRON, V61, P4881, DOI 10.1016/j.tet.2005.03.053; Krishnan VV, 1997, J MAGN RESON, V124, P468, DOI 10.1006/jmre.1996.1082; Kuroiwa K, 2004, J AM CHEM SOC, V126, P2016, DOI 10.1021/ja037847q; Larson R. G., 1999, STRUCTURE RHEOLOGY C; Lee GH, 2002, J MAGN MAGN MATER, V246, P404, DOI 10.1016/S0304-8853(02)00113-0; Lhotak P, 2002, TETRAHEDRON LETT, V43, P3665, DOI 10.1016/S0040-4039(02)00627-5; Li SL, 2011, CHEM-EUR J, V17, P10716, DOI 10.1002/chem.201100691; Liu Y., 2004, ANGEW CHEM, V116, P2744, DOI 10.1002/ange.200352973; Lohmeijer BGG, 2003, J POLYM SCI POL CHEM, V41, P1413, DOI 10.1002/pola.10685; MILLER B, 1991, J AM CHEM SOC, V113, P6291, DOI 10.1021/ja00016a067; Nakahata M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1521; Palma CA, 2008, CHEM COMMUN, P5289, DOI 10.1039/b811534f; POLITIS C, 1992, EUROPHYS LETT, V17, P175, DOI 10.1209/0295-5075/17/2/016; Rahman M, 2006, SPECTROCHIM ACTA A, V65, P901, DOI 10.1016/j.saa.2006.01.029; Rauwald U., 2008, ANGEW CHEM, V120, P4014, DOI 10.1002/ange.200705591; Sanchez L., 2002, ANGEW CHEM, V114, P866, DOI 10.1002/1521-3757(20020301)114:5<866::AID-ANGE866>3.0.CO;2-S; Sariciftci NS, 1999, CURR OPIN SOLID ST M, V4, P373, DOI 10.1016/S1359-0286(99)00044-3; Schmuck C., 2001, ANGEW CHEM, V113, P4493, DOI 10.1002/1521-3757(20011203)113:23<4493::AID-ANGE4493>3.0.CO;2-E; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Tellini VHS, 2006, J AM CHEM SOC, V128, P5728, DOI 10.1021/ja0572809; Thompson B. C., 2008, ANGEW CHEM, V120, P62, DOI 10.1002/ange.200702506; Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506; Tian Y.-K., 2014, ANGEW CHEM, V126, P6204; WANG HH, 1991, INORG CHEM, V30, P2962, DOI 10.1021/ic00015a004; Xu H, 2003, CHEM COMMUN, P2828, DOI 10.1039/b309580k; Yamaguchi N, 1998, ANGEW CHEM INT EDIT, V37, P2361, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2361::AID-ANIE2361>3.0.CO;2-P; Yamaguchi N., 1998, ANGEW CHEM, V110, P2518, DOI 10.1002/(SICI)1521-3757(19980904)110:17<2518::AID-ANGE2518>3.0.CO;2-1; Yanase M, 2000, TETRAHEDRON LETT, V41, P493, DOI 10.1016/S0040-4039(99)02099-7; Yebeutchou R. M., 2008, ANGEW CHEM, V120, P4580, DOI 10.1002/ange.200801002; Zhang M., 2012, ANGEW CHEM, V124, P7117, DOI DOI 10.1002/ANGE.201203063; Zhu LL, 2011, MACROMOLECULES, V44, P4092, DOI 10.1021/ma200825t	172	6	6	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16138	16146		10.1002/chem.201404328		9	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700016		
J	Marcelo, F; Garcia-Martin, F; Matsushita, T; Sardinha, J; Coelho, H; Oude-Vrielink, A; Koller, C; Andre, S; Cabrita, EJ; Gabius, HJ; Nishimura, SI; Jimenez-Barbero, J; Canada, FJ				Marcelo, Filipa; Garcia-Martin, Fayna; Matsushita, Takahiko; Sardinha, Joao; Coelho, Helena; Oude-Vrielink, Anneloes; Koller, Christiane; Andre, Sabine; Cabrita, Eurico J.; Gabius, Hans-Joachim; Nishimura, Shin-Ichiro; Jimenez-Barbero, Jesus; Javier Canada, F.			Delineating Binding Modes of Gal/GalNAc and Structural Elements of the Molecular Recognition of Tumor-Associated Mucin Glycopeptides by the Human Macrophage Galactose-Type Lectin	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						binding studies; macrophage galactose-type lectin; molecular modeling; molecular recognition; mucin glycopeptides	C-TYPE LECTIN; STD NMR-SPECTROSCOPY; TRANSFER DIFFERENCE NMR; N-ACETYLGALACTOSAMINE; CRYSTAL-STRUCTURE; DENDRITIC CELLS; LIGAND-BINDING; X-RAY; CONFORMATIONAL-ANALYSIS; PROTEIN RECEPTORS	The human macrophage galactose-type lectin (MGL) is a key physiological receptor for the carcinoma-associated Tn antigen (GalNAc--1-O-Ser/Thr) in mucins. NMR and modeling-based data on the molecular recognition features of synthetic Tn-bearing glycopeptides by MGL are presented. Cognate epitopes on the sugar and matching key amino acids involved in the interaction were identified by saturation transfer difference (STD) NMR spectroscopy. Only the amino acids close to the glycosylation site in the peptides are involved in lectin contact. Moreover, control experiments with non-glycosylated MUC1 peptides unequivocally showed that the sugar residue is essential for MGL binding, as is Ca2+. NMR data were complemented with molecular dynamics simulations and Corcema-ST to establish a 3D view on the molecular recognition process between Gal, GalNAc, and the Tn-presenting glycopeptides and MGL. Gal and GalNAc have a dual binding mode with opposite trend of the main interaction pattern and the differences in affinity can be explained by additional hydrogen bonds and CH- contacts involving exclusively the NHAc moiety.	[Marcelo, Filipa; Sardinha, Joao; Coelho, Helena; Cabrita, Eurico J.] UNL, Fac Ciencias & Tecnol, REQUIMTE, CQFB,Dept Quim, P-2829516 Caparica, Portugal; [Marcelo, Filipa; Oude-Vrielink, Anneloes; Jimenez-Barbero, Jesus; Javier Canada, F.] CSIC, CIB, E-28040 Madrid, Spain; [Garcia-Martin, Fayna; Matsushita, Takahiko; Nishimura, Shin-Ichiro] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Garcia-Martin, Fayna; Matsushita, Takahiko; Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Koller, Christiane; Andre, Sabine; Gabius, Hans-Joachim] Univ Munich, Inst Physiol Chem, Fac Vet Med, D-80539 Munich, Germany	Marcelo, F (reprint author), UNL, Fac Ciencias & Tecnol, REQUIMTE, CQFB,Dept Quim, P-2829516 Caparica, Portugal.	filipa.marcelo@fct.unl.pt; jcanada@cib.csic.es	Marcelo, Filipa/C-9588-2013; Canada, francisco/D-5837-2014; JESUS, JIMENEZ-BARBERO/D-4431-2014; Cabrita, Eurico/E-8053-2011; Partearroyo, CIB-Biblioteca/L-3262-2014	Marcelo, Filipa/0000-0001-5049-8511; Canada, francisco/0000-0003-4462-1469; JESUS, JIMENEZ-BARBERO/0000-0001-5421-8513; Cabrita, Eurico/0000-0002-0720-2751; Partearroyo, CIB-Biblioteca/0000-0002-1692-4481	FCT Portugal [SFRH/BPD/65462/2009]; CQFB [PEst-C/EQB/LA0006/2013]; MINECO, Spain [CTQ2012-32025]; FCT-Portugal [RECI/BBB-BQB/0230/2012]; EC [PITN-GA-2012-317297, 260600]; JSPS Wakatte B KAKENHI [24710242]; Japanese Ministry of Education, Culture, Science and Technology; JSPS KAKENHI [25220206];  [EXPL/QEQ/MED/0799/2012]	The authors thank FCT Portugal for a post-doc research grant (SFRH/BPD/65462/2009) and for the financial support of EXPL/QEQ/MED/0799/2012 project, CQFB Strategic Project PEst-C/EQB/LA0006/2013 and MINECO, Spain, for the financial support of project CTQ2012-32025. The NMR spectrometer at FCT-UNL is part of the National NMR Network (RNRMN) and is funded by FCT-Portugal RECI/BBB-BQB/0230/2012. The generous financial support by the EC-funded Marie Curie Initial Training Network GLYCOPHARM (PITN-GA-2012-317297) and the GLYCOHIT program (grant agreement 260600) are also gratefully acknowledged. F.G.M. acknowledges the Japanese Special Coordination Fund for Promotion of Science and Technology for accelerated innovation of the fostering system for female scientists and JSPS Wakatte B KAKENHI Grant Number 24710242. We also thank S. Oka and A. Tokumitsu for ESI-HRMS measurements and T. Hirose for amino acid analysis at Instrumental Analysis Division, Equipment Management Center, Creative Research Institution, Hokkaido University. MUC1 (glyco)peptides syntheses of this work was supported by Project for Developing Innovation Systems of the Japanese Ministry of Education, Culture, Science and Technology and JSPS KAKENHI Grant Number 25220206.	Brooks CL, 2010, P NATL ACAD SCI USA, V107, P10056, DOI 10.1073/pnas.0915176107; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Kolatkar AR, 1998, J BIOL CHEM, V273, P19502, DOI 10.1074/jbc.273.31.19502; Marcelo F, 2012, ORG BIOMOL CHEM, V10, P5916, DOI 10.1039/c2ob07135e; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Fiege B, 2012, ANGEW CHEM INT EDIT, V51, P928, DOI 10.1002/anie.201105719; Murphy PV, 2013, MOLECULES, V18, P4026, DOI 10.3390/molecules18044026; Enriquez-Navas PM, 2011, CHEM-EUR J, V17, P1547, DOI 10.1002/chem.201002519; Yongye AB, 2012, BIOCHEMISTRY-US, V51, P7278, DOI 10.1021/bi300761s; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Moller H, 2002, EUR J BIOCHEM, V269, P1444, DOI 10.1046/j.1432-1033.2002.02787.x; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Fernandez-Alonso MD, 2012, CURR PROTEIN PEPT SC, V13, P816; Suzuki N, 1996, J IMMUNOL, V156, P128; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Angulo J, 2008, CHEMBIOCHEM, V9, P2225, DOI 10.1002/cbic.200800361; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Ribeiro JP, 2010, CHEMMEDCHEM, V5, P415, DOI 10.1002/cmdc.200900476; Arda A, 2013, J AM CHEM SOC, V135, P2667, DOI 10.1021/ja3104928; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Corzana F, 2011, CHEM-EUR J, V17, P3105, DOI 10.1002/chem.201003124; Wang YS, 2004, MAGN RESON CHEM, V42, P485, DOI 10.1002/mrc.1381; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Dokurno P, 1998, J MOL BIOL, V284, P713, DOI 10.1006/jmbi.1998.2209; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; Walker JR, 2004, BIOCHEMISTRY-US, V43, P3783, DOI 10.1021/bi035871a; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Corzana F, 2011, CHEM COMMUN, V47, P5319, DOI 10.1039/c1cc10192g; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jayalakshmi V, 2004, J MAGN RESON, V168, P36, DOI 10.1016/j.jmr.2004.01.017; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; van Vliet SJ, 2008, TRENDS IMMUNOL, V29, P83, DOI 10.1016/j.it.2007.10.010; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; Ng WC, 2014, J VIROL, V88, P1659, DOI 10.1128/JVI.02014-13; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Amano M, 2012, FEBS J, V279, P4062, DOI 10.1111/febs.12001; Angulo J, 2010, CHEM-EUR J, V16, P7803, DOI 10.1002/chem.200903528; Calle L, 2013, CHEM-EUR J, V19, P4262, DOI 10.1002/chem.201203673; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P503; Case D., 2012, AMBER 12; Fiege B., 2012, ANGEW CHEM, V124, P952; Gabius HJ, 2011, BIOCHEM SOC T, V39, P399, DOI 10.1042/BST0390399; Gready J. E., 2009, SUGAR CODE FUNDAMENT, P329; Groves P, 2007, MAGN RESON CHEM, V45, P745, DOI 10.1002/mrc.2041; Hatakeyama T, 2011, J BIOL CHEM, V286, P10305, DOI 10.1074/jbc.M110.200576; Jegouzo SAF, 2013, GLYCOBIOLOGY, V23, P853, DOI 10.1093/glycob/cwt022; Kopitz J, 2013, MOL PHARMACEUT, V10, P2054, DOI 10.1021/mp4000629; Krishna N. R., 2007, TOP CURR CHEM, V273, P15; Lazoura E, 2006, IMMUNOLOGY, V119, P306, DOI 10.1111/j.1365-2567.2006.02434.x; Marcelo F., 2012, ANTICARBOHYDRATE ANT, P385; Martin-Santamaria S, 2012, PURE APPL CHEM, V84, P49, DOI 10.1351/PAC-CON-11-10-01; Mayer M., 1999, ANGEW CHEM, V111, P1902; Meyer B., 2003, ANGEW CHEM, V115, P890, DOI 10.1002/ange.200390202; Napoletano C, 2012, EUR J IMMUNOL, V42, P936, DOI 10.1002/eji.201142086; Patsos G., 2009, SUGAR CODE FUNDAMENT, P111; Serruto D, 2006, FEBS LETT, V580, P2985, DOI 10.1016/j.febslet.2006.04.084; Sakakura M, 2008, J BIOL CHEM, V283, P33665, DOI 10.1074/jbc.M804067200; Smetana K, 2013, EXPERT OPIN THER TAR, V17, P379, DOI 10.1517/14728222.2013.750651; Solis D., 2014, BIOCH BIOPHYS ACTA; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; Tayubi I. A., 2011, INT J PHARM PHARM S2, V3, P212; Wang GN, 2012, ORG BIOMOL CHEM, V10, P6893, DOI 10.1039/c2ob25870f	72	7	7	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16147	16155		10.1002/chem.201404566		9	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700017		
J	Shimizu, D; Mori, H; Kitano, M; Cha, WY; Oh, J; Tanaka, T; Kim, D; Osuka, A				Shimizu, Daiki; Mori, Hirotaka; Kitano, Masaaki; Cha, Won-Young; Oh, Juwon; Tanaka, Takayuki; Kim, Dongho; Osuka, Atsuhiro			Nucleophilic Aromatic Substitution Reactions of meso-Bromosubporphyrin: Synthesis of a Thiopyrane-Fused Subporphyrin	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						fluorescence; fusion reactions; nucleophilic aromatic substitution; porphyrinoids; subporphyrins	SENSITIZED SOLAR-CELLS; EFFICIENT SYNTHESIS; DIRECT ARYLATION; PORPHYRINS; SUBPHTHALOCYANINES; REFINEMENT; ABSORPTION; SYSTEMS; DIMERS; AZIDE	meso-Bromosubporphyrin undergoes nucleophilic aromatic substitution (SNAr) reactions with arylamines, diarylamines, phenols, ethanol, thiophenols, and n-butanethiol in the presence of suitable bases to provide the corresponding substitution products. The SNAr reactions also proceed well with pyrrole, indole, and carbazole to provide substitution products in moderate to good yields. Finally, the SNAr reaction with 2-bromothiophenol and subsequent intramolecular peripheral arylation reaction affords a thiopyrane-fused subporphyrin.	[Shimizu, Daiki; Mori, Hirotaka; Kitano, Masaaki; Tanaka, Takayuki; Osuka, Atsuhiro] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Cha, Won-Young; Oh, Juwon; Kim, Dongho] Yonsei Univ, Spect Lab Funct Elect Syst, Seoul 120749, South Korea; [Cha, Won-Young; Oh, Juwon; Kim, Dongho] Yonsei Univ, Dept Chem, Seoul 120749, South Korea	Kim, D (reprint author), Yonsei Univ, Spect Lab Funct Elect Syst, Seoul 120749, South Korea.	dongho@yonsei.ac.kr; osuka@kuchem.kyoto-u.ac.jp			JSPS KAKENHI [25220802, 25620031]; JSPS; Global Research Laboratory through National Research Foundation of Korea (NRF) - Ministry of Science, ICT (Information and Communication Technologies) and Future Planning [2013K1A1A2A02050183]	The work at Kyoto was supported by JSPS KAKENHI Grant Numbers No. 25220802 and 25620031. H.N. and M.K. acknowledge a JSPS Fellowship for Young Scientists. The work at Yonsei was supported by the Global Research Laboratory (2013K1A1A2A02050183) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (Information and Communication Technologies) and Future Planning.	Kawamata Y, 2011, ANGEW CHEM INT EDIT, V50, P8867, DOI 10.1002/anie.201102318; Chen Q, 2014, ORG LETT, V16, P1590, DOI 10.1021/ol500191j; Liu YZ, 2012, PHYS CHEM CHEM PHYS, V14, P16703, DOI 10.1039/c2cp43165c; Kitano M, 2012, ANGEW CHEM INT EDIT, V51, P5593, DOI 10.1002/anie.201201853; Pereira AMVM, 2008, J ORG CHEM, V73, P7353, DOI 10.1021/jo800975c; Xue ZL, 2008, J AM CHEM SOC, V130, P16478, DOI 10.1021/ja8068769; Liu YZ, 2011, CHEM COMMUN, V47, P4010, DOI 10.1039/c0cc03306e; Favereau L, 2013, J MATER CHEM A, V1, P7572, DOI 10.1039/c3ta11380a; [Anonymous], SHELXL 97 SHELXS 97; Osuka A, 2011, B CHEM SOC JPN, V84, P679, DOI 10.1246/bcsj.20110118; Inokuma Y, 2006, ANGEW CHEM INT EDIT, V45, P961, DOI 10.1002/anie.200503426; Mysliborski R, 2006, ANGEW CHEM INT EDIT, V45, P3670, DOI 10.1002/anie.200600589; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Takeuchi Y, 2007, J AM CHEM SOC, V129, P8271, DOI 10.1021/ja0712120; Inokuma Y, 2008, J AM CHEM SOC, V130, P12234, DOI 10.1021/ja804846v; Kobayashi N, 2007, ANGEW CHEM INT EDIT, V46, P758, DOI 10.1002/anie.200603520; Claessens CG, 2014, CHEM REV, V114, P2192, DOI 10.1021/cr400088w; Torres T, 2006, ANGEW CHEM INT EDIT, V45, P2834, DOI 10.1002/anie.200504265; Kuzuhara D, 2011, CHEM COMMUN, V47, P722, DOI 10.1039/c0cc04286b; Yorimitsu H, 2013, ASIAN J ORG CHEM, V2, P356, DOI 10.1002/ajoc.201200183; Balaban MC, 2008, J PHYS CHEM B, V112, P5512, DOI 10.1021/jp801510b; Inokuma Y, 2007, J AM CHEM SOC, V129, P4747, DOI 10.1021/ja069324z; Cha WY, 2014, CHEM COMMUN, V50, P8491, DOI 10.1039/c4cc02368d; CROSSLEY MJ, 1987, TETRAHEDRON, V43, P4569, DOI 10.1016/S0040-4020(01)86899-X; CROSSLEY MJ, 1988, TETRAHEDRON LETT, V29, P1597, DOI 10.1016/S0040-4039(00)80363-9; Devillers CH, 2014, J ORG CHEM, V79, P6424, DOI 10.1021/jo5005586; GONG LC, 1985, CAN J CHEM, V63, P406, DOI 10.1139/v85-067; Haumesser J, 2013, ORG LETT, V15, P6282, DOI 10.1021/ol403132f; Hayashi S, 2010, ORG LETT, V12, P4148, DOI 10.1021/ol101746d; Inokuma Y., 2008, ANGEW CHEM, V120, P4918, DOI 10.1002/ange.200801192; Inokuma Y, 2008, ANGEW CHEM INT EDIT, V47, P4840, DOI 10.1002/anie.200801192; Inokuma Y, 2008, DALTON T, P2517, DOI 10.1039/b719808f; Inokuma Y., 2006, ANGEW CHEM, V118, P975, DOI 10.1002/ange.200503426; Kawamata Y., 2011, ANGEW CHEM, V123, P9029; Kitano M., 2012, ANGEW CHEM, V124, P5691; Kitano M, 2013, CHEM-EUR J, V19, P16523, DOI 10.1002/chem.201303767; Kitano M, 2012, CHEM-EUR J, V18, P8929, DOI 10.1002/chem.201201256; Kitano M., 2014, J POR PHTHA IN PRESS; Kobayashi N., 2007, ANGEW CHEM, V119, P772, DOI 10.1002/ange.200603520; Liu YZ, 2014, J PHYS CHEM C, V118, P1426, DOI 10.1021/jp408737f; Mysliborski R., 2006, ANGEW CHEM, V118, P3752, DOI 10.1002/ange.200600589; Ryan AA, 2014, CHEM COMMUN, V50, P353, DOI 10.1039/c3cc46828c; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Torres T., 2006, ANGEW CHEM, V118, P2900, DOI 10.1002/ange.200504265; Yamamoto Y., 2014, HETEROCYCLES, V88, P231; Yamamoto Y, 2013, ASIAN J ORG CHEM, V2, P320, DOI 10.1002/ajoc.201200198; Yamashita K, 2012, ORG LETT, V14, P190, DOI 10.1021/ol202973z; Zhao S, 2014, SYNTHESIS-STUTTGART, V46, P1674, DOI 10.1055/s-0033-1341055	48	5	5	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16194	16202		10.1002/chem.201405110		9	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700022		
J	Truong, QD; Devaraju, MK; Sasaki, Y; Hyodo, H; Honma, I				Quang Duc Truong; Devaraju, Murukanahally Kempaiah; Sasaki, Yoshikazu; Hyodo, Hiroshi; Honma, Itaru			Polytype and Stacking Faults in the Li2CoSiO4 Li-Ion Battery Cathode	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						crystal growth; phase transitions; polytypes; silicates; stacking interactions	INDIUM-PHOSPHIDE NANOWIRES; DER-WAALS EPITAXY; ANTISITE DEFECTS; NANOCRYSTALS; TRANSITION; CRYSTAL; SUPERLATTICES; GENERATION; MECHANISM; MOS2	Atomic-resolution imaging of the crystal defects of cathode materials is crucial to understand their formation and the correlation between the structure, electrical properties, and electrode performance in rechargeable batteries. The polytype, a stable form of varied crystal structure with uniform chemical composition, holds promise to engineer electronic band structure in nanoscale homojunctions.1-3 Analyzing the exact sites of atoms and the chemistry of the boundary in polytypes would advance our understanding of their formation and properties. Herein, the polytype and stacking faults in the lithium cobalt silicates are observed directly by aberration-corrected scanning transmission electron microscopy. The atomic-scale imaging allows clarification that the polytype is formed by stacking of two different close-packed crystal planes in three-dimensional space. The formation of the polytype was induced by Li-Co cation exchange, the transformation of one phase to the other, and their stacking. This finding provides insight into intrinsic structural defects in an important Li2CoSiO4 Li-ion battery cathode.	[Quang Duc Truong; Devaraju, Murukanahally Kempaiah; Hyodo, Hiroshi; Honma, Itaru] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sasaki, Yoshikazu] JEOL Ltd, DATUM Solut Business Operat, Akishima, Tokyo 1960022, Japan	Devaraju, MK (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	devaraju113@gmail.com; i.honma@tagen.tohoku.ac.jp			Japan Society for Promotion of Science (JSPS, Japan) [P13070]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); Core Technology Consortium for Advanced Energy Devices, Tohoku University, Japan; shared equipment program of "Tohoku Innovative Materials Technology Initiatives for Reconstruction"	This research work was financially supported by the Japan Society for Promotion of Science (JSPS, Japan, Grant No. P13070 for Q.D.T.), Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), and Core Technology Consortium for Advanced Energy Devices, Tohoku University, Japan. This work was also supported by a shared equipment program of "Tohoku Innovative Materials Technology Initiatives for Reconstruction".	Utama MIB, 2013, ADV FUNCT MATER, V23, P1636, DOI 10.1002/adfm.201202027; Santamaria-Perez D, 2012, INORG CHEM, V51, P5779, DOI 10.1021/ic300320r; Truong QD, 2013, ACS APPL MATER INTER, V5, P9926, DOI 10.1021/am403018n; Armstrong AR, 2010, CHEM MATER, V22, P1892, DOI 10.1021/cm9034374; Lin YC, 2014, NAT NANOTECHNOL, V9, P391, DOI [10.1038/nnano.2014.64, 10.1038/NNANO.2014.64]; Hojo H, 2010, NANO LETT, V10, P4668, DOI 10.1021/nl1029336; Utama MIB, 2012, ACS NANO, V6, P2281, DOI 10.1021/nn204344z; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Barth S, 2011, NANO LETT, V11, P1550, DOI 10.1021/nl104339w; Caroff P, 2009, NAT NANOTECHNOL, V4, P50, DOI [10.1038/nnano.2008.359, 10.1038/NNANO.2008.359]; Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.1219831, 10.1126/science.12198331]; Huang J, 2010, J AM CHEM SOC, V132, P15866, DOI 10.1021/ja105132u; Algra RE, 2008, NATURE, V456, P369, DOI 10.1038/nature07570; Jeon N, 2013, NANO LETT, V13, P3947, DOI 10.1021/nl402117b; Devaraju MK, 2013, RSC ADV, V3, P20633, DOI 10.1039/c3ra42540a; Chung SY, 2009, ANGEW CHEM INT EDIT, V48, P543, DOI 10.1002/anie.200803520; Yu HJ, 2013, J PHYS CHEM LETT, V4, P1268, DOI 10.1021/jz400032v; Lee GH, 2013, SCIENCE, V340, P1073, DOI 10.1126/science.1235126; Shmeliov A, 2014, ACS NANO, V8, P3690, DOI 10.1021/nn5003387; Eda G, 2012, ACS NANO, V6, P7311, DOI 10.1021/nn302422x; Sirisopanaporn C, 2011, J AM CHEM SOC, V133, P1263, DOI 10.1021/ja109695r; Ikejiri K, 2011, NANO LETT, V11, P4314, DOI 10.1021/nl202365q; Yu HJ, 2013, ANGEW CHEM INT EDIT, V52, P5969, DOI 10.1002/anie.201301236; Dick KA, 2010, NANO LETT, V10, P3494, DOI 10.1021/nl101632a; Wang R, 2013, ADV ENERGY MATER, V3, P1358, DOI 10.1002/aenm.201200842; Meng F, 2012, NANO LETT, V12, P234, DOI 10.1021/nl203385u; Hughes SM, 2013, NANO LETT, V13, P106, DOI 10.1021/nl3036417; Shin N, 2013, NANO LETT, V13, P1928, DOI 10.1021/nl3042728; Chung S. Y., 2009, ANGEW CHEM, V121, P551, DOI 10.1002/ange.200803520; Dayeh SA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739948; Dinesh R., 2012, NANO LETT, V12, P1146; Hemesath ER, 2012, SMALL, V8, P1717, DOI 10.1002/smll.201102404; Kitauchi Y, 2010, NANO LETT, V10, P1699, DOI 10.1021/nl1000407; Lopez FJ, 2011, ACS NANO, V5, P8958, DOI 10.1021/nn2031337; Truong QD, 2014, CHEM MATER, V26, P2770, DOI 10.1021/cm501452p; Wang JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3340; Yu H., 2013, ANGEW CHEM, V125, P6085; Zhang YX, 2014, J MATER CHEM A, V2, P11574, DOI 10.1039/c4ta01819b	38	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16210	16215		10.1002/chem.201403691		6	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700024		
J	Ikawa, T; Urata, H; Fukumoto, Y; Sumii, Y; Nishiyama, T; Akai, S				Ikawa, Takashi; Urata, Hirohito; Fukumoto, Yutaka; Sumii, Yuta; Nishiyama, Tsuyoshi; Akai, Shuji			Concise Synthesis of Multisubstituted Isoquinolines from Pyridines by Regioselective Diels-Alder Reactions of 2-Silyl-3,4-pyridynes	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						cycloaddition; furans; isoquinolines; pyridynes; silyl groups	SELECTIVE NUCLEOPHILIC-ADDITION; HETARYNE CYCLOADDITIONS; HETEROCYCLIC ARYNES; 3,4-PYRIDYNES; ELLIPTICINE; DERIVATIVES; GENERATION; FUNCTIONALIZATION; 3-BORYLBENZYNES; SILYLBENZYNES	A four-step regioselective synthesis of multisubstituted isoquinoline derivatives from 3-bromopyridines was developed by the Diels-Alder (DA) reactions of 2-silyl-3,4-pyridynes with furans, followed by functional-group transformations. In particular, the silyl group at the C2-position of the 3,4-pyridynes played two important roles: firstly, it functioned as the directing group for the DA reaction, and secondly, it served to introduce diverse substituents at the C1-position of the isoquinolines by electrophilic ipso-substitution.	[Ikawa, Takashi; Fukumoto, Yutaka; Sumii, Yuta; Akai, Shuji] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Urata, Hirohito; Nishiyama, Tsuyoshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Ikawa, T (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	ikawa@phs.osaka-u.ac.jp; akai@phs.osaka-u.ac.jp			JSPS KAKENHI [23790017, 25460018]; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; University of Shizuoka; Uehara Memorial Foundation; Hoansha foundation	This work was supported by the JSPS KAKENHI Grant Number 23790017, 25460018, and Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT. We thank University of Shizuoka, the Uehara Memorial Foundation, and Hoansha foundation for financial support. We also acknowledged National Institute of Biomedical Innovation for sharing a Bruker NMR instrument.	Akai S., 2008, ANGEW CHEM, V120, P7787, DOI 10.1002/ange.200803011; Wenk HH, 2003, ANGEW CHEM INT EDIT, V42, P502, DOI 10.1002/anie.200390151; Bronner SM, 2012, J AM CHEM SOC, V134, P13966, DOI 10.1021/ja306723r; Takagi A, 2013, TETRAHEDRON, V69, P4338, DOI 10.1016/j.tet.2013.03.016; Ikawa T, 2013, J ORG CHEM, V78, P2965, DOI 10.1021/jo302802b; Zhu JT, 2012, ANGEW CHEM INT EDIT, V51, P12353, DOI 10.1002/anie.201207356; Zhu YP, 2013, CHEM-EUR J, V19, P10132, DOI 10.1002/chem.201301734; Gilmore CD, 2008, J AM CHEM SOC, V130, P1558, DOI 10.1021/ja0780582; Takagi A, 2013, ORG BIOMOL CHEM, V11, P8145, DOI [10.1039/c3ob41787e, 10.1039/c3Ob41787e]; ALLRED AL, 1958, J INORG NUCL CHEM, V5, P264, DOI 10.1016/0022-1902(58)80003-2; Guimond N, 2009, J AM CHEM SOC, V131, P12050, DOI 10.1021/ja904380q; WHALEY WM, 1951, ORG REACTIONS, V6, P74; Lin WW, 2007, TETRAHEDRON, V63, P2787, DOI 10.1016/j.tet.2007.01.027; Liu JK, 2005, NEUROCRIT CARE, V2, P124, DOI 10.1385/Neurocrit.Care2005;2:124-132; Goetz AE, 2014, J ORG CHEM, V79, P846, DOI 10.1021/jo402723e; Zheng LY, 2012, J ORG CHEM, V77, P5794, DOI 10.1021/jo3010414; Shekarrao K, 2014, RSC ADV, V4, P14013, DOI 10.1039/c3ra46722h; Saito N, 2013, ORG LETT, V15, P386, DOI 10.1021/ol303352q; Akai S, 2008, ANGEW CHEM INT EDIT, V47, P7673, DOI 10.1002/anie.200803011; Goetz AE, 2012, ANGEW CHEM INT EDIT, V51, P2758, DOI 10.1002/anie.201108863; Nguyen TD, 2011, ORG LETT, V13, P1370, DOI 10.1021/ol200057j; Pellissier H, 2003, TETRAHEDRON, V59, P701, DOI 10.1016/S0040-4020(02)01563-6; Tadross PM, 2012, CHEM REV, V112, P3550, DOI 10.1021/cr200478h; Ikawa T, 2011, ANGEW CHEM INT EDIT, V50, P5673, DOI 10.1002/anie.201100360; Goetz AE, 2013, NAT CHEM, V5, P54, DOI [10.1038/nchem.1504, 10.1038/NCHEM.1504]; Pilgrim BS, 2013, ORG LETT, V15, P6190, DOI 10.1021/ol4030309; Yang DQ, 2012, J ORG CHEM, V77, P4466, DOI 10.1021/jo300494a; Birdsall T. C., 1997, Alternative Medicine Review, V2, P94; Bozzo C, 2000, SYNLETT, P550; Connon SJ, 2000, J CHEM SOC PERK T 1, P1245, DOI 10.1039/a909772d; Crossley JA, 2010, TETRAHEDRON LETT, V51, P6608, DOI 10.1016/j.tetlet.2010.10.052; Diaz MT, 1998, SYNLETT, P157; Diaz M, 2001, EUR J ORG CHEM, P4543; Diemer V, 2011, EUR J ORG CHEM, P341, DOI 10.1002/ejoc.201001283; DUFLOS J, 1981, J ORG CHEM, V46, P1195, DOI 10.1021/jo00319a030; Dyke AM, 2006, SYNTHESIS-STUTTGART, P4093, DOI 10.1055/s-2006-950370; EFFENBERGER F, 1991, CHEM BER, V124, P2119, DOI 10.1002/cber.19911240939; Enamorado MF, 2010, ORG LETT, V12, P4513, DOI 10.1021/ol101887b; Goetz A. E., 2012, ANGEW CHEM, V124, P2812; Heiss C, 2005, EUR J ORG CHEM, P5236, DOI 10.1002/ejoc.200500553; Ikawa T., 2011, ANGEW CHEM, V123, P5792; Iwayama T, 2009, CHEM COMMUN, P5245, DOI 10.1039/b912022j; Katritzky A.R., 2010, HDB HETEROCYCLIC CHE; KAUFFMANN T, 1962, CHEM BER-RECL, V95, P949, DOI 10.1002/cber.19620950420; Lennox JR, 2001, J ORG CHEM, V66, P7078, DOI 10.1021/jo010534y; LEVINE R, 1955, SCIENCE, V121, P780, DOI 10.1126/science.121.3152.780; Majumdar KC, 2011, HETEROCYCLES IN NATURAL PRODUCT SYNTHESIS, P1, DOI 10.1002/9783527634880; MATSUMOTO T, 1993, SYNLETT, P843; Pierrat P, 2005, ORG LETT, V7, P697, DOI 10.1021/ol047482u; Saito N, 2014, HETEROCYCLES, V88, P929, DOI 10.3987/COM-13-S(S)86; Stiborova M, 2004, CANCER RES, V64, P8374, DOI 10.1158/0008-5472.CAN-04-2202; Suzawa K, 2006, CHEM COMMUN, P4850, DOI 10.1039/b611090h; TSUKAZAKI M, 1993, HETEROCYCLES, V35, P689; TSUKAZAKI M, 1992, HETEROCYCLES, V33, P533; VinterPasquier K, 1997, HETEROCYCLES, V45, P2113; Wenk H. H., 2003, ANGEW CHEM, V115, P518, DOI 10.1002/ange.200390119; Woltermann C. J., 2002, FINE CHEM, P5; Zhu J., 2012, ANGEW CHEM, V124, P12519	58	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16228	16232		10.1002/chem.201404633		5	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700026		
J	Yamamura, M; Yamakawa, K; Okazaki, Y; Nabeshima, T				Yamamura, Masaki; Yamakawa, Koji; Okazaki, Yuki; Nabeshima, Tatsuya			Coordination-Driven Macrocyclization for Locking of Photo- and Thermal cis -> trans Isomerization of Azobenzene	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						azo compounds; iron; isomerization; macrocycles; supramolecular chemistry	PHOTOCHROMIC REACTIVITY; MOLECULAR LOGIC; PHOTOISOMERIZATION; COMPLEXES; INVERSION; LIGANDS; ISOMER; LIGHT; PHOTOCHEMISTRY; CONSTRUCTION	Both trans and cis isomers of azobenzene-linked bis-terpyridine ligand L1 were incorporated in rigid macrocycles linked by Fe-II(tpy)(2) (tpy: terpyridine) units. The complex of the longer trans-L1 is dinuclear [(trans-L1)(2)Fe-2(II)], whereas the complex of the shorter cis-L1 is mononuclear [cis-L1Fe(II)]. The complex cis-L1Fe(II) was not only thermally stable but also photochemically inactive. These results indicate a perfectly locked state of cis-azobenzene. The stable macrocyclic structure of cis-L1Fe(II) causes locking of the isomerization. To the best of our knowledge, this is first example of dual locking of photo- and thermal isomerization of cis-azobenzene.	[Yamamura, Masaki; Yamakawa, Koji; Okazaki, Yuki; Nabeshima, Tatsuya] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Yamamura, Masaki; Nabeshima, Tatsuya] Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci TIMS, Tsukuba, Ibaraki 3058571, Japan	Yamamura, M (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tennodai 1-1-1, Tsukuba, Ibaraki 3058571, Japan.	myama@chem.tsukuba.ac.jp; nabesima@chem.tsukuba.ac.jp	Yamamura, Masaki/F-1366-2014	Yamamura, Masaki/0000-0002-8801-2406	Ministry of Education, Culture, Sports, Science, and Technology of Japan	This research was financially supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Norikane Y, 2002, ORG LETT, V4, P3907, DOI 10.1021/ol026760r; Norikane Y, 2008, CHEM COMMUN, P1898, DOI 10.1039/b718813g; [Anonymous], 1988, ANGEW CHEM INT ED EN, V27, P1189; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; RAU H, 1982, J AM CHEM SOC, V104, P1616, DOI 10.1021/ja00370a028; Chen SJ, 2013, ACS APPL MATER INTER, V5, P5623, DOI 10.1021/am4009506; Siewertsen R, 2009, J AM CHEM SOC, V131, P15594, DOI 10.1021/ja906547d; Belfrekh N, 2000, INORG CHEM, V39, P5169, DOI 10.1021/ic991502k; Reuter R, 2009, EUR J ORG CHEM, P5647, DOI 10.1002/ejoc.200900861; Newkome GR, 2006, SCIENCE, V312, P1782, DOI 10.1126/science.1125894; Umeki S, 2010, CHEM LETT, V39, P204, DOI 10.1246/cl.2010.204; [Anonymous], 2008, SPARTAN 08; Bandara HMD, 2010, J ORG CHEM, V75, P4817, DOI 10.1021/jo100866m; RAU H, 1984, J PHOTOCHEM, V26, P221, DOI 10.1016/0047-2670(84)80041-6; Wu Y, 2012, CHEM COMMUN, V48, P528, DOI 10.1039/c1cc15824d; de Silva AP, 2007, NAT NANOTECHNOL, V2, P399, DOI 10.1038/nnano.2007.188; Yutaka T, 2003, INORG CHEM, V42, P6306, DOI 10.1021/ic0260466; Nagamani SA, 2005, J ORG CHEM, V70, P9304, DOI 10.1021/jo0513616; NISHIMURA N, 1976, B CHEM SOC JPN, V49, P1381, DOI 10.1246/bcsj.49.1381; Bleger D, 2012, J AM CHEM SOC, V134, P20597, DOI 10.1021/ja310323y; Marchi E, 2012, J AM CHEM SOC, V134, P15277, DOI 10.1021/ja307522f; [Anonymous], 1990, ANGEW CHEM INT ED EN, V29, P105; Venkataramani S, 2011, SCIENCE, V331, P445, DOI 10.1126/science.1201180; Li XC, 2008, ORG LETT, V10, P3639, DOI 10.1021/ol8013655; Cardenas DJ, 1997, J AM CHEM SOC, V119, P2656, DOI 10.1021/ja963955j; Constable EC, 1997, CHEM COMMUN, P827, DOI 10.1039/a701366c; Dobrawa R, 2005, MACROMOLECULES, V38, P1315, DOI 10.1021/ma047737j; Feringa B. L., 2001, MOLECULAR SWITCHES; Frisch M. J., 2009, GAUSSIAN 09 REVISION; HOGG R, 1962, J CHEM SOC, P341, DOI 10.1039/jr9620000341; Kume S, 2001, CHEM COMMUN, P1656, DOI 10.1039/b104381c; Losensky H.-W., 1988, ANGEW CHEM, V100, P1225, DOI 10.1002/ange.19881000924; Priimov GU, 2000, J CHEM SOC DALTON, P445, DOI 10.1039/a907543g; Reuter R, 2011, CHEM COMMUN, V47, P12267, DOI 10.1039/c1cc13773e; Romero FM, 1996, CHEM COMMUN, P551, DOI 10.1039/cc9960000551; Ruslim C, 1999, J MATER CHEM, V9, P673, DOI 10.1039/a808083f; Takeshita M, 1998, TETRAHEDRON LETT, V39, P7717, DOI 10.1016/S0040-4039(98)01681-5; Tamaoki N., 1990, ANGEW CHEM, V102, P66, DOI 10.1002/ange.19901020111; Tang HS, 2007, ORGANOMETALLICS, V26, P22, DOI 10.1021/om0609719; Vogtle F., 1989, SUPRAMOLECULAR CHEMI; Wei WH, 2000, J ORG CHEM, V65, P8979, DOI 10.1021/jo000926p; Yamamura M, 2012, CHEM COMMUN, V48, P5724, DOI 10.1039/c2cc18014f; Yoshino J, 2007, CHEM COMMUN, P559, DOI 10.1039/b615966d	43	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16258	16265		10.1002/chem.201404620		8	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700030		
J	Yoshii, Y; Hoshino, N; Takeda, T; Moritomo, H; Kawamata, J; Nakamura, T; Akutagawa, T				Yoshii, Yuya; Hoshino, Norihisa; Takeda, Takashi; Moritomo, Hiroki; Kawamata, Jun; Nakamura, Takayoshi; Akutagawa, Tomoyuki			The Formation of Organogels and Helical Nanofibers from Simple Organic Salts	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						gels; helical structures; hydrogen bonds; nanofibers; self assembly	THERMALLY-REVERSIBLE ORGANOGELS; MOLECULAR-MASS ORGANOGELATORS; SUPRAMOLECULAR GELS; MICELLAR FIBERS; GELATORS; GELATION; WATER; UREA; LIQUIDS; ACID	Simple organic salts based on aniline-derived cations and D-tartrate anions formed organogels and helical nanofibers. The organic salt (p-fluoroanilinium)(D-tartrate) was found to generate an organogel despite the absence of a hydrophobic alkyl chain, whereas (p-iodoanilinium)(D-tartrate) formed helical nanofibers in braided ropelike structures through a rolling-up process. The helicity of these nanofibers could be reversed by changing the growth solvent. The driving forces responsible for the formation of the nanofibers were determined to be 1D OHO- hydrogen-bonding interactions between D-tartrate anions and stacking of anilinium cations, as well as steric hindrance between the hydrogen-bonded chains.	[Yoshii, Yuya; Hoshino, Norihisa; Takeda, Takashi; Akutagawa, Tomoyuki] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808577, Japan; [Hoshino, Norihisa; Takeda, Takashi; Akutagawa, Tomoyuki] Tohoku Univ, IMRAM, Sendai, Miyagi 9808577, Japan; [Moritomo, Hiroki; Kawamata, Jun] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Nakamura, Takayoshi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 060, Japan	Akutagawa, T (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808577, Japan.	akuta@tagen.tohoku.ac.jp	Nakamura, Takayoshi/A-5251-2012; Hoshino, Norihisa/B-2168-2015	Hoshino, Norihisa/0000-0002-9841-6375	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Management Expenses Grants for National Universities of Japan	This work was supported by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Management Expenses Grants for National Universities of Japan.	Abdallah DJ, 2000, CHEM MATER, V12, P406, DOI 10.1021/cm990437+; Akutagawa T., 2005, ANGEW CHEM, V117, P7449, DOI 10.1002/ange.200502336; George M, 2005, CHEM-EUR J, V11, P3243, DOI 10.1002/chem.200401066; Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926; Grassi S, 2011, NEW J CHEM, V35, P445, DOI 10.1039/c0nj00673d; Binnemans K, 2005, CHEM REV, V105, P4148, DOI 10.1021/cr0400919; Mukhopadhyay S, 2004, J AM CHEM SOC, V126, P15905, DOI 10.1021/ja046788t; TERECH P, 1994, LANGMUIR, V10, P3406, DOI 10.1021/la00022a009; KONING J, 1993, J AM CHEM SOC, V115, P693; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Kapoor I, 2012, SOFT MATTER, V8, P3446, DOI 10.1039/c2sm07183e; Estroff LA, 2000, ANGEW CHEM INT EDIT, V39, P3447, DOI 10.1002/1521-3773(20001002)39:19<3447::AID-ANIE3447>3.0.CO;2-X; Dastidar P, 2008, CHEM SOC REV, V37, P2699, DOI 10.1039/b807346e; Meazza L, 2013, NAT CHEM, V5, P42, DOI [10.1038/nchem.1496, 10.1038/NCHEM.1496]; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Oda R, 1998, ANGEW CHEM INT EDIT, V37, P2689, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2689::AID-ANIE2689>3.0.CO;2-Z; Hanabusa K, 1996, ANGEW CHEM INT EDIT, V35, P1949, DOI 10.1002/anie.199619491; George M, 2003, J AM CHEM SOC, V125, P10275, DOI 10.1021/ja0362407; Pringle JM, 2010, J MATER CHEM, V20, P2056, DOI 10.1039/b920406g; Akutagawa T, 2005, ANGEW CHEM INT EDIT, V44, P7283, DOI 10.1002/anie.200502336; Coates IA, 2009, CHEM-EUR J, V15, P6340, DOI 10.1002/chem.200900858; Schon EM, 2014, CHEM-EUR J, V20, P10720, DOI 10.1002/chem.201402436; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Zang L, 2008, ACCOUNTS CHEM RES, V41, P1596, DOI 10.1021/ar800030w; FUHRHOP JH, 1987, J AM CHEM SOC, V109, P3387, DOI 10.1021/ja00245a032; ELDRIDGE JE, 1954, J PHYS CHEM-US, V58, P992, DOI 10.1021/j150521a013; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; FUHRHOP JH, 1990, J AM CHEM SOC, V112, P2827, DOI 10.1021/ja00163a069; Edwards W, 2014, J AM CHEM SOC, V136, P1116, DOI 10.1021/ja411724r; NAKASHIMA N, 1985, J AM CHEM SOC, V107, P509, DOI 10.1021/ja00288a043; Ayabe M, 2003, ORG BIOMOL CHEM, V1, P2744, DOI 10.1039/b304224c; Ballabh A, 2003, CHEM MATER, V15, P2136, DOI 10.1021/cm021792u; Estroff L. A., 2000, ANGEW CHEM, V112, P3589, DOI 10.1002/1521-3757(20001002)112:19<3589::AID-ANGE3589>3.0.CO;2-P; Freemantle M, 2010, INTRODUCTION TO IONIC LIQUIDS, P1; Fuhrhop J. H., 1994, MEMBRANES MOL ASSEMB; Hanabusa K., 1996, ANGEW CHEM, V108, P2086, DOI 10.1002/ange.19961081719; Jeffrey G. A., 1997, INTRO HYDROGEN BONDI; Lu LD, 1996, CHEM COMMUN, P2029, DOI 10.1039/cc9960002029; Mercurio DJ, 2001, J PHYS CHEM B, V105, P2091, DOI 10.1021/jp002247o; Oda R, 1998, ANGEW CHEM, V110, P2835, DOI 10.1002/(SICI)1521-3757(19981002)110:19<2835::AID-ANGE2835>3.0.CO;2-R; PORTE G, 1980, J PHYS CHEM-US, V84, P3105, DOI 10.1021/j100460a027; Quyang Q, 1991, NATURE, V352, P610; Smart L. E., 2005, SOLID STATE CHEM, V3rd; Trivedi DR, 2006, CRYST GROWTH DES, V6, P763, DOI 10.1021/eg050590i; Waguespack YY, 2000, LANGMUIR, V16, P3036, DOI 10.1021/la990797b; Wang GJ, 2003, CHEM COMMUN, P310, DOI 10.1039/b205733f; Weiss R. G., 2006, MOL GELS	48	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16279	16285		10.1002/chem.201404043		7	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700033		
J	Akamatsu, M; Mori, T; Okamoto, K; Sakai, H; Abe, M; Hill, JP; Ariga, K				Akamatsu, Masaaki; Mori, Taizo; Okamoto, Ken; Sakai, Hideki; Abe, Masahiko; Hill, Jonathan P.; Ariga, Katsuhiko			Multicolour Fluorescent Memory Based on the Interaction of Hydroxy Terphenyls with Fluoride Anions	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						fluorescence; molecular memory; fluorides; phenols; volatiles	RESONANCE DELOCALIZATION; POLYPYRIDYL COMPLEXES; LIGHT; DERIVATIVES; INHIBITION; MOIETIES; VOLATILE; SENSORS; DESIGN; SYSTEM	Memory operations based on variation of a molecule's properties are important because they may lead to device miniaturization to the molecular scale or increasingly complex information processing protocols beyond the binary level. Molecular memory also introduces possibilities related to information-storage security where chemical information (or reagents) might be used as an encryption key, in this case, acidic/basic reagents. Chemical memory that possesses both volatile and non-volatile functionality requires reversible conversion between at least two chemically different stable or quasi-stable states. Here we have developed the phenol-phenoxide equilibrium of phenol fluorophores as a data storage element, which can be used to write or modulate data using chemical reagents. The properties of this system allow data to be stored and erased either in non-volatile or volatile modes. We also demonstrate non-binary switching of states made possible by preparation of a composite containing the molecular memory elements.	[Akamatsu, Masaaki; Sakai, Hideki; Abe, Masahiko] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2780022, Japan; [Akamatsu, Masaaki; Mori, Taizo; Okamoto, Ken; Hill, Jonathan P.; Ariga, Katsuhiko] Natl Inst Mat Sci, WPI Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Mori, Taizo; Hill, Jonathan P.; Ariga, Katsuhiko] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Hill, JP (reprint author), Natl Inst Mat Sci, WPI Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Jonathan.HILL@nims.go.jp; ARIGA.Katsuhiko@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011		World Premier International Research Center Initiative on Materials Nanoarchitechtonics from MEXT, Japan; Core Research for Evolutional Science and Technology (CREST) program of JST, Japan	This research was partly supported by the World Premier International Research Center Initiative on Materials Nanoarchitechtonics from MEXT, Japan, and the Core Research for Evolutional Science and Technology (CREST) program of JST, Japan.	Agbaria RA, 1996, J PHYS CHEM-US, V100, P17133, DOI 10.1021/jp9617884; Raymo FM, 2003, J AM CHEM SOC, V125, P2361, DOI 10.1021/ja027977j; Nakaya M, 2010, ADV MATER, V22, P1622, DOI 10.1002/adma.200902960; Pariani G, 2011, J MATER CHEM, V21, P13223, DOI 10.1039/c1jm11870f; de Ruiter G, 2010, ANGEW CHEM INT EDIT, V49, P169, DOI 10.1002/anie.200905358; Naumov P, 2010, J AM CHEM SOC, V132, P11566, DOI 10.1021/ja102885g; Pina F, 1998, CHEM-EUR J, V4, P1184, DOI 10.1002/(SICI)1521-3765(19980710)4:7<1184::AID-CHEM1184>3.0.CO;2-6; de Ruiter G, 2010, ANGEW CHEM INT EDIT, V49, P4780, DOI 10.1002/anie.201000785; Donhauser ZJ, 2001, SCIENCE, V292, P2303, DOI 10.1126/science.1060294; Wu Y, 2014, ANGEW CHEM INT EDIT, V53, P2090, DOI 10.1002/anie.201309915; Irie M, 2002, NATURE, V420, P759, DOI 10.1038/420759a; Saishoji A, 2007, LANGMUIR, V23, P320, DOI 10.1021/la061506j; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Gareis T, 1997, CHEM COMMUN, P1717, DOI 10.1039/a703536e; Liu YW, 2012, CHEM MATER, V24, P1212, DOI 10.1021/cm3003172; Guo ZQ, 2007, ANGEW CHEM INT EDIT, V46, P5549, DOI 10.1002/anie.200700526; Jose DA, 2007, INORG CHEM, V46, P5576, DOI 10.1021/ic070165+; Lu W, 2011, SENSOR ACTUAT B-CHEM, V160, P1005, DOI 10.1016/j.snb.2011.09.018; CLARK JH, 1984, J CHEM SOC CHEM COMM, P1014, DOI 10.1039/c39840001014; CLARK JH, 1986, SPECTROCHIM ACTA A, V42, P815, DOI 10.1016/0584-8539(86)80110-6; Damaceanu MD, 2013, DYES PIGMENTS, V99, P228, DOI 10.1016/j.dyepig.2013.04.035; de Ruiter G., 2010, ANGEW CHEM, V122, P173; de Ruiter G, 2010, ACS APPL MATER INTER, V2, P3578, DOI 10.1021/am1007497; Fan Y, 2007, DALTON T, P3885, DOI 10.1039/b707797a; Guo Z, 2007, ANGEW CHEM, V119, P5645, DOI 10.1002/ange.200700526; Huang J. Z., 2012, EUR PHYS J D, V66, P1; Kim T.W., 2012, NPG ASIA MATER, V4, P1; Kumar M, 2011, RSC ADV, V1, P1045, DOI 10.1039/c1ra00313e; Lavin JM, 2007, CHEM COMMUN, P228, DOI 10.1039/b614853k; Lee SJ, 2011, ETRI J, V33, P611, DOI 10.4218/etrij.11.0110.0392; Mori T., 2013, SCI TECHNOL ADV MAT, V14; Motiei L., 2010, ANGEW CHEM, V122, P4890; Nagatsu N, 1996, IEEE J SEL AREA COMM, V14, P893, DOI 10.1109/49.510912; Pina F, 1997, J AM CHEM SOC, V119, P5556, DOI 10.1021/ja9704646; Pischel U, 2010, NEW J CHEM, V34, P2701, DOI 10.1039/c0nj00498g; Shundo A, 2009, CHEM-EUR J, V15, P2486, DOI 10.1002/chem.200802469; Sindelar V, 2006, CHEM COMMUN, P2185, DOI 10.1039/b601959e; Uchida K, 2003, ADV MATER, V15, P121, DOI 10.1002/adma.200390023; Wu Y., 2014, ANGEW CHEM, V126, P2122; Yamaguchi I, 2009, TETRAHEDRON, V65, P3645, DOI 10.1016/j.tet.2009.02.073	40	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16293	16300		10.1002/chem.201404089		8	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700035		
J	Wieteck, M; Tokimizu, Y; Rudolph, M; Rominger, F; Ohno, H; Fujii, N; Hashmi, ASK				Wieteck, Marcel; Tokimizu, Yusuke; Rudolph, Matthias; Rominger, Frank; Ohno, Hiroaki; Fujii, Nobutaka; Hashmi, A. Stephen K.			Dual Gold Catalysis: Synthesis of Polycyclic Compounds via C-H Insertion of Gold Vinylidenes	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						alkynes; CH insertion; gold; vinylidene ligands; polycycles	HOMOGENEOUS CATALYSIS; ALKYNES; CYCLIZATIONS; ACTIVATION; 3-SILYLOXY-1,5-ENYNES; HYDROARYLATION; PRECATALYSTS; HETEROCYCLES; CARBOCYCLES; DERIVATIVES	New and interesting polycyclic compounds have been synthesized from non-conjugated diyne systems by dual gold catalysis. A quaternary carbon center in the backbone and the accompanying Thorpe-Ingold effect enabled the unprecedented insertion of sp(3) and sp(2) CH bonds that for the first time were incorporated within the backbone of the diyne system and allowed the construction of complex polycyclic carbon scaffolds inaccessible by previous approaches in which the CH bonds for the insertion were situated at the other end of the alkyne.	[Wieteck, Marcel; Rudolph, Matthias; Rominger, Frank; Hashmi, A. Stephen K.] Heidelberg Univ, Organ Chem Inst, D-69120 Heidelberg, Germany; [Tokimizu, Yusuke; Ohno, Hiroaki; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Hashmi, A. Stephen K.] King Abdulaziz Univ, Dept Chem, Fac Sci, Jeddah 21589, Saudi Arabia	Ohno, H (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	hohno@pharm.kyoto-u.ac.jp; nfujii@pharm.kyoto-u.ac.jp; hashmi@hashmi.de	Hashmi, A./B-5188-2013		Japan Society for the Promotion of Science (JSPS)	The authors thank Umicore AG & Co. KG for the generous donation of gold salts. Y.T. is grateful to the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation as well as Research Fellowships for Young Scientists from the Japan Society for the Promotion of Science (JSPS).	Braun I, 2013, ACS CATAL, V3, P1902, DOI 10.1021/cs400437s; [Anonymous], 2005, ANGEW CHEM, V117, P7150; Shen HC, 2008, TETRAHEDRON, V64, P3885, DOI 10.1016/j.tet.2008.01.081; Gomez-Suarez A, 2012, ANGEW CHEM INT EDIT, V51, P8156, DOI 10.1002/anie.201203587; Hoffmann-Roder A, 2005, ORG BIOMOL CHEM, V3, P387, DOI 10.1039/b416516k; Li ZG, 2008, CHEM REV, V108, P3239, DOI 10.1021/cr068434l; [Anonymous], 2000, ANGEW CHEM, V112, P4407; [Anonymous], 2012, ANGEW CHEM, V124, P4532; Arcadi A, 2008, CHEM REV, V108, P3266, DOI 10.1021/cr068435d; [Anonymous], 2013, ANGEW CHEM, V125, P7949; Hashmi ASK, 2012, ANGEW CHEM INT EDIT, V51, P4456, DOI 10.1002/anie.201109183; Hashmi ASK, 2004, GOLD BULL, V37, P51; [Anonymous], 2012, ANGEW CHEM, V124, P8278; Hashmi ASK, 2008, CHEM SOC REV, V37, P1766, DOI 10.1039/b615629k; Vachhani DD, 2013, CHEM COMMUN, V49, P7171, DOI 10.1039/c3cc43418d; [Anonymous], 2012, ANGEW CHEM, V124, P6026; Hashmi ASK, 2007, CHEM REV, V107, P3180, DOI 10.1021/cr000436x; Hashmi ASK, 2000, ANGEW CHEM INT EDIT, V39, P2285, DOI 10.1002/1521-3773(20000703)39:13<2285::AID-ANIE2285>3.0.CO;2-F; Asao N, 2002, J AM CHEM SOC, V124, P12650, DOI 10.1021/ja028128z; Shen HC, 2008, TETRAHEDRON, V64, P7847, DOI 10.1016/j.tet.2008.05.082; [Anonymous], 2012, ANGEW CHEM, V124, P10785; Hashmi ASK, 2013, CHEM-EUR J, V19, P1058, DOI 10.1002/chem.201203010; Heckler JE, 2012, ANGEW CHEM INT EDIT, V51, P5924, DOI 10.1002/anie.201201744; Nosel P, 2013, J AM CHEM SOC, V135, P15662, DOI 10.1021/ja4085385; Furstner A, 2007, ANGEW CHEM INT EDIT, V46, P3410, DOI 10.1002/anie.200604335; Pflasterer D, 2014, CHEM-EUR J, V20, P6752, DOI 10.1002/chem.201402015; [Anonymous], 2000, ANGEW CHEM, V112, P2382; Schmidbaur H, 2012, CHEM SOC REV, V41, P370, DOI 10.1039/c1cs15182g; Vilhelmsen MH, 2014, CHEM-EUR J, V20, P1901, DOI 10.1002/chem.201303636; [Anonymous], 2006, ANGEW CHEM, V118, P8064; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; [Anonymous], 2012, ANGEW CHEM, V124, P8503; Ye LW, 2012, J AM CHEM SOC, V134, P31, DOI 10.1021/ja2091992; Lauterbach T, 2014, ADV SYNTH CATAL, V356, P680, DOI 10.1002/adsc.201400104; Dankwardt JW, 2001, TETRAHEDRON LETT, V42, P5809, DOI 10.1016/S0040-4039(01)01146-7; Hashmi ASK, 2012, ORGANOMETALLICS, V31, P644, DOI 10.1021/om200946m; [Anonymous], 2013, ANGEW CHEM, V125, P972; Rudolph M, 2012, CHEM SOC REV, V41, P2448, DOI 10.1039/c1cs15279c; Hashmi ASK, 2000, J AM CHEM SOC, V122, P11553, DOI 10.1021/ja005570d; Wang YL, 2013, ANGEW CHEM INT EDIT, V52, P7795, DOI 10.1002/anie.201301057; [Anonymous], 2009, ANGEW CHEM, V121, P5843; [Anonymous], 2003, ANGEW CHEM, V115, P4536; Hashmi ASK, 2012, ADV SYNTH CATAL, V354, P555, DOI 10.1002/adsc.201200086; [Anonymous], 2010, ANGEW CHEM, V122; Gorin DJ, 2007, NATURE, V446, P395, DOI 10.1038/nature05592; Corma A, 2011, CHEM REV, V111, P1657, DOI 10.1021/cr100414u; Chen KH, 2010, ORGANOMETALLICS, V29, P6829, DOI 10.1021/om101017p; [Anonymous], 2013, ANGEW CHEM, V125, P2653; Roithova J, 2012, ANGEW CHEM INT EDIT, V51, P8378, DOI 10.1002/anie.201204003; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; Dyker G, 2003, ANGEW CHEM INT EDIT, V42, P4399, DOI 10.1002/anie.200352160; Gomez-Suarez A, 2013, ANGEW CHEM INT EDIT, V52, P938, DOI 10.1002/anie.201208234; [Anonymous], 2011, ANGEW CHEM, V123, P5882; [Anonymous], 2007, ANGEW CHEM, V119, P3478; Hashmi ASK, 2012, CHEM-EUR J, V18, P6576, DOI 10.1002/chem.201200314; Dyker G, 2000, ANGEW CHEM INT EDIT, V39, P4237, DOI 10.1002/1521-3773(20001201)39:23<4237::AID-ANIE4237>3.0.CO;2-A; Hansmann MM, 2013, ANGEW CHEM INT EDIT, V52, P2593, DOI 10.1002/anie.201208777; Hashmi ASK, 2003, GOLD BULL, V36, P3; Hashmi ASK, 2010, ANGEW CHEM INT EDIT, V49, P5232, DOI 10.1002/anie.200907078; Hashmi ASK, 2012, ANGEW CHEM INT EDIT, V51, P10633, DOI 10.1002/anie.201204015; Hashmi ASK, 2011, ANGEW CHEM INT EDIT, V50, P5761, DOI 10.1002/anie.201100989; Hashmi ASK, 2014, ACCOUNTS CHEM RES, V47, P864, DOI 10.1021/ar500015k; Hashmi ASK, 2005, ANGEW CHEM INT EDIT, V44, P6990, DOI 10.1002/anie.200502735; Hashmi ASK, 2008, ADV SYNTH CATAL, V350, P2059, DOI 10.1002/adsc.200800385; Jimenez-Nunez E, 2007, CHEM COMMUN, P333, DOI 10.1039/b612008c; Weber D, 2009, ANGEW CHEM INT EDIT, V48, P5733, DOI 10.1002/anie.200902049	66	16	16	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-6539	1521-3765		CHEM-EUR J	Chem.-Eur. J.	DEC 1	2014	20	49					16331	16336		10.1002/chem.201404987		6	Chemistry, Multidisciplinary	Chemistry	AU3LW	WOS:000345515700040		
